–k—˘‘ĺŠwˆăŠw•”E‘ĺŠw•a‰@Œ¤‹†‹ĆŃW 1994 •˝Ź‚T”N“x –k—˘‘ĺŠwˆăŠw•”E‘ĺŠw•a‰@Œ¤‹†‹ĆŃW
i’Fo”Ĺ•¨‚ĹŒäŠm”F‰ş‚ł‚˘j
<<01 ‰đ–UŠw>>

1. mŒ´’˜n Fibulo-tibial weight index - A new criterion for sex identification based on the lower leg bones. ÷–؍W•FC’r“c•qŽqCŽ›“ct…i‰đj. Acta Anat., 147: 193`196, 1993.

2. mŒ´’˜n Electron microscopic study on the development of the chicken ultimobranchial glands, with special reference to innervation of C cells. ‹T“c•‡Žqi‰đj. Anat. Embryol., 188(6): 561`570, 1993.

3. mŒ´’˜n Immunohistochemical study on the rat heart conduction system using anti-Leu-7 antibody. ÂŽR’ź‘PC–ؐě“c—˛ˆęi“ŕjCŽR‰Čł•˝i‰đj: Arch. Histol. Cytol., 56(3): 303`315, 1993.

4. mŒ´’˜n Immunohistochemical localization of a neuron-specific ƒŔ-tubulin isotype in the developing chicken ultimobranchial glands. ‹T“c•‡Žqi‰đjC‹T’J“Oi•a—jCAnthony FrankfurteriUniv. Virginiaj. Brain Res., 628(1`2): 121`127, 1993.

5. mŒ´’˜n Staining of pancreatic centroacinar cells, liver bile canaliculi and testicular Leydig cells with a monoclonal antibody against adrenocortical cells. ‹T“c•‡ŽqCL“cç•äC‘şăŒöŽi‰đjC‹{“ŕ—ş•ăi•Ÿ‰Ş‘ĺj. Cell Tissue Res., 272(3): 407`416, 1993.

6. mŒ´’˜n Developmental changes in intestinal globule liukocytes of normal rats. ’r“c‚â‚悢CŽR‰Čł•˝i‰đj: Cell Tissue Res., 273: 447`455, 1993.

7. mŒ´’˜n Immuno-electron-microscopic localization of enkephalin in the secretory granules of C cells in the chicken ultimobranchial glands. ‹T“c•‡ŽqCL“cç•äC‘şăŒöŽi‰đj. Cell Tissue Res., 274(2): 257`265, 1993.

8. mŒ´’˜n Distribution of ƒż-6 integrin subunit in developing mouse submandibular gland. –ĺ’J—TˆęCŽR‰Čł•˝i‰đj: J. Hisochem. Cytochem., 41(11): 1707`1714, 1993.

9. mŒ´’˜n ‰ˇ”M•‰‰×‚É‚ć‚č—U”­‚ł‚ę‚˝ƒ‰ƒbƒgŠďŒ`S‚̐S‘Ÿ‚¨‚ć‚Ń‘ĺŒŒŠÇ‚ĚˆŮí. ÂŽR’ź‘Pi“ŕjCŽR‰Čł•˝i‰đj: ‰đ–UŠwŽGŽ, 69(1): 33`40, 1994.

10. m€Œ´’˜n ‘Á‰t‘B‚Ě”S‰t•Ş”ĺ×–E. ŽR‰Čł•˝C‹Ę–؉p–ži‰đjCÂŽR’ź‘Pi“ŕjCŸ–”CiŒ`‘ÔŒnj: ×–E, 25(6): 200`204, 1993.

11. m€Œ´’˜n ś‚Ť‚˝×–E‚Ě tight junctional permealulity ‚̉đÍ: ‹¤Ĺ“_ƒŒ[ƒU[Œ°”÷‹ž‚É‚ć‚éV‚ľ‚˘ƒAƒvƒ[ƒ`. Łě˛‹vi‰đj: ‘gD”|—{, 19(8): 287`290, 1993.


<<01 2 ‰đ–UŠw>>

12. muŔn ƒRƒ“ƒsƒ…[ƒ^[ƒOƒ‰ƒtƒBƒbƒNƒX‚É‚ć‚é—§‘̍č\’z–@| Cosmozone 2SA Žg—p‚ĚŽŔŰ|. ‹Ę–؉p–ži‰đjCÂŽR’ź‘Pi“ŕjCŸ–”CiŒ`‘ÔŒnjCŽR‰Čł•˝i‰đj: ×–E, 25(12): 481`484, 1993.

13. muŔn ×–E‚Ş‘Á‰t‚𕪔傡‚éuŠÔ|‹¤Ĺ“_ƒŒ[ƒU[Œ°”÷‹ž‚Ş‘¨‚Ś‚˝V‚ľ‚˘˘ŠE|. Łě˛‹vi‰đj: “ú–{Ž•‰Č•]˜_, (612): 5`7, 1993.


<<01 3 ‰đ–UŠw>>

14. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn i•Ş’SŽˇ•Mj Œű‚͉˝‚Ě‚˝‚ß‚É‚ ‚é‚Š; Œű‚Ě”­ś‚ƍ\‘˘, p.31`84, Łě˛‹vi‰đj. •ŇW ŽR“c@–riŠÖ“ŒŠw‰@‘ĺjC •—lŽĐ, “Œ‹ž, 93.02.25”­s.


<<01 5 ‰đ–UŠw>>

15. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Salivary secretion directly visualized by confocal laser microscopy. Łě˛‹vi‰đj: Saliary Glands & Saliva i93.09.16j, ƒCƒMƒŠƒX, Abstracts, p.24, 1993.

16. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Development of the rat conduciton system as determined by Leu-7 immunohistochemistry and scanning electron microscopy. ÂŽR’ź‘PC–ؐě“c—˛ˆęi“ŕjCŽR‰Čł•˝i‰đj: 4th International Symposium on Etiology and Morphogenesis of Congenital Heart Disease i93.11.25j, “Œ‹ž, Abstract, p.112`113, 1993.

17. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Exocytosis-endocytosis coupling: plasma membrane events directly visualized by confocal microscopy. Łě˛‹vi‰đj: ‘ć33‰ńƒAƒƒŠƒJ×–Eś•¨Šw‰ď i93.12.15j, ƒjƒ…[ƒIƒŠƒ“ƒY, Molicular Biology of the Cell, 4(suppl.): 351a, 1993.

18. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Identification of two distinct exocytosis-endocytosis coupling mechanisms in salivary secretion: possible regulation by microfilaments and calcium. Łě˛‹vi‰đj: Intracellular Channels, Organelles and All Function i93.04.23j, ƒCƒ^ƒŠƒA, Abstracts, p.76, 1993.

19. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Protein sorting in exocrine secretory cells: crosstalk between constitutive and regulated pathways?. Łě˛‹vCŽR‰Čł•˝i‰đjC˛Œ´‹IsC—é–Ř˜a•viź–{Ž•‘ĺj: “ŕ“ĄƒRƒ“ƒtƒ@ƒŒƒ“ƒX uProtein Translocation in the Cell [‡V]v i93.11.04j, ”ö’Łˆę‹{, —\eW, p.113, 1993.

20. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‹¤Ĺ“_ƒŒ[ƒU[Œ°”÷‹ž‚É‚ć‚鐜‚Ť‚˝×–E‚Ě’č—ĘĽŽOŽŸŒłŽžŒn—ń“IŠĎŽ@–@. Łě˛‹vi‰đj: ƒRƒ“ƒtƒH[ƒJƒ‹488ƒTƒ}[ƒVƒ“ƒ|ƒWƒEƒ€ i93.08.09j, ‘O‹´, —\eW, p.11, 1993.

21. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Exocytosis-endocytosis coupling directly visualized by confocal microscopy. Łě˛‹vi‰đj: ‘ć34‰ń“ú–{‘gD×–E‰ťŠw‰ď‘‰ď i93.10.29j, _ŒË, Acta Histochem. Cytochem., 26(5); 463`464, 1993, —\eW, p.28, 1993.

22. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Para-and transcellular pathways in salivary secretion studied by confocal microscopy. Łě˛‹vi‰đj: ‘ć71‰ń“ú–{ś—Šw‰ď‘ĺ‰ďƒVƒ“ƒ|ƒWƒEƒ€ i94.03.24j, ‚ź.

23. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ¸‘c×–E‚ĚŽOŽŸŒł“IŠĎŽ@. ’†–{’źi‰đj: “ú–{”­śś•¨Šw‰ď i93.05.26j, •Ÿ‰Ş, —vŽ|W, p.122, 1993.

24. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ž÷Ž‰•ď–„ŒăőF‚É‚ć‚é“dŒ°×–E‰ťŠw‚ĚŒŸ“˘|ŒăŒĹ’č‚ĆŽ÷Ž‰‚Ě‘I‘đ‚É‚ć‚é‘œ‚̉ü‘P|. ‹Ę–؉p–ži‰đjCŸ–”CiŒ`‘ÔŒnjCŽR‰Čł•˝i‰đj: ‘ć49‰ń“ú–{“dŽqŒ°”÷‹žŠw‰ďŠwpu‰‰‰ď i93.05.27j, _ŒË, J. Electron Microsc., 42(4): 250, 1993, —\eW, p.65, 1993.

25. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒŔ-tubulin isotype ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ě‚Ć“dŒ°‚É‚ć‚éƒjƒƒgƒŠŒz“Ž–ŹŹ‘Ě‚ĚŒÂ‘Ě”­ś. ‹T“c•‡Žqi‰đj: ‘ć98‰ń“ú–{‰đ–UŠw‰ď‘‰ď i93.07.22j, ŽD–y, ‰đ–UŠwŽGŽ, 68(6): 660, 1993

26. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒjƒƒgƒŠă”珬‘̂̐_ŒoŽx”z‚ɂ‚˘‚Ä. L“cç•äC‹T“c•‡Žqi‰đj: ‘ć98‰ń“ú–{‰đ–UŠw‰ď‘‰ď i93.07.22j, ŽD–y, ‰đ–UŠwŽGŽ, 68(6): 661, 1993

27. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠďŒ`S‚É‚¨‚Ż‚é’†Šu‹y‚ѐS“ŕ–Œ°‚ĚŒ`ŹˆŮí‚ĆŽhŒƒ“`“ąŒn‚Ě”­’B. ÂŽR’ź‘Pi“ŕjCŽR‰Čł•˝i‰đj: ‘ć98‰ń“ú–{‰đ–UŠw‰ď‘‰ď i93.07.22j, ŽD–y, ‰đ–UŠwŽGŽ, 68(6): 668, 1993.

28. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒSƒ‹ƒW‘•’u‚ĚŒ`‘ÔŒ`Ź‰ß’ö‚É‚¨‚Ż‚éƒSƒ‹ƒW’`”’‚Ě“Ž‘Ô. ‹Ę–؉p–žCŽR‰Čł•˝i‰đj: ‘ć98‰ń“ú–{‰đ–UŠw‰ď‘‰ď i93.07.24j, ŽD–y, ‰đ–UŠwŽGŽ, 68(6): 756, 1993, —\eW, p.154, 1993.

29. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ¸ŽqŒ`Ź‰ß’ö‚ɉ—‚Ż‚éŽxŽ×–E‚Ě Actin üˆŰ‚̕ωť. ŽđˆäNOCŽR‰Čł•˝i‰đj: ‘ć98‰ń“ú–{‰đ–UŠw‰ď‘‰ď i93.07.24j, ŽD–y, ‰đ–UŠwŽGŽ, 68(6): 760, 1993.

30. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘Á‰t•Ş”ĺ‚É‚Í‚˝‚ˇ‹Řă”ç×–E‚Ě–đŠ„: Žűk‚É‚ć‚鉟‚ľo‚ľŕ‚͐ł‚ľ‚˘‚ŠH. Łě˛‹vi‰đjCŻˆä‚Ě‚čŽqiŠwśjCŽR‰Čł•˝i‰đj: ‘ć98‰ń“ú–{‰đ–UŠw‰ď‘‰ď i93.07.24j, ŽD–y, ‰đ–UŠwŽGŽ, 68(6): 764, 1993, —\eW, p.161, 1993.

31. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j äCœ‘Ě‚Š‚ç“ž‚ç‚ę‚éî•ń. ÷–؍W•FC’r“c•qŽqi‰đj: ‘ć47‰ń“ú–{l—ŢŠw‰ďĽ“ú–{–Ż‘°Šw‰ď˜A‡‘ĺ‰ď i93.10.30j, é‹Ę, —\eW, p.54, 1993

32. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŻˆęŒÂ‘Ě‚Ĺ‚Ě‘ĺ”]”ź‹…‚Ě’ˇ•ŽŚ”‚Ć“ŞŽŚ”‚Ć‚Ě‘ŠŠÖ. ’r“c•qŽqC÷–؍W•Fi‰đj: ‘ć47‰ń“ú–{l—ŢŠw‰ďĽ“ú–{–Ż‘°Šw‰ď˜A‡‘ĺ‰ď i93.10.30j, “Œ‹ž, —\eW, p.57, 1993

33. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒVƒOƒiƒ‹“`’BŒn‚É‚ć‚é‘Á‰t•Ş”ĺ‚Ě’˛ß‹@\: V‚ľ‚˘‰źŕ. Łě˛‹vi‰đj: ‘ć35‰ńŽ•‰ČŠî‘bˆăŠw‰ď‘‰ď i93.11.13j, ’ˇč, Ž•‰ČŠî‘bˆăŠw‰ďŽGŽ, 35(•â): 220, 1993.

34. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŽhŒƒ“`“ąŒn‚Ě”­ś‚ƐS‘Ÿ“ŕ•”\‘˘•¨‚Ć‚ĚŠÖ˜A; łíS‚ĆŠďŒ`S‚Ě”äŠr‚É‚ć‚錟“˘. ÂŽR’ź‘PC–ؐě“c—˛ˆęi“ŕjCŽR‰Čł•˝i‰đj: ‘ć58‰ń“ú–{zŠÂŠíŠw‰ď‘‰ď i94.03.28`30j, “Œ‹ž, Jpn. Circ. J., 58(Suppl.): 179, 1994.

35. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’†S‘Oa‚Ć“Ş’¸ŠÔa‚Ě”]a’ę‚É‚¨‚Ż‚é’f‘ąŤ‚ɂ‚˘‚Ä. ‘şăŒöŽi‰đj: ‘ć98‰ń“ú–{‰đ–UŠw‰ď‘‰ď i93.07.24j, ŽD–y, ‰đ–UŠwŽGŽ, 68(6): 782, 1993

36. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ž¨‰ş‘B‘B–[×–E‚Ě•Ş”ĺ‰ß’ö‚É—^‚Ś‚éƒIƒJƒ_Ž_‚̍ě—p. ŽR‰Čł•˝C‹Ę–؉p–ži‰đjCŸ–”CiŒ`‘ÔŒnj: ‘ć46‰ń“ú–{×–Eś•¨Šw‰ď‘ĺ‰ď i93.10.21j, ‘O‹´, —\eW, p.185, 1993.

37. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j •Ş”ĺ‚Ć×–EœŠii‡UjƒVƒOƒiƒ‹“`’BŒn‚ĆƒAƒNƒ`ƒ“‚Ě‘ŠŒÝě—p. Łě˛‹vCŽR‰Čł•˝i‰đj: ‘ć46‰ń“ú–{×–Eś•¨Šw‰ď‘ĺ‰ď i93.10.21j, ‘O‹´, —\eW, p.186, 1993.

38. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –Ɖu‘gD‰ťŠw‚Ć‘–¸“dŒ°–@‚Ĺ‚Ý‚˝ŽhŒƒ“`“ąŒn‚Ě”­ś. ÂŽR’ź‘Pi“ŕjCŽR‰Čł•˝i‰đj: ‘ć‚R‰ń“ú–{‰đ–UŠw‰ďŠÖ“Œ’n•ű‰ď§˜b‰ď i93.06.05j, ‘Š–ÍŒ´, ‰đ–UŠwŽGŽ, 68(5): 582, 1993.

39. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘Á‰t•Ş”ĺ‚Ě’˛ß‹@\: ×–E“ŕî•ń“`’BŒn‚Ć×–EœŠi‚Ě‘ŠŒÝě—p. Łě˛‹vi‰đj: ‘ć58‰ńŒűo•aŠw‰ďŠwp‘ĺ‰ď i93.11.27j, “Œ‹ž, —\eW, p.18, 1993.

40. mŒ¤‹†‰ďi‘Űjn iƒ[ƒNƒVƒ‡ƒbƒvj Para-and transcellular pathways in salivary secretion studied by confocal microscopy. Łě˛‹vi‰đj: 2nd International Workshop on Salivary Secretion i94.03.22j, ‰Şč.

41. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘Á‰t•Ş”ĺ‚Ć‹Řă”ç×–E. Łě˛‹vi‰đjCŻˆä‚Ě‚čŽqiŠwśjC‹{˜e“ÖŽjCŒäŹŽÄŽ•Fiˆă‰ČŒ¤j: ‘ć7‰ń‘Á‰t‘B’k˜b‰ď i93.10.11j, ’ˇč, —\eW, p.20, 1993.


<<01 7 ‰đ–UŠw>>

42. mŠw‰ďŽĺĂi’n•ű‰ďjn ‘ć3‰ń“ú–{‰đ–UŠw‰ďŠÖ“Œ’n•ű‰ď§˜b‰ďi•˝Ź5”N6ŒŽ5“ú–k—˘‘ĺŠwˆăŠw•”‹łˆç“M-36u‹`Žşj, ŽR‰Čł•˝i‰đj.


<<02 ś—Šw>>

43. mŒ´’˜n A ring-shaped structure with a crown formed by streptolysin O on the eryt hrocyte membrane. ŠÖ’J˜aŽĄi–ňŠw•”jC˛“Ą—ş•˝iś—jC’hŒ´G•śi–ňŠw•”jC“ńdě–Li‰qśŠw•”j: J. Bacteriol., 175(18): 5953`5961, 1993.

44. m’Z•ńĽ‘Ź•ńn Roles of adenylate cyclase on circadian rhythm. ’ˇ’JěŒšŽĄiś—jC“‡–{š˜ai¸jC“c’†ŠÚ–ž”Žiś•¨•¨—ŒnjC’ËŒ´•Ű•vi“Œ–k‘ĺj: Neurosci. Res., 18: 220, 1993.


<<02 2 ś—Šw>>

45. m‘ŕn _ŒoŒn‚É‚¨‚Ż‚é“dˆĘˆË‘śŤCaƒ`ƒƒƒ“ƒlƒ‹‚Ě–đŠ„‚ÉŠÖ‚ˇ‚éÄŒŸ“˘. ‚–Ř”Ži‘‘ĺjC—é–ؐM”Viś—jC‹g‰Ş‹œi‘‘ĺj: ś‘̂̉Ȋw 44: 178`183, 1993.

46. mŠwp‘n i•Ş’SŽˇ•Mj ĹVˆăŠw‚Š‚ç‚ĚƒAƒvƒ[ƒ`, ‘ć7ŠŞuƒCƒIƒ“ƒ`ƒƒƒ“ƒlƒ‹(2)v: ×–E‹@”\‚Ö‚ĚŠÖ—^‚Ć‚ť‚ĚˆŮí; Ť—ˆ‚Ö‚Ě“W–], p.186`195, —é–ؐM”Viś—jC‹g‰Ş‹œi‘‘ĺj. •ŇW “Œ“c—z”Ži‹ŕ‘ň‘ĺjC ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 93.05.00”­s.


<<02 3 ś—Šw>>

47. m‚ť‚Ě‘ź‚Ě’˜‘iŽŤ“Tjn i•Ş’SŽˇ•Mj •¨—ŠwŽŤ“Ti‰ü’ů”Łj; ’EŠ´ě, p.1217, —é–ؐM”Viś—j. •ŇW •¨—ŠwŽŤ“T•ŇWˆĎˆő‰ďC ”|•—ŠŮ, “Œ‹ž, 92.04.10”­s.

48. m‚ť‚Ě‘ź‚Ě’˜‘iŽŤ“Tjn i•Ş’SŽˇ•Mj •¨—ŠwŽŤ“Ti‰ü’ů”Łj; ƒpƒbƒ`ƒNƒ‰ƒ“ƒv, p.1622`1623, —é–ؐM”Viś—j. •ŇW •¨—ŠwŽŤ“T•ŇWˆĎˆő‰ďC ”|•—ŠŮ, “Œ‹ž, 92.04.10”­s.


<<02 5 ś—Šw>>

49. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Circadian behavior in Paramecium and resting changes in membrane potential and cyclic nucleotides. ’ˇ’JěŒšŽĄiś—jC“‡–{š˜ai¸jCůŒ´•Žui”÷jC“c’†ŠÚ–ž”Žiś•¨•¨—ŒnjC’ËŒ´•Ű•vi“Œ–k‘ĺj: ‘ć11‰ń‘Űś•¨•¨—Šw‰ď‘ĺ‰ď i93.07.28j, ƒuƒ_ƒxƒXƒg, Abstract, p.113, 1993.

50. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j A circadian rhythm feedbacks to modulate the clock period in Paramecium population. ’ˇ’JěŒšŽĄiś—jC“c’†ŠÚ–ž”Žiś•¨•¨—ŒnjC“‡–{š˜ai¸jCSasahara, T.CMiwa, I.C’ËŒ´•Ű•vi“Œ–k‘ĺjCSuzuki, H.: ‘ć32‰ń‘Űś—Šw˜A‡‰ď‹c i93.08.01j, ƒOƒ‰ƒXƒS[, Abstracts, p.564, 1993.

51. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Changes of pH values in cremaster muscle microvessels from arterioles to venules through capillaries. ‘ę‘ň’ź’čiś—jCSano, H.iŒc‘ĺjCź“c‘•ciś•¨•¨—ŒnjCŹ—эO—Si“ŕj: ‘ć32‰ń‘Űś—Šw˜A‡‰ď‹c i93.08.02j, ƒOƒ‰ƒXƒS[, Abstracts(Monday), p.49, 1993.

52. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Po2 profile in and around microvessels in rat cremaster muscle. H. SanoCK. TanishitaiŒc‘ĺjC‘ę‘ň’ź’čiś—jCŹ—эO—SC•y“c—FKi“ŕj: ‘ć32‰ń‘Űś—Šw˜A‡‰ď‹c i93.08.02j, ƒOƒ‰ƒXƒS[, Abstracts(Monday), p.49, 1993.

53. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j The blockade of epithelial sodium conducting channels of frog skin by sodium can be detected using current fluctuation analysis without amiloride. •Đ‘q—˛C‘ę‘ň’ź’čiś—j: ‘ć32‰ń‘Űś—Šw˜A‡‰ď‹c i93.08.02j, ƒOƒ‰ƒXƒS[, Abstracts(Monday), p.80, 1993.

54. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Conservation property between parameters for transmission from hair cells to cochlear nucleus neurons. ‘ĺŠŃMiś—j: 32nd Congress of Int. Union of Physiol. Sci. i93.08.03j, Glasgow, Abstract, 169(10): 1993.

55. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Circadian regulation of motility, membrane potential and cAMP formation in Paramecium. ’ˇ’JěŒšŽĄiś—jC“‡–{š˜ai¸jC“c’†ŠÚ–ž”Žiś•¨•¨—ŒnjC’ËŒ´•Ű•vi“Œ–k‘ĺj: Homma Fundation Inter. Sympo. on Biol. Rhythms i93.08.25j, ŽD–y, Abstract, p.53, 1993.

56. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Noise analysis of shert-circuit currents of frog skin in the non-amiloride-inhibited state. •Đ‘q—˛iś—j: “ú–{ś—Šw‰ď i93.04.03j, b•{, Jpn. J. Physiol., 43(Suppl.2): 77, 1993.

57. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ]ƒEƒŠƒ€ƒV‚É‚¨‚Ż‚écAMP(cGMP)‚ĚŠT“ú•Ď‰ť. ’ˇ’JěŒšŽĄiś—jC“‡–{š˜ai¸jCź–{Ÿti“Œ—mˆăŠwU‹ť‰ďjC“c’†ŠÚ–ž”Žiś•¨•¨—ŒnjC’ËŒ´•Ű•vi“Œ–k‘ĺj: ‘ć4‰ń“ú–{”äŠrś—ś‰ťŠwŠw‰ď‘ĺ‰ď i93.07.03j, ĺ‘ä, —\eW, p.53, 1993.

58. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ]ƒEƒŠƒ€ƒVś•¨ŽžŒv‚É‚¨‚Ż‚éŠÂóƒkƒNƒŒƒIƒ`ƒh‚Ě–đŠ„. ’ˇ’JěŒšŽĄiś—jC“‡–{š˜ai¸jC™–{Ÿti“Œ—mˆăŠwU‹ťŕ’cjC“c’†ŠÚ–ž”Žiś•¨•¨—ŒnjC’ËŒ´•Ű•vi“Œ–k‘ĺj: ‘ć31‰ń“ú–{ś•¨•¨—Šw‰ď”N‰ď i93.10.12j, –źŒĂ‰Ž, ś•¨•¨—, p.60, 1993.

59. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Effects of Ca2+/calmodulin inhibitors on the regulation of the density of sodium channel in embryonic chick skeletal muscle cells. ˛“Ą—ş•˝iś—jC’†—Ń—R”üŽqiś•¨•¨—ŒnjC‰Á”Zł–žiś—j: ‘ć64‰ń“ú–{“Ž•¨Šw‰ď i93.11.20j, ‰Ť“ę, Zool. Sci., 10(Suppl.): 92, 1993.

60. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Reduction in K+ channel conductance is associated with long-term depression in rat cerebellum. ‚–Ř”ŽC‚‘şŒőˆęi‘‘ĺjCH“Ą‰Ŕ‹viŽO•H‰ťŹś–˝Œ¤jC—é–ؐM”Viś—jCˆäăGŽqC‹g‰Ş‹œi‘‘ĺj: ‘ć17‰ń“ú–{_Œo‰ČŠwŠw‰ď i93.12.07`09j, –źŒĂ‰Ž, Neurosci. Res., 18(Suppl.): 146, 1993.

61. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠT“úƒŠƒYƒ€‚ɑ΂ˇ‚éƒAƒfƒjƒŒ[ƒgƒVƒNƒ‰[ƒ[‚Ě–đŠ„. ’ˇ’JěŒšŽĄiś—jC“‡–{š˜ai¸jC“c’†ŠÚ–ž”Žiś•¨•¨—ŒnjC’ËŒ´•Ű•vi“Œ–k‘ĺj: ‘ć17‰ń“ú–{_Œo‰ČŠwŠw‰ď i93.12.08j, –źŒĂ‰Ž.

62. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Chronic effects of calmodulin inhibitors on sodium channel development in cultured chick skeletal muscle cells. ˛“Ą—ş•˝iś—jC’†—Ń—R”üŽqiś•¨•¨—ŒnjC‰Á”Zł–žiś—j: ‘ć70‰ń“ú–{ś—Šw‰ď i93.04.01`03j, ŽR—œ, Jpn. J. Physiol., 43(Suppl.): 174, 1993.

63. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Photon emission from eggs during first cleavage. ‘ĺŠŃMiś—jC—´čłŽmiś•¨j: ‘ć70‰ń“ú–{ś—Šw‰ď i93.04.01`03j, ŽR—œ, Jpn. J. Physiol., 43(Suppl.): 303, 1993.

64. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒAƒ~ƒƒ‰ƒCƒh”ń‘śÝ‰ş‚ɉ—‚Ż‚éŠ^ă”ç’Z—“d—ŹƒmƒCƒY‰đÍ. •Đ‘q—˛iś—j: “ú–{ś•¨•¨—Šw‰ď i93.10.14j, –źŒĂ‰Ž, ś•¨•¨—, 33(Suppl.): 221, 1993.

65. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Cortical photon emission in early development of frog eggs. ‘ĺŠŃMiś—jC—´čłŽmiś•¨j: ‘ć64‰ń“ú–{“Ž•¨Šw‰ď i93.11.20j, ‰Ť“ę, Zool. Sci., 10(Suppl.): 38, 1993.

66. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j —‘”­ś‰ß’ö‚Ĺ‚ĚƒtƒHƒgƒ“•úŽË‚Ě‘Ş’č. ‘ĺŠŃMiś—jC—´čłŽmiś•¨j: ś•¨”­Œő‰ťŠwƒVƒ“ƒ|ƒWƒEƒ€ i93.12.04j, “Œ‹ž, Abstract, p.4, 1993.


<<03 ś‰ťŠw>>

67. mŒ´’˜n Regional differences in sulfated oligosaccharides of rat gastrointestinal mucin as detected by two-dimensional chromatography. ŒÜäzsMC–x“c‹ąŽqiś‰ťj: Arch. Biochem. Biophys., 302(1): 212`217, 1993.

68. mŒ´’˜n Experiments on maternal and paternal transmission of Creutzfeldt-Jakob disease in mice. “cŒű•śÍi‰qśŠw•”jC‹Ęˆä—mˆęiś‰ťjCŽO‰Y’ĺ‘Ľi¸j: Arch. Virol., 130: 219`224, 1993.

69. mŒ´’˜n Purification from adult pig testicular P-450 and 17ƒż-hydroxylase activity of P-450 containing liposomal membranes. ŒK“cłLiś‰ťjC‘]Ş—R”üŽqC•ô“c—Œbiś‰ťŒnj: Biochem. Biophys. Res. Commun., 196(2): 816`824, 1993.

70. mŒ´’˜n Biosynthesis of two distinct types of mucin in HM3 human colon cancer cells. ŹŒ´iiś‰ťjCJames C. ByrdCJames R. GumCYoung SkimiUniv. of California, SFj: Biochem. J., 297(3): 509`516, 1994.

71. mŒ´’˜n Stimulation of mucus glycoprotein biosynthesis in rat gastric mucosa by gastrin. Žsě‘¸•śiś‰ťjCÎŒ´˜a•Fi‰ťjCźŒłŽ›Ž—çi“ŕjC–x“c‹ąŽqiś‰ťj: Biochem. Pharmacol., 46(9): 1551`1557, 1993.

72. mŒ´’˜n The validity of the ethanol precipitation method for the measurement of mucin content in human gastric juices and its possible relationship to gastroduodenal diseases. ˆŔŠC‹`—ji“ŕjCŽsě‘¸•śiś‰ťjCÎŒ´˜a•Fi‰ťjC–x“c‹ąŽqiś‰ťj: Clin. Chim. Acta, 221: 219`225, 1993.

73. mŒ´’˜n Development of an HPLC method to estimate hexosamines and its application to determine mucin content in rat and human gastric mucosa. ÎŒ´˜a•Fi‰ťjC‹TŽRmˆęiŽRŒ`‘ĺjC–x“c‹ąŽqiś‰ťj: Comp. Biochem. Physiol.[B], 104: 781`786, 1993.

74. mŒ´’˜n Comparative study on rat enteromucins. ŹŒ´iiś‰ťjCÎŒ´˜a•Fi‰ťjC–x“c‹ąŽqiś‰ťj: Comp. Biochem. Physiol.[B], 106(1): 147`152, 1993.

75. mŒ´’˜n Regional differences in pig gastric mucus. ŹŒ´iiś‰ťjCÎŒ´˜a•Fi‰ťjC–x“c‹ąŽqiś‰ťj: Comp. Biochem. Physiol.[B], 106(1): 153`158, 1993.

76. mŒ´’˜n Effects of acid-inhibitory antiulcer drugs on mucin biosynthesis in the rat stomach. Žsě‘¸•śiś‰ťjCÎŒ´˜a•Fi‰ťjCźŒłŽ›Ž—çi“ŕjC–x“c‹ąŽqiś‰ťj: Eur. J. Pharmacol., 251: 107`111, 1994.

77. mŒ´’˜n A monoclonal antibody against carbohydrate moiety of rat gastric surface epithelial cell-derived mucin. ÎŒ´˜a•Fi‰ťjCŒIŒ´˝iŠÖ“Œ‰ťŠwjC‰q“ĄŒői”çjCŠ}ˆäŒ‰i•a—jC“‡“ŕŽl˜YiŠÖ“Œ‰ťŠwjC–x“c‹ąŽqiś‰ťj: Hybridoma, 12: 609`620, 1993.

78. mŒ´’˜n Isolation of a subclonal cell line of PC12 transfected with dexamethasone-regulated ras oncogens: morphological differentiation, biochemical properties, and tumorigenicity. Ź“ˆ‹vŽqiś‰ťjCŒ´˜a–îi‰qśŠw•”jC•ô“c—Œbiś‰ťŒnjC“cŒű•śÍi‰qśŠw•”jCź’JL“ńCŽR–{¸iŠĹŒěŠw•”jCŹŠŮTĆiZ—F‹ŕ‘ŽƒoƒCƒIƒTƒCƒGƒ“ ƒXjC”’‘鑝’jiˆă—pî•ńjC‹Ęˆä—mˆęiś‰ťj: J. Biochem., 114(2): 194`202, 1993.

79. mŒ´’˜n A novel fucosylated glycosphingolipid with a GalƒŔ1-4GlcƒŔ1-3Gal sequence in plerocercoids of the parasite, Spirometra erinacei. ěă‘ׁi–ƒ•z‘ĺjC’†‘ş˜aśCŹ“ˆ‹vŽqiś‰ťjC—é–ŘŠ°CˆîŠ_“~•FC—é–Ř–žgi“s—Տ°Œ¤jC‘´–ؖΑĽC“ŕ“c–ž•FC‘ş“c‹`•Fi–ƒ•z‘ĺjC‹Ęˆä—mˆęiś‰ťj: J. Biochem., 114(5): 677`683, 1993.

80. mŒ´’˜n Less polar glycolipids in Alaskan pollack brain: isolation and characterization of acyl galactosyl diacylglycerol, acyl galactosyl ceramide, and acyl glucosyl ceramide. ‹Ęˆä—mˆęC’†‘ş˜aśiś‰ťjC‚ŽR‹v”üŽqiś‰ťŒnjC“ŕ“c‹I‹vŽ}iś‰ťjCŠ}ŠÔŒ’Žki“Œ‹žˆăŽ•‘ĺjCŹ”ŠŠ°iƒx[ƒŠƒ“ƒK[Ľƒ}ƒ“ƒnƒCƒ€j: J. Lipid Res., 34: 601`608, 1993.

81. mŒ´’˜n Metamorphic changes in glycolipids and myelin proteins and 2',3'-cyclic nucleotide 3'-phosphohydrolase in bullfrog and axolotl brains. ‹Ęˆä—mˆęCŹ“ˆ‹vŽqiś‰ťjCÄ“ĄM‘ž˜YiŽR—œ’†‰›•a‰@jC“ŕ“c‹I‹vŽ}iś‰ťjC•ô“c—Œbiś‰ťŒnjCŹź”Žiś‰ťjCX’JíśiŽD–yˆă‘ĺj: J. Neurochem., 60(5): 1854`1863, 1993.

82. mŒ´’˜n Effects of the new histamine H2 receptor antagonist, FRG-8813, on gastric mucin in rats with or without acidified ethanol-induced gastric damage. Žsě‘¸•śiś‰ťjCÎŒ´˜a•Fi‰ťjCŹŽş—TˆęCŹ“‡—m“ńCźŒłŽ›Ž—çi“ŕjC–x“c‹ąŽqiś‰ťj: Life Sci., 54: 159`164, 1994.

83. mŒ´’˜n Effects of the muscarinic receptor agonist carbachol and/or antagonist pirenzepine on gastric mucus secretion in rats. Ź“‡—m“ńi“ŕjCÎŒ´˜a•Fi‰ťjCŹŽş—TˆęCźŒłŽ›Ž—çi“ŕjC–x“c‹ąŽqiś‰ťj: Scand. J. Gastroenterol., 28: 647`651, 1993.

84. mŒ´’˜n Ex-vivo gastric chamber ‚đ—p‚˘‚˝•Ş”ĺ”S‰t‚Ě‘Ş’č‚ĚŽŽ‚Ý. Ź“‡—m“ńC•ű—D”üCźŒłŽ›Ž—çi“ŕjCÎŒ´˜a•Fi‰ťŠwjCŽsě‘¸•śC–x“c‹ąŽqiś‰ťj: Ther. Res., 14(6): 2281`2283, 1993.

85. mŒ´’˜n Rƒ‰ƒbƒgˆÝƒ€ƒ`ƒ“ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ě‚Ěěť‚Ć‚ť‚̐Ťó‚ĚŒŸ“˘. ÎŒ´˜a•Fi‰ťjCŒIŒ´˝iŠÖ“Œ‰ťŠwjCŒÜäzsMCŹŒ´iC–x“c‹ąŽqiś‰ťj: Ther. Res., 14(suppl.1): 141`143, 1993.

86. mŒ´’˜n Ex-vivo gastric chamber ‚đ—p‚˘‚˝ƒ‰ƒbƒgˆÝ•Ş”ĺ”S‰t‘Ş’č–@‚ĚŠJ”­. Ź“‡—m“ńi“ŕjCÎŒ´˜a•Fi‰ťjCźŒłŽ›Ž—çi“ŕjC–x“c‹ąŽqiś‰ťj: –k—˘ˆăŠw, 23(4): 259`265, 1993.

87. mŒ´’˜n ƒ‰ƒbƒgƒGƒ^ƒm[ƒ‹’×ᇂɂ¨‚Ż‚éˆÝ”S‰t“œ’`”’Žż•Ď“Ž‚ɑ΂ˇ‚écetraxate‘O“Š—^‚ĚŒř‰Ę. ÎŒ´˜a•Fi‰ťjCŽsě‘¸•śiś‰ťjC‰Y“c’Ă‹MŽqiś‰ťŒnjCŹ“‡—m“ńC•ű—D”üi“ŕjC–x“c‹ąŽqiś‰ťj: –ň—‚ĆŽĄ—Ă, 21: 1469`1473, 1993.

88. m€Œ´’˜n ˆÝ”S‰t‘ăŽÓ‚É‹y‚Ú‚ˇŽ_•Ş”ĺŽhŒƒ•¨Žż‚̉e‹ż|ƒKƒXƒgƒŠƒ“‚Ě”S‰tś‡Ź‚É‹y‚Ú‚ˇě—p‚ÉŠÖ‚ˇ‚éŽŔŒą“IŒŸ“˘|. Žsě‘¸•śiś‰ťjCÎŒ´˜a•Fi‰ťjCŹŒ´iCŒÜäzsMiś‰ťjC•ű—D”üCŹ“‡—m“ńCźŒłŽ›Ž—çi“ŕjC–x“c‹ąŽqiś‰ťj: Prog. Med., 13(9): 2074`2077, 1993.

89. m€Œ´’˜n ƒ‰ƒbƒgƒGƒ^ƒm[ƒ‹’×ᇂɔş‚¤ˆÝ”S‰t—Ę•Ď“Ž‚ɑ΂ˇ‚锟‰ÄŕbS“’‚ĚŒř‰Ę|ˆÝ”S‰t—Ę•Ď“Ž‚É‚ć‚錟“˘|. •ű—D”üi“ŕjCÎŒ´˜a•Fi‰ťŠwjCŒÜäzsMCŽsě‘¸•śiś‰ťjCźŒłŽ›Ž—çi“ŕjC–x“c‹ąŽqiś‰ťj: Ulcer Res., 20(2): 62`64, 1993.

90. m€Œ´’˜n ŠeŽíH2Žó—e‘̝hRÜ‚Ěƒ‰ƒbƒgˆÝ”S‰t“œ’`”’Žżś‡ŹŠˆŤ‚É‹y‚Ú‚ˇŒř‰Ę‚Ě”äŠr. Žsě‘¸•śiś‰ťjCÎŒ´˜a•Fi‰ťjCźŒłŽ›Ž—çi“ŕjC–x“c‹ąŽqiś‰ťj: Ulcer Res., 20: 58`61, 1993.

91. mŒ¤‹†•ńi•ś•”Čjn Á‰ťŠÇƒ€ƒ`ƒ““œ˝‚̉đÍ‚Ć•a‘Ô. –x“c‹ąŽqCŒÜäzsMiś‰ťj: “œ˝ś•¨Šw‚̐V“WŠJ‘‡Œ¤‹†A•ńW, p.24`27, 1993.

92. mŒ¤‹†•ńi•ś•”Čjn ƒNƒƒCƒcƒtƒFƒ‹ƒgĽƒ„ƒRƒu•a‚Ě”­ÇˆöŽq‚Ć”­Ç‹@˜‚̉đ–ž. ‹Ęˆä—mˆęiś‰ťj: •˝Ź5”N“x‰ČŠwŒ¤‹†”ďŽŔŃ•ń‘.

93. mŒ¤‹†•ńiŒúśČjn CJD‚ĚŠ´ő‹@˜‚ÉŠÖ‚ˇ‚é2, 3‚Ě–â‘č: •ęŒn, •ƒŒnŠ´ő‚ĚŒŸő, VśŽeƒ}ƒEƒX‚ւ̐ڎí, ‘ŮŽ™, ‘Ů”Ő, ¸‰t‚ĚŠ´őŤ, Š´őƒ}ƒEƒX‚Ě”]‚̏‰Šú‘œ. ‹Ęˆä—mˆęiś‰ťjC“cŒű•śÍi‰qśŠw•”jCÎŒ´DOi“s_ŒoŒ¤jCŒĂŠÚęˆęiŽŔ“ŽjCŹ“ˆ‹vŽqC’†‘ş˜aśiś‰ťjC‘ĺ’J‹`•vCŽO‰Y’ĺ‘Ľi¸j: •˝Ź5”N“xŒúśČu’x”­ŤƒEƒCƒ‹ƒXŠ´őv’˛¸Œ¤‹†”ǐŹ‰Ę•ń‘, 1994.


<<03 2 ś‰ťŠw>>

94. m‘ŕn ”S‰t‚̐ś‰ťŠw. ÎŒ´˜a•Fi‰ťjC–x“c‹ąŽqiś‰ťj: ×–E, 25: 195`199, 1993.

95. muŔn ”S‰tŹ•Ş‚ĚŒŸ¸|ƒ€ƒ`ƒ“i”S‰t“œ’`”’Žżj|. Žsě‘¸•śiś‰ťjCÎŒ´˜a•Fi‰ťjC–x“c‹ąŽqiś‰ťj: —Տ°ŒŸ¸, 37(7): 747`751, 1993.

96. mŠwp‘n i•Ş’SŽˇ•Mj ƒOƒŠƒRƒpƒ\ƒƒW[; ƒ€ƒ`ƒ“‚ĚŠŕŤ•Ď‰ť‚Ćƒ€ƒ`ƒ“Œ^“œ˝‚ĚˆŮí, 6: 65`76, ŒÜäzsMC–x“c‹ąŽqiś‰ťj. •ŇW ” Žçĺˆę˜NiƒƒVƒ“ƒgƒ“‘ĺjC‰iˆäŽFi“Œ‹ž“s—Տ°Œ¤jC–Ř”Ś—zi“Œ‹ž“s˜VlŒ¤jC u’kŽĐ, “Œ‹ž, 93.10.10”­s.


<<03 5 ś‰ťŠw>>

97. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Glycosphingolipids of plerocercoids of parasite, Spirometra erinacei. ěă‘ׁC’†‘ş˜aśCŹ“ˆ‹vŽqiś‰ťjC—é–ŘŽŔCˆîŠ_“~•FC—é–Ř–žgi“s—Տ°Œ¤jC‘´–ؖΑĽC“ŕ“c–ž•FC‘ş“c‹`•Fi–ƒ•z‘ĺjC‹Ęˆä—mˆęiś‰ťj: 12th Int. Symp. on Glycoconjugates i93.08.17j, Krakow, Poland, Glycoconj. J., 10(4): 339, 1993.

98. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j A monoclonal antibody against mucin derived from rat gastric surface epithelial cells and partial characterization of the epitope structure by enzyme immunoassay. ŒIŒ´˝iŠÖ“Œ‰ťŠwjCÎŒ´˜a•Fi‰ťjC“c’†G”üiŠÖ“Œ‰ťŠwjC‰q“ĄŒői”çjC“‡“ŕŽl˜YiŠÖ“Œ‰ťŠwjC–x“c‹ąŽqiś‰ťj: 12th Int. Symp. Glycoconjugate i93.08.15j, Poland, Glycoconj. J., 10: 345, 1993.

99. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j A monoclonal antibody, RGM41, specific for the mucin derived from the gland mucous cells of mammalian stomach. ÎŒ´˜a•Fi‰ťjCŒIŒ´˝iŠÖ“Œ‰ťŠwjCŒÜäzsMiś‰ťjC‘ž“c_—ǁCŸŽR“wiM‘ĺjC–x“c‹ąŽqiś‰ťj: 12th Int. Symp. Glycoconjugate i93.08.15j, Poland, Glycoconj. J., 10: 346, 1993.

100. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Characterization of a rat corpus sulfotransferase for the 6-0-sulfation of ƒŔ-D-N-acetylglucosamine residues on oligosaccharides. ŒÜäzsMC–x“c‹ąŽqiś‰ťj: 12th International Symposium on Glycoconjugates i93.08.16j, Poland, Glycoconj. J., 10(4): 226, 1993.

101. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Partial purification and characterization of an endo-ƒż-N-acetylgalactosaminidase from the culture medium of Streptomyces sp. OH-11242. ŽPˆčŽqCŠâŁm—EC–x“c‹ąŽqiś‰ťj: ‘ć12‰ń‘Ű•Ą‡“œŽżƒVƒ“ƒ|ƒWƒEƒ€ i93.08.16j, Poland, Glycoconj. J., 10(4): 229`230, 1993.

102. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Analysis of protein portion of porcine gastric mucus glycoprotein after release of O-linked oligosaccharide by gas-phase hydrazinolysis. ŠâŁm—ECŽPˆčŽqC–x“c‹ąŽqiś‰ťj: ‘ć12‰ń‘Ű•Ą‡“œŽżƒVƒ“ƒ|ƒWƒEƒ€ i93.08.17j, Poland, Glycoconj. J., 10(4): 345, 1993.

103. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Cell proliferation induced by brain injury. W.T. NortonCH. IshiguroC’†‘ş˜aśiś‰ťjCM. FarooqCJ.A. Amat: 14th Meeting of International Society for Neurochemistry i93.08.23j, Montpellier, France, J. Neurochem., 61(Suppl.): 44, 1993.

104. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Gangliosides of ray brain: occurrence of polysialogangliosides with sialic acid linked to N-acetylgalactosamine. ’†‘ş˜aśCŹ“ˆ‹vŽqC‹Ęˆä—mˆęiś‰ťj: 14th Meeting of International Society for Neurochemistry i93.08.27j, Montpellier, France, J. Neurochem., 61(Suppl.): 160, 1993.

105. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Differentiation of mouse neuroblastoma cells and rat pheochromocytoma cells induced by specific inhibitors of protein kinase. Ź“ˆ‹vŽqiś‰ťjC•ô“c—ŒbC‘ĺŠŃ—TŽqiś‰ťŒnjC–xˆä‰pŽqi¸jC’†‘ş˜aśC‹Ęˆä—mˆęiś‰ťj: 14th Meeting of International Society for Neurochemistry i93.08.27j, Montpellier, France, J. Neurochem., 61(Suppl.): 219, 1993.

106. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Alteration in GDP-fucose: glycosphingolipids fucosyltransferase activities of PC12 cells during differentiation. Ź“ˆ‹vŽqC’†‘ş˜aśiś‰ťjC•ô“c—Œbiś‰ťŒnjC‹Ęˆä—mˆęiś‰ťj: 8th Rinsyoken Int. Confer. i93.09.27j, “Œ‹ž, Abstracts, p.115`116, 1993.

107. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j A novel fucosylated glycosphingolipid with a GalƒŔ1-4GlcƒŔ1-3Gal sequence in plerocercoids of the parasite, Spirometra erinacei. ěă‘ׁi–ƒ•z‘ĺjCŹ“ˆ‹vŽqC’†‘ş˜aśiś‰ťjC—é–ŘŽŔCˆîŠ_“~•FC—é–Ř–žgi“s—Տ°Œ¤jC“ŕ“c–ž•FC‘ş“c‹`•Fi–ƒ•z‘ĺjC‹Ęˆä—mˆęiś‰ťj: 8th Rinsyoken Int. Confer. i93.09.27j, “Œ‹ž, Abstracts, p.91`92, 1993.

108. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Comparative study of glycoform of O-glycan on serum IgA from healthy control and IgA myeloma patient. ŠâŁm—ECŽPˆčŽqiś‰ťjC”äŠé”\”ViŠĹŒěŠw•”jCŹ—Ń–Li“ŕjC–x“c‹ąŽqiś‰ťj: ‘ŰIgAtÇƒVƒ“ƒ|ƒWƒEƒ€ i94.02.28j, ƒI[ƒXƒgƒ‰ƒŠƒA, —vŽ|W, p.20, 1994.

109. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Reactive microglia express ganglioside GD3. Amat, J.A.CIshiguro, H.C’†‘ş˜aśiś‰ťjCNorton, W.T.: 25th Meeting of American Society for Neurochemistry i94.03.00j, Albuqueque, U.S.A., J. Neurochem., 62(Suppl.): 70C, 1994.

110. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j O-ƒOƒŠƒRƒVƒhŒ^“œ˝—V—Ł‚Ě‚˝‚߂̐V‚ľ‚˘ƒ€ƒ`ƒ“•Ş‰đy‘f‚¨‚ć‚Ńƒqƒhƒ‰ƒNƒ‰ƒu‚đŽg—p‚ľ‚˝‹C‘Šƒqƒhƒ‰ƒWƒ“•Ş‰đ–@‚ɂ‚˘‚Ä. ŠâŁm—ECŽPˆčŽqC–x“c‹ąŽqiś‰ťj: ‘ć15‰ń“œŽżƒVƒ“ƒ|ƒWƒEƒ€ i93.07.29j, ĺ‘ä, —vŽ|W, p.61`62, 1993.

111. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Ź–E‘ĚŒ^ƒ`ƒgƒNƒ[ƒ€ P-450 ‚Ě“_•ĎˆŮ“ą“ü‚É‚ć‚é×–E“ŕ‹ÇÝ•”ˆĘ‚̕ωť. ÎŒ´’‰’źi‹ă‘ĺjCŽR‰Čł•˝i‰đjCâŒű‰ë˜YCŽOŒ´Ÿ–FC‘ĺ‘şP—Yi‹ă‘ĺj: ‘ć46‰ń“ú–{×–Eś•¨Šw‰ď‘ĺ‰ď i93.10.20j, ‘O‹´, —\eW, p.70, 1993.

112. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ}ƒ“ƒ\ƒ“—ô“Şđ’Ž‚Š‚ç“ž‚ç‚ę‚˝ƒXƒtƒBƒ“ƒS“œŽ‰Žż‚Ě“œ˝\‘˘‚ɂ‚˘‚Ä. ěă‘ׁC“ŕ“c–ž•FC‘ş“c‹`•Fi–ƒ•z‘ĺjC’†‘ş˜aśCŹ“ˆ‹vŽqC‹Ęˆä—mˆęiś‰ťj: ‘ć62‰ń“ú–{Šńś’ŽŠw‰ď i93.04.07j, “Ţ—Ç, Jpn. J. Parasitol., 42: 70, 1993.

113. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Creutzfeldt-Jakob•aiŠC–ȏó”]ÇŒ^j‚đÚŽíŒ´‚Ć‚ľ‚˝ƒ}ƒEƒX“`’BŤŠC–ȏó”]Ç(Transmissible Sapongiform Encephalopathies: TSEs)‚É‚¨‚Ż‚éŠC–ȏó•Ď‰ť‚ĆƒAƒXƒgƒƒOƒŠƒA×–E‚ĚŒoŽž“IŒ`‘ÔŠĎŽ@. ÎŒ´DOi“s_ŒoŒ¤,ˆăĽ•a—jC‹Ęˆä—mˆęiś‰ťj: ‘ć34‰ń“ú–{_Œo•a—Šw‰ď‘‰ď i93.05.11j, “Œ‹ž, ´˜^W, p. 51.

114. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒgˆÝƒ€ƒ`ƒ“‚Ě•Ş‰ć‰ß’ö‚É‚¨‚Ż‚é‘gD‰ťŠw“IŒŸo–@‚Ě—˜—p. ŒÜäzsMC–x“c‹ąŽqiś‰ťj: ‘ć66‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď i93.10.02j, “Œ‹ž, ś‰ťŠw, 65(8): 703, 1993.

115. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒg‘ĺ’°ƒ€ƒ`ƒ“‚̐ś‡Ź. ŹŒ´iCŽsě‘¸•śC–x“c‹ąŽqiś‰ťj: ‘ć66‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď i93.10.02j, “Œ‹ž, ś‰ťŠw, 65(8): 703, 1993.

116. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j PC12×–E‚Ě•Ş‰ť‚Ć“œ“]ˆÚy‘fŠˆŤ‚̕ωť‚ɂ‚˘‚Ä. Ź“ˆ‹vŽqiś‰ťjC•ô“c—Œbiś‰ťŒnjC’†‘ş˜aśC‹Ęˆä—mˆęiś‰ťj: ‘ć66‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď i93.10.02j, “Œ‹ž, ś‰ťŠw, 65(8): 706, 1993.

117. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ˆÝ‘B”S‰t×–E—R—ˆ‚Ěƒ€ƒ`ƒ“‚É”˝‰ž‚ˇ‚郂ƒmƒNƒ[ƒiƒ‹R‘Ě‚Ěěť‚Ć‚ť‚̐Ťó‚ĚŒŸ“˘. ŒIŒ´˝C“c’†G”üC“‡“ŕŽl˜YiŠÖ“Œ‰ťŠwjCÎŒ´˜a•Fi‰ťjCŒÜäzsMiś‰ťjC‰Y“c’Ă‹MŽqiś‰ťŒnjC–x“c‹ąŽqiś‰ťj: ‘ć66‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď i93.10.02j, “Œ‹ž, ś‰ťŠw, 65: 704, 1993.

118. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Streptomyces sp. OH-11242 ”|—{‰t’†‚ÉŽYś‚ł‚ę‚éendo-GalNAc-ase-S‚̊“ÁˆŮŤ‚ĚŒŸ“˘. ŽPˆčŽqCŠâŁm—EC–x“c‹ąŽqiś‰ťj: ‘ć66‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď i93.10.03j, “Œ‹ž, ś‰ťŠw, 65(8): 888, 1993.

119. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹C‘Šƒqƒhƒ‰ƒWƒ“•Ş‰đ‚É‚ć‚éO-ƒOƒŠƒRƒVƒhŒ^“œ˝—V—Ł‚ÉŠÖ‚ˇ‚éŠî‘b“IŒŸ“˘. ŠâŁm—ECŽPˆčŽqC–x“c‹ąŽqiś‰ťj: ‘ć66‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď i93.10.03j, “Œ‹ž, ś‰ťŠw, 65(8): 888, 1993.

120. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “‹›—Ţ(Rajiformes)”]‚ĚƒKƒ“ƒOƒŠƒIƒVƒh. ’†‘ş˜aśCŹ“ˆ‹vŽqC‹Ęˆä—mˆęiś‰ťj: ‘ć66‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď i93.10.03j, “Œ‹ž, ś‰ťŠw, 65(8): 890, 1993.

121. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ}ƒ“ƒ\ƒ“—ô“Şđ’Ž‚Š‚ç’P—Ł‚ł‚ę‚˝V‚ľ‚˘ƒXƒtƒBƒ“ƒS“œŽ‰Žż‚̍\‘˘‰đÍ. ěă‘ׁi–ƒ•z‘ĺjCŹ“ˆ‹vŽqC’†‘ş˜aśiś‰ťjC—é–ŘŽŔCˆîŠ_“~•FC—é–Ř–žgi“Œ‹ž“s—Տ°Œ¤jC“ŕ“c–ž•Fiś‰ťjC‘ş“c‹`•Fi–ƒ•z‘ĺjC‹Ęˆä—mˆęiś ‰ťj: ‘ć66‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď i93.10.03j, “Œ‹ž, ś‰ťŠw, 65(8): 890, 1993.

122. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒIƒLƒ\ƒAƒ‹ƒfƒqƒh’E…‘fy‘f‚đ—p‚˘‚˝3-ƒfƒIƒLƒVƒOƒ‹ƒRƒ\ƒ“‚Ě”÷—Ę’č—Ę–@‚ĚŠJ”­. “Ąˆä‰pi“ŕjCŠâŁm—ECŽPˆčŽqiś‰ťjC–‹`’‰i“ŕjC–x“c‹ąŽqiś‰ťj: ‘ć66‰ń“ú–{ś‰ťŠw‰ď i93.10.03j, “Œ‹ž, ś‰ťŠw, 65(8): 902, 1993.

123. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒg‰–Ž_ƒAƒXƒsƒŠƒ“’×ᇂɂ¨‚Ż‚éˆÝ”S‰t“œ’`”’Žż•Ď“Ž‚ɑ΂ˇ‚éT-593‘O“Š—^‚ĚŒř‰Ę. Žđˆä’C•FC•ű—D”üC“n•Ó•üŒbi“ŕjCÎŒ´˜a•Fi‰ťjCŽsě‘¸•śC–x“c‹ąŽqiś‰ťjCźŒłŽ›Ž—çi“ŕj: ŽŔŒą’×ᇊw‰ď i93.12.03j, ç—t.

124. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’×ᇐŤ‘ĺ’°‰Š•a‘Ôƒ‚ƒfƒ‹ěť‚ĚŽŽ‚Ý. ŹŒ´iiś‰ťjCŒÜ\—’łLC“n•Ó•üŒbi“ŕjC–x“c‹ąŽqiś‰ťj: ‘ć21‰ń“ú–{ŽŔŒą’×ᇊw‰ď i93.12.03j, ç—t, ƒvƒƒOƒ‰ƒ€Ľ´˜^W, p.38, 1993.

125. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j R‘B”S‰t×–EŒ^ƒ€ƒ`ƒ“R‘Ě(HIK1083)‚Ě“ÁˆŮŤ‚ĚŒŸ“˘|Œn“”­śŠw“IŠĎ“_‚ć‚č. ‘ž“c_—ǁC’†‘ş’źCÎˆäŒbŽqCŸŽR“wiM‘ĺjCÎŒ´˜a•Fi‰ťjC–x“c‹ąŽqiś‰ťj: •a—Šw‰ď i94.03.29j, ‹ž“s.

126. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒg’P—ŁˆÝ•\‘w”S‰t×–E‚Ě”S‰tś‡Ź‚ɑ΂ˇ‚éŽ_•Ş”ĺŽhŒƒÜiƒqƒXƒ^ƒ~ƒ“j‚̉e‹ż. •ű—D”üi“ŕjCŒÜäzsMiś‰ťjCÎŒ´˜a•Fi‰ťjCŽsě‘¸•śiś‰ťjCźŒłŽ›Ž—çi“ŕjC–x“c‹ąŽqiś‰ťj: ‘ć35‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď i93.09.20j, _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ, 90(—Ő‘): 133, 1993.

127. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒeƒgƒ‰ƒKƒXƒgƒŠƒ“‚ĚˆÝ”S‰t“œ’`”’Žżiƒ€ƒ`ƒ“jś‡ŹŠˆŤ˜´iě—p‚̉đ–ž. Žsě‘¸•śiś‰ťjCÎŒ´˜a•Fi‰ťjCŹŽş—TˆęCźŒłŽ›Ž—çi“ŕjC–x“c‹ąŽqiś‰ťj: ‘ć35‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď i93.09.20j, _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ, 90(—Ő‘): 1748, 1993.

128. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ}ƒ“ƒ\ƒ“—ô“Şđ’Ž‚Š‚ç’P—Ł‚ł‚ę‚˝V‚ľ‚˘“œ˝\‘˘‚đ‚ŕ‚“œŽ‰Žż. ěă‘ׁC‘´–ؖΑĽC“ŕ“c–ž•FC‘ş“c‹`•Fi–ƒ•z‘ĺjC’†‘ş˜aśCŹ“ˆ‹vŽqC‹Ęˆä—mˆęiś‰ťjC—é–ŘŽŔC—é–Ř–žgCˆîŠ_“~•Fi“s—Տ°Œ¤j: “ú–{Ž‰Žżś‰ťŠwŒ¤‹†‰ďW‰ď i93.06.04j, “Œ‹ž, Ž‰Žżś‰ťŠwŒ¤‹†, 35: 39`42, 1993.

129. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒgˆÝ‰Â—nŤ”S‰t•Ş”ĺ“Ž‘Ô‚É‹y‚Ú‚ˇƒqƒXƒ^ƒ~ƒ“‚̉e‹ż|Ex vivo gastric chamber‚đ—p‚˘‚˝•Ş”ĺ”S‰t‘Ş’č–@‚É‚ć‚錟“˘. ÎŒ´˜a•Fi‰ťjCŹ“‡—m“ńCŽđˆä’C•Fi“ŕjCŽsě‘¸•śCŹŒ´iC–x“c‹ąŽqiś‰ťj: ‘ć13‰ńƒqƒXƒ^ƒ~ƒ“ƒŒƒZƒvƒ^[Œ¤‹†‰ď i93.07.30j, ‹ž“s.

130. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ’Pˆęś–ň‚Ěƒ‰ƒbƒgƒGƒ^ƒm[ƒ‹’×ᇂɑ΂ˇ‚éŒř‰Ę‚ĚŒŸ“˘|“Á‚ɐś›I‚̍R’×ᇍě—p‹y‚ŃˆÝ”S‰t‚ւ̉e‹ż‚ɂ‚˘‚ā|. •ű—D”üi“ŕjCÎŒ´˜a•Fi‰ťjCŒÜäzsMCŽsě‘¸•śiś‰ťjCźŒłŽ›Ž—çi“ŕjC–x“c‹ąŽqiś‰ťj: ‘ć45‰ńƒyƒvƒVƒ“Œ¤‹†‰ď i94.02.25j, “Œ‹ž.

131. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ˆÝ”S–Œ–hŒä‚É‚¨‚Ż‚éƒKƒXƒgƒŠƒ“‚Ě–đŠ„|”S‰tś‡Ź‚É‹y‚Ú‚ˇě—p‚ÉŠÖ‚ˇ‚éŽŔŒą“IŒŸ“˘|. Žsě‘¸•śiś‰ťjCÎŒ´˜a•Fi‰ťjCŹŽş—TˆęC•ű—D”üCŽđˆä’C•FC“n•Ó•üŒbCźŒłŽ›Ž—çi“ŕjC–x“c‹ąŽqiś‰ťj: ‘ć8‰ń_“ސěƒTƒCƒgƒvƒƒeƒNƒVƒ‡ƒ“Œ¤‹†‰ď i93.11.18j, ‰Ą•l, ´˜^W, p.14, 1993.

132. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j HPLC‚É‚ć‚éƒOƒŠƒP[ƒVƒ‡ƒ“’†ŠÔ‘Ě(3DG)‚Ě‘Ş’č. “Ąˆä‰pi“ŕjCŠâŁm—ECŽPˆčŽqiś‰ťjC–‹`’‰i“ŕjC–x“c‹ąŽqiś‰ťj: ‘ć21‰ń“ŕ•Ş”ĺ‘ăŽÓŒ¤‹†‰ď i93.11.20j, “Œ‹ž, —\eW, p.15, 1993.


<<03 7 ś‰ťŠw>>

133. mŠwpÜi‘“ŕÜjn “ú–{ŽŔŒą’×ᇊw‰ď§—ăÜi‘ć21‰ń“ú–{ŽŔŒą’×ᇊw‰ďu’×ᇐŤ‘ĺ’°‰Š•a‘Ôƒ‚ƒfƒ‹ěť‚ĚŽŽ‚݁vj, ŹŒ´iiś‰ťjCŒÜ\—’łLC“n•Ó•üŒbi“ŕjC–x“c‹ąŽqiś‰ťj.

134. mŠwpÜi‘“ŕÜjn ƒqƒXƒ^ƒ~ƒ“ƒŒƒZƒvƒ^[Üi‘ć13‰ńƒqƒXƒ^ƒ~ƒ“ƒŒƒZƒvƒ^[Œ¤‹†‰ďj, ÎŒ´˜a•Fi‰ťjC–x“c‹ąŽqiś‰ťj.


<<04 •ŞŽqś•¨Šw>>

135. mŒ´’˜n O2Ľ- Scavenging activity of lignins tannins and PSK. Sakagami, H.CKohno, S.CTakeda, M.iş˜a‘ĺjC’†‘ş‘‰qi•ŞśjC–ěŒł‚Ż‚˘Žqiś‰ťŒnjCUeno, I.CKanegasaki, S.i“Œ‘ĺjCNaoe, T.CKawazoe, Y.i–źŒĂ‰ŽŽs‘ĺj: Anticancer Res., 12(6): 1995`2000, 1992.

136. mŒ´’˜n Prevention of autoimmune inflammation polyarthritis in male NZB/KN mice by transplantation of bone marrow cells plus bone (stromal cells). Nakagawa, T.CNagata, N.CHosaka, N.COgawa, R.iŠÖźˆă‘ĺjC’†‘ş‘‰qi•ŞśjCIkehara, S.iŠÖźˆă‘ĺj: Arthritis Rheum., 36(2): 263`268, 1993.

137. mŒ´’˜n A new member of the C1s family of complement proteins found in a bactericidal factor, Ra-reactive factor, in human serum. ‚“cŽj’jiŽ™jC‚ŽR‹g‰ii•ŞśjC‰Ł—m”üiś‰ťjCěăł–çi•Şśj: Biochem. Biophys. Res. Commun., 196(2): 1003`1009, 1993.

138. mŒ´’˜n Immune complex independent activation of complement, C1s secreted from hamster embryo malignant fibroblasts, Nil2C2 in serum free culture medium. ŽRŒűŠěˆę˜YC‰Á“Ą‘Ľ•vCŽđˆä‚Ě‚č‚Śi•úŽËüˆăŠwŒ¤‹†ŠjCź–{‚Ý‚łŽqiŹl•aƒZƒ“ƒ^[jC’ˇ‘ňŽ ŽĄi–k‘ĺjC‰Ł—m”üiś•¨‰ťŠwŒnjC–L“c“Oi•úŽËüˆăŠw Œ¤‹†ŠjCX‰ŽG–΁iç—t‘ĺjCčŽR‹vŽqi•úŽËüˆăŠwŒ¤‹†Šj: Biochim. Biophys. Acta, 1205: 133`138, 1994.

139. mŒ´’˜n Oxidative stress relief for cancer-bearing hosts by protein bound polysaccharide of Coriolus versicolor QUEL with SOD mimicking activity. Ź—Ń—F‹Li“ŕjCŠĺ’J˜a”Ni•ŞśjCźŒłŽ›Ž—çi“ŕjC’†‘ş‘‰qi•Şśj: Cancer Biotherapy, 9(1): 55`62, 1994.

140. mŒ´’˜n Suppression of cancer cell growth in vitro by the protein-bound polysaccharide of Coriolus versicolor QUEL (PS-K) with SOD mimicking activity. Ź—Ń—F‹Li“ŕjCŠĺ’J˜a”Ni•ŞśjCźŒłŽ›Ž—çi“ŕjC’†‘ş‘‰qi•Şśj: Cancer Biotherapy, 9(1): 63`69, 1994.

141. mŒ´’˜n Reaction rats constants of chlorophyll derivatives with superoxide. Antioxidative activity of oxygen stress relievers. Suzuki, N.i…ŽY‘ĺŠwZjCKanamori, N.i“ż“‡‘ĺjC’†‘ş‘‰qi•ŞśjCNamiki, M.CNomoto, T.CYoda, B.: Chemistry Express, 8(9): 709`712, 1993.

142. mŒ´’˜n ƒOƒ‰ƒ€‰AŤ‹Ű‚Š‚ç‚ĚƒGƒ“ƒhƒgƒLƒVƒ“—V—Ł‚É‚¨‚ć‚Ú‚ˇR‹ŰÜ‚̉e‹ż|ƒCƒ~ƒyƒlƒ€‚Ć‘źÜ‚Ě”äŠr|. ź“ck“ńi•ŞśjCŽÄ“cŒ“—ǁC^“cŽŔC’†ěWiäݗLť–ň‚‚­‚ÎŒ¤jCěăł–çi•Şśj: Chemotherapy (Jpn.), 41(3): 345`350, 1993.

143. mŒ´’˜n A 100-KDa protein in the C4-activating component of Ra-reactive factor is a new serine protease having module organization similar to C1r and C1s. ‚ŽR‹g‰iC‚“cŽj’jC‚‹´–ž‹`Cěăł–çi•Şśj: J. Immunol., 152(6): 2308`2316, 1994.

144. mŒ´’˜n Pit-1/GH factor-1 involvement in the gene expression of somatolactin. Ź–ě‰ë•vi•ŞśjC’Ł‘Ö‹MŽui…ŽYŠw•”jC‹ŕŽq–L“ńiŠC—mŒ¤jC˛“Ą—Yˆęi•a—jC’–Œ´ß”V‰îiŒ`ŠOjCě“ŕ_Žii…ŽYŠw•”j: Mol. Endocrinol., 8(1): 109`115, 1994.

145. mŒ´’˜n —L‹@ƒQƒ‹ƒ}ƒjƒEƒ€‰ť‡•¨‚̐ś—ŠˆŤ|—L‹@ƒQƒ‹ƒ}ƒjƒEƒ€‰ť‡•¨‚É‚ć‚éMillard”˝‰ž‚Ě’˛ß. ’†‘ş‘‰qi•ŞśjC–ěŒł‚Ż‚˘Žqiś‰ťŒnjC‘ĺ‘ňr•Fi–ź‘ĺjC‚‹´K’jCH—tŒő—YCŠ`–{‹I”ŽióˆäƒQƒ‹ƒ}Œ¤j: “ú–{‰ťŠw‰ďŽ, 1994(3): 307`316, 1994.

146. mŒ´’˜n ƒAƒNƒAŽ_‰ť…‚ĚŽE‹ŰŒř‰Ę‚ɑ΂ˇ‚錟“˘. Šâ‘ň“ĘYC’†‘ş—ÇŽqi“Ą‹u•a‰@jC’†‘ş‘‰qi•ŞśjC‘şˆä“N–çiŽO‰Y“dŽqj: –ň—‚Ć—Ő°, 3(9): 1555`1562, 1993.

147. m’Z•ńĽ‘Ź•ńn V‚ľ‚˘•â‘ĚŠˆŤ‰ťˆöŽqRaRF. ‚‹´–ž‹`i…ŽYŠw•”jCěăł–çi•Şśj: Jasco Report, 36(2): 21`23, 1994.

148. m’Z•ńĽ‘Ź•ńn Rapid microbe detection system development on a membrane filter. “AłŒ CŁŒËii“ú–{ƒ~ƒŠƒ|ƒAjCěăł–çi•Şśj: Proc. China-Japan Int. Cong. Microbiol., 5: 107`108, 1993.


<<04 1 •ŞŽqś•¨Šw>>

149. mŒ¤‹†•ńi…ŽY’Ąjn ”]‰ş‚‘Ěƒzƒ‹ƒ‚ƒ“ˆâ“`Žq‚Ě”­Œť’˛ß‹@\. Ź–ě‰ë•vi•Şśj: …ŽYƒoƒCƒeƒN‹ZpŠî”ՐŽ”őŽ–‹Ć•ń‘, p.29`33, 1993.


<<04 2 •ŞŽqś•¨Šw>>

150. m‘ŕn Chemistry of melanin-concentrating hormone. ě“ŕ_Žii…ŽYŠw•”jC“ŕ“Ą‰„Žqiş˜a‘ĺjCŹ–ě‰ë•vi•Şśj: Ann. NY Acad. Sci., 680: 64`77, 1993.

151. m‘ŕn ˆâ“`ŽqŽĄ—Ẩۑč. ěăł–çi•Şśj: ŒŽŠ§–ňŽ–, 36(1): 35`40, 1994.

152. muŔn ÔŒŒ‹…‚đ—p‚˘‚˝ŠˆŤŽ_‘f‘Ş’č–@-Oxidative stress‚Ě’ö“x‚đŒť‚í‚ˇś‰ťŠw“Iƒpƒ‰ƒ[ƒ^[‚Ć‚ľ‚Ä‚Ě—L—pŤ‚ɂ‚˘‚ā|. ’†‘ş‘‰qi•ŞśjCŒF–ě˜a—Yi”ĺj: t‚Ć“§Í, 36(2): 205`210, 1994.

153. muŔn ˆâ“`î•ń‚đ“Ç‚Ţ•űŒü‚đŽwŽŚ‚ˇ‚éˆĂ†. ěăł–çi•Şśj: “ú–{ˆăŽ–V•ń, p.135`136, 1993.


<<04 5 •ŞŽqś•¨Šw>>

154. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Gene structure and expression of somatolactin. Ź–ě‰ë•vi•Şśj: Advences in the Molecular Endocrinology of Fish i93.05.24j, ƒgƒƒ“ƒg, ƒJƒiƒ_, Abstract, p.2, 1993.

155. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j The structure of a C4-activating component in Ra-reactive factor. ‚ŽR‹g‰iC‚“cŽj’ji•ŞśjC‰Ł—m”üiś‰ťŒnjC‚‹´–ž‹`Cěăł–çi•Şśj: ‘ć15‰ń‘Ű•â‘Ěƒ[ƒNƒVƒ‡ƒbƒv i93.09.28j, ‹ž“s, Mol. Immunol., 30(suppl.): 54, 1993.

156. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Prevention and reversible solubilization of AGE by organic germanium compounds. ’†‘ş‘‰qi•ŞśjC–ěŒł‚Ż‚˘Žqiś‰ťŒnjCŠ`–{‹I”ŽióˆäƒQƒ‹ƒ}Œ¤j: 3rd International Congress on Amino Acids i93.08.23`27j, Vienna, Austria.

157. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Regulation of the Maillard reaction by organic germanium compounds and their mode of action in the reaction between arginine and ribose. ’†‘ş‘‰qi•ŞśjC–ěŒł‚Ż‚˘Žqiś‰ťŒnjC‘ĺ‘ňr•Fi–ź‘ĺjCŠ`–{‹I”ŽióˆäƒQƒ‹ƒ}Œ¤j: 3rd International Congress on Amino Acids i93.08.23`27j, Vienna, Austria.

158. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Prevention of DM-complications by organic germanium compounds and their mode of action in reversible solubilization of Maillard products. ’†‘ş‘‰qi•ŞśjC–ěŒł‚Ż‚˘Žqiś‰ťŒnjCŠĺ’J˜a”Ni•ŞśjCŠ`–{‹I”ŽióˆäƒQƒ‹ƒ}Œ¤j: 5th International Symposium on the Maillard Reaction i93.08.29`09.01j, Minneapolis, USA.

159. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j The structure of a C4-activating component in Ra-reactive factor. ‚ŽR‹g‰iC‚“cŽj’ji•ŞśjC‰Ł—m”üiś‰ťŒnjC‚‹´–ž‹`Cěăł–çi•Şśj: ‘ć15‰ń‘Ű•â‘Ěƒ[ƒNƒVƒ‡ƒbƒv i93.09.28j, ‹ž“s, Mol. Immunol., 30(suppl.): 53, 1993.

160. mŠw‰ďi‘S‘jn i‹łˆçu‰‰j •â‘ĚŠˆŤ‰ťƒŒƒNƒ`ƒ“RaRF(MBPĽƒvƒƒeƒA[ƒ[•Ą‡‘Ě). ěăł–çi•Şśj: ‘ć21‰ń“ú–{—Տ°–ƉuŠw‰ď‘‰ď i93.09.09j, ŽD–y, —\eW, p.71, 1993.

161. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j u…v‚ÉŠÖ‚ˇ‚éĹV‚̉ťŠw‚Ć‚ť‚̉ž—pĽu…v‚ĚÄ”­ŒŠ‚É‚ć‚éuV‹ZpvuVŽY‹Ćv‚̉”\Ť. ˆăŠw‚É‚¨‚Ż‚éV‚ľ‚˘u…v‚̉ťŠw. uŽĽ‹C‹L‰Ż‘fŽqv‚Ć‚ľ‚Ă̐…‚Ě–đŠ„. ’†‘ş‘‰qi•Şśj: “ú–{‰ťŠw‰ď‘ć67‰ńtŠú”N‰ď“Á•ĘƒVƒ“ƒ|ƒWƒEƒ€ i94.03.29j, “Œ‹ž.

162. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j H•¨ƒZƒ“ƒC‚É‚ć‚錌´ƒRƒŒƒXƒeƒ[ƒ‹‚̒ቺ‚ĆƒAƒ|ƒŠƒ|ƒ^ƒ“ƒpƒNŽżˆâ“`Žq”­Œť‚Ć‚ĚŠÖ˜A. źě”Ž”VC‹ËŽRCli–k‘ĺjC‚ŽR‹g‰iCěăł–çi•Şśj: “ú–{‰h—{H—ĆŠw‰ď i93.05.15`17j, “Œ‹ž.

163. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j 2'ƒ‚ƒmƒzƒXƒzADP-ƒŠƒ{[ƒX‚É‚ć‚éƒOƒ‹ƒR[ƒX-6-ƒŠƒ“Ž_’E…‘fy‘f‚ĚŽ¸Šˆ‚ɂ‚˘‚Ä. ’†“‡—mˆęC’†‘ş‘‰qi•Şśj: ‘ć66‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď i93.10.03j, “Œ‹ž.

164. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Maillard”˝‰ž‚Ě—L‹@ƒQƒ‹ƒ}ƒjƒEƒ€‚É‚ć‚é’˛ß. ’†‘ş‘‰qi•ŞśjC–ěŒł‚Ż‚˘Žqiś‰ťŒnjC‘ĺ‘ňr•Fi–ź‘ĺjCŠ`–{‹I”ŽióˆäƒQƒ‹ƒ}Œ¤j: ‘ć66‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď i93.10.04j, “Œ‹ž.

165. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰ßŽ_‰ť…‘f‚É‚ć‚éCu, Zn-SOD‚̐ؒf‚ɂ‚˘‚Ä. –ěŒł‚Ż‚˘Žqiś‰ťŒnjC’†“‡—mˆęC’†‘ş‘‰qi•Şśj: ‘ć66‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď i93.10.04j, “Œ‹ž.

166. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”’‹ŕ‰ť‡•¨‚̍R‚Ş‚ńě—p‚Ɛt“ŐŤ“™‚Ě•›ě—p”­Œť‹@\‚̉đ–ž. Šĺ’J˜a”NC’†‘ş‘‰qi•Şśj: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.06j, ĺ‘ä.

167. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j V‚ľ‚˘Š´ő–hŒäˆöŽqRa-Reactive factor. ‚“cŽj’jiŽ™jC‚ŽR‹g‰iCěăł–çi•Şśj: ‘ć16‰ń“ú–{ŹŽ™ˆâ“`ˆăŠw‰ďŠwpW‰ď i93.12.04j, “Œ‹ž, —\eW, p.24, 1993.

168. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j V‚ľ‚˘•â‘ĚŠˆŤ‰ťˆöŽqRaRF‚ĚP1OOŹ•Ş‚ĚcDNAƒNƒ[ƒjƒ“ƒO. ‚“cŽj’jiŽ™jC‚ŽR‹g‰ii•ŞśjC‰Ł—m”üiś‰ťŒnjC‹Gˆç‰ŘCŽü“řCěăł–çi•Şśj: ‘ć38‰ń“ú–{l—Ţˆâ“`Šw‰ď‘ĺ‰ď i93.10.21j, “Œ‹ž, —\eW, p.195, 1993.

169. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒgRaRFĽP100‚ĚcDNA\‘˘. ‚“cŽj’jiŽ™jC‚ŽR‹g‰iCěăł–çi•Şśj: ‘ć16‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ď i93.12.19j, ç—t, —\eW, p.384, 1993.

170. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j •â‘ĚˆË‘śŤŽE‹ŰˆöŽq-RaRF-‚ĚƒvƒƒeƒA[ƒ[Ź•ŞP100’`”’‚̍\‘˘. ‚ŽR‹g‰iC‚‹´–ž‹`C‚“cŽj’jCěăł–çi•Şśj: ‘ć16‰ń“ú–{•ŞŽqś•¨Šw‰ď i93.12.19j, ç—t, —\eW, p.384, 1993.

171. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j “]ŽĘˆöŽqPit-1‚Ěƒ\ƒ}ƒgƒ‰ƒNƒ`ƒ“ˆâ“`Žq”­Œť‚Ö‚ĚŠÖ—^. Ź–ě‰ë•vi•ŞśjC’Ł‘Ö‹MŽui…ŽYŠw•”j: ‘ć16‰ń“ú–{•ŞŽqś•¨Šw‰ď i93.12.19j, ç—t, —vŽ|W, p.399, 1993.

172. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆâ“`Ť˜ËŽňÇƒ‰ƒbƒgrdw‚É‚¨‚Ż‚é“]ŽĘˆöŽqPit-1‚Ě”­Œť. ’Ł‘Ö‹MŽui…ŽYŠw•”jCŒĂŠÚęˆęiŽŔ“ŽjCŹ–ě‰ë•vi•Şśj: ‘ć16‰ń“ú–{•ŞŽqś•¨Šw‰ď i93.12.19j, ç—t, —vŽ|W, p.400, 1993.

173. mŠw‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j •â‘ĚŠˆŤ‰ťƒŒƒNƒ`ƒ“RaRF. ‚ŽR‹g‰iCěăł–çi•Şśj: ‘ć69‰ń“ú–{×‹ŰŠw‰ďŠÖ“ŒŽx•”‘‰ď i93.06.25j, ‘Š–ÍŒ´, —\eW, p.68`69, 1993.

174. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒƒ`ƒVƒŠƒ“‘ϐŤ‰ŠFƒuƒhƒE‹…‹Ű‚ĚŽŠŒČ—n‹Ű‚ÉŠÖ‚ˇ‚錤‹†|‘ć3•ń|ŽŠŒČ—n‹Ű‘ϐŤ•ĎˆŮŠ”‚ɂ‚˘‚Ä. ’†‘şŒiŽqCˆŔ’B—RiäݗLť–ňjCź“ck“ńi•ŞśjC^“cŽŔC’†ěWiäݗLť–ňjCěăł–çi•Şśj: ‘ć69‰ń“ú–{×‹ŰŠw‰ďŠÖ“ŒŽx•”‘‰ď i93.06.24j, ‘Š–ÍŒ´, —\eW, p.23, 1993.

175. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ”÷ś•¨‚̐v‘ŹŒŸo–@: RMDS–@‚É‚ć‚鐜‹Ű”‚Ě‘Ş’č. ŁŒËiC“AłŒ C–ĺŽi‰Ŕ•vi“ú–{ƒ~ƒŠƒ|ƒAjCěăł–çi•Şśj: ‘ć69‰ń“ú–{×‹ŰŠw‰ďŠÖ“ŒŽx•”‘‰ď i93.06.24j, ‘Š–ÍŒ´, —\eW, p.50, 1993.

176. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒqƒgRaRF‚Ě•â‘ĚŠˆŤ‰ťŹ•ŞP1OO‚ĚˆęŽŸ\‘˘. ‚“cŽj’jiŽ™jC‚ŽR‹g‰ii•ŞśjC‰Ł—m”üiś‰ťŒnjCŽü“řCěăł–çi•Şśj: ‘ć30‰ń•â‘ĚƒVƒ“ƒ|ƒWƒEƒ€ i93.07.21j, “Œ‹ž, —\eW, p.46`47, 1993.

177. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŒŒ´ŽE‹ŰˆöŽqRaRF‚ĚƒvƒƒeƒA[ƒ[Ź•Ş‚ĚˆęŽŸ\‘˘. ‚ŽR‹g‰iC‚“cŽj’ji•ŞśjC‰Ł—m”üiś‰ťŒnjCěăł–çi•Şśj: ‘ć6‰ńˆâ“`Žq‚Ć‚ť‚ĚŽü•ÓŒ¤‹†‰ď i93.07.31j, ÂX, ˆâ“`Žq‚Ć‚ť‚ĚŽü•Ó, 6: 20, 1993.

178. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ”’‹ŕ‰ť‡•¨‚̍R‚Ş‚ńě—p‚Ɛt“ŐŤ“™‚Ě•›ě—p”­Œť‹@\‚̉đ–ž. Šĺ’J˜a”Ni•ŞśjC–ěŒł‚Ż‚˘Žqiś‰ťŒnjC’†“‡—mˆęC’†‘ş‘‰qi•Şśj: ‘ć5‰ńt‚ĆƒtƒŠ[ƒ‰ƒWƒJƒ‹Œ¤‹†‰ď i93.09.16j, “Œ‹ž.

179. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ‹›‚Ěƒzƒ‹ƒ‚ƒ“‚Š‚çƒqƒg‚Ěƒzƒ‹ƒ‚ƒ“‚Ö. Ź–ě‰ë•vi•Şśj: _“ސě‹ZpƒAƒJƒfƒ~[ˆâ“`ŽqHŠwƒR[ƒXuK‰ď i93.07.29j, ‘Š–ÍŒ´.

180. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ƒ`ƒIƒyƒ“ƒ^[ƒ‹—n‰t‚Š‚ç”­ś‚ˇ‚éĽOH‚Ɛś‘Ě‚ĚƒqƒhƒƒLƒVƒ‹ƒ‰ƒWƒJƒ‹ƒXƒgƒŒƒX. ’†‘ş‘‰qCŠĺ’J˜a”Ni•ŞśjC‰œ•xr”Vi–ƒjC–ěŒł‚Ż‚˘Žqiś‰ťŒnj: ‘ć5‰ń‹ž•l’nˆćś‘ĚƒtƒŠ[ƒ‰ƒWƒJƒ‹ŽŔŒą‹ZpŒđ—Ź‰ď i93.12.18j, ‰Ą{‰ę.

181. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ƒ`ƒIƒyƒ“ƒ^[ƒ‹—n‰t‚Š‚ç”­ś‚ˇ‚éĽOHƒ‰ƒWƒJƒ‹‚Ɛś‘Ě‚Ě"Hydroxyl Radical Stress. ‰œ•xr”Vi–ƒjC’†‘ş‘‰qi•Şśj: ‘ć5‰ń‹ž•l’nˆćś‘ĚƒtƒŠ[ƒ‰ƒWƒJƒ‹ŽŔŒą‹ZpŒđ—Ź‰ď i93.12.18j, ‰Ą{‰ę.

182. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ”’‹ŕ‰ť‡•¨‚ĚƒqƒhƒƒLƒVƒ‹ƒ‰ƒWƒJƒ‹‚ĚŽYś‚ĆDNA‚É‹y‚Ú‚ˇě—p. ’†‘ş‘‰qCŠĺ’J˜a”Ni•ŞśjC‰œ•xr”Vi–ƒjC–ěŒł‚Ż‚˘Žqiś‰ťŒnj: ‘ć5‰ń‹ž•l’nˆćś‘ĚƒtƒŠ[ƒ‰ƒWƒJƒ‹ŽŔŒą‹ZpŒđ—Ź‰ď i93.12.18j, ‰Ą{‰ę.

183. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ”’‹ŕ‰ť‡•¨ƒVƒXƒvƒ‰ƒ`ƒ“‚É‚ć‚éĽOHƒ‰ƒWƒJƒ‹ŽYś‚ĆDNA‚ւ̉e‹ż. Šĺ’J˜a”NC’†‘ş‘‰qi•Şśj: ‘ć5‰ń‹ž•l’nˆćś‘ĚƒtƒŠ[ƒ‰ƒWƒJƒ‹ŽŔŒą‹ZpŒđ—Ź‰ď i93.12.18j, ‰Ą{‰ę.


<<04 7 •ŞŽqś•¨Šw>>

184. m“Á‹–ĽˆÓ “o˜^n ś‹Ű”‚Ě‘Ş’č•ű–@, ěăł–çi•ŞśjCŁŒËiC“AłŒ i“ú–{ƒ~ƒŠƒ|ƒAj.

185. m“Á‹–ĽˆÓ “o˜^n Organogermanium compounds and process for producing the samei—L‹@ƒQƒ‹ƒ}ƒjƒEƒ€‰ť‡•¨‚̍‡Ź–@‚ÉŠÖ‚ˇ‚é“Á‹–j, Š`–{‹I”ŽióˆäƒQƒ‹ƒ}Œ¤jC’†‘ş‘‰qi•ŞśjC‹gŒ´“OióˆäƒQƒ‹ƒ}Œ¤j.

186. mŠw‰ďŽĺĂi’n•ű‰ďjn ‘ć69‰ń“ú–{×‹ŰŠw‰ďŠÖ“ŒŽx•”‘‰ď(93.06.24`25), ěăł–çi•Şśj.


<<05 –ň—Šw>>

187. mŒ´’˜n Major kininases in rat urine are neutral endopeptidase and carboxypeptidase Y-like exopeptidase. ŒI—Ń‹`˜aC”n“ˆł—˛CŽ­ŽćMi–ň—jC‰Á“Ą‹v—Yi‘—§zŠÂŠí•aƒZƒ“ƒ^[j: Biomedical Research, 14(3): 191`201, 1993.

188. mŒ´’˜n Transmigration routes and a delayed systemic hypertension in rats after intraperitoneal injection of endotoxin from Escherichia coli. ™–{Ÿ•Fi‹~–˝jCě‘ş“šŽqCŽ­ŽćMi–ň—jCV“Ął‹PC‘ĺ˜a“c—˛i‹~–˝j: Circ. Shock, 41: 185`196, 1993.

189. mŒ´’˜n The presence of two sites of action of endothelins in the isolated rabbit iris sphincter and dilator muscles. Îě‹ĎC‹g•xŒ’ŽuiŠájCŒ´“c–FĆCŽ­ŽćMi–ň—jCÎě“NiŠáj: Curr. Eye Res., 12: 1049`1055, 1993.

190. mŒ´’˜n Poststatin, a novel inhibitor of bradykinin-degrading enzymes in rat urine. ”n“ˆł—˛i–ň—jC“‡çŽqCÄ“Ą^Šóiś•¨‰ťŠwŒnjCŒI—Ń‹`˜aCŽ­ŽćMi–ň—jCÂ–ö‚–žiş˜a–ň‘ĺj: Eur. J. Pharmacol., 232: 181`190, 1993.

191. mŒ´’˜n High sensitivity to salt in kininogen-deficient Brown Norway Katholiek rats. ”n“ˆł—˛i–ň—jC‹g“cCCŽOŒ´°Ž}iŽŔ“ŽŒnjC•“ĄŒ’iŽŔ“ŽjCaăiiŽO•H‰ťŹjCŒI—Ń‹`˜aCŽ­ŽćMi–ň—jC‘ĺÎKŽqi–ňŠw•”j: Hypertension, 22(5): 705`714, 1993.

192. mŒ´’˜n Activation of phospholipase C as a primary target of the thromboxane A2-mediated amplification mechanism in thrombin-induced rabbit platelete activation. ě‘ş“šŽqC‰Šˆ¤—ćCŒ´“c–FĆCŽ­ŽćMi–ň—j: Platelets, 5: 20`28, 1994.

193. mŒ´’˜n Interaction of substance P and leukotriene C4 in ehanol-induced mucosal injury of rat stomach. Ž­ŽćMC‘ĺ–ě—˛CźŽR˜a’ji–ň—j: Regul. Pep., 46: 241`243, 1993.

194. m€Œ´’˜n Multiple effects of eicosapentaenoic acid on the arachidonic acid metabolism in human platelets. Ž­ŽćMCě‘ş“šŽqi–ň—j: Advances in Polyunsaturated Fatty Acid Research, p.87`90, 1993.

195. m€Œ´’˜n A preventive mechanism of capsaicin in microcirculation against ethanol-induced gastric mucosal injury in rat. ‘ĺ–ě—˛CŽ­ŽćMC—эO”üCźŽR˜a’ji–ň—jCźŒłŽ›Ž—çi“ŕj: Microcirc. Ann., 9: 121`122, 1993.

196. m€Œ´’˜n Mechanism of the passage of polymorphonuclear leukocytes between endothelial cells in hamster cheek pouch. ”¨’†ŒöCŽ­ŽćMi–ň—j: Microcirc. Ann., 9: 153`154, 1993.

197. m€Œ´’˜n “ŕ”ç×–E‚Ě‘˝Ę‚Č–đŠ„. Ž­ŽćMi–ň—j: Therapeutic Research, 14(12): 5152`5164, 1993.

198. mŒ¤‹†•ńi•ś•”Čjn •a‘Ôƒ‚ƒfƒ‹‚É‚¨‚Ż‚郊ƒCƒRƒgƒŠƒGƒ“‚Ć‘ź‚Ěmediator‚Ě‘ŠŒÝě—p‚Ć‚ť‚̐§Œä. Ž­ŽćMi–ň—j: •˝Ź2`4”N“x•ś•”Č‰ČŠwŒ¤‹†”ď•â•‹ŕiˆę”ĘŒ¤‹†(B)jŒ¤‹†Ź‰Ę•ń‘, p.1`31, 1993.


<<05 2 –ň—Šw>>

199. m‘ŕn ‰ŠÇ”˝‰ž‚Ɛڒ…•ŞŽq. Ž­ŽćMi–ň—j: ƒzƒ‹ƒ‚ƒ“‚Ć—Ő°, 41(4): 323`328, 1993.

200. m‘ŕn ƒAƒ‰ƒLƒhƒ“Ž_‘ăŽÓ•¨. Ž­ŽćMC”¨’†ŒöCŒ´“c–FĆCě‘ş“šŽqC‘ĺ–ě—˛i–ň—j: ƒƒrƒI, 10(9): 92`101, 1993.

201. m‘ŕn ƒLƒjƒmƒQƒ“Œ‡‘šƒ‰ƒbƒg‚É‚¨‚Ż‚鍂ŒŒˆł‚Ě”­Ç‚ĆƒŒƒZƒvƒ^[. ”n“ˆł—˛CŽ­ŽćMi–ň—j: ˆăŠw‚Ě‚ ‚ä‚Ý, 168(4): 241`244, 1994.

202. m‘ŕn ”’ŒŒ‹…‚ĚŒŒŠÇ•Ç’ʉ߂Ɛڒ…ˆöŽq. Ž­ŽćMC”¨’†Œöi–ň—j: ‰ŠÇ‚ƖƉu, 1(5): 444`450, 1993.

203. m‘ŕn ‰ŠÇ. Ž­ŽćMi–ň—j: Œť‘ăˆă—Ă, 25(5): 1651`1656, 1993.

204. m‘ŕn ”÷ŹzŠÂáŠQ‚ĆƒGƒCƒRƒTƒCƒmƒCƒh. Ž­ŽćMi–ň—j: Œť‘ăˆă—Ă, 26(2): 109`115, 1994.

205. m‘ŕn ‹CŠÇŽxšb‘§‚Ěmediator‚Ć‚ľ‚Ä‚Ěleukotrienes, thromboxane, PAF‚¨‚ć‚Ńkinin. Ž­ŽćMC”n“ˆł—˛i–ň—jCă–ěWŒ›i–ňŠw•”jC‰Pˆä—TCˆîŁ’ź•Fi“Œ‹žˆăŽ•‘ĺj: ŒÄ‹z, 12(12): 1526`1537, 1993.

206. m‘ŕn ƒGƒ^ƒm[ƒ‹‚ĆˆÝ”S–ŒŠQ|H‰–…‚Ɛ_Œoƒyƒvƒ`ƒh|. Ž­ŽćMC‘ĺ–ě—˛CźŽR˜a’jC—é–Ř—Ti–ň—j: –k—˘ˆăŠw, 23(4): 239`250, 1993.

207. m‘ŕn •›ě—p‚Ě‚Č‚˘V‚ľ‚˘ƒ^ƒCƒv‚Ě”ńƒXƒeƒƒCƒhŤR‰ŠÇ–ň‚̉”\Ť. Œ´“c–FĆCŽ­ŽćMi–ň—j: –ň‹Ç, 45(1): 481`485, 1994.

208. m‘ŕn ‰ŠÇ‚ĚƒƒfƒBƒG[ƒ^ĽƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“‚̐ł‘Ě: ‰ŠÇ‚É‚¨‚Ż‚éƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“‚Ě–đŠ„. Œ´“c–FĆCŽ­ŽćMi–ň—j: –ň‹Ç, 45(3): 945`951, 1994.

209. mŠwp‘n i•Ş’SŽˇ•Mj ƒAƒŒƒ‹ƒM[Ť‰ŠÇ; ƒAƒŒƒ‹ƒM[Ť‰ŠÇ‚ĚŠT”O‚ƍl‚Ś•ű, p.10`19, Ž­ŽćMi–ň—j. •ŇW –q–ě‘‘•˝i“Ć‹Śˆă‘ĺjC ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽĐ, “Œ‹ž, 93.11.20”­s.

210. mŠwp‘n i•Ş’SŽˇ•Mj ƒLƒjƒ“‚ĆƒAƒ“ƒWƒIƒeƒ“ƒVƒ“; ‡T. ˜Í, p.1`8, Ž­ŽćMi–ň—j. •ŇW ‘ĺÎKŽqi–ňŠw•”jC‰Á“Ą‹v—Yi‘—§zŠÂŠí•aƒZƒ“ƒ^[jCŽO‘î‰Â_iś‘Ě‹@”\Œ¤jC ŠÄC Ž­ŽćMCź”öŽő”VC u’kŽĐƒTƒCƒGƒ“ƒeƒBƒtƒBƒN, “Œ‹ž, 94.02.10”­s.

211. mŠwp‘n i•Ş’SŽˇ•Mj ƒLƒjƒ“‚ĆƒAƒ“ƒWƒIƒeƒ“ƒVƒ“; ‡X. ś‘Ě“ŕ‚Ě–đŠ„ 1.1 ‘˜_, p.104`110, Ž­ŽćMi–ň—j. •ŇW ‘ĺÎKŽqi–ňŠw•”jC‰Á“Ą‹v—Yi‘—§zŠÂŠí•aƒZƒ“ƒ^[jCŽO‘î‰Â_iś‘Ě‹@”\Œ¤jC ŠÄC Ž­ŽćMCź”öŽő”VC u’kŽĐƒTƒCƒGƒ“ƒeƒBƒtƒBƒN, “Œ‹ž, 94.02.10”­s.

212. mŠwp‘n i•Ş’SŽˇ•Mj ƒLƒjƒ“‚ĆƒAƒ“ƒWƒIƒeƒ“ƒVƒ“; ‡V.3 ƒLƒjƒ“•Ş‰đy‘f, p.59`68, ”n“ˆł—˛i–ň—j. •ŇW ‘ĺÎKŽqi–ňŠw•”jC‰Á“Ą‹v—Yi‘—§zŠÂŠí•aƒZƒ“ƒ^[jCŽO‘î‰Â_iś‘Ě‹@”\Œ¤jC ŠÄC Ž­ŽćMCź”öŽő”VC u’kŽĐƒTƒCƒGƒ“ƒeƒBƒtƒBƒN, “Œ‹ž, 94.02.10”­s.

213. mŠwp‘n i•Ş’SŽˇ•Mj ƒLƒjƒ“‚ĆƒAƒ“ƒWƒIƒeƒ“ƒVƒ“; ‡X.1.1.3 ƒLƒjƒ“‚ƏzŠÂ, p.119`129, ”n“ˆł—˛i–ň—j. •ŇW ‘ĺÎKŽqi–ňŠw•”jC‰Á“Ą‹v—Yi‘—§zŠÂŠí•aƒZƒ“ƒ^[jCŽO‘î‰Â_iś‘Ě‹@”\Œ¤jC ŠÄC Ž­ŽćMCź”öŽő”VC u’kŽĐƒTƒCƒGƒ“ƒeƒBƒtƒBƒN, “Œ‹ž, 94.02.10”­s.

214. mŠwp‘n iŠÄCj ƒLƒjƒ“‚ĆƒAƒ“ƒWƒIƒeƒ“ƒVƒ“; ŠÄC Ž­ŽćMi–ň—jCź”öŽő”Vi‘—§zŠÂŠí•aƒZƒ“ƒ^[jC u’kŽĐƒTƒCƒGƒ“ƒeƒBƒtƒBƒN, “Œ‹ž, 94.02.10”­s.


<<05 5 –ň—Šw>>

215. mŠw‰ďi‘Űjn i“Á•Ęu‰‰j Natriuretic role of the urinary kallikrein-kinin system in the development of hypertension in rats. Ž­ŽćMC”n“ˆł—˛i–ň—j: 10th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology i93.05.10j, Malaysia, Asia Pac. J. Pharmacol., 8(suppl.2): 80, 1993.

216. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Analyses of neutrophil extravasation in microcirculation of hamster cheek pouch by intravital microscopy. Ź“c—˛ŽĄC”¨’†ŒöCŽ­ŽćMi–ň—j: 1st Asian Congress for Microcirculation i93.09.27`29j, ‘ĺă, abstracts, p.52, 1993.

217. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Are selective cyclooxygenase-2 inhibitors useful as selective anti-inflammatory drugs?. Ž­ŽćMi–ň—j: World Congress of Inflammation (Inflammation '93) i93.10.10`15j, ƒEƒB[ƒ“, Abstract, p.41, 1993.

218. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Sodium retention as a cause of hypertension in kininogen-deficient Brown Norway Katholiek rats. Ž­ŽćMC”n“ˆł—˛i–ň—jC‘ĺÎKŽqi–ňŠw•”j: KININ'93 i93.10.17`22j, ƒuƒ‰ƒWƒ‹, Abstract book, p.142, 1993.

219. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Development of high sensitive enzyme-linked immunosorbent assay (ELISA) of bradykinin and its aplication for determination of free kinin levels in human biological fluids. ‰Á“Ą‹v—Yi‘—§zŠÂŠí•aƒZƒ“ƒ^[jCŒI—Ń‹`˜aC”n“ˆł—˛CŽ­ŽćMi–ň—jCÂ–ö‚–žiş˜a–ň‘ĺj: KININ'93 i93.10.17`22j, ƒuƒ‰ƒWƒ‹, Program and Abstract book, p.62, 1993.

220. mŠw‰ďi‘Űjn iƒ[ƒNƒVƒ‡ƒbƒvj Possible involvement of inducible cyclooxygenase (COX) in carrageenin-incuced pleurisy. Œ´“c–FĆC”¨’†ŒöCě‘ş“šŽqC”n“ˆł—˛i–ň—jC‚Œ´ŽO’qŽqCÄ“Ą^Šóiś•¨‰ťŠwŒnjC‘ĺ–ě—˛CŽ­ŽćMi–ň—j: World Congress of Inflammation (Inflammation '93) i93.10.10`15j, ƒEƒB[ƒ“, Abstract, p.52, 1993.

221. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j A preventive mechanism of capsaicin against ethanol-induced gastric mucosal injury in rats. ‘ĺ–ě—˛CŽ­ŽćMC—эO”üCźŽR˜a’ji–ň—jCźŒłŽ›Ž—çi“ŕj: 1st Asian Congress for Microcirculation i93.09.27`29j, ‘ĺă, Abstracts, p.128, 1993.

222. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Characterization of a novel carboxypeptidase Y-like kininase in rat urine. ”n“ˆł—˛i–ň—jCťŒ´Œ›”Vi‘ĺ“ú–{ť–ňjCźŽRkˆę˜YiŽ¨•@jCŽ­ŽćMi–ň—j: KININ'93 i93.10.17`22j, ƒuƒ‰ƒWƒ‹, Abstract book, p.127, 1993.

223. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Enhancement of bradykinin-induced bronchoconstriction by captopril is not due to inhibition of kininase ‡U, but to neuropeptide release in guinea-pigs. ”n“ˆł—˛C‰Pˆä—TCˆîŁ’ź•Fi–ň—jCrě^”VC‰iˆäˆęŹi–ƒjCŽ­ŽćMi–ň—j: KININ'93 i93.10.17`22j, ƒuƒ‰ƒWƒ‹, Abstract book, p.62, 1993.

224. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j A low dose angiotensin ‡U-induced hypertension in kininogen deficient Brown Norway Katholiek rats. ”n“ˆł—˛i–ň—jCaăiiŽO•H‰ťŹjCŽ­ŽćMi–ň—j: KININ'93 i93.10.17`22j, ƒuƒ‰ƒWƒ‹, Abstract book, p.87, 1993.

225. mŠw‰ďi‘S‘jn i“Á•Ęu‰‰j tƒJƒŠƒNƒŒƒCƒ“|ƒLƒjƒ“Œn‚ĚƒiƒgƒŠƒEƒ€”rŸ•ě—p‚É‚ć‚鍂ŒŒˆł”­Ç‚Ě—}§. Ž­ŽćMi–ň—j: ‘ć67‰ń“ú–{–ň—Šw‰ď”N‰ď i94.03.21`24j, ‹ž“s, Jpn. J. Pharmacol., 64(suppl.1): 4, 1994.

226. mŠw‰ďi‘S‘jn i‹łˆçu‰‰j ×–EŠÔƒVƒOƒiƒ‹‚Ěƒpƒ‹ƒXó”­ś‚É‚ć‚é‹}Ť‰ŠÇ‚ĚŒo‰ß. Ž­ŽćMi–ň—j: ‘ć14‰ń“ú–{‰ŠÇŠw‰ď i93.06.24`25j, Šň•Œ, —\eW, p.57, 1993.

227. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‚ŒŒˆł”­Ç‚Ěˆâ“`“I”wŒi‚Ć‚ľ‚Ă̐tƒJƒŠƒNƒŒƒCƒ“[ƒLƒjƒ“Œn. ”n“ˆł—˛CŽ­ŽćMi–ň—j: ‘ć29‰ń‚ŒŒˆłŽŠ‘R”­Çƒ‰ƒbƒgŠw‰ď‘‰ď i93.09.30`10.01j, “Œ‹ž, —\eW, p.26, 1993.

228. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒLƒjƒmƒQƒ“Œ‡‘šƒ‰ƒbƒg‚É‚¨‚Ż‚鍂ŒŒˆł‚Ě”­Ç‚ĆƒŒƒZƒvƒ^[. Ž­ŽćMC”n“ˆł—˛i–ň—j: ‘ć21‰ń–ň•¨ŠˆŤƒVƒ“ƒ|ƒWƒEƒ€ i93.11.12`13j, ‰Ą•l, —vŽ|W, p.159`166, 1993.

229. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒGƒ^ƒm[ƒ‹ŠQŽž‚ĚˆÝ”S–Œ”÷ŹzŠÂ‚̕ωť‚Ć‚ť‚Ě–hŒä. Ž­ŽćMC‘ĺ–ě—˛CźŽR˜a’ji–ň—j: ‘ć21‰ń“ú–{ŽŔŒą’×ᇊw‰ď i93.12.04j, ç—t, —\eW, p.22, 1993.

230. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒLƒjƒ“•Ş‰đ‘jŠQ‚ƍ~ˆł. ”n“ˆł—˛CŽ­ŽćMi–ň—j: ‘ć67‰ń“ú–{–ň—Šw‰ď”N‰ď i94.03.21`24j, ‹ž“s, Jpn. J. Pharmacol., 64(suppl.1): 47, 1994.

231. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒGƒ“ƒhƒgƒLƒVƒ“‚Ěƒ‰ƒbƒgĂ–Ź“ŕ“Š—^‚É‚ć‚鏬’°•a•Ď‚Ě‹@˜‚Ć‚ť‚Ě—}§. V“Ął‹PC™–{Ÿ•FC‘ĺ˜a“c—˛i‹~–˝jC‘ĺ–ě—˛C”n“ˆł—˛CŽ­ŽćMi–ň—j: ‘ć8‰ń“ú–{ShockŠw‰ď‘‰ď i93.04.17j, ě‰z, Shock, 8(2): 29, 1993.

232. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ×Ă–ŹŒŒŠÇ“ŕ”ç×–Eă‚É”S’…‚ľ‚˝D’†‹…‚Ě“ŕ”ç×–EŠÔ’ʉߋ@\. ”¨’†ŒöCŽ­ŽćMi–ň—j: ‘ć18‰ń“ú–{”÷ŹzŠÂŠw‰ď‘‰ď i93.04.22`23j, “Œ‹ž, ´˜^W, p.34, 1993.

233. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒGƒ^ƒm[ƒ‹(EtOH)ˆÝ”S–ŒŠQ‚É‚¨‚Ż‚écalcitonin gene-related peptide (CGRP)‚Ě–đŠ„. ‘ĺ–ě—˛CŽ­ŽćMC—эO”üCźŽR˜a’ji–ň—jCźŒłŽ›Ž—çi“ŕj: ‘ć18‰ń“ú–{”÷ŹzŠÂŠw‰ď‘‰ď i93.04.22`23j, “Œ‹ž, ´˜^W, p.51, 1993.

234. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒAƒiƒtƒBƒ‰ƒLƒV[Ťƒ‚ƒ‹ƒ‚ƒbƒg”ç“ŕ”˝‰ž‚¨‚ć‚Ń‹C“š”˝‰ž‚ɑ΂ˇ‚éƒXƒŒƒvƒ^ƒ“Ž_ƒƒ`ƒ‹ƒvƒŒƒhƒjƒ]ƒƒ“(V-67590A)‚Ě‘ŚŽžŤ—}§Œř‰Ę. ‹´–{@Oi–ň—jCŽÂč—F”üiƒAƒbƒvƒWƒ‡ƒ“jCŽ­ŽćMi–ň—j: ‘ć14‰ń“ú–{‰ŠÇŠw‰ď i93.06.24`25j, Šň•Œ, —\eW, p.113, 1993.

235. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠeŽí•˝ŠŠ‹Ř‚É‚¨‚Ż‚éƒyƒvƒ`ƒhƒƒCƒRƒgƒŠƒGƒ“Žó—e‘Ě‚Ě‹@”\“I‚Č•Ş—Ţ. Œ´“c–FĆi–ň—jCT. BjorckCS.-E. DahlenCP. HedqvistiƒJƒƒŠƒ“ƒXƒJŒ¤‹†ŠjCŽ­ŽćMi–ň—j: ‘ć14‰ń“ú–{‰ŠÇŠw‰ď i93.06.24`25j, Šň•Œ, —\eW, p.127, 1993.

236. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j G-CSF“Š—^Žž‚Ěƒ‰ƒbƒgƒJƒ‰ƒQƒjƒ“‹š–Œ‰ŠZD’†‹‰”‚ĚŒoŽž•Ď‰ť. ‚Œ´ŽO’qŽqiś•¨‰ťŠwŒnjC”n“ˆł—˛Cě‘ş“šŽqi–ň—jCÄ“Ą^Šóiś•¨‰ťŠwŒnjC‘ĺ–ě—˛CŽ­ŽćMi–ň—j: ‘ć14‰ń“ú–{‰ŠÇŠw‰ď i93.06.24`25j, Šň•Œ, —\eW, p.140, 1993.

237. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j D’†‹…‚Ě×Ă–Ź“ŕ’ʉ߂ɑ΂ˇ‚錌Ÿ÷Ÿřo‘jŠQ–ň‚ĚŒř‰Ę. ”¨’†ŒöC”n“ˆł—˛CŽ­ŽćMi–ň—j: ‘ć14‰ń“ú–{‰ŠÇŠw‰ď i93.06.24`25j, Šň•Œ, —\eW, p.71, 1993.

238. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒgƒJƒ‰ƒQƒjƒ“‹š–Œ‰Š‚É‚¨‚Ż‚éƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“H‡Źy‘f°2‚Ě‘I‘đ“I”­Œť. Œ´“c–FĆC”¨’†Œöi–ň—jCÄ“Ą^Šóiś•¨‰ťŠwŒnjC”n“ˆł—˛i–ň—jC‚Œ´ŽO’qŽqiś•¨‰ťŠwŒnjCě‘ş“šŽqC‘ĺ–ě—˛CŽ­ŽćMi–ň—j: ‘ć67‰ń“ú–{–ň—Šw‰ď”N‰ď i94.03.21`24j, ‹ž“s, Jpn. J. Pharmacol., 64(suppl.1): 94, 1994.

239. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆÝ”S–Œ‰ş”÷ŹzŠÂ‚ɑ΂ˇ‚éƒGƒ“ƒhƒZƒŠƒ“-1‹y‚ŃƒGƒ“ƒhƒZƒŠƒ“-3‚̍ě—p. ‘ĺ–ě—˛CŽ­ŽćMC—эO”üCźŽR˜a’ji–ň—jCźŒłŽ›Ž—çi“ŕj: ‘ć35‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď i93.09.20`22j, _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ, 90(—Ő): 1860, 1993.

240. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒg‚É‚¨‚Ż‚éƒIƒLƒVƒgƒVƒ“Ă’‚É‚ć‚é”AƒJƒŠƒNƒŒƒCƒ“‚Ě”rŸ•‘‘ĺ. ˆŔ’BŒhˆęC”n“ˆł—˛i–ň—jCź“‡ł”ŽiŽY•wjCŽ­ŽćMi–ň—j: ‘ć67‰ń“ú–{–ň—Šw‰ď”N‰ď i94.03.21`24j, ‹ž“s, Jpn. J. Pharmacol., 64(suppl.1): 258, 1994.

241. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒGƒ^ƒm[ƒ‹ˆÝ”S–ŒŠQ‚ɑ΂ˇ‚éƒJƒvƒTƒCƒVƒ“‚Ě•ŰŒě‹@\. ‘ĺ–ě—˛C—эO”üC”¨’†ŒöCŽ­ŽćMi–ň—j: ‘ć67‰ń“ú–{–ň—Šw‰ď”N‰ď i94.03.21`24j, ‹ž“s, Jpn. J. Pharmacol., 64(suppl.1): 284, 1994.

242. mŠw‰ďi’n•űjn i“Á•Ęu‰‰j ”÷ŹzŠÂ‚É‚¨‚Ż‚é‘˝Ę‚ČŒŒŠÇ“ŕ”ç×–E‚Ě–đŠ„. Ž­ŽćMi–ň—j: ‘ć31‰ń–k“ú–{Šá‰ČŠw‰ď, ‘ć10‰ńŠá”÷ŹzŠÂŒ¤‹†‰ď i93.07.01`03j, •Ÿ“‡, Therapeutic Research, 14(12): 230`242, 1993.

243. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒGƒ“ƒhƒgƒLƒVƒ“Ă’Œă‚Ěƒ‰ƒbƒg’°ŠÇŠQ‚Ěƒgƒƒ“ƒ{ƒLƒTƒ“‡Źy‘f‘jŠQ–ň‚É‚ć‚é—}§. V“Ął‹PC™–{Ÿ•Fi‹~–˝jC‘ĺ–ě—˛Cě‘ş“šŽqC”n“ˆł—˛CŽ­ŽćMi–ň—j: ‘ć88‰ń“ú–{–ň—Šw‰ďŠÖ“Œ•”‰ď i93.06.19j, ç—t.

244. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒGƒ“ƒhƒgƒLƒVƒ“Ă’Œă‚Ěƒ‰ƒbƒg’°ŠÇŠQ‚Ěƒgƒƒ“ƒ{ƒLƒTƒ“‡Źy‘f‘jŠQ–ň‚É‚ć‚é—}§. V“Ął‹PC™–{Ÿ•Fi‹~–˝jC‘ĺ–ě—˛Cě‘ş“šŽqC”n“ˆł—˛CŽ­ŽćMi–ň—j: ‘ć88‰ń“ú–{–ň—Šw‰ďŠÖ“Œ•”‰ď i93.06.19j, ç—t, “ú–{–ň—ŠwŽGŽ, 102(4): 63, 1993.

245. mŒ¤‹†‰ďi‘S‘jn i“Á•Ęu‰‰j ƒGƒ^ƒm[ƒ‹ˆÝ”S–ŒŠQ‚Ě”­ś‹@\‚Ć‚ť‚Ě—}§|‰–‚Ćƒjƒ…[ƒƒyƒvƒ^ƒCƒh|. Ž­ŽćMi–ň—j: Á‰ťŤ’×ᇍĔ­—\–hŒ¤‹†‰ď(APRT)’†ŠÔŒŸ“˘‰ď i93.05.21j, “Œ‹ž.

246. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ŠeŽíŽŔŒą“Ž•¨‚É‚¨‚Ż‚éTXB2‚Š‚ç11-dehydro-TXB2‚Ö‚Ě•ĎŠˇ‚̮퍷. ě‘ş“šŽqCŒ´“c–FĆCŽ­ŽćMi–ň—j: ‘ć3‰ń“Œ‹žƒvƒƒXƒ^ƒOƒ‰ƒ“ƒfƒBƒ“Œ¤‹†‰ď i93.05.22j, “Œ‹ž.


<<06 ”÷ś•¨Šw>>

247. mŒ´’˜n ƒOƒ‰ƒ€—zŤ‹…‹Ű‚ɑ΂ˇ‚é teicoplanin ‚̍R‹Ű—Í‚Ć‚ť‚ĚŠî‘b“IŒŸ“˘. ˆäăź‹vi”÷jC’ˇ‘]•”‹IŽqC–ěXŽRŸliŽ™j: Chemotherapy (Jpn.), 41(S-2): 47`55, 1993.

248. mŒ´’˜n ‘˝Ü‘ϐŤ‰ŠFƒuƒhƒE‹…‹Ű‚ÉŠÖ‚ˇ‚錤‹† (‡Z)š\႗R—ˆ‚Ě MRSA ‚¨‚ć‚їΔ^‹Ű‚ɑ΂ˇ‚é arbekasin ‚Ć cefuzonam ‚Ě in vitro •š—pŒř‰Ę. “n•Ó˛CŻŽiăŕC”óŒű“OCˆäăź‹vi”÷j: Chemotherapy (Jpn.), 42: 19`25, 1994.

249. mŒ´’˜n pŒăŠ´őÇ‚ɑ΂ˇ‚é cefuzonam ‚Ě—Ő°“IŒŸ“˘. ‘’nM–çC’YŽR‰ĂLCŒI“cŽŔCˆäě–M•FC‰Ş–{NC—L”n—zˆęCÂ–ö—zˆęC‹g“c—SˆęC”óŒű“OCˆäăź‹vi”÷j: Chemotherapy (Jpn.), 42: 47`52, 1994.

250. mŒ´’˜n CD4+CD8+ cells lacking self-Mls reactive T cells are induced in mesenteric lymph nodes of Salmonella enteritidis infected mice. ‹Ę“ŕGˆęCůŒ´•Žui”÷jCŠ_ś‰€Žqi“ŒŠC‘ĺj: Immunology Letters, 37: 123`130, 1993.

251. mŒ´’˜n Unique properties of a cytotoxic CD4+CD8+ intraepithelial T-cell line established from the mouse intestinal epithelium. ůŒ´•ŽuC‹Ę“ŕGˆęi”÷jC’r˜eM’źiŠĹŒěŠw•”jC‹v•Ű“cFˆęi”÷j: Microbiol. Immunol., 38(3): 191`199, 1994.

252. mŒ´’˜n Modulation of cell surface antigens and regulation of phagocytic activity mediated by CD116 in the monocyte-like cell line 0937 in response to lipopolysaccharide. ’r˜eM’źiŠĹŒěŠw•”jC‹Ę“ŕGˆęi”÷jC’–Žq‰pri“ŒŠC‘ĺj: Tissue Antigens, 42: 125`132, 1993.

253. mŒ´’˜n Mupiroshin •@o—p“îp‚Ě MRSA ‚ɑ΂ˇ‚é—Տ°“IŒŸ“˘; ‘ć‡V‘Š—Տ°ŽŽŒą. ´…Šě”ޘYCŽÄ“c—Y‰îCě–ź—ŃŽĄCÄ“Ą˜aDCÂ–ؑ׎qCŽ–쏹rCŹ—ŃŠ°ˆÉCˆäăź‹vi”÷jC‘ź21–ź: ŠÂ‹ŤŠ´ő, 8: 47`55, 1993.

254. mŒ´’˜n ’áŽ_‘f×–E‘Š´Ü RP-170Eś‘̉ž“šCü•¨Žż OK-432 •š—p•úŽËüŽĄ—Ẩ”\Ť. ‘şŽRçŒbŽqi“ŒŠC‘ĺjC‹Ę“ŕGˆęi”÷jCśŽqFLiƒ|[ƒ‰‰ťśjC•ę—˘’m”Vi“ŒŠC‘ĺj: Šŕ‚Ě—Ő°, 39(14): 1685`1691, 1993.

255. mŒ´’˜n LPS ŽhŒƒ’P‹…Œn×–EŠ”(U937)‚Ě homotypic cell adhesion ‚đ‘jŽ~‚ˇ‚郂ƒmƒNƒ[ƒiƒ‹R‘Ě. ’r˜eM’źiŠĹŒěŠw•”jCůŒ´•ŽuC‹Ę“ŕGˆęi”÷jC’–Žq‰pri“ŒŠC‘ĺj: “ú–{×‹ŰŠwŽGŽ, 48(2): 429`433, 1993.


<<06 2 ”÷ś•¨Šw>>

256. m‘ŕn —Δ^‹ŰŠ´őÇ‚ĚŒť‹ľ‚ĆŽĄ—ĂŽwj| —Δ^‹Ű‚Ě–ňÜ‘ϐŤ“ŽŒü. ˆäăź‹vi”÷j: ƒ‰ƒCƒtƒTƒCƒGƒ“ƒXƒƒfƒCƒJ, 14: 1`7, 1994.

257. m‘ŕn ŠO‘—R—ˆ MRSA ‚Ě–ňÜ‘ϐŤŒ^. ˆäăź‹vi”÷jCˆä“cFŽuC‰Ş–{—šˆę: ˆăŠw‚Ě‚ ‚ä‚Ý, 166: 234`238, 1993.

258. m‘ŕn MRSA ‚Ěƒtƒ@|ƒWŒ^. ˆäăź‹vi”÷jC–ěXŽRŸliŽ™jC‘ĺ‹v•Ű–LŽi: ˆăŠw‚Ě‚ ‚ä‚Ý, 166: 270`273, 1993.

259. m‘ŕn MRSA‚Ě‹łŒP‚ƍĄŒă‚̉@“ੴő–hŽ~‘΍ô(4)‘ϐŤ‹@\‚Š‚ç‚Ý‚˝ŠeŽíR‹ŰÜ‚Ě•Ş—Ţ. –ěXŽRŸliŽ™jCˆäăź‹vi”÷j: ĹVˆăŠw, 49(3): 432`436, 1994.

260. m‘ŕn MRSA ‚Ě‹łŒP‚ƍĄŒă‚̉@“ੴő–hŽ~‘΍ô. (4)‘ϐŤ‹@\‚Š‚ç‚Ý‚˝ŠeŽíR‹ŰÜ‚Ě•Ş—Ţ. –ěXŽRŸliŽ™jCˆäăź‹vi”÷j: ĹVˆăŠw, 49: 432`436, 1994.

261. m‘ŕn –ňÜ‘ϐŤ‚Ćƒgƒ‰ƒ“ƒXƒ|-ƒ\ƒ“. ˆäăź‹vi”÷jC‰Ş–{—šˆę: —Տ°‚Ć”÷ś•¨, 20: 793`800, 1993.

262. m‘ŕn ˆâ“`Žq‚ĹŠ´őÇ‚Í‚Ç‚ą‚܂ʼnđ‚é‚Š. ‚ą‚ą‚܂Ői•ŕ‚ľ‚˝ˆâ“`Žqf’f. (4) MRSA‚̑ϐŤˆâ“`Žq. ˆäăź‹vi”÷j: —Տ°•ŞŽqˆăH, 1: 246`253, 1993.

263. mŠwp‘n i•Ş’SŽˇ•Mj ŽĄ—Ă–ňƒKƒCƒhkŹ”Ĺ; •aŒ´”÷ś•¨‚ɑ΂ˇ‚鎥—Ă–ň/R‹Ű–ň. ƒeƒgƒ‰ƒTƒCƒNƒŠƒ“ŒnRś•¨Žż, p.490`496, ˆäăź‹vi”÷jC‹´–{ŒšˆęC‰iˆä˜aŒČC”óŒű“O. •ŇW ˜a“cUC‘ĺ‹v•ŰşsC‰i“c’źˆęC–îč‹`—YC •śŒő“°C“Œ‹žC1994”­s.

264. mŠwp‘n i•Ş’SŽˇ•Mj •aŒ´‹Ű‚Ě–ňÜ‘ϐŤ; ‹@\‚̉𖞂Ƃť‚Ě‘Îô/˜˜_, p.1`17, ‹´–{ˆęCˆäăź‹vi”÷j. •ŇW ‹´–{ˆęCˆäăź‹vC Šw‰ďo”ĹƒZƒ“ƒ^-C“Œ‹žC1993”­s.

265. mŠwp‘n i•Ş’SŽˇ•Mj ƒLƒmƒƒ“Œn–ňÜ‚ĚŽg‚˘•ű; ƒLƒmƒƒ“–ň‚̍ě—p‹@˜, p.56`75, ˆäăź‹vi”÷j. •ŇW “ˆ“crŒÜ˜YC ˆă–ňƒWƒƒ|ƒiƒ‹ŽĐC“Œ‹žC1993”­s.

266. mŠwp‘n i•Ş’SŽˇ•Mj —Δ^‹Ű‚ť‚ĚŠî‘b‚Ć—Ő°; 2. –ňÜ‘ϐŤ; (6)—Δ^‹Ű‚ĚƒŔ-ƒ‰ƒNƒ^ƒ}|ƒ[‚É‚ć‚é–ňÜ‘ϐŤ, p.37`43, ˆäăź‹vi”÷j. •ŇW “ˆ“crŒÜ˜YC —Δ^‹ŰŒ¤‹†‰ďC“Œ‹žC1993”­s.

267. mŠwp‘n i•Ş’SŽˇ•Mj –ňÜŠ´ŽóŤî•ń(1993”N”Ĺ); “ń–ňÜ‚Ě‘ŠŠÖŠÖŒW‚Š‚ç‚Ý‚˝‰ß‹Ž10”NŠÔ‚Ě–ňÜŠ´ŽóŤ, p.59`83, ˆäăź‹vi”÷j. ˆă—Ïî•ńƒVƒXƒeƒ€ŠJ”­ƒZƒ“ƒ^|’˛¸‰^—p•”,1993”­s.

268. mŠwp‘n i•Ş’SŽˇ•Mj MRSAŠ´őÇ; PCR–@‚É‚ć‚éMRSAv‘Źf’f–@, p.84`90, ‰Ş–{—šˆęC‘ĺ‹v•Ű–LŽiCˆäăź‹vi”÷j. •ŇW ‰Ą“cŒ’C V‹ťˆăŠwo”ŎЁC“Œ‹žC1994”­s.


<<06 3 ”÷ś•¨Šw>>

269. m‚ť‚Ě‘ź‚Ě’˜‘iŽŤ“Tjn i•Ş’SŽˇ•Mj –ƉuŠwŽ–“T; ‹Ę“ŕGˆęi”÷j. •ŇW ‘ĺ‘ň—˜şCŹŽRŽŸ˜YC‰œ“cŒ¤Ž˘C–î“cƒˆęC “Œ‹ž‰ťŠw“Żl, “Œ‹ž, 93.11.15”­s.


<<06 5 ”÷ś•¨Šw>>

270. mŠw‰ďi‘Űjn i“Á•Ęu‰‰j Present status and prospects of antimicrobial agants. Antibiotic resistance in clinical isolates of gram-negative bacteria. Especially ƒŔ-lactam resistance involved in third generation cephems. ˆäăź‹vi”÷j: 5th China-Japan International Congress of Microbiology i93.08.00j, Shanghai, Abstracts, p.1`3, 1993.

271. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j In vitro antibacteria activities of BO-2727, a new ƒŔ-methyl carbapenem. ˆäăź‹vi”÷jC–ěXŽRŸliŽ™jC‰Ş–{—šˆęC’ˇ‘]•”‹IŽqCˆä“cFŽu: 33rd ICAAC i93.00.00j, New Orleans, USA, Abstracts, p.284, 1993.

272. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Antimicrobial activity of arbekacin against gentamicin resistant MRSA. ˆäăź‹vi”÷jCˆä“cFŽuC–ěXŽRŸliŽ™jC’ˇ‘]•”‹IŽqC‰Ş–{—šˆę: 18th ICC i93.00.00j, Stockholm, Abstracts, p.331, 1993.

273. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j In vitro antibacteria activities of BAYy3118, a new quinolone. ˆäăź‹vi”÷jC’ˇ‘]•”‹IŽq: 33rd ICAAC i93.00.00j, New Orleans, Abstracts, p.388, 1993.

274. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Multimodal cancer treatment with radiation therapy, hypoxic cell sensitizer (RP-170) and biological response modifier (OK-432). •ę—˘’m”VC‘şŽRçŒbŽqi“ŒŠC‘ĺjC‹Ę“ŕGˆęi”÷jCśŽqFLi“ŒŠC‘ĺjC‘ź: 8th International Conference on Chemical Modifiers of Cancer Treatment i93.06.16`19j, ‹ž“s, Abstracts, p.207, 1993.

275. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The modification of radiation therapy by RP-170, hypoxic cell sensitizer, and Ok-432, biological response modifier (BRM). ‘şŽRçŒbŽqCśŽqFLi“ŒŠC‘ĺjC‹Ę“ŕGˆęi”÷jCSakaguchi, M.CMori, T.iƒ|[ƒ‰‰ťśj: International Congress of Radiation Oncology i93.06.21`25j, ‹ž“s, Abstracts, p.495, 1993.

276. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€j ’áŽ_‘f×–E‘Š´ÜE–Ɖu•ŠŠˆÜ•š—p•úŽËüŽĄ—Ă‚ĚŠî‘b“IŒ¤‹†. ‘şŽRçŒbŽqi“ŒŠC‘ĺjC‹Ę“ŕGˆęi”÷jC•ę—˘’m”Vi“ŒŠC‘ĺj: ‘ć23‰ń•úŽËü‚É‚ć‚鐧ŠŕƒVƒ“ƒ|ƒWƒEƒ€|Šî‘b‚Ć—Ő°‚Ć‚Ě‘Î˜b| i93.07.10j, “ż“‡, ´˜^W, p.48`49, 1993.

277. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j OVA “ÁˆŮ“I TCR ƒgƒ‰ƒ“ƒXƒWƒ…ƒjƒbƒNƒ}ƒEƒX‚̍쐻‚ƖƉu‰ž“š‚ĚŒŸ“˘. ˛“ĄŒ’li“ŒŠC‘ĺjCůŒ´•Žui”÷jC‘˝“cŒG‘ěŽjCŒF’J‘P”ŽiŒc‰ž‘ĺjCŸ–ŘŒł–çi‹ă‘ĺjCŠ_ś‰€Žqi“ŒŠC‘ĺj: ‘ć23‰ń“ú–{–ƉuŠw‰ď‘‰ď i93.10.18j, ĺ‘ä, “ú–{–ƉuŠw‰ď‘‰ďEŠwpW‰ď‹L˜^, 23: 328, 1993.

278. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •@o“ŕ MRSA ‚Ě•Ű—Ló‹ľ‚ÉŠÖ‚ˇ‚錟“˘. “‡“ŕçŒbŽqC–ěXŽRŸliŽ™jC´…——ĽŽqCˆä“cFŽuCˆäăź‹vi”÷j: ‘ć‚X‰ń“ú–{ŠÂ‹ŤŠ´őŠw‰ď‘‰ď i94.02.19j, “Œ‹ž, ´˜^W, p.38, 1994.

279. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j MRSA ‚̉@“ੴő‚ÉŠÖ‚ˇ‚é‰uŠw“IŒŸ“˘. ˆä“cFŽuC–ěXŽRŸliŽ™jC“‡“ŕçŒbŽqC’ˇ‘]•”‹IŽqCˆäăź‹vi”÷j: ‘ć‚X‰ń“ú–{ŠÂ‹ŤŠ´őŠw‰ď‘‰ď i94.02.19j, “Œ‹ž, ´˜^W, p.72, 1994.

280. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒvƒ‰ƒXƒ~ƒhŽx”z‚̊“ÁˆŮŤ‚̍L‚˘ƒŔ-ƒ‰ƒNƒ^ƒ}|ƒ[ŽYśˆâ“`Žq‚ĚDNA‰–Šî”z—ń‚ɂ‚˘‚Ä. ˆäăź‹vC’ˇ‘]•”‹IŽqC–ěXŽRŸliŽ™jCˆä“cFŽuC‰Ş–{—šˆęi”÷j: ‘ć67‰ń“ú–{×‹ŰŠw‰ď‘‰ď i94.03.29j, “Œ‹ž, “ú–{×‹ŰŠwŽGŽ, 49(1): 200, 1994.

281. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j E. coli ‚É‚¨‚Ż‚é ampC ‚Ě×–E“ŕ—A‘—‚É‚¨‚Ż‚é chapironine ‚ÉŠÖ‚ˇ‚錟“˘. Îˆä—Ç’mC‘ĺ–쏲CŽRŒűŒbŽOCˆäăź‹vi”÷j: ‘ć67‰ń“ú–{×‹ŰŠw‰ď‘‰ď i94.03.29j, “Œ‹ž, “ú–{×‹ŰŠwŽGŽ, 49(1): 217, 1994.

282. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j S. aureus ‚Ě restriction, modification ‚ɂ‚˘‚Ä; S. aureus Smith ‚Ě phage Œ^•Ę‚ɂ‚˘‚Ä. ‘ĺ‹v•Ű–LŽiCˆÉ—\•”Žu’ĂŽqCˆäăź‹vi”÷j: ‘ć67‰ń“ú–{×‹ŰŠw‰ď‘‰ď i94.03.29j, “Œ‹ž, “ú–{×‹ŰŠwŽGŽ, 49(1): 295, 1994.

283. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j •úŽËü‹ÇŠ—Ă–@‚É‚ć‚éŽîᇓÁˆŮ“IƒLƒ‰[ŠˆŤ‚đ—L‚ˇ‚éŽîᇓŕZƒŠƒ“ƒp‹…‚Ě—U“ą. ‹Ę“ŕGˆęi”÷jC‘şŽRçŒbŽqC•ę—˘’m”Vi“ŒŠC‘ĺj: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05j, ĺ‘ä, “ú–{ŠŕŠw‰ď‘‰ď‹LŽ–, p.678, 1993.

284. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j WŠw“I‚Ş‚ńŽĄ—Ái•úŽËü‘BÜ–Ɖu—Ă–@j‚É‚ć‚éŽŔŒąŽîᇂ̋ǏŠŽĄ–ü‚¨‚ć‚ѐś‘ś—Ś‚̉ü‘P. ‘şŽRçŒbŽqCśŽqFLi“ŒŠC‘ĺjC‹Ę“ŕGˆęi”÷jC•ę—˘’m”Vi“ŒŠC‘ĺj: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05j, ĺ‘ä, “ú–{ŠŕŠw‰ď‘‰ď‹LŽ–, p.678, 1993.

285. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŽîᇑB‚Ě—}§‚ł‚ę‚˝ƒŠƒ“ƒpŽî~łíƒŠƒ“ƒp‹…—U“ą×–E‚É‚¨‚Ż‚鐳íƒŠƒ“ƒp‹…ƒQƒmƒ€‚Ě•\ŒťŒ^‚Ě—DˆĘŤ. ‹v•Ű“cFˆęi”÷jC’†—˘˜a”üi—\–hˆăŠwŒnjC‹Ę“ŕGˆęCůŒ´•Žui”÷j: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.06j, ĺ‘ä, “ú–{ŠŕŠw‰ď‘‰ď‹LŽ–, p.230, 1993.

286. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŽîᇑB‚Ě—}§‚ł‚ę‚˝ƒŠƒ“ƒpŽî~łíƒŠƒ“ƒp‹…—Z‡×–E‚É‚¨‚Ż‚鐳íƒŠƒ“ƒp‹…ƒQƒmƒ€‚Ě•\ŒťŒ^‚Ě—DˆĘŤ. ‹v•Ű“cFˆęi”÷jC’†—˘˜a”üi—\–hˆăŠwŒnjC‹Ę“ŕGˆęCůŒ´•Žui”÷j: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.06j, ĺ‘ä, “ú–{ŠŕŠw‰ď‘‰ď‹LŽ–, p.230, 1993.

287. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j TCR ƒgƒ‰ƒ“ƒXƒWƒ…ƒjƒbƒNƒ}ƒEƒX‚đ—p‚˘‚˝ MHC S‘Š•ŞŽq‚É”ńˆË‘ś“I‚ɕމť‚ˇ‚é’°ŠÇă”ç“ŕ‚sƒŠƒ“ƒp‹… (IEL) ‚̉đÍ. ‹Ę“ŕGˆęi”÷jC‘ş“c‹M‘Ľi‰qśŠw•”jCźŒ´—Ż”ü“ށi“ŒŠC‘ĺjCůŒ´•ŽuCˆäăź‹vi”÷jCŽ›“c‰pŽii‰qśŠw•”jC’|“c“ńiă‘ĺjCDennis, Y. L.(HHMI)CŠ_ś‰€Žqi“ŒŠC‘ĺj: ‘ć23‰ń“ú–{–ƉuŠw‰ď‘‰ď i93.11.18j, ĺ‘ä, “ú–{–ƉuŠw‰ď‘‰ďEŠwpW‰ď‹L˜^, 23: 594, 1993.

288. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j E. faecalis —R—ˆƒyƒjƒVƒŠƒi[ƒ[ŽYś—}§ˆâ“`Žq‚ɂ‚˘‚ā| PCR –@‚É‚ć‚錟o. ‰Ş–{—šˆęC’rN‰ĂCˆä“cFŽuC–ěXŽRŸliŽ™jCˆäăź‹vi”÷j: ‘ć67‰ń“ú–{×‹ŰŠw‰ď‘‰ď i94.03.29j, “Œ‹ž, “ú–{×‹ŰŠwŽGŽ, 49(1): 121, 1994.

289. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒuƒhƒE‹…‹Ű‚ĚƒAƒ~ƒm”z“œ‘̍‚“x‘ϐŤ‰ť‚É‹y‚Ú‚ˇhŽĺ‚Ě•ĎˆŮ. ˆä“cFŽuC–ěXŽRŸliŽ™jC‰Ş–{—šˆęC’ˇ‘]•”‹IŽqCˆäăź‹vi”÷j: ‘ć69‰ń“ú–{×‹ŰŠw‰ďŠÖ“ŒŽx•”‘‰ď i93.06.24j, ‘Š–ÍŒ´.

290. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒuƒhƒE‹…‹Ű‚É‚¨‚Ż‚éƒAƒ~ƒm”z“œ‘̑ϐŤ‰ť‚ĚDNAf’f. –ěXŽRŸliŽ™jCˆä“cFŽui”÷jC‰Ş–{—šˆęiŒQ”n‘ĺjC’ˇ‘]•”‹IŽqCˆäăź‹vi”÷j: ‘ć69‰ń“ú–{×‹ŰŠw‰ďŠÖ“ŒŽx•”‘‰ď i93.06.24j, _“ސě, ƒvƒƒOƒ‰ƒ€, p.25, 1993.

291. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒuƒhƒE‹…‹Ű‚É‚¨‚Ż‚éƒAƒ~ƒm”z“œ‘̑ϐŤ‰ť‚ĚDNAf’f. –ěXŽRŸliŽ™jCˆä“cFŽuC‰Ş–{—šˆęC’ˇ‘]•”‹IŽqCˆäăź‹vi”÷j: ‘ć69‰ń“ú–{×‹ŰŠw‰ďŠÖ“ŒŽx•”‘‰ď i93.06.24j, _“ސě, ƒvƒƒOƒ‰ƒ€, p.25, 1993.

292. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘S‘30Ž{Ý‚ć‚č•Ş—Ł‚ł‚ę‚˝ MRSA ‚Ě×‹ŰŠw“IŒŸ“˘. ˆä“cFŽuC–ěXŽRŸliŽ™jC‰Ş–{—šˆęC’ˇ‘]•”‹IŽqC“‡“ŕçŒbŽqCˆäăź‹vi”÷j: ‘ć40‰ń“ú–{‰ťŠw—Ă–@Šw‰ď“Œ“ú–{Žx•”‘‰ď i93.10.14j, ÂX.

293. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j MRSA‚Ěƒtƒ@[ƒWŒ^•Ę. –ěXŽRŸliŽ™jCˆä“cFŽui”÷jC‰Ş–{—šˆęC‘ĺ‹v•Ű–LŽiiŒQ”n‘ĺjCź‰YM•viŽ™jCˆäăź‹vi”÷j: ‘ć40‰ń“ú–{‰ťŠw—Ă–@Šw‰ď“Œ“ú–{Žx•”‘‰ď i93.10.14j, ÂX, ƒvƒƒOƒ‰ƒ€, p.57, 1993.

294. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€j ‘S‘30Ž{Ý‚ć‚č•Ş—Ł‚ł‚ę‚˝ MRSA ‚̉uŠw“IŒŸ“˘. ˆä“cFŽuC–ěXŽRŸliŽ™jC’ˇ‘]•”‹IŽqC“‡“ŕçŒbŽqC‰Ş–{—šˆęCˆäăź‹vi”÷j: ‘ć22‰ń–ňÜ‘ϐŤ‹ŰƒVƒ“ƒ|ƒWƒEƒ€ i93.08.27j, ˆÉ•Ű.

295. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ABK ‘ϐŤ‹Ű‚Ş•Ş—Ł‚ł‚ę‚é”wŒi‚ƑϐŤ‹@\. ˆä“cFŽui”÷j: ‘ć‚S‰ńMRSAƒtƒH[ƒ‰ƒ€ i93.011.20j, “Œ‹ž.

296. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j MRSA ‚Ěƒtƒ@[ƒWŒ^•Ę‚É—L—p‚Čƒtƒ@[ƒW‚ɂ‚˘‚Ä. –ěXŽRŸliŽ™jCˆä“cFŽuC‰Ş–{—šˆęC‘ĺ‹v•Ű–LŽiCˆäăź‹vi”÷j: ‘ć38‰ńƒuƒhƒE‹…‹ŰŒ¤‹†‰ď i93.09.03j, ‹ž“s, ƒvƒƒOƒ‰ƒ€E´˜^W, p.29, 1993.

297. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j •@o“ŕ MRSA ŒŸ¸Š””‚ÉŠÖ‚ˇ‚錟“˘. “‡“ŕçŒbŽqC–ěXŽRŸliŽ™jC´…——ĽŽqCˆä“cFŽuCˆäăź‹vi”÷j: ‘ć38‰ď‰ńƒuƒhƒE‹…‹ŰŒ¤‹†‰ď i93.09.03j, ‹ž“s, ƒvƒƒOƒ‰ƒ€E´˜^W, p.35, 1993.

298. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j MRSA‚Ěƒtƒ@[ƒWŒ^•Ę‚É—L—p‚Čƒtƒ@[ƒW‚ɂ‚˘‚Ä. –ěXŽRŸliŽ™jCˆä“cFŽui”÷jC‰Ş–{—šˆęC‘ĺ‹v•Ű–LŽiiŒQ”n‘ĺjCˆäăź‹vi”÷j: ‘ć38‰ńƒuƒhƒE‹…‹ŰŒ¤‹†‰ď i93.09.03j, ‹ž“s, —\eW, p.29.

299. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ś‰ťŠw“I‘ϐŤ‹@\‚Š‚猊‚˝‘ă•\–ňÜ§. ˆäăź‹vi”÷j: ‘ć‚S‰ń–ňÜŠ´ŽóŤî•ńŒ¤‹†‰ď i93.11.00j, “Œ‹ž, u‰‰´˜^W, 4: 39`43, 1993.

300. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‚Q–ňÜ‚Ě‘ŠŠÖŠÖŒW‚Š‚猊‚˝‰ß‹Ž10”NŠÔ‚Ě–ňÜŠ´ŽóŤ. ˆäăź‹vi”÷j: ‘ć‚S‰ń–ňÜŠ´ŽóŤî•ńŒ¤‹†‰ď i93.11.00j, “Œ‹ž, u‰‰´˜^W, 4: 9`12, 1993.

301. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j PCR –@‚É‚ć‚éƒuƒhƒE‹…‹Ű‚ĚƒAƒ~ƒm”z“œ‘̏Cüy‘fŽYśˆâ“`Žq‚ĚŒŸo. ˆä“cFŽuC‰Ş–{—šˆęC–ěXŽRŸliŽ™jC’ˇ‘]•”‹IŽqC“‡“ŕçŒbŽqCˆäăź‹vi”÷j: ‘ć‚U‰ńŒ¤‹†‰ďuˆâ“`Žq‚Ć‚ť‚ĚŽü•Óv i93.07.31j, \˜a“c.

302. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j RŽ_‹Ű‚̉@“ੴőŠw‚ɂ‚˘‚ā|‘ć‚P•ń. “–‰@‚̉ߋŽ20”NŠÔ‚̍RŽ_‹ŰŒŸ¸. Ź”ŚiC‘şăŽuDC–ě‘ňťŽqCŞŠÝ–ƒ‹|CŹ“cŘ—R”üC—é–؍˛’mŽqC––O‡ŽqC“ĄŽR—T‹GŽqC‹TˆäçLCˆäăŽ}C“ŕ“cˆęOC’†čM•FC•˝“c‘חǁC‘ĺ’J‰pŽ÷ i—Ő•a—jC‘Š”nˆęˆĺi‹~–˝jCˆäăź‹vi”÷jCÎ‹´Wi”ĺj: ‘ć34‰ń_“ސ슴őÇŒ¤‹†‰ď i93.09.25j.

303. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j RŽ_‹Ű‚̉@“ੴőŠw‚ɂ‚˘‚ā|‘ć‚Q•ń. RŽ_‹Ű‚Ě–ňÜŠ´ŽóŤ‚ɂ‚˘‚Ä. “ĄŽR—T‹GŽqCŹ”ŚiC‘şăŽuDC–ě‘ňťŽqCŞŠÝ–ƒ‹|CŹ“cŘ—R”üC—é–؍˛’mŽqC––O‡ŽqC‹TˆäçLCˆäăŽ}C“ŕ“cˆęOC’†čM•FC•˝“c‘חǁC‘ĺ’J‰pŽ÷ i—Ő•a—jC‘Š”nˆęˆĺi‹~–˝jCˆäăź‹vi”÷jCÎ‹´Wi”ĺj: ‘ć34‰ń_“ސ슴őÇŒ¤‹†‰ď i93.09.25j.

304. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‹š‘B”ńˆË‘ś“I‚ɕމť‚ľ‚˝’°ŠÇă”ç“ŕ‚sƒŠƒ“ƒp‹…(i-IEL) ‚̉đÍ|TCR ƒgƒ‰ƒ“ƒXƒWƒFƒjƒbƒNƒ}ƒEƒX‚đ—p‚˘‚ā|. ‹Ę“ŕGˆęi”÷jC‘ş“c‹M‘Ľi‰qśŠw•”jCźŒ´—Ż”ü“ށi“ŒŠC‘ĺjCůŒ´•Žui”÷jCŽ›“c‰pŽii‰qśŠw•”jC’|“c“ńiă‘ĺjCDennis, Y.L.(HHMI)CŠ_ś‰€Žqi“ŒŠC‘ĺj: ‘ć29‰ńÁ‰ťŠí‚ƖƉuŒ¤‹†‰ď i94.02.26j, “Œ‹ž, ´˜^W, p.14, 1993.


<<07 –ƉuŠw>>

305. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒCƒ“ƒXƒŠƒ“‚̍RŒ´’ńŽŚ‚ĆHLA|ƒNƒ‰ƒX‡U•ŞŽq‚Ć‚ĚŠÖŒW‚ɂ‚˘‚Ä. ˆÉ“Ą‚ä‚čŽqCćѓc”ü]i“Œ‘ĺjCź‘şŒłŽqi’†‰›“úÔjC“ŕŠƒˆŔŽqi“Œ—ˆă‘ĺjC“ż‰iŸŽui’†‰›“úÔjCŒK“c¸ŽĄi“Œ‘ĺjCŹ”Ś•ś–íi–ƉujC•˝“cKłC‘ĺ XˆŔŒbC“cŠŒ›ŽĄi“Œ—ˆă‘ĺjC\Žš–Ň•vi’†‰›“úÔj: ‘ć23“ú–{–ƉuŠw‰ďŠwpW‰ď i93.11.17j, ĺ‘ä, “ú–{–ƉuŠw‰ď‘‰ďŠwpW‰ď‹L˜^, 23: 259, 1993.

306. mŒ´’˜n A single universal primer for the T-cell receptor (TCR) variable genes enables enzymatic amplification and direct sequencing of TCRƒŔ cDNA of various T-cell clones. Ź”Ś•ś–íi–ƉujCŠp“c‚Ý‚ł‚đi—\–hˆăŠwŒnjCˆÉ“ĄIˆęi–ƉujCˆÉ“Œˆę˜Yi—\–hˆăŠwŒnjC‹ŕŽq„‹vi–ƉujCGraham Paweleciƒ`ƒ…ƒrƒ“ƒQƒ“‘ĺjC”–Ř“oi–Ɖuj: Hum. Immunol., 36: 163`167, 1993.

307. mŒ´’˜n Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. ˆÉ“Ą‚ä‚čŽqCćѓc”ü]i“Œ‘ĺjCź‘şŒłŽqi’†‰›“úÔjC“ŕŠƒˆŔŽqi“Œ—ˆă‘ĺjC“ż‰iŸŽui’†‰›“úÔjCŒK“c¸ŽĄi“Œ‘ĺjCŹ”Ś•ś–íi–ƉujC•˝“cKłC‘ĺ XˆŔŒbi“Œ—ˆă‘ĺjC“cŠŒ›ŽĄC\Žš–Ň•vi’†‰›“úÔj: J. Immunol., 151(10): 5770`5776, 1993.

308. mŒ´’˜n Polymerase chain reaction (PCR)/single-strand conformation polymorphism (SSCP) analysis of the human HLA-DQB regions. HŽRŸ‘ĽC‹gˆä•x•vi’é‹ž‘ĺjCŹ”Ś•ś–íC”–Ř“oi–ƉujCÎŽRÝ•v: Jpn. J. Legal Med., 48(1): 38`43, 1994.

309. mŒ´’˜n Analysis of the HLA-DR gene frequencies in Japanese cases of juveniles rheumatoid arthritis and rheumatoid arthritis by oligonucleotide DNA typing. ‘ĺ‹v•Ű‚Đ‚ëŽqiˆÇ—Ń‘ĺjCˆÉ“ĄIˆęi–ƉujC“c’†M‰îC“n•”M•viˆÇ—Ń‘ĺjC”–Ř“oCŹ”Ś•ś–íi–Ɖuj: Rheumatol. Int., 13: 65`69, 1993.

310. m€Œ´’˜n A preliminary study on detection of maternal cells in fetal blood by HLA genotype markers. ›šŕ†‹Ęi‘—§‘ĺ‘ •a‰@jCŹ”Ś•ś–íi–ƉujC“c’†’‰•vC’ç‹I•vi‘—§‘ĺ‘ •a‰@jC”–Ř“oi–Ɖuj: Proceedings of the 7th Annual Meeting of Japan Society for Immunology of Reproduction, p.188`191, 1993.

311. mŒ¤‹†•ńi•ś•”Čjn ˆÚAt‚Ě‹‘â”˝‰ž‚É“Žˆő‚ł‚ę‚é‚s×–ERŒ´ƒŒƒZƒvƒ^[‚̉đÍ. Ź”Ś•ś–íi–Ɖuj: •ś•”Č‰ČŠwŒ¤‹†”ď•â•‹ŕiˆę”ĘŒ¤‹†‚bj•ń‘, p.1`33, 1993.


<<07 2 –ƉuŠw>>

312. m‘ŕn ˆÚA‚É‚¨‚Ż‚éRŒ´“ÁˆŮ“I–Ɖu—}§–@|ƒhƒi[RŒ´“Š—^‚É‚ć‚éˆÚA•Đ‚̐ś’…‰„’ˇŒř‰Ę|. “n•”_“ńi–Ɖuj: Ą“ú‚ĚˆÚA, 6(2): 169`176, 1993.


<<07 5 –ƉuŠw>>

313. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŒŒ’†”÷—ʍŹ“ü×–EŒŸo‚ĚŽŽ‚Ý: HLAˆâ“`Žqƒ^ƒCƒsƒ“ƒO‚É‚ć‚錟“˘. ›šŕ†‹Ęi‘—§‘ĺ‘ •a‰@jCŹ”Ś•ś–íi–ƉujC“c’†’‰•vC’ç‹I•vC‘q“‡•x‘ăCˆÉ“ĄŽĄ‰pi‘—§‘ĺ‘ •a‰@jC”–Ř“oi–Ɖuj: ‘ć45‰ń“ú–{ŽY•wl‰ČŠw‰ď‘‰ď i93.04.12j, ‘ĺă.

314. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒCƒkMHC(DLA)‚ĚPCRĽSSO–@‚É‚ć‚éƒ^ƒCƒsƒ“ƒO‚ƐV‚ľ‚˘RŒ´Œ^‚Ě”­ŒŠ. ‘ĺ’J•ś—Yi–ƉujCˆÉ“Œˆę˜YCŠp“c‚Ý‚ł‚đi—\–hˆăŠwŒnjCŹ”Ś•ś–íi–ƉujC‘ĺ‹v•Ű‚Ý‚Ç‚či—\–hˆăŠwŒnjC‹ŕŽq„‹vC“n•”_“ńC”–Ř“oi–Ɖuj: ‘ć2‰ń“ú–{‘gD“K‡ŤŠw‰ď‘ĺ‰ď i93.07.22j, ˆŽě, ´˜^W, p.72, 1993.

315. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ˆÚAt‚Ě‹‘â”˝‰ž‚É“Žˆő‚ł‚ę‚é‚s×–EƒŒƒZƒvƒ^[‚Ě‘˝—lŤ‚̉đÍ. Ź”Ś•ś–íi–ƉujCŠp“c‚Ý‚ł‚đC‘ĺ‹v•Ű‚Ý‚Ç‚či—\–hˆăŠwŒnjCŒF–ě˜a—Yi”ĺjC‰ś“cŒ[“ńiŽœŒbˆă‘ĺjC”–Ř“oi–Ɖuj: ‘ć29‰ń“ú–{ˆÚAŠw‰ď‘‰ď i93.09.17j, ‹ŕ‘ň, ˆÚA, 28(‘‰ď—ŐŽž†): 41, 1993.

316. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒƒ‹ƒJƒ][ƒ‹•ž—p’†‚ĚGraves•a‚É”­Ç‚ˇ‚éƒCƒ“ƒXƒŠƒ“ŽŠŒČ–ƉuÇŒóŒQi•˝“c•aj. “ŕŠƒˆŔŽqi“Œ—ˆă‘ĺjCˆÉ“Ą‚ä‚čŽqCŒK“c¸ŽĄi“Œ‘ĺjC“ż‰iŸŽui’†‰›“úÔjCŹ”Ś•ś–íi–ƉujC\Žš–Ň•vi’†‰›“úÔjC‘ĺXˆŔŒbC‘Δn•q•vi“Œ—ˆă ‘ĺj: ‘ć23“ú–{–ƉuŠw‰ďŠwpW‰ď i93.11.17j, ĺ‘ä, “ú–{–ƉuŠw‰ď‘‰ďŠwpW‰ď‹L˜^, 23: 252, 1993.

317. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒCƒ“ƒXƒŠƒ“‚̍RŒ´’ńŽŚ‚ĆHLA|ƒNƒ‰ƒX‡U•ŞŽq‚Ć‚ĚŠÖŒW‚ɂ‚˘‚Ä. ˆÉ“Ą‚ä‚čŽqCćѓc”ü]i“Œ‘ĺjCź‘şŒłŽqi’†‰›“úÔjC“ŕŠƒˆŔŽqi“Œ—ˆă‘ĺjC“ż‰iŸŽui’†‰›“úÔjCŒK“c¸ŽĄi“Œ‘ĺjCŹ”Ś•ś–íi–ƉujC•˝“cKłC‘ĺ XˆŔŒbC“cŠŒ›ŽĄi“Œ—ˆă‘ĺjC\Žš–Ň•vi’†‰›“úÔj: ‘ć23“ú–{–ƉuŠw‰ďŠwpW‰ď i93.11.17j, ĺ‘ä, “ú–{–ƉuŠw‰ď‘‰ďŠwpW‰ď‹L˜^, 23: 259, 1993.

318. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ˆÚAtZ×–E‚É‚¨‚Ż‚é‚s×–ERŒ´ƒŒƒZƒvƒ^[‚̉đÍ. Ź”Ś•ś–íi–ƉujCŠp“c‚Ý‚ł‚đC‘ĺ‹v•Ű‚Ý‚Ç‚či—\–hˆăŠwŒnjCŒF–ě˜a—Yi”ĺjC‰ś“cŒ[“ńiŽœŒbˆă‘ĺjC‰ş“c—EŽĄ(SMI)C”–Ř“oi–Ɖuj: ‘ć23‰ń“ú–{–ƉuŠw‰ďŠwpW‰ď i93.11.18j, ĺ‘ä.

319. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹŒ˘‚É‚¨‚Ż‚鍜‘ˆÚA‚đ•š—p‚ľ‚˝–ƉuŠ°—e“ą“ü‚Ě“Ž‘Ԃɂ‚˘‚Ä. “n•”_“ńi–ƉujCˆÉ“Œˆę˜Yi—\–hˆăŠwŒnjC‘ĺ’J•ś—Yi–ƉujC‘ĺ‹v•Ű‚Ý‚Ç‚či—\–hˆăŠwŒnjC”–Ř“oi–Ɖuj: ‘ć23‰ń“ú–{–ƉuŠw‰ď‘‰ď i93.11.18j, ĺ‘ä, “ú–{–ƉuŠw‰ď‘‰ďŠwpW‰ď‹L˜^, 23: 550, 1993.

320. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŹŒ˘‚É‚¨‚Ż‚édonor‚Š‚ç‚̍œ‘ˆÚA(BMT)‚đ•š—p‚ľ‚˝ˆÚA–ƉuŠ°—e‚Ě“ą“ü. “n•”_“ńi–ƉujCˆÉ“Œˆę˜Yi—\–hˆăŠwŒnjC˛“ĄŒőŽjCÎ“c˜a•vC’†ŽR‹`‰îCŠ`“cÍiŠOjC^č‹`•FiŽŔ“ŽŒnj: ‘ć94‰ń“ú–{ŠO‰ČŠw‰ď‘‰ď i94.03.31j, “Œ‹ž, “ú–{ŠO‰ČŠw‰ďŽGŽ, (‘ć95‰ń—ŐŽž‘Š§†): 301, 1994.

321. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒr[ƒOƒ‹Œ˘‚ĚŽĺ—v‘gD“K‡RŒ´(DLA)‚ɑ΂ˇ‚éPCR-SSOƒ^ƒCƒsƒ“ƒO–@. ‘ĺ’J•ś—Yi–ƉujCˆÉ“Œˆę˜YCŠp“c‚Ý‚ł‚đC‘ĺ‹v•Ű‚Ý‚Ç‚či—\–hˆăŠwŒnjC‹ŕŽq„‹vCŹ”Ś•ś–íC“n•”_“ńC”–Ř“oi–Ɖuj: ‘ć17‰ń–k—˘ˆăŠw‰ď‘‰ď i93.11.13j, ‘Š–ÍŒ´, –k—˘ˆăŠw, 23(6): 524, 1993.

322. mŒ¤‹†‰ďi‘S‘jn i‹łˆçu‰‰j ƒAƒ_ƒ€ƒX‚ĆƒCƒuƒX|HLARŒ´ˆâ“`Žq‚Ɛl—ނ̐i‰ť|. ‘ĺ’J•ś—Yi–Ɖuj: “ú–{‹~–˝‹~‹}Žw“ąˆăƒZƒ~ƒi[ i93.08.26j, ˆÉ“Œ.

323. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j HLA-DRˆâ“`ŽqŒ^‚ĚDNAƒ^ƒCƒsƒ“ƒO: ˆÝŠŕ”­Ç‰đÍ‚ւ̉ž—p. Ź”Ś•ś–íi–ƉujC‘ĺ‹v•Ű‚Ý‚Ç‚čCŠp“c‚Ý‚ł‚đi—\–hˆăŠwŒnjCś‰z‹Ş“ńC’ŇŒö”üi“ŒŠC‘ĺjC”–Ř“oi–Ɖuj: ‘ć2‰ńŠŕ•a‘ÔŽĄ—ĂŒ¤‹†‰ď i93.05.15j, ç—t, ´˜^W, p.11, 1993.

324. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ‘ŸŠíˆÚA‚ĆT-cell receptor. Ź”Ś•ś–íi–Ɖuj: ‘ć11‰ń‹ß‹EHLAŒ¤‹†‰ď i94.02.19j, ‘ĺă, —\eW, p.6`7, 1994.

325. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ˆÚAt‚Ě‹‘â”˝‰ž‚É“Žˆő‚ł‚ę‚é‚s×–EƒŒƒZƒvƒ^[‚̉đÍ. ”–Ř“oi–ƉujCŠp“c‚Ý‚ł‚đC‘ĺ‹v•Ű‚Ý‚Ç‚či—\–hˆăŠwŒnjC‰ś“cŒ[“ńiŽœŒbˆă‘ĺjCŹ”Ś•ś–íi–Ɖuj: ‘ć6‰ńˆâ“`Žq‚Ć‚ť‚ĚŽü•ÓŒ¤‹†‰ď i93.07.31j, \˜a“c.

326. mŒ¤‹†‰ďi’n•űjn iŒöŠJuŔj ś‘Ě“ŕ‚É‚¨‚Ż‚é–Ɖu‹@\. ‘ĺ’J•ś—Yi–Ɖuj: –k—˘‘ĺŠw‰qśŠw•”ŒöŠJuŔ i93.09.05j, ‘Š–ÍŒ´.


<<08 •a—Šw>>

327. mŒ´’˜n Immunohistochemical analysis of 61 pituitary adenomas with a monoclonal antibody to the neuron-specific ƒŔ-tubulin isotype. ŒĂŠř–΁C‹T’J“Oi•a—jCŒË’Jd—YCAnthony Frankfuter: Acta Neuropathol, 86: 518`520, 1993.

328. mŒ´’˜n Pathologic analysis of non-overt necrotizing type Kikuchi and Fujimoto's disease. ‚–ěN—YCŽOŽ}MC‰œ•˝‰ë•Fi•a—j: Acta Pathol. Jpn., 43: 635`645, 1993.

329. mŒ´’˜n Epstein-Barr virus infection is associated with increased apoptosis in untreated and phorbolester-treated human Burkitt's lymphoma (AW-Ramos) cells. Îˆä‰pşi•a—jCGlenda C. GobeiQueensland Med. Sch.j: Biochem. Biophys. Res. Commun., 192(3): 1415`1423, 1993.

330. mŒ´’˜n A possible role for Epstein-Barr virus in tumorigenesis after immunosuppression in cases of renal transplantation. —é–ؐł“šC‚–ěN—YCŽR‰ş˜a–çi•a—jC˛“ĄŒőŽjCŠ`“cÍiŠOjC‰œ•˝‰ë•Fi•a—j: J. Cancer Res. Clin. Oncol., 119: 627`629, 1993.

331. mŒ´’˜n Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinoma|An enhanced immunohistochemical approach. ŽOŽ}MC‚–ěN—Yi•a—jCKishimoto, H.CWakabayashi, G.CNohga, K.iěčŽs—§•a‰@jC‰œ•˝‰ë•Fi•a—j: J. Cancer Res. Clin. Oncol., 119: 737`744, 1993.

332. mŒ´’˜n Thyrotropin-producing microadenoma associated with pituitary resistance to thyroid hormone. Kenji WatanabeC‹T’J“Oi•a—jCAkira YamauchiCNaohito YamamotoCAkira KuwayamaCIzumi TakeiCHiroshi MaruyamaCTakao Saruta: J. Clinical Endocrinol. Metab., 76(4): 1025`1030, 1993.

333. mŒ´’˜n Down-regulation of human AFP promoter by c-jun and c-fos. ŽOŽ}Mi•a—jCIdo, A.i’ˇč‘ĺjCNakabayashi, H.iUniv. of CalgaryjCSakai, M.i–k‘ĺjCTamaoki, T.iUniv. of Calgaryj: J. Tumor Marker Oncol., 9(1): 29`34, 1994.

334. mŒ´’˜n Comparative immunohistochemical studies of p53 and proliferating cell nuclear antigen expression and argyrophilic nuclear organizer regions in pancreatic duct cell carcinomas. —é–ؐł“šC‚–ěN—Yi•a—j: Jpn. J. Cancer Res., 84: 1072`1077, 1993.

335. mŒ´’˜n Human hepatic infarction; histopathological and post mortem angiological studies. ŽOŽ}MC‚–ěN—YC‰œ•˝‰ë•Fi•a—j: Liver, 13: 239`245, 1993.

336. mŒ´’˜n Apoptosis induced by microtubule disrupting drugs in cultured human lymphoma cells|Inhibitory effects of phorbol ester and zinc sulphate. ‚–ěN—YC‰œ•˝‰ë•Fi•a—jCB.V. HarmoniQueensland‘ĺj: Pathol. Res. Pract., 189: 197`203, 1993.

337. mŒ´’˜n Long-term impact of conservative management on localized prostatic cancer-A twenty-year experience in Japan. ‰oěWi•a—jCŻŽi´ŽuCŒŕŠ˛ƒC“ŕ“c–Lşi”ĺjCŒK”ö’čmi•a—jCŹŽÄŒ’i”ĺj: Urology, 42(5): 521`527, 1993.

338. mŒ´’˜n Ź’ˇƒzƒ‹ƒ‚ƒ“, ƒvƒƒ‰ƒNƒ`ƒ“—źƒzƒ‹ƒ‚ƒ“ŽYś|‰ş‚‘Ě‘BŽî24—á‚Ě“dŒ°ă‚Ě“Á’Ľ. ŒĂŠř–΁C’†ź—şC”эâ—zˆęCŹ‚•˝ŽĄC‘ĺ’JŒőOCŒË’Jd—YC‹T’J“Oi•a—j: ƒzƒ‹ƒ‚ƒ“‚Ć—Ő°, (‘), 1993.

339. mŒ´’˜n ’ź’°], ŒŒ´‘O—§‘B“ÁˆŮRŒ´’l‚¨‚ć‚ŃŒo’ź’°“I’´‰š”g–@‚Ě•š—p‚É‚ć‚é‘O—§‘BŠŕŒŸo—Ś‚ĚŒŸ“˘. ‰oěWi•a—jC—ŤŻŻi”ĺjCŒK”ö’čmi•a—jC“ŕ“c–LşC‰ĄŽR‰p“ńC^‰şß•vCŹŽÄŒ’i”ĺj: “ú–{”ĺ”AŠí‰ČŠw‰ďŽGŽ, 84(7): 1236`1243, 1993.

340. mŒ´’˜n ‘O—§‘BŠŕ‚Ě’´‰š”gf’fŠî€‚̍čl|hypoechoic lesion‚Ě”ń“ÁˆŮŤ‚ɂ‚˘‚ā|. ‰oěWCŒK”ö’čmi•a—jC“ŕ“c–LşC‰ĄŽR‰p“ńC^‰şß•vCŹŽÄŒ’i”ĺj: “ú–{”ĺ”AŠí‰ČŠw‰ďŽGŽ, 84(8): 1456`1464, 1993.

341. mŒ´’˜n ‚­‚ŕ–Œ‰şoŒŒ‚É‚¨‚Ż‚éS‹Ř‚Ě•a—‘gDŠw“IŒŸ“˘. ‰Ą“ŕ‘ŽqCŒK”ö’čmi•a—j: –k—˘ˆăŠw, 24(1): 21`29, 1994.

342. m€Œ´’˜n IPH‚Ć‚ť‚Ě—ŢŽ—ŽžŠł‚Ě•a—|ŠĚ•a•Ď‚ĆäB‘Ÿ‚Ć‚ĚŠÖ˜A‚ɂ‚˘‚ā|. ‘ĺ•”˝C‰œ•˝‰ë•Fi•a—j: ŠĚŽžŠłŒ¤‹†‚̐i•ŕ, 9: 189`200, 1993.

343. mŒ¤‹†•ńiŒúśČjn ˆŮíŒŒs˜H‚ĆäB‘Ÿ‚Ć‚Ě‘ŠŠÖ‚ɂ‚˘‚Ä. ‘ĺ•”˝CŽOŽ}MC‰œ•˝‰ë•Fi•a—j: ŒúśČ“Á’莞Šł–ĺ–ŹŒŒsˆŮíÇ’˛¸Œ¤‹†”Ç•˝Ź4”N“xŒ¤‹†•ń‘, p.21`24, 1993.

344. mŒ¤‹†•ńiŒúśČjn ˆŮíŒŒs˜H‚Ě—Ő°•a—Šw“IŒŸ“˘. ‘ĺ•”˝CŽOŽ}MC‰œ•˝‰ë•Fi•a—jC‘şă‹§lC‘•Ş–ΔŽi“ŕj: ŒúśČ“Á’莞Šł–ĺ–ŹŒŒsˆŮíÇ’˛¸Œ¤‹†”Ç•˝Ź4”N“xŒ¤‹†•ń‘, p.17`20, 1993.


<<08 2 •a—Šw>>

345. mÇ—á•ńn Gastric adenocarcinoma with differentiation to sarcomatous components associated with monoclonal Epstein-Barr virus infection and LMP-1 expression. –Ř“c–FŽ÷i“ŕjC‹{“ŕ–M_iŠOjC‚–ěN—Yi•a—j: Virchows Arch. A Pathol. Anat. Histopathol., 423: 383`387, 1993.

346. mÇ—á•ńn ’_`×–Ef‚Ĺ‘’_ŠÇ‘BŽî‚Ɛf’f‚ł‚ę‚˝1—á. ’†‰p’jCźŽR•Ű”äŒĂCŽO•xO”VCă™G‰ii•a—jC‹v•Űěˆę]CŽR‰ş˜a–çC“cŠ‰xŽqi•a—•”j: “ú–{—Տ°×–EŠw‰ďŽGŽ, 33(1): 69`72, 1994.

347. mÇ—á•ńn ˆŮŠŤ‚𔺂Á‚˝ƒ|ƒŠ[ƒv‚đ”F‚ß‚˝Peutz-JeghersÇŒóŒQ‚Ě1—á. ‘ĺŒIŒ’•FC‰Á‰ę“c–LC‹ŕŽq‘C‰Ą“ŕ‘ŽqC‘ĺŔ“cŽĄC’Ë–{GlCŠâŸşŒ[ˆęC‹T’J“Oi•a—j: –k—˘ˆăŠw, 23(2): 130`134, 1993.

348. m‘ŕn ƒzƒ‹ƒ‚ƒ“ŽYśŽîá‡. ‹T’J“Oi•a—j: ×–E, 25(7): 230`231, 1993.

349. m‘ŕn äX“ŕ•Ş”ĺŽîá‡. ‹T’J“Oi•a—j: ×–E, 25(7): 39`45, 1993.

350. m‘ŕn ˆŤŤƒŠƒ“ƒpŽî‚Ě•a—. ‚–ěN—YC‹T’J“Oi•a—j: Ž¨•@ˆôA‰ČĽ“ŞŒz•”ŠO‰Č, 66(3): 183`194, 1994.

351. m‘ŕn ‰ş‚‘Ě×–E‚̖Ɖu‘gD‰ťŠw. ŒĂŠř–΁C‹T’J“Oi•a—j: “ú–{—Տ°, 51(10): 2524`2529, 1993.

352. m‘ŕn ”xÇ×–E‚Ş‚ńi‰”ž×–E‚Ş‚ńj‚̐ś•¨Šw“I“ÁŤ|Ĺ‹ß‚ĚŒ¤‹†Ź‰Ę|. ‹T’J“Oi•a—j: –k—˘ˆăŠw, 23(5): 299`309, 1993.

353. m‘ŕn ”x×–EƒVƒŠ[ƒY2.”x‚̐_Œo“ŕ•Ş”ĺ×–EiƒNƒ‹ƒ`ƒbƒL[×–Ej. ‹T’J“Oi•a—j: —Տ°‰ČŠw, 29(11): 1515`1524, 1993.

354. m‘ŕn ×–EŽ€‚Ě•ŞŽqś•¨Šw. ‚–ěN—Yi•a—j: —Տ°•a—, (“Á94): 187`196, 1993.

355. m•ŇWŽŇ‚ւ̎莆i‰p•śjn High incidence of Epstein-Barr virus associated non-Hodgkin's lymphomas in the Bolivian mountains. ‚–ěN—Yi•a—jCRony Pedro ColanziiJapones•a‰@jCJunji Sigai’é‹ž‘ĺj: Pathology International, 44: 237`240, 1994.

356. mŠwp‘n i•Ş’SŽˇ•Mj ĹV“ŕ‰ČŠw‘ĺŒn; ƒJƒ‹ƒVƒgƒjƒ“ŽYśŽîá‡, 14: 111`117, ‹T’J“Oi•a—j. 00.00.00”­s.

357. mŠwp‘n i•Ş’SŽˇ•Mj ĹV“ŕ‰ČŠw‘ĺŒn; Á‰ťŠÇƒzƒ‹ƒ‚ƒ“ŽYśŽîᇁ|ƒ\ƒ}ƒgƒXƒ^ƒ`ƒm[ƒ}iƒ\ƒ}ƒgƒXƒ^ƒ`ƒ“ŽYśŽîᇁj, 17: 326`331, ‹T’J“Oi•a—j. 00.00.00”­s.


<<08 3 •a—Šw>>

358. m‹ł‰Č‘n i•Ş’SŽˇ•Mj ƒRƒAƒeƒLƒXƒgĽ•a—Šw(2); “ŕ•Ş”ĺ‚Ě•a•Ď, p.361`386, ‹T’J“Oi•a—j. •ŇW ó–ěŒŢ˜YC‹žVˆę˜YC œAě‘“X, “Œ‹ž, 93.05.30”­s.

359. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ƒJƒ‰[ƒAƒgƒ‰ƒX: —Տ°“ŕ•Ş”ĺ•a—f’fŠw; äX“ŕ•Ş”ĺŽîá‡, p.265`273, ‹T’J“Oi•a—j. •ŇW ů–ěLşi“Œ–k‘ĺjC ˆăŽ•–ňo”Ĺ, “Œ‹ž, 93.00.00”­s.

360. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn i•Ş’SŽˇ•Mj [ÝŤ^‹ŰÇ‚̍ŐVŽĄ—ĂŒv‰ć; “ŕ‘Ÿ^‹ŰÇ‚ĚŒŒ´f’f|‚ť‚ĚŒă‚̐i•ŕ, ‹v•ÄŒői•a—j. •ŇW ă“c‘ׁiŽœŒbˆă‘ĺjC´…Šě”ޘYišƒ}ƒŠˆă‘ĺjC ƒƒfƒBƒJƒ‹ĽƒWƒƒ[ƒiƒ‹ŽĐ, “Œ‹ž, 93.09.00”­s.


<<08 5 •a—Šw>>

361. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Four autopsy cases of dixeminated trichosporon infection in humans. –Ř‘ş‰ë‹vi‹ß‹E‘ĺjC‹v•ÄŒői•a—j: ‘ć12‰ń‘Űˆă^‹ŰŠw‰ď i94.03.15j, ƒAƒfƒŒ[ƒh, 12th Congress of the International Society for Human and Animal Mycology, (Suppl.), p.64, 1994.

362. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Genome typing for Aspergillus fumigatus strains by random amplified polymorphic DNA. ŽRč•q˜aC‹v•ÄŒői•a—jC‘şźGŽ÷i—Ő•a—jCŽR‰ş‚Ś‚čŽqi“ŕj: ‘ć12‰ń‘Űˆă^‹ŰŠw‰ď i94.03.15j, ƒAƒfƒŒ[ƒh, 12th Congress of the International Society for Human and Animal Mycology, (Suppl.), p.123, 1994.

363. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj R^‹Ű—Ă–@‚̐i•ŕ‚Ć–â‘č“_|[ÝŤ^‹ŰÇ‚Ě•š—p—Ă–@|. ‹v•ÄŒői•a—j: ‘ć37‰ń“ú–{ˆă^‹ŰŠw‰ď‘‰ď i93.10.10j, ‰Ą•l, ^‹ŰŽ, 34(Suppl.): 91, 1993.

364. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j NPŒ^”xƒAƒXƒyƒ‹ƒMƒ‹ƒXÇ‚ɑ΂ˇ‚éR^‹ŰÜ‚Ěin vivo‚Č‚ç‚Ń‚Éin vitro‚É‚¨‚Ż‚é•š—pŒř‰Ę‚ɂ‚˘‚Ä. ŽRč•q˜aC‹v•ÄŒői•a—jCŽR‰ş‚Ś‚čŽqi“ŕjCM‰Ş”üťŽqC–]ŒŽ^‹|C‘şŁ¨’ĂŽqi–ňÜj: ‘ć67‰ń“ú–{Š´őÇŠw‰ď i93.04.15j, “Œ‹ž, Š´őÇŠwŽGŽ, 67(9): 889`890, 1993.

365. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹CŠÇŽxŽC‰ß×–Ef‚É‚¨‚Ż‚éP53Šŕ—}§ˆâ“`ŽqŽY•¨‚ÉŠÖ‚ˇ‚錟“˘. •ž•”ŠwC‘ĺ–ě‰pŽĄC‰ĄŽR‘ĺC‚ŽR–žŽqC–L‰i^Ÿi•a‰@•a—jCŒK”ö’čmi•a—jC–î“ߐŁM—Yi“ŕjC‹g‘ş”Ž–Mi‹šŠOjC‘ –{”ŽsiŽY•wj: ‘ć34‰ń“ú–{—Տ°×–EŠw‰ď‘‰ď i93.05.27j, ĺ‘ä, “ú–{—Տ°×–EŠw‰ďŽGŽ, 32(2): 208, 1993.

366. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j bó‘BúŽh‹zˆř×–Ef‚É‚¨‚Ż‚é“ű“ŞŠŕ‚ĚÄŒŸ“˘|“Á‚É“ű“ޏó\‘˘‚đŽŚ‚ˇ”ńŠŕŤŽžŠł‚Ƃ̊ӕʂɂ‚˘‚ā|. ‰ĄŽR‘ĺC‘ĺ–ě‰pŽĄC•ž•”ŠwC‚ŽR–žŽqC–L‰i^Ÿi•a‰@•a—jCŒY•”“ŒŽĄi•a—jC‘ –{”ŽsiŽY•wj: ‘ć34‰ń“ú–{—Տ°×–EŠw‰ď‘‰ď i93.05.27j, ĺ‘ä, “ú–{—Տ°×–EŠw‰ďŽGŽ, 32(2): 247, 1993.

367. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”ńd•ĎŤ–ĺ–Źˆł˜´iÇŠĚ‚É‚¨‚Ż‚éˆŮíŒŒs˜H‚Ě”äŠrŒŸ“˘. ‘ĺ•”˝C“n•Ó´ŽĄC‰œ•˝‰ë•Fi•a—j: ‘ć29‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď i93.07.17j, “Ţ—Ç, ŠĚ‘Ÿ, 34(Suppl.1): 276, 1993.

368. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŽîᇍזE‚É‚¨‚Ż‚éVirus‚ĆApoptosis‚ĚŠÖŒW‚ɂ‚˘‚Ä‚Ě’´”÷Œ`‘ÔŠw“IŒ¤‹†. Îˆä‰pşCé‰şŽi•a—j: ‘ć25‰ń“ú–{—Տ°“dŽqŒ°”÷‹žŠw‰ď‘‰ď i93.09.28j, ź–{, —\eW, p.87, 1993.

369. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹŒ^×–E‚ć‚č‚Č‚é“űŠŕ‚Ě×–EŠw“IŒŸ“˘|“Á‚ɏŹ—tŠŕ‚ɂ‚˘‚Ä. ‚ŽR–žŽqC‘ĺ–ě‰pŽĄC‰ĄŽR‘ĺC•ž•”ŠwC–L…^Ÿi•a‰@•a—jC‘ĺ•”˝CŠâŸşŒ[ˆęi•a—jC’|’†°KiŠOjC‘ –{”ŽsiŽY•wjC‹T’J“Oi•a—j: ‘ć32‰ń“ú–{—Տ°×–EŠw‰ďHŠú‘ĺ‰ď i93.10.16j, ˆŽě.

370. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹŒ^×–E‚ć‚č‚Č‚é“űŠŕ‚Ě×–EŠw“IŒŸ“˘|“Á‚ɏŹ—tŠŕ‚ɂ‚˘‚Ä. ‚ŽR–žŽqC‘ĺ–ě‰pŽĄC‰ĄŽR‘ĺC•ž•”ŠwC–L‰i^Ÿi•a‰@•a—jC‘ĺ•”˝CŠâŸşŒ[ˆęi•a—jC’|’†°KiŠOjC‘ –{”ŽsiŽY•wjC‹T’J“Oi•a—j: ‘ć32‰ń“ú–{—Տ°×–EŠw‰ďHŠú‘ĺ‰ď i93.10.16j, ˆŽě, “ú–{—Տ°×–EŠw‰ďŽGŽ, 32(5): 732, 1993.

371. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ×–EŠw“I‚É‹ť–Ą[‚˘Œ`‘Ô‚đŽŚ‚ľ‚˝‹´–{•a‚Ě1Ç—á. ŒY•”“ŒŽĄi•a—jC‰ĄŽR‘ĺC•ž•”ŠwC‚ŽR–žŽqC–L‰i^ŸCˆäěˆç‘ăi•a‰@•a—jC“n•Ó´ŽĄCŒK”ö’čmCŠâŸşŒ[ˆęi•a—jC‘ĺ–ě‰pŽĄi•a‰@•a—jC‘ –{”Žs iŽY•wjC‹T’J“Oi•a—jCŠ`“cÍiŠOj: ‘ć32‰ń“ú–{—Տ°×–EŠw‰ďHŠú‘ĺ‰ď i93.10.16j, ˆŽě, “ú–{—Տ°×–EŠw‰ďŽGŽ, 32(5): 746, 1993.

372. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “Á”­Ť–ĺ–Źˆł˜´iÇ‚ĚŠĚ•a•Ď‚ĆäB‘Ÿ‚Ć‚ĚŠÖ˜A‚ɂ‚˘‚Ä. ‘ĺ•”˝C“n•Ó´ŽĄi•a—j: ‘ć28‰ń“ú–{ŠĚ‘ŸŠw‰ď“Œ•”‰ď i93.11.20j, ç—t, ŠĚ‘Ÿ, 34(Suppl.3): 107, 1993.

373. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Žq‹{‘ĚŠŕ‚É‚¨‚Ż‚é‚Ş‚ń“]ˆÚ—}§ˆâ“`Žqnm23‚Ě”­Œť‚Ć“]ˆÚ‚Ć‚Ě‘ŠŠÖ‚ɂ‚˘‚Ä. “n•ÓƒC˛“Ą—YˆęCě‹v•ŰˆŔ˜Ni•a—jC‘ –{”ŽsiŽY•wjC‹T’J“Oi•a—j: ‘ć83‰ń“ú–{•a—Šw‰ď‘‰ď i94.03.30j, ‹ž“s, “ú–{•a—Šw‰ď‰ďŽ, 83(1): 211, 1994.

374. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒpƒ‰ƒtƒBƒ“Ř•Đ‚đ—p‚˘‚˝‘O—§‘BŠŕ‚ĚƒAƒ“ƒhƒƒQƒ“ĽƒŒƒZƒvƒ^[‚̖Ɖu‘gDŠw“IŒŸ“˘. ŒK”ö’čmC˛“Ą—YˆęCě‹v•ŰˆŔ˜NC˛“ĄgC‹T’J“Oi•a—j: “ú–{•a—Šw‰ďt‹G‘‰ď i94.03.31j, ‹ž“s, “ú–{•a—Šw‰ď‰ďŽ, 83(1): 298, 1994.

375. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”xŠŕ‚É‚¨‚Ż‚éEpstein-Barr VirusŠ´ő‚Ě•ŞŽq•a—Šw“IŒŸ“˘. Š}ˆäŒ‰C˛“Ą—YˆęCě‹v•ŰˆŔ˜NCˆäă€lC˛“ĄgC‹T’J“Oi•a—j: ‘ć82‰ń“ú–{•a—Šw‰ď‘‰ď i93.04.06`08j, “Œ‹ž.

376. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒzƒ‹ƒ}ƒŠƒ“ŒĹ’čĽƒpƒ‰ƒtƒBƒ“•ď–„Ř•Đ‚É‚¨‚Ż‚éRNA‚Ěin situ bybridization‚Ö‚Ěƒ}ƒCƒNƒƒEƒF[ƒu‚̉ž—p. ˛“Ą—YˆęCˆäă€lC˛“ĄgCŠ}ˆäŒ‰CŒK”ö’čmC‹T’J“Oi•a—j: ‘ć82‰ń“ú–{•a—Šw‰ď‘‰ď i93.04.06`08j, “Œ‹ž.

377. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j EBER-1 RNA‚Ěin situ bybridization–@‚đ—p‚˘‚˝ăˆô“ŞŠŕ‚É‚¨‚Ż‚éEpstein-Barr Virus‚ĚŘ–ž. ˆäă€lC“n•ÓŒőNC˛“Ą—YˆęC˛“ĄgCŠ}ˆäŒ‰C‹T’J“Oi•a—j: ‘ć82‰ń“ú–{•a—Šw‰ď‘‰ď i93.04.06`08j, “Œ‹ž.

378. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j EBERs-RNA‚Ěin situ hybridization–@‚đ—p‚˘‚˝ƒzƒWƒLƒ“•a‚É‚¨‚Ż‚éEpstein-Barr Virus‚ĚŘ–ž. ˛“ĄgiŒ`‘ÔŒnjC˛“Ą—YˆęCˆäă€lCŠ}ˆäŒ‰CŒK”ö’čmC‹T’J“Oi•a—j: ‘ć82‰ń“ú–{•a—Šw‰ď‘‰ď i93.04.06`08j, “Œ‹ž.

379. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚­‚ŕ–Œ‰şoŒŒŽž‚̐S‹ŘáŠQ‚Ě—Ő°Ľ•a—Šw“IŒŸ“˘. ‰Ą“ŕ‘ŽqCŒK”ö’čmi•a—jCŹ—Ń–ž–FC‘“c‘ěC–ؐě“c—˛ˆęi“ŕjC‹T’J“Oi•a—j: ‘ć82‰ń“ú–{•a—Šw‰ď‘‰ď i93.04.06`08j, “Œ‹ž.

380. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j nm23Šŕ“]ˆÚ—}§ˆâ“`ŽqŽY•¨‚ɑ΂ˇ‚é“ÁˆŮ“IR‘̂̐Ťó‚Ć”x‘BŠŕ×–E‚Ěnm23”­Œť‚̉đÍ. ě‹v•ŰˆŔ˜NCŠ}ˆäŒ‰C˛“Ą—YˆęC‰¤‘ě•PC•xŠ~˜a”üC‹T’J“Oi•a—jCěăł–çi•ŞśjCŽě‹č—m: ‘ć82‰ń“ú–{•a—Šw‰ď‘‰ď i93.04.06`08j, “Œ‹ž.

381. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j CAP(capillary action plate)–@‚̖Ɖu‘gD‰ťŠw‚Ö‚Ě“ą“ü‚ÉŠÖ‚ˇ‚éŠî‘b“IŒ¤‹†. ŒK”ö’čmCŠ}ˆäŒ‰C˛“Ą—YˆęCě‹v•ŰˆŔ˜Ni•a—jC˛“ĄgiŒ`‘ÔŒnjC‹T’J“Oi•a—j: ‘ć82‰ń“ú–{•a—Šw‰ď‘‰ď i93.04.06`08j, “Œ‹ž.

382. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j äX“ŕ•Ş”ĺŽîᇂŌŒ’†ƒKƒXƒgƒŠƒ“‹y‚ŃACTH‚ލ‚’l‚đŽŚ‚ľ‚˝ŽîᇍזE‚ĚƒKƒXƒgƒŠƒ“‹y‚ŃƒŔ-MSHŽYś‚đŘ–ž‚ľ“ž‚˝1–UŒŸ—á. ŽO•xO”VC’†‰p’jCźŽR•Ű”äŒĂC‹T’J“Oi•a—j: ‘ć82‰ń“ú–{•a—Šw‰ď‘‰ď i93.04.06`08j, “Œ‹ž.

383. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Rhabdoid appearance‚đ’悡‚éŽq‹{“ŕ–ŒĽäNă÷‚É”­ś‚ľ‚˝sarcoma‚Ě‚QÇ—á. ŠâŸşŒ[ˆęC‹ŕŽq‘C‰Á‰ę“c–LC‰œ•˝‰ë•Fi•a—j: ‘ć82‰ń“ú–{•a—Šw‰ď‘‰ď i93.04.07j, “Œ‹ž, “ú–{•a—Šw‰ď‰ďŽ, 82(1): 213, 1993.

384. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”ńd•ĎŤ–ĺ–Źˆł˜´iÇŠĚ‚É‚¨‚Ż‚éˆŮíŒŒs˜H‚Ě”äŠrŒŸ“˘. ‘ĺ•”˝C“n•Ó´ŽĄC‰œ•˝‰ë•Fi•a—j: ‘ć82‰ń“ú–{•a—Šw‰ď‘‰ď i93.04.07j, “Œ‹ž, “ú–{•a—Šw‰ď‰ďŽ, 82(1): 237, 1993.

385. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j V‚ľ‚˘–ƉuőF–@capillary actio plate–@‚ĚŠJ”­‚Ɛf’f‚ւ̉ž—p. ŒK”ö’čmC‰oěWC˛“Ą—YˆęC‹T’J“Oi•a—j: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05j, ĺ‘ä.

386. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j In situ hybridization–@‚É‚ć‚é”xŠŕ‚É‚¨‚Ż‚éEpstein-Barr VirusŠ´ő‚Ě•ŞŽq•a—Šw“IŒŸ“˘. Š}ˆäŒ‰C‹T’J“OC˛“Ą—YˆęCě‹v•ŰˆŔ˜Ni•a—jCˆäă€li‹šŠOj: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05`07j, ĺ‘ä.

387. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j “úŒőŠp‰ťÇ‚É‚¨‚Ż‚ép53ˆâ“`Žq‚Ě“_“Ë‘R•ĎˆŮ‚ĚŒŸ“˘. “cŒű—ŽjC“n•”šC”Ş“‡ˆę•vCÎŒ´˜a”VC˛“Ą—YˆęC‹T’J“OCŠÖ’J„’ji•a—j: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05`07j, ĺ‘ä.

388. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”x‘BŠŕ‚É‚¨‚Ż‚énm23“]ˆÚ—}§ˆâ“`ŽqŽY•¨‚Ě”­Œť. ě‹v•ŰˆŔ˜NC˛“Ą—YˆęCŠ}ˆäŒ‰C‘ĺŒIŒ’•FC‹T’J“Oi•a—jC‰Y–ěŒ’CŽě‹č—m: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05`07j, ĺ‘ä.

389. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆŤŤƒŠƒ“ƒpŽî‚É‚¨‚Ż‚énm23“]ˆÚ—}§ˆâ“`ŽqŽY•¨‚̖Ɖu‘gD‰ťŠw“IŒŸ“˘. ˛“Ą—YˆęC‰Y–ěŒ’Cě‹v•ŰˆŔ˜NC‘ĺŒIŒ’•FCŽě‹č—mC‹T’J“Oi•a—j: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05`07j, ĺ‘ä.

390. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆÝŠŕ‚É‚¨‚Ż‚énm23-H1, H2’`”’‚Ě”­Œť. ‘ĺŒIŒ’•FC˛“Ą—YˆęCě‹v•ŰˆŔ˜Ni•a—jCŹň˜aŽO˜YCźŒłŽ›Ž—çi“ŕjC‰Y–ěŒ’CŽě‹č—m: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05`07j, ĺ‘ä.

391. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Arbitary Primer PCR–@‚É‚ć‚éAspergillus fumigatus strains‚Ěgenome typing‚ÉŠÖ‚ˇ‚錤‹†. ŽRč•q˜aC‹v•ÄŒői•a—jC‘şź‰pŽ÷i—Ő•a—jCŽR‰ş‚Ś‚čŽqi“ŕj: ‘ć37‰ń“ú–{ˆă^‹ŰŠw‰ď‘‰ď i93.10.10j, ‰Ą•l, ^‹ŰŽ, 34(Suppl.): 104, 1993.

392. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒƒ“ƒuƒŒƒCƒ“ĽƒtƒBƒ‹ƒ^[‚É‚ć‚éĚŽć×–E‚̖Ɖu‘gD‰ťŠw“ą“ü‚ÉŠÖ‚ˇ‚錟“˘. ŒK”ö’čmC“n•Ó´ŽĄC‹T’J“Oi•a—jC‘ĺ–ě‰pŽĄi•a‰@•a—jC‹e’rˆęŽőC‘ŽŔ–FŽq: ‘ć32‰ń“ú–{—Տ°×–EŠw‰ďHŠú‘ĺ‰ď i93.10.16j, ˆŽě.

393. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j p’†v‘Źf’f‚ɍזEf‚Ş—LŒř‚Ĺ‚ ‚Á‚˝—‘‘ƒdysgerminoma‚Ě1—á. “n•Ó´ŽĄCŒK”ö’čmi•a—jC‘ĺ–ě‰pŽĄi•a‰@•a—jC‹T’J“Oi•a—j: ‘ć32‰ń“ú–{—Տ°×–EŠw‰ďHŠú‘ĺ‰ď i93.10.16j, ˆŽě.

394. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žq‹{“ŕ–Œ‘BÇ‚¨‚ć‚Ńƒzƒ‹ƒ‚ƒ“ˆŮí“ŕ–Œ‚Ě”wŒi‚ÉŠÖ‚ˇ‚é×–EŠw“IŒŸ“˘. –L‰i^ŸC‘ĺ–ě‰pŽĄC‰ĄŽR‘ĺC•ž•”ŠwC‚ŽR–žŽqi•a‰@•a—jCŠâŸşŒ[ˆęCŒK”ö’čmi•a—jC‘ –{”ŽsiŽY•wjC‹T’J“Oi•a—j: ‘ć32‰ń“ú–{—Տ°×–EŠw‰ďHŠú‘ĺ‰ď i93.10.16j, ˆŽě, “ú–{—Տ°×–EŠw‰ďŽGŽ, 32(5): 698, 1993.

395. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Borrmann 4Œ^ˆÝ’á•Ş‰ť‘BŠŕ‚ĚƒJƒeƒvƒVƒ“‚c”­Œť‚ÉŠÖ‚ˇ‚é–Ɖu‘gDŠw“IŒŸ“˘. ă™G‰iCŽO•xO”VCźŽR•Ű”äŒĂC’†‰p’ji•a—j: ‘ć83‰ń“ú–{•a—Šw‰ď‘‰ď i94.03.29j, ‹ž“s.

396. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘˝Ží—ނ̐^‹Ű‚ލŹ‡Š´ő‚ľ‚˝‘SgŤƒgƒŠƒRƒXƒ|ƒƒ“Š´őÇ‚Ě1—á. –Ř‘ş‰ë‹vC‘źi‹ß‹E‘ĺjC‹v•ÄŒői•a—j: ‘ć83‰ń“ú–{•a—Šw‰ď‘‰ď i94.03.29j, ‹ž“s, “ú–{•a—Šw‰ďŽ, 83(1): 185, 1994.

397. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Virus‚Ě—L–ł‚ĆŽîᇍזE‚ĚApoptosis‚ÉŠÖ‚ˇ‚éŒ`‘ÔŠw“I‚Š‚Â•ŞŽqś•¨Šw“IŒ¤‹†. Îˆä‰pşC‘q—Ń—ÇKC×‘ş‘וvCé‰şŽi•a—j: ‘ć42‰ń“ú–{Š´őÇŠw‰ď“Œ“ú–{’n•ű‰ď‘‰ď i93.10.15j, ÂX, —\eW, p.113, 1993.

398. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘ٔՎîᇋy‚Ń‚ť‚̑ٔՂɂć‚č”­ś‚ľ‚˝VśŽ™–UŒŸ—á‚Ě1—á. “n•Óƒi•a—j: ‘ć16‰ń_“ŢěŒ§•a—ˆă‰ď‘‰ď i93.12.16j, ěč.

399. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Pulmonary capillary hemangiomatosis. Îˆä‰pşi•a—j: ‘ć52‰ń_“ސě•a—ˆă‰ď i94.03.03j, ˆÉ¨Œ´.

400. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‘ĺ’°smŠŕ‚ć‚č‚Ý‚˝Šŕ‘gDf’fŠî€|•\–ĘŒ^‚Ć—˛‹NŒ^Šŕ‚Ě”äŠr|. ŽO•xO”VC’†‰p’jCźŽR•Ű”äŒĂi•a—jCă™G‰iCŒÜ\—’łLCŸ–””ş‰hi“ŕjC‘ęK‹ĎCH“ĄNśC‘ĺ’J„łiŠOj: ‘ć39‰ń‘ĺ’°ŠŕŒ¤‹†‰ď i93.07.17j, •Ÿ‰Ş.

401. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ”]“ŕ•a•Ď‚đ”F‚ß‚˝ć“VŤ•—]ÇŒóŒQ‚Ě1—á. “n•ÓƒCŒK”ö’čmi•a—jC‰Ź–ěƒ‘ăCŠ—Œ´FCŹŒűO‹BiŽ™jC‹T’J“Oi•a—jCÎŒ´DOi“s_Œo‰ČŠw‘‡Œ¤‹†Šj: ‘ć46‰ńŠÖ“Œ—Տ°_Œo•a—§˜b‰ď i93.11.27j, “Œ‹ž.

402. mŒ¤‹†‰ďi’n•űjn iŒöŠJuŔj ƒAƒ|ƒg[ƒVƒX‚ĚŠT”O. Îˆä‰pşi•a—j: ŒQ”n‘ĺŠwŒöŠJuŔ i93.09.10j, ‘O‹´.


<<08 7 •a—Šw>>

403. mŠw‰ďŽĺĂi‘“ŕŠw‰ďjn Ŕ’ˇ, ‘ć34‰ń“ú–{”xŠŕŠw‰ď‘‰ďi93.11.09`10j, “Œ‹ž, ‹T’J“Oi‹šŠOj.


<<09 ‰qśŠwEŒöO‰qśŠw>>

404. mŒ´’˜n Magnetometric evaluation of the effects of gallium arsenide on the clearance and relaxation of iron particles. ‘Š‘ňDŽĄC‚“c™ŚCŠĄ•”‚ЂƂ݁C’F—mCˆäŒű“Ţ“sŽqi‰qjCŹ’J˝i“Œ‹ž“d‹C‘ĺjCç‘ă’JŒcŽOiŒ]”x˜JĐ•a‰@j: Industrial Health, 31: 143`153, 1993.

405. mŒ´’˜n ƒ}ƒEƒXŽl‰–‰ť’Y‘fŽä‹NŤŠĚáŠQŽž‚Ěƒ~ƒNƒƒ\[ƒ€ƒVƒgƒNƒƒ€P-450—Ę‚Ć•a—‘gDŠw“I•Ď‰ť‚Ě‘Î”äŒŸ“˘. ŠĄ•”‚ЂƂ݁i‰qj: ƒAƒ‹ƒR[ƒ‹Œ¤‹†‚Ć–ň•¨ˆË‘ś, 28(2): 54`63, 1993.

406. mŒ´’˜n Eę‚Ěƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‚̑Ήž‚ÉŠÖ‚ˇ‚éˆęlŽ@|Ž–‹Ćę‚Ěƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‚ÉŠÖ‚ˇ‚éŽŔ‘Ô’˛¸‚Š‚ç|. —›‹ĘžÄi‰qjC’†‘şŒŤiˆă—ÎЉďŠwjCŒ´“c˝ˆęi´˜a•a‰@jC‚“c™ŚC‘Š‘ňDŽĄCŠĄ•”‚ЂƂ݁i‰qj: ƒXƒgƒŒƒX‰ČŠw, 8(3): 49`57, 1994.

407. mŒ´’˜n ˆă—ĂŢ—ż‚ĚƒGƒ`ƒŒƒ“ƒIƒLƒTƒCƒhƒKƒX–Ĺ‹Ű‚É”ş‚¤ˆŔ‘SŤ. •Đ‹Ë—TŽjCĄˆäDC–ĺ˜e•”ŽiŠĹŒěŠw•”jC‚“c™Śi‰qjC•€Œű—ćŽqC™“c”ÍŽqi’†‰›–Ĺ‹ŰŢ—żŽşj: ŠÂ‹ŤŠ´ő, 8(2): 17`22, 1993.

408. mŒ´’˜n ˜J“­ˆŔ‘S‰qśƒRƒ“ƒTƒ‹ƒ^ƒ“ƒg. ‚“c™Śi‰qj: ŒöO‰qś, 57(11): 765`768, 1993.

409. mŒ´’˜n ŽY‹Ćˆă§“x‚đ‚ß‚Ž‚鏔–â‘č. ‚“c™Śi‰qj: _“ŢěŒ§ˆăŽt‰ďŽY‹Ćˆă•”‰ď‰ď•ń, 1(1): 15`19, 1993.

410. mŒ´’˜n ‚ą‚ę‚Š‚ç‚ĚŽY‹Ć•ŰŒ’‚̉ۑč|ƒXƒgƒŒƒXŠÖ˜AŽžŠł‚đ‚ß‚Ž‚Á‚ā|. ‚“c™ŚC‘Š‘ňDŽĄi‰qj: _“ŢěŒ§SgˆăŠw‰ďŽ, 3: 1`14, 1992.

411. mŒ´’˜n ‚ś‚ń”x—LŠŒŠŽŇ‚É‚¨‚Ż‚éT×–EƒTƒuƒZƒbƒg. ˆäŒű“Ţ“sŽqC‘Š‘ňDŽĄC‹´–{‹Nˆę˜YC’F—mC‚“c™Śi‰qjC’†‘şŒŤiˆă—ÎЉďŠwj: “ú–{ĐŠQˆăŠw‰ď‰ďŽ, 41(2): 93`98, 1993.

412. mŒ´’˜n Analysis of factors influencing the tendency among persons with spinal cord injury to be afflicted with multiple complications. ĄˆäDC–ĺ˜e•”ŽiŠĹŒěŠw•”jC•Ÿ•x˜a•vi‘—§ŒöO‰qś‰@jC‚“c™Śi‰qj: “ú–{ĐŠQˆăŠw‰ď‰ďŽ, 41(4): 327`334, 1993.

413. mŒ´’˜n ‚ś‚ń”x—LŠŒŠŽŇ‚É‚¨‚Ż‚é”x‹@”\ŒŸ¸‚ĚˆŤ‰ť—vˆö‚ÉŠÖ‚ˇ‚éc’f“IŒ¤‹†|“Á‚É‹i‰Œ‚̉e‹ż‚ɂ‚˘‚ā|. ˆäŒű“Ţ“sŽqC‘Š‘ňDŽĄCŠĄ•”‚ЂƂ݁i‰qj: “ú–{ĐŠQˆăŠw‰ď‰ďŽ, 41(9): 613`620, 1993.

414. mŒ´’˜n ’†ŹŠé‹Ć‚É‚¨‚Ż‚錒Nf’f‚ĆŠÇ—|ˆăŽt‰ď‚Ć‚Ě‹Ś—́iŽY‹Ć•ŰŒ’ƒZƒ“ƒ^[j|. ‚“c™Śi‰qj: —Տ°Źl•a, 23(9): 1280`1284, 1993.

415. mŒ¤‹†•ńn ƒNƒŠ[ƒjƒ“ƒOŽć‚čŽŸ‚Ź“X‚Ěƒeƒgƒ‰ƒNƒƒƒGƒ`ƒŒƒ“‚ÉŠÖ‚ˇ‚錤‹†|ŠŐŽUŠú‚ƔɖZŠú‚Ě”äŠr|. ‚“c™ŚC‘Š‘ňDŽĄCˆäŒű“Ţ“sŽqi‰qjCˆäă—tŽqi—\–hˆăŠwŒnjC–ĺ˜e•”ŽCĄˆäDC•Đ‹Ë—TŽjiŠĹŒěŠw•”jC’†‘şŒŤiˆă—ÎЉďŠwj: ƒNƒŠ[ƒjƒ“ƒO‚ĆŒöO‰qś‚ÉŠÖ‚ˇ‚錤‹†•˝Ź4”N“x•ń‘, p.6`16, 1993.

416. mŒ¤‹†•ńn —LlƒTƒ|[ƒgˆĎˆő‰ď‚ɑ΂ˇ‚鎐–â‚ɂ‚˘‚Ä. ‚“c™Śi‰qj: ‰F’ˆŠJ”­Ž–‹Ć’c—LlƒTƒ|[ƒgˆĎˆő‰ď“š\.

417. mŒ¤‹†•ńn ‚ś‚ń”x‚芳ŽŇ‚Ě•aŒă‚ĚŒo‰ß‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†Œ‹‰Ę•ń. Šâ“cO•qiŠň•Œ‘ĺjC‘ĺ‹v•Ű—˜WiŽY‹Ćˆă‘ĺjC‘ĺčé`iŠâŒŠ‘ň˜JĐ•a‰@jC‰Í–ěŒcŽOiŽŠŽĄˆă‘ĺjC“‡łŒái“Ą“c•ŰŒ’‰qś‘ĺjC‚“c™Śi‰qjCç‘ă’JŒcŽO iŒ]”x˜JĐ•a‰@jC”nę‰ő•Fi”nę˜J“­‰qśƒRƒ“ƒTƒ‹ƒ^ƒ“ƒgjC‰ĄŽR–M•Fi‘—§—Ă—{ŠjC‰ĄŽR“N˜NiŒc‘ĺjC‘Š‘ňDŽĄi‰qjC]ŒűŒ¤“ńi‘—§‚Ş‚ńƒZƒ“ ƒ^[jCÖ“Ą–FWiŒ]”x˜JĐ•a‰@jC’†‘ş‘biŽY‹ĆˆăŠw‘‡Œ¤‹†ŠjCX”öáÁ‰îi’šŽć‘ĺjC‹g“c•×i“Ą“c•ŰŒ’‰qś‘ĺj: Œ¤‹†Œ‹‰Ę•ń‘i’†‰›˜J“­ĐŠQ–hŽ~‹Ś‰ďj, p.1`122, 1993.

418. mŒ¤‹†•ńn ŽY‹Ć•ŰŒ’ˆĎˆő‰ď“š\. ‚“c™Śi‰qjC“ŕ“Ąâli•şŒÉŒ§ˆăŽt‰ďjC‰F–ě‹`’mi•xŽRŒ§ˆăŽt‰ďjC‘ĺ‹v•Ű—˜WiŽY‹Ćˆă‘ĺjC‘ĺ‰zŽŸ’jiˆďéŒ§ˆăŽt‰ďjC‘ĺŽR’ŠOi‰Ť“ęŒ§ˆăŽt‰ďjCÖ“Ą C–íi–kŠC“šˆăŽt‰ďjC˛“ĄŒö•Fi‘ĺă•{ˆăŽt‰ďjC‚‹´Œ’iŠâŽčŒ§ˆăŽt‰ďjC‚‹´Š°’jiVh‹ćˆăŽt‰ďjC’†ě—˜ˆęi“ż“‡Œ§ˆăŽt‰ďjC–ěŒŠŽRˆęśiŽŠŽĄˆă ‘ĺj: ŽY‹Ć•ŰŒ’ˆĎˆő‰ď“š\i“ú–{ˆăŽt‰ďj, p.1`12, 1994.

419. mŒ¤‹†•ńn Źl•a—\–hŒŸfŽófŽŇ‚ĚŒ’NśŠˆ’˛¸. ‚“c™Śi‰qjC’†‘şŒŤiˆă—ÎЉďŠwj: ­•{ŠÇśŒ’N•ŰŒŻŽ–‹Ć‚ĚŒř—Ś‰ť‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†i‘S‘ŽĐ‰ď•ŰŒŻ‹Ś‰ď˜A‡‰ďj, p.7`20, 1993.

420. mŒ¤‹†•ńn ‚ś‚ń”xi“W—vˆö‚ÉŠÖ‚ˇ‚錤‹†. ‚“c™ŚC‘Š‘ňDŽĄi‰qj: •˝Ź5”N“x˜J“­ČˆĎ‘őŒ¤‹†•ń‘, p.1`27, 1994.

421. mŒ¤‹†•ńn ŽY‹Ćˆă‰Č‘ĺŠwŠî–{–â‘荧’k‰ď•ń|ŽY‹Ć•ŰŒ’Šw•”Ý’u\‘z‚ɂ‚˘‚ā|. —é–؏G˜YiŽY‹Ćˆă‘ĺjCÎě‚–ži“ú–{ˆăŽt‰ďjCˆäă•ś•Fi˜J“­•ŸŽƒŽ–‹Ć’cjCň‘žiŽY‹Ćˆă‘ĺjCŠâčL•vi˜J“­ČjC]“Ą•riŽO•H‰ťŹjC‚™šK iŽY‹Ćˆă‘ĺjC‚“c™Śi‰qjC‚—œ¸ŽOi“ú–{Œo‰c’c‘Ě˜A–żjC“c’†Šě‘ăŽji˜J“­ČjC’|‘ş‹BC•x’Ł¸iŽY‹Ćˆă‘ĺjC‹ŃDŕöi‘S‘’†ŹŠé‹Ć’c‘Ě’†‰›‰ďjC‰Ą “c_i˜J“­ČjCaŒű‰ĂłiŽY‹ĆˆăŠwU‹ťŕ’cjC‘ĺÎ–ži˜J“­Čj: •ń‘iŽY‹ĆˆăŠwU‹ťŕ’cj, p.1`51, 1993.

422. mŒ¤‹†•ńiŒúśČjn ƒXƒgƒŒƒXƒ}ƒl[ƒWƒƒ“ƒg‚Ě•]‰ż‚ÉŠÖ‚ˇ‚錤‹†. ‚“c™Śi‰qjC’†‘şŒŤiˆă—ÎЉďŠwjC‘Š‘ňDŽĄCŠĄ•”‚ЂƂ݁CˆäŒű“Ţ“sŽqC—›‹Ę‰hi‰qjCŒ´“c˝ˆęi_ŒoŒ¤j: •˝Ź4”N“xŒúśČ‰ČŠwŒ¤‹†i¸_•ŰŒ’ˆă—ĂŒ¤‹†jS‚ĚŒ’N‚Ă‚­‚č‚Ě•]‰ż‚Ć‹Z–@‚ÉŠÖ‚ˇ‚錤‹†, p.73`107, 1993.

423. mŒ¤‹†•ńiŠÂ‹Ť’Ąjn ”÷ŹƒAƒXƒxƒXƒg‚Ě‹z“ü‚É‚ć‚鐜‘̉e‹ż’˛¸Œ¤‹†. ‘Š‘ňDŽĄi‰qjC‰|–{^i“ú–{ƒoƒCƒIƒAƒbƒZƒCŒ¤jC_ŽRé•Fi˜J“­ČŽY‹ĆˆăŠw‘‡Œ¤jC—`dŽĄi’†Đ–h˜J“­‰qśŒŸ¸ƒZƒ“ƒ^[jCŹźiliƒwƒ‹ƒXĽƒTƒCƒG ƒ“ƒXjC‚“c™Śi‰qjC’J‘ž”ü—YiŽÄ“c‰ČŠwH‹ĆjC–ěč˜j‰EC“Ą“c”Ž•śCŽR–{ĂŒěCŒă“ĄŒOi“ú–{ƒoƒCƒIƒAƒbƒZƒCj: •ń‘, p.1`66, 1993.

424. mŒ¤‹†•ńi˜J“­Čjn ˜’É‚Ě—\–h‘΍ô‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†ˆĎˆő‰ď•ń‘i’†ŠÔ•ńj. ‘Š‘ňDŽĄi‰qjCŽs‰‰p”ViŽs‰ŽŒ`ŠO‰ČjC‘ĺˆäi—YiŽŠŽĄˆă‘ĺjCŹ“c“oi“úŽYŽŠ“ŽŽÔjC”’ˆäNłi“úˆă‘ĺjC“ż‰i—Í—YiŠÖźˆă‘ĺjC–{‘˝ƒ’ji˜J“­•Ÿ ŽƒŽ–‹Ć’cjC–ĺ”n•qi‘O“cŒšÝjC”Şă‹Žii“Œ‹žŠČˆŐ•ŰŒŻ—X•Ö”N‹ŕ‰ďŠŮŒŸfƒZƒ“ƒ^[jCŽR–{@•˝iŽY‹ĆˆăŠw‘‡Œ¤‹†ŠjC’†‘şŒŤiˆă—ÎЉďŠwjCŒĂě—S “ńC‚“cšKCâ“c‘PœAC“c’†KŽĄC’†ŽRŽŒČC“ę“c‰pŽ÷C–…”ö—TŽĄi˜J“­ČˆŔ‘S‰qś•”jCě‘şŽO˜YCÖ“ĄG–íi’†‰›˜J“­ĐŠQ–hŽ~‹Ś‰ďj: ’†ŠÔ•ń‘, p.1`53, 1993.

425. mŒ¤‹†•ńi˜J“­Čjn ‘ą”­Ť‹CŠÇŽx‰Š“™‚ś‚ń”x‡•šÇ—á‚Ě”x‹@”\ŒŸ¸‚É‹y‚Ú‚ˇ‹i‰Œ‰e‹ż‚ÉŠÖ‚ˇ‚錤‹†. ‚“c™ŚC‘Š‘ňDŽĄi‰qj: •˝Ź4”N“xĐŠQ‰ČŠw‚ÉŠÖ‚ˇ‚éˆĎ‘őŒ¤‹†•ń‘, p.1`21, 1993.


<<09 2 ‰qśŠwEŒöO‰qśŠw>>

426. m‘ŕn ƒjƒ…[ƒLƒmƒƒ“Ţ‚Ě—L—pŤ‚ĆŒŔŠE. ŠĄ•”‚ЂƂ݁C‘Š‘ňDŽĄC‚“c™Śi‰qj: Medicina, 30(7): 1252`1254, 1993.

427. m‘ŕn •˛‚ś‚ńě‹ĆŽŇ‚Ě”x‹@”\‚ɉe‹ż‚đ‹y‚Ú‚ˇˆöŽq‚ɂ‚˘‚Ä. ˆäŒű“Ţ“sŽqC‘Š‘ňDŽĄC‚“c™Śi‰qj: ŽY‹ĆˆăŠwƒWƒƒ[ƒiƒ‹, 16(3): 93`96, 1993.

428. m‘ŕn ”ź“ą‘ĚŽY‹Ć‚Ě˜J“­‰qśŠÇ—‚ɂ‚˘‚Ä. ’F—mC‘Š‘ňDŽĄC‚“c™Śi‰qj: ŽY‹ĆˆăŠwƒWƒƒ[ƒiƒ‹, 16(4): 67`72, 1993.

429. m‘ŕn ŽY‹Ć•ŰŒ’Šˆ“Ž‚É—Ő°ˆăŠw‚Ě—Z‡‚ĆŠˆ—p‚đ. ˜a“cUi“Œ‘ĺjC‘Š‘ňDŽĄi‰qjC—é–؏G˜YiŽY‹Ćˆă‰Č‘ĺjC•“c˜a‹vi‰Ş‘ĺjCç—tČŽOi‰Ą•l˜JĐ•a‰@j: ŽY‹ĆˆăŠwƒWƒƒ[ƒiƒ‹, 16(5): 18`28, 1993.

430. m‘ŕn ˆůŽđ‚Ě•žŠQ‚ɂ‚˘‚Ä. ŠĄ•”‚ЂƂ݁C‘Š‘ňDŽĄC‚“c™Śi‰qj: ŽY‹ĆˆăŠwƒWƒƒ[ƒiƒ‹, 16(5): 90`94, 1993.

431. m‘ŕn ŽY‹ĆˆăŠw‘˜_. ‚“c™Śi‰qj: ŽY‹ĆˆăŠwƒWƒƒ[ƒiƒ‹, 16(‘): 40`57, 1993.

432. m‘ŕn Eę‚É‚¨‚Ż‚錒N‘iƒvƒƒOƒ‰ƒ€‚Ě”ď—p•Ö‰v•ŞÍ. ’†‘şŒŤiˆă—ÎЉďŠwj: ˜J“­‰qś, (406): 52`53, 1994.


<<09 3 ‰qśŠwEŒöO‰qśŠw>>

433. m‹ł‰Č‘n i•Ş’SŽˇ•Mj ‰qśŠÇ—ŽŇ‚ĚŽŔ–ą|”\—ÍŒüă‹łˆç—pƒeƒLƒXƒg|; Šé‹ĆŠˆ“Ž‚É‚¨‚Ż‚é˜J“­‰qśŠÇ—, p.63`76, ‚“c™Śi‰qjC’†‘şŒŤiˆă—ÎЉďŠwj. ’†‰›˜J“­ĐŠQ–hŽ~‹Ś‰ď, “Œ‹ž, 93.00.00”­s.


<<09 5 ‰qśŠwEŒöO‰qśŠw>>

434. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Industrial hygienic aspects in microelectronics industry. ‘Š‘ňDŽĄC‚“c™ŚCŠĄ•”‚ЂƂ݁CˆäŒű“Ţ“sŽqi‰qjCˆäă—tŽqC™‰Y—R”üŽqC–‹I”ü‘ăi—\–hˆăŠwŒnj: International Congress of Clinical Ecology i93.09.04j, –kŠC“š, Abstracts, p.44, 1993.

435. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Spinal cord injury caused by industrial accidents|Incidence and mortality in Japan. ĄˆäDC–ĺ˜e•”ŽC•Đ‹Ë—TŽjiŠĹŒěŠw•”jC‚“c™Śi‰qjC•Ÿ•x˜a•vi‘—§ŒöO‰qś‰@j: 24th International Congress on Occupational Health i93.09.28j, ƒj[ƒX, Abstracts, p.261, 1993.

436. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Indoor environmental contamination with tetrachloroethylene remained in dry-cleaned clothes. –ĺ˜e•”ŽC•Đ‹Ë—TŽjCĄˆäDiŠĹŒěŠw•”jC‚“c™ŚC‘Š‘ňDŽĄi‰qjC’†‘şŒŤiˆă—ÎЉďŠwjCˆäŒű“Ţ“sŽqi‰qjCo“‡”ÁiƒNƒŠ[ƒjƒ“ƒO˜A‡‰ďj: 24th International Congress on Occupational Health i93.09.29j, ƒj[ƒX, Abstracts, p.356, 1993.

437. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ě‹ĆŠÖ˜AŽžŠł‚ĚŠÇ—‚Ćƒ‰ƒCƒtƒXƒ^ƒCƒ‹. ‘Š‘ňDŽĄi‰qj: ‘ć9‰ń“ú–{ƒXƒgƒŒƒXŠw‰ď i93.11.16j, “Œ‹ž, ƒXƒgƒŒƒX‰ČŠw, 8(2): 39, 1993.

438. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ň‘‘šŽŇ‚É‚¨‚Ż‚鍂ŒŒˆłÇ‚¨‚ć‚Ń“œ”A•a‚̍‡•š•p“x. ĄˆäDC•Đ‹Ë—TŽjC–ĺ˜e•”ŽiŠĹŒěŠw•”jC‘Š‘ňDŽĄC‚“c™Śi‰qjC•Ÿ•x˜a•vi‘—§ŒöO‰qś‰@j: ‘ć63‰ń“ú–{‰qśŠw‰ď i93.04.07j, “Œ‹ž, “ú–{‰qśŠwŽGŽ, 18(1): 241, 1993.

439. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒhƒ‰ƒCƒNƒŠ[ƒjƒ“ƒOŽć‚čŽŸ‚Ź“X‚Ěƒeƒgƒ‰ƒNƒƒƒGƒ`ƒŒƒ“‚ÉŠÖ‚ˇ‚錤‹†. •Đ‹Ë—TŽjCĄˆäDC–ĺ˜e•”ŽiŠĹŒěŠw•”jCˆäă—tŽqi—\–hˆăŠwŒnjC‚“c™Śi‰qj: ‘ć63‰ń“ú–{‰qśŠw‰ď i93.04.07j, “Œ‹ž, “ú–{‰qśŠwŽGŽ, 18(1): 546, 1993.

440. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”xŽĽŠE‘Ş’č‚É‚ć‚é”xáŠQ•]‰ż|ƒVƒŠƒJ‚ĆƒKƒŠƒEƒ€áĺ‘f|. ‘Š‘ňDŽĄC‚“c™ŚCŠĄ•”‚ЂƂ݁C’F—mCˆäŒű“Ţ“sŽqi‰qjCˆäă—tŽqC™‰Y—R”üŽqC–‹I”ü‘ăCŹ’J”ŽŽqi—\–hˆăŠwŒnjCŹ’J˝i“Œ‹ž“d‹C‘ĺj: ‘ć2‰ń“ú–{—Տ°ŠÂ‹ŤˆăŠw‰ď i93.04.18j, “Œ‹ž, —Տ°ŠÂ‹ŤˆăŠw, 2(1): 56, 1993.

441. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹Î˜JŽŇ‚É‚¨‚Ż‚é•K{Œł‘f‚Ě“Ž‘ԁi‡TjƒZƒŒƒ“. —é–؍_ˆęCŹ“cŒ›ˆęC’†“‡Šî”ŽiŠÖ“Œ˜JĐ•a‰@jC‰““ĄŹ‘ăŽqi—\–hˆăŠwŒnjC‹ß“Ą‚Ś‚čCˆę™łŽĄC‚“c™Śi‰qj: ‘ć66‰ń“ú–{ŽY‹Ć‰qśŠw‰ď i93.05.06j, ‰Ą•l, ŽY‹ĆˆăŠw, 35(—Ő‘): 134, 1993.

442. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹Î˜JŽŇ‚É‚¨‚Ż‚é•K{Œł‘f‚Ě“Ž‘ԁi‡UjˆŸ‰”, “ş. ’†“‡Šî”ŽCŹ“cŒ›ˆęC—é–؍_ˆęiŠÖ“Œ˜JĐ•a‰@jC‰““ĄŹ‘ăŽqi—\–hˆăŠwŒnjC‹ß“Ą‚Ś‚čCˆę™łŽĄC‚“c™Śi‰qj: ‘ć66‰ń“ú–{ŽY‹Ć‰qśŠw‰ď i93.05.06j, ‰Ą•l, ŽY‹ĆˆăŠw, 35(—Ő‘): 135, 1993.

443. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠOŤŇ‘‘šŽŇ‚ĚŒ’N“ÁŤ. ĄˆäDC•Đ‹Ë—TŽjC–ĺ˜e•”ŽiŠĹŒěŠw•”jC‘Š‘ňDŽĄC‚“c™Śi‰qj: ‘ć41‰ń“ú–{ĐŠQˆăŠw‰ď i93.09.17j, –kŠC“š, “ú–{ĐŠQˆăŠw‰ď‰ďŽ, 41(—Ő‘): 136, 1993.

444. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Žl‰–‰ť’Y‘fŽä‹NŤƒ}ƒEƒX‹y‚Ńƒ‰ƒbƒg‚ĚŒoŽž“I‹}ŤŠĚáŠQ‚Ě•a—‘gDŠw“I‘Δ䌟“˘. ŠĄ•”‚ЂƂ݁C‚“c™ŚC‘Š‘ňDŽĄCˆäŒű“Ţ“sŽqi‰qjC’†‘şŒŤiˆă—ÎЉďŠwjCˆäă—tŽqC™‰Y—R”üŽqCĄ–ě—mŽŔC–‹I”ü‘ăi—\–hˆăŠwŒnj: ‘ć41‰ń“ú–{ĐŠQˆăŠw‰ď i93.09.17j, –kŠC“š, “ú–{ĐŠQˆăŠw‰ď‰ďŽ, 41(—Ő‘): 148, 1993.

445. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚ś‚ń”x—á‚É‚¨‚Ż‚é”x‹@”\ŒŸ¸‚É‹y‚Ú‚ˇˆŤ‰ť—vˆö•ŞÍ|‚Ć‚­‚É‹i‰Œ‚̉e‹ż‚ɂ‚˘‚ā|. ˆäŒű“Ţ“sŽqC‘Š‘ňDŽĄCŠĄ•”‚ЂƂ݁i‰qjC™‰Y—R”üŽqC–‹I”ü‘ăi—\–hˆăŠwŒnjC‚“c™Śi‰qjC’†‘şŒŤiˆă—ÎЉďŠwj: ‘ć41‰ń“ú–{ĐŠQˆăŠw‰ď i93.09.17j, –kŠC“š, “ú–{ĐŠQˆăŠw‰ď‰ďŽ, 41(—Ő‘): 156, 1993.

446. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠJ•úŒ^‚Ć•Â˝Œ^ƒhƒ‰ƒCƒNƒŠ[ƒjƒ“ƒO‚É‚ć‚éƒeƒgƒ‰ƒNƒƒƒGƒ`ƒŒƒ“Žc—Ż—Ę‚Ě”äŠr. •Đ‹Ë—TŽjCĄˆäDC–ĺ˜e•”ŽiŠĹŒěŠw•”jC‚“c™Śi‰qj: ‘ć52‰ń“ú–{ŒöO‰qśŠw‰ď i93.10.21j, –k‹ăB, “ú–{ŒöO‰qśŽGŽ, 40(10): 1333, 1993.

447. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –h…ƒXƒvƒŒ[–\˜I‚É‚ć‚éƒCƒkŒŒ‰tĽ‘ŸŠí’†ƒgƒŠƒNƒƒƒGƒ^ƒ“—Ę‚Ě‘Ş’č. •Đ‹Ë—TŽjC–ĺ˜e•”ŽiŠĹŒěŠw•”jCˆäă—tŽqi—\–hˆăŠwŒnjC‘Š‘ňDŽĄC‚“c™Śi‰qjCÂ–Ř‘Ľ–žC‘Š”nˆęˆĺi‹~–˝j: ‘ć67‰ń“ú–{ŽY‹Ć‰qśŠw‰ď i94.03.22j, ‰ŞŽR, ŽY‹ĆˆăŠw, 36: 1994.

448. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –h…ƒXƒvƒŒ[‚̉ESŒn‚É—^‚Ś‚é‰e‹ż‚ĚŒŸ“˘. Â–Ř‘Ľ–žC‘Š”nˆęˆĺi‹~–˝jC•Đ‹Ë—TŽjC–ĺ˜e•”ŽiŠĹŒěŠw•”jC‘Š‘ňDŽĄC‚“c™ŚCŠĄ•”‚ЂƂ݁CˆäŒű“Ţ“sŽqi‰qśjCˆäă—tŽqi—\–hˆăŠwŒnj: ‘ć60‰ń“ú–{ŽY‹Ć‰qśŠw‰ď i94.03.24j, ‰ŞŽR.

449. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒzƒ‹ƒ€ƒAƒ‹ƒfƒqƒh–Ĺ‹Űě‹Ć‚̊‹Ť‰e‹ż. –ĺ˜e•”ŽC•Đ‹Ë—TŽjCĄˆäDiŠĹŒěŠw•”jCˆäă—tŽqi—\–hˆăŠwŒnjCŠĄ•”‚ЂƂ݁CˆäŒű“Ţ“sŽqC‘Š‘ňDŽĄC‚“c™Śi‰qj: ‘ć67‰ń“ú–{ŽY‹Ć‰qśŠw‰ď i94.03.24j, ‰ŞŽR, ŽY‹ĆˆăŠw, 36: 1994.

450. mŒ¤‹†‰ďi‘Űjn iˆę”ʍu‰‰j Effects of GaAs and Ga2O3 on magnetometric behavior of iron particles in rabbit lungs. ‘Š‘ňDŽĄC‚“c™ŚCŠĄ•”‚ЂƂ݁CˆäŒű“Ţ“sŽqi‰qjCŹ’J˝i“Œ‹ž“d‹C‘ĺj: 6th International Symposium Environmental and Industrial Arsenic i93.11.14j, ěč.

451. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ”x“஥Ť—ąŽq‚Ě“Ž‘Ԃɑ΂ˇ‚éŽ_‰ťƒKƒŠƒEƒ€‹CŠÇ“ŕ“Š—^‚̉e‹ż. Ź’J”ŽŽqi—\–hˆăŠwŒnjC‚“c™ŚC‘Š‘ňDŽĄi‰qjC’†‘şŒŤiˆă—ÎЉďŠwjCŠĄ•”‚ЂƂ݁CˆäŒű“Ţ“sŽqi‰qjCŹ’J˝i“Œ‹ž“d‹C‘ĺjC–ĺ˜e•”ŽC•Đ‹Ë—TŽjiŠĹ ŒěŠw•”j: ƒ}ƒOƒlƒeƒBƒbƒNƒXŒ¤‹†‰ď i93.11.30j, “Œ‹ž, “d‹CŠw‰ďŒ¤‹†‰ďŽ‘—ż, p.9`14, 1993.

452. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‚ś‚ń”xŒ’f. ‘Š‘ňDŽĄi‰qj: _“ŢěŒ§ˆăŽt‰ďŽY‹ĆˆăŒ¤C‰ď i94.01.22j, _“ސě.

453. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‚ą‚ę‚Š‚ç‚ĚŽY‹Ć•ŰŒ’, “Á‚É’nˆćŽY‹Ć•ŰŒ’‚Ć‚ť‚ĚŽü•Ó. ‘Š‘ňDŽĄi‰qj: _“ŢěŒ§ˆăŽt‰ď”F’čŽY‹ĆˆăŒ¤C‰ď i94.02.05j, ěč.


<<09 7 ‰qśŠwEŒöO‰qśŠw>>

454. mŠw‰ďŽĺĂi‘“ŕŠw‰ďjn ‘ć66‰ń“ú–{ŽY‹Ć‰qśŠw‰ď, ‚“c™Śi‰qj.


<<10 –@ˆăŠw>>

455. mŒ´’˜n ’‚‘§‹@\‚É‚¨‚Ż‚éƒnƒvƒgƒOƒƒrƒ“‚Ě–đŠ„(‡U)‹}Ť“MŽ€‚¨‚ć‚ŃăoŒz. ’†“cLŽqi“Œ—ˆă‘ĺjCŹ’J~ˆęi–@ˆăj: “ú–{–@ˆăŠwŽGŽ, 48(1): 26`32, 1994.


<<10 2 –@ˆăŠw>>

456. mŠwp‘n i•Ş’SŽˇ•Mj —Տ°‚ĆŒŒ‰tŒ^; ÔŒŒ‹…Œ^, p.21`26, Ź’J~ˆęi–@ˆăj. •ŇW ‘ňŒű˛ŽqCaŒűGşC´…Ÿi“Œ—ˆă‘ĺjC ’Š‘q‘“X, “Œ‹ž, 93.05.25”­s.


<<10 5 –@ˆăŠw>>

457. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Identification of blood stains as antemortem or postmortem: Quantitation of nucleotides, nucleosides and bases in bloodstains by high-performance liquid chromatography. ™]G–ži–@ˆăjCźě—˛i—Ő•a—jC‘D”ö’‰Fi–@ˆăj: 13th Meeting International Association of Forensic Sciences i93.08.22`28j, ƒfƒ†ƒbƒZƒ‹ƒhƒ‹ƒt.

458. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Quantitative analysis on autolysis of the center cerebellar cortex in brain death by color image analysis system. ŒĂě—FC‘D”ö’‰Fi–@ˆăj: 2nd International Symposium Advances in Legal Medicine i93.08.30`09.01j, Berlin, Zentralblatt Recht-Medizin, 40: 256`257, 1993.

459. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Re-evaluation of death by asphyxia based on cerebral blood flow (‡[) A study on examples of drowning with short duration or water inhalation. Ź’J~ˆęi–@ˆăjC‘ňŒű˛Žqi“Œ—ˆă‘ĺjC‘D”ö’‰Fi–@ˆăjC’†“cLŽqC‰z‘ňˆŸ]Žqi“Œ—ˆă‘ĺj: 2nd International Symposium Advances in Legal Medicine i93.08.30`09.01j, Berlin, Zentralblatt Rechtsmedizin, 40: 257, 1993.

460. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒVƒ“ƒ|ƒWƒEƒ€‡Tu‹ß˘]ŒË‚Ě‘’§‚ƕ搧v3. Ž€‘̍d’ź‚ĆŽ€ŒăŒo‰ßŽžŠÔ‚ɂ‚˘‚Ä. ŒĂě—Fi–@ˆăj: ‘ć47‰ń“ú–{l—ŢŠw‰ď“ú–{–Ż‘°Šw‰ď˜A‡‘ĺ‰ď i93.10.30j, VŔ, ƒvƒƒOƒ‰ƒ€ĽŒ¤‹†”­•\´˜^, p.28, 1993.

461. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”]ŒŒ—Ź“Ž‘Ô‚Š‚ç‚Ý‚˝’‚‘§Ž€‚ĚÄŒŸ“˘(‡[)“M…‹z“üŽžŠÔ‚Ě’Z‚˘“MŽ€—á‚ɂ‚˘‚Ä. Ź’J~ˆęi–@ˆăjC‘ňŒű˛Žqi“Œ—ˆă‘ĺjC‘D”ö’‰Fi–@ˆăjC’†ŽR–ΐMiŽŔ“ŽŒnjC’†“cLŽqC‰z‘ňˆŸ]Žqi“Œ—ˆă‘ĺj: ‘ć77ŽŸ“ú–{–@ˆăŠw‰ď‘‰ď i93.04.23j, •Ÿ‰Ş, “ú–{–@ˆăŠwŽGŽ, 47(•â): 91, 1993.

462. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j HPLC‚É‚ć‚éŠjŽ_\ŹŹ•Ş‚̐śĽŽ€‘ĚŒŒ­‚É‚¨‚Ż‚é‘Šˆá“_. ™]G–žCŒIŒ´•ś’jC‘D”ö’‰Fi–@ˆăj: ‘ć77ŽŸ“ú–{–@ˆăŠw‰ď‘‰ď i93.04.21`23j, •Ÿ‰Ş, “ú–{–@ˆăŠwŽGŽ, 47(•â): 246, 1993.

463. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ž€Œă•Ď‰ť‚ÉŠÖ‚ˇ‚é‘gDŠw“IŒ¤‹†i‘ć7•ńj”]Ž€—á‚̏Ź”]‚É‚¨‚Ż‚éč÷—ą‘w•ö‰ó‚Ě3ŽŸŒł‰ć‘œ‰đÍ‚ɂ‚˘‚Ä. ŒĂě—FC‘D”ö’‰Fi–@ˆăj: ‘ć77ŽŸ“ú–{–@ˆăŠw‰ď‘‰ď i93.04.22j, •Ÿ‰Ş, “ú–{–@ˆăŠwŽGŽ, 47(Suppl.): 131, 1993.

464. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j “MŽ€‚É‚¨‚Ż‚錌Ÿ÷’`”’Ź•Ş‚̕ωť. ’†“cLŽqC‘ňŒű˛ŽqCŽR‰şƒPƒTŽqC‰¤G—ći“Œ—ˆă‘ĺjCŹ’J~ˆęi–@ˆăj: ‘ć77ŽŸ“ú–{–@ˆăŠw‰ď‘‰ď i93.04.22j, •Ÿ‰Ş, “ú–{–@ˆăŠwŽGŽ, 47(•â): 152, 1993.

465. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ”]Ž€—á‚É‚¨‚Ż‚鏬”]č÷—ą‘w‚ĚŽŠŒČ—Z‰đ‚ÉŠÖ‚ˇ‚é‘gDŒv—Ę“IŒ¤‹†. ŒĂě—FC‘D”ö’‰Fi–@ˆăj: ‘ć19‰ń–k—˘ˆăŠw‰ď‘‰ď i93.11.13j, ‘Š–ÍŒ´, –k—˘ˆăŠw, 23(6): 524, 1993.


<<11 Šńś’ŽŠw>>

466. mŒ´’˜n Higher sensitivity of the developing larvae of Angiostrongylus cantonensis than the adult worms to flubendazole and mebendazole. –qƒiŠńjCSusumu Kandai“Œ‘ĺj: Kitasato Arch. Exp. Med., 65(2`3): 131`136, 1992.

467. m’Z•ńĽ‘Ź•ńn In vitro observation on egg release by Angiostrongylus cantonensis from rats treated with flubendazole. Susumu Kandai“Œ‘ĺjC–qƒiŠńj: Kitasato Arch. Exp. Med., 65(2`3): 155`158, 1992.

468. mŒ¤‹†•ńn First progress report - What a Guatemalan-Japanese dream is. –qƒiŠńjCA. CaceresiƒOƒ@ƒeƒ}ƒ‰‘—§ƒTƒ“ƒJƒ‹ƒƒX‘ĺj: JICA: Report of the Activities in 1992 and the Plan of 1993, The Project of Research for Control of Tropical Diseases in Guatemalai‘Ű‹Ś—ÍŽ–‹Ć’cj, p.1`5, 1993.

469. mŒ¤‹†•ńn ƒOƒ@ƒeƒ}ƒ‰‹¤˜a‘”M‘Ń•aŒ¤‹†ƒvƒƒWƒFƒNƒgę–ĺ‰Ć•ń‘. –qƒiŠńj: JICA•ń‘, p.1`2, 1993.

470. mŒ¤‹†•ńn Activided tripanocida vegetal. A. CaceresiƒOƒ@ƒeƒ}ƒ‰‘—§ƒTƒ“ƒJƒ‹ƒƒX‘ĺjC–qƒiŠńj: Proyecto Enfermedad de Chagas: Un Enfogue Integral Informe FinaliƒOƒ@ƒeƒ}ƒ‰‘—§ƒTƒ“ƒJƒ‹ƒƒX‘ĺŠwj, p.1`12, 1993.

471. mŒ¤‹†•ńn Preliminary studies on the effects of plant-origin drugs against parasites, especially Trypanosoma cruzi in Guatemala. –qƒiŠńjCA. CaceresiƒOƒ@ƒeƒ}ƒ‰‘—§ƒTƒ“ƒJƒ‹ƒƒX‘ĺj: ƒOƒ@ƒeƒ}ƒ‰‘ƒ}ƒ‰ƒŠƒAŒ¤‹†Š•ń‘, p.1`21, 1993.


<<11 2 Šńś’ŽŠw>>

472. m‘ŕn R”牺ŠńśƒtƒBƒ‰ƒŠƒAŹ’Ž–ňŠJ”­‚Ě‚˝‚ß‚Ěin vitro culture system‚ɂ‚˘‚Ä(minireview). –qƒiŠńj: ’ˇč‘ĺŠw”M‘ŃˆăŠwŒ¤‹†ŠŒ¤‹†W‰ď•ń‘; RŽ…ó’ŽÜƒWƒGƒ`ƒ‹ƒJƒ‹ƒoƒ}ƒWƒ“‚̍ě—p‹@˜, p.13`17, 1993.

473. m‘ŕn ƒyƒbƒg‚Š‚ç‚ĚŠ´ő|Šńś’ŽÇ|. ˆÉ“Ą—mˆęiŠńj: “ú–{ŹŽ™”畆‰ČŠw‰ďŽGŽ, 12(2): 177`184, 1993.


<<11 3 Šńś’ŽŠw>>

474. m‚ť‚Ě‘ź‚Ě’˜‘iŽŤ“Tjn i•Ş’SŽˇ•Mj Ą“ú‚ĚŽĄ—ĂŽwj; ƒAƒŒƒ‹ƒM[ŽžŠł|Šńś’ŽƒAƒŒƒ‹ƒM[1994”N“x, p.541, ˆÉ“Ą—mˆęiŠńj. •ŇW ˆîŠ_‹`–žC‘źC ˆăŠw‘‰@, “Œ‹ž, 94.03.15”­s.


<<11 5 Šńś’ŽŠw>>

475. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Ĺ‹ß˜b‘č‚ĚŠ´őÇ|ƒyƒbƒg‚Š‚ç‚ĚŠ´ő. ˆÉ“Ą—mˆęiŠńj: ‘ć17‰ń“ú–{ŹŽ™”畆‰ČŠw‰ď i93.06.18j, “Œ‹ž, —\eW, p.37, 1993.

476. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒlƒYƒ~•Ú’Ž(Trichuris muris)‚Ě”r’Ž‚ÍCD4+T×–E‚É‚ć‚萧Œä‚ł‚ę‚é. ŹŽR_ˆęiŠńjC‹Ę“ŕGˆęi”÷jC’ˇ“c–[Žqi—\–hˆăŠwŒnjCˆÉ“Ą—mˆęiŠńj: ‘ć62‰ń“ú–{Šńś’ŽŠw‰ď‘ĺ‰ď i93.04.08j, “Ţ—Ç, Šńś’ŽŠwŽGŽ, 42(‘): 59, 1993.

477. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ}ƒ“ƒ\ƒ“—ô“Şđ’ŽƒvƒŒƒƒZƒ‹ƒRƒCƒh—R—ˆ‚ĚƒVƒXƒeƒCƒ“ƒvƒƒeƒA[ƒ[cDNA‚ĚƒNƒ[ƒjƒ“ƒO. ź‰YłC‘ˇŽ÷ŠżC›Şˆę’jC‹v•Ű_‹`iMB‘ĺjC’†‘şŒ’‚`iŠńj: ‘ć62‰ń“ú–{Šńś’ŽŠw‰ď‘ĺ‰ď i93.04.08j, “Ţ—Ç, Šńś’ŽŠwŽGŽ, 42(‘): 66, 1993.

478. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j đ’Ž‹Ř‚Ěƒgƒƒ|ƒ~ƒIƒVƒ“: ƒTƒuƒ†ƒjƒbƒg\‘˘‚Ě”äŠrś‰ťŠw. ’†‘şŒ’‚`iŠńjC•–žŽqi—\–hˆăŠwŒnjCˆŔˆä”ü]i‘‡—Տ°ŒnjCěă‘ׁi–ƒ•z‘ĺjCŽRŒűłOi‡“V“°‘ĺj: ‘ć62‰ń“ú–{Šńś’ŽŠw‰ď‘ĺ‰ď i93.04.08j, “Ţ—Ç, Šńś’ŽŠwŽGŽ, 42(‘): 69, 1993.

479. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Šńś’ŽÇŽĄ—Ă‚É—p‚˘‚ç‚ę‚Ä‚Ť‚˝ƒOƒ@ƒeƒ}ƒ‰‚Ě“`ł–ň—pA•¨‚ÉŠÖ‚ˇ‚é•śŒŁŒŸő. –qƒCˆÉ“Ą—mˆęiŠńjC–ö“N—YC_Œ´œA“ńi’ˇč‘ĺjC‘˝“cŒ÷i‹ă‘ĺjC“ě“ˆ—mˆęC•ôźr•vi‹{čˆă‘ĺjC•űˆęŠěiJICA”M‘Ń•aƒvƒƒWƒFƒNƒgjCA. CaceresiƒOƒ@ƒeƒ}ƒ‰‘—§ƒTƒ“ƒJƒ‹ƒƒX‘ĺj: ‘ć35‰ń“ú–{”M‘ŃˆăŠw‰ď‘‰ď i93.11.14j, “Ţ—Ç, “ú–{”M‘ŃˆăŠw‰ďŽGŽ, 21(‘): 95, 1993.

480. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒlƒYƒ~•Ú’ŽŠ´őƒ}ƒEƒX‚É‚¨‚Ż‚éR‘ĚŽYś×–E‚Ě•Ď“Ž‚ɂ‚˘‚Ä. ŹŽR_ˆęiŠńjC‹Ę“ŕGˆęi”÷jCˆÉ“Ą—mˆęiŠńj: ‘ć23‰ń“ú–{–ƉuŠw‰ď‘‰ďĽŠwpW‰ď i93.11.18j, ĺ‘ä, “ú–{–ƉuŠw‰ď‘‰ďĽŠwpW‰ď‹L˜^, 23: 665, 1993.

481. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j •Ú’Ž”r’Ž‹@˜‚É‚¨‚Ż‚éCD4+, CD8+T×–E‚Ě–đŠ„. ŹŽR_ˆęiŠńjC‹Ę“ŕGˆęi”÷jCˆÉ“Ą—mˆęiŠńj: ‘ć23‰ń“ú–{–ƉuŠw‰ď‘‰ďĽŠwpW‰ď i93.11.18j, ĺ‘ä, “ú–{–ƉuŠw‰ď‘‰ďĽŠwpW‰ď‹L˜^, 23: 665, 1993.

482. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ’†•ÄƒOƒ@ƒeƒ}ƒ‰‹¤˜a‘‚É‚¨‚Ż‚éA•¨—R—ˆRŠńś’Ž–ň‚ĚŒ¤‹†i—\•ńj. –qƒiŠńjCA. CaceresiƒOƒ@ƒeƒ}ƒ‰‘—§ƒTƒ“ƒJƒ‹ƒƒX‘ĺj: ‘ć53‰ń“ú–{Šńś’ŽŠw‰ď“Œ“ú–{‘ĺ‰ď i93.10.09j, “Ą‘ň, ƒvƒƒOƒ‰ƒ€, p.40, 1993.

483. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j đ’Ž‹Ř‚Ěƒgƒƒ|ƒ~ƒIƒVƒ“: (ƒŔ)2ƒTƒuƒ†ƒjƒbƒg\‘˘‚Ě‘śÝ. ’†‘şŒ’‚`iŠńjC•–žŽqi—\–hˆăŠwŒnjCŽRŒűłOi‡“V“°‘ĺj: ‘ć53‰ń“ú–{Šńś’ŽŠw‰ď“Œ“ú–{‘ĺ‰ď i93.10.09j, “Ą‘ň, —\eW, p.29, 1993.


<<12 ŽŔŒą“Ž•¨Šw>>

484. mŒ´’˜n Œ˘‚É‚¨‚Ż‚éƒlƒ“ƒuƒ^[ƒ‹‚Ě—nŒŒě—p‚ɂ‚˘‚Ä. ˜kě_ŽiiŽŔ“ŽŒnjCˆ°Œ´‹v‘ăi‘‡—Տ°ŒnjC”ŻN—YC•“ĄŒ’iŽŔ“Žj: ŽŔŒą“Ž•¨‹Zp, 28(2): 121`125, 1993.

485. mŒ¤‹†•ńi•ś•”Čjn ŽŔŒą“Ž•¨‚Ě–ƒŒ–@Šm—§‚ÉŠÖ‚ˇ‚錤‹†; ”L‚Ě‘Sg–ƒŒ. ”ŻN—YiŽŔ“ŽjC‘q—я÷i‰Ş‘ĺj: •˝Ź2”N“x`•˝Ź4”N“x•ś•”Č‰ČŠwŒ¤‹†”ď•â•‹ŕi‘‡Œ¤‹†AjŒ¤‹†Ź‰Ę•ń‘, p.167`172, 1993.


<<12 3 ŽŔŒą“Ž•¨Šw>>

486. m‚ť‚Ě‘ź‚Ě’˜‘i“ü–ĺ‘jn i•Ş’SŽˇ•Mj ƒoƒCƒIƒƒfƒBƒJƒ‹ƒŠƒT[ƒ`ƒ}ƒjƒ…ƒAƒ‹|“Ž•¨ŽŔŒą–@|Vol.‡U–ƒŒ‚ĆŽŔŒąI—šŒă‚̏ˆ’u; ƒlƒR‚Ě–ƒŒ–@, p.96`104, ”ŻN—YiŽŔ“Žj. •ŇW ‘q—я÷i‰Ş‘ĺjC —{ŒŤ“°, “Œ‹ž, 94.02.14”­s.


<<12 5 ŽŔŒą“Ž•¨Šw>>

487. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Reduction in both growth hormone (GH) and prolactin (PRL) in thyroidectomized rat pituitary gland. ŒĂŠÚęˆęiŽŔ“ŽjCŠŰŽR–ΑPiŽŔ“ŽŒnjC•“ĄŒ’iŽŔ“Žj: ‘ć12‰ń‘Ű”äŠr“ŕ•Ş”ĺŠw‰ď i93.05.18j, ƒgƒƒ“ƒg, —vŽ|W, p.49, 1993.

488. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”ńŠJ‹š‰ş‚É‚¨‚Ż‚éƒCƒk‚̐S‹Ř[Ç‚¨‚ć‚эĩÁ—Źƒ‚ƒfƒ‹|‡X. ŽŔŒąŽč‹Z‚É‚ć‚éTCK‚Ě•Ď“Ž. ”ŻN—YiŽŔ“ŽjCˆ°Œ´‹v‘ăi‘‡—Տ°ŒnjC’†ŽR–ΐMCŠŰŽR–ΑPC˜kě_ŽiiŽŔ“ŽŒnjC•“ĄŒ’iŽŔ“ŽjC“ޗljŔ—miś•¨•¨—ŒnjC—ŠZF“ńC’r“cŒ›şC‹{ Œ´‰p•viˆă—pî•ńj: ‘ć58‰ń“ú–{bˆăzŠÂŠíŠw‰ď i93.05.16j, “Œ‹ž, ´˜^W, p.18`21, 1994.

489. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ˆâ“`Ť˜ËŽňÇƒ‰ƒbƒg(rdw)‚̉ş‚‘́|bó‘BŒn‚Ě‹@”\‚ɂ‚˘‚Ä. ŒĂŠÚęˆęiŽŔ“ŽjC‘ĺŽR‹XGCŽÄŽRŒ[ŽqiŽ™jCŹ–ě‰ë•vi•ŞśjC•“ĄŒ’iŽŔ“Žj: ‘ć40‰ń“ú–{ŽŔŒą“Ž•¨Šw‰ď i93.06.02j, ĺ‘ä, —vŽ|W, p.143, 1993.

490. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‚ƒ‹ƒ‚ƒbƒg‚É‚¨‚Ż‚鎔—żH‚ׂą‚Ú‚ľs“Ž‚̉đÍ. •“ĄŒ’iŽŔ“ŽjC‹g“cCC’†ŽOě’qŒbŽqCă‘ş‹v”üŽqiŽŔ“ŽŒnj: ‘ć40‰ń“ú–{ŽŔŒą“Ž•¨Šw‰ď i93.06.02j, ĺ‘ä, —vŽ|W, p.181, 1993.

491. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œ˘‹y‚Ń”Lƒ‰ƒZƒ“‹Ű‚Ěƒ}ƒEƒX‚É‚¨‚Ż‚é’č’…Ť‚Ć•aŒ´Ť. •“ĄŒ’C”ŻN—YiŽŔ“Žj: ‘ć116‰ń“ú–{bˆăŠw‰ď i93.10.06j, ŽRŒű, —vŽ|W, p.66, 1993.

492. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j bó‘B“Eo‚É‚ć‚éGH, PRL‚ĚŽYś—}§. ŒĂŠÚęˆęiŽŔ“ŽjCŠŰŽR–ΑPiŽŔ“ŽŒnjC—é–Ř‘”üiś‰ťŒnjC•“ĄŒ’iŽŔ“Žj: ‘ć116‰ń“ú–{bˆăŠw‰ď i93.10.07j, ŽRŒű, —vŽ|W, p.78, 1993.

493. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j V‚ľ‚˘ˆâ“`Ť˜ËŽňÇƒ‰ƒbƒg(rdw)‚ĚŽžŠłƒ‚ƒfƒ‹“Ž•¨‚Ć‚ľ‚Ä‚Ě—L—pŤ‚Ć•aˆö‰đÍ. ŒĂŠÚęˆęiŽŔ“ŽjC‘ĺŽR‹XGCŽÄŽRŒ[ŽqiŽ™jCŹ–ě‰ë•vi•ŞśjC•“ĄŒ’iŽŔ“Žj: ‘ć6‰ńˆâ“`Žq‚Ć‚ť‚ĚŽü•ÓŒ¤‹†‰ď i93.07.31j, \˜a“c, —vŽ|W, p.9, 1993.


<<13 ś•¨•¨—‰ťŠw>>

494. mŒ´’˜n New subunit in L-phenylalanine oxidase from Pseudomonas sp. P-501 and the primary structure. ŒüŽRŒb’ĂŽqiś‰ťŒnjC—é–؏t’jiś•¨•¨—‰ťjCHirokazu KoyamaiƒLƒbƒR[ƒ}ƒ“j: Arch. Biochem. Biophys., 308(2): 400`406, 1994.

495. mŒ´’˜n Globin chain synthesis in hemolytic anemia reticulocytes: A case of hemoglobin Burke. —é–؏t’jiś•¨•¨—‰ťjC˜a“c’m‰vi—Ő•a—jCŠ™“cvŽőC‚‹´‰fŽqC˛“Ą’ź”Vi“ŕjCTetsunosuke Kunitomoi“ŒƒŒj: Biochemistry and Molecular Biology International, 30(3): 425`431, 1993.

496. mŒ¤‹†•ńi”_—ѐ…ŽYČjn R‘̍y‘fěo‚Ě‚˝‚ß‚ĚŠî‘b“IŽč–@‚̉đ–ž. —é–؏t’jiś•¨•¨—‰ťj: ƒoƒCƒIƒeƒNƒmƒƒW[ć’[‹ZpƒV[ƒY”|—{Œ¤‹†•˝Ź4”N“xŹ‰Ę•ńW, p.125`132, 1993.


<<13 2 ś•¨•¨—‰ťŠw>>

497. m‘ŕn ƒwƒ‚ƒOƒƒrƒ“‚̐ś‡Ź‚ƍč\Ź. —é–؏t’jCŹźNŽqiś•¨•¨—‰ťj: –k—˘ˆăŠw, 23(2): 97`103, 1993.


<<13 5 ś•¨•¨—‰ťŠw>>

498. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Identification of another subunit in L-phenylalanine oxidase from Pseudomonas sp. P-501 and the primary structure of the subunit. ŒüŽRŒb’ĂŽqiś‰ťŒnjC—é–؏t’jC˛X–Ř–Ť‰piś•¨•¨—‰ťjCHirokazu KoyamaiƒLƒbƒR[ƒ}ƒ“j: 11th Int. Symp. on Flavins and Flavoproteins i93.07.28j, –źŒĂ‰Ž, Abstracts, p.9, 1993.

499. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Substrate specificity of immobilized Pseudomonas L-phenylalanine oxidase. —é–؏t’jiś•¨•¨—‰ťj: 3rd Int. Congress on Amino Acids, Peptides, and Analogues i93.08.26j, ƒI[ƒXƒgƒŠƒA, ƒEƒC[ƒ“, Amino Acids, 5(1): 111, 1993.

500. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Sarcosine oxidase: Structure, function, and the application to creatinine determination. —é–؏t’jiś•¨•¨—‰ťj: 3rd Int. Congress on Amino Acids, Peptides, and Analogues i93.08.26j, ƒI[ƒXƒgƒŠƒA, ƒEƒC[ƒ“, Amino Acids, 5(1): 111, 1993.

501. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Folding of cold-denatured Streptomyces subtilisin inhibitor - A study by CD stopped-flow method. ˜@ŒŠ‰p˘iś•¨•¨—‰ťjCŠâčŒ›ŽĄC“c‘şŒú•vi‹ž‘ĺjCÔâˆę”Vi_ŒË‘ĺj: 5th International Conference on Circular Dichroism i93.08.20j, ƒRƒƒ‰ƒh, USA, —\eW, p.199, 1993.

502. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ž_Ť‚‰–”Z“x‘śÝ‰ş‚É‚¨‚Ż‚éƒAƒ|ƒ~ƒIƒOƒƒrƒ“‚Ćƒwƒ€‚Ć‚Ě‘ŠŒÝě—p. ç—t‚Š‚¨‚čC’–Ž”“āi“ŒH‘ĺjCŹźNŽqiś•¨•¨—‰ťjC–ŘŒ´—TiŽŠŽĄˆă‘ĺj: ‘ć31‰ń“ú–{ś•¨•¨—Šw‰ď”N‰ď i93.10.12j, –źŒĂ‰Ž, ś•¨•¨—, 33(suppl.): 94, 1993.

503. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j pHƒWƒƒƒ“ƒv‚É‚ć‚éSSI‚Ěfolding. ˜@ŒŠ‰p˘iś•¨•¨—‰ťjCÔâˆę”Vi_ŒË‘ĺj: SSIŒ¤‹†”ǔljď‹c i93.12.27j, ”މ¤Žq.


<<14 “ŕ‰ČŠw>>

504. mŒ´’˜n Expression of monocyte chemotactic and activating factor in rheumatoid arthritis: Regulation of its production in synovial cells by interleukin-l and tumor necrosis factor. ÔŻ“§i“ŕjC˜a“c’m‰vi—Ő•a—jC‰““Ą•˝mCL“c˜a‰iC•äâ–΁i“ŕjC‚ŠÝŒ›“ńiŽŠOjC‹ß“ĄŒ[•śi“ŕjC”č’ő•vCź“‡jŽĄi“Œ—ˆă‘ĺj: Arthritis Rheum., 36: 762`771, 1993.

505. mŒ´’˜n Regional difference of capillary-to-fiber ratio in the heart of monocrotaline-treated rats. Ź—эO—Si“ŕjC‹g‘ş‚ä‚Š‚čC—é–Ř‚Đ‚ë‚ľC×“c‘׍OiŒc‘ĺj: Basic Res. Cardiol., 89: 118`127, 1994.

506. mŒ´’˜n HBeRŒ´—zŤ‚Ě‚aŒ^–ŤŠĚ‰Š‚ɑ΂ˇ‚é Lentinan “Š—^‚ĚŒř‰Ę‚ɂ‚˘‚Ä. ” čK–çC”’•l—´‹ťC‰Á“Ą‰ëŽmiŽŠ‰q‘ŕ’†‰›•a‰@jC“Ą‰Ş‚Oi“ŕjC^•ű—Ç•FC’†ěŽ–çiŽŠ‰q‘ŕ’†‰›•a‰@j: Biotherapy, 7(2): 191`197, 1993.

507. mŒ´’˜n Á‰ťŠÇˆŤŤŽîᇂɂ¨‚Ż‚éRŠŕÜ“Š—^Œă‚Ě”’ŒŒ‹…Œ¸­Ç‚ɑ΂ˇ‚é G-CSF “Š—^•ű–@‚ĚŒŸ“˘. ĄňOCŹň˜aŽO˜YCŸ–””ş‰hCźŒłŽ›Ž—çi“ŕj: Biotherapy, 7(4): 649`654, 1993.

508. mŒ´’˜n Long-term effect of oral calcitriol pulse therapy on bone in hemodialysis patients. ’Ë–{—Y‰îCŽç‰Ž—˜‰ŔC–ě‘şK”́C˛“Ą’ź”Vi“ŕjCFaugere, M.C., Malluche, H.H.iƒPƒ“ƒ^ƒbƒL|‘ĺj: Bone, 14: 421`425, 1993.

509. mŒ´’˜n A phase ‡U study of combination therapy with 5'-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci. Źň˜aŽO˜Yi“ŕjCŒIŒ´–Ť‚`CŽÂˆäŠiC‹g“c–ΏşCXŁŒö—FCĄ‘ş“N—CÔ‘ňCŒáC•Ę–đFC‘ĺ‹v•ŰrŽĄC‚‹´OCH’JŽőˆęC•l“c•×CŠô˘‹´“Ä: Cancer, 72(3): 658`662, 1993.

510. mŒ´’˜n Follow-up study of early colorectal cancer after endoscopic resection. ŒÜ\—’łLCŸ–””ş‰hC“ŕ“Ą‹g—˛CŹ—ѐ´“TC‘ĺŒ´–ž•FCźŒłŽ›Ž—çi“ŕjCŽO•xO”VC’†‰p’ji•a—j: Digestive Endoscopy, 5(4): 359`365, 1993.

511. mŒ´’˜n Interleikin-l up-regulates transcription of its own receptor in a human fibroblast cell line TIG-l: role of endogenous PGE2 and cAMP. Takii, T.CÔŻ“§i“ŕjCKato, K.CHayashi, H.CMarunouchi, T.COnozaki, K.i“Œ—ˆă‘ĺj: Eur. J. Immunol., 22: 1221`1227, 1992.

512. mŒ´’˜n “ŕŽ‹‹ž“IĂ–ŹáŽ‘˘‰e (EVIS) ‚É‚¨‚Ż‚é–ĺ–Ź-”xĂ–Ź•Ť‡ (PPVA) ‚Ě‘śÝ‚ƍ‡•šÇ‚ĚŒŸ“˘. ‘şă‹§lC‘•Ş–ΔŽCŽRăp‚ł‚ä‚čC”’čŒh“ńC™–{­’źCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕjCŠOŽR‹v‘ž˜Yi•˝’Ë‹¤Ď•a‰@j: Gastroenterol. Endosc., 34(11): 2543`2551, 1992.

513. mŒ´’˜n ÔŠOü“dŽq“ŕŽ‹‹ž‚É‚ć‚éˆÝŠŕZ”͈͐f’f‚ĚŒŸ“˘. “c•Ó‘CŹň˜aŽO˜YC‹ß“Ąˆę‰pCÎˆäŒ\‘žC‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕjC›’m–çC’†‰p’ji•a—j: Gastroenterol. Endosc., 35(10): 2372`2379, 1993.

514. mŒ´’˜n Š×‰šŒ^ˆÝ‘BŽî‚Ě“ŕŽ‹‹ž“IŒŸ“˘|‡UcŒ^‘ŠúŠŕ‚Ć‚ĚŠÓ•Ę. ŽR“cŽŠlC‘ĺˆä“cłlCâŒű“NÍC–Ř“cŒőLCŹň˜aŽO˜YC‰ĄŽR–őCźŒłŽ›Ž—çi“ŕjCŽOd–슰ŠěC”äŠé”\Ž÷iŠOjC›’m–çCŽO•xO”VC’†‰p’ji•a—j: Gastroenterol. Endosc., 35(10): 2392`2400, 1993.

515. mŒ´’˜n ×Œa’´‰š”gƒvƒ[ƒu‚É‚ć‚é\“ńŽw’°’×ᇂ̌Ÿ“˘|ƒ[ƒŠ[’“ü–@‚̉ž—p|. ŽR“cŽŠlCâŒű“NÍC–Ř“cŒőLC–ě“o˝CÎˆäŒ\‘žC“c•Ó‘CŹň˜aŽO˜YC‰ĄŽR–őCŽO‹´—˜‰ˇC‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕj: Gastroenterol. Endosc., 36(3): 499`408, 1994.

516. mŒ´’˜n Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier. ’†‘ň‹MGi“ŕjC‰Á“Ąé”VC‘ĺ’ĂŽR—SŽqCŠÖ’Jm”üi‘—§‚Ş‚ńƒ^[jC“Ą‰Ş‚OCa’J–ž—˛C‰ş‰“–ě–M’‰i“ŕj: Int. J. Cancer, 56: 204`207, 1994.

517. mŒ´’˜n Rapid fall in blood myoglobin in massive rhabdomyolysis and acute renal failure. Žá—Ń–ő‹vi“ŕjC‹e–ě—˛–žC‘ĺ˜a“c—˛i‹~–˝jC–ؐě“c—˛ˆęi“ŕj: Intensive Care Med., 20(2): 109`112, 1994.

518. mŒ´’˜n Immunoglobulin-complexed aspartate aminotransferase. ^‹ĘŽő”üśCˆÉ“Ą‹ĎC“c•Ó‘Ca’J–ž—˛CŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕjC÷ˆäŒc‘˘i—ŐŒŸjC’ˇ’Jě‚Ţ‚Ë‚¨i’ˇ’JěƒNƒŠƒjƒbƒNj: Intern. Med., 32(2): 156`159, 1993.

519. mŒ´’˜n Current fever of unknown origin. ”э‘–퐜C‰Ş“cƒC‹ß“ĄŒ[•śi“ŕjC”č’ő•vi“Œ—ˆă‘ĺj: Intern. Med., 33: 67`73, 1994.

520. mŒ´’˜n Detection of tracheal stenosis by frequency analysis of tracheal sounds. •ÄŠŰ—şC‹e’rŒ÷ŽŸCXł–žC‰Í‡ÍiŒc‘ĺjCˆ˘•”’źi“ŕjCěéä•vCÎŒ´P•vC‰ĄŽR“N˜NiŒc‘ĺj: J. Appl. Physiol., 75(2): 605`612, 1993.

521. mŒ´’˜n ƒgƒŒƒbƒhƒ~ƒ‹‰^“Ž•‰‰×, ƒnƒ“ƒhƒNƒŠƒbƒv, ŠŚ—⏸ˆłŽŽŒą‚Ě”äŠrŒŸ“˘: zŠÂ“Ž‘Ô, ŒÄ‹CƒKƒX, ŒđŠ´_ŒoŒn‚ւ̉e‹ż‚𒆐S‚É. ´…ŠŽ‰xC–kŠp”Ž“šCě•Ó•q”VCVČˆę•vCěŒű’|’jCźŽRŒcŽqCŠ“c”ü—ć”TC–ě˜C’‰ŽœC˜Ič‹P•vC–ؐě“c—˛ˆęi“ŕj: J. Cardiol., 22(2,3): 557`568, 1992.

522. mŒ´’˜n ‰EŽş[Ç‚Ě”­ÇƒƒJƒjƒYƒ€‚ÉŠÖ‚ˇ‚é—Տ°•a—Šw“IŒŸ“˘. ‹ß“ĄLŽqi“ŕjCŒK”ö’čmi•a—jC–ؐě“c—˛ˆęi“ŕj: J. Cardiol., 23(1): 51`59, 1993.

523. mŒ´’˜n Modification of spleen phospholipid fatty acid composition by dietary fish oil and by n-3 fatty acid ethyl esters. Robinson, D.R.CXu, L.L.CKnoell, C.T.iHarvard ‘ĺjCŠÚ–ěƒśi“ŕjCOlesiak, W.iHarvard ‘ĺj: J. Lipid. Res., 34: 1423`1434 1993.

524. mŒ´’˜n Suppression of autoimmune disease by dietary n-3 fatty acids. Robinson, D.R.CXu, L.L.CŠÚ–ěƒśi“ŕjCM. Guo, R.B. ColiniHarvard ‘ĺj: J. Lipid. Res., 34: 1435`1444, 1993.

525. mŒ´’˜n A clinico-pathological study of adult histiocytosis X involving the brain. ’ˇ’JěˆęŽqCŽO•x“N˜YCŒĂ˜a‹vKC–{‹§i“ŕjC–ö‰şŽO˜Yi•a—j: J. Neurol. Neurosurg. Psychiatry, 56: 1008`1012, 1993.

526. mŒ´’˜n Humoral immune response to hypervariable region l of the putative envelope glycoprotein (gp70) of hepatitis C virus. ‰Á“Ąé”VCŠÖ’Jm”üC‘ĺ’ĂŽR—SŽqi‘—§‚Ş‚ńƒZƒ“ƒ^[jC’†‘ň‹MGi“ŕjC“y•ű˝C‘ĺ‰zÍŒáC‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ƒ^[j: J. Virol., 67(7): 3923`3930, 1993.

527. mŒ´’˜n Haemodialysis-filtration using sodium bicarbonate depresses cardiac function in critically ill patients with acute renal failure. Žá—Ń–ő‹vi“ŕjC‘ĺ˜a“c—˛i‹~–˝jC–ؐě“c—˛ˆęi“ŕj: Jpn. Circ. J., 58(2): 81`86, 1994.

528. mŒ´’˜n Dilazep prevents glomerulosclerosis in accelerated Masugi nephritis in the rat. Žç‰Ž’B”üi“ŕjCNakazawa, K.CKasai, S.CYamazaki, T.CKomiyama, Y.CdźGˆęiMB‘ĺjCAkiba, T.CKoga, T.iƒR[ƒj: Jpn. J. Nephrol., 35(4): 329`335, 1993.

529. mŒ´’˜n The significance of tubulointerstitial nephritis in IgA nephritis. dźGˆęiMB‘ĺjCŹ—Ń–LCŠÚ–ěƒśi“ŕjC”äŠé”\”ViŠĹŒěŠw•”jCŒK”ö’čmi•a—j: Jpn. J. Nephrol., 36(1): 25`32, 1994.

530. mŒ´’˜n Noninvasive measurement method for hardness in muscular tissue. Horikawa, M.CEbihara, S.Câˆä•ś•Fi“ŕjCAkiyama, M.: Med. Biol. Eng. Comput., 31: 623`627, 1993.

531. mŒ´’˜n Role of necrosed lesions in the malignant change of experimental liver cirrhosis-viewed from intrahepatic microvasculature (‡U). ÎˆäŒö“šCź–Ř–ÎŽ÷C^‹ĘŽő”üśC“Ą“c–F–MCŽÄ“c‹v—Yi“ŕjCŠĄ•”‚ЂƂ݁i‰qjC‰œ•˝‰ë•Fi•a—jCŒú“cKˆę˜Yi–ňÜ•”j: Microcirc. Ann., p.89`90, 1993.

532. mŒ´’˜n High-dose 15-deoxyspergualin monotherapy surpasses methylprednisolone in its therapeutic effect on advanced lupus nephritis in New ZealandBlack/White F1 hybrid mice, and low-dose combination may be synergistic. ‘ĺ‹v•Ű[lCˆäăŒcˆęC‰J‹{ŒŤˆęCŹ—Ń’ź”Vi“ŕjC^č‹`•FiŽŔ“ŽŒnjCŠ™“cvŽői“ŕj: Nephrol. Dial. Transplant., 8: 720`724, 1993.

533. mŒ´’˜n Loss of glomerular anionic sites and the development of albuminuria in rats with streptozotocin-induced diabetes. Žç‰Ž’B”üi“ŕjCNakazawa, K.CItoh, N.CdźGˆęCOkada, N.CAizawa, T.CYamada, T.iMB‘ĺjC–‹`’‰i“ŕj: Nephron, 65(3): 444`448, 1993.

534. mŒ´’˜n Řœ•s”\isˆÝŠŕ‚ɑ΂ˇ‚é 5'-DFUR+CDDP+MMC —Ă–@. •ŸŽR‰x’jiŒN’Ă’†‰›•a‰@jCŹň˜aŽO˜Yi“ŕjCŒIŒ´–Ť‚`iş˜a‘ĺjC‹v•Ű•Ű•Fi‘ĺ–´“cŽs—§•a‰@jC–]ŒŽ•ŸŽĄiĺ‘äƒI[ƒvƒ“•a‰@jCÎě–MŽki“ŒŽD–y•a ‰@jC•l“c•×i‡“V“°‘ĺjC‘ě˝i–ź“S•a‰@j: Oncologia, 26(3): 345`350, 1993.

535. mŒ´’˜n HMG|CoA ŠŇŒły‘f‘jŠQ–ň(pravastatin)‚É‚ć‚鍂Ž‰ŒŒÇŽĄ—ĂŽž‚̐S‹@”\‚̕ωť. ‘şź€C”Ş“‡—ǘaCŹ—Ń–ž–FC’r“c‘׎qC’ˇ’Jě‰„LC–ؐě“c—˛ˆęi“ŕj: Prog. Med., 13: 2196`2202, 1993.

536. mŒ´’˜n ŠeŽí~ˆł–ňŽĄ—Ă’†‚Ě–{‘ԐŤ‚ŒŒˆł‚É”ş‚¤‚Ž‰ŒŒÇ‚ɑ΂ˇ‚éHMG|CoAŠŇŒły‘f‘jŠQ–ňŽĄ—Ă‚É‚ć‚錌´Ž‰Žż, “Á‚É‘ƒRƒŒƒXƒeƒ|ƒ‹‚̕ωť‚ɂ‚˘‚Ä. ‘şź€C’ˇ’Jě‰„LCŹ—Ń–ž–FCóŒŠ‘C˛“ĄŽüC–ؐě“c—˛ˆęi“ŕj: Prog. Med., 13: 597`604, 1993.

537. mŒ´’˜n HMG|CoA ŠŇŒły‘f‘jŠQ–ň Simvastatin ŽĄ—Ă‚É‚ć‚鍂Ž‰ŒŒÇ‚̉ü‘P‚É”ş‚¤zŠÂ“Ž‘Ԃ̕ωť. ‘şź€CŹ—Ń–ž–FCóŒŠ‘CŹ‚L]C’ˇ’Jě‰„LC–ؐě“c—˛ˆęi“ŕj: Prog. Med., 14(1): 113`120, 1994.

538. mŒ´’˜n ‹•ŒŒŤSŽžŠł‚É‚¨‚Ż‚éÔŒŒ‹…—R—ˆ, ŠˆŤŽ_‘f‚Ě“Ž‘Ô. Ź‚L]C’ˇ’Jě‰„LC•‘ň—˜˜YC‹v•Ű‹MşCŠ“c”ü—ć”TC‘şź€C–ؐě“c—˛ˆęi“ŕjC’†‘ş‘‰qi•Şśj: Ther. Res., 14(8): 3418`3423, 1993.

539. mŒ´’˜n Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. ź–{ˆĚ’ji“ŕjCMcCaughan, G.W.CPainter, D.M.CBishop, G.A.iRoyal Prince Alfred Hospitalj: Transplantation, 56(1): 69`75, 1993.

540. mŒ´’˜n Continuous pulse oximetry in the breath-hold diving women of Korea and Japan. Stanek, K.S.CGuyton, G.P.CHurford, W.E.CPark, Y.S.CAhn, D.W.CQvist, J.CFalke, K.J.CHong, S.K.CKobayashi, K.CŹ—эO—Si“ŕjCZapal, W.M.iHarvard Medical Schoolj: Undersea Hyperb. Med., 20(4): 297`307, 1993.

541. mŒ´’˜n Ultrastructural study of glomerular basement membrane in diabetic rats by quick-freezing and deep-etching method. Žç‰Ž’B”üi“ŕjCOhno, S.iŽR—œˆă‘ĺjCNakazawa, K.CdźGˆęiMB‘ĺjC–‹`’‰i“ŕj: Virchows Arch. B Cell Pathol., 64(2): 107`114, 1993.

542. mŒ´’˜n Systemic lupus erythematosus and polymyositis overlap syndrome. Miyamoto, H.CSaito, S.CNakajima, H.i‰Ą•lŽs‘ĺjCŽá—Ń–ő‹vi“ŕj: Yokohama Med. Bull., 43(1-2): 1`6, 1992.

543. mŒ´’˜n ‘SgŤƒGƒŠƒeƒ}ƒg[ƒfƒX‚̐S•Ů–Œ•a•Ď‚ƍRƒŠƒ“Ž‰ŽżR‘Ě‚ĚŠÖŒW. •äâ‹v”üC‰Ş“cƒC‰ŹŒ´“āCŹ—Ń–ž–FC‹ß“ĄŒ[•śi“ŕj: ƒŠƒEƒ}ƒ`, 34: 22`29, 1994.

544. mŒ´’˜n “ŤˆÝ’×á‡‚Ě“ŕŽ‹‹ž“IŒŸ“˘; “—vˆö‚Ć’ˇŠúŒo‰ß. źŒłŽ›Ž—çCŽO‹´—˜‰ˇCˆ°Œ´‹BC›’m–çC‘ĺˆä“cłlCMarcos, S.Cde Arruda, B.i“ŕj: ˆÝ‚Ć’°, 28(4): 251`262, 1993.

545. mŒ´’˜n ŒŠ‚¨‚Ć‚ľ‘ĺ’°Šŕ‚ĚŒŸ“˘; ’’°‘˘‰eŒŸ¸‚Ć‘ĺ’°“ŕŽ‹‹žŒŸ¸‚đŽĺ‘Ě‚É. ŒÜ\—’łLCŸ–””ş‰hC“ŕ“Ą‹g—˛CźŒłŽ›Ž—çi“ŕjCH“ĄNśC‘ĺ’J„łiŠOjCŽO•xO”VC’†‰p’ji•a—jCŹ—ѐ´“Ti“ŕj: ˆÝ‚Ć’°, 28(8): 775`784, 1993.

546. mŒ´’˜n Effect of alminoprofen on renal function|A comparative clinical trial with indomethacin|. ”č’ő•vi“Œ—ˆă‘ĺjCSaito, E.CIrimajiri, S.CKawagoe, M.CÔŻ“§i“ŕjCMatsuoka, Y.CHara, M.CKawai, S.C‹gˆäş•vC•ŸˆäŒő•śi“ŕj: ‰ŠÇ, 13: 345`353, 1993.

547. mŒ´’˜n H“šˆÝĂ–ŹáŽŒŒs“Ž‘Ô‚É‚¨‚Ż‚鍶ˆÝ“Ž–Ź‘˘‰e (LGA) ‚Ě—L—pŤ|“ŕŽ‹‹ž“IĂ–ŹáŽ‘˘‰e (EVIS) ‚Ƃ̑Δ䂊‚ç|. ‘şă‹§lC‘•Ş–ΔŽi“ŕj: ŠĚ‘Ÿ, 34(12): 965`974, 1993.

548. mŒ´’˜n ŠĚd•ĎÇ‚É‚¨‚Ż‚é–ĺ–ŹŒŒs“Ž‘Ô‚Ě“ÁŤ‚Ě•ŞÍ|’´‰š”gƒJƒ‰[ƒhƒvƒ‰‚đ—p‚˘‚ā|. ˆÉ“Ą‹ĎC^‹ĘŽő”üśCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕj: ŠĚ‘Ÿ, 34(9): 696`704, 1993.

549. mŒ´’˜n Řœ•s”\isĽÄ”­ˆÝŠŕ‚ɑ΂ˇ‚é UFTPM (UFTĽCDDPĽMMC) —Ă–@‚ĚŒŸ“˘. Šâč—ÇŽOi‡“V“°‘ĺjCˆŔ•Wˆęi•şŒÉŒ§—§Źl•aƒZƒ“ƒ^[jC•ŸŽR‰x’jiŒN’Ă’†‰›•a‰@jC’ˇ’Jě_ˆęiŽœŽR‰ď’Řˆä•a‰@jCŹň˜aŽO˜Yi“ŕjCŽÂˆäŠii‘—§ ‰ŞŽR•a‰@jCŒIŒ´–Ť‚`iş˜a‘ĺjC‹v•Ű•Ű•Fi‘ĺ–´“cŽs—§•a‰@jCÎě–MŽki“ŒŽD–y•a‰@jC‘ě˝i–ź“S•a‰@j: Šŕ‚ƉťŠw—Ă–@, 20(9): 1179`1185, 1993.

550. mŒ´’˜n –{‘ԐŤ‚ŒŒˆłÇ‚ɑ΂ˇ‚éƒAƒ“ƒWƒIƒeƒ“ƒVƒ“•ĎŠˇy‘f‘jŠQ–ň(Delapril)‚Ć, CahR–ň(Manidipine)‚Ě•š—pŽĄ—Ă. ‘şź€C”Ş“‡—ǘaCŹ—Ń–ž–FCŹă”Ž•śC‘Ł’qLC’r“c‘׎qC•˝źT‰EC‰“ŽR”ŽCV’Ă’J^lCŹ‚L]Cě”¨˜alC’čG•vCóŒŠ‘C’ˇ’Jě‰„LC–ؐě“c—˛ ˆęi“ŕj: Šî‘b‚Ć—Ő°, 27(5): 1627`1646, 1993.

551. mŒ´’˜n ˆ’u—p‘O•űŽÎŽ‹Œ^“dŽq“ŕŽ‹‹ž‚Ě—L—pŤ. ‰ĄŽR–őC‘ĺˆä“cłlCrěä•vC’†ˆä‹v—YC‹e’rVCÎˆäŒ\‘žC“c•Ó‘CŹň˜aŽO˜YCŽO‹´—˜‰ˇCźŒłŽ›Ž—çi“ŕj: Á‰ťŠí“ŕŽ‹‹ž‚̐i•ŕ, 42: 48`50, 1993.

552. mŒ´’˜n –{‘ԐŤ’ጌˆłÇ‚É‚¨‚Ż‚鉺”źg‰Aˆł•‰‰×Žž‚̏zŠÂ“Ž‘Ô. Ź‘ňŒ°ˆęC”öŒ`’ˇ—YC´…ŠŽ‰xCě•Ó•q”VC–ě˜C’‰ŽœC–ؐě“c—˛ˆęi“ŕj: S‘Ÿ, 25(2): 16`17, 1993.

553. mŒ´’˜n ‰^“Žƒjƒ…[ƒƒ“•a‚ĚŠî’ęŠj•a•Ď|‘gD‰ťŠw“IŒŸ“˘|. ’ˇ’JěˆęŽqi“ŕj: _Œo‰ťŠw, 32: 538`539, 1993.

554. mŒ´’˜n ŠĚd•ĎÇ‚ɍ‡•š‚ľ‚˝—LÇó’_ÎÇ‚Ě—\Œă. ‘•Ş–ΔŽCÎŠ_“ż]C‚“c‰ë”ŽCÄ“ĄrŽiC‘şă‹§lCˆÉ“Ą‹ĎC^‹ĘŽő”üśCŽÄ“c‹v—Yi“ŕjC‰Ą“c“™C‹g“c@‹ICˆ­”üƒ•vC”äŠé”\Ž÷iŠOj: ’_‚ĆäX, 14(5): 641`648, 1993.

555. mŒ´’˜n •Đ“Ş’ÉŠłŽŇ‚Ě‹ÇŠ”]ŒŒ—Ź‚ĚŒŸ“˘. ŒÜ\—’‹v‰ŔCâˆä•ś•FC”Ń’Ë‚_C”Š_mC_“c’źi“ŕj: “Ş’ÉŒ¤‹†‰ď‰ďŽ, 20(1): 12`14, 1993.

556. mŒ´’˜n ƒ}ƒEƒXBSAt‰Š‚ɑ΂ˇ‚émethylpredmisolone‚Ě—}§Œř‰Ę. ’”üi’†‘jCŹ—Ń–Li“ŕj: “út‰ďŽ, 35(3): 265`272, 1993.

557. mŒ´’˜n ŒŒ‰tŽžŠł‚É‚¨‚Ż‚é“ŕ‘Ÿ^‹ŰÇf’fƒvƒƒgƒR|ƒ‹‚ĆFluconazole‚ĚŒř‰Ę. ŽR‰ş‚Ś‚čŽqi“ŕjC‹v•ÄŒői•a—jC‰–’J–΁i“ŕjC–]ŒŽ^‹|i–ňÜ•”jC‰œ•˝‰ë•FiƒoƒCƒIƒAƒbƒZƒCj: “ú–{ˆă^‹ŰŠw‰ďŽGŽ, 34(3): 331`341, 1993.

558. mŒ´’˜n ƒp[ƒLƒ“ƒ\ƒ“•a‚É‚¨‚Ż‚élH’YŽ_ň—ÜŽg—p‚É‚ć‚é“ü—‚ɂ‚˘‚Ä. ł–Ř‚Š‚‚çC‘O“c^ŽĄC—ŠZF“ńCź‰ŞłŒhCf‘ň’BŽui“ŕj: “ú–{‰ˇň‹CŒó•¨—ˆăŠw‰ďŽGŽ, 56: 227`234, 1993.

559. mŒ´’˜n Œ`ó‹L‰Żƒvƒ‰ƒXƒ`ƒbƒN‚Ě•â‘•‹ď‚ւ̉ž—p. ‘O“c^ŽĄi“ŕjC˛“ĄŒMi•˝ˆä‹`ŽˆŒ¤‹†ŠjC“‡“c—˛ŽqC’ˇ‘ňOCŒă“ĄˆŔŒbC{“Ą“ޏ”üC’Ř“c—R”üC•˝‰ę‚ć‚ľ‚݁C“y”쐳”VC˛ŽĄ–L•iƒŠƒn•”j: “ú–{‹`Žˆ‘•‹ďŠw‰ďŽ, 9: 205`210, 1993.

560. mŒ´’˜n dÇŒÄ‹z•s‘S‚đ’ć‚ľ‚˝ƒŒƒWƒIƒlƒ‰”x‰Š‚ĚŒŸ“˘|–k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚é‚V—á‚𒆐S‚Ć‚ľ‚ā|. ‚“cM˜ai“ŕjC‘Š”nˆęˆĺi‹~–˝jC“y‹´‚ä‚Š‚či“ŕjC‹ß“Ą‚Ś‚či‰qjCŽR–{”Ž”VC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: “ú–{‹š•”ŽžŠłŠw‰ďŽGŽ, 32(2): 138`145, 1994.

561. mŒ´’˜n ‹CŠÇŽxšb‘§ŠłŽŇ”­ě‰Á—Ă’†‚Ě“Ž–ŹŒŒ‰tƒKƒX‚¨‚ć‚ŃŽ_‘f–O˜a“x‚ĚŒoŽž“IŒŸ“˘. —é–Ř“šOCŹ—эO—SC•y“c—FKi“ŕj: “ú–{—Տ°ś—Šw‰ďŽGŽ, 23(4): 327`332, 1993.

562. mŒ´’˜n Nasal-CPAP ‚Şó• ‹ŘŒQ‚É‹y‚Ú‚ˇ‰e‹ż. “팴”Í”VCˆ˘•”’źC‹g‘şŽ‚C•y“c—FKi“ŕj: “ú–{—Տ°ś—Šw‰ďŽGŽ, 23: 565`570, 1993.

563. mŒ´’˜n Prospective study of steroid myopathy in connective tissue disease. —é–ŘŒúC‰Ş“cƒi“ŕjC”č’ő•vi“Œ—ˆă‘ĺj: “ú–{—Տ°–ƉuŠw‰ď‰ďŽ, 16: 262`271, 1993.

564. mŒ´’˜n Ž•óŠj’W‘“‹…ƒ‹ƒC‘ĚˆŢkÇ‚Ě‘ĺ”]”’Žż•a•Ď‚ĚŒŸ“˘. aˆä—߈ęi“ŕjCŁě•ś“żCŠ™“c˜a•FCtŒ´Œo•FC’†ŽRGi‘—§¸_E_ŒoƒZƒ“ƒ^[jC–žÎr—Yi’ˇ–ěŒ§—§‹îƒ–Ş•a‰@j: ”]‚Ɛ_Œo, 46(2): 145`151, 1994.

565. mŒ´’˜n ˆÝ\“ńŽw’°ŽžŠł‚É‚¨‚Ż‚錌’†R Helicobacter pylori R‘Ě‚Ě—L—pŤ‚ɂ‚˘‚Ä. ˆŔ’BŒŁCˆŔŠC‹`—jCźŒłŽ›Ž—çi“ŕj: –k—˘ˆăŠw, 23(2): 104`112, 1993.

566. mŒ´’˜n —e—Ę•‰‰×‚𔺂¤S•Ů–ŒÇ‚É‚¨‚Ż‚鍶Žş”ě‘ĺ‚Ě”­Œť‚ɂ‚˘‚Ä. ‰Í“c—TC˜Ič‹P•vC´…ŠŽ‰xCźŽRŒcŽqC–ؐě“c—˛ˆęi“ŕj: –k—˘ˆăŠw, 23(4): 266`274, 1993.

567. mŒ´’˜n ‹Ů’Ł’ቺŤ~ˆł”˝‰ž‚đŽŚ‚ˇ‹N—§Ť’˛ßáŠQ‚É”ş‚¤zŠÂ“Ž‘ԏ””’l‚̕ωť‚ĚˆÓ–Ą. ‰Í“c—TC•˝–쐽ˆę˜YCˆ˘•”˜jC‰Í–ě“š˘C‚‹´‚Ý‚Ç‚čC•zěTˆę˜YC–ؐě“c—˛ˆęi“ŕj: –k—˘ˆăŠw, 23(5): 348`353, 1993.

568. mŒ´’˜n ‚bŒ^ŠĚ‰Š‚ĚŒo‰ß‚Ć’ˇŠú—\Œă. “Ą‰Ş‚OCa’J–ž—˛i“ŕj: –k—˘ˆăŠw, 23(6): 482`489, 1993.

569. mŒ´’˜n S–[×“Ž‚É”ş‚¤”]ÇđÇ‚ɂ‚˘‚Ä‚Ě—Ő°“IŒŸ“˘. ‹ĘˆäL–žC_“c’źC”Ń’Ë‚_CHŽR‹vŽC”Š_mCˆ˘‹v’Ă“ń•vC–kˆä‘Ľ•vC”¨—˛ŽuCâˆä•ś•Fi“ŕj: –k—˘ˆăŠw, 23: 455`461, 1993.

570. mŒ´’˜n ’†•Ť‹y‚Ń––˝Ťƒmƒ‹ƒAƒhƒŒƒiƒŠƒ“Šˆ“Ž‚ƉÁ—î‚ĚŠÖŒW|”]‘˛’†ŠłŽŇ‚É‚¨‚Ż‚錟“˘|. ‹ĘˆäL–žC“Œ–M•FC_“c’źi“ŕj: –k—˘ˆăŠw, 23: 462`468, 1993.

571. mŒ´’˜n ˆÝĽ\“ńŽw’°’×ᇂ̍Ĕ­‚ƍR Helocobacter pylori IgG R‘Ě‚Ć‚ĚŠÖ˜A‚ɂ‚˘‚Ä. Źň˜aŽO˜YC’†ˆä‹v—YC“ú”äŒŞˆęCˆŔ’BŒŁC“c•Ó‘C‘ĺˆä“cłlCˆŔŠC‹`—jCźŒłŽ›Ž—çi“ŕj: –k—˘ˆăŠw, 24(1): 30`34, 1994.

572. mŒ´’˜n ‘ŠúŽűk‚É‚ć‚鍶‰E—źŽş‹@”\‚̕ωť‚ɂ‚˘‚Ä. ˆ˘•”˜jC’|“c’萜C’ˇ’Jě‰„LC–ؐě“c—˛ˆęi“ŕj: –k—˘ˆăŠw, 24(1): 35`47, 1994.

573. mŒ´’˜n •Đ“Ş’É‚Ě•a‘Ô. âˆä•ś•Fi“ŕj: –Ťáu’É, 12(1): 230`232, 1993.

574. mŒ´’˜n ŒŒŠÇě“Ž•¨Žż“Ž–Ź“ŕ’“ü‚É‚ć‚éŽîᇌŒs“Ž‘Ԃ̕ωť|ƒ‰ƒbƒgŠĚŠŕ‘gDŒŒ—Ź‚Ě‘Ş’č|. –{‹´CCźŒłŽ›Ž—çi“ŕj: –ŹŠÇŠw, 34(1): 23`29, 1994.

575. mŒ´’˜n Prostaglandin ‡T2, angiotensin ‡UŽ‘ą’“ü‚ĚŽîᇌŒ—Ź‚ɑ΂ˇ‚é‰e‹ż|ƒ‰ƒbƒgŒ´”­“űŠŕ‘gDŒŒ—Ź‚Ě‘Ş’č|. –{‹´CCźŒłŽ›Ž—çi“ŕjC’†ŽR–ΐMiŽŔ“ŽŒnj: –ŹŠÇŠw, 34(2): 105`109, 1994.

576. mŒ´’˜n ƒ‰ƒbƒgƒGƒ^ƒm[ƒ‹’×ᇂɔş‚¤ˆÝ”S‰t—Ę•Ď“Ž‚ɑ΂ˇ‚锟‰ÄŕbS“’‚ĚŒř‰Ę. •ű—D”üi“ŕjCÎŒ´˜a•Fi‰ťŠwjCŒÜäzsMCŽsě‘¸•śiś‰ťjCŹ“‡—m“ńCźŒłŽ›Ž—çi“ŕjC–x“c‹ąŽqiś‰ťj: –ň—‚ĆŽĄ—Ă, 21(6): 109`113, 1993.

577. mŒ´’˜n V‚ľ‚˘ŒoŒűŒŒ“œ~‰şÜ CS-045 ‚Ě‘ć‡T‘ŠŽŽŒą|’P“Š—^‚É‚ć‚éˆŔ‘SŤ‚¨‚ć‚Ń–ň•¨“Ž‘Ô‚ĚŒŸ“˘|. ŽÄ“c‹v—YCVˆäd‹Ii“ŕjCŹ—Ń”ü•ci—Տ°–ň—jCň‚ŽiC‘O“cŒb”üŽqCůŒ´–MGCŽRŒűLˆę˜YCX“c–žCź˜eH‘ĽiŽO‹¤j: —Տ°ˆă•ń, 9(7): 1503`1518, 1993.

578. mŒ´’˜n V‚ľ‚˘ŒoŒűŒŒ“œ~‰şÜ CS-045 ‚Ě‘ć‡T‘ŠŽŽŒą|˜A‘ą“Š—^‚É‚ć‚éˆŔ‘SŤ‚¨‚ć‚Ń–ň•¨“Ž‘Ô‚ĚŒŸ“˘|. ŽÄ“c‹v—YCVˆäd‹Ii“ŕjCŹ—Ń”ü•ci—Տ°–ň—jCň‚ŽiC‘O“cŒb”üŽqCůŒ´–MGCŽRŒűLˆę˜YCX“c–žCź˜eH‘ĽiŽO‹¤j: —Տ°ˆă•ń, 9(7): 1519`1537, 1993.

579. mŒ´’˜n ƒ‰ƒbƒg‚É‚¨‚Ż‚é’áŽ_‘f•‰‰×Žž‚Ě”x×“Ž–ŹŒa‚̕ωť. “c’†’ź•FCŹ—эO—SC˛“Ą“N–çC‹v•Ű“cŸC‚“cM˜aC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: —Տ°ŒÄ‹zś—, 25(2): 173`177, 1993.

580. mŒ´’˜n ‡–°–ň‚ĆƒGƒ^ƒm[ƒ‹‚đ•š—p‚ľ‚˝‚Ć‚Ť‚Ě‘Ě“ŕ“Ž‘Ô‚ÉŠÖ‚ˇ‚錟“˘|ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“—U“ą‘Ě‚Ć‚ť‚Ěƒvƒƒhƒ‰ƒbƒO‚ɂ‚˘‚ā|. Ź—Ń”ü•ci—Տ°–ň—jCŽÄ“c‹v—Yi“ŕjC—é–Ř–q•FC“ŕŠCŒő’ŠCÎ‹˝‰ŞƒC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸jC”óŒűiC‘ş‰Ş‰p—Yi‹v—˘•l•a‰@jC‰Í–{O”üCŹ“ěŒĺ˜Y i‰––ě‹`Œ¤‹†Šj: —Տ°–ň—, 24(4): 579`588, 1993.

581. mŒ´’˜n ‚—îŽŇ‹•ŒŒŤ‘ĺ’°‰Š‚Ě—Ő°“IŒŸ“˘. Ä“ĄrŽiCŒÜ\—’łLCŸ–””ş‰hC“ŕ“Ą‹g—˛CŹ—ѐ´“TCźŒłŽ›Ž—çi“ŕjCŽO•xO”Vi•a—j: ˜V”NÁ‰ťŠí•a, 5(1): 33`38, 1993.

582. m€Œ´’˜i‰p•śjn Optimal body weight control improves erythropoietin (EPO) induced hypertension in hemodialysis (HD) patients. Ź—Ń’ź”VCŠ™“cvŽőC‹g“cŕˆC‘ĺ‹v•Ű[li“ŕj: Current Therapy in Nephrology, p.397`398, 1992.

583. m€Œ´’˜i‰p•śjn The role of esophageal involvement in the aggravation of pulmonary fibrosis in systemic sclerosis. ‹ß“ĄŒ[•śCÎěÍC•äâ–΁C‰““Ą•˝mi“ŕj: Proceedings of the International Symposium on Pathogenesis and Management of Scleroderma and Connective Tissue Disorders, p.111`118, 1994.

584. m€Œ´’˜i‰p•śjn Mesangial immunoglobulin A deposition and focal Glomerulosclerosis in a renal transplant patient with nephrotic syndrome|Berger's disease alone or superimposition of focal glomerulosclerosis? ‘ĺ‹v•Ű[lC‚‹´‰fŽqC“c‘ş_ŽOCŠ™“cvŽőCŹ—Ń–Li“ŕjC’†ŽR‹`‰îCŒY•”“ŒŽĄC˛“ĄŒőŽjiŠOjCŒF–ě˜a—YC‰““Ą’‰—Yi”ĺj: Transplant. Proc., 25(2): 2109`2112, 1993.

585. m€Œ´’˜n Bond toxic polyneuropathy due to glue sniffing|Clinical and experimental studies|. Ä“Ą–L˜aC‹y”\ŽGC’š‹‡ŽOCŒĂ˜a‹vKi“ŕj: Proceedings of the International Conference on Peripheral Nerve Toxicity, (1993): 141`144, 1993.

586. m€Œ´’˜n ‚bŒ^ŠĚ‰ŠƒEƒCƒ‹ƒX‚Ěˆâ“`Žq\‘˘‚Ć‚ť‚Ěˆâ“`“I‘˝—lŤ‹y‚Ń•ĎˆŮŤ. ‰Á“Ąé”Vi‘—§‚Ş‚ńƒZƒ“ƒ^[jC’†‘ň‹MGi“ŕjCŠÖ’Jm”üC‘ĺ’ĂŽR—SŽqC“y•ű˝C‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ƒ^[j: RƒEƒCƒ‹ƒX‰ťŠw—Ă–@Œ¤‹†‚̐i•ŕ|‘ć‚S‰ńRƒEƒCƒ‹ƒX‰ťŠw—Ă–@Œ¤‹†‰ďƒvƒƒV[ƒfƒBƒ“ƒO|, p.52`58, 1993.

587. m€Œ´’˜n Š×‰šŒ^‘ŠúˆÝŠŕ‚̐Z”͈͂Ɋւˇ‚éƒtƒ@ƒCƒo[ƒXƒR[ƒv‚Ć“dŽq“ŕŽ‹‹ž‚̐f’f”\‚Ě”äŠrŒŸ“˘. ’†ˆä‹v—YC‘ĺˆä“cłlCŽRăp‚ł‚ä‚čC›’m–çC“c•Ó‘CŹň˜aŽO˜YC‰ĄŽR–őCźŒłŽ›Ž—çi“ŕj: Á‰ťŠí“ŕŽ‹‹ž‚̐i•ŕ, 43: 96`99, 1993.

588. m€Œ´’˜n ’´‰š”g“ŕŽ‹‹ž‚É‚ć‚é’_”X—˛‹NŤ•a•Ď‚̐f’f. –ě“o˝CâŒű“NÍC–Ř“cŒőLCŽR“cŽŠlCˆÉ“Ą‹ĎC^‹ĘŽő”üśCźŒłŽ›Ž—çi“ŕjC‹g“c@‹IC‘ĺ‹{“ŒśC”äŠé”\Ž÷iŠOj: “ú–{’´‰š”gˆăŠw‰ďu‰‰˜_•śW, 63: 443`444, 1993.

589. m€Œ´’˜n ×Œa’´‰š”gƒvƒ[ƒu‚É‚ć‚é\“ńŽw’°’×ᇂ̌Ÿ“˘. ŽR“cŽŠlCâŒű“NÍC–Ř“cŒőLCźŒłŽ›Ž—çi“ŕj: “ú–{’´‰š”gˆăŠw‰ďu‰‰˜_•śW, 63: 55`56, 1993.

590. m€Œ´’˜n –ň—Šw“I“ŕŽ‹‹ž; ”÷ŹˆÝŠŕ. ‘ĺˆä“cłlCŹň˜aŽO˜YCźŒłŽ›Ž—çi“ŕj: —Տ°Á‰ťŠí“ŕ‰Č, 8(9): 1531`1536, 1993.

591. m’Z•ńn Ź”]‘gD‚ɑ΂ˇ‚鎊ŒČR‘Ě‚đ”F‚ß‚˝Epstein-BarrƒEƒCƒ‹ƒXŠ´ő‚É”ş‚¤‹}ŤŹ”]Ž¸’˛Ç. ˛ŽRßŽqCˆÉ“Ą”Ž–žC“ü]KŽqCÄ“Ą–L˜aCŒĂ˜a‹vKi“ŕj: _Œo“ŕ‰Č, 39(2): 195`198, 1993.

592. m’Z•ńn ’ʏí‚ĚŒŸ¸–@‚Ĺ‚l’`”’‚đŠm”F‚Ĺ‚Ť‚Č‚Š‚Á‚˝R myelin-associated glycoprotein R‘Ě—zŤ‚Ě‘˝”­Ťƒjƒ…[ƒƒpƒ`[‚Ě‚P—á. ‰eŽR‹ąŽjCŽsěŒj“ńC“Ą‰ŞíGi•şŒÉŒ§—§“ňč•a‰@jC‹ŕ’Ă˜a˜Yi•şŒÉŒ§—§“ňč•a‰@jCÄ“Ą–L˜ai“ŕj: —Տ°_Œo, 33(2): 210`212, 1993.

593. mŒ¤‹†•ńn ƒŠƒEƒ}ƒ`ŤŽžŠł‚É‚¨‚Ż‚éƒCƒ“ƒe[ƒƒCƒLƒ“‚W‚ĚˆÓ‹`‚Ć‚ť‚̐§Œä‚ÉŠÖ‚ˇ‚錤‹†. ÔŻ“§i“ŕj: _“ސě“ď•aŕ’c•˝Ź‚R”N“xŒ¤‹†•ń‘, p.1`3, 1993.

594. mŒ¤‹†•ńiŒúśČjn 1. New Zealand B/WF1 ƒ}ƒEƒXtÇ‚Ě”­Ç, i“W‚ɑ΂ˇ‚éDP-1904‚ĚŽĄ—ĂŒř‰Ę, 2. Heymannt‰Šƒ‰ƒbƒg‚ĚŽŔŒą–ŒŤtÇ‚É‚¨‚ć‚Ú‚ˇDP-1904‚ĚŒř‰Ę. ‘ĺ‹v•Ű[lCŠ™“cvŽőC‰J‹{ŒŤˆęC‚‹´‰fŽqC“ŕ“c–ž”üŽqi“ŕjC^č‹`•FiŽŔ“ŽŒnj: ŒúśČƒI[ƒtƒ@ƒ“ƒhƒ‰ƒbƒOŠJ”­Œ¤‹†Ž–‹Ć, ƒ‹[ƒvƒXt‰ŠŽĄ—Ă–ň‚ĚŠJ”­Œ¤‹†”Ç•˝Ź4”N“x•Ş’SŒ¤‹†•ń‘, p.3`5,1993.

595. mŒ¤‹†•ńiŒúśČjn –ŤŠÖßƒŠƒEƒ}ƒ`ŠłŽŇ‚ĚQOL‚Ć‚ť‚̉ü‘P‚Ö‚ĚƒAƒvƒ[ƒ`. ‹ß“ĄŒ[•śC‰““Ą•˝mi“ŕjCů–{Œ›’jiŽŠOj: ŒúśČƒŠƒEƒ}ƒ`’˛¸Œ¤‹†Ž–‹Ć‘‡Œ¤‹†•ń‘, p.292`294, 1993.

596. mŒ¤‹†•ńiŒúśČjn Á‰ťŠí‚Ş‚ń‰ťŠw—Ă–@Ç—á‚ĚŒř‰Ę”ť’č‚Ě–â‘č“_‚ĚŒŸ“˘. Źň˜aŽO˜Yi“ŕj: ŒúśČŒ¤‹†•ń‘, 1993.

597. mŒ¤‹†•ńiŒúśČjn ŽŔŒą“Iƒ`ƒAƒ~ƒ“Œ‡–Ró‘Ô‚É‚¨‚Ż‚éŒăŞ_Œoß‚Ě‘gD‰ťŠw“I•Ď‰ť. Ä“Ą–L˜aC•y•Ű˜aGCˆÉ“Ą”Ž–žCŒĂ˜a‹vKi“ŕj: ŒúśČ¸_E_ŒoŽžŠłŒ¤‹†ˆĎ‘ő”ď, –ŤisŤƒ|ƒŠƒjƒ…[ƒƒpƒ`[‚̐Źˆö‚ĆŽĄ—Ă‚ÉŠÖ‚ˇ‚錤‹†”Ç, •˝Ź‚T”N“xŒ¤‹†•ń‘, p.15`17,1994.

598. mŒ¤‹†•ńiŒúśČjn –ŤÄ”­ŤŽŔŒą“IƒAƒŒƒ‹ƒM[Ť_Œo‰Š‚̖Ɖu—}§Ü‚É‚ć‚鎥—ĂŒř‰Ę‚ĚŒŸ“˘|‘ć‚Q•ń: ‹}ŤŽŔŒą“IƒAƒŒƒ‹ƒM[_Œo‰Š‚É‚¨‚Ż‚é–ƉuƒOƒƒuƒŠƒ“‚Ě“Š—^Œř‰Ę|. Ä“Ą–L˜aC‹y”\ŽGCˆÉ“Ą”Ž–žCŒĂ˜a‹vKi“ŕj: ŒúśČ¸_E_ŒoŽžŠłŒ¤‹†ˆĎ‘ő”ď, –ŤisŤƒ|ƒŠƒjƒ…[ƒƒpƒ`[‚̐Źˆö‚ĆŽĄ—Ă‚ÉŠÖ‚ˇ‚錤‹†”Ç, •˝Ź‚T”N“xŒ¤‹†•ń‘, p.43`46, 1994.

599. mŒ¤‹†•ńiŒúśČjn ƒvƒƒWƒFƒNƒgŒ¤‹†kˆă—ĂƒVƒXƒeƒ€EŠÖ“Œb‰zlŠÖ“ŒEb‰z’n‹ć‚É‚¨‚Ż‚éƒXƒ‚ƒ“ŠłŽŇ‚ĚŒŸf|‘ć‚U•ń|. “c•Ó“™i“s—§_Œo•a‰@jCç“cŒőˆęi“ú‘ĺjCˆŔ“Ą“ż•Fi‰ĄŽs‘ĺjCç–ě’źˆęiŒc‘ĺƒŠƒnjC‰Ô˜U—Ljęi‚˘‚í‚ăŠƒnjC•ž•”F“šiç—t‘ĺjCŒĂ˜a‹vKi“ŕjC ŒKŒ´••viVŠƒ‘ĺjC‘O“c^ŽĄi“ŕjC’†‘ş—˛ˆęi‘—§g‘̏áŠQŽŇƒŠƒn•a‰@jCźžŠˆęŽ~i’}”g‹Zp’Z‘ĺjC‰Ş–{KŽsiŒQ‘ĺjC‰ŞŽRŒ’ŽŸi‘ĺ‹{Ô\Žš•a‰@jC ÷ˆäłŽ÷i“Œ‘ĺjC’O‘ňÍ”ށi–žŽĄčI‹„‘ĺjCă“c•qi’é‹ž‘ĺŽsŒ´•a‰@ƒŠƒnjC“n粐°—Yi“Œ—ˆă‘ĺjCrčŒ\‰îi“ú—§‘‡•a‰@jC‰–‘ň‘SŽiiŽR—œˆă‘ĺjC“c ‘şłli“ú‘唋´•a‰@jC‚{r–ži“ú‘ĺj: ŒúśČ“Á’莞ŠłƒXƒ‚ƒ“’˛¸Œ¤‹†”Ç, •˝Ź‚T”N“x•ń‘, p.16`17, 1994.

600. mŒ¤‹†•ńiŒúśČjn ƒvƒƒWƒFƒNƒgŒ¤‹†kˆă—ĂƒVƒXƒeƒ€EŠÖ“Œb‰zlŠÖ“ŒEb‰z’n‹ć‚É‚¨‚Ż‚éƒXƒ‚ƒ“ŠłŽŇ‚ĚŒŸfi‘ć‚T•ń). “c•Ó“™i“Œ‹ž“s—§_Œo•a‰@jC‚{r–ži“ú‘ĺ_Œo“ŕ‰ČjC‘ź10–źCŒĂ˜a‹vKi“ŕjC‘ź‚R–źCç“cŒőˆęi“ú‘ĺ_Œo“ŕ‰ČjC‘ź‚T–ź: ŒúśČ“Á’莞ŠłƒXƒ‚ƒ“’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†‹ĆŃW, p.502`512, 1993.

601. mŒ¤‹†•ńiŒúśČjn _“ŢěŒ§‚Ĺ‚ĚƒXƒ‚ƒ“ŠłŽŇ‚ĚŽŔ‘Ô’˛¸|ŒŸfŒ‡ČŽŇ‚̒ǐՒ˛¸|. ŽO•x“N˜YCŒĂ˜a‹vKC’ˇ’JěˆęŽqC‘O“c^ŽĄC—Ŕł•ŁCź‰ŞłŒhC‹y”\ŽGCÂŒË˜aŽqi“ŕjC–Ř“Ą‹žŽqCXěň”üi“Œ•a‰@ŠĹŒě•”jC•ŸŽR‰ĂjC‰œŽRFŽqi“Œ •a‰@‘‡‘Š’k•”j: ŒúśČ“Á’莞ŠłƒXƒ‚ƒ“’˛¸Œ¤‹†”Ç•˝Ź‚T”N“xŒ¤‹†•ńWC1994.

602. mŒ¤‹†•ńiŒúśČjn Ň‘Ź”]•ĎŤÇ‚É‚¨‚Ż‚éŠÉ™Šá‹…‰^“Ž‚ĚˆÓ–Ą‚Ă‚Ż. ŽO•x“N˜YC’ˇ’JěˆęŽqCŒĂ˜a‹vKi“ŕj: ŒúśČ“Á’莞Šł‰^“ŽŽ¸’˛’˛¸Œ¤‹†”Ç1993”N“xŒ¤‹†•ń‘, 1994.

603. mŒ¤‹†•ńiŒúśČjn Ň‘Ź”]•ĎŤÇ‚É‚¨‚Ż‚é•ŕsáŠQ‚Ě’č—Ę“I‰đÍ‚Ć—Ő°Çó‚ĚŒŸ“˘. ŒĂ‘ň‰p–žCŽO•x“N˜YC’ˇ’JěˆęŽqCŒĂ˜a‹vKi“ŕj: ŒúśČ“Á’莞Šł‰^“ŽŽ¸’˛’˛¸Œ¤‹†”Ç1993”N“xŒ¤‹†•ń‘, 1994.

604. mŒ¤‹†•ńiŒúśČjn ‹­”çÇ‚Ě”xüˆŰÇ‚É‚¨‚Ż‚éH“š•a•Ď‚Ě–đŠ„. ‹ß“ĄŒ[•śC–ě‘şł˘C•äâ–΁C‰““Ą•˝mCÎěÍi“ŕj: ŒúśČ“Á’莞Šł‹­”çÇ’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†•ń‘, p.133`136, 1993.

605. mŒ¤‹†•ńiŒúśČjn RD’†‹…×–EŽżR‘̂𔺂¤‹­”çÇ‚Ě—Ő°“Á’Ľ. ‹ß“ĄŒ[•śC‰““Ą•˝mC×–ěF˜Yi“ŕj: ŒúśČ“Á’莞Šł‹­”çÇ’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†•ń‘, p.158`163, 1993.

606. mŒ¤‹†•ńiŒúśČjn ‹­”çÇ‚ĚŽĄ—Ă. ‹ß“ĄŒ[•śi“ŕj: ŒúśČ“Á’莞Šł‹­”çÇ’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†•ń‘, p.215`217, 1993.

607. mŒ¤‹†•ńiŒúśČjn MCTD‚É‚¨‚Ż‚é”x•a•Ď‚ƍRnRNPR‘̉ż. ‹ß“ĄŒ[•śC•äâ–΁C–ě‘şł˘i“ŕj: ŒúśČ“Á’莞ŠłŹ‡ŤŒ‹‡‘gD•a’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†•ń‘, p.37`39, 1993.

608. mŒ¤‹†•ńiŒúśČjn ’`”’‘rŽ¸ŤˆÝ’°Ç‚Ć‹š–Œ‰Š‚đ‡•š‚ľ‚˝MCTD‚ÉCyclophosphamide‚Ěƒpƒ‹ƒX—Ă–@‚Ş’˜Œř‚đŽŚ‚ľ‚˝‚PÇ—á. ‹ß“ĄŒ[•śCŠp‰Ć–ž•śC–ě‘şł˘C‰Ş“cƒi“ŕj: ŒúśČ“Á’莞ŠłŹ‡ŤŒ‹‡‘gD•a’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†•ń‘, p.40`42, 1993.

609. mŒ¤‹†•ńiŒúśČjn NZW/BXSF1(N/B)mouse ‚̍R cardiolipin R‘Ě‚ĚˆÓ‹`. ‰Ş“cƒC–ě‘şł˘C‹ß“ĄŒ[•śi“ŕj: ŒúśČ“Á’莞ŠłŽŠŒČ–ƉuŽžŠł’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†•ń‘, p.115`117, 1993.

610. mŒ¤‹†•ńiŒúśČjn IgAtÇ‚Ě’ˇŠú“I—\Œă—\‘ވöŽq‚ĚŒŸ“˘. Ź—Ń–LCŹ‹v•Ű“§i“ŕjC”äŠé”\”ViŠĹŒěŠw•”jCŠÚ–ěƒśi“ŕj: ŒúśČ“Á’莞ŠłisŤtáŠQ’˛¸Œ¤‹†”Ç•˝Ź4”N“xŒ¤‹†‹ĆŃW, p.6`13,1993.

611. mŒ¤‹†•ńiŒúśČjn IgAt‰Š‚É‚¨‚Ż‚é”A×ŠÇŠÔŽżt‰Š‚ĚˆÓ‹`. dźGˆęiMB‘ĺjCŹ—Ń–Li“ŕj: ŒúśČ“Á’莞ŠłisŤtáŠQ’˛¸Œ¤‹†”Ç•˝Ź4”N“xŒ¤‹†‹ĆŃW, p.14`20, 1993.

612. mŒ¤‹†•ńiŒúśČjn ’jŤ SLE ‚É‚¨‚Ż‚é‘ĺ‘ڍœ“Ş‰óŽ€Ç‚Ě‰đÍ. ‰Ş“cƒC–ě‘şł˘CÎěÍC‹ß“ĄŒ[•śi“ŕjC”č’ő•vi“Œ—ˆă‘ĺj: ŒúśČ“Á’莞Šł“Á”­Ť‘ĺ‘ڍœ“Ş‰óŽ€Ç’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†•ń‘, p.91`93, 1993.

613. mŒ¤‹†•ńiŒúśČjn ‘SgŤƒGƒŠƒeƒ}ƒg[ƒfƒXŠłŽŇ‚ĚQOL‚ÉŠÖ‚ˇ‚錤‹†(2). ‰Ş“cƒC–ě‘şł˘C‰““Ą•˝mC‹ß“ĄŒ[•śi“ŕj: ŒúśČ“Á’莞Šł“ď•a‚ĚƒPƒAƒVƒXƒeƒ€’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†•ń‘, p.135`138, 1993.

614. mŒ¤‹†•ńiŒúśČjn Guillain-BarreÇŒóŒQ‚É‚¨‚Ż‚錌´RGQ1bR‘Ě‚ĚŒŸ“˘. Ä“Ą–L˜aC“ü]KŽqCˆÉ“Ą”Ž–žCŒĂ˜a‹vKi“ŕjC‹ŕ‘ň’ź”üiŒ¤‹†Œnj: ŒúśČ“Á’莞Šł–ƉuŤ_ŒoŽžŠł’˛¸Œ¤‹†”Ç, •˝Ź‚T”N“xŒ¤‹†”ljď‹c´˜^W, 1993.

615. mŒ¤‹†•ńiŒúśČjn ‘˝”­Ťd‰ťÇ‚É‚¨‚Ż‚鐑‰tƒTƒCƒgƒJƒCƒ“‚ĚŒŸ“˘. Ä“Ą–L˜aC“ü]KŽqC‹y”\ŽGCˆÉ“Ą”Ž–žCŒĂ˜a‹vKi“ŕjC‹ŕ‘ň’ź”üi“Œ•a‰@Œ¤‹†Œnj: ŒúśČ“Á’莞Šł–ƉuŤ_ŒoŽžŠł’˛¸Œ¤‹†”Ç, •˝Ź‚T”N“xŒ¤‹†”ljď‹c´˜^W, 1994.

616. mŒ¤‹†•ńiŒúśČjn Œ`ó‹L‰Żƒvƒ‰ƒXƒ`ƒbƒN‚Ě•â‘•‹ď‚ւ̉ž—pi‘ć‚Q•ń: ’Z‰şŽˆ‘•‹ď‚ĚŠJ”­). ‘O“c^ŽĄi“ŕjC˛“ĄŒMi•˝ˆä‹`ŽˆŒ¤‹†ŠjC“‡“c—˛ŽqC’ˇ‘ňOCŒă“ĄNŒbC{“Ą“ޏ”üC’Ř“c—R”üC“y”쐳”ViƒŠƒn•”jC˛ŽĄ–L•iŽO•HdHj: ’†•_ŒoáŠQ‚ĚƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‹@Ší‚ĚŠJ”­‚ÉŠÖ‚ˇ‚錤‹†”ǁC•˝Ź‚T”N“xŒ¤‹†•ń‘, p.72`81, 1993.

617. mŒ¤‹†•ńiŒúśČjn ”]ŒŒŠÇŤ’s•đ‚Ě–ň•¨—Ă–@|”]‘˛’†”­ěŒă‚̒ǐՒ˛¸‚Š‚ç‚ĚŒŸ“˘|. âˆä•ś•Fi“ŕj: ’ˇŽő‰ČŠw‘‡Œ¤‹†•˝Ź‚S”N“xŒ¤‹†•ń‘, p.234`236, 1993.

618. mŒ¤‹†•ńiŒúśČjn ”]ŒŒŠÇáŠQ‚Ě’ˇŠú—\Œă‚ÉŠÖ‚ˇ‚錤‹†. _“c’źi“ŕj: •˝Ź‚S”N“xŒúśČzŠÂŠí•aŒ¤‹†ˆĎ‘ő”ď‚É‚ć‚錤‹†•ń‘, p.104, 1993.


<<14 1 “ŕ‰ČŠw>>

619. mŒ¤‹†•ńi_“ŢěŒ§jn ˜VlŤ’s•đŽžŠłŒ¤‹†Ž–‹Ć•ń‘|’s•đ‚đ‚Ť‚˝‚ˇ“ÁŽę_ŒoŽžŠł‚ĚŽŔ‘ԁ|D Ä“Ą–L˜ai“ŕj: ˜V”NŠú’s•đ‚̉uŠw‚ÉŠÖ‚ˇ‚錤‹†”Ç, •˝Ź‚S”N“x_“ŢěŒ§ˆĎ‘őŽ–‹Ć•ń‘, 1993.


<<14 2 “ŕ‰ČŠw>>

620. mÇ—á•ńn A case of severe IgA nephropathy associated with psoriatic arthritis and idiopathic interstitial nephritis. ”äŠé”\”ViŠĹŒěŠw•”jCŹ‹v•Ű“§C–xˆäşC‰Ą“ŕ‘Žqi“ŕjC˛“ĄłŽ÷CŒK”ö’čmi•a—jCdźGˆęiMB‘ĺjCŹ—Ń–Li“ŕj: Acta Pathol. Jpn., 43: 522`528, 1993.

621. mÇ—á•ńn ƒx[ƒ`ƒFƒbƒg•a‚ĚŒo‰ß’†‚É‹­”çÇ‚đ‡•š‚ľ‚˝‚P—á. ×–ěF˜YC‹ß“ĄŒ[•śi“ŕj: Connective Tissue, 25: 271`275, 1994.

622. mÇ—á•ńn ‰AŒs“ŕˆŮ•¨’“üpŒă‚É”­Ç‚ľ‚˝‚˘‚í‚ä‚éƒqƒgƒAƒWƒ…ƒoƒ“ƒg•a‚Ě‚P—á. ÎěÍC‰Ş“cƒC‹ß“ĄŒ[•śi“ŕjC”č’ő•vi“Œ—ˆă‘ĺj: Connective Tissue, 25: 91`94, 1993.

623. mÇ—á•ńn Diffuse and broad podocytic detachment in a case of nephrotic syndrome associated with Kimura's disease. Žç‰Ž’B”üi“ŕjCShinoda, T.i•‘ –ě“úÔjCKannou, Y.i‘Š‘ň•a‰@jCNakajima, K.CTakeda, T.CTakasu, N.CAizawa, T.CYamada, T.CHayata, Y.CItoh, N.CdźGˆęiMB‘ĺj: Jpn. J. Nephrol., 36(1): 69`75, 1994.

624. mÇ—á•ńn 5'DFUR,MMC,CDDP •š—p—Ă–@‚Ş‘tŒ÷‚ľ‚˝Řœ•s”\isˆÝŠŕ‚Ě‚P—á. Źň˜aŽO˜YC‹ß“Ąˆę‰pC’†ˆä‹v—YCŽRăp‚ł‚ä‚čC“c•Ó‘CŽO•xO”VC‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕj: Karkinos, 6(5): 571`576, 1993.

625. mÇ—á•ńn HŽ–—Ă–@‚Š‚ç‚Ě drop out |Ç—á‚ɂ݂錴ˆö‚Ć‘Îô|. –k‘şMˆęiĎś‰ďŒü“‡•a‰@jC–{‹{“N–çi“ŕj: ƒvƒ‰ƒNƒeƒBƒX, 10(5): 406`410, 1993.

626. mÇ—á•ńn äPŒ´•a‚Ć‚ĚŠÓ•Ę‚Ş˘“ď‚Ĺ‚ ‚Á‚˝ Castleman •a‚Ě‚R—á. •äâ–΁C‹ß“ĄŒ[•śi“ŕj: ƒŠƒEƒ}ƒ`, 34: 42`47, 1994.

627. mÇ—á•ńn ‡Ua Œ^•\‘wŠg‘ĺŒ^ˆÝŠŕ. “c•Ó‘CŹň˜aŽO˜YC‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕjCŽO•xO”Vi•a—j: ˆÝ‚Ć’°, 28(11): 1136`1138, 1993.

628. mÇ—á•ńn ”S–Œ‰ş‘w[‘w‚܂ŐZ‚ľ‚˝‡Uc{‡VŒ^‘ŠúˆÝŠŕ‚Ě‚P—á. ‰ĄŽR–őC–Ř“cŒőLC‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕjCă™G‰iCŽO•xO”Vi•a—j: ˆÝ‚Ć’°, 28(13): 1415`1417, 1993.

629. mÇ—á•ńn ‡Uc —ŢŽ—isŠŕ‚Ɛf’f‚ľ‚˝‡Uc Œ^‘ŠúˆÝŠŕ‚Ě‚P—á. ‘ĺˆä“cłlC›’m–çCŹň˜aŽO˜YCźŒłŽ›Ž—çi“ŕj: ˆÝ‚Ć’°, 28(7): 614`616, 1993.

630. mÇ—á•ńn śŒŸ‚Ĺ Group ‡V‚Ɛf’f‚ľ“ŕŽ‹‹ž“I”S–ŒŘœ‚Ĺ sm Z‚đ”F‚ß‚˝‡Ua Œ^‘ŠúˆÝŠŕ‚Ě‚P—á. ‰ĄŽR–őCÎˆäŒ\‘žCˆŔ’BŒŁC‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕjC“ˆ”ömCŽOd–슰ŠěiŠOjCă™G‰iC’†‰p’ji•a—j: ˆÝ‚Ć’°, 29(2): 239`243, 1994.

631. mÇ—á•ńn Arotinolol‚Ě–{‘ԐŤUí‚ɑ΂ˇ‚é—Տ°“I—L—pŤ‚ĚŒŸ“˘|‘˝Ž{Ý“ńd–ÓŒŸ–@‚É‚ć‚é‘ć‡V‘ŠŒQŠÔ”äŠrŽŽŒą|. –ö‘ňM•viMB‘ĺjC“c‘ă–M’ji–k‘ĺjC“Œ‹V‰p•viŠâŽčˆă‘ĺjC…–ě”ü–Mi‡“V‘ĺjC“c•Ó“™i“Œ‹ž“s—§_Œo•a‰@jCŒĂ˜a‹vKi“ŕjCœAŁŒš“ń˜Yi‹ŕ‘ňˆă ‘ĺjCŠC˜VŒ´ş•viŽŠŽĄˆă‰Č‘ĺj: ˆăŠw‚Ě‚ ‚ä‚Ý, 165(4): 215`240, 1993.

632. mÇ—á•ńn —ź‘¤ŤMLFÇŒóŒQ‚Ě‚P—á. f‘ň’BŽuC‹ŕŽqmi“ŕj: ‰^“ŽáŠQŒ¤‹†‰ď‹@ŠÖŽ, 3(2): 81`84, 1993.

633. mÇ—á•ńn ƒCƒ“ƒXƒŠƒ“”ńˆË‘śŒ^“œ”A•a‚ɍ‡•š‚ľ‚˝‰şŽˆ‚Ě”ńƒNƒƒXƒgƒŠƒWƒEƒ€ŤƒKƒXŽYśŤŠ´őÇ‚Ě1—á|‚ˆłŽ_‘f—Ă–@‚ĚŒř‰Ę‚ĚŒŸ“˘‚đŠÜ‚߂ā|. ‘ĺ˜a“c—˘C‹ŕXWC•˝ˆä–@”ŽC–‹`’‰i“ŕj: Š´őÇŠwŽGŽ, 68(2): 263`267, 1994.

634. mÇ—á•ńn ‰E–[”S‰tŽî‚Ě‚P—á|Žčp‘OŒă‚̐SƒGƒR|ŠŒŠ‚𒆐S‚É. ‘ĺŒIŽĄ•FC´…ŠŽ‰xC‰ĄŽRŒOC‰Í“c—Ti“ŕjC“ü‘ň˛mi‹šŠOjC–ؐě“c—˛ˆęi“ŕj: ŒÄ‹z‚ƏzŠÂ, 41(4): 397`401, 1993.

635. mÇ—á•ńn H“šŠŕŽčpŒă”­ś‚ľ‚˝ÄŒšˆÝŠÇŠŕ‚Ě‚P—á. ‚–ؐ¸ˆęC‚–ě‚‚é‘ăC•Đ‹ËšqiŒ§—§‚Ş‚ńƒZƒ“ƒ^[jC–{‹´CC˛–ěG–íi“ŕjC‹ĘˆäŮ•vCˆÉ“Ą‹`•FC‘ĺěLˆęC‘˝—…”ö˜a˜YCŠô˘‹´“āC–{‹´‹v•FiŒ§—§‚Ş ‚ńƒZƒ“ƒ^[j: Á‰ťŠí“ŕŽ‹‹ž‚̐i•ŕ, 42: 185`188, 1993.

636. mÇ—á•ńn ˆÝŽá”NŤƒ|ƒŠƒ|[ƒVƒX‚Ě‚P—á. rěä•vC‘ĺˆä“cłlC“c•Ó‘CŹň˜aŽO˜YC‰ĄŽR–őCźŒłŽ›Ž—çi“ŕjCă™G‰iC’†‰p’ji•a—j: Á‰ťŠí“ŕŽ‹‹ž‚̐i•ŕ, 43: 154`157, 1993.

637. mÇ—á•ńn ˆÝ‘BG•˝ă”çŠŕ‚Ě‚P—á. –{‹´CCŠô˘‹´“āC˛–ěG–íi“ŕjC‚–ؐ¸ˆęC–{‹´‹v•FC‹T“c—zˆęi_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[j: Á‰ťŠí“ŕŽ‹‹ž‚̐i•ŕ, 43: 166`169, 1993.

638. mÇ—á•ńn ’ź’°‚Š‚ç‰ń’°––’[‚Ü‚Ĺ‚Ě‘˝”­’×á‡‚đ‚Ť‚˝‚ľ‚˝’°Œ^ Behcet •a‚Ě‚P—á. ŽR˜e´ˆęCˆŔ’BŒŁi“ŕjC–ě‘şŽő˜aC’†‘ş—zŽqC‹´–{“NC“ˆ’Ă—TC´…–΁CÎěŽĺĹCˆäo“NC“n•”K•vCˆŔ•”–ž˜YCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: Á‰ťŠí“ŕŽ‹‹ž‚̐i•ŕ, 43: 234`237, 1993.

639. mÇ—á•ńn ‘˝”­ŤŒ‹ßWâƗl‘ĺ’°•a•Ď‚Ě‚P—á. •˝ŠÔË’qśiŹ“cŒ´Žs—§•a‰@jCŹ—ѐ´“Ti“ŕjC–{‘˝VC“n•Ó‹`˜YiŹ“cŒ´Žs—§•a‰@jCˆęŒ´—şi“ŕjC“n•ÓňCŽR“cL•vC’ˇ’JěÍ—YiŹ“cŒ´Žs—§•a‰@j: Á‰ťŠí“ŕŽ‹‹ž‚̐i•ŕ, 43: 259`262, 1993.

640. mÇ—á•ńn d‰ť—Ă–@‚Ě•â•—Ă–@‚Ć‚ľ‚Ä‚ĚˆÝĂ–ŹáŽŒ‹ăFp•š—p‚Ć‚ĚŽŽ‚Ý. ÎŠ_“ż]C‘•Ş–ΔŽC‘şă‹§lC‚“c‰ë”ŽC’†ˆä‹v—YC™–{­’źCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕj: Á‰ťŠí“ŕŽ‹‹ž‚̐i•ŕ, 43: 87`91, 1993.

641. mÇ—á•ńn Kronkheit-Canada ÇŒóŒQ‚đŒ´•a‚Ć‚ľRŠŕÜ•ž—p’†‚É”­Ç‚ľ‚˝“ŤˆÝ’×ᇂ̂P—á. ‘ĺˆä“cłlCŸ–””ş‰hCźŒłŽ›Ž—çC‰Ş•”ŽĄ–íi“ŕj: Á‰ťŤ’×á‡-Šî‘b‚Ć—Ő°-, 12(2): 96`100, 1993.

642. mÇ—á•ńn ‘ŠúŹäXŠŕ‚Ě‚PÇ—á. ă™G‰ii“ŕjC‹ĘˆäŮ•vC‘ĺěLˆęCˆÉ“Ą‹`•FC‘˝—…”ö˜a˜YC™­Ş•vC‹T“c—zˆęC”ѐX˜ali_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[j: ’_‚ĆäX, 14(—Ő‘): 1171`1175, 1993.

643. mÇ—á•ńn Œo‰ß’†‚É‹}Ťt•s‘S‚đ•š”­‚ľ‚˝AŒ^‹}ŤŠĚ‰Š‚Ě‚Q—á. ’|“ŕN—YCâŒű“NÍCŽá—Ń–ő‹vC–kˆä‘Ľ•vi“ŕjC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: “ú–{‹~‹}ˆă‰ďŠÖ“ŒŽ, 14: 267`268, 1993.

644. mÇ—á•ńn ”]oŒŒ‚đ‰”­Çó‚Ć‚ľ‚˝‹}Ť‘Oœ‘‹…Ť”’ŒŒ•a‚Ě‚PÇ—á. HŽR‹vŽC–kˆä‘Ľ•vCŽá—Ń–ő‹vC•‘ň—˜˜Yi“ŕjC•Đ‰Ş—SˆęC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: “ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ďŽGŽ, 14(2): 672`673, 1993.

645. mÇ—á•ńn ˆę‰ßŤ‚Ě”x…Žî‚ސf’f‚ĚŒ_‹@‚Ć‚Č‚Á‚˝S‘ŸŽîᇂ̂P—á. ‰Ô“cL‰pC‹g“c“OC•‘ň—˜˜Yi“ŕjC‘“c‘ěC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: “ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ďŽGŽ, 14: 170`172, 1993.

646. mÇ—á•ńn ŒÄ‹z•s‘S‚đŽĺ’Ľ‚Ć‚ľ‚˝ Amyopathic dermatomyositis ‚Ě‚P—á. ŠOŽRWi“ŕjC•Đ‰Ş—SˆęC–x’rdŽĄC’ç–M•FC‘“c‘ěC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: “ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ďŽGŽ, 14: 620`621, 1993.

647. mÇ—á•ńn “Ý“I‹š•”ŠO‚É‚ć‚č‹}ŤS‹Ř[Ç‚𔺂Á‚˝ŠĽ“Ž–Ź‘š‚ƐS‹ŘÁ‚đ•š”­‚ľ‚˝‚P—á. HŽR‹vŽi“ŕjC‘“c‘ěC•‘ň—˜˜YC”’J‹`GC“y‰Ž’ź—˛C‘ĺ˜a“c—˛i‹~–˝j: “ú–{‹~‹}ˆăŠw‰ďŽGŽ, 4(6): 643`647, 1993.

648. mÇ—á•ńn ƒpƒ‹ƒXƒIƒLƒVƒ[ƒ^‚É‚ć‚Á‚ÄŒo‰ßŠĎŽ@‚ˇ‚é‚ą‚Ć‚Ş‚Ĺ‚Ť‚˝‹}ŤƒAƒjƒŠƒ“’†“Ĺ‚Ě‚P—á. ‹v•Ű“cŸC—é–Ř“šOC‰Ô“cL‰pC‚“cM˜aC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕjC‘Š”nˆęˆĺi‹~–˝j: “ú–{‹š•”ŽžŠłŠw‰ďŽGŽ, 31(7): 886`889, 1993.

649. mÇ—á•ńn ‹CŠÇŽx”x–Eôň‰t‚ĚƒŠƒ“ƒp‹…ŽhŒƒŽŽŒą‚ސf’f‚É—L—p‚Ĺ‚ ‚Á‚˝ŹŽÄŒÓ“’—U‹NŤ”x‰Š‚Ě‚P—á. ‚“cM˜aCrˆäiC“팴”Í”VC•Đ‹Ë^lC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: “ú–{‹š•”ŽžŠłŠw‰ďŽGŽ, 31(9): 1163`1139, 1993.

650. mÇ—á•ńn “Á”­Ť”xüˆŰÇ‚ÉŽŠŒČ–ƉuŤ—nŒŒŤ•nŒŒ‚đ‡•š‚ľ‚˝‚P—á. ň–őOC‹{–{–”‹gC“Ąˆä–F–žC“ń‹{C‰Ô“cL‰pi“ŕjC‘“cç‘ă•FC‰iŒŠŒ\ˆęC_’J’mŽŠC’†Œ´Ž•FC•ž•”Ź•FC‰ĄŽR„iŒx—F•a‰@j: “ú–{‹š•”—Տ°, 53(1): 70`74, 1994.

651. mÇ—á•ńn ’ZŠúŠÔ‚ĚŒo‰ß‚ŐS“d}ă, isŤ‚Ě ST-T •Ď‰ť‚ŞŽŚ‚ł‚ę‚˝”ě‘ĺŒ^S‹ŘÇ‚Ě‚P—á. ‘şź€C’†“ˆ^ˆęCŹ‚L]C˛“ĄŽüCŹ—Ń–ž–FC’ˇ’Jě‰„LC–ؐě“c—˛ˆęi“ŕjC”nę”ŽNi‘Š–ÍŒ´ˆăŽt‰ďj: –k—˘ˆăŠw, 23(2): 137`142, 1993.

652. mÇ—á•ńn ƒoƒ‹[ƒ“Šg’Łp‚Ş—LŒř‚Ĺ‚ ‚Á‚˝ŠĚŠO‚Ń–ŸŒ^Œ´”­Ťd‰ťŤ’_ŠÇ‰Š‚Ě‚P—á. “n•Ó•üŒbC^‹ĘŽő”üśCˆÉ“Ą‹ĎCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕjCŽO•xO”VC’†‰p’ji•a—j: –k—˘ˆăŠw, 23(4): 292`297, 1993.

653. mÇ—á•ńn ƒAƒ~ƒmŽ_ťÜ‚É‚ć‚éhypoglycemic neuropathy‚Ě‚P—á. ź‰ŞłŒhi“ŕjC“ú–ě‰p’‰Cdˆä•ś”ŽC‰J‹{ŒőCă“ˆ\˜YiŹ“cŒ´Žs—§•a‰@j: –k—˘ˆăŠw, 23(6): 503`504, 1993.

654. mÇ—á•ńn DIC ‚đ•š”­‚ľ‹~–˝‚ľ‚Ś‚˝‚‚‚ޒŽ•a‚Ě‚P—á. ŽO“Ą‹vC×–ěF˜YC–ě‘şł˘C•äâ–΁CÔŻ“§C”э‘–퐜i“ŕjC‚‹{t’ji—ŐŒŸjC‘Š”nˆęˆĺi‹~–˝jC‹ß“ĄŒ[•śi“ŕj: –k—˘ˆăŠw, 23(6): 505`509, 1993.

655. mÇ—á•ńn WPWÇŒóŒQ‚É•š”­‚ľ‚˝S‹Ř[ÇÇ—á‚̐S“d}•Ď‰ť|Ç—á’掌‚Ć—źŽŇ‚̍‡•š—á‚ɂ‚˘‚Ä‚ĚlŽ@|. ‘şź€C‹g“cTC‚‹´“OCŠ“c”ü—ć”TC’Ĺ–źł_C–ؐě“c—˛ˆęi“ŕj: –k—˘ˆăŠw, 23: 362`368, 1993.

656. mÇ—á•ńn ‰ťŠw—Ă–@‚Ş‘tŒ÷‚ľ‚˝ Borrmann ‚SŒ^ˆÝŠŕ‚Ě‚Q—á. –{ŠÔ“ń˜Yi“ŕjCŠOŽR‹v‘ž˜YC‰ĄŽR‰xŽqC“n•Ó—˛ŽiCź“c–€–çC›–ě‘C–ě“o˝C‚“cˆę‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@jC’ˇ“‡—mŽĄi‰Ą•lŽs‘ĺj: —Տ°‚ĆŒ¤‹†, 70(9): 2857`2862, 1993.

657. mÇ—á•ńn ‰–Ž_ƒAƒƒ`ƒmƒ[ƒ‹‚Ě–{‘ԐŤUí‚ɑ΂ˇ‚é—Տ°Œř‰Ę‚ĚŒŸ“˘|‘˝Ž{Ý“ńd–ÓŒŸŒQŠÔ”äŠr–@‚É‚ć‚é—p—ʐݒ莎Œą|. –ö‘ňM•viMB‘ĺjC“c‘ă–M’ji–k‘ĺjC“Œ‹V‰p•viŠâŽčˆă‘ĺjC…–ě”ü–Mi‡“V‘ĺjC“c•Ó“™i“Œ‹ž“s—§_Œo•a‰@jCŒĂ˜a‹vKi“ŕjCœAŁŒš“ń˜Yi‹ŕ‘ňˆă ‘ĺjCŠC˜VŒ´ş•viŽŠŽĄˆă‘ĺj: —Տ°ˆă–ň, 9(6): 1343`1371, 1993.

658. mÇ—á•ńn ŒŒ´RMAGR‘Ě‚ĆRGM1R‘Ě‚đ—L‚ˇ‚éIgM paraproteinemic polyneuropathy‚Ě‚P—á. ‘˝‰ę’J–]i“Œ–M‘ĺjCÄ“Ą–L˜ai“ŕjC“Ą‰ŞrŽ÷i“Œ–M‘ĺjC–{“c”ü‘ăŽqiĎś‰ď_“ŢěŒ§•a‰@jC–؉ş^’ji“Œ–M‘ĺj: —Տ°_ŒoŠw, 33(3): 322`326, 1993.

659. mÇ—á•ńn ”­ěŤ–éŠÔŒŒF‘f”AÇ‚ɍ‡•š‚ľ‚˝ă–îóĂ–Ź“´ŒŒđÇ‚Ě‚P–UŒŸ—á. ˆî•Ÿ“O–çC”¨—˛ŽuCˆ˘‹v’Ă“ń•vC_“c’źi“ŕj: —Տ°_ŒoŠw, 33(4): 427`433, 1993.

660. mÇ—á•ńn äC• ‹Ř”ě‘ĺ‚É’E‘Ťƒjƒ…[ƒƒpƒ`[‚𔺂Á‚˝”şŤ—ňŤ‹…Ň‘Ť‹ŘˆŢkÇ‚Ě‚P—á. Ä“Ą–L˜aCź‰ŞłŒhCł–Ř‚Š‚‚çC’š‹‡ŽOCŒĂ˜a‹vKi“ŕj: —Տ°_ŒoŠw, 33(5): 514`518, 1993.

661. mÇ—á•ńn ‰şŽˆ_ŒoŒ´Ť‹ŘˆŢk‚ĆăŽˆ‘Ńƒ~ƒIƒpƒ`[‚đ’ć‚ľ‚˝RHTLV-‡TR‘Ě—zŤ—á. ‹y”\ŽGCˆÉ“Ą”Ž–žC’ˇ’Jě‚ЂƂ݁CÄ“Ą–L˜aCŒĂ˜a‹vKi“ŕj: —Տ°_ŒoŠw, 33(7): 754`757, 1993.

662. mÇ—á•ńn Ž‹_ŒoˆŢk, _Œo“ď’Ž, ‘Ě˜H’ĽŒó‚𔺂Á‚˝ˆâ“`Ť‰^“ŽEŠ´ŠoŤƒjƒ…[ƒƒpƒ`[Type ‚h‚Ě’jŤ—á. Ä“Ą–L˜aCź‰Şš‹IC‰Ź–ě”üŒbŽqC‰““ĄˆęĆCŒĂ˜a‹vKi“ŕj: —Տ°_ŒoŠwC33(5): 519`524, 1993.

663. mÇ—á•ńn B-HT920 (‰–Ž_ƒ^ƒŠƒyƒLƒ\[ƒ‹j‚Ěƒp[ƒLƒ“ƒ\ƒ“•a‚ɑ΂ˇ‚é—Տ°•]‰ż|ƒƒVƒ‹Ž_ƒuƒƒ‚ƒNƒŠƒvƒ`ƒ“‚đ‘ÎĆ‚Ć‚ľ‚˝‘ć‡V‘Š‘˝Ž{Ý“ńd–ÓŒŸ”äŠrŽŽŒą|. ’†źF—YiŽOh•a‰@jCŒĂ˜a‹vKi“ŕjC…–ě”ü–Mi‡“V‘ĺjC–ö‘ňM•viMB‘ĺj: —Տ°•]‰ż, 21(1): 59`110, 1993.

664. m—Տ°ŽĄŒąn Preliminary study of B-HT920, a novel Dopamine agonist, for the treatment of Parkinson's disease. Mizuno, Y.i‡“V‘ĺjCŒĂ˜a‹vKi“ŕjCNakanishi, T.iNational Mishuku HospitaljCYanagisawa, N.iMB‘ĺj: Drug Invest., 5(3): 186`192, 1993.

665. m—Տ°ŽĄŒąn ƒp[ƒLƒ“ƒ\ƒ“ÇŒóŒQ‚ɑ΂ˇ‚éƒ}ƒŒƒCƒ“Ž_ƒŠƒXƒŠƒh‚Ě—L—pŤ‚ĚŒŸ“˘|‘˝Ž{Ý‹¤“ŻƒI[ ƒvƒ“ŽŽŒą|. –ö‘ňM•viMB‘ĺjCŒĂ˜a‹vKi“ŕjC…–ě”ü–Mi‡“V‘ĺjCŹě‹I—Yi‰Ş‘ĺjC‹ŕ‘ňˆę˜Yi“Œ‘ĺjCi“Ą­biMB‘ĺj: ˆăŠw‚Ć–ňŠw, 29(2): 479`541, 1993.

666. m—Տ°ŽĄŒąn ‚—îŽŇŒyÇS•s‘S‚ɑ΂ˇ‚éƒNƒ‰ƒeƒP[ƒXƒGƒLƒX‚Ě—Ő°–Ę•]‰ż|“Á‚ɐS“d}‚É‚Ý‚éQTŽžŠÔ‚Ě’ZkŒř‰Ę. ˆÉŽRç°Cˆ˘•”•qOi“Œˆă‘ĺjC‘şź€i“ŕjC•“ĄŒ’ˆęiŒúś’†‰›•a‰@jCŽş“cŒhˆęi‚í‚ç‚ŃŽs—§•a‰@j: ˆăŠw‚Ć–ňŠw, 31(2): 465`477, 1994.

667. m—Տ°ŽĄŒąn ƒp[ƒLƒ“ƒ\ƒ“ÇŒóŒQ‚ɑ΂ˇ‚éƒ}ƒŒƒCƒ“Ž_ƒŠƒXƒŠƒh’ˇŠú“Š—^‚Ě—L—pŤ|‘˝Ž{Ý‹¤“ŻƒI[ƒvƒ“ŽŽŒą|. –ö‘ňM•viMB‘ĺjCŒĂ˜a‹vKi“ŕjC…–ě”ü–Mi‡“V‘ĺjCŹě‹I—Yi‰Ş‘ĺjC‹ŕ‘ňˆę˜Yi“Œ‘ĺjCi“Ą­biMB‘ĺj: ˆăŠw‚Ć–ň•i, 30(6): 1472`1513, 1993.

668. m—Տ°ŽĄŒąn Œ´”­Ťƒlƒtƒ[ƒ[ÇŒóŒQ‚ɑ΂ˇ‚é U-67590A ‚Ě—Ő°Œř‰Ę. Ź—Ń–LCŹ‹v•Ű“§C–xˆäşi“ŕjC”äŠé”\”ViŠĹŒěŠw•”jCŠ™“cvŽőCŠÚ–ěƒśi“ŕj: Šî‘b‚Ć—Ő°, 27(12): 84`96, 1993.

669. m—Տ°ŽĄŒąn ˆÝ’×ᇂɑ΂ˇ‚郌ƒoƒ~ƒsƒh‚ĆH2Žó—e‘̝hR–ň•š—p—Ă–@‚Ě—L—pŤ‚ĚŒŸ“˘i‘ć1•ńj‰ŠúŽĄ—Ă‚É‚¨‚Ż‚é—L—pŤ. ŽO—֍„i“ŒŠC‘ĺjC’j‘SłŽOi‰Ą•lŽs—§Žs–Ż•a‰@jC›“c•ś•viş˜aˆă‘ĺjC‰Ş•”˜a•Fišƒ}ƒŠˆă‘ĺjCźŒłŽ›Ž—çi“ŕjC‚—W—T‘ž˜Yi‰Ą•lŽs‘ĺj: Šî‘b‚Ć—Ő°, 27(9): 3709`3726, 1993.

670. m—Տ°ŽĄŒąn ‹}Ť”xÇđÇ‚Ě‘Šúf’f‚ĆŽĄ—Ă‘Îô|‘˝Ž{Ý225—á‚Ě—Ő°“I‰đÍ|. ’ˇ’Jě_ˆęC‘ňŽRr–Żiěčˆă‘ĺjCˆÉŽRç°i“Œˆă‘ĺjC‘şź€i“ŕjCŹ‘ň—F‹I—Yi“ú‘ĺjCŒ“–{Ź•ki“ŒŠC‘ĺjCL–Ř’‰si•Ÿ‘ĺjCěˆäM‹`iŽœŒb‰ď •a‰@j: ŒÄ‹z‚ƏzŠÂ, 41(8): 773`777, 1993.

671. m—Տ°ŽĄŒąn –ŤŠÖßƒŠƒEƒ}ƒ`‚ɑ΂ˇ‚éƒ~ƒiƒ‹ƒtƒFƒ“ůiƒAƒ‹ƒ~ƒmƒvƒƒtƒFƒ“j‚Ě—LŒřŤ‚ĆˆŔ‘SŤ‚Ě PMS ’˛¸|‚Ć‚­‚É QOL Œ’N“x•]‰ż‚đŠÜ‚߂ā|. –öě–žC—é–؍N•vC…“‡—TCŽOD–M’BC“ŒˆĐCĄˆä–]C“üŒđşˆę˜YC‘ĺXŒO—YCŽR–{^C”č’ő•vCŽR“cş•vCŽR“cŸ‹vC’†“‡_ŽuC‹{éŒ›ˆęC‹gčŒŤˆęC™Œ´ rOCź‰ŞN•vC—L•xŠ°C’Ë–{s—YC•“ŕ“S•vCŽR‘O–MbC—é–Řˆę‘žC“Ą“c•Că“c”ŽCŒĂ–îm: f—ÂƐV–ň, 30: 49`61, 1993.

672. m—Տ°ŽĄŒąn ’°Œ^Behcet•a‚ɑ΂ˇ‚鐏•Ş‰h—{—Ă–@‚Ě—L—pŤ‚ɂ‚˘‚Ä‚Ě—Ő°“IŒŸ“˘. Ź—ѐ´“TCŸ–””ş‰hC“ŕ“Ą‹g—˛CŒÜ\—’łLCźŒłŽ›Ž—çi“ŕjC‘ĺęł›ßC”äŠé”\Ž÷iŠOjC“‡“cŽœ•Fi–ňÜjC–ěŒű‹…Žqi‰h—{•”j: —A‰tĽ‰h—{ƒWƒƒ[ƒiƒ‹, 15(5): 446`449, 1993.

673. m—Տ°ŽĄŒąn •Đ“ޒɂɑ΂ˇ‚é SN-308 (ƒXƒ}ƒgƒŠƒvƒ^ƒ“)”牺’ŽË‰t‚Ě—Ő°“I—L—pŤ‚ĚŒŸ“˘|••“›–@‚É‚ć‚鎊“K—e—Ę‚ĚŒŸ“˘|. “cč‹`şCâˆä•ś•Fi“ŕjC“c‘ă–M—YC‘ź: —Տ°ˆă–ň, 9: 1077`1093, 1993.

674. m—Տ°ŽĄŒąn ŒQ”­“ޒɂɑ΂ˇ‚é SN-308 (ƒXƒ}ƒgƒŠƒvƒ^ƒ“)”牺’ŽË‰t‚Ě—Ő°“I—L—pŤ‚ĚŒŸ“˘|••“›–@‚É‚ć‚鎊“K—e—Ę‚ĚŒŸ“˘|. “cč‹`şCâˆä•ś•Fi“ŕjC“c‘ă–M—YC‘ź: —Տ°ˆă–ň, 9: 1095`1106, 1993.

675. m—Տ°ŽĄŒąn ‹­”çÇĽ–ŤŠÖßƒŠƒEƒ}ƒ`‚É”ş‚¤ă• •”Á‰ťŠíÇó‚Č‚ç‚тɐt”ro”\‚ɑ΂ˇ‚é AS-4370 ‚ĚŒř‰Ę. —é–Ř‹M”ŽC”č’ő•vC“n•Ó•x”ŽC‹ß“ĄŒ[•śCÎěÍC‚•iŽĆi“ŕj: —Տ°ˆă–ň, 9: 2185`2197, 1993.

676. m—Տ°ŽĄŒąn ‹­”çÇ‚Ěă• •”Á‰ťŠíÇó‚ɑ΂ˇ‚é AS-4370 ‚Ě’ˇŠú“Š—^ŽŽŒą. —é–Ř‹M”ŽC”č’ő•vC‹ß“ĄŒ[•śCLŁrˆęCŽë–쏯Œái“ŕj: —Տ°ˆă–ň, 9: 2199`2211, 1993.

677. m—Տ°ŽĄŒąn –ŤŠÖßƒŠƒEƒ}ƒ`‚đ‘ÎŰ‚Ć‚ľ‚˝ƒiƒCƒLƒTƒ“R ƒJƒvƒZƒ‹‚Ě’ˇŠúŽg—p’˛¸‚̐ŹŃ|“o˜^§‚đ—p‚˘‚ÄŠÇ—‚ľ‚˝Prospective study|. –{ŠÔŒő•vC“ŒžŠ‹BCŽOXŒo˘CÔ^GlC“V–ěGˆęCˆŔ”{’BCě‰zŒő”ŽCŒ´‚Ü‚łŽqCj’JłËC‰Ş“cƒi“ŕjC“üŒđşˆę˜YC•˝Œ`“šlC‘ĺ‘]ŞN•vC’†ŽR¸“ńC źŠCł•FCˆî“cVˆęCě‡^ˆęC“L–؏~ˆę: —Տ°ˆă–ň, 9: 231`143, 1993.

678. m—Տ°ŽĄŒąn •Đ“ޒɂɑ΂ˇ‚é SN-308 (ƒXƒ}ƒgƒŠƒvƒ^ƒ“)ů‚Ě’ˇŠú”˝•œ“Š—^Žž‚Ě—LŒřŤ‚¨‚ć‚ŃˆŔ‘SŤ‚ĚŒŸ“˘. “cč‹`şCâˆä•ś•Fi“ŕjC“c‘ă–M—YC‘ź: —Տ°ˆă–ň, 9: 2357`2378, 1993.

679. m—Տ°ŽĄŒąn •Đ“ޒɂɑ΂ˇ‚é SN-308 (ƒXƒ}ƒgƒŠƒvƒ^ƒ“)ů‚Ě—Ő°“IŒŸ“˘|‘O’›‚ ‚邢‚Í—\’›Žž“Š—^‚Ě—LŒřŤ, ˆŔ‘SŤ‚ĚŒŸ“˘|. “cč‹`şCâˆä•ś•Fi“ŕjC“c‘ă–M—YC‘ź: —Տ°ˆă–ň, 9: 2655`2669, 1993.

680. m—Տ°ŽĄŒąn •Đ“ޒɂɑ΂ˇ‚é SN-308 (ƒXƒ}ƒgƒŠƒvƒ^ƒ“)ů‚Ě—Ő°•]‰ż|‰Šú—Տ°‘ć‡U‘ŠŽŽŒą|. “cč‹`şCâˆä•ś•Fi“ŕjC“c‘ă–M—YC‘ź: —Տ°ˆă–ň, 9: 777`794, 1993.

681. m—Տ°ŽĄŒąn ˆâ“`Žq‘gŠˇ‚ŚƒqƒgƒGƒŠƒXƒƒ|ƒGƒ`ƒ“‚Ě‘˝”­Ťœ‘Žî‚É”ş‚¤•nŒŒ‚ɑ΂ˇ‚é‘ć‡U‘Š—Տ°ŽŽŒą. ‰Y•”ť•viŠÖ“Œ’üM•a‰@jCaŒűGşi“Œ—ˆă‘ĺjC‚‹vŽj–›i‘—§ˆă—ĂƒZƒ“ƒ^|jC‰–’J–΁i“ŕjC‘ź: —Տ°ŒŒ‰t, 34(8): 919`927, 1993.

682. m—Տ°ŽĄŒąn ˆâ“`Žq‘gŠˇ‚ŚƒqƒgƒGƒŠƒXƒƒ|ƒGƒ`ƒ“‚̍œ‘ˆŮŒ`ŹÇŒóŒQ‚É”ş‚¤•nŒŒ‚ɑ΂ˇ‚é‘ć‡U‘Š—Տ°ŽŽŒą. ‰Y•”ť•viŠÖ“Œ’üM•a‰@jCaŒűGşi“Œ—ˆă‘ĺjC‚‹vŽj–›i‘—§ˆă—ĂƒZƒ“ƒ^|jC‰–’J–΁i“ŕjC‘ź: —Տ°ŒŒ‰t, 34(8): 928`936, 1993.

683. m—Տ°ŽĄŒąn ˆâ“`Žq‘gŠˇ‚ŚƒqƒgƒGƒŠƒXƒƒ|ƒGƒ`ƒ“‚̍Đś•s—ǐŤ•nŒŒ‚ɑ΂ˇ‚éŒř‰Ę|‘ć‡U‘Š—Տ°ŽŽŒą. ‰Y•”ť•viŠÖ“Œ’üM•a‰@jCaŒűGşi“Œ—ˆă‘ĺjC‚‹vŽj–›i‘—§ˆă—ĂƒZƒ“ƒ^|jC‰–’J–΁i“ŕj: —Տ°ŒŒ‰t, 34(9): 1002`1010, 1993.

684. m‘ŕn “ŕ‰Čˆă‚Ě‚˝‚ß‚Ě”]ŽžŠłuŔ; •Đ“Ş’É. âˆä•ś•Fi“ŕj: Brain Medical, 5(2): 82`83, 1993.

685. m‘ŕn “Ş’É‚Ě•Ş—Ţ‚Ć•a‘Ԑś—. âˆä•ś•Fi“ŕj: Brain Nursing, 10(3): 5`8, 1994.

686. m‘ŕn “œ”A•aŤtÇ‚É‚¨‚Ż‚é”AƒAƒ‹ƒuƒ~ƒ“Ľ’`”’ŒŸ¸|tÇ—Տ°Œo‰ß‚ĚŽw•W‚Ć‚ľ‚Ä‚ĚˆÓ‹`. –‹`’‰CŽç‰Ž’B”üi“ŕj: Diabetes Frontier, 4: 573`576, 1993.

687. m‘ŕn Çó‚Š‚ç‚Ý‚˝ŒŸ¸‚̐i‚ß•ű; –ƒáƒ. –kˆä‘Ľ•vi“ŕj: Emergency Nursing, 1993H(‘): 229`231, 1993.

688. m‘ŕn Çó‚Š‚ç‚Ý‚˝ŒŸ¸‚̐i‚ß•ű; ázš. –kˆä‘Ľ•vi“ŕj: Emergency Nursing, 1993H(‘): 232`234, 1993.

689. m‘ŕn “úíf—Ă‚É‘˝‚˘˜V”NŽŇ‚Ě‘i‚Ś; “Ş’É, “ޏd. âˆä•ś•Fi“ŕj: Geriatr. Med., 31(11): 1432`1434, 1993.

690. m‘ŕn ˆÝĽ\“ńŽw’°’×á‡. ŽO‹´—˜‰ˇCźŒłŽ›Ž—çi“ŕj: Geriatric Medicine, 31(9): 1121`1124, 1993.

691. m‘ŕn _ŒoŽžŠł‚É‚¨‚Ż‚éƒ^[ƒ~ƒiƒ‹ƒPƒA. ŒĂ˜a‹vKi“ŕj: Gerontology, 5(3): 279`284, 1993.

692. m‘ŕn “ÁW: ”]‘˛’†‚É‚ć‚éázk‚Ö‚ĚƒAƒvƒ[ƒ`|”]‘˛’†‚É‚ć‚é‹Ř‹Ů’ŁˆŮí‚Ć‚ť‚Ě‚Ý‚Š‚˝|. ‘O“c^ŽĄi“ŕj: J. Clin. Rehabil., 2(7): 523`529, 1993.

693. m‘ŕn –ŤŽ…‹…‘̐t‰Š: is‚ˇ‚ét‰Š‚Ƃ́|IgA tÇ‚𒆐S‚É. Ź—Ń–LC–xˆäşCŹ‹v•Ű“§C”äŠé”\”VCŠÚ–ěƒśi“ŕj: Medical Practice, 10(7): 1301`1306, 1993.

694. m‘ŕn ŠeŽíŽžŠł‚É‚¨‚Ż‚éĂ–Ź‰h—{ĽŒo’°‰h—{‚Ěƒ|ƒCƒ“ƒg|’°ŽžŠł. Ÿ–””ş‰hC“ŕ“Ą‹g—˛CŒÜ\—’łLCźŒłŽ›Ž—çCŹ—ѐ´“Ti“ŕj: Medical Practice, 10(—Ő‘): 196`204, 1993.

695. m‘ŕn ”ńƒXƒeƒƒCƒhÜ‚̐V‚ľ‚˘Žg—p•ű–@. ‹ß“ĄŒ[•śi“ŕj: Medical Practice, 10: 1987`1990, 1993.

696. m‘ŕn Á‰ťŤ’×á‡, ‚ť‚̐f’f‚ĆŽĄ—Ă–ň‚ĚŽg‚˘•ű|H2ƒuƒƒbƒJ[. ‘ĺˆä“cłli“ŕj: Medicament News, (1430): 4`5, 1993.

697. m‘ŕn •ÂÇŤ”xŽžŠł‚̐f’f‚ĆŽĄ—Ă; •ÂÇŤ”xŽžŠł‚Ě•a‘Ԑś—|ŒÄ‹z‹Ř‚Ě•‰‰×‚Ć”ć˜J. ‹g‘şŽ‚Cˆ˘•”’źi“ŕj: Medicina, 30(12): 2089`2091, 1993.

698. m‘ŕn ”M‚ĆŒŒ‰tň‰ť—Ă–@. Žá—Ń–ő‹vi“ŕj: Medicina, 30(5): 916`920, 1993.

699. m‘ŕn Á‰ťŤ’×ᇎĄ—Ă‚ĚŒťó‚Ć“W–]. źŒłŽ›Ž—çi“ŕj: Medicina, 30(9): 1596`1597, 1993.

700. m‘ŕn –ň•¨—Ă–@‚đ‚Ç‚¤i‚ß‚é‚Š. źŒłŽ›Ž—çi“ŕj: Medicina, 30(9): 1628`1631, 1993.

701. m‘ŕn NSAIDs•š—p—á‚ĚŽĄ—Ă. ˆŔ’BŒŁCÎěŽĺĹCźŒłŽ›Ž—çi“ŕj: Medicina, 30(9): 1676`1678, 1993.

702. m‘ŕn “Ť’×ᇂ̎Ą—Ă. ‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕj: Medicina, 30(9): 1679`1681, 1993.

703. m‘ŕn ’×ᇍ‡•šÇ‚͕ωť‚ľ‚˝‚Š|“ŕ‰Č‚Ě—§ę‚Š‚ç. ŽO‹´—˜‰ˇCźŒłŽ›Ž—çi“ŕj: Medicina, 30(9): 1736`1737, 1993.

704. m‘ŕn äPŒ´•a; Undifferentiated connective tissue syndrome (UCTS). ‹ß“ĄŒ[•śi“ŕjCŠÖŽRŘ•ä: Medicina, 30: 1920`1921, 1993.

705. m‘ŕn ‘ĺ’°ƒ|ƒŠ[ƒv‚Ć‘ŠúŠŕ|“ŕŽ‹‹žŽĄ—Ă‚Ě“K‰ž‚ĆŒŔŠE. ŒÜ\—’łLCŸ–””ş‰hi“ŕj: Medicina, 31(1): 63`68, 1994.

706. m‘ŕn tŤœˆŮ‰h—{Ç‚ĚŠˆŤŒ^ƒrƒ^ƒ~ƒ“‚c‚É‚ć‚éƒpƒ‹ƒX—Ă–@. ’Ë–{—Y‰îi“ŕj: Medicina, 31(2): 376`378, 1994.

707. m‘ŕn ƒŒƒVƒ`ƒ“ĽƒRƒŒƒXƒeƒ[ƒ‹ƒAƒVƒ‹ƒgƒ‰ƒ“ƒXƒtƒFƒ‰[ƒ[(LCAT). ŽÄ“c‹v—Yi“ŕj: Modern Physician, 13(11): 1559`1560, 1993.

708. m‘ŕn Schonlein-HenochŒ^Ž‡”Á•a‚̏Á‰ťŠÇ•a•Ď. ŒÜ\—’łLCŸ–””ş‰hi“ŕj: Monthly Book Gastro., 2(11): 103`109, 1992.

709. m‘ŕn ‘Šú‘ĺ’°Šŕ‚Ě“ŕŽ‹‹ž“IŽĄ—Ă. ŒÜ\—’łLC“ŕ“Ą‹g—˛CŸ–””ş‰hi“ŕj: Monthly Book Gastro., 3(5): 77`85, 1993.

710. m‘ŕn Proton pump inhibitor‚Ě“K‰ž‚ĆŒř‰Ę. ‘ĺˆä“cłlCŽR“cŽŠlCźŒłŽ›Ž—çi“ŕj: Monthly Book Gastro., 3(7): 25`30, 1993.

711. m‘ŕn ƒZƒƒgƒjƒ“. âˆä•ś•Fi“ŕj: Nano GIGA, 2(9): 106`110, 1993.

712. m‘ŕn táŠQ‚đŠÜ‚Ţ‘˝‘ŸŠí•s‘S. Žá—Ń–ő‹vi“ŕjC‘Oě˜a•Fi“Œ‘ĺj: Pharma Medica, 11(7): 69`73, 1993.

713. m‘ŕn Ž_Ť”ńƒXƒeƒƒCƒhŤR‰ŠÇ–ň‚Ě•Ş—Ţ‚ĆŽg‚˘•ű. ‰Ş“cƒi“ŕj: Physician's Therapy Manual, 8(2): 1993.

714. m‘ŕn “ÁW: ŒÄ‹z•s‘S‚ĚŽĄ—Ă‚ĆŠÇ—‚ĚŽŔŰ|“Ž–ŹŒŒƒKƒX•ŞÍƒf[ƒ^‰đŽßă‚Ě’ˆÓ“_. ‹g‘şŽ‚Cˆ˘•”’źi“ŕj: Practitioners, 2(12): 1599`1603, 1993.

715. m‘ŕn ’_”Xƒ|ƒŠ[ƒv. ŽÄ“c‹v—YC”’čŒh“ńi“ŕj: Practitioners, 2(2): 271`275, 1993.

716. m‘ŕn ”]ŒŒŠÇŽžŠł‚Ě—Ő°; f’f‚̐i‚ß•ű. _“c’źi“ŕj: Practitioners, 2: 1018`1022, 1993.

717. m‘ŕn RƒŠƒ“Ž‰ŽżR‘Ě. ‰Ş“cƒC‹ß“ĄŒ[•śi“ŕj: Practitioners, 2: 947`976, 1993.

718. m‘ŕn ‚Š‚şÇŒóŒQ; ‚Š‚ş‚É‚Š‚Š‚č‚₡‚˘l, ‚Š‚Š‚č‚É‚­‚˘l. ”э‘–퐜i“ŕj: ‚Š‚ç‚ž‚̉Ȋw, (12ŒŽ): 59`62, 1993.

719. m‘ŕn ”]ŒŒ—ŹŒŸ¸. âˆä•ś•Fi“ŕj: ‚Š‚ç‚ž‚̉Ȋw, (‘Š§): 61`65, 1994.

720. m‘ŕn IgAtÇ. Ź—Ń–Li“ŕj: ‚Š‚ç‚ž‚̉Ȋw, (‘Š§†): 50`54, 1993.

721. m‘ŕn ‘SgŤƒGƒŠƒeƒ}ƒg[ƒfƒX‚Ě”­Ç‹@˜. ‰Ş“cƒC‹ß“ĄŒ[•śi“ŕj: ƒAƒCƒr[, 4: 6`10, 1993.

722. m‘ŕn Ä”­‚đŒJ‚č•Ô‚ˇ’×ᇂ̗Տ°“I“Á’Ľ‚Ć‘Îô. ‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕj: ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 11(4): 127`130, 1993.

723. m‘ŕn ’_”Xƒ|ƒŠ[ƒv. ŽÄ“c‹v—Yi“ŕj: ƒhƒNƒ^[ƒTƒƒ“, 37(12): 17`21, 1993.

724. m‘ŕn ‹}Ť”xŤS‚Ě‹Ů‹}“IŽĄ—Ă. •‘ň—˜˜Yi“ŕjC‘Š”nˆęˆĺi‹~–˝j: ƒn[ƒgƒi[ƒVƒ“ƒO, 6(4): 273`277, 1993.

725. m‘ŕn ƒTƒCƒgƒJƒCƒ“‚Ě‘Ş’č–@‚Ć—Ő°“IˆÓ‹`. ‰Ş“cƒC–ě‘şł˘i“ŕj: ƒŠƒEƒ}ƒ`‰Č, p.477, 1993.

726. m‘ŕn “ÁW: ‘˝”­Ť‹Ř‰Š‚Ɣ畆‹Ř‰Š‡T: Šˆ“ŽŤ‚ĚŒˆ‚ß•ű. ‰Ş“cƒi“ŕj: ƒŠƒEƒ}ƒ`‰Č, p.6`10, 1993.

727. m‘ŕn ^ŤÔŒŒ‹…‘‰ÁÇ. ‰–’J–΁i“ŕj: ˆăŠw‚Ě‚ ‚ä‚Ý, (•Ęű): 327`329, 1993.

728. m‘ŕn ‰ŠÇ‚ĆƒPƒ‚ƒJƒCƒ“. ÔŻ“§i“ŕj: ˆăŠw‚Ě‚ ‚ä‚Ý, 167: 399`402, 1993.

729. m‘ŕn Á‰ťŠÇŽžŠł‚Ě—A‰t—Ă–@. ^‹ĘŽő”üśCźŒłŽ›Ž—çi“ŕj: ˆăŠw‚Ě‚ ‚ä‚Ý, 168(5): 401`404, 1994.

730. m‘ŕn RƒŠƒ“Ž‰ŽżR‘ĚÇŒóŒQ: RƒŠƒ“Ž‰ŽżR‘ĚÇŒóŒQ‚Ě•a‘œ‚Ć‘˝—lŤ. ‰Ş“cƒi“ŕj: ˆăŠw‚Ě‚ ‚ä‚Ý, 587`590, 1993.

731. m‘ŕn ŒoŒűƒrƒ^ƒ~ƒ“‚cƒpƒ‹ƒX—Ă–@‚ĚĹ‘Oü. ’Ë–{—Y‰îi“ŕj: ˆăŠw‚Ě•ŕ‚Ý, 167(1): 32`35, 1993.

732. m‘ŕn Á‰ťŤ’×ᇂ̐f’f. ŽO‹´—˜‰ˇCL–ĺˆęFi“ŕj: ˆă–ňƒWƒƒ[ƒiƒ‹, 30(1): 359`363, 1994.

733. m‘ŕn –ŤŠÖßƒŠƒEƒ}ƒ`‚É‚¨‚Ż‚éƒPƒ‚ƒJƒCƒ“‚ĚŽYś‚Ć‚ť‚ĚˆÓ‹`. ÔŻ“§C‰““Ą•˝mC•äâ–΁C‹ß“ĄŒ[•śi“ŕjC”č’ő•vi“Œ—ˆă‘ĺj: ‰ŠÇ‚ƖƉu, 2: 31`39, 1993.

734. m‘ŕn ƒTƒCƒgƒJƒCƒ“. ÔŻ“§CŠÖŽRŘ•äi“ŕj: ‰ŠÇ‚ƖƉu, 2: 47`52, 1994.

735. m‘ŕn ‹~‹}ŠO—ˆ‚É‚¨‚Ż‚éÁ‰ťŠíŒn‹Ů‹}“ŕŽ‹‹žŒŸ¸‚Ě—L—pŤ‚Ć–â‘č“_. âŒű“NÍi“ŕjC™–{Ÿ•Fi‹~–˝jC‘꓇í‰ëiŠOjCźŒłŽ›Ž—çi“ŕjC”äŠé”\Ž÷iŠOj: ‹~‹}ˆăŠw, 17(5): 504`508, 1993.

736. m‘ŕn ”źŒŽ‘ĚŒ`ŹŤŽ…‹…‘̐t‰Š. Ź—Ń–LCŹ‹v•Ű“§C–xˆäşi“ŕj: Œť‘ăˆă—Ă, 25(6): 136`142, 1993.

737. m‘ŕn ŒQ”­“Ş’É. âˆä•ś•Fi“ŕj: ĄŒŽ‚ĚŽĄ—Ă, (1): 18`19, 1994.

738. m‘ŕn ‚bŒ^ƒEƒCƒ‹ƒXŠĚ‰Š–Ť‰ťŹ—§‹@˜. ŠÖ’Jm”üC‰Á“Ąé”Vi‘—§‚Ş‚ńƒZƒ“ƒ^[jC’†‘ň‹MGi“ŕjC‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ƒ^[j: ĹVˆăŠw, 48(12): 26`34, 1993.

739. m‘ŕn •š‘śŽžŠł‚Ě–ň•¨ŽĄ—Ă: äPŒ´•a‚Ɛ_ŒoĽ‹ŘÇó. ‹ß“ĄŒ[•śi“ŕj: ŽĄ—Ă, 75: 598`601, 1993.

740. m‘ŕn Á‰ťŤ’×ᇂĚnatural history. źŒłŽ›Ž—çi“ŕj: ŽŔŒąŽĄ—Ă, (629): 136`137, 1992.

741. m‘ŕn ‚bŒ^ŠĚ‰ŠƒEƒCƒ‹ƒX‚̍\‘˘‚Ć‹@”\. ŒSŽirHC‰Á“Ąé”VC“y•ű˝C“c’†“Đ•Fi‘—§‚Ş‚ńƒZƒ“ƒ^[jC’†‘ň‹MGi“ŕjC‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ƒ^[j: Á‰ťŠíf—Ăƒvƒ‰ƒNƒeƒBƒX, 2: 18`24, 1993.

742. m‘ŕn –ňÜŤÁ‰ťŠí•a•Ď‚ĚŒ´ˆö–ňÜ‚Ě‘ăŽÓ. ŽÄ“c‹v—Yi“ŕj: Á‰ťŠí“ŕŽ‹‹ž, 5(4): 467`473, 1993.

743. m‘ŕn Rectosigmoid‚̒ʉ߂ƂróŒ‹’°‘}“üŽž‚Ě’ˆÓ. ŒÜ\—’łLCŸ–””ş‰hi“ŕj: Á‰ťŠí“ŕŽ‹‹ž, 5(5): 615`621, 1993.

744. m‘ŕn “ÁW: –Ť_ŒoŽžŠł‚ĚÝ‘îˆă—ĂĽ‹ŘˆŢkŤ‘¤őd‰ťÇ‚ĚÝ‘îˆă—Ă. ŒĂ˜a‹vKi“ŕj: _ŒoŽĄ—ĂŠw, 10(4): 279`283, 1993.

745. m‘ŕn “ÁŽę‚Č”]ŒŒŠÇáŠQ‚Ć‹~–˝‹~‹}ˆă—Ă. ”Ń’Ë‚_C_“c’źi“ŕj: _ŒoŽĄ—ĂŠw, 10: 407`414, 1993.

746. m‘ŕn SPECT‚Š‚ç‚Ý‚˝‹ÇŠ”]zŠÂáŠQ. âˆä•ś•Fi“ŕj: _Œo“ŕ‰Č, 39: 461`464, 1993.

747. m‘ŕn Šá‚̉œ‚Ě‹­‚˘’É‚Ý. âˆä•ś•Fi“ŕj: _“ŕˆăƒjƒ…[ƒX, (17): 5, 1994.

748. m‘ŕn “ÁW: ƒp[ƒLƒ“ƒ\ƒ“•a‚̐f’f‚ĆŽĄ—Ă Series ; ƒp[ƒLƒ“ƒ\ƒ“•a‚̏‰Šúf’f–@‚Ɗӕʐf’f–@. ŒĂ˜a‹vKi“ŕj: f’f‚ĆŽĄ—Ă, 81(7): 1489`1491, 1993.

749. m‘ŕn IBD‚Ć”DP. Ź—ѐ´“TCŒÜ\—’łLCŸ–””ş‰hCźŒłŽ›Ž—çi“ŕjCŽR“cL•viŹ“cŒ´Žs–Ż•a‰@j: f’f‚ĆŽĄ—Ă, 81(8): 1574`1579, 1993.

750. m‘ŕn ‘ą”­Ť•›bó‘B‹@”\˜´iÇ‚É‚ć‚éüˆŰŤœ‰Š‚Ć‚ť‚ĚŽĄ—Ă. ’Ë–{—Y‰îi“ŕj: t‚ƍœ‘ăŽÓ, 7(1): 29`34, 1994.

751. m‘ŕn ‹}‘ŹisŤŽ…‹…‘̐t‰Š. Ź—Ń–LCX‰ş“N•vC’ˇę‘ׁi“ŕj: t‚Ć“§Í, 35(6): 707`712, 1993.

752. m‘ŕn ƒGƒŠƒXƒƒ|ƒGƒ`ƒ“‚ސSĽzŠÂŠíŒn‚É‹y‚Ú‚ˇ‰e‹ż. Š™“cvŽőC‘ĺ‹v•Ű[li“ŕj: t•s‘S, 5(1): 31`35, 1993.

753. m‘ŕn ÇŒó‚Š‚ç‚ĚƒAƒvƒ[ƒ`; “Ş’É. âˆä•ś•Fi“ŕj: ‘‡—Տ°, 43(3): 495`498, 1994.

754. m‘ŕn ƒRƒŠƒ“ƒGƒXƒeƒ‰[ƒ[(ChE). ŽÄ“c‹v—Yi“ŕj: “ŕ‰Č, 71(6): 1020`1021, 1993.

755. m‘ŕn 5'ƒkƒNƒŒƒIƒ`ƒ_[ƒ[(5'N). ŽÄ“c‹v—Yi“ŕj: “ŕ‰Č, 71(6): 1029, 1993.

756. m‘ŕn ”]ŒŒŠÇáŠQ‚Ö‚ĚƒAƒvƒ[ƒ`GRƒŠƒ“Ž‰ŽżR‘Ě. ‰Ş“cƒC–ě‘şł˘i“ŕj: “ŕ‰Č, 71: 470`472, 1993.

757. m‘ŕn IgAtÇ‚Ě—\ŒăŒˆ’č—vˆö. Ź—Ń–LCŹ‹v•Ű“§C–xˆäşC”äŠé”\”VCŠÚ–ěƒśi“ŕj: “ŕ‰Č, 72(2): 222`227, 1993.

758. m‘ŕn “§ÍœÇ‚Ě•a‘Ô‚Ć‘Îô. ’Ë–{—Y‰îi“ŕj: “ŕ‰Č, 72(2): 324`328, 1993.

759. m‘ŕn –ňÜ”M (Drug fever). ”э‘–퐜i“ŕj: “úíf—Ă‚ĆŒŒ‰t, 3: 39`45, 1993.

760. m‘ŕn ƒNƒ[ƒ“•a‚̏Á‰ťŠÇ•a•Ď. ŒÜ\—’łLCŸ–””ş‰hi“ŕj: “ú–{ˆăŽ–V•ń, 3612: 129, 1993.

761. m‘ŕn ”íŠkoŒŒ‚Ě—Ő°“Œv“IŒ¤‹†. –kˆä‘Ľ•vi“ŕj: “ú–{—Տ°, 51(‘): 108`114, 1993.

762. m‘ŕn Ź”]oŒŒ‚Ě•Ű‘ś“IŽĄ—Ái“ŕ‰Č“IŽĄ—Ă). –kˆä‘Ľ•vi“ŕj: “ú–{—Տ°, 51(‘): 248`254, 1993.

763. m‘ŕn ”][Ç‚̏dÇ“x”ť’čŠî€. ”¨—˛Žui“ŕj: “ú–{—Տ°, 51(‘): 440`448, 1993.

764. m‘ŕn ”]ŒŒđ‚Ě—\–h‚ƍRŒŒŹ”–ň. _“c’źi“ŕj: “ú–{—Տ°, 51(‘): 470`475, 1993.

765. m‘ŕn ’×ᇐŤ‘ĺ’°‰Š‚Ɣ畆•a•Ď. ŒÜ\—’łLCŸ–””ş‰hi“ŕj: ”畆•af—Ă, 15(7): 577`581, 1993.

766. m‘ŕn Á‰ťŠíŽžŠł‚É—p‚˘‚éV–ň|ƒ‰ƒ“ƒ\ƒvƒ‰ƒ][ƒ‹. ÎˆäŒ\‘žCźŒłŽ›Ž—çi“ŕj: —Տ°‚Ć–ň•¨ŽĄ—Ă, 12(3): 77`80, 1993.

767. m‘ŕn CIDPi–Ť‰ŠÇŤ’E‘Ťƒjƒ…[ƒƒpƒ`[). Ä“Ą–L˜ai“ŕj: —Տ°ˆă, 19(11): 137, 1993.

768. m‘ŕn GOT, GPT, m-GOT. a’J–ž—˛CŽÄ“c‹v—Yi“ŕj: —Տ°ˆă, 19(‘): 126`127, 1993.

769. m‘ŕn ŽĄ—Ă‚Ě—v‚ç‚Č‚˘•sŽ–Ź‚Ě‚Ý‚Š‚˝. ‘şź€i“ŕj: —Տ°ˆă, 19: 1162`1164, 1993.

770. m‘ŕn Œp‘ą“I‰h—{ŠÇ—‚É‚¨‚Ż‚éNST‚ĚŒťó. Ÿ–””ş‰hi“ŕjC‘ĺ’J„łiŠOjC“‰’”EiŠĹŒě•”jCŹěK—Yi–ňÜjC‹e’r^”üi‰h—{•”jC“ŕ“Ą‹g—˛i“ŕjC‘ĺęł›ßiŠOjCŠp“c‡ŽqiŠĹŒě•”jC“‡“c Žœ•Fi–ňÜjC–ěŒű‹…Žqi‰h—{•”jC”äŠé”\Ž÷iŠOjC’|“ŕ”üŒbŽqiŠĹŒě•”j: —Տ°‰h—{, 82(4): 382`387, 1993.

771. m‘ŕn Á‰ťŤ’×ᇁ|Ä”­—\–h‘΍ô‚Ć–â‘č“_. źŒłŽ›Ž—çi“ŕj: —Տ°‰ČŠw, 29(7): 819`824, 1993.

772. m‘ŕn ’áŽü”gŽĄ—ĂŠí. t“ú”ü•ŰC’ˇ‘ňOiƒŠƒn•”jC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2034`2037, 1993.

773. m‘ŕn ƒxƒbƒhEĺń጗\–h—p‹ď. –Ř“Ą‹žŽqiŠĹŒěŠw•”jC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2043`2045, 1993.

774. m‘ŕn •ÖŠíE•ÖŔ. ŽR“cŽŔ•äC“ŞŽR‰xŽqC–Ř“Ą‹žŽqiŠĹjC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2046`2048, 1993.

775. m‘ŕn W”AŠí. ‰““ĄMŽqiŠĹjC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2049`2052, 1993.

776. m‘ŕn ƒXƒg[ƒ}—p‘•‹ď. ’†‘şG‘ăC–Ř“Ą‹žŽqiŠĹjC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2053`2055, 1993.

777. m‘ŕn ‚¨‚ނC‚¨‚Ţ‚ÂƒJƒo[. Îě”üŽ}C–Ř“Ą‹žŽqiŠĹjC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2056`2058, 1993.

778. m‘ŕn —‘…C“ü——p‹ď. ŠÖŞ˜aŽqC–Ř“Ą‹žŽqiŠĹjC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2059`2061, 1993.

779. m‘ŕn ˆÚć—p‹@Ší. •˝‰ę‚ć‚ľ‚݁C’ˇ‘ňOiƒŠƒn•”jC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2062`2065, 1993.

780. m‘ŕn HŽ–—p‹@Ší. {“Ą“Ţ•ä”üCŒă“ĄˆŔŒbC“‡“c—˛ŽqiƒŠƒn•”jC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2066`2070, 1993.

781. m‘ŕn Ž—e—p‹@Ší. {“Ą“Ţ•ä”üCŒă“ĄˆŔŒbC“‡“c—˛ŽqiƒŠƒn•”jC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2071`2074, 1993.

782. m‘ŕn Xˆß—p‹@Ší. {“Ą“Ţ•ä”üCŒă“ĄˆŔŒbC“‡“c—˛ŽqiƒŠƒn•”jC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2075`2077, 1993.

783. m‘ŕn ƒŠ[ƒ`ƒƒ[. “‡“c—˛ŽqCŒă“ĄˆŔŒbC{“Ą“Ţ•ä”üiƒŠƒn•”jC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2078`2080, 1993.

784. m‘ŕn ¸@ŽÔ. –Ř“Ą‹žŽqiŠĹjC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2081`2082, 1993.

785. m‘ŕn ń. {“Ą^mC’ˇ‘ňOiƒŠƒn•”jC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2083`2085, 1993.

786. m‘ŕn •ŕsŠí. ’Ř“c—R”üC’ˇ‘ňOiƒŠƒn•”jC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2086`2087, 1993.

787. m‘ŕn ŽÔˆÖŽq. “y”쐳”VC’ˇ‘ňOiƒŠƒn•”jC‘O“c^ŽĄi“ŕj: —Տ°ŠĹŒě, 11: 2088`2090, 1993.

788. m‘ŕn ‘ĺ’°‘ŠúŠŕ“ŕŽ‹‹ž“IŽĄ—Ă‚Ě“K‰ž‚ĆŒŔŠE. ŒÜ\—’łLCŸ–””ş‰hCŹ—ѐ´“TCźŒłŽ›Ž—çi“ŕj: —Տ°Źl•a, 22(6): 781`787, 1992.

789. m‘ŕn “§ÍŠłŽŇ‚̐S”X‰t’™—Ż. Š™“cvŽőC•‘ň—˜˜Yi“ŕj: —Տ°“§Í, 10(3): 331`336, 1993.

790. m‘ŕn R cardiolipin R‘Ě‚Ě‘Ş’č‚Ć‚ť‚Ě—Ő°“IˆÓ‹`. ‰Ş“cƒC–ě‘şł˘i“ŕj: —Տ°•a—, 41: 859`865, 1993.

791. m‘ŕn IL-8 ƒŒƒZƒvƒ^[‚̍\‘˘‚ĆˆÓ‹`. ÔŻ“§i“ŕj: —Տ°–Ɖu, 25: 509`515, 1993.

792. m‘ŕn IL-8 ‚ÍŒŒŠÇVśˆöŽq‚Ĺ‚ ‚é. ÔŻ“§i“ŕj: —Տ°–Ɖu, 26: 367`370, 1994.

793. m‘ŕn ”]’ę“Ž–Ź•ÂÇÇ‚¨‚ć‚Ń”]Š˛oŒŒ. –kˆä‘Ľ•vC_“c’źi“ŕj: ˜V‰ť‚ĆŽžŠł, 6(6): 806`811, 1993.

794. muŔn S“d}ƒgƒŒ[ƒjƒ“ƒO: S–ŒĽS‹Ř‰ŠĽ“Á”­ŤS‹ŘÇ. Źă”Ž•śC‘şź€i“ŕj: Expert Nurse, 10(1): 92`99, 1994.

795. muŔn S“d}ƒgƒŒ[ƒjƒ“ƒO: –ň•¨, “d‰đŽżˆŮí, ŽŠ—Ľ_ŒoˆŮí, ƒy[ƒXƒ[ƒJ[S“d}. •‘ň—˜˜YC‘şź€i“ŕj: Expert Nurse, 10(2): 93`101, 1994.

796. muŔn S“d}ƒgƒŒ[ƒjƒ“ƒO: •sŽ–Ź‚ĚŠî‘b. ‘şź€i“ŕj: Expert Nurse, 10(3): 92`99, 1994.

797. muŔn S“d}ƒgƒŒ[ƒjƒ“ƒO: ‰ž—p•Ň‚P|‹ˇSÇ. •˝źT‰EC‘şź€i“ŕj: Expert Nurse, 9(10): 92`99, 1993.

798. muŔn S“d}ƒgƒŒ[ƒjƒ“ƒO: ‰ž—p•Ň‚Q|S‹Ř[Ç. Ź—Ń–ž–FC‘şź€i“ŕj: Expert Nurse, 9(11): 84`89, 1993.

799. muŔn S“d}ƒgƒŒ[ƒjƒ“ƒO: śŽş•‰‰×ŽžŠł. ’ˇ’Jě‰„LC‘şź€i“ŕj: Expert Nurse, 9(12): 84`89, 1993.

800. muŔn S“d}ƒgƒŒ[ƒjƒ“ƒO: ‰EŽş•‰‰×ŽžŠł. ‰ş—˘ŒöşC‘şź€i“ŕj: Expert Nurse, 9(14): 84`89, 1993.

801. muŔn S“d}ƒgƒŒ|ƒjƒ“ƒO: S“d}‚ĚŠî‘b. ‘şź€i“ŕj: Expert Nurse, 9(5): 84`89, 1993.

802. muŔn S“d}ƒgƒŒ|ƒjƒ“ƒO:łíS“d}. ‘şź€i“ŕj: Expert Nurse, 9(7): 84`89, 1993.

803. muŔn S“d}ƒgƒŒ[ƒjƒ“ƒO: ˆŮíS“d}(1). ‘şź€i“ŕj: Expert Nurse, 9(8): 83`88, 1993.

804. muŔn S“d}ƒgƒŒ[ƒjƒ“ƒO: ˆŮíS“d}(2). ‘şź€i“ŕj: Expert Nurse, 9(9): 92`97, 1993.

805. muŔn _ŒoŽžŠł‚ĚŽĄ—Ăƒ}ƒjƒ…ƒAƒ‹|‹ŘˆŢkŤ‘¤őd‰ťÇ|. Ä“Ą–L˜ai“ŕj: Modern Physician, 13(7): 1033`1034, 1993.

806. muŔn Çó•Ę‚­‚ˇ‚čƒKƒCƒh: ’m‚Á‚Ä‚¨‚Ť‚˝‚˘‚ą‚Ě’mŽŻ| zŠÂŠíÇó, ‹š’É. Ź—Ń–ž–Fi“ŕj: ŠĹŒě‹Zp, 40(2): 39`42, 1994.

807. muŔn ę–ĺˆă‚Ş–ž‚Š‚ˇf’fĽŽĄ—Ăƒ`ƒƒ[ƒgC”畆d‰ť. ‹ß“ĄŒ[•śi“ŕj: ŽĄ—Ă, 76: 725`728, 1994.

808. muŔn Œ¤Cˆăƒm[ƒgĽƒxƒbƒhƒTƒCƒh‚ĚŽč‹Z‚Ɛf—Á| ‹}ŤS‹Ř[Ç. Ź—Ń–ž–Fi“ŕj: f’f‚ĆŽĄ—Ă, 81(‘Š§): 355`356, 1993.

809. muŔn ‹CŠÇŽxšb‘§|”­ěŽžĽ”ń”­ěŽž‚Ěƒ}ƒl[ƒWƒƒ“ƒg|. ‹v•Ű“cŸCŹ—эO—Si“ŕj: f’f‚ĆŽĄ—Ă, 81: 1195`1199, 1993.

810. muŔn ‰ßŒëŽîŤƒ|ƒŠƒ|[ƒVƒX. ŒÜ\—’łLCŸ–””ş‰hCźŒłŽ›Ž—çCŹ—ѐ´“Ti“ŕj: ‘‡—Տ°, 42(8): 2456`2461, 1993.

811. muŔn “fŒŒĽ‰şŒŒ. ‰ĄŽR–őCźŒłŽ›Ž—çi“ŕj: ‘‡—Տ°, 42: 1377`1384, 1993.

812. muŔn Š×‰šŒ^‘ŠúˆÝŠŕ. źŒłŽ›Ž—çi“ŕj: ‘‡—Տ°, 43(1): 183`190, 1994.

813. muŔn Á‰ťŠÇ‚Ě‚wü‘œ(‡U)Ź(”÷Ź)ˆÝŠŕ. źŒłŽ›Ž—çi“ŕj: ‘‡—Տ°, 43(2): 395`400, 1994.

814. muŔn Á‰ťŠÇ‚Ě‚wü‘œ|—˛‹NŒ^‘ŠúˆÝŠŕ. ‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕj: ‘‡—Տ°, 43(3): 617`624, 1994.

815. muŔn Ý‘îˆă—Ă‚É‚¨‚Ż‚éę–ĺ•a‰@‚Ě–đŠ„. ”¨—˛Žui“ŕj: ’nˆć•ŰŒ’, (5): 43`50, 1993.

816. muŔn “ÁW; IgG, ƒIƒŠƒSƒNƒ[ƒiƒ‹ƒoƒ“ƒh|ŒŸ¸’l‚đ“Ç‚Ţ93|. Ä“Ą–L˜ai“ŕj: “ŕ‰Č, 71(6): 1489`1491, 1993.

817. muŔn “úŒoƒƒfƒBƒNƒCƒY. Žá—Ń–ő‹vi“ŕj: “úŒoƒƒfƒBƒJƒ‹, 296: 31`32, 1993.

818. muŔn Case study: –ň•¨ŽĄ—Ă‚Ş•K—v‚Č•sŽ–Ź| ’‹ŒŤS–ŒS‹Ř‰Š‚É”ş‚¤SŽş•p”. ‘şź€C’ˇ’Jě‰„LCóŒŠ‘i“ŕj: “úŒoƒƒfƒBƒJƒ‹, 8(“Á): 168`171, 1993.

819. muŔn —Ěˆć•ĘÇŒóŒQƒVƒŠ[ƒY(No.4) ŒÄ‹zŠíÇŒóŒQ|ŠÖ˜AŒÄ‹zŠíŽžŠł‚đŠÜ‚߂ā|. ‚čŒő‹IC•y“c—FKi“ŕj: “ú–{—Տ°, (•Ęű‰ş): 655`657, 1993.

820. m•ŇWŽŇ‚ւ̎莆i‰p•śjn RecklingHausen's neurofibromatosis associated with membranous nephropathy. Ź‹v•Ű“§C”äŠé”\”VC–xˆäşCŹ—Ń–Li“ŕj: Nephron, 65: 486, 1993.

821. mŠwp‘n i•Ş’SŽˇ•Mj ĹV“ŕ‰ČŠw‘ĺŒn28|^‹ŰĽŠńś’ŽŠ´őÇ; ƒJƒ“ƒWƒ_Ç/ƒAƒXƒyƒ‹ƒMƒ‹ƒXÇ, p.83`101, ‹v•ÄŒői•a—j. •ŇW ˆä‘ş—T•vi‹ž‘ĺjC”öŒ`‰x˜YiŠŕŒ¤jC‚‹vŽj–›iˆă—ĂƒZƒ“ƒ^[jC ’†ŽR‘“X, “Œ‹ž, 94.03.31”­s.

822. mŠwp‘n i•Ş’SŽˇ•Mj Á‰ťŤ’×ᇂ̈ݎ_•Ş”ĺ—}§Ü‚ĚŒŠ’ź‚ľ; R’×ᇍ܂̊J”­‚Ě—đŽj‚ĆŒť‹ľ, p.10`17, ˆŔŠC‹`—jCźŒłŽ›Ž—çi“ŕj. •ŇW ŽODH”niL‘ĺjC ˆă–ňƒWƒƒ[ƒiƒ‹ŽĐ, “Œ‹ž, 93.09.10”­s.

823. mŠwp‘n i•Ş’SŽˇ•Mj ˜V”NŽŇ‚̏Á‰ťŤ’×á‡; ˜V”NŽŇÁ‰ťŤ’×ᇂ̐f’f, p.30`36, ŽO‹´—˜‰ˇCźŒłŽ›Ž—çi“ŕj. •ŇW ‘哇”Ži“úˆă‘ĺjC’†‘şFŽii’é‹ž‘ĺjCźŒłŽ›Ž—çi“ŕjC ’†ŠOˆăŠwŽĐ, “Œ‹ž, 93.10.01”­s.

824. mŠwp‘n i•Ş’SŽˇ•Mj ˜V”NŽŇ‚̏Á‰ťŤ’×á‡; ‚—îŽŇoŒŒŤ’×ᇂ̗Տ°“IŒŸ“˘, p.121`125, “c•Ó‘CźŒłŽ›Ž—çi“ŕj. •ŇW ‘哇”Ži“úˆă‘ĺjC’†‘şFŽii’é‹ž‘ĺjCźŒłŽ›Ž—çi“ŕjC ’†ŠOˆăŠwŽĐ, “Œ‹ž, 93.10.01”­s.

825. mŠwp‘n i•Ş’SŽˇ•Mj CDDP‚đŠÜ‚ß‚˝Šŕ‰ťŠw—Ă–@‚ĚŒťó‚ƏŤ—ˆ; Žčp•s”\ˆÝŠŕ‚ɑ΂ˇ‚éCDDP•š—p‰ťŠw—Ă–@‚ĚŒťó‚ƏŤ—ˆ, p.1`18, Źň˜aŽO˜Yi“ŕjCŒIŒ´–Ť‚`iş˜a‘ĺjC“‡“cˆŔ”Ži‘—§‚Ş‚ńƒZƒ“ƒ^[jC Šŕ‚ƉťŠw—Ă–@ŽĐ, “Œ‹ž, 93.11.10”­s.

826. mŠwp‘n i•Ş’SŽˇ•Mj Šá‚Ĺ‚Ý‚éÁ‰ťŤ’×ᇁ|Ĺ‹ß‚ĚƒgƒsƒbƒNƒX; Ž_•Ş”ĺ—}§Ü‚̓I[ƒ‹ƒ‰ƒEƒ“ƒhƒvƒŒ[ƒ„[‚Š, źŒłŽ›Ž—çi“ŕjC •ŇW ’|–{’‰—ǁi“Œ—ˆă‘ĺjC ƒXƒ^ƒ“ƒ_[ƒgƒ}ƒbƒLƒ“ƒ^ƒCƒ„[, “Œ‹ž, 93.00.00”­s.

827. mŠwp‘n i•Ş’SŽˇ•Mj zŠÂŠíƒZƒ~ƒi|; S‘Ÿ•a‚Ć”DPĽoŽY, –ؐě“c—˛ˆęi“ŕj. •ŇW ŒÜ“‡—Yˆę˜Yi“ŒŠC‘ĺjC “ú–{S‘Ÿŕ’c, “Œ‹ž, 94.01.20”­s.

828. mŠwp‘n i•Ş’SŽˇ•Mj ˆă—Ă‰ßŒë‘i×ŠÓ’č‘Wi‘ćŒÜWj; ŠĽ“Ž–ŹŠg’ŁÜ“™‚Ě“Š—^‚đˆę‹C‚É’†Ž~‚ľ‚Ä, ‹ˇSÇ‚đ—U“ą‚ľ, ‚Š‚S“d}ă‚Ě‹•ŒŒŤ•Ď‰ť‚đŒŠ—Ž‚Ć‚ľ, “KŘ‚Č‘[’u‚đŽ{‚ł‚¸S’âŽ~‚ÉŽŠ‚ç‚ľ‚ß‚˝Ç—á, p.265`278, ‘şź€i“ŕj. ˆă—ĂŽ–ŒĚî•ńƒZƒ“ƒ^|, –źŒĂ‰Ž, 94.01.20”­s.

829. mŠwp‘n i•Ş’SŽˇ•Mj Ą“ú‚ĚŽĄ—ĂŽwj; ’ጌˆłÇ, 36: 328, –ؐě“c—˛ˆęi“ŕj. •ŇW ˆîŠ_‹`–žC‘źC ˆăŠw‘‰@, “Œ‹ž, 94.02.15”­s.

830. mŠwp‘n i•Ş’SŽˇ•Mj “§ÍŠłŽŇ‚̍œ•a•Ď; ‘ć8Í “§ÍŠłŽŇ‚̍œ•a•Ď, p.81`85, ‘ć21Í ƒrƒ^ƒ~ƒ“‚cƒpƒ‹ƒX—Ă–@, p.271`276, ’Ë–{—Y‰îi“ŕj. “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^|, “Œ‹ž, 93.06.25”­s.

831. mŠwp‘n i•Ş’SŽˇ•Mj —A‰tƒnƒ“ƒhƒuƒbƒN; ‘ć7Í ”÷—Ę‹ŕ‘Ž, p.67`72, ’Ë–{—Y‰îi“ŕj. ’†ŠOˆăŠwŽĐ, “Œ‹ž, 94.03.10”­s.

832. mŠwp‘n i•Ş’SŽˇ•Mj Ą“ú‚ĚŽĄ—ĂŽwj1994”N”Ĺ; ‘ć12Í tŽžŠł ˘’ˇŠú“§Í‚̍‡•šÇŁ, p.428, ’Ë–{—Y‰îi“ŕj. ˆăŠw‘‰@, “Œ‹ž, 94.03.15”­s.

833. mŠwp‘i‰p•śjn i•Ş’SŽˇ•Mj The Mechanism and New Approach on Drug Resistance of Cancer Cells; Detection of MDR1 mRNA on acute myelogenous leukemia cells, p.45`54, ˛“ĄGi“ŕj. •ŇW T. Miyazakii–k‘ĺjCF. TakakuiŒł“Œ‘ĺjCK. Sakuradai–k‘ĺjC Excerpta Medica, Amsterdam, (Elsevier Science Pablishers), 93.07.18”­s.

834. mŠwp‘i‰p•śjn i•Ş’SŽˇ•Mj Headaches; Management of Cluster Headache, p.591`599, Ekbom, K.Câˆä•ś•Fi“ŕj. •ŇW Olesen, J., Tfelt-Hansen, P., Wlch, K.M.A., Raven Press, New York, 93.10.00”­s.

835. mŠwp‘i‰p•śjn i•Ş’SŽˇ•Mj Headaches; Diagnosis and differential diagnosis of migraine, p.175`183, Compbell, J.K.Câˆä•ś•Fi“ŕj. •ŇW Olesen, J., Tfelt-Hansen, P., Wlch, K.M.A., Raven Press, New York, 93.10.00”­s.

836. mŠwp‘i‰p•śjn i•Ş’SŽˇ•Mj Microstasis in the Brain; Low flow measured by SPECT and clinical correlation, p.497`501, âˆä•ś•FC”Ń’Ë‚_CŒÜ\—’‹v‰ŔC_“c’źi“ŕj. •ŇW Tomita, M., et al., Elsevier Science Publishers, Amsterdam, 93.11.00”­s.

837. mŠwp‘i‰p•śjn i•Ş’SŽˇ•Mj Tension-Type Headache: Classification, Mechanism and Treatment; Peripherally acting analgesics and muscle relaxant, 3: 255`261, âˆä•ś•Fi“ŕj. •ŇW Olesen, J., Schoenen, J., Raven Press, New York, 93.00.00”­s.

838. mŠwp‘n i•Ş’SŽˇ•Mj ‚Š‚ç‚ž‚̉Ȋw(‘Š§) ƒŠƒEƒ}ƒ`ĽäPŒ´•a; ‹­”çÇ, p.58`61, ‹ß“ĄŒ[•śi“ŕj. •ŇW ”č’ő•vC “ú–{•]˜_ŽĐ, “Œ‹ž, 93.00.00”­s.

839. mŠwp‘n i•Ş’SŽˇ•Mj ƒŠƒEƒ}ƒ` '93; äPŒ´•a‚É‚¨‚Ż‚é ANCA ‚Ě—Ő°“IˆÓ‹`, p.136`144, ‰““Ą•˝mC×–ěF˜YC‹ß“ĄŒ[•śi“ŕj. ƒƒfƒBƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 93.00.00”­s.

840. mŠwp‘n i•Ş’SŽˇ•Mj ĹV“ŕ‰ČŠw‘ĺŒn 24, –ƉuĽƒAƒŒƒ‹ƒM[ŤŽžŠł, 3. äPŒ´•a‚ƗމŽžŠł; ‹­”çÇ, p.95`105, ‹ß“ĄŒ[•śi“ŕj. •ŇW Žë–쏯ŒáC‘ź, ’†ŽR‘“X, “Œ‹ž, 93.00.00”­s.

841. mŠwp‘n i•Ş’SŽˇ•Mj ƒxƒbƒhƒTƒCƒhƒŠƒEƒ}ƒ`Šw|ƒŠƒEƒ}ƒ`ˆăŒ¤C‚Ě‚˝‚߂Ɂ|; ‘SgŤƒGƒŠƒeƒ}ƒg[ƒfƒX, p.386`398, ‹ß“ĄŒ[•śi“ŕj. •ŇW ŽR–{^C”č’ő•v, “ě]“°, “Œ‹ž, 93.00.00”­s.

842. mŠwp‘n i•Ş’SŽˇ•Mj }ŕ•a‘Ô“ŕ‰ČuŔ 16: ƒAƒŒƒ‹ƒM[ĽäPŒ´•a; ‹­”çÇ, p.220`229, ‹ß“ĄŒ[•śi“ŕj. •ŇW ”č’ő•v, ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 93.00.00”­s.

843. mŠwp‘n i•Ş’SŽˇ•Mj Ą“ú‚ĚŽĄ—ĂŽwj '94; isŤ‘SgŤd‰ťÇi‹­”çÇj, p.546`548, ‹ß“ĄŒ[•śi“ŕj. ˆăŠw‘‰@, “Œ‹ž, 93.00.00”­s.

844. mŠwp‘n i•Ş’SŽˇ•Mj Funktionsanalyse biologischer Systeme 23: Respiration in Health and Disease; Gas exchange in fish swimbladder, p.113`120, Ź—эO—Si“ŕjCPelster, B.CScheid, P.(Ruhr Univ.): •ŇW Peter ScheidC Gustar Fischer Verlag, Mainz, Stuttgart, Jena, New York, 93.00.00”­s.

845. mŠwp‘n i•ŇWj ˜V”NŽŇ‚̏Á‰ťŤ’×á‡; •ŇW ‘哇”Ži“úˆă‘ĺjC’†‘şFŽii’é‹ž‘ĺjCźŒłŽ›Ž—çi“ŕjC ’†ŠOˆăŠwŽĐ, “Œ‹ž, 93.10.01”­s.


<<14 3 “ŕ‰ČŠw>>

846. m‹ł‰Č‘n i•Ş’SŽˇ•Mj V—Տ°“ŕ‰ČŠw‘ć6”Ĺ; ‹}ŤˆÝ‰Š, p.456`458, źŒłŽ›Ž—çi“ŕj. •ŇW ‘ĺ“Ął—Yiç—t‘ĺjC”č’ő•vi“Œ—ˆă‘ĺjC‘źC ˆăŠw‘‰@, “Œ‹ž, 93.02.01”­s.

847. m‹ł‰Č‘n i•Ş’SŽˇ•Mj ƒi[ƒX‚Ě‚˝‚ß‚Ě–ňŽ–“T; ŒÄ‹zŠíŒně—p–ň, p.139`152, ‰Ô“cL‰pCˆ˘•”’źi“ŕj: •ŇW Î‹´WC ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 93.00.00”­s.

848. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj ŠĚĽ’_ĽäXf—Ăƒ}ƒjƒ…ƒAƒ‹; ’_ÎÇ, p.347`352, –ě“o˝i“ŕj. •ŇW ‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@jC—Ń’ź—ȁi‘—§‰Ą•l•a‰@jC‘˝—…”ö˜a˜Yi_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[jC ‹ŕŒ´o”Ĺ, “Œ‹ž, 93.03.20”­s

849. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj Á‰ťŠíŽžŠłĹV‚ĚŽĄ—Ă; ‹•ŒŒŤ‘ĺ’°‰Š, p.186`188, Ÿ–””ş‰hi“ŕj. •ŇW ’O‰HŠ°•śi–h‰qˆă‘ĺjCŒË•”—˛‹gi‘—§‹ž“s•a‰@jCŒË“c„‘ž˜Yi“Œ‹žŽœŒbˆă‘ĺjC “ě]“°, “Œ‹ž, 93.04.15”­s.

850. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj 21˘‹I‚đ–ÚŽw‚ľ‰H‚΂˝‚­Á‰ťŠí•aŠw; Á‰ťŠÇˆŤŤƒŠƒ“ƒpŽî‚ɑ΂ˇ‚éWŠw“IŽĄ—Ă‚Ě—L—pŤ, p.442`443, Ÿ–””ş‰hi“ŕjCŽOd–슰ŠěiŠOj. •ŇW Œ´“cŽi“Ć‹Śˆă‘ĺjC “ú–{ˆăŠwŠŮ, “Œ‹ž, 93.09.19”­s.

851. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj ‚bŒ^ŠĚ‰Š|ƒCƒ“ƒ^[ƒtƒFƒƒ“ŽĄ—Ă‚Ć‚ť‚ĚŒo‰ß; ‚bŒ^ŠĚ‰Š‚ĚŒo‰ß‚Ć’ˇŠú—\Œă, p.38`45, “Ą‰Ş‚OCa’J–ž—˛C”’čŒh“ńi“ŕjC’|“ŕ“ÖŽqi“Œ•a‰@Œ¤‹†ŒnjCŽÄ“c‹v—YC™–{­’źi“ŕjC’†‰p’jC‰œ•˝‰ë•Fi•a—j. •ŇW Žu•űr•vCŒĂ“c¸ŽsC–î–ě‰ElC ’†ŠOˆăŠwŽĐ, “Œ‹ž, 93.00.00”­s.

852. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj Œo‰ß‚Ĺ‚Ý‚éS“d}|ŽžŒn—ńf’f; ‚­‚ŕ–Œ‰şoŒŒ, p.41`42: ƒlƒtƒ|ƒ[ÇŒóŒQi•‚Žî), p.192`193; lH“§Í—\Œă, p.190`191, ‘şź€CŹ—Ń–ž–Fi“ŕj. •ŇW Ź‘ň—F‹I—Yi“ú‘ĺjCóˆä—˜•vi“Œ—ˆă‘ĺjC ’†ŠOˆăŠwŽĐ, “Œ‹ž, 93.05.07”­s.

853. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj Ą“ú‚Ě“ŕ‰ČŠwi‘ć‚R”Ĺ); ––˝_ŒoáŠQ, p.1339`1352, ŒĂ˜a‹vKi“ŕj. •ŇW ‹{–{şłC…“‡—TC ˆăŽ•–ňo”Ĺ, “Œ‹ž, 93.06.20”­s.

854. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj ƒz[ƒ€ƒPƒAi–k—˘‘ĺŠw“Œ•a‰@‘‡‘Š’k•”•ŇjPart.2G–K–âŠĹŒě‚Ě‚˝‚ß‚Ěƒ}ƒjƒ…ƒAƒ‹; ”]Š´ŠoŒn•”–ĺ, p.118`132, ‘O“c^ŽĄi“ŕj. ˆăŽ•–ňo”Ĺ, “Œ‹ž, 93.07.25”­s.

855. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj ”]_ŒoŽžŠł‚Ě‚Ý‚Š‚˝ABC; ”]_ŒoŽžŠł‚̐f’f‚ĆŽĄ—Ă: ––˝_ŒoŽžŠł, p.295`305, Ä“Ą–L˜ai“ŕj. •ŇW ŽÂŒ´KlC…–ě”ü–MC “ú–{ˆăŽt‰ď, “Œ‹ž, 93.08.00”­s.

856. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj ”]_ŒoŽžŠł‚Ě‚Ý‚Š‚˝ABC; ”]_ŒoŽžŠł‚̐f’f‚ĆŽĄ—Ă: –ň•¨‚É”ş‚¤_ŒoÇŒó‚¨‚ć‚Ń’†“Ĺ, p.335`337, Ä“Ą–L˜ai“ŕj. •ŇW ŽÂŒ´KlC…–ě”ü–MC “ú–{ˆăŽt‰ď, “Œ‹ž, 93.08.00”­s.

857. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj ‘ćŒÜ’ů”Ĺ; •ŸŽƒ§“x—v——: ˜Vl‚Ě•ŸŽƒ§“x; ˜Vl•ŰŒ’, p.306`329, ‘ĺ‹v•Ű—˘i‘‡‘Š’k•”j. •ŇW ŽĐ‰ď•ŸŽƒŒ¤‹†‰ďC ě“‡‘“X, 93.12.10”­s.

858. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj ƒƒ`ƒ‹‚a12|‚ť‚̍ě—p‚Ě‹Á‚­‚ׂŤ‘˝—lŤ; ŽŔŒą“IƒAƒŒƒ‹ƒM[Ť_Œo‰Š‚Ě––˝_Œo‘gD‚ɑ΂ˇ‚郁ƒ`ƒ‹‚a12‚Ě“Š—^Œř‰Ę, p.5`7, Ä“Ą–L˜ai“ŕj. •ŇW ‹TŽRł–Mi“ŕj, (Š”)ƒCƒ“ƒ^[ƒƒbƒh, 93.12.15”­s.

859. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj _Œo“ŕ‰ČŠO—ˆƒ}ƒjƒ…ƒAƒ‹|Žĺ—v’ĽŒó‚Ć‚ť‚Ěƒvƒ‰ƒCƒ}ƒŠƒPƒA|; “Ş’É, p.1`10; Š´ŠoˆŮí, p.11`20; ‚ß‚Ü‚˘, p.55`64; Šç–ʒɁEŠç–Ę–ƒáƒ, p.91`96; •ŕsˆŮí, p.157`168; ˜’É, p.169`175; ”ć‚ę‚₡‚˘iˆŐ”ć˜JŠ´), p.219`226; ŽlŽˆ‚Ě’É‚Ý, p.227`233, ŒĂ˜a‹vKi“ŕj. •ŇW ŒĂ˜a‹vKi“ŕjC ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 94.01.05”­s.

860. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj _Œo“ŕ‰ČŠO—ˆƒ}ƒjƒ…ƒAƒ‹ |Žĺ—v’ĽŒó‚Ć‚ť‚Ěƒvƒ‰ƒCƒ}ƒŠƒPƒA|; ázš, p.21`34; ˆÓŽŻáŠQ, p.105`124; ’s•đ, p.141`155, ŒĂ‹´‹I‹vi“ŕj. •ŇW ŒĂ˜a‹vKi“ŕjC ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 94.01.05”­s.

861. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj _Œo“ŕ‰ČŠO—ˆƒ}ƒjƒ…ƒAƒ‹|Žĺ—v’ĽŒó‚Ć‚ť‚Ěƒvƒ‰ƒCƒ}ƒŠƒPƒA|; ŽlŽˆ–ƒáƒ, p.65`90; Ž¸_, p.125`140; ‹ŘˆŢk, p.235`253, Ä“Ą–L˜ai“ŕj. •ŇW ŒĂ˜a‹vKi“ŕjC ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 94.01.05”­s.

862. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj _Œo“ŕ‰ČŠO—ˆƒ}ƒjƒ…ƒAƒ‹ |Žĺ—v’ĽŒó‚Ć‚ť‚Ěƒvƒ‰ƒCƒ}ƒŠƒPƒA|; Uí, p.35`43; •sˆÓ‰^“Ž, p.45`54, ’ˇ’JěˆęŽqi“ŕj. •ŇW ŒĂ˜a‹vKi“ŕjC ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 94.01.05”­s.

863. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj _Œo“ŕ‰ČŠO—ˆƒ}ƒjƒ…ƒAƒ‹|Žĺ—v’ĽŒó‚Ć‚ť‚Ěƒvƒ‰ƒCƒ}ƒŠƒPƒA|; •ĄŽ‹, p.97`104; ”r”AáŠQ, p.207`217, ˆÉ“Ą”Ž–ži“ŕj. •ŇW ŒĂ˜a‹vKi“ŕjC ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 94.01.05”­s.

864. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj ƒxƒbƒhƒTƒCƒhƒŠƒEƒ}ƒ`ŠwiƒŠƒEƒ}ƒ`ˆăŒ¤C‚Ě‚˝‚߂Ɂj; ‹Ř—Í, p.56`58, Ä“Ą–L˜ai“ŕj. •ŇW ŽR–{^C”č’ő•vC “ě]“°C“Œ‹ž, 94.02.01”­s.

865. m‚ť‚Ě‘ź‚Ě’˜‘n i•ŇWj _Œo“ŕ‰ČŠO—ˆƒ}ƒjƒ…ƒAƒ‹|Žĺ—v’ĽŒó‚Ć‚ť‚Ěƒvƒ‰ƒCƒ}ƒŠƒPƒA|; •ŇW ŒĂ˜a‹vKi“ŕjC ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 94.01.05”­s.

866. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj QOUH‚Ě•]‰ż‚đ‚ß‚Ž‚Á‚ā|Á‰ťŤ’×ᇂ̍őOü; Pharmacoendoscopy‚É‚ć‚éˆÝ’×ᇂ̎Ą–ü”ť’č, p.63`70, ĄňOC‘ĺˆä“cłlC—эO”üCźŒłŽ›Ž—çi“ŕj. •ŇW Ź—ŃˆşŽOi‘ĺăŽs—§‘ĺjCˆä“c˜a“żi’Š“ú‘ĺjCrě“N’ji‘ĺăŽs—§‘ĺjC “Œ‹žˆăŠwŽĐ, “Œ‹ž, 93.08.30”­s.

867. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj Šŕ•š—p‰ťŠw—Ă–@ƒnƒ“ƒhƒuƒbƒN93; Section 2 Á‰ťŠíŒnŽîá‡, 11: 260`261, •ŸŽR‰x’jCŹň˜aŽO˜Yi“ŕjCŒIŒ´–Ť‚`iş˜a‘ĺjC‹v•Ű•Ű•FC–]ŒŽ•ŸŽĄCÎě–MŽkC•l“c•×C‘ě˝C “ú–{‰ť–ň, “Œ‹ž, 93.12.16”­s.

868. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj Ą“ú‚ĚŽĄ—ĂŽwj; ˆÝôň–@, 36: 77`78, ^‹ĘŽő”üśi“ŕjC •ŇW ˆîŠ_‹`–žiç—t‘ĺjC‘˝‰ę{K’jiŠÖ“Œ’üM•a‰@jC”öŒ`‰x˜YiŠŕŒ¤jC ˆăŠw‘‰@, “Œ‹ž, 94.02.15”­s.

869. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj Ą“ú‚ĚŽĄ—ĂŽwj1994”N”Ĺ; Á‰ťŠÇ‚ĚƒŠƒ“ƒpŽî, ”˝‰žŤƒŠƒ“ƒp×–ԍזE‘BÇ, p.352`353, Ÿ–””ş‰hi“ŕjC •ŇW ˆîŠ_‹`–žiç—t‘ĺjC‘˝‰ę{K’jiŠÖ“Œ’üM•a‰@jC”öŒ`‰x˜YiŠŕŒ¤jC ˆăŠw‘‰@, “Œ‹ž, 94.02.15”­s.

870. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“‚ƏÁ‰ťŤ’×á‡; ˆŰŽ—Ă–@‚ĚŠî–{•űj, p.86`87, ‰ĄŽR–őCźŒłŽ›Ž—çi“ŕjC •ŇW rě“N’jC’Ë–{ƒ‹vC ˆă–ňƒWƒƒ[ƒiƒ‹ŽĐ, “Œ‹ž, 93.00.00”­s.

871. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ƒƒfƒBƒRƒsƒA 29|_ŒoŽĄ—ĂŠw‚̐i•ŕ‚Ć”­“W|; ‘ć‚QÍ: _ŒoŽžŠłŽĄ—Ă‚Ě—˜_‚ĆŽŔŰ, _Œo“ď•a‚ĚƒPƒA‚ĆÝ‘îˆă—Ă, p.149`157, Ä“Ą–L˜ai“ŕj, •ŇW ŽR’†ŠwC‹T“cŽĄ’jC‰Í‡’‰C•˝ŽRŒb‘˘C ‹Ś˜aŠé‰ć’ʐMC“Œ‹ž, 94.02.15”­s.

872. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ƒ‚ƒ_ƒ“ƒNƒŠƒjƒJƒ‹ƒ|ƒCƒ“ƒg_Œo“ŕ‰Či‘ć‚P”Ĺ); ŒQ”­“Ş’É, p.128`129, âˆä•ś•Fi“ŕj. •ŇW •˝ŽRŒb‘˘, ‹ŕŒ´o”ŁC“Œ‹ž, 93.04.00”­s.

873. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ƒ‚ƒ_ƒ“ƒRƒ“ƒZƒvƒg_Œo“ŕ‰Č; V‚ľ‚˘“Ş’É‚Ě•Ş—Ţ‚ĆŽĄ—Ă–@‚̐i•ŕ, 3: 36`39, âˆä•ś•Fi“ŕj. •ŇW …–ě”ü–MC‘źC ˆăŠw‘‰@C“Œ‹ž, 93.05.15”­s.

874. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ƒƒfƒBƒRƒsƒA29|_ŒoŽĄ—ĂŠw‚̐i•ŕ‚Ć”­“W|; “ޒɁi•Đ“ޒɁCŒQ”­“ޒɁC‹Ů’ŁŒ^“ޒɁj‚ĚŽĄ—Ă, 29: 64`68, âˆä•ś•Fi“ŕj. •ŇW ŽR’†ŠwC‹T“cŽĄ’jC‰Í‡’‰C•˝ŽRŒb‘˘C ‹Ś˜aŠé‰ć’ʐMC“Œ‹ž, 94.02.15”­s.

875. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj Ą“ú‚ĚŽĄ—ĂŽwj; Ž¸_, 36: 179`180, âˆä•ś•Fi“ŕj. •ŇW ˆîŠ_‹`–žC”öŒ`‰x˜YC“c‰ę{K’jC ˆăŠw‘‰@C“Œ‹ž, 94.02.15”­s.

876. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj _Œo“ď•a•KŒg‡U; ‹}•ĎŽž‚̑Ήž, p.30`39, –kˆä‘Ľ•vi“ŕj. •ŇW –k—˘‘ĺŠw“Œ•a‰@“ď•aŽĄ—ĂŒ¤‹†ƒZƒ“ƒ^[_Œo“ď•aŒ¤C‰ďŽŔsˆĎˆő‰ďC –k—˘‘ĺŠw“Œ•a‰@“ď•aŽĄ—ĂŒ¤‹†ƒZƒ“ƒ^[C‘Š–ÍŒ´, 93.09.00”­s.

877. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn iŠÄCj ƒŠƒEƒ}ƒ`f—Ăƒƒ‚. ŠÄC ”č’ő•vC‹ß“ĄŒ[•śi“ŕj. “ú“ŒƒvƒŠƒeƒbƒN, “Œ‹ž, 93.00.00”­s.

878. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn i’P’˜j “ŕ‘Ÿ^‹ŰÇ‘΍ôƒ}ƒjƒ…ƒAƒ‹; ‹v•ÄŒői•a—j. •ŇW ‹v•ÄŒői•a—jC ‚Š‚Ü‚í‚ʏ‘–[, “Œ‹ž, 94.03.01”­s.

879. m‚ť‚Ě‘ź‚Ě’˜‘i“ü–ĺ‘jn i’P’˜j ƒvƒŠƒ“ƒVƒpƒ‹—Տ°‹Ř“d}C ’š‹‡ŽOi“ŕj. “ú–{ˆăŽ–V•ńŽĐC“Œ‹ž, 93.11.01”­s.

880. m‚ť‚Ě‘ź‚Ě’˜‘i“ü–ĺ‘jn i•Ş’SŽˇ•Mj Á‰ťŠí“ŕŽ‹‹ž‹ZŽt‚Ě‚˝‚ß‚Ěƒnƒ“ƒhƒuƒbƒN; ƒq[ƒ^[ƒvƒ[ƒu, “c•Ó‘CźŒłŽ›Ž—çi“ŕj. •ŇW č“c—˛•vC’|–{’‰—ǁC•˝’ˏG—YC‘źC ˆăŠw}‘o”Ĺ, “Œ‹ž, 93.04.24”­s.

881. m‚ť‚Ě‘ź‚Ě’˜‘i“ü–ĺ‘jn i•Ş’SŽˇ•Mj ƒŠƒEƒ}ƒ`Šw‚̐f’f‚ĆŽĄ—Ăƒnƒ“ƒhƒuƒbƒN; ‘SgŤƒGƒŠƒeƒ}ƒg[ƒfƒX‚ĚŽĄ—Ă, p.161`164, ‰Ş“cƒi“ŕj. •ŇW ”č’ő•vC ƒƒfƒBƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 93.00.00”­s.

882. m‚ť‚Ě‘ź‚Ě’˜‘iŽŤ“Tjn i•Ş’SŽˇ•Mj ŠĹŒě‚Ě‚˝‚ß‚Ě–ňŽ–“T; zŠÂŒně—p–ň, ‰đŕ, p.103`105, ´…ŠŽ‰xC–]ŒŽr’źCě•Ór”VC‘ę‘ňrŽ÷i“ŕj. ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 93.12.05”­s.


<<14 4 “ŕ‰ČŠw>>

883. m–|–ón i•Ş’SŽˇ•Mj ƒz[ƒ€ƒPƒA Part 2@–K–âŠĹŒě‚Ě‚˝‚ß‚Ěƒ}ƒjƒ…ƒAƒ‹; Ä“Ą–L˜aC^‹ĘŽő”üśC‘O“c^ŽĄCź‰ŞłŒhCˆÉ“Ą‹ĎC˛“Ą—FşC“Ąˆä•ŰŽĄC“n•Ó—˛ŽiC‹e’rVC‚“c‰ë”ŽC–öˆäÍFC”~‘ňTˆęC‰iŒŠ–žśC—эO”üC•ű—D ”üCÎˆäˆ¤ŽqCŽO—Ö˜ji“ŕjCŒĂ“cˆę“żC“c’†~ŽiiŠOjC•Ä–{Œőˆęi“Œ—ˆă‘ĺjC‰““ĄMŽqC…‹´ŒbŽqC—é–ؐ´ŽqC•Đ•ŁŒ[ŽqCLŁœA”üC’š‰z‹v”üŽqCŽR–{—T ”üiŠĹŒě•”jC–x‰z—R‹NŽqCźŽR^Căđ^ŽqCˆÉ¨“c–žŽqC‹ŕŽq‰ŔŽqC‘ĺ‹v•Ű—˘C•ŸŽR‰ĂjC’Ř“c—R”üi‘‡‘Š’k•”j: ˆăŽ•–ňo”Ĺ, “Œ‹ž, 93.07.25”­s.

884. m–|–ón iŠÄCj ƒz[ƒ€ƒPƒA Part 2@–K–âŠĹŒě‚Ě‚˝‚ß‚Ěƒ}ƒjƒ…ƒAƒ‹; ŠÄC Ä“Ą–L˜aC^‹ĘŽő”üśi“ŕj: ˆăŽ•–ňo”Ĺ, “Œ‹ž, 93.07.25”­s.


<<14 5 “ŕ‰ČŠw>>

885. mŠw‰ďi‘Űjn i“Á•Ęu‰‰j Headache in the elderly. âˆä•ś•Fi“ŕj: Philippine Neurological Association 15th Annual Convention i93.11.10j, Manila.

886. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Oxygen flux and pH changes in microvessels of rat cremaster muscle. Ź—эO—Si“ŕjCSano, H.iŒc‘ĺjCź“c‘•ciś•¨•¨—ŒnjC•y“c—FKi“ŕjC‘ę‘ň’ź’čiś—j: Asian Congress for Microcirculation i93.09.27j, ‘ĺă, Abstracts, p.216, 1993.

887. mŠw‰ďi‘Űjn iƒ[ƒNƒVƒ‡ƒbƒvj Other side effects and safety. ‹ß“ĄŒ[•śi“ŕj: 13th ILAR Congress of Rheumatology i93.07.04`09j, Barcelona.

888. mŠw‰ďi‘Űjn iƒ[ƒNƒVƒ‡ƒbƒvj Dietary supplement of fish oil rich in eicosapentaenoic acid enhances bovine serum albumin induced immune complex nephritis in NZB/W F1 mice. ŠÚ–ěƒśCŹ—Ń–Li“ŕj: World Congress Inflammation '93 i93.10.12j, Wien.

889. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Diaphragm function during sighs in awake canines after laparatomy. •Đ‹Ë“ú˛ŽqC•Đ‹Ë^li“ŕjCYoung, R.N.CKieser, T.M.CEaston, P.A.(Univ. of Calgary): American Thoracic Society and American Lung Association 1993 International Conference i93.05.16j, San Francisco, USA, Am. Rev. Respir. Dis., 147(4): 164, 1993.

890. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Low flow by SPECT and clinical correlation. âˆä•ś•FC”Ń’Ë‚_i“ŕj: Microcirculatory Stasis in the Brain i93.05.28j, “Œ‹ž.

891. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Migraine with aura; Regional cerebral blood flow during aura, pre-aura and headache. âˆä•ś•FCŒÜ\—’‹v‰ŔC_“c’źi“ŕj: 16th International Cerebral Blood Flow and Metabolism i93.06.04j, ĺ‘ä.

892. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Bond toxic polyneuropathy due to glue sniffing|Clinical and experimental studies|. Ä“Ą–L˜aC‹y”\ŽGC’š‹‡ŽOCŒĂ˜a‹vKi“ŕj: International Conference on Peripheral Nerve Toxicity i93.06.13j, ‹ŕ‘ň.

893. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Avidity of anticardiolipin antibodies in patients with antiphosphilipid syndrome. ‰Ş“cƒC–ě‘şł˘C‹ß“ĄŒ[•śi“ŕjC”č’ő•vi“Œ—ˆă‘ĺj: 13th ILAR Congress of Rheumatology i93.07.04`09j, Barcelona.

894. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j PCR analysis of intercrine superfamily gene expression in rheumatoid arthritis. •äâ–΁CÔŻ“§C‹ß“ĄŒ[•śi“ŕj: 13th ILAR Congress of Rheumatology i93.07.04`09j, Barcelona.

895. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j New endoscopic ultrasonographic classification of gastric malignant lymphoma. –Ř“cŒőLCŽR“cŽŠlCâŒű“NÍC–ě“o˝CźŒłŽ›Ž—çi“ŕj: ‘ć2‰ń‰˘BÁ‰ťŠí•aŠw‰ď i93.07.19`24j, ƒoƒ‹ƒZƒƒi, —\eW, p.279, 1993.

896. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j A peculiar case showinggFestinaying GaithiƒrƒfƒIj. ŽO•x“N˜YCŒĂ˜a‹vKi“ŕj: International Medical Symposium on Parkinson Disease i93.07.22j, Wahsington, DC.

897. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Hepatitis C virus infections and cryoglobulinemia in patients with primary Sjogren syndrome. ‰Ş“cƒC•äâ–΁CŠp‰Ć–ž•śC‹ß“ĄŒ[•śi“ŕj: 4th International Symposium on Sjogren Syndrome i93.08.11`13j, “Œ‹ž.

898. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The reduction of rCBF during aura of migraine in regions corresponding to the cerebral arterial territory. ŒÜ\—’‹v‰ŔCâˆä•ś•FC_“c’źi“ŕjCYoshio Saito: 6th International Headache Congress i93.08.26j, Paris.

899. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Comparative study on anterior horn cells and muscle degeneration in amyotorophic lateral sclerosis. ź“csłC’ˇ’JěˆęŽqCŒĂ˜a‹vKi“ŕjC–ö‰şŽO˜Yi_“Ţě‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“j: 15th World Congress of Neurology i93.09.05j, Vancouver, Canada.

900. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Serum anti-GM1 antibody with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. Ä“Ą–L˜aC“ü]KŽqC‹y”\ŽGi“ŕjC‹ŕ‘ň’ź”üi“Œ•a‰@Œ¤‹†ŒnjCˆÉ“Ą”Ž–žCŒĂ˜a‹vKi“ŕj: 15th World Congress of Neurology i93.09.06j, Vancouver, Canada.

901. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Extrapyramidal system involvement in amyotorophic lateral sclerosis. ’ˇ’JěˆęŽqCŒĂ˜a‹vKi“ŕjC–ö‰şŽO˜Yi_“Ţě‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“j: 15th World Congress of Neurology i93.09.06j, Vancouver, Canada.

902. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Monocyte chemotactic and activating factor in longterm haemodialysed patients. ÔŻ“§CKobayashi, N.i“ŕj: 30th Congress of the EDTA i93.09.15`18j, Scotland.

903. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Essential involvement of IL-8 on neutrophil recruitment and joint destruction in experimental acute arthritis. ÔŻ“§C‰““Ą•˝mC•äâ–΁C‹ß“ĄŒ[•śi“ŕjC”č’ő•vCź“‡jŽĄi“Œ—ˆă‘ĺj: Combined Meeting of the 8th International Lymphokine Workshop and the 4th International Workshop on Cytokines i93.10.17`21j, ‘ĺă.

904. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The role of esophageal involvement in the aggravation of pulmonary fibrosis in systemic sclerosis. ‹ß“ĄŒ[•śCÎěÍC•äâ–΁C‰““Ą•˝mi“ŕj: International Symposium on Pathogenesis and Management of Scleroderma and Connective Tissue Disorders i93.10.26`27j, ‘ĺă.

905. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Clinical prognosticators of adult HUS/TTP. Š™“cvŽőC‚‹´‰fŽqC“ŕ“c–ž”üŽqC’|“ŕN—YCŹ—Ń’ź”VC‘ĺ‹v•Ű[l: ‘ć26‰ńƒAƒƒŠƒJt‘ŸŠw‰ď i93.11.15j, Boston, JASN, 4(3): 318, 1993.

906. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Clinical features of 30 adult renal transplant patients who survived for l0 years or longer. ‘ĺ‹v•Ű[lCŠ™“cvŽői“ŕjC’|“ŕN—YCŹ—Ń’ź”VCź‘ňŽ“TC˛“ĄŒőŽjiŠOjCŒF–ě˜a—YC‰““Ą’‰—Yi”ĺj: ‘ć26‰ńƒAƒƒŠƒJt‘ŸŠw‰ď i93.11.15j, Boston, JASN, 4(3): 953, 1993.

907. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Respiratory muscle function during REM and non REM sleep in the intact canines. Young, R.N.(Univ. of Calgary)C•Đ‹Ë^li“ŕjCPlatt, R.S.CKieser, T.M.CEaston, P.A.(Univ. of Calgary): Federation of American Societies for Experimental Biology i92.04.08j, Anaheim, USA, FASEB J., 6(5): 1755, 1992.

908. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j EMG power spectra of crural diaphragm during inspiration and post inspiration in the awake canines. Platt, R.S.(Univ. of Calgary)C•Đ‹Ë^li“ŕjCKieser, T.M.CEaston, P.A.(Univ. of Calgary): Federation of American Societies for Experimental Biology i92.04.09j, Anaheim, USA, FASEB J., 6(5): 2025, 1992.

909. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Lung and diaphragm function in open (OC) versus laparoscopic (LAPC) cholecystectomy in human. •Đ‹Ë^li“ŕjCYoung, R.N.CRothwell, B.C.CGolar, S.D.CNixon, J.A.CEaston, P.A.CFord, G.T.(Univ. of Calgary): Federation of American Societies for Experimental Biology i92.04.09j, Anaheim, USA, FASEB J., 6(5): 2027, 1992.

910. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Costal (COS) and crural (CRU) diaphragm function after laparoscopic cholecystectomy (LAPC). Rothwell, B.C.(Univ. of Calgary)C•Đ‹Ë^li“ŕjCYoung, R.N.CNixon, J.A.CEaston, P.A.CFord, G.T.(Univ. of Calgary): American Thoracic Society and Americal Lung Association 1992 International Conference i92.05.17j, Miami, USA, Am. Rev. Respir. Dis., 145(4): 152, 1992.

911. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Respiratory muscle compensation for diaphragm paresis in awake canines. •Đ‹Ë^li“ŕjCHeard, R.R.CLeininger, R.W. Kieser, T.M.CEaston, P.A.(Univ. of Calgary): American Thoracic Society and Americal Lung Association 1992 International Conference i92.05.17j, Miami, USA, Am. Rev. Respir. Dis., 145(4): 154, 1992.

912. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Effect of three respiratory maneuver on costal (COS) and Crural (CRU) diaphragm function after laparoscopic cholecystectomy (LAPC). Young, R.N.(Univ. of Calgary)C•Đ‹Ë^li“ŕjCRothwell, B.C.CGolar, S.D.CFord, G.T.CEaston, P.A.(Univ. of Calgary): American Thoracic Society and Americal Lung Association 1992 International Conference i92.05.19j, Miami, USA, Am. Rev. Respir. Dis., 145(4): 515, 1992.

913. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j EMG power spectra of diaphragm and transversus abdominus in right lateral decubitus, sitting and standing posture in awake canines. Platt, R.W.(Univ. of Calgary)C•Đ‹Ë^li“ŕjCYoung, R.N.CKieser, T.M.CEaston, P.A.(Univ. of Calgary): Federation of American Societies for Experimental Biology i93.03.30j, New Orleans, USA, FASEB J., 7(3): 232, 1993.

914. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Respiratory muscle function during sustained hypoxia in the intact canine. Young, R.N.(Univ. of Calgary)C•Đ‹Ë^li“ŕjCEaston, P.A.(Univ. of Calgary): Federation of American Societies for Experimental Biology i93.03.30j, New Orleans, USA, FASEB J., 7(3): 233, 1993.

915. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Respiratory muscle compensation for unilateral or bilateral diaphragm paralysis during CO2 rebreathing in awake canines. •Đ‹Ë^li“ŕjCYoung, R.N.CFord, G.T.CEaston, P.A.(Univ. of Calgary): Federation of American Societies for Experimental Biology i93.03.30j, New Orleans, USA, FASEB J., 7(3): 233, 1993.

916. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Diaphragm motion and respiratory muscle coordination during diaphragm paralysis in awake canines. •Đ‹Ë^li“ŕjCYoung, R.N.CPlatt, R.S.CKieser, T.M.CEaston, P.A.(Univ. of Calgary): American Thoracic Society and American Lung Association 1993 International Conference i93.05.18j, San Francisco, USA, Am. Rev. Respir. Dis., 147(4): 701, 1993.

917. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Respiratory muscle function during airflow resisted and obstructed REM and non-REM sleep in awake canine. Young, R.N.(Univ. of Calgary)C•Đ‹Ë^li“ŕjCPlatt, R.S.CKieser, T.M.CEaston, P.A.(Univ. of Calgary): American Thoracic Society and American Lung Association 1993 International Conference i93.05.18j, San Francisco, USA, Am. Rev. Respir. Dis., 147(4): 953, 1993.

918. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Acute and chronic reduction of blood pressure in essential hypertensives and its influence on blood pressure response during exercise and exercise capacity. ´…ŠŽ‰xCě•Ó•q”VCX“cGlC–]ŒŽr’źC–ؐě“c—˛ˆęi“ŕj: American Society of Hypertension 8th Annual Meeting i93.05.20j, New York, USA, Am. J. Hypertens., 6: 124, 1993.

919. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Pregnancy in systemic sclerosis (SSc) and polymyositis-dermatomyositis (PM-DM). ‹ß“ĄŒ[•śC˛“Ą”ü’ĂŽ}C‰Ş“cƒi“ŕjC”č’ő•vi“Œ—ˆă‘ĺj: 13th ILAR Congress of Rheumatology i93.07.04`09j, Barcelona.

920. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Vitamin D3 enhances soft-tissue calcification in patients with SLE. –ě‘şł˘C‰Ş“cƒC‹ß“ĄŒ[•śi“ŕj: 13th ILAR Congress of Rheumatology i93.07.04`09j, Barcelona.

921. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Normotensice renal failure in systemic sclerosis with antineutrophil cytoplasmic autoantibody. ‰““Ą•˝mC×–ěF˜YC‹ß“ĄŒ[•śi“ŕj: 13th ILAR Congress of Rheumatology i93.07.04`09j, Barcelona.

922. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Oxygen flux via microvessels in rat cremaster muscle at normoxia and hypoxia. Ź—эO—Si“ŕjCSano, H.iŒc‘ĺjC“c’†’ź•FC•y“c—FKi“ŕjC‘ę‘ň’ź’čiś—j: Congress of the International Union of Physiological Sciences i93.08.02j, Glasgow, UK, Abstracts, p.48, 1993.

923. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Antineuronal antibodies in Epstein-Barr virus infection with neurologic complications. ˆÉ“Ą”Ž–žC˛ŽRßŽqC“ü]KŽqi“ŕjC‹ŕ‘ň’ź”üi“Œ•a‰@Œ¤‹†ŒnjC‹y”\ŽGCaˆä—߈ęCÄ“Ą–L˜aCŒĂ˜a‹vKi“ŕjC‰H‰ę˝ˆęC’r“c˜a•Fi“s¸Œ¤j: 15th World Congress of Neurology i93.09.06j, Vancouver, Canada.

924. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Pathophysiology of eclampsia studied by CT, MRI and SPECT. ˆ˘‹v’Ă“ń•vCâˆä•ś•FC_“c’źC”Ń’Ë‚_C”¨—˛Žui“ŕj: 15th World Congress of Neurology i93.09.06`12j, Vancouver, Canada.

925. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Diagnostic importance and clinical course of one-and-a half syndrome. ”Ń’Ë‚_C”¨—˛ŽuCˆî•Ÿ“O–çCŠC–ě‰ŔŽqCâˆä•ś•FC_“c’źi“ŕj: 15th World Congress of Neurology i93.09.06`12j, Vancouver, Canada.

926. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Change of Mn OSD activity in mitochondrial fraction in acute phase of ischemic gerbil brain. Ąˆä¸C–ě•˝CC‹{“c‰Ă˘ŽqC‰Ş•”‘˝‰ÁŽuC•lŒűŸ•Fi“ŕj: 15th World Congress of Neurology i93.09.06`12j, Vancouver, Canada.

927. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Ultrastructural study of glomerular basement membrane in diabetic rats by quick-freezing and deep-etching method. Žç‰Ž’B”üi“ŕjCOhno, S.iŽR—œˆă‘ĺjC‹ŕXWC“Ię´˜aC–‹`’‰i“ŕj: ‘ć29‰ń‰˘B“œ”A•aŠw‰ď‹c(EASD) i93.09.06`09j, ƒCƒXƒ^ƒ“ƒu[ƒ‹, Abstract, p.222, 1993.

928. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Respiratory muscle compensation after diaphragm paralysis during CO2 stimulated breathing in awake canines. •Đ‹Ë^li“ŕjCKieser, T.M.CEaston, P.A.(Univ. of Calgary): 1993 Annual Meeting of Canadian Society for Clinical Investigation i93.09.11j, Vancouver, Canada, Clinical and Investigative Medicine, 16(4): B127, 1993.

929. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Diagnosis of gastric cancer using infrared ray electronic endoscope. “c•Ó‘CŹň˜aŽO˜YC‹ß“Ąˆę‰pC’†ˆä‹v—YCrěä•vCŽRăp‚ł‚ä‚čCÎˆäŒ\‘žCŽO‹´—˜‰ˇC‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕjC›’m–çC’†‰p’ji•a—j: 11th Asia Pacific Cancer Conference i93.11.16j, ƒoƒ“ƒRƒN.

930. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Reduction of metastatic liver tumor under the systemic chemotherapy for advanced gastric cancer. Źň˜aŽO˜YC‹ß“Ąˆę‰pCŽRăp‚ł‚ä‚čC’†ˆä‹v—YCĄňOCŽR“cŽŠlCrěä•vCÎˆäŒ\‘žC“c•Ó‘C‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕj: 11th Asia Pacific Cancer Conference i93.11.16j, ƒoƒ“ƒRƒN, Abstract, p.159, 1993.

931. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Treatment with 5'DFUR+CDDP+MMC for inoperable gastric cancer. •ŸŽR‰x’jCŒIŒ´–Ť‚`CŹň˜aŽO˜Yi“ŕjC‹v•Ű•Ű•FC–]ŒŽ•ŸŽĄCÎě–MŽkC•l“c•×C‘ě˝iisˆÝŠŕŽĄ—ĂŒ¤‹†“ŻD‰ďj: 11th Asia Pacific Cancer Conference i93.11.16j, ƒoƒ“ƒRƒN, Abstract, p.183, 1993.

932. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j A clinicopathologic study of poorly dif. advanced gastric cancers. ÎŠ_“ż]C‹ß“Ąˆę‰pCŹň˜aŽO˜YC“c•Ó‘C‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕjCĺŒ´÷iŠOjC›’m–çC’†‰p’ji•a—j: 11th Asia Pacific Cancer Conference i93.11.19j, ƒoƒ“ƒRƒN.

933. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Influence of pregnancy on a long-term clinical course in IgA nephroapthy patients. Žç‰Ž—˜‰ŔCă‘C“ě‹˝‰p–žC”äŠé”\”VCŹ—Ń–Li“ŕj: 9th International Congress on Hypertension in Pregnancy i94.03.16j, ƒI[ƒXƒgƒ‰ƒŠƒA.

934. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Immunoblotting analysis of sera from patients with candidiasis. ŽR‰ş‚Ś‚čŽqi“ŕjC‹v•ÄŒői•a—jC‰–’J–΁i“ŕjCŽRč•q˜ai•a—j: 12th Congress of International Society for Human and Annimal Mycology i94.03.17j, Adelaide, Australia, Abstracts, p.123, 1994.

935. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Hemodynamic analysis of a selective ƒż1-adrenocepter antagonist doxazosin in essential hypertension. ˜Ič‹P•vC•zěTˆę˜YCŹ‚L]C‚‹´‚Ý‚Ç‚čC´…ŠŽ‰xC–ؐě“c—˛ˆęi“ŕj: 15th Scientific Meeting of the International Society of Hypertension i94.03.20`24j, Melborne, Australia, J. Hypertens., 12(Suppl.3): 101, 1994.

936. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j –łÇŒóŤ”][Ç‚ւ̑ΉžiŽw’č”­Œž). _“c’źi“ŕj: ‘ć18‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i93.04.22j, ç—t.

937. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘ŠúˆÝŠŕˆÝ‘BŽî‚ɑ΂ˇ‚éClipping•š—p”S–ŒŘœp‚ĚŒŸ“˘. Źň˜aŽO˜YC‰ĄŽR–ői“ŕj: ‘ć45‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.05.13j, VŠƒ, —\•ńW, p.136, 1993.

938. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Endoscopic varicealography during injection sclerotherapy(EVIS)ŠŒŠ‚đdŽ‹‚ľ‚˝H“šĂ–ŹáŽ‚ɑ΂ˇ‚铧Ž‹‰şd‰ť—Ă–@‚Ě—L—pŤ. ‘•Ş–ΔŽC‘şă‹§li“ŕj: ‘ć45‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ďVTRƒŠƒ“ƒ|ƒWƒEƒ€BuH“šĂ–ŹáŽd‰ť—Ă–@v i93.05.14j, VŠƒ, —\eW, p.131, 1993.

939. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŠĚ’_“šŽžŠł‚É”ş‚¤‰Šát‚ɑ΂ˇ‚éDibutyryl cyclic AMP(DBcAMP)‚ĚŒř‰Ę|Dopamin(DOA), Phenobarbital‚Ć‚Ě”äŠr|. Ä“ĄrŽiCź–{ˆĚ’jC‘•Ş–ΔŽC‘şă‹§lCa’J–ž—˛CÎˆäŒö“šC‚“c‰ë”ŽCŽÄ“c‹v—YC™–{­’źi“ŕj: ‘ć29‰ń“ú–{’_“šŠw‰ď‘‰ď i93.09.21j, _ŒË, ’_“š, 7(3): 377, 1993.

940. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j IBD|dÇ“xf’f‚Ě–â‘č“_|’×ᇐŤ‘ĺ’°‰Š‚ĚŽĄ—Ă‚É‚¨‚Ż‚édÇ“x•Ş—Ţ‚Ě–đŠ„‚ĆTalstad score‚Ě—L—pŤ‚ɂ‚˘‚Ä. ŒÜ\—’łLCŸ–””ş‰hi“ŕj: ‘ć35‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď i93.09.22j, _ŒË.

941. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘ĺ’°”S–Œ“ŕŠŕ‚Š‚çisŠŕ‚ւ̐i“WŒ`ŽŽ‚ÉŠÖ‚ˇ‚錟“˘|”S–Œ‰ş‘wZŠŕ‚̉đÍ‚𒆐S‚Ɂ|. ŽO•xO”Vi•a—jCŒÜ\—’łLi“ŕj: ‘ć46‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.09.24j, _ŒË.

942. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ×Œo’´‰š”gƒvƒ[ƒu‚É‚ć‚é\“ńŽw’°’×ᇂ̌Ÿ“˘. ŽR“cŽŠlCâŒű“NÍC–Ř“cŒőLCźŒłŽ›Ž—çi“ŕj: ‘ć63‰ń“ú–{’´‰š”gˆăŠw‰ďŒ¤‹†”­•\‰ď i93.11.10j, ç—t.

943. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j S‹Ř[Ç”­ÇŽž‚Ě•a‘Ô‚ĆŽĄ—Ă; ‹}ŤS‹Ř[Ç‚ɑ΂ˇ‚銼“Ž–ŹŒ`Źp (CTCA). •‘ň—˜˜YCŠ“c”ü—ć”TC’ˇ’Jě‰„LC‹g“cTC’Ĺ–źł_CŹ—Ń–ž–Fi“ŕjC‘“c‘ěi‹~–˝jC‘şź€C–ؐě“c—˛ˆęi“ŕjC‘ĺ˜a“c—˛i‹~–˝j: ‘ć21‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ď i93.11.18j, L“‡, “ú–{‹~‹}ˆăŠw‰ďŽGŽ, 4(5): 414, 1993.

944. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ¸_‰Č‹~‹}‚ĚŒťó‚Ɖۑč. źŽR^i‘‡‘Š’k•”j: ‘‡•a‰@¸_ˆăŠw‰ď i93.12.02`03j, •lź.

945. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j –Ťáu’É—Ěˆć‚É‚¨‚Ż‚éƒ\[ƒVƒƒƒ‹ƒ[ƒJ[‚ĚŠˆ–ô. źŽR^i‘‡‘Š’k•”j: “ú–{–Ťáu’ÉŠw‰ď i94.02.03`04j, ‘ĺă.

946. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j uNIDDM‚É‚¨‚Ż‚é“œ”A•aŤtÇ‚ĚŽĄ—Á|V‚ľ‚˘“WŠJvƒJƒ‹ƒVƒEƒ€hRÜ‚Ě–đŠ„. “Ię´˜aC–‹`’‰i“ŕj: ‘ć28‰ń“œ”A•aŠw‚̐i•ŕ i94.02.17j, “Œ‹ž, u‰‰—vŽ|W, p.67, 1994.

947. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj RA ŽĄ—Ă‚É‚¨‚Ż‚銿•ű‚ĚˆĘ’u•t‚Ż; –ŤŠÖßƒŠƒEƒ}ƒ`‚ɑ΂ˇ‚é“Œ—mˆăŠw“IŽĄ—Ă‚Ě–đŠ„. ×–ěF˜YC•äâ–΁C‰““Ą•˝mC”э‘–퐜C‹ß“ĄŒ[•śi“ŕj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž.

948. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‹­’źŤŇ’ʼnŠ‚̐f’f‚ĆŽĄ—Ă‚É‚¨‚Ż‚é–â‘č“_; ”ń“TŒ^“I‚Č—Ő°Œo‰ß‚đ’ć‚ľ‚˝ seronegative spondyloarthropathy ‚Ě‚S—á. •äâ–΁C‚‹´“š—YC‹ß“ĄŒ[•śi“ŕj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž.

949. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒŠƒEƒ}ƒ`ŤŽžŠł‚̐V‚ľ‚˘‘ŸŠí•a•Ď; ‹­”çÇ‚̐_Œo•a•Ď. ‹ß“ĄŒ[•śC‚•iŽĆi“ŕjC”č’ő•vi“Œ—ˆă‘ĺj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž.

950. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ŽŠŒČ–ƉuŤŽžŠł‚Ć“Ž•¨ƒ‚ƒfƒ‹; R IL-8 R‘Ě‚É‚ć‚é‰Ć“eŽŔŒąŠÖß‰Š‚̐§Œä. ‰““Ą•˝mCÔŻ“§i“ŕjC‚ŠÝŒ›“ńiŽŠOjC‹ß“ĄŒ[•śi“ŕjC”č’ő•vi“Œ—ˆă‘ĺj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž, ´˜^W, p.140, 1993.

951. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ŽŠŒČ–ƉuŽžŠłŽĄ—Â̐i•ŕ: ƒ‹[ƒvƒXt‰Š‚ɑ΂ˇ‚éƒXƒeƒƒCƒhƒpƒ‹ƒX—Ă–@‚Ě—L—pŤ‚ÉŠÖ‚ˇ‚錤‹†. Žsě—zˆęC‹´–{”ŽŽjC”č’ő•vC‹ß“ĄŒ[•śi“ŕjCHŒŽłŽjC›Œ´łOC–{ŠÔŒő•v: ‘ć21‰ń“ú–{—Տ°–ƉuŠw‰ď‘‰ď i93.09.08`10j, ŽD–y.

952. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj “ŕŽ‹‹ž“IĂ–ŹáŽ‘˘‰e(Endoscopic varicealography during infection sclerotherapy, EVIS)‚ĚŒŸ“˘i‘ć6•ńjŒŒ—Ź•űŒü‚ĆŽĄ—ĂŒř‰Ę, Ă–ŹáŽŒ`‘Ô. ‚“c‰ë”ŽC‘•Ş–ΔŽC‘şă‹§lCŽ›ÎŒOCÄ“ĄrŽiC˛“ĄłŽ÷C”’čŒh“ńC™–{­’źCa’J–ž—˛CŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕjC–ĺ˜eŒ›C”äŠé”\Ž÷iŠOj: ‘ć46‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.09.24j, _ŒË, u‰‰—\•ńW, p.139, 1993.

953. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”x‹C—Ę•Ş‰ć‚ɉe‹ż‚đ‹y‚Ú‚ˇˆöŽq‚ĚŒŸ“˘|—zˆłŒÄ‹z‚Ć‘ĚˆĘ‚É‚Â‚˘‚ā|. ‘ĺ–Ř–ƒ‹LŽqC’†ź‹vKC”Ş‹X­ŽqC‹vź’mŽqC“Ąś”ü”Ti—ŐŒŸjC‹g‘şŽ‚C˛“Ą“N–çC“팴”Í”VCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć39‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i92.10.16j, ’ˇč, —Տ°•a—, 40(•â): 269, 1992.

954. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŒoŒűŰŽć‚Ş—Uˆö‚Ć‚Č‚Á‚˝AGML‚Ě—Ő°“IŒ¤‹†. ’†ˆä‹v—YC‘ĺˆä“cłlC‘şăK‘ž˜YC—Ń“c_–žC“ú‚‰›C‚“c‰ë”ŽCÄ“ĄrŽiCrěä•vCŽRăp‚ł‚ä‚čC‹ß“Ąˆę‰pC‹e’rVCÎˆäŒ\‘žC“c•Ó‘CŹň˜aŽO˜YC‰Ą ŽR–őCŽO‹´—˜‰ˇCźŒłŽ›Ž—çi“ŕj: ‘ć79‰ń“ú–{Á‰ťŠí•aŠw‰ď‘‰ď i93.03.29`31j, ‹ž“s, —\eW, p.463, 1993.

955. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j NuD‚ɑ΂ˇ‚écisapride‚Ćdiazepam‚Ě”äŠrŽŽŒą|Œo”ç“IˆÝ“d‹CŠˆ“Ž‹L˜^(EGG)‚É‚ć‚錟“˘. “c•Ó‘CÎˆäŒ\‘žC‹ß“Ąˆę‰pCrěä•vCŽRăp‚ł‚ä‚čC’†ˆä‹v—YC‹e’rVCŹň˜aŽO˜YC‰ĄŽR–őC‘ĺˆä“cłlCŽO‹´—˜‰ˇCźŒłŽ›Ž—çi“ŕjCÎ‹˝‰ŞƒC“ŕŠCŒő ’ŠCŽO‰Y’ĺ‘Ľi¸j: ‘ć79‰ń“ú–{Á‰ťŠí•aŠw‰ď‘‰ď i93.03.30j, ‹ž“s, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ, 90(—Ő‘): 290, 1993.

956. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –{‘ԐŤ‚ŒŒˆł‚Ě“œ”A•a‡•šÇ—á‚É‚¨‚Ż‚é”]ŒŒŠÇáŠQ‚ƐS‹Ř[Ç‚Ě•š”­•p“x‚ÉŠÖ‚ˇ‚élŽ@. ‘şź€C‘Ł’qLCŹă”Ž•śC˛“ĄŽüCóŒŠ‘CŹ—Ń–ž–FC’ˇ’Jě‰„LC–ؐě“c—˛ˆęi“ŕj: ‘ć90‰ń“ú–{“ŕ‰ČŠw‰ď‘‰ď i93.04.01`03j, ‰ŞŽR.

957. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –{‘ԐŤ‚ŒŒˆłÇ‚É‚¨‚Ż‚é—§ˆĘ•‰‰×Žž‚̐SĽ–ŹŠÇ”˝‰ž‚Ƒ̉tŤˆöŽq. ˜Ič‹P•vC•zěTˆę˜YCŹ‚L]C‰Í“c—TCě•Ó•q”VC‚‹´‚Ý‚Ç‚čC”öŒ`’ˇ—YC´…ŠŽ‰xC–ؐě“c—˛ˆęi“ŕj: ‘ć90‰ń“ú–{“ŕ‰ČŠw‰ď‘‰ď i93.04.01`03j, ‰ŞŽR.

958. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j S‹Ř[Ç‹}ŤŠú‚Ě‘¤•Ç—U“ą‚É‚¨‚Ż‚é ST •ÎˆĘ‚ĚŒŸ“˘. Ź—Ń–ž–FC‰ŹŒ´“āC‹g“cTCŹ‚L]C•‘ň—˜˜YC’ˇ’Jě‰„LC‘şź€C–ؐě“c—˛ˆęi“ŕj: ‘ć90‰ń“ú–{“ŕ‰ČŠw‰ď‘‰ď i93.04.01`03j, ‰ŞŽR.

959. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j SLE ‚É”ş‚¤S–Œ•a•Ď‚ƍRƒŠƒ“Ž‰ŽżR‘ĚÇŒóŒQ‚Ć‚ĚŠÖ˜A‚ɂ‚˘‚Ä. Ź—Ń–ž–FC‰ŹŒ´“āC‹g“cTCŹ‚L]C•‘ň—˜˜YC’ˇ’Jě‰„LC‰Ş“cƒC‹ß“ĄŒ[•śC‘şź€C–ؐě“c—˛ˆęi“ŕj: ‘ć90‰ń“ú–{“ŕ‰ČŠw‰ď‘‰ď i93.04.01`03j, ‰ŞŽR.

960. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j S”j—ô‚Ě”j—ôŽžŠú‚É‚¨‚Ż‚é expansion ‚ĚŠÖ—^. ‰ŹŒ´“āCV’Ă’J^lC•˝źT‰ECŹ—Ń–ž–FC‹g“cTC‘şź€C–ؐě“c—˛ˆęi“ŕj: ‘ć90‰ń“ú–{“ŕ‰ČŠw‰ď‘‰ď i93.04.01`03j, ‰ŞŽR.

961. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j SŽžŠł, ”]ŒŒŠÇáŠQ‚É‚¨‚Ż‚錌Ÿ÷‚¨‚ć‚ѐ‘‰t’†‚ĚƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh (NP) ƒtƒ@ƒ~ƒŠ[”Z“x. ‹v•Ű‹MşC•‘ň—˜˜YC’ˇ’Jě‰„LCŹ‚L]CŠ“c”ü—ć”TCŹ—Ń–ž–FC‘şź€C–ؐě“c—˛ˆęi“ŕj: ‘ć90‰ń“ú–{“ŕ‰ČŠw‰ď‘‰ď i93.04.01`03j, ‰ŞŽR.

962. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j IgA tÇ‚ɑ΂ˇ‚éƒXƒeƒƒCƒh—Ă–@‚Ě’ˇŠúŒř‰Ę. Ź—Ń–LC”äŠé”\”VCŠ™“cvŽőC’Ë–{—Y‰îCŠÚ–ěƒśC‘ĺ‹v•Ű[lC–ؐě“c—˛ˆęi“ŕj: ‘ć90‰ń“ú–{“ŕ‰ČŠw‰ď‘‰ď i93.04.01`03j, ‰ŞŽR.

963. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •s–ž”MŠłŽŇ‚̉đÍi‘ć‚Q•ń). ”э‘–퐜C•äâ–΁CÎěÍC‰Ş“cƒC‹ß“ĄŒ[•śi“ŕjC”č’ő•vi“Œ—ˆă‘ĺj: ‘ć90‰ń“ú–{“ŕ‰ČŠw‰ď‘‰ď i93.04.01`03j, ‰ŞŽR.

964. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –{‘ԐŤ‚ŒŒˆł‚É‚¨‚Ż‚é BMI (body mass index) ‚Ć‘Ď“œ”\‚¨‚ć‚ŃƒCƒ“ƒXƒŠƒ“Š´ŽóŤ, ‚Č‚ç‚Ń‚ÉŽ‰Žż‘ăŽÓˆŮí‚Ć‚ĚŠÖ˜A‚ɂ‚˘‚Ä. ‘Ł’qLCŹă”Ž•śC‚“cˆę‘ž˜YC‘şź€C–ؐě“c—˛ˆęi“ŕj: ‘ć90‰ń“ú–{“ŕ‰ČŠw‰ď‘‰ď i93.04.01`03j, ‰ŞŽR, “ú“ŕ‰ďŽ, 82(‘): 115, 1993.

965. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –ŒŤŽ…‹…‘̐t‰Š Heymann nephritis ‚̍RŒ´‚Ć”­Ç‹@˜‚̉đ–ž. Š™“cvŽőC˛“Ą’ź”VC‚‹´‰fŽqC‘ĺ‹v•Ű[lCŹ—Ń–LC–ؐě“c—˛ˆęi“ŕj: ‘ć90‰ń“ú–{“ŕ‰ČŠw‰ď‘‰ď i93.04.01`03j, ‰ŞŽR, “ú–{“ŕ‰ČŠw‰ďŽGŽ, 82(‘): 212, 1993.

966. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚l’`”’ŒŒÇ‚𔺂¤ƒjƒ…[ƒƒpƒ`[‚Ě—Ő°‘œ‚ĆŒŒ´R––˝_ŒoR‘Ě‚ĚŒŸ“˘. Ä“Ą–L˜aC“ü]KŽqC‹y”\ŽGCł–Ř‚Š‚‚çCˆÉ“Ą”Ž–žCŒĂ˜a‹vKi“ŕj: ‘ć90‰ń“ú–{“ŕ‰ČŠw‰ďu‰‰‰ď i93.04.03j, ‰ŞŽR.

967. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒg‚É‚¨‚Ż‚é’áŽ_‘fŤ”xŒŒŠÇškŽž‚ĚŽűk•”ˆĘ‚ĚŒŸ“˘. “c’†’ź•FCŽO“Ą‹vC‰Ş–{O”VC˛“Ą“N–çC‚“cM˜aC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć33‰ń“ú–{‹š•”ŽžŠłŠw‰ď‘‰ď i93.04.08j, ‰Ą•l, “ú–{‹š•”ŽžŠłŠw‰ďŽGŽ, 31(‘): 240, 1993.

968. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹C“š‰ß•qŤŒŸ¸’†‚É‚¨‚Ż‚é’áŽ_‘fŒŒÇ‚Ě‹@˜‚ÉŠÖ‚ˇ‚錟“˘. —é–Ř“šOC“y‹´‚ä‚Š‚čC“c’†’ź•FC‰Ô“cL‰pC‚“cM˜aC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć33‰ń“ú–{‹š•”ŽžŠłŠw‰ď‘‰ď i93.04.08j, ‰Ą•l, “ú–{‹š•”ŽžŠłŠw‰ďŽGŽ, 31(‘): 284, 1993.

969. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒpƒ‹ƒXƒIƒLƒVƒ[ƒ^‚đ—p‚˘‚˝Ý‘îŽ_‘f—Ă–@‚Ěƒ‚ƒjƒ^ƒŠƒ“ƒOƒVƒXƒeƒ€‚ÉŠÖ‚ˇ‚錟“˘. ‹v•Ű“cŸC‹ß“Ą‚Ś‚čC‰Ô“cL‰pC—é–Ř“šOC‚“cM˜aC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć33‰ń“ú–{‹š•”ŽžŠłŠw‰ď‘‰ď i93.04.09j, ‰Ą•l, “ú–{‹š•”ŽžŠłŠw‰ďŽGŽ, 31(‘): 173, 1993.

970. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –Ť•ÂÇŤ”xŽžŠł—á‚Ć”xŒ‹ŠjŒăˆâÇ—á‚Ƃ̐‡–°Žž’áŽ_‘fŒŒÇ‚Ě”äŠr. ‚“cM˜aC‹g‘şŽ‚Cň–őOC‹v•Ű“cŸCŹ‘qŒš•vC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć33‰ń“ú–{‹š•”ŽžŠłŠw‰ď‘‰ď i93.04.09j, ‰Ą•l, “ú–{‹š•”ŽžŠłŠw‰ďŽGŽ, 31(‘): 195, 1993.

971. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Nasal CPAP ‚Ć CO2 ‚ɑ΂ˇ‚éŒÄ‹C‹Ř‚Ě”˝‰ž. “팴”Í”VC‹g‘şŽ‚C˛“Ą“N–çC“c’†’ź•FC‹v•Ű“cŸC‚“cM˜aCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć33‰ń“ú–{‹š•”ŽžŠłŠw‰ď‘‰ď i93.04.09j, ‰Ą•l, “ú–{‹š•”ŽžŠłŠw‰ďŽGŽ, 31(‘): 265, 1993.

972. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’nŽ“IŽ¸”F‚É‚¨‚Ż‚é\ŹáŠQ‚Ć‚ť‚Ě‘Îˆ–@‚ɂ‚˘‚Ä. ‘O“c^ŽĄCŒĂ‹´‹I‹vCł–Ř‚Š‚‚çC—ŠZF“ńi“ŕjC‰ĄŽRŠŢ: ‘ć18‰ń“ú–{”]‘˛’†Šw‰ď i93.04.22`23j, –‹’Ł.

973. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”]oŒŒŒă‚Ě”]ŒŒŠÇáŠQ. “ĄŔ–M•FCˆ˘‹v’Ă“ń•vi“ŕjC’†‘şŒł’ĺCÄ“ĄşlC’†‘ş˜[iŹ“cŒ´Žs—§•a‰@j: ‘ć18‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i93.04.22j, ç—t.

974. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĚ“ŕ‹•ŒŒŤ•a•Ď‚ŞŽ˘Œă‚̩̏áŠQ–Ť‰ť•Ŕ‚Ń‚ÉˆŤŤi“W‚É‹y‚Ú‚ˇ‰e‹ż|ŒŒŠÇ\’z‘œ‚ć‚č‚ĚŒŸ“˘. ÎˆäŒö“šCź–Ř–ÎŽ÷C^‹ĘŽő”üśC“Ą“c–F–MCŠĄ•”‚ЂƂ݁CŽÄ“c‹v—Yi“ŕjC‰œ•˝‰ë•Fi•a—jC‘ź: ‘ć18‰ń“ú–{”÷ŹzŠÂŠw‰ď‘‰ď i93.04.22j, “Œ‹ž, —\eW, p.45, 1993.

975. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ~ˆł–ň‚Ě“Š—^ŠJŽnŒă’ZŠúŠÔ‚Ě‚¤‚ż‚É”­Ç‚ľ‚˝”][Ç‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ”Ń’Ë‚_C_“c’źCHŽR‹vŽCˆî•Ÿ“O–çC”¨—˛ŽuCâˆä•ś•Fi“ŕj: ‘ć18‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i93.04.23j, ç—t.

976. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”]ŽĺŠ˛“Ž–Ź•ÂÇŤŽžŠł‚É‚¨‚Ż‚é‹ÇŠ”]ŒŒ—ŹáŠQ‚Ě’ˇŠú“I—\Œă. ”Š_mCâˆä•ś•FC”Ń’Ë‚_CHŽR‹vŽC_“c’źi“ŕj: ‘ć18‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i93.04.23j, ç—t.

977. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Žá”NŽŇ‚Ě”][Ç|“Á‚ÉŠî‘bŽžŠł‚Ş–ž‚ç‚Š‚Ĺ‚Č‚˘Ç—á‚ĚŒŸ“˘|. ˆîŠ_“O–çC”¨—˛ŽuC–kˆä‘Ľ•vC‹ĘˆäL–žC•Ÿ“c—Ď–çCâˆä•ś•FC_“c’źi“ŕj: ‘ć18‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i93.04.23j, ç—t.

978. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŒŒ‰t“§ÍŠłŽŇ‚É‚¨‚Ż‚é”]“ŕoŒŒ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. HŽR‹vŽC–kˆä‘Ľ•vCˆî•Ÿ“O–çC”¨—˛ŽuCâˆä•ś•FC_“c’źi“ŕj: ‘ć18‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i93.04.23j, ç—t, ´˜^W, p.143, 1993.

979. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j p‘Of’f‚ލ˘“ď‚Ĺ‚ ‚Á‚˝ƒI[ƒƒ‰óhigh echo‚đ’ć‚ľ‚˝Gauzeoma‚Ě‚P—á. ‚“c‰ë”ŽC‘•Ş–ΔŽCˆÉ“Ą‹ĎC”’čŒh“ńCâŒű“NÍC^‹ĘŽő”üśCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕjC‹g“c@‹IC‘ĺ‹{“ŒśiŠOj: ‘ć62‰ń“ú–{’´‰š”gˆăŠw‰ď i93.05.06j, “Œ‹ž, “ú’´ˆă˜_•śWĽ62, 20: 353`354, 1993.

980. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰^“Žƒjƒ…[ƒƒ“•a‚É‚¨‚Ż‚éŠî’ęŠj•a•Ď‚ĚŒŸ“˘|. ’ˇ’JěˆęŽqC—Ŕł•ŁCź“csłCŒĂ˜a‹vKi“ŕjC–ö‰şŽO˜Yi_“Ţě‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“j: ‘ć34‰ń“ú–{_Œo•a—Šw‰ď‘‰ď i93.05.11`13j, ‘˝–€.

981. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Joseph•a‚ĚˆŮíŠá‹…‰^“Ž‚ÉŠÖ‚ˇ‚é—Տ°E•a—Šw“IŒŸ“˘. ’ˇ’JěˆęŽqCÂŒË˜aŽqCf‘ň’BŽuCź“csłCŒĂ˜a‹vKi“ŕjC–ö‰şŽO˜Yi_“Ţě‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“j: ‘ć34‰ń“ú–{_Œo•a—Šw‰ď‘‰ď i93.05.11`13j, ‘˝–€.

982. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j STZ“œ”A•aƒ‰ƒbƒgt•a•ĎŹ—§‰Šú‚ĚŽ…‹…‘Ě”÷×\‘˘‚̉đÍ. Žç‰Ž’B”üi“ŕjC‘ĺ–ěLˆęiŽR—œˆă‘ĺjC•˝ˆä–@”ŽC‹ŕXWC“Ię´˜aC“Ą“c–F–MC–‹`’‰i“ŕj: ‘ć36‰ń“ú–{“œ”A•aŠw‰ď‘‰ď i93.05.13j, ĺ‘ä, “œ”A•a, 36(Suppl.1): 132, 1993.

983. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j \“ńŽw’°ˆŮŠŤˆÝ”S–Œ‚Ě“ŕŽ‹‹ž“IŒŸ“˘i‘ć2•ńj. ’†ˆä‹v—YCŹň˜aŽO˜YCrěä•vC‹ß“Ąˆę‰pC‹e’rVCÎˆäŒ\‘žCĄňOC“c•Ó‘C‰ĄŽR–őCŽO‹´—˜‰ˇC‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕjC›’m–çC’†‰p’ji•a —j: ‘ć45‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.05.13j, VŠƒ, —\•ńW, p.207, 1993.

984. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘ĺ’°vascular ectasia(VE)8—á‚Ě“ŕŽ‹‹ž“I—Տ°“IŒŸ“˘. –{ŠÔ“ń˜YCŠOŽR‹v‘ž˜YCź“c–€–çC›–ě‘C“n•Ó—˛ŽiC–ě“o˝C‚“cˆę‘ž˜YC‹ŕŽRł–ži“ŕj–kđtli‰Ą•lŽs‘ĺj: ‘ć45‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.05.14j, VŠƒ.

985. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’´‰š”g“ŕŽ‹‹ž‚É‚ć‚é‘ĺ’°Šŕ[’B“xf’fŒëf—á‚ĚŒŸ“˘. Ź—ѐ´“Ti“ŕjC“n•Ó‹`˜YiŹ“cŒ´Žs—§•a‰@jCˆęŒ´—şi“ŕjC“n•ÓňCŽR“cL•viŹ“cŒ´Žs—§•a‰@jC“ŕ“Ą‹g—˛CŒÜ\—’łLCŸ–””ş‰hCźŒłŽ›Ž—çi“ŕjC ‘ĺ’J„łiŠOjCŽO•xO”VC’†‰p’ji•a—j: ‘ć45‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.05.14j, VŠƒ.

986. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰@‚É‚¨‚Ż‚éˆÝƒAƒjƒTƒLƒXÇ‚Ě—Ő°“IŒŸ“˘. ‚’Jˆç’ji“ŕjCź‰ŞŠ˛—Yi‰Ą{‰ę‹¤Ď•a‰@jC“°X‹ťˆę˜YC‚”öł•Fi“ŕjCÄ“Ą^—C‰Şč”ŽCŽO‰ŽŒö‹ICŠÖ‘ň‰pˆęi‰Ą{‰ę‹¤Ď•a‰@j: ‘ć45‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.05.14j, VŠƒ.

987. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚“œ”Z“x‰ş‚Ĺ”|—{‚ľ‚˝ƒƒTƒ“ƒMƒEƒ€×–E‚ĚƒAƒ“ƒWƒIƒeƒ“ƒVƒ“‡U‚¨‚ć‚Ńƒoƒ]ƒvƒŒƒVƒ“‚ɑ΂ˇ‚é”˝‰žŤ. ‹ŕXWCˆ˘•”D•śCŽç‰Ž’B”üC“Ię´˜aC–‹`’‰i“ŕj: ‘ć36‰ń“ú–{“œ”A•aŠw‰ď‘‰ď i93.05.14j, ĺ‘ä, “œ”A•a, 36(Suppl.1): 234, 1993.

988. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ANP‚ĚƒƒTƒ“ƒMƒEƒ€×–E‹@”\‚ɑ΂ˇ‚é‰e‹ż|×–E“ŕƒJƒ‹ƒVƒEƒ€‚đŽw•W‚Ć‚ľ‚ā|. “Ię´˜aCˆ˘•”D•śC•˝ˆä–@”ŽCŽç‰Ž’B”üC‹ŕXWC“Ą“c–F–MC–‹`’‰i“ŕj: ‘ć36‰ń“ú–{“œ”A•aŠw‰ď‘‰ď i93.05.14j, ĺ‘ä, “œ”A•a, 36(Suppl.1): 235, 1993.

989. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰ć‘œ‰đÍ‚đ—p‚˘‚˝’×á‡á­•”‚ɑ΂ˇ‚épharmacoencoscopy‚É‚ć‚éF’˛•Ď‰ť‚ĚŒŸ“˘. ĄňOC‘ĺˆä“cłlC—эO”üC’†ˆä‹v—YC‹e’rVCÎˆäŒ\‘žC’|‹g—R‰ÁŽuC“c•Ó‘CŹň˜aŽO˜YC‰ĄŽR–őCźŒłŽ›Ž—çi“ŕj: ‘ć45‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.05.14j, VŠƒ, —\eW, p.218, 1993.

990. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ˆÝĂ–ŹáŽd‰ť—Ă–@‘OŒă‚ĚŒŒs“Ž‘Ԃ̕ωť‚ɂ‚˘‚ā|“Á‚ɍśˆÝ“Ž–Ź‘˘‰e(LGA), äB“Ž–Ź‘˘‰e(SPA)‚Ĺ‚ĚŒŸ“˘. ‘şă‹§lC‘•Ş–ΔŽCŽ›ÎŒOC‚“c‰ë”ŽCÄ“Ą—˛ŽiC”’čŒh“ńC™–{­’źCa’J–ž—˛CŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕjCźŠŞ”ŽC‰““Ą‚Cˆé•”‹`Œ›i•új: ‘ć45‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.05.14j, VŠƒ, —\•ńW, p.150, 1993.

991. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j …ávÇ‚É”ş‚¤H“š•a•Ď‚Ě“ŕŽ‹‹ž“IŒŸ“˘. ÎˆäŒ\‘žCŽO‹´—˜‰ˇC‘ĺŒICŠâ–xŒöŠîCÎŠ_“ż]C“c•Ó‘C‰ĄŽR–őCźŒłŽ›Ž—çi“ŕjC‹´–{–ž•FCźŽR–Εvi”çj: ‘ć45‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.05.14j, VŠƒ, —\•ńW, p.86, 1993.

992. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ¸_‰ČƒfƒCEƒPƒA‚Ĺ‚ĚA˜J‰‡•‚É‚¨‚Ż‚é‚PlŽ@|ƒOƒ‹[ƒvEƒ[ƒN‚Ĺ‚ĚŽ{ÝŒŠŠw‚đŽŽ‚Ý‚Ä|. Šâ–{‘€CźŽR^C‹ŕŽq‰ŔŽqC–x‰z—R‹IŽqCŽR–{–ž”üC—é–؏ƒŒbCź˜e~C”’–ŘŒ´ŽsŽŸC’Ř“ŕ—F”üC’ËŒ´•qłC’†“‡ß•vi¸j: “ú–{ˆă—ÎЉ‹Ć‹Ś‰ďŠw‰ď i93.05.15j, _ŒË.

993. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŕŽ‹‹ž‰ş’´‰š”gUltrasonic Probe‚É‚ć‚é\“ńŽw’°’×ᇂ̌Ÿ“˘. ŽR“cŽŠlC‰~’n^’mŽqCâŒű“NÍC–Ř“cŒőLC–ě“o˝CˆÉ“Ą‹ĎC“c•Ó‘CŹň˜aŽO˜YC‰ĄŽR–őCŽO‹´—˜‰ˇC‘ĺˆä“cłlC^‹ĘŽő”üśCźŒłŽ›Ž—çi“ŕjCŽOd–ě Š°ŠěC”äŠé”\Ž÷iŠOjC–Ř“c–FŽ÷C›’m–çC’†‰p’ji•a—j: ‘ć45‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.05.15j, VŠƒ, —\eW, p.276, 1993.

994. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œ`ó‹L‰Żƒvƒ‰ƒXƒ`ƒbƒN‚̉şŽˆ‘•‹ď‚ւ̉ž—p. ‘O“c^ŽĄi“ŕjC˛“ĄŒMi•˝ˆä‹`ŽˆŒ¤‹†ŠjC’ˇ‘ňOC“‡“c—˛ŽqCŒă“ĄˆŔŒbiƒŠƒn•”jC˛ŽĄ–L•iŽO•HdHj: “ú–{ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ď i93.05.20j, ĺ‘ä.

995. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –ŤŠú”]‘˛’†ŠłŽŇ‚É‚¨‚Ż‚éW’cŒP—ű‚Ćƒ}ƒ“ƒc[ƒ}ƒ“ŒP—ű‚ĚˆÓ‹`|YGŤŠiŒŸ¸‚đ—p‚˘‚˝ŒŸ“˘‚Š‚ç|. ‰F–ěNLi‘ĺ‘ Čˆóü‹Ç“Œ‹ž•a‰@jCŠO“‡—T”ViƒŠƒn•”jC‘O“c^ŽĄi“ŕj: ‘ć20‰ń“ú–{—Šw—Ă–@ŽmŠw‰ď i93.05.20`21j, ‰Ą•l.

996. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”]oŒŒŠłŽŇ‚Ě’ˇŠú—\Œă|‘މ@ŽžADL‚Ć‚Ě”äŠr|. _“c’źC”Š_mC‹ĘˆäL–žC”¨—˛ŽuCâˆä•ś•Fi“ŕj: ‘ć30‰ń“ú–{ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ˆăŠw‰ď i93.05.20j, ĺ‘ä.

997. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œ`ó‹L‰Żƒvƒ‰ƒXƒ`ƒbƒN‚ĚRAŠłŽŇ‚ĚƒXƒvƒŠƒ“ƒg. ‘O“c^ŽĄi“ŕjC˛“ĄŒMi•˝ˆä‹`ŽˆŒ¤‹†ŠjC“‡“c—˛ŽqCŒă“ĄˆŔŒbiƒŠƒn•”jC˛ŽĄ–LiŽO•HdHj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď i93.05.22`24j, –źŒĂ‰Ž.

998. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j üˆŰ‰č×–EƒRƒ‰[ƒQƒ“‘ăŽÓ‚É‹y‚Ú‚ˇ IL-4 ‚̍ě—p. ÔŻ“§C•äâ–΁C“c’†Z–žCŠÖŽRŘ•äC‹ß“ĄŒ[•śi“ŕj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž.

999. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j RD’†‹…×–EŽżR‘̂𔺂¤‹­”çÇ‚Ě—Ő°“I“Á’Ľ. ‰““Ą•˝mC×–ěF˜YC‹ß“ĄŒ[•śi“ŕj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž.

1000. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”xoŒŒ‚đ’ć‚ľ‚˝–ŤŠÖßƒŠƒEƒ}ƒ`‚Ě‚P—á. ŠÖŽRŘ•äCŠp‰Ć–ž•śC×–ěF˜YC‰““Ą•˝mC‰Ş“cƒC‹ß“ĄŒ[•śi“ŕj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž.

1001. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j RA –ň•¨—Ă–@‚ĚŒťó‚Ć‚P”NŒă‚̒ǐՒ˛¸iƒŠƒEƒ}ƒ`ę–ĺ•a‰@17Ž{Ý‚É‚ć‚鋤“ŻŒ¤‹†). ‹´–{–žC”č’ő•vC‰„‰iłC‰Ş“cƒi“ŕjC‘ź14–źiŒúśČƒŠƒEƒ}ƒ`’˛¸Œ¤‹†Ž–‹Ć“ŕ‰Č“IŽĄ—ĂŒ¤‹†”ǁj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž.

1002. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –ŤŠÖßƒŠƒEƒ}ƒ`‚Ě QOL •]‰ż–@. …“‡—TC‚‹´GmCHŒŽłŽjC‹ß“ĄŒ[•śi“ŕjC‰Ź“c’‰ŒúCóˆä•x–žC•’‡‘PFC‹‘ş–ΖžC‹g“c‰ëŽqCŻŒbŽqC—L•xŠ°C’ŘˆäşŽŚC•Ä–žO”ViŒúśČRA’˛¸ Œ¤‹†QOL‚ÉŠÖ‚ˇ‚錤‹†”ǁj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž.

1003. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –ŤŠÖßƒŠƒEƒ}ƒ` (RA) ‚É‚¨‚Ż‚é intercrine family mRNA ‚Ě”­Œť‚ĚŒŸ“˘. •äâ–΁CÔŻ“§C‹ß“ĄŒ[•śi“ŕjC”č’ő•vi“Œ—ˆă‘ĺj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž.

1004. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j RƒŠƒ“Ž‰ŽżR‘ĚÇŒóŒQ (APS) ‚É‚¨‚Ż‚éR cardiolipin R‘Ě (aCL) ‚ĚŒ‹‡”\‚ÉŠÖ‚ˇ‚錟“˘. ‰Ş“cƒCŠOŽRWC–ě‘şł˘C•äâ‹v”üC‹ß“ĄŒ[•śi“ŕj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž.

1005. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Vitamin D3 (Vit D3) ‚Ě SLE ˆŮŠÎŠD‰ť‚ɑ΂ˇ‚é‰e‹ż. –ě‘şł˘CÎěŽçC‘]Ž˘‘’qŽqC‰Ş“cƒC‹ß“ĄŒ[•śi“ŕj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž.

1006. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j D’†‹…Œ¸­Ç‚É”ş‚¤Š´őÇ‚ɑ΂ˇ‚é CAZ+G-CSF •š—p—Ă–@‚ĚŒŸ“˘. ‰Y•”ť•viŠÖ“Œ’üM•a‰@jC‚‹vŽj–›i‘—§‘Űˆă—ĂƒZƒ“ƒ^[jC‰–’J–΁i“ŕjC‘ź: ‘ć41‰ń“ú–{‰ťŠw—Ă–@Šw‰ď‘‰ď i93.06.00j, “Œ‹ž.

1007. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”]ŒŒŠÇáŠQŠłŽŇ‚É‚¨‚Ż‚élH’YŽ_ň—Ü‚É‚ć‚é”]zŠÂ. ź‰ŞłŒhC‘O“c^ŽĄCł–Ř‚Š‚‚çC—ŠZF“ńCf‘ň’BŽui“ŕjC‰ĄŽRŠŢ: “ú–{‰ˇň‹CŒó•¨—ˆăŠw‰ď‘‰ď i93.06.03`04j, ŽD–y.

1008. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒgt”玿”A×ŠÇŠî’ę–Œ Ca ƒ|ƒ“ƒv‚ĚƒŠƒ|ƒ][ƒ€‚Ö‚ĚÄ\Ź‚Ć•”•Ş¸ť. ™‘şˆę˝CŠÝ–{•—˜iă‘ĺjC’Ë–{—Y‰îi“ŕjCWadin, S.(Baylor College): ‘ć66‰ń“ú–{“ŕ•Ş”ĺŠw‰ď i93.06.03j, ‹ŕ‘ň, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 69(4): 414, 1993.

1009. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒqƒgbó‘BŠŕ×–E‚É‚¨‚Ż‚éƒvƒŠƒ“ě“ŽŤŽó—e‘Ě‚ĚƒVƒOƒiƒ‹“`’B‹@\‚ĚˆŮí. ˆ˘•”D•śC‹ŕXWC–‹`’‰i“ŕjCˆÉ“Ą‘•F: ‘ć66‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠwp‘‰ď i93.06.04j, ‹ŕ‘ň, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 69(4): 358, 1993.

1010. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰EŠĽ“Ž–Ź (RCA) •a•Ď‚ɑ΂ˇ‚銼“Ž–ŹŒ`Źp (PTCA) ‚̍‡•šÇ”­ś—á, •sŹŒ÷—á‚ĚŒŸ“˘. ‹v•Ű‹MşC•‘ň—˜˜YC’ˇ’Jě‰„LCŠ“c”ü—ć”TCŹ‚L]CŹ—Ń–ž–FC‘şź€C–ؐě“c—˛ˆęi“ŕj: ‘ć20‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď‘‰ď i93.06.08`11j, ŽD–y, ICU‚ĆCCU, 17(‘): 149, 1993.

1011. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹Ů‹}ŠĽ“Ž–ŹŒ`Źp (PTCA) ‚Ě•sŹŒ÷—á‚ĚŒŸ“˘. Š“c”ü—ć”TC•‘ň—˜˜YC’ˇ’Jě‰„LCŹ‚L]C‹v•Ű‹MşCŹ—Ń–ž–FCŽá—Ń–ő‹vi“ŕjC‘“c‘ěi‹~–˝jC‘şź€C‘ĺ˜a“c—˛i‹~–˝jC–ؐě“c—˛ˆęi“ŕj: ‘ć20‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď‘‰ď i93.06.08`11j, ŽD–y, ICU‚ĆCCU, 17(‘): 149, 1993.

1012. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰şŒă•Ç[Ç‹}ŤŠú‚Ě ST •ÎˆĘ‚É‚¨‚ć‚Ú‚ˇ‰e‹ż‚ɂ‚˘‚Ä. Ź—Ń–ž–FC‹g“cTC‰ŹŒ´“āC’Ĺ–źł_C‹v•Ű‹MşC˛“ĄŽüCŠ“c”ü—ć”TCŹ‚L]C•˝źT‰EC•‘ň—˜˜YC’ˇ’Jě‰„LC‘şź€C–ؐě“c—˛ˆęi“ŕj: ‘ć20‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď‘‰ď i93.06.08`11j, ŽD–y, ICU‚ĆCCU, 17(‘): 207, 1993.

1013. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j S‹Ř[ÇÇ‚É‚¨‚Ż‚é‰ES‹@”\‚Ě•]‰ż‚ƍśS•a‘Ô. •˝źT‰ECÎě’źŽ÷CV’Ă’J^lC‰ŹŒ´“āCŹ—Ń–ž–FC’ˇ’Jě‰„LC‘şź€C–ؐě“c—˛ˆęi“ŕj: ‘ć20‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď‘‰ď i93.06.08`11j, ŽD–y, ICU‚ĆCCU, 17(‘): 208, 1993.

1014. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ˆŸÉŽ_Ü‚ĚŒŒˆł’˛ß‚¨‚ć‚Ń 24 ŽžŠÔŒŒˆł‚É‹y‚Ú‚ˇ‰e‹ż‚ɂ‚˘‚Ä. ´…ŠŽ‰xC–]ŒŽr’źCě•Ó•q”VCX“cGlC‘ę‘ňrŽ÷CŹ‘ňŒ°ˆęC”öŒ`’ˇ—YC‘ĺŒIŽĄ•FCěŒű’|’jC•ěMŒĺC˜Ič‹P•vCˆÉ˜@‰ÔC–ؐě“c—˛ˆęi“ŕj: ‘ć20‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď‘‰ď i93.06.08`11j, ŽD–y, ICU‚ĆCCU, 17(‘): 219, 1993.

1015. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒp[ƒLƒ“ƒ\ƒ“•a‚ɉ—‚Ż‚é’m“I‹@”\ 2j|_Œo•a—Šw“I‰Á—î•Ď‰ť‚ɂ‚˘‚Ä. —Ŕł•ŁC’ˇ’JěˆęŽqCŒĂ‹´‹I‹vCŒĂ˜a‹vKi“ŕjC–ö‰şŽO˜Yi_“Ţě‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“j: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.09j, ç—t.

1016. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •Đ“Ş’É”­ě‚Ě‹ÇŠ”]ŒŒ—Ź‚ĚŒŸ“˘. ŒÜ\—’‹v‰ŔCâˆä•ś•FC_“c’źi“ŕj: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.09j, ç—t.

1017. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}ŤŒÄ‹z•s‘S‚ɑ΂ˇ‚é‹CŠÇŽx”x–Eôň‰t (BALF) ‚Ě—L—pŤ‚ÉŠÖ‚ˇ‚錤‹†. ‹v•Ű“cŸC‚“cM˜aC–î“ߐŁM—YC•y“c—FKi“ŕjCó—˜–őC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć20‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď‘‰ď i93.06.09j, ŽD–y, ICU‚ĆCCU, 17(‘): 153, 1993.

1018. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰Ć‘°Ťƒp[ƒLƒ“ƒ\ƒ“•a‰ĆŒn‚QÇ—á‚̐_Œo•a—Šw“IŒŸ“˘. ’ˇ’JěˆęŽqC—Ŕł•ŁC˛ŽRßŽqCŒĂ˜a‹vKi“ŕjC–ö‰şŽO˜Yi_“Ţě‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“j: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.10j, ç—t.

1019. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹ŘˆŢkŤ‘¤őd‰ťÇ‚É‚¨‚Ż‚éŇ‘‘OŠp×–E‚ƍœŠi‹ŘˆŢk. ź“csłC’ˇ’JěˆęŽqCŒĂ˜a‹vKi“ŕjC–ö‰şŽO˜Yi_“Ţě‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“j: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.10j, ç—t.

1020. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒp[ƒLƒ“ƒ\ƒ“•a‚̉^“ŽŠÖ˜A“dˆĘ‚ÉŠÖ‚ˇ‚éŽá”NŽŇ‚¨‚ć‚э‚—îŽŇƒRƒ“ƒgƒ[ƒ‹‚Ć‚Ě”äŠr. aˆä—߈ęC˛ŽRßŽqC’ˇ’JěˆęŽqCŒĂ˜a‹vKi“ŕjCŠŽi–r•śi—ŐŒŸj: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.10j, ç—t.

1021. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒp[ƒLƒ“ƒ\ƒ“Çó‚ɑ΂ˇ‚鉖Ž_ƒCƒ“ƒfƒƒLƒTƒWƒ“‚ĚŒř‰Ę:—Տ°“I—L—pŤ‚ɂ‚˘‚Ä. ł–Ř‚Š‚‚çCŒĂ‹´‹I‹vCź‰ŞłŒhCŒĂ‘ň‰p–žCŒĂ˜a‹vKi“ŕj: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.11j, ç—t.

1022. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ő“ŽŤŠá‹…‰^“Ž‚Ćčň•”‰^“Ž‚ĚŠÖŒW‚ɂ‚˘‚Ä(‘ć‚Q•ń). ŽO•x“N˜YC’ˇ’JěˆęŽqC˛ŽRßŽqCÂŒË˜aŽqCŒĂ˜a‹vKi“ŕj: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.11j, ç—t.

1023. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œ´ˆö•s–ž‚Ě––˝_ŒoáŠQŠłŽŇ‚É‚¨‚Ż‚éŒűOśŒŸ‚Ě—Ő°“IˆÓ‹`‚ɂ‚˘‚Ä. ‹y”\ŽGCÄ“Ą–L˜aCÂŒË˜aŽqCŒĂ˜a‹vKC’š‹‡ŽOi“ŕj: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.11j, ç—t.

1024. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’E‘Ťƒjƒ…[ƒƒpƒ`[‚É‚¨‚Ż‚éRGN1 R‘Ě‚ĚƒXƒyƒNƒgƒ‰ƒ€. “ü]KŽqCÄ“Ą–L˜aC‹y”\ŽGCˆÉ“Ą”Ž–žCŒĂ˜a‹vKi“ŕj: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.11j, ç—t.

1025. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –Ť‰ŠÇŤ’E‘Ťƒjƒ…[ƒƒpƒ`[iCIDP) ‚ĚGmƒAƒƒ^ƒCƒv. ˆŔ“c•ŽiC–ö–ąi–źŒĂ‰Ž‘ć‚Q“úÔjC‘c•ƒ]ŒłC–žŠÔĆ“Tiˆ¤’mˆă‘ĺjCÄ“Ą–L˜ai“ŕjC‹{čŽžŽqiăˆă‘ĺj: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.11j, ç—t.

1026. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’ˇŠú‚É‚í‚˝‚čŒo‰ßŠĎŽ@‚đ‚¨‚ą‚Č‚˘“ž‚˝ŹŽ™CIDP ‚R—á‚Ě—Ő°‘œ. ÂŒË˜aŽqCÄ“Ą–L˜aC“ü]KŽqC‹y”\ŽGCŒĂ˜a‹vKi“ŕjC–{‘˝ĺi•v: ‘ć35‰ń“ú–{ŹŽ™_ŒoŠw‰ď‘‰ď i93.06.17j, ‹ž“s.

1027. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŽlŽˆ‚Ě’×ᇥ‰óás‚đ‡•š‚ľ‚˝R centromere R‘Ě—zŤ‚Ě‚UÇ—á. ‚‹´“š—YCÎěÍC‰Ş“cƒC‹ß“ĄŒ[•śi“ŕjC”č’ő•vi“Œ—ˆă‘ĺj: ‘ć25‰ń“ú–{Œ‹‡‘gDŠw‰ď‘‰ď i93.06.17`18j, ‘ĺă.

1028. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j R IL-8 R‘Ě‚É‚ć‚é‰Ć“eŽŔŒąŠÖß‰Š‚̐§Œä. ÔŻ“§C‰““Ą•˝mC‹ß“ĄŒ[•śi“ŕjC”č’ő•vCź“‡jŽĄi“Œ—ˆă‘ĺj: ‘ć14‰ń“ú–{‰ŠÇŠw‰ď i93.06.24`25j, Šň•Œ.

1029. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ˆž—ąŒ‹Šj‚̐f’f‚É‚¨‚Ż‚é‹CŠÇŽx‹žŒŸ¸‚Ě—L—pŤ. ‚“cM˜ai“ŕjC‘Š”nˆęˆĺi‹~–˝jC‰Ô“cL‰pC—é–Ř“šOC‹ß“Ą‚Ś‚čC‹v•Ű“cŸC“팴”Í”VC–î“ߐŁM—YC•y“c—FKi“ŕj: ‘ć16‰ń“ú–{‹CŠÇŽxŠw‰ď‘‰ď i93.06.24j, –źŒĂ‰Ž, ‹CŠÇŽxŠw, 15(4): 341, 1993.

1030. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒAƒ‹ƒR[ƒ‹ŤŠĚáŠQ‚É‚¨‚Ż‚éTissue Polypeptide Antigen‚Ě—Ő°•a—Šw“IŒŸ“˘. ” čK–çC“Ą‰Ş‚OC”’•l—´‹ťCŒKŒ´‹I”VCź–{rŽĄi“ŕj: ‘ć29‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď i93.07.16j, “Ţ—Ç, ŠĚ‘Ÿ, 34(3): 110, 1993.

1031. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚bŒ^–ŤŠĚ‰Š‚ɑ΂ˇ‚éƒCƒ“ƒ^[ƒtƒFƒƒ“’ˇŠúĽŠÔŸ[—Ă–@‚ĚŽĄ—ĂŒř‰Ę‚ɂ‚˘‚Ä. ” čK–çC“Ą‰Ş‚OC‰Á“Ą‰ëŽmC”’•l—´‹ťi“ŕj: ‘ć29‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď i93.07.16j, “Ţ—Ç, ŠĚ‘Ÿ, 34(3): 69, 1993.

1032. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŽŔŒą“I‘e‘ĺŒ‹ßŤd•ĎŠĚ‚ĚˆŤŤ•Ď‰ť‚É‹y‚Ú‚ˇŠĚ“ŕ‰óŽ€Ť•a•Ď‚ĚˆÓ‹`. ÎˆäŒö“šCź–Ř–ÎŽ÷C™–{­’źC”’čŒh“ńCŽÄ“c‹v—Yi“ŕjC‰œ•˝‰ë•Fi•a—j: ‘ć29‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď i93.07.16j, “Ţ—Ç, ŠĚ‘Ÿ, 34(Suppl.1): 159, 1993.

1033. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j H“šĂ–ŹáŽŒŒ‰tƒKƒX•ŞÍ‚ĚŒŸ“˘(‘ć2•ń)d‰ť—Ă–@’†‚̕ωť‚Š‚ç‚Ý‚˝—Տ°“IˆÓ‹`. ‘•Ş–ΔŽC‘şă‹§lC‚“c‰ë”ŽCŽOŽ}MC˛“ĄłŽ÷C”’čŒh“ńC™–{­’źCa’J–ž—˛CÎˆäŒö“šCŽÄ“c‹v—Yi“ŕj: ‘ć29‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď i93.07.16j, “Ţ—Ç, ŠĚ‘Ÿ, 34(Suppl.1): 183, 1993.

1034. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j _ŒoŤHŽv•sUÇ‚É‚¨‚Ż‚éŠĚáŠQ, “Á‚ɏdÇ—á‚ɂ‚˘‚Ä. Šâ–xŒöŠîCÄ“ĄrŽiCa’J–ž—˛C”’čŒh“ńC‘şă‹§lC‘•Ş–ΔŽCŽÄ“c‹v—YC™–{­’źi“ŕjCŒĂ’m‹MŒbŽqi¸j: ‘ć29‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď i93.07.16j, “Ţ—Ç, ŠĚ‘Ÿ, 34(Suppl.1): 338, 1993.

1035. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ˆŔ‘§Ž_ƒGƒXƒgƒ‰ƒWƒI[ƒ‹‚ĆBCG•š—p—Ă–@‚É‚ć‚éŠĚd•Ď‚ĚˆŤŤi“W‘jŽ~‚ĚŽŽ‚Ý. ÎˆäŒö“šC™–{­’źC”’čŒh“ńCź–Ř–ÎŽ÷CŽÄ“c‹v—Yi“ŕj: ‘ć29‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď i93.07.16j, “Ţ—Ç, ŠĚ‘Ÿ, 34(Suppl.1): 348, 1993.

1036. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĚ×–EŠŕ‚É“ÁˆŮ“I‚ČƒAƒ‹ƒfƒqƒh’E…‘fy‘fƒAƒCƒ\ƒUƒCƒ€‚Ě”­Œť‚ÉŠÖ‚ˇ‚錤‹†. a’J–ž—˛i“ŕjC’|“ŕ“ÖŽqi“Œ•a‰@Œ¤‹†ŒnjCŽÄ“c‹v—Yi“ŕjC‹g“cşiCity of HopeŒ¤‹†Šj: ‘ć29‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď i93.07.16j, “Ţ—Ç, ŠĚ‘Ÿ, 34(Suppl.1): 94, 1993.

1037. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j HCV–łÇŒóŤƒLƒƒƒŠƒA‚É‚¨‚Ż‚éƒGƒ“ƒxƒ[ƒv’`”’Žż‚Ě•ĎˆŮ‚Ć‚ť‚̑̉tŤ–Ɖu‰ž“š. ’†‘ň‹MGi“ŕjC‰Á“Ąé”VCŠÖ’Jm”üC‘ĺ’ĂŽR—SŽqi‘—§‚Ş‚ńƒZƒ“ƒ^[jC“Ą‰Ş‚OCa’J–ž—˛i“ŕjC‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ƒ^[j: ‘ć29‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď i93.07.16`17j, “Ţ—Ç, —vŽ|W, 34(1): 140, 1993.

1038. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}ŤŠĚ‰Š‚ć‚č–Ť‰ť‚ľ‚˝Ç—á‚É‚¨‚Ż‚éHCVƒGƒ“ƒxƒ[ƒv’`”’Žż‚Ě•ĎˆŮ‚Ć‚ť‚ę‚ɑ΂ˇ‚é‘̉tŤ–Ɖu‰ž“š. ŠÖ’Jm”üC‰Á“Ąé”VC‘ĺ’ĂŽR—SŽqi‘—§‚Ş‚ńƒZƒ“ƒ^[jC’†‘ň‹MGi“ŕjCŽR“ŕŽŒČi“Œ—ˆă‘ĺjC‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ƒ^[j: ‘ć29‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď i93.07.16`17j, “Ţ—Ç, —vŽ|W, 34(1): 140, 1993.

1039. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒGƒ“ƒxƒ[ƒu’`”’Žż‚É‘śÝ‚ˇ‚é’´‰Â•Ď—Ěˆć‚ĚŒoŽž“I•Ď‰ť‚Ć‚ť‚ę‚ɑ΂ˇ‚é“ÁˆŮR‘Ě‚ĚŒŸo. ‰Á“Ąé”VCŠÖ’Jm”üi‘—§‚Ş‚ńƒZƒ“ƒ^[jC’†‘ň‹MGi“ŕjC‘ĺ’ĂŽR—SŽqC“y•ű˝i‘—§‚Ş‚ńƒZƒ“ƒ^[jC‘ĺ‰zÍŒáiVŠƒ‘ĺjC‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ ƒ^[j: ‘ć29‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď i93.07.16`17j, “Ţ—Ç, —vŽ|W, 34(1): 287, 1993.

1040. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j —nŒŒŤ”A“ĹÇÇŒóŒQ (HUS) —l•a•Ď, ŒŒŹ”ÂŒ¸­‚ɃXƒeƒƒCƒh, ƒGƒ“ƒhƒLƒTƒ“ƒpƒ‹ƒX, ŒŒŸ÷ŒđŠˇ—Ă–@‚Ş—LŒř‚Ĺ‚ ‚Á‚˝‹š‘B‘B‚𔺂Á‚˝ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚Ě‚P—á. ŠÚ–ěƒśCĄč‹MśC‘ęŽR—eŽqC–xˆäşCŹ‹v•Ű“§CŽç‰Ž—˜‰ŔCŹ—Ń–Li“ŕj: ‘ć38‰ń“ú–{“§Í—Ă–@Šw‰ď‘‰ď i93.07.17`18j, ç—t.

1041. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŒŒ‰t“§ÍŠłŽŇ‚É‚Ý‚ç‚ę‚鎊ŒČŠÇ—•s—Ç‚Ć‚ť‚Ě—vˆö‚ɂ‚˘‚Ä‚Ě•ŞÍ. ‹{“‡•Ÿ]CŠ™“cvŽőC‹g“cŕˆCŹ—Ń’ź”VC—é–Ř˜ćŽqi“ŕj: ‘ć38‰ń“ú–{“§Í—Ă–@Šw‰ď‘‰ď i93.07.17`18j, ç—t.

1042. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j BIA–@‚É‚ć‚é‘ĚŽ‰–b—Ś‚ĆŠĚ‹@”\ˆŮí‚Ě•p“x‚ÉŠÖ‚ˇ‚錟“˘. ‚“cˆę‘ž˜YC“n•Ó—˛ŽiC–{ŠÔ“ń˜YC–ě“o˝CŠOŽR‹v‘ž˜YC‹ŕŽRł–ži“ŕjC•“c–ž‰pC‰Á“Ąƒ†ƒLŽqC“ě—˘‚ł‚ćŽqi•˝’Ë‹¤Ď•a‰@j: ‘ć34‰ń“ú–{lŠÔƒhƒbƒNŠw‰ď i93.08.26j, –źŒĂ‰Ž.

1043. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘˝”­Ť‹Ř‰ŠĽ”畆‹Ř‰Š‚Ě‹Ř‘gD‚É‚¨‚Ż‚éÚ’…ˆöŽq‚ĚˆÓ‹`. ‰Ş“cƒC’š‹‡ŽOC‹ß“ĄŒ[•śi“ŕj: ‘ć21‰ń“ú–{—Տ°–ƉuŠw‰ď‘‰ď i93.09.08`10j, ŽD–y.

1044. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Lupus enteritis ‚Ě CT ŒŸ¸‚Ě—L—pŤ‚ɂ‚˘‚Ä. •äâ–΁C×–ěF˜YC‹ß“ĄŒ[•śi“ŕj: ‘ć21‰ń“ú–{—Տ°–ƉuŠw‰ď‘‰ď i93.09.08`10j, ŽD–y.

1045. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒx[ƒ`ƒFƒbƒg•a‚ɉ—‚Ż‚éRD’†‹…×–EŽżR‘Ě‚ĚˆÓ‹`. ×–ěF˜YC‹ß“ĄŒ[•śC‰““Ą•˝mi“ŕj: ‘ć21‰ń“ú–{—Տ°–ƉuŠw‰ď‘‰ď i93.09.08`10j, ŽD–y.

1046. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ś‘̐tˆÚAƒhƒi[‚̐t’ń‹ŸŒă‚̐t‹@”\‚ĚŒŸ“˘. ’|“ŕN—YCŠ™“cvŽőC‘ĺ‹v•Ű[lC“ŕ“c–ž”üŽqi“ŕjCź‘ňŽ“TC˛“ĄŒőŽjCŠ`“cÍiŠOjCŒF–ě˜a—YC‰““Ą’‰—Yi”ĺj: ‘ć29‰ń“ú–{ˆÚAŠw‰ď i93.09.17j, ‹ŕ‘ň, ˆÚA, 28: 99, 1993.

1047. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚bŒ^–ŤŠˆ“ŽŤŠĚ‰Š‚ɑ΂ˇ‚éƒCƒ“ƒ^[ƒtƒFƒƒ““Š—^‘O‹y‚ŃŒo‰ß‚É‚¨‚Ż‚錟¸ŹŃ. ź–{ˆĚ’jC”’čŒh“ńC‘şă‹§lCa’J–ž—˛C‘•Ş–ΔŽCŽÄ“c‹v—Yi“ŕjC™–{­’źi—Տ°–ň—j: ‘ć35‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď i93.09.20j, _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ, 90(—Ő‘): 1910, 1993.

1048. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’´‰š”g“ŕŽ‹‹žŒŸ¸‚É‚ć‚éäX‘š‚̐f’f. âŒű“NÍi“ŕjC‘꓇í‰ëiŠOjC™–{Ÿ•FC‘ĺ˜a“c—˛i‹~–˝jC‘ĺ‹{“ŒśCŠ`“cÍiŠOjCźŒłŽ›Ž—çi“ŕj: ‘ć24‰ń“ú–{äX‘ŸŠw‰ď‘ĺ‰ď i93.09.20j, _ŒË, äX‘Ÿ, 8(4): 305, 1993.

1049. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰@‚É‚¨‚Ż‚éĹ‹ß10”NŠÔ‚ĚˆÝŠŕ‚Ě“ŽŒü|‚—îŽŇÇ—á‚𒆐S‚É. ŠÖ‘ň‰pˆęCź‰ŞŠ˛—YCŽO‰ŽŒö‹IC‰Şč”Ži‰Ą{‰ę‹¤Ď•a‰@jC‚’Jˆç’ji“ŕjCÄ“Ą^—i‰Ą{‰ę‹¤Ď•a‰@jC‚”öł•FC“°X‹ťˆę˜Yi“ŕj: ‘ć35‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď i93.09.21j, _ŒË.

1050. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j RI‚đ—p‚˘‚˝ˆÝ”ro”\‚É‚¨‚Ż‚éŠČˆŐŽŽŒąH‚ĚŽŽ‚Ý. ÎˆäŒ\‘žC“c•Ó‘C‰iŒŠ–žśCrěä•vCŽRăp‚ł‚ä‚čC’†ˆä‹v—YC‹e’rVC‹ß“Ąˆę‰pCĄňOCŹň˜aŽO˜YC‰ĄŽR–őC‘ĺˆä“cłlCŽO‹´—˜‰ˇCźŒłŽ›Ž—ç i“ŕjCźŠŞ”ŽCˆé•”‹`Œ›i•új: ‘ć35‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď i93.09.21j, _ŒË, —\eW, p.1953, 1993.

1051. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ž‰—nŤ HMG-CoA ŠŇŒły‘f‘jŠQ–ň (Simvastatin) ŽĄ—Ă‚É‚ć‚鍂Ž‰ŒŒÇ‰ü‘PŽž‚ĚŒŒs—ÍŠw“I•Ď‰ť‚ɂ‚˘‚Ä. ‘şź€CŹ—Ń–ž–FCóŒŠ‘CŹ‚L]C’ˇ’Jě‰„LC–ؐě“c—˛ˆęi“ŕj: ‘ć14‰ń“ú–{—Տ°–ň—Šw‰ď i93.09.21`22j, ‰Ą•l, —vŽ|W, p.82, 1993.

1052. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}ŤS‹Ř[Ç‚É‚¨‚Ż‚éSŽş’x‰„“dˆĘ‚Ě”­śˆöŽq‚ÉŠÖ‚ˇ‚錟“˘|˜V”NŽŇ‚Ć‘s”NŽŇ‚̑Δä|. ˛“ĄŽüCóŒŠ‘C‘şź€CŹ—Ń–ž–FC’ˇ’Jě‰„LC–ؐě“c—˛ˆęi“ŕj: ‘ć35‰ń“ú–{˜V”NˆăŠw‰ď i93.09.22`24j, ŽD–y, “ú–{˜V”NˆăŠw‰ďŽGŽ, 30(´): 88, 1993.

1053. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰^“Žƒjƒ…[ƒƒ“•a‚É‚¨‚Ż‚é‰Á—î‚̉e‹ż|•a—Šw“I‰Á—•Ď‰ť‚ɂ‚˘‚ā|. —Ŕł•ŁC’ˇ’JěˆęŽqCŒĂ‹´‹I‹vCŽO•xO”Vi“ŕjC–ö‰şŽO˜Yi_“Ţě‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“j: ‘ć30‰ń“ú–{˜V”NˆăŠw‰ď‘‰ď i93.09.23j, ŽD–y.

1054. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”]oŒŒŠłŽŇ‚Ě’ˇŠú—\Œă|‰Á—î‚ĆŒŒŽî•”ˆĘ‚Ě–Ę‚Š‚ç‚ĚŒŸ“˘|. ‹ĘˆäL–žCHŽR‹vŽC”Ń’Ë‚_C•Ÿ“c—Ď–çC–kˆä‘Ľ•vC”¨—˛ŽuCâˆä•ś•FC_“c’źi“ŕj: ‘ć35‰ń“ú–{˜V”NˆăŠw‰ď‘‰ď i93.09.23j, ŽD–y.

1055. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŕŽ‹‹ž“IĂ–ŹáŽ‘˘‰e(EVIS)‚ĚŒŸ“˘i‘ć5•ńj–ĺ–Ź|”xĂ–Ź•Ť‡(PPVA)‚Ě‘śÝ‚ƍ‡•šÇ‚ɂ‚˘‚Ä. ‘şă‹§lC‘•Ş–ΔŽCŽ›ÎŒOC‚“c‰ë”ŽCÄ“ĄrŽiCź–{ˆĚ’jC˛“ĄłŽ÷C”’čŒh“ńC™–{­’źCa’J–ž—˛CŽÄ“c‹v—YCźŒłŽ›Ž—çCŠOŽR‹v‘ž˜Yi“ŕj: ‘ć46‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.09.23j, _ŒË, u‰‰—\•ńW, p.190, 1993.

1056. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĚ—ǐŤŒ‹ßŤ•a•Ď‚Ě• o‹žŠŒŠ. a’J–ž—˛C”’čŒh“ńC˛“ĄłŽ÷C‘şă‹§lC™–{­’źC‘•Ş–ΔŽC^‹ĘŽő”üśCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕj: ‘ć46‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.09.24j, _ŒË, u‰‰—\•ńW, p.262, 1993.

1057. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ICG•š—pÔŠOü“ŕŽ‹‹ž‚É‚ć‚éˆÝ•Ç“ŕŒŒŠÇ‚ĚŠĎŽ@‚Ć‚ť‚ĚŒŔŠE. Źň˜aŽO˜YC“c•Ó‘C‹ß“Ąˆę‰pC’†ˆä‹v—YC‹e’rVCÎˆäŒ\‘žC‰ĄŽR–őC‘ĺˆä“cłlCŽO‹´—˜‰ˇCźŒłŽ›Ž—çi“ŕjC”äŠé”\Ž÷iŠOjC›’m–çC’†‰p’ji•a —j: ‘ć46‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.09.24j, _ŒË, u‰‰—\•ńW, p.48, 1993.

1058. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ý‘îŽ_‘f—Ă–@’†‚Ě–ŤŒÄ‹zŠíŽžŠłŠłŽŇ‚É‚¨‚Ż‚鐇–°Žž’áŽ_‘fŒŒÇ. ‚“cM˜aC—é–Ř“šOC‰Ô“cL‰pC‹ß“Ą‚Ś‚čC‹v•Ű“cŸC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć35‰ń“ú–{˜V”NˆăŠw‰ď‘‰ď i93.09.24j, ŽD–y, “ú–{˜V”NˆăŠw‰ďŽGŽ, 30(‘): 120, 1993.

1059. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –ŤŠĚ‰Ši“W‚ĚŽw•W‚Ć‚ľ‚Ă̊̐üˆŰ‰ťƒ}[ƒJ[‚ĚŒŸ“˘. ˆŔ•”–ž˜YC“n•”K•vi‘—§‘Š–ÍŒ´•a‰@jCˆŔ’BŒŁi“ŕjCˆäo“NC‹´–{“Ni‘—§‘Š–ÍŒ´•a‰@jCÎěŽĺĹi“ŕjC’†‘ş—zŽqC“‡’Ă—TCó”ö•Žmi‘—§‘Š–ÍŒ´•a ‰@j: ‘ć48‰ń‘—§—Ă—{Š‘‡ˆăŠw‰ď i93.09.30j, ŽD–y, ˆă—Ă, 47(‘): 110, 1993.

1060. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –ŤŠÖßƒŠƒEƒ}ƒ`‚ɍ‡•š‚ľ‚˝ˆÝ’×ᇂ̗Տ°“IŒŸ“˘|“—vˆö‚Ě“ŕŽ‹‹ž“IŒŸ“˘‚đŠÜ‚߂ā|. ÎěŽĺĹCˆŔ’BŒŁi“ŕjC’†‘ş—zŽqC“‡’Ă—TCˆäo“NC“n•”K•vCˆŔ•”–ž˜Yi‘—§‘Š–ÍŒ´•a‰@jC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´ r‹BiŠOjC‘Šě’ŽjCŽR“cş•vi‘—§‘Š–ÍŒ´•a‰@j: ‘ć48‰ń‘—§—Ă—{Š‘‡ˆăŠw‰ď i93.09.30j, ŽD–y, ˆă—Ă, 47(‘): 92, 1993.

1061. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j RHelicobacter pylori(HP)R‘Ě‚Ě—L—pŤ‚Ć–ŤŠÖßƒŠƒEƒ}ƒ`(RA)‡•šˆÝ’×ᇂ̌Ÿ“˘. ˆŔ’BŒŁi“ŕjC’†‘ş—zŽqC“‡’Ă—Ti‘—§‘Š–ÍŒ´•a‰@jCÎěŽĺĹi“ŕjCˆäo“NC“n•”K•vC‘Šě’ŽjCŽR“cş•vi‘—§‘Š–ÍŒ´•a‰@jCˆŔŠC‹`—jCźŒłŽ›Ž—ç i“ŕj: ‘ć48‰ń‘—§—Ă—{Š‘‡ˆăŠw‰ď i93.09.30j, ŽD–y, ˆă—Ă, 47(‘): 92, 1993.

1062. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j HCVƒGƒ“ƒxƒ[ƒv’`”’Žż“ŕ‚Ě’´‰Â•Ď—Ěˆć‚ɑ΂ˇ‚é‘̉tŤ–Ɖu‰ž“š‚ĆHCVŽ‘ąŠ´ő‚Ć‚ĚŠÖŒW. ‰Á“Ąé”VCŠÖ’Jm”üi‘—§‚Ş‚ńƒZƒ“ƒ^[jC’†‘ň‹MGi“ŕjC‘ĺ’ĂŽR—SŽqC“y•ű˝i‘—§‚Ş‚ńƒZƒ“ƒ^[jC‘ĺ‰zÍŒáiVŠƒ‘ĺjC‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ ƒ^[j: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05`07j, ĺ‘ä, “ú–{ŠŕŠw‰ď‘‰ď‹LŽ–, p.144, 1993.

1063. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĚ‰Š–Ť‰ť‚É”ş‚¤‚bŒ^ŠĚ‰ŠƒEƒCƒ‹ƒX‚ĚƒGƒ“ƒxƒ[ƒv’`”’Žż‚đƒR[ƒh‚ˇ‚é—Ěˆć‚ĚŒoŽž“I•ĎˆŮ. ‘ĺ’ĂŽR—SŽqC‰Á“Ąé”Vi‘—§‚Ş‚ńƒZƒ“ƒ^[jC’†‘ň‹MGi“ŕjCŠÖ’Jm”üi‘—§‚Ş‚ńƒZƒ“ƒ^[j: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05`07j, ĺ‘ä, “ú–{ŠŕŠw‰ď‘‰ď‹LŽ–, p.152, 1993.

1064. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}ŤŠĚ‰Š‚ć‚č–Ť‰ť‚ľ‚˝Ç—á‚É‚¨‚Ż‚éHCVƒGƒ“ƒxƒ[ƒu’`”’Žż‚Ě•ĎˆŮ‚Ć‚ť‚ę‚ɑ΂ˇ‚é‘̉tŤ–Ɖu‰ž“š. ŠÖ’Jm”üC‘ĺ’ĂŽR—SŽqC‰Á“Ąé”Vi‘—§‚Ş‚ńƒZƒ“ƒ^[jC’†‘ň‹MGi“ŕjCŽR“ŕŽŒČi“Œ—ˆă‘ĺjC‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ƒ^[j: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05`07j, ĺ‘ä, “ú–{ŠŕŠw‰ď‘‰ď‹LŽ–, p.152, 1993.

1065. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j HCV–łÇŒóŤƒLƒƒƒŠƒA‚É‚¨‚Ż‚鎝‘ąŠ´ő‹@\‚ĚŒŸ“˘. ’†‘ň‹MGi“ŕjC‰Á“Ąé”VC‘ĺ’ĂŽR—SŽqCŠÖ’Jm”üC‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ƒ^[j: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05`07j, ĺ‘ä, “ú–{ŠŕŠw‰ď‘‰ď‹LŽ–, p.331, 1993.

1066. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰@‚É‚¨‚Ż‚é‰ß‹Ž10”NŠÔ‚ĚˆÝƒAƒjƒTƒLƒXÇ‚ĚŒŸ“˘. “c’†”ŽŽuC‹k“c‹P—YC‘ň“c‹žŽqC‰ĄŽRŒOC‚‹´—B˜Yi“ŕjC•ÄŽRŒj”ށiˆÉ¨Œ´‹Ś“Ż•a‰@j: ‘ć42‰ń“ú–{”_‘şˆăŠw‰ď‘‰ď i93.10.07j, ‰Ą•l.

1067. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}Ť‰şŒă•Ç[Ç‚É”ş‚¤‹š•”—U“ą‚Ě ST •ÎˆĘ‚̐Źˆö‚ɂ‚˘‚Ä. ‹g“cTCŹ—Ń–ž–FC‰ŹŒ´“āC’Ĺ–źł_CŠ“c”ü—ć”TCŽí“cGŽiC•‘ň—˜˜YC’ˇ’Jě‰„LC‘şź€C–ؐě“c—˛ˆęi“ŕj: ‘ć41‰ń“ú–{S‘Ÿ•aŠw‰ď i93.10.07j, •Ÿ‰Ş.

1068. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}ŤS‹Ř[Ç (AMI) ‚É‚¨‚Ż‚é Opioid peptide (OP) •Ş”ĺ“Ž‘Ô‚ĚŒŸ“˘. Š“c”ü—ć”TC•‘ň—˜˜YC’ˇ’Jě‰„LCŹ‚L]C‹v•Ű‹MşCŹ—Ń–ž–FC‘şź€C–ؐě“c—˛ˆęi“ŕj: ‘ć41‰ń“ú–{S‘Ÿ•aŠw‰ď i93.10.07j, •Ÿ‰Ş.

1069. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –{‘ԐŤ‚ŒŒˆłÇŠłŽŇ‚É‚¨‚Ż‚éƒGƒiƒ‰ƒvƒŠƒ‹‚̐S‹Ř”ě‘ĺ‘ޏkŒř‰Ę‚Ɖ^“Ž‘Ď—e”\‚Ć‚ĚŠÖŒW. ´…ŠŽ‰xCě•Ó•q”VCX“cGlC‘ę‘ňrŽ÷CŒF’J“TŽqCŹ‘ňŒ°ˆęCěŒű’|’jC–]ŒŽr’źC˜Ič‹P•vC–ؐě“c—˛ˆęi“ŕj: ‘ć41‰ń“ú–{S‘Ÿ•aŠw‰ď i93.10.07j, •Ÿ‰Ş.

1070. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚ŒŒˆłŤSŽžŠł‚̉ES‹@”\‚¨‚ć‚эśS•a‘Ô‚Ć‚ĚŠÖ˜A. •˝źT‰ECV’Ă’J^lC‰ŹŒ´“āi“ŕjC“cŒ´‰pˆęCź‘ňN—YiŔ’ĂŽs—§•a‰@jC‘şź€C–ؐě“c—˛ˆęi“ŕj: ‘ć41‰ń“ú–{S‘Ÿ•aŠw‰ď i93.10.07j, •Ÿ‰Ş, ´˜^W, p.36, 1993.

1071. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ý‘îŽ_‘f—Ă–@ŠłŽŇ‚Ěƒpƒ‹ƒXƒIƒLƒVƒ[ƒ^[‚đ—p‚˘‚˝ƒ‚ƒjƒ^ƒŠƒ“ƒOƒVƒXƒeƒ€i‘ć‚Q•ń). –î“ߐŁM—YC‹ß“Ą‚Ś‚čC‹v•Ű“cŸC‚“cM˜aCŹ—эO—SCˆ˘•”’źC•y“c—FKi“ŕjCŠ™“c›‰CĄˆäŸiz–K’†‰›•a‰@jC–ƒś–΁i“ú–{Œő“dj: ‘ć‚V‰ń“ú–{MEŠw‰ďH‹G‘ĺ‰ď i93.10.07j, “Œ‹ž, “ú–{MEŠw‰ďŽGŽ, 31(‘): 13, 1993.

1072. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Rƒgƒƒ|ƒjƒ“R‘Ě‚É‚ć‚鍜Ši‹ŘüˆŰ‚Ěƒ^ƒCƒv•Ş‚Ż. ź–{MŽqi“ŕjCˆŔˆä”ü]i‘‡—Տ°ŒnjC’†‘şŒ’‚`iŠńjC’š‹‡ŽOi“ŕj: ‘ć42‰ń“ú–{”_‘şˆăŠw‰ď‘‰ď i93.10.08j, ‰Ą•l, “ú–{”_‘şˆăŠw‰ďŽGŽ, 42(3): 872`873, 1993.

1073. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”]‘˛’†•Đ–ƒáƒ‚ÉŒśŽˆ‚𔺂Á‚˝‚PÇ—á. {“Ą^mC’ˇ‘ňOC’Ř“c—R”üC•˝‰ę‚ć‚ľ‚݁C“y”쐳”VCt“ú”ü•ŰiƒŠƒn•”jC‘O“c^ŽĄi“ŕj: ‘ć11‰ń“ú–{Ž„—§ˆă‰Č‘ĺŠw—Šw—Ă–@Šw‰ď i93.10.09j, –k‹ăBŽs.

1074. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –łÇŒóŤƒLƒƒƒŠƒA‚ć‚č“ž‚ç‚ę‚˝HCVƒQƒmƒ€‚ĚŒoŽž“I•ĎˆŮ‚Ć‚ť‚̑̉tŤ–Ɖu‰ž“š. ’†‘ň‹MGi“ŕjC‰Á“Ąé”VC‘ĺ’ĂŽR—SŽqCŠÖ’Jm”üC‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ƒ^[j: ‘ć41‰ń“ú–{ƒEƒCƒ‹ƒXŠw‰ď‘‰ď i93.10.13`15j, ŽD–y, ´˜^W, p.92, 1993.

1075. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}ŤŠĚ‰Š‚ć‚č–Ť‰ť‚ľ‚˝Ç—á‚É‚¨‚Ż‚éHCVƒGƒ“ƒxƒ[ƒv’`”’Žż‚Ě•ĎˆŮ‚Ć‚ť‚ę‚ɑ΂ˇ‚é‘̉tŤ–Ɖu‰ž“š. ŠÖ’Jm”üC‘ĺ’ĂŽR—SŽqC‰Á“Ąé”Vi‘—§‚Ş‚ńƒZƒ“ƒ^[jC’†‘ň‹MGi“ŕjCŽR“ŕŽŒČi“Œ—ˆă‘ĺjC‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ƒ^[j: ‘ć41‰ń“ú–{ƒEƒCƒ‹ƒXŠw‰ď‘‰ď i93.10.13`15j, ŽD–y, ´˜^W, p.93, 1993.

1076. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j HCVƒGƒ“ƒxƒ[ƒv’`”’Žż“ŕ‚É‘śÝ‚ˇ‚é’´‰Â•Ď—Ěˆć‚Ě•ĎˆŮ‚ĆHCVŽ‘ąŠ´ő‚Ć‚ĚŠÖŒW. ‰Á“Ąé”VCŠÖ’Jm”üC‘ĺ’ĂŽR—SŽqi‘—§‚Ş‚ńƒZƒ“ƒ^[jC’†‘ň‹MGi“ŕjC“y•ű˝i‘—§‚Ş‚ńƒZƒ“ƒ^[jC‘ĺ‰zÍŒáiVŠƒ‘ĺjC‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ ƒ^[j: ‘ć41‰ń“ú–{ƒEƒCƒ‹ƒXŠw‰ď‘‰ď i93.10.13`15j, ŽD–y, ´˜^W, p.93, 1993.

1077. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹š’Ĺ Flexion myelopathy ‚Ě‚P—á. aˆä—߈ęC’ˇ’JěˆęŽqCŽO•x“N˜YC‰Á“Ą’m–çCŒĂ˜a‹vKi“ŕjCŽOˆäŒö•Fi”]ŠOj: ‘ć28‰ń“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆăŠw‰ď i93.10.15j, Ž­Ž™“‡.

1078. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –{‘ԐŤ‚ŒŒˆłÇ‚̏zŠÂ“Ž‘Ô‚É‹y‚Ú‚ˇ‰–Ž_ tilisolol ‚̉e‹ż. ˜Ič‹P•vC•zěTˆę˜YC”öŒ`’ˇ—YCŹ‚L]C‚‹´‚Ý‚Ç‚čC´…ŠŽ‰xC–ؐě“c—˛ˆęi“ŕj: ‘ć30‰ń“ú–{—Տ°ś—Šw‰ď i93.10.15`16j, “Œ‹ž, “ú–{—Տ°ś—Šw‰ďŽGŽ, 23(Suppl.): 119, 1993.

1079. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –{‘ԐŤ‚ŒŒˆł‚É‚¨‚Ż‚éŠeŽí~ˆł–ňŽĄ—Ă‚É‚ć‚éƒCƒ“ƒXƒŠƒ“Š´ŽóŤ‚¨‚ć‚ŃŽ‰Žż‘ăŽÓˆŮí‚ÉŠÖ‚ˇ‚錟“˘. ‘Ł’qLCŹă”Ž•śC‘şź€CóŒŠ‘C˛“ĄŽüC‰ş—˘ŒöşC’ˇ’Jě‰„LC–ؐě“c—˛ˆęi“ŕj: ‘ć30‰ń“ú–{—Տ°ś—Šw‰ď i93.10.15`16j, “Œ‹ž, “ú–{—Տ°ś—Šw‰ďŽGŽ, 23(Suppl.): 134, 1993.

1080. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}ŤS‹Ř[ÇŠłŽŇ‚É‚¨‚Ż‚é‹}ŤŠú‚̐SƒGƒR[Žw•W‚¨‚ć‚Ń24ŽžŠÔŒŒˆłĽS””‚Ě•Ď“Ž. ‘ę‘ňrŽ÷C´…ŠŽ‰xCˆÉ˜@‰ÔCX“cGlC–]ŒŽr’źC˛“ĄŽüC˜Ič‹P•vC–ؐě“c—˛ˆęi“ŕj: ‘ć30‰ń“ú–{—Տ°ś—Šw‰ď i93.10.15`16j, “Œ‹ž, “ú–{—Տ°ś—Šw‰ďŽGŽ, 23(Suppl.): 79, 1993.

1081. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}Ť‘O•Ç[Ç‚̐SŽş’x‰„“dˆĘ—zŤ—á‚É‚¨‚Ż‚é•a‘Ԑś—Šw“I“Á’Ľ‚ɂ‚˘‚Ä. Ží“cGŽiC˛“ĄŽüCóŒŠ‘C‘şź€CŹ—Ń–ž–FC’ˇ’Jě‰„LC–ؐě“c—˛ˆęi“ŕj: ‘ć30‰ń“ú–{—Տ°ś—Šw‰ď i93.10.15`16j, “Œ‹ž, “ú–{—Տ°ś—Šw‰ďŽGŽ, 23(Suppl.): 97, 1993.

1082. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŒoŒűÉŽ_–ň‚ĚŒŒˆł’˛ß‚ւ̉e‹ż. –ö–Εvi‘‡—Տ°ŒnjC´…ŠŽ‰xC–]ŒŽr’źCX“cGlC‘ę‘ňrŽ÷CŒF’J“TŽqC–ؐě“c—˛ˆęi“ŕj: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.20j, L“‡, —Տ°•a—, 41: 134, 1993.

1083. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚bŒ^–ŤŠĚ‰ŠƒCƒ“ƒ^[ƒtƒFƒƒ“—Ă–@‚É‚¨‚Ż‚錌´’†SIL-2R‚ɂ‚˘‚Ä‚ĚŒŸ“˘. “Ą‰Ş‚Oi“ŕjCŠž“ˆT‰îC˜nŽĄŒžC”’•l—´‹ťC^•ű—Ç•FC‰““Ą—šˆęCrŁNŽiCŒď“cŒMiŽŠ‰q‘ŕ’†‰›•a‰@jC’|“ŕ“ÖŽqi“Œ•a‰@Œ¤‹†ŒnjCa’J–ž—˛CŽÄ“c‹v—Y i“ŕj: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.21j, L“‡.

1084. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œ’íŹl‚É‚¨‚Ż‚鑧‚ą‚ç‚Ś’†‚Ě desaturation ‚É‹y‚Ú‚ˇ”x‹C—ʂ̉e‹ż. ‹vź’mŽqC’†ź‹vKC‘ĺ–Ř–ƒ‹LŽqC“n•Ó‹žŽqC“Ąś”ü”Ti—ŐŒŸjC“c’†^Ÿi‘‡—Տ°ŒnjC‹g‘şŽ‚C‚“cM˜aCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.21j, L“‡, —Տ°•a—, 41(•â): 226, 1993.

1085. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •ĎŤ‹Ř‚É‚¨‚Ż‚é‹Ř\Ź’`”’‚Ě“d‹C‰j“Ž“IlŽ@. ź–{MŽqC’š‹‡ŽOi“ŕjC’†‘şŒ’‚`iŠńjCˆŔˆä”ü]i‘‡—Տ°Œnj: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.22j, L“‡, —Տ°•a—, 41(•â): 391, 1993.

1086. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j TXA2 ‡Ź‘jŠQÜ‚ĚŒŒŹ”|D’†‹…‘ŠŒÝě—p‚É‹y‚Ú‚ˇ‰e‹ż. ‰““Ą•˝mC‹ß“ĄŒ[•śi“ŕj: ‘ć43‰ń“ú–{ƒAƒŒƒ‹ƒM[Šw‰ď i93.10.23`25j, ‰Ą•l.

1087. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œ´”­Ť Sjogren ÇŒóŒQ‚ɉ—‚Ż‚é HCV ‚ĚŠÖ—^. Šp‰Ć–ž•śC‰Ş“cƒC‹ß“ĄŒ[•śi“ŕj: ‘ć43‰ń“ú–{ƒAƒŒƒ‹ƒM[Šw‰ď i93.10.23`25j, ‰Ą•l.

1088. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒvƒƒeƒCƒ“ƒLƒi[ƒ[‚bŠˆŤ‰ť‚ĚƒJƒ‹ƒfƒXƒ‚ƒ“”­Œť‚É‹y‚Ú‚ˇ‰e‹ż. ă“cŠ°”VC‰““Ą•˝mC‹ß“ĄŒ[•śi“ŕjC”č’ő•vi“Œ—ˆă‘ĺj: ‘ć43‰ń“ú–{ƒAƒŒƒ‹ƒM[Šw‰ď i93.10.23`25j, ‰Ą•l.

1089. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ˆÝƒAƒjƒTƒLƒXÇ‚Ě41—á‚ĚŒŸ“˘. “n•Ó—˛Žii“ŕjCŠOŽR‹v‘ž˜Yi•˝’Ë‹¤Ď•a‰@jC“ú‚‰›C‘şăK‘ž˜YC›–ě‘C–{ŠÔ“ń˜YC–ě“o˝i“ŕjC‚“cˆę‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@j: ‘ć42‰ń‹¤ĎˆăŠw‰ď‘‰ď i93.10.27j, “Œ‹ž.

1090. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”ě–ž‚Ě”ť’č‚É‚¨‚Ż‚é‘ĚŽ‰–b—Ś”ť’č‚ĚˆÓ‹`. ‚“cˆę‘ž˜Yi•˝’Ë‹¤Ď•a‰@jC›–ě‘C“n•Ó—˛ŽiC–{ŠÔ“ń˜YC–ě“o˝i“ŕjCŠOŽR‹v‘ž˜YC‹ŕŽRł–žC•“c–ž”üC“ě—˘‚ł‚ćŽqC‚‹´—DŽqCŒ´“c”Ži•˝’Ë‹¤Ď•a ‰@j: ‘ć42‰ń‹¤ĎˆăŠw‰ď‘‰ď i93.10.27j, “Œ‹ž.

1091. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Řœ•s”\isĽpŒăˆÝŠŕ‚ɑ΂ˇ‚éCDDP+5'DFUR‚đƒx[ƒX‚Ć‚ľ‚˝•š—p—Ă–@‚Ě”äŠrŒ¤‹†i‘ć1•ńj. Źň˜aŽO˜Yi“ŕjC•Ÿ“cŒhGC•ŸŽR‰x’jC’ˇ’Jě_ˆęC‰Ô’J—EŽĄCŒIŒ´–Ť‚`CŠâč—ÇŽOCś“c–ÚŒö’jCH’JŽőˆęCŹ“‡•Ű–žCŠ™–ěr‹IC“Œ¸i“Œ‹žŠŕ‰ťŠw—Ă–@Œ¤ ‹†‰ďj: ‘ć31‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď‘‰ď i93.10.27j, ‘ĺă, “ú–{ŠŕŽĄ—ĂŠw‰ďŽGŽ, 28(9): 1239, 1993.

1092. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j isˆÝŠŕ‰ťŠw—Ă–@Ž{sÇ—á‚É‚¨‚Ż‚é’ˇŠúś‘ś—á‚ĚŒŸ“˘. ‹{“c‰Ŕ“TC‘ĺ’ÓցCŠÖ–ÎŽ÷C‹g“c–ΏşC”’”ö‘şC“‡“cˆŔ”ŽCÄ“Ą”ŽCXŁŒöŽxC‘ĺ‹v•ŰrŽĄCŽÂˆäŠiCŹň˜aŽO˜Yi“ŕjCŒIŒ´–Ť‚`C‰şŽRł“żiŒúśČ‚Ş‚ń• Ź‹ŕˆÝŠŕ“ŕ‰ČƒOƒ‹[ƒvj: ‘ć31‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď‘‰ď i93.10.27j, ‘ĺă, “ú–{ŠŕŽĄ—ĂŠw‰ďŽGŽ, 28(9): 1384, 1993.

1093. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Prostaglandin I2, Angiotensin ‡UŽ‘ą’“ü‚Ěƒ‰ƒbƒgŒ´”­“űŠŕ‘gDŒŒ—Ź‚É‹y‚Ú‚ˇ‰e‹ż. –{‹´CCŠô˘‹´“āC˛–ěG–íC‚–ؐ¸ˆęCźŒłŽ›Ž—çi“ŕjC’†ŽR–ΐMiŽŔ“Žj: ‘ć34‰ń“ú–{–ŹŠÇŠw‰ď‘‰ď i93.10.28j, –źŒĂ‰Ž, –ŹŠÇŠw, 33(9): 722, 1993, 34(2): 105`109, 1994.

1094. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j HMG-CoA ŠŇŒły‘f‘jŠQ–ň (pravastatin) ‚Ě’ˇŠúŽĄ—Ă‚É‚ć‚é–Ź”g‘Ź‚̕ωť‚ɂ‚˘‚Ä. ‘şź€CŹ—Ń–ž–FC’ˇ’Jě‰„LC‘Ł’qLC‰ş—˘ŒöşCóŒŠ‘C–ؐě“c—˛ˆęi“ŕj: ‘ć34‰ń“ú–{–ŹŠÇŠw‰ď i93.10.28j, –źŒĂ‰Ž, –ŹŠÇŠw, 33(9): 734, 1993.

1095. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒg‚É‚¨‚Ż‚é’áŽ_‘f‹z“ü•‰‰×Žž‚Ě”÷ŹzŠÂ“Ž‘Ô‚ĚŒŸ“˘. “c’†’ź•FCŽO“Ą‹vC˛“Ą“N–çC—é–Ř“šOC‚“cM˜aC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć34‰ń“ú–{–ŹŠÇŠw‰ď‘‰ď i93.10.28j, –źŒĂ‰Ž, –ŹŠÇŠw, 33(9): 783, 1993.

1096. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œ`ó‹L‰Żƒvƒ‰ƒXƒ`ƒbƒN‚Ě•â‘•‹ď‚ւ̉ž—pi‘ć‚Q•ń). ‘O“c^ŽĄi“ŕjC˛“ĄŒMi•˝ˆä‹`ŽˆŒ¤‹†ŠjC“‡“c—˛ŽqC’ˇ‘ňOCŒă“ĄˆŔŒbiƒŠƒn•”jC˛ŽĄ–L•iŽO•HdHj: ‘ć‚X‰ń“ú–{‹`Žˆ‘•‹ďŠw‰ď‘‰ď i93.11.05`06j, _ŒË.

1097. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒVƒŠƒRƒ“‘fŢ‚đ—p‚˘‚˝‘ϐ…ŤAFO‚ĚŠJ”­. ‘O“c^ŽĄi“ŕjCt“ú”ü•ŰCH“c‘PsCŹŠÖ‡‹vC’ˇ‘ňOiƒŠƒn•”j: ‘ć‚X‰ń“ú–{‹`Žˆ‘•‹ďŠw‰ď‘‰ď i93.11.05`06j, _ŒË.

1098. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’´‰š”g“ŕŽ‹‹ž‚É‚ć‚é’_”X—˛‹NŤ•a•Ď‚̐f’f. –ě“o˝CâŒű“NÍC–Ř“cŒőLCŽR“cŽŠlCˆÉ“Ą‹ĎC^‹ĘŽő”üśCźŒłŽ›Ž—çi“ŕjC‹g“c@‹IC‘ĺ‹{“ŒśC”äŠé”\Ž÷iŠOj: ‘ć63‰ń“ú–{’´‰š”gˆăŠw‰ďŒ¤‹†”­•\‰ď i93.11.10j, ç—t.

1099. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒp[ƒLƒ“ƒ\ƒ“•aEŇ‘Ź”]•ĎŤÇE‘˝Œn“•ĎŤÇ‚É‚¨‚Ż‚鋐‘ĺSEP‚ĚŒŸ“˘. ŠŽi–r•śi—ŐŒŸjC‹g‘ş‹vmŽqi“Œ•a‰@Œ¤‹†ŒnjC’ˇ’JěˆęŽqi“ŕjC‹kŽ ‘i”]ŠOj: ‘ć23‰ń“ú–{”]”gE‹Ř“d}Šw‰ď i93.11.11j, Ž­Ž™“‡.

1100. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j H“š‰šş‚̍\‰š‚Ě“ďˆŐ“x‚ɂ‚˘‚ā|‰šßƒŒƒxƒ‹‚Ĺ‚ĚŒŸ“˘|. Ź’rŽO“ŢŽqCÎ–Ń”ü‘ăŽqiƒŠƒn•”jC‰Ş–{˜NŽqCŒ´—R‹Ii–{‰@ƒŠƒn•”jCŹ—є͎qCLŁ”Łiˆă—ÉqśŠw•”j: ‘ć38‰ń“ú–{‰šşŒžŒęˆăŠw‰ď‘‰ď i93.11.12`13j, ç—t.

1101. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’mŠo_ŒoŠˆ“Ž“dˆĘ SNAP ‚ɑ΂ˇ‚é‚Q“_ŽhŒƒ‚Ĺ‚ĚŒŸ“˘; ‘ć‚Q•ń|ŽčŞŠÇÇŒóŒQ‚Ĺ‚ĚŒŸ“˘|. Ä“Ą]”üŽqCr”Ś“āi—ŐŒŸjC‹kŽ ‘i”]ŠOjC’š‹‡ŽOi“ŕj: ‘ć23‰ń“ú–{”]”gĽ‹Ř“d}Šw‰ďŠwp‘ĺ‰ď i93.11.17j, Ž­Ž™“‡.

1102. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Visual Hallucination ‚Ě‹ÇŠ”]ŒŒ—Ź. ŒÜ\—’‹v‰ŔCâˆä•ś•FC”Ń’Ë‚_CHŽR‹vŽC_“c’źi“ŕj: ‘ć‚T‰ń“ú–{”]zŠÂ‘ăŽÓŠw‰ď‘‰ď i93.11.24`27j, •Ÿ‰Ş.

1103. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Monocrotaline ‚Ě”L”]zŠÂ’˛ß‚É—^‚Ś‚é‰e‹ż‚ɂ‚˘‚Ä. •Ÿ“c—Ď–çC”¨—˛ŽuCˆî•Ÿ“O–çCŠŰŽR”ŽŽuC–kˆä‘Ľ•vC–k‘şşCâˆä•ś•FC_“c’źi“ŕj: ‘ć‚T‰ń“ú–{”]zŠÂ‘ăŽÓŠw‰ď‘‰ď i93.11.24`27j, •Ÿ‰Ş.

1104. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”ź‹…ŠÔE“ŕ—Ł’f‚ލl‚Ś‚ç‚ę, OEŒz•”‚É–ł–Ú“I‚Č“Ž‚Ť‚đ”F‚ß‚˝”]—Ŕ‘O•ű`‘O“Ş—t“ŕ‘¤–ʏoŒŒ‚Ě‚P—á. ‘O“c^ŽĄi“ŕjC’ˇ‘ňOiƒŠƒn•”jCŒĂ‹´‹I‹vi“ŕj: ‘ć17‰ńŽ¸ŒęÇŠw‰ď‘‰ď i93.12.01`02j, Ž­Ž™“‡.

1105. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ~ƒIƒOƒƒrƒ“‚É‚ć‚ét‹@”\áŠQ‚ɑ΂ľ‚Ä‚Ě‚k-ƒAƒ‹ƒMƒjƒ“‚Ě•ŰŒěŒř‰Ę. Žá—Ń–ő‹vi“ŕjCŠŰŽR–ΑPiŽŔ“ŽŒnjC‘ĺ˜a“c—˛i‹~–˝jC–ؐě“c—˛ˆęi“ŕj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.03j, ‰Ą•l.

1106. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j IgA tÇ‚É‚¨‚Ż‚é IgA1 ƒqƒ“ƒW•”ƒ€ƒ`ƒ“Œ^“œ˝‚ĚŒŸ“˘|”­Ç, i“W‹@“]‚Ö‚Ě–đŠ„‚Ě‰Â”\Ť|. ”äŠé”\”VC–xˆäşCŹ‹v•Ű“§CŹ—Ń–Li“ŕj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.03j, ‰Ą•l.

1107. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j —nŒŒŤ”A“ĹÇÇŒóŒQ/ŒŒđŤŒŒŹ”ÂŒ¸­ŤŽ‡”Á•a (HUS/TTP) ‚Ě—\Œă„’čˆöŽq‚ĚŒŸ“˘. ‚‹´‰fŽqCŠ™“cvŽőCŽç‰Ž—˜‰ŔC•ěşCŹ—Ń–Li“ŕjCŒK”ö’čmi•a—jC‘ĺ‹v•Ű[l: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.03j, ‰Ą•l, ´˜^W, p.199, 1993.

1108. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}‘Ź“€Œ‹ƒfƒB[ƒvƒGƒbƒ`ƒ“ƒOĽƒŒƒvƒŠƒJ(QF-DE)–@‚É‚ć‚éƒqƒgtŽ…‹…‘Ě”÷×\‘˘: “œ”A•a•Ď‰ť‚ɂ‚˘‚Ä. Žç‰Ž’B”üC•˝ˆä–@”ŽC‹ŕXWC“Ię´˜aC–‹`’‰i“ŕjC‘ĺ–ěLˆęiŽR—œˆă‘ĺj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.03j, ‰Ą•l, ´˜^W, p.245, 1993.

1109. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Directional coronary atherectomy (DCA) ‚É‚ć‚銼“Ž–Ź‰đ—Ł‚Ĺ‘¤”Â•ÂÇ‚đ‚¨‚ą‚ľ‚˝‚P—á. •˝źT‰Ei“ŕjC“cŒ´‰pˆęiŔ’ĂŽs—§•a‰@jCV’Ă’J^lC‰ŹŒ´“āi“ŕjC‰iˆä‡iŔ’ĂŽs—§•a‰@jC‘şź€C–ؐě“c—˛ˆęi“ŕj: ‘ć‚V‰ń“ú–{ŠĽŽžŠłŠw‰ď i93.12.11j, ‘ĺă, ´˜^W, p.70, 1993.

1110. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j HCVƒGƒ“ƒxƒ[ƒv’`”’Žż‚Ě•ĎˆŮ‚ĆŽ‘ąŠ´ő‚Ć‚ĚŠÖŒW. ‰Á“Ąé”VCŠÖ’Jm”üC‘ĺ’ĂŽR—SŽqi‘—§‚Ş‚ńƒZƒ“ƒ^[jC’†‘ň‹MGi“ŕjC“y•ű˝C‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ƒ^[j: ‘ć16‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ď i93.12.16`19j, –‹’Ł, ƒvƒƒOƒ‰ƒ€Ľu‰‰—vŽ|W, p.187, 1993.

1111. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –łÇŒóŤƒLƒƒƒŠƒA‚É‚¨‚Ż‚éHCVƒGƒ“ƒxƒ[ƒv’`”’Žż‚Ě•ĎˆŮ‚Ć‚ť‚̑̉tŤ–Ɖu‰ž“š. ’†‘ň‹MGi“ŕjC‰Á“Ąé”VC‘ĺ’ĂŽR—SŽqCŠÖ’Jm”üC‰ş‰“–ě–M’‰i‘—§‚Ş‚ńƒZƒ“ƒ^[j: ‘ć16‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ď i93.12.16`19j, –‹’Ł, ƒvƒƒOƒ‰ƒ€Ľu‰‰—vŽ|W, p.187, 1993.

1112. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚ŒŒˆłŽĄ—Ă‚É‚¨‚Ż‚éƒŔŽó—e‘ĚŽŐ’f–ň Tilisolol ‚ĚŒŒs—ÍŠw“IŒŸ“˘|’ďR˜´iŒ^‚𒆐S‚Ɂ|. ˜Ič‹P•vC•zěTˆę˜YCX“cGlCŹ‚L]C”öŒ`’ˇ—YC‚‹´‚Ý‚Ç‚čC´…ŠŽ‰xC–ؐě“c—˛ˆęi“ŕj: ‘ć28‰ń“ú–{Źl•aŠw‰ď i94.01.14j, “Œ‹ž, “ú–{Źl•aŠw‰ď‰ďŽ, p.49, 1993.

1113. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”ń“§ÍŠú‚ɃGƒŠƒXƒƒ|ƒGƒ`ƒ“ (EPO) •â[—Ă–@‚đŽ{s‚ľ•Ş•Ř‚ɐŹŒ÷‚ľ‚˝–Ťt•s‘S‚Ě‚P—á. ’ˇę‘ׁCŠ™“cvŽőC’|“ŕN—YCX‰ş“N•vCŹ—Ń–Li“ŕjC“y‹Š˛Cź“‡ł”ŽiŽY•wj: ‘ć‚S‰ńt‚Ć”DPŒ¤‹†‰ď i94.02.12j, _ŒË.

1114. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •›t”玿ƒXƒeƒƒCƒhÜ‚¨‚ć‚Ń‹Ř’oŠÉÜ•š—p‚É”ş‚¤Acute Neuromyopathy‚Ě‚Q—á. ă“cN‹vC’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽŔC’ˇ“cŒúCŠÖŞ“OiŽ™jC‘Š”nˆęˆĺC‘ĺ“c„•äC‘“c‘ěC‘ĺ˜a“c—˛i‹~–˝j: ‘ć21‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď‘‰ď i94.02.24j, –źŒĂ‰Ž.

1115. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j S”x’âŽ~ó‘Ô‚Ĺ”­ŒŠ‚ł‚ę“Ć•ŕ‘މ@‚ľ‚Ś‚˝‚P—á. “cŒ´‰pˆęiŔ’ĂŽs—§•a‰@jCV’Ă’J^lC‰ŹŒ´“āC•˝źT‰EC’ˇ’Jě‰„LCŹ—Ń–ž–FC‘şź€C–ؐě“c—˛ˆęi“ŕj: ‘ć21‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď i94.02.24`26j, –źŒĂ‰Ž, “ú–{W’†ŽĄ—ĂˆăŠw‰ďŽGŽ, (´), 1993.

1116. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}ŤS‹Ř[Ç (AMI) ŠłŽŇ‚É‚¨‚Ż‚é‹}ŤŠú‚ĚŒŒˆł‚¨‚ć‚ѐS””‚Ě•Ď“Ž. ‘ę‘ňrŽ÷C´…ŠŽ‰xCX“cGlCŒF’J“TŽqC–]ŒŽr’źC˜Ič‹P•vC–ؐě“c—˛ˆęi“ŕj: ‘ć21‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď i94.02.24`26j, –źŒĂ‰Ž, “ú–{W’†ŽĄ—ĂˆăŠw‰ďŽGŽ, (´): 137, 1993.

1117. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}ŤS‹Ř[ÇŠłŽŇ‚É‚¨‚Ż‚éĎ‹É“I‰^“Ž—Ă–@‚Ě‹}ŤŠú‰^“Ž‘Ď—e”\‚̉ü‘PŒř‰Ę‚Ć‚ť‚ę‚ɉe‹ż‚ˇ‚éˆöŽq. ´…ŠŽ‰xCě•Ó•q”VCX“cGlC‘ę‘ňrŽ÷CŒF’J“TŽqCâŒł—šŽqC“n•Ó‰Á‘ăŽqC–ؐě“c—˛ˆęi“ŕj: ‘ć21‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď i94.02.24`26j, –źŒĂ‰Ž, “ú–{W’†ŽĄ—ĂˆăŠw‰ďŽGŽ, (´): 206, 1993.

1118. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j • •”‘ĺ“Ž–ŹáŽ‚Ć”]ŒŒŠÇáŠQ. ŠC–ě‰ŔŽqCˆ˘‹v’Ă“ń•vi“ŕj: ‘ć19‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i94.03.10j, ‹ž“s.

1119. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j 111In •WŽŻ”’ŒŒ‹…SPECT–@‚É‚ć‚é”]‰ć‘œf’f|”][Ç‹}ŤŠú‚Ě•a‘Ô‚ĚŒŸ“˘. ”Ń’Ë‚_Câˆä•ś•FC“ĄŔ–M•FC–kˆä‘Ľ•vC”¨—˛ŽuC_“c’źi“ŕj: ‘ć19‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i94.03.10j, ‹ž“s.

1120. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŒđŠ´_ŒoŒn‚ĚŒŒˆł“ú“ŕ•Ď“Ž‚É‹y‚Ú‚ˇ‰e‹ż. “Œ–M•FC‹ĘˆäL–žC•Ÿ“c—Ď–çCHŽR‹vŽCĄˆä¸CŒÜ\—’‹v‰ŔCâˆä•ś•FC_“c’źi“ŕj: ‘ć19‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i94.03.10j, ‹ž“s.

1121. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”]‘˛’†‚Ě”­ÇŽž‚ɂ‚˘‚Ä‚ĚŒŸ“˘. •Ÿ“c—Ď–çCHŽR‹vŽCĄˆä¸C”¨—˛ŽuC_“c’źi“ŕj: ‘ć19‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i94.03.10j, ‹ž“s.

1122. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒg‹“á΋؂̔÷ŹzŠÂŒn‚É‚¨‚Ż‚é pH ‚̕ωť. Ź—эO—Si“ŕjC‘ę‘ň’ź’čiś—jC˛–ě_ŽjiŒc‘ĺjCź“c‘•ciś•¨•¨—ŒnjC•y“c—FKi“ŕj: ‘ć71‰ń“ú–{ś—Šw‰ď‘ĺ‰ď i94.03.26j, ‚ź, —\eW, p.278, 1994.

1123. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚­‚ŕ–Œ‰şoŒŒ‚É”F‚ß‚ç‚ę‚éS‹Ř‚Ě•a—‘gDŠw“IŒŸ“˘. ‰Ą“ŕ‘ŽqC–ؐě“c—˛ˆęi“ŕjCŒK”ö’čmC‹T’J“Oi•a—jC‘“c‘ěi‹~–˝j: ‘ć58‰ń“ú–{zŠÂŠíŠw‰ď‘‰ď i94.03.28`30j, “Œ‹ž, Jpn. Circ. J., 58(Suppl.): 178, 1994.

1124. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j śŽşŠg’Ł‘Šú—Ź“ü-‘š“xŠÖŒW‚É‚ć‚鍶ŽşŠg’ŁŤ‚Ě•]‰ż. ‘ĺŒIŽĄ•FC•ěMŒĺCů‰Ş‘ĺŽjC–ؐě“c—˛ˆęi“ŕj: ‘ć58‰ń“ú–{zŠÂŠíŠw‰ď‘‰ď i94.03.28`30j, “Œ‹ž, Jpn. Circ. J., 58(Suppl.): 231, 1994.

1125. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”]oŒŒ‚Ě•”ˆĘ|‚ŒŒˆłŽĄ—ÂƉÁ—î‚Ě–Ę‚Š‚ç‚ĚŒŸ“˘. ‹ĘˆäL–žC•Ÿ“c—Ď–çCHŽR‹vŽC”Ń’Ë‚_Cˆî•Ÿ“O–çC”Š_mC–kˆä‘Ľ•vC”¨—˛ŽuCâˆä•ś•FC_“c’źi“ŕj: ‘ć90‰ń“ú–{“ŕ‰ČŠw‰ď i93.04.03j, ‰ŞŽR.

1126. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒƒTƒRƒŠƒ“‹z“ü’†‚ĚŒÄ‹CƒKƒX‚¨‚ć‚Ń“Ž–ŹŒŒŽ_‘f–O˜a“x‚ĚŒoŽž“I‘Ş’č. ˛“Ą“N–çCˆäŒË“cĆ‹`CrˆäiC‚“cM˜aCÎě—şC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć33‰ń“ú–{‹š•”ŽžŠłŠw‰ď‘‰ď i93.04.08j, ‰Ą•l, “ú–{‹š•”ŽžŠłŠw‰ďŽGŽ, 31(‘): 304, 1993.

1127. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”xŠŕ‰ťŠw—Ă–@‚É‚ć‚éD’†‹…Œ¸­‚ɑ΂ˇ‚é rhG-CSF ‚ĚŽŠ“K“Š—^—Ę‚ĚŒŸ“˘. ‰Ô“cL‰pC—é–Ř“šOC‹v•Ű“cŸC–î“ߐŁM—YC•y“c—FKi“ŕjCrˆäii‰Y˜aŽs—§•a‰@jC‚‹´łŒőiěčŽs—§ˆä“c•a‰@j: ‘ć33‰ń“ú–{‹š•”ŽžŠłŠw‰ď‘‰ď i93.04.08j, ‰Ą•l, “ú–{‹š•”ŽžŠłŠw‰ďŽGŽ, 31(‘): 348, 1993.

1128. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Nasal CPAP ‰ş‚Ě• ‹Ř‚Ě”˝‰ž|—§ˆĘ‚Ƌ‰çˆĘ|. ‹g‘şŽ‚CŹ–ě’‰LC˛“Ą“N–çC—é–Ř“šOC‚“cM˜aC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć33‰ń“ú–{‹š•”ŽžŠłŠw‰ď‘‰ď i93.04.09j, ‰Ą•l, “ú–{‹š•”ŽžŠłŠw‰ďŽGŽ, 31(‘): 387, 1993.

1129. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j “œ”A•a‚ɍ‡•š‚ľ‰ü‘P‚đ‚Ý‚˝‘gDNPŒ^‹CŠÇŽx”xƒAƒXƒyƒ‹ƒMƒ‹ƒXÇ‚Ě‚P—á. ŽR‰ş‚Ś‚čŽqCŽç‰Ž’B”üC_N”Vi“ŕjC‹v•ÄŒői•a—jC‰–’J–΁i“ŕjCM‰Ş”üťŽqC‘şŁ¨’ĂŽqi–ňÜ•”jCˆ˘•””ü’mŽqi—ŐŒŸj: ‘ć67‰ń“ú–{Š´őÇŠw‰ď‘‰ď i93.04.16j, “Œ‹ž, Š´őÇŠwŽGŽ, 37(9): 908, 1993.

1130. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ä•s•nĽMDS ‚ɑ΂ˇ‚é rhG-CSF ‚Ć rhEPO ‚Ě•š—p—Ă–@. •Ä‘qCŽii“ŒŠC‘ĺjCź•˝_ˆęi_“ސ쏬Ž™ˆă—ĂƒZƒ“ƒ^[jC‰–’J–΁i“ŕjC‘ź: ‘ć55‰ń“ú–{ŒŒ‰tŠw‰ď‘‰ď i93.04.22j, Žl“úŽs, Int. J. Hematol., 57(Suppl.1): 248, 1993.

1131. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ž_‘f—R—ˆƒ‰ƒWƒJƒ‹‚É‚ć‚éƒCƒ“ƒXƒŠƒ“‚Ě’f•Đ‰ť‚ĆHbAcŠÖ—^‚̉”\Ť. “Ą“c–F–Mi“ŕjC’†‘ş‘‰qi•ŞśjCŽç‰Ž’B”üC“Ię´˜aC–‹`’‰i“ŕj: ‘ć36‰ń“ú–{“œ”A•aŠw‰ď‘‰ď i93.05.13j, ĺ‘ä, “œ”A•a, 36(Suppl.1): 178, 1993.

1132. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒIƒLƒ\ƒAƒ‹ƒfƒqƒh’E…‘fy‘f(OAD)‚đ—p‚˘‚˝3-ƒfƒIƒLƒVƒOƒ‹ƒRƒ\ƒ“‚Ě”÷—Ę’č—Ę–@‚ĚŠJ”­. “Ąˆä‰pi“ŕjCŠâŁm—ECŽPˆčŽqiś‰ťjC–‹`’‰i“ŕjC–x“c‹ąŽqiś‰ťj: ‘ć36‰ń“ú–{“œ”A•aŠw‰ď‘‰ď i93.05.13j, ĺ‘ä, “œ”A•a, 36(Suppl.1): 184, 1993.

1133. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘Šú“œ”A•aŤtÇ‚É‚¨‚Ż‚é”A×ŠÇ‹@”\ˆŮí‚¨‚ć‚Ń‚ť‚Ě”A’†ƒAƒ‹ƒuƒ~ƒ“”rŸ•‚ɑ΂ˇ‚é‰e‹ż. •˝ˆä–@”Ži“ŕjCÄ“Ą^—CŠÖ‘ň‰pˆęi‰Ą{‰ę‹¤Ď•a‰@jC“Ię´˜aCŽç‰Ž’B”üC‹ŕXWC“Ą“c–F–MC–‹`’‰i“ŕj: ‘ć36‰ń“ú–{“œ”A•aŠw‰ď‘‰ď i93.05.14j, ĺ‘ä, “œ”A•a, 36(Suppl.1): 295, 1993.

1134. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ś”ź‘¤Ž‹‹óŠÔŽ¸”F‚ɑ΂ˇ‚鉚ŠyŽhŒƒ‚̉e‹ż (‘ć‚Q•ń). ÂŒË˜aŽqC‘O“c^ŽĄCŒĂ‹´‹I‹vCŒĂ˜a‹vKi“ŕjCŒă“ĄˆŔŒbiƒŠƒn•”j: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.09`11j, ç—t.

1135. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚’źŤŠá‹…‰^“ŽáŠQ‚ĆMRI. ˆî•Ÿ“O–çC”¨—˛ŽuC•Ÿ“c—Ď–çC‹ĘˆäL–žC”Ń’Ë‚_Câˆä•ś•FC_“c’źi“ŕj: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.09j, ç—t.

1136. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”]‘˛’†‚Ć‹CŰđŒ. –ě•˝CCĄˆä¸C‹{“c‰Ă˘ŽqC‰Ş•”‘˝‰ÁŽuC•lŒűŸ•Fi“ŕj: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.09j, ç—t.

1137. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Epstein-Barr virus (EBV)Š´ő‚É”ş‚¤_Œo‡•šÇ‚É‚¨‚Ż‚é antineuronal autoantibodies. ˆÉ“Ą”Ž–žC‹y”\ŽGC“ü]KŽqCÄ“Ą–L˜aCŒĂ˜a‹vKi“ŕj: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.10j, ç—t.

1138. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒgƒgƒƒ|ƒjƒ“-‡Tƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ě‚É‚ć‚é_ŒoŒ´ŤśŒŸ‹Ř‚̖Ɖu‘gDőF. ź–{MŽqC’š‹‡ŽOi“ŕjCˆŔˆä”ü]i‘‡—Տ°ŒnjC’†‘şŒ’‚`iŠńj: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.10j, ç—t, —Տ°_ŒoŠw, 33(12): 1432, 1993.

1139. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j SPECT‚É‚ć‚é”]‰Š‚Ě‰ć‘œf’f. ”Ń’Ë‚_Câˆä•ś•FCHŽR‹vŽC”Š_mC–kˆä‘Ľ•vC”¨—˛ŽuC_“c’źi“ŕj: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.11j, ç—t.

1140. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j •sˆŔ’č Hb Ç (Hb Burke) ‚𔺂Á‚˝ rHuEPO •s‰žŤ•nŒŒ‚Ě‚P“§Í—á. ˛“Ą’ź”VCŠ™“cvŽőC‚‹´‰fŽqC–ě‘şK”́C“ŕ“c–ž”üŽqCX‰ş“N•vi“ŕjC˜a“c’m‰vi—Ő•a—jC—é–؏t’jiś•¨•¨—‰ťjC‘ĺ‹v•Ű[li“ŕjC‘—F“N”V•ăi“Œ ƒŒj: ‘ć38‰ń“ú–{“§Í—Ă–@Šw‰ď‘‰ď i93.07.17`18j, ç—t.

1141. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚ƒNƒŠƒAƒ‰ƒ“ƒX“§Í‚É‚ć‚Á‚Ä‘Ě“ŕ—nŽż (UN) ‚Ě•s‹Ďˆę‚Í‹N‚Ť‚é‚ŠH Ź–ě“ÖŽjC‰ł’Ă•ś•vCŹ–쎛şŽqCˆÉ“Ą‘ž•ăCă“c“N–çC—é–Ř˜ćŽqC”ŠŽRƒ†ƒLŽqCŽÄ“cs•vi‚ł‚Ş‚ÝzŠÂŠíƒNƒŠƒjƒbƒNjCŹ—Ń’ź”VC‹g“cŕˆC“ě•”łlCŠ™“cv Žői“ŕj: ‘ć38‰ń“ú–{“§Í—Ă–@Šw‰ď‘‰ď i93.07.17`18j, ç—t.

1142. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆÚAt‹‘âŒă‚Ě CAPD —Ă–@‚ĚŒŸ“˘. “ŕ“c–ž”üŽqC’|“ŕN—YC‚‹´‰fŽqCŽç‰Ž—˜‰ŔCŹ‹v•Ű“§C–xˆäşCŠ™“cvŽői“ŕjC˛“ĄŒőŽjiŠOjCŒF–ě˜a—YC‰““Ą’‰—Yi”ĺjC‘ĺ‹v•Ű[lCŹ—Ń–Li“ŕj: ‘ć38‰ń“ú–{“§Í—Ă–@Šw‰ď‘‰ď i93.07.17`18j, ç—t, “ú–{“§Í—Ă–@Šw‰ďŽGŽ, 26(Suppl.1): 1023, 1993.

1143. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j –ĺ–Źˆł˜´iÇ‚É‚¨‚Ż‚éˆÝ”S–Œ•a•Ď‚ĚŒŸ“˘. “c•Ó‘C‘•Ş–ΔŽCŠâ–xŒöŠîCŽRăp‚ł‚ä‚čCrěä•vC‹ß“Ąˆę‰pC‹e’rVC’†ˆä‹v—YCÎˆäŒ\‘žC‘şă‹§lCCŹň˜aŽO˜YC‰ĄŽR–őC‘ĺˆä“cłlCŽO‹´—˜‰ˇCŽÄ “c‹v—YCźŒłŽ›Ž—çi“ŕj: ‘ć35‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď i93.09.20j, _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ, 90(—Ő‘): 143, 1993.

1144. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j \“ńŽw’°•a•Ď‚Ě“ŕŽ‹‹ž“IŒŸ“˘. ’†ˆä‹v—YCŹň˜aŽO˜YC‹ß“Ąˆę‰pC‹e’rVCÎˆäŒ\‘žC“c•Ó‘C‰ĄŽR–őC‘ĺˆä“cłlCŽO‹´—˜‰ˇCźŒłŽ›Ž—çi“ŕj: ‘ć35‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď i93.09.20`22j, _ŒË, —\eW, p.1959, 1993.

1145. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j äXŽžŠł‚ɍ‡•š‚ľ‚˝H“šˆÝĂ–ŹáŽ‚Ě—Ő°“IŒŸ“˘. ^‹ĘŽő”üśCˆÉ“Ą‹ĎC™–{­’źC‘•Ş–ΔŽCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕj: ‘ć35‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď i93.09.21j, _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ, 90(—Ő‘): 2011, 1993.

1146. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘ĺ’°‘BŽîĽ‘ĺ’°‘ŠúŠŕ‚É‚¨‚Ż‚ép53ˆâ“`ŽqŽY•¨–Ɖu‘gDŠw“IŒŸő. ‚–ؐ¸ˆęi_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[jC–{‹´CC˛–ěG–íCŠô˘‹´“āi“ŕjC‹ĘˆäŮ•vCˆÉ“Ą‹`•FC‘ĺěLˆęC‘˝—…”ö˜a˜YC´…ş’ji_“ŢěŒ§—§‚Ş‚ńƒZƒ“ ƒ^[j: ‘ć35‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď i93.09.21j, _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ, 90: 233, 1993.

1147. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j VasopressionŽ‘ą“Ž’‚¨‚ć‚ѐҍ‚É‚ć‚錌s“Ž‘Ԃ̕ωť|ŽGŒ˘‚É‚ć‚éŽŔŒą“IlŽ@|. –{‹´CCŠô˘‹´“āC˛–ěG–íC‚–ؐ¸ˆęCźŒłŽ›Ž—çi“ŕj: ‘ć35‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď i93.09.21j, _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ, 90: 243, 1993.

1148. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j “dŽq“ŕŽ‹‹ž‚É‚ć‚鑁ŠúˆÝŠŕ‚̐F’˛Œv‘Ş‚Ć—Ő°‰ž—p. ’†ˆä‹v—YC‘ĺˆä“cłlCŽRăp‚ł‚ä‚čC‹ß“Ąˆę‰pC‹e’rVCÎˆäŒ\‘žCĄňOC“c•Ó‘CŹň˜aŽO˜YC‰ĄŽR–őCŽO‹´—˜‰ˇCźŒłŽ›Ž—çi“ŕj: ‘ć46‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.09.24j, _ŒË, u‰‰—\•ńW, p.234, 1993.

1149. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰ć‘œ‰đÍ‚đ—p‚˘‚˝”S–Œ“ŕŒŒ‰t—Ę‚Ćpharmacoendoscopy‚É‚ć‚éF’˛•Ď‰ť‚ĚŒŸ“˘. ĄňOC‘ĺˆä“cłlC—эO”üCŽRăp‚ł‚ä‚čC’†ˆä‹v—YC‹ß“Ąˆę‰pC‹e’rVCÎˆäŒ\‘žC“c•Ó‘CŹň˜aŽO˜YC‰ĄŽR–őCŽO‹´—˜‰ˇCźŒłŽ›Ž—çi“ŕj: ‘ć46‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.09.24j, _ŒË, u‰‰—\•ńW, p.234, 1993.

1150. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ––˝ŒŒ”’ŒŒ•a×–E‚ĚƒAƒ~ƒmŽ_×–E“ŕ—A‘—. ‰–’J–΁i“ŕj: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05j, ĺ‘ä, “ú–{ŠŕŠw‰ď‘‰ď‹LŽ–, p.306, 1993.

1151. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j “ŕ‘ŸƒJƒ“ƒWƒ_Ç‚É‚¨‚Ż‚錌’†ƒJƒ“ƒWƒ_R‘Ě‚Ě•ŞŽqś•¨Šw“IŒŸ“˘. ŽR‰ş‚Ś‚čŽqC“Ą–ě—R”üC‰–’J–΁i“ŕjCŽsěŒbŽqi‘‡—Տ°ŒnjCŽRč•q˜aC‹v•ÄŒői•a—j: ‘ć37‰ń“ú–{ˆă^‹ŰŠw‰ď‘‰ď i93.10.11j, ‰Ą•l, “ú–{ˆă^‹ŰŠw‰ďŽGŽ, 34(Suppl.1): 104, 1993.

1152. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j “œ”A•a‚đ‡•š‚ľ‚˝ƒ~ƒgƒRƒ“ƒhƒŠƒA”]‹ŘÇ(MELAS)‚Ě1—á|“œ‘ăŽÓˆŮí‚ĚŒŸ“˘|. ‹ŕXWC“c’†Œ[Ži‚`C”~‘ňTˆęC–ěŒű‹§ŽqC‘ĺ˜a“c—˘CŽç‰Ž’B”üC”Ń’Ë‚_C”¨—˛ŽuC–‹`’‰i“ŕjCŒă“Ą—Yˆęi‘—§¸__ŒoƒZƒ“ƒ^[j: ‘ć66‰ń“ú–{“ŕ•Ş”ĺŠw‰ďH‹GŠwp‘ĺ‰ď i93.10.27j, ÂX, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 69(8): 747, 1993.

1153. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j łíg’ˇ‚đ’ć‚ľ‚˝ś‰şŽž‚̉ş‚‘ĚŒs’f—ô‚É‚ć‚鉺‚‘Ě‹@”\’ቺÇ‚Ě1—á. –ěŒű‹§ŽqC‹ŕXWC‘ĺ˜a“c—˘CŽç‰Ž’B”üC“Ię´˜aC“Ą“c–F–MC–‹`’‰i“ŕj: ‘ć66‰ń“ú–{“ŕ•Ş”ĺŠw‰ďH‹GŠwp‘ĺ‰ď i93.10.28j, ÂX, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 69(8): 792, 1993.

1154. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Fluconazole ‘ϐŤ Candida glabrata ‚đ•Ş—Ł‚ľ‚˝‚SÇ—á. ŽR‰ş‚Ś‚čŽqC’hŒ´Š˛śC“Ą–ě—R”üC‰–’J–΁C–ؐě“c—˛ˆęi“ŕjCŽRč•q˜aC‹v•ÄŒői•a—j: ‘ć35‰ń“ú–{—Տ°ŒŒ‰tŠw‰ď‘‰ď i93.11.11j, L“‡, —Տ°ŒŒ‰t, 34(10): 1319, 1993.

1155. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ}ƒNƒƒ‰ƒCƒhŒnRś•¨Žż“™‚Ş‘tŒř‚ľ‚˝–ŤŠˆ“ŽŤ EB ƒEƒCƒ‹ƒXŠ´őÇ (CAEBV) ‚Ě‚P—á. “Ą–ě—R”üC“żO‰pśCŽR‰ş‚Ś‚čŽqC‰–’J–΁C–ؐě“c—˛ˆęi“ŕjC•˝”ü–çŽqi‘‡—Տ°Œnj: ‘ć35‰ń“ú–{—Տ°ŒŒ‰tŠw‰ď‘‰ď i93.11.11j, L“‡, —Տ°ŒŒ‰t, 34(10): 1357, 1993.

1156. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j –Ťœ‘Ť”’ŒŒ•a‚ɑ΂ˇ‚é HLBI ‚ĚŒř‰Ę|‘˝Ž{Ý‹¤“ŻŒ¤‹†|i‘ą•ń). —LX–΁i“ŒŠC‘ĺjCŽ›“cG•viš˜H‰ž‘Ű•a‰@jC‰–’J–΁i“ŕjC‘ź: ‘ć35‰ń“ú–{—Տ°ŒŒ‰tŠw‰ď‘‰ď i93.11.12j, L“‡, —Տ°ŒŒ‰t, 34(10): 1390, 1993.

1157. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j MELAS ‚ÉŒŠ‚ç‚ę‚˝ PLEDs ‚ĚŒŸ“˘. ”Ń’Ë‚_C”¨—˛Žui“ŕjC‹g–{gŽqC—é–؏~Žqi—ŐŒŸjCŽí“c^ť—Yi¸j: ‘ć23‰ń“ú–{”]”gĽ‹Ř“d}Šw‰ďŠwp‘ĺ‰ď i93.11.17j, Ž­Ž™“‡.

1158. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ź”]oŒŒ‚ĚŽĄ—Ă•űj‚ĚŒŸ“˘. –kˆä‘Ľ•vCHŽR‹vŽi“ŕjC–kŒ´F—YC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝jC_“c’źi“ŕj: ‘ć21‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ď i93.11.17j, L“‡, “ú–{‹~‹}ˆăŠw‰ďŽGŽ, 4(5): 487, 1993.

1159. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒg”|—{ƒƒTƒ“ƒMƒEƒ€×–E‚É‚¨‚Ż‚éƒoƒ]ƒvƒŒƒVƒ“(AVP)ě—p‚ɑ΂ˇ‚é”ńƒyƒvƒ`ƒhŤAVPhR–ňOPC-21268‚ĚŒř‰Ę. ‹ŕXWC“Ię´˜aC–‹`’‰i“ŕj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.02j, ‰Ą•l, ƒvƒƒOƒ‰ƒ€Ľ´˜^W, p.339, 1993.

1160. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j IgA tÇ‚Ě’ˇŠú—\Œă‚É‹y‚Ú‚ˇ‚ŒŒˆł‚̉e‹ż. Ź‹v•Ű“§C”äŠé”\”VCŠ™“cvŽőCŠÚ–ěƒśCŹ—Ń–Li“ŕj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.03j, ‰Ą•l.

1161. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j –ŒŤtÇ‚Ě’ˇŠú—\Œă|10”NŠÔŒo‰ßŠĎŽ@—á‚ɂ‚˘‚ā|. –xˆäşC”äŠé”\”VCŠ™“cvŽőCŠÚ–ěƒśCŹ—Ń–Li“ŕj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.03j, ‰Ą•l.

1162. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j NZB/W F1 ƒ}ƒEƒX (B/W) ‚É‚¨‚Ż‚é BSA t‰Š‚ɑ΂ˇ‚éƒGƒCƒRƒTƒyƒ“ƒ^ƒGƒ“Ž_ (EPA) ‚Ě‘ŁiŒř‰Ę. ŠÚ–ěƒśCŹ—Ń–Li“ŕj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.03j, ‰Ą•l.

1163. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Kluver-Bucy syndrome ‚đ’ć‚ľ‚˝”]‘˛’†ŠłŽŇ‚É‚¨‚Ż‚鑤“Ş—t‚ĚŠÖ—^. ÂŒË˜aŽqC‘O“c^ŽĄCŒĂ‹´‹I‹vCł–Ř‚Š‚‚çi“ŕj: ‘ć19‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i94.03.10`11j, ‹ž“s.

1164. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”’ŒŒ•a‚¨‚ć‚їމŽžŠłŠłŽŇ‚É‚¨‚Ż‚é“ŞŠW“ŕoŒŒ—á‚ɂ‚˘‚Ä‚ĚŒŸ“˘. HŽR‹vŽC–kˆä‘Ľ•vCĄˆä¸C”¨—˛ŽuCâˆä•ś•FC_“c’źi“ŕj: ‘ć19‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i94.03.10j, ‹ž“s, ´˜^W, p.190, 1994.

1165. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚ƒAƒ~ƒ‰[ƒ[Ť‹š…‚𔺂˘äXcŠu“ŕᑂđŠm”F‚ľ“ž‚˝–ŤäX‰Š‚Ě1—á. ‚“c‰ë”ŽC‘•Ş–ΔŽCŽ›ÎŒOCŽRăp‚ł‚ä‚čC’†ˆä‹v—YCˆÉ“Ą‹ĎC‰ĄŽR–őCŽO‹´—˜‰ˇC^‹ĘŽő”üśCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕjC‘ĺ‹{“ŒśCŠ`“cÍiŠOj: ‘ć22‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď i94.03.11j, •ó’Ë.

1166. mŠw‰ďi’n•űjn i‹łˆçu‰‰j “ŕŽ‹‹ž‚Ě‘}“ü‚ƏŠŒŠ‚Ě‹LÚ–@. ‘ĺˆä“cłli“ŕj: ‘ć4‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒƒZƒ~ƒi[ i94.02.19j, ‰Ą•l, u‰‰W, p.14`16, 1994.

1167. mŠw‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘ŠúˆÝŠŕ‚ɑ΂ˇ‚é“ŕŽ‹‹ž“IŽĄ—Ă. ‰ĄŽR–ői“ŕjC“ˆ”ömiŠOj: ‘ć226‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.09.11j, “Œ‹ž.

1168. mŠw‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰ć‘œ‰đÍ‚đ—p‚˘‚˝ˆÝ’×á‡‚Ě“ŕŽ‹‹ž“IŽĄ–ü”ť’č‚ĚŽŽ‚Ý. ĄňOC‘ĺˆä“cłli“ŕj: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.20j, ‰YˆŔ, —\eW, p.38, 1993.

1169. mŠw‰ďi’n•űjn iƒ[ƒNƒVƒ‡ƒbƒvj H“šˆÝĂ–ŹáŽd‰ť—Ă–@‚É‚¨‚Ż‚é“ŕŽ‹‹ž“IĂ–ŹáŽ‘˘‰e(Endoscopic Varicealography during Infection Sclerotheraphy: EVIS)‚Ě—L—pŤ. ‘şă‹§lC‘•Ş–ΔŽi“ŕj: ‘ć28‰ń“ú–{ŠĚ‘ŸŠw‰ď“Œ•”‰ď i93.11.20j, ç—t, ŠĚ‘Ÿ, 34(Suppl.3): 46, 1993.

1170. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Äś•s—ǐŤ•nŒŒ‚̐f’f 14 ”NŒă‚É–Ťœ‘’P‹…Ť”’ŒŒ•a (CMMoL) ‚Ɉڍs‚ľ‚˝‚P—á. ˆÉ“Ą˜a•FCŽR‰ş‚Ś‚čŽqC˛“ĄGC“Ą–ě—R”üC‰–’J–΁i“ŕj: ‘ć116‰ń“ú–{—Տ°ŒŒ‰tŠw‰ď—á‰ď i92.12.12j, “Œ‹ž, —Տ°ŒŒ‰t, 34: 507, 1993.

1171. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j bó‘B‘—lŠŕ‚Ě1Ç—á. –{ŠÔ“ń˜YC‚“cˆę‘ž˜YCŠOŽR‹v‘ž˜Yi•˝’Ë‹¤Ď•a‰@jC›–ě‘Cź“c–€–çC“n•Ó—˛ŽiC–ě“o˝i“ŕjCŒF–{‹gˆęi•˝’Ë‹¤Ď•a‰@jCˆäă€ˆęC‹T’J“Oi•a—j: ‘ć416‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.02.13j, “Œ‹ž.

1172. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –ƉuŠw“IŠ°—e—Ă–@‚Ş‘tŒř‚ľ‚˝ƒnƒCƒŒƒXƒ|ƒ“ƒ_[ŒŒ—F•a‚`‚Ě‚P—á. ŽR‰ş‚Ś‚čŽqC˛“ĄGC“Ą–ě—R”üC‰–’J–΁C–ؐě“c—˛ˆęi“ŕj: ‘ć117‰ń“ú–{—Տ°ŒŒ‰tŠw‰ď—á‰ď i93.02.27j, “Œ‹ž, —Տ°ŒŒ‰t, 34(8): 970, 1993.

1173. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŒŒŹ”ÂŒ¸­ŤŽ‡”Á•a, ŽŠŒČR‘Ě‚ĚoŒť‚đ—ˆ‚ľ‚˝‰ŠÇŤ‘ĺ“Ž–ŹáŽ‚Ě‚P—á. LŁ—˛ˆęC’ˇ’Jě‚ЂƂ݁C‰ĄXOşCŽO—Ö—SˆęC‹g“c•ŽjC‰i“c–ΔVC“‡“c”ŁC‘ş‰ŞźśC“‡“c‰p˘i“ŕj: ‘ć418‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.05.08j, “Œ‹ž.

1174. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˆŮŠŤACTHŽYś‚É‚ć‚é—ź‘¤•›tŽî‘ĺ‚𔺂Á‚˝Zollinger-EllisonÇŒóŒQ‚Ě‚P—á. “n•Ó•üŒbC^‹ĘŽő”üśCˆÉ“Ą‹ĎC‹ß“Ąˆę‰pC‹e’rVCźŒłŽ›Ž—çCŽO•xO”Vi“ŕj: ‘ć418‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.05.08j, “Œ‹ž, ´˜^W, ‘ć5†, 1994.

1175. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “Á”­Ť–ŒŤtÇ‚É‘ƒóŽ…‹…‘̍d‰ťÇ (FGS) —l•a•Ď‚𔺂Á‚˝‚R—á. –xˆäşCŹ‹v•Ű“§C”äŠé”\”VCŹ—Ń–Li“ŕjCdźGˆęiM‘ĺj: ‘ć23‰ń“ú–{t‘ŸŠw‰ď“Œ•”•”‰ď i93.05.14j, ‰Ą•l.

1176. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “Á”­Ť‹}‘ŹisŤŽ…‹…‘̐t‰Š‚Ě‚W—á. Ź‹v•Ű“§C–xˆäşCŽç‰Ž—˜‰ŔC‰J‹{ŒŤˆęC”äŠé”\”VCŠ™“cvŽőCŠÚ–ěƒśCŹ—Ń–Li“ŕjCdźGˆęiM‘ĺj: ‘ć23‰ń“ú–{t‘ŸŠw‰ď“Œ•”•”‰ď i93.05.14j, ‰Ą•l.

1177. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Á‰Š’Á’ÉÜ (NSAID) ‚É‚ć‚č‹}Ť”A×ŠÇŠÔŽżŤt‰Š‚Ćƒlƒtƒ[ƒ[ÇŒóŒQ‚đ•š”­‚ľ‚˝‚S—á. Žç‰Ž—˜‰ŔC‚‹´‰fŽqC”äŠé”\”VCŠ™“cvŽőCŠÚ–ěƒśCŹ—Ń–LCă‘C“ě‹˝‰p–ži“ŕjCdźGˆęiM‘ĺj: ‘ć23‰ń“ú–{t‘ŸŠw‰ď“Œ•”•”‰ď i93.05.14j, ‰Ą•l.

1178. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒ}ƒ“ƒjƒg[ƒ‹“Š—^Œă‚É”­Ç‚ľ‚˝’˜–ž‚Č’áƒiƒgƒŠƒEƒ€ŒŒÇ‚𔺂Á‚˝‚’ŁŤ’E…Ç‚Ě‚P—á. ’|“ŕN—YCŠ™“cvŽőCŹ‹v•Ű“§C–xˆäşCŽç‰Ž—˜‰ŔC‘ĺ‹v•Ű[lCŹ—Ń–Li“ŕj: ‘ć23‰ń“ú–{t‘ŸŠw‰ď“Œ•”•”‰ď i93.05.14j, ‰Ą•l, —\eW, p.41, 1993.

1179. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒKƒXƒgƒƒOƒ‰ƒtƒBƒ“–@‚ސf’f‚ĆŽĄ—Ă‚É—LŒř‚Ĺ‚ ‚Á‚˝’°ŠÇLß—ô“Şđ’ŽÇ‚Ě‚P—á. “°X‹ťˆę˜Yi“ŕjCź‰ŞŠ˛—Yi‰Ą{‰ę‹¤Ď•a‰@jC‚”öł•Fi“ŕjCÄ“Ą^—i‰Ą{‰ę‹¤Ď•a‰@jC‚’Jˆç’ji“ŕjC‰Şč”ŽCŽO‰ŽŒö‹ICŠÖ‘ň‰pˆęi‰Ą{‰ę‹¤Ď •a‰@j: ‘ć224‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.05.22j, ‰Ą•l.

1180. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Strip biopsy‚Ő؏œ‚ľ“ž‚˝\“ńŽw’°ƒJƒ‹ƒ`ƒmƒCƒh‚Ě1Ç—á. –{ŠÔ“ń˜Yi“ŕjCŠOŽR‹v‘ž˜YCź“c–€–çC›–ě‘C“n•Ó—˛ŽiC–ě“o˝C‚“cˆę‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@jC’ˇ“‡—mŽĄi‰Ą•lŽs‘ĺj: ‘ć224‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.05.22j, ‰Ą•l.

1181. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Cyanoacrylate-LipiodolŹ˜a‰t‚É‚ć‚éŠĚ“ŕmarking‚ĚŽŽ‚݁|PEI‚Ě•â•Žč‹Z‚Ć‚ľ‚Ä. “n•Ó‹`˜Yi“ŕjC–{‘˝VC•˝ŠÔË’qśCŹ—ѐ´“TCˆęŒ´—şC“n•ÓňCŽR“cL•viŹ“cŒ´Žs—§•a‰@j: ‘ć224‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.05.22j, ‰Ą•l.

1182. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ”x–奏cŠuĽŠĚ–ĺ•”ƒŠƒ“ƒpßŽî‘ĺ‚đŽĺ’Ľ‚Ć‚ľ‚˝Œ‹ŠjÇ‚Ě‚P—á. ˛“Ą“N–çC—é–Ř“šOC‰Ô“cL‰pC‹v•Ű“cŸC‚“cM˜aC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć104‰ń“ú–{‹š•”ŽžŠłŠw‰ďŠÖ“Œ’n•ű‰ď i93.05.22j, “Œ‹ž.

1183. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŒyÇ‹}ŤS‹Ř[ÇŠłŽŇ‚̐SŒ`‘Ô‚¨‚ć‚ŃŒŒˆł‚Ě”­Ç‘Šú‚̕ωť. ˆÉ˜@‰ÔC‘ę‘ňrŽ÷C´…ŠŽ‰xCX“cGlCě•Ó•q”VC•‘ň—˜˜YC˜Ič‹P•vC–ؐě“c—˛ˆęi“ŕj: ‘ć148‰ń“ú–{zŠÂŠíŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i93.06.05j, “Œ‹ž.

1184. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j t[Ç‚ƍ‡•š‚ľ‚˝ƒCƒ“ƒXƒŠƒ“”ńˆË‘śŒ^“œ”A•a‚Ě1—á. ‘ĺ˜a“c—˘C‹ŕXWC–ěŒű‹§ŽqCŽç‰Ž’B”üC“Ię´˜aC“Ą“c–F–MC–‹`’‰i“ŕj: ‘ć419‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.12j, ç—t.

1185. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒuƒVƒ‰ƒ~ƒ““Š—^‚É‚ć‚č”ÄŒŒ‹…Œ¸­Ç‚đ‚Đ‚Ť‚¨‚ą‚ľ‚˝–ŤŠÖßƒŠƒEƒ}ƒ`‚Ě1Ç—á. –{ŠÔ“ń˜Yi“ŕjCŠOŽR‹v‘ž˜YC“ú‚‰›C‘şăK‘ž˜Yi•˝’Ë‹¤Ď•a‰@jC›–ě‘C“n•Ó—˛ŽiC–ě“o˝i“ŕjC‚“cˆę‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@j: ‘ć419‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.12j, “Œ‹ž.

1186. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŽžŒn—ń˜^‰ć‚đ—p‚˘‚˝ˆÝ’×á‡á­•”‚Ěpharmacoendoscopy‚É‚ć‚é”S–Œ“ŕƒwƒ‚ƒOƒƒrƒ“—Ę‚ĚŒoŽž“I•Ď‰ť. ‹e’rVC‘ĺˆä“cłlCĄňOCrěä•vCŽRăp‚ł‚ä‚čC’†ˆä‹v—YC“c•Ó‘CŹň˜aŽO˜YC‰ĄŽR–őCźŒłŽ›Ž—çi“ŕj: ‘ć56‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.18`19j, “Œ‹ž.

1187. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j •Ű‘ś“IŽĄ—Ă‚É‚ć‚čœ‹Ž‚ľ“ž‚˝‹‘ĺ–Ń”ŻˆÝÎÇ‚Ě1—á. ‰iŒŠ–žśC‘ĺˆä“cłlC‘ĺŒICrěä•vC‹ß“Ąˆę‰pCź–{ˆĚ’jCÎˆäŒ\‘žC‘şă‹§lCŽR“cŽŠlC‰ĄŽR–őCźŒłŽ›Ž—çi“ŕjC“ˆ”ömiŠOj: ‘ć56‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.18`19j, “Œ‹ž.

1188. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –ŤŠÖßƒŠƒEƒ}ƒ`‚ɍ‡•š‚ľ‚˝ˆÝ’×ᇂ̌Ÿ“˘|“ŕŽ‹‹žŠŒŠ‚𒆐S‚Ć‚ľ‚Ä. ÎěŽĺĹCˆŔ’BŒŁi“ŕjC’†‘ş—zŽqC“ˆ’Ă—TC‹´–{“NCˆäo“NC“n•”K•vCŽR“cş•vCˆŔ•”–ž˜Yi‘—§‘Š–ÍŒ´•a‰@j: ‘ć56‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.18j, “Œ‹ž, Gastroenterological Endoscopy, 36(1): 177, 1994.

1189. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j • o‹ž‰şŽîᇐśŒŸ‚ĹŠm’čf’f‚ľ“ž‚˝Gastrinoma‚Ě1—á. ‘ĺŒIC‘şă‹§lCŽ›ÎŒOCÎŠ_“ż]C”’čŒh“ńC™–{­’źCa’J–ž—˛C‘•Ş–ΔŽCŽÄ“c‹v—YCźŒłŽ›Ž—çC˛“ĄłŽ÷Cˆé•”‹`Œ›i“ŕj: ‘ć56‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.18j, “Œ‹ž, u‰‰—\•ńW, p.49, 1994.

1190. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘ĺ’°“ŕ‚É‘˝”­‚ˇ‚錋ßWâƗl•a•Ď‚đ”F‚ß‚˝1—á. •˝ŠÔË’qśiŹ“cŒ´Žs—§•a‰@jCŹ—ѐ´“Ti“ŕjC–{‘˝VC“n•Ó‹`˜YCˆęŒ´—şi“ŕjC“n•ÓňCŽR“cL•vC’ˇ’JěÍ—YiŹ“cŒ´Žs—§•a‰@j: ‘ć56‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.19j, “Œ‹ž.

1191. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘ĺ—ʉşŒŒ‚É‚ć‚čf’f‚ÉŽŠ‚Á‚˝ˆŤŤ•FŽî“]ˆÚŤˆÝŽîᇂĚ1—á. Ä“Ą^—i“ŕjCź‰ŞŠ˛—YCŽO‰ŽŒö‹Ii‰Ą{‰ę‹¤Ď•a‰@jC‚”öł•FC“°X‹ťˆę˜YC‚’Jˆç’ji“ŕjC‰Şč”ŽCŠÖ‘ň‰pˆęi‰Ą{‰ę‹¤Ď•a‰@j: ‘ć56‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.19j, “Œ‹ž.

1192. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰^“ŽŤ”]_ŒoáŠQ‚𔺂Á‚˝‹}ŤŠ´ŠoŤŽ¸’˛Ťƒjƒ…[ƒƒpƒ`[‚Ě‚Q—á. ŒĂ‘ň‰p–žCł–Ř‚Š‚‚çC‹y”\ŽGCÄ“Ą–L˜aCŒĂ˜a‹vKi“ŕj: ‘ć125‰ń“ú–{_ŒoŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.19j, “Œ‹ž.

1193. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j —DŤˆâ“`‚ĆŽv‚í‚ę, rimmed vacuole‚𔺂Á‚˝‹ßˆĘŒ^ƒ~ƒIƒpƒ`[‚Ě‚P‰ĆŒn. ŠÝ—яCtŒ´Œo•FCÄ“Ą—zŽqC”W’†ŞĆi‘—§¸_E_ŒoƒZƒ“ƒ^[jCaˆä—߈ęi“ŕj: ‘ć125‰ń“ú–{_ŒoŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.19j, “Œ‹ž.

1194. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒAƒXƒyƒ‹ƒMƒ‹ƒX‚É‚ć‚閝Ťd–Œ‰Š‚Ě‚P—á. •Ÿ“c—Ď–çCHŽR‹vŽC”Ń’Ë‚_C”¨—˛ŽuC_“c’źi“ŕj: ‘ć125‰ń“ú–{_ŒoŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.19j, “Œ‹ž.

1195. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –UŒŸ‚É‚ć‚č“ŕŽ‹‹ž“IH“šĂ–ŹáŽŒ‹ăFp(EVL)‚ĚŒř‰Ę‚đ‘gDŠw“I‚ÉŠm”F‚ľ“ž‚˝1—á. ŽRč‚˘‚Â݁C‘şă‹§lC‘•Ş–ΔŽC‰ĄŽR–őCÎŠ_“ż]Cź–{ˆĚ’jC˛“ĄłŽ÷C”’čŒh“ńC™–{­’źCa’J–ž—˛CŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕj: ‘ć56‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.19j, “Œ‹ž, u‰‰—\•ńW, p.59, 1993.

1196. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ”]oŒŒ‚đ‰”­Çó‚Ć‚ľ‚˝‹}Ť‘Oœ‘‹…Ť”’ŒŒ•a‚Ě‚PÇ—á. HŽR‹vŽC•Đ‰Ş—SˆęCŽá—Ń–ő‹vC•‘ň—˜˜YC–kˆä‘Ľ•vi“ŕjC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć35‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.26j, “Œ‹ž.

1197. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŒÄ‹z•s‘S‚đŽĺ’Ľ‚Ć‚ľ‚˝ Amyopathic dermatomyositis ‚Ě‚P—á. ŠOŽRWi“ŕjCăžŠ‹glC•Đ‰Ş—SˆęC–x’rdŽĄC’ç–M•FC‘“c‘ěC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć35‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.26j, “Œ‹ž.

1198. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j •ÂÇŤ‰Šát‚đ‚Ť‚˝‚ľäX‘S‘ĚŠŕ‚Ć‚ĚŠÓ•Ę‚đ—v‚ľ‚˝–ŤäX‰Š‚Ě1—á. _N”VCˆÉ“Ą‹ĎC^‹ĘŽő”üśCźŒłŽ›Ž—çi“ŕjC’†‰p’ji•a—j: ‘ć420‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.07.10j, Š‘ň.

1199. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˜’Ĺ“Ž–Ź‚đ‰h—{ŒŒŠÇ‚Ć‚ľf’f‚É‹ę—ś‚ľ‚˝t×–EŠŕ‚Ě1—á. “ú‚‰›CŠOŽR‹v‘ž˜YCź“c–€–çC›–ě‘C“n•Ó—˛ŽiC–{ŠÔ“ń˜YC–ě“o˝i“ŕjC‚“cˆę‘ž˜YC’†‘ňGşC˛–ěm—Ei•˝’Ë‹¤Ď•a‰@j: ‘ć420‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.07.10j, Š‘ň.

1200. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j —ź‘¤MLFÇŒóŒQ‚đŽŚ‚ľ‚˝Žá”NŤ”][Ç‚Ě‚P—á. “y‹´‚Š‚¨‚čC”Ń’Ë‚_CHŽR‹vŽC”¨—˛ŽuCâˆä•ś•FC_“c’źi“ŕj: ‘ć420‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.07.10j, “Œ‹ž.

1201. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˆÝ’×ᇂ̒ˇŠúŒo‰ßŠĎŽ@’†‚É”­ŒŠ‚ł‚ę‚˝ˆÝ”÷ŹˆŤŤƒŠƒ“ƒpŽî‚Ě1—á. “ú”äŒŞˆęC“c•Ó‘CÎˆäŒ\‘žC˛“ĄłŽ÷C–Ř“cŒőLCŹň˜aŽO˜YC‰ĄŽR–őCŽO‹´—˜‰ˇC‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕjCů–{_C‚–ě—eKCŽOd–슰ŠěC”äŠé”\ Ž÷iŠOjCă™G‰iCŽO•xO”VC–{‹§C’†‰p’ji•a—j: ‘ć225‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.07.24j, “Œ‹ž.

1202. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‹‘ĺ’P”­Ť”X–EŤ•a•Ď‚đ’ć‚ľ‚˝ŠĚ×–EŠŕ‚Ě1—á. “n•Ó—˛ŽiCŠOŽR‹v‘ž˜YC“ú‚‰›C‘şăK‘ž˜YC›–ě‘C–{ŠÔ“ń˜YC–ě“o˝i“ŕjC‚“cˆę‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@j: ‘ć226‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.09.11j, “y‰Y.

1203. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j AFP‚’l‚đŽŚ‚ľ‚˝‚ˇ‚˘“Ş•”Ç‚Ě1—á. źŽRŹ‘ž˜YCź‰ŞŠ˛—YCÄ“Ą^—C‚’Jˆç’jC“°X‹ťˆę˜Yi“ŕjCŔ“c˜aŽiC”’“yˆęlCŠÖ‘ň‰pˆęi‰Ą{‰ę‹¤Ď•a‰@j: ‘ć226‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.09.11j, “y‰Y.

1204. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Strip biopsy‚É‚ÄŘœ‚ľ‚˝ˆÝƒJƒ‹ƒ`ƒmƒCƒh‚Ě1Ç—á. ‘OěŒö’jCŹŽş—Tˆęi“ŕjC‘剪‚Ý‚ä‚Ťi“ŒŽĹ—ŃŠÔ•a‰@jCŽ›ÎŒOi“ŕjCÄ“Ą^—i‰Ą{‰ę‹¤Ď•a‰@jC’†‰p’ji•a—j: ‘ć226‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.09.11j, “y‰Y.

1205. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Œ´”­ŤRƒŠƒ“Ž‰ŽżR‘ĚÇŒóŒQ‚Ě‚P—á. ň“c‚˘‚Ô‚ŤC‘Š’m‹IŽqCLŁ—˛ˆęC“‡“c”ŁCŹ—Ń–Li“ŕj: ‘ć421‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.09.11j, “Œ‹ž.

1206. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j CRST ÇŒóŒQ‚ÉŽŠŒČ–ƉuŤŠĚ‰Š‚đ‡•š‚ľ‚˝‚P—á. ÎěŽçC‚‹´“š—YCŠÖŽRŘ•äCa’J–ž—˛C”э‘–퐜C‰Ş“cƒC‹ß“ĄŒ[•śi“ŕj: ‘ć421‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.09.11j, “Œ‹ž.

1207. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j S‹Ř[ÇŠłŽŇ‚É‚¨‚Ż‚é‰^“ŽŽžśŽş‹ěo—Ś‚ĆƒgƒŒƒbƒhƒ~ƒ‹‰^“Ž•‰‰×Žw•W‚Ć‚ĚŠÖŒW. X“cGlC´…ŠŽ‰xC‘ę‘ňrŽ÷CŒF’J“TŽqC–]ŒŽr’źC˜Ič‹P•vC–ؐě“c—˛ˆęi“ŕj: ‘ć149‰ń“ú–{zŠÂŠíŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i93.09.18j, ŒQ”n.

1208. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰ĄŠu–Œƒwƒ‹ƒjƒA’EoˆÝ‚̐úE‚đ‡•š‚ľ‚˝”^‹š‚Ě‚P—á. ň–őOC–{‘˝Œ¤–çC—é–Ř“šOC‰Ô“cL‰pC‹v•Ű“cŸC‚“cM˜aC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć106‰ń“ú–{‹š•”ŽžŠłŠw‰ďŠÖ“Œ’n•ű‰ď i93.09.18j, “Œ‹ž.

1209. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒvƒŠƒIƒ“’`”’ˆŮí (Codon 200: Glu¨Lys)‚Ş‚Ý‚ç‚ę‚˝CJD ‚Ě–UŒŸ—á. ŒĂ‘ň‰p–žCˆÉ“Ą”Ž–žC’ˇ’JěˆęŽqCÄ“Ą–L˜aCŒĂ˜a‹vKi“ŕj: ‘ć126‰ń“ú–{_ŒoŠw‰ďŠÖ“Œ’n•ű‰ď i93.09.21j, “Œ‹ž.

1210. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Ň‘‰~ÇŒóŒQ‚ŏ‰”­‚ľ‚˝‘˝”­Ťd‰ťÇ‚Ě‚P—á. •Ÿ“c—Ď–çCHŽR‹vŽC”Ń’Ë‚_C”¨—˛ŽuC_“c’źi“ŕj: ‘ć126‰ń“ú–{_ŒoŠw‰ďŠÖ“Œ’n•ű‰ď i93.09.25j, “Œ‹ž.

1211. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒCƒ“ƒXƒŠƒ“”ńˆË‘śŒ^“œ”A•a‚¨‚ć‚ѩ̍d•Ď‚ɉť”^ŤŇ’ʼnŠ, ’°˜‹Ř”^á‡‚đ‡•š‚ľ‚˝1—á. “c’†Œ[Ži‚`C‹ŕXWC–ěŒű‹§ŽqC‘ĺ˜a“c—˘CŽç‰Ž’B”üC“Ię´˜aC“Ą“c–F–MC–‹`’‰i“ŕj: ‘ć422‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.10.09j, ‰Ą•l.

1212. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j —‘‘ƒŠŕŽĄ—ĂŒă‚É”­Ç‚ľ‚˝‹}ŤƒŠƒ“ƒpŤ”’ŒŒ•a‚Ě‚P—á. ’hŒ´Š˛śC‰Ô‰ŞłlCŽR‰ş‚Ś‚čŽqC˛“ĄGC“Ą–ě—R”üC‰–’J–΁C–ؐě“c—˛ˆęi“ŕjC`GŽ÷C‘ –{”ŽsiŽY•wj: ‘ć422‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.10.09j.

1213. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Diabetic Truncal Neuropathy ‚đ’ć‚ľ‚˝’jŽq—á. ł–Ř‚Š‚‚çCÄ“Ą–L˜aCŒĂ‘ň‰p–žC‹y”\ŽGCŒĂ˜a‹vKi“ŕj: ‘ć51‰ń_“ŢěŒ§“ŕ‰ČˆăŠw‰ďW’k‰ď i93.10.17j, ‰Ą•l.

1214. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ’ጌˆłŽ¸_‚đ’ć‚ľ‚˝ŠŒF×–EŽî‚Ě‚P—á. ŒF’J“TŽqC´…ŠŽ‰xC–k–ě‹`˜aCŠ“c”ü—ć”TC‹g“cTC‘ę‘ňrŽ÷CX“cGlC•‘ň—˜˜YC–ؐě“c—˛ˆęi“ŕj: ‘ć51‰ń_“ŢěŒ§“ŕ‰ČˆăŠw‰ďW’k‰ď i93.10.17j, ‰Ą•l, _“ސěˆăŠw‰ďŽGŽ, 21(1): 59, 1994.

1215. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j HAVŠ´ő‚É‚ć‚édÇŠĚáŠQ‚đ’ć‚ľ’ZŠúŠÔ‚ɩ̍d•Ď‚֐i“W‚ľ‚˝1—á. ›–ě‘i“ŕjCŠOŽR‹v‘ž˜Yi•˝’Ë‹¤Ď•a‰@jC“ú‚‰›C‘şăK‘ž˜YC“n•Ó—˛Žii“ŕjC–{ŠÔ“ń˜YC–ě“o˝i“ŕjC‚“cˆę‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@j: ‘ć423‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.13j, “y‰Y.

1216. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Œ´”­Ť haptoglobin Œ‡‘šÇ‚ɍ‡•š‚ľ‚˝ă–îóĂ–Ź“´ŒŒđÇ‚Ě‚P—á. “y‹´‚Š‚¨‚čCHŽR‹vŽC”Ń’Ë‚_C‹ĘˆäL–žC”¨—˛ŽuCâˆä•ś•FC_“c’źi“ŕj: ‘ć423‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.13j, “y‰Y.

1217. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j •sˆŔ’čƒwƒ‚ƒOƒƒrƒ“Ç‚𔺂Á‚˝ˆŰŽ“§ÍŠłŽŇ‚Ö‚ĚƒqƒgƒGƒŠƒXƒƒ|ƒGƒ`ƒ“‚Ě‘ĺ—Ę“Š—^—á. ˛“Ą’ź”VCŠ™“cvŽőC‚‹´‰fŽqi“ŕjC—é–؏t’jiś•¨•¨—‰ťjC˜a“c’m‰vi—Ő•a—jCŹ—Ń–LC–ؐě“c—˛ˆęC‘ĺ‹v•Ű[li“ŕj: ‘ć19‰ń–k—˘ˆăŠw‰ď‘‰ď i93.11.13j, ‘Š–ÍŒ´, –k—˘ˆăŠw, 23(6): 525, 1993.

1218. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j 2 channelƒXƒR[ƒv(XCF-27200)‚ĚŽg—pŒoŒą. ŒÜ\—’łLCŸ–””ş‰hC“ŕ“Ą‹g—˛C‚‹´KGCŽO‹´—˜‰ˇCźŒłŽ›Ž—çi“ŕj: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.19j, ‰YˆŔ.

1219. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j \“ńŽw’°‚É’×ᇐŤ‘ĺ’°‰Š—ŢŽ—•a•Ď‚𔺂Á‚˝ś”źŒ‹’°Œ^’×ᇐŤ‘ĺ’°‰Š‚Ě1—á. “n•Ó—˛ŽiCŠOŽR‹v‘ž˜YC“ú‚‰›C‘şăK‘ž˜YC›–ě‘C–{ŠÔ“ń˜YC–ě“o˝C‚“cˆę‘ž˜YC‹ŕŽRł–ži“ŕj: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.19j, ‰YˆŔ.

1220. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –ŤŠÖßƒŠƒEƒ}ƒ`(RA)‚ɍ‡•š‚ľ‚˝stercoral ulcerih•Ö’×ᇁj‚Ě1—á. ’†‘ş—zŽqCˆŔ’BŒŁi“ŕjC“‡’Ă—Ti‘—§‘Š–ÍŒ´•a‰@jCÎěŽĺĹi“ŕjCˆäo“NC“n•”K•vCˆŔ•”–ž˜YCŽRŒűWOC‘Šě’ŽjCŽR“cş•vi‘—§‘Š–ÍŒ´•a‰@jCŒĂ ”g‘qŽjŽqC‚‹´r‹BiŠOjCŽO•xO”Vi“ŕjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.19j, ‰YˆŔ.

1221. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˆÝ‚ÉŒŔ‹Ç‚ľ‚Ä”F‚ß‚ç‚ę‚˝Žá”NŤƒ|ƒŠƒ|[ƒWƒX‚Ě1—á. rěä•vC‘ĺˆä“cłlCŽÄN•FCŽRăp‚ł‚ä‚čC‹e’rVC’†ˆä‹v—YC‹ß“Ąˆę‰pC“c•Ó‘CŹň˜aŽO˜YC‰ĄŽR–őCźŒłŽ›Ž—çi“ŕjCă™G‰iC’†‰p’ji•a—j: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.19`20j, ‰YˆŔ.

1222. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j śŒŸ‚É‚ÄŠŕ‚đ‹^‚í‚ę‚˝‹U“÷Žî—l•Ď‰ť‚𔺂¤ˆÝ‰ßŒ`ŹŤƒ|ƒŠ[ƒv‚Ě1—á. ”’“yˆęlCź‰ŞŠ˛—YC“°X‹ťˆę˜Yi“ŕjCźŽRŹ‘ž˜YCÄ“Ą^—C‚’Jˆç’jCŠÖ‘ň‰pˆęCŔ“c˜aŽii‰Ą{‰ę‹¤Ď•a‰@j: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.19j, ‰YˆŔ.

1223. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j —Ż’uƒXƒlƒA‚Ě—L—pŤ‚ÉŠÖ‚ˇ‚錟“˘. ‚‹´KGCŒÜ\—’łLCŸ–””ş‰hC“ŕ“Ą‹g—˛C˛“c”ü˜aCŽO‹´—˜‰ˇCźŒłŽ›Ž—çi“ŕjCŽO•xO”Vi•a—j: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.19j, ‰YˆŔ.

1224. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒ|ƒŠƒyƒNƒgƒ~[ŒăŽčp‚đŽ{s‚ľ‚˝’ź’°ƒJƒ‹ƒ`ƒmƒCƒh‚Ě2—á. ‚–ؐ¸ˆęC‚–ě‚‚é‘ăC˛–ěG–íC–{‹´Ci“ŕjC‘ĺěLˆęCˆÉ“Ą‹`•FC‹ĘˆäŮ•vi_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[jCŠô˘‹´“āi“ŕjC‘˝—…”ö˜a˜YCÔ’rMC™­Ş •vC•‹{ČŽĄi_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[j: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.19j, ‰YˆŔ, ƒvƒƒOƒ‰ƒ€, p.12, 1993.

1225. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒ|ƒŠƒyƒNƒgƒ~[‚É‚ć‚čŘœ‚ľ‚Ś‚˝‹‘ĺ\“ńŽw’°‹…•”ƒ|ƒŠ[ƒv‚Ě1—á. Šô˘‹´“āC˛–ěG–íC–{‹´Ci“ŕjC‚–ؐ¸ˆęC‹T“c—zˆęCŽRŒűł’źC”Ń“cä݈ęi_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[j: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.19j, ‰YˆŔ, ƒvƒƒOƒ‰ƒ€, p.27, 1993.

1226. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒY[ƒ€ŽŽŠg‘ĺ“ŕŽ‹‹žiƒIƒŠƒ“ƒpƒXŽĐťŽŽěXCF-200Zj‚ĚŽg—pŒoŒą. ˛“c”ü˜aCŒÜ\—’łLC“ŕ“Ą‹g—˛C‚‹´KGCÎŠ_“ż]CŸ–””ş‰hi“ŕjCŽO•xO”Vi•a—j: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.19j, ‰YˆŔ, ƒvƒƒOƒ‰ƒ€, p.32, 1993.

1227. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Yersinia enterocolitica’°‰Š‚Ě2—á. ÎŠ_“ż]CŒÜ\—’łLC˛“c”ü˜aC“ŕ“Ą‹g—˛C^‹ĘŽő”üśCŸ–””ş‰hCźŒłŽ›Ž—çi“ŕj: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.19j, ‰YˆŔ, u‰‰—\•ńW, p.58, 1993.

1228. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ’˜–ž‚Č”xŤS‚đ—ˆ‚ľŽ€–S‚ľ‚˝ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ě‚P—á. –{‘˝Œ¤–çCň–őOC‰Ô“cL‰pC‹v•Ű“cŸC‚“cM˜aC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć107‰ń“ú–{‹š•”ŽžŠłŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.20j, ‰Y˜a.

1229. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “÷‰čŽîŤˆÝ‰Š‚Ě1—á. ˛–ěG–íC‚–ؐ¸ˆęC–{‹´CCŠô˘‹´“āi“ŕjCˆÉ“Ą‹`•FC‘ĺěLˆęC‹ĘˆäŮ•vC‘˝—…”ö˜a˜YCŹ—Ń—C–{‹´‹v•FC‹T“c—zˆęC”Ń“cä݈ęi_“ŢěŒ§—§‚Ş‚ńƒZƒ“ ƒ^[j: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.20j, ‰YˆŔ, ƒvƒƒOƒ‰ƒ€, p.12, 1993.

1230. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j G•˝ă”牝ś‚đ—ˆ‚ľ‚˝ˆÝ’×ᇂĚ1—á. ó–ě˜NCĄňOCŽl‹{—R”üŽqCźŽR˜a’jCâŒű“NÍi“ŕjC‘“c‰p–žCˆË“c•qCĄ‘ş´ŽqC˛“‡Œh´C˛–ěm—EC’†‘şéśi‰Ą•lŽs—§Žs–Ż•a‰@j: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.20j, ‰YˆŔ, ƒvƒƒOƒ‰ƒ€, p.87, 1993.

1231. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j BRTOiƒoƒ‹[ƒ“•ÂÇ‰ş‹tsŤŒoĂ–Ź“IÇđpj‚É‚ć‚éˆÝĂ–ŹáŽŽĄ—Ă. ź“c–€–çC‘•Ş–ΔŽC^‹ĘŽő”üśC‘şă‹§lC‚“c‰ë”ŽC˛“ĄłŽ÷Cź–{ˆĚ’jC”’čŒh“ńC™–{­’źCa’J–ž—˛CÎˆäŒö“šCŽÄ“c‹v—Yi“ŕjC‰““Ą‚CźŠŞ”ŽC ˆé•”‹`Œ›i•új: ‘ć28‰ń“ú–{ŠĚ‘ŸŠw‰ď“Œ•”‰ď i93.11.20j, ç—t, ŠĚ‘Ÿ, 34(Suppl.3): 104, 1993.

1232. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ’ź’°”S–Œ‰şŽîᇂđŽv‚í‚š‚˝‘¤•›ŒŒs˜H‚𔺂¤ŠĚŠŕ‡•šŠĚd•ĎÇ‚Ě1—á. ‚“c‰ë”ŽCŽÄ“c‹v—YCŠâ–xŒöŠîC“ŕ“Ą‹g—˛CˆÉ“Ą‹ĎCź“c–€–çCÄ“ĄrŽiC‘şă‹§lCa’J–ž—˛C‘•Ş–ΔŽi“ŕj: ‘ć28‰ń“ú–{ŠĚ‘ŸŠw‰ď“Œ•”‰ď i93.11.20j, ç—t, ŠĚ‘Ÿ, 34(Suppl.3): 123, 1993.

1233. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰ć‘œŠÔ‰‰ŽZ•\ŽŚ‚đ—p‚˘‚˝H“š•\ÝŠŕ‚̐Z”͈͐f’f. ’†ˆä‹v—YC‘ĺˆä“cłlCÎˆäŒ\‘žCˆäă’mŽqCŽRăp‚ł‚ä‚čC‹ß“Ąˆę‰pC‹e’rVCĄňOC“c•Ó‘CŹň˜aŽO˜YC‰ĄŽR–őCŽO‹´—˜‰ˇCźŒłŽ›Ž—çi“ŕj: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.20j, ‰YˆŔ, —\eW, p.90, 1993.

1234. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Žá”NŽŇ‚ĚˆÝĽ‘ĺ’°“ŻŽžŤ‘˝”­Šŕ‚Ě1—á. Ź—ѐ´“Ti“ŕjC–{‘˝VC•˝ŠÔË’qśC“n•Ó‹`˜YiŹ“cŒ´Žs—§•a‰@jCˆęŒ´—şi“ŕjC“n•ÓňCŽR“cL•vCˆäăˆç•vC’ˇ’JěÍ—YiŹ“cŒ´Žs—§•a‰@j: ‘ć26‰ń_“ŢěŒ§Á‰ťŠí•aˆăŠw‰ď‘‰ď i93.11.27j, ‰Ą•l.

1235. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˆÝ“ŕ•Ş”ĺ×–EŠŕ‚Ě1–UŒŸ—á. –ě“o˝i“ŕjCŠOŽR‹v‘ž˜Yi•˝’Ë‹¤Ď•a‰@jC‘şăK‘ž˜YC›–ě‘C“n•Ó—˛Žii“ŕjC–{ŠÔ“ń˜YC‚“cˆę‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@jC’ˇ“‡—mŽĄC˛–ěm—E i‰Ą•lŽs‘ĺj: ‘ć26‰ń_“ŢěŒ§Á‰ťŠí•aˆăŠw‰ď‘‰ď i93.11.27j, ‰Ą•l.

1236. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˆÝĽŠĚd•ĄŠŕ‚Ě4—á. ‘şăK‘ž˜Yi“ŕjCŠOŽR‹v‘ž˜Yi•˝’Ë‹¤Ď•a‰@jC“ú‚‰›C›–ě‘C“n•Ó—˛ŽiC–{ŠÔ“ń˜YC–ě“o˝i“ŕjC‚“cˆę‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@j: ‘ć26‰ń_“ŢěŒ§Á‰ťŠí•aˆăŠw‰ď‘‰ď i93.11.27j, ‰Ą•l.

1237. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –ŒŤtÇ‚ĚŒo‰ß’†‚W”NŒă‚É SLE ‚̏”Çó‚Ş”­Œť‚ľ‚˝‚P—á. ě’[M–íCHŽRŽuDC’|“ŕN—YCŠÚ–ěƒśCŹ—Ń–LC–ؐě“c—˛ˆęi“ŕj: ‘ć424‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.12.01j, •˝’Ë.

1238. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒAƒ‹ƒR[ƒ‹‚É‚ć‚銼šk‚ŞŒ´ˆö‚ƍl‚Ś‚ç‚ę‚˝Žá”NS‹Ř[Ç‚Ě‚P—á. Ží“cGŽiCŹ—Ń–ž–FC’Ĺ–źł_C‹g“cTC’ˇ’Jě‰„LC•‘ň—˜˜YC´…ŠŽ‰xC–ؐě“c—˛ˆęi“ŕj: ‘ć424‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.12.01j, •˝’Ë.

1239. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j IFN‚Ş‘tŒř‚ľ‚˝NBNCŠĚ‰Š‚Ě1—á. Ž­ŠÔL–žCa’J–ž—˛C˛“ĄłŽ÷Cź–{ˆĚ’jC‘şă‹§lC”’čŒh“ńC‘•Ş–ΔŽCÎˆäŒö“šCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕjC’†‰p’ji•a—j: ‘ć227‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.12.04j, “Œ‹ž.

1240. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‚bŒ^–ŤŠĚ‰ŠŠłŽŇ‚ĚƒCƒ“ƒ^[ƒtƒFƒƒ“‚ĚŽĄ—ĂŒř‰Ę‹y‚ѐüˆŰ‰ťƒ}[ƒJ[‚ĚŒŸ“˘. ÎěŽĺĹi“ŕjCˆŔ•”–ž˜YC“n•”K•vi‘—§‘Š–ÍŒ´•a‰@jCˆŔ’BŒŁi“ŕjCˆäo“NC’†‘ş—zŽqC“‡’Ă—TCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć227‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.12.04j, “Œ‹ž.

1241. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŠĚL”͉󎀂𔺂Á‚˝Žá”N—Ť‚ĚäX”X–E‘BŠŕ‚Ě1—á. —Ń“c_–ži“ŕjCrěłˆęCă–ě^‹|C‘źi“Œ‹žŽ•‘ĺj: ‘ć227‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.12.04j, “Œ‹ž.

1242. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŠÇo“ŕ‚É–|“]‚ľ‚˝Ź’°ŒeŽş‚ɏoŒŒŤ’×ᇂđŒ`Ź‚ľ‚˝1—á. “ú‚‰›i“ŕjCŠOŽR‹v‘ž˜Yi•˝’Ë‹¤Ď•a‰@jC‘şăK‘ž˜YC›–ě‘C“n•Ó—˛ŽiC–{ŠÔ“ń˜YC–ě“o˝i“ŕjC’†‘ňGşC‚“cˆę‘ž˜YC‹ŕŽRł–žC•ĐŽR´•śCŒF–{‹g ˆęC˛–ěm—Ei•˝’Ë‹¤Ď•a‰@jC’Řˆä‰hˆęi’Řˆäˆă‰@j: ‘ć227‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.12.04j, “Œ‹ž.

1243. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j APƒVƒƒƒ“ƒg‚Ş”F‚ß‚ç‚ę‚˝3‚ŠŒŽŒă‚É‹}‘Ź‚ÉŽîáŽ‚Ş‘‘ĺ‚ľ‚˝ŠĚ×–EŠŕ‚Ě1—á. ‹v•Ű“c•q•FCÎˆäŒö“šC‘şă‹§lCŸŔ‰p‘žC™–{­’źCa’J–ž—˛C‘•Ş–ΔŽC^‹ĘŽő”üśCŽÄ“c‹v—Yi“ŕj: ‘ć227‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.12.04j, “Œ‹ž.

1244. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒCƒ“ƒ^[ƒtƒFƒƒ“—Ă–@Œă‚ÉŠĚ‚É“÷‰čŽîŒ`Ź‚đ”F‚ß‚˝‚bŒ^–ŤŠĚ‰Š‚Ě1—á. a’J–ž—˛C˛“ĄłŽ÷Cź–{ˆĚ’jC‘şă‹§lC™–{­’źC‘•Ş–ΔŽCÎˆäŒö“šCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕjCă™G‰ii•a—j: ‘ć424‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.12.11j, •˝’Ë.

1245. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j _ŒoŤHŽv•sUÇ‚É‹UŤBartterÇŒóŒQ‚đ‡•š‚ľ‚˝1—á. –ěŒű‹§ŽqC‹ŕXWC‘ĺ˜a“c—˘CŽç‰Ž’B”üC“Ię´˜aC“Ą“c–F–MC–‹`’‰i“ŕj: ‘ć424‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.12.11j, •˝’Ë.

1246. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –ŤŠÖßƒŠƒEƒ}ƒ`(RA)‚ɍ‡•š‚ľ‚˝NSAIDs‹NˆöŤˆÝ’×ᇂ̗Տ°“IŒŸ“˘. ÎěŽĺĹCˆŔ’BŒŁi“ŕjC’†‘ş—zŽqC“‡’Ă—TCˆäo“NC“n•”K•vCˆŔ•”–ž˜YC‘Šě’ŽjCŽR“cş•vi‘—§‘Š–ÍŒ´•a‰@j: ‘ć424‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.12.11j, •˝’Ë.

1247. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Œ´”­Ť’_`ŤŠĚd•Ď‚ĚŒo‰ß’†‚ÉŠĚ×–EŠŕ‚đ‡•š‚ľ‚˝1—á. ›–ě‘i“ŕjCŠOŽR‹v‘ž˜Yi•˝’Ë‹¤Ď•a‰@jC“ú‚‰›C‘şăK‘ž˜YC“n•Ó—˛ŽiC–{ŠÔ“ń˜YC–ě“o˝i“ŕjC‚“cˆę‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@jC’ˇ“‡—mŽĄ i‰Ą•lŽs‘ĺj: ‘ć424‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.12.11j, •˝’Ë.

1248. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘˝”­’×á‡‚đ‚Ť‚˝‚ľ‚˝’°Œ^Behcet•a‚Ě1Œo‰ßŠĎŽ@—á. “‡’Ă—TCˆŔ’BŒŁC’†‘ş—zŽqCÎěŽĺĹi“ŕjCˆäo“NC“n•”K•vCˆŔ•”–ž˜YC‘Šě’ŽjCŽR“cş•vCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć4‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ďŠÖ“Œ’n•ű‰ď i93.12.11j, …ŒË.

1249. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˆŤŤŒo‰ß‚ĚŒŒŠÇŽî‚𔺂Á‚˝Crow-FukaseÇŒóŒQ‚Ě–UŒŸ—á. ÂŒË˜aŽqC’ˇ’JěˆęŽqCÄ“Ą–L˜aCŒĂ˜a‹vKi“ŕjC‘‘ňŠ˛’ji”çj: ‘ć127‰ń“ú–{_ŒoŠw‰ďŠÖ“Œ’n•ű‰ď i93.12.11j, “Œ‹ž.

1250. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Ž‘ą‚ˇ‚éšq“fCˆÓŽŻÁŽ¸”­ě‚Ɉř‚Ť‘ą‚˘‚Ä—ź‘¤“ŕ‘¤c‘ŠÇŒóŒQ‚Ĺ”­Ç‚ľ‚˝•HŒ`”]‰Š‚Ě‚P—á. •Ÿ“c—Ď–çC”Ń’Ë‚_CĄˆä¸C”¨—˛ŽuC_“c’źi“ŕj: ‘ć127‰ń“ú–{_ŒoŠw‰ďŠÖ“Œ’n•ű‰ď i93.12.11j, “Œ‹ž.

1251. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ”畆ŒŒŠÇ•a•Ď‚𔺂Á‚˝ amyopathic dermatomyositis ‚Ě‚P—á. Šp‰Ć–ž•śCě’[M–íCŠÖŽRŘ•äC”э‘–퐜CÔŻ“§C‰Ş“cƒC‹ß“ĄŒ[•śi“ŕj: ‘ć424‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.12.11j, •˝’Ë.

1252. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Methotrexate (MTX), sulfasalazine (SASP) •š—p—Ă–@’†‚É‹Ô‰č‹…Ť•nŒŒ‚đ”F‚ß‚˝–ŤŠÖßƒŠƒEƒ}ƒ`(RA)‚Ě‚P—á. ‚‹´“š—YC•äâ–΁CŠp‰Ć–ž•śCŠÖŽRŘ•äCÔŻ“§C‰Ş“cƒC‹ß“ĄŒ[•śi“ŕj: ‘ć4‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ďŠÖ“Œ’n•ű‰ď i93.12.11j, …ŒË.

1253. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j S‹ŘƒuƒŠƒbƒW‚É‚ć‚čS‹Ř[Ç‚đ”­Ç‚ľ‚˝‚ƍl‚Ś‚ç‚ę‚˝‚PÇ—á. ‹g“c“OC“‚‘ň’źŽqC’čG•vCě”¨˜alC‘şź€C–ؐě“c—˛ˆęi“ŕj: ‘ć150‰ń“ú–{zŠÂŠíŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i93.12.18j, “Œ‹ž.

1254. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒqƒgŒ^ƒCƒ“ƒXƒŠƒ“‚ɑ΂ľ‚ăAƒŒƒ‹ƒM[‚đ’ć‚ľ‚˝“œ”A•a‚Ě1—á. •˝ˆä–@”Ži“ŕjCź‰ŞŠ˛—YCŠÖ‘ň‰pˆęi‰Ą{‰ę‹¤Ď•a‰@jC“Ię´˜aC‹ŕXWC–‹`’‰i“ŕj: ‘ć31‰ń“ú–{“œ”A•aŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i94.01.22j, “Œ‹ž.

1255. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‹U–ŒŤ’°‰Š‚đ‡•š‚ľ‚˝“œ”A•aŤt•s‘S‚Ě2—á. Žç‰Ž’B”üC“c’†Œ[Ži‚`C”~‘ňTˆęC–ěŒű‹§ŽqC‘ĺ˜a“c—˘C‹ŕXWC“Ię´˜aC“Ą“c–F–MC–‹`’‰i“ŕj: ‘ć31‰ń“ú–{“œ”A•aŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i94.01.22j, “Œ‹ž.

1256. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŠO—ˆ“œ”A•aŠłŽŇ‚Ě–éŠÔŽžŠÔ”A‚É‚ć‚éƒAƒ‹ƒuƒ~ƒ“”rŸ•—Ś(AER)‘Ş’č‚Ě—Ő°“IˆÓ‹`|5”NˆČă‚Ě’ˇŠúŠĎŽ@‚É‚ć‚éŒo‰ß|. ‘ĺ˜a“c—˘C“Ię´˜aC“c’†Œ[Ži‚`C”~‘ňTˆęC–ěŒű‹§ŽqCŽç‰Ž’B”üC‹ŕXWC“Ą“c–F–MC–‹`’‰i“ŕj: ‘ć31‰ń“ú–{“œ”A•aŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i94.01.22j, “Œ‹ž.

1257. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j f’f‚É‹ę—ś‚ľ‚˝‹UƒAƒ‹ƒhƒXƒeƒƒ“Ç‚Ě‚P—á. ‚‹´ŠîC•‘ň—˜˜YCÂ–Ř‘Ľ–žCŽá—Ń–ő‹vC‹ß“Ąˆę‰pC”’čŒh“ńi“ŕjC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć36‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ď i94.02.05j, “Œ‹ž.

1258. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ’˜–ž‚ȍ‚ƒJƒ‹ƒVƒEƒ€ŒŒÇ‚đ’ć‚ľ‚˝ƒoƒZƒhƒE•a‚Ě1—á. “c’†Œ[Ži‚`C‹ŕXWCŹ‘ň„‹vC”~‘ňTˆęC–ěŒű‹§ŽqC‘ĺ˜a“c—˘CŽç‰Ž’B”üC“Ię´˜aC“Ą“c–F–MC–‹`’‰i“ŕj: ‘ć425‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i94.02.12j, “Œ‹ž.

1259. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŽŠŒČ–ƉuŤ—nŒŒŤ•nŒŒ‚đ‡•š‚ľ‚˝MCTD‚Ě1Ç—á. –{ŠÔ“ń˜YCŠOŽR‹v‘ž˜Yi•˝’Ë‹¤Ď•a‰@jC‘şăK‘ž˜YC“ú‚‰›C›–ě‘C“n•Ó—˛ŽiC–ě“o˝i“ŕjC‚“cˆę‘ž˜YC–kžŠ°li•˝’Ë‹¤Ď•a‰@jC‹gˆäş•vi“ŕj: ‘ć425‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i94.02.12j, “Œ‹ž.

1260. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j —AŒŒ‚É‚ć‚éˆÚA•Đ‘ΏhŽĺ•a‚ĹŽ€–S‚ľ‚˝‚ƍl‚Ś‚ç‚ę‚éŠĚ×–EŠŕ‚Ě1—á. ’JěˆęŽuC”’čŒh“ńCa’J–ž—˛C‘•Ş–ΔŽCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕjCŽO•xO”Vi•a—j: ‘ć425‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i94.02.12j, “Œ‹ž.

1261. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –ŒŤtÇ‚ƍRŽ…‹…‘ĚŠî’ę–ŒR‘̐t‰Š‚Ě‚P‡•š—á. ˛–ě—˛C’|“ŕN—YCX‰ş“N•vCŠ™“cvŽőCŠÚ–ěƒśCŹ—Ń’ź”VC‹g“cŕˆCŹ—Ń–LC–ؐě“c—˛ˆęi“ŕj: ‘ć425‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i94.02.12j, “Œ‹ž.

1262. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Lemierre syndrome ‚ƍl‚Ś‚ç‚ę‚˝ Fusobacterium necrophorum ”sŒŒÇ‚Ě‚P—á. –{‘˝Œ¤–çCň–őOC—é–Ř“šOC‹v•Ű“cŸC•Đ‹Ë“ú˛ŽqC•Đ‹Ë^lCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć425‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i94.02.12j, “Œ‹ž.

1263. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˆęŽ_‰ť’‚‘f‹z“ü—Ă–@‚đs‚Á‚˝dÇŒÄ‹z•s‘SÇ—á‚ĚŽŠŒą—á. “c’†’ź•FCŹ—эO—SC˛“Ą“N–çC•y“c—FKi“ŕjC´…‹ĹC–Lě‹MŽiC˛“ĄŒőŽjCŠ`“cÍiŠOjC“n•Ó•qi–ƒjC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝jCLŁ–ŤiMEƒZ ƒ“ƒ^[j: ‘ć108‰ń“ú–{‹š•”ŽžŠłŠw‰ďŠÖ“Œ’n•ű‰ď i94.02.19j, “Œ‹ž.

1264. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘ĺ’°ŽîᇐŤŽžŠł‚̐f’f. ŒÜ\—’łLi“ŕj: ‘ć4‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒƒZƒ~ƒi[ i94.02.20j, ‰Ą•l.

1265. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰şŒŒ‚đŒ_‹@‚É”­ŒŠ‚ł‚ę, Œo‰ß’†“ÁˆŮ‚ČŒ`‘ԕωť‚đ’ć‚ľ‚˝ˆÝ•˝ŠŠ‹ŘŽî‚Ě1—á. –ěŒű‘ŽqC“c•Ó‘C‘ĺ˜a“c^‹IŽqC“ú”äŒŞˆęCÎˆäŒ\‘žCˆÉ“Ą‹ĎCŹň˜aŽO˜YC‰ĄŽR–őC‘ĺˆä“cłlCŽO‹´—˜‰ˇC^‹ĘŽő”üśCźŒłŽ›Ž—çi“ŕjC’|“cC”äŠé ”\Ž÷iŠOjCă™G‰iCŽO•xO”VC’†‰p’ji•a—j: ‘ć228‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i94.02.26j, “Œ‹ž.

1266. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j AFP‚’l‚đŽŚ‚ľ‚˝äXŠŕ‚ĆŽv‚í‚ę‚é1–UŒŸ—á. “n•Ó—˛Žii“ŕjCŠOŽR‹v‘ž˜Yi•˝’Ë‹¤Ď•a‰@jC‘şăK‘ž˜YC“ú‚‰›C›–ě‘C–{ŠÔ“ń˜YC–ě“o˝i“ŕjC‚“cˆę‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@j: ‘ć228‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i94.02.26j, “Œ‹ž.

1267. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j šb‘§dĎ”­ěŽĄ—ĂŒă‚É‹}ŤŽlŽˆ–ƒáƒ‚đ’ć‚ľ‚˝’jŽq—á. ‰Á“Ą’m–çCaˆä—߈ęC’ˇ’JěˆęŽqCÄ“Ą–L˜aCŒĂ˜a‹vKi“ŕj: ‘ć128‰ń“ú–{_ŒoŠw‰ďŠÖ“Œ’n•ű‰ď i94.03.05j, “Œ‹ž.

1268. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j —ź‘¤Ť“ď’Ž‚ĆŠç–ʐ_Œo–ƒáƒ‚Ĺ”­Ç‚ľ‚˝Œ´”­‘ƒ•s–ž‚Ě‘BŠŕ‚Ě‚P—á. •Ÿ“c—Ď–çCĄˆä¸C”¨—˛ŽuCâˆä•ś•FC_“c’źi“ŕj: ‘ć128‰ń“ú–{_ŒoŠw‰ďŠÖ“Œ’n•ű‰ď i94.03.05j, “Œ‹ž.

1269. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰ń’°‹y‚Ń‘SŒ‹’°‚É‘˝”­Ť’×ᇂđŒ`Ź‚ľ‚˝–ňÜŤ’°‰Š‚Ě1—á. ‘şăK‘ž˜Yi“ŕjCŠOŽR‹v‘ž˜Yi•˝’Ë‹¤Ď•a‰@jC“ú‚‰›C“n•Ó—˛ŽiC–{ŠÔ“ń˜YC–ě“o˝C›–ě‘i“ŕjC‚“cˆę‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@j: ‘ć426‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i94.03.12j, “Œ‹ž.

1270. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Vertical one-and-a-halfÇŒóŒQ‚đ’ć‚ľ‚˝’†”][Ç‚Ě‚P—á. “y‹´‚Š‚¨‚čCHŽR‹vŽCĄˆä¸C”Ń’Ë‚_C”¨—˛ŽuCâˆä•ś•FC_“c’źi“ŕj: ‘ć426‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i94.03.12j, “Œ‹ž.

1271. mŠw‰ďi’n•űjn iƒ|ƒXƒ^[u‰‰j Tumor-Associated ALDH‚̖Ɖu‘gDŠw“IŒŸ“˘. a’J–ž—˛i“ŕjC’|“ŕ“ÖŽqi“Œ•a‰@Œ¤‹†ŒnjCŽÄ“c‹v—Yi“ŕjC’†‰p’ji•a—j: ‘ć28‰ń“ú–{ŠĚ‘ŸŠw‰ď“Œ•”‰ď i93.11.19j, ç—t, ŠĚ‘Ÿ, 34(Suppl.3): 86, 1993.

1272. mŠw‰ďi’n•űjn iƒ|ƒXƒ^[u‰‰j H“šˆÝĂ–ŹáŽd‰ť—Ă–@Œă‚É‹ť–Ą‚ ‚é–ĺ–ŹŒŒs“Ž‘Ô‚đ—ˆ‚ľEVIS(“ŕŽ‹‹ž“IĂ–ŹáŽ‘˘‰e: Endoscopic Varicealography during Injection Sclerotherapy)‚ŞĂ–ŹáŽ‚Ě•`o, ŽĄ—Ă‚ÉĹ‚ŕ—L—p‚Ĺ‚ ‚Á‚˝1—á. ˛“c”ü˜aC‘şă‹§lC‘•Ş–ΔŽC‚“c‰ë”ŽCÎŠ_“ż]Cź–{ˆĚ’jC˛“ĄłŽ÷C”’čŒh“ńC™–{­’źCa’J–ž—˛CŽÄ“c‹v—Yi“ŕjC‰““Ą‚CźŠŞ”ŽCˆé•”‹`Œ› i•új: ‘ć28‰ń“ú–{ŠĚ‘ŸŠw‰ď“Œ•”‰ď i93.11.20j, ç—t, ŠĚ‘Ÿ, 34(Suppl.3): 124, 1993.

1273. mŒ¤‹†‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j 0-linked oligosaccharide on IgA1 hinge region in IgA nephropathy|Fundamental studies for precise structure and possible rules. ”äŠé”\”VC–xˆäşi“ŕjCŠâŁm—EC–x“c‹ąŽqiś‰ťjCŹ—Ń–Li“ŕj: 6th International Symposium of IgA Nephropathy i94.02.28j, ƒI[ƒXƒgƒ‰ƒŠƒA.

1274. mŒ¤‹†‰ďi‘Űjn iˆę”ʍu‰‰j Evaluation of gastric ulcer healing by age analysis. ĄňOC‘ĺˆä“cłlCźŒłŽ›Ž—çi“ŕj: 2nd Osaka International Symposium on Gastroenterology i93.11.22j, ‘ĺă, Abstracts, p.44, 1993.

1275. mŒ¤‹†‰ďi‘Űjn iˆę”ʍu‰‰j Steroid therapy in IgA nephropathy|A 10-year follow-up study. Ź—Ń–LC”äŠé”\”VCŹ‹v•Ű“§C–xˆäşCŠÚ–ěƒśi“ŕj: 6th International Symposium of IgA Nephropathy i94.03.01j, ƒI[ƒXƒgƒ‰ƒŠƒA.

1276. mŒ¤‹†‰ďi‘S‘jn i“Á•Ęu‰‰j •a‰@î•ńƒVƒXƒeƒ€‚ĚŒťó‚Ć–˘—ˆ. ŒĂ˜a‹vKi“ŕj: “ú–{ˆă—Ïî•ńŠw‰ď‘ć‚X‰ńŠĹŒěî•ńƒVƒXƒeƒ€Œ¤‹†‰ď i93.06.26j, “Œ‹ž.

1277. mŒ¤‹†‰ďi‘S‘jn i“Á•Ęu‰‰j IgA tÇ‚Ě—Ő°‚Ć•a—. Ź—Ń–Li“ŕj: ’†‘tŽžŠł•a—‘gDŒ¤‹†‰ď i93.07.03j, –k‹ž.

1278. mŒ¤‹†‰ďi‘S‘jn i“Á•Ęu‰‰j ‰ŠÇ‚ĆƒTƒCƒgƒJƒCƒ“. ÔŻ“§i“ŕj: ‘ć15‰ń–ƒŒ–ň‘ăŽÓ‚Ć‘ŸŠíáŠQŒ¤‹†‰ďƒVƒ“ƒ|ƒWƒEƒ€ i93.11.26j, •Ÿ‰Ş.

1279. mŒ¤‹†‰ďi‘S‘jn i‹łˆçu‰‰j ‘ĺ’°‚Ş‚ńŒŸf‚̐¸ŒŸ‹Zp‚̏K“ž‚ɂ‚˘‚Ä. Ÿ–””ş‰hi“ŕj: ‘ć7‰ń_“ŢěŒ§ˆăŽt‚Ş‚ńŒŸfŒ¤‹†‰ď i93.03.13j, ‰Ą•l, ´˜^W, p.7`12, 1993.

1280. mŒ¤‹†‰ďi‘S‘jn i‹łˆçu‰‰j ’ጌˆł‚Ě•a‘Ԑś—‚Ć‚ť‚ĚŽĄ—Âɂ‚˘‚Ä. –ؐě“c—˛ˆęi“ŕj: “ú–{ˆăŽt‰ďśŠU‹łˆçuŔ i93.07.14j, “Œ‹ž.

1281. mŒ¤‹†‰ďi‘S‘jn i‹łˆçu‰‰j ˜V”NŽŇ‚Ěƒp[ƒLƒ“ƒ\ƒ“•a |—Տ°‘œ‚Ě“Á’Ľ|. ’ˇ’JěˆęŽqi“ŕj: ‘ć‚W‰ń‘ĺ”]Šî’ęŠjŒ¤‹†‰ď i93.08.05j, ˆÉ¨.

1282. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ˆÝŠŕ|f’f‚Š‚ç“ŕŽ‹‹žŽĄ—Ă‚Ü‚Ĺ. źŒłŽ›Ž—çi“ŕj: ‘ć1‰ń“ú–{Šwp‰ď‹cÁ‰ťŠíŠwŒ¤ƒVƒ“ƒ|ƒWƒEƒ€ i93.07.31j, ŽD–y.

1283. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j wƒOƒ‹[ƒvƒXƒLƒ‹ƒgƒŒ[ƒjƒ“ƒOx–ʐڋZp‚ĚŒüă‚đl‚Ś‚é. ‘ĺ‹v•Ű—˘i‘‡‘Š’k•”jC‚‹´ŽŽqCŽR–{—R‹ICě“YŒcˆę˜YCr‹v•ŰşŽqC‰““Ą—DŽq: “ú–{ƒAƒ‹ƒR[ƒ‹ŠÖ˜A–â‘čƒ\[ƒVƒƒƒ‹ƒ[ƒJ[‹Ś‰ďŒ¤‹†‘ĺ‰ď i93.09.22`23j, ’ˇč.

1284. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Ž…‹…‘Ě‚Ě”÷×\‘˘|‹}‘Ź“€Œ‹ĽƒfƒB[ƒvƒGƒbƒ`ƒ“ƒO–@‚É‚ć‚錟“˘‚𒆐S‚É. Žç‰Ž’B”üi“ŕj: ‘ć28‰ń“œ”A•aŠw‚̐i•ŕ i94.02.17j, “Œ‹ž, u‰‰—vŽ|W, p.34, 1994.

1285. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j lH“§Í’†‚É‹}Ť”­Ç‚ľ‚˝‘˝”­ƒjƒ…[ƒƒpƒ`[‚Ě‚R—á. Ä“Ą–L˜aC‹y”\ŽGCŒĂ˜a‹vKC’š‹‡ŽOi“ŕj: ‘ć20‰ń_Œo‹ŘƒJƒ“ƒtƒ@ƒŒƒ“ƒXiNMCj i93.00.00j, “Œ‹ž.

1286. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Muscle cramp, exertional myalgia, elevated Ckemia‚đ—L‚ˇ‚鐏l’jŽq—á. ÂŒË˜aŽqCHitomi Beatriz KiyomotoCˆÉ“Ą”Ž–žCÄ“Ą–L˜aCŒĂ˜a‹vKi“ŕj: ‘ć20‰ń_Œo‹ŘƒJƒ“ƒtƒ@ƒŒƒ“ƒXiNMCj i93.00.00j, “Œ‹ž.

1287. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ’`”’˜RoŤˆÝ’°Ç‚Ć‹š–Œ‰Š‚đ‡•š‚ľ‚˝ MCTD ‚É Cyclophosphamide ƒpƒ‹ƒX—Ă–@‚Ş’˜Œř‚ľ‚˝‚P—á. Šp‰Ć–ž•śC‰Ş“cƒC–ě‘şł˘C‹ß“ĄŒ[•śi“ŕj: ŒúśČ“Á’莞ŠłŹ‡ŤŒ‹‡‘gD•a’˛¸Œ¤‹†”Ç•˝Ź‚S”N“x‘ć‚Q‰ń”ljď‹c i93.01.11j, “Œ‹ž.

1288. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ’jŤ SLE ‚É‚¨‚Ż‚é‘ĺ‘ڍœ“Ş‰óŽ€Ç‚Ě”­ÇˆöŽq‚̉đÍ. –ě‘şł˘C‰Ş“cƒCÎěÍC‹ß“ĄŒ[•śi“ŕjC”č’ő•vi“Œ—ˆă‘ĺj: ŒúśČ“Á’莞Šł“Á”­Ť‘ĺ‘ڍœ“Ş‰óŽ€Ç’˛¸Œ¤‹†”Ç•˝Ź‚S”N“x‘ć‚Q‰ń”ljď‹c i93.01.11j, “Œ‹ž.

1289. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Á‰ťŠÇˆŤŤŽîᇂɂ¨‚Ż‚éRŠŕÜ“Š—^Œă‚Ě”’ŒŒ‹…Œ¸­Ç‚ɑ΂ˇ‚éG-CSF‚Ě“Š—^•ű–@‚ĚŒŸ“˘. ĄňOCŹň˜aŽO˜YCŸ–””ş‰hCźŒłŽ›Ž—çi“ŕjC˛“‡Œh´i‰Ą•lŽs—§Žs–Ż•a‰@j: ‘ć16‰ńŠŕŽĄ—ͧ˜b‰ď i93.02.13j, ‰Ą•l, —\eW, p.17`18, 1993.

1290. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‘SgŤƒGƒŠƒeƒ}ƒg[ƒfƒXŠłŽŇ‚É‚¨‚Ż‚é QOL ‚ĚŒ¤‹†(2). ‰Ş“cƒC–ě‘şł˘C‰““Ą•˝mC‹ß“ĄŒ[•śi“ŕj: ŒúśČ“Á’莞Šł“ď•a‚ĚƒPƒAƒVƒXƒeƒ€’˛¸Œ¤‹†”Ç•˝Ź‚Q”N“xŒ¤‹†•ń‰ď‹c i93.03.00j, “Œ‹ž.

1291. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ’´‰š”g“ŕŽ‹‹ž‚É‚ć‚é’_”X—˛‹NŤ•a•Ď‚̐f’f. –ě“o˝C–Ř“cŒőLCâŒű“NÍCŽR“cŽŠlCˆÉ“Ą‹ĎC^‹ĘŽő”üśCźŒłŽ›Ž—çi“ŕjC‹g“c@‹IC‘ĺ‹{“ŒśC”äŠé”\Ž÷iŠOj: ‘ć45‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď•t‘ŽŒ¤‹†‰ď‘ć1‰ń“ŕŽ‹‹ž“I’´‰š”gf’f‚̐¸“xŒüă‚ÉŠÖ‚ˇ‚錤‹†‰ď i93.05.14j, VŠƒ.

1292. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ”ńú’ʐŤ‹š•”ŠO‚É‚ć‚銼“Ž–Ź‘š‚ĚŽĄ–ü‰ß’ö‚đŠm”F‚ľ“ž‚˝‚P—á. HŽR‹vŽi“ŕjC‘“c‘ěC•‘ň—˜˜YC–kˆä‘Ľ•vCŽá—Ń–ő‹vCâŒű“NÍC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć7‰ń“ú–{ŠOŒ¤‹†‰ď i93.05.21j, “ß”e, “ú–{ŠOŒ¤‹†‰ďŽGŽ, 7(2): 192, 1993.

1293. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰@‚ĹŒoŒą‚ľ‚˝–ŤƒŠƒ“ƒpŤ”’ŒŒ•a‚ĚŒŸ“˘. ŽR‰ş‚Ś‚čŽqC’hŒ´Š˛śC“Ą–ě—R”üC‰–’J–΁i“ŕj: ‘ć‚U‰ń‘˘ŒŒŠíŽîᇎĄ—ĂŒ¤‹†‰ď i93.05.29j, “Œ‹ž.

1294. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒg‚É‚¨‚Ż‚é’áŽ_‘f•‰‰×Žž‚Ě×“Ž–ŹŒa‚̕ωť. “c’†’ź•FC˛“Ą“N–çC‰Ô“cL‰pC‹v•Ű“cŸC‚“cM˜aC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć70‰ń—Տ°ŒÄ‹zś—Œ¤‹†‰ď i93.06.12j, “Œ‹ž, —\eW, p.1, 1993.

1295. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒg‚É‚¨‚Ż‚é’áŽ_‘f•‰‰×Žž‚Ě”÷ŹzŠÂ“Ž‘Ô‚ĚŒŸ“˘. “c’†’ź•FCŽO“Ą‹vC˛“Ą“N–çC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: ‘ć‚T‰ń”xzŠÂŒ¤‹†‰ď i93.06.27j, “Œ‹ž, —\eW, p.24, 1993.

1296. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ’f’ԐŤ\‰šáŠQ‚ĆŒőE‰šEäF’@‘Ĺ‚É‚ć‚č—U”­‚ł‚ę‚éŽlŽˆ‚Ěmyoclonic jerky movements‚đŽŚ‚ˇ—Ť—áiƒrƒfƒIj. ÂŒË˜aŽqi“ŕj: ‘ć‚W‰ń‘ĺ”]Šî’ęŠjŒ¤‹†‰ď i93.08.05j, ˆÉ¨.

1297. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j äPŒ´•a‚É‚¨‚Ż‚éRD’†‹…×–EŽżR‘Ě (ANCA) ‚Ě—Ő°“IˆÓ‹`. ‰““Ą•˝mC‹ß“ĄŒ[•śi“ŕj: ‘ć‚W‰ńAAĽICŒ¤‹†‰ď i93.08.28j, “Œ‹ž.

1298. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŒŒ’†RHelicobacter pylori(HP)R‘Ě‚Ě—L—pŤ‚ɂ‚˘‚ā|–ŤŠÖßƒŠƒEƒ}ƒ`(RA)‡•š’×ᇂ̌Ÿ“˘‚đŠÜ‚ß‚Ä. ˆŔ’BŒŁi“ŕjC’†‘ş—zŽqC“‡’Ă—Ti‘—§‘Š–ÍŒ´•a‰@jCÎěŽĺĹi“ŕjCˆäo“NC“n•”K•vCˆŔ•”–ž˜YCŽR“cş•vi‘—§‘Š–ÍŒ´•a‰@jCˆŔŠC‹`—jCźŒłŽ›Ž—ç i“ŕj: ‘ć35‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď•’uŒ¤‹†‰ď i93.09.21j, _ŒË, —\eW, 90(—Ő‘): 316, 1993.

1299. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ”S–ŒŘœ‚É‚ÄŽĄ—Ă‚ľ‚˝‘ĺ’°‘ŠúŠŕ‚ĚŒŸ“˘. ‚‹´KGCŒÜ\—’łLC“ŕ“Ą‹g—˛C˛“c”ü˜aCÎŠ_“ż]CŸ–””ş‰hCźŒłŽ›Ž—çi“ŕjCŽO•xO”VC’†‰p’ji•a—jCŹ—ѐ´“Ti“ŕj: ‘ć11‰ń‘ĺ’°ŒŸ¸–@Œ¤‹†‘‰ď i93.10.02j, “Œ‹ž.

1300. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j rHuEPO ‘ĺ—Ę“Š—^‚Í•sˆŔ’čƒwƒ‚ƒOƒƒrƒ“Ç‚𔺂Á‚˝ˆŰŽ“§ÍŠłŽŇ‚Ĺ‘ŮŽ™Œ^ƒwƒ‚ƒOƒƒrƒ“‘‰Á‚Ć•nŒŒ‰ü‘P‚đ‚ŕ‚˝‚炡. ‚‹´‰fŽqCŠ™“cvŽőC˛“Ą’ź”VC“ŕ“c–ž”üŽqCŹ—Ń–Li“ŕjC˜a“c’m‰vi—Ő•a—jC—é–؏t’jiś•¨•¨—‰ťjC‘—F“N”V•ăi“ŒƒŒjC‘ĺ‹v•Ű[li“ŕj: ‘ć‚Q‰ńt‚ĆƒGƒŠƒXƒƒ|ƒGƒ`ƒ“Œ¤‹†‰ď i93.10.16j, “Œ‹ž.

1301. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j FNHŽîᇐśŒŸŽž‚É‚¨‚Ż‚é•a—‘gDŠw“IŒŸ“˘. ˛“ĄłŽ÷C‘•Ş–ΔŽCź“c–€–çCa’J–ž—˛C^‹ĘŽő”üśCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕj: ‘ć10‰ńŠĚŽîᇐśŒŸŒ¤‹†‰ď, ‘ć8‰ńŠĚŠŕÇ—ጟ“˘‰ď i93.10.23j, “Œ‹ž, ´˜^W, p.9, 1993.

1302. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ×Œa’´‰š”gƒvƒ[ƒu‰ćŽżŒüă‚Ě‘Îô|ƒ[ƒŠ[’“ü–@‚̉ž—p|. âŒű“NÍCŽR“cŽŠlC–Ř“cŒőLC“ŕ“Ą‹g—˛C‹ß“Ąˆę‰pCˆÉ“Ą‹ĎC–ě“o˝C^‹ĘŽő”üśCźŒłŽ›Ž—çi“ŕj: ‘ć2‰ń×Œa’´‰š”gƒvƒ[ƒuŒ¤‹†•”‰ď i93.11.10j, ç—t.

1303. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŒQ”­“Ş’É”­ě’†‚Ě“ŕŒz“Ž–Ź‚̕ωť|MRI‚É‚ć‚錟“˘|. ŒÜ\—’‹v‰ŔCâˆä•ś•FC‹ĘˆäL–žC_“c’źi“ŕj: ‘ć21‰ń“Ş’ÉŒ¤‹†‰ď i93.11.20j, “Œ‹ž.

1304. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j –éŠÔ‚É“´’âŽ~Cšq“fC”AŽ¸‹Ö‚Č‚Ç‚Ě‘˝Ę‚ȏǏó‚đ’ć‚ľ‚˝‡–°Žž–łŒÄ‹zÇŒóŒQ‚Ě‚P—á. ŽO“Ą‹vCˆ˘•”’źC‹g‘şŽ‚CŹ–ě’‰LCň–őOC‰Ô“cL‰pC‚“cM˜aC•y“c—FKi“ŕj: —Տ°ŒÄ‹zś—Œ¤‹†‰ď i93.11.27j, “Œ‹ž.

1305. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j “œ”A•aŤtÇ‘Šú‚̐tŽ…‹…‘Ě’´”÷Œ`‘Ô. Žç‰Ž’B”üC“Ię´˜aC–‹`’‰i“ŕj: ‘ć5‰ń“œ”A•aŤtÇŒ¤‹†‰ď i93.11.28j, “Œ‹ž, —\eW, 1993.

1306. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŒÄo•‰‰×‚ɑ΂ˇ‚éƒqƒg• ‹Ř‚Ě”˝‰ž. ‹g‘şŽ‚Cˆ˘•”’źC•y“c—FKi“ŕj: ‘ć‚Q‰ńŒÄ‹z‹ŘƒRƒ“ƒfƒBƒVƒ‡ƒjƒ“ƒOŒ¤‹†‰ď i93.12.11j, “Œ‹ž.

1307. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j –łÇŒóŤS‹Ř[Ç‚𔺂˘, ‰ş‘Ú‚ĚŠ´ŠoáŠQ‚Ĺ”­Ç‚ľ, ’ZŠúŠÔ‚őΖƒáƒ‚Ɉڍs‚ľ‚˝‚Ě‚ż‚É, “Ť‰ş‘Ú’×ᇂɂć‚艺ŽˆŘ’f‚ÉŽŠ‚Á‚˝68Î‚Ě’jŽq—á. Ä“Ą–L˜aCÂŒË˜aŽqC‹y”\ŽGCŒĂ˜a‹vKi“ŕj: ‘ć21‰ń_Œo‹ŘƒJƒ“ƒtƒ@ƒŒƒ“ƒXiNMCj i94.00.00j.

1308. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j •›t”玿ƒXƒeƒƒCƒh“Š—^Œă‚ɐlHŒÄ‹zŠÇ—–Ú“I‚Ć‚ľ‚ďL‰ťƒpƒ“ƒNƒƒjƒEƒ€, ƒWƒAƒ[ƒpƒ€‚Ş“Š—^‚ł‚ę, —Ł’EŒă‚ÉŽlŽˆ–ƒáƒ‚Ş–ž‚ç‚Š‚Ć‚Č‚Á‚˝‹CŠÇŽxšb‘§”­ěŠłŽŇ. Hitomi Beatriz KiyomotoC˛–ě—˛C’ˇ’JěˆęŽqCÄ“Ą–L˜aCŒĂ˜a‹vKi“ŕj: ‘ć21‰ń_Œo‹ŘƒJƒ“ƒtƒ@ƒŒƒ“ƒXiNMCj i94.00.00j, “Œ‹ž.

1309. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j IgA tÇ|ƒXƒeƒƒCƒh—Ă–@‚Ć‚ť‚Ě“K‰ž‚ɂ‚˘‚ā|. Ź—Ń–LCŹ‹v•Ű“§C–xˆäşC”äŠé”\”VCŠÚ–ěƒśi“ŕj: ŒúśČ“Á’莞ŠłisŤtáŠQ’˛¸Œ¤‹†”Ç•˝Ź‚T”N“xŒ¤‹†‹ĆŃ”­•\‰ď i94.01.13j, “Œ‹ž.

1310. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j GM1–Ɖu‚É‚ć‚éŽŔŒą“Iƒjƒ…[ƒƒpƒ`[. ˆÉ“Ą”Ž–žC•y•Ű˜aGC“ü]KŽqi“ŕjC‹ŕ‘ň’ź”üCˆŔ“cCˆęi“Œ•a‰@Œ¤‹†ŒnjCÄ“Ą–L˜aCŒĂ˜a‹vKi“ŕj: ‘ć‚U‰ń“ú–{_Œo–ƉuŒ¤‹†‰ďŠwpW‰ď i94.01.21j, “Œ‹ž, _Œo–ƉuŠw, 2(1): 64`65, 1994.

1311. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Žö“ű’†‚ĚƒoƒZƒhƒE•aŠłŽŇ‚ɑ΂ˇ‚éMMI‚Ě“Š—^–@‚ÉŠÖ‚ˇ‚錟“˘. ˆ˘•”D•śi“ŕjCäGli“ŒŠC‘ĺjC‘ĺŽRéGiŽ™jC‹ŕXWC–ěŒű‹§Žqi“ŕjC‘şŁ¨’ĂŽqi–ňÜ•”jCˆÉ“Ą‘•FiˆÉ“Ą•a‰@j: ‘ć10‰ńbó‘B•a‘Ԑś—Œ¤‹†‰ď i94.01.29j, “Œ‹ž.

1312. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ’áŽ_‘f•‰‰×Žž‚ĚˆęŽ_‰ť’‚‘f‹z“ü‚É‚ć‚é”x“Ž–Źˆł‚¨‚ć‚Ń“Ž–ŹŒŒ‰tƒKƒX‚Ě”Z“xE”˝‰žŠÖŒW‚ɂ‚˘‚Ä. ˛“Ą“N–çCŹ—эO—SC“c’†’ź•FCŽO“Ą‹vCň–őOC•y“c—FKi“ŕj: ‘ć48‰ń•ÂÇŤ”xŽžŠłŒ¤‹†‰ď i94.01.30j, “Œ‹ž.

1313. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j HCC“ÁˆŮ“IALDH‚̖Ɖu‘gDŠw“IŒ¤‹†. a’J–ž—˛i“ŕjC’|“ŕ“ÖŽqi“Œ•a‰@Œ¤‹†Œnj: ‘ć14‰ńƒAƒ‹ƒR[ƒ‹ˆăŠwś•¨ŠwŒ¤‹†‰ďŠwpW‰ď i94.02.03j, ŽD–y, ƒvƒƒOƒ‰ƒ€Ľ´˜^W, p.45.

1314. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ”S–ŒŘœŒă‹ÇŠÄ”­‚ľ‚˝‘Šú‘ĺ’°Šŕ‚Ě1—á. ‚‹´KGCŒÜ\—’łLC˛“c”ü˜aCź‘q“ż]C“ŕ“Ą‹g—˛CŸ–””ş‰hCźŒłŽ›Ž—çi“ŕjCH“ĄNśC‘ĺ’J„łiŠOjCŽO•xO”Vi•a—jCŹ—ѐ´“Ti“ŕj: ‘ć40‰ń‘ĺ’°ŠŕŒ¤‹†‰ď i94.02.04j, ‹v—Ż•Ä.

1315. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ”ě‘名S‹ŘÇŠłŽŇ‚ł̉ş”źg‰Aˆł•‰‰×–@‚É‚ć‚éˆłŽó—e‘Ě”˝ŽË‹@”\‚ĚŒŸ“˘. ´…ŠŽ‰xC–]ŒŽr’źCX“cGlC‘ę‘ňrŽ÷CŒF’J“TŽqCŹ‘ňŒ°ˆęC˜Ič‹P•vC–ؐě“c—˛ˆęi“ŕj: ‘ć38‰ńzŠÂŠí•‰‰×Œ¤‹†‰ď i94.02.05j, “Œ‹ž, ´˜^W, p.49, 1994.

1316. mŒ¤‹†‰ďi‘S‘jn iŒöŠJuŔj ‰ŠÇŤƒTƒCƒgƒJƒCƒ“‚ƍRƒŠƒEƒ}ƒ`–ň. ‹ß“ĄŒ[•śi“ŕj: ‰ŠÇŒ¤‹†U‹ť‰ď‘ć‚X‰ń‰ŠÇƒtƒH[ƒ‰ƒ€ i93.10.29j, ” Ş.

1317. mŒ¤‹†‰ďi‘S‘jn iŒöŠJuŔj ‰ŠÇ‚ĚƒƒfƒBƒG[ƒ^[. ‹ß“ĄŒ[•śi“ŕj: “úŽ‰ď”F’čƒŠƒEƒ}ƒ`ˆăŽ‘ŠiŒp‘ą‚Ě‚˝‚ß‚ĚŒ¤C‰ď i94.02.13j, “Œ‹ž.

1318. mŒ¤‹†‰ďi‘S‘jn iŒöŠJuŔj ‰ŠÇ‚ĚƒƒfƒBƒG[ƒ^[. ‹ß“ĄŒ[•śi“ŕj: “úŽ‰ď”F’čƒŠƒEƒ}ƒ`ˆăŽ‘ŠiŒp‘ą‚Ě‚˝‚ß‚ĚŒ¤C‰ď i94.02.20j, ‘ĺă.

1319. mŒ¤‹†‰ďi’n•űjn i‹L”Ou‰‰j “ď•a‘΍ô‚Ě—đŽjE‚ť‚̐Ź‰Ę‚ĆˆÓ‹`. ŒĂ˜a‹vKi“ŕj: –kŠC“š“ď•a˜AŒ‹Ź20Žü”N‹L”O‘ĺ‰ď i93.07.31j, ŽD–y.

1320. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ‹}‘Ź“€Œ‹ĽƒfƒB[ƒvƒGƒbƒ`ƒ“ƒO–@‚É‚ć‚éSTZ“œ”A•aƒ‰ƒbƒgtŽ…‹…‘Ě”÷×\‘˘. Žç‰Ž’B”üi“ŕj: ‘ć7‰ń“Œ‹ž“œ”A•aŤtÇƒZƒ~ƒi[ i93.03.15j, “Œ‹ž.

1321. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j CCU ‚É‚¨‚Ż‚é‹}ŤS‹Ř[ÇŠłŽŇ‚ĚŠÇ—. ‘şź€i“ŕj: Mexiletine ”­”„‹L”Ou‰‰‰ď i93.06.23j, –źŒĂ‰Ž.

1322. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j Chemokines in rheumatoid arthritis. ÔŻ“§i“ŕj: 2nd Symposium of the Korean Research Group of Collagen Disease and Related Disorders i93.09.24j, Seoul.

1323. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—Ă–ň‚Ě‘I‘đ. ŒĂ˜a‹vKi“ŕj: “ú“ŕ’†‘Žx•”‘ć‚W‰ńśŠU‹łˆçu‰‰‰ď i93.05.16j, •ÄŽq.

1324. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ŒŒ‰tƒKƒXƒf[ƒ^‚Ě“Ç‚Ý•ű‚ĚŠî‘b. ˆ˘•”’źi“ŕj: _“ŢěŒ§—Տ°‰qśŒŸ¸‹ZŽt‰ď i93.09.18j, ‰Ą•l.

1325. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ŒÄ‹z‹@”\ŒŸ¸‚Ě’†‚Ĺ‚ĚŒŒ‰tƒKƒXŒŸ¸‚ĚˆĘ’u|‚Č‚şŒŸ¸‚Ş•K—v‚Š|. Ź—эO—Si“ŕj: _“ŢěŒ§—Տ°‰qśŒŸ¸‹ZŽt‰ď i93.10.16j, _“ސě.

1326. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j •ÖöŒŒ”˝‰ž‚Ć‘ĺ’°ŽžŠł. ŒÜ\—’łLi“ŕj: _“ŢěŒ§—Տ°‰qśŒŸ¸‹ZŽtŒ¤C‰ď i94.02.17j, ‰Ą•l.

1327. mŒ¤‹†‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ˆÝŠŕ‚Ě“ŕŽ‹‹žŽĄ—Âɂ‚˘‚ā|“–‰@‚É‚¨‚Ż‚鑁ŠúˆÝŠŕŽĄ—Ă—á‚ĚŒŸ“˘|. –{‹´CCŠô˘‹´“āC˛–ěG–íi“ŕjC‚–ؐ¸ˆęC‹yě—T–]C‹ĘˆäŮ•vC–{‹´‹v•FCź˜AŽ›ˆÓŒMCŹ—Ń—C—˜–ě–ői_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[j: ‘ć4‰ń_“ސěˆÝŠŕŽĄ—ĂŒ¤‹†‰ď i93.06.20j, ‰Ą•l, ´˜^W, p.31 1993.

1328. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j RI‚đ—p‚˘‚˝ˆÝ”ro”\‚É‚¨‚Ż‚éŠČˆŐŽŽŒąH‚ĚŽŽ‚Ý. ÎˆäŒ\‘žC“c•Ó‘CŽO‹´—˜‰ˇCźŒłŽ›Ž—çi“ŕj: ‘ć6‰ń_“ސěGIMDƒNƒ‰ƒu i93.00.00j, _“ސě.

1329. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j –{‘ԐŤ‚ŒŒˆłÇŠłŽŇ‚É‚¨‚Ż‚é‹}Ť~ˆł‚̉^“Ž•‰‰×‚ɑ΂ˇ‚é‰e‹ż. ´…ŠŽ‰xCě•Ó•q”VCX“cGlC˜Ič‹P•vC–ؐě“c—˛ˆęi“ŕj: ‘ć‚P‰ń‚ŒŒˆłSŒ¤‹†‰ď i93.04.24j, “Œ‹ž.

1330. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j d‰ť—Ă–@‚É‚¨‚Ż‚é•Ź–ĺĂ–Ź‘p•`o‚ĚˆÓ‹`. ‚“c‰ë”ŽC‘•Ş–ΔŽC‘şă‹§li“ŕj: ‘ć6‰ńEVIS•×‹­‰ď i93.05.15j, VŠƒ.

1331. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j “–‰@‚É‚¨‚Ż‚é‚bŒ^–ŤŠĚ‰Š‚ĚƒCƒ“ƒ^[ƒtƒFƒƒ“ŽĄ—Ă‚Ě‚PlŽ@. ‹´–{“Ni“ŕjCˆŔ•”–ž˜YC“n•”K•vCˆäo“Ni‘—§‘Š–ÍŒ´•a‰@jCˆŔ’BŒŁCÎěŽĺĹi“ŕjC’†‘ş—zŽqC“ˆ’Ă—TC“c’†—LjęC”M“c—ǁCó”ö•Žm: ‘ć38‰ń_“ŢěŒ§Á‰ťŠí•aŒ¤‹†‰ď i93.06.05j, ‰Ą•l.

1332. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ƒrƒŠƒ‹ƒrƒ“‹z’…–@‚Ş—LŒř‚Ĺ‚ ‚Á‚˝–ňÜŤ’_`‚¤‚Á‘ŘŒ^ŠĚáŠQ‚Ě1—á. Ž›ÎŒOCÎŠ_“ż]Cź–{ˆĚ’jC˛“ĄłŽ÷C‘şă‹§lCa’J–ž—˛C‘•Ş–ΔŽCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕjC™–{­’źi—Տ°–ň—j: ‘ć38‰ń_“ŢěŒ§Á‰ťŠí•aŒ¤‹†‰ď i93.06.05j, ‰Ą•l.

1333. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Z-STENT‚É‚ć‚é“ŕŠŕ‰ť‚đŽ{s‚ľ‚˝‚—îŽŇ’_äXŒnˆŤŤŽîᇂĚ4—á. –ě“o˝i“ŕjCŠOŽR‹v‘ž˜Yi•˝’Ë‹¤Ď•a‰@jCź“c–€–çC›–ě‘C“n•Ó—˛Žii“ŕjC–{ŠÔ“ń˜YC‚“cˆę‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@j: ‘ć38‰ń_“ŢěŒ§Á‰ťŠí•aŒ¤‹†‰ď i93.06.05j, ‰Ą•l.

1334. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ƒ‰ƒbƒg‚É‚¨‚Ż‚é’áŽ_‘f•‰‰×Žž‚Ě”÷ŹzŠÂ“Ž‘Ô‚ĚŒŸ“˘. “c’†’ź•FC˛“Ą“N–çC‰Ô“cL‰pC‹v•Ű“cŸC‚“cM˜aC“팴”Í”VCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕj: _“ސěŒÄ‹zƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX i93.06.05j, Œú–Ř.

1335. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j “ÁŽę‚ČˆÝ’×á‡, RA‡•šˆÝ’×ᇏǗá‚ĚŒŸ“˘. ˆŔ’BŒŁi“ŕj: ‘ć3‰ń_“ސěPPIŒ¤‹†‰ď i93.06.10j, ‰Ą•l.

1336. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ˜V”NŽŇ‚Ě“œ”A•a‚Ě—Ő°“IŒŸ“˘. ‚“cˆę‘ž˜YC“ú‚‰›C›–ě‘C“n•Ó—˛ŽiC–{ŠÔ“ń˜YC–ě“o˝i“ŕjCŠOŽR‹v‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@j: ‘ć10‰ń_“Ţě“œ”A•aŒ¤‹†‰ď i93.07.03j, ‰Ą•l.

1337. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j “œ”A•aŤƒPƒgƒAƒVƒh[ƒVƒX(DKA)‚ɉşŽˆ“Ž–Ź•ÂÇÇ‚đ‡•š‚ľ‚˝1—á. ”~‘ňTˆęC‹ŕXWC–ěŒű‹§ŽqC‘ĺ˜a“c—˘CŽç‰Ž’B”üC“Ię´˜aC“Ą“c–F–MC–‹`’‰i“ŕj: ‘ć10‰ń_“Ţě“œ”A•aŒ¤‹†‰ď i93.07.03j, ‰Ą•l.

1338. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘Šú“œ”A•aŤtÇ‚É‚¨‚Ż‚é”A×ŠÇ‹@”\ˆŮí‚Ć”A’†ƒAƒ‹ƒuƒ~ƒ“”rŸ•. •˝ˆä–@”ŽC“Ię´˜aC‹ŕXWCŽç‰Ž’B”üi“ŕjCŠÖ‘ň‰pˆęi‰Ą{‰ę‹¤Ď•a‰@jC–‹`’‰˝i“ŕj: ‘ć10‰ń_“Ţě“œ”A•aŒ¤‹†‰ď i93.07.03j, ‰Ą•l.

1339. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j PSE‚Ş‘tŒř‚ľ‚˝IPH‚Ě2—á. ‚“c‰ë”ŽC‘•Ş–ΔŽC‘şă‹§lC‘ĺŒIC‰iŒŠ–žśCŠâ–xŒöŠîCÄ“ĄrŽiC˛“ĄłŽ÷C“c•Ó‘C™–{­’źCa’J–ž—˛CŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕj: ‘ć16‰ńH“šĂ–ŹáŽd‰ť—Ă–@Œ¤‹†‰ď i93.07.29j, ‹ŕ‘ň, u‰‰—\•ńW, p.49, 1993.

1340. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j “ŕŽ‹‹ž“IH“šĂ–ŹáŽd‰ť—Ă–@Ž{s—á‚É‚¨‚Ż‚éPortal hypertensive Gastropathy‚ĚŒŸ“˘. Šâ–xŒöŠîC“c•Ó‘C‘•Ş–ΔŽC‚“c‰ë”ŽC‘şă‹§lCˆÉ“Ą‹ĎCŹň˜aŽO˜YC‘ĺˆä“cłlCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕj: ‘ć16‰ńH“šĂ–ŹáŽd‰ť—Ă–@Œ¤‹†‰ď i93.07.29j, ‹ŕ‘ň, u‰‰—\•ńW, p.52, 1993.

1341. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j H“šĂ–ŹáŽd‰ť—Ă–@‚É‚¨‚Ż‚éĂ–ŹáŽ‘˘‰e(EVIS)‚ĚŒŸ“˘. ‘şă‹§lC‘•Ş–ΔŽCź“c–€–çC‚“c‰ë”ŽCź–{ˆĚ’jC˛“ĄłŽ÷C”’čŒh“ńC™–{­’źCa’J–ž—˛CŽÄ“c‹v—Yi“ŕj: ‘ć19‰ń_“ސěŠĚ’k˜b‰ď i93.07.31j, ‰Ą•l.

1342. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ˆÝĂ–ŹáŽ‚ɑ΂ˇ‚éBRTOiƒoƒ‹[ƒ“•ÂÇ‰ş‹tsŤŒoĂ–Ź“IÇđpj‚ĚŒoŒą. ź“c–€–çC‘•Ş–ΔŽC‘şă‹§lC‚“c‰ë”ŽCÄ“ĄrŽiCź–{ˆĚ’jC˛“ĄłŽ÷C™–{­’źCa’J–ž—˛CŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕjC‰““Ą‚CźŠŞ”ŽCˆé•”‹`Œ› i•új: ‘ć19‰ń_“ސěŠĚ’k˜b‰ď i93.07.31j, ‰Ą•l.

1343. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ś‰şŽž‚̉ş‚‘ĚŒsŘ’f‚É‚ć‚é‚ĆŽv‚í‚ę‚鉺‚‘Ě‹@”\’ቺÇ‚Ě1—á. ‹ŕXWC–ěŒű‹§ŽqC–‹`’‰i“ŕj: ‘ć4‰ń_“ސě“ŕ•Ş”ĺÇ—ጟ“˘‰ď i93.09.04j, ‰Ą•l.

1344. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j IgG-ƒČŒ^‘˝”­Ťœ‘Žî‚É‚Ý‚ç‚ę‚˝ƒNƒŠƒIƒOƒƒuƒŠƒ“tÇ‚Ě‚P—á. ’|“ŕN—YCX‰ş“N•vC’ˇę‘ׁC–xˆäşC”äŠé”\”VCŠ™“cvŽőCŠÚ–ěƒśCŹ—Ń–Li“ŕjCdźGˆęiM‘ĺj: ‘ć20‰ń_“ސět‰ŠŒ¤‹†‰ď i93.09.04j, ‰Ą•l.

1345. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ƒCƒ“ƒ^[ƒtƒFƒƒ“‚Ě’˜Œř—἖łŒř—á‚Ě• o‹ž“I„ˆÚ. a’J–ž—˛C”’čŒh“ńC™–{­’źCź–{ˆĚ’jC‘şă‹§lC˛“ĄłŽ÷C‘•Ş–ΔŽCŽÄ“c‹v—Yi“ŕj: ‘ć34‰ń• o‹ž§˜b‰ď i93.09.09j, “Œ‹ž, u‰‰—\•ńW, p.5, 1993.

1346. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j “–‰@‚ɉ—‚Ż‚é‚bŒ^–ŤŠĚ‰ŠƒCƒ“ƒ^[ƒtƒFƒƒ“—LŒř—á‚ĚŒŸ“˘. ÎěŽĺĹi“ŕjCˆŔ•”–ž˜YC“n•”K•vi‘—§‘Š–ÍŒ´•a‰@jCˆŔ’BŒŁi“ŕjCˆäo“NC’†‘ş—zŽqC“‡’Ă—TCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć8‰ń_“ސěŠĚ‰ŠƒZƒ~ƒi[ i93.09.18j, ‰Ą•l.

1347. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ƒCƒ“ƒ^[ƒtƒFƒƒ“—Ă–@‚É‚ć‚éŠĚśŒŸ‘gD‘œ‚̐„ˆÚ. ˛“ĄłŽ÷Ca’J–ž—˛Cź–{ˆĚ’jC‘şă‹§lC‘•Ş–ΔŽCŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕj: ‘ć8‰ń_“ސěŠĚ‰ŠƒZƒ~ƒi[ i93.09.18j, ‰Ą•l.

1348. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j SLE‚É—â”^á‡‚đ‡•š‚ľ‚˝‚Ě‚P—á. Šp‰Ć–ž•śC”э‘–퐜C‰Ş“cƒC‹ß“ĄŒ[•śi“ŕjCÎˆä‘¸—YC‘ –{”ŽsiŽY•wj: ‘ć34‰ń_“ŢěŒ§Š´őÇŒ¤‹†‰ď i93.09.25j, ‰Ą•l.

1349. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‰ťŠw—Ă–@‚Ş—LŒř‚Ĺ‚ ‚Á‚˝ATL‚Ě1—á. –ě“o˝i“ŕjCŠOŽR‹v‘ž˜Yi•˝’Ë‹¤Ď•a‰@jC“ú‚‰›C›–ě‘C“n•Ó—˛Žii“ŕjC–{ŠÔ“ń˜YC‚“cˆę‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@j: ‘ć51‰ń_“ŢěŒ§“ŕ‰ČˆăŠw‰ďW’k‰ď i93.10.15j, ‰Ą•l.

1350. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ŒoŠÇ‰h—{’†‚É‹Ô‰č‹…Ť•nŒŒ‚đ’ć‚ľ‚˝•›t”’ŽżƒWƒXƒgƒƒtƒB[‚Ě1—á. ›–ě‘i“ŕjCŠOŽR‹v‘ž˜Yi•˝’Ë‹¤Ď•a‰@jC“ú‚‰›Cź“c–€–çC“n•Ó—˛Žii“ŕjC–{ŠÔ“ń˜Yi•˝’Ë‹¤Ď•a‰@jC–ě“o˝i“ŕjC‚“cˆę‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤ Ď•a‰@j: ‘ć51‰ń_“ŢěŒ§“ŕ‰ČˆăŠw‰ďW’k‰ď i93.10.15j, ‰Ą•l.

1351. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j BIA–@‚É‚ć‚é‘ĚŽ‰–b—Ś‚ĆŠĚ‹@”\ˆŮí‚Ě•p“x‚ÉŠÖ‚ˇ‚錟“˘. ‚“cˆę‘ž˜YC“ú‚‰›C›–ě‘C“n•Ó—˛ŽiC–{ŠÔ“ń˜YC–ě“o˝i“ŕjCŠOŽR‹v‘ž˜YC‹ŕŽRł–ži•˝’Ë‹¤Ď•a‰@j: ‘ć51‰ń_“ŢěŒ§“ŕ‰ČˆăŠw‰ďW’k‰ď i93.10.15j, ‰Ą•l.

1352. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ŒŔ‹ÇŤ‹­”çÇ‚ÉŽŠŒČ–ƉuŤŠĚ‰Š‚đ‡•š‚ľ‚˝‚P—á. ÎěŽçC‚‹´“š—YCŠÖŽRŘ•äCa’J–ž—˛C”э‘–퐜C‰Ş“cƒC‹ß“ĄŒ[•śi“ŕj: ‘ć51‰ń_“ŢěŒ§“ŕ‰ČˆăŠw‰ďW’k‰ď i93.10.17j, ‰Ą•l.

1353. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ƒAƒXƒyƒ‹ƒMƒ‹ƒX‚É‚ć‚é”]d–Œ‰Š‚Ě‚P—á. •Ÿ“c—Ď–çC”Ń’Ë‚_CHŽR‹vŽC“Œ–M•FC”¨—˛ŽuCâˆä•ś•FC_“c’źi“ŕj: _“ŢěŒ§“ŕ‰ČW’k‰ď i93.11.06j, ‰Ą•l.

1354. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ŠO—ˆ“œ”A•aŠłŽŇ‚É‚¨‚Ż‚é”A’†ƒAƒ‹ƒuƒ~ƒ“‘Ş’č‚Ě—Ő°“IˆÓ‹`. ‘ĺ˜a“c—˘C“Ię´˜aC“c’†Œ[Ži‚`C”~‘ňTˆęC–ěŒű‹§ŽqCŽç‰Ž’B”üC‹ŕXWC“Ą“c–F–MC–‹`’‰i“ŕj: ‘ć19‰ń–k—˘ˆăŠw‰ď‘‰ď i93.11.13j, ‘Š–ÍŒ´.

1355. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ’†Ž¨‰Š‚Ĺ”­Ç‚ľRMPOR‘Ě—zŤ‚Ĺ‚ ‚Á‚˝Wegener“÷‰čŽîÇ‚Ě‚P—á. ˛–ě—˛C•äâ–΁CŠÖŽRŘ•äCŠp‰Ć–ž•śCÔŻ“§C‰Ş“cƒC‹ß“ĄŒ[•śi“ŕj: ‘ć25‰ń_“ŢěƒŠƒEƒ}ƒ`ˆă‰ď i93.11.20j, ‰Ą•l.

1356. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j DIC‚ÉMTX/5FU sequential therapy‚Ş‘tŒř‚ľ‚˝Borrmann 4Œ^ˆÝŠŕ‚Ě1—á. Šô˘‹´“āC˛–ěG–íC–{‹´Ci“ŕjC‚–ؐ¸ˆęCŹ–쎛˝ŒĺCŹ—Ń—Cź˜AŽ›ˆÓŒMC–{‹´‹v•Fi_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[j: ‘ć5‰ń_“ސěˆÝŠŕŽĄ—ĂŒ¤‹†‰ď i93.12.25j, ‰Ą•l.

1357. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j VP3ŠĚ×–EŠŕÇ—á‚̐H“šˆÝĂ–ŹáŽ‚ɑ΂ˇ‚é—\–h“IEVL‚ĚŽŽ‚Ý. ‚”öł•FC‘•Ş–ΔŽC‘şă‹§lCź“c–€–çC‹v•Ű“c•q•FCź‘q“ż]C‚“c‰ë”ŽCź–{ˆĚ’jC˛“ĄłŽ÷C™–{­’źCa’J–ž—˛CŽÄ“c‹v—YCźŒłŽ›Ž—çi“ŕj: ‘ć17‰ńH“šĂ–ŹáŽd‰ť—Ă–@Œ¤‹†‰ď i94.01.08j, “Œ‹ž.

1358. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Syndrome of gait ignition failure‚Ě‚QÇ—á. ł–Ř‚Š‚‚çC‹y”\ŽGCÄ“Ą–L˜aCŒĂ˜a‹vKi“ŕj: ‘ć‚V‰ń‰^“ŽáŠQŒ¤‹†‰ď i94.01.29j, “Œ‹ž.

1359. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Fluconazole ‘ϐŤ Candida glabrata ‚đ•Ş—Ł‚ľ‚˝‚SÇ—á. ŽR‰ş‚Ś‚čŽqC’hŒ´Š˛śC“Ą–ě—R”üC‰–’J–΁i“ŕjCŽRč•q˜aC‹v•ÄŒői•a—j: ‘ć29‰ń_“ŢěŒŒ‰tŒ¤‹†‰ď i94.02.05j, ‰Ą•l.

1360. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ’×ᇐŤ‘ĺ’°‰Š‚ĚŽĄ—Ă‚ĆŽčp“K‰ž. ŒÜ\—’łLi“ŕj: ‘ć13‰ń_“ސě‘ĺ’°Œ¤‹†‰ď i94.02.10j, ‰Ą•l.

1361. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ś—‘‚̐ێć‚É‚ć‚éƒAƒ[ƒoŠĚ”^ᇂĚ1—á. ‘ĺ˜a“c^‹IŽqC‘•Ş–ΔŽC‘şă‹§lC–ěŒű‘ŽqC‚“c‰ë”ŽCˆÉ“Ą‹ĎC™–{­’źCŽÄ“c‹v—Yi“ŕj: ‘ć3‰ńé“켐_“ސ애•”’´‰š”g“lje‰ď i94.02.15j, ‰Ą•l.

1362. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Řœ•s”\ˆÝŠŕ‚ɑ΂ˇ‚é5'DFUR+CDDP•š—p—Ă–@. Źň˜aŽO˜YC‹ß“Ąˆę‰pCźŒłŽ›Ž—çi“ŕj: _“ސěŠŕŽĄ—ͧ˜b‰ď i94.02.19j, ‰Ą•l.

1363. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Stage ‡WŠĚ×–EŠŕÇ—á‚ɑ΂ˇ‚é”牺–„ž‚݃|[ƒg‚đ—p‚˘‚˝“Ž’‰ťŠw—Ă–@‚ĚŒŸ“˘. ‹v•Ű“c•q•FCź–{ˆĚ’jCź“c–€–çC‚“c‰ë”ŽC˛“ĄłŽ÷C”’čŒh“ńC™–{­’źCa’J–ž—˛C‘•Ş–ΔŽCŽÄ“c‹v—Yi“ŕj: ‘ć20‰ń_“ސěŠĚ’k˜b‰ď i94.02.19j, ‰Ą•l.

1364. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ˆůŽđ‚É‚ć‚銼“Ž–Źšk‚ŞŒ´ˆö‚ƍl‚Ś‚ç‚ę‚˝Žá”N”­Ç‚Ě‹}ŤS‹Ř[Ç‚Ě‚P—á. ‘ę‘ňrŽ÷CŽí“cGŽiC‹g“cTCŹ—Ń–ž–FC’ˇ’Jě‰„LC´…ŠŽ‰xC–ؐě“c—˛ˆęi“ŕj: ‘ć18‰ń_“ސěŽáŽčzŠÂŠíˆă‚Ě‰ď i94.02.19j, ‰Ą•l.

1365. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ”­Œę‚É‚ć‚č‘‹­‚ˇ‚éŽlŽˆ‘ĚŠ˛‚Ě•sˆÓ‰^“Ž. ‰Á“Ą’m–çCł–Ř‚Š‚‚çC’ˇ’JěˆęŽqCÄ“Ą–L˜aCŒĂ˜a‹vKi“ŕj: ‘ć‚V‰ń_“ސěEVisual Neurology i94.02.19j, ‰Ą•l.

1366. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j • •”ˆŮí‰A‰e‚̏oŒť‚đ‹@‚É‘ˆŤ‚ľ‚˝ƒ‹ƒ|ƒCƒhŠĚ‰Š‚Ě1—á. HŽRŽuDCa’J–ž—˛Cź–{ˆĚ’jC‘şă‹§lC‘•Ş–ΔŽCÎˆäŒö“šCŽÄ“c‹v—Yi“ŕj: ‘ć35‰ń‰ë–‰€ƒŠƒo[ƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX i94.02.24j, “Œ‹ž.

1367. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j S‹Ř[Ç•”ˆĘ‚É‚ć‚é 24 ŽžŠÔŒŒˆłĽS””‚Ě•Ď“Ž‚̍ˇˆŮ. ‘ę‘ňrŽ÷C´…ŠŽ‰xCX“cGlCŒF’J“TŽqC˜Ič‹P•vC–ؐě“c—˛ˆęi“ŕj: ‘ć‚X‰ńSŽžŠłƒŠƒXƒNƒtƒ@ƒNƒ^[Œ¤‹†‰ď i94.03.01j, ‰Ą•l.

1368. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ’˜‚ľ‚˘‚ƒJƒ‹ƒVƒEƒ€ŒŒÇ‚đ’ć‚ľ‚˝ƒoƒZƒhƒE•a‚Ě1—á. ‹ŕXWC“c’†Œ[Ži‚`C–ěŒű‹§ŽqC–‹`’‰i“ŕj: ‘ć5‰ń_“ސě“ŕ•Ş”ĺÇ—ጟ“˘‰ď i94.03.12j, ‰Ą•l.

1369. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j oŽYŒă‚É Toxic shock syndrome (TSS) ‚đ‡•š‚ľ‚˝ SLE ‚Ě‚P—á. Šp‰Ć–ž•śCŠÖŽRŘ•äC•äâ–΁C”э‘–퐜CÔŻ“§C‰Ş“cƒC‹ß“ĄŒ[•śi“ŕj: _“ŢěŒ§Š´őÇŒ¤‹†‰ď i94.03.12j, ‰Ą•l.

1370. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ”DP‚ĚŒo‰ß’†‚ÉPH, TTP‚̍‡•š‚đ‚Ý‚˝MCTD‚Ě‚P—á. ÎěŽçC‘]Ž˘‘’qŽqCŠÖŽRŘ•äC‚‹´“š—YC•äâ–΁C‰Ş“cƒC‹ß“ĄŒ[•śi“ŕj: ‘ć26‰ń_“ŢěƒŠƒEƒ}ƒ`ˆă‰ď i94.03.12j, ‰Ą•l.

1371. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Lemierre syndrome ‚ƍl‚Ś‚ç‚ę‚˝ Fusobacterium necrophorum ”sŒŒÇ‚Ě‚P—á. –{‘˝Œ¤–çCň–őOC—é–Ř“šOC‹v•Ű“cŸC•Đ‹Ë“ú˛ŽqC•Đ‹Ë^lCŹ—эO—SC–î“ߐŁM—YCˆ˘•”’źC•y“c—FKi“ŕjC‘Š”nˆęˆĺi‹~–˝j: ‘ć35‰ń_“ŢěŒ§Š´őÇŒ¤‹†‰ď i94.03.12j, ‰Ą•l.

1372. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Dementia‚É‚Ä”­Ç‚ľ, ’˜–ž‚Č“ŞŠW“ŕÎŠD‰ť‚đ”F‚ß‚˝SLE‚Ě‚P—á. ‚‹´“š—YC–ěŒű‘ŽqCŠÖŽRŘ•äC•äâ–΁C‰Ş“cƒC‹ß“ĄŒ[•śi“ŕj: ‘ć34‰ńŠÖ“ŒƒŠƒEƒ}ƒ` i94.07.17j, “Œ‹ž.

1373. mŒ¤‹†‰ďi’n•űjn iŒöŠJuŔj –ŤŠÖßƒŠƒEƒ}ƒ`‚Ć QOL. ‹ß“ĄŒ[•śi“ŕj: –kŠC“š’n‹ćƒŠƒEƒ}ƒ`‹łˆçŒ¤C‰ď i93.10.24j, ŽD–y.


<<14 7 “ŕ‰ČŠw>>

1374. mŠwpÜi‘“ŕÜjn “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďÜ(93.09.24). ‘ĺˆä“cłli“ŕj.

1375. mŠwpÜi‘“ŕÜjn •˝Ź5”N“x“ú–{Á‰ťŠí•aŠw‰ď§—ăÜ, ŹŽş—Tˆęi“ŕj.

1376. mŠw‰ďŽĺĂi’n•ű‰ďjn ‘ć425‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď (94.02.12), “Œ‹ž, –‹`’‰i“ŕj.


<<14, “ŕ‰ČŠw>>

1377. mŒ´’˜n V‚ľ‚˘”ńƒXƒeƒƒCƒhŤR‰ŠÇÜ CS-670 ‚Ě—Ő°‘ć‡T‘ŠŽŽŒą. ź–Ř–ÎŽ÷C™–{­’źCŹ—Ń”ü•ci—Տ°–ň—jCŽÄ“c‹v—Yi“ŕjCě’[´CŻŽR˜aŽqCůŒ´–M•FiŽO‹¤j: ‰ŠÇ, 13(2): 195`212, 1993.


<<15 ŠO‰ČŠw>>

1378. mŒ´’˜n Basic and clinical study of the indications and efficacy of endoscopic treatment in early gastric cancer. “ˆ”ömC”äŠé”\Ž÷CĺŒ´÷iŠOjC‰ĄŽR–ői“ŕj: Acta Endoscopica, 23(1): 9`26, 1993.

1379. mŒ´’˜n Spontaneous carotid cavernous fistula presenting only with cranial nerve palsies. ‘q“c˛C‚–쐽Cí”Ő‰ĂˆęC‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOjC›Mˆęi•új: Am. J. Neuroradiol., 14: 1097`1101, 1993.

1380. mŒ´’˜n Fabric heart retractor for coronary artery bypass operations. •—ŠÔ”ɁCÎŒ´şi‹šŠOj: Ann. Thorac. Surg., 55(6): 1582`1583, 1993.

1381. mŒ´’˜n Origin of craniopharyngioma: An electron microscopic study. ě–ěM”VC‰ŞGGCz–K’m–çCˆÉ“Ą”ä˜CŽuC–î“cŒŤŽOi”]ŠOjC‹T’J“OC–ö‰şŽO˜Yi•a—j: Brain Tumor Pathol., 10: 117`123, 1993.

1382. mŒ´’˜n Invasive meningiomas in relation to high proliferating potential. z–K’m–çCě–ěM”V(”]ŠO)C‹T’J“Oi•a—jCˆÉ“Ą”ä˜CŽuC‰ŞGGC–î“cŒŤŽOi”]ŠOj: Brain Tumor Pathol., 10: 63`67, 1993.

1383. mŒ´’˜n Measurement of the vena cava at postmortem examination, from the upper end of the superior vena cava via the right atrium to the lower end of the inferior vena cava. ‚ŽRr­C•˝ˆäŽO˜Yi‹šŠOjCÎŒ´Ć•vCYamaguchi KazuyoshiiŠÖ“Œ’üM•a‰@jCFukuda JunyaCKishimoto HiroshiiKawasaki Municipal HospitaljC‹g‘ş”Ž–Mi‹šŠOj: Clinical Anatomy, 6(6): 349`352, 1993.

1384. mŒ´’˜n Endoscopic treatment of early gastric cancer. ”äŠé”\Ž÷iŠOj: Gastric Cancer, p.392`403, 1993.

1385. mŒ´’˜n Pharmacokinetic analysis of mannitol in relation to the decrease of ICP. ‚–؍Gi”]ŠOjC“c’†š‘ăi–ňŠw•”jC‘ĺ˜a“c—˛i‹~–˝jC’Š’ˇ•ś–íi–ňÜj: Intracranial Pressure, 8: 596`600, 1993.

1386. mŒ´’˜n Importance of nitric oxide synthase inhibition to the attenuated vascular responses induced by topical L-Nitroarginine during vibrissal stimulation. “ü‘qŽŒČi”]ŠOjCKenneth I. MaynardCMichael A. MoskowitziHarvard Med. Sch.j: J. Cereb. Blood Flow Metab., 14: 45`48, 1994.

1387. mŒ´’˜n Basic fibroblast growth factor dilates rat pial arterioles. Sami RosenblattiHarvard Med. Sch.jC“ü‘qŽŒČi”]ŠOjCCornelio G. CadayCSeth P. FinklesteinCMichael A. MoskowitziHarvard Med. Sch.j: J. Cereb. Blood Flow Metab., 14: 70`74, 1994.

1388. mŒ´’˜n Venous ischemia caused by dural arteriovenous malformation. ‘q“c˛C‹{â‰Ŕ’jC‹g“cF—FC‘ˆäł„C–î“cŒŤŽOi”]ŠOjC›Mˆęi•új: J. Neurosurg., 80: 552`555, 1994.

1389. mŒ´’˜n Comparison of depolarizing and direct current systems on iontophoretic enhancement of transport of sodium benzoate through human and hairless rat skin. S. NumajiriCH. SakuraiCK. SugibayashiCY. MorimotoC‘ĺ‹{“ŒśC’|’†°KCHŽRŒ›‹`iŠOj: J. Pharm. Pharmacol., 45: 610`613, 1993.

1390. mŒ´’˜n Measurement of tissue blood volume in a model system and in the canine intestine by dynamic light scattering. Ž­“ˆiiƒAƒhƒoƒ“ƒXjC‰ŞTˆę˜YCÎě~C”äŠé”\Ž÷iŠOj: Lasers in the Life Sciences, 5(3): 1`12, 1993.

1391. mŒ´’˜n ƒsƒƒŠƒ“Ž_ƒJƒ‹ƒVƒEƒ€Œ‹ť’ž’…Ç. ě–ěM”Vi”]ŠOjC‹{‘ňŽľ˜Yi“dŒ°ƒZƒ“ƒ^[j: Mebio, 7: 137`139, 1993.

1392. mŒ´’˜n Radical removal of craniopharyngioma: A long-term follow-up. ě–ěM”Vi”]ŠOjC‘ĺ˜a“c—˛i‹~–˝jC–î“cŒŤŽOi”]ŠOj: Neurol. Med. Chir., 33: 543`546, 1993.

1393. mŒ´’˜n Subcortical cerebral hemorrhage with reference to vascular malformations and hypertension as causes of hemorrhage. ‘q“c˛C‹{â‰Ŕ’ji”]ŠOjC–kŒ´F—Yi‹~–˝jC›Mˆęi•újC‚–؍Gi”]ŠOj: Neurosurgery, 32: 505`511, 1993.

1394. mŒ´’˜n Endoscopic surgery for gastric cancer. ”äŠé”\Ž÷C“ˆ”ömCŽOd–슰ŠěiŠOj: Recent Advances in Management of Digestive Cancers, p.98`103, 1993.

1395. mŒ´’˜n Draining vein pressure increases and hemorrhage in patients with arteriovenous malformation. ‹{â‰Ŕ’jC‘q“c˛Cí”Ő‰ĂˆęC“c’†–ö…C–î“cŒŤŽOi”]ŠOjC‘ĺ˜a“c—˛i‹~–˝j: Stroke, 25: 504`507, 1994.

1396. mŒ´’˜n Correlation between intravascular pressure and risk of hemorrhage due to arteriovenous malformations. ‹{â‰Ŕ’jC–î“cŒŤŽOC‘q“c˛Cí”Ő‰ĂˆęC“ü‘qŽŒČC“c’†–ö…i”]ŠOjC‘ĺ˜a“c—˛C–kŒ´F—Yi‹~–˝j: Surg. Neurol, 39: 370`373, 1993.

1397. mŒ´’˜n Minimally invasive surgery: Endoscopic treatment of gastric cancer. ”äŠé”\Ž÷C“ˆ”ömCŽOd–슰ŠěCĺŒ´÷iŠOj: Surgical Oncology Clinics of North America, 2(3): 483`491, 1993.

1398. mŒ´’˜n Lipo PGE1‹ÇŠ“Š—^‚É‚ć‚éĺń‘nŽĄ—Ă. ‹ŕéł‰ŔCźŽR’ź‹vC]“ސ´“żCXŁšŽ÷C“‡’ÐˇˆęCŞ–{ECŠ`“cÍiŠOj: Therapeutic Research, 14(5): 2011`2016, 1993.

1399. mŒ´’˜n –Ť“Ž–Ź•ÂÇÇ: —Տ°ŠŒŠ‚É‚ć‚éf’f. Ş–{EiŠOj: ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 11(5): 920`922, 1993.

1400. mŒ´’˜n “ŕŽ‹‹ž“I”S–ŒŘœp‚Ĺ•sŠŽ‘SŘœ‚Ć‚Č‚Á‚˝—á‚ɑ΂ˇ‚郌[ƒU[ĆŽË‚ĚŒř‰Ę‚Ć•]‰ż•ű–@‚ɑ΂ˇ‚錟“˘. “ˆ”ömiŠOjC‰ĄŽR–ői“ŕjCŽOd–슰ŠěCĺŒ´÷CŹ—ѐLsC‚‹´ŒúC‰ĄŽR‹žŽqiŠOjCŹň˜aŽO˜YCźŒłŽ›Ž—çi“ŕjC”äŠé”\Ž÷iŠOj: ˆÝ‚Ć’°, 28(13): 1427`1432, 1993.

1401. mŒ´’˜n Ř’fŒă‚ĚŠĚ‘Ÿ_Œo‚̍Đś‚ÉŠÖ‚ˇ‚é–Ɖu‘gD‰ťŠw“IŒ¤‹†. “cŠ•ś•FiŠOj: ŠĚ‘Ÿ, 35(1): 29`37, 1994.

1402. mŒ´’˜n “ŞŠW“ŕˆł‘Ş’č–@‚Ć–ň•¨—Ă–@. ‚–؍Gi”]ŠOj: ‹~‹}ˆăŠw, 17: 1023`1027, 1993.

1403. mŒ´’˜n “œ”A•aŤ‰óás‚ɑ΂ˇ‚éLipo PGE1‹ÇŠŽU•z—Ă–@. ‹ŕéł‰ŔCŞ–{EC]“ސ´“żCźŽR’ź‹vCXŁšŽ÷CĄˆäŒ‰CˆÉ“Ą—ǐmC“‡’ÐˇˆęCŠ`“cÍiŠOj: ŒŒŠÇŠO‰Č, 12(2): 159`162, 1993.

1404. mŒ´’˜n FK506, ciclosporin, mizoribineŽOÜ‚đ—p‚˘‚˝ƒCƒkäX\“ńŽw’°ˆÚA. ˛“ĄŒőŽjCĄˆäŒ‰C“cŠ•ś•FCÎ“c˜aŒČCźˆäŒ’Cź‘ňŽ“TCŠ`“cÍiŠOj: Ą“ú‚ĚˆÚA, 7(2): 155`160, 1994.

1405. mŒ´’˜n ‘ŠúˆÝŠŕ‚ɑ΂ˇ‚é“ŕŽ‹‹ž“IƒŒ[ƒU[ŽĄ—Ă‚Ě–đŠ„. “ˆ”ömCŽOd–슰ŠěCĺŒ´÷C”äŠé”\Ž÷iŠOj: Á‰ťŠí“ŕŽ‹‹ž‚̐i•ŕ, 42: 38`42, 1993.

1406. mŒ´’˜n ”ńŠOŤŇ‘d–ŒŠOŒŒŽî. ‘ĺ“ä’mC‹kŽ ‘i”]ŠOj: Ň’ŐҐ‘ƒWƒƒ[ƒiƒ‹, 6: 325`328, 1993.

1407. mŒ´’˜n ‹š• •”‰đ—ŁŤ‘ĺ“Ž–ŹáŽŽĄ—Ă‚ÉŰ‚ľ‚Ä‚Ě‹}ŤŇ‘‰Ą’fÇŒóŒQ. ‘ĺ“ä’mi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝j: Ň’ŐҐ‘ƒWƒƒ[ƒiƒ‹, 6: 355`359, 1993.

1408. mŒ´’˜n Œ‹’°Ľ’ź’°Šŕ‚ĚŽĄ–üŘœÇ—á‚ɑ΂ˇ‚éPSK‚É‚ć‚é•â•–Ɖu‰ťŠw—Ă–@‚Ěrandomized controlled study|pŒă5”N‚̐ŹŃiĹI•ńj|. ŽO•x—˜•vC“y‰ŽŽü“ńC”Ń“‡“oCˆ˘‘]OˆęCźŽRŒ‰C“V–ě•xŒOC‚‹´r‹BiŠOjC‰ŞšćŽmC‘şŽRŒ›‰iC‘ĺ–î˜aŒőC–ě“o—˛CŹě’¨–ç: “ú–{ŠŕŽĄ—ĂŠw‰ďŽ, 28(1): 71`83, 1993.

1409. mŒ´’˜n cŠuZ‚đ—L‚ˇ‚éT4”xŠŕ‚ɑ΂ˇ‚éŠO‰ČŽĄ—ÐŹŃ. ‹g‘ş”Ž–MC•i“cƒC‚—˛˝CÎŒ´şi‹šŠOj: “ú–{‹CŠÇH“š‰ČŠw‰ď‰ď•ń, 44(5): 385`390, 1993.

1410. mŒ´’˜n Clinical and pathological evaluation for patients with central type early lung cancer. ‹g‘ş”Ž–MC•i“cƒC‚—˛˝Cˆ˘•””\–žCÎŒ´şi‹šŠOjC–î“ߐŁM—YC•y“c—FKi“ŕjC‹T’J“Oi•a—j: “ú–{‹CŠÇH“š‰ČŠw‰ď‰ď•ń, 45(1): 22`29, 1994.

1411. mŒ´’˜n ‘‰Á‚ˇ‚éƒ|ƒŠƒOƒ‰ƒtƒ‚ƒjƒ^[‚ւ̑Ήž. ŹźF’jC“y‹´Ž•FCŽR‰ş•ŽjC‚é•ś—YC‰Ş–{kˆę˜YC—é–؍DMi’†‰›Žčp•”jCŞ–{EiŠOjCˆŔ—˘•ś—Yi–ƒj: “ú–{Žčp•”ˆăŠw‰ďŽ, 14(3): 430`433, 1993.

1412. mŒ´’˜n Žĺ”x“Ž–Ź‚É‚¨‚Ż‚éŠg’ŁŠú‡—Ź”gŒ`‚̉đÍ. ‹ß“Ą‡‹`C”ź’JĂ—YCÎŒ´şi‹šŠOj: “ú–{ŹŽ™zŠÂŠíŠw‰ďŽGŽ, 9(3): 445`450, 1993.

1413. mŒ´’˜n “ű–[‚ĚŽŠŒČŒŸf‚ÉŠÖ‚ˇ‚éˆÓŽŻ’˛¸|ˆę”ĘŽĺ•w‚Ć•a‰@Eˆő‚Ć‚Ě”äŠr. ‘ě“TŽqC˛“Ąˆ¤C‹î‘ň‹MŽqC‘Oěˆę]C’†ž—R”üCŽRčƒJƒcŽqi‘—§‘Š–ÍŒ´•a‰@jCHŽRŒ›‹`iŠOj: “ú–{“űŠŕŒŸfŠw‰ďŽGŽ, 2(3): 273`277, 1993.

1414. mŒ´’˜n Ź”]“ŽĂ–ŹŠďŒ`‚ɑ΂ˇ‚é‹~‹}ŽĄ—Ă. ‰iˆäŹŽ÷C‹{â‰Ŕ’jC‘q“c˛C“c’†–ö…Cí”Ő‰ĂˆęC–î“cŒŤŽOi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝jC‰““ĄšFi”]ŠOj: ”]ŠOŽ, 2: 302`306, 1993.

1415. mŒ´’˜n •ÂÇŤ…“ޏǂɂć‚鎋–ěáŠQ. í”Ő‰ĂˆęC‘q“c˛C‹{â‰Ŕ’jC‹kŽ ‘C–î“cŒŤŽOi”]ŠOjC‘ĺ˜a“c—˛i‹~–˝jC›Mˆęi•újCŒü–ě˜a—YiŠájC‚–؍Gi”]ŠOj: ”]_ŒoŠO‰ČƒWƒƒ[ƒiƒ‹, 2(2): 128`132, 1993.

1416. mŒ´’˜n “ŞŠW“ŕ‰đ—ŁŤ’ōœ“Ž–ŹáŽ‚ĚŽĄ—Ïă‚Ě–â‘č“_. ŽR“cŸC‹{â‰Ŕ’jC‘q“c˛C–î“cŒŤŽOi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝jC‚–؍Gi”]ŠOj: ”]‘˛’†‚ĚŠO‰Č, 22: 41`46, 1994.

1417. mŒ´’˜n ŠĚäXŘœ‚É‹Nˆö‚ˇ‚épŒă• o“ŕoŒŒ—á‚ĚŒŸ“˘. ŒĂ“cˆę“żC‹g“c@‹ICň‰Ć‹v’źC‚‹´‹BC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: • •”‹~‹}f—Â̐i•ŕ, 13(1): 55`59, 1993.

1418. mŒ´’˜n ƒCƒŒƒEƒX‚É‚¨‚Ż‚éŽčp“K‰ž‚Ćƒ^ƒCƒ~ƒ“ƒO|•Ű‘ś—Ă–@‚Ć‚ľ‚Ä‚Ěƒƒ“ƒOƒ`ƒ…[ƒu‚Ě—L—pŤ‚ɂ‚˘‚ā|. ź‘ňŽ“TC’Ë–{GlC‚‹´ŒúCŠ“cç”ü”TCÎ“c˜a•vC˛“ĄŒőŽjC‘ĺ‹{“ŒśCŠ`“cÍiŠOj: • •”‹~‹}f—Â̐i•ŕ, 13(4): 505`509, 1993.

1419. mŒ´’˜n ƒRƒ‰[ƒQƒ“ƒQƒ‹”|—{‚đ—p‚˘‚˝RŠŕÜŠ´ŽóŤƒeƒXƒg‚ĚŽŽ‚݁|Š”‰ťƒqƒg‘ĺ’°Šŕ×–E‚đ—p‚˘‚ā|. ‹e’rŽj˜YiŠOj: –k—˘ˆăŠw, 23(4): 251`258, 1993.

1420. mŒ´’˜n ‚—îŽŇ”xŠŕpŒă‡•šÇ‚Ɖh—{Žw”‚Ć‚ĚŠÖŒW‚ɂ‚˘‚Ä. ‚ŽRr­C•˝ˆäŽO˜Yi‹šŠOjCŽR“c—˛ˆęiNTT’†‰›Œ’NŠÇ—ƒZƒ“ƒ^[jC‹g‘ş”Ž–MCÎŒ´şi‹šŠOj: –k—˘ˆăŠw, 23(4): 284`287, 1993.

1421. mŒ´’˜n ”ńŹ×–E”xŠŕ‚ɑ΂ˇ‚ép‘OŽĄ—ĂŽ{sÇ—á‚ĚŒŸ“˘. ‹g‘ş”Ž–MC•i“cƒC‚—˛˝CÎŒ´şi‹šŠOjC‹T’J“Oi•a—jCź—Ń—˛i•újC–î“ߐŁM—YC•y“c—FKi“ŕj: –k—˘ˆăŠw, 23(5): 310`319, 1993.

1422. mŒ´’˜n ŠĽzŠÂ“Ž‘Ô‚Š‚ç‚Ý‚˝‘ĺ“Ž–Ź•Ů’uŠˇp‚Ě•]‰ż|‘ĺ“Ž–Ź•Ů‹ˇóÇ—á‚đ‘ÎŰ‚Ć‚ľ‚ā|. źŽR´ŒhC”ź’JĂ—YCÎŒ´şi‹šŠOj: –k—˘ˆăŠw, 23(6): 405`416, 1993.

1423. mŒ´’˜n Results of the surgical resction for lung cancer involving the base of the pulmonary vein or the left atrium. ‹g‘ş”Ž–MC•i“cƒC‚—˛˝Cˆ˘•””\–žCÎŒ´şi‹šŠOjC‹T’J“Oi•a—jC•˝ˆäŽO˜Yi‹šŠOjCŠ}ˆäŒ‰i•a—j: –k—˘ˆăŠw, 23(6): 431`439, 1993.

1424. mŒ´’˜n Evaluation of the use of cardiopulmonary bypass in the treatment of lung cancer. ‹g‘ş”Ž–MC•i“cƒC‚—˛˝Cˆ˘•””\–žCÎŒ´şi‹šŠOj: –k—˘ˆăŠw, 23(6): 440`445, 1993.

1425. mŒ´’˜n Chest wall invasion on carcinoma of the lung: Therapeutic and prognostic implication. ‹g‘ş”Ž–MC•i“cƒC‚—˛˝Cˆ˘•””\–žCÎŒ´şi‹šŠOj: –k—˘ˆăŠw, 23(6): 446`451, 1993.

1426. mŒ´’˜n ”]Š˛•” Cavernous angioma ‚ĚŽŠ‘RŒo‰ß. í”Ő‰ĂˆęC‹{â‰Ŕ’jC‘q“c˛C–î“cŒŤŽOi”]ŠOjC_“c’źi“ŕjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝jC›Mˆęi•újC‘ĺ‚O–Ťi”]ŠOj: –k—˘ˆăŠw, 23: 18`21, 1993.

1427. mŒ´’˜n ŽčŞŠÇÇŒóŒQ‚Ě“d‹Cś—Šw“IŒŸ“˘. –kŒ´s—YC”Ń“cG•vCŽR“cŸC‰ŞGGC‹kŽ ‘i”]ŠOj: —Տ°”]”g, 35: 461`465, 1993.

1428. m€Œ´’˜n –łÇŒóŤ’_Î‚ĚŽĄ—Ă•űj. Š`“cÍCŒĂ“cˆę“żC‹g“c@‹IC‚‹´‹BC‘ĺ‹{“ŒśiŠOj: —Տ°‚ĆŒ¤‹†, 71(2): 365`376, 1994.

1429. m’Z•ńn Ý‘îŠŕ‰ťŠw—Ă–@‚̏”–â‘č|“K‰ž‚Ć‘gD‘̐§‚𒆐S‚Ɂ|. ‘ĺ’J„łCŒĂě—T‰îC‘ęK‹ĎC”äŠé”\Ž÷iŠOj: ŠŕŽĄ—Ă‚ĆQOL, 3(1): 6`8, 1994.

1430. mŒ¤‹†•ńiŒúśČjn Šŕˆă—Ă‚É‚¨‚Ż‚éQOL‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†uisÁ‰ťŠíŠŕŠłŽŇ‚ĚQOL‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v|Ý‘îŠŕŽĄ—Ă‚É‚¨‚Ż‚éQOL‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†|. ‘ĺ’J„łiŠOj: ŒúśČ”ÇŒ¤‹†•Ş’SŒ¤‹†•ń‘i•˝Ź5”N“xj.

1431. mŒ¤‹†•ńiŒúśČjn ‘Š‡Œ¤‹†•ń. –î“cŒŤŽOi”]ŠOj: Ň‘‹ó“´Ç‚Ć‚ť‚ĚŠÖ˜AŽžŠł‚Ě•a‘Ô‚ĆŽĄ—Ă‚ÉŠÖ‚ˇ‚錤‹†•˝Ź4”N“xŒ¤‹†•ń‘, p.3`5, 1993.

1432. mŒ¤‹†•ńiŒúśČjn Ň‘“ŕˆł•Ď‰ť‚Ě‹ó“´Šg‘ĺ‚ɑ΂ˇ‚éŠÖ—^. –î“cŒŤŽOC”Ń“cG•vC‹kŽ ‘i”]ŠOj: Ň‘‹ó“´Ç‚Ć‚ť‚ĚŠÖ˜AŽžŠł‚Ě•a‘Ô‚ĆŽĄ—Ă‚ÉŠÖ‚ˇ‚錤‹†•˝Ź4”N“xŒ¤‹†•ń‘, p.40`42, 1993.

1433. mŒ¤‹†•ńiŒúśČjn Œă“ŞŠWâ|Žîᇂɔş‚¤Ň‘‹ó“´Ç‚ĚŒ¤‹†. ‹kŽ ‘C–î“cŒŤŽOC”Ń“cG•vi”]ŠOjC‘ž“cŒ°Źi•új: Ň‘‹ó“´Ç‚Ć‚ť‚ĚŠÖ˜AŽžŠł‚Ě•a‘Ô‚ĆŽĄ—Ă‚ÉŠÖ‚ˇ‚錤‹†•˝Ź4”N“xŒ¤‹†•ń‘, p.55`59, 1993.


<<15 2 ŠO‰ČŠw>>

1434. mÇ—á•ńn An unruptured arteriovenous malformation with edema. ‹{â‰Ŕ’jC–î“cŒŤŽOC‘q“c˛Cí”Ő‰ĂˆęC“c’†–ö…i”]ŠOjC‘ĺ˜a“c—˛i‹~–˝j: Am. J. Neuroradiol., 15: 385`388, 1994.

1435. mÇ—á•ńn Focal nodular hyperplasia of the liver: A patient with two concarrunt lesions that manifested different behavior on radiographic imaging tests. ‚‹´‹BCŠ`“cÍC–ě‘ň’źŽjCŒĂ“cˆę“żCň‰Ć‹v’źC‹g“c@‹IC‘ĺ‹{“ŒśiŠOjC’†‰p’ji•a—j: Journal of Hepato-Biliary-Pancreatic Surgery, 1(2): 189`194, 1994.

1436. mÇ—á•ńn Men type 1 associated with mediastinal carcinoid producing parathyroid hormone, calcitonin and chorionic gonadotropin. ‚ŽRr­i‹šŠOjC‹T’J“Oi•a—jCInagaki KeizouCNonaka MakotoCMiyazawa HidekiCOgawa NoburoCYano MakotoCMorita TakatomoCArai TakashiCNiino SatoshiCTajima HiroshiiNakano National Chest HospitaljCYamaguchi KeniNational Cancer Centerj: Pathol. Res. Pract., 189(9): 1090`1096, 1993.

1437. mÇ—á•ńn Pleural lipoma: Report of a case. ‚ŽRr­C•˝ˆäŽO˜Yi‹šŠOjCÎŒ´Ć•vCŒFč’qŽiC˛–ěŒőˆęCŽO“‡GNCM. OhtaiŠÖ“Œ’üM•a‰@j: Surgery Today, 24(2): 173`175, 1994.

1438. mÇ—á•ńn pŒă’ˇŠúś‘ś’†‚ĚŠĚ×–EŠŕ”j—ô‹Ů‹}ŽčpÇ—á. ‹g“c@‹IC‘ĺ‹{“ŒśCˆ­”üƒ•vCŒĂ“cˆę“żCň‰Ć‹v’źC‚‹´‹BC”äŠé”\Ž÷CŠ`“cÍiŠOj: Therapeutic Research, 14(9): 3885`3890, 1993.

1439. mÇ—á•ńn ‰Eă—tŘœŒă‰óŽ€Ť‹CŠÇŽx‰Š‚đ•š”­‚ľ‚˝ Neoadjuvant chemotherapy •š—p”x‘BŠŕ‚Ě‚P—á. ‚ŽRr­C•˝ˆäŽO˜Yi‹šŠOjCÎŒ´Ć•vCŒFč’qŽiC˛–ěŒőˆęCŽO“‡GNC˛“ĄOˆęiŠÖ“Œ’üM•a‰@j: ‹CŠÇŽxŠw, 16(1): 40`44, 1994.

1440. mÇ—á•ńn ‰ş‘ĺĂ–ŹŒ´”­•˝ŠŠ‹Ř“÷Žî‚Ě1Žčp—á. Ş–{EC“‡’ÐˇˆęCXŁšŽ÷CźˆäŒ’Ců–{_C‚‹´ŒúC‹ŕéł‰ŔCŠ`“cÍiŠOj: ŒŒŠÇŠO‰Č, 12(1): 89`93, 1993.

1441. mÇ—á•ńn VśŽ™“ŞŠWŠ×–vœÜ‚Ě1ŽŠ‘RŽĄ–ü—á. ‘ĺ“ä’mC‹{â‰Ŕ’jCŽRč‹`‹éC‘q“c˛C–î“cŒŤŽOi”]ŠOj: ŹŽ™‚Ě”]_Œo, 18: 151`154, 1993.

1442. mÇ—á•ńn ’°•ÂÇ. ”A•Â‚đ‚Ť‚˝‚ľ‚˝ĺœ‘O_Œo‰č×–EŽî. Î“c˜a•vCŠ“cç”ü”TC‘ĺ‹{“ŒśCŠ`“cÍiŠOjCĄˆäƒDC“‡–{—R‹IŽqiŽ™jC‰ĄŽR‰p“ńi”ĺjCŠâŸşŒ[ˆęC’†‰p’ji•a—j: ŹŽ™ŠO‰Č, 25(7): 783`787, 1993.

1443. mÇ—á•ńn H“šƒvƒƒe[ƒ[‘}“ü‚Ć“ŕŽ‹‹ž“IˆÝᑑ˘Ý‚É‚ć‚éÝ‘îŒo’°‰h—{‚Ě•š—p‚Ş—LŒř‚Ĺ‚ ‚Á‚˝‹CŠÇŽxᑕš”­H“šŠŕ‚Ě1Ç—á. Ź—ѐLsC“ˆ”ömC”äŠé”\Ž÷CŠ`“cÍiŠOj: Á‰ťŠí“ŕŽ‹‹ž, 5(8): 1105`1109, 1993.

1444. mÇ—á•ńn p‘O‚Ń‚Ü‚ńZŒ^‚Ɛf’f‚ł‚ę‚˝1Œ^’ź’°Šŕ‚Ě1—á. ˆäŒ´ŒúC‘ĺ’J„łC‘ęK‹ĎCŒĂě—T‰îC’Ň—şěC‰Ş‘ş—ĽŽqC”äŠé”\Ž÷CŠ`“cÍiŠOj: Á‰ťŠí“ŕŽ‹‹ž, 6(3): 421`426, 1994.

1445. mÇ—á•ńn ƒvƒƒe[ƒ[‘}“ü‚É‚ć‚č’ˇŠúš‹‰şáŠQ‚̏ÁŽ¸‚ľ‚˝H“šŠŕ‚Ě1—á. ’çCC“ˆ”ömC–ĺ˜eŒ›CâEŠ_˝C‰Á“ĄNsCŽOd–슰ŠěCĺŒ´÷C”äŠé”\Ž÷iŠOj: Á‰ťŠí“ŕŽ‹‹ž‚̐i•ŕ, 42: 177`180, 1993.

1446. mÇ—á•ńn ‘SŽüŤ‘e‘ĺŒ‹ßó—˛‹NŤ•a•Ď‚𔺂¤’ź’°”S–Œ’EÇŒóŒQ‚Ě1—á. ’çCC‰J‹{–ž•śCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´Ź–žC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjCó”ö•Žmi•a—j: Á‰ťŠí“ŕŽ‹‹ž‚̐i•ŕ, 43: 271`273, 1993.

1447. mÇ—á•ńn H“šŠŕpŒă, ”畆‹CŠÇᑑ˘ÝŠłŽŇ‚Ě‹CŠÇĽś‘Œz“Ž–Źá‘‚Ě1—á. ’çCiŠOjCźŒűŽ•FCó—˜–őC™–{Ÿ•FC–x’rdŽĄC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: “ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ďŽGŽ, 14(2): 294`295, 1993.

1448. mÇ—á•ńn ˆÝŠŕ“÷Žî‚Ě1Ç—á. ‹{“ŕ–M_iŠOjC‚–ěN—Yi•a—jC‘哇s•FC´…ł•vC“n•Ó—´•FCź”ŞŽkC’Ň—şěC‰ĄŽR‹žŽqC’†‘şG•viŠOj: “ú–{Á‰ťŠí•aŠw‰ďŽGŽ, 91(1): 75`79, 1994.

1449. mÇ—á•ńn p‘OCDDP, 5-FU‚Ĺ’˜Œř‚ľ‚˝H“šŠŕ‚Ě1ŽčpÇ—á. ŒĂ“cˆę“żC–ĺ˜eŒ›CŽOd–슰ŠěCâEŠ_˝C“ˆ”ömCĺŒ´÷C”äŠé”\Ž÷iŠOj: “ú–{—Տ°ŠO‰ČˆăŠw‰ďŽGŽ, 54(3): 655`659, 1993.

1450. mÇ—á•ńn “]ˆÚŤ”]ŽîᇏoŒŒ‚Ĺ”­Ç‚ľ‚˝áΊۗ‘‰Š”XŽî. ‚–쏮ŽĄCÄ“ĄŒł—ǁi”]ŠOjC‘ĺ•”˝i•a—jC‹{â‰Ŕ’jC–î“cŒŤŽOC‚–؍Gi”]ŠOj: ”]_ŒoŠO‰Č, 21: 533`537, 1993.

1451. mÇ—á•ńn ˆŤŤ“]‰ť‚đŽŚ‚ľ‚˝‘–ŒŽî|meningothelial type ‚Š‚ç papillary type ‚֕ωť‚ľ‚˝‚PÇ—á|. ŽRč‹`‹éCě–ěM”VCz–K’m–çCˆÉ“Ą”ä˜CŽuC–î“cŒŤŽOi”]ŠOjCŒK”ö’čmi•a—j: ”]_ŒoŠO‰Č, 22: 285`289, 1994.

1452. mÇ—á•ńn SóŒ‹’°‚É”­ś‚ľ‚˝”ń“ÁˆŮŤ‘ĺ’°’×ᇂĚ2—á. ‘ĺ‹v•ŰŽi–k‘ĺjC‚‹´‹BiŠOjC“í–{ŒŤŽńC‘ň“cN•vC‹´–{ˆÉ‹v—YC“ŕ–ěƒˆęi“VŽg•a‰@j: –kŠC“šŠO‰ČŽGŽ, 38(1): 121`124, 1993.

1453. mÇ—á•ńn öÝŤ“űŠŕ‚Ě2Ç—á. Ź—ѐLsiŠOjCź‘ş”Žsi–kM‘‡•a‰@jCŠÔ’†˝CŠ`“cÍiŠOj: –k—˘ˆăŠw, 23(3): 205`209, 1993.

1454. mÇ—á•ńn pŒă5”NˆČăś‘ś‚ľ‚˝’ź’°•˝ŠŠ‹Ř“÷Žî‚Ě1Žčp—á. “cŠ•ś•FC‰Ą“c˜a•FC˛“ĄŒőŽjCŠ`“cÍiŠOjC‰oěWi•a—jC“ŕ“c–LşC‰““Ą’‰—Yi”ĺjC‘ĺ•”˝i•a—j: –k—˘ˆăŠw, 23(4): 288`291, 1993.

1455. m—Տ°ŽĄŒąn tˆÚAŒă‚̖Ɖu—}§—Ă–@‚É‚ć‚éD’†‹…Œ¸­Ç‚ɑ΂ˇ‚éKRN 8601(rhG-CSF)‚Ě‘ć‡U‘Š—Տ°ŽŽŒą. ‘ž“c˜a•vCŽ›‰ŞŒdC‚‹´Œö‘ži“Œ‹ž—ˆă‘ĺjCHŽR’¨•vi“Œ‘ĺjC‘ĺ’؏CiŒŐƒm–ĺ•a‰@jCŹŽÄŒ’i”ĺjCŠ`“cÍiŠOjC”ö–{—ÇŽOié‹Ęˆă‘ĺjC‘ĺę”Ei—§ě ‘‡•a‰@jC‚–؍Oi–źŒĂ‰Ž‘ĺjC‘Ĺ“c˜aŽĄi–źŒĂ‰Ž‘ć“ńÔ\Žš•a‰@jC‘哇LˆęiŽĐ‰ď•ŰŒŻ’†‹ž•a‰@jC“Ą“c–Ż•vi–źŒĂ‰Ž‹L”O•a‰@jC‰Ş—˛Gi‹ž“s•{—§ˆă ‘ĺjCŒI“cFi‹ß‘ĺjC‰J‹{_i‘—§zŠÂŠí•aƒZƒ“ƒ^[jCÜ“cŒOŽOi‰Ş‘ĺjC“c’†Mˆę˜Yi‘—§‰ŞŽR•a‰@jC–œ”g˝iŽs—§‰F˜a“‡•a‰@jC–xŒŠ’‰Žii‚’mŒ§—§ ’†‰›•a‰@jC˜a“cDOi•Ÿ‰ŞÔ\Žš•a‰@jC’†“‡ŒőDi•lźˆă‘ĺj: Ą“ú‚ĚˆÚA, 6(5): 577`588, 1993.

1456. m—Տ°ŽĄŒąn pŒăƒXƒgƒŒƒX‚É‚ć‚éˆÝŽ_•Ş”ĺ˜´i‚ɑ΂ˇ‚郉ƒjƒ`ƒWƒ“’ŽË‰t‚Ě—Ő°“I—L—pŤ‚ĚŒŸ“˘|‰–Ž_ƒsƒŒƒ“ƒ[ƒsƒ“‚đ‘ÎĆ–ň‚Ć‚ľ‚˝“ńd–ÓŒŸŽŽŒą|. Â–ŘĆ–žiŽœŒbˆă‘ĺjC“n•”—mŽOi‡‘ĺjC–k“‡­Ž÷iŒc‘ĺjC™ŽRvi‰Ą•lŽs‘ĺjC•Ŕ–؏ş‹`iŽD–yˆă‘ĺjCÄ“Ą˜aDiŠâŽčˆă‘ĺjC‹´–{•Ű•Fi“Œ–k‘ĺjCŒł –Ř—Çˆęi•Ÿ“‡Œ§—§ˆă‘ĺjC•“Ą‹PˆęiVŠƒ‘ĺjC’ˇ’ŹK—YiŒQ”n‘ĺjC•˝‘ň”Ž”Viç—t‘ĺjCě“Y‘ž˜Yié‹Ęˆă‘ĺjC—§ěŒMiˆÇ—Ń‘ĺjCŒ´Œű‹`ŔiŽŠŒx‰ď“Œ‹ž ŒxŽ@•a‰@jC“V‰HŒh—Si“Œ‹žˆăŽ•‘ĺjC”čCiŽœŒbˆă‘ĺjC‹T’J”Eišƒ}ƒŠˆă‘ĺjC–ěŒűƒˆęiěčŽs—§ěč•a‰@jC”äŠé”\Ž÷iŠOjCŽO•x—˜•vi“ŒŠC‘ĺjC ŽR–{CŽOiĎś‰ď_“ŢěŒ§•a‰@jC—é–؝ƁiŽRŒű‘ĺjC“ŕ“c—YŽOi‘ĺ•Şˆă‘ĺjC“‡’Ă‹v–žiŽ­Ž™“‡‘ĺjC’†“‡ŒőDi•lźˆă‘ĺj: —Տ°Źl•a, 23(1): 127`137, 1993.

1457. m‘ŕn •Ť‡•”’×ᇂ̎Ą—Ă. ’Ë–{GlC”äŠé”\Ž÷iŠOjCŽO‹´—˜‰ˇi“ŕj: Medicina, 30(9): 1716`1718, 1993.

1458. m‘ŕn “ŕŽ‹‹ž‰ş‚Ĺ‚Ě”ńNP“IŽĄ—Ă–@. ”äŠé”\Ž÷iŠOj: ˆă—Ă, 9(4): 52`55, 1993.

1459. m‘ŕn ‚ą‚ĚÇ—á‚É‚¨‚Ż‚éŠĚáŠQ‚Ě•]‰ż‚Ć‚ť‚ĚŽĄ—Ă•űj. Š`“cÍCˆ­”üƒ•vC‘ĺ‹{“ŒśC‹g“c@‹ICˆ˘‘]˜a“NiŠOj: ŠO‰Č, 52(7): 655`660, 1990.

1460. m‘ŕn ‹Ů‹}“ŕŽ‹‹žŒŸ¸. ’Ë–{GlC”äŠé”\Ž÷iŠOj: ŠO‰ČŽĄ—Ă, 68(5): 587`590, 1993.

1461. m‘ŕn • o‹ž‰ş’Ž‚Řœp. ‹ŕ“cŒĺ˜YC‚‹´r‹BC‰J‹{–ž•śCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`iŠOj: ŠO‰Čf—Ă, 35(12): 1507`1511, 1993.

1462. m‘ŕn ‹Ů‹}“ŕŽ‹‹žŒŸ¸. ’Ë–{GlC‚‹´ŒúC”äŠé”\Ž÷iŠOj: ŠO‰Čf—Ă, 35(9): 1083`1088, 1993.

1463. m‘ŕn ŽĄ—͢“ď‚Č’_ÎÇ. Š`“cÍC‹g“c@‹ICŒĂ“cˆę“żCň‰Ć‹v’źC‚‹´‹BC‘ĺ‹{“ŒśiŠOj: ŠĚ’_äX, 27(5): 919`925, 1993.

1464. m‘ŕn Ý‘îŠŕŽĄ—Ă‚É‚¨‚Ż‚éƒCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg. ‘ĺ’J„łC÷–{MˆęC‘ęK‹ĎC”äŠé”\Ž÷iŠOj: ŠŕŽĄ—Ă‚ĆhŽĺ, 5(2): 105`109, 1993.

1465. m‘ŕn “Ş•”ŠO‚̐f’f‚ĆŽĄ—Á|ŠOŤ”]ŒŒŠÇáŠQ. ‹{â‰Ŕ’ji”]ŠOj: ‹~‹}ˆăŠw, 17: 1082`1086, 1993.

1466. m‘ŕn “Ş•”ŠO‚̐f’f‚ĆŽĄ—Á|ăˆĘŒz’ĹĽŒz‘‘š. ”Ń“cG•vi”]ŠOj: ‹~‹}ˆăŠw, 17: 1087`1090, 1993.

1467. m‘ŕn ŠĚŠŕ‚ĚŽčp: ŠĚ’†‰›2‹ćˆćŘœp. Š`“cÍC‚‹´‹BC‹g“c@‹ICŒĂ“cˆę“żC‘ĺ‹{“ŒśiŠOj: Á‰ťŠíŠO‰Č, 16(11): 1617`1626, 1993.

1468. m‘ŕn Á‰ťŠí‘ŠúŠŕ‚ɑ΂ˇ‚é“ŕŽ‹‹žŘœ–@‚̏Ť—ˆ“W–]. ”äŠé”\Ž÷C“ˆ”ömCŹ—ѐLsiŠOj: Á‰ťŠí“ŕŽ‹‹ž, 5(9): 1197`1202, 1993.

1469. m‘ŕn “ŕŽ‹‹žf—Ă‚ĚŒť‹ľ‚Ć“W–]|‚Ć‚­‚ɏÁ‰ťŠÇŽîᇂɑ΂ˇ‚鎥—Ă. ”äŠé”\Ž÷iŠOj: Vˆă—Ă, (2ŒŽ†): 32`35, 1994.

1470. m‘ŕn Œz‘/_ŒoŞ‚Ě“Ž‘Ô—ÍŠw“IŒŸ“˘. ‹kŽ ‘i”]ŠOj: _ŒoŒ¤‹†‚̐i•ŕ, 37: 188`196, 1993.

1471. m‘ŕn Ň‘‹ó“´Ç‚Ě”­ś‚ĆŠg‘ĺ‚ÉŠÖ‚í‚鐑‰t“Ž‘Ô. ‹kŽ ‘i”]ŠOj: _Œo“ŕ‰Č, 39: 349`354, 1993.

1472. m‘ŕn ŠOŤŠÂ’Ł|Œă“ލœ’E‰P‚̐f’f‚ĆŽĄ—Ă. ”Ń“cG•vC‹kŽ ‘i”]ŠOjC‘ĺ˜a“c—˛i‹~–˝j: Ň’ŐҐ‘ƒWƒƒ[ƒiƒ‹, 6: 661`666, 1993.

1473. m‘ŕn Žčp‚ĚƒeƒNƒjƒbƒN|Ň‘‹ó“´Ç‚ĚŽčp. ‹kŽ ‘i”]ŠOj: Ň’ŐҐ‘ƒWƒƒ[ƒiƒ‹, 7: 133`138, 1994.

1474. m‘ŕn Ă–Ź“ŕ—Ż’uŒ^lH”x. ‹g‘ş”Ž–MCĄˆäŠ°C•i“cƒCÎŒ´şi‹šŠOj: “ŕ‰Č, 71(4): 725`727, 1993.

1475. m‘ŕn • o‹ž‰ş’_”X“Eop‚ĚŒťó‚Ć“W–]. ‹g“c@‹IC”äŠé”\Ž÷iŠOj: “ú–{ˆăŽ–V•ń, (3615): 163, 1993.

1476. m‘ŕn ‹}ŤcŠu‰Š. ‘꓇í‰ëiŠOjC‘Š”nˆęˆĺi‹~–˝j: “ú–{‹CŠÇH“š‰ČŠw‰ď‰ď•ń, 44(5): 378`384, 1993.

1477. m‘ŕn ”]Žş“ŕoŒŒ|Źˆö, ‰ć‘œf’f‚̐i•ŕ‚Ć‹~–˝—Ś‚ĚŒüă|. ‹{â‰Ŕ’ji”]ŠOj: “ú–{—Տ°, 51: 262`271, 1993.

1478. m‘ŕn H“š•Ź–ĺ•”isŠŕŤ‹ˇó‚ɑ΂ˇ‚é“ŕŽ‹‹žŽĄ—Ă. “ˆ”ömC”äŠé”\Ž÷iŠOj: —Տ°Á‰ťŠí“ŕ‰Č, 8(5): 639`647, 1993.

1479. muŔn ŒăŇ‘“Ž–ŹÇŒóŒQ. ŽRč‹`‹éC‹kŽ ‘i”]ŠOj: Clin. Neurosci., 12: 230, 1994.

1480. muŔn IABP ‚̍‡•šÇ‚ƍRŒŒđ‘΍ô. •y‰i˝ˆęi‹šŠOj: Clinical Engineering, 5(2): 104`105, 1994.

1481. muŔn Ź‚ł‚Ȑ‘“ŕŽîᇁ|f’f‚¨‚ć‚ŃŽĄ—Ïă‚Ě–â‘č“_|. ŽOˆäŒö•FC“c’†ç•FC‹kŽ ‘C–î“cŒŤŽOi”]ŠOjC—щëOC‘哇‹`•FiŽRŒ`‘ĺjC–]ŒŽ^lCŽç‰ŽG”Ɂiç—t‘ĺj: Ň‘ŠO‰Č, 7: 46`51, 1993.

1482. mŠwp‘n i•Ş’SŽˇ•Mj “Ş•”, Ň’ŐҐ‘ŠOŽĄ—Ăƒ}ƒjƒ…ƒAƒ‹; Žó’źŒă‚Ě‹Ů‹}f’f, p.1`20, ‹{â‰Ŕ’ji”]ŠOj. •ŇW –î“cŒŤŽOi”]ŠOjC‹ŕ“c´ŽuCŽR‰YťC ˆăŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1483. mŠwp‘n i•Ş’SŽˇ•Mj “Ş•”, Ň’ŐҐ‘ŠOŽĄ—Ăƒ}ƒjƒ…ƒAƒ‹; ‹Ů‹}ˆ’u, p.32`35, ‹{â‰Ŕ’ji”]ŠOj. •ŇW –î“cŒŤŽOi”]ŠOjC‹ŕ“c´ŽuCŽR‰YťC ˆăŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1484. mŠwp‘n i•Ş’SŽˇ•Mj “Ş•”, Ň’ŐҐ‘ŠOŽĄ—Ăƒ}ƒjƒ…ƒAƒ‹; ŽOŽŸˆă—Ă‹@ŠÖ‚Ö‚ĚˆÚ‘—Žž‚Ěƒ`ƒFƒbƒNƒ|ƒCƒ“ƒg, p.36`39, ‹{â‰Ŕ’ji”]ŠOj. •ŇW –î“cŒŤŽOi”]ŠOjC‹ŕ“c´ŽuCŽR‰YťC ˆăŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1485. mŠwp‘n i•Ş’SŽˇ•Mj Microcirculatory Stasis in the Brain; L-arginine infusion promotes nitric oxide-dependent vasodilation in the rat cerebrovasculature, p.287`295, Michael A. MoskowitzCEiharu MorikawaCZhihong HuangCSami RosenblattCTazuka YoshidaC“ü‘qŽŒČi”]ŠOjCTurga Dalkara. •ŇW M. Tomita, et al.C Elsevier Science Publishers, Boston, 93.00.00”­s.

1486. mŠwp‘n i•Ş’SŽˇ•Mj Á‰ťŠíŽžŠłĹV‚ĚŽĄ—Ă'93`'94; ˆÝŒeŽş, \“ńŽw’°ŒeŽş, p.143`145, ”äŠé”\Ž÷CâEŠ_˝iŠOj. “ě]“°, “Œ‹ž, 93.04.15”­s.

1487. mŠwp‘n i•Ş’SŽˇ•Mj ŠŕˆŤ‰tŽż|•a‘Ô‚ĆŽĄ—Ă‚ĚĹV‚Ě“ŽŒü; Ý‘îˆă—Ă‚É‚ć‚é‰h—{ŠÇ—, p.209`215, ‘ĺ’J„łC÷–{MˆęC”äŠé”\Ž÷iŠOj. •ŇW Ž˝čˆę˜NiŽD–yˆă‘ĺjC ć’[ˆăŠwŽĐ, “Œ‹ž, 93.04.30”­s.

1488. mŠwp‘n i•Ş’SŽˇ•Mj }ŕ—Տ°ŠŕƒVƒŠ[ƒY|Šŕ‚Ě“ŕŽ‹‹žŽĄ—Ă; Šŕ‚É‚ć‚éH“š‹ˇó‚Ě“ŕŽ‹‹ž“IŠg’Łp, 37: 23`27, “ˆ”ömC”äŠé”\Ž÷iŠOj. •ŇW ––‘CŒbˆęC‚ŽRşŽOi‘—§‚Ş‚ńƒZƒ“ƒ^[jC•ž•”Mi“s—§‹îž•a‰@jCł‰Ş“Oi‘ĺă•{—§Źl•aƒZƒ“ƒ^[jC ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 93.05.20”­s.

1489. mŠwp‘n i•Ş’SŽˇ•Mj Vˆę”ĘŠO‰Č|p‘OĽp’†ĽpŒăŠÇ—i‘ć2”Łj; “ŕŽ‹‹ž“Iƒ|ƒŠƒyƒNƒgƒ~[iˆÝj, p.769`776, “ˆ”ömC”äŠé”\Ž÷iŠOj. •ŇW oŒŽN•vi“Œ‘ĺjC“ŕ–ěƒˆęi–k‘ĺjC÷ˆäŒ’ŽiiŽœŒbˆă‘ĺjCŽO•x—˜•vi“ŒŠC‘ĺjC ‚ւ邡o”Ĺ, “Œ‹ž, 93.09.09”­s.

1490. mŠwp‘n i•Ş’SŽˇ•Mj Vˆę”ĘŠO‰Č|p‘OĽp’†ĽpŒăŠÇ—i‘ć2”Łj; ŠO’_`ᑑ˘Ýp, p.793`800, Š`“cÍCň‰Ć‹v’źiŠOj. •ŇW oŒŽN•vi“Œ‘ĺjC“ŕ–ěƒˆęi–k‘ĺjC÷ˆäŒ’ŽiiŽœŒbˆă‘ĺjCŽO•x—˜•vi“ŒŠC‘ĺjC ‚ւ邡o”Ĺ, “Œ‹ž, 93.09.09”­s.

1491. mŠwp‘n i•Ş’SŽˇ•Mj ŠŕŽĄ—Ă‚É‚¨‚Ż‚郌[ƒU[ˆăŠw; ˆŤŤŽîᇂɑ΂ˇ‚郌[ƒU[ŠO‰Č, p.99`106, ”äŠé”\Ž÷CŹ—ѐLsCŽR”ö“N•FC“ˆ”ömiŠOj. •ŇW Ź•”ŞŽľ˜Yi‘—§‚Ş‚ńƒZƒ“ƒ^[jC ˆăŠw}‘o”Ĺ, “Œ‹ž, 91.10.01”­s.

1492. mŠwp‘i‰p•śjn i•Ş’SŽˇ•Mj Staging and Treatment of Gastric Cancer; Preoperative staging of T by endoscopy and endoscopic ultrasonography for diagnosing the degree of gastric cancer invasion, p.161`166, ”äŠé”\Ž÷iŠOjC–Ř“cŒőLi“ŕj. PICCIN, Padua, 91.00.00”­s.

1493. mŠwp‘n i•ŇWj “ű‘BĽbó‘BŠO‰ČPractical Discussion-3i”ńG’m“űŠŕ‚đf’f‚ˇ‚é|ƒoƒZƒhƒE•a‚đl‚Ś‚é|j‘ć1”Ĺ; •ŇW “n•ÓOC“Ą–{‹gGCŽR–{_C‰ŕ•xŽm—YC“c“‡’m˜YC•Ÿ“c÷C{“c“C´…“NC‹g“c–žC’|’†°KiŠOjC ƒCƒ“ƒ^[ƒ‹ƒN, “Œ‹ž, 93.00.00”­s.


<<15 3 ŠO‰ČŠw>>

1494. m‹ł‰Č‘n i•Ş’SŽˇ•Mj ŽŔ‘HÁ‰ťŠÇ‰^“Ž‹@”\’˛ßÜ(1)’P“Ć—Ă–@‚Ć•š—p—Ă–@‚Ě—Ő°“IˆÓ‹`; ŠeÁ‰ťŠÇ‰^“Ž‹@”\’˛ßÜ‚Ě‘ă•\“I–ňÜ‚̍ě—p‹@˜‚ĆŽĺ‚ȏÁ‰ťŠÇŽžŠł‚ɑ΂ˇ‚éŽg‚˘•űiÇ—á‚Əˆ•űj‡@ƒRƒŠƒ“ě“ŽŤ–ň•¨, 1: 18`24, ‰Á“ĄNsiŠOj. •ŇW źŽ}Œ[i‘—§•a‰@ˆă—ĂƒZƒ“ƒ^[jC ˆă–ňƒWƒƒ[ƒiƒ‹ŽĐ, ‘ĺă, 93.04.20”­s.

1495. m‹ł‰Č‘n i•Ş’SŽˇ•Mj }ŕ• Ľ‹šo‹ž‰şŽčp; ‘’_ŠÇŒ‹ÎÇ‚ĚŽčp, p.111`118, ‹ŕ“cŒĺ˜YC‚‹´r‹BiŠOj. •ŇW oŒŽN•vC“ŒŒ´‰p“ńi“Œ‘ĺjC ƒƒfƒBƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 93.12.10”­s.

1496. m‹ł‰Č‘n i•Ş’SŽˇ•Mj TEXTŠO‰ČŠw; ’_“š, p.572`597, Š`“cÍC‘ĺ‹{“ŒśC‹g“c@‹IiŠOj. •ŇW ™’ŹŒ\‘ i‹ă‘ĺjC–ˆÉł‹`i‹ŕ‘ň‘ĺjC‰Ş“cłiă‘ĺjC•“Ą“Oˆę˜Yi“Œ‘ĺjC “ěŽR“°, “Œ‹ž, 94.03.18”­s.

1497. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj Á‰ťŠíf—Ăƒvƒ‰ƒNƒeƒBƒX4.’_”XŽžŠł; ’_”XŒ‹Î‚ĚŽĄ—ĂESWL|“K‰ž‚ĆŒŔŠE(1)…’†ƒXƒp[ƒN•űŽŽ, p.89`95, –ĺ˜eŒ›iŠOjCˆęŒ´—şi“ŕjCă–ěˆę–çi‘Š–Í‘ä•a‰@jC•˝“cMliş˜a‘ĺ“ĄƒP‹uj. •ŇW ˆäŒËŒ’ˆęiŽŠŽĄˆă‘ĺjC •śŒő“°, “Œ‹ž, 93.06.26”­s.


<<15 5 ŠO‰ČŠw>>

1498. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Endoscopic treatment for early gastric cancer|selected cases of lymph node metastasis and new surgical techniques. ”äŠé”\Ž÷iŠOj: WHO-CC 10th International Seminar & Workshop 5th General Meeting i93.09.13j, ƒ~ƒ…ƒ“ƒwƒ“.

1499. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The effects of nitric oxide synthease (NOS) inhibition on pial arterial dilation produced by somatosensory stimulation and hypercapnea. “ü‘qŽŒČi”]ŠOjCRosenblatt, S.CKontos, M.A.CMoskowitz, M.A.iHarvard Med. Sch.j: 16th International Symposium on Cerebral Blood Flow and Metabolism i93.05.24j, ĺ‘ä.

1500. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Arachnoid trabecular cell hyperplasia; A case report. ě–ěM”VCˆÉ“Ą”ä˜CŽuCz–K’m–çi”]ŠOjC‹T’J“Oi•a—jC–î“cŒŤŽOi”]ŠOj: 69th Annual Meeting of the American Association of Neuropathologists i93.06.08j, Salt Lake City, U.S.A.,

1501. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The effectiveness of double-balloon to the tumor for laparoscopic surgery. ‹ŕ“cŒĺ˜YC‚‹´‹BCˆî–؉pŽĄC‹ß“ĄŒŤŽiC’çCC‰J‹{–ž•śCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`iŠOj: 1st Asian Pacific Congress of Endoscopic Surgery i93.08.06`08j, Singapor.

1502. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Percutaneous endoscopic gastrostomy: comparison of push method with inroduce method. “ˆ”ömC”äŠé”\Ž÷C‹{“ŕ–M_CŽOd–슰ŠěCĺŒ´÷CŠ`“cÍiŠOj: 35th World Congress of International Society of Surgery i93.08.24j, Hong Kong, —\eW, p.1031, 1993.

1503. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Cause of death after renal transplantation (A long term follow up study). ˛“ĄŒőŽjC“cŠ•ś•FCÎ“c˜a•vCź‘ňŽ“TC‰Ą“c˜a•FC’†ŽR‹`‰îCŠ`“cÍiŠOjCŒF–ě˜a—YC‰““Ą’‰—Yi”ĺjC’|“ŕN—YCŠ™“cvŽőC‘ĺ‹v•Ű[li“ŕjC“n•”_ “ńi–Ɖuj: 3rd Congress of Asian Society of Transplantation i93.12.03j, ƒ^ƒC.

1504. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Development of cancer in renal allograft recipient. ‰Ą“c˜a•FCFukumitsu, M.CKuzuhara, K.COtsubo, O.CTomikawa, S.CNagao, T.C“ŕ“c‹v‘ĽC˛“ĄŒőŽjC’†ŽR‹`‰îiŠOjC‰““Ą’‰—Yi”ĺjCŠ™“cvŽői“ŕj: 3rd Congress of Asian Society of Transplantation i93.12.05j, ƒ^ƒC.

1505. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Effectiveness of triple regimen immunosuppression in canine pancreatic allotransplantation. ˛“ĄŒőŽjCź‘ňŽ“TCĄˆäŒ‰CźˆäŒ’C“cŠ•ś•FC”äŠé”\Ž÷CÎ“c˜a•vCŠ`“cÍiŠOj: 3rd Congress of Asian Society of Transplantation i93.12.06j, ƒ^ƒC.

1506. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Evaluation of causes of death in renal transplantation. ˛“ĄŒőŽjC“cŠ•ś•FCÎ“c˜a•vCź‘ňŽ“TC’†ŽR‹`‰îCŠ`“cÍiŠOj: 3rd Congress of Asian Society of Transplantation i93.12.06j, ƒ^ƒC.

1507. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Two new techniques for coranary artery bypass grafting. •—ŠÔ”ɁCÎŒ´şi‹šŠOj: 2nd Annual Meeting of the Asian Society for Cardiovascular i94.02.00j, –źŒĂ‰Ž.

1508. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Contraction property of gallbladder muscle under variation of intracholecystic pressure and blood pressure. ‰Á“ĄNsiŠOjC‘ę‘ň’ź’čC‘ĺŠŃMiś—j: 32nd Congress of the International Union of Physiological Sciences(IUPS) i93.08.02j, Glasgowi‰p‘j, Abstract, p.227, 1993.

1509. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Strategy for treatment of mechanical intestinal obstruction. ź‘ňŽ“TC˛“ĄŒőŽjC’Š’ˇ“N–íC‚–ě—eKC”Ń–ě‘Pˆę˜YC‘ĺŔ[ŽjC‘ĺŔ“cŽĄCźč”ŽsC—§ÎWC‘D–{TěC’Ë–{GlCŽOd–슰ŠěC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ` “cÍiŠOj: International Surgical Week i93.08.22`27j, Hong Kong.

1510. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Evaluation of simple closure for perforated duodenal ulcers. ’Ë–{GlCâEŠ_˝Cź‘ňŽ“TCŽOd–슰ŠěC˛“ĄŒőŽjC‘ĺ‹{“ŒśCĺŒ´÷C”äŠé”\Ž÷CŠ`“cÍiŠOjC‘꓇í‰ëC™–{Ÿ•Fi‹~–˝j: 35th World Congress of International Society of Surgery i93.08.24j, Hong Kong.

1511. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j The status of open procedures after the introduction of laparoscopic cholecystectomy for primary benign lesions of the gallbladder. ‚‹´‹BCŠ`“cÍCŒĂ“cˆę“żCň‰Ć‹v’źC‹g“c@‹IC‘ĺ‹{“ŒśC”äŠé”\Ž÷iŠOj: 35th Congress of Surgery, International Society of Surgery i93.08.24j, Hong Kong, Abstracts, p. 274, 1993.

1512. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Clinicopathological study on the gallbladder and choledochus of the patients with anomalous arrangement of the pancreaticobiliary duct system. ŒĂ“cˆę“żCŠ`“cÍC‹g“c@‹ICň‰Ć‹v’źC‚‹´‹BC‘ĺ‹{“ŒśC”äŠé”\Ž÷iŠOj: 35th World Congress of Surgery i93.08.25j, Hong Kong.

1513. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j The effect of altering cerebrospinal pressure on the spinal cord blood flow. An implication in spinal cord protection during thoracoabdominal aneurysm operations. •—ŠÔ”ɁCě~C‰e‘ňŒ’Žii‹šŠOjC^č‹`•FCŠŰŽR–ΑPiŽŔ“ŽjCÎŒ´şi‹šŠOj: The 21st World Congress of the International Society for Cardiovascular Surgery i93.09.00j, Lisbon, Portugal.

1514. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j No reflow phenomenon in skeletal muscle ischemia reperfusion. Ş–{EC“‡’ÐˇˆęCXŁšŽ÷C‹ŕéł‰ŔCŠ`“cÍiŠOj: 21st World Congress International Society for Cardiovascular Surgery i93.09.12j, ƒŠƒXƒ{ƒ“, Abstract, p.54, 1993.

1515. mŠw‰ďi‘S‘jn i‹łˆçu‰‰j Ň‘‹ó“´Ç‚ĚŽĄ—Ă. –î“cŒŤŽOi”]ŠOj: ‘ć13‰ń“ú–{”]_ŒoŠO‰ČƒRƒ“ƒOƒŒƒX i93.05.20j, •Ÿ“‡.

1516. mŠw‰ďi‘S‘jn i‹łˆçu‰‰j Ň‘‚Ě‰ć‘œf’f. ‹kŽ ‘i”]ŠOj: ‘ć34‰ń“ú–{_ŒoŠw‰ď‘‰ď i93.06.09j, ç—t.

1517. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ”xŠŕŽčp‚̐ŹŃŒüă‚đ‚ß‚´‚ľ‚ā|p‘O‰ťŠw—Ă–@, •úŽËü—Ă–@‚ĚŽŽ‚Ý. ‹g‘ş”Ž–MC•i“cƒC‚—˛˝C“c’†Ž•FCÎŒ´şi‹šŠOj: ‘ć18‰ń“ú–{ŠO‰ČŒn˜A‡Šw‰ď i93.06.26j, ‘ĺ‹{, “ú–{ŠO‰ČŒn˜A‡Šw‰ďŽ, 18(ŠwpW‰ď´˜^†): 304, 1993.

1518. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j • o‹ž‰ş’_“šŽčp‚É‚¨‚Ż‚ép‘OĽp’†’_“š‘˘‰e‚ĚˆÓ‹`. ‹ŕ“cŒĺ˜YC‚‹´r‹BCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`iŠOj: ‘ć42‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď i93.07.22j, ‘ĺă.

1519. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’_”XŠŕŽčp‚ĆQOL|’_”XŠŕ‚ɑ΂ˇ‚é• o‹ž‰ş’_”X“Eop“ą“ü‚̉”\Ť‚ƏđŒ. ‹g“c@‹IC‚‹´‹BC“‡“cŒŞCŒĂ“cˆę“żCň‰Ć‹v’źC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć42‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď i93.07.23j, ‘ĺă, “ú–{Á‰ťŠíŠO‰ČŠw‰ďŽGŽ, 26(6): 1472, 1993.

1520. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘ŠúˆÝŠŕ‚ɑ΂ˇ‚é”S–ŒŘœ–@‚̒ljÁƒŒ[ƒU[ĆŽË—á‚ĚŒŸ“˘. “ˆ”ömC”äŠé”\Ž÷iŠOj: ‘ć14‰ń“ú–{ƒŒ[ƒU[ˆăŠw‰ď‘ĺ‰ďƒVƒ“ƒ|ƒWƒEƒ€ i93.08.18j, ‘ĺă, ƒvƒƒOƒ‰ƒ€Ľ´˜^W, p.65, 1993.

1521. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j • o‹ž‰ş’_”X“Eop‚̏p’†‡•šÇ‚Ć‘Îô. ‹g“c@‹IC”äŠé”\Ž÷C‚‹´‹BCŒĂ“cˆę“żCň‰Ć‹v’źC‘ĺ‹{“ŒśCŠ`“cÍiŠOj: ‘ć21‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď i93.09.02j, “Œ‹ž, ´˜^W, p.77, 1993.

1522. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j pŒăƒCƒŒƒEƒX‚Ě”­ś—vˆö‚Ć‚ť‚Ě‘Îô. ź‘ňŽ“TC’Ë–{GlC‰ĄŽR‹žŽqC‚–ě—eKC“n•ÓŒ’Ž™C˛“ĄŒőŽjC‘ĺ‹{“ŒśCŠ`“cÍiŠOj: ‘ć21‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď i93.09.03j, “Œ‹ž, ´˜^W, p.113, 1993.

1523. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Œz‘/_ŒoŞ‚Ě“Ž‘Ô—ÍŠw“I“ÁŤ‚Ćcervical spondylosis. ‹kŽ ‘i”]ŠOj: ‘ć14‰ńŇ‘ƒVƒ“ƒ|ƒWƒEƒ€ i93.09.11j, “Œ‹ž.

1524. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ”]“ŽĂ–ŹŠďŒ`‚É‚¨‚Ż‚éĂ–ŹŠŇ—Ź‚Ě—Ő°“IˆÓ‹`. ‹{â‰Ŕ’jC‘q“c˛Cí”Ő‰ĂˆęC“c’†–ö…C“ü‘qŽŒČC‘ĺ“ä’mCŽOŽ}GˆÉC–î“cŒŤŽOi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝j: ‘ć52‰ń“ú–{”]_ŒoŠO‰ČŠw‰ď‘‰ď i93.09.20j, “Œ‹ž.

1525. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’_”XŠŕ‚̐[’B“x‚ĆŽčpŽĄ—ÐŹŃ. ‹g“c@‹ICŠ`“cÍC“‡“cŒŞCˆÉ“Ą‹`–çCŒĂ“cˆę“żCň‰Ć‹v’źC‹ŕ“cŒĺ˜YC‚‹´‹BC‘ĺ‹{“ŒśC”äŠé”\Ž÷iŠOj: ‘ć29‰ń“ú–{’_“šŠw‰ď‘‰ď i93.09.20j, _ŒË, ’_“š, 7(3): 353, 1993.

1526. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Źl‚É‚¨‚Ż‚éäXŠÇ’_“š‡—ŹˆŮí‚Ş’_ŠÇŠg’ŁÇ‚É‚¨‚ć‚Ú‚ˇ‰e‹ż‚ɂ‚˘‚Ä‚Ě—Ő°•a—Šw“IŒŸ“˘. ŒĂ“cˆę“żC‹g“c@‹IC‚‹´‹BCň‰Ć‹v’źC’Š’ˇ“N–íCÎ“c˜a•vC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć29‰ń“ú–{’_“šŠw‰ď‘‰ď i93.09.21j, _ŒË, ’_“š, 7(3): 357, 1993.

1527. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’×ᇐŤ‘ĺ’°‰Š‚̉ń’°ăč–ĺ•Ť‡p‚Ě“K‰ž‚ƍH•v. ‘ĺ’J„łC‘ęK‹ĎCH“ĄNśCĺŒ´÷C”äŠé”\Ž÷iŠOjCŒÜ\—’łLCŸ–””ş‰hi“ŕj: ‘ć1‰ńJDDW, ‘ć48‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ď‘‰ď i93.09.24j, _ŒË, “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ, 46(5): 490, 1993.

1528. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j łíŠĽ“Ž–Ź“ŕŒŒ—Ź—lŽŽ‚Ě•ŞÍ|‘ĺ“Ž–Ź“ŕˆłĽ—Ź‘Ź‚Ć‚Ě“ŻŽžŒv‘Ş‚É‚ć‚錟“˘|. ”ź’JĂ—Yi‹šŠOjC‘ź: ‘ć30‰ń“ú–{—Տ°ś—Šw‰ď‘‰ď i93.10.15j, “Œ‹ž, “ú–{—Տ°ś—Šw‰ďŽGŽ, 23(—Ő‘): 53, 1993.

1529. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j p‘O‰ć‘œf’f‚ć‚č‚Ý‚˝• o‹ž‰ş’_”X“Eop‚É‚¨‚Ż‚éŠJ• —á‹y‚ŃŠJ• ˆÚs—á‚ĚŒŸ“˘. ‹ŕ“cŒĺ˜YC‚‹´r‹BCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`iŠOj: ‘ć55‰ń“ú–{—Տ°ŠO‰ČˆăŠw‰ď‘‰ď i93.11.10j, “Œ‹ž.

1530. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘ŠúˆÝŠŕ‚ɑ΂ˇ‚é“ŕŽ‹‹žŽĄ—Ă‚ĚŒť‹ľ‚ƐŹŃ. “ˆ”ömCŽOd–슰ŠěC”äŠé”\Ž÷iŠOj: ‘ć55‰ń“ú–{—Տ°ŠO‰ČˆăŠw‰ď‘‰ď i93.11.10j, “Œ‹ž, “ú–{—Տ°ŠO‰ČˆăŠw‰ďŽGŽ, 54(‘): 136, 1993

1531. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j • o‹ž‰şƒwƒ‹ƒjƒAC•œp‚ĚŽč‹Z‚Ć–â‘č“_. ŒĂ“cˆę“żC”äŠé”\Ž÷C‹g“c@‹IC‚‹´‹BC‹ŕ“cŒĺ˜YC–x]˜aLCň‰Ć‹v’źC‘ĺ‹{“ŒśCŠ`“cÍiŠOj: ‘ć2‰ńƒNƒŠƒjƒJƒ‹ƒrƒfƒIƒtƒH[ƒ‰ƒ€ i94.02.04j, “Œ‹ž.

1532. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j “ńl‚ōs‚¤‚REŽŽ• o‹ž‰ş’_”X“Eop. ‹ŕ“cŒĺ˜YC‚‹´r‹BCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`iŠOj: ‘ć2‰ńƒNƒŠƒjƒJƒ‹ƒrƒfƒIƒtƒH[ƒ‰ƒ€ i94.02.04j, “Œ‹ž.

1533. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’×ᇐŤ‘ĺ’°‰Š‚É‚¨‚Ż‚é‰ń’°”Xăč–ĺ•Ť‡p‚Ěpouch‚̍H•v. ‘ĺ’J„łCŒĂě—T‰îC‰Ş‘ş—ĽŽqCˆäŒ´ŒúCH“ĄNśC‘ęK‹ĎCĺŒ´÷C”äŠé”\Ž÷iŠOj: ‘ć43‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď i94.02.23j, “Œ‹ž, “ú–{Á‰ťŠíŠO‰ČŠw‰ďŽGŽ, 27(2): 130, 1994.

1534. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj S‘ĺŒŒŠÇZ‚đ—L‚ˇ‚éÇ—á‚ɑ΂ˇ‚élHS”xŽg—p‰ş‚̍‡•šŘœ. ‹g‘ş”Ž–MC•i“cƒC‚—˛˝CÎŒ´şi‹šŠOj: ‘ć93‰ń“ú–{ŠO‰ČŠw‰ď‘‰ď i93.04.22j, ĺ‘ä, “ú–{ŠO‰ČŠw‰ďŽGŽ, 94(—Ő‘): 56, 1993.

1535. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ’×ᇐŤ‘ĺ’°‰Š‚ĚŽčpŽžŠú‚Ć“K‰ž. H“ĄNśC‘ĺ’J„łC‘ęK‹ĎCŒĂ”g‘qŽjŽqC‚‹´r‹BCĺŒ´÷CŠ`“cÍC”äŠé”\Ž÷iŠOj: ‘ć42‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď i93.07.22j, ‘ĺă.

1536. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ˆÝᑑ˘Ý‚đ‚ß‚Ž‚Á‚ā|Push, Pull, Introducer–@‚Ě”äŠr|. Ź—ѐLsiŠOj: ‘ć46‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.09.23j, _ŒË.

1537. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ŠO‰ČŒn‚Š‚çŽčp•”‚Ö‚Ě’ńŒž‚ĆQuality Assurance. Ş–{EiŠOj: ‘ć15‰ń“ú–{Žčp•”ˆăŠw‰ď‘‰ď i93.10.02j, “Œ‹ž, ´˜^W, p.39, 1993.

1538. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj Źl‚̐ć“VŤ’_“šŠg’ŁÇ‚Ě—Ő°•a—Šw“IŒŸ“˘‚Š‚ç‚Ý‚˝Žčp•űj‚ĚŒˆ’č. ŒĂ“cˆę“żC‹g“c@‹IC‚‹´‹BCň‰Ć‹v’źC’Š’ˇ“N–íCÎ“c˜a•vC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć55‰ń“ú–{—Տ°ŠO‰ČˆăŠw‰ď‘‰ď i93.11.10j, “Œ‹ž, “ú—ŐŠOˆă‰ďŽ, 54(‘): 126, 1993.

1539. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j tˆÚAŒăŠĚáŠQ‚̐f’f‚ĆŽĄ—Ă. ź‘ňŽ“TC˛“ĄŒőŽjC”‹´_ˆęC’Š’ˇ“N–íCÎ“c˜a•vC‘ĺ‹{“ŒśCŠ`“cÍiŠOjC’|“ŕN—YC‘ĺ‹v•Ű[li“ŕj: ‘ć29‰ń“ú–{ˆÚAŠw‰ď‘‰ď i93.09.18j, ‹ŕ‘ň, ´˜^W, p.368, 1993.

1540. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ű‘B”X–E“ŕ—˛‹NŤ•a•Ď‚ĚŒŸ“˘. HŽRŒ›‹`C‘ŠŒ´ŹşC•˝–ěiC’|“cC•Đ“c‰Ä–çC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FC‚‹´r‹BiŠOj: ‘ć47‰ń‘—§•a‰@—Ă—{Š‘‡ˆăŠw‰ď i92.11.12j, ‘ĺă.

1541. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –ŤŠÖßƒŠƒEƒ}ƒ`(RA)‚̏Á‰ťŠÇŽčp‚ĚŒŸ“˘i‘ć2•ńj. –Ľ‰YG•FC‘ŠŒ´ŹşC•˝–ěiC’|“cC•Đ“c‰Ä–çC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć47‰ń‘—§•a‰@—Ă—{Š‘‡ˆăŠw‰ď i92.11.13j, ‘ĺă.

1542. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŕŽ‹‹ž“Iƒ|ƒŠƒyƒNƒgƒ~[‚đŽ{s‚ľ‚˝ăsŒ‹’°Ž‰–bŽî‚Ě2—á. ŒĂ”g‘qŽjŽqC‘ŠŒ´ŹşC•˝–ěiC’|“cC•Đ“c‰Ä–çC‰J‹{–ž•śC‹ŕ“cŒĺ˜YC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć47‰ń‘—§•a‰@—Ă—{Š‘‡ˆăŠw‰ď i92.11.13j, ‘ĺă.

1543. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŕŽ‹‹ž“Iƒ|ƒŠƒyƒNƒgƒ~[‚đŽ{s‚ľ‚˝ăsŒ‹’°Ž‰–bŽî‚Ě2—á. ŒĂ”g‘qŽjŽqC‘ŠŒ´ŹşC•˝–ěiC’|“cC•Đ“c‰Ä–çC‰J‹{–ž•śC‹ŕ“cŒĺ˜YC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć47‰ń‘—§•a‰@—Ă—{Š‘‡ˆăŠw‰ď i92.11.13j, ‘ĺă.

1544. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”ńŽŠŒČ”­ŒŠ“űŠŕ‚ĆŽŠŒČ”­ŒŠ“űŠŕ‚Ć‚Ě—Ő°•a—“IŒŸ“˘. HŽRŒ›‹`iŠOjCŽRčƒJƒcŽqCŽR‰şŒhŽqC’†ž—R”üC‹g‰i‚Ü‚ˇ‚݁C‘ě“TŽqi‘—§‘Š–ÍŒ´•a‰@j: ‘ć2‰ń“ú–{“űŠŕŒŸfŠw‰ď‘‰ď i92.11.13j, •Ÿ“‡.

1545. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –ŤŠÖßƒŠƒEƒ}ƒ`ŠłŽŇ‚É‚¨‚Ż‚鉺•”Á‰ťŠÇúE‹Ů‹}Žčp—á‚Ě—Ő°•a—Šw“IŒŸ“˘. ‚‹´r‹BC‘ŠŒ´ŹşC•˝–ěiC’|“cC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`iŠOj: ‘ć54‰ń“ú–{—Տ°ŠO‰ČˆăŠw‰ď‘‰ď i92.11.21j, “Œ‹ž.

1546. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĽó“Ž–ŹƒoƒCƒpƒXŽčp‚̍H•viƒrƒfƒIj. •—ŠÔ”ɁCě~C“V–ě—˛bCÎŒ´şi‹šŠOj: ‘ć93‰ń“ú–{ŠO‰ČŠw‰ď‘‰ď i93.04.00j, ĺ‘ä.

1547. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”j—ô”]“Ž–ŹáŽ‹}ŤŠú‚É‚¨‚Ż‚é”]ŒŒŠÇCO2”˝‰žŤ‚ĚŒŸ“˘. í”Ő‰ĂˆęC‹{â‰Ŕ’ji”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝jC‘ĺ“ä’mCŽOŽ}GˆÉC‘q“c˛C–î“cŒŤŽOi”]ŠOjC–ÎŽč–Ř—R—˘i–ƒj: ‘ć18‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i93.04.23j, ç—t.

1548. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŞŠWŠO“ŽĂ–Źá‘ěŹ‚É‚ć‚é”]“ŒŒƒ‚ƒfƒ‹‚ĚŒŸ“˘. ‹{â‰Ŕ’jCí”Ő‰ĂˆęC“ü‘qŽŒČC“c’†–ö…CŽR“cŸC‘q“c˛CXˆä˝“ńC–î“cŒŤŽOi”]ŠOj: ‘ć18‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i93.04.23j, ç—t.

1549. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j oŒŒ‚É‚Ä”­Ç‚ľ‚˝ganglioglioma‚Ě‚P—á. z–K’m–çCě–ěM”VCˆÉ“Ą”ä˜CŽuC‰ŞGGi”]ŠOjC–ö‰şŽO˜Yi•a—jC–î“cŒŤŽOi”]ŠOj: ‘ć34‰ń“ú–{_Œo•a—Šw‰ďŠwpŒ¤‹†‰ď i93.05.11j, “Œ‹ž.

1550. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Extracerebral leptomeningeal glioma‚Ě‚P—á. ‰ŞGGCě–ěM”VCXˆä˝“ńi”]ŠOjCÔ’ː˝Ćiˆä“c•a‰@jCÄ“Ą•Žui”]ŠOj: ‘ć34‰ń“ú–{_Œo•a—Šw‰ďŠwpŒ¤‹†‰ď i93.05.11j, “Œ‹ž.

1551. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŽĄ–ü‚ƍl‚Ś‚ç‚ę‚˝Glioblastoma‚Ě‚QÇ—á. ‹g“cF—FCě–ěM”VC‘ĺ“ä’mC‰ŞGGCz–K’m–çCˆÉ“Ą”ä˜CŽuC–î“cŒŤŽOi”]ŠOjC–ö‰şŽO˜Yi•a—j: ‘ć34‰ń“ú–{_Œo•a—Šw‰ďŠwpŒ¤‹†‰ď i93.05.11j, “Œ‹ž.

1552. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j úEŤ\“ńŽw’°’×ᇂ̌Ÿ“˘. ’Ë–{GlC’†ŒF‘¸ŽmCâEŠ_˝C÷–{MˆęC–ĺ˜eŒ›C‰Á“ĄNsC“ˆ”ömCŽOd–슰ŠěC˛“ĄŒőŽjC‘ĺ‹{“ŒśCĺŒ´÷C”äŠé”\Ž÷CŠ`“cÍiŠOjC‘꓇í‰ëCâŒű“N ÍC™–{Ÿ•Fi‹~–˝j: ‘ć45‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.05.13j, VŠƒ.

1553. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j • o‹ž‰ş’_“šŽčp‚É‚¨‚Ż‚ép‘OĽp’†’_“š‘˘‰e‚ĚˆÓ‹`. ‹ŕ“cŒĺ˜YC‚‹´r‹BCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`iŠOj: ‘ć45‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.05.13j, VŠƒ.

1554. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŕŽ‹‹žˆÝᑑ˘Ýp‚ĚŒŸ“˘|ŒđŠˇ‰Â”\‚ČPull•űŽŽƒ`ƒ…[ƒu‚ĆPush–@, Introducer–@‚Ě”äŠr|. âEŠ_˝C“ˆ”ömC‹{“ŕ–M_C–ĺ˜eŒ›C‰Á“ĄNsCŽOd–슰ŠěCĺŒ´÷C”äŠé”\Ž÷iŠOj: ‘ć45‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď i93.05.13j, VŠƒ.

1555. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰şŽˆ[•”Ă–ŹŒŒđÇ‚đ•š”­‚ľ‚˝œ”Ő“ŕŽîᇏǗá‚ĚŒŸ“˘. “‡’ÐˇˆęCXŁšŽ÷CŞ–{EC™–ěŽOç’jCĄˆäŒ‰C‹ŕéł‰ŔCˆÉ“Ą—ǐmCŠ`“cÍiŠOj: ‘ć13‰ń“ú–{Ă–ŹŠw‰ď i93.05.14j, Šň•Œ, ´˜^W, p.12, 1993.

1556. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹š’Ĺ‘O‹üˆĘŇ‘Ç‚Ě‚P—á. ŽOˆäŒö•FC“c’†ç•FC´…‹Ĺi”]ŠOjCźX–Mşi‘—§‘Š–ÍŒ´•a‰@j: ‘ć13‰ń“ú–{”]_ŒoŠO‰ČƒRƒ“ƒOƒŒƒX i93.05.20j, •Ÿ“‡.

1557. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŒŒŹ”ťÜ‚Ě“KłŽg—p‚ɂ‚˘‚Ä. ’|“ŕ—LCŹ–{”ü“ށCH“Ą”g—Ż”üC•—ŠÔ‚ ‚Ť‚݁C”Ş–Ř˜a˘Cˆž–ě•ś„i—ŐŒŸjC•y‰i˝ˆęi‹šŠOjCź“c—zi—Ő•a—j: ‘ć41‰ń“ú–{—AŒŒŠw‰ď‘‰ď i93.05.26j, “Œ‹ž, ‘ć41‰ń“ú–{—AŒŒŠw‰ď‘‰ď†, 39(2): 513, 1993.

1558. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j V‘N“€Œ‹ŒŒŸ÷‚ĚŽg—pó‹ľ. Ź–{”ü“ށC’|“ŕ—LCH“Ą”g—Ż”üC•—ŠÔ‚ ‚Ť‚݁C”Ş–Ř˜a˘Cˆž–ě•ś„i—ŐŒŸjCź“c—zi—Ő•a—jC•y‰i˝ˆęi‹šŠOj: ‘ć41‰ń“ú–{—AŒŒŠw‰ď‘‰ď i93.05.26j, “Œ‹ž, ‘ć41‰ń“ú–{—AŒŒŠw‰ď‘‰ď†, 39(2): 513, 1993.

1559. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒƒbƒPƒ‹ŒeŽşŽŠŒą—á28—á‚ĚŒŸ“˘. Î“c˜a•vCŠ“cç”ü”TC’Š’ˇ“N–íC’†ŒF‘¸ŽmC‘ĺ‹{“ŒśCŠ`“cÍiŠOj: ‘ć30‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ď‘‰ď i93.05.26j, ‘ĺă, “ú–{ŹŽ™ŠO‰ČŠw‰ďŽGŽ, 29(3): 528, 1993.

1560. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “űŽ™Šú’Ž‚‰Š‚ĚŒŸ“˘. Š“cç”ü”TCÎ“c˜a•vCŠ`“cÍiŠOj: ‘ć30‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ď‘‰ď i93.05.26j, ‘ĺă, “ú–{ŹŽ™ŠO‰ČŠw‰ďŽGŽ, 29(3): 675, 1993.

1561. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒgŠĚ_Œo‚̕ϐŤ‚ƍĐś‚ÉŠÖ‚ˇ‚é“dŽqŒ°”÷‹ž“IŒ¤‹†. “cŠ•ś•FiŠOjCŽđˆäNOi‰đjCŠ`“cÍiŠOjCŽR‰Čł•˝i‰đj: ‘ć49‰ń“ú–{“dŽqŒ°”÷‹žŠw‰ď i93.05.28j, _ŒË, —\eW, p.122, 1993.

1562. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j cŠuŒ´”­Non-seminomatous germ cell tumor‚ĚŽĄ—ĂŒoŒą. •i“cƒC‹g‘ş”Ž–MC‚—˛˝CÎŒ´şi‹šŠOj: ‘ć10‰ń“ú–{ŒÄ‹zŠíŠO‰ČŠw‰ď‘‰ď i93.06.03j, ç—t, “ú–{ŒÄ‹zŠíŠO‰ČŠwŽGŽ, 7(3): 367, 1993.

1563. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j 20MHz Doppler guidewire‚Ě—L—pŤ‚Ć–â‘č“_. ‹ß“Ą‡‹`C”ź’JĂ—Yi‹šŠOjC‘ź: ‘ć16‰ń“ú–{ƒoƒCƒIƒŒƒIƒƒW[Šw‰ď i93.06.17j, “Œ‹ž, ´˜^W, p.62, 1993.

1564. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘OŠg’ŁŠúŠĽŒŒ—Ź‚Ě•ŞÍ. źŽR´ŒhC”ź’JĂ—Yi‹šŠOjC‘ź: ‘ć16‰ń“ú–{ƒoƒCƒIƒŒƒIƒƒW[Šw‰ď i93.06.17j, “Œ‹ž, ´˜^W, p.65, 1993.

1565. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĽ“Ž–Ź“ŕ—Ź‘Ź‚Ĺ‚Ý‚ç‚ę‚émidsystolic cove‚̐Źˆö‚ÉŠÖ‚ˇ‚錟“˘. ‘q“c“āC”ź’JĂ—Yi‹šŠOjC‘ź: ‘ć16‰ń“ú–{ƒoƒCƒIƒŒƒIƒƒW[Šw‰ď i93.06.17j, “Œ‹ž, ´˜^W, p.66, 1993.

1566. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĽ“Ž–Ź“ŕŽűk‰ŠúspikeóŒŒ—Ź(systolic spike)‚̐Źˆö‚ÉŠÖ‚ˇ‚錟“˘. “‡“cŒúC”ź’JĂ—Yi‹šŠOjC‘ź: ‘ć16‰ń“ú–{ƒoƒCƒIƒŒƒIƒƒW[Šw‰ď i93.06.17j, “Œ‹ž, ´˜^W, p.68, 1993.

1567. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}Ť‰şŽˆ“Ž–Ź•ÂÇŽž‚̍ĩÁ—ŹáŠQ‚ÉŠÖ‚ˇ‚錟“˘|‚Ć‚­‚ɍD’†‹…-“ŕ”ç×–E‘ŠŒÝ”˝‰ž‚ɂ‚˘‚ā|. Ş–{ECXŁšŽ÷C™–ěŽOç’jCĄˆäŒ‰C‹ŕéł‰ŔC“‡’ÐˇˆęCŠ`“cÍiŠOj: ‘ć21‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ď i93.06.18j, “Œ‹ž, “ú–{ŒŒŠÇŠO‰ČŠw‰ďŽGŽ, 2(2): 174, 1993.

1568. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j oŒŒŤƒVƒ‡ƒbƒN‚É‚Ä”­Ç‚ľŒŒŠÇ‘˘‰e‚ސf’f‚É—LŒř‚Ĺ‚ ‚Á‚˝ƒƒbƒPƒ‹ŒeŽş‚Ě1—á. –k‘ş‰ë–çiŠOjC‘ĺ“c„•äC•ˆäŒ¤“ńCă“cN‹vC”~Œ´ŽŔiŽ™jCó—˜–őCâŒű“NÍC‘꓇í‰ëC™–{Ÿ•FC–x’rdŽĄC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć7‰ń“ú–{‹~‹}ˆăŠw‰ď i93.06.26j, “Œ‹ž, ´˜^W, p.10, 1993.

1569. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j oŒŒŤˆÝĽ\“ńŽw’°’×ᇋً}Žčp—á‚ĚŒŸ“˘|“Á‚ÉŽčpŹŃ‚Š‚ç‚Ý‚˝pŽŽ‘I‘đ‚ɂ‚˘‚Ä. ’Ë–{GlCâEŠ_˝C’†ŒF‘¸ŽmC÷–{MˆęC“ˆ”ömCŽOd–슰ŠěC‘ĺ‹{“ŒśCĺŒ´÷C”äŠé”\Ž÷CŠ`“cÍiŠOjC‘꓇í‰ëC™–{Ÿ•Fi‹~–˝j: ‘ć42‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď i93.07.22j, ‘ĺă, “ú–{Á‰ťŠíŠO‰ČŠw‰ďŽGŽ, 26(6): 1625, 1993.

1570. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĚ”X–E‘BŠŕ‚Ě—Ő°•a—Šw“I“Á’Ľ‚ĆŽĄ—Ă. ŒĂ“cˆę“żC‹g“c@‹ICň‰Ć‹v’źC‚‹´‹BC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć42‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď i93.07.22j, ‘ĺă, “ú–{Á‰ťŠíŠO‰ČŠw‰ďŽGŽ, 26(6): 1665, 1993.

1571. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĚ“ŕ’_ŠÇŠŕ‚ĚŒť‹ľ‚Ć“W–]|i“WŒ`ŽŽ‚Š‚ç‚Ý‚˝ŠO‰ČŽĄ—Ïă‚Ě–â‘č“_‚ĆŽĄ—Ă•űj. ň‰Ć‹v’źC‹g“c@‹IC“‡“cŒŞCŒĂ“cˆę“żC‚‹´‹BC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć42‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď i93.07.22j, ‘ĺă, “ú–{Á‰ťŠíŠO‰ČŠw‰ďŽGŽ, 26(6): 1674, 1993.

1572. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒqƒg’ź’°Šŕ×–EŠ”(RKK-I)‚ĚŽ÷—§‚Ć‚ť‚̐Ťó. ‘ęK‹ĎC‰Á“ĄNsCˆäŒ´ŒúC÷–{MˆęiŠOj: ‘ć11‰ń“ú–{ƒqƒg×–EŠw‰ď‘ĺ‰ď i93.08.27j, ĺ‘ä.

1573. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j —A“ü‹r•ÂÇÇ‚̐f’f‚ĆŽĄ—Ă. ŒĂ“cˆę“żCŽOd–슰ŠěCâEŠ_˝C‚‹´ŒúC‘ĺ‹{“ŒśCŠ`“cÍC”äŠé”\Ž÷iŠOj: ‘ć21‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď i93.09.02j, “Œ‹ž, ´˜^W, p.136, 1993.

1574. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “űŠŕÄ”­Œă’ˇŠúś‘ś—á‚ĚŒŸ“˘. ’|’†°KCÎ“c˜a•vC“n•ÓŒ’Ž™CźˆäŒ’C‘D–{TěCŒY•”“ŒŽĄC‘ĺęł›ßCŠ`“cÍiŠOj: ‘ć1‰ń“ú–{“űŠŕŠw‰ď i93.09.03`04j, “Œ‹ž.

1575. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j tˆÚAŽ€–S—á‚ĚŒŸ“˘‚ƍĄŒă‚Ě‘Îô. ˛“ĄŒőŽjCź‘ňŽ“TC”‹´_ˆęC”Ń–ě‘Pˆę˜YCÎ“c˜aŒČC“cŠ•ś•FC’†ŽR‹`‰îCÎ“c˜a•vCŠ`“cÍiŠOjC’|“ŕN—YC‘ĺ‹v•Ű[li“ŕjCŒF–ě˜a—YC^‰şß•vC ‰““Ą’‰—YCŹŽÄŒ’i”ĺjC“n•”_“ńC”–Ř“oi–Ɖuj: ‘ć29‰ń“ú–{ˆÚAŠw‰ď‘‰ď i93.09.17j, ‹ŕ‘ň, —\eW, p.293, 1993.

1576. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ž€‘̐tˆÚA‚É‚¨‚Ż‚éRCMVR‘Ě—zŤƒhƒi[‚ĚŽć‚čˆľ‚˘•ű. ’†ŽR‹`‰îCˆ˘•””\–žCFerix,T. RapaportCź‘ňŽ“TC˛“ĄŒőŽjCŠ`“cÍiŠOj: ‘ć29‰ń“ú–{ˆÚAŠw‰ď‘‰ď i93.09.18j, ‹ŕ‘ň, “ú–{ˆÚAŠw‰ďŽ, 28(—Ő‘): 369, 1993.

1577. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŞŠW“ŕ‰đ—ŁŤ’ōœ“Ž–ŹáŽ‚ĚŒŒŠÇ‘˘‰eŠŒŠ‚ĚŒoŽž“I•Ď‰ť. ŽR“cŸC‘q“c˛C‹{â‰Ŕ’jC“c’†ç•FC–î“cŒŤŽOi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝jCXˆä˝“ńi”]ŠOj: ‘ć52‰ń“ú–{”]_ŒoŠO‰ČŠw‰ď‘‰ď i93.09.20j, “Œ‹ž.

1578. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ź”]G“ƒwƒ‹ƒjƒA‚É”ş‚¤Ň‘‹ó“´Ç‚Ě”­ś‹@˜. ‹kŽ ‘C”Ń“cG•vCŽRč‹`‹éCŽOŽ}GˆÉC–î“cŒŤŽOi”]ŠOj: ‘ć52‰ń“ú–{”]_ŒoŠO‰ČŠw‰ď‘‰ď i93.09.20j, “Œ‹ž.

1579. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Tethered cord syndrome‚Ě•a‘Ԑś—. ”Ń“cG•vC‹kŽ ‘CŽRč‹`‹éC–î“cŒŤŽOi”]ŠOj: ‘ć52‰ń“ú–{”]_ŒoŠO‰ČŠw‰ď‘‰ď i93.09.20j, “Œ‹ž.

1580. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Fast scan‚É‚ć‚éMRI‚đ—p‚˘‚˝”]“Ž–ŹáŽ’Šo–@. ‰““ĄšFC‰iˆäŹŽ÷i”]ŠOj: ‘ć52‰ń“ú–{”]_ŒoŠO‰ČŠw‰ď‘‰ď i93.09.20j, “Œ‹ž.

1581. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Invasive meningioma: ‚ť‚Ě‘B”\‚ĆÄ”­‚ɂ‚˘‚Ä. z–K’m–çCě–ěM”Vi”]ŠOjC‹T’J“Oi•a—jCˆÉ“Ą”ä˜CŽuC‰ŞGGC–î“cŒŤŽOi”]ŠOj: ‘ć52‰ń“ú–{”]_ŒoŠO‰ČŠw‰ď‘‰ď i93.09.21j, “Œ‹ž.

1582. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ÇŒóŤƒ‰ƒgƒP—ô”X–E‚Ě•a—‘gDŠw“IŒŸ“˘|ŒőŒ°‚¨‚ć‚Ń“dŒ°‚É‚ć‚錟“˘|. ‰ŞGGCě–ěM”Vi”]ŠOjC–ö‰şŽO˜Yi•a—jCz–K’m–çC‹g“cF—FCŹ—Ńˆč•vC‘O‘ň_C–î“cŒŤŽOi”]ŠOj: ‘ć52‰ń“ú–{”]_ŒoŠO‰ČŠw‰ď‘‰ď i93.09.21j, “Œ‹ž.

1583. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”j—ô”]“Ž–ŹáŽ‹}ŤŠú‚É‚¨‚Ż‚é”]ŒŒŠÇCO2”˝‰žŤ‚ĚŒŸ“˘. í”Ő‰ĂˆęC‹{â‰Ŕ’ji”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝jC‘ĺ“ä’mCŽOŽ}GˆÉC‘q“c˛C–î“cŒŤŽOi”]ŠOj: ‘ć52‰ń“ú–{”]_ŒoŠO‰ČŠw‰ď‘‰ď i93.09.21j, “Œ‹ž.

1584. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –Ťd–Œ‰şŒŒŽî‚É‚¨‚Ż‚éDŽ_‹…—V‘–ˆöŽq‚Ć‚ľ‚Ä‚ĚPAF, ƒCƒ“ƒ^[ƒƒCƒLƒ“‚ĚŠÖ—^‚ɂ‚˘‚Ä. źX–MşCÄ“Ą”ŽŽmi‘—§‘Š–ÍŒ´•a‰@jC“c’†ç•FCŽOˆäŒö•Fi”]ŠOjCM‘ž—˛•vi‘—§‘Š–ÍŒ´•a‰@j: ‘ć52‰ń“ú–{”]_ŒoŠO‰ČŠw‰ď‘‰ď i93.09.22j, “Œ‹ž.

1585. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ÇŒóŤƒ‰ƒgƒP—ô”X–E‚Ě•úŽËüŠw“IŒŸ“˘. ‰ŞGGCě–ěM”Vi”]ŠOjC›Mˆęi•újCz–K’m–çC‘ˆäł„C‚–쐽C‘ĺ“ä’mC–î“cŒŤŽOi”]ŠOj: ‘ć52‰ń“ú–{”]_ŒoŠO‰ČŠw‰ď‘‰ď i93.09.22j, “Œ‹ž.

1586. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘ĺ’°•Ş‰ťŒ^‘BŠŕ‚Ě—Ő°•a—Šw“IŒŸ“˘. ŒĂ”g‘qŽjŽqCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śC‹ŕ“cŒĺ˜YC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć48‰ń“ú–{‘ĺ’°ăč–ĺ•a—Šw‰ď‘‰ď i93.09.23j, _ŒË.

1587. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘¤•űi“ü–@‚É‚ć‚č‘O•űœˆł‚đŽ{s‚ľ‚˝“ŞŠW’ęŠ×“üÇ‚Ě‚P—á. ŽOˆäŒö•FC“c’†’qŽqCz–K’m–çi”]ŠOjCźX–Mşi‘—§‘Š–ÍŒ´•a‰@jC“c’†ç•FC´…‹Ĺi”]ŠOj: ‘ć47‰ń‘—§•a‰@—Ă—{Š‘‡ˆăŠw‰ď i93.09.30j, ŽD–y.

1588. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”]Ň‘ˆł•Ď‰ť‚̐Ґ‘ŒŒ—Ź—ʂɑ΂ˇ‚é‰e‹ż. ‹š•”‰şs‘ĺ“Ž–ŹŽŐ’fŽž‚̐Ґ‘•ŰŒě‚Ć‚ĚŠÖ˜A. ’ŹˆäłlC•—ŠÔ”ɁCÎŒ´şi‹šŠOj: ‘ć46‰ń“ú–{‹š•”ŠO‰ČŠw‰ď‘‰ď i93.10.00j, ŽD–y.

1589. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰@‚É‚¨‚Ż‚é’Ž‚‰Š‚Ě’´‰š”gŒŸ¸‚ĚˆÓ‹`. ’†‘ş‘בăCo‘q‘PŽl˜YCŽRŒűGŽ÷C“ě‰_Œ÷C“n•Ó”ü“sŽqi‘—§‘Š–ÍŒ´•a‰@jC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć48‰ń‘—§•a‰@—Ă—{Š‘‡ˆăŠw‰ď i93.10.01j, ŽD–y.

1590. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “űƒKƒ“Ä”­“]ˆÚf’f‚É‚¨‚Ż‚éŽîᇃ}[ƒJ[—L—pŤ‚ĚŒŸ“˘. HŽRŒ›‹`C‘ŠŒ´ŹşC‹ß“ĄŒŤŽiCˆî–؉pŽĄC’çCCŒĂ”g‘qŽjŽqC‹ŕ“cŒĺ˜YC‰J‹{–ž•śC–Ľ‰YG•FC‚‹´r‹BiŠOj: ‘ć48‰ń‘—§•a‰@—Ă—{Š‘‡ˆăŠw‰ď i93.10.01j, ŽD–y.

1591. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰@‚É‚¨‚Ż‚éƒCƒŒƒEƒX‚Ě—Ő°“IŒŸ“˘. ‰J‹{–ž•śCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć48‰ń‘—§•a‰@—Ă—{Š‘‡ˆăŠw‰ď i93.10.01j, ŽD–y.

1592. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰@‚É‚¨‚Ż‚é‘Ě•\’´‰š”gŒŸ¸‚Ć•a—Šw“IŒŸő‚Ě”äŠrŒŸ“˘‚ɂ‚˘‚Ä. ŽRŒűGŽ÷Co‘q‘PŽl˜YC“ě‰_Œ÷C’†‘ş‘בăC“n•””ü“sŽqi‘—§‘Š–ÍŒ´•a‰@jC‹ŕ“cŒĺ˜YC‰J‹{–ž•śC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć48‰ń‘—§•a‰@—Ă—{Š‘‡ˆăŠw‰ď i93.10.01j, ŽD–y.

1593. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’_”Xƒ|ƒŠ[ƒvŤ•a•Ď‚ɑ΂ˇ‚é• o‹ž‰ş’´‰š”g‚Ě—L—pŤ. ‹ŕ“cŒĺ˜YC‚‹´r‹BCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`iŠOj: ‘ć48‰ń‘—§•a‰@—Ă—{Š‘‡ˆăŠw‰ď i93.10.01j, ŽD–y.

1594. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j w“ü’źŒă‚Ěˆă—Ă‹@Ší‚Ěƒgƒ‰ƒuƒ‹”­ś‚Ě–â‘č. —é–؍DMCŹźF’jC‚é•ś—YC‚‹´‘Ľ•vC‰Ş–{kˆę˜Yi’†‰›Žčp•”jCŞ–{EiŠOj: ‘ć15‰ń“ú–{Žčp•”ˆăŠw‰ď‘‰ď i93.10.02j, “Œ‹ž, ´˜^W, p.47, 1993.

1595. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j p‘OŒă‚ĚŠĽŒŒŠÇ’ďR‚Š‚ç‚Ý‚˝•Ů’uŠˇp‚Ě•]‰ż|AVR‚ĆMVR‚̑Δä‚É‚¨‚Ż‚錟“˘|. ”ź’JĂ—Yi‹šŠOjC‘ź: ‘ć46‰ń“ú–{‹š•”ŠO‰ČŠw‰ď‘‰ď i93.10.06j, ŽD–y, “ú–{‹š•”ŠO‰ČŠw‰ďŽGŽ, 41: 1993.

1596. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’_ŠÇ×–EŠŕ‚̐i“W‚Ě“Á’Ľ‚ĆŽčpŽĄ—Ă•űj. ‹g“c@‹IC‚‹´‹BCŒĂ“cˆę“żCň‰Ć‹v’źC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć5‰ń“ú–{ŠĚ’_äXŠO‰ČŠw‰ď i93.10.14j, “Œ‹ž, ´˜^W, p.65, 1993.

1597. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j VśŽ™Ň‘d–ŒŠO”^ᇂ̂P—á. ‘O‘ň_C‘ˆäł„C”Ń“cG•vCŽRč‹`‹éC‹kŽ ‘C–î“cŒŤŽOi”]ŠOj: ‘ć28‰ń“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆăŠw‰ď i93.10.15j, Ž­Ž™“‡.

1598. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ň‘‘“ŕŒ‹ŠjŽî‚Ě‚P—á. –kŒ´s—YCŹ—Ńˆč•vi”]ŠOjC’†ŽRŒŤŽiCˆäăŒł•ŰC×’Jr•Fi‘‡‘ž“c•a‰@j: ‘ć28‰ń“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆăŠw‰ď i93.10.15j, Ž­Ž™“‡.

1599. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œz’ĹĽŒz‘‘š‚É‚¨‚Ż‚é“Ş•”ŠO‚̍‡•š. ”Ń“cG•vC‹kŽ ‘i”]ŠOjC–kŒ´F—Yi‹~–˝jCŽRč‹`‹éi”]ŠOjC‘ĺ˜a“c—˛i‹~–˝jC–î“cŒŤŽOi”]ŠOj: ‘ć28‰ń“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆăŠw‰ď i93.10.15j, Ž­Ž™“‡.

1600. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĽ“Ž–Ź“ŕˆł”gŒ`—lŽŽ‚ĚŒŸ“˘|pressure guidewire‚É‚ć‚éŒv‘ށ|. “‡“cŒúC”ź’JĂ—Yi‹šŠOjC‘ź: ‘ć30‰ń“ú–{—Տ°ś—Šw‰ď‘‰ď i93.10.15j, “Œ‹ž, “ú–{—Տ°ś—Šw‰ďŽGŽ, 23(—Ő‘): 100, 1993.

1601. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĽ“Ž–Źˆł‘Ş’č—ppressure guidewire‚Ě—Ő°‰ž—p‚ÉŠÖ‚ˇ‚錟“˘. ‘q“c“āC”ź’JĂ—Yi‹šŠOjC‘ź: ‘ć30‰ń“ú–{—Տ°ś—Šw‰ď‘‰ď i93.10.15j, “Œ‹ž, “ú–{—Տ°ś—Šw‰ďŽGŽ, 23(—Ő‘): 100, 1993.

1602. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘ĺ“Ž–Ź•Ů’uŠˇp‘OŒă‚ĚŠĽzŠÂ“Ž‘Ô‚Ě”äŠr. źŽR´ŒhC”ź’JĂ—Yi‹šŠOjC‘ź: ‘ć30‰ń“ú–{—Տ°ś—Šw‰ď‘‰ď i93.10.15j, “Œ‹ž, “ú–{—Տ°ś—Šw‰ďŽGŽ, 23(—Ő‘): 101, 1993.

1603. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘¤•űi“ü–@‚É‚ć‚č‘O•űœˆł‚đŽ{s‚ľ‚˝“ŞŠW’ęŠ×“üÇ‚Ě‚P—á. ŽOˆäŒö•FC“c’†’qŽqCz–K’m–çi”]ŠOjCźX–Mşi‘—§‘Š–ÍŒ´•a‰@jC´…‹ĹC“c’†ç•Fi”]ŠOj: ‘ć28‰ń“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆăŠw‰ď i93.10.16j, Ž­Ž™“‡.

1604. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Rate stress‚É‚ć‚銼zŠÂŽŠŒČ’˛ß”\‚Ě•]‰ż|Doppler catheter‚đ—p‚˘‚ā|. {“Ą‹ąˆęC”ź’JĂ—Yi‹šŠOjC‘ź: ‘ć30‰ń“ú–{—Տ°ś—Šw‰ď‘‰ď i93.10.16j, “Œ‹ž, “ú–{—Տ°ś—Šw‰ďŽGŽ, 23(—Ő‘): 120, 1993.

1605. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘ĺ’°ŠŕŽĄ–üŘœ—á‚ɑ΂ˇ‚éUFT‚̏pŒă‰ťŠw—Ă–@‚ĚŒŸ“˘. ‘ĺ’J„łiŠOjC“V–ě•xŒOC‘ĺ–ؔɒji‰Ą•lŽs‘ĺjC”\“o—˛CŽO•x—˜•vi“ŒŠC‘ĺjCŽR‘ş‘ě–çišƒ}ƒŠ‘ĺjC‰ŞšćŽmiş˜a‘ĺjCźŽRŒ‰i‰Ą{‰ę‹¤Ď•a‰@jC‚ ‹´r‹BiŠOj: ‘ć31‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď‘‰ď i93.10.27j, ‘ĺă, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ, 28(9): 1304, 1993C“ú–{ŠŕŽĄ—ĂŠw‰ďŽ, 29(2): 160, 1994.

1606. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŽűkŠúŠĽŒŒ—Ź”gŒ`‚Ě•ŞÍ|łíS‚Ć•s‘SS‚̑Δä‚É‚¨‚Ż‚錟“˘|. ”ź’JĂ—Yi‹šŠOjC‘ź: ‘ć34‰ń“ú–{–ŹŠÇŠw‰ď‘‰ď i93.10.28j, –źŒĂ‰Ž, –ŹŠÇŠw, 33(9): 761, 1993.

1607. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĽzŠÂ“Ž‘Ô‚Š‚ç‚Ý‚˝‘ĺ“Ž–Ź•Ů’uŠˇp‚Ě•]‰ż. źŽR´ŒhC”ź’JĂ—YCÎŒ´şi‹šŠOj: ‘ć34‰ń“ú–{–ŹŠÇŠw‰ď‘‰ď i93.10.28j, –źŒĂ‰Ž, –ŹŠÇŠw, 33(9): 762, 1993.

1608. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j —Տ°‚É‚¨‚Ż‚épressure guidewire‚Ě“ÁŤ‚ÉŠÖ‚ˇ‚錟“˘. ‹ß“Ą‡‹`C”ź’JĂ—Yi‹šŠOj: ‘ć34‰ń“ú–{–ŹŠÇŠw‰ď‘‰ď i93.10.28j, –źŒĂ‰Ž, –ŹŠÇŠw, 33(9): 763, 1993.

1609. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}Ť‰şŽˆ“Ž–Ź•ÂÇŽž‚̍ĩÁ—ŹáŠQ‚ÉŠÖ‚ˇ‚錟“˘|‚Ć‚­‚Éno reflowŒťŰ‚ɂ‚˘‚Ä. Ş–{EC“‡’ÐˇˆęCXŁšŽ÷C™–ěŽOç’jCĄˆäŒ‰C‹ŕéł‰ŔCŠ`“cÍiŠOj: ‘ć34‰ń“ú–{–ŹŠÇŠw‰ď i93.10.29j, –źŒĂ‰Ž, –ŹŠÇŠw, 33(9): 863, 1993

1610. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹CŠÇ6ƒŠƒ“ƒO‚̩ǏóŘœ‚đŽ{s‚ľ‚˝‘B—l”X–EŠŕ‚Ě1Žčp—á. •i“cƒC‹g‘ş”Ž–MC‚—˛˝CÎŒ´şi‹šŠOj: ‘ć34‰ń“ú–{”xŠŕŠw‰ď‘‰ď i93.11.09j, “Œ‹ž, “ú–{”xŠŕŠw‰ďŽGŽ, 33(‘‰ď†): 804, 1993.

1611. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}Ť’Ž‚‰Š‚É‚¨‚Ż‚é’´‰š”gŒŸ¸‚Ě—L—pŤ|ŠÓ•Ęf’fĽŽčp“K‰ž‚đŠÜ‚߂ā|. ‰J‹{–ž•śCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć55‰ń“ú–{—Տ°ŠO‰ČˆăŠw‰ď‘‰ď i93.11.10j, “Œ‹ž.

1612. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹlBochdalekEƒwƒ‹ƒjƒA‚ĚŽčp—áiƒrƒfƒIj. ‘ęK‹ĎC‘ĺ’J„łC‚–ě—eKC’çCC‰Ş‘ş—ĽŽqC“ŕ“c‘׎ŠC‘ĺŔ“cŽĄCH“ĄNśCĺŒ´÷C”äŠé”\Ž÷iŠOj: ‘ć55‰ń“ú–{—Տ°ŠO‰ČˆăŠw‰ď‘‰ď i93.11.11j, “Œ‹ž.

1613. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰@”]_ŒoŠO‰Č‚ɉ—‚Ż‚é“ŽŠá_Œo–ƒáƒÇ—á‚Ě•ŞÍ. “c’†ç•FC‘q“c˛C‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOjCŒü–ě˜a—YiŠáj: ‘ć31‰ń“ú–{_ŒoŠá‰ČŠw‰ď i93.11.12j, ‰Ą•l.

1614. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j dÇ“Ş•”ŠO‚Ě‹}Ť“ŞŠW“ŕˆł˜´i‚Ć‚ť‚Ě‘Sg•a‘Ô. ‰““ĄšFC‰iˆäŹŽ÷C“ü‘qŽŒČC‹{â‰Ŕ’ji”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝j: ‘ć21‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ď i93.11.17j, L“‡.

1615. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”]“Ž–ŹáŽ”j—ô‹}ŤŠú‚É‚¨‚Ż‚é”]ŒŒŠÇCO2”˝‰žŤ‚ĚŒŸ“˘. í”Ő‰Ăˆęi”]ŠOjC–kŒ´F—YC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝jCŹ—Ńˆč•vCŽOŽ}GˆÉC‘ĺ“ä’mC‘O‘ň_C‘q“c˛C‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOj: ‘ć21‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ď i93.11.18j, L“‡.

1616. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”]“ŽĂ–ŹŠďŒ`‚É‹Nˆö‚ˇ‚é”]Žş“ŕoŒŒ‚ĚŒŸ“˘. “c’†–ö…C‹{â‰Ŕ’jC‘q“c˛C‘O‘ň_C–î“cŒŤŽOi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝j: ‘ć21‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ď i93.11.18j, L“‡.

1617. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŞŠWŠO“ŽĂ–Źá‘ěŹ‚É‚ć‚é”]“ŒŒ–ŤŠúƒ‚ƒfƒ‹‚ĚŒŸ“˘. í”Ő‰ĂˆęC‹{â‰Ŕ’jCŽR“cŸC“c’†ç•FC“c’†–ö…C“ü‘qŽŒČC‘q“c˛C–î“cŒŤŽOi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝j: ‘ć5‰ń“ú–{”]zŠÂ‘ăŽÓŠw‰ď‘‰ď i93.11.26j, •Ÿ‰Ş.

1618. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “œ”A•aŤ‰óás‚ÉŠÖ‚ˇ‚錟“˘|‚Ć‚­‚Éneuropathic ulcerÇ—á‚ɂ‚˘‚ā|. Ş–{EC“‡’ÐˇˆęCXŁšŽ÷CŠ`“cÍiŠOj: ‘ć28‰ń“ú–{Źl•aŠw‰ď i94.01.15j, “Œ‹ž, “ú–{Źl•aŠw‰ď‰ďŽ, 20: 71, 1994.

1619. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ZÄ”­Œ`ŽŽ‚Š‚ç‚Ý‚˝is’_”XŠŕ‚̊̐Z, ’_ŠÇÄ”­‚ɑ΂ˇ‚éŽčppŽŽ‘I‘đ‚̍H•v‚ĆŽĄ—ÐŹŃ. ‹g“c@‹IC‚‹´‹BCŒĂ“cˆę“żCň‰Ć‹v’źC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć43‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď i94.02.24j, “Œ‹ž, “ú–{Á‰ťŠíŠO‰ČŠw‰ďŽGŽ, 27(2): 520, 1994.

1620. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŕ‘Ÿ’ɏœ‹Ž‚đ–Ú“I‚Ć‚ˇ‚éŒo‹š“I‹šo‹ž‰ş“ŕ‘Ÿ_ŒoŘœp‚ÉŠÖ‚ˇ‚éŠî‘b“IŒŸ“˘. ‚‹´‹BCŠ`“cÍCň‰Ć‹v’źC‹ŕ“cŒĺ˜YCŒĂ“cˆę“żC‹g“c@‹IC‘ĺ‹{“ŒśC”äŠé”\Ž÷iŠOj: ‘ć43‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď i94.02.25j, “Œ‹ž, “ú–{Á‰ťŠíŠO‰ČŠw‰ďŽGŽ, 27(2): 372, 1994.

1621. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠíŽż“IŽžŠł‚É‚ć‚é’°dĎÇ—á‚ĚŒŸ“˘. “n•ÓŒ’Ž™C’Ë–{GlC‘ĺŔ“cŽĄC‰ĄŽR‹žŽqC’Š’ˇ“N–íCź‘ňŽ“TC’|’†°KCÎ“c˜a•vC‘ĺ‹{“ŒśCŠ`“cÍiŠOj: ‘ć22‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď i94.03.10j, •ó’Ë.

1622. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĚŘœŒă‚ɍ‡•š‚ľ‚˝”xŒŒÇÇ—á‚ĚŒŸ“˘. ŒĂ“cˆę“żC‹g“c@‹IC‚‹´‹BCň‰Ć‹v’źCˆÉ“Ą‹`–çC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć22‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď i94.03.10j, •ó’Ë, “ú–{• •”‹~‹}ˆăŠw‰ďŽGŽ, 14(1): 146, 1994.

1623. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ˆÝĽ\“ńŽw’°’×ᇐúE‚ɑ΂ˇ‚鎥—Ă‚Ě‘I‘đ. ’Ë–{GlC“n•ÓŒ’Ž™CâEŠ_˝Cź‘ňŽ“TC‰Á“ĄNsC“ˆ”ömCŽOd–슰ŠěC˛“ĄŒőŽjC‘ĺ‹{“ŒśCĺŒ´÷C”äŠé”\Ž÷CŠ`“cÍiŠOjC‘꓇í‰ëC™–{Ÿ•Fi‹~ –˝j: ‘ć22‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď i94.03.10j, •ó’Ë, “ú–{• •”‹~‹}ˆăŠw‰ďŽGŽ, 14(1): 152, 1994.

1624. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j VśŽ™Ç—á‚đœ‚­ŹŽ™Œ´”­ŤƒCƒŒƒEƒX‚ĚŒŸ“˘. ’Š’ˇ“N–íCÎ“c˜a•vCŒ´‰pC“n•ÓŒ’Ž™Cź‘ňŽ“TCŒĂě—T‰îC‘ĺ‹{“ŒśCŠ`“cÍiŠOj: ‘ć22‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď i94.03.10j, •ó’Ë, “ú–{• •”‹~‹}ˆăŠw‰ďŽGŽ, 14(1): 167, 1994.

1625. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ă’°ŠÇ–Œ“ŽĂ–Ź”P“]Ç‚Ě1Řœ—á. ‰ĄŽR‹žŽqCŒĂ“cˆę“żCň‰Ć‹v’źC‚‹´‹BC‹g“c@‹IC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć22‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď i94.03.10j, •ó’Ë, “ú–{• •”‹~‹}ˆăŠw‰ďŽGŽ, 14(1): 223, 1994.

1626. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j AVM‚É‚¨‚Ż‚錌ŠÇ“ŕˆł‚ĚˆłŒů”z‚ĆˆŐoŒŒŤ|“Á‚É, —ŹoĂ–Ź‚Ě‹ˇó, •ÂÇ—á‚ɂ‚˘‚ā|. ‹{â‰Ŕ’jC‘ĺ“ä’mCŽOŽ}GˆÉC“c’†–ö…C“c’†ç•FCŽR“cŸCí”Ő‰ĂˆęC‘q“c˛C–î“cŒŤŽOi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝j: ‘ć19‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i94.03.11j, ‹ž“s.

1627. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j PTCS—pƒgƒ‰ƒ“ƒyƒbƒg•t‚ŤôňĽ‹zˆřƒ‹[ƒg‚ĚŽg—pŒoŒą. ‹ŕ“cŒĺ˜YC‚‹´r‹BCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`iŠOj: ‘ć94‰ń“ú–{ŠO‰ČŠw‰ď‘‰ď i94.03.29j, “Œ‹ž.

1628. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ä”­Œă’ˇŠúś‘ś—á‚ĚŒŸ“˘. ’|’†°KC“n•ÓŒ’Ž™C‘D–{TěCźˆäŒ’CŒY•”“ŒŽĄCÎ“c˜a•vC‘ĺęł›ßCŠ`“cÍiŠOj: ‘ć94‰ń“ú–{ŠO‰ČŠw‰ď‘‰ď i94.03.29j, “Œ‹ž.

1629. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŽűkŠúŠĽ—Ź‘Ź”gŒ`‚̉đÍ|łíS‚Ć”ě‘ĺS‚Ĺ‚ĚŒŸ“˘|. ”ź’JĂ—Yi‹šŠOjC‘ź: ‘ć58‰ń“ú–{zŠÂŠíŠw‰ď‘‰ď i94.03.29j, “Œ‹ž, Jpn. Circ. J., 58(Suppl.1): 363, 1993.

1630. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –Ťt•s‘S‚É‚ć‚錌‰t“§ÍŠłŽŇ‚Ě• •”ŠO‰ČŽčp‚̏p‘OŠëŒŻˆöŽq‚ƏpŒă‡•šÇ‚Ě‘Îô. ˛“ĄŒőŽjCź‘ňŽ“TC‰Ą“c˜a•FCŽ­Žćł“šC‰ĄŽR‹žŽqC‚–ě—eKC‰Ş‘ş—ĽŽqC’Š’ˇ“N–íC’|’†°KC’Ë–{GlCÎ“c˜a•vC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć94‰ń“ú–{ŠO‰ČŠw‰ď‘‰ď i94.03.30j, “Œ‹ž.

1631. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĽŒŒŠÇŽŠŒČ’˛ß”\‚Š‚ç‚Ý‚˝ŠĽ“Ž–ŹƒoƒCƒpƒXp‚Ě•]‰ż. ”ź’JĂ—Yi‹šŠOjC‘ź: ‘ć94‰ń“ú–{ŠO‰ČŠw‰ď‘‰ď i94.03.30j, “Œ‹ž, “ú–{ŠO‰ČŠw‰ďŽGŽ, (—Ő‘): 260, 1993.

1632. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œo‹š“I‹šo‹ž‰ş“ŕ‘Ÿ_ŒoŘ’fp|“ŕ‘ŸŤáu’ɏœ‹Ž‚Ě‚˝‚߂̐V‚ľ‚˘pŽŽ|. ‚‹´‹BCŠ`“cÍCň‰Ć‹v’źC‹ŕ“cŒĺ˜YCŒĂ“cˆę“żC‹g“c@‹IC‘ĺ‹{“ŒśC”äŠé”\Ž÷iŠOj: ‘ć94‰ń“ú–{ŠO‰ČŠw‰ď‘‰ď i94.03.30j, “Œ‹ž, “ú–{ŠO‰ČŠw‰ďŽGŽ, 95(—Ő‘): 94, 1994

1633. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒgŠĚ_Œo‚̍Đś‚ÉŠÖ‚ˇ‚éŒ`‘ÔŠw“IŒ¤‹†. “cŠ•ś•FiŠOjCŽđˆäNOi‰đjCŠ`“cÍiŠOjCŽR‰Čł•˝i‰đj: ‘ć94‰ń“ú–{ŠO‰ČŠw‰ď‘‰ď i94.03.31j, “Œ‹ž.

1634. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j is’_”XŠŕ‚ɑ΂ˇ‚éŠg‘卪ŽĄŘœ‚̏pŒăQOL|“Á‚ÉŠĚäX“ŻŽžŘœpÇ—á‚Ě—\Œă|. ‹g“c@‹ICŠ`“cÍCŒĂ“cˆę“żCň‰Ć‹v’źC‚‹´‹BC‘ĺ‹{“ŒśC”äŠé”\Ž÷iŠOj: ‘ć94‰ń“ú–{ŠO‰ČŠw‰ď‘‰ď i94.03.31j, “Œ‹ž, “ú–{ŠO‰ČŠw‰ďŽGŽ, 95(—Ő‘): 158, 1994

1635. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆÝ“]ˆÚ‚đ‚Ť‚˝‚ľ‚˝”xG•˝ă”çŠŕ‚Ě1—á. –Ľ‰YG•FC‘ŠŒ´ŹşC•˝–ěiC’|“cC•Đ“c‰Ä–çC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć54‰ń“ú–{—Տ°ŠO‰ČˆăŠw‰ď‘‰ď i92.11.21j, “Œ‹ž.

1636. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j hM-CSF‚ĚŒŒŹ”‘˘ŒŒŒn‚ɑ΂ˇ‚éě—p‚ÉŠÖ‚ľ‚Ä‚ĚŠî‘b“IŒŸ“˘. ‘D–{TěCź‘ňŽ“TC˛“ĄŒőŽjC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć93‰ń“ú–{ŠO‰ČŠw‰ď‘‰ď i93.04.23j, ĺ‘ä.

1637. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰Eă—tŘœ, R2aƒŠƒ“ƒpßŠs´pŒă‰óŽ€Ť‹CŠÇŽx‰Š‚đ•š”­‚ľ‚˝1—á. ‚ŽRr­C•˝ˆäŽO˜Yi‹šŠOjCÎŒ´Ć•vCŒFč’qŽiC˛–ěŒőˆęCŽO“‡GNC˛“ĄOˆęC‰ŹŒ´çŒbŽqC‘PęŒł”üiŠÖ“Œ’üM•a‰@j: ‘ć16‰ń“ú–{‹CŠÇŽxŠw‰ď‘‰ď i93.06.25j, –źŒĂ‰Ž, ‹CŠÇŽxŠw, 15(4): 383.

1638. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘ĺ’°ăO–ѐŤŽîᇎčpÇ—á11—á‚Ě—Ő°•a—Šw“IŒŸ“˘. ŒĂ”g‘qŽjŽqCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śC‹ŕ“cŒĺ˜YC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć42‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď i93.07.23j, ‘ĺă.

1639. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒTƒ‰ƒ]ƒXƒ‹ƒtƒ@ƒsƒŠƒWƒ“, ƒXƒeƒƒCƒh“Š—^‰ş‚Ě–ŤŠÖßƒŠƒEƒ}ƒ`‚ɍ‡•š‚ľ‚˝’×ᇐŤ‘ĺ’°‰Š‚Ě1Žčp—á. ‘ŠŒ´ŹşC•˝–ěiC’|“cC•Đ“c‰Ä–çC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjCˆŔ’BŒŁi“ŕjC“n•”K•vCŽR“cş•vCó”ö• Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć48‰ń“ú–{‘ĺ’°ăč–ĺŠw‰ď‘‰ď i93.09.23j, _ŒË.

1640. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j “–‰@‚É‚¨‚Ż‚éƒ}ƒ“ƒ‚ƒOƒ‰ƒtƒB[CƒGƒR[ŒŸ¸‚đŽĺ‚Ć‚ľ‚˝¸“xŠÇ—‚ĚŽŽ‚݂ɂ‚˘‚Ä. HŽRŒ›‹`iŠOjCo‘q‘PŽl˜YCŽRŒűGŽ÷C“ě‰_Œ÷C’†‘ş‘בăCŽRčƒJƒcŽqCŽR‰şŒhŽqC’†ž—R”üi‘—§‘Š–ÍŒ´•a‰@j: ‘ć3‰ń“ú–{“űŠŕŒŸfŠw‰ď‘‰ď i93.11.18j, “ż“‡.

1641. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j —Տ°ŒŸ¸‹ZŽt‚É‚ć‚é’´‰š”gŒŸ¸‚ɂ‚˘‚Ä‚ĚŒŸ“˘. “ě‰_Œ÷Co‘q‘PŽl˜YCŽRŒűGŽ÷C’†‘ş‘בăCˆÉ“Ąˆ¤C‘Oěˆę]C‘ě“TŽqi‘—§‘Š–ÍŒ´•a‰@jCHŽRŒ›‹`iŠOj: ‘ć3‰ń“ú–{“űŠŕŒŸfŠw‰ď‘‰ď i93.11.18j, “ż“‡.

1642. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j “űŠŕ‚É‚¨‚Ż‚émammographyf’f‚ĚŒŔŠE‚ɂ‚˘‚Ä. “n•ÓŒ’Ž™C’|’†°KCÎ“c˜a•vC‘D–{TěCźˆäŒ’CŒY•”“ŒŽĄC‘ĺęł›ßCŠ`“cÍiŠOj: ‘ć3‰ń“ú–{“űŠŕŒŸfŠw‰ď‘‰ď i93.11.18j, “ż“‡.

1643. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚ŕ‚â‚ŕ‚â•a‚É‚¨‚Ż‚é“ŞŠWŠO“ŕŒz“Ž–Ź•a•Ď‚ĚŒŸ“˘. ‘ˆäł„C‚–؍GC‹{â‰Ŕ’jCí”Ő‰ĂˆęC“c’†–ö…C–î“cŒŤŽOi”]ŠOj: ‘ć19‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i94.03.10j, ‹ž“s.

1644. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒg”]‹•ŒŒŽŔŒąƒ‚ƒfƒ‹‚É‚¨‚Ż‚ébasic fibroblast growth factor(bFGF)“Š—^Œř‰Ę‚ɂ‚˘‚Ä. “c’†–ö…i”]ŠOjCŠŰŽR–ΑPiŽŔ“ŽŒnjCâ–{‚˘‚Â݁CŽOŽ}GˆÉCŽO“‡‘ĺ“żC“’‘ňňCŽR“cŸC“c’†ç•FC‘q“c˛C‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOj: ‘ć19‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i94.03.10j, ‹ž“s.

1645. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”]“Ž–ŹáŽ‚É‹Nˆö‚ˇ‚é“ŽŠá_Œo–ƒáƒ‚ĚŒŸ“˘. “c’†ç•FC‘q“c˛Cí”Ő‰Ăˆęi”]ŠOjC–kŒ´F—Yi‹~–˝jC‹{â‰Ŕ’ji”]ŠOjC‘ĺ˜a“c—˛i‹~–˝jC–î“cŒŤŽOi”]ŠOj: ‘ć19‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i94.03.10j, ‹ž“s.

1646. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒNƒ‚–Œ‰şoŒŒ‚Ĺ”­Ç‚ľ‚˝“ŞŠW“ŕ‰đ—ŁŤ’ōœ“Ž–ŹáŽ|”ńŽčpÇ—á12—á‚ĚŒŸ“˘|. ŽR“cŸC‹{â‰Ŕ’jC‘q“c˛Cí”Ő‰ĂˆęCŽOŽ}GˆÉC–î“cŒŤŽOi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝jCXˆä˝“ńi”]ŠOj: ‘ć19‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i94.03.11j, ‹ž“s.

1647. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j “ŞŠWŠO“ŽĂ–Źá‘ěŹ‚É‚ć‚閝ŤŠú”]“ŒŒƒ‚ƒfƒ‹‚ɂ‚˘‚Ä‚ĚŒŸ“˘. í”Ő‰ĂˆęC‹{â‰Ŕ’jCŽR“cŸC“ü‘qŽŒČC‘q“c˛C–î“cŒŤŽOi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝j: ‘ć19‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i94.03.11j, ‹ž“s.

1648. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j “Ť• •Çፍ­ƒwƒ‹ƒjƒAC•œŢ‚Ć‚ľ‚Ä‚Ě“€Œ‹ŠŁ‘‡ƒqƒgd–Œ‚Ě—L—pŤ. ź‘ňŽ“TC‘ĺ‹{“ŒśC”‹´_ˆęC‰ĄŽR‹žŽqC‚–ě—eKC’Ë–{GlC˛“ĄŒőŽjCŠ`“cÍiŠOj: ‘ć94‰ń“ú–{ŠO‰ČŠw‰ď‘‰ď i94.03.30j, “Œ‹ž, ´˜^W, p.229.

1649. mŠw‰ďi’n•űjn i‹łˆçu‰‰j “ŕŽ‹‹žŽĄ—Áiă•”Á‰ťŠÇŽîᇁj. “ˆ”ömiŠOj: ‘ć6‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď–k—¤ƒZƒ~ƒi[ i94.02.26j, •xŽR, u‰‰—vŽ|W, p.13`22, 1993.

1650. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “ÁˆŮ‚ČÄ”­Œ`ŽŽ‚đ‚Ć‚Á‚˝”S‰tŽYśŤ’_”XŠŕ‚Ě1—á. ‘ŠŒ´ŹşC•˝–ěiC’|“cC•Đ“c‰Ä–çC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć224‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.05.22j, ‰Ą•l.

1651. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “ű‘BŠÇóŠŕ‚Ě1—á. ”‹´‘˘ˆęC’|’†°KC’†ŒF‘¸ŽmC“n•ÓŒ’Ž™CÎ“c˜a•vC‘ĺ‹{“ŒśC‘ĺęł›ßCŠ`“cÍiŠOjCŠâŸşŒ[ˆęi•a—j: ‘ć749‰ńŠO‰ČW’k‰ď i93.06.05j, “Œ‹ž.

1652. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŒÄ‹z˘“ď”­Ç‚ľ‚˝‹CŠÇŒ´”­•˝ŠŠ‹ŘŽî‚Ě1—á. •i“cƒC‹g‘ş”Ž–MC‚—˛˝C“c’†Ž•FC‰e‘ňŒ’ŽiC{“Ą‹ąˆęCÎŒ´şi‹šŠOj: ‘ć65‰ń“ú–{‹CŠÇŽxŠw‰ďŠÖ“ŒŽx•”‰ď i93.06.12j, “Œ‹ž.

1653. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‹CŠÇŠÇóŘœ‚đŽ{s‚ľ‚˝‹CŠÇŒ´”­‘B—l”X–EŠŕ‚Ě1—á. {“Ą‹ąˆęC‹g‘ş”Ž–MC•i“cƒC‚—˛˝C“c’†Ž•FC‰e‘ňŒ’ŽiCÎŒ´şi‹šŠOj: ‘ć86‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i93.06.12j, “Œ‹ž.

1654. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “–‰@‚É‚¨‚Ż‚éă’°ŠÔ–Œ“Ž–ŹÇđÇÇ—á‚ĚŒŸ“˘. ˛“ĄˆęŠěC‹{–{‰p—YCŽíŽq“cŠxŽjCź–{–LiŠOjC•˝“cŒő”Ži‹~–˝jCŹź˝CVˆäLNC‰Ą“c“™C–ĺ˜eŒ›Cź‘ş”ŽsiŠOj: ‘ć81‰ńMBŠO‰ČW’k‰ď i93.06.13j, ’ˇ–ě.

1655. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j • o‹ž‰ş’_”X“Eop‚Ě—Ő°‹y‚Ń‰ć‘œŒo‰ßŠĎŽ@‚É‚¨‚Ż‚錟“˘. ‹ŕ“cŒĺ˜YC‚‹´r‹BCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`iŠOj: ‘ć56‰ń“ú–{“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.18j, “Œ‹ž.

1656. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘SŽüŤ‘e‘ĺŒ‹ßó—˛‹NŤ•a•Ď‚𔺂¤’ź’°”S–Œ’EÇŒóŒQ(MPS)‚Ě1—á. ’çCCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć56‰ń“ú–{“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.18j, “Œ‹ž.

1657. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Colony stimulating factor(CSF)ŽYś”x‹×–EŠŕ‚Ě1Žčp—á. •i“cƒC‹g‘ş”Ž–MC‚—˛˝C“c’†Ž•FCÎŒ´şi‹šŠOj: ‘ć107‰ń“ú–{”xŠŕŠw‰ďŠÖ“Œ•”‰ď i93.06.19j, ˆÉ¨Œ´.

1658. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‹}Ťd–Œ‰şŒŒŽî‚đ’ć‚ľ‚˝”]“ŽĂ–ŹŠďŒ`‚Ě‚P—á. ŽO“‡‘ĺ“żCŽOŽ}GˆÉC‘ˆäł„C‘q“c˛C‹{â‰Ŕ’ji”]ŠOj: ‘ć50‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.26j, “Œ‹ž.

1659. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j H“šŠŕpŒă”畆‹CŠÇᑑ˘ÝŠłŽŇ‚Ě‹CŠÇĽś‘Œz“Ž–Źá‘‚Ě1—á. ’çCiŠOjCźŒűŽ•FCó—˜–őC™–{Ÿ•FC–x’rdŽĄC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć35‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.26j, “Œ‹ž.

1660. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ’°dĎ‚đ‚Ť‚˝‚ľ‚˝Ź’°ƒŠƒ“ƒpŠÇŽî‚Ě1—á. ‰ĄŽR‹žŽqC’Ë–{GlCŠ“cç”ü”TC•˝–ěiC‚–ě—eKC“n•ÓŒ’Ž™C’Š’ˇ“N–íCź‘ňŽ“TCÎ“c˜a•vC˛“ĄŒőŽjC‘ĺ‹{“ŒśCŠ`“cÍiŠOjC“n•Ó´ŽĄi•a—j: ‘ć225‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.07.24j, “Œ‹ž.

1661. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Žq‹{“ŕ–ŒÇ‚É‚ć‚č’ź’°‹ˇó‚đ‚Ť‚˝‚ľ‚˝2Ç—á. ‘ĺŔ“cŽĄC‘哇s•FC’†‘şlLC‹{“ŕ–M_Cź”ŞŽkC“n•Ó—´•FC´…ł•vC’†‘şG•viŠOj: ‘ć225‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.07.24j, “Œ‹ž.

1662. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j œŒ`Ź•s‘SÇ‚É”ş‚Á‚˝“ŞŠW’ęŠ×“üÇ‹y‚ѐҐ‘‹ó“´Ç‚Ě‚Q—á. “c’†’qŽqCz–K’m–çCŽOˆäŒö•Fi”]ŠOjCźX–Mşi‘—§‘Š–ÍŒ´•a‰@jC“c’†ç•Fi”]ŠOj: ‘ć51‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.09.04j, “Œ‹ž.

1663. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “ÁˆŮ‚ČCT‘œ‚đ’ć‚ľ‚˝”˝•œŤ”]“ŕoŒŒ‚Ě‚P—á. â–{‚˘‚Â݁C‘q“c˛C‘ĺ“ä’mC•˝ŽRŽőC‹{â‰Ŕ’ji”]ŠOj: ‘ć51‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.09.04j, “Œ‹ž.

1664. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŠOŤ‹š•”‘ĺ“Ž–Ź‘š‚ĚŠO‰ČŽĄ—Ái”­Ç 24ŽžŠÔ“ŕ hear DOA ‚đŠÜ‚Ţ‹Ů‹}Žčp—á‚ɂ‚˘‚āj. ćѐłŠîCźŒűŽ•FCźŽR´ŒhC•—ŠÔ”ɁC’ŹˆäłlC‘•c“wCÎŒ´şi‹šŠOj: “ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i93.09.11j, “Œ‹ž.

1665. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ’_ŠÇƒ|ƒŠ[ƒv‚đ”F‚ß‚˝Vater“ű“Ş•”Šŕ. •˝ˆäC“ńC‘D–{TěC–ؐěŽOŽl˜YC’ˇ’JěŒ’C’†—˘—F•FC•˝ŠÔŒł”ŽC]’[‰p—˛iŽD–y“żB‰ď•a‰@jCŠ`“cÍiŠOj: ‘ć73‰ń–kŠC“šˆăŠw‘ĺ‰ďŠO‰Č•Ş‰Č‰ď i93.10.02j, ˆŽě.

1666. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰ü—ÇŒ^ƒ_ƒuƒ‹ƒoƒ‹[ƒ“‚đ—p‚˘‚˝• o‹ž•â•‰ş‚róŒ‹’°ŘœpiƒrƒfƒI). ‹ŕ“cŒĺ˜YC‚‹´r‹BCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`iŠOj: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.19`20j, ‰YˆŔ.

1667. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ’‹ŒŤ’°ŽžŠł‚É‚ć‚éƒ|ƒŠƒ|[ƒVƒX“ŕ‚É‚Ý‚ç‚ę‚˝SóŒ‹’°‘Šú‘ĺ’°Šŕ‚Ě1—á. ‹ß“ĄŒŤŽiCˆî–؉pŽĄC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.19j, ‰YˆŔ.

1668. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j H“š‚É”F‚ß‚ç‚ę‚˝”玉‘B‚Ě2—á. ’†ŒF‘¸ŽmC‹ŕ‘ňGŽ÷CˆäŒ´ŒúiŠOjC‰~’n^’mŽqCŹ“‡—m“ńCŽR“cŽŠli“ŕjC”äŠé”\Ž÷CŠ`“cÍiŠOjCÎˆäŒ\‘žCźŒłŽ›Ž—çCŽO•xO”Vi“ŕj: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.19`20j, ‰YˆŔ, —\eW, p.64, 1993.

1669. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Œë‚Á‚ĉşsŒ‹’°‚ɃXƒ‰ƒCƒfƒBƒ“ƒOƒ`ƒ…[ƒu‚Ş›Ć“ü‚ľ‚Ä‚ľ‚Ü‚Á‚˝1—á. Ź‘ňłKC‹v•ŰK—SCÎě~C‚‹´•éiŠOj: ‘ć57‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.20j, ‰YˆŔ.

1670. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Œ´ˆö•s–ž‚Ě‹ó’°‹ˇó‚Ě1—á. ’Š’ˇ“N–íCÎ“c˜a•vCŠ“cç”ü”TC‰|–{‘ń–΁C‘ĺ‹{“ŒśCŠ`“cÍiŠOjC^“ş‘ž˜YiŽ™jCŠâŸşŒ[ˆęi•a—j: ‘ć28‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i93.11.20j, “Œ‹ž.

1671. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘˝”­Ť‘–ŒŽî‚Ě‚P—á. •˝ŽRŽőCâ–{‚˘‚Â݁C‘ĺ“ä’mC‘q“c˛Cě–ěM”Vi”]ŠOj: ‘ć52‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i93.11.27j, “Œ‹ž.

1672. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰óŽ€Œ^‹•ŒŒŤ‘ĺ’°‰Š‚Ɛf’f‚ľ‚˝1—á. –x]˜aLCˆÉ“Ą‹`–çC‰FˆäF‘ž˜YC‘OěŒö’jiŠOjCů–{‚Ý‚ä‚ŤCŽ›ÎŒOC’†‰p’ji•a—j: ‘ć751‰ńŠO‰ČW’k‰ď i93.11.27j, ‰Ą•l.

1673. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j \“ńŽw’°‚Ć‹ó’°‚É‘˝”­‚ľ‚˝•˝ŠŠ‹ŘŽî‚Ě‚P—á. ’çCCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjCÎěŽĺĹCˆŔ’BŒŁi“ŕjC“n•”K•vCˆ˘•”–ž ˜YCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć26‰ń_“ŢěŒ§Á‰ťŠí•aˆăŠw‰ď‘‰ď i93.11.27j, ‰Ą•l.

1674. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˆÝ‚É“]ˆÚ‚đ—ˆ‚ľ‚˝“űŠŕ‚Ě1—á. ˛–ؐLˆę˜YC’|’†°KCŽRŒű—Tˆę˜YCŞ–{—YŽĄC“ŕ“ĄCC‚–ě—eKC“n•ÓŒ’Ž™C’Ë–{GlCÎ“c˜a•vC‘ĺ‹{“ŒśC‘ĺęł›ßCŠ`“cÍiŠOjCŠâŸşŒ[ˆęi•a—j: ‘ć751‰ńŠO‰ČW’k‰ď i93.11.27j, ‰Ą•l.

1675. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ’˜‚ľ‚˘ÎŠD‰ť‚𔺂Á‚˝ˆÝŠŕ‚Ě1—á. ’†‘şlLC‘哇s•FC´…ł•vC“n•Ó—´•FCź”ŞŽkC‘ĺŔ“cŽĄC’†‘şG•viŠOj: é‹ĘŒ§ŠO‰Čˆă‰ď i93.11.27j, é‹Ę, ´˜^W, p.17, 1993.

1676. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –Ťt•s‘S‡•š‚Ě’_ŠÇŠŕ‚Ě1Žčp—á. Ž­Žćł“šC’Ë–{GlC“ŕ“ĄCC’Ň—şěC‚–ě—eKCź‘ňŽ“TC’|’†°KC˛“ĄŒőŽjC‘ĺ‹{“ŒśCŠ`“cÍiŠOj: ‘ć227‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.12.04j, “Œ‹ž.

1677. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˆÝŒ´”­‹‘ĺ•˝ŠŠ‹Ř‰čŽî‚Ě1—á. •˝“cŒő”Ži‹~–˝jC‰Ą“c“™iŠOjCÎ•‹§Žji–kM‘‡•a‰@jCź–{–LC˛“ĄˆęŠěiŠOjCŹź˝i–kM‘‡•a‰@jCVˆäLNiŠOjC‹{–{‰p—Yi–kM‘‡•a ‰@jC–ĺ˜eŒ›iŠOjCź‘ş”ŽsC“’–{“Œ‹gi–kM‘‡•a‰@j: ‘ć82‰ńMBŠO‰ČW’k‰ď i93.12.05j, ź–{.

1678. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j • •”‚ÉŒŔ‹Ç‚ľ‚˝‰đ—ŁŤ‘ĺ“Ž–ŹáŽ‚Ě1ŽĄŒą—á. Ş–{—YŽĄCŞ–{ECXŁšŽ÷C“‡’ÐˇˆęCŠ`“cÍiŠOj: ‘ć1‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i93.12.25j, “Œ‹ž, ´˜^W, p.20, 1993.

1679. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “–‰@‚É‚¨‚Ż‚é‹}Ť’Ž‚‰Š‚ĚŒŸ“˘. ‘ĺŔ“cŽĄCź”ŞŽkC’†‘şlLC‹{“ŕ–M_C“n•Ó—´•FC´…ł•vC‘哇s•FC’†‘şG•viŠOj: ‘ć31‰ńé‹ĘŒ§ˆăŠw‰ď‘‰ď i94.01.23j, ‰Y˜a.

1680. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘ĺ’°ƒ|ƒŠ[ƒvŠŕ‚Š‚猊‚˝“ŕŽ‹‹žŽĄ—Ă‚ĚŒŸ“˘. ‹{“ŕ–M_C‘哇s•FC´…ł•vC“n•Ó—´•FCź”ŞŽkC‘ĺŔ“cŽĄC’†‘şlLC’†‘şG•viŠOj: ‘ć31‰ńé‹ĘŒ§ˆăŠw‰ď‘‰ď i94.01.23j, ‰Y˜a, —\eW, p.72, 1994.

1681. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j d–Œ“ŽĂ–ŹŠďŒ`‚É‚ć‚é‹}Ťd–Œ‰şŒŒŽî‚Ě‚P—á. ŽO“‡‘ĺ“żi”]ŠOjC–kŒ´F—Yi‹~–˝jCí”Ő‰ĂˆęC‘ĺ“ä’mi”]ŠOjC‘ĺ˜a“c—˛i‹~–˝jC‘q“c˛C‹{â‰Ŕ’ji”]ŠOj: ‘ć36‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ď i94.02.05j, “Œ‹ž.

1682. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘ŤŞŠÇÇŒóŒQ‚Ě•a‘Ô. “’‘ňňCŽOŽ}GˆÉCŽRč‹`‹éC”Ń“cG•vC‹kŽ ‘i”]ŠOj: ‘ć53‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i94.02.05j, “Œ‹ž.

1683. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŠOŤŇ‘‹ó“´Ç‚Ě‚P—á. “c’†’qŽqCŽOˆäŒö•FCz–K’m–çi”]ŠOjCźX–Mşi‘—§‘Š–ÍŒ´•a‰@j: ‘ć53‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠÖ“Œ’n•ű‰ď i94.02.05j, “Œ‹ž.

1684. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘m–X•ŮlH•Ůi‹@‰ď•Ůj’uŠˇpŒă‚̍ś–[“ŕ•‚—VŒŒđÇ‚Ě‚P—á. ‹{‰i–ÎŽ÷C’ŹˆäłlCćѐłŠîCŽOD–LCźŽR´ŒhC•—ŠÔ”ɁCÎŒ´şi‹šŠOj: ‘ć89‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i94.02.19j, ‰Ą•l.

1685. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰şsŒ‹’°ŠŕpŒă‚É”­ś‚ľ‚˝ŠĚ–ĺ•”ŽîᇂĚ1—á. ů–{_C’Ë–{GlC˛“ĄŒőŽjCÎˆäŒ’ˆę˜YC–Lě‹MŽiCŒĂě—T‰îCź‘ňŽ“TC‘ĺ‹{“ŒśCŠ`“cÍiŠOjC‘ĺ•”˝i•a—j: ‘ć228‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i94.02.26j, “Œ‹ž.

1686. mŒ¤‹†‰ďi‘Űjn iˆę”ʍu‰‰j Curative endoscopic tumor-therapy of the stomach. “ˆ”ömC”äŠé”\Ž÷CĺŒ´÷CŽOd–슰ŠěiŠOj: Joint Meeting German Society for Surgery Japan Surgical Society i93.06.30j, ç—t, —\eW, p.51, 1993.

1687. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Stage•Ę‚É‚Ý‚˝\“ńŽw’°“ű“Ş•”Šŕ‚ĚŽčppŽŽ. Š“cç”ü”TC‹g“c@‹ICň‰Ć‹v’źC—é–ؐł“šC‰Ą“c“™CŒĂ“cˆę“żC˛“ĄŒőŽjC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć21‰ń“ú–{’_“šŠO‰ČŒ¤‹†‰ď i92.05.28j, ŽD–y.

1688. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŒăŠ˛–ŔŘ‚đ•t‰Á‚ľ‚˝linear gastrectomy‚ĚŽŽ‚Ý. –Ľ‰YG•FC‘ŠŒ´ŹşC•˝–ěiC’|“cC•Đ“c‰Ä–çC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć5‰ń“ú–{“ŕŽ‹‹ž‰şŽčpŽč‹ZŒ¤‹†‰ď i93.01.29j, ‰Ą•l.

1689. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‰đ—ŁŤ’ōœ“Ž–ŹáŽ‚ĚŽĄ—Ïă‚Ě–â‘č“_. ŽR“cŸC‘q“c˛C‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝j: ‘ć22‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŒ¤‹†‰ď i93.04.20j, b•{.

1690. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Œă“ŞŠWâ|d–Œ“ŽĂ–ŹŠďŒ`‚Ćvenous ischemia. ‘q“c˛C‹{â‰Ŕ’jCí”Ő‰ĂˆęC‹g“cF—FC‘ˆäł„CŽR“cŸC‘ĺ“ä’mCŽOŽ}GˆÉC–î“cŒŤŽOi”]ŠOjC›Mˆęi•új: ‘ć22‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŒ¤‹†‰ď i93.04.20j, b•{.

1691. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Ă–ŹŤŒŒŠÇŠďŒ`‚𔺂Á‚˝Ź”]oŒŒ‚ĚŽĄ—Ă. “c’†–ö…C‹{â‰Ŕ’jC‘q“c˛Cí”Ő‰ĂˆęC‘ˆäł„C‰iˆäŹŽ÷C–î“cŒŤŽOi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝j: ‘ć22‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŒ¤‹†‰ď i93.04.20j, b•{.

1692. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ”]Š˛•”cavernous angioma‚ĚŽŠ‘RŒo‰ß. í”Ő‰ĂˆęC‹{â‰Ŕ’jC‘ĺ“ä’mCŽOŽ}GˆÉC‘q“c˛C‘ĺ‚O–ŤC–î“cŒŤŽOi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝jC›Mˆęi•újC_“c’źi“ŕj: ‘ć22‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŒ¤‹†‰ď i93.04.21j, b•{.

1693. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Œă“ŞŠWâ|AVM‚ɑ΂ˇ‚é“Eop. ‹{â‰Ŕ’jC“c’†–ö…C‰iˆäŹŽ÷C‘q“c˛Cí”Ő‰ĂˆęCŽOŽ}GˆÉC‘ĺ“ä’mC–î“cŒŤŽOi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝j: ‘ć22‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŒ¤‹†‰ď i93.04.21j, b•{.

1694. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Invasive meningioma: ‚ť‚Ěbiological behavior‚ɂ‚˘‚Ä. z–K’m–çCě–ěM”VCˆÉ“Ą”ä˜CŽuC‰ŞGGC–î“cŒŤŽOi”]ŠOjC‹T’J“Oi•a—j: ‘ć11‰ń“ú–{”]Žîᇕa—Œ¤‹†‰ď i93.05.09j, “Œ‹ž.

1695. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Astrocytic tumor‚Ě‘gDŠw“Igrading‚Ć—\Œă‚Ć‚ĚŠÖŒW‚ɂ‚˘‚Ä. ě–ěM”VC‘ĺ“ä’mCz–K’m–çC‰ŞGGCˆÉ“Ą”ä˜CŽuC–î“cŒŤŽOi”]ŠOj: ‘ć11‰ń“ú–{”]Žîᇕa—Œ¤‹†‰ď i93.05.09j, “Œ‹ž.

1696. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Hemangioblastoma‚̖Ɖu‘gDŠw“I“dŒ°“IŒŸ“˘. ŹźˆęOi”]ŠOjC–ö‰şŽO˜Yi•a—jC‘ĺ“ä’mCě–ěM”Vi”]ŠOj: ‘ć11‰ń“ú–{”]Žîᇕa—Œ¤‹†‰ď i93.05.09j, “Œ‹ž.

1697. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Intracranial angiolipoma‚Ě‚P—á. ‘ĺ“ä’mCě–ěM”VC‘O‘ň_C‚–쐽C‘q“c˛C–î“cŒŤŽOi”]ŠOjC‹T’J“Oi•a—j: ‘ć11‰ń“ú–{”]Žîᇕa—Œ¤‹†‰ď i93.05.09j, “Œ‹ž.

1698. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ’_”XŠŕ‚̐i“W‚Š‚ç‚Ý‚˝ŘœpŽŽ‘I‘đ‚Ě‘Ă“–Ť‚Ć“W–]. ‹g“c@‹ICŠ`“cÍC“‡“cŒŞCˆÉ“Ą‹`–çCŒĂ“cˆę“żCň‰Ć‹v’źC‹ŕ“cŒĺ˜YC‚‹´‹BC‘ĺ‹{“ŒśC”äŠé”\Ž÷iŠOj: ‘ć22‰ń“ú–{’_“šŠO‰ČŒ¤‹†‰ď i93.05.13j, ˛‰ę, ƒvƒƒV[ƒfƒBƒ“ƒOƒX, p.234, 1993.

1699. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j äXŠŕ‚Ć‚ĚŠÓ•Ę‚Ş“ď‚ľ‚­Řœ‚Ć‚Č‚Á‚˝–ŤäX‰ŠÇ—á‚ĚŒŸ“˘. ‹g“c@‹ICŠ`“cÍCŒĂ“cˆę“żCŠ“cç”ü”TCň‰Ć‹v’źC’Ë–{GlC‚‹´‹BC˛“ĄŒőŽjC‘ĺ‹{“ŒśiŠOj: ‘ć19‰ń“ú–{äXŘŒ¤‹†‰ď i93.05.21j, ‰Ą•l, ´˜^W, p.48, 1993.

1700. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒqƒgŠĚ‚É‚¨‚Ż‚éPGP9,5‚đ—p‚˘‚˝ƒOƒŠƒ\ƒ“Œn_Œo‚̖Ɖu‘gD‰ťŠw“IŒŸő‚ĚˆÓ‹`. “cŠ•ś•FCŠ`“cÍC‹g“c@‹ICŒĂ“cˆę“żC‚‹´‹BCň‰Ć‹v’źC‘ĺ‹{“ŒśiŠOj: ŒúśČ“Á’莞ŠłŠĚ“ŕŒ‹ÎÇ’˛¸Œ¤‹†”Ç•˝Ź5”N“x‘ć1‰ń”ljď‹c i93.06.04j, “Œ‹ž, •˝Ź5”N“xŒ¤‹†•ń‘.

1701. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ”j—ô”]“Ž–ŹáŽ‹}ŤŠú‚É‚¨‚Ż‚ép’†CO2”˝‰žŤ‚ĚŒŸ“˘. í”Ő‰Ăˆęi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝jC‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOj: ‘ć6‰ń”]Ž€Ľ”]‘hśŒ¤‹†‰ď i93.06.12j, ‰F•”.

1702. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‹š’Ĺ‘O‹üˆĘŇ‘Ç‚Ě‚P—á. ŽOˆäŒö•FC“c’†ç•FC´…‹Ĺi”]ŠOjCźX–Mşi‘—§‘Š–ÍŒ´•a‰@jC’ˇ’JěˆęŽqCaˆä—߈ęi“ŕj: ‘ć8‰ń“ú–{Ň‘ŠO‰ČŒ¤‹†‰ď i93.06.26j, ‘ĺă.

1703. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Œz‘“Ž‘Ô‚É‚ć‚č”­ś‚ˇ‚鐑“ŕshearing force‚Ě•Ş•z. ”Ń“cG•vC‹kŽ ‘CŽRč‹`‹éC–kŒ´s—YC–î“cŒŤŽOi”]ŠOj: ‘ć8‰ń“ú–{Ň‘ŠO‰ČŒ¤‹†‰ď i93.06.26j, ‘ĺă.

1704. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Œă“ŞŠWâ|Žîᇂɔş‚¤Ň‘‹ó“´Ç‚ĚŒŸ“˘. ‹kŽ ‘i”]ŠOjCŒ´“cvŽmiă‘ĺjCŽR“cŽĄsiŽY‹Ćˆă‘ĺjCŽR“c”ŽĽiˆ¤’mˆă‘ĺjCˆ˘•”rşiŽœŒbˆă‘ĺj: ‘ć8‰ń“ú–{Ň‘ŠO‰ČŒ¤‹†‰ď i93.06.26j, ‘ĺă.

1705. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŠÓ•Ęf’f‚ލ˘“ď‚Ĺ‚ ‚Á‚˝Ň‘‰Ą’fÇŒóŒQ‚Ě‚P—á. ‘O‘ň_C”Ń“cG•vC‹kŽ ‘C‚–쐽C‰iˆäŹŽ÷C–î“cŒŤŽOi”]ŠOj: ‘ć8‰ń“ú–{Ň‘ŠO‰ČŒ¤‹†‰ď i93.06.26j, ‘ĺă.

1706. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j \“ńŽw’°ZˆÝŠŕ‚ɑ΂ˇ‚é“ŕŽ‹‹ž“I‹…•””˝“]–@‚Ě—L—pŤ. ÷–{MˆęCŽOd–슰ŠěC‚‹´ŒúCâEŠ_˝C˛“Ą–΁C’Ë–{GlC–ĺ˜eŒ›C‰Á“ĄNsC“ˆ”ömCĺŒ´÷C”äŠé”\Ž÷iŠOj: ‘ć61‰ńˆÝŠŕŒ¤‹†‰ď i93.07.02j, ‹v—Ż•Ä.

1707. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰@‚Ĺ‚Ě—H–ĺ—Ö‰ˇ‘śäX“ޏ\“ńŽw’°Řœ3—á‚ĚŒoŒą. ˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć21‰ń“Œ‹ž’n‹ć‘—§•a‰@ŠO‰ČŒ¤‹†‰ď i93.07.03j, “Œ‹ž.

1708. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j pŒă8”NˆČăś‘ś‚ľ‚˝ŠĚŠŕŘœÇ—á‚ĚŒŸ“˘. —§ÎWC‹g“c@‹IC‚‹´‹BCň‰Ć‹v’źCŒĂ“cˆę“żCâEŠ_˝CˆÉ“Ą‹`–çC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć29‰ń“ú–{ŠĚŠŕŒ¤‹†‰ď i93.07.15j, ‘ĺă, —vŽ|W, p.45, 1993.

1709. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ’°œ“ŽĂ–Ź•ÂÇŒă, • •”‘ĺ“Ž–ŹáŽ‚Ě”j—ô‚đ‚Ť‚˝‚ľ‚˝Behcet•a‚Ě‚P—á. źŽR’ź‹vCŞ–{EC“‡’ÐˇˆęCXŁšŽ÷C™–ěŽOç’jCĄˆäŒ‰C‹ŕéł‰ŔCŠ`“cÍiŠOj: ‘ć13‰ńŒŒŠÇŠO‰Č‡“ŻŒ¤‹†‰ď i93.07.17j, –źŒĂ‰Ž, —\eW, p.5, 1993.

1710. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ––ŠúŠŕ‚É‚¨‚Ż‚éÝ‘îĂ–Ź‰h—{‚ĚŒoŒą. âEŠ_˝C‘ĺ’J„łC‘ęK‹ĎC”äŠé”\Ž÷iŠOj: ‘ć4‰ńÝ‘îŠŕŽĄ—ĂŒ¤‹†‰ď i93.08.07j, “Œ‹ž.

1711. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j • o‹ž‰ş’_“šŽčp‚É‚¨‚Ż‚é’_“š‘˘‰e—pƒoƒ‹[ƒ“ƒJƒe[ƒ^[‚̉ü—Ç‹y‚Ń‚ť‚Ě—L—pŤ. ‹ŕ“cŒĺ˜YC‚‹´r‹BCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`iŠOj: ‘ć6‰ń“ŕŽ‹‹ž‰şŠO‰ČŽčpŒ¤‹†‰ď i93.09.03j, •ó’Ë.

1712. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j • o‹ž‰ş’_”X“Eop‚̍‡•šÇ‚Ć‘Îô. ŒĂ“cˆę“żC‹g“c@‹IC”äŠé”\Ž÷C‚‹´‹BCň‰Ć‹v’źC‘ĺ‹{“ŒśC•Đ“c‰Ä–çC—§ÎWC–Ř‘ş“OC˛–ؐLˆę˜YC’†‘şlLCŠ`“cÍiŠOj: ‘ć6‰ń“ŕŽ‹‹ž‰şŠO‰ČŽčpŒ¤‹†‰ď i93.09.03j, •ó’Ë, ´˜^W, p.76, 1993.

1713. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĚäX“ŻŽžŘœŒŔŠE‚ÉŠÖ‚ˇ‚éŠî‘b“I, —Տ°“IŒ¤‹†. ‹g“c@‹ICň‰Ć‹v’źCŒĂ“cˆę“żC‚‹´‹BC‘ĺ‹{“ŒśCŠ`“cÍiŠOj: ŒúśČ‚Ş‚ńŒ¤‹†•Ź‹ŕ’_“šŠŕ, äX“Ş•”Šŕ‚ĚŠg‘ĺŘœ‚É‚¨‚Ż‚鍪ŽĄŤ‚ĆˆŔ‘SŤŒüă‚ÉŠÖ‚ˇ‚錤‹†”Ç‘ć1‰ń”ljď‹c i93.09.08j, “Œ‹ž.

1714. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ––ŠúˆÝŠŕ‚É‚¨‚Ż‚éÝ‘îĂ–Ź‰h—{‚ĚŒoŒą. âEŠ_˝C‘ĺ’J„łC‘ęK‹ĎC”äŠé”\Ž÷iŠOj: ‘ć8‰ńÝ‘îĂ–Ź‰h—{(HPN)Œ¤‹†‰ď i93.09.18j, ‰Ą•l.

1715. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j äX“ޏ\“ńŽw’°Řœp‚É‚¨‚Ż‚éäX‹ó’°•Ť‡‚̍H•v‚Ć‘Šú‡•šÇ‚ĚŒŸ“˘. ‹g“c@‹IC‚‹´‹BCŒĂ“cˆę“żCň‰Ć‹v’źC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć20‰ń“ú–{äXŘŒ¤‹†‰ď i93.11.18j, ‘ĺă, ´˜^W, p.70, 1993.

1716. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŠOŒz“Ž–ŹŒn’´‘I‘đ“IÇđp‚ĚŠëŒŻŤ‚ɂ‚˘‚Ä. “c’†ç•FC‘q“c˛C“c’†–ö…C‘ĺ“ä’mCâ–{‚˘‚Â݁C“’‘ňňC‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOjC›Mˆęi•új: ‘ć9‰ń“ú–{”]_ŒoŒŒŠÇ“ŕŽčpŒ¤‹†‰ď i93.11.21j, ĺ‘ä.

1717. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‘I‘đ“IÇđp‚Ş—LŒř‚Ĺ‚ ‚Á‚˝“ŞŠW’ęœÜ‚É”ş‚¤•@oŒŒ‚Ě‚QÇ—á. ŽOŽ}GˆÉC‘q“c˛C“c’†ç•FC‘ĺ“ä’mCí”Ő‰Ăˆęi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝jC‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOjC›Mˆęi•új: ‘ć9‰ń“ú–{”]_ŒoŒŒŠÇ“ŕŽčpŒ¤‹†‰ď i93.11.21j, ĺ‘ä.

1718. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŠOŤCCFŒă‚̍d–Œ“ŽĂ–Źá‘‚Ě”­’B‚ɂ‚˘‚Ä. ‘ĺ“ä’mC‘q“c˛C“c’†ç•FC‹{â‰Ŕ’jC–î“cŒŤŽOCŽOŽ}GˆÉi”]ŠOjC–kŒ´F—Yi‹~–˝jC›Mˆęi•új: ‘ć9‰ń“ú–{”]_ŒoŒŒŠÇ“ŕŽčpŒ¤‹†‰ď i93.11.22j, ĺ‘ä.

1719. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j “ŕŒz“Ž–Ź‹‘ĺ“Ž–ŹáŽ‚ɑ΂ˇ‚éBalloon occlusion test‚Ě–â‘č“_. “c’†ç•FC‘q“c˛C“c’†–ö…CŽR“cŸC‘ĺ“ä’mCŽO“‡‘ĺ“żC‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOjC›Mˆęi•új: ‘ć9‰ń“ú–{”]_ŒoŒŒŠÇ“ŕŽčpŒ¤‹†‰ď i93.11.22j, ĺ‘ä.

1720. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j “ŕŒz“Ž–Ź•ÂÇƒeƒXƒg‚É‚¨‚Ż‚éback pressure‘Ş’čˆÓ‹`‹y‚Ń‚ť‚Ě•]‰ż. ‘q“c˛C‘ĺ“ä’mC“c’†ç•FC‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOjC›Mˆęi•új: ‘ć9‰ń“ú–{”]_ŒoŒŒŠÇ“ŕŽčpŒ¤‹†‰ď i93.11.22j, ĺ‘ä.

1721. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‰–Ž_ƒyƒpƒxƒŠƒ“ŠĽ“Ž–Ź“ŕ“Š—^‚ދǏŠS‹Ř‚É‹y‚Ú‚ˇ‰e‹ż|ŠĽ—\”ő”\‘Ş’č‚ĚˆŔ‘SŤ|. ‹ß“Ą‡‹`C›Œ´ŠîWi“Œ—ˆă‘ĺjC”ź’JĂ—Yi‹šŠOj: ‘ć18‰ńzŠÂŠíŒn‚É‚¨‚Ż‚é—Ź‚ę‚ĚŒv‘Ş, •]‰ż, §Œä‚ÉŠÖ‚ˇ‚錤‹†‰ď i93.12.11j, “Œ‹ž.

1722. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĚŘœpŒă‚ĚŒŒ‰tň‰ť—Ă–@‚̉ž—p. ŒĂ“cˆę“żCŠ`“cÍC‹g“c@‹ICň‰Ć‹v’źC‚‹´‹BC‘ĺ‹{“ŒśCˆÉ“Ą‹`–çiŠOj: ŒúśČ‚Ş‚ńŒ¤‹†•Ź‹ŕ|’_“šŠŕ, äX“Ş•”Šŕ‚ĚŠg‘ĺŘœ‚É‚¨‚Ż‚鍪ŽĄŤ‚ĆˆŔ‘SŤŒüă‚ÉŠÖ‚ˇ‚錤‹†”Ç‘ć2‰ń”ljď‹c i93.12.15j, “Œ‹ž.

1723. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĚ“ŕŒ‹ÎÇ‚É‚¨‚Ż‚éŠĚ“ŕ_Œo‚Ě•a‘Ô‚ÉŠÖ‚ˇ‚錤‹†. “cŠ•ś•FCŠ`“cÍC‹g“c@‹ICŒĂ“cˆę“żC‚‹´‹BCň‰Ć‹v’źC‘ĺ‹{“ŒśiŠOj: ŒúśČ“Á’莞Šł|ŠĚ“ŕŒ‹ÎÇ’˛¸Œ¤‹†”Ç•˝Ź5”N“x‘ć2‰ń”ljď‹c i93.12.17j, ‘ĺă, •˝Ź5”N“xŒ¤‹†•ń‘.

1724. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j tˆÚAŒăŠĚáŠQ‚̐f’f‚ĆŽĄ—Ă. ź‘ňŽ“TC˛“ĄŒőŽjC”‹´_ˆęC’Š’ˇ“N–íC’†ŽR‹`‰îCÎ“c˜a•vCŠ`“cÍiŠOjC’|“ŕN—Yi“ŕjCŒF–ě˜a—YC‰““Ą’‰—Yi”ĺjC‘ĺ‹v•Ű[li“ŕj: ‘ć27‰ń“ú–{tˆÚA—Տ°Œ¤‹†‰ď i94.01.28j, ’ˇč.

1725. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j tˆÚAŒăŽ€–S—á‚ĚŒŸ“˘‚ƍĄŒă‚Ě‘Îô. ˛“ĄŒőŽjCź‘ňŽ“TC”‹´_ˆęCÎ“c˜aŒČC“cŠ•ś•FC’†ŽR‹`‰îCÎ“c˜a•vCŠ`“cÍiŠOjC’|“ŕN—YC‘ĺ‹v•Ű[li“ŕjCŒF–ě˜a—YC^‰şß•vC‰““Ą’‰—YCŹ ŽÄŒ’i”ĺjC“n•”_“ńC”–Ř“oi–Ɖuj: ‘ć27‰ń“ú–{tˆÚA—Տ°Œ¤‹†‰ď i94.01.28j, ’ˇč, ´˜^W, p.73.

1726. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Balloon occlusion testŒă‚ÉŒŠ‚ç‚ę‚鋐‘ĺ”]“Ž–ŹáŽ‚ĚŒ`‘ԕωť. “c’†ç•FC‘q“c˛C“c’†–ö…CŽR“cŸC‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOjC›Mˆęi•új: ‘ć17‰ń“ú–{”]_ŒoCIŒ¤‹†‰ď i94.01.29j, “Œ‹ž.

1727. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒKƒ“ƒVƒNƒƒrƒ‹CŒŒ‰tň‰ť—Ă–@‚ŞŽĄ—Ă‚É—LŒř‚Ĺ‚ ‚Á‚˝dÇCMVŠ´őÇ‚Ě1—á. ”‹´_ˆęCź‘ňŽ“TC’Š’ˇ“N–íC’†ŽR‹`‰îCÎ“c˜a•vC˛“ĄŒőŽjCŠ`“cÍiŠOjC’|“ŕN—Yi“ŕjCŒF–ě˜a—YC‰““Ą’‰—Yi”ĺjC‘ĺ‹v•Ű[li“ŕj: ‘ć27‰ń“ú–{tˆÚA—Տ°Œ¤‹†‰ď i94.01.29j, ’ˇč, tˆÚA—Տ°Œ¤‹†‰ďŽ, p.115, 1994.

1728. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‘ĺ’°SMŠŕÄ”­ŠëŒŻˆöŽq‚ĚŒŸ“˘. ŒĂě—T‰îC‘ĺ’J„łC‰Ş‘ş—ĽŽqC–Lě‹MŽiCŹěŒ›ÍC‰ĄŽR‹žŽqC‘ęK‹ĎCˆäŒ´ŒúCH“ĄNśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć40‰ń‘ĺ’°ŠŕŒ¤‹†‰ď i94.02.04j, ‹v—Ż•Ä, —\eW, p.47. 1994.

1729. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ÇŒóŤƒ‰ƒgƒP—ô”X–E‚Ě•úŽËüŠw“IŒŸ“˘. ‰ŞGGCXˆä˝“ńCě–ěM”VCz–K’m–çC–î“cŒŤŽOi”]ŠOjC›Mˆęi•új: ‘ć23‰ń“ú–{_Œo•úŽËüŒ¤‹†‰ď i94.02.10j, _ŒË.

1730. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‰Ć“e”]Ž€ƒ‚ƒfƒ‹‚É‚¨‚Ż‚ézŠÂ“Ž‘Ô‚ĚŽŔŒą“IŒŸ“˘. ĄˆäŒ‰C˛“ĄŒőŽjCÎ“c˜aŒČC“cŠ•ś•FCź‘ňŽ“TC˛“Ą‹`–çC’†ŽR‹`‰îCÎ“c˜a•vCŠ`“cÍiŠOj: ‘ć21‰ńäXˆÚAŒ¤‹†‰ď i94.02.18j, “Ţ—Ç.

1731. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ’ź’BŽčp˘“ď‚Č”]“Ž–ŹáŽ‚ɑ΂ˇ‚ép’†DSA, non-detachable micro balloon catheter‚Ě—L—pŤ‚ɂ‚˘‚Ä. ‘ĺ“ä’mC‘q“c˛C“c’†ç•FC‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOjC›Mˆęi•új: ‘ć23‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŒ¤‹†‰ď i94.03.08j, ‹ž“s.

1732. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j p’†‹ÇŠ”]ŒŒ—Ź—Ę‘Ş’č‚Ě—L—pŤ. í”Ő‰ĂˆęC‹{â‰Ŕ’jC‘q“c˛C‘ĺ“ä’mCŽOŽ}GˆÉC–î“cŒŤŽOi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝j: ‘ć23‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŒ¤‹†‰ď i94.03.08j, ‹ž“s.

1733. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j “ŕŒz“Ž–Źƒoƒ‹[ƒ“•ÂÇƒeƒXƒg‚É‚¨‚Ż‚éStump pressure‚Ě‘Ş’čˆÓ‹`‹y‚Ń‚ť‚Ě•]‰ż. ‘q“c˛C‘ĺ“ä’mC“c’†ç•FC‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOjC›Mˆęi•új: ‘ć23‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŒ¤‹†‰ď i94.03.09j, ‹ž“s.

1734. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Œz’ĹĽŒz‘‘š‚É‚¨‚Ż‚é“Ş•”ŠO‡•š‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ”Ń“cG•vC‹kŽ ‘i”]ŠOjC–kŒ´F—Yi‹~–˝jC–î“cŒŤŽOi”]ŠOjC‘ĺ˜a“c—˛i‹~–˝j: ‘ć17‰ń“ú–{_ŒoŠOŒ¤‹†‰ď i94.03.17j, ŽOd.

1735. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ˆÝŠŕpŒă’_Î”­ś‚ĚŒŸ“˘. ‚‹´ŒúC’Ë–{GlCâEŠ_˝CŹ—ѐLsC‰Á“ĄNsC“ˆ”ömCŽOd–슰ŠěCĺŒ´÷C”äŠé”\Ž÷iŠOj: ‘ć23‰ńˆÝŠO‰ČŒ¤‹†‰ď i94.03.18j, ‘ĺă, ƒvƒƒOƒ‰ƒ€, p.30.

1736. mŒ¤‹†‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘ĺ’°ŠŕŠĚ“]ˆÚ‚ĚŽĄ—Ă. ‰Ş‘ş—ĽŽqCH“ĄNśC‘ęK‹ĎC“n•ÓŒ’Ž™CŒĂ”g‘qŽjŽqC‚‹´r‹BC‘ĺ’J„łCĺŒ´÷CŠ`“cÍC”äŠé”\Ž÷iŠOj: ‘ć38‰ń‘ĺ’°ŠŕŒ¤‹†‰ď i93.02.06j, ‘ĺă, ´˜^W, p.58.

1737. mŒ¤‹†‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j • o‹ž‰ş’_‚Ě‚¤“Eop“ą“üˆČŒă‚̗ǐŤ’_‚Ě‚¤ŽžŠł‚ɑ΂ˇ‚éŠO‰Č“IŽĄ—Ă‚ĚŒť‹ľ. ‚‹´‹BC‹g“c@‹ICŒĂ“cˆę“żCň‰Ć‹v’źC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć29‰ń“ú–{’_“šŠw‰ď‘‰ď i93.09.20j, _ŒË, ’_“š, 7(3): 416, 1993.

1738. mŒ¤‹†‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠĚ“]ˆÚÇ—á‚Ě—Ő°•a—Šw“IŠŒŠ‚Ć—\Œă. ‚‹´ŒúCĺŒ´÷CŽOd–슰ŠěC“ˆ”ömC‰Á“ĄNsCŹ—ѐLsCâEŠ_˝C”äŠé”\Ž÷iŠOj: ‘ć62‰ńˆÝŠŕŒ¤‹†‰ď i94.01.21j, ‘ĺă, ƒvƒƒOƒ‰ƒ€, p.47.

1739. mŒ¤‹†‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘Šú‘ĺ’°Šŕ‚ĚÄ”­—á. –ě‘ň’źŽjCŽÂŒ´‰›C‘吟‰pˆűC•Äě•áCŒIŒ´”Ž–žC÷ˆä—^Žu•FCŒĂěrŽĄCŠâŁO’‰CX––~i‘—§‘ĺ‘ •a‰@j: ‘ć40‰ń‘ĺ’°ŠŕŒ¤‹†‰ď i94.02.04j, ‹v—Ż•Ä.

1740. mŒ¤‹†‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Â‘s”NŽŇ–Ťd–Œ‰şŒŒŽî|“Á‚ɃNƒ‚–Œ”X–E‚Ć‚Ě‡•š•p“x‚ÉŠÖ‚ľ‚ā|. ŽRč‹`‹éC‹kŽ ‘i”]ŠOjC‘ĺ˜a“c—˛C–kŒ´F—Yi‹~–˝jC–î“cŒŤŽOi”]ŠOj: ‘ć17‰ń“ú–{_ŒoŠOŒ¤‹†‰ď i94.03.17j, ŽOd.

1741. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j isH“šĽ•Ź–ĺ•”Šŕ‚Ě“ŕŽ‹‹žŽĄ—Ă. ”äŠé”\Ž÷iŠOj: ‘ć4‰ńŠň•ŒŒ§Á‰ťŠí“ŕŽ‹‹žƒtƒH[ƒ‰ƒ€ i93.07.08j, Šň•Œ.

1742. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j Ň‘áŠQ‚É‚¨‚Ż‚éŇ’ĹĽŇ‘Ľ_ŒoŞ‚Ě“Ž‘Ô—ÍŠw“I“ÁŤ. ‹kŽ ‘i”]ŠOj: ‘ć4‰ń‹{čŇ’ŐҐ‘Œ¤‹†‰ď i93.07.10j, ‹{č.

1743. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ŠO‰Č‚Š‚ç‚Ý‚˝ˆÝŠŕŽĄ—Ă‚Ě–â‘č“_|ŽŠŒą—á‚ć‚č|. ”äŠé”\Ž÷iŠOj: ‘ć2‰ńŽRŒűŒ§ŽĄ—Ă“ŕŽ‹‹žŒ¤‹†‰ď i93.09.29j, ‰F•”.

1744. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j “ŕŽ‹‹ž‚ĚŒť‹ľ‚ƏŤ—ˆ‚Ě“W–]. ”äŠé”\Ž÷iŠOj: ‘ć1‰ń‰Ą•lÁ‰ťŠí“ŕŽ‹‹žˆă‰ď‘‰ď i93.10.13j, ‰Ą•l.

1745. mŒ¤‹†‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’_”XŠŕ‚̐i“W“x•ĘŽčpŽĄ—Ă•űj. ‹g“c@‹IC‚‹´‹BC–Ř‘ş“OC•Đ“c‰Ä–çCŒĂ“cˆę“żCň‰Ć‹v’źC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć38‰ń_“ސěÁ‰ťŠí•aŒ¤‹†‰ďƒVƒ“ƒ|ƒWƒEƒ€ i93.06.03j, ‰Ą•l.

1746. mŒ¤‹†‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘ŠúˆÝŠŕ‚ɑ΂ˇ‚郌[ƒU[ŽĄ—Ă‚ĚŒoŒą. –Ľ‰YG•FCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć4‰ń_“ސěˆÝŠŕŒ¤‹†‰ď i93.06.26j, ‰Ą•l.

1747. mŒ¤‹†‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘ŠúˆÝŠŕ‚ɑ΂ˇ‚é“ŕŽ‹‹ž“IƒŒ[ƒU[ŽĄ—Ă. “ˆ”ömC”äŠé”\Ž÷iŠOj: ‘ć5‰ńbMÁ‰ťŠíŒ¤‹†‰ďƒVƒ“ƒ|ƒWƒEƒ€ i94.02.19j, b•{.

1748. mŒ¤‹†‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŽčpNP‚ĆAGML. ’Ë–{GliŠOj: –kŠC“šSofalcone Symposium-'94 i94.02.19j, ŽD–y.

1749. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ŠĚŠOpŒă‚̓Ť’_`ᑍE‚Ə\“ńŽw’°‚ŞŒđ’Ę‚ľ‚˝1—á. ’|“cCŒĂ”g‘qŽjŽqC‘ŠŒ´ŹşC•˝–ěiC•Đ“c‰Ä–çC‰J‹{–ž•śC‹ŕ“cŒĺ˜YC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć21‰ń_“ŢěŒ§Á‰ťŠíŠO‰ČŒ¤‹†‰ď i92.05.30j, ‰Ą•l.

1750. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ŠĚ“]ˆÚ‚É‚ć‚é‚ĆŽv‚í‚ę‚éˆÓŽŻáŠQ‚𔺂¤’ጌ“œ”­ě‚đŒJ‚č•Ô‚ľ‚˝ˆÝŠŕ‚Ě1—á. •˝–ěiCŒĂ”g‘qŽjŽqC‘ŠŒ´ŹşC’|“cC•Đ“c‰Ä–çC‰J‹{–ž•śC‹ŕ“cŒĺ˜YC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć37‰ń_“ŢěŒ§Á‰ťŠí•aŒ¤‹†‰ď i92.06.06j, ‰Ą•l.

1751. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ˆÝ‹ó’°•Ť‡37”NŒă‚ÉŒŠ‚ç‚ę‚˝‘ŠúˆÝŠŕ‚Ě1—á. ’|“cC‘ŠŒ´ŹşC•˝–ěiC•Đ“c‰Ä–çC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć2‰ń_“ŢěŒ§ˆÝŠŕŽĄ—ĂŒ¤‹†‰ď i92.06.20j, ‰Ą•l.

1752. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ƒrƒfƒI‹L˜^‚Ş—L—p‚Ĺ‚ ‚Á‚˝• o‹ž‰ş’_”X“EoŒă’_`ᑂĚ1—á. •˝–ěiC‘ŠŒ´ŹşC’|“cC•Đ“c‰Ä–çC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć18‰ń“Œ‹ž’n‹ć‘—§•a‰@ŠO‰ČŒ¤‹†‰ď i92.07.25j, “Œ‹ž.

1753. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j “ÁˆŮ‚Č”­Ç‚đ‚ľ‚˝’ŽŘŒă• o“ŕ”^ᇂĚ2—á. ‘ŠŒ´ŹşC•˝–ěiC’|“cC•Đ“c‰Ä–çC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjC“n•”K•vCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć74‰ń_“ŢěŒ§—Տ°ŠO‰ČˆăŠw‰ďW’k‰ď i92.09.26j, Šƒ–č.

1754. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘Š–ÍŒ´Žs‚É‚¨‚Ż‚é‘ĺ’°‚Ş‚ńŒŸf‚ɂ‚˘‚āi‘ć3•ńj. —œ–{„i‘—§‘Š–ÍŒ´•a‰@jC‚‹´r‹BiŠOj: ‘ć354‰ń‘Š–͈ăŠw‰ď‘‰ď i92.10.24j, ‘Š–ÍŒ´.

1755. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j •nŒŒ‚đŒ_‹@‚É”­ŒŠ‚ł‚ę‚˝\“ńŽw’°, ‹ó’°, leiomyomatosis‚Ě1—á. ’|“cC‘ŠŒ´ŹşC•˝–ěiC•Đ“c‰Ä–çC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć19‰ń“Œ‹ž’n‹ć‘—§•a‰@ŠO‰ČŒ¤‹†‰ď i92.11.07j, “Œ‹ž.

1756. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j –ŤŠÖßƒŠƒEƒ}ƒ`‚đ‡•š‚ľ‚˝—ź‘¤”AŠÇ”畆ᑂƐlHăč–呢ÝŠłŽŇ‚ĚƒXƒgƒ}ƒPƒA‚ɂ‚˘‚Ä. “c‘şŒjŽqCŹ—Ń—ćŽqC’n‘ ˆ¤Žqi‘—§‘Š–ÍŒ´•a‰@jCŒĂ”g‘qŽjŽqC•˝–ěiC’|“cC‰J‹{–ž•śC‚‹´r‹BiŠOj: ‘ć15‰ń_“ސěƒXƒg[ƒ}Œ¤‹†‰ď i92.12.19j, ‰Ą•l.

1757. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‹}Ť’Ž‚‰Š‚É‚¨‚Ż‚é’´‰š”gf’f‚Ě—L—pŤ. ‰J‹{–ž•śC‘ŠŒ´ŹşC•˝–ěiC’|“cC•Đ“c‰Ä–çC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć20‰ń“Œ‹ž’n‹ć‘—§•a‰@ŠO‰ČŒ¤‹†‰ď i93.03.27j, “Œ‹ž.

1758. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘’_ŠÇŒ‹Î‚ɑ΂ˇ‚é• o‹ž‰şŽčp. ‹ŕ“cŒĺ˜YC‚‹´r‹BCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`iŠOj: ‘ć22‰ń_“ސěÁ‰ťŠíŠO‰ČŒ¤‹†‰ď i93.04.10j, ‰Ą•l.

1759. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j • o‹ž‰ş’_‚Ě‚¤“EopˆČŒă‚Ě’_‚Ě‚¤—ǐŤ•a•Ď‚ɑ΂ˇ‚éŠO‰ČŽĄ—Ă‚Ě“ŽŒü. ‚‹´‹BCŒĂ“cˆę“żCň‰Ć‹v’źC‹g“c@‹IC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć22‰ń_“ސěÁ‰ťŠíŠO‰ČŒ¤‹†‰ď i93.04.10j, ‰Ą•l, ´˜^W, p.1, 1993.

1760. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j pŒă’ˇŠúś‘ś’†‚ĚŠĚ×–EŠŕ”j—ô‹Ů‹}Žčp—á. ‹g“c@‹IC‘ĺ‹{“ŒśCŒĂ“cˆę“żCň‰Ć‹v’źC‚‹´‹BC”äŠé”\Ž÷CŠ`“cÍiŠOjCˆé•”‹`Œ›i•újC’†‰p’ji•a—jC‘–쐳ˆęi•új: ‘ć7‰ńŠĚŠŕÇ—ጟ“˘‰ď i93.04.24j, “Œ‹ž, ´˜^W, p.3, 1993.

1761. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Gore-texŽg—paxillo-bifemoral bypasspŒă‚É’†•‘¤•ÂÇ‚đ‚Ť‚˝‚ľ‚˝1Ç—á. źŽR’ź‹vC“‡’ÐˇˆęCXŁšŽ÷C‹ŕéł‰ŔCŞ–{ECŠ`“cÍiŠOj: ‘ć78‰ńŒŒŠÇŠO‰ČÇ—ጟ“˘‰ď i93.05.08j, ç—t.

1762. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j • o‹ž‰ş’_”X“Eop‚Ě‹łˆçƒVƒXƒeƒ€i“Á‚ɃŒƒWƒfƒ“ƒgƒVƒXƒeƒ€‚Ö‚Ě“ą“ü‚ɂ‚˘‚āj. ‹g“c@‹IC”äŠé”\Ž÷CŒĂ“cˆę“żCň‰Ć‹v’źC‚‹´‹BC‘ĺ‹{“ŒśCŠ`“cÍiŠOj: ‘ć3‰ń• o‹ž‰ş’_”X“EopŒ¤‹†‰ď i93.05.15j, VŠƒ.

1763. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j MNMS”­Ç—á‚ĚŒŸ“˘. Ş–{EiŠOj: ‘ć7‰ń_“ŢěŒŒŠÇŠO‰ČŒ¤‹†‰ď i93.05.21j, ‰Ą•l, ´˜^W, p.5, 1993.

1764. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j –Ó”XÇŒóŒQ‚Ě1Žčp—á. ‹ß“ĄŒŤŽiCŒĂ”g‘qŽjŽqCˆî–؉pŽĄC’çCC‘ŠŒ´ŹşC‰J‹{–ž•śC‹ŕ“cŒĺ˜YC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjCŽO“‡Œ’i‘—§‘Š–ÍŒ´•a‰@jCˆŔ’BŒŁi“ŕj: ‘ć38‰ń_“ŢěŒ§Á‰ťŠí•aŒ¤‹†‰ď i93.06.05j, ‰Ą•l.

1765. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j • o‹ž‚ĹŠm”F‚ľ‚Ś‚˝’ź’°Žq‹{“ŕ–ŒÇ‚Ě1—á. ŒĂ”g‘qŽjŽqiŠOj: ‘ć12‰ń_“ސě‘ĺ’°ŽžŠłŒ¤‹†‰ď i93.06.24j, ‰Ą•l.

1766. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Žčp˘“ď‚Č‘ŠúˆÝŠŕÇ—á‚ɑ΂ˇ‚é“ŕŽ‹‹ž“IƒŒ[ƒU[ĆŽË‚ĚŒŸ“˘. ‰ĄŽR‹žŽqC“ˆ”ömCŽOd–슰ŠěC‰Í–ě˜a”VC—я@”ŽCů–{_C‚–ě—eKC‚‹´ŒúCâEŠ_˝CŹ—ѐLsC“cŒ´”ŽC‰Á“ĄNsCĺŒ´÷C”äŠé”\Ž÷iŠOj: ‘ć4‰ń_“ސěˆÝŠŕŒ¤‹†‰ď i93.06.26j, ‰Ą•l.

1767. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j SóŒ‹’°‚ŞŽ˛”P—l›Ć“Ú‚ľ‚˝śŠO‘lŒaƒwƒ‹ƒjƒA‚Ě1—á. ˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć77‰ń_“ŢěŒ§—Տ°ŠO‰ČˆăŠwW’k‰ď i93.09.18j, ‰Ą•l.

1768. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j äXƒCƒ“ƒXƒŠƒm[ƒ}Řœ11—á‚Ě—Ő°•a—Šw“IŒŸ“˘. “ŕ“ĄCC‹g“c@‹ICŒĂ“cˆę“żCň‰Ć‹v’źC‚‹´‹BC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć750‰ńŠO‰ČW’k‰ď i93.09.18j, “Œ‹ž, ´˜^W, p.48, 1993.

1769. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ŠĽó“Ž–ŹƒoƒCƒpƒXŽčp‚É‚¨‚Ż‚éH•v. •—ŠÔ”ɁCÎŒ´şi‹šŠOj: ‘ć2‰ń_“ސěS‘ŸŒŒŠÇŠO‰ČŒ¤‹†‰ď i93.10.00j, ‰Ą•l.

1770. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘—§‘Š–ÍŒ´•a‰@ŠO‰Č‚É‚¨‚Ż‚éĹ‹ß‚ĚMRSAŠłŽŇ‚Ě“ŽŒü‚Ć‘Îô. ‹ŕ“cŒĺ˜YC’çCCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC‰J‹{–ž•śCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć22‰ń“Œ‹ž’n‹ć‘—§•a‰@ŠO‰ČŒ¤‹†‰ď i93.11.13j, “Œ‹ž.

1771. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Źl‚É‚¨‚Ż‚éä`‚ÉŠÖ˜A‚ľ‚˝ŽžŠł‚ĚŒŸ“˘. ’Š’ˇ“N–íCÎ“c˜a•vCŠ“cç”ü”TC‘ĺ‹{“ŒśCŠ`“cÍiŠOj: ‘ć19‰ń–k—˘ˆăŠw‰ď‘‰ď i93.11.13j, ‘Š–ÍŒ´.

1772. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j p‘OTAEŒăŘœp‚މ”\‚Ĺ‚ ‚Á‚˝–ĺ–Ź“ŕŽîá‡Çđ‡•šŠĚ×–EŠŕ‚Ě1—á. ˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjC’|‘şŽ“ńi’|‘şƒNƒŠƒjƒbƒNj: ‘ć751‰ńŠO‰ČW’k‰ď i93.11.27j, ‰Ą•l.

1773. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j p‘O‚ɐf’f‚ľ“ž‚˝Foreing body granuloma‚Ě1—á. “ŕ“c‘׎ŠC‹g“c@‹ICŒĂ“cˆę“żCň‰Ć‹v’źC‚‹´‹BC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć751‰ńŠO‰ČW’k‰ď i93.11.27j, ‰Ą•l, ´˜^W, p.31, 1993.

1774. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j “űŠŕpŒă‚̍ś‘O‹š•”•úŽËüŤ”畆‰Š‚¨‚ć‚эœ‰óŽ€‚ɑ΂ľL”w‹Ř”ç•ŮˆÚA‚đs‚Á‚˝‚P—á. ˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjC‹ËśçŒ‰îi‹Ëśˆă‰@j: ‘ć78‰ń_“ŢěŒ§—Տ°ŠO‰ČˆăŠwW’k‰ď i93.12.04j, ěč.

1775. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Šŕ‚ĆŠÓ•Ę‚Ş˘“ď‚Ĺ‚ ‚Á‚˝‹‘ĺ’_”X‘BŽî‚Ě1Řœ—á. ‰|–{‘ń–΁C‹g“c@‹ICŒĂ“cˆę“żCň‰Ć‹v’źC‚‹´‹BC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć227‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď i93.12.04j, “Œ‹ž, ´˜^W, p.38, 1993.

1776. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j p‘OŠÓ•Ęf’f‚É“ďa‚ľ‚˝•›bó‘B(Accessory thyroid glad)‘BŽî‚Ě‚P—á. ź–{–LiŠOjCŹź˝iMB‘ĺjCÎ•‹§ŽjC•˝“cŒő”ŽC˛“ĄˆęŠěC‰Ą“c“™CVˆäLNiŠOjC‹{–{‰p—YiMB‘ĺjC–ĺ˜eŒ›iŠOjCź‘ş”ŽsiMB‘ĺj: ‘ć82‰ńMBŠO‰ČW’k‰ď i93.12.05j, ź–{.

1777. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‰źŤ“Ž–ŹáŽ‚đ3‰ńŒ`Ź‚ľ‚˝Vasculo-Behchet•a‹^‚˘‚Ě1—á. •Ÿ“cŽ CŞ–{EC“ŕ“ĄCC•Đ“c‰Ä–çCXŁšŽ÷C“‡’ÐˇˆęiŠOjC’Ň—şěC‹{“ŕ–M_C“n•Ó—´•FC‘哇s•Fiă”ö’†‰›‘‡•a‰@j: ‘ć80‰ńŒŒŠÇŠO‰ČÇ—ጟ“˘‰ď i93.12.18j, “Œ‹ž.

1778. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ”X–E“ŕ‚É“ű“ޏ󔭈ç‚đ’ć‚ľ‚˝äX”X–E‘BŠŕ‚Ě1Řœ—á. ’Ň—şěC‹g“c@‹ICŒĂ“cˆę“żC“‡“cŒŞCˆÉ“Ą‹`–çCň‰Ć‹v’źC‚‹´‹BC‘ĺ‹{“ŒśiŠOj: ‘ć53‰ń• •”ƒGƒR[Œ¤‹†‰ď i94.01.29j, “Œ‹ž.

1779. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ÎŠD‰ť‚𔺂Á‚˝‰ş‘ĺĂ–Ź‹y‚Ń—ź‰şŽˆĂ–ŹŒŒđÇ‚Ě1—á. •˝ŽRŽőCXŁšŽ÷CŞ–{EC–Lě‹MŽiC“‡’ÐˇˆęCŠ`“cÍiŠOj: ‘ć81‰ńŒŒŠÇŠO‰ČÇ—ጟ“˘‰ď i94.02.19j, “Œ‹ž.

1780. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j LeVeen Shunt‚Ş‘tŒř‚ľ‚˝PDpŒă‚̓Ť• …‚Ě1—á. źŽR’ź‹vC‹g“c@‹ICŒĂ“cˆę“żCň‰Ć‹v’źC‚‹´‹BC‘ĺ‹{“ŒśC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘ć752‰ńŠO‰ČW’k‰ď i94.03.05j, “Œ‹ž, ´˜^W, p.35, 1994.

1781. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‹ˇó‚𔺂¤‰ńŒ‹’°•Ť‡•”—֏ó’×ᇂĚ1—á. ˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjCźŽR•Ű”äŒĂCŽO•xO”Vi“ŕjC“n•”‰p”Vi“ú ˆă‘ĺjC‹g“c—TŽOi“ú–{“d‹C‹ĘěŒ’NŠÇ—ƒZƒ“ƒ^[j: ‘ć79‰ń_“ŢěŒ§—Տ°ŠO‰ČW’k‰ď i94.03.12j, Š™‘q.

1782. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Seldinger–@‚É‚ć‚é• •”‘ĺ“Ž–Ź‘˘‰e‚ŞŒ´ˆö‚ĆŽv‚í‚ę‚é‰đ—ŁŤ‘ĺ“Ž–ŹáŽ‚Ě1ŽĄŒą—á. Ş–{ˆę•FC”Ń–ě‘Pˆę˜YCXŁšŽ÷C“‡’ÐˇˆęCŞ–{ECŠ`“cÍiŠOj: ‘ć79‰ń_“ŢěŒ§—Տ°ŠO‰ČW’k‰ď i94.03.12j, Š™‘q.

1783. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ÄŒš‚đs‚í‚Č‚˘ę‡‚Ě‘•‹ď‚̍H•v“_, ‚Ü‚˝‘•‹ď‘S”ʂɂ‚˘‚Ä. ’|’†°KiŠOj: ‘ć10‰ń_“ŢěŒ§“ű‘Bbó‘BŠO‰ČŒ¤‹†‰ď i94.03.12j, ‰Ą•l.

1784. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‹ť–Ą‚ ‚é”­ˆçi“WŒ`ŽŽ‚đ‚Ć‚Á‚˝ˆÝ•˝ŠŠ‹Ř“÷Žî‚Ě1—á. ’çCCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC‰J‹{–ž•śC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘ć23‰ń“Œ‹ž’n‹ć‘—§•a‰@ŠO‰ČŒ¤‹†‰ď i94.03.26j, “Œ‹ž.

1785. mŒ¤‹†‰ďi’n•űjn iƒ|ƒXƒ^[u‰‰j lHăč–ĺ’Eo‚ɑ΂ľƒ{ƒ^ƒ“ŒĹ’č–@, ŽO—Ö-Gant–@, lHăč–ĺÄŒšp‚đŽ{s‚ľ‚˝1Ç—á‚ɂ‚˘‚Ä. ŒĂ”g‘qŽjŽqCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‰J‹{–ž•śC‹ŕ“cŒĺ˜YC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjC×ěˆčŽqCŽRčƒJƒcŽqC”~Ş‚ ‚ŽŽqC’n‘ ˆ¤ Žqi‘—§‘Š–ÍŒ´•a‰@j: ‘ć16‰ń_“ŢěŒ§ƒXƒg[ƒ}Œ¤‹†‰ď i93.12.18j, ěč.

1786. mŒ¤‹†‰ďi’n•űjn iƒ|ƒXƒ^[u‰‰j –ń40”N‘O‚ĆĹ‹ß‚É‚¨‚Ż‚éˆÝŠŕŽčp—á‚ĚŒŸ“˘. ‰J‹{–ž•śCˆî–؉pŽĄC‹ß“ĄŒŤŽiC‘ŠŒ´ŹşC’çCC‹ŕ“cŒĺ˜YCŒĂ”g‘qŽjŽqC–Ľ‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘ć5‰ń_“ސěˆÝŠŕŽĄ—ĂŒ¤‹†‰ď i93.12.25j, ‰Ą•l.

1787. mŒ¤‹†‰ďi’n•űjn iŒöŠJuŔj ƒXƒg[ƒ}ŠO—ˆ‚ɂ‚˘‚Ä. ‘ĺ’J„łiŠOj: ‘ć9‰ń_“ސěƒXƒgƒ}ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“uK‰ď i93.06.20j, ‘Š–ÍŒ´.


<<15 7 ŠO‰ČŠw>>

1788. mŠwpÜn ‘ć43‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď: “ŕ‘ŸŤ’ɏœ‹Ž‚đ–Ú“I‚Ć‚ˇ‚éŒo‹š“I‹šo‹ž‰ş“ŕ‘Ÿ_ŒoŘ’fp‚ÉŠÖ‚ˇ‚éŠî‘b“IŒ¤‹†, ‚‹´‹BCŠ`“cÍCň‰Ć‹v’źC‹ŕ“cŒĺ˜YCŒĂ“cˆę“żC‹g“c@‹IC‘ĺ‹{“ŒśC”äŠé”\Ž÷iŠOj.

1789. m“Á‹–ĽˆÓ “o˜^n ŽŔ—pVˆÄ“o˜^i“o˜^‘ć2008485†’ŽfŠí1994”N(•˝Ź)6”N3ŒŽ9“új, •—ŠÔ”Ɂi‹šŠOj.

1790. m“Á‹–ĽˆÓ “o˜^n ŽŔ—pVˆÄoŠčŒöi•˝5°15920’ŽfŠíŽŔ—pVˆÄL•ń(Y2)1993”N4ŒŽ22“ú, p.63`65j, •—ŠÔ”Ɂi‹šŠOj.

1791. m“Á‹–ĽˆÓ “o˜^n “ú–{ŹŽ™ŠO‰ČŠw‰ďŽw“ąˆă: Ž‘Ši”F’č, Î“c˜a•viŠOj.

1792. mŠw‰ďŽĺĂi’n•ű‰ďjn ‘ć759‰ńŠO‰ČW’k‰ď, Š`“cÍiŠOj.

1793. mŠw‰ďŽĺĂi‚ť‚Ě‘źjn ‘ć‚Q‰ń_“ސěS‘ŸŒŒŠÇŠO‰ČƒtƒH[ƒ‰ƒ€iS‘ŸŒŒŠÇŠO‰Č‚ÉŠÖ‚ˇ‚é_“ŢěŒ§‰ş‚𒆐S‚Ć‚ľ‚˝Œ¤‹†‰ďj, •y‰i˝ˆęi‹šŠOj.


<<16 ŹŽ™‰ČŠw>>

1794. mŒ´’˜n Impaired cardiac function in rats with healed myocardial infarction: cellular vs myocardial mechanisms. Joseph Y. CheungCTimothy I. MuschiPennsylvenia State Univ.jCŽO‘ňmŽiiŽ™jCAnne SemanchickCMarybeth ElenskyCRao V. YelamartyCRussell L. MooreiPennsylvenia State Univ.j: Am. J. Physiol., 266: 29`36, 1994.

1795. mŒ´’˜n Changes in pulmonary veuous flow pattern during early neonatal life. ăp—z‘ž˜YC•˝Î‘CŹŒűO‹BC–ě“nł•FC”ó‰YDC”Ş‘ăŒö•viŽ™jC‰ş“c—˛•viŽY•wj: Br. Heart J., 71: 182`186, 1994.

1796. mŒ´’˜n Noninvasive quantitative evaluation of the morphology of the major pulmonary arterial branches in cyanotic congenital heart diasease|Angiographic and echocardiographic correlative study|. •˝Î‘CŽO‘ňmŽiCL“c•l•vCăp—z‘ž˜YC–xŒű‘דTC“Ą–ěé”VC”Ş‘ăŒö•viŽ™jC’†]˘–žC‰Í“c­–ži‹šŠOj: Circulation, 89: 1306`1316, 1994.

1797. mŒ´’˜n Multicenter study on clinical evaluation of disposable syringes pre-loaded with growth hormone (Genotropin kabiquick). Seizo SuwaCKatsuhiko Tachibanai_“ސ쏬Ž™ˆă—ĂƒZƒ“ƒ^[jC‘ĺŽR‹XGiŽ™jCMasatoshi Fujimotoišƒ}ƒŠˆă‘ĺjCOsamu Shinoharai“ŒŠC‘ĺjCEtsuro TokuhiroiŹ“cŒ´Žs—§•a‰@jCŹ–ě‰ë•vi•ŞśjCŒĂŠÚęˆęiŽŔ“Žj: Clin. Pediatr. Endocrinol., 2(Suppl.1): 27`32, 1993.

1798. mŒ´’˜n Two-year results of sustained-release leuprorelin acetate (TAP-144-SR) treatment in children with central precocious puberty. Toshiaki TanakaCItsuro Hibii‘—§ŹŽ™•a‰@jCKiyohiko KatoiŽR—œˆă‘ĺjCShiro Saitoi“ż“‡‘ĺjCNaokata Shimizui’é‹ž‘ĺjCSeizo Suwai_“ސ쏬Ž™ˆă—ĂƒZƒ“ƒ^[jCHitoo Niimiiç—t‘ĺjCYukitaka Miyachii“Œ–M‘ĺjCKazue Takanoi“Œ‹ž—ˆă‘ĺjCKazue Fujiwarai–n“Œ•a‰@jCNaoki KageyamaiŠÝ˜a“c•a‰@jCKenji Fujiedai–k‘ĺjCYutaka IgarashiCEishin Ogawai“Œ–k‘ĺjCToshiyuki Yasudaiç—t‘ĺjCNaoya Kodaié‹Ę‚ą‚Ç‚ŕˆă—ĂƒZƒ“ƒ^[jCReiko HorikawaCJunko ItoCMasahiro Tanakai‘—§ŹŽ™•a‰@jCNobutake MatsuoCShin AnzoiŒc‘ĺjCKatsuhiko TachibanaCHatae MaesakaCNobuyuki Kikuchii_“ސ삹‚Ç‚ŕˆă—ĂƒZƒ“ƒ^[jC‘ĺŽR‹XGiŽ™jCMasanori OtaiŽR—œˆă‘ĺjCYoshio Igarashii•lźˆă‘ĺjCMasamichi Ogawai–ź‘ĺjCHiroaki Takahashii‹ŕ‘ňˆă‘ĺjCShintaro OkadaCKoji InuiCHiroko Tsukamotoiă‘ĺjCYoshikazu Nishii“úÔL“‡•a‰@jCYoshihisa Shirakawai“ż“‡‘ĺjCHitoshi Konoi•Ÿ‰ŞŽs—§ŹŽ™•a‰@jCYoshiro TsujiCMasaaki YoshimotoCHidekazu Kinoshitai’ˇč‘ĺjCMotoko KojimaCTahei Gomibuchii•Ÿ“‡ˆă‘ĺj: Clin. Pediatr. Endocrinol., 2: 49`58, 1993.

1799. mŒ´’˜n Lack of regional variation in IDDM risk in Japan. Japan IDDM Epidemiology Study GroupCź‰YM•viŽ™j: Diabetes Care, 16(5): 796`800, 1993.

1800. mŒ´’˜n Trial of insulin|like growth factor I therapy for patients with extreme insulin resistance syndromes. Š‹’J‰pŽki‹ž‘ĺjCź‰YM•viŽ™jCâ–{”üˆęi’é‹ž‘ĺjCŽÜ–ě‰pˆęiç—t‘ĺjC–ĺ˜eFC—é–Ř—Ç”üi“Œ‘ĺjCŹ—ѐłiŽ ‰ę‘ĺjCÔŕVD‰ˇC–ě‘ş˝C‹g­N’ź i‘—§‹ž“s•a‰@jCt“ú‰ëlC‹˝ŽiŽŒČC’ˇ‘ëdMC‘ĺˆŔ‹Ďi’ˇč‘ĺj: Diabetes, 42(5): 696`705, 1993.

1801. mŒ´’˜n The long-term effect of cyproterone acetate on growth in girls with idiopathic precocious puberty. K. KatoiŽR—œˆă‘ĺjCM. Fujimotoišƒ}ƒŠˆă‘ĺjCI. Hibii‘—§ŹŽ™•a‰@jCS. Suwai_“ސ삹‚Ç‚ŕˆă—ĂƒZƒ“ƒ^[jCN. Shimizui’é‹ž‘ĺjCK. Fujiedai–k‘ĺjCA. OkunoiˆŽěˆă‘ĺjCK. Sanayamaiç—t‘ĺjCK. Shimozawai“Œ‹žˆăŽ•‘ĺjCN. MatsuoiŒc‘ĺjC‘ĺŽR‹XGiŽ™jCY. Igarashii•lźˆă‘ĺjCM. Ogawai–ź‘ĺjCS.Okadaiă‘ĺjCT. Kondoi‘ĺăŹŽ™ˆă—ĂƒZƒ“ƒ^[jCY. NishiiL“‡“úÔ•a‰@j: Eur. J. Pediatr., 152: 297`300, 1993.

1802. mŒ´’˜n Development of diabetic nephropathy in Japanese patients with insulin-dependent diabetes mellitus: Tokyo Women's Medical College epidemiologic study. Hiroki YokoyamaCYasuko UchigataCToshika OtaniCAkiko MaruyamaCKawori Yano-AokiCSachiko KanematsuCTadasu KasaharaCź‰YM•viŽ™jCYasue Omori: J. Diabets Complications, 8(1): 7`12, 1994.

1803. mŒ´’˜n Expression of mRNA coding for pituitary hormones and pituitary-specific transcription factor in the pituitary gland of the rdw rat with hereditary dwarfism. ŽÄŽRŒ[ŽqC‘ĺŽR‹XGiŽ™jCŹ–ě‰ë•vi•ŞśjCŒĂŠÚęˆęiŽŔ“Žj: J. Endocrinol., 138(2): 307`313, 1993.

1804. mŒ´’˜n Metacarpophalangeal pattern profile analysis in 14 Japanese children with Sotos syndrome. ‚‹´NCĄň´C‚“cŽj’jiŽ™jC•–Ř—Ç˜ai_“ŢěŒ§—§‚ą‚Ç‚ŕˆă—ĂƒZƒ“ƒ^[j: Jpn. J. Hum. Genet., 39(1): 187`191, 1994.

1805. mŒ´’˜n Endocrine functions in children with suprasellar germinoma. ‡“c•qŒőCˆ˘•”OC“ĄŽ}Œ›“ńi–k‘ĺjCź‰YM•viŽ™j: Neurol. Med. Chir., 33(3): 152`157, 1993.

1806. mŒ´’˜n TZ-T4(ƒŒƒ{ƒ`ƒƒLƒVƒ“ƒiƒgƒŠƒEƒ€ŽUÜ)‚Ě“ű—cŽ™bó‘B‹@”\’ቺÇ‚ɑ΂ˇ‚é—Տ°ŽŽŒą. V”üm’jiç—t‘ĺjC‰Á“Ą¸•FiŽR—œˆă‘ĺjCŹz–KŽOi_“ŢěŒ§—§‚ą‚Ç‚ŕˆă—ĂƒZƒ“ƒ^[jC“ĄŽ}Œ›“ńi–k‘ĺjCź‰YM•viŽ™jC‰œ–ěWłiˆŽěˆă‘ĺjCŒÜ\ —’—Ti“Œ–k‘ĺjC•”~‹ą–FiŒQ”n‘ĺjCb“c’ź–çié‹ĘŒ§—§ŹŽ™ˆă—ĂƒZƒ“ƒ^[jC˛X–Ř–]iç—tŒ§—§‚ą‚Ç‚ŕ•a‰@jC’–ŒŇO–ži’é‹ž‘ĺjC˛“Ą_ˆęiŽĐ‰ď•ŰŒŻ ‘D‹´’†‰›•a‰@jCź”öé•iŒc‰ž‘ĺjC‘ş“cŒő”́i“Œ‹ž—Žqˆă‘ĺj“ú”äŒőˆí˜Yi‘—§ŹŽ™•a‰@jC“y‰Ž—Ti“s—§´ŁŹŽ™•a‰@jC—§‰ÔŽ•Fi_“ŢěŒ§—§‚ą‚Ç‚ŕˆă —ĂƒZƒ“ƒ^[jC’†ŕVáÁ•˝iŽR—œˆă‘ĺjCŒÜ\—’—Ç—Yi•lźˆă‘ĺjCŹěł“ši–źŒĂ‰Ž‘ĺjC˜a“c‹`˜Yi–źŒĂ‰ŽŽs—§‘ĺjC˛“Ą•Űi‹ŕ‘ň‘ĺjC‚‹´Oşi‹ŕ‘ňˆă ‘ĺjC{“ĄłŽi•Ÿˆäˆă‘ĺjCŽO‰ÍtŽ÷i‹ž‘ĺjCˆßŠ}ş•Fi‹ž“s•{—§ˆă‘ĺjCŒ´“c“ż‘ i‘ĺă‘ĺjCˆęFŒşi‘ĺăŽs—§‘ĺjC“Ą“cŒh”V•i‘ĺăŽs—§ŹŽ™•ŰŒ’ƒZ ƒ“ƒ^[jC´–ě‰Ŕ‹Ii‰Ş‘ĺjCź”ü˜aiL“‡Ô\ŽšĽŒ´”š•a‰@jC•“c‘׍Oi“ż“‡‘ĺjC‹M“c‰Ăˆęiˆ¤•Q‘ĺjC‘q”É—˛Mi‚’mˆă‘ĺjC‰Í–ěÄi•Ÿ‰ŞŽs—§‚ą‚Ç‚ŕ •a‰@jC’Ň–F˜Yi’ˇč‘ĺjCźŽR@˜ZiŒF–{‘ĺjCŹ–쐯ŒáiŽ­Ž™“‡‘ĺj: ƒzƒ‹ƒ‚ƒ“‚Ć—Ő°, 41(9): 61`78, 1993.

1807. mŒ´’˜n ƒNƒŒƒ`ƒ“Çƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚Ĺ”­ŒŠ‚ł‚ę‚˝“Ż–E—á|bó‘B‹@”\ˆŮíŽŇ‚Ě23‰ĆŒn. Œ´“cł•˝CŽsŒ´Š¤i–kŠC“š—§‰qśŒ¤‹†ŠjCź‰YM•viŽ™jC“ĄŽ}Œ›“ńC‰œ–ěWłCH“Ą‹œC•ŸŽmŸC‹e’n—RśŽqi“l“ě•a‰@j: ƒzƒ‹ƒ‚ƒ“‚Ć—Ő°, 41(‘): 120`125, 1993.

1808. mŒ´’˜n —cŽ™Šú‚É• •”ŽîᎂŔ­ŒŠ‚ł‚ę‚˝”X–Et‚Ě‚QÇ—á. ’†‘şM–çC–kžŠ‚Ý‚Ç‚čC”э‚Šě‹v—YiŽ™jCŽđˆä‹Ši”ĺj: ŠÖ“ŒŹŽ™t‘ŸŒ¤‹†‰ďŽ, 9(1): 45`47, 1993.

1809. mŒ´’˜n Ý‘Ů32TˆČ‰ş‚Ě‘o‘Ů–˘nŽ™‚ĚŽüŽYŠúŠÇ—‚Ě–â‘č“_. ŹŒűO‹BCŽR“cr•FC˛“Ą‰ë•FCă–ěM–íC–ě“nł•FCŠ—Œ´FiŽ™jC–ě“c–FlC“V–슎iŽY•wj: ŽüŽYŠúŠwSymposium, 11: 43`54, 1993.

1810. mŒ´’˜n DiazepamżÜ‚Ě”­”MŽžŠÔŸ[“Š—^–@‚É‚ć‚é”MŤ‚Ż‚˘‚ę‚ń‚ĚÄ”­—\–hŠJŽnŒă‚É‚Ä‚ń‚Š‚ń‚ֈڍs‚ľ‚˝Ç—á‚Ě—\Œă. ”’ˆäGKCŽO‰YŽő’jC‚—œ‰hCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqC•Đ‹Ë’q–çiŽ™j: ŹŽ™‰Č—Տ°, 47(2): 254`260, 1994.

1811. mŒ´’˜n ‚RÎŽ™ŒŸ”A‚ĚŽŔŽ{•ű–@‚ɂ‚˘‚ā|—cŽ™ŒŸ”A‚Ö‚Ě”AƒŔ2 microglobulin‘Ş’č‚Č‚ç‚тɐt’´‰š”gŒŸ¸‚Ě“ą“ü|. ‰Íź‹IşiŽ™j: t, (7Ľ8‡•š†): 3`7, 1993.

1812. mŒ´’˜n ƒˆ[ƒhŠÜ—LÁ“ōܮg—p’†Ž~‚É‚ć‚éƒNƒŒƒ`ƒ“Çƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‹U—zŤŽŇ‚ĚŒ¸­. Œ´“cł•˝CŽsŒ´Š¤i–kŠC“š—§‰qśŒ¤‹†ŠjCź‰YM•viŽ™jC“ĄŽ}Œ›“ńi–k‘ĺj: “ú–{ŹŽ™‰ČŠw‰ďŽGŽ, 97(6): 1431`1436, 1993.

1813. mŒ´’˜n ƒˆ[ƒh‰ßč‚É‚ć‚éVśŽ™bó‘B‹@”\’ቺÇ‚ĚŽw•W‚Ć‚ľ‚Ä‚Ě”A’†ƒˆƒE‰ť•¨ƒCƒIƒ“”Z“x‘Ş’č‚ĚˆÓ‹`. Œ´“cł•˝CŽsŒ´Š¤i–kŠC“š—§‰qśŒ¤‹†ŠjCź‰YM•viŽ™jC“ĄŽ}Œ›“ńi–k‘ĺj: “ú–{VśŽ™Šw‰ďŽGŽ, 29(2): 405`410, 1993.

1814. mŒ´’˜n –˘nŽ™‚Ě”A—ʂƉe‹żˆöŽq|‹ÉŹ–˘nŽ™‚Ě–ňÜŤ‹}Ť”ń–R”AŤt•s‘S‚É‚¨‚Ż‚錟“˘|. ‰Íź‹IşiŽ™j: •‘ –ě—Žq‘ĺŠw‹I—v, 29(2): 189`191, 1994.

1815. mŒ´’˜n ”­ěŠÔŒ‡Šú‚É”]”gˆŮí‚đ”F‚ß‚Č‚˘‘O“Ş—t‹NŒš‚Ě•ĄŽG•”•Ş”­ě‚Ě‚P—á. ”ޏ\“ˆOˆęi“l“ě•a‰@jCź‰YM•viŽ™jCŽu“c’ź’îi“l“ě•a‰@jCâ”ECŠˆä’ź•śi–k‘ĺj: —Տ°ŹŽ™ˆăŠw, 41(3): 143`146, 1993.

1816. mŒ´’˜n ŽŠŒČ–ƉuŤbó‘B‹@”\’ቺÇ, ŽŠŒČ–ƉuŤ—nŒŒŤ•nŒŒ‚Ĺ”­Ç‚ľ‚˝”şŤ—ňŤŽŠŒČ–ƉuŤ’°Ç‚Ě‚P—á. ˛’|“TŽqC‰Ş–ě‘f•FC’†źłŒ›C•x‘ňˆę_CÎâ–žlCŹ“‡ŒöˆęCŹ–쎛‰ëŽjC—L‰ęłCčŽRK—Yi–k‘ĺjC˛’|–žCĄ–앐’ĂŽqCÎěM‹`i–kŒŠÔ\Žš•a ‰@jCź‰YM•viŽ™jCź–{ăůŽOi–k‘ĺj: —Տ°ŹŽ™ˆăŠw, 41(6): 263`267, 1993.

1817. m€Œ´’˜i‰p•śjn Long-term prognosis of developed epilepsies after starting intermittent therapy with rectal diazepam suppositories for the prevention of recurrent febrile convulsions. ”’ˆäGKCŽO‰YŽő’jC‚—œ‰hCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqiŽ™j: Brain Dev., 15(5): 396`397, 1993.

1818. m€Œ´’˜i‰p•śjn Skin rash caused by carbamazepine. ×“c‚Ě‚ź‚݁CŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂCˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqiŽ™j: Jpn. J. Psychiatry Neurol., 47(2): 300`301, 1993.

1819. m€Œ´’˜n ŹŽ™‚Ě•”•Ş”­ě‚ɑ΂ˇ‚ézonisamide’PÜ1“ú1‰ń“Š—^–@‚ĚŒř‰Ę‚ĆŒŒ’†”Z“x. ×“c‚Ě‚ź‚݁CŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂCˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqC•Đ‹Ë’q–çiŽ™j: TDMŒ¤‹†, 10(3): 240`241, 1993.

1820. m€Œ´’˜n ŹŽ™‚̐öˆöŤ‹ÇÝŠÖ˜AŤ‚Ä‚ń‚Š‚ń‚ɑ΂ˇ‚ézonisamide’PÜ1“ú1‰ń“Š—^–@‚ĚŒř‰Ę‚Ć•›ě—p. ×“c‚Ě‚ź‚݁CŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂCˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqC•Đ‹Ë’q–çiŽ™j: ‘ć3‰ń—Տ°¸__Œo–ň—Œ¤‹†‰ďƒVƒmƒvƒVƒX, p.37`40, 1994.

1821. m€Œ´’˜n ‘źÜ–łŒř‚Č‚Ä‚ń‚Š‚ńÇ—á‚ɑ΂ˇ‚éacetazolamide‚Ě’ˇŠúŒř‰Ę‚Ć•›ě—p. ˆŔ•ŰŒŤˆęCŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰƒŽqiŽ™j: ”­’B–ň—Ľ–ň•¨ŽĄ—ĂŒ¤‹†‰ďŽGŽ, 6(1): 14`16, 1993.

1822. mŒ¤‹†•ńn Expression of mRNA coding for pituitary hormones and pituitary-specific transcriptin factor in the pituitary gland of the rdw rat with hereditary dwarfism. ŽÄŽRŒ[ŽqC‘ĺŽR‹XGiŽ™jCŹ–ě‰ë•vi•ŞśjCŒĂŠÚęˆęiŽŔ“Žj: ŕĽŹ’ˇ‰ČŠw‹Ś‰ďŒ¤‹†”N•ń, (16): 473`485, 1992.

1823. mŒ¤‹†•ńi•ś•”Čjn ŹŽ™‚É‚¨‚Ż‚éR‚Ä‚ń‚Š‚ń–ň‚Ě‘Ě“ŕ“Ž‘Ôƒ‚ƒjƒ^ƒŠƒ“ƒO. ŽO‰YŽő’jC”’ˆäGKCť‰ŸÂCˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqC•Đ‹Ë’q–çiŽ™j: •˝Ź5”N“x‰ČŠwŒ¤‹†”ď•â•‹ŕŽŔŃ•ń‘, 1994.

1824. mŒ¤‹†•ńiŒúśČjn ƒNƒŒƒ`ƒ“ÇƒXƒNƒŠ[ƒjƒ“ƒO‚̐¸“xŠÇ—|ƒJƒbƒgƒIƒt’l‚Ɛ¸ŒŸ—Ś”­ŒŠ•p“x‚ĚŠÖŒW. ź‰YM•viŽ™jCŒ´“cł•˝CŽsŒ´Š¤i–kŠC“š—§‰qśŒ¤‹†ŠjC“ĄŽ}Œ›“ńi–k‘ĺj: ŒúśČSgáŠQŒ¤‹†|ƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒOƒVƒXƒeƒ€‚Ě•]‰ż•ű–@‚ÉŠÖ‚ˇ‚錤‹†, •˝Ź4”N“xŒ¤‹†•ń‘, p.212`214, 1993.

1825. mŒ¤‹†•ńiŒúśČjn ŹŽ™‚É‚¨‚Ż‚éR‚Ä‚ń‚Š‚ń–ň‚Ě‘Ě“ŕ“Ž‘Ôƒ‚ƒjƒ^ƒŠƒ“ƒO: carbamazepine‚Ě•š—p‚Şzonisamide‚ĚŒŒ’†”Z“x‚É‚¨‚ć‚Ú‚ˇ‰e‹ż. ŽO‰YŽő’jC”’ˆäGKCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqiŽ™j: ŒúśČ¸_Ľ_ŒoŽžŠłŒ¤‹†ˆĎ‘ő”ď, “‚Ä‚ń‚Š‚ń‚ĚŽĄ—Ă–@ŠJ”­‚ÉŠÖ‚ˇ‚錤‹†•˝Ź4”N“xŒ¤‹†•ń, p.193`197, 1993.

1826. mŒ¤‹†•ńiŒúśČjn –kŠC“š‚ɉ—‚Ż‚鏬Ž™Šú”­Ç IDDM ‚̉uŠw‚ÉŠÖ‚ˇ‚錤‹†|”­Ç‚ÉŠÖ—^‚ˇ‚éŠÂ‹ŤˆöŽq‚̉đÍ|. ź‰YM•viŽ™jCŒ´“cł•˝i–kŠC“š—§‰qśŒ¤‹†Šj: ŒúśČ“œ”A•a‚̉uŠw‚ÉŠÖ‚ˇ‚錤‹†•˝Ź4”N“xŒ¤‹†•ń‘, p.137`141, 1993.

1827. mŒ¤‹†•ńiŒúśČjn CAPDŠłŽ™‚É‚¨‚Ż‚鐏’ˇ‚ÉŠÖ‚ˇ‚錤‹†. ”э‚Šě‹v—YC–kžŠ‚Ý‚Ç‚čC’†‘şM–çCŽO‘şM‰piŽ™j: •˝Ź‚S”N“xŒúś‰ČŠwŒ¤‹†t•s‘Sˆă—ĂŒ¤‹†Ž–‹ĆŒ¤‹†•ń‘, p.140`144, 1993.


<<16 2 ŹŽ™‰ČŠw>>

1828. mÇ—á•ńn ŒŒ’†thyroglobulin(Tg)•Ş”ĺ•s‘S‚đŽŚ‚ľ‚˝TgŒ‡‘šÇiTg“]‘—ˆŮíj‚Ě‚P’jŽ™—á. ’†‘şM–çC‘ĺŽR‹XGCˆŔ•ŰƒŽqC•—’ŁKŽiCŒ´^lCŠÖŞ“OCŽÄŽRŒ[ŽqC‰Ą“csŽjiŽ™jC‹T’J“Oi•a—jC—é–Ř“żşC×’J“Œˆę˜Yiç—t‘ĺj: ƒzƒ‹ƒ‚ƒ“‚Ć—Ő°, 41(‘): 96`99, 1993.

1829. mÇ—á•ńn Ź’ˇƒzƒ‹ƒ‚ƒ“•Ş”ĺ”\łí‚Ĺ, ŒŒ’†ƒ\ƒ}ƒgƒƒWƒ“C, GHŒ‹‡’`”’‚Ş’á’l‚đŽŚ‚ˇ‚UÎ‚U‚ŠŒŽ‚Ě’ág’ˇ’jŽ™‚Ě‚P—á. •—’ŁKŽiC‘ĺŽR‹XGC‰Ą“csŽjCŽÄŽRŒ[ŽqC‚“cŽj’jC‰Í‘ş˝ŽŸC’†‘şM–çC–ěXŽRŸlC•~“‡N•śiŽ™jCŒÜ\—’“oi‹ŕ‘ň‘ĺjC’ˇ’Jěs—mi“s—§´ŁŹŽ™•a ‰@jCź‰YM•viŽ™j: ƒzƒ‹ƒ‚ƒ“‚Ć—Ő°, 42(‘): 49`52, 1994.

1830. mÇ—á•ńn thyroglobulinŒ‡‘šÇiTg“]‘—ˆŮíj‚ĚÇ—á‚É‚¨‚Ż‚éTg‚Ě—€‘f‰ť‚ÉŠÖ‚ˇ‚é‚PlŽ@. ‘ĺŽR‹XGiŽ™jC×’J“Œˆę˜Yiç—t‘ĺjC‹T’J“Oi•a—jC—é–Ř“żşiç—t‘ĺjC’†‘şM–çCˆŔ•ŰƒŽqCŒ´^lCŠÖŞ“OC•—’ŁKŽiCŽÄŽRŒ[ŽqC‰Ą“csŽjCź‰Y M•viŽ™j: ƒzƒ‹ƒ‚ƒ“‚Ć—Ő°, 42(‘): 86`88, 1994.

1831. mÇ—á•ńn DepotŒ^LHRHƒAƒiƒƒO‚đ‚P”NˆČăŽg—p‚ľ‚˝Ť‘nÇ—Ž™‚T—á. ‰Ą“csŽjC•—’ŁKŽiCŽÄŽRŒ[ŽqC‘ĺŽR‹XGiŽ™j: ƒzƒ‹ƒ‚ƒ“‚Ć—Ő°, : 217`221, 1993.

1832. mÇ—á•ńn ŽŠ‘R‘ޏkŒXŒü‚đ‚P”NŠÔŠĎŽ@‚Ĺ‚Ť‚˝_Œo‰č×–EŽî‚Ě‚P—á. ĄˆäƒDiŽ™jCÎ“c˜a•viŠOjC“‡–{—R‹IŽqC‰““Ą‹I—YiŽ™j: ŹŽ™‚Ş‚ń, 30: 98`100, 1993.

1833. m‘ŕn ŹŽ™‰Č‚Š‚ç“ŕ‰Č‚Ö‚ĚŠłŽŇ‚ĚŽó“n‚ľ•ű‚ɂ‚˘‚Ä. ź‰YM•viŽ™j: Diabetes J., 21(4): 155`157, 1993.

1834. m‘ŕn A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) seabetes mellitus. Karvones, M.CTuomilehto, J.iNational Public Institute, FinlandjCLibman, I.CLaporte, R. iUniv. of PittsburghjCź‰YM•viŽ™j: Diabetologia, 36(10): 883`892, 1993.

1835. m‘ŕn Developmental and therapeutic pharmacology of antiepileptic drugs. ŽO‰YŽő’jiŽ™j: Jpn. J. Psychiatry Neurol., 47(2): 169`174, 1993.

1836. m‘ŕn bó‘BŽžŠł‡•š”D•w‚Š‚çoś‚ľ‚˝VśŽ™. ź‰YM•viŽ™j: Perinatal Care, 12(4): 317`324, 1993.

1837. m‘ŕn H‚אˇ‚č‚̐HŽ–—Ă–@. ź‰YM•viŽ™j: ‚ׂń‚ż‚́[‚Ć, 7(3): 10`11, 1994.

1838. m‘ŕn ć“VˆŮí‚ĆƒRƒ“ƒsƒ…[ƒ^f’f. ‚“cŽj’jiŽ™j: ŽüŽYŠúˆăŠw, 23(9): 1326`1330, 1993.

1839. m‘ŕn tŽžŠł‚ɑ΂ˇ‚é’`”’•Ş‰đy‘f‘jŠQÜ: ƒƒVƒ‹Ž_ƒKƒxƒLƒT[ƒg. ‰Íź‹IşiŽ™j: ŹŽ™‰Č, 34(7): 903`908, 1993.

1840. m‘ŕn ‘I‘đ“IŒŒŸ÷ŒđŠˇ—Ă–@. ’†‘şM–çC”э‚Šě‹v—YiŽ™j: ŹŽ™‰Č, 35(1): 1`5, 1994.

1841. m‘ŕn S•s‘S(1)Çó, ŠŒŠ‚Ɛf’f(2)ŽĄ—Ă. •˝Î‘iŽ™j: ŹŽ™‰Čf—Ă, (’ǘ^‘ć16†): 1512`1517, 1993.

1842. m‘ŕn śŽş’áŒ`ŹÇŒóŒQ. •˝Î‘iŽ™j: ŹŽ™‰Čf—Ă, 56(Suppl.): 155, 1993.

1843. m‘ŕn ŹŽ™‚ĚÇŒóŒQ|ć“VŤƒlƒtƒ[ƒ[ÇŒóŒQ. ”э‚Šě‹v—YiŽ™j: ŹŽ™‰Čf—Ă, 56(‘): 288, 1993.

1844. m‘ŕn —cŽ™ĽŠw“ś‚Ěšq“f‚Ć’Á“fÜ‚ĚŽg‚˘‚Š‚˝. Ź“‡–M•FiŽ™j: ŹŽ™“ŕ‰Č, 25(6): 43`48, 1993.

1845. m‘ŕn LHRHťÜ, hCGĽhMGťÜ. ‰Ą“csŽjiŽ™j: ŹŽ™“ŕ‰Č, 25(8): 1153`1156, 1993.

1846. m‘ŕn “ŕ•Ş”ĺÇŒóŒQ; Aarskog ÇŒóŒQ. ź‰YM•viŽ™j: “ú–{—Տ°, (•Ęű): 374`377, 1993.

1847. muŔn VśŽ™‚Ż‚˘‚ę‚ń‚Ć”MŤ‚Ż‚˘‚ę‚ń. ŽO‰YŽő’jiŽ™j: Clin. Neurosci., 12(3): 312`315, 1994.

1848. muŔn ”MŤ‚Ż‚˘‚ę‚ń‚ĚŽĄ—Ă. ŽO‰YŽő’jiŽ™j: ŹŽ™‰Čf—Ă, 56(9): 1674`1682, 1993.

1849. muŔn ŹŽ™‚ĚÇŒóŒQ: LennoxÇŒóŒQ(Lennox-GastautÇŒóŒQ). ŽO‰YŽő’jiŽ™j: ŹŽ™‰Čf—ÁC56(‘): 123, 1993.

1850. muŔn ŠO—pÜĽżÜ‚Ć‚ť‚ĚŽg‚˘•ű: R‚Ż‚˘‚ę‚ń–ň. ŽO‰YŽő’jiŽ™j: ŹŽ™“ŕ‰Č, 25(11): 1633`1637, 1993.

1851. muŔn R‚Ż‚˘‚ę‚ńÜ‚Ě–ň—. ŽO‰YŽő’jiŽ™j: ŹŽ™“ŕ‰Č, 25(9): 1243`1248, 1993.

1852. muŔn ŒŸ¸’l‚Ě‚Ý‚Š‚˝: ƒtƒFƒjƒgƒCƒ“, ƒtƒFƒmƒoƒ‹ƒrƒ^[ƒ‹, ‚ť‚Ě‘ź‚̍R‚Ä‚ń‚Š‚ń–ň‚ĚŒŒ’†”Z“x. ŽO‰YŽő’jiŽ™j: —Տ°ˆă, 19(‘): 1070`1071, 1993.

1853. muŔn ¸__Œo‰Č‚ĚÇŒóŒQ: WestÇŒóŒQ. ŽO‰YŽő’jiŽ™j: —Տ°¸_ˆăŠw, 23(‘5): 264`268, 1994.

1854. mŠwp‘i‰p•śjn i•Ş’SŽˇ•Mj 80 Years of Hashimoto Disease; Long-term growth in children with atrophic autoimmune thyroiditis, p.515`519, ź‰YM•viŽ™jCŒ´“cł•˝i“š—§‰qśŒ¤j. •ŇW Nagataki, S.CMori, T.CTorizuka, K.C Elsevier Science Publishers, 93.00.00”­s.

1855. mŠwp‘i‰p•śjn i•Ş’SŽˇ•Mj Iodine Deficiency in Europe; Iodine excess and thyroid autoimmunity, p.93`99, ź‰YM•viŽ™jCŒ´“cł•˝i“š—§‰qśŒ¤j. •ŇW Delange, F.CDunn, J.T.CGlinoer, D.C Plenum Press, 93.00.00”­s.

1856. mŠwp‘n i•Ş’SŽˇ•Mj ŹŽ™‚̐SƒGƒR[}; –˘nŽ™“Ž–ŹŠÇŠJ‘ś‚Ě•]‰ż, p.81`89, •˝Î‘iŽ™j. •ŇW ‰Á“Ą—T‹vi‹v—Ż•Ä‘ĺjC ‹ŕŒ´o”Ĺ, “Œ‹ž, 93.09.30”­s.

1857. mŠwp‘n i•Ş’SŽˇ•Mj ŹŽ™—Տ°ŒŸ¸ƒ}ƒjƒ…ƒAƒ‹; ”A“œ, ƒPƒgƒ“”A, ‰ŠŞ: 556`560, ź‰YM•viŽ™j. •ŇW ‘ĺ‘^•FC‰Í–ě‹Ď–çi“ú‘ĺjC •śŒő“°, “Œ‹ž, 93.10.23”­s.

1858. mŠwp‘n i•Ş’SŽˇ•Mj ŹŽ™—Տ°ŒŸ¸ƒ}ƒjƒ…ƒAƒ‹; ”AöŒŒ”˝‰ž, p.569`571, ’†‘şM–çC”э‚Šě‹v—YiŽ™j. •ŇW ‘ĺ‘^•FC‰Í–ě‹Ď–çi“ú‘ĺjC •śŒő“°, “Œ‹ž, 93.10.23”­s.

1859. mŠwp‘n i•Ş’SŽˇ•Mj ŹŽ™—Տ°ŒŸ¸ƒ}ƒjƒ…ƒAƒ‹; ”A’žŸÔ, p.566`568, ’†‘şM–çC”э‚Šě‹v—YiŽ™j. •ŇW ‘ĺ‘^•FC‰Í–ě‹Ď–çi“ú‘ĺjC •śŒő“°, “Œ‹ž, 93.10.23”­s.

1860. mŠwp‘n i•Ş’SŽˇ•Mj Ą“ú‚̏ŹŽ™ŽĄ—ĂŽwji10”Łj; bó‘BŽî, p.273, ź‰YM•viŽ™j. •ŇW ”ˇ‰Ă”Vi“Œ–M‘ĺjCŽO‰ÍtŽ÷iŠÖź“d—Í•a‰@jCd“c­MiŹňd“cjC–î“cƒˆęi“Œ‹žˆăŽ•‘ĺjC ˆăŠw‘‰@, “Œ‹ž, 93.11.01”­s.

1861. mŠwp‘n i•Ş’SŽˇ•Mj ŹŽ™‰ČŠw”NŠÓ 1993: ŹŽ™‰Č‚̐i•ŕ13; DiazepamżÜ‚É‚ć‚é”MŤ‚Ż‚˘‚ę‚ń‚ĚÄ”­—\–h, p.120`124, ŽO‰YŽő’jiŽ™j. •ŇW ‘OěŠě•˝i“Œ‹žŽœˆă‘ĺjCĄ‘ş‰hˆęC f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 93.10.25”­s.


<<16 3 ŹŽ™‰ČŠw>>

1862. m‹ł‰Č‘i‰p•śjn i•Ş’SŽˇ•Mj Pediatric Nephrology, 3rd Edition; Pediatric nephrology from around the world Japan: Screening problems, p.1434`1435, ”э‚Šě‹v—YiŽ™j. •ŇW M.A. HollidayCT.M. BarrattCE.D. AvnerC Williams & Wilkins, Baltimore, 94.00.00”­s.

1863. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj Ą“ú‚̏ŹŽ™ŽĄ—ĂŽwji10”Łj; tŤœˆŮ‰h—{Ç, p.489`490, ”э‚Šě‹v—YiŽ™j. •ŇW ”ˇ‰Ă”Vi“Œ–M‘ĺjCŽO‰ÍtŽ÷iŠÖź“d—Í•a‰@jCd“c­MiŹňd“cjC–î“cƒˆęi“Œ‹žˆăŽ•‘ĺjC ˆăŠw‘‰@, “Œ‹ž, 93.11.01”­s.

1864. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj Ą“ú‚̏ŹŽ™ŽĄ—ĂŽwji10”Łj; ŠŒF×–EŽî, p.270, ‘ĺŽR‹XGiŽ™j. •ŇW ”ˇ‰Ă”Vi“Œ–M‘ĺjCŽO‰ÍtŽ÷iŠÖź“d—Í•a‰@jCd“c­MiŹňd“cjC–î“cƒˆęi“Œ‹žˆăŽ•‘ĺjC ˆăŠw‘‰@, “Œ‹ž, 93.11.01”­s.

1865. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ƒ]ƒjƒTƒ~ƒh‚̐˘ŠE: ’˜Œř100Ç—áW; öˆöŤ‹ÇÝŠÖ˜AŤ‚Ä‚ń‚Š‚ń: “ńŽŸŤ‘S”ʉť”­ě, p.76, ŽO‰YŽő’jiŽ™j. ‘n‘˘o”Ĺ, “Œ‹ž, 94.03.15”­s.

1866. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj Œü¸_–ňƒnƒ“ƒhƒuƒbƒN; ŹŽ™‚É‚¨‚Ż‚éŽĺ—vR‚Ä‚ń‚Š‚ń–ň‚Ě“Š—^—Ę, ŒŒ’†”źŒ¸Šú, —LŒřŒŒ’†”Z“x, ’†“ĹŒŒ’†”Z“x‚¨‚ć‚Ń•›ě—p, p.221`225, ŽO‰YŽő’jiŽ™j. •ŇW ‘ĺ“ú–{ť–ňC ‘ĺ“ú–{ť–ň, ‘ĺă, 93.10.01”­s.


<<16 4 ŹŽ™‰ČŠw>>

1867. m–|–ón i•Ş’SŽˇ•Mj ƒCƒ“ƒXƒŠƒ“—Ă–@ 1992; ƒCƒ“ƒXƒŠƒ“—Ă–@‚ƍ‡•šÇ, p.103`116, ź‰YM•viŽ™j. •ŇW ’r“c‹`—YC ƒmƒ{ƒmƒ‹ƒfƒBƒXƒNƒtƒ@[ƒ}, “Œ‹ž, 93.03.10”­s.


<<16 5 ŹŽ™‰ČŠw>>

1868. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Thyroid function in mothers and fetus during pregnancy and outcome in the children. ź‰YM•viŽ™j: 1st Asian Pacific Regional Meeting of International Society for Neonatal Screening i93.06.21`23j, ŽD–y.

1869. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Long-term prognosis of west syndrome treated combined with ACTH and clonazepam. ”’ˆäGKCŽO‰YŽő’jC‚—œ‰hCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqC•Đ‹Ë’q–çiŽ™j: ‘ć4‰ńƒAƒWƒAĽƒIƒZƒAƒjƒAŹŽ™_ŒoŠw‰ď‹c(The 4th Asian and Oceanian Congress of Child Neurology) (93.11.22), Chiang Mai, Program and Abstracts, p.137, 1993.

1870. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Once-daily dose of zonisamide monotherapy in the control of partial seizures in children: Clinical effects and their pharmacokinetic basis. ŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqC•Đ‹Ë’q–çiŽ™j: ‘ć4‰ńƒAƒWƒAĽƒIƒZƒAƒjƒAŹŽ™_ŒoŠw‰ď‹c(4th Asian and Oceanian Congress of Child Neurology) (93.11.22), Chiang Mai, Program and Abstracts, p.139, 1993.

1871. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Peritoneal equilibration test (PET) in children on CAPD. ’†‘şM–çC”э‚Šě‹v—YC–kžŠ‚Ý‚Ç‚čiŽ™jCŽđˆä‹Ši”ĺj: 4th Asian Congress of Pediatric Nephrology i93.04.09`11j, Taiwan.

1872. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Effect of ductus arteriosus on left ventricular output and regional blood distribution during early neonatal life. ăp—z‘ž˜YC•˝Î‘CŽO‘ňmŽiCL“c•l•vC“Ą–ěé”VC–xŒű‘דTC–ě“nł•FiŽ™j: •Ä‘ Western Society for Pediatric Research i94.02.12j, •Ä‘, ƒJ[ƒƒ‹, Clin. Res., 42(1): 91, 1994.

1873. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Effect of Concurrent Administration of Carbamazepine on the Plasma Concentrations of Zonisamide. ŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqiŽ™j: ‘ć20‰ń‘Ű‚Ä‚ń‚Š‚ńŠw‰ď‹c(20th International Epilepsy Congress) (93.07.06), Oslo, Epilepsia, 34(suppl.2): 90, 1993.

1874. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Long-term prognosis of developed epilepsies after starting intermittent therapy with rectal diazepam suppositories for prevention of recurrent febrile convulsions. ”’ˆäGKCŽO‰YŽő’jC‚—œ‰hCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqiŽ™j: ‘ć20‰ń‘Ű‚Ä‚ń‚Š‚ńŠw‰ď‹c(20th International Epilepsy Congress) (93.07.08), Oslo, Epilepsia, 34(suppl.2): 166, 1993.

1875. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Long-team treatment with recombinant human insulin-like growth factor-1 (rhIGF-1) for patients with extreme insulin resistant diabetes. ź‰YM•viŽ™j: ‘ć4‰ń‰˘B•Ä‘ŹŽ™“ŕ•Ş”ĺŠw‰ď i93.06.03`07j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR, Pediatr. Res., 33(Suppl.5): 78, 1993.

1876. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Long-term treatment with recombinant human insulin-like growth factor 1 (rhIGF-1) for patients with extreme insulin resistant diabetes. ź‰YM•viŽ™j: ‘ć4‰ń‰˘B•Ä‘ŹŽ™“ŕ•Ş”ĺŠw‰ď i93.06.04j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR, Pediatr. Res., 33(Suppl.): 78, 1993.

1877. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j A case of congenital euthyroid goiter with impaired thyroglobulin (TG) transport: Immunohistochemical evidence of intracellular Tg iodination. ‘ĺŽR‹XGC’†‘şM–çC•—’ŁKŽiCŽÄŽRŒ[ŽqC‰Ą“csŽjiŽ™jC‹T’J“Oi•a—jCN. SuzukiCT. Hosoyaiç—t‘ĺj: ‘ć4‰ń‰˘B•Ä‘ŹŽ™“ŕ•Ş”ĺŠw‰ď i93.06.04j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR, Pediatr. Res., 33(Suppl.): 91, 1993.

1878. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Developmental expression of growth hormone-releasing hormone and somatostatin gene and their peptide products in rat hypothalamus. ‘ĺŽR‹XGCŽÄŽRŒ[ŽqC•—’ŁKŽiC‰Ą“csŽjiŽ™j: 75th Annual Meeting of Endocrine Society i93.06.11j, Las Vegas, Program and Abstracts, p.415, 1993.

1879. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Moment analysis of multiple breath nitrogen washout in asthmatic children. Žl‘qł”ŽC“n•Ó“oC’†“ˆ‰p•FC˛“Ą—Y“ńC”~Œ´ŽŔC–Ľ‰YŽ‘ĽC’ˇ“cŒúCŠÖŞ“OCŒ´^liŽ™j: 17th World Congress on Disease of the Chest i93.06.15j, Amsterdam, Chest, 103(Suppl.): 217, 1993.

1880. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Effects of recombinant insulin like growth factor 1 on insulin secretion in patients with extreme insulin resistant diabetes. ź‰YM•viŽ™j: 19th Annual Meeting of ISGD i93.09.02`06j, Greece, Diabetes in the Young, p.70, 1993.

1881. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j The effect of rhuepo (epoetin-A) on the anemia of predialysis CRF patients in children. ˆÉ“ĄŽŒČi“Œ‹ž—ˆă‘ĺjC–kěĆ’ji“ú‘ĺjCŹźNGi“Œ‹ž—ˆă‘ĺjC”’”ŻGŽiiç—tŒ§‚ą‚Ç‚ŕ•a‰@jC”э‚Šě‹v—YiŽ™jCRhuepo Japanese Multicenter Study Group: ‘ć27‰ńƒˆ[ƒƒbƒpŹŽ™t‘ŸŠw‰ď i93.09.08j, ƒnƒCƒfƒ‹ƒxƒ‹ƒO.

1882. mŠw‰ďi‘S‘jn i‹łˆçu‰‰j bó‘B‹@”\‚̕ꎙ‘ŠŠÖ. ź‰YM•viŽ™j: ‘ć38‰ń“ú–{–˘nŽ™VśŽ™Šw‰ď i93.10.28`29j, ŽD–y.

1883. mŠw‰ďi‘S‘jn i‹łˆçu‰‰j ‡TŒ^“œ”A•a‚Ě•aˆö‚ÉŠÖ‚ˇ‚éĹ‹ß‚Ě’mŒŠ. ź‰YM•viŽ™j: ‘ć28‰ń“œ”A•aŠw‚̐i•ŕi“ú–{“œ”A•aŠw‰ďj i94.02.17`18j, “Œ‹ž.

1884. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj Šw—îŠút•s‘SŠłŽŇ‚ŞŠwZśŠˆ‚đ‚¨‚­‚éđŒ‚ɂ‚˘‚Ä. ‰Á“‡–žC‘O“cŒiŽqC–@—R”üŽqCŽćo—ÁŽqC–x‰z—R‹IŽqi‘‡‘Š’k•”jC–kžŠ‚Ý‚Ç‚čC’†‘şM–çC”э‚Šě‹v—YiŽ™jCŽđˆä‹Ši”ĺj: ‘ć38‰ń“ú–{“§Í—Ă–@Šw‰ď‘‰ď i93.07.17`18j, ç—t.

1885. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Carbamazepine‚Ě•š—p‚Şzonisamide‚ĚŒŒ’†”Z“x‚É‚¨‚ć‚Ú‚ˇ‰e‹ż. ˆŔ•ŰƒŽqCŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰŒŤˆęiŽ™j: ‘ć96‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (93.04.25), ‰Ą•l, “ú–{ŹŽ™‰ČŠw‰ďŽGŽ, 97(2): 402, 1993.

1886. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹŽ™‚Ě•”•Ş”­ě‚ɑ΂ˇ‚éclonazepam’PÜŽĄ—Ă‚ĚŒř‰Ę|‰‰ńˆŰŽ—Ę0.05 mg/kg/day‚ĚŒŸ“˘|. ˆŔ•ŰŒŤˆęCŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰƒŽqiŽ™j: ‘ć96‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (93.04.25), ‰Ą•l, “ú–{ŹŽ™‰ČŠw‰ďŽGŽ, 97(2): 402, 1993.

1887. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹŽ™‚Ě•”•Ş”­ě‚ɑ΂ˇ‚ézonisamide’PÜ1“ú1‰ń“Š—^–@‚ĚŒř‰Ę‚ĆŒŒ’†”Z“x. ×“c‚Ě‚ź‚݁CŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂCˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqC•Đ‹Ë’q–çiŽ™j: ‘ć10‰ń“ú–{TDMŠw‰ď (93.06.04), “Œ‹ž, —vŽ|W, p.68, 1993.

1888. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹŽ™‚Ě•”•Ş”­ě‚ɑ΂ˇ‚éclonazepam’PÜŽĄ—Ă‚Ě’ˇŠúŒř‰Ę|‰‰ńˆŰŽ—Ę0.05 mg/kg/day‚ĚŒŸ“˘|. ˆŔ•ŰŒŤˆęCŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰƒŽqiŽ™j: ‘ć35‰ń“ú–{ŹŽ™_ŒoŠw‰ď‘‰ď (93.06.17), ‹ž“s, ”]‚Ć”­’B, 25(‘‰ď†): 163, 1993.

1889. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹŽ™‚Ě•”•Ş”­ě‚ɑ΂ˇ‚ézonisamide’PÜ1“ú1‰ń“Š—^–@‚ĚŒř‰Ę‚ĆŒŒ’†”Z“x|”N—î‚Ć‚ĚŠÖŒW‚ɂ‚˘‚ā|. ×“c‚Ě‚ź‚݁CŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂCˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqC•Đ‹Ë’q–çiŽ™j: ‘ć27‰ń“ú–{‚Ä‚ń‚Š‚ńŠw‰ď (93.10.01), O‘O, ƒvƒƒOƒ‰ƒ€Ľ—\eW, p.128, 1993.

1890. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ˆâ“`‘Š’k‚ĚŒťó, –â‘č“_. ‚“cŽj’jCŹŒűO‹BiŽ™jC‘O“c“OiŠĹŒěŠw•”j: ‘ć15‰ń“ú–{ŹŽ™ˆâ“`ˆăŠw‰ďŠwpW‰ď i92.05.14j, źŽR, —\eW, p.24, 1992.

1891. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹŽ™CAPDŠłŽŇ‚É‚¨‚Ż‚é• –Œ•˝t‹@”\ŒŸ¸(PET). ’†‘şM–çC–kžŠ‚Ý‚Ç‚čC”э‚Šě‹v—YiŽ™j: ‘ć35‰ń“ú–{t‘ŸŠw‰ď‘‰ď i92.12.04j, ‰Ą•l, —\eW, p.266, 1992.

1892. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’´‚‘ŹCT‚É‚ć‚éěč•aSŒŒŠÇ•a•Ď‚Ě•]‰ż|SƒGƒR[}, SŒŒŠÇ•a•Ď‚Ć‚Ě”äŠr|. –xŒű‘דTC–Ľ‰YŽ‘ĽiŽ™jC“n•Ó’qŽqiŠƒ–č“żB‰ď‘‡•a‰@jC•˝Î‘CŽO‘ňmŽiCăp—z‘ž˜YC“Ą–ěé”VCL“c•l•viŽ™j: ‘ć96‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď i93.04.23j, ‰Ą•l, “ú–{ŹŽ™‰ČŠw‰ďŽGŽ, 97(2): 341, 1993.

1893. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j VśŽ™Šú‘Šú‚É‚¨‚Ż‚éS”o—Ę‚¨‚ć‚Ń‚ť‚ĚŒŒ—Ź•Ş•z‚Ě•Ď“Ž. ăp—z‘ž˜YC–ě“nł•FC”ó‰YDCŹŒűO‹BC•˝Î‘iŽ™j: ‘ć96‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď i93.04.23j, ‰Ą•l, “ú–{ŹŽ™‰ČŠw‰ďŽGŽ, 97(2): 483, 1993.

1894. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j N2‘˝ŒÄ‹zô‚˘o‚ľ–@ƒ‚[ƒƒ“ƒg‰đÍ‚É‚ć‚é‹CŠÇŽxšb‘§Ž™‚ĚŠˇ‹C•s‹Ď“™•Ş•z‚ĚŒŸ“˘. Žl‘qł”ŽC’†“ˆ‰p•FC“n•Ó“oC˛“Ą—Y“ńC”~Œ´ŽŔC–Ľ‰YŽ‘ĽC’ˇ“cŒúCŠÖŞ“OCŒ´^liŽ™j: ‘ć96‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď i93.04.23j, ‰Ą•l, “ú–{ŹŽ™‰ČŠw‰ďŽGŽ, 97(2): 522, 1993.

1895. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j IGF-1 ‚É‚ć‚éƒCƒ“ƒXƒŠƒ“’ďRŤ“œ”A•a‚ĚŽĄ—Á|ƒCƒ“ƒXƒŠƒ“•Ş”ĺ‚É‹y‚Ú‚ˇ‰e‹ż|. ź‰YM•viŽ™j: ‘ć36‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď i93.05.13`15j, ĺ‘ä.

1896. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j œë•aŠúŠÔ10”NˆČ“ŕ‚É‘B–Ô–ŒÇ‚đ’ć‚ľ‚˝ƒCƒ“ƒXƒŠƒ“ˆË‘śŒ^“œ”A•a(IDDM)‚ĚŒŸ“˘. –î–ě‚Š‚𗢁C‰ĄŽRGŽ÷C“ŕŠƒˆŔŽqCŠŰŽR–žŽqC‘ĺ’J•q‰ĂCŒ“źKŽqC”óă—TŽqCŠ}Œ´“Cź‰YM•viŽ™jC‘ĺXˆŔŒb: ‘ć36‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď i93.05.13`15j, ĺ‘ä.

1897. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j CAPD‚É‚¨‚Ż‚é• –Œ‰Š‚̍‡•š. ’†‘şM–çC‰ş“c‰vOC–kžŠ‚Ý‚Ç‚čC”э‚Šě‹v—YiŽ™j: ‘ć28‰ń“ú–{ŹŽ™t‘Ÿ•aŠw‰ď i93.05.19`21j, •Ÿ“‡.

1898. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –˘nŽ™–ňÜŤ‹}Ťt•s‘S. ‰Íź‹IşC‰Ź–ěƒ‘ăCŠ—Œ´FC’†‘şM–çC–kžŠ‚Ý‚Ç‚čC”э‚Šě‹v—YiŽ™jCŽđˆä‹Ši”ĺj: ‘ć28‰ń“ú–{ŹŽ™t‘Ÿ•aŠw‰ď i93.05.21j, •Ÿ“‡.

1899. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚QŽ™‚đ”DPoŽY‚ľ41Î‚Ü‚Ĺ‹•ŒŒŤSŽžŠł‚Ě–ł‚˘LDL-receptor negative type‰Ć‘°Ť‚ƒRƒŒƒXƒeƒ[ƒ‹ŒŒÇƒzƒ‚Ú‡‘Ě—á. –xŒű‘דTC•˝Î‘CŽO‘ňmŽiiŽ™jCŹo’Š’jiSMIƒuƒŠƒXƒgƒ‹jCŽO‘îNŽqCŽR–{Íi‘—§zŠÂŠí•aƒZƒ“ƒ^[j: ‘ć25‰ń“ú–{“Ž–Źd‰ťŠw‰ď‘‰ď i93.05.21j, •Ÿ‰Ş, “Ž–Źd‰ť, 21(3): 212, 1993.

1900. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒg‘ٔՂɂ¨‚Ż‚éThyrotropin-releasing hormone (TRH)ˆâ“`Žq‚Ě”­Œť. ŽÄŽRŒ[ŽqC•—’ŁKŽiC‘ĺŽR‹XGCź‰YM•viŽ™j: ‘ć66‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠwp‘‰ď i93.06.03j, ‹ŕ‘ň, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 69(4): 284, 1993.

1901. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j SƒGƒR[–@‚É‚ć‚é”x“Ž–Ź•ŞŽ}Œ`‘Ô‚Ě•]‰ż|”x“Ž–Ź•ŞŽ}‹ˇó‚¨‚ć‚эś, ‰E•ŞŽ}•s‹Ď“™‚̐f’f¸“x‚𒆐S‚Ɂ|‘ć‚Q•ń. •˝Î‘CŽO‘ňmŽiCăp—z‘ž˜YCL“c•l•vC–xŒű‘דTC“Ą–ěé”VC”Ş‘ăŒö•viŽ™jC’†]˘–žC‰Í“c­–ži‹šŠOj: ‘ć29‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ď i93.07.01j, ‰Ą•l.

1902. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹŽ™‚É‚¨‚Ż‚錌’†RHelicobacter pyloriR‘Ě‚Ě—Ő°“IŒŸ“˘. ‘ĺ“c„•äCŹ“‡–M•FC^“ş‘ž˜YC“ŕ“Ą„•FiŽ™j: ‘ć20‰ń“ú–{ŹŽ™‰h—{Á‰ťŠí•aŠw‰ď i93.10.20j, ŽD–y, ´˜^W, p.75, 1993.

1903. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “Œ‹ž—Žqˆă‘ĺ“œ”A•aƒZƒ“ƒ^[‚É‚¨‚Ż‚é30Î–˘–ž”­ÇƒCƒ“ƒXƒŠƒ“ˆË‘śŒ^‚̐ś–˝—\Œă. ŠŰŽR–žŽqC‰ĄŽRGŽ÷C‘ĺ’J•q‰ĂCÂ–Ř‚Š‚𗢁CŒ“źKŽqC“ŕŠƒˆŔŽqCź‰YM•viŽ™jC‘ĺXˆŔŒbC“c›×ŽŽq: ‘ć27‰ń“ú–{ŹŽ™“ŕ•Ş”ĺŠw‰ď i93.10.21`22j, “Œ‹ž.

1904. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Prolonged PROM, —r…‰ß­‚É”ş‚¤–˘nŽ™‚ĚŒÄ‹záŠQ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. Š—Œ´FCŹŒűO‹BC–ě“nł•FC˛“Ą‰ë•FCŽR“cr•FCă–ěM–íC‰Ź–ěƒ‘ăCź‰YM•viŽ™j: ‘ć38‰ń“ú–{–˘nŽ™VśŽ™Šw‰ď i93.10.28`29j, ŽD–y.

1905. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”]ŽżŽüˆÍ”’Žż“(PVL)‚Ě•p“x. –ĺˆäL‹ĹCŠ—Œ´FCŹŒűO‹BC–ě“nł•FC˛“Ą‰ë•FCŽR“cr•FCź‰YM•viŽ™j: ‘ć38‰ń“ú–{–˘nŽ™VśŽ™Šw‰ď i93.10.28`29j, ŽD–y.

1906. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j łíVśŽ™‚É‚¨‚Ż‚é‘ĺ“Ž–ŹŒa‚ĚŒoŽž“I•Ď‰ť. “Ą–ěé”VC‰Ą“csŽjCĄˆäƒDC’†‘şM–çC•˝Î‘CŹŒűO‹BCŽO‘ňmŽiCăp—z‘ž˜YCŠ—Œ´FC–xŒű‘דTCL“c•l•viŽ™j: ‘ć38‰ń“ú–{–˘nŽ™VśŽ™Šw‰ď i93.10.28j, ŽD–y.

1907. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j VśŽ™Šú‘Šú‚É‚¨‚Ż‚鍶Žş”o—Ę‚¨‚ć‚Ń‘ŸŠíŒŒ—Ź—ʂ̕ωť|’č—Ę“IŒŸ“˘|. ăp—z‘ž˜YCŹŒűO‹BCL“c•l•vC“Ą–ěé”VC•˝Î‘C–xŒű‘דTCŽO‘ňmŽiCź‰YM•viŽ™j: ‘ć38‰ń“ú–{–˘nŽ™VśŽ™Šw‰ď i93.10.28`29j, ŽD–y, ´˜^W, p.192, 1993.

1908. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j N2‘˝ŒÄ‹zô‚˘o‚ľ–@ƒ‚[ƒƒ“ƒg‰đÍ‚É‚ć‚銡‹C•s‹Ď“™•Ş•z‚ĚŒŸ“˘i‘ć‚R•ńj. Žl‘qł”ŽC’†“ˆ‰p•FC“n•Ó“oC˛“Ą—Y“ńC”~Œ´ŽŔC–Ľ‰YŽ‘ĽC’ˇ“cŒúCŠÖŞ“OCŒ´^liŽ™j: ‘ć26‰ń“ú–{ŹŽ™ŒÄ‹zŠíŽžŠłŠw‰ď i93.11.05j, ‘ĺă, ´˜^W, p.39, 1993.

1909. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”x‚Ě‘˝”­Ť“]ˆÚ‚Ĺ”­ŒŠ‚ł‚ę‚˝isŤăO–ŃŠŕ‚Ě‚P—á. ă“cN‹vC“‡–{—R‹IŽqCĄˆäƒDC‰““Ą‹I—YiŽ™j: ‘ć9‰ń“ú–{ŹŽ™‚Ş‚ńŠw‰ď i93.12.00j, ’}”g.

1910. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j LDL-ƒAƒtƒFƒŒ[ƒVƒXŒă‚ĚƒŠƒoƒEƒ“ƒhĽƒJ[ƒu‰đÍ‚É‚ć‚éƒRƒŒƒXƒeƒ[ƒ‹, Lp(a)‚ĚƒLƒlƒeƒBƒNƒX. Žz”g^—ŽqC–L“cNŽkC–Ř“cˆęŹCŽR‘ş‘ěCŽR–{ÍC–Ř‘şŒşŽŸ˜YC“s“‡Šî•vC‹ž’JWŒái‘—§zŠÂŠí•aƒZƒ“ƒ^[jC–xŒű‘דTiŽ™j: ‘ć58‰ń“ú–{zŠÂŠíŠw‰ď‘‰ďŠwpW‰ď i94.03.30j, “Œ‹ž, Jpn. Circ. J., 58(Suppl.1): 217, 1994.

1911. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Diclofenac sodiumżÜ‚Ě•š—p‚ŞdiazepamżÜ‚Ě’ź’°‚Š‚ç‚Ě‹zŽű‚É‚¨‚ć‚Ú‚ˇ‰e‹ż. •Đ‹Ë’q–çCŽO‰YŽő’jC”’ˆäGKCť‰ŸÂiŽ™jCŹ—Ń‹P–ži–ňÜjC‹gŽR—F“ńi–ňŠw•”jC’Š’ˇ•ś–íi–ňÜjC{“Ą–FłC‹g“c´•FCŒSŽi´iSMIƒuƒŠƒXƒg ƒ‹j: ‘ć27‰ń“ú–{‚Ä‚ń‚Š‚ńŠw‰ď (93.10.02), O‘O, ƒvƒƒOƒ‰ƒ€Ľ—\eW, p.212, 1993.

1912. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŹŽ™IDDMŠłŽ™‚É‚¨‚Ż‚ég’ˇ”­ˆç‚ƍœ‰–—Ę‚ĚŒo”N“I•Ď‰ť‚ɂ‚˘‚ā|ŒŒ’†IGF-I‚Ć‚ĚŠÖŒW|. ‰Ą“csŽjC•—’ŁKŽiC‘ĺŽR‹XGiŽ™j: ‘ć36‰ń“ú–{“œ”A•aŠw‰ď i93.05.13j, ĺ‘ä, “œ”A•a, 36(Suppl.1): 186, 1993.

1913. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Long-acting LHRHƒAƒiƒƒO(LHRHa, TAP-144-SR)‚𒡊ú“Š—^‚ł‚ę‚˝’†•ŤŽvtŠú‘”­Ç(CPP)—Ž™7—á‚É‚¨‚Ż‚é—Տ°“I, “ŕ•Ş”ĺŠw“IŒŸ“˘. •—’ŁKŽiC‰Ą“csŽjC‘ĺŽR‹XGiŽ™j: ‘ć66‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠwp‘‰ď i93.06.03j, ‹ŕ‘ň, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 69(4): 261, 1993.

1914. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’´‚‘ŹCT‚É‚ć‚éƒtƒHƒ“ƒ^ƒ“pŒă‚Ě”xzŠÂŽžŠÔ‘Ş’č‚ĚˆÓ‹`|‘ć‚P•ń|. –xŒű‘דTC–Ľ‰YŽ‘ĽC“n•Ó’qŽqC•˝Î‘CŽO‘ňmŽiCăp—z‘ž˜YC“Ą–ěé”VCL“c•l•viŽ™jC’†]˘–žC‰Í“c­–ži‹šŠOj: ‘ć29‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ď i93.07.02j, ‰Ą•l, “ú–{ŹŽ™zŠÂŠíŠw‰ďŽGŽ, 9(1): 165, 1993.

1915. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j VśŽ™, “űŽ™‚Ěsymptomatic‘ĺ“Ž–ŹkóÇ‚É‚¨‚Ż‚éDoppler—Ź‘Ź‘Ş’č‚ĚˆÓ‹`. ŽO‘ňmŽiC•˝Î‘CL“c•l•vCăp—z‘ž˜YC“Ą–ěé”VC–xŒű‘דTiŽ™jC‰Í“c­–žC’†]˘–ži‹šŠOjC”Ş‘ăŒö•viŽ™j: ‘ć29‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ď i93.07.03j, ‰Ą•l, “ú–{ŹŽ™zŠÂŠíŠw‰ďŽGŽ, 9(1): 226, 1993.

1916. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Acrodysostosis ‚ÉŒ´”­Ťbó‘B‹@”\’ቺÇ‚đ‡•š‚ľ‚˝3—á. •—’ŁKŽiC‘ĺŽR‹XGC•—’Ł^—R”üCŽÄŽRŒ[ŽqC‰Ą“csŽjCŹ’r–ž”üC—R—˜ŒŤŽŸCź‰YM•viŽ™j: ‘ć27‰ń“ú–{ŹŽ™“ŕ•Ş”ĺŠw‰ď i93.10.21`22j, “Œ‹ž.

1917. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŒoŒű’_”X‘˘‰eÜSodium Ipodate‚ĹŽĄ—Ă‚ľ‚˝VśŽ™bó‘B’†“ĹÇ‚Ě1—á. ŠâčŒ\ŽqC‘ĺŽR‹XGCŹŒűO‹BC‰Ą“csŽjCŽÄŽRŒ[ŽqCŠ—Œ´FC•—’ŁKŽiC•—’Ł^—R”üC•“cM—TCź‰YM•viŽ™j: ‘ć27‰ń“ú–{ŹŽ™“ŕ•Ş”ĺŠw‰ď i93.10.21`22j, “Œ‹ž, Clin. Pediatr. Endocrinol., 2(2): 173, 1993.

1918. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”ě–žĽ•F”畆Ç(AN)ĽƒCƒ“ƒXƒŠƒ“’ďRŤ(IR)Ľ‚ƒAƒ“ƒhƒƒQƒ“ŒŒÇ(HA)‚đ’悡‚éÇŒóŒQ‚Ě2—Ž™—á‚É‚¨‚Ż‚é‘̏dŒ¸­‚Ě’ˇŠúŒř‰Ę. •—’Ł^—R”üC‰Ą“csŽjC•—’ŁKŽiCŽÄŽRŒ[ŽqC‘ĺŽR‹XGCź‰YM•viŽ™j: ‘ć27‰ń“ú–{ŹŽ™“ŕ•Ş”ĺŠw‰ď i93.10.21`22j, “Œ‹ž, ´˜^W, p.70, 1993.

1919. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j SRY—zŤ‚Ěˆę—‘ŤˆŮŤ‘o‘Ů‚ĚŽo’í—á. ‰Ą“csŽjC’†ž–í’jCÔŞ“ցC˛“Ą–FşCź‰YM•viŽ™j: ‘ć66‰ń“ú–{“ŕ•Ş”ĺŠw‰ďH‹GŠwp‘ĺ‰ď i93.10.27`28j, ÂX, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 69(8): 821, 1993.

1920. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Œă“ŞŠWâ|‚Ě“î–Œ‰şŒŒŽî‚đ”F‚ß‚˝2—á. ˛“Ą‰ë•FCŹŒűO‹BC–ě“nł•FCŽR“cr•FCă–ěM–íCź‰YM•vC–ĺˆäL‹ĹiŽ™j: ‘ć38‰ń“ú–{–˘nŽ™VśŽ™Šw‰ď i93.10.28`29j, ŽD–y.

1921. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j VśŽ™ƒwƒ‹ƒyƒX”]‰Š‚Ě‰ć‘œŠŒŠ|“Á‚É“Ş•”ƒGƒR[‚É‚ć‚éŒoŽž“I•Ď‰ť‚ĚŠĎŽ@. •ĐŽR•ś•FC‰Ź–ěƒ‘ăC–ě“nł•FCŠ—Œ´FCŹŒűO‹BiŽ™j: ‘ć38‰ń“ú–{–˘nŽ™VśŽ™Šw‰ď i93.10.28j, ŽD–y.

1922. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘ŮŽ™SƒGƒR[}‚É‚ć‚č‘ŮŽ™Šú‚É—‘‰~E•Â˝‚đ”F‚ß‚˝‘m–X•Ů‹ˇó, •Â˝•s‘S‚¨‚ć‚Ń‘ĺ“Ž–Ź’áŒ`Ź‚Ě‚P—á. ŽO‘ňmŽiCŹŒűO‹BCL“c•l•vCăp—z‘ž˜YC“Ą–ěé”VC•˝Î‘Cź‰YM•viŽ™j: ‘ć38‰ń“ú–{–˘nŽ™VśŽ™Šw‰ď i93.10.28`29j, ŽD–y, ´˜^W, p.147, 1993.

1923. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j • –Œ•˝t‹@”\ŒŸ¸‚É‚¨‚Ż‚éy‘f–@‚Ćƒ„ƒbƒtƒF–@‚đ—p‚˘‚˝ƒNƒŒƒAƒ`ƒjƒ“‘Ş’č‚Ě”äŠr. ’†‘şM–çCâŔ“‡C–kžŠ‚Ý‚Ç‚čC”э‚Šě‹v—YiŽ™jCź“c—zi—Ő•a—j: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.02`04j, ‰Ą•l.

1924. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŹŽ™–ŒŤ‘BŤt‰Š‚Ě—Ő°•a—Šw“IŒŸ“˘. ”э‚Šě‹v—YCÎŠŮ••vC’†‘şM–çCâŔ“‡C–kžŠ‚Ý‚Ç‚čC‰Íź‹IşiŽ™jC‰ş“c‰vOCŽđˆä‹Ši”ĺj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.02`04j, ‰Ą•l, —\eW, p.211, 1993.

1925. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŹŽ™• –Œ“§ÍŠłŽŇ‚É‚¨‚Ż‚é• –Œ‹@”\‚ĆƒŠƒ“ƒp‹zŽű‚ĚŒŸ“˘. âŔ“‡C’†‘şM–çC–kžŠ‚Ý‚Ç‚čC”э‚Šě‹v—YiŽ™jC‰ş“c‰vOCŽđˆä‹Ši”ĺj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.04j, ‰Ą•l.

1926. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŒŒ‰tŸó—Ź‚đs‚Á‚˝ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“’†“Ĺ‚Ě‚P—á. ‘剎ŹsiŠƒ–č“żF‰ď‘‡•a‰@jCŽRŠÝňC–Ľ‰YŽ‘ĽC–xŒű‘דTiŽ™jC{“Ą”ŽiŠƒ–č“żF‰ď‘‡•a‰@j: ‘ć202‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ސě’n•ű‰ď (93.04.17), ‰Ą•l, _“ސěˆăŠw‰ďŽGŽ, 20(2): 138, 1993.

1927. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰^“Ž•‰‰×‚ɑ΂ˇ‚éƒtƒHƒ“ƒ^ƒ“pŒă‚̐SŒŒs“Ž‘Ԃ̕ωť|’´‚‘ŹCT‚É‚ć‚é•]‰ż|. –xŒű‘דTC”’ˆäGKCˆŔ•ŰŒŤˆęC•Ÿ“‡’‹`C•˝Î‘CŽO‘ňmŽiCăp—z‘ž˜YiŽ™jC’†]˘–ži‹šŠOj: ‘ć206‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ސě’n•ű‰ď (94.02.19), ‰Ą•l.

1928. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Sodium ipodate ‚ĹŽĄ—Ă‚ľ‚˝VśŽ™bó‘B’†“ĹÇ‚Ě‚P—á. ŠâčŒ\ŽqC‘ĺŽR‹XGCŹŒűO‹BC‰Ą“csŽjCŽÄŽRŒ[ŽqCŠ—Œ´FC•—’ŁKŽiC•—’Ł^—R”üC•“cM—TCŽO‰YŽő’jiŽ™j: ‘ć202‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ŢěŒ§’n•ű‰ď i93.04.17j, ‰Ą•l.

1929. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j VśŽ™‚¨‚ć‚Ń“űŽ™‚É‚¨‚Ż‚é”A˜HŠ´őÇ‚ĚŒŸ“˘. –xŒű‘דTC–Ľ‰YŽ‘ĽiŽ™jC•Ÿ“‡“‹`iŠƒ–č“żB‰ď‘‡•a‰@j: ‘ć203‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ސě’n•ű‰ď i93.06.19j, ‰Ą•l.

1930. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ”­ěŤ–éŠÔŒŒF”AÇ‚Ě‚P—á. •“cM—SCŠâčr”VC•Đ‹Ë’q–çC–ĺˆäL‹ĹCĄˆäƒDC‰““Ą‹I—YiŽ™j: ‘ć203‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ސě’n•ű‰ď i93.06.19j, ‰Ą•l.

1931. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰^“Ž•‰‰×‚ɑ΂ˇ‚éƒtƒHƒ“ƒ^ƒ“pŒă‚̐SŒŒs“Ž‘Ԃ̕ωť|’´‚‘ŹCT‚É‚ć‚é•]‰ż|. –xŒű‘דTC”’ˆäGKCˆŔ•ŰŒŤˆęC•Ÿ“‡“‹`C•˝Î‘CŽO‘ňmŽiCăp—z‘ž˜YiŽ™jC’†]˘–ži‹šŠOj: ‘ć206‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ސě’n•ű‰ď i94.02.19j, ‰Ą•l.

1932. mŒ¤‹†‰ďi‘S‘jn i‹łˆçu‰‰j R‚Ä‚ń‚Š‚ń–ň‚ĚTDM. ŽO‰YŽő’jiŽ™j: ‘ć15‰ń–ň•¨ŽĄ—Ăƒ‚ƒjƒ^ƒŠƒ“ƒOŒ¤‹†‰ď“Á•Ęƒ[ƒ~ƒi[ƒ‹ (93.09.26), “Œ‹ž, Clinical pharmacokinetics‚Ě—˜_‚ĆŽŔŰ|’†‹‰•Ň|, p.46`54, 1993.

1933. mŒ¤‹†‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj “ű—cŽ™Šú‚̐t•s‘SÇ—á‚Ě–â‘č“_. –kžŠ‚Ý‚Ç‚čC”э‚Šě‹v—YiŽ™j: ‘ć15‰ńŹŽ™t•s‘SŒ¤‹†‰ď i93.09.10j, ‘q•~, —\eW, p.35, 1993.

1934. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j AcetaminophenżÜ‚Ě•š—p‚ŞdiazepamżÜ‚Ě’ź’°‚Š‚ç‚Ě‹zŽű‚É‚¨‚ć‚Ú‚ˇ‰e‹ż. •Đ‹Ë’q–çCŽO‰YŽő’jC”’ˆäGKCť‰ŸÂiŽ™jC‹gŽR—F“ńi–ňŠw•”jCŹ—Ń‹PşC’Š’ˇ•ś–íi–ňÜjC‹g“c´•FCŒSŽi´C{“Ą–FłiSMIƒuƒŠƒXƒgƒ‹j: ‘ć20‰ń”­’B–ň—Ľ–ň•¨ŽĄ—ĂŒ¤‹†‰ď (93.11.13), ŒF–{, ƒvƒƒOƒ‰ƒ€Ľ´˜^W, p.17, 1993.

1935. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j VśŽ™‘̉ˇ‚Ě“ú“ŕƒŠƒYƒ€‚ÉŠÖ‚ˇ‚錟“˘. źě˛Ž}C‹gŽR—F“ńCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjCŽO‰YŽő’jiŽ™j: ‘ć20‰ń”­’B–ň—Ľ–ň•¨ŽĄ—ĂŒ¤‹†‰ď (93.11.13), ŒF–{, ƒvƒƒOƒ‰ƒ€Ľ´˜^W, p.18, 1993.

1936. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŹŽ™‚̐öˆöŤ‹ÇÝŠÖ˜AŤ‚Ä‚ń‚Š‚ń‚ɑ΂ˇ‚ézonisamide’PÜ1“ú1‰ń“Š—^–@‚ĚŒř‰Ę‚Ć•›ě—p. ×“c‚Ě‚ź‚݁CŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂCˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqC•Đ‹Ë’q–çiŽ™j: ‘ć3‰ń—Տ°¸__Œo–ň—Œ¤‹†‰ď (93.11.18), “Œ‹ž, ƒvƒƒOƒ‰ƒ€Ľ´˜^W, p.13, 1993.

1937. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‰đ”M–ňżÜ‚Ě•š—p‚ŞdiazepamżÜ‚Ě’ź’°‚Š‚ç‚Ě‹zŽű‚É‚¨‚ć‚Ú‚ˇ‰e‹ż|Œ’NŹl‚Ĺ‚ĚŒŸ“˘|. •Đ‹Ë’q–çCŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqiŽ™j: ‘ć16‰ń”MŤázš§˜b‰ď (93.12.18), “Œ‹ž.

1938. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‘źÜ–łŒř‚Č‚Ä‚ń‚Š‚ńÇ—á‚ɑ΂ˇ‚éacetazolamide‚Ě’ˇŠúŒř‰Ę‚Ć•›ě—p. ŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqiŽ™j: •˝Ź5”N“xŒúśČ¸_Ľ_ŒoŽžŠłŒ¤‹†ˆĎ‘ő”ď; “‚Ä‚ń‚Š‚ń‚ĚŽĄ—Ă–@ŠJ”­‚ÉŠÖ‚ˇ‚錤‹†”ljď‹c (93.12.21), “Œ‹ž, ´˜^W, p.45, 1993.

1939. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒq[ƒgƒvƒ[ƒu–@‚É‚ÄŽ~ŒŒ‚ľ‚˝ŹŽ™Á‰ťŤ’×ᇂ̂Q—á. ‘ĺ“c„•äC“ŕ“Ą„•FC^“ş‘ž˜YCŹ“‡–M•FiŽ™jCâŒű“NÍi“ŕj: ‘ć20‰ń“ú–{ŹŽ™“ŕŽ‹‹žŒ¤‹†‰ď i93.07.03j, “Œ‹ž, ´˜^W, p.21, 1993.

1940. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Œ‹ßŤ‘˝”­“Ž–Ź‰Š‚É‚ć‚ét•s‘S‚É‚Ä’ˇŠú“ü‰@‚đ—v‚ľ‚˝ŠłŽ™‚̏AŠw‚ւ̉‡•. ç—t‹IŽqCˆÉ“Ą‰ëŽqC–ű’J˜aŽqiŠĹŒě•”jCă“cN‹vCâŔ“‡C”э‚Šě‹v—YiŽ™j: ‘ć7‰ńŹŽ™PDŒ¤‹†‰ď i93.09.08j, ‘q•~, —\eW, p.11, 1993.

1941. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ’ˇŠúŒo‰ß’†‚ɐt•s‘S‚ɊׂÁ‚˝HBtÇ‚ĆŽv‚í‚ę‚é‚P—á. âŔ“‡C”э‚Šě‹v—YC’†‘şM–çC–kžŠ‚Ý‚Ç‚čiŽ™jC‰ş“c‰vOCŽđˆä‹Ši”ĺj: ‘ć15‰ńŹŽ™t•s‘SŒ¤‹†‰ď i93.09.09j, ‘q•~.

1942. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŠÔŽżŤäNă÷‰Š‚đ•š”­‚ľ‚˝ƒRƒ“ƒgƒ[ƒ‹—ǍD‚ČIDDM‚Ě15Î’jŽ™—á. •—’Ł^—R”üC‰Ą“csŽjC•—’ŁKŽiCŽÄŽRŒ[ŽqC‘ĺŽR‹XGC”э‚Šě‹v—YCź‰YM•viŽ™jC‰““Ą’‰—Yi”ĺj: ‘ć11‰ńŹŽ™“œ”A•aƒJƒ“ƒtƒ@ƒŒƒ“ƒX i93.09.18j, ‘ĺă, —\eW, p.70.

1943. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ěč•a•aˆö‚ÉŠÖ‚ˇ‚é×‹ŰŠw“IŒ¤‹†‚̉uŠw‰ť‚ÉŒü‚Ż‚Ä. ‘ĺ’Ép“ńiŽ™jCŽ›“cŒúi“ú–{bˆă’{ŽY‘ĺjC“Ą‘ň—Ď•Fi_“ސě‰qśŒ¤jCŽ›‰ŞO•śi“Œ‹žˆăŽ•‘ĺj: ‘ć13‰ń“ú–{ěč•aŒ¤‹†‰ď i93.10.15j, ˇ‰Ş, ´˜^W, p.46.

1944. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j DiazepamżÜ‚É‚ć‚é”MŤ‚Ż‚˘‚ę‚ń‚ĚÄ”­—\–h. ŽO‰YŽő’jiŽ™j: ‘ć13‰ń_“ސ쏬Ž™_Œo§˜b‰ď (94.01.20), ‰Ą•l, ´˜^W, p.11, 1994.

1945. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Zonisamide’PÜŽĄ—Ă‚Ş–łŒř‚Ĺ‚ ‚Á‚˝öˆöŤ‹ÇÝŠÖ˜AŤ‚Ä‚ń‚Š‚ń‚ɑ΂ˇ‚écarbamazepine‚ĚŒř‰Ę‚ĆŒŒ’†”Z“x. ˆŔ•ŰƒŽqCŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰŒŤˆęC•Đ‹Ë’q–çiŽ™j: ‘ć12‰ń_“ސ쏬Ž™_Œo§˜b‰ď (93.07.08), ‰Ą•l, ´˜^W, p.6, 1993.

1946. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ’f–ň‚É‚ć‚č—Տ°Çó, ”]”gŠŒŠ‚Ć‚ŕ‚É’˜–ž‚ȉü‘P‚đ‚Ý‚˝WestÇŒóŒQ‚Š‚çLennoxÇŒóŒQ‚ֈڍs‚ľ‚˝1—á. •Đ‹Ë’q–çCŽO‰YŽő’jC”’ˆäGKCť‰ŸÂCˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqiŽ™j: ‘ć32‰ń_“ސě‚Ä‚ń‚Š‚ń§˜b‰ď (93.07.24), ‰Ą•l.

1947. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘Šú‚ć‚čŠJŽn‚ľ‚˝ƒrƒ^ƒ~ƒ“B6‘ĺ—Ę—Ă–@‚Ş‘tŒř‚ľ‘Šú‚ÉŽĄ—Â𒆎~‚ľ‚˝öˆöŤWestÇŒóŒQ‚Ě‚P—á. •Ÿ“‡’‹`C”’ˆäGKC–xŒű‘דTCˆŔ•ŰŒŤˆęiŽ™jC‘ĺ–î’B•viš˜H‰Á‘Ű•a‰@j: ‘ć13‰ń_“ސ쏬Ž™_Œo§˜b‰ď (94.01.20), ‰Ą•l, ´˜^W, p.1, 1994.

1948. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Zonisamide‚Ě•›ě—p‚Ć‚ľ‚č‚ŽŸ¸_‹@”\áŠQ‚đ”F‚ß‚˝Ç—á. ”’ˆäGKCŽO‰YŽő’jC‚—œ‰hCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqC•Đ‹Ë’q–çiŽ™j: ‘ć13‰ń_“ސ쏬Ž™_Œo§˜b‰ď (94.01.20), ‰Ą•l, ´˜^W, p.4, 1994.

1949. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j WestÇŒóŒQ‚ɑ΂ˇ‚évitamin B6‘ĺ—Ę—Ă–@‚ĚŒř‰Ę‚Č‚ç‚Ń‚É—LŒř—á‚Ě’ˇŠú—\Œă. ”’ˆäGKCŽO‰YŽő’jC‚—œ‰hCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰŒŤˆęCˆŔ•ŰƒŽqC•Đ‹Ë’q–çiŽ™j: ‘ć33‰ń_“ސě‚Ä‚ń‚Š‚ń§˜b‰ď (94.01.29), ‰Ą•l.

1950. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ć“VŤ”]\‘˘ˆŮíiś•Đ‘¤Ť‹”]Çj‚𔺂˘Early infantile epileptic encephalopathy with suppression burst (EIEE)‚Š‚çWestÇŒóŒQ‚ֈڍs‚ľ‚˝1—á. ˆŔ•ŰŒŤˆęCŽO‰YŽő’jC‚—œ‰hC”’ˆäGKCť‰ŸÂC×“c‚Ě‚ź‚݁CˆŔ•ŰƒŽqC•Đ‹Ë’q–çiŽ™j: ‘ć21‰ńŠÖ“ŒŹŽ™_ŒoŠwŒ¤‹†‰ď (94.3.19), “Œ‹ž.

1951. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‹š•”‘˝”­Œ‹ßó‰A‰e‚đ’ć‚ľ‚˝ăO–ŃŠŕ‚Ě‚P—á. ă“cN‹vCŹ‘ň”ü˜aCĄˆäƒDC”~Œ´ŽŔC“‡–{—R‹IŽqC‰““Ą‹I—YC’†“ˆ‰p•FiŽ™j: ‘ć19‰ń_“ސ쏬Ž™Žîᇌ¤‹†‰ď i93.09.00j, ‰Ą•l.

1952. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j śŒă‚R‚ŠŒŽ–˘–ž‚Ě“űŽ™‚Ě”­”M. •ĐŽR•ś•FC’†‘şM–çCĄˆäƒDC“Ą–ěé”VC‰Ą“csŽjiŽ™j: ‘Š–ÍŒ´ˆă‰ď i94.01.19j, ‘Š–ÍŒ´.


<<17 ŽY‰ČŠw>>

1953. mŒ´’˜n ‰ßŠú”DP‚Ě‘Îô. “‡“cMGiŽY•wj: ŽY•wl‰ČŽĄ—Ă, 66(5): 723`726, 1993.

1954. mŒ´’˜n Œv‰ć•Ş•Ř‚Ě–â‘č“_‚Ć‘Îô. “‡“cMGiŽY•wj: ŽüŽYŠúˆăŠw, 23(7): 985`988, 1993.

1955. mŒ´’˜n •Ş•Ř‘J‰„Žž‚ĚŒŸ¸. “‡“cMGiŽY•wj: ŽüŽYŠúˆăŠw, 23(‘): 283`288, 1993.

1956. mŒ´’˜n Žq‹{Œz•”Žîᇂɑ΂ˇ‚éŠO—ˆ‚Ĺ‚ĚƒŒ[ƒU[‰~Řœp. ˜e“c–M•vCň‹M•śC‘ –{”ŽsCź“‡ł”ŽiŽY•wj: ‘ć13‰ń“ú–{ƒŒ[ƒU[ˆăŠw‰ď‘ĺ‰ď˜_•śW, p.165`168, 1992.

1957. mŒ´’˜n ”DP’†‚ĚƒNƒ‰ƒ~ƒWƒAŠ´ő‚ɑ΂ˇ‚鎥—ÐŹŃ. Ż“c—˛C–ě“c–FlC‘ĺ‰ÍŒ´‘C‰ş“c—˛•vC‹v“ˆ‘ĽsC“cŒű–žC“‡“cMGCź“‡ł”ŽiŽY•wj: “ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‰ď•ń, 30(3): 369`372, 1993.

1958. mŒ´’˜n •Ş•ŘŽž–ƒŒ‚Ş‘ŮŽ™S””‚É—^‚Ś‚é‰e‹ż. Ä“ĄŽC–ě“c–FlC’Jş”ŽCA–ěM…C‹gŒ´ˆęC’F‰pŽ÷C“‡“cMGCź“‡ł”ŽiŽY•wj: “ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‰ď•ń, 30(3): 379`385, 1993.

1959. mŒ´’˜n ‘o‘Ů‚É‚¨‚Ż‚é•Ş•Ř—lŽŽ‚ÉŠÖ‚ˇ‚錟“˘. –ě“c–FlCĄˆä‰ë•vCÄ“ĄŽCŻ“c—˛C’Jş”ŽC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: “ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‰ď•ń, 31(1): 37`41, 1994.

1960. mŒ´’˜n Œo• , ŒoäT’´‰š”g–@‚Š‚ç‚Ý‚˝ CRL ‚ĚÄ•]‰ż. ’F‰pŽ÷iŽY•wj: “ú–{ŽY‰Č•wl‰ČŠw‰ď_“ސě’n•ű•”‰ď‰ďŽ, 30(1): 10`13, 1993.

1961. mŒ´’˜n ‘ٕ֐Ť• –Œ‰Š‚̏oś‘Of’f‚ÉŠÖ‚ˇ‚錟“˘. ‘O“c@“żC“V–슎Cź“‡ł”ŽiŽY•wj: “ú–{VśŽ™Šw‰ďŽGŽ, 29(3): 446`451, 1993.

1962. mŒ´’˜n Ž™‚Ě’ZŠú—\Œă‚Š‚ç‚Ý‚˝‘o‘ŮŠÇ—‚Ě–â‘č“_. –ě“c–FlC‘O“c@“żC’Jş”ŽC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wjCŹŒűO‹BCŠ—Œ´FiŽ™j: “ú–{VśŽ™Šw‰ďŽGŽ, 29(4): 885`891, 1993.

1963. mŒ´’˜n Rś•¨Žż‚Ě‘Ů”ŐˆÚs‚ÉŠÖ‚ˇ‚錟“˘. –ě“c–FlCŒăŒŤCÄ“ĄŽCŻ“c—˛C’Jş”ŽC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: “ú–{VśŽ™Šw‰ďŽGŽ, 30(1): 189`194, 1994.

1964. mŒ´’˜n Bupivacaine, Fentanyl Ž‘ąd–ŒŠO’“ü‚É‚ć‚é•Ş•ŘŽž–ƒŒ‚ĚŒř‰Ę. “V–슎CˆŔ’BŒhˆęCź“‡ł”ŽiŽY•wj: •Ş•Ř‚Ć–ƒŒ, 71: 20`25, 1993.

1965. m€Œ´’˜i‰p•śjn Effects of oxidative stress on few-maternal blood superoxide during labor. ‘O“c@“żC‹gŒ´ˆęCŻ“c—˛C“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wjC’†‘ş‘‰qi•Şśj: 2nd World Congress of Perinatal Medicine Proceeding of Communications and Posters, p.1343`1346, 1993.

1966. m€Œ´’˜n ‘ŽY—Ś. ź“‡ł”ŽC–ě“c–FliŽY•wj: ŽY‰Č‚Ć•wl‰Č, 60(‘): 99`101, 1993.

1967. m€Œ´’˜n ”DP’†Šú‚É‚¨‚Ż‚é‘ŮŽ™•]‰ż‚Ć–â‘č“_: ‚â‚Ţ‚đ“ž‚¸”DP’†Šú‚É•Ş•Ř‚Ć‚Č‚éÇ—á‚ɂ‚˘‚ā|•Ş•Ř—lŽŽ‚đ‚ß‚Ž‚Á‚Ä. –ě“c–FlC“‡“cMGCź“‡ł”ŽiŽY•wj: ŽüŽYŠúˆăŠw, 23(5): 713`715, 1993.

1968. mŒ¤‹†•ńiŒúśČjn ‰Á—î‚É”ş‚¤”DP‡•šÇ‚ÉŠÖ‚ˇ‚錤‹†. ˛“ĄÍi•Ÿ“‡Œ§—§ˆă‘ĺjC‰F‰ę’źŽ÷iˆ¤ˆç•a‰@jCź“‡ł”ŽiŽY•wjC—éXŒOi–źŒĂ‰ŽŽs‘ĺjC‰Ź“cK—Yi‘ĺăŽs‘ĺjCH“ĄŽ•śi‰Ş‘ĺj: ŒúśČSgáŠQŒ¤‹†ƒnƒCƒŠƒXƒN”DP‚ÉŠÖ‚ˇ‚錤‹†•˝Ź‚S”N“xŒ¤‹†•ń‘, p.5`9, 1993.


<<17 2 ŽY‰ČŠw>>

1969. mÇ—á•ńn Prenatal diagnosis and treatment strategy for congenital mesoblastic nephroma. Matsumura MitsuyoshiCNishi ToshijiCSasaki YoshiroCYamada RyojiCYamamoto HiroshiCOhhama YokatsuCTanaka Yukichii_“ސěˆă—ĂƒZƒ“ƒ^[jC•{•s“ń’jC“V–슎iŽY•wj: J. Pediatr. Surg., 28(12): 1607`1609, 1993.

1970. m—Տ°ŽĄŒąn ”DP’†“ĹÇ‚É‘Î‚ˇ‚é EPA •t‰ÁH‚ĚŒř‰Ę. “V–슎C‘O“c@“żC“‡“cMGCź“‡ł”ŽiŽY•wj: “ú–{ŽY‰Č•wl‰ČŠw‰ďŽGŽ, 46(3): 281`283, 1994.

1971. m‘ŕn ś•¨•¨—Šw“If’f|”DP’†i•Ş•Ř‘Oj‘ŮŽ™S””}‚É‚ć‚éf’f. ź“‡ł”ŽiŽY•wj: New Mook ŽY•wl‰Č, (5): 29`35, 1993.

1972. m‘ŕn ŒŽŒo/ŒŽŒoŽž‚ĚƒPƒA. ă–V•qŽqCź“‡ł”ŽiŽY•wj: ŽY•wl‰Č‚ĚŽŔŰ, 42(7): 977`979, 1993.

1973. m‘ŕn ‚í‚Ş‘‚É‚¨‚Ż‚é–ł’É•Ş•Ř‚ĚŒťó. ź“‡ł”ŽC•{•s“ń’jiŽY•wj: ŽY•wl‰ČŽĄ—Ă, 68(2): 191`194, 1994.

1974. m‘ŕn ¸_–ĘŽx‰‡‚Ć”DPĽ•Ş•ŘŒř‰Ę. ź“‡ł”ŽC‹gŒ´ˆęiŽY•wj: ŽüŽYŠúˆăŠw, 23(10): 1451`1454, 1993.

1975. m‘ŕn PROM-‚ą‚ę‚Š‚ç‚ĚŽüŽYŠúˆă—Ă‚Ć‚Ě‚Š‚Š‚í‚č‡‚˘. “‡“cMGiŽY•wj: ŽüŽYŠúˆăŠw, 24(3): 314`316, 1993.

1976. m‘ŕn STD-”~“Ĺ, AIDS. –ě“c–FlCź“‡ł”ŽiŽY•wj: —Տ°ƒŠƒXƒeƒBƒ“ƒO, p.366`372, 1994.

1977. muŔn ŽY“š‚̉đ–U. “V–슎iŽY•wj: Perinatal Care, 13(3): 9`15, 1994.

1978. muŔn ‡•šÇ”DP‚ĚŠÇ—|šb‘§. ź“‡ł”ŽC‘O“c@“żiŽY•wj: ŽY•wl‰Č‚̐˘ŠE, 45(12): 985`991, 1993.

1979. muŔn ƒRƒ‹ƒlƒŠƒAĽƒfĽƒ‰ƒ“ƒWƒFÇŒóŒQ. “‡“cMGiŽY•wj: ŽüŽYŠúˆăŠw, 23(4): 462`463, 1993.

1980. muŔn ”DP’†Šú‚É‚¨‚Ż‚é‘ŮŽ™•]‰ż‚Ć‚ť‚Ě–â‘č“_|•Ş•ŘŽž‚Ě‘ŮŽ™ŠÇ—. “V–슎iŽY•wj: ŽüŽYŠúˆăŠw, 23(5): 707`710, 1993.

1981. muŔn CST (contraction stress test). “V–슎iŽY•wj: ŽüŽYŠúˆăŠw, 23(‘): 127`133, 1993.

1982. muŔn łí•Ş•ŘŒă2ŽžŠÔ‚Ěƒ`ƒFƒbƒNƒ|ƒCƒ“ƒg‚ĆƒPƒA. “‡“cMGiŽY•wj: ŽüŽYŠúˆăŠw, 24(2): 169`173, 1994.

1983. muŔn —Ť‚̍˜’Ɂ|ŽY•wl‰Č“If—Â𒆐S‚Ć‚ľ‚Ä. “‡“cMGiŽY•wj: —Տ°‚ĆŒ¤‹†, 70(11): 3541`3545, 1993.

1984. muŔn ośŽž‚É‚¨‚Ż‚éVśŽ™‚ĚŠO‰A‚Ě‚Ý‚Š‚˝. “‡“cMGiŽY•wj: —Տ°•wl‰ČŽY‰Č, 47(6): 695`697, 1993.

1985. muŔn —r…•â[—Ă–@. ź“‡ł”ŽC“V–슎iŽY•wj: —Տ°•wl‰ČŽY‰Č, 47(8): 970`971, 1993.

1986. mŠwp‘n i•Ş’SŽˇ•Mj Vˆę”ĘŠO‰Čp‘OĽp’†ĽpŒăŠÇ—; •š‘śŽžŠł‚đ‚ŕ‚ŠłŽŇ‚̏p‘OŒŸ¸‚Əp‘Oˆ’u, ”DPĽŒŽŒo, p.374`378, ź“‡ł”ŽCă–V•qŽqiŽY•wj. •ŇW oŒŽN•vi“Œ‘ĺjC“ŕ–ěƒˆęi–k‘ĺjC÷ˆäŒ’ŽiiŽœŒbˆă‘ĺjCŽO•x—˜•vi“ŒŠC‘ĺjC ‚ւ邡o”Ĺ, “Œ‹ž, 93.09.09”­s.

1987. mŠwp‘n i•Ş’SŽˇ•Mj Ą“ú‚ĚŽĄ—ĂŽwj 1994; ŽY‰Č–ƒŒ, p.669, ź“‡ł”ŽiŽY•wj. •ŇW ˆîŠ_‹`–žiç—t‘ĺjC‘˝‰ę{K’jiŠÖ“Œ’üM•a‰@jC”öŒ`‰x˜YiŠŕŒ¤jC ˆăŠw‘‰@, “Œ‹ž, 94.03.15”­s.

1988. mŠwp‘n i•Ş’SŽˇ•Mj •ŽY•w, ŠĹŒě•w‚Ě‚˝‚ß‚Ě’´‰š”g‰ć‘œf’f; ”D•wŠÇ—‚Ć’´‰š”gf’f, p.147`158, ź“‡ł”ŽiŽY•wj. •ŇW ‚‹´ŽKi‘—§ĺ‘ä•a‰@jC…–쐳•Fi“Œ‘ĺjC “ě]“°, “Œ‹ž, 93.11.15”­s.

1989. mŠwp‘n i•Ş’SŽˇ•Mj }ŕŽY•wl‰Č View-4mŽY‰ČŽĄ—Án‘ŮŽ™‰źŽ€, ‘ŮŽ™‰źŽ€‚ĚŽĄ—Ă, “V–슎iŽY•wj. •ŇW ź“‡ł”ŽiŽY•wjC’†–ěm—Yi‹ă‘ĺjC ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 94.03.20”­s.

1990. mŠwp‘n i•Ş’SŽˇ•Mj }ŕŽY•wl‰Č View-4mŽY‰ČŽĄ—Án‘ŮŽ™‰źŽ€; “ďŽY‚Ě—\‘Ş‚Ćf’f, p.104`111, ź“‡ł”ŽiŽY•wj. •ŇW ź“‡ł”ŽiŽY•wjC’†–ěm—Yi‹ă‘ĺjC ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 94.03.20”­s.

1991. mŠwp‘n i•Ş’SŽˇ•Mj }ŕŽY•wl‰Č View-4mŽY‰ČŽĄ—Án‘ŮŽ™‰źŽ€; ‘ŮŽ™‰źŽ€‚Ć“ďŽY, p.10`17, ź“‡ł”ŽiŽY•wj. •ŇW ź“‡ł”ŽiŽY•wjC’†–ěm—Yi‹ă‘ĺjC ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 94.03.20”­s.

1992. mŠwp‘n i•ŇWj }ŕŽY•wl‰Č View-4mŽY‰ČŽĄ—Án‘ŮŽ™‰źŽ€, •ŇW ź“‡ł”ŽiŽY•wjC’†–ěm—Yi‹ă‘ĺjC ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 94.03.20”­s.


<<17 3 ŽY‰ČŠw>>

1993. m‹ł‰Č‘n i’P’˜j ‘ŮŽ™S””ƒ‚ƒjƒ^ƒŠƒ“ƒO, ‰ü’ů‘ć3”Ĺ; “‡“cMGiŽY•wj. “Œ‹žˆăŠwŽĐ, “Œ‹ž, 93.03.25”­s.

1994. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ŠĹŒě‚Ě‚˝‚ß‚Ě–ňŽ–“T; ”ĺ”AĽśBŠíŠŻ—pÜ, p.182`187, ă–V•qŽqiŽY•wj. •ŇW Î‹´Wi”ĺjCŽ›č–ž”üC“Ą“cŒbŽqiŠĹŒě•”jC•ŽR­ˆęi–ňÜjC ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 93.12.05”­s.


<<17 5 ŽY‰ČŠw>>

1995. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Low power laser therapy for gynecologic patients with complications after lymphadenectomy. ˜e“c–M•vCÄ“ĄŽCÎˆä‘¸—YCĄˆä‰ë•vC‘ –{”ŽsCź“‡ł”ŽiŽY•wj: 10th Congress of Pan-Pacific Surgical Association Japan Chapter i93.10.30j, “Œ‹ž, Abstract, p.45, 1993.

1996. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Laser excisional conization for uterine cervical neoplasia at an out patient basis. ˜e“c–M•vC‘ –{”ŽsCÄ“ĄŽCŽR–{G”üCă–V•qŽqCź“‡ł”ŽiŽY•wj: 8th World Congress of Cervical Pathology and Colposcopy i93.05.13j, Chicago, U.S.A.

1997. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Clinical studies on the transplacental transfer of cefotaxine, desacetyl-cefotaxine. –ě“c–FlC’Jş”ŽC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: 18th International Congress of Chemotherapy i93.06.27j, ƒXƒgƒbƒNƒzƒ‹ƒ€.

1998. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Significance of antibiotic therapy in the management of preterm labor and premature rupture of the membranes. “V–슎C’Jş”ŽC•{•s“ń’jCź“‡ł”ŽiŽY•wj: ‘ć18‰ń‘Ű‰ťŠw—Ă–@Šw‰ď i93.07.01j, ƒXƒgƒbƒNƒzƒ‹ƒ€.

1999. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Effects of oxidative stress on few-maternal blood superoxide during labor. ‘O“c@“żC‹gŒ´ˆęCŻ“c—˛C’Jş”ŽC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: 2nd World Congress of Perinatal Medicine i93.09.23j, Roma.

2000. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j •wl‰Č—ĚˆćƒŒ[ƒU[ŽĄ—Ă‚ĚŒťó‚Ć“W–]; ŠO‰AĽäT•a•Ď‚ɑ΂ˇ‚郌[ƒU[ŽĄ—Ă. ˜e“c–M•vC‘ –{”ŽsiŽY•wj: ‘ć14‰ń“ú–{ƒŒ[ƒU[ˆăŠw‰ď i93.10.08j, ‘ĺă, “ú–{ƒŒ[ƒU[ˆăŠw‰ď‰ďŽ, 14(3): 63, 1993.

2001. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘ŮŽ™ŽĄ—Ă‚Ě—Ő° aminioinfusion|“K‰ž‚ĆŒŔŠE. “V–슎iŽY•wj: ‘ć12‰ń“ú–{ŽüŽYŠúŠw‰ď i94.01.22j, •Ÿ‰Ş.

2002. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”DPŽR—r‚đ—p‚˘‚˝‘ŮŽeoŒŒ‚̉e‹ż‚ÉŠÖ‚ˇ‚錤‹†. ‹gŒ´ˆęCŒš“c’C—YCŞ–{‘‘ˆęC“‡“cMGCź“‡ł”ŽCóˆämŽiC‰–’Ép”VC˛“ĄŠěˆęiŽY•wj: ‘ć45‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď i93.04.12j, ‘ĺă.

2003. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ„ƒM‘ŮŽe‚̏oŒŒŽž‚̏zŠÂŒn‚̕ωť‚ĆŒŒ’†ƒzƒ‹ƒ‚ƒ“”Z“x‚ĚŠÖŒW. ‹gŒ´ˆęCŒš“c’C—YC‘O“c@“żC“‡“cMGCź“‡ł”ŽCŞ–{‘‘ˆęCóˆämŽiC‰–’Ép”VC˛“ĄŠěˆęiŽY•wj: “ú–{ŽY‰Č•wl‰ČME§˜b‰ď i93.07.04j, •lź.

2004. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Rś•¨Žż‚Ě‘Ů”ŐˆÚs‚ÉŠÖ‚ˇ‚錟“˘. –ě“c–FlC’Jş”ŽCÄ“ĄŽCŻ“c—˛C•{•s“ń’jC—§‰Ş˜aOC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć29‰ń“ú–{VśŽ™Šw‰ď i93.07.16j, ‹ž“s.

2005. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”DP’†‚É‘ˆŤ‚đ‚Ý‚˝‘˝”­Ťd‰ťÇ‡•š”DP‚Ě‚P—á. Ż“c—˛C‹gŒ´ˆęCVˆäłGC•{•s“ń’jC‘O“c@“żC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wjCŹŒűO‹BCŠ—Œ´FiŽ™j: ‘ć29‰ń“ú–{VśŽ™Šw‰ď i93.07.16j, ‹ž“s.

2006. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •ęb‚Ö‚ĚƒCƒ\ƒtƒ‹ƒŒƒ““Š—^‚Ş‘ŮŽe‚É—^‚Ś‚é‰e‹ż. ‰–’Ép”VC‹gŒ´ˆęCŞ–{‘‘ˆęCŒš“c’C—YC“‡“cMGCź“‡ł”ŽCóˆämŽiC˛“ĄŠěˆęiŽY•wj: ‘ć29‰ń“ú–{VśŽ™Šw‰ď‘‰ď i93.07.20j, ‹ž“s.

2007. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Cystic Hygroma‚ĚŽY‰ČŠÇ—‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ‘O“c@“żCŻ“c—˛C•{•s“ń’jC–ě“c–FlC‹gŒ´ˆęC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć33‰ń“ú–{ć“VˆŮíŠw‰ďŠwpW‰ď i93.07.23j, –źŒĂ‰Ž.

2008. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Žq‹{o“ŕ•a•Ď‚ɑ΂ˇ‚é Resectoscopy. ˜e“c–M•vCĄˆä‰ë•vCÎˆä‘¸—YC‰ş“c—˛•vCă–V•qŽqC‘ –{”ŽsCź“‡ł”ŽiŽY•wj: ‘ć33‰ń“ú–{ŽY‰Č•wl‰Č“ŕŽ‹‹žŠw‰ď i93.08.04j, –źŒĂ‰Ž, ´˜^W, p.46, 1993.

2009. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •i‘ŮĽŽl‘Ů‚ĚŽüŽYŠú—\Œă‚ÉŠÖ‚ˇ‚錟“˘. Ąˆä‰ë•vC–ě“c–FlC“cŒű‰ë”VCŻ“c—˛C“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć38‰ń“ú–{–˘nŽ™VśŽ™Šw‰ď i93.10.28j, ŽD–y.

2010. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ž™‚Ě’ZŠú—\Œă‚Š‚ç‚Ý‚˝‘ŽY—á‚Ě•Ş•Ř—lŽŽ‚ÉŠÖ‚ˇ‚錟“˘. –ě“c–FlCĄˆä‰ë•vCŻ“c—˛C‘O“c@“żC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć38‰ń“ú–{–˘nŽ™VśŽ™Šw‰ď i93.10.28j, ŽD–y.

2011. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •Ş•Ř‘O‚ĚAmunioinfusion‚ɂ‚˘‚Ä. •{•s“ń’jC“cŒű‰ë”VC“y‹Š˛C˛“Ą—Ď–çC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć38‰ń“ú–{–˘nŽ™VśŽ™Šw‰ď i93.10.28j, ŽD–y.

2012. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j •Ş•ŘŽž‚É‚¨‚Ż‚éä`‘Ń“ŽĂ–ŹŒŒÔŒŒ‹…—R—ˆ02Ľ-‚Ćoxidative stress‚Ć‚ĚŠÖ˜AŤ‚ɂ‚˘‚Ä. ‘O“c@“żC‹gŒ´ˆęCŻ“c—˛C’Jş”ŽC–ě“c–FlC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wjC’†‘ş‘‰qi•Şśj: ‘ć45‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď‘‰ď i93.04.12j, ‘ĺă.

2013. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”DP’†Šú‚Ě—r…őF‘Ě•ŞÍ3050—á‚ĚŒŸ“˘. •{•s“ń’jiŽY•wjC‘ĺ–ě“šŽqi—ŐŒŸjCźMťC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć45‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď‘‰ď i93.04.13j, ‘ĺă.

2014. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒpƒ‹ƒXƒIƒLƒVƒ[ƒ^‚É‚ć‚é‘ŮŽ™ŠÇ—‚đs‚Č‚Á‚˝ŠŽ‘S–[ŽşƒuƒƒbƒN‚Ě‚P—á. “V–슎C“Ąś—TŽqC‚źˆ¤C‘O“c@“żC“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć38‰ń“ú–{–˘nŽ™VśŽ™Šw‰ď i93.10.29j, ŽD–y.

2015. mŠw‰ďi’n•űjn i“Á•Ęu‰‰j ˆŔ‘S‚Č•Ş•ŘŠÇ—‚đ‚ŕ‚Ć‚ß‚Ä. ź“‡ł”ŽiŽY•wj: •˝Ź‚T”N“x“ú–{ŽY‰Č•wl‰ČŠw‰ďŽR—œ’n•ű•”‰ďĽ“ú–{•ęŤ•ŰŒěˆă‹Ś‰ďŽR—œŒ§Žx•”‡“ŻŒ¤C‰ď i93.04.24j, b•{.

2016. mŠw‰ďi’n•űjn i“Á•Ęu‰‰j ’鉤ŘŠJ‚Ě“K‰ž‚Ě•Ď‘J. ź“‡ł”ŽiŽY•wj: ‘ć4‰ńKOGRA‚Ě‰ď i93.10.28j, ‰Ą•l.

2017. mŠw‰ďi’n•űjn i“Á•Ęu‰‰j •Ş•Ř—U”­‚Ć‘Łi. “‡“cMGiŽY•wj: ‘ć15‰ńˆďéˆăŠw‰ďŽY•wl‰Č•Ş‰Č‰ď, ‘ć100‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďˆďé’n•ű•”‰ď i93.10.30j, …ŒË.

2018. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Cystic hygroma‚ĚŽY‰ČŠÇ—‚ɂ‚˘‚Ä. ‘O“c@“żC•{•s“ń’jCŻ“c—˛C–ě“c–FlC‹gŒ´ˆęC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć292‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď_“ސě’n•ű•”‰ď i93.05.15j, ‰Ą•l.

2019. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j oś‘O‚ɐf’f‚ľ“ž‚˝ƒGƒuƒXƒ^ƒCƒ“ŠďŒ`‚Ě‚PÇ—á. ‘O“c@“żCÄ“ĄŽCŻ“c—˛C•{•s“ń’jC’Jş”ŽC–ě“c–FlC‹gŒ´ˆęC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć85‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‘‰ď i93.06.06j, “Œ‹ž.

2020. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Žq‹{“ŕ‚ŏzŠÂ•s‘S‚ɊׂÁ‚˝‚ĆŽv‚í‚ę‚é‚RÇ—á‚ĚŒŸ“˘. •{•s“ń’jCĄˆä‰ë•vCŻ“c—˛C‘O“c@“żC’Jş”ŽC–ě“c–FlC‹gŒ´ˆęC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć85‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‘‰ď i93.06.06j, “Œ‹ž.

2021. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j œ”Ő“ŕƒŠƒ“ƒpßŠs´Œă‚Ě•›áŠQ‚ɑ΂ˇ‚é’áo—Í”ź“ą‘ĚƒŒ[ƒU[ŽĄ—Ă‚ĚŽŽ‚Ý. Ä“ĄŽC˜e“c–M•vCĄˆä‰ë•vC‘ –{”ŽsCź“‡ł”ŽiŽY•wj: ‘ć85‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‘‰ď i93.06.06j, “Œ‹ž, “ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‰ď•ń, 30(2): 286, 1993.

2022. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŕhŽ†ŒŒELISA–@‚É‚ć‚é”DP’†ŠúMSAFP‘Ş’č‚ɂ‚˘‚Ä. ‹ß“Ą‰ëŽqC‰Á“Ą—ÇŽ÷C‘“c—Ç•˝C“cŒű–žC“V–슎Cź“‡ł”ŽiŽY•wj: ‘ć85‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‘‰ď i93.06.06j, “Œ‹ž, “ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‰ď•ń, 30(2): 290, 1993.

2023. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –ƒŒ•Ş•ŘŽž‚Ě•ę‘ّ̉ˇ‚̕ωť‚ɂ‚˘‚Ä. “V–슎C“Ąś—TŽqCŻ“c—˛C•{•s“ń’jC–ě“c–FlC‹gŒ´ˆęC“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć86‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‘‰ď i93.10.24j, •lź.

2024. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘ŮŽ™• •”ŽžŠł‚̏oś‘OŠÇ—‚ÉŠÖ‚ˇ‚錟“˘. ŠŰŽR—TŽqCÄ“ĄŽCŻ“c—˛C‘O“c@“żC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć295‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď_“ސě’n•ű•”‰ďC‘ć35‰ń_“ސěˆăŠw‰ď‘‰ď•Ş‰Č‰ď i93.11.13j, ěč.

2025. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ä`‘Ń“Ž–ŹŒŒpH’á’l—á(<7.00)‚ĚŽY‰Č—vˆö‚ĆŽ™‚Ě—\Œă‚ÉŠÖ‚ˇ‚錟“˘. Ż“c—˛C‹ŕˆä“”VC–ě“c–FlC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć296‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď_“ސě’n•ű‰ď i93.12.00j, ‰Ą•l.

2026. mŒ¤‹†‰ďi‘S‘jn i“Á•Ęu‰‰j ‚ą‚ę‚Š‚ç‚̏•ŽY•w‚É•K—v‚ČŽüŽYŠúˆăŠw“IŠĎŽ@Šá. “‡“cMGiŽY•wj: ƒƒCƒXĽƒG[ƒUƒCClinical MeetingŠwpu‰‰‰ď i93.06.26j, “Œ‹ž.

2027. mŒ¤‹†‰ďi‘S‘jn i“Á•Ęu‰‰j •Ş•Ř—U”­Ľ‘Łi‚ÉŠÖ‚ˇ‚éŽY‰ČŽüŽYŠúˆă—Ă. “‡“cMGiŽY•wj: ‘ć15‰ńĹVŽüŽYŠúˆăŠwƒZƒ~ƒi[i‰f‚Š‚ç•Ş•Ř‚܂Łj i93.07.24`25j, “Œ‹ž.

2028. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j •Ş•ŘŽž‚̍d–ŒŠO–ƒŒ‚Ƒ̉ˇ‚ɂ‚˘‚Ä. “Ąś—TŽqCŻ“c—˛C•{•s“ń’jC–ě“c–FlC‹gŒ´ˆęC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć86‰ń–ł’É•Ş•ŘŒ¤‹†‰ď i93.06.05j, “Œ‹ž.

2029. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j •Ş•ŘŽžŽ_‘f“Š—^‚ĚˆÓ‹`|ƒX[ƒp[ƒIƒLƒVƒh‚ĚŒŸ“˘‚ć‚č. ‘O“c@“żC‹gŒ´ˆęCŻ“c—˛C•{•s“ń’jC–ě“c–FlC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć86‰ń–ł’É•Ş•ŘŒ¤‹†‰ď i93.06.05j, “Œ‹ž.

2030. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ”DP’†“ĹÇ‚É‘Î‚ˇ‚éEPAH‚ĚŽŽ‚Ý. ‘O“c@“żC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wjC’†“‡‚Ć‚ľ‚݁i‰h—{•”j: ‘ć17‰ń“ú–{ŽY•wl‰Č‰h—{Ľ‘ăŽÓŒ¤‹†‰ď i93.08.28j, Ž­Ž™“‡.

2031. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ä`‘Ń“Ž–ŹŒŒPH’á’l—á(<7.00)‚ĚŽY‰Č—vˆö‚ĆŽ™‚Ě—\Œă‚ÉŠÖ‚ˇ‚錟“˘. Ż“c—˛C‹ŕˆä“”VC–ě“c–FlC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć87‰ń–ł’É•Ş•ŘŒ¤‹†‰ď i93.12.00j, ‰Ą•l.

2032. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ‘˝‘Ů”DPĽ•Ş•Ř‚ĚŠÇ—. ź“‡ł”ŽiŽY•wj: ‚ŔĽŠC˜V–źŽY•wl‰Čˆă‰ď i93.07.27j, Œú–Ř.

2033. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ˆŔ‘S‚Č•Ş•ŘŠÇ—‚đ‚ß‚´‚ľ‚Ä. ź“‡ł”ŽiŽY•wj: “š“ěŽY‰Č•wl‰Čˆă‰ďŠwpu‰‰‰ď i94.01.27j, ”ŸŠŮ.

2034. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ‘˝‘Ů”DPĽ•Ş•Ř‚ĚŠÇ—. ź“‡ł”ŽiŽY•wj: “ú–{•ęŤ•ŰŒěˆă‹Ś‰ďé‹ĘŒ§Žx•”Œ¤C‰ď i94.02.19j, ‰Y˜a.

2035. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ‚ą‚Ě10”NŠÔ‚ĹƒOƒŒƒCƒhƒAƒbƒv‚ľ‚˝ŽY‰ČŽüŽYŠúˆă—Ă‚Ě‚ł‚ç‚Č‚é”­“W‚đ. “‡“cMGiŽY•wj: “Œ–kŽüŽYŠúƒZƒ~ƒi[ i93.07.31j, ĺ‘ä.

2036. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ‘ŮŽ™S””}‚Ě‚ć‚Ý•ű. “‡“cMGiŽY•wj: ‘ć6‰ń–kŠC“šŽüŽYŠúƒZƒ~ƒi[ i93.10.09j, ŽD–y.

2037. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j •Ş•Ř—U”­Ľ‘Łi‚ÉŠÖ‚ˇ‚éŽY‰ČŽüŽYŠúˆă—Ă. “‡“cMGiŽY•wj: ‘ć15‰ńŠâŽčŒ§ŽüŽYŠúˆăŠwĽŠĹŒěƒZƒ~ƒi[ i93.10.16j, ‰ÔŠŞ.

2038. mŒ¤‹†‰ďi’n•űjn iƒ[ƒNƒVƒ‡ƒbƒvj Ç—á‚Š‚ç‚Ý‚˝—r…’“ü–@. “V–슎iŽY•wj: ‘ć1‰ń•Ş•ŘŠÄŽ‹Œ¤‹†‰ď i93.06.19j, “Œ‹ž.

2039. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ŠŒF×–EŽî‡•š”DP‚ĚŠÇ—. ‹ß“Ą‰ëŽqC‘“c—Ç•˝C‰Á“Ą—ÇŽ÷C“cŒű–žC“V–슎Cź“‡ł”ŽiŽY•wj: ‘ć86‰ń–ł’É•Ş•ŘŒ¤‹†‰ď i93.06.05j, “Œ‹ž.

2040. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘ŮŽ™S”ƒ‚ƒjƒ^ƒŠƒ“ƒO‚Ĺ—\‘ލ˘“ď‚Ĺ‚ ‚Á‚˝•Ş•Ř’źŒăVśŽ™Ž€–S—á. ‰Á“Ą—ÇŽ÷C‘“c—Ç•˝CŞ–{—ćŽqC“cŒű–žiŽY•wj: ‘ć1‰ń•Ş•ŘŠÄŽ‹Œ¤‹†‰ď i93.06.19j, “Œ‹ž.

2041. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j d–ŒŠO–ƒŒ‚É‚ć‚é•Ş•ŘŽž‚Ěƒ}ƒCƒi[ƒgƒ‰ƒuƒ‹. ŠŰŽR—TŽqC“Ąś—TŽqC“V–슎C“‡“cMGCź“‡ł”ŽiŽY•wj: ‘ć308‰ńŽl…‰ď i93.10.20j, ěč.

2042. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Amnioinfusion ‚É‚ć‚Á‚ďŠŒŠ‚̉ü‘P‚Ş‚Ý‚ç‚ę‚˝‚P—á. “V–슎Cź“‡ł”ŽiŽY•wj: ‘ć2‰ń•Ş•ŘŠÄŽ‹Œ¤‹†‰ď i93.12.11j, “Œ‹ž.

2043. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Feto-maternal transfusion ‚Ě‚P—á. “V–슎Cź“‡ł”ŽiŽY•wj: ‘ć2‰ń•Ş•ŘŠÄŽ‹Œ¤‹†‰ď i93.12.11j, “Œ‹ž.

2044. mŒ¤‹†‰ďi’n•űjn iŒöŠJuŔj ‘o‘Ů‚Ě”DPĽ•Ş•ŘŠÇ—. –ě“c–FliŽY•wj: •˝Ź5”N“x“úˆăśŠU‹łˆçuŔ•wl‰ČŒ¤C‰ď i93.11.06j, ‘Š–ÍŒ´.


<<17 7 ŽY‰ČŠw>>

2045. mŠw‰ďŽĺĂi’n•ű‰ďjn ‘ć299‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď_“ސě’n•ű•”‰ď, ź“‡ł”ŽiŽY•wj.

2046. mŠw‰ďŽĺĂi’n•ű‰ďjn ‘ć7‰ń_“ŢěŒ§•ęŤ‰qśŠw‰ď, ź“‡ł”ŽiŽY•wj.


<<18 •wl‰ČŠw>>

2047. mŒ´’˜n A novel tumor-associated protein: clinical significance of serum levels in various clinical conditions with special reference to gynecological malignant diseases. ’†‹ŒőśCě“ŕ”ŽlCˆ­”üł“TC”n“ˆP—YCÎě‰ëˆęiŽY•wj: Eur. J. Obstet. Gynecol. Reprod. Biol., 43: 143`147, 1992.

2048. mŒ´’˜n Žq‹{ŒzŠŕ|Žq‹{Œz•”‰ŠúŠŕ‚ɑ΂ˇ‚é•Ű‘ś—Ă–@|. ‘ –{”ŽsC˜e“c–M•vCÎˆä‘¸—YCă–V•qŽqiŽY•wj: ˆă–ňƒWƒƒ[ƒiƒ‹, 30(3): 818`823, 1994.

2049. mŒ´’˜n ”DP’†‚Ě—‘‘ƒŽîᇂ̕ۑś—Ă–@. ‘ –{”ŽsCă–V•qŽqCŠâ’JO–žiŽY•wj: ŽY•wl‰Č‚ĚŽŔŰ, 42(8): 1239`1244, 1993.

2050. mŒ´’˜n pŒă–ü’…—\–hô‚Ć‚ľ‚Ä‚ĚpŒă‘Šú Second-look laparoscopy ‰ş‚Ě–ü’…”—Ł. ě“ŕ”ŽlCÎě‰ëˆęCçݎ–ŤC”Ń–ě÷“ńC’†‹ŒőśiŽY•wj: ŽY•wl‰Čƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ďŽGŽ, 6(1): 88`92, 1993.

2051. mŒ´’˜n •wl‰ČˆŤŤŽîᇉťŠw—Ă–@Žž‚̍œ‘—}§‚ɑ΂ˇ‚érhG-CSF‚V“úŠÔ“Š—^‚̉ü‘PŒř‰Ę. ‘ –{”ŽsC`GŽ÷CŒË‰ęč‹`–žC‰ş“c—˛•vCň‹M•śCçݎ–ŤiŽY•wj: “ú–{ŠŕŽĄ—ĂŠw‰ďŽ, 28(6): 879`885, 1993.

2052. mŒ´’˜n 21Ž{Ý‚É‚ć‚éis—‘‘ƒŠŕ‚ĚŽĄ—ÐŹŃ|‚Ć‚­‚ÉŽĄ—Ă–@‚Ě‘Šˆá‚É‚ć‚鐜‘ś—Ś‚̍ˇˆŮ‚𒆐S‚É. Ž›“‡–F‹PC˛X–ŘŠ°C‰ĄŽRŽu˜YC—Ž‡˜a“żiŽœŒbˆă‘ĺjCA“c‘şC‹gě—T”VC…’JŸ”üi“s—§‹îž•a‰@jC–ňŽtŽ›“š–žCź‘şŽĄ•vi‹v—Ż•Ä‘ĺjCPź—˛ˆę˜Y i‘—§‚Ş‚ńƒZƒ“ƒ^[jC“c’†Œ›ˆęCŽ™‹ĘČ“ńiVŠƒ‘ĺjC’|“ŕłŽľi’é‹ž‘ĺjCŽR‰şK‹Ii‘—§ŽD–y•a‰@jC•Ŕ–؍P•vCX’ËˆĐ“ń˜Yi‘—§ĺ‘ä•a‰@jC˜ZŽ­ł•ś i‘—§–źŒĂ‰Ž•a‰@jC“ĄˆäP•vi‘—§Œŕ•a‰@jC“ú‰Ył“šiŽl‘‚Ş‚ńƒZƒ“ƒ^[jCŽŠŒŠşŽii‘—§•a‰@‹ăB‚Ş‚ńƒZƒ“ƒ^[jC“Ą–{Şˆę˜Yi–k‘ĺjC–‘i“Œ–k ‘ĺjCź“‡ł”ŽiŽY•wjC—F“c–Li–ź‘ĺjC–ě“c‹Nˆę˜Yi‹ß‘ĺjC‰Ź“cK—Yi‘ĺăŽs—§‘ĺjC’Ë–{’źŽ÷i‹ă‘ĺjCŽR•Ó“Oi’ˇč‘ĺjC”g‘˝]ł‹IiŽ­Ž™“‡Žs—§•a ‰@jCŒĂ—˘Ş‘iŽœŒbˆă‘ĺjC’Ă‹ŕšˆę˜Yi‘—§‚Ş‚ńƒZƒ“ƒ^[jCâ–{–s•Fi“Œ‘ĺjC•Ÿ“‡‰ë“Tiˆ¤’mŒ§‚Ş‚ńƒZƒ“ƒ^[j: “ú–{ŽY‰Č•wl‰ČŠw‰ďŽGŽ, 45(4): 363`370, 1993.

2053. mŒ´’˜n •wl‰ČŽîᇂɂ¨‚Ż‚錌´ Sialyl Tn RŒ´‚Ě—Ő°“IˆÓ‹`. ă–V•qŽqCÎˆä‘¸—YC`GŽ÷C‘ –{”ŽsCź“‡ł”ŽiŽY•wj: “ú–{ŽY‰Č•wl‰ČŠw‰ď_“ސě’n•ű•”‰ď‰ďŽ, 30(1): 18`21, 1993.

2054. mŒ´’˜n Žq‹{‘ĚŠŕ‚Ě•ŞŽqĽ×–Eś•¨Šw|‘B’˛ß‚ĆŠŕˆâ“`Žq. `GŽ÷iŽY•wjC•l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jC’Ňˆä“āCŒË‰ęč‹`–žC‘ –{”ŽsiŽY•wjCź“cłli’}”g‘ĺjCˆŔźŒˇCErlio GurpideiMount Sinai Sch. of Med.j: “ú–{•wl‰Č•a—ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ďŽGŽ, 11(2): 167`173, 1993.

2055. mŒ´’˜n Žq‹{“ŕ–ŒŸ÷‰tŤ‘BŠŕ‚Ě×–EŠŒŠ. —§‰Ş˜aOCă–V•qŽqC‹v“ˆ‘ĽsC‘ĺ‰ÍŒ´‘C—Ń—ćŽqC‘ –{”ŽsiŽY•wj: “ú–{—Տ°×–EŠw‰ďŽGŽ, 32(6): 948`955, 1993.

2056. m’Z•ńĽ‘Ź•ńn ŠO‰A•”‚É—p‚˘‚éƒ^ƒ‹ƒNƒpƒEƒ_[‚É‚Í—‘‘ƒŠŕ‚Ě‹°‚ęHi´–ój. ‘ –{”ŽsiŽY•wj: Modern Medicine, 6: 115, 1993.

2057. m’Z•ńĽ‘Ź•ńn •›t‹@”\ˆŮí‚Ć•s”D. ’†‹ŒőśiŽY•wj: —Տ°•wl‰ČŽY‰Č, 47(10): 1174`1175, 1993.

2058. mŒ¤‹†•ńi•ś•”Čjn IshikawaŠŕ‚ĚƒGƒXƒgƒƒQƒ“—U“ąŤ‘BˆöŽq. ‘ –{”ŽsiŽY•wj: •˝Ź2Ľ3Ľ4”N“x‚Ş‚ń“Á•ĘŒ¤‹†i‚PjŤƒzƒ‹ƒ‚ƒ“—U“ąŤ‘BˆöŽq‚É‚ć‚éŠŕ‘BŒ¤‹†Ź‰Ę•ń‘, p.21`22, 53`69, 1993.


<<18 2 •wl‰ČŠw>>

2059. mÇ—á•ńn 15Î‚̏­—‚ÉŒŠ‚ç‚ę‚˝‹‘ĺ”X–Eóč÷—ą–Œ×–EŽî‚Ě‚P—á. ă•Đ•˝ş“ńCă–V•qŽqCŠp“cV•˝C‘ –{”ŽsCź“‡ł”ŽiŽY•wj: “ú–{ŽY‰Č•wl‰ČŠw‰ď_“ސě’n•ű•”‰ď‰ďŽ, 30(2): 186`189, 1994.

2060. mÇ—á•ńn • –Œ•\–ĘŸ÷‰tŤ“ű“ޏó‘BŠŕ‚Ě‚P—á. ˛“Ą—Ď–çCă–V•qŽqC–Ř“c–FŽ÷CŠp“cV•˝C‰ş“c—˛•vC‘ –{”ŽsiŽY•wjC‘ĺ–ě‰pŽĄi•a‰@•a—•”jC‹T’J“Oi•a—j: “ú–{—Տ°×–EŠw‰ďŽGŽ, 32(4): 536`542, 1993.

2061. m‘ŕn “ÁW: Ťƒzƒ‹ƒ‚ƒ“—U“ąŤŠŕ‘B‚Ć‚ť‚Ě‘rŽ¸|Žq‹{‘ĚŠŕ×–E‚Ěƒzƒ‹ƒ‚ƒ“‚Č‚ç‚Ń‚É‘BˆöŽqˆË‘śŤ‚ĚŒ¤‹†. `GŽ÷iŽY•wjC•l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jC’Ňˆä“āCŒË‰ęč‹`–žC‘ –{”ŽsiŽY•wjCź“cłli’}”g‘ĺjCˆŔźŒˇCErlio GurpideiMount Sinai Sch. of Med.j: Human Cell, 6(3): 182`187, 1993.

2062. m‘ŕn Žq‹{ŒzŠŕ‚Ć”D›sŤ‰ˇ‘śŽčp. ‘ –{”ŽsC˜e“c–M•vCň‹M•śC‹v“ˆ‘ĽsCÄ“ĄŽiŽY•wj: ŽY‰Č‚Ć•wl‰Č, 60(5): 645`650, 1993.

2063. m‘ŕn Žq‹{Œz•”Žîᇂɑ΂ˇ‚郌[ƒU[—Ă–@‚ĚŽĄ—ÐŹŃ. ‘ –{”ŽsiŽY•wj: ŽY‰Č‚Ć•wl‰Č, 60(Suppl.): 200`202, 1993.

2064. m‘ŕn Ä”­Žq‹{‘ĚŠŕ‚ĚŽĄ—Ă. ‘ –{”ŽsC’Ňˆä“āCŒË‰ęč‹`–žC‹v“ˆ‘ĽsiŽY•wj: ŽY•wl‰Č‚ĚŽŔŰ, 42(4): 547`551, 1993.

2065. m‘ŕn ×–Ef|Ĺ‹ß‚̐i•ŕ|. ‘ –{”ŽsiŽY•wjC‘ĺ–ě‰pŽĄi•a‰@•a—jC—Ń—ćŽqiŽY•wj: ŽY•wl‰Č‚ĚŽŔŰ, 42(4): 597`600, 1993.

2066. m‘ŕn —‘‘ƒ‚Ş‚ń‰ťŠw—Ă–@‚É‚¨‚Ż‚éG-CSF‚ĚŒř‰Ę“I“Š—^–@. ‘ –{”ŽsCŒË‰ęč‹`–žC`GŽ÷Cçݎ–ŤiŽY•wj: “úíf—Ă‚ĆŒŒ‰t, 3(5): 543`547, 1993.

2067. m‘ŕn Žq‹{ŒzŠŕĽ‘ĚŠŕ‚ĚŽá”N‰ť. ‘ –{”ŽsiŽY•wj: —Տ°•wl‰ČŽY‰Č, 47(12): 1394`1395, 1993.

2068. m‘ŕn ƒzƒ‹ƒ‚ƒ“•â[—Ă–@‚ĆŽq‹{‘ĚŠŕ‚ĚƒŠƒXƒN, ƒzƒ‹ƒ‚ƒ“•â[—Ă–@; HRT. —Ń—ćŽqC‘ –{”ŽsiŽY•wj: —Տ°•wl‰ČŽY‰Č, 47(7): 868`869, 1993.

2069. mŠwp‘n i•Ş’SŽˇ•Mj }ŕŽY•wl‰Č VIEW-2mŽîᇁn×–Ef; Žq‹{‘Ě•”‚ĚŽîᇍזEf|Žq‹{‘ĚŠŕ‚¨‚ć‚Ń“÷Žî, p.98`111, ‘ –{”ŽsiŽY•wjC‘ĺ–ě‰pŽĄi•a‰@•a—j. •ŇW ŽR•Ó“Oi’ˇč‘ĺjC–ě‘ňŽu˜NiŒc‘ĺjC ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 93.12.10”­s.

2070. mŠwp‘i‰p•śjn i•Ş’SŽˇ•Mj Recent Advances in Cervical Pathology and Colposcopy; The evaluation of receptors for estrogen and growth-related factors in human uterine cervical epithelium and neoplasias, p.73`91, ‘ –{”ŽsC`GŽ÷iŽY•wjC•l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jC‰ş“c—˛•viŽY•wj. •ŇW Luigi CarenzaCGuiseppe AtlanteCVincenzo PozziC Parthenon Publ., New York, 93.00.00”­s.


<<18 3 •wl‰ČŠw>>

2071. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj Œ’NĽ•ŰŒ’‚̉Ȋw|oś‘O‚Š‚ç‚ĚŒ’N‚đ‚ß‚´‚ľ‚ā|; Žq‚Ç‚ŕ‚̐Sg‚Ě”­’B‚Ć“Á’Ľ|¸_“I”­’B, p.115`125, ’†‹ŒőśiŽY•wj. “ú–{ŹŽ™ˆăŽ–o”ĹŽĐ, 94.03.00”­s.

2072. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj ‚ą‚ą‚Ü‚Ĺo—ˆ‚éƒAƒgƒ‰ƒXŽY•wl‰ČŠO—ˆf—Ă; –łŒŽŒo, ‘ć‡U•Ň3Í, ’†‹ŒőśiŽY•wj. •ŇW —é–؏H‰xiŒc‘ĺjC “ě]“°, 94.00.00”­s.

2073. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj —‘ŠÇ‚ĚŠî‘b‚ĆŽžŠł; —‘ŠÇ‚Ćƒzƒ‹ƒ‚ƒ“, ’†‹ŒőśiŽY•wj. •ŇW —é–؏H‰xiŒc‘ĺjC‘źC “ěŽR“°, 94.00.00”­s.


<<18 5 •wl‰ČŠw>>

2074. mŠw‰ďi‘Űjn i“Á•Ęu‰‰j Surgical management of endometrial carcinoma. ‘ –{”ŽsiŽY•wj: 2nd Annual Conference of the Association of Gynecologic Oncologists of India i94.02.12j, Chandigarh, India.

2075. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Laser therapy for early carcinomas of the cervix|SymposiumgCarcinoma cervix: A preventable and curable disease| What should be our future planning in the year 2000?h. ‘ –{”ŽsiŽY•wj: 2nd Annual Conference of the Association of Gynecologic Oncologists of India i94.02.12j, Chandigarh, India.

2076. mŠw‰ďi‘Űjn iƒ[ƒNƒVƒ‡ƒbƒvj Our procedure of radical hysterectomy. ‘ –{”ŽsiŽY•wj: Workshop at Medical College of Jammu i94.02.10j, Jammu, India.

2077. mŠw‰ďi‘Űjn iƒ[ƒNƒVƒ‡ƒbƒvj Live demonstration of radical hysterectomy. ‘ –{”ŽsiŽY•wj: Workshop at Medical College of Jammu i94.02.11j, Jammu, India.

2078. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The autocrine regulations of cell proliferation of human endometrial adenocarcinoma cells by estrogen induced transforming growth factor-ƒż. `GŽ÷iŽY•wjC•l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jCŒË‰ęč‹`–žC’Ňˆä“āC“n•ÓƒC‘ –{”ŽsiŽY•wj: 2nd Conference on gThe Endometriumh i93.09.22j, Bologna, Italy, Abstract Book, p.78, 1993.

2079. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Clinicopathological analysis of small cell carcinoma of the uterine cervix. Šp“cV•˝Că–V•qŽqC—§‰Ş˜aOCă•Đ•˝ş“ńC˛“Ą—Ď–çC‘ –{”ŽsiŽY•wj: 8th World Congress of Cervical Pathology and Colposcopy i93.05.13j, Chicago.

2080. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Chemosensitivity of ovarian cancer. ă–V•qŽqiŽY•wjCTerashima Y.CYakushiji M.CYamabe T.CYajima S.Cź“‡ł”ŽiŽY•wjCFukushima M.CYanagawa T.: 84th Annual Meeting American Association for Cancer Research i93.05.20j, Orlando, —\eW, p.204, 1993.

2081. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Surgical treatment for endometrial carcinoma-Necessity for paying attention to the parametrium. ‘ –{”ŽsCă–V•qŽqC‹v“ˆ‘ĽsC‘ĺ‰ÍŒ´‘CŠp“cV•˝iŽY•wj: 4th Biennial Meeting of the International Gynecologic Cancer Society i93.08.31j, Stockholm, Sweden, Int. J. Gynecol. Cancer, 3(Suppl. 1): 46, 1993.

2082. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Effect of TAT-59 on the proliferation of endometrial carcinoma cells. •l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jC`GŽ÷CŒË‰ęč‹`–žC“n•ÓƒC’Ňˆä“āC‘ –{”ŽsiŽY•wj: 2nd Conference on gThe Endometriumh i93.09.20`22j, Bologna, Italy, Abstract Book, p.80, 1993.

2083. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Immunohistochemical study for the structural proteins of basal membrane and cathepsin-D in normal and neoplastic endometrium. ŒË‰ęč‹`–žC’Ňˆä“āC`GŽ÷iŽY•wjC•l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jC“n•ÓƒC‘ –{”ŽsiŽY•wj: 2nd Conference on gThe Endometriumh i93.09.20`22j, Bologna, Italy, Abstract Book, p.81, 1993.

2084. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Immunohistochemical study for EGFR, IGF-1R, c-erbB-2 and p53 in normal and neoplastic endometrium. ’Ňˆä“āC`GŽ÷iŽY•wjC•l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jCŒË‰ęč‹`–žC“n•ÓƒC‘ –{”ŽsiŽY•wj: 2nd Conference on gThe Endometriumh i93.09.20`22j, Bologna, Italy, Abstract Book, p.82, 1993.

2085. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒVƒ“ƒ|ƒWƒEƒ€‡VuŤƒzƒ‹ƒ‚ƒ“‚̍ě—p‹@˜vŽq‹{‘ĚŠŕ×–E‚Ě‘B‚É‚¨‚Ż‚éƒzƒ‹ƒ‚ƒ“‚Č‚ç‚Ń‚É‘BˆöŽqˆË‘śŤ‚ĚŒ¤‹†. `GŽ÷iŽY•wjC•l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jC’Ňˆä“āCŒË‰ęč‹`–žC‘ –{”ŽsiŽY•wjCź“cłli’}”g‘ĺjCˆŔźŒˇCErlio GurpideiMount Sinai Med. Centerj: ‘ć66‰ń“ú–{‘gD”|—{Šw‰ď i93.06.18j, ‚‚­‚Î, ‘gD”|—{Œ¤‹†, 12(2): 124, 1993.

2086. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒVƒ“ƒ|ƒWƒEƒ€‡UuŽq‹{‘ĚŠŕ‚Ě•ŞŽqĽ×–Eś•¨Šwv‘B’˛ß‚ĆŠŕˆâ“`Žq. `GŽ÷iŽY•wj: ‘ć22‰ń•wl‰Č•a—ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ď i93.07.30j, “Œ‹ž, ŠwpW‰ďƒvƒƒOƒ‰ƒ€´˜^W, p.35, 1993.

2087. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Šŕ‰ťŠw—Ă–@‚Ě•›ě—p‘΍ô; ‚Ş‚ń‰ťŠw—Ă–@‚̍D’†‹…Œ¸­‘΍ô. ‘ –{”ŽsiŽY•wj: ‘ć31‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď‘‰ď i93.10.28j, ‘ĺă.

2088. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Žq‹{‘Ě‚Ş‚ń‹^—zŤ—á‚ĚŽć‚čˆľ‚˘; Žq‹{“ŕ–Œ×–Ef‹^—zŤ‚đ’ć‚ľ‚₡‚˘‹@”\ŤoŒŒ—á‚ĚŒŸ“˘. —Ń—ćŽqC‘ –{”ŽsCă–V•qŽqiŽY•wjC‘ĺ–ě‰pŽĄi•a‰@•a—•”j: ‘ć2‰ń•wl‰Č‚Ş‚ńŒŸfŠw‰ď i93.11.06j, “Œ‹ž.

2089. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j X”NŠúˆăŠw‚ĚŠî‘b‚Ć—Ő°: Žq‹{“ŕ–Œ‚̐ś—‚Ć•a—|Žq‹{‘ĚŠŕ‚Ě—Ő°•a—Šw“IŠŒŠ‚Ć‘ĚŠŕŒŸf. ă–V•qŽqiŽY•wj: ‘ć8‰ń“ú–{X”NŠúˆăŠw‰ďŠwpW‰ď i93.11.27j, “Œ‹ž, —\eW, p.57, 1993.

2090. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ŠŕW’cŒŸf‚đl‚Ś‚é; Žq‹{‘ĚŠŕ‚ɑ΂ˇ‚錟f‘ÎŰ‚ĚŠg‘ĺ‚Ş–]‚Ü‚ę‚é. ‘ –{”ŽsCă–V•qŽqC‘ĺ‰ÍŒ´‘C—Ń—ćŽqiŽY•wj: ‘ć31‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď‘‰ď i93.10.28j, ‘ĺă, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ, 28(9): 1198, 1993, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ, 29(2): 138, 1994

2091. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j —‘‘ƒŠŕ‚É‚¨‚Ż‚é—Տ°isŠú‚Ć”N—î•Ş•z‚Ć‚Ě‘ŠŠÖ‚ÉŠÖ‚ˇ‚錟“˘. Šâ’JO–žCă–V•qŽqCŠp“cV•˝C‹v“ˆ‘ĽsC‘ –{”ŽsCź“‡ł”ŽC—Ń—ćŽqiŽY•wj: ‘ć45‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď‘‰ď i93.04.12j, ‘ĺă, “ú–{ŽY‰Č•wl‰ČŠw‰ďŽGŽ, 45(Suppl.): 443, 1993.

2092. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Žq‹{‘Ě•”G•˝ă”çŠŕ‚Ě‚PÇ—á. ˛“Ą—Ď–çCň‹M•śCŒš“c’C—YCă–V•qŽqCź“‡ł”ŽiŽY•wj: ‘ć45‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď‘‰ď i93.04.13j, ‘ĺă, “ú–{ŽY‰Č•wl‰ČŠw‰ďŽGŽ, 45(Suppl.): 262, 1993.

2093. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Žq‹{‘ĚŠŕ×–E‚Ě‘B’˛ß‚Ćc-erbB-2, p53Šŕˆâ“`Žq”­Œť. `GŽ÷C‘ –{”ŽsiŽY•wjC•l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jC“n•ÓƒCŒË‰ęč‹`–žC’Ňˆä“āCŽRŒű“T—˜Cź“‡ł”ŽiŽY•wj: ‘ć45‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď‘‰ď i93.04.13j, ‘ĺă, “ú–{ŽY‰Č•wl‰ČŠw‰ďŽGŽ, 45(Suppl.): 265, 1993.

2094. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •słoŒŒ‚đ”F‚ß‚Č‚Š‚Á‚˝Žq‹{‘ĚŠŕÇ—á‚ĚŒŸ“˘. ‹v“ˆ‘ĽsCă–V•qŽqC‘ĺ‰ÍŒ´‘C‘ –{”ŽsiŽY•wj: ‘ć34‰ń“ú–{—Տ°×–EŠw‰ď‘‰ď i93.05.26j, ĺ‘ä, “ú–{—Տ°×–EŠw‰ďŽGŽ, 32(2): 216, 1993.

2095. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}Ť”’ŒŒ•a‚ĚŽq‹{“ŕ–Œ×–EfŠŒŠ. —§‰Ş˜aOCă–V•qŽqC`GŽ÷C‹v“ˆ‘ĽsC“Ąś—TŽqC‘ –{”ŽsiŽY•wjC‘ĺ–ě‰pŽĄi•a‰@•a—•”j: ‘ć34‰ń“ú–{—Տ°×–EŠw‰ď‘‰ď i93.05.26j, ĺ‘ä, “ú–{—Տ°×–EŠw‰ďŽGŽ, 32(2): 305, 1993.

2096. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Žq‹{“ŕ–Œ×–Ef‚ɏoŒť‚ˇ‚é—‘‘ƒ–ž×–E‘BŠŕ‚ĆŽq‹{‘Ě•”–ž×–E‘BŠŕ‚Ě×–EŠŒŠ‚Ě”äŠr. Šâ’JO–žCă–V•qŽqC“y‰ŽŒłˆęCâ–{ˆÉ“¤”üC—Ń—ćŽqCŠp“cV•˝C‘ –{”ŽsiŽY•wjC‘ĺ–ě‰pŽĄi•a‰@•a—•”j: ‘ć34‰ń“ú–{—Տ°×–EŠw‰ď‘‰ď i93.05.26j, ĺ‘ä, “ú–{—Տ°×–EŠw‰ďŽGŽ, 32(2): 308, 1993.

2097. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚Žü”g“d‹Cƒ‹[ƒv‚É‚ć‚éŽq‹{Œz•”Žîᇂ̐V‚ľ‚˘•Ű‘ś—Ă–@. ‘ –{”ŽsC˜e“c–M•vCÄ“ĄŽCň‹M•śiŽY•wj: ‘ć22‰ń“ú–{•wl‰Č•a—ĽƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ď i93.07.29j, “Œ‹ž, ´˜^W, p.68, 1993, “ú–{•wl‰Č•a—ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ďŽGŽ, 11(1): 62, 1993.

2098. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Žq‹{Œz•”ă”ç“ŕŽîᇂ̃Œ[ƒU[—Ă–@‚É‚¨‚Ż‚éöŽU–@‚Ɖ~Řœp‚Ě”äŠrŒŸ“˘. ˜e“c–M•vC‘ –{”ŽsCň‹M•śCĄˆä‰ë•vCÎˆä‘¸—YCź“‡ł”ŽiŽY•wj: ‘ć22‰ń“ú–{•wl‰Č•a—ĽƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ď i93.07.29j, “Œ‹ž, ´˜^W, p.68C“ú–{•wl‰Č•a—ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ďŽGŽ, 11(1): 62`63, 1993.

2099. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰Č‚É‚¨‚Ż‚éƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[‚̐ŹŃ|pŒă‘Šú Second-look laparoscopy Ž{s—á, ”ńŽ{s—á‚Ě”äŠr|. ě“ŕ”ŽlCçݎ–ŤCÎě‰ëˆęC”Ń–ě÷“ńC’†‹ŒőśiŽY•wj: ‘ć16‰ńŽY•wl‰Čƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď i93.08.03j, –źŒĂ‰Ž, ŽY•wl‰Čƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ďŽGŽ, p.34, 1993.

2100. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j —‘ŠÇ”DP‚ɑ΂ˇ‚é• o‹ž‰şŽčp|Early second-look laparoscopy ‚Š‚ç‚Ý‚˝ŽŠ“Kˆ’u–@‚ɂ‚˘‚ā|. ě“ŕ”ŽlCçݎ–ŤC”Ń–ě÷“ńCÎě‰ëˆęC’†‹ŒőśiŽY•wj: ‘ć33‰ń“ú–{ŽY‰Č•wl‰Č“ŕŽ‹‹žŠw‰ď i93.08.04j, –źŒĂ‰Ž, “ú–{ŽY‰Č•wl‰Č“ŕŽ‹‹žŠw‰ďŽGŽ, p.61, 1993.

2101. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ëŒ\ƒRƒ“ƒWƒƒ}‚ɑ΂ˇ‚郌[ƒU[ŽĄ—Ă. Îˆä‘¸—YC˜e“c–M•vCĄˆä‰ë•vCÄ“ĄŽC‹v“ˆ‘ĽsC‘ –{”ŽsCź“‡ł”ŽCň‹M•śiŽY•wj: ‘ć86‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‘‰ď i93.10.24j, •lź, “ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‰ď•ń, 30(4): 647, 1993.

2102. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •wl‰ČˆŤŤŽîᇉťŠw—Ă–@‚É‚¨‚Ż‚éCBDCAŽg—p‚É‚ć‚鍂’PˆĘƒvƒ‰ƒ`ƒi—Ă–@‚ĚŒř‰Ę. `GŽ÷C‘ –{”ŽsCŒË‰ęč‹`–žC‹v“ˆ‘ĽsC˜e“c–M•vCă–V•qŽqiŽY•wj: ‘ć31‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď‘‰ď i93.10.27j, ‘ĺă, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ, 28(9): 1235, 1993, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ, 29(2): 187, 1994.

2103. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •wl‰ČŠŕ‰ťŠw—Ă–@‚É‚¨‚Ż‚é rhG-CSF ‚Ě“Š—^–@•Ę—L—pŤ‚ĚŒŸ“˘. ŒË‰ęč‹`–žC`GŽ÷C‰Á“Ą—ÇŽ÷C‰ş“c—˛•vCçݎ–ŤCŠp“cV•˝C‘ –{”ŽsiŽY•wjC‘OěŠâ•viŔ’ĂŽs—§•a‰@j: ‘ć31‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď‘‰ď i93.10.28j, “ú–{ŠŕŽĄ—ĂŠw‰ď‰ďŽ, 28: 1408, 1993.

2104. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”DP‡•š—‘‘ƒˆŤŤŽîá‡10Ç—á‚Ě—Ő°“IŒŸ“˘. Šâ’JO–žCă–V•qŽqC—§‰Ş˜aOCÄ“ĄŽCVˆäłGC‘ –{”ŽsCź“‡ł”ŽiŽY•wj: ‘ć31‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď‘‰ď i93.10.28j, ‘ĺă, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ, 28(9): 1360, 1993.

2105. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j —‘‘ƒˆŤŤŽîᇂɑ΂ˇ‚é second surgery ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ŒăŒŤCă–V•qŽqC˜e“c–M•vC`GŽ÷CŠp“cV•˝CŠâ’JO–žC‘ –{”ŽsCź“‡ł”ŽCň‹M•śiŽY•wj: ‘ć31‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď‘‰ď i93.10.28j, ‘ĺă, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ, 28(9): 1360, 1993.

2106. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Žq‹{ŒzŠŕ‚̐f’fĽŽĄ—Ă‚¨‚Ż‚é SCC ‘Ş’č‚Ě•]‰ż. ˛“Ą—Ď–çCă–V•qŽqCŠp“cV•˝C‘ –{”ŽsCź“‡ł”ŽC—Ń—ćŽqiŽY•wj: ‘ć31‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď‘‰ď i93.10.28j, ‘ĺă, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ, 28(9): 1408, 1993.

2107. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Žq‹{‘ĚŠŕŽčp—Ă–@‚É‚¨‚Ż‚éŽq‹{ÓŒ‹‡D“Eœ‚ĚˆÓ‹`. ‹v“ˆ‘ĽsC‘ –{”ŽsCă–V•qŽqC‘ĺ‰ÍŒ´‘CŠp“cV•˝CŠâ’JO–žC˛“Ą—Ď–çCĄˆä‰ë•vC“yˆäŠ˛iŽY•wj: ‘ć31‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď‘‰ď i93.10.28j, ‘ĺă, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ, 28(9): 1428, 1993, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ, 29(2): 368, 1994.

2108. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j is—‘‘ƒŠŕ‚ĚŽĄ—ÐŹŃ. —§‰Ş˜aOCă–V•qŽqC`GŽ÷C˜e“c–M•vCŠp“cV•˝C‹v“ˆ‘ĽsCŠâ’JO–žC‘ –{”ŽsiŽY•wj: ‘ć31‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď‘‰ď i93.10.28j, ‘ĺă, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ, 28(9): 1428, 1993.

2109. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j • o‹ž‰şŽčpŒă‚Ě Early second-look laparoscopy ‚ɂ‚˘‚Ä. ě“ŕ”ŽlCÎě‰ëˆęCçݎ–ŤC”Ń–ě÷“ńC’†‹ŒőśiŽY•wj: ‘ć45‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď i93.04.12j, ‘ĺă, “ú–{ŽY‰Č•wl‰ČŠw‰ďŽGŽ, 45(—Ő‘): 395, 1993.

2110. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘ŠúŒz•”‘BŒnŽîᇂ̔­ŒŠ‚É‚¨‚Ż‚郌[ƒU[‰~Řœp•š—p‚ĚˆÓ‹`. Ä“ĄŽC˜e“c–M•vCĄˆä‰ë•vC`GŽ÷Că–V•qŽqC‘ –{”ŽsiŽY•wj: ‘ć34‰ń“ú–{—Տ°×–EŠw‰ď‘‰ď i93.05.27j, ĺ‘ä, “ú–{—Տ°×–EŠw‰ďŽGŽ, 32(2): 298, 1993.

2111. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žq‹{‘ĚŠŕ×–E‚Ě‘B’˛ß‚Ćc-erbB-2Šŕˆâ“`Žq”­Œť. `GŽ÷C‘ –{”ŽsiŽY•wjC•l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jC“n•ÓƒiŽY•wj: ‘ć66‰ń“ú–{“ŕ•Ş”ĺŠw‰ď i93.06.04j, ‹ŕ‘ň, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 69(4): 377, 1993.

2112. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žq‹{‘ĚŠŕ×–E‘B‚É‚¨‚ć‚Ú‚ˇTAT-59‚̉e‹ż. •l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jC`GŽ÷CŒË‰ęč‹`–žC“n•ÓƒC‘ –{”ŽsiŽY•wj: ‘ć66‰ń“ú–{‘gD”|—{Šw‰ď i93.06.18j, ‚‚­‚Î, ‘gD”|—{Œ¤‹†, 12(2): 182, 1993.

2113. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žq‹{‘ĚŠŕ×–E‚Ěƒzƒ‹ƒ‚ƒ“‚¨‚ć‚Ń‘BˆöŽqˆË‘śŤ‘B‚ĚŒŸ“˘. `GŽ÷C‘ –{”ŽsiŽY•wjC•l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jCŒË‰ęč‹`–žC“n•ÓƒiŽY•wj: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05j, ĺ‘ä, “ú–{ŠŕŠw‰ď‘‰ď‹LŽ–, p.303, 1993.

2114. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j —‘‘ƒŠŕ”|—{×–EŠ”(Ovas-21)‚Ě‘B‚Ć×–EŽüŠú‚É‚¨‚ć‚Ú‚ˇCDDP‚Č‚ç‚тɉÁ‰ˇ‚̉e‹ż. ‹g“c“TśC”Ń“c’q”ŽC—^“ß—ä‹žŽqCŠâ“cł”́C—Ń˜a•Fišƒ}ƒŠˆă‘ĺjC•l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jC‰ş“c—˛•vC`GŽ÷C‘ –{”ŽsiŽY•wj: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05j, ĺ‘ä, “ú–{ŠŕŠw‰ď‘‰ď‹LŽ–, p.309, 1993.

2115. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žq‹{‘ĚŠŕ‚É‚¨‚Ż‚éEGFR, IGF-1R, C-erbB-2, p53‚̖Ɖu‘gDŠw“IŒŸ“˘. ’Ňˆä“āC`GŽ÷C“n•ÓƒCŒË‰ęč‹`–žCă–V•qŽqC‘ –{”ŽsiŽY•wjC•l–ě”üŒbŽqi‘gD”|—{ƒZƒ“j: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.06j, ĺ‘ä, “ú–{ŠŕŠw‰ď‘‰ď‹LŽ–, p.237, 1993.

2116. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j V‚ľ‚˘RƒGƒXƒgƒƒQƒ“ÜTAT-59‚ĚŽq‹{‘ĚŠŕ×–E‘B‚É‚¨‚ć‚Ú‚ˇ‰e‹ż. •l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jC`GŽ÷CŒË‰ęč‹`–žC‘ –{”ŽsiŽY•wj: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.06j, ĺ‘ä, “ú–{ŠŕŠw‰ď‘‰ď‹LŽ–, p.631, 1993.

2117. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j —‘‘ƒŒ´”­‚Ě–˘•Ş‰ť“÷Žî‚Ş‹^‚í‚ę‚˝‚P—á. Ąˆä‰ë•vCă–V•qŽqCŠp“cV•˝C‹ŕˆä“”VC‘ –{”ŽsiŽY•wjCŠâŸşŒ[ˆęi•a—jC‚ŽR–žŽqC‘ĺ–ě‰pŽĄi•a‰@•a—•”j: ‘ć32‰ń“ú–{—Տ°×–EŠw‰ďH‹G‘ĺ‰ď i93.10.16j, ˆŽě, “ú–{—Տ°×–EŠw‰ď‰ďŽ, 32(5): 716, 1993.

2118. mŠw‰ďi’n•űjn i“Á•Ęu‰‰j Žq‹{“ŕ–ŒŠŕĽ‘BÇ‚Ě×–Ef. ‘ –{”ŽsiŽY•wj: ‘ć14‰ń“ú–{—Տ°×–EŠw‰ď–kŠC“šŽx•”ŠwpW‰ď i93.11.20j, ŽD–y.

2119. mŠw‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Žq‹{‘Ě•”‚É‚¨‚Ż‚éŠî–{“I‚Č×–E‘œ‚Ě“Ç‚Ý•ű|ƒŒƒtƒŒƒbƒVƒƒ[ƒR[ƒXuŠî–{“I‚Č×–E‘œ‚Ě“Ç‚Ý•űv. ‘ĺ–ě‰pŽĄC‰ĄŽR‘ĺC•ž•”ŠwC‚ŽR–žŽqC–L‰i^Ÿi•a‰@•a—jC‘ –{”ŽsiŽY•wjC‹T’J“Oi•a—j: ‘ć7‰ń“ú–{—Տ°×–EŠw‰ďŠÖ“Œ˜A‡‘‰ď i93.09.11j, •lź, ƒvƒƒOƒ‰ƒ€, p.11, 1993.

2120. mŠw‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Žq‹{‘ĚŠŕ‚Ě‘Šú”­ŒŠ‚ɂ‚˘‚ā|ƒŒƒtƒŒƒbƒVƒƒ[ƒR[ƒXuŠî–{“I‚Č×–E‘œ‚Ě“Ç‚Ý•űv. ‘ –{”ŽsiŽY•wj: ‘ć7‰ń“ú–{—Տ°×–EŠw‰ďŠÖ“Œ˜A‡‘‰ď i93.09.11j, •lź, “ú–{—Տ°×–EŠw‰ďŠÖ“Œ˜A‡‘‰ďƒvƒƒOƒ‰ƒ€, 11.

2121. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j •ÂŒoŠú‚ĚŽq‹{“ŕ–ŒŒú‘Ş’č‚ĚˆÓ‹`. “y‹Š˛C‰Á“Ą—ÇŽ÷CŞ–{—ćŽqC‘“c—Ç•˝C“cŒű–žiŽY•wj: ‘ć292‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď_“ސě’n•ű•”‰ď i93.05.15j, ‰Ą•l, “ú–{ŽY‰Č•wl‰ČŠw‰ď_“ސě’n•ű•”‰ď‰ďŽ, 30(2): 94, 1994.

2122. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j •słoŒŒ‚đ”F‚ß‚Č‚Š‚Á‚˝Žq‹{‘ĚŠŕÇ—á‚ĚŒŸ“˘. ‹v“ˆ‘ĽsCă–V•qŽqC‘ĺ‰ÍŒ´‘CŠp“cV•˝C—§‰Ş˜aOC˛“Ą—Ď–çC‘ –{”ŽsCź“‡ł”ŽiŽY•wj: ‘ć85‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‘‰ď i93.06.06j, “Œ‹ž, “ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‰ď•ń, 30(2): 251, 1993.

2123. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “–‰Č‚ĹŒoŒą‚ľ‚˝—‘‘ƒč÷—ą–Œ×–EŽî‚ĚŒŸ“˘. ă•Đ•˝ş“ńCă–V•qŽqCŠâ’JO–žCĄˆä‰ë•vCÎˆä‘¸—YCŒăŒŤC‘ –{”ŽsCź“‡ł”ŽiŽY•wj: ‘ć85‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‘‰ď i93.06.06j, “Œ‹ž, “ú–{ŽY‰Č•wl‰ČŠw‰ďŠÖ“Œ˜A‡’n•ű•”‰ď‰ď•ń, 30(2): 261, 1993.

2124. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j f’f‚ލ˘“ď‚Ĺ‚ ‚Á‚˝Œ‹Šj‚Ě‚R—á. ŒăŒŤCă–V•qŽqC‹v“ˆ‘ĽsC—§‰Ş˜aOCŠâ’JO–žC‘ –{”ŽsCź“‡ł”ŽiŽY•wj: ‘ć298‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď_“ސě’n•ű•”‰ď i94.02.19j, ‰Ą•l, “ú–{ŽY‰Č•wl‰ČŠw‰ď_“ސě’n•ű•”‰ď‰ďŽ.

2125. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‚Q“x‚Ě”DP‚É‚í‚˝‚čHELLPÇŒóŒQ‚đ”˝•œ‚ľ‚˝‚P—á. ă•Đ•˝ş“ńCŠp“cV•˝C–]ŒŽˆ¤˜YC—Ń‹P—YiŽY•wj: ‘ć299‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď_“ސě’n•ű•”‰ď i94.03.19j, ‰Ą•l.

2126. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒfƒBƒXƒJƒbƒTƒ“ƒg, ƒVƒ“ƒ|ƒWƒEƒ€; Žq‹{‘ĚŠŕ‚Ě“ŕ•Ş”ĺi‰ťŠwj—Ă–@‚ĚÄ•]‰ż. ‘ –{”ŽsiŽY•wj: ‘ć33‰ńŽq‹{ŠŕŒ¤‹†‰ďŠwpW‰ď i93.12.04j, ˇ‰Ş.

2127. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒVƒ“ƒ|ƒWƒEƒ€‚Q|Žq‹{‘ĚŠŕ“ŕ•Ş”ĺi‰ťŠwj—Ă–@‚ĚÄ•]‰ż; Žq‹{‘ĚŠŕ“ŕ•Ş”ĺ—Ă–@‚ĚŠî‘b“IŒŸ“˘. `GŽ÷C‘ –{”ŽsiŽY•wjC•l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jCŒË‰ęč‹`–žC’Ňˆä“āC“n•ÓƒCă–V•qŽqCź“‡ł”ŽiŽY•wjCź“cłli’}”g‘ĺjCˆŔź ŒˇCErlio GurpideiMount Sinai Sch. of Medj: ‘ć33‰ńŽq‹{ŠŕŒ¤‹†‰ďŠwpW‰ď i93.12.04j, ˇ‰Ş, ƒvƒƒOƒ‰ƒ€Ľ´˜^W, p.16, 1993.

2128. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Žq‹{‘ĚŠŕ‚Ě”­ś‹@˜‚ÉŠÖ‚ˇ‚錤‹†|‘BˆöŽq‚ĆŠŕˆâ“`Žq. ‘ –{”ŽsC`GŽ÷CŒË‰ęč‹`–žiŽY•wj: ŒúśČ‘΂ނńí—ŞŒ¤‹†Ž–‹Ću‚Ş‚ń‚Ě“ńŽŸ—\–h‚ÉŠÖ‚ˇ‚éf’f‹Zp‚ĚŠJ”­‚ÉŠÖ‚ˇ‚錤‹†v”ljď‹c i93.09.02j, “Œ‹ž.

2129. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Žq‹{ŒzŠŕ‚̐f’fĽŽĄ—Ă‚É‚¨‚Ż‚é SCC ‘Ş’č‚Ě•]‰ż. “cŒű‰ë”VCŒăŒŤC˛“Ą—Ď–çCă–V•qŽqCŠp“cV•˝C‘ –{”ŽsCź“‡ł”ŽiŽY•wj: ‘ć10‰ńŽY•wl‰ČŽîᇃ}[ƒJ[Œ¤‹†‰ď i94.02.11j, ‰F•”, —\eW, p.25, 1993.

2130. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Žîᇃ}[ƒJ[‚É‚ć‚éis—‘‘ƒŠŕŽĄ—ĂŒř‰Ę‚Ě”ť’č. —§‰Ş˜aOCă–V•qŽqC‹v“ˆ‘ĽsCŠâ’JO–žC˜e“c–M•vC`GŽ÷C‘ –{”ŽsCź“‡ł”ŽiŽY•wj: ‘ć10‰ńŽY•wl‰ČŽîᇃ}[ƒJ[Œ¤‹†‰ď i94.02.11j, ‰F•”, —\eW, p.27, 1993.

2131. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Žq‹{‘ĚŠŕ‚Ě”­ś‹@˜‚ÉŠÖ‚ˇ‚錤‹†|Žq‹{‘ĚŠŕŒŸf‘Ώۮҩg‘ĺ‚ÉŠÖ‚ˇ‚錤‹†. ‘ –{”ŽsC`GŽ÷CŒË‰ęč‹`–žiŽY•wjC•l–ě”üŒbŽqi‘gD”|—{ƒZƒ“jC’Ňˆä“āiŽY•wj: ŒúśČ‘΂ނńí—ŞŒ¤‹†Ž–‹Ću‚Ş‚ń‚Ě“ńŽŸ—\–h‚ÉŠÖ‚ˇ‚éf’f‹Zp‚ĚŠJ”­‚ÉŠÖ‚ˇ‚錤‹†v”ljď‹c i94.02.14j, “Œ‹ž.

2132. mŒ¤‹†‰ďi‘S‘jn iŒöŠJuŔj Žq‹{“ŕ–Œ‚Ě×–Ef. ‘ –{”ŽsiŽY•wj: ‘ć94‰ń“ú–{—Տ°×–EŠw‰ď×–EfƒXƒNƒŠ[ƒi[—{ŹuK‰ď i93.07.14j, “Œ‹ž.

2133. mŒ¤‹†‰ďi‘S‘jn iŒöŠJuŔj Žq‹{‘Ě•”. ‘ –{”ŽsiŽY•wj: ‘ć95‰ń“ú–{—Տ°×–EŠw‰ď×–EfƒXƒNƒŠ[ƒi[—{ŹuK‰ď i93.07.29j, “Œ‹ž.

2134. mŒ¤‹†‰ďi‘S‘jn iŒöŠJuŔj Žq‹{“ŕ–Œ. ‘ –{”ŽsiŽY•wj: ‘ć18‰ń“ú–{—Տ°×–EŠw‰ď×–Ef’fŠwƒZƒ~ƒi[ i93.08.09j, “Œ‹ž.

2135. mŒ¤‹†‰ďi‘S‘jn iŒöŠJuŔj •wl‰Č×–Ef|Œz•”Ľ‘Ě•”‘BŠŕ. ‘ –{”ŽsiŽY•wj: •˝Ź‚T”N“xŒúśČ‚Ş‚ń—\–h‹ZpEˆői—Տ°ŒŸ¸‹ZŽtjŒ¤C‰ď i93.10.19j, “Œ‹ž.

2136. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ‚’PˆĘƒvƒ‰ƒ`ƒi—Ă–@‚É‚¨‚Ż‚ét‹@”\•]‰ż‚Č‚ç‚Ń‚ÉŽxŽ—Ă–@‚̏d—vŤ. `GŽ÷iŽY•wj: ‹{čŒ§ˆăŽt‰ď‹Î–ąˆă•”‰ď i94.03.05j, ‹{č.

2137. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j •wl‰Č“ŕ–Œ×–Ef. ‘ –{”ŽsiŽY•wj: ŠŕŒ¤×–EfƒXƒNƒŠ[ƒi[—{ŹŠ i93.04.21j, “Œ‹ž.

2138. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Žq‹{“ŕ–Œ‰ßŒ`Ź‚ĆG1“ŕ–ŒŠŕ‚̊ӕʂ𒆐S‚É. ‘ –{”ŽsiŽY•wj: ˆÇ—Ń‘ĺŠw•ŰŒ’Šw•”×–Ef i93.07.07j, “Œ‹ž.

2139. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Žq‹{‘Ě‚Ş‚ńĽ“ŕ–Œ‘BÇ‚Ě×–Ef. ‘ –{”ŽsiŽY•wj: •˝Ź‚T”N“xŽq‹{ŠŕŒŸf×–Ef]Ž–ŽŇuK‰ď i93.12.17j, ‘O‹´.

2140. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j B-MAS–@‚É‚ć‚é’†‚”N•wl‚̍œ—Ę‘Ş’č‚ĆŠeŽíŽĄ—Ă‚É‚¨‚Ż‚é’ǐՂɂ‚˘‚Ä. “cŒű–žC‘“c—Ç•˝C‰Á“Ą—ÇŽ÷CŞ–{—ćŽqC‹ß“Ą‰ëŽqiŽY•wj: ‘ć15‰ń_“ސěCaĽœ‘ăŽÓŒ¤‹†‰ď i94.01.08j, ‰Ą•l.

2141. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j œ‘e頏ǂɂ‚˘‚Ä. “cŒű–žiŽY•wj: ‘ć22‰ń_“ŢěŒ§ˆćŽY•wl‰ČŒ¤‹†‰ď, ‘ć39‰ń‰Ą{‰ę, ŽO‰YŽY•wl‰Čˆă‰ď i94.01.24j, ‰Ą{‰ę.

2142. mŒ¤‹†‰ďi’n•űjn iŒöŠJuŔj •wl‰Č×–Ef|Ĺ‹ß‚̐i•ŕ|. ‘ –{”ŽsiŽY•wj: •˝Ź‚T”N“xŽY‰Č•wl‰Č‰ÄŠúƒZƒ~ƒi[ i93.07.18j, VŠƒ, ƒZƒ~ƒi[ƒeƒLƒXƒg, p.47`56, 1993.

2143. mŒ¤‹†‰ďi’n•űjn iŒöŠJuŔj ‘ĚŠŕ‚Ě‘Šú”­ŒŠ‚đ–Ú“I‚Ć‚ľ‚˝Žq‹{‘ĚŠŕŒŸf. ‘ –{”ŽsiŽY•wj: •˝Ź‚T”N“xŹl•aŒŸf]Ž–ŽŇiŽq‹{‚Ş‚ńjuK‰ď i93.10.02j, ŒF–{.

2144. mŒ¤‹†‰ďi’n•űjn iŒöŠJuŔj Žq‹{‚Ş‚ńŒŸf‚Ě‚ ‚č•ű. ‘ –{”ŽsiŽY•wj: _“ŢěŒ§—\–hˆăŠw‹Ś‰ďŠĹŒě‰ČEˆőŒ¤C‰ď i94.02.26j, ‰Ą•l.


<<18 7 •wl‰ČŠw>>

2145. m“Á‹–ĽˆÓ “o˜^n ‚Ş‚ń”­ś’`”’28KD‚đ”FŽŻ‚ˇ‚é’PƒNƒ[ƒ“R‘Ě‹y‚ŃŠY’PƒNƒ[ƒ“R‘Ě‚đŠÜ—L‚ˇ‚éf’fŽŽ–ňi06-013985j, ’†‹ŒőśCÎě‰ëˆęiŽY•wj.


<<19 ŽŒ`ŠO‰ČŠw>>

2146. mŒ´’˜n Fractures of the hook of hamate in athletes-8 cases of followed for 6 years. “ńŒŠr˜YCÂ–ؐ°•FC’Ë–{s’jiŽŠOj: Acta Orthop. Scand., 64: 469`471, 1993.

2147. mŒ´’˜n Clinical investigation on anterior interosseous nerve syndrome. “ńŒŠr˜YCŹ—Ń–žłC’†‘şˆęmC“‡Kˆč•vC“Ą“cłiŽŠOj: J. Jpn. Soc. Surg. Hand., 10: 338`341, 1993.

2148. mŒ´’˜n MR imaging of recurrent dislocation and impingement syndrome of the shoulder. ‰ĄŽRˆę•FC‚ŠÝŒ›“ńCŽ…–žˇŒ›Cr–ؐ’ˆęC’r“c‹MGCź‘ş–žlCŽR–{^iŽŠOj: J. Orthopedic. Surgery., 1: 99`101, 1993.

2149. mŒ´’˜n Therapeutic strategy for treating the scaphoid waist fracture. “ńŒŠr˜YC“‡Kˆč•vCÂ–ؐ°•FiŽŠOj: J. Western Pacific Orthop. Assoc., 29(2): 105`110, 1992.

2150. mŒ´’˜n •I“ŕ‘¤‘¤•›x‘ŃÄŒšp(jobe–@)‚̍lŽ@|“ŕ‘¤x‘э\‘˘‚Š‚ç‚Ý‚˝–â‘č“_‚𒆐S‚Ć‚ľ‚ā|. “ńŒŠr˜YC’Ë–{s’jC“Ą“cłC—é–؏~CŹ—Ń–žłCÂ–ؐ°•FiŽŠOj: JOINT, 8: 135`138, 1993.

2151. mŒ´’˜n Euro-collins‰t‚É‚ć‚郉ƒbƒgŒăŽˆ‚Ě’Pƒ•\–Ę—â‹p•Ű‘ś‚ÉŠÖ‚ˇ‚éŽŔŒą“IŒ¤‹†|‘ć‚Q•ń; CoQ10‚Ě‘gDŠw“I•Ď‰ť‚É‹y‚Ú‚ˇ‰e‹ż‚ɂ‚˘‚ā|. ‰ĄŽRˆę•FCŽ…–žˇŒ›C‚ŠÝŒ›“ńCŽR–{^iŽŠOj: ˆÚA, 28(2): 164`169, 1993.

2152. mŒ´’˜n •I“ŕ‘¤‘¤•›x‘Ń‚Ě“÷Šá“IŒ`‘ÔŠĎŽ@. “ńŒŠr˜YCŹ—Ń–žłC“Ą“cłCÂ–ؐ°•FC’Ë–{s’jiŽŠOj: ŠÖ“ŒŽĐŽ, 24: 486`489, 1993.

2153. mŒ´’˜n ŠÖß…Žî‚𔺂¤•ĎŒ`Ť•GŠÖßÇ‚ɑ΂ˇ‚éƒCƒ“ƒtƒŠ[‚Ě—Ő°“IŒř‰Ę‚ĚŒŸ“˘. Ž…–žˇŒ›CŠÖŒűš˜aCźX“N˜NiŽŠOj: V–ň‚Ć—Ő°, 42(7): 167`174, 1993.

2154. mŒ´’˜n Œ¨ŠÖßŽüˆÍ‰Š‚Ě–éŠÔ’É, ‹N°Žž’ɂɑ΂ˇ‚é‘gDŠˆŤŒ^’Á’ÉĽR‰ŠÇÜƒCƒ“ƒtƒŠ[‚Ě—Ő°“IŒř‰Ę‚ĚŒŸ“˘|Visual analogue scale‚đ—p‚˘‚˝•]‰ż|. ‚ŠÝŒ›“ńCŽ…–žˇŒ›iŽŠOj: V–ň‚Ć—Ő°, 43(2): 52`59, 1994.

2155. mŒ´’˜n ‘ĺ‘ڍœ“]Žq•”•sˆŔ’čŒ^œÜ‚ɑ΂ˇ‚éCompression hip screw–@‚Ě‚wüŠw“IŹŃ•s—Ç—á‚ĚŒŸ“˘. H—t—iŽŠOjCŒÜ\—’ŽO“s’jCŒy•”r“ńC˛“ĄłKC’†–ě˜a•Fi“Œ‹ž“s˜Vlˆă—ĂƒZƒ“ƒ^[j: “Œ“ú–{—Տ°ŽŒ`ŠO‰ČŠw‰ďŽGŽ, 5(3): 410`413, 1993.

2156. mŒ´’˜n ‹C“š‹ˇó‚đŽĺ’Ľ‚Ć‚ľ‚˝cŠu”^ᇂƍl‚Ś‚ç‚ę‚˝‚PÇ—á. ŒKŒ´­’jiŽŠOjC•Đ‰Ş—SˆęCźŒűŽ•FC–x’rdŽĄC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: “ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ďŽGŽ, 14: 16`18, 1993.

2157. mŒ´’˜n Clinical study of bone allografts in the upper extremity. Ź—Ń–žłC“ńŒŠr˜YCŽ…–žˇŒ›C“Ą“cłC’Ë–{s’jiŽŠOj: “ú–{Žč‚ĚŠO‰ČŠw‰ďŽGŽ, 10(6): 997`1001, 1994.

2158. mŒ´’˜n ––ŠúŒŇŠÖßÇŠłŽŇ‚ĚŠO”˝œŘ‚čpŒă‚ĚƒXƒ|[ƒcŠˆ“Ž. Ž…–žˇŒ›CŠÖŒűš˜aCb”ăGŽŔC‚ŠÝŒ›“ńCŽR–{^C“ߐ{–ěG“ńiŽŠOj: “ú–{ŽŒ`ŠO‰ČƒXƒ|[ƒcˆăŠw‰ďŽ, 12: 91`93, 1993.

2159. mŒ´’˜n ˆ—“ŻŽíäF‚đ—p‚˘‚˝•G‘O\Žšx‘ŃÄŒš‚ÉŠÖ‚ˇ‚éŽŔŒą“IŒ¤‹†. ŠÖŒűš˜aCŽ…–žˇŒ›C‰¤‹žŽqiŽŠOjCX“c^Žjiś‘̍Hj: –k—˘ˆăŠw, 23(4): 275`283, 1993.

2160. m€Œ´’˜n –ě‹…•IĽƒeƒjƒX•I‚Ě‹@”\•]‰ż. ’Ë–{s’jiŽŠOj: ŠÖßŠO‰Č, 12(7): 71`77, 1993.

2161. m€Œ´’˜n ”r”AáŠQ‚đ’ć‚ľ‚˝˜’ĹŠÔ”Âƒwƒ‹ƒjƒA‚ĚŒŸ“˘. –Ř‘şł“C’Ë–{s’jCŽO—֐´ŽuCŠÖŒűš˜aC‹ŕˆä“ż˛C•˝“c‰ë—TCŽ…–žˇŒ›iŽŠOj: ŠÖ“ŒŽĐŽ, 24(5): 511`514, 1993.

2162. m€Œ´’˜n –ŤŠÖßƒŠƒEƒ}ƒ`ŠłŽŇ‚ĚŒŒ´’†‚¨‚ć‚ъ֐߉t’†ƒPƒ‰ƒ^ƒ“—°Ž_’l. ‰Ô“ˆ”ü“ŢŽqC‚ŠÝŒ›“ńCŽ…–žˇŒ›Cr–ؐ’ˆęC‘O“cŒ’“ńCź‘ş–žlCŽR–{^iŽŠOjCŒÜäzsMC–x“c‹ąŽqiś‰ťj: ŠÖ“ŒŽĐŽ, 24(6): 701`704, 1993.

2163. m€Œ´’˜n Gustilo Type ‡V‚̐V‘NŠJ•úœÜ‚ɑ΂ˇ‚éˆęŽŸ“I“ŕŒĹ’čp‚ĚŽĄ—ĂŒoŒą. ‘OŒ´G•vCŽ…–žˇŒ›CŹ—Ń–žłiŽŠOjC‰ĄŽRˆę•FCV“Ął‹Pi‹~–˝jC‘ĺ’J’Ă‹ą”VC•“cŒ[iŒ`ŹjCŽR–{^i‹ăB˜JĐ•a‰@j: œÜ, 15(1): 127`132, 1993.

2164. m€Œ´’˜n ‘“ŕ“B‚É‚ć‚鍜Ú‡Žž‚̐‘“ŕ‚ĚŒŸ“˘i‘ć‚Q•ńj|‘“ŕ“B“ŕ‘gD‚É‚ć‚é•…H‚ĚŒŸ“˘|. Ź—Ń–žłC“ě‘ňˆç—YC‘ĺ–ěŽiCŽ…–žˇŒ›C’Ë–{s’jiŽŠOjCX“c^Žjiś‘̍HjCˆäă—tŽqi‰qj: œÜ, 15(1): 136`139, 1993.

2165. m€Œ´’˜n œÜ•Ş—Ţ‚ÉŠÖ‚ˇ‚éƒAƒ“ƒP[ƒg’˛¸Œ‹‰Ę‚Ě•ń|“ú–{œÜŽĄ—ĂŠw‰ďœÜ‚Ě•Ş—Ţ•]‰żˆĎˆő‰ď|. Ž…–žˇŒ›iŽŠOj: œÜ, 15(1): 1`6, 1993.

2166. m€Œ´’˜n “–‰Č‚É‚¨‚Ż‚é”˝•œŤŒ¨ŠÖß’E‰P‚ĚŽĄ—ĂŒoŒą. “n•Ó“NĆC‚ŠÝŒ›“ńC‰Ô“ˆ”ü“ŢŽqCŹ—Ń–žłC–q–ěk•śCŽ…–žˇŒ›iŽŠOj: _“ސ쐎Œ`ĐŠQŠO‰Čˆă‰ďŽGŽ, 6(2): 203`206, 1993.

2167. m€Œ´’˜n •IŠÖß‚É”­ś‚ľ‚˝ÎŠD‰ť‚Ě3—á. “Ą“cłC“ńŒŠr˜YC–k’ܐLmCŽ›ŽtG”VC’Ë–{s’jCů–{Œ›’jiŽŠOj: ‘ć5‰ń“ú–{•IŠÖßŒ¤‹†‰ďŽ, p.105`107, 1993.

2168. m€Œ´’˜n •I“ŕ‘¤‘¤•›x‘ŃÄŒšp‚ɑ΂ˇ‚élŽ@. “ńŒŠr˜YC’Ë–{s’jC“Ą“cłC—é–؏~CŹ—Ń–žłCÂ–ؐ°•FiŽŠOj: ‘ć5‰ń“ú–{•IŠÖßŒ¤‹†‰ďŽ, p.8`10, 1993.

2169. m€Œ´’˜n Žč‚¨‚ć‚ŃŽčŠÖß‚É”­ś‚ľ‚˝œĽ“î•”ˆŤŽîᇂ̎Ą—ĂŒoŒą. Â–ؐ°•FC“ńŒŠr˜YCŹ—Ń–žłC‘ĺ–ěŽiC“Ą“cłC’Ë–{s’jiŽŠOj: “Œ“ú–{—Տ°ŽŒ`ŠO‰ČŠw‰ďŽ, 6: 81`84, 1994.

2170. m€Œ´’˜n ƒŠƒEƒ}ƒ`ŽčŠÖß‚ɑ΂ˇ‚éSauve-Kapandji–@‚Ě“K‰ž‚ĆŒŔŠE. •Ä–{ŒőˆęCˆäă˜a•FCÄ“Ąš“ńi“Œ—ˆă‘ĺjC“ńŒŠr˜YiŽŠOjC—L•xŠ°i‚Ý‚Š‚Č‚Ź•a‰@j: “ú–{Žč‚ĚŠO‰ČŠw‰ďŽGŽ, 10(6): 912`915, 1994.

2171. m€Œ´’˜n “–‰Č‚É‚¨‚Ż‚錨˝ŠÖß’E‰P‚ĚŽĄ—ĂŒoŒą. ‚ŠÝŒ›“ńCŽ…–žˇŒ›C’Ë–{s’jCŽR–{^iŽŠOj: “ú–{ŽŒ`ŠO‰ČƒXƒ|[ƒcˆăŠw‰ďŽ, 12: 295`297, 1993.

2172. m€Œ´’˜n Œ¨bă_Œo–ƒáƒ‚Ě6—á. ‚ŠÝŒ›“ńCr–ؐ’ˆęCź‘ş–žlC—˜Şě‰ëriŽŠOjC’r“crşi•újCŽ…–žˇŒ›CŽR–{^iŽŠOj: —Տ°ƒXƒ|[ƒcˆăŠw, 10: 285`287.

2173. mŒ¤‹†•ńi•ś•”Čjn ŠeŠÖßŽžŠł‚É‚¨‚Ż‚錌´’†, ŠÖß‰t’†, ”A’†ƒPƒ‰ƒ^ƒ“—°Ž_’l‚Ě‘Ş’č. ‚ŠÝŒ›“ńiŽŠOjCŒÜäzsMC–x“c‹ąŽqiś‰ťjCŽR–{^iŽŠOj: •˝Ź4”N“x•ś•”Č‰ČŠwŒ¤‹†•â•‹ŕˆę”ĘŒ¤‹†(C)•ń‘, 1992.

2174. mŒ¤‹†•ńi•ś•”Čjn ’´‰š”g‚É‚ć‚é‘Ě•\‚Š‚ç‚̍œˆĘ’uŒv‘ށ|‘˝ŠÖßŒ^ƒƒ{ƒbƒg‚đ—p‚˘‚˝x‘Ń‘šf’f‚ւ̉ž—p|. ’Ë–{s’jiŽŠOjC“Ą]—T“šiś‘̍Hj: •˝Ź4”N“x•ś•”Č‰ČŠwŒ¤‹†•â•‹ŕˆę”ĘŒ¤‹†(C)•ń‘, 1994.

2175. mŒ¤‹†•ńi•ś•”Čjn •ĎŒ`ŤŠÖßÇ‚É‚¨‚Ż‚é‡UŒ^ƒRƒ‰[ƒQƒ“‚¨‚ć‚Ń“îœŒ^ƒvƒƒeƒIƒOƒŠƒJƒ“‚ɑ΂ˇ‚é–Ɖu”˝‰ž. ‚ŠÝŒ›“ńiŽŠOjCŒÜäzsMiś‰ťjCź‘ş–žlC—˜Şě‰ëriŽŠOj: •˝Ź5”N“x•ś•”Č‰ČŠwŒ¤‹†•â•‹ŕˆę”ĘŒ¤‹†(C)•ń‘, 1993.

2176. mŒ¤‹†•ńiŒúśČjn ŒŒŠÇ•ż•t‚ŤŽxŽœ’ŒœˆÚAp‚Ě’ZŠúŹŃ. Ž…–žˇŒ›CŹ—Ń–žłC“ě‘ňˆç—YCŽR–{^iŽŠOj: ŒúśČ“Á’莞Šł“Á”­Ť‘ĺ‘ڍœœ“Ş‰óŽ€’˛¸Œ¤‹†”Ç‘ć2‰ń”ljď‹c•˝Ź5”N“x”ljď‹c.

2177. mŒ¤‹†•ńiŒúśČjn ’ˇŠú“§ÍŠłŽŇ‚É”­ś‚ľ‚˝‘ĺ‘ڍœ“ފזv—á‚ĚŒŸ“˘. Ž…–žˇŒ›CŹ—Ń–žłC‘ĺ–ěŽiC“ě‘ňˆç—YiŽŠOjCŒK”ö’čmi•a—j: ŒúśČ“Á’莞Šł“Á”­Ť‘ĺ‘ڍœœ“Ş‰óŽ€’˛¸Œ¤‹†”Ç•˝Ź4”N“xŒ¤‹†•ń‘, p.107`110, 1993.


<<19 2 ŽŒ`ŠO‰ČŠw>>

2178. mÇ—á•ńn ŽčŞŠÇ•”‚Ĺ’e”­ŒťŰ‚đ’ć‚ľ‚˝Žîᇗl•a•Ď‚Ě‚P—á. Ź—Ń–žłC“ńŒŠr˜YC•“c‘וăC’Ë–{s’jiŽŠOj: ŠÖ“ŒŽĐŽ, 24(2): 179`181, 1993.

2179. mÇ—á•ńn ‹}Œƒ‚ɏă˜rœ“Ş‚Ě”j‰ó‚đ‚Ý‚˝Ň‘‹ó“´Ç‚É”ş‚¤_Œo•aŤŒ¨ŠÖßÇ‚Ě‚P—á. •‚“c–L•FC‚ŠÝŒ›“ńCŽR“ż‹`˜YC‘ĺ‚•ś“TCŹ—Ń–žłCŽ…–žˇŒ›iŽŠOjC‹kŽ ‘i”]ŠOj: ŠÖ“ŒŽĐŽ, 24(3): 262`265, 1993.

2180. mÇ—á•ńn •IŠÖß‹ß–T‚ɐś‚ś‚˝tumoral calcinosis‚Ě2Ç—á. Ž›ŽtG”VC“ńŒŠr˜YC–k’ܐLmCŽO—֐´ŽuC“y‰Ž“ցC‘O”V‰€‘˝KC’Ë–{s’jiŽŠOjCů–{Œ›’ji–k—˘Œ¤‹†Šj: ŠÖ“ŒŽĐŽ, 24(6): 649`653, 1993.

2181. mÇ—á•ńn Salmonella‚É‚ć‚éăřœœ‘‰Š‚Ě‚P—á. ‘•ŞˆęłCŹ—Ń–žłCź‘ş–žlC“ě‘ňˆç—YCŽ…–žˇŒ›iŽŠOj: ŠÖ“ŒŽĐŽ, 25(1): 60`63, 1994.

2182. mÇ—á•ńn p’†”xÇđÇ‚É‚ć‚č•sK‚Č“]‹A‚đ‚Ć‚Á‚˝ăřœ‹ßˆĘ’[œÜ‚Ě‚P—á. “n•ÓŽC“ńŒŠr˜YC‹v•ŰŽ›‘ĺ–çCŽO—֐´ŽuC“y‰Ž“ցC‘OŒ´G•vCŽu‘şKFC–k’ܐLmC’Ë–{s’jiŽŠOj: _“ސ쐎ĐŽ, 6(1): 39`42, 1993.

2183. mÇ—á•ńn Œ™‹CŤ‹Ű‚ŞŒ´ˆö‚ƍl‚Ś‚ç‚ę‚é‹}Ť‹š’ōd–ŒŠO”^ᇂ̂P—á. ’†‘ş‘–žiŽŠOjC–I’JŤŽjC‘źi‰Ą•l“실Ď•a‰@j: _“ސ쐎ĽĐŽ, 6(1): 75`80, 1993.

2184. mÇ—á•ńn ŽŚŽwMPŠÖßƒƒbƒLƒ“ƒO‚Ě1—á. ŽR‰Ž’qNC“ńŒŠr˜YCÂ–ؐ°•FC“y‰Ž“ցC“Ą“cłC‘OŒ´G•vC–ź‘q’źFC’Ë–{s’jiŽŠOj: _“ސ쐎ĽĐŽ, 6(2): 129`132, 1993.

2185. mÇ—á•ńn ŽčŞŠÇÇŒóŒQ‚𔺂Á‚˝Trigger Wrist‚Ě1—á. ’r“c‹M‰pCŹ—Ń–žłCH—t—C“ńŒŠr˜YiŽŠOjCŒK”ö’čmi•a—j: _“ސ쐎ĽĐŽ, 6(2): 169`172, 1993.

2186. mÇ—á•ńn Carpal tunnel syndrome caused by aberrant lumbrical muscle: A case report. “ńŒŠr˜YCÂ–ؐ°•FiŽŠOj: –k—˘ˆăŠw, 23(2): 135`136, 1993.

2187. m‘ŕn Œ¨ŠÖßŽüˆÍ‰Š‚Ě•Ű‘ś“IŽĄ—Ă. ‚ŠÝŒ›“ńC‰¤‹žŽqiŽŠOj: Monthly Orthopedics, 6: 71`75, 1993.

2188. m‘ŕn äF‹…‘}“ü‚É‚ć‚é•ęŽwCMŠÖßŒ`Źp. “ńŒŠr˜YC‹g‘ňŒö—˜C“‡Kˆč•vC’†‘şˆęmiŽŠOj: OS Now, p.114`119, 1993.

2189. m‘ŕn ă˜rœŠOăč÷‰Š‚Ě•a‘Ô‚ĆŽĄ—Ă. “ńŒŠr˜YC“‡Kˆč•vC“Ą“cłCŽ…–žˇŒ›iŽŠOj: ƒŠƒEƒ}ƒ`‰Č, 10(3): 174`181, 1993.

2190. m‘ŕn Œ¨ŠÖß‹@”\‚đ‚ǂ̂悤‚É•]‰ż‚ˇ‚é‚Š. ‚ŠÝŒ›“ńiŽŠOj: ƒŠƒEƒ}ƒ`‰Č, 8: 371`375, 1992.

2191. m‘ŕn isŠúŒŇŠÖßÇ‚ɑ΂ˇ‚éŠO”˝‹ü‹ČœŘ‚čp‚Ě’ˇŠúŹŃ‚Ć•]‰ż. Ž…–žˇŒ›CŠÖŒűš˜aCb”ăGŽŔC“ߐ{–ěG“ńiŽŠOj: ŠÖßŠO‰Č, 12(6—Ő‘): 106`114, 1993.

2192. m‘ŕn œŽîᇂ̎čp—Ă–@|Œ¨ŠÖßŽü•Ó‚É”­ś‚ˇ‚éŽîᇁ|. ‚ŠÝŒ›“ńiŽŠOjCŽÂŒ´“T’jC‘“cË’j: ŠÖßŠO‰Č, 12: 1041`1045, 1993.

2193. m‘ŕn Œ¨äF”•s’f—ô|f—Ă‚ĆŽĄ—Á|3.’´‰š”g. ‚ŠÝŒ›“ńiŽŠOj: ŠÖßŠO‰Č, 13: 37`42, 1994.

2194. m‘ŕn ‘˝”­ŠO‚É‚¨‚Ż‚鍜ŠÖß‘š‚ĚŽĄ—Á|ŠOŤŠÖß’E‰P|. “ě‘ňˆç—YCŽ…–žˇŒ›iŽŠOj: œĽŠÖßĽx‘Ń, 6(4): 453`457, 1993.

2195. m‘ŕn d“x•ĎŒ`ŤŒŇŠÖßÇ‚ɑ΂ˇ‚é“]Žq•”ŠO”˝‹ü‹ČœŘ‚čp. Ž…–žˇŒ›CŠÖŒűš˜aCb”ăGŽŔC“ߐ{–ěG“ńiŽŠOj: œĽŠÖßĽx‘Ń, 6(7): 747`752, 1993.

2196. m‘ŕn ŠŁáŤŠÖß‰Š. ‚ŠÝŒ›“ńiŽŠOj: ŽŔ‘H—Տ°ƒŠƒEƒ}ƒ`•aŠw, p.111`115.

2197. m‘ŕn “Á”­Ť–ł‹ŰŤ‘ĺ‘ڍœ“Ş‰óŽ€Ç. Ž…–žˇŒ›iŽŠOj: ŽŔ‘H—Տ°ƒŠƒEƒ}ƒ`•aŠw, p.187`192.

2198. m‘ŕn “ńŽŸŤ•ĎŒ`ŤŒŇŠÖßÇ‚ɑ΂ˇ‚é“]ŽqŠÔœŘ‚čp. •Ä–{Œőˆęi“Œ—ˆăjCŽ…–žˇŒ›CŽR–{^iŽŠOj: ŽŒ`ŠO‰Č Mook, (66): 53`66, 1993.

2199. m‘ŕn •GŠWœœÜ‚ɑ΂ˇ‚éŒo”ç“I|üŒĹ’č–@. Ž…–žˇŒ›iŽŠOj: ŽŒ`ŠO‰Č Mook, (‘Š§2): 66`69, 1993.

2200. m‘ŕn ‚˘‚í‚ä‚éŒÜ\Œ¨‚ɑ΂ˇ‚é”ńŠĎŒŒ“IŽó“Žp. ‚ŠÝŒ›“ńiŽŠOj: ŽŒ`ŠO‰Č Mook, (‘Š§2): 97`99, 1993.

2201. m‘ŕn •ęŽwCMŠÖß•ĎŒ`ŤŠÖßÇ‚ɑ΂ˇ‚éŠO‰Č“I—Ă–@|ŠO“]‘Η§žśóœŘ‚čp|. “ńŒŠr˜YCÂ–ؐ°•FiŽŠOj: ŽŒ`ŠO‰Č Mook, (‘Š§2-D): 172`176, 1993.

2202. m‘ŕn žôœ‰“ˆĘ’[œÜ‚ɑ΂ˇ‚éŠČˆŐŒĹ’č‘•‹ď‚É‚ć‚鎥—Ă. “ńŒŠr˜YC—é–؏~iŽŠOj: ŽŒ`ŠO‰Č Mook, p.130`130, 1993.

2203. m‘ŕn “ŻŽíœˆÚAđĄ. Ž…–žˇŒ›iŽŠOj: ŽŒ`ŠO‰Č, 44(13): 1846, 1993.

2204. m‘ŕn ŒŇŠÖßÇ‚̐_”é. Ž…–žˇŒ›iŽŠOj: ŽŒ`ĽĐŠQŠO‰Č, 37(2): 119`120, 1994.

2205. m‘ŕn ŽlŽˆ‚Ě’É‚ÝĽ‰ş‘ÚĽ‘ŤŽń‚Ě’É‚Ý, ‘Ť‚Ě’É‚Ý. ’Ë–{s’jiŽŠOj: ‘‡—Տ°, 42(10): 2958`2961, 1993.

2206. m‘ŕn •ĎŒ`ŤŠÖßÇĽƒŠƒEƒ}ƒ`. ’Ë–{s’jiŽŠOj: —Տ°‚ĆŒ¤‹†, 70(12): 74`80, 1993.

2207. m‘ŕn ƒXƒ|[ƒcŒ¨áŠQ‚ɑ΂ˇ‚éMRIŒŸ¸. ‚ŠÝŒ›“ńiŽŠOj: —Տ°ƒXƒ|[ƒcˆăŠw, 12: 1491, 1993.

2208. m‘ŕn ˜V‰ť‚É‚ć‚éŠÖßáŠQ‚Ć‚ť‚Ě‘Îô. ’Ë–{s’jiŽŠOj: ˜V‰ť‚ĆŽžŠł, 6(8): 100`105, 1993.


<<19 3 ŽŒ`ŠO‰ČŠw>>

2209. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj ƒXƒ|[ƒcŠOĽáŠQ‚ĚMRI; ‡W.Œ¨ŠÖß, D.KŠľŤŒ¨ŠÖß’E‰P, p.116`119, ‚ŠÝŒ›“ńiŽŠOjC’r“crşi•új. •ŇW ‚‘ň°•vCŒ´“cŞsC •śŒő“°, “Œ‹ž, 93.11.15”­s.

2210. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj ƒxƒbƒhƒTƒCƒh‚ĚƒŠƒEƒ}ƒ`Šw|ƒŠƒEƒ}ƒ`ˆăŒ¤C‚Ě‚˝‚߂Ɂ|; ‡V.Žĺ—vÇó‚Š‚ç‚ĚƒAƒvƒ[ƒ`. B.áu’É 9)•I’É‚¨‚ć‚Ń10)Œ¨’É, p.156`162, ‚ŠÝŒ›“ńiŽŠOj. •ŇW ŽR–{^iŽŠOjC”č’ő•vC “ě]“°, 94.00.00”­s.

2211. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj —Տ°ŽŒ`ŠO‰ČŽčp‘S‘(14); —L’ɐŤ‘Ť•”ŽžŠł, p.237`243, “ńŒŠr˜YCŽR–{^iŽŠOj. ‹ŕŒ´o”Ĺ, “Œ‹ž, 93.00.00”­s.

2212. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj ƒXƒ|[ƒcŠOĽáŠQ‚ĚMRIf’f; ŽčŞŠÇÇŒóŒQiŽčŠÖßj, p.166`169, “ńŒŠr˜YiŽŠOj. •śŒő“°, “Œ‹ž, 93.11.15”­s.

2213. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj ƒxƒbƒhƒTƒCƒh‚ĚƒŠƒEƒ}ƒ`|ƒŠƒEƒ}ƒ`Œ¤Cˆă‚Ě‚˝‚ß‚É; œĽ_ŒoĽäFĽ‚ť‚Ě‘ź‚Ě“î•”‘gD, p.69`75, p.82`90, “ńŒŠr˜YiŽŠOj. •ŇW ŽR–{^iŽŠOjC”č’ő•vC “ě]“°, “Œ‹ž, 94.00.00”­s.


<<19 4 ŽŒ`ŠO‰ČŠw>>

2214. m‚ť‚Ě‘źn i•Ş’SŽˇ•Mj ŽŒ`ŠO‰Čˆă; ƒCƒ‰ƒXƒg, ‹~‹}ˆ’uƒ}ƒjƒ…ƒAƒ‹, 44: 512, Ž…–žˇŒ›iŽŠOj. 93.00.00”­s.


<<19 5 ŽŒ`ŠO‰ČŠw>>

2215. mŠw‰ďi‘Űjn i“Á•Ęu‰‰j Tissue banking in Asia. Ž…–žˇŒ›iŽŠOj: 2nd Congress of the European Association of Tissue Banks i93.05.05`08j, ƒMƒŠƒVƒƒ, ´˜^W, p.9, 1993.

2216. mŠw‰ďi‘Űjn i“Á•Ęu‰‰j Bone banking in Kitasato University: With special reference to screening and starilization of cadaver bones. Ž…–žˇŒ›iŽŠOj: IAEA, ˆăŠwś•¨Šw—Ěˆć‚É‚¨‚Ż‚é•úŽËü—˜—p‚ÉŠÖ‚ˇ‚鍑Űę–ĺ‰ĆŽ–â‰ď‹c i94.03.07`09j, ‚č.

2217. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Clinical significance of superoxide in blood on ischemia-induce reperfusion injury. ‰ĄŽRˆę•FiŽŠOjC’†‘ş‘‰qi•ŞśjC˜e“c—˛ŽiiŽŠOjC‘ĺ’J’Ă‹ą”VC‰FˆäŒŞ“ńiŒ`ŠOjCŽ…–žˇŒ›iŽŠOj: International Society of Reconstructive Microsurgery, 11th Symposium i93.06.05`08j, ƒI[ƒXƒgƒŠƒA.

2218. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€j An experimental study on reconstructive surgery of the anterior cruciate ligament using a bone-patellar tendon-bone allograft. ŠÖŒűš˜aCŽ…–žˇŒ›C‘OŒ´G•viŽŠOjCX“c^Žjiś‘̍Hj: American Association of Tissue Banks i93.08.21`25j, ƒ{ƒXƒgƒ“, ƒvƒƒOƒ‰ƒ€, p.13, 1993.

2219. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€j Tissue banking and grafting in asian countries. Ž…–žˇŒ›CŠÖŒűš˜aC‘OŒ´G•viŽŠOj: American Association of Tissue Banks i93.08.21`25j, ƒ{ƒXƒgƒ“, ƒvƒƒOƒ‰ƒ€, p.8, 1993.

2220. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€j Sterilization of bones. “ě‘ňˆç—YCŽ…–žˇŒ›C‘OŒ´G•vCŹ—Ń–žłC“n•Ó“NĆiŽŠOj: 2nd International Radiation Technology in Biomedical Materials, 1994 i94.03.10`11j, ‚č.

2221. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Current status of tissue banking and grafting in Japan and report form Kitasato bone bank. Ž…–žˇŒ›Cb”ăGŽŔC傌´—L’jCŠÖŒűš˜aC“ߐ{–ěG“ńCŹ—Ń–žłiŽŠOj: 2nd Congress of the European Association of Tissue Banks i93.05.05`08j, ƒMƒŠƒVƒƒ, ´˜^W, p.10, 1993.

2222. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Allograft reconstruction of the acetabular bone defect in revision THR: Radiological investigation of fate of the allograft. Ž…–žˇŒ›Cb”ăGŽŔC傌´—L’jCŠÖŒűš˜aC“ߐ{–ěG“ńiŽŠOj: 2nd Congress of the European Association of Tissue Banks i93.05.05`08j, ƒMƒŠƒVƒƒ, ´˜^W, p.16, 1993.

2223. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Sonographic evaluation of the biceps tendon. ‚ŠÝŒ›“ńCŹ“‡—˛ŽjCź‘ş–žlC—˜Şě‰ërCÄ“Ąş•FC‰¤‹žŽqCŽ…–žˇŒ›iŽŠOj: 3rd Scandinavian-Japanese meeting of the shoulder surgery i93.06.07`09j, denmark.

2224. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Spontaneous polyarthritis in New-Zealand black K/N mice. ’Ë–{s’jC’†‘şˆęmC‘O”V‰€‘˝KiŽŠOj: 17th ILAR Congress of Rheumatology i93.07.04`09j, Barcelona.

2225. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Serum and joint keratan sulfate in ostoarthritis and rheumatoid arthritis. ‚ŠÝŒ›“ńC‰Ô“ˆ”ü“ŢŽqiŽŠOjCŒÜäzsMiś‰ťjCŽ…–žˇŒ›iŽŠOjC‰Ş‘ş˜a•vC‹g“c—TŽqiś‰ťŠwH‹Ćj: 17th ILAR Congress of Rheumatology i93.07.04`09j, Barcelona.

2226. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Absence of immunity to type‡U collagen and proteoglycan in osteoathritic C57BL mice. ‚ŠÝŒ›“ńC‘O“cŒ’“ńiŽŠOjCŒÜäzsMiś‰ťjCŽ…–žˇŒ›CŽR–{^iŽŠOj: 17th ILAR Congress of Rheumatology i93.07.04`09j, Barcelona.

2227. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j High-molecular weight sodium hyaluronate for the treatment of periarthritis scapulohumeralis. ŽR–{—´“ńiş˜a‘ĺjC“c”¨Žl˜Yi”֏鋤—§•a‰@jCŽOŠ}Œł•Fi“s—§‘ĺ’Ë•a‰@jC‚ŠÝŒ›“ńiŽŠOjCŹě´‹viŒc‘ĺj: 17th ILAR Congress of Rheumatology i93.07.04`09j, Barcelona.

2228. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Strut bone graft in the treatment of Kienbock's disease. “ńŒŠr˜YCŽR–{^C’Ë–{s’jiŽŠOj: SICOT 93 Seoul i93.08.23`09.03j, ŠŘ‘.

2229. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Arthroscopic furgerry in the treatment of carpal tunnel syndrome. “ńŒŠr˜YC’Ë–{s’jiŽŠOj: SICOT 93 Seoul i93.08.23`09.03j, ŠŘ‘.

2230. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The isolated paralysis of the infraspinatus muscle. ‚ŠÝŒ›“ńCź‘ş–žlC—˜Şě‰ërCŽ…–žˇŒ›C’Ë–{s’jiŽŠOj: SICOT 93 Seoul i93.08.23`09.03j, ŠŘ‘, ´˜^W, p.314, 1993.

2231. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Allograft reconstruction of acetabular bone defect in revision THR-Radiological investigation on fate of allograft-. Ž…–žˇŒ›CŠÖŒűš˜aCŹ—Ń–žłC‚ŠÝŒ›“ńC“ߐ{–ěG“ńiŽŠOj: SICOT 93 Seoul i93.08.23`09.03j, ŠŘ‘, ´˜^W, p.322, 1993.

2232. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Comminuted fractures of the femoral shaft treated by interlocking cylinder nailing. Ź—Ń–žłCŽ…–žˇŒ›C‰ĄŠÖ~Ců–{Œ›’jCŽR–{^iŽŠOj: SICOT 93 Seoul i93.08.23`09.03j, ŠŘ‘, ´˜^W, p.367, 1993.

2233. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Absence of immunity to type‡U collagen and proteoglycan in osteoathritic C57BL mice. ‚ŠÝŒ›“ńC‘O“cŒ’“ńiŽŠOjCŒÜäzsMiś‰ťjCŽ…–žˇŒ›CŽR–{^iŽŠOj: SICOT 93 Seoul i93.08.26`28j, ŠŘ‘.

2234. mŠw‰ďi‘S‘jn i‹łˆçu‰‰j œˆÚA‚ĚŠî‘b‚Ć—Ő°. Ž…–žˇŒ›iŽŠOj: ‘ć8‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď i93.10.07`08j, ź–{, “úŽ‰ďŽ, 67(8): 1494, 1993.

2235. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€j Š°œ‰PœÜ‚ĚŽĄ—Ă‚Ć—\Œă. Ž…–žˇŒ›C“n•Ó“NĆC•˝“c_ŽqC‘ĺ–ěŽiC“ě‘ňˆç—YiŽŠOj: ‘ć41‰ń“ú–{ĐŠQˆăŠw‰ď i93.09.16`17j, ŽD–y, “ú–{ĐŠQˆăŠw‰ď‰ďŽ, 41(—Ő‘): 51, 1993.

2236. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€j ˆęŽŸ“I“ŕŒĹ’čp‚Ě“K‰ž‚𐏐Ń(‡V)Žĺ‚ɐ‘“ŕ“BŒĹ’čp‚ɂ‚˘‚Ä. ‰ĄŽRˆę•FiŽŠOjCV“Ął‹Pi‹~–˝j: ‘ć41‰ń“ú–{ĐŠQˆăŠw‰ď i93.09.16`17j, ŽD–y, “ú–{ĐŠQˆăŠw‰ď‰ďŽ, 41(—Ő‘): 57, 1993.

2237. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒRƒ‰[ƒQƒ“ŠÖß‰Š‚É‚¨‚Ż‚錌´’†ƒqƒAƒ‹ƒƒ“Ž_’l. ‚ŠÝŒ›“ńCź‘ş–žliŽŠOjC‹{Œ´Žő–ži‹ă‘ĺjC—˜Şě‰ëriŽŠOjC•§•ŁF•vi‹ă‘ĺjCŠLŒ´MăEiŠLŒ´ŽŒ`ŠO‰Čj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž, ´˜^W, p.140, 1993.

2238. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒ‰ƒbƒgŒăŽˆ‚Ě—â‘jŒŒŒăÄŠÁ—ŹŽŔŒą‚É‚¨‚Ż‚錌’†ŠˆŤŽ_‘f(02-)‚ĚˆÓ‹`. ‰ĄŽRˆę•FiŽŠOjC’†‘ş‘‰qi•ŞśjC‚ŠÝŒ›“ńCŽ…–žˇŒ›iŽŠOj: ‘ć29‰ń“ú–{ˆÚAŠw‰ď‘‰ď i93.09.16`17j, ‹ŕ‘ň, ˆÚA, 28(—Ő‘): 200, 1993.

2239. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰@‚É‚¨‚Ż‚éGustilos ‡VŒ^‚̉ş‘ڍœŠJ•úœÜ‚ÉŠÖ‚ˇ‚錟“˘. ‰ĄŽRˆę•FCV“Ął‹Pi‹~–˝jCb”ăGŽŔC_ŒłŒ›KCŽ…–žˇŒ›iŽŠOj: ‘ć66‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwpW‰ď i93.04.08`11j, _ŒË, “úŽ‰ďŽ, 67(2): 107, 1993.

2240. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒŠƒEƒ}ƒ`ŽčŠÖßŽčp‚É‚¨‚Ż‚éŽÚœ“މˇ‘ś–@‚ĚˆÓ‹`. •Ä–{ŒőˆęCˆäă˜a•FCÖ“Ąš“ńi“Œ—ˆăjC“ńŒŠr˜YC—L•xŠ°iŽŠOj: ‘ć66‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwpW‰ď i93.04.08`11j, _ŒË, “úŽ‰ďŽ, 67(2): 622, 1993.

2241. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ă˜rœŠOăč÷‰Š‚ɑ΂ˇ‚錟“˘|•Ű‘ś“IŽĄ—ĂŒQ‚̐ŹŃ‚¨‚ć‚ŃŽčp—á‚̏p’†ŠŒŠĽ‘gDŠŒŠ‚𒆐S‚Ć‚ľ‚ā|. “ńŒŠr˜YC“Ą“cłC—é–؏~C“y‰Ž“ցCŽO—֐´ŽuC–k’ܐLmC’Ë–{s’jiŽŠOj: ‘ć66‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwpW‰ď i93.04.08`11j, _ŒË, “úŽ‰ďŽ, 67(2): 631, 1993.

2242. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “e”|—{“×–E‚É‚¨‚ć‚Ú‚ˇƒTƒCƒgƒJƒCƒ“‚̉e‹ż. ź‘ş–žlC‚ŠÝŒ›“ńC—˜Şě‰ëriŽŠOjCÔŻ“§C‰““Ą•˝mi“ŕjCŽ…–žˇŒ›C’Ë–{s’jiŽŠOj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž, ´˜^W, p.216, 1993.

2243. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”|—{“eŹ’ˇ˜]“×–E‚Ě”j‰ó‚É‹y‚Ú‚ˇIL-1,6,8‚̉e‹ż. —˜Şě‰ërC‚ŠÝŒ›“ńCź‘ş–žliŽŠOjCÔŻ“§C‰““Ą•˝mi“ŕjCŽ…–žˇŒ›C’Ë–{s’jiŽŠOjCr–ؐ’ˆęiŒF–{‘ĺj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž, ´˜^W, p.219, 1993.

2244. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠÖßŽžŠłŠłŽŇ‚ĚŒŒ´’†‚¨‚ć‚ъ֐߉t’†ƒPƒ‰ƒ^ƒ“—°Ž_’l. ‚ŠÝŒ›“ńC‰Ô“ˆ”ü“ŢŽqiŽŠOjCŒÜäzsMiś‰ťjC‘O“cŒ’“ńCź‘ş–žlC—˜Şě‰ërCŽ…–žˇŒ›iŽŠOjC‰Ş‘ş˜a•vC‹g“c—TŽqiś‰ťŠwH‹Ć‰ž—pŒ¤j: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.22`24j, –źŒĂ‰Ž, ´˜^W, p.261, 1993.

2245. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •ĎŒ`Ť•GŠÖßÇ‚ĚQCT–@‚É‚ć‚鍜‰–—ʂ̕ωť. —L•xŠ°iŽŠOjC÷ˆä´Žqi•újCŽR“ż‹`˜YiŽŠOjCX“c^Žjiś‘̍Hj: ‘ć37‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ď i93.05.24j, –źŒĂ‰Ž, —\eW, p.254, 1993.

2246. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ăŽˆ‚É‚¨‚Ż‚é“ŻŽíœˆÚA‚Ě—Ő°“IŒŸ“˘. Ź—Ń–žłC“ńŒŠr˜YCŽ…–žˇŒ›C“Ą“cłC’Ë–{s’jiŽŠOj: ‘ć36‰ń“ú–{Žč‚ĚŠO‰ČŠw‰ď‘‰ď i93.05.27`28j, ŽD–y, ´˜^W.

2247. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘OœŠÔ_Œo–ƒáƒ‚đŽĺ’Ľ‚Ć‚ˇ‚鎞ŠłŒQ‚ÉŠÖ‚ˇ‚錟“˘. “ńŒŠr˜YCŹ—Ń–žłC’†‘şˆęmC“‡Kˆč•vC“Ą“cłiŽŠOj: ‘ć36‰ń“ú–{Žč‚ĚŠO‰ČŠw‰ď‘‰ď i93.05.27`28j, ŽD–y, “úŽč‰ďŽ, 10: 134, 1993.

2248. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒŠƒEƒ}ƒ`ŽčŠÖß‚ɑ΂ˇ‚éSauve-Kapandjii–@‚Ě“K‰ž‚ĆŒŔŠE. •Ä–{ŒőˆęCˆäă˜a•FCÖ“Ąš“ńi“Œ—ˆăjC“ńŒŠr˜YC—L•xŠ°iŽŠOj: ‘ć36‰ń“ú–{Žč‚ĚŠO‰ČŠw‰ď‘‰ď i93.05.27`28j, ŽD–y, “úŽč‰ďŽ, 10: 160, 1993.

2249. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰~“›Œ^‘“ŕ“B‚Ë‚ś‰ĄŽ~‚ß–@‚É‚ć‚é‘ŤŠÖßŒĹ’čp‚̐ŹŃ. ‘•ŞˆęłC“ě‘ňˆç—YCŹ—Ń–žłC‘ĺ–ěŽiCŽ…–žˇŒ›C’Ë–{s’jiŽŠOj: ‘ć18‰ń“ú–{‘Ť‚ĚŠO‰ČŠw‰ď i93.06.25`26j, “Ţ—Ç, ´˜^W, p.35.

2250. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒŠ[ƒ~ƒ“ƒO‚š‚¸‚ɉ~“›Œ^‘“ŕ“B‚Ë‚ś‰ĄŽ~‚ß–@‚ĹŽĄ—Ă‚ľ‚˝‘ĺ‘ڍœœÜ‚ĚŒŸ“˘. Ź—Ń–žłC“ě‘ňˆç—YC‘ĺ–ěŽiCV“Ął‹PCů“‡Œł‘ĽCŽ…–žˇŒ›CŽR–{^Ců–{Œ›’jiŽŠOj: ‘ć19‰ń“ú–{œÜŽĄ—ĂŠw‰ď i93.07.09`10j, “Œ‹ž, ´˜^W, p.41, 1993.

2251. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠJ•úŤd“xFloating Knee‚Ě‚Q—á. ‰ĄŽRˆę•FCŽ…–žˇŒ›C˜e“c—˛ŽiCb”ăGŽŔiŽŠOjCV“Ął‹Pi‹~–˝jC‰FˆäŒŞ“ńC–ŘŒŇŠŽmiŒ`ŠOj: ‘ć19‰ń“ú–{œÜŽĄ—ĂŠw‰ď i93.07.09`10j, “Œ‹ž, ´˜^W, p.43, 1993.

2252. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰~“›Œ^‘“ŕ“B‚đ—p‚˘‚˝ă˜rœœÜ‚ĚŽĄ—ĂŒoŒą. ů“‡Œł‘ĽCŹ—Ń–žłC“n•Ó“NĆC“ě‘ňˆç—YCŽ…–žˇŒ›C’Ë–{s’jiŽŠOj: ‘ć19‰ń“ú–{œÜŽĄ—ĂŠw‰ď i93.07.09`10j, “Œ‹ž, ´˜^W, p.74, 1993.

2253. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j äF”Â’f—ôpŒă‚ĚMRI. ‚ŠÝŒ›“ńCÄ“Ąş•FC‰¤‹žŽqC—˜Şě‰ërC‰Ô“ˆ”ü“ŢŽqCŽ…–žˇŒ›iŽŠOjC’r“crşi•új: ‘ć20‰ń“ú–{Œ¨ŠÖßŠw‰ď i93.10.01`02j, ’ˇč, ´˜^W, p.82, 1993.

2254. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ă˜r“ń“Ş‹Ř’ˇ“ŞäFäFâ‚Ě–łƒGƒR[—Ěˆć. Ź“‡—˛ŽjC‚ŠÝŒ›“ńC‰¤‹žŽqCÄ“Ąş•FCŽ…–žˇŒ›iŽŠOj: ‘ć20‰ń“ú–{Œ¨ŠÖßŠw‰ď i93.10.01`02j, ’ˇč, ´˜^W, p.97, 1993.

2255. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”ńÚGŒ^•ĎˆĘ‘Ş’č‘•’u‚đ—p‚˘‚˝‘O˜rĽ•IŠÖß‰^“Ž‰đÍ. “Ą“cłCÂ–ؐ°•FC’†‘şˆęmC“ńŒŠr˜YC’Ë–{s’jiŽŠOjC“Ą]—T“šiś‘̍Hj: ‘ć20‰ń“ú–{—Տ°ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ď i93.11.05`06j, ‹ž“s.

2256. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰ˇ‘jŒŒŒăÄŠÁ—ŹŽž‚É‚¨‚Ż‚銈ŤŽ_‘f‚ĚŒoŽž“I•Ď‰ť|‰Ć“eŒăŽˆÄŠÁ—Źƒ‚ƒfƒ‹‚đ—p‚˘‚ā|. –Ř‘şł“C‰ĄŽRˆę•FiŽŠOjC’†‘ş‘‰qi•ŞśjCÂ–ؐ°•FC’r“c‹M‰pCŽ…–žˇŒ›iŽŠOj: ‘ć20‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď i93.11.26`27j, –źŒĂ‰Ž.

2257. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j •I“ŕ‘¤‘¤•›x‘Ń‘gD‚ĚŒ`‘ÔŠw“IŒŸ“˘. “ńŒŠr˜YCŹ—Ń–žłC“Ą“cłCÂ–ؐ°•FC’Ë–{s’jiŽŠOj: ‘ć19‰ń“ú–{ŽŒ`ŠO‰ČƒXƒ|[ƒcˆăŠw‰ďŠwpW‰ď i93.07.22`23j, ‹{č, “ú–{ŽŒ`ŠO‰ČƒXƒ|[ƒcˆăŠw‰ďŽ, 13(2): 254, 1993.

2258. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ž™‰ş‹Ř’P“Ć–ƒáƒ. ‚ŠÝŒ›“ńCź‘ş–žlC—˜Şě‰ërCŽ…–žˇŒ›C’Ë–{s’jiŽŠOjC’r“crşi•új: ‘ć19‰ń“ú–{ŽŒ`ŠO‰ČƒXƒ|[ƒcˆăŠw‰ďŠwpW‰ď i93.07.22`23j, ‹{č, “ú–{ŽŒ`ŠO‰ČƒXƒ|[ƒcˆăŠw‰ďŽ, 13(2): 267, 1993.

2259. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j •…H“dˆĘ‹““Ž‚Š‚ç‚Ý‚˝ƒ`ƒ^ƒ“‡‹ŕ‚Ě‘Ď–€–Ő“ÁŤ‚Ě•]‰ż. ’†‘şL”VC’Ë–{s’jC傌´—L’jiŽŠOjCX“c^Žjiś‘̍HjCů“c’źiç—tH‘ĺj: ‘ć8‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď i93.10.07`08j, ź–{, “úŽ‰ďŽ, 67(8): 1438, 1993.

2260. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”|—{“eŹ’ˇ˜]“×–EŠOŠîŽż‚Ě”j‰ó‚É‹y‚Ú‚ˇƒTƒCƒgƒJƒCƒ“‚̉e‹ż. —˜Şě‰ërC‚ŠÝŒ›“ńCź‘ş–žlC‰Ô“ˆ”ü“ŢŽqCŽ…–žˇŒ›iŽŠOjCÔŻ“§i“ŕjCŒÜäzsMiś‰ťj: ‘ć8‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď i93.10.07`08j, ź–{, “úŽ‰ďŽ, 67(8): 1638, 1993.

2261. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘̉t’†ƒPƒ‰ƒ^ƒ“—°Ž_’l‚Ě‘Ş’č|Sandwich–@‚đ—p‚˘‚ā|. ‚ŠÝŒ›“ńC‰Ô“ˆ”ü“ŢŽqC‘O“cŒ’“ńCź‘ş–žlC—˜Şě‰ërCŽ…–žˇŒ›iŽŠOjCŒÜäzsMiś‰ťjC‰Ş‘ş˜a•vC‹g“c—TŽqiś‰ťŠwH‹Ć“Œ‹žŒ¤‹†Šj: ‘ć8‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď i93.10.07`08j, ź–{, “úŽ‰ďŽ, 67(8): 1643, 1993.

2262. mŠw‰ďi’n•űjn i“Á•Ęu‰‰j •˛ÓœÜ‚É‚¨‚Ż‚éInterlocking Nailing‚Ć‚˘‚­‚‚Š‚̍H•v. Ž…–žˇŒ›iŽŠOj: ‘ć1‰ń‘Š–ÍŒ´ˆăŽt‰ďŽŒ`ŠO‰Č•”‰ď i93.06.05j, ‘Š–ÍŒ´.

2263. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j RśÜŹ“üƒZƒƒ“ƒg‚É‚ć‚éMRSAœ‘‰Š‚ĚŽĄ—Ă. –q–ěk•śCŹ—Ń–žłC‘•ŞˆęłC“n•Ó“NĆC’r“c‹M‰pCŽ…–žˇŒ›C’Ë–{s’jiŽŠOj: ‘ć26‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď i93.05.15j, “Œ‹ž, ŠÖ“ŒŽĐŽ, 24(—Ő‘): 40, 1993.

2264. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ÎŠD’ž’…ŤäF‰Š‚É‚¨‚Ż‚é•Ű‘ś“IŽĄ—Ă‚ĚŒŸ“˘. Ä“Ąş•FC‚ŠÝŒ›“ńC‰¤‹žŽqC’Ë–{s’jiŽŠOj: ‘ć26‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď i93.05.15j, “Œ‹ž, ŠÖ“ŒŽĐŽ, 24(—Ő‘): 56, 1993.

2265. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Žr‘ĚŽˆ‚É‚¨‚Ż‚é•I“ŕ‘¤‘¤•›x‘э\‘˘‚ĚŠĎŽ@. “ńŒŠr˜YCŹ—Ń–žłC“Ą“cłCÂ–ؐ°•FCŽR‰Ž’qNC’Ë–{s’jiŽŠOj: ‘ć26‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď i93.05.15j, “Œ‹ž, ŠÖ“ŒŽĐŽ, 24(—Ő‘): 57, 1993.

2266. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŽĄ—Ă‚É“ďa‚ľ‚˝Gustilo ‡VŒ^‚̉ş‘ڍœ‰đ•úœÜ‚Ě‚P—á. •˝“c_ŽqCŽ…–žˇŒ›C˜e“c—˛ŽiiŽŠOjC‰ĄŽRˆę•FCV“Ął‹PC‰FˆäŒŞ“ńi‹~–˝jCb”ăGŽŔiŽŠOjC‘ĺ˜a“c—˛i‹~–˝j: ‘ć35‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.25j, “Œ‹ž.

2267. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‹ŽwÇ‚ɍ‡•š‚ľ‚˝ŽčŞŠÇÇŒóŒQ‚Ě‚P—á. ”’{ˆę–çCŽR“ż‹`˜YCŹ—Ń–žłC‘ĺ–ěŽiC–q–ěk•śCŽ…–žˇŒ›iŽŠOj: ‘ć550‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ďŒŽ—á‰ď i93.06.26j, “Œ‹ž.

2268. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘ĺ‘ÚŽl“Ş‹ŘSkÇ‚Ě‚P—á. ”Ş–Ř‰pŒ›C“y‰Ž“ցCŽ›ŽtG”VCÂ–ؐ°•FC–k’ܐLmCŽO—֐´ŽuC“ńŒŠr˜YC’Ë–{s’jiŽŠOj: ‘ć88‰ń_“ސ쐎Œ`ĐŠQŠO‰Čˆă‰ď i93.07.03j, ‰Ą•l, ƒvƒƒOƒ‰ƒ€Ľ´˜^W, p.14, 1993.

2269. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “–‰Č‚É‚¨‚Ż‚é”˝•œŤŒ¨ŠÖß’E‰P‚ĚŽĄ—ĂŒoŒą. “n•Ó“NĆC‚ŠÝŒ›“ńCŹ—Ń–žłC–q–ěk•śCŽ…–žˇŒ›iŽŠOj: ‘ć88‰ń_“ސ쐎Œ`ĐŠQŠO‰Čˆă‰ď i93.07.03j, ‰Ą•l, ƒvƒƒOƒ‰ƒ€Ľ´˜^W, p.36, 1993.

2270. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j —ź•GŠÖßŠŠ–ŒŘœ‚đŽ{s‚ľ‚˝ŠŁáŤŠÖß‰Š‚Ě‚P—á. •˝“c_ŽqC‚ŠÝŒ›“ńC“n•Ó“NĆC—L”n—mmC‘ĺ–ěŽiCŽ…–žˇŒ›iŽŠOj: ‘ć34‰ńŠÖ“ŒƒŠƒEƒ}ƒ`Šw‰ď i93.07.17j, “Œ‹ž.

2271. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒSƒ‹ƒtƒ@[‚ɐś‚ś‚˝’e”­•ęćä‚Ě‚P—á. ’†‘ş‘–žC‚ŠÝŒ›“ńCů“‡Œł‘ĽC˜e“c—˛ŽiC“n•Ó“NĆCŹ—Ń–žłCŽ…–žˇŒ›iŽŠOj: ‘ć1‰ń‚ć‚ą‚͂܃Xƒ|[ƒcŽŒ`ŠO‰ČƒtƒH[ƒ‰ƒ€ i93.07.24j, ‰Ą•l.

2272. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‹žŽ‹‰şŠŠ–ŒŘœ‚đŽ{s‚ľ‚˝ŠŁáŤŠÖß‰Š‚Ě‚P—á. •˝“c_ŽqC‚ŠÝŒ›“ńC“n•Ó“NĆC—L”n—mmC‘ĺ–ěŽiCŽ…–žˇŒ›iŽŠOj: ‘ć17‰ń_“ސěŠÖßŠO‰ČŒ¤‹†‰ď i93.09.11j, ‰Ą•l.

2273. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j •I•”ŠÇÇŒóŒQ‚ĚŽĄ—Á|‹ÇŠŽ‰–b”ç•Ů‚đ—p‚˘‚˝_Œo‘O•űˆÚsp‹y‚ŃNeviaser–@‚𒆐S‚Ɂ|. ‚•˝ŽLC“ńŒŠr˜YC“y‰Ž“ցC”Ş–Ř‰pŒ›C–{•”ƒŽqC’Ë–{s’jiŽŠOj: ‘ć42‰ń“Œ“ú–{—Տ°ŽŒ`ŠO‰ČŠw‰ď i93.09.24`25j, ˇ‰Ş, “Œ“ú–{—ՐŽ‰ďŽ, 5(4): 597, 1993.

2274. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –{Šw‚É‚¨‚Ż‚é“ű—cŽ™‰ť”^ŤŒŇŠÖß‰Š‚ĚŽĄ—ÐŹŃ. ’r“c‹M‰pC“ě‘ňˆç—YCŹ—Ń–žłCŽR“ż‹`˜YC’Ë–{’B˜YCŽ…–žˇŒ›iŽŠOj: ‘ć42‰ń“Œ“ú–{—Տ°ŽŒ`ŠO‰ČŠw‰ď i93.09.24`25j, ˇ‰Ş, “Œ“ú–{—ՐŽ‰ďŽ, 5(4): 628, 1993.

2275. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Žč‹y‚ŃŽčŠÖß‚É”­ś‚ľ‚˝œĽ“î•”ˆŤŤŽîᇂ̎Ą—ĂŒoŒą. Â–ؐ°•FC“ńŒŠr˜YCŹ—Ń–žłC‘ĺ–ěŽiC“Ą“cłC’Ë–{s’jiŽŠOj: ‘ć42‰ń“Œ“ú–{—Տ°ŽŒ`ŠO‰ČŠw‰ď i93.09.24`25j, ˇ‰Ş, “Œ“ú–{—ՐŽ‰ďŽ, 5(4): 642, 1993.

2276. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ăřœč÷•”œÜ‚ĚŽĄ—ÐŹŃ. ŽR“c—F‹vC–k’ܐLmC‘O”V‰€‘˝KC‘OŒ´G•vC•“cŒo—mC’Ë–{s’jiŽŠOj: ‘ć42‰ń“Œ“ú–{—Տ°ŽŒ`ŠO‰ČŠw‰ď i93.09.24`25j, ˇ‰Ş, “Œ“ú–{—ՐŽ‰ďŽ, 5(4): 688, 1993.

2277. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˆęŽŸ“IŠÖßŒĹ’čp‚đs‚Č‚Á‚˝ŒŒŠÇ‘š‡•šŠJ•úŤ•GŠÖß’E‰P‚Ě‚P—á. ˛X–ؐ瑐C‘ĺ–ěŽiCŹ—Ń–žłC‘ĺ‚•ś“TCŽ…–žˇŒ›iŽŠOj: ‘ć553‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ďŒŽ—á‰ď i93.10.30j, “Œ‹ž, ŠÖ“ŒŽĐ, 25(1): 115, 1994.

2278. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j •sK‚Č“]‹A‚đ‚Ć‚Á‚˝ˆŤŤŠÖßƒŠƒEƒ}ƒ`‚Ě‚P—á. “ŕ–쐳—˛C“y‰Ž“ցCŽR“c—F‹vC•˝“c_ŽqC“ńŒŠr˜YC’Ë–{s’jiŽŠOj: ‘ć89‰ń_“ސ쐎Œ`ĐŠQŠO‰Čˆă‰ď i93.11.06j, ‰Ą•l.

2279. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ăřœPlafondœÜ‚ĚŒŸ“˘. Žu‘şKFC‰ĄŽRˆę•FC‘ĺ–ěŽiC–q–ěk•śC‚ŠÝŒ›“ńCŽ…–žˇŒ›iŽŠOj: ‘ć89‰ń_“ސ쐎Œ`ĐŠQŠO‰Čˆă‰ď i93.11.06j, ‰Ą•l.

2280. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰ť”^ŤŒ¨ŠÖß‰Š‚Ě‚P—á. “čŒ´G”VC‚ŠÝŒ›“ńCŹ‹{Gˆę˜YC’†‘ş‘–žC•—p‘וăC“ě‘ňˆç—YCŽ…–žˇŒ›iŽŠOj: ‘ć25‰ń_“ŢěƒŠƒEƒ}ƒ`Œ¤‹†‰ď i93.11.20j, ‰Ą•l.

2281. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Œ¨ÎŠD’ž’…ŤäF‰Š‚Ě’ž’…•¨Žż‚̐ԊO‹zŽűƒXƒyƒNƒgƒ‹‚É‚ć‚é‘gŹ. Ä“Ąş•FC‚ŠÝŒ›“ńCŽ…–žˇŒ›iŽŠOjCź–ěVŽmi‰ťj: ‘ć27‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď i93.11.27j, “Œ‹ž, ŠÖ“ŒŽĐŽ, 24(—Ő‘): 107, 1993.

2282. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Œz•”‚É”­ś‚ľ‚˝ƒfƒXƒ‚ƒCƒh‚Ě‚Q—á. ‘ĺ–ěŽiC‚ŠÝŒ›“ńCŹ—Ń–žłC“ߐ{–ěG“ńC˜e“c—˛ŽiCŽ…–žˇŒ›iŽŠOj: ‘ć27‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď i93.11.27j, “Œ‹ž, ŠÖ“ŒŽĐŽ, 24(—Ő‘): 115, 1993.

2283. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “–‰@‚É‚¨‚Ż‚éACLÄŒšŒă‚Ě’†Ľ’ˇŠúŹŃ. ‹g–ěŽő˜YC–k’ܐLmC”Ş–Ř‰pŒ›C“n•ÓŽC‘O”V‰€‘˝KC‹{“c—fC–kŒŠŒ\ŽiCˆŔ’BŒöC“y‰Ž“ցC“ńŒŠr˜YC’Ë–{s’jiŽŠOj: ‘ć27‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď i93.11.27j, “Œ‹ž, ŠÖ“ŒŽĐŽ, 24(—Ő‘): 39, 1993.

2284. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j PCAŒ^lHŒŇŠÖßpŒă‚ĚADL‚Ě‹–—eŒŔ“x. Ź‘qˆę‹vC–I’JŤŽjC‘ĺ‹v•Űr•FC‘吏ŽOC“Ąˆä‰p˘CŒËŒű~C‹v•ŰŽŔC“yŽjłCŁč‘sˆęC“c’†KˆęCŽR“cŸ‹vi‰Ą•l“실Ď•a‰@jC•“cŒo—mC_ŒłŒ›K iŽŠOj: ‘ć27‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď i93.11.27j, “Œ‹ž, ŠÖ“ŒŽĐŽ, 24(—Ő‘): 40, 1993.

2285. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “ŕŒĹ’čŢ‚É–â‘č‚𐜂ś‚˝‰~“›Œ^‘“ŕ“B‚Ë‚ś‰ĄŽ~‚ߎĄ—Ă—á‚ĚŒŸ“˘. Žu‘şKFCŹ—Ń–žłC“ě‘ňˆç—YC‘ĺ–ěŽiCŒKŒ´­’jCŽ…–žˇŒ›iŽŠOj: ‘ć27‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď i93.11.27j, “Œ‹ž, ŠÖ“ŒŽĐŽ, 24(—Ő‘): 62, 1993.

2286. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŹŽ™‘ĺ‘ڍœœÜ–ü‡‚ĚƒŠƒ‚ƒfƒŠƒ“ƒO‚ɂ‚˘‚Ä. b”ăGŽŔC傌´—L’jCŽ…–žˇŒ›iŽŠOj: ‘ć27‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď i93.11.27j, “Œ‹ž, ŠÖ“ŒŽĐŽ, 24(—Ő‘): 62, 1993.

2287. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŹŽ™‰ş‘ڍœœÜ‚Ě—\Œă‚ĆƒŠƒ‚ƒfƒŠƒ“ƒO‚ɂ‚˘‚Ä‚ĚŒŸ“˘. 傌´—L’jCb”ăGŽŔCŽ…–žˇŒ›iŽŠOj: ‘ć27‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď i93.11.27j, “Œ‹ž, ŠÖ“ŒŽĐŽ, 24(—Ő‘): 63, 1993.

2288. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˜’Ĺ’ĹŠÔ”Âƒwƒ‹ƒjƒA‚ɑ΂ˇ‚éŒo”ç“I‘Šj“Eop‚ĚŒŸ“˘. ˆŔ’BŒöC“n•ÓŽCŽR“c—F‹vC‚•˝ŽLC‘•ŞˆęłC“y‰Ž“ցC–k’ܐLmC“ńŒŠr˜YC’Ë–{s’jiŽŠOjCŽO—֐´ŽuiŽO—Ö‹L”O•a‰@j: ‘ć27‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď i93.11.27j, “Œ‹ž, ŠÖ“ŒŽĐŽ, 24(—Ő‘): 79, 1993.

2289. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Recombinant human BMP-2‚đ—p‚˘‚˝œŒ‡‘š•”C•œ‚ÉŠÖ‚ˇ‚éŽŔŒą“IŒ¤‹†i‘ć‚P•ńj‚wüŠw“IŒŸ“˘. ‘OŒ´G•vCŽ…–žˇŒ›CŠÖŒűš˜aC“ߐ{–ěG“ńiŽŠOjC’†ŽR–ΐMiŽŔ“ŽjC‚‹´_ˆę˜YiŽR”V“ŕť–ňj: ‘ć27‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď i93.11.27j, “Œ‹ž, ŠÖ“ŒŽĐŽ, 24(—Ő‘): 91, 1993.

2290. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “ŻŽíœ“ˆÚA‚ɂčČš‚ľ‚˝•GŠÖßŠJ•úŤ‘š‚Ě‚P—á. ŹŁNŽĄC‘ĺ–ěŽiCŹ—Ń–žłCŽÂŒ´OsCŽu‘şKFCŽ…–žˇŒ›iŽŠOj: ‘ć554‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ďŒŽ—á‰ď i93.12.18j, “Œ‹ž.

2291. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŹŽ™‚̉ť”^ŤŒ¨ŠÖß‰Š‚Ě‚P—á. “čŒ´G”VC‚ŠÝŒ›“ńCŹ‹{Gˆę˜YC’†‘ş‘–žC“ě‘ňˆç—YCŽ…–žˇŒ›iŽŠOj: ‘ć555‰ńŠÖ“ŒŽŒ`ŠO‰ČŠw‰ďŒŽ—á‰ď i94.01.29j, “Œ‹ž.

2292. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŽŠ‘RÁŽ¸‚ľ‚˝‹š’Ĺ•”‹}Ťd–ŒŠOŒŒŽî‚Ě‚P—á. ŽÂŒ´OsCˆŔ’BŒöC“n•ÓŽC“ńŒŠr˜YC’Ë–{s’jiŽŠOjCĄ–ě~iĂ“ě’†‰›•a‰@j: ‘ć90‰ń_“ސ쐎Œ`ĐŠQŠO‰Čˆă‰ď i94.02.26j, ‰Ą•l, ƒvƒƒOƒ‰ƒ€Ľ´˜^W, p.24.

2293. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘ĺ‘ڍœč÷ăœÜ‚ĚŽĄ—ĂŒoŒą. Ź‹{Gˆę˜YC“ě‘ňˆç—YCŹ—Ń–žłC‘ĺ–ěŽiC’†‘ş‘–žC“čŒ´G”VCŽ…–žˇŒ›iŽŠOj: ‘ć90‰ń_“ސ쐎Œ`ĐŠQŠO‰Čˆă‰ď i94.02.26j, ‰Ą•l, ƒvƒƒOƒ‰ƒ€Ľ´˜^W, p.32.

2294. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j MPŠÖßŒĹ’čp‚đŽ{s‚ľ‚˝ć“VŤ‹›—Ř‚š‚ńÇ‚Ě‚P—á. “c•Ó‰ę‘ĽC“ńŒŠr˜YCŽÂŒ´OsCÂ–ؐ°•FCˆŔ’BŒöC–k’ܐLmC“y‰Ž“ցC’Ë–{s’jiŽŠOj: ‘ć557‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ďŒŽ—á‰ď i94.03.26j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€.

2295. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j •ęćä’ZkÇ‚ɑ΂ľœ‰„’ˇ‚đŽ{s‚ľ‚˝‚P—á. “ŒŒvC˜e“c—˛ŽiC“y‰Ž“ցC–k’ܐLmCˆŔ’BŒöC“ńŒŠr˜YC’Ë–{s’jiŽŠOj: ‘ć557‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ďŒŽ—á‰ď i94.03.26j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€.

2296. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j MRI‚ɂčœ•a•Ď‚Ş‹^‚í‚ę‚˝“]ˆÚ‚Ě‚Č‚˘‘ĺŒ‹ßœÜ‚Ě‚P—á. ’Ë–{’B˜YC‚ŠÝŒ›“ńC‰Ô“ˆ”ü“ŢŽqC’†‘ş‘–žC“čŒ´G”VCŽ…–žˇŒ›iŽŠOj: ‘ć557‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ďŒŽ—á‰ď i94.03.26j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€.

2297. mŒ¤‹†‰ďi‘Űjn i“Á•Ęu‰‰j Vagus-Flexion osteotomy for severely advanced osteoarthritis of the hip joint. Ž…–žˇŒ›CŠÖŒűš˜aC‘OŒ´G•vC“ߐ{–ěG“ńiŽŠOj: ƒ”ƒ@[ƒWƒjƒA‘ĺŠwˆăŠw•”ŽŒ`ŠO‰Č‘˛ŒăŒ¤Cu‰‰‰ď i93.08.17j, ƒ”ƒ@[ƒWƒjƒA.

2298. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Massive segmental bone allografts‚Ě’ˇŠú“IŒŸ“˘. “ߐ{–ěG“ńCŽ…–žˇŒ›CŹ—Ń–žłC‘ĺ–ěŽiCŠÖŒűš˜aCb”ăGŽŔiŽŠOj: ‘ć12‰ń“ú–{œĽŠÖßĽ“î•”‘gDˆÚAŒ¤‹†‰ď i93.10.15`16j, Šň•Œ, ´˜^W, p.64, 1993.

2299. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒż-TCPœƒZƒƒ“ƒg’“ü‘ĺ‘ڍœœŠ˛•”‚É‚¨‚Ż‚鍜ŠE–Ę‚Ě‘gDŠw“I•Ď‰ť‚ɂ‚˘‚Ä. 傌´—L’jCŽ…–žˇŒ›C’†‘şL”ViŽŠOjCX“c^Žjiś‘̍Hj: ‘ć13‰ńŽŒ`ŠO‰ČƒZƒ‰ƒ~ƒbƒNĽƒCƒ“ƒvƒ‰ƒ“ƒgŒ¤‹†‰ď i93.12.11j, “Œ‹ž.

2300. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Euro-Collins‰t‚É‚ć‚郉ƒbƒgŒăŽˆ‚Ě—â‹p•Ű‘ś‚ÉŠÖ‚ˇ‚éŽŔŒą“IŒ¤‹†. ‰ĄŽRˆę•FiŽŠOjC’†‘ş‘‰qi•ŞśjC–Ř‘şł“CŽ…–žˇŒ›iŽŠOj: ‘ć20‰ń“ú–{’ቡˆăŠwŒ¤‹†‰ď‘‰ď i94.02.10j, “Œ‹ž.

2301. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒJƒjƒNƒCƒUƒ‹‚Ě•I“ŕ‘¤‘¤•›x‘Ń‚ĚŒ`‘ÔŠĎŽ@|ƒqƒg‚Ć‚Ě”äŠr‚É‚¨‚˘‚ā|. Â–ؐ°•FC“ńŒŠr˜YC“Ą“cłC–{•”ƒŽqC’Ë–{s’jiŽŠOj: ‘ć6‰ń“ú–{•IŠÖßŒ¤‹†‰ď i94.02.19j, “Œ‹ž, ´˜^W, p.24.

2302. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j V‘NžôœŒz•”œÜ‚ɑ΂ˇ‚éŒo”ç“IŽ•œ‚ĚŽŽ‚Ý. “ńŒŠr˜YC“Ą“cłCÂ–ؐ°•FCŹ—Ń–žłC’Ë–{s’jCŽ…–žˇŒ›iŽŠOj: ‘ć6‰ń“ú–{•IŠÖßŒ¤‹†‰ď i94.02.19j, “Œ‹ž, ´˜^W, p.35.

2303. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ”|—{“eŹ’ˇ˜]“×–EŠOŠîŽż‚Ě”j‰ó‚É‹y‚Ú‚ˇƒTƒCƒgƒJƒCƒ“‚̉e‹ż. —˜Şě‰ërC‚ŠÝŒ›“ńiŽŠOjCÔŻ“§i“ŕjCŒÜäzsMiś‰ťjCź‘ş–žlCŽ…–žˇŒ›iŽŠOj: ‘ć7‰ń“ú–{“‘ăŽÓŒ¤‹†‰ď i94.03.04`05j, L“‡, ´˜^W, p.56.

2304. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Œo”ç“I‘Šj“EoŽčp‚̐ŹŃ‚É‚¨‚ć‚Ú‚ˇ”ˆöŽq‚ĚŒŸ“˘. ˆŔ’BŒöC“n•ÓŽCŽR“c—F‹vC‚•˝ŽLC“ńŒŠr˜YC’Ë–{s’jCŽO—֐´ŽuiŽŠOj: ‘ć6‰ń“ú–{Œo”ç“I’ŊԔ“EoŽčpŒ¤‹†‰ď i94.03.06j, “Č–Ř, ´˜^W, p.11.

2305. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j •ĎŒ`ŤŒŇŠÖßÇ‚ɑ΂ˇ‚éŠO”˝‹ü‹ČœŘ‚čp. Ž…–žˇŒ›iŽŠOj: ‘ć348‰ń‰Ą•lŽs—§‘ĺŠwŽŒ`ŠO‰Č“Ż–ĺ‰ď–Y”N’k˜b‰ď i93.11.29j, ‰Ą•l.

2306. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ’ˇŠÇœœÜŽĄ—Ă‚É‚¨‚Ż‚éinterlocking nail‚Ě–đŠ„. Ž…–žˇŒ›iŽŠOj: ‘ć6‰ńœĽŠÖßŽžŠłƒVƒ“ƒ|ƒWƒEƒ€ i94.01.22j, •Ÿ‰Ş.

2307. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ‘ĺ‘ڍœœŠ˛•”•˛ÓœÜ‚ĚŽĄ—Á|‘“ŕ“B‚É‚ć‚鎥—Á|. Ž…–žˇŒ›iŽŠOj: “Œ‹ž‘ĺŠwŽŒ`ŠO‰ČŒ¤‹†‰ď i94.02.10j, “Œ‹ž.

2308. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ‚Ů‚Ů‚Ă‚Ś“B‚É‚ć‚éŒz•”“ŕ‘¤œÜ‚ĚŽĄ—Ă. Ž…–žˇŒ›iŽŠOj: ‘ć6‰ń_“ސ쐎Œ`ŽčpŽč‹ZŒ¤‹†‰ď i93.06.11j, ‰Ą•l.

2309. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j œ‹âs‚ĚŒťó‚Ć‚ą‚ę‚Š‚ç. Ž…–žˇŒ›iŽŠOj: ‘ć58‰ń–k—˘‘ĺŠwŽŒ`ŠO‰ČŒŽ—áƒJƒ“ƒtƒ@ƒŒƒ“ƒX i93.06.14j, ‘Š–ÍŒ´.

2310. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ŠÖß‚ĚƒoƒCƒIƒƒJƒjƒNƒX. ’Ë–{s’jiŽŠOj: L“‡œŠÖßŽžŠłŒ¤‹†‰ď i93.07.24j, L“‡.

2311. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ŹŽ™‚̉şŽˆœÜŽĄ—Ïă‚Ě–â‘č“_. Ž…–žˇŒ›iŽŠOj: ˆŽěŽŒ`ŠO‰Čˆă‰ď i93.10.21j, ˆŽě.

2312. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j •ĎŒ`ŤŠÖßÇ‚ĚŽĄ—Ă. ’Ë–{s’jiŽŠOj: “Ą‘ňŽsŽŒ`ŠO‰Čˆă‰ď i93.12.11j, “Ą‘ň.

2313. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j Œ¨‚Ě’´‰š”gf’f. ‚ŠÝŒ›“ńiŽŠOj: ‘ć1‰ń‰Ą•lŽŒ`ŠO‰ČƒGƒR[‰ď i94.02.17j, ‰Ą•l.

2314. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ’ˇŠÇœœÜŽĄ—Ă‚É‚¨‚Ż‚éƒWƒŒƒ“ƒ}|‘“ŕ“B‚Ë‚ś‰ĄŽ~‚ß–@‚đ—p‚˘‚é—§ę‚Š‚ç|. Ž…–žˇŒ›iŽŠOj: “Ą‘ňŽsŽŒ`ŠO‰Čˆă‰ď i94.02.23j, “Ą‘ň.

2315. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ƒXƒ|[ƒc‚Ě•K—vŤ. ‚ŠÝŒ›“ńiŽŠOj: Œ’N‚Ă‚­‚čƒZƒ~ƒi[ i93.10.22j, ” Ş.

2316. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j •ĎŒ`ŤŒŇŠÖßÇ‚É‚¨‚Ż‚éŠÖß•\–Ę‚ĚC•œ‘gD‚ÉŠÖ‚ˇ‚錟“˘. Ž…–žˇŒ›C“ߐ{–ěG“ńiŽŠOj: ‘ć11‰ńŒŇŠÖßŒ¤‹†ƒZƒ~ƒi[ i93.11.03j, Šň•Œ, ´˜^W, p.10, 1994.

2317. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ”˝•œŤŒ¨ŠÖß’E‰PĽˆŸ’E‰P‚ĚŽčpŽč‹Z. Ž…–žˇŒ›iŽŠOj: ‘ć7‰ń_“ސ쐎Œ`ŽčpŽč‹ZŒ¤‹†‰ď i93.12.10j, ‰Ą•l.

2318. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Modified inferior capsular shift‚̍H•v. ‚ŠÝŒ›“ńiŽŠOj: ‘ć7‰ń_“ސ쐎Œ`ŽčpŽč‹ZŒ¤‹†‰ď i93.12.10j, ‰Ą•l.

2319. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ’Ž—l‹Ř‚Ě”jŠi‚Ş”­Ç‚ÉŠÖ—^‚ľ‚˝‚ĆŽv‚í‚ę‚˝ŽčŞŠÇÇŒóŒQ‚Ě‚P—á. –{•”ƒŽqCŽR‰Ž’qNCÂ–ؐ°•FC“y‰Ž“ցC“ńŒŠr˜YC’Ë–{s’jiŽŠOj: ‘ć8‰ń“Œ“ú–{Žč‚ĚŠO‰ČŒ¤‹†‰ď i94.02.05j, “Œ‹ž, ´˜^W, p.33.

2320. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ’ˇŠú“§ÍŠłŽŇ‚É”­ś‚ľ‚˝ŽčŞŠÇÇŒóŒQŽčp—á‚ĚŒŸ“˘. Ź—Ń–žłC“ńŒŠr˜YCÂ–ؐ°•FCŽ…–žˇŒ›iŽŠOj: ‘ć8‰ń“Œ“ú–{Žč‚ĚŠO‰ČŒ¤‹†‰ď i94.02.05j, “Œ‹ž, ´˜^W, p.60.

2321. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j äF‹…‘}“ü‚É‚ć‚éTFCC‹@”\ÄŒš‚ĚŽŽ‚Ý. “ńŒŠr˜YCŹ—Ń–žłCÂ–ؐ°•FC“Ą“cłC’†‘şˆęmCŽá—ѐL”VC’Ë–{s’jiŽŠOjC–I’JŤŽji‰Ą•l“실Ď•a‰@j: ‘ć8‰ń“Œ“ú–{Žč‚ĚŠO‰ČŒ¤‹†‰ď i94.02.05j, “Œ‹ž, ´˜^W, p.68.

2322. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Œ¨ŠÖß‚Éáu’É‚ĆŽî’Ż‚đ‚Ť‚˝‚ľ‚˝10Î, —Ž™. —˜Şě‰ëriŽŠOj: ‘ć2‰ńŠÖ“ŒŒ¨‚đŒę‚é‰ď i94.02.12`13j, “Œ‹ž.

2323. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j —ź˝œ‰“ˆĘ’[‚̏ă•űˆÚ“Ž‚đ”F‚ß‚˝15Î, ’jŽ™. Ä“Ąş•FC‰Ô“ˆ”ü“ŢŽqiŽŠOj: ‘ć2‰ńŠÖ“ŒŒ¨‚đŒę‚é‰ď i94.02.12`13j, “Œ‹ž.

2324. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Successful osteotomyŒă‚ĚŠÖß–ĘC•œ‘gD‚ÉŠÖ‚ˇ‚é‘gDŠw“IŒŸ“˘. “ߐ{–ěG“ńCŽ…–žˇŒ›C‘ĺ–ěŽiCŠÖŒűš˜aC‘OŒ´G•vC‚ŠÝŒ›“ńC“ě‘ňˆç—YiŽŠOj: ‘ć18‰ń_“ސěŠÖßŠO‰ČŒ¤‹†‰ď i94.03.05j, ‰Ą•l, ƒvƒƒOƒ‰ƒ€.

2325. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘ĺ‘ڍœ“Ş‹y‚ŃŒz•”‚É‹‘ĺ”XŽîó•Ď‰ť‚đ”F‚ß‚˝–ŤŠÖßƒŠƒEƒ}ƒ`‚Ě‚P—á. ‘ĺ‚•ś“TC“y‰Ž“ցC”Ş–Ř‰pŒ›CŽÂŒ´OsCˆŔ’BŒöC–k’ܐLmC“ńŒŠr˜YC’Ë–{s’jiŽŠOj: ‘ć18‰ń_“ŢěŒ§ŠÖßŠO‰ČŒ¤‹†‰ď i94.03.05j, ‰Ą•l, ƒvƒƒOƒ‰ƒ€.

2326. mŒ¤‹†‰ďi’n•űjn iŒöŠJuŔj œ‘e‚ľ‚傤Ç‚̏ăŽč‚Ȃ‚Ť‚ ‚˘•ű|Q‚˝‚Ť‚č‚É‚Č‚ç‚Č‚˘‚˝‚߂Ɂ|. ŽR“ż‹`˜YiŽŠOj: –k—˘‘ĺŠw•a‰@ŒöŠJuŔ i94.02.26j, ‘Š–ÍŒ´. ƒvƒƒOƒ‰ƒ€Ľ´˜^W, p.32.


<<19 7 ŽŒ`ŠO‰ČŠw>>

2327. mŠw‰ďŽĺĂi’n•ű‰ďjn ‘ć27‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď(93.11.27), “Œ‹ž. ’Ë–{s’jiŽŠOj.


<<20 Œ`ŹŠO‰ČŠw>>

2328. mŒ´’˜n ŽčpŠÂ‹Ť‚É‚¨‚Ż‚éQOL‚Ě–â‘č“_|“™‰ż‘›‰šƒŒƒxƒ‹‚Ĺ‚Ě•]‰ż. “ŕŔ‰hŽ÷iŒ`ŠOj: Œ`ŹŠO‰Č, 36(10): 1161`1165, 1993.

2329. mŒ´’˜n L”͈͔M‚ɑ΂ˇ‚é“ŻŽíA”ç‚Ě—Ő°“IŒŸ“˘. ŽR‰ş—ŠGC‘ĺ’J’Ă‹ą”VC•“cŒ[iŒ`ŠOjC‘ĺ˜a“c—˛i‹~–˝jC‰–’JMKiŒ`ŠOj: Œ`ŹŠO‰Č, 36(5): 501`505, 1993.

2330. mŒ´’˜n ăüLÇŽčpŠłŽŇ‚ɑ΂ˇ‚éƒAƒ“ƒP[ƒg’˛¸. ŽÄ“c—T’BC‚‹´ŒłC‘ĺ’|Ž”VC‰–’JMKiŒ`ŠOj: Œ`ŹŠO‰Č, 36(5): 581`586, 1993.

2331. mŒ´’˜n ‘s”N‚Ě—ź‘¤–„–vŽ¨‚ĚŽĄ—ĂŒoŒą. ŽR“c’źlC“잊ş—YC“ŕŔ‰hŽ÷C‰–’JMKiŒ`ŠOj: Ž¨•@ˆôA‰ČĽ“ŞŒz•”ŠO‰Č, 65(13): 1039`1042, 1993.

2332. mŒ´’˜n •Ą‡”|—{”畆‚đŽg—p‚ľ‚˝R‹ŰÜ‚Ě×–E“ŐŤŽŽŒą. ”’Îť•FC‰–’JMKiŒ`ŠOjC•–ö”\Œőiś‘̍Hj: “ú–{Œ`ŹŠO‰ČŠw‰ď‰ďŽ, 14: 1`10, 1994.

2333. mŒ´’˜n ŽŠŽEŠé‰ć‚É‚ć‚é”MŠłŽŇ‚ĚŒŸ“˘. ŽR‰ş—ŠGC•“cŒ[C‘ĺ’J’Ă‹ą”VC‰–’JMKiŒ`ŠOj: ”M, 19(3): 131`135, 1993.

2334. mŒ´’˜n ƒ|ƒŠƒEƒŒƒ^ƒ“–Œ‚Ɛś‘ĚŢ—żƒXƒ|ƒ“ƒW‘w‚Š‚ç‚Č‚éR‹ŰÜŠÜ—L‘n”핢Ţ‚ĚŠJ”­; —Տ°•]‰ż. ˆŔ•y‹`“NC’†–kMşC‰–’JMKiŒ`ŠOjC•–ö”\Œőiś‘̍Hj: ”M, 19: 102`116, 1993.

2335. m€Œ´’˜n ƒ|ƒŠƒEƒŒƒ^ƒ“–Œ‚ƍ‚‹‰…Ť•sD•z‚Š‚琏‚éR‹ŰÜŠÜ—L‘n”핢Ü‚Ěĺń]‚É‚¨‚Ż‚é•]‰ż. ’†‘şŒłMC‰–’JMKiŒ`ŠOjC•–ö”\Œőiś‘̍Hj: Prog. Med., 13(11): 225`228, 1993.

2336. mŒ¤‹†•ńi•ś•”Čjn ‘nŽĄ–ü‚É‚¨‚Ż‚é•\”ç×–E–Œ•\–ĘƒŒƒZƒvƒ^[(ƒż5ƒŔ1)‚Ě’˛ß‹@\. ÎŒ´GˆęiŒ`ŠOj: •ń‘.


<<20 2 Œ`ŹŠO‰ČŠw>>

2337. mÇ—á•ńn Reverse saphenous pedicle cutaneous and sartorius Flap ‚É‚ć‚鉺‘ڍČš. ŽR“c’źlC‘ĺ’|Ž”VC•“cŒö—˜CŽR‰ş—ŠGC‰–’JMKiŒ`ŠOj: “ú–{Œ`ŹŠO‰ČŠw‰ď‰ďŽ, 13(12): 699`704, 1993.

2338. mÇ—á•ńn ƒsƒAƒXŒă‚É”­ś‚ľ‚˝ƒPƒƒCƒh‚Ě‚PÇ—á. ’†‘şŒłMC“ŕŔ‰hŽ÷CˆÉ“ĄłŽkC‰–’JMKiŒ`ŠOj: “ú–{”ü—eŠO‰ČŠw‰ď‰ď•ń, 15(3): 22`28, 1993.

2339. m‘ŕn lH‘ŸŠí|‚ą‚ą‚Ü‚Ĺ‚Ć‚ą‚ę‚Š‚ç|Œ`ŹŠO‰Č—Ěˆć. ‘ĺ’|Ž”VC‰–’JMKiŒ`ŠOj: “ú–{ˆăŽt‰ďŽGŽ, (108): 1767`1770, 1993.

2340. muŔn ‚ ‚´‚đ‚Ç‚¤Žć‚é‚Š|ƒŒ[ƒU[‚đŠÜ‚ß‚˝ŽĄ—Ă–@‚Ě‚ ‚ę‚ą‚ę|. ‚‹´ŒłiŒ`ŠOj: JA‚â‚Ü‚Ć, (219): 1993.

2341. muŔn ‰pŒę‚ĆŽ„|‘ĺŘ‚Č‚Ě‚Íƒ‚ƒ`ƒ”ƒF[ƒVƒ‡ƒ“‚ĆŒp‘ą. ‚‹´ŒłiŒ`ŠOj: Medical English, 10(12): 42`43, 1993.

2342. muŔn Œ`ŹŠO‰Č‚É‚¨‚Ż‚é—L–Ń•”‚ĚÄŒš. ‘ĺ’|Ž”ViŒ`ŠOj: Science of Hair, p.57`69, 1993.

2343. muŔn ˜V‰ť‚Ö‚Ě‘Îô|Œ`ŹŠO‰Č“IƒAƒvƒ[ƒ`|. ‘ĺ’|Ž”ViŒ`ŠOj: “ú–{Ď•i‰ČŠw‰ďŽ, 18(1): 63`70, 1994.

2344. muŔn ”ĺ”AŠí‰Čˆă‚ɖ𗧂‘ź‰Č—Ěˆć‚ĚŽčp13; •ďŒs. ‚‹´ŒłiŒ`ŠOj: —Տ°”ĺ”AŠí‰Č, 48(1): 21`28, 1994.


<<20 3 Œ`ŹŠO‰ČŠw>>

2345. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn i•Ş’SŽˇ•Mj JAƒOƒ‹[ƒv_“ސě; ÔƒAƒUŽĄ—Ă‚ÉƒŒ[ƒU[Œőü, p.15, ‚‹´ŒłiŒ`ŠOj. •ŇW ”’ˆäDŽŸC _“ŢěŒ§JA’†‰›‰ď, ‰Ą•l, 93.04.20”­s.


<<20 5 Œ`ŹŠO‰ČŠw>>

2346. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Phinoplasty in orientals. ‘ĺ’|Ž”VC‰–’JMKiŒ`ŠOj: 6th Asian Pacific Congress of International Society of PRS i93.10.26j, Seoul.

2347. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j “ŞŒz•”ŽîᇂƏp’†v‘Źf’f. “ŕŔ‰hŽ÷C—é–Ř•q•FC“c’†ł”üCŽR‰ş—ŠGC‰–’JMKiŒ`ŠOj: ‘ć4‰ń“ú’†Œ`ŹŠO‰ČŒđ—ŹŠwpW‰ď i93.06.29j, ‹ŕ‘ň.

2348. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j R‹ŰÜŠÜ—L‘n”핢Ţ‚̍쐬‚Ć—Ő°•]‰ż. ’†‘şŒłMC‰–’JMKiŒ`ŠOjC•–ö”\Œőiś‘̍Hj: “ú’†Œ`ŹŠO‰ČŒđ—ŹŠwpW‰ď i93.06.29j, ‹ŕ‘ň.

2349. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Teflon catheer and siliconized needle ring method for local infection metal allergic dermatitis and trauma. ’†‘şŒłMC“ŕŔ‰hŽ÷C‘ĺ’|Ž”VC‰–’JMKiŒ`ŠOj: 12th International Society of Aesthetic Plastic Surgery, 1993 i93.09.08j, Paris.

2350. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Augmentation thinoplasty using cartilage. ‘ĺ’|Ž”VCŽR‰ş—ŠGC‰–’JMKiŒ`ŠOj: 10th Congress of Internasion Society of Aesthetic Plastic Surgery i93.09.11j, Paris.

2351. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Psychological effects of plastic surgery. Mitsuko KajiharaC‘ĺ’|Ž”VC‰–’JMKiŒ`ŠOj: 10th Congress of Internasion Society of Aesthetic Plastic Surgery i93.09.11j, Paris.

2352. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j A new wound dressing composed of hyaluronic acid spongy sheet and medicated cavering material. ‰eŽRL”üC‰–’JMKiŒ`ŠOjC•–ö”\Œőiś‘̍Hj: International Symposium on Advances in Wound Healing and Wound Managiment i94.02.22j, Maui.

2353. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The use of composite cultured skin in conjunction with medicated covering material. ŽR‰ş—ŠGiŒ`ŠOj: Advances in Wound Healing and Wound Management i94.02.22j, Hawaii.

2354. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Clinical evaluation of silversulfadiazine inpregnated wound dressing. ’†‘şŒłMC‰–’JMKiŒ`ŠOjC•–ö”\Œőiś‘̍Hj: Advances in Wound Healing And Wound Managment i94.02.25j, Maui.

2355. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Wound-site-specific expression of K6-keratin and tenascin in fetal rat skin. ’–Œ´ß”V‰îiŒ`ŠOjC–{—Ń—R”üŽqiś‰ťŒnj: International society of Developmental Biologists 12th International Congress i93.08.08`13j, Vienna, —\eW, p.34, 1993.

2356. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Pseudocyst of the auricle ‚ĚŒŸ“˘. ź‘q’m”VC“ŕŔ‰hŽ÷CŽR‰ş—ŠGC“c’†ł‰pC’Ň–ěˆę˜YCŽÄ“c—T’BC_‘ň•qC—Ń˜aOCŞ–{[CƒvƒŠƒ“ƒ„[EƒsƒpƒbƒVƒ…ƒLƒƒƒbƒgC‰–’JMKiŒ`ŠOj: ‘ć36‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď i93.05.13j, ˇ‰Ş.

2357. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰óŽ€Ť‹Ř–Œ‰Š‚Ě—Ő°“IŒŸ“˘. ŽR‰ş—ŠGCˆÉ“ĄłŽkCŽÄ“c—T’BC—é–؉ë”üC—Ń˜aOC“c’†ł‰pCź‘q’m”VC•“cŒ[C‰–’JMKiŒ`ŠOj: ‘ć36‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď i93.05.13j, ˇ‰Ş. “ú–{Œ`ŹŠO‰ČŠw‰ď‰ďŽ, 13(—Ő): 45, 1993.

2358. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ž¨‰îŹ•ĎŒ`‚ɑ΂ˇ‚é”ńŠĎŒŒ‹¸ł—á‚ĚŒŸ“˘. ‚‹´ŒłC”Ń“c„CŽR‰ş—ŠGiŒ`ŠOjC‰Ą“csŽjC“Ą–ěé”VC‘ĺ‘ňÍŒáiŽ™jC‰–’JMKCˆÉ“ĄłŽkC‰eŽRL”üC”’Îť•FiŒ`ŠOjC“‡‘qNliŽY•wj: ‘ć36‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď i93.05.13`15j, ˇ‰Ş, “ú–{Œ`ŽŒ`ŠO‰ČŠw‰ď‰ďŽ, 13(—Ő‘): 112, 1993.

2359. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰Č‚É‚¨‚Ż‚é”S–Œ‰şŒűŠW—ô‚ĚŒŸ“˘. •“cŒ[CŽRčˆŔ°C“c’†ł‰pCŽR‰ş—ŠGC‰–’JMKiŒ`ŠOjC‰Ş–{˜NŽqiŽ¨•@jC’šŽ”Ÿsi_“ŢěŒ§—§Žq‹Ÿˆă—ĂƒZƒ“ƒ^[jCăÎOi‹ß‹E‘ĺj: ‘ć36‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď i93.05.14j, ˇ‰Ş.

2360. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j R‹ŰÜŠÜ—Lƒ|ƒŠƒEƒŒƒ^ƒ“–Œ‚ĆƒAƒeƒƒRƒ‰[ƒQƒ“‚đ•š—p‚ľ‚˝”MŽĄ—Ă. ÎŒ´GˆęiŒ`ŠOjC•–ö”\Œőiś‘̍HjCŽÄ“c—T’BC–ŘŒŇŠŽmC˛“Ą–ž’jC‰FˆäŒŞ“ńiŒ`ŠOjC‘ĺ˜a“c—˛i‹~–˝j: ‘ć36‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď i93.05.14j, ˇ‰Ş.

2361. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ű–[ŠO Paget •a‚Ě—Ő°•a—Šw“IŒŸ“˘. “c’†ł‰pC“ŕŔ‰hŽ÷CŽR‰ş—ŠGC’Ň–ěˆę˜YCź‘q’m”VCŞ–{[C_‘ň•qCƒvƒŠƒ“ƒ„[EƒsƒpƒbƒVƒ…ƒLƒƒƒbƒgiŒ`ŠOjC‹ŕŽq‘i•a—j: ‘ć36‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ď i93.05.14j, ˇ‰Ş.

2362. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”ü—eŠO‰Č‚É‚¨‚Ż‚邢‚í‚ä‚éƒGƒXƒeƒeƒBƒbƒN‚ĚŒř—p‚ɂ‚˘‚Ä. ‘ĺ’|Ž”VC‰–’JMKiŒ`ŠOjCdź„: ‘ć57‰ń“ú–{”ü—eŠO‰ČŠw‰ďŠwpW‰ď i93.05.21j, “Œ‹ž.

2363. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –j•”‚É”­ś‚ľ‚˝”S‰tŒ^Ž‰–b“÷Žî‚Ě×–E‚¨‚ć‚Ń‘gD‘œ. ’|“ŕ‰pŽqC“cŠ‰qC–ě‘şr”VC‚‹´ŒłCŹ–“–F•FCŽR–{GbiŒ`ŠOj: ‘ć34‰ń“ú–{—Տ°×–EŠw‰ď‘‰ď i93.05.26`28j, ĺ‘ä.

2364. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹z…Ť•sD•z‚Ćƒ|ƒŠƒEƒŒƒ^ƒ“–Œ‚Š‚琏‚éR‹ŰÜŠÜ—L‘n”핢Ü‚Ě”M(DDB, DB)‚É‚¨‚Ż‚é•]‰ż. ’†‘şŒłMC‰–’JMKiŒ`ŠOjC•–ö”\Œőiś‘̍Hj: ‘ć19‰ń“ú–{”MŠw‰ď‘‰ď i93.05.28j, ‘q•~, ”M, 19(4): 182, 1993.

2365. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘Š–ÍŒ´‹Ś“Ż•a‰@Œ`ŹŠO‰ČŠJÝ‚R”NŠÔ‚Ě“Œv“IŠĎŽ@. ŽR‰ş—ŠGC‚‹´ŒłC”’čËWC–ŘŒŇŠŽmiŒ`ŠOj: ‘ć42‰ń“ú–{”_‘şˆăŠw‰ď‘‰ď i93.10.07j, ‰Ą•l.

2366. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’PƒŤŒŒŠÇŽî‚É‚¨‚Ż‚éF‘fƒŒ[ƒU[ŽĄ—Ă‚ĚŒoŒą. ‚‹´ŒłCŽR‰ş—ŠGC”’čËWC–ŘŒŇŠŽmCŽđˆä’ź•FiŒ`ŠOj: ‘ć42‰ń“ú–{”_‘şˆăŠw‰ď‘‰ď i93.10.07j, ‰Ą•l, “ú–{”_‘şˆăŠw‰ďŽGŽ, 42(3): 584, 1994.

2367. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”|—{”畆‚É“K‚ľ‚˝ˆÚA°ÄŒš‚Ě‚˝‚ß‚Ě‘n”핢Ţ‚ĚŒŸ“˘. ”’čËWC•“cŒ[CŽR‰ş—ŠGC‰–’JMKiŒ`ŠOjC•–ö”\Œőiś‘̍Hj: ‘ć2‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď i93.10.09j, ĺ‘ä.

2368. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”|—{”畆ƒ‚ƒfƒ‹‚đ—p‚˘‚˝×–E“ŐŤŽŽŒą. •“cŒ[C”’čËWCŽR‰ş—ŠGC”’Îť•FC‰–’JMKiŒ`ŠOjC•–ö”\Œőiś‘̍Hj: ‘ć2‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď i93.10.09j, ĺ‘ä.

2369. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠíŠŻ”|—{Œn‚É‚ć‚é•\”çŒ`Ź‚̉đÍ. –ŘŒŇŠŽmC’–Œ´ß”V‰îC‰–’JMKiŒ`ŠOj: ‘ć2‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď i93.10.10j, ĺ‘ä.

2370. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠO—ˆŽčpŒă‚ĚŒĹ’č–@‚ĚˆęH•v. ’†‘şŒłMCˆÉ“ĄłŽkC‰–’JMKiŒ`ŠOj: ‘ć16‰ń“ú–{”ü—eŠO‰ČŠw‰ď‘‰ď i93.10.22j, “Œ‹ž.

2371. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒsƒAƒXŽ{sŽž‚ĚŽ¨‚‚̍ś‰Eˇ‚ɂ‚˘‚Ä. ’†‘şŒłMiŒ`ŠOjC’r“c•qŽqi‰đjCˆÉ“ĄłŽkC‰–’JMKiŒ`ŠOj: ‘ć16‰ń“ú–{”ü—eŠO‰ČŠw‰ď‘‰ď i93.10.22j, “Œ‹ž, —\eW, p.26, 1993.

2372. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •@ë•”Œ`Źp‚É‚¨‚Ż‚鎊‰ĆˆÚA‚̍H•v. ‘ĺ’|Ž”VC’Ň–ěˆę˜YCź‘q’m”VC‰–’JMKCÎěCˆęiŒ`ŠOj: ‘ć16‰ń“ú–{”ü—eŠO‰ČŠw‰ď‘‰ď i93.10.23j, “Œ‹ž.

2373. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰@‹~–˝‹~‹}ƒZƒ“ƒ^[‚É‚¨‚Ż‚é‚U”NŠÔ‚ĚŠç–ʍœÜÇ—á‚ĚŒŸ“˘. Xěˆę•FC‘ĺ’J’Ă‹ą”VC‰FˆäŒŞ“ńC•“cŒ[C‰–’JMKiŒ`ŠOjC‘ĺ˜a“c—˛i‹~–˝j: “ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ď i93.11.12j, ŽD–y, —\eW, p.106, 1993.

2374. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŒűŠW—ôˆęŽŸŽčp‚¨‚ć‚Ń“ńŽŸŽčp‚É‚¨‚Ż‚é–j‹Ř”S–Œ•Ů‚̉ž—p. ’†–kMşCŽRčˆŔ°C’Ň–ěˆę˜YCź‘q’m”VC˛“Ą‰p–žC•“cŒ[C‰–’JMKC’šŽ”ŸsiŒ`ŠOj: ‘ć11‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ď i93.11.13j, ŽD–y.

2375. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ă”ç|ŠÔ[D‘ŠŒÝě—p‚É‚ć‚郉ƒbƒg‘ŮŽe”畆‚Ě tenascin mRNA ‚Ě”­Œť‚Ě’˛ß. –{—Ń—R”üŽqiś‰ťŒnjC’–Œ´ß”V‰îiŒ`ŠOj: ‘ć64‰ń“ú–{“Ž•¨Šw‰ď‘ĺ‰ď i93.11.23j, ‰Ť“ę, Zool. Sci., 10(suppl.): 77, 1993, —\eW, p.143, 1993.

2376. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘ŮŽeŠú‘nŽĄ–ü K6-keratin ‚¨‚ć‚Ń tenascin ‚Ě‘n•”ˆć“ÁˆŮ“I”­Œť‚ɂ‚˘‚Ä. ’–Œ´ß”V‰îiŒ`ŠOjC–{—Ń—R”üŽqiś‰ťŒnj: ‘ć64‰ń“ú–{“Ž•¨Šw‰ď‘ĺ‰ď i93.11.23j, ‰Ť“ę, Zool. Sci., 10(suppl.): 77, 1993, —\eW, p.143, 1993.

2377. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ž¨‰îŒ`‘ÔˆŮíŽĄ—ĂŽx‰‡ƒVƒXƒeƒ€i‹¸ł‹ďŒ`ó‚̐śŹj. ‰Ô–[ş•FCŠÖŒűs—YCˆé‘şPiŒ`ŠOjCŠ_–{‰fiE‹Ć”\—ÍŠJ”­‘ĺjC‚‹´ŒłiŒ`ŠOjC“y”ěŒ’ƒi“Œ‘ĺjC“čŒ´O”Vi–k‘ĺj: ‘ć48‰ńî•ńˆ—Šw‰ď i94.03.25j, –ě“c, ‘ĺ‰ďu‰‰˜_•śW(1), p.403, 1994.

2378. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”X–Ei•˛áŽj‚ɑ΂ˇ‚鎥—Ă–@‚ĚˆęH•v. ’†‘şŒłMCź–{‹MŽqC“ŕŔ‰hŽ÷C‰–’JMKiŒ`ŠOj: ‘ć36‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď i93.05.15j, ˇ‰Ş, “ú–{Œ`ŹŠO‰ČŠw‰ď‰ďŽ, 13: 100, 1993.

2379. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Š{—ô•”‚Ö‚ĚŽŠ‰Ć’°œŠC–ČŽż×•ĐˆÚA‚ɂ‚˘‚Ä. ŽRčˆŔ°C•“cŒ[C‰eŽRL”üCŽR‰ş—ŠGC“c’†ł‰pC‰–’JMKC‘D–؏ƒŽOiŒ`ŠOjC’šŽ”Ÿsi_“ŢěŒ§—§Žq‹Ÿˆă—ĂƒZƒ“ƒ^[jC•“cŒh”Vi“Œ‹žŽ•‘ĺj: ‘ć17‰ń“ú–{ŒűŠW—ôŠw‰ď‘‰ď i93.07.08j, VŠƒ, “ú–{ŒűŠW—ôŠw‰ďŽGŽ, 18: 458, 1993.

2380. mŠw‰ďi’n•űjn i‹łˆçu‰‰j ˜V‰ť‚Ö‚Ě‘Îô|Œ`ŹŠO‰Č“IƒAƒvƒ[ƒ`|. ‘ĺ’|Ž”ViŒ`ŠOj: ‘ć18‰ń“ú–{Ď•i‰ČŠw‰ď‹łˆçƒZƒ~ƒi[ i93.11.17j, “Œ‹ž.

2381. mŠw‰ďi’n•űjn iƒ[ƒNƒVƒ‡ƒbƒvj ŽŠ‘î‰ÎĐ‚ĹŽó‚ľ‚˝Šç–Ę”M|“ލœ‚Ě˜Io‚ľ‚˝”M‘n‚ĚŽĄ—Ă. “c’†ł‰piŒ`ŠOjCˆŔ“Ął‰pi˛‹v‘‡•a‰@j: ‘ć7‰ń“ú–{”MŠw‰ďMB’n•ű‰ď i94.03.05j, ”Ń“c.

2382. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Anesthesia using iontophoresis for dye laser treatment of port wine stains of children. ‚‹´ŒłC”Ń“c„C‰–’JMKCˆÉ“ĄłŽkiŒ`ŠOj: American Society for Laser Medicine and Surgery 13th Annual Meeting i93.04.18`20j, New Orleans, Lasers in Surgery and Medicine, (Suppl.5): 1993.

2383. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Reverse sahenous pediche cutaueaes and sariorius flap ‚É‚ć‚鉺‘ڍČš. ŽR“c’źlC“잊ş—YC‘ĺ’|Ž”VC•“cŒö—˜CŽR‰ş—ŠGC–{“c~CÎ•‹§ŽjC‰–’JMKiŒ`ŠOj: ‘ć174‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.05.08j, “Œ‹ž, “ú–{Œ`ŹŠO‰ČŠw‰ď‰ďŽ, 13: 607, 1993.

2384. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Ž¨‰ş‘B‚Ě warthin Žîᇓŕ‚É”­Ç‚ľ‚˝—ޏă”ç×–EŤ“÷‰čŽî‚Ě‚P—á. ŽR“c’źlC[ˆäF˜YC“ŕŔ‰hŽ÷C“잊ş—YC‰–’JMKiŒ`ŠOj: ‘ć177‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.11.06j, “Œ‹ž.

2385. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰şŠ{œ‘Ě•”‚ÉŒ´”­‚ľ‚˝œŽî‚Ě‚P—á. ‘哇•ŕCÎŒ´GˆęCŽÄ“c—T’BiŒ`ŠOj: “ú–{Œ`ŹŠO‰ČŠw‰ďŠÖ“ŒŽx•”“Œ‹ž’n•ű‰ď i93.12.11j, “Œ‹ž.

2386. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “–‰Č‚É‚¨‚Ż‚éĹ‹ß‚T”NŠÔ‚̔畆—ǐŤŽîᇂ̓Œv. [ˆäF˜YC‘ĺ’|Ž”VC‰–’JMKCŽR“c’źliŒ`ŠOj: ‘ć31‰ńé‹ĘŒ§ˆăŠw‰ď‘‰ď i94.01.22j, ‰Y˜a.

2387. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “–‰Č‚É‚¨‚Ż‚éĹ‹ß‚U”NŠÔ‚ĚŠç–ʍœÜ‚Ě“Œv. ŽR“c’źlC[ˆäF˜YC‘ĺ’|Ž”VC“잊ş—YC‰–’JMKiŒ`ŠOj: ‘ć31‰ńé‹ĘŒ§ˆăŠw‰ď‘‰ď i94.01.23j, ‰Y˜a.

2388. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Œy‚˘’s•đ‚É‚ć‚莥—Ă‚Ş’x‚ę‚˝‚—îŽŇ”M. “c’†ł‰piŒ`ŠOjCˆŔ“Ął‰pi˛‹v‘‡•a‰@j: ‘ć7‰ń“ú–{”MŠw‰ďMB’n•ű‰ď i94.03.05j, ”Ń“c.

2389. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –K–âf—Ă‚É‚¨‚Ż‚éĺń—Ă‚ĚŽĄ—Âɂ‚˘‚Ä. ’†‘şŒłMCˆÉ“ĄłŽkC‰–’JMKiŒ`ŠOj: ‘ć180‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠÖ“ŒŽx•”“Œ‹ž’n•ű‰ď i94.03.12j, “Œ‹ž.

2390. mŒ¤‹†‰ďi‘Űjn iˆę”ʍu‰‰j Cytotoxicity tests on antimicrobial agents using cultured skin substitutes. •“cŒ[C”’Îť•FC‰–’JMKiŒ`ŠOjC•–ö”\Œőiś‘̍Hj: Advancs in Wound Healing and Wound Management i94.02.23j, Hawaii.

2391. mŒ¤‹†‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Mixed cultures comprising syngeneic and allogeneic mouse keratinocytes as a graftable skin substitute. —é–Ř•q•FC’–Œ´ß”V‰îC‰FˆäŒŞ“ńC‰–’JMKiŒ`ŠOj: 38th Annual Meeting Plastic Surgery Research Council i93.05.01j, Houston, —\eW, p.258, 1993.

2392. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j “ŻŽí•Ą‡”|—{^”ç‚ƍR‹ŰÜŠÜ—L‘n”핢Ü‚Ě•š—p. ŽR‰ş—ŠGC”’čËWC•“cŒ[C‚‹´ŒłC‰–’JMKiŒ`ŠOjC•–ö”\Œőiś‘̍Hj: ‘nŽĄ–üŒ¤‹†‰ď i93.12.04j, ŽRŒ`.

2393. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j R‹ŰÜŠÜ—L‘n”핢Ţ‚Ě“Ž•¨ŽŔŒą•]‰ż: ƒfƒuƒŠ[ƒhƒ}ƒ“‚ľ‚˝‘n–ʂ̔핢Œř‰Ę. ’†‘şŒłMC‰–’JMKiŒ`ŠOjC•–ö”\Œőiś‘̍Hj: ‘ć23‰ń‘nŽĄ–üŒ¤‹†‰ď i93.12.04j, ŽRŒ`.

2394. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ƒsƒAƒX‚É‚ć‚é‹ŕ‘ŽƒAƒŒƒ‹ƒM[. ‚‹´ŒłiŒ`ŠOj: _“ŢěŒ§‚“™ŠwZ‹ł‰ČŒ¤‹†‰ďĽŒ§—§ŠwZ•ŰŒŻ‰ď—{Œě‹ł—@•”‰ď i94.03.08j, ‰Ą•l.


<<21 ”畆‰ČŠw>>

2395. mŒ´’˜n Confocal laser scanning microscopic and immunoelectron microscopic studies of the anatomical distribution of fibrillar IgA deposits in dermatitis herpetiformis. ě–ź˝Žii”çjCŁě˛‹vi‰đj: Arch. Dermatol., 129: 456`459, 1993.

2396. mŒ´’˜n Erythroderma, hair loss and sinus histiocytosis with massive lymphadenopathy in a XYY-male. ’ËŒ´“NĆC–x“ŕ•ŰGC‘ĺěŽiC‘‘ňŠ˛’jCźŽR–Εvi”çjC‘ĺˆä“cłli•a—j: J. Dermatol., 20(1): 49`55, 1993.

2397. mŒ´’˜n Significance of elevated serum squamous cell carcinoma (SCC)-related antigen and lactate dehydrogenase (LDH) levels in senile erythroderma following eczema. ’ËŒ´“NĆC‰šŽR˜aéC–x“ŕ•ŰGi”çj: J. Dermatol., 20(6): 346`350, 1993.

2398. mŒ´’˜n 1ƒż, 25-dihydroxy vitamin D3 modulation of HLA-DR mRNA induced by ƒÁ-interferon in cultured epithelial tumor cell lines. “”I‹BC‰q“ĄŒőC‰Á“ĄFŽqi”çjC‘ĺ’J•ś—Yi–ƁjCźŽR–Εvi”çj: J. Dermatol., 20(9): 581`584, 1993.

2399. mŒ´’˜n Immunohistochemical study of elevated expression of squamous cell carcinoma (SCC)-related antigens in erythrodermic epidermis. –x“ŕ•ŰGC’ËŒ´“NĆC‰šŽR˜aéi”çj: J. Dermatol., 21(2): 67`72, 1994.

2400. mŒ´’˜n ƒƒ‰ƒjƒ“F‘f‘‰ÁŽžŠł‚ɑ΂ˇ‚éƒAƒ[ƒ‰ƒCƒ“Ž_‚Ě—Ő°Œř‰Ę. ‹TŽRFˆę˜YCŽđˆä’qŒbC‹ß“ĄŽ •vC•ÄŒłN‘ i”çj: ź“ú–{”畆‰Č, 55: 319`311, 1993.

2401. mŒ´’˜n ˆŤŤŒŒŠÇ“ŕ”ç×–EŽî‚ĚrIL°2 one shot“Ž’—Ă–@. Žđˆä’qŒbC‘ĺěŽiC‘ž“cK‘ĽC‘‘ňŠ˛’jCźŽR–Εvi”çjC‘ž“cKGi’ˇŒă”畆‰Čj: “ú–{”畆‰ČŠw‰ďŽGŽ, 103(13): 1777`1781, 1993.

2402. mŒ´’˜n ’ˇŠú“§ÍŠłŽŇ‚̉ş‘ڂɐś‚ś‚˝äéŽ_ƒJƒ‹ƒVƒEƒ€’ž’…Ç. ›’J˜a]i‘ĺ˜aŽs—§jC—é–Ř—T‰îC‰q“ĄŒőCźŽR–Εvi”çjCVˆätŽ}C‚‹´—Tˆę˜YCX—˛Žii‘ĺ˜aŽs—§j: “ú–{”畆‰ČŠw‰ďŽGŽ, 103: 1189`1195, 1993.

2403. mŒ´’˜n SLE”畆•a•Ď•”‚É’~Ď‚ˇ‚郊ƒ|ƒtƒXƒeƒ“i‘ć2•ńj‰ŠFŽî—l•a•Ď‚Ěceroid-laden macrophage‚ĚŒ`Ź‚¨‚ć‚Ń’~Ď‚Ě‹@˜. VˆätŽ}C›’J˜a]i‘ĺ˜aŽs—§jCóˆäŽőŽqCŠÖŞ“ÖŽqC‹ß“ĄŽ •vC‰q“ĄŒőCźŽR–Εvi”çj: “ú–{”畆‰ČŠw‰ďŽGŽ, 103: 1747`1766, 1993.

2404. mŒ´’˜n SLE‚̔畆•a•Ď•”‚É’~Ď‚ˇ‚郊ƒ|ƒtƒXƒeƒ“|‘ć‚P•ń. VˆätŽ}C›’J˜a]i‘ĺ˜aŽs—§jCóˆäŽőŽqCŠÖŞ“ÖŽqC‰q“ĄŒőCźŽR–Εvi”çj: “ú–{”畆‰ČŠw‰ďŽGŽ, 103: 625`641, 1993.

2405. mŒ´’˜n ƒAƒgƒs[Ť”畆‰Š‚ĚŠç–Ę‚Ě”­Ôi‰ŠÇŤ[ŒŒj‚ɑ΂ˇ‚鉊˜A‰đ“Ĺ“’‚Ɲh[Îp‚Ě—L—pŤ‚ĚŒŸ“˘. “Œˆę‹IC“Ą‰Ş˛C–ěŒűr•FCŒüˆäGŽ÷i”çj: ”畆‰Č‹I—v, 88(4): 391`401, 1993.

2406. mŒ´’˜n –{‘ԐŤŒŒŹ”ÂŒŒÇ‚É”ş‚Á‚˝’O“Ĺ—lŽî’Ż. “Ą“c—T‰îC“Ą‘ş‹ż’jC‘‘ňŠ˛’ji”çjCˆÉ“Ą“āCÂŽR’C•viˆßŠ}j: ”畆•af—Ă, 15(5): 395`398, 1993.

2407. mŒ´’˜n ”畆‹Ř‰ŠŠłŽŇ‚ɐś‚ś‚˝DDSÇŒóŒQ. ‹ŔęLěC‰q“ĄŒői”çj: ”畆•af—Ă, 15(9): 787`790, 1993.

2408. mŒ´’˜n ‘˝”­Ť”’FŹŒ‹ß‚Ş‚Ý‚ç‚ę‚˝“§ÍƒAƒ~ƒƒCƒh[ƒVƒX. ‘‘ňŠ˛’jC‘ĺěŽiC‰Á“Ąˆę˜Yi”çjC•ěƒi–kŒ¤ƒƒfƒBƒJƒ‹j: ”畆•af—Ă, 16(2): 149`153, 1994.

2409. mŒ´’˜n F‘fŤáy]. “Ą“c—T‰îCŸ‰ŞŒ›śi”çj: ”畆•af—Ă, 16(3): 227`230, 1994.

2410. mŒ´’˜n Fibrillar IgA type ‚Ě Duhring áv]ó”畆‰Š. ě–ź˝Žii”çjCŁě˛‹vi‰đj: ”畆—Տ°, 35(11): 1657`1658, 1733`1738, 1993.

2411. mŒ´’˜n Bullous lichen planus. ě–ź˝ŽiC“cŔO”Vi”çj: —Տ°”畆‰Č, 47: 127`132, 1993.

2412. mŒ´’˜n L”͈͂ɕޕz‚ľ‚˝‘˝”­Ť•˝ŠŠ‹ŘŽî|–k—˘‘ĺŠw”畆‰Č10”NŠÔ‚̏WŒv‚¨‚ć‚іƉu‘gD‰ťŠw“IŒŸ“˘|. –îŒűŒúC•ÄŒłN‘ i”çj: —Տ°”畆‰Č, 47: 449`452, 1993.

2413. m€Œ´’˜n ƒGƒbƒNƒŠƒ“ŠžŠíŠŻŠŕ‚Ě×–EŠ”Ž÷—§‚Ć‚ť‚Ě“ÁŤ. •ÄŒłN‘ C‰H‹ŕdŠěC–îŒűŒúCóˆäŽőŽqC‰q“ĄŒői”çj: Human Cell, 6: 104, 1993.

2414. m€Œ´’˜n Pitted keratolysis. ‰q“ĄŒőC‹{“c‘Žqi”çj: ”畆•af—Ă, 15(11): 973`976, 1993.

2415. mŒ¤‹†•ńn –Ťĺ@–ƒ]‚ɑ΂ˇ‚鉖Ž_ƒAƒ[ƒ‰ƒXƒ`ƒ“‚Ě—L—pŤ. ě–ź˝ŽiC’ž‘—Yi”çj: Prog. Med., 13(8): 1652`1658, 1993.

2416. mŒ¤‹†•ńiŒúśČjn qíŤ“VávጂŠ‚ç—Ž—tó“Vávጂֈڍs‚ľ‚˝‚Q—á|—Տ°, ‘gDŠw“IŠŒŠ, “VávግRŒ´‚̕ωť|. ě–ź˝Žii”çjC‹´–{—˛Cźě•“ńiŒc‘ĺj: ŒúśČ“Á’莞Šł‹H­“ŤŽžŠł’˛¸Œ¤‹†”Ç•˝Ź4”N“xŒ¤‹†•ń‘, p.229`233, 1993.


<<21 2 ”畆‰ČŠw>>

2417. mÇ—á•ńn ’†•_ŒoZ‚𔺂Á‚˝ T-immunoblastic sarcoma‚ƍl‚Ś‚ç‚ę‚é1—á. —´–썲’mŽqCŠâč‰ëC‹´–{–ž•FC’|čLˆę˜YCVˆätŽ}CźŽR–Εvi”çj: ”畆‚ĚƒŠƒ“ƒtƒH[ƒ}, 8: 74`77, 1993.

2418. mÇ—á•ńn Tufted hair folliculitis ‚Ě 1—á. rˆä—şCŸ‰ŞŒ›śi”çj: ”畆‰Č‚Ě—Ő°, 35(13): 2010`2011, 1993.

2419. mÇ—á•ńn ‰@“ŕ–ń‘Šˆ•ű. •ÄŒłN‘ i”çj: ”畆‰Č‚Ě—Ő°, 35(9): 1506`1507, 1993.

2420. mÇ—á•ńn “]ˆÚŤŠĚŠŕ‚É”ş‚¤”畆ŒŒŠÇ‰Š. ‹´–{–ž•FC‰šŽR˜aéCó’J‰ë•śi”çj: ”畆•af—Ă, 16(1): 49`52, 1994.

2421. m—Տ°ŽĄŒąn Oxiconazole nitrateiƒIƒLƒiƒ][ƒ‹RƒNƒŠ[ƒ€j‚Ć20%”A‘f“îp‚Ě•š—p‚É‚ć‚éŠpŽż‘BŒ^”’á‚ĚŽĄ—ĂŒř‰Ę. ’†‘şŒ’ˆęCě–ź˝ŽiC’ž‘—Yi”çj: Šî‘b‚Ć—Ő°, 27(11): 4509`4516, 1993.

2422. m—Տ°ŽĄŒąn ‘Ť”’ᝁićäŠÔŒ^, Ź…ávŒ^j‚ɑ΂ˇ‚éOxiconazole nitrateiƒIƒLƒiƒ][ƒ‹RƒNƒŠ[ƒ€j‚ĚŽĄ—ĂŒř‰Ę‚ɂ‚˘‚Ä. ’†‘şŒ’ˆęCě–ź˝ŽiC’ž‘—Yi”çj: Šî‘b‚Ć—Ő°, 27(11): 4517`4524, 1993.

2423. m—Տ°ŽĄŒąn ƒAƒgƒs[Ť”畆‰Š‚ĚŠç–Ę‚Ěg”Á‚ĚŽĄ—Ă‚ÉŠż•ű–ň•š—p‚Ş‘tŒř‚ľ‚˝1—á|‰Š˜A‰đ“Ĺ“’‚Ɲh[Îp‚Ě“ŕ•ž—Ă–@|. “Œˆę‹IC“V–ě—˛•śC‘ĺěŽiC“Ą‰Ş˛i”çj: ź“ú–{”畆‰Č, 55(2): 323`326, 1993.

2424. m—Տ°ŽĄŒąn Ŕጂɑ΂ˇ‚éRoxithromyciniƒ‹ƒŠƒbƒhRj‚Ě—L—pŤ. ’†‘şŒ’ˆęCě–ź˝ŽiCŒ´“c°”üC’ž‘—YC‰Ź–ě—ĎŽqi”çj: ź“ú–{”畆‰Č, 55(6): 1136`1140, 1993.

2425. m—Տ°ŽĄŒąn ƒAƒgƒs[Ť”畆‰Š‚ɑ΂ˇ‚é•Ä”­yƒGƒLƒX“ü—‰tuƒNƒAƒ^ƒCƒ€Rv‚ĚŒř‰Ę. “Ą‰Ş˛CŽđˆä’qŒbC‰H‹ŕdŠěC•ÄŒłN‘ CźŽR–Εvi”çj: ź“ú–{”畆‰Č, 56(1): 127`131, 1994.

2426. m‘ŕn “~‚Ěƒhƒ‰ƒCƒXƒLƒ“‘΍ô. ě–ź˝Žii”çj: MBK Life, (1ŒŽ): 57, 1994.

2427. m‘ŕn ‘ŸŠí•a•Ď‚Š‚ç‚Ý‚˝äPŒ´•a‚̐f’fĽŽĄ—ĂĽŠÇ—‚Ěƒ|ƒCƒ“ƒg|”畆•a•Ď|. ‰q“ĄŒői”çj: Practitioners, 2(7): 941`950, 1993.

2428. m‘ŕn ŒŒŠÇ“÷Žî|‚Ć‚­‚ɈŤŤŒŒŠÇ“ŕ”ç×–EŽî‚ɂ‚˘‚ā|. ‘‘ňŠ˛’ji”çj: Šŕ‚ƉťŠw—Ă–@, 20(10): 1314`1319, 1993.

2429. m‘ŕn POEMSÇŒóŒQ. ‘‘ňŠ˛’ji”çj: “ú–{—Տ°, —Ěˆć•ĘÇŒóŒQƒVƒŠ[ƒY(No.2): 598`601, 1993.

2430. m‘ŕn ŒŒ‰t‚Ě•a‘ԁuŽ‡”Á•av. ‰Á“Ąˆę˜Yi”çj: –ň‹Ç, 45(1): 345`347, 1994.

2431. m‘ŕn ’ź’°Ľăč–ĺ•”•a•Ď(4)ăč–ĺ•””畆•a•Ď. Žíˆä—Ç“ńCźŽR–Εvi”çj: —Տ°Á‰ťŠí“ŕ‰Č, 8(13): 2111`2118, 1993.

2432. muŔn ”畆‰Čˆă‚Ě Minimum requirement. ‰q“ĄŒői”çj: ”畆‰Č‚Ě—Ő°, 36(3): 335`336, 1994.

2433. mŠwp‘n i•Ş’SŽˇ•Mj ‚ć‚­‚Ý‚é”畆•aŽĄ—Ă‚ĚControversy; Œ‹ßŤg”Á, p.42, ŒűŠp‰Š, p.114, ˜VlŤF‘f”Á, p.130, Žđ‚ł, p.142, ‰q“ĄŒői”çj. •ŇW źŽR–Εvi”çjC “ě]“°, “Œ‹ž, 93.04.10”­s.

2434. mŠwp‘n i•Ş’SŽˇ•Mj ‚ć‚­‚Ý‚é”畆•aŽĄ—Ă‚ĚControversy; 13.–ŤF‘fŤŽ‡”Á, p.52, 20.Gibert‚΂çFâáf], p.79, 26.G•˝ánćŇ, p.103, 27.“`őŤ“î‘ŽŽî, p.106, ě–ź˝Žii”çj. •ŇW źŽR–Εvi”çjC “ě]“°, “Œ‹ž, 93.04.10”­s.

2435. mŠwp‘n i•Ş’SŽˇ•Mj Ą“ú‚ĚŽĄ—ĂŽwj1993; ƒx[ƒ`ƒFƒbƒg•a, p.565, ě–ź˝Žii”çj. •ŇW ˆîŠ_‹`–žiç—t‘ĺjC‘˝‰ęK’jC”öŒ`‰x˜YC ˆăŠw‘‰@, “Œ‹ž, 93.05.10”­s.

2436. mŠwp‘n i•Ş’SŽˇ•Mj ”畆‰Čf’fŽĄ—Ă‘ĺŒn; ‹ŕ], (Suppl.3): 112`113, ‘‘ňŠ˛’ji”çjC‹{‘ňŽľ˜Yi“dŒ°ƒZƒ“j. •ŇW •Ÿ‘ă—Ljęi‹ŕ‘ň‘ĺjCźŽR–Εvi”çjCX‰Ş’ĺ—YC—é–ŘŒ[”Vi“ú‘ĺjC_č•ŰiŽ­Ž™“‡‘ĺjC u’kŽĐ, “Œ‹ž, 93.00.00”­s.

2437. mŠwp‘n i•Ş’SŽˇ•Mj ”畆‰Čf’fŽĄ—Ă‘ĺŒn; ƒlƒR‚Đ‚Á‚Š‚Ť•aCat-scratch disease, (Suppl.3): 120`121, ’ŘˆäL”üC‰q“ĄŒői”çj. •ŇW •Ÿ‘ă—Ljęi‹ŕ‘ň‘ĺjCźŽR–Εvi”çjCX‰Ş’ĺ—YC—é–ŘŒ[”Vi“ú‘ĺjC_č•ŰiŽ­Ž™“‡‘ĺjC u’kŽĐ, “Œ‹ž, 93.00.00”­s.

2438. mŠwp‘n i•ŇWj ‚ć‚­‚Ý‚é”畆•aŽĄ—Ă‚ĚControversy; •ŇW źŽR–Εvi”çjC “ě]“°, “Œ‹ž, 93.04.10”­s.

2439. mŠwp‘n i•ŇWj ”畆‰Čf’fŽĄ—Ă‘ĺŒn; •ŇW •Ÿ‘ă—Ljęi‹ŕ‘ň‘ĺjCźŽR–Εvi”çjCX‰Ş’ĺ—YC—é–ŘŒ[”Vi“ú‘ĺjC_č•ŰiŽ­Ž™“‡‘ĺjC u’kŽĐ, “Œ‹ž, 93.00.00”­s.


<<21 3 ”畆‰ČŠw>>

2440. m‹ł‰Č‘n i•Ş’SŽˇ•Mj Šá‰ČŠw‘ĺŒn; ”畆Ľ”S–ŒŽžŠł‚ĆŠá, p.181`192, ‘‘ňŠ˛’ji”çj. •ŇW ‘“c•xŽŸ˜Yi“Œ‘ĺjC’––“–Ёi‹ă‘ĺjC‹ĘˆäMi“Œ–k‘ĺjC–{“cEŽmi‹ž‘ĺjC ’†ŽR‘“X, “Œ‹ž, 94.02.10”­s.

2441. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj _Œo“ď•a•KŒg‡U|—Ă—{śŠˆ‚̉‡•|; —Ă—{śŠˆ‚ĆŠĹŒě|”畆ŽžŠłiámᝁj, p.42`46, ‘ĺěŽii”çj. •ŇW –k—˘‘ĺŠw“Œ•a‰@“ď•aŽĄ—ĂŒ¤‹†ƒZƒ“ƒ^[C_Œo“ď•aŒ¤C‰ďŽŔsˆĎˆő‰ďC –k—˘‘ĺŠw“Œ•a‰@“ď•aŽĄ—ĂŒ¤‹†ƒZƒ“ƒ^[, _Œo“ď•aŒ¤C‰ďŽŔsˆĎˆő‰ď, _“ސě, 93.09.00”­s.

2442. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ŠĹŒě‚Ě‚˝‚ß‚Ě–ňŽ–“T; ”畆‰Č—pÜ, p.220`221, ‰q“ĄŒői”çj. •ŇW Î‹´Wi”ĺjCŽ›č–ž”üC“Ą“cŒbŽqC•ŽR­ˆęi–ňÜjC ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 93.12.05”­s.


<<21 5 ”畆‰ČŠw>>

2443. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Complement membrane attack in vasulitis. ě–ź˝Žii”çj: Dermatology 2000 i93.05.18`21j, ƒEƒB[ƒ“.

2444. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j The cytotoxic effects of scleroderma sera on human dermal microvascular endothelial cells. ‘‘ňŠ˛’jC“Ą‘ş‹ż’jCźŽR–Εvi”çj: International Symposium on Pathogenesis and Management of PSS and Connective Tissue Disorders i93.10.26`27j, ‘ĺă.

2445. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Shift in clinical features, histologic findings, and antigen profiles from pemphigus vulgaris to pemphigus foliaceus-Two case studies. ě–ź˝Žii”çjC‹´–{—˛Cźě•“ńiŒc‘ĺjCźŽR–Εvi”çj: Tricontinental Symposium on Autoimmune Skin Diseases i93.11.01j, ‹ž“s.

2446. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Reconstruction of psoriatic epidermis followed by T cell hyperproliferation in transplanted psoriasis skin in SCID mice. ‘ĺěŽiC“Ą‘ş‹ż’ji”çjC•l“c—SŽqiś‰ťŒnjC‰q“ĄŒőC‘‘ňŠ˛’jCźŽR–Εvi”çj: 2nd Tricontinental Meeting of JSLD, SID and ESDR i93.10.28j, ‹ž“s, J. Invest. Dermatol., 101(3): 445, 1993, J. Dermatol. Sci., 6(1): 74, 1993.

2447. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Establishment and characterization of an eccrine carcinoma cell line. óˆäŽőŽqC•ÄŒłN‘ C–îŒűŒúC‰H‹ŕdŠěC‚{”ŽC‰q“ĄŒőCźŽR–Εvi”çjC˜a“c’m‰vi—Ő•a—j: Dermatology 2000 i93.05.21j, ƒEƒB[ƒ“.

2448. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j 1,24(OH)2-D3 enchances expression of GM-CSF mRNA and IL-8 mRNA in activated human dermal microvascular endothelial cells. B. FarkasC“Ą‘ş‹ż’jC“”I‹BC‰q“ĄŒőC‘‘ňŠ˛’ji”çjC‘ĺ’J•ś—Yi–ƁjCźŽR–Εvi”çj: 2nd Tricontinental Meeting of JSID, SID and ESDR i93.10.28`31j, ‹ž“s.

2449. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Establishment and characterization of a Merkel cell carcinoma cell line. ‰q“ĄŒőC•ÄŒłN‘ C“Ą‘ş‹ż’ji”çjC•l“c—SŽqiś‰ťŒnjCźŽR–Εvi”çjC‘ĺ–ě“šŽqi—ŐŒŸjC‘O“c“OiŽY•wjCät“n’‰’ji“Œ–k‘ĺj: 2nd Tricontinental Meeting of JSID, SID and ESDR i93.10.31j, ‹ž“s, J. Invest. Dermatol., 101(3): 439, 1993, J. Dermatol. Sci., 6(1): 65, 1993.

2450. mŠw‰ďi‘S‘jn i‹łˆçu‰‰j ƒGƒŠƒeƒ}ƒg[ƒfƒX. ‰q“ĄŒői”çj: “ú–{”畆‰ČŠw‰ď‘OŽŔŃŒ¤CuK‰ď•K{‚aƒR[ƒX i94.01.23j, “Œ‹ž.

2451. mŠw‰ďi‘S‘jn i‹łˆçu‰‰j –ŹŠÇ“÷Žî. ‘‘ňŠ˛’ji”çj: “ú–{”畆‰ČŠw‰ď•˝Ź5”N“x“Œ‹žŽx•”ŽĺĂśŠU‹łˆçƒZƒ~ƒi[ i94.02.06j, “Œ‹ž.

2452. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰~Œ`’E–ŃÇ‚ĆƒAƒgƒs[‘fˆö. Ÿ‰ŞŒ›śCrˆä—şCźŽR–Εvi”çj: ‘ć45‰ń“ú–{”畆‰ČŠw‰ďź•”Žx•”‘‰ď i93.11.21j, ‘ĺ•Ş.

2453. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •@‚ɐś‚ś‚˝ˆŤŤŒŒŠÇ“ŕ”ç×–EŽî‹^f—á. “V–ě—˛•śC‘‘ňŠ˛’jCźŽR–Εvi”çj: ‘ć90‰ń“ú–{”畆‰ČŠw‰ď‘‰ď i93.04.10j, Šň•Œ.

2454. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Exfoliative foxinŽYśMRSA‚Ş‘ˆŤˆöŽq‚ƍl‚Ś‚ç‚ę‚˝ŹlƒAƒgƒs[Ť”畆‰Š. ‹´–{–ž•FCŽđˆä’qŒbC’ŘˆäL”üCŠÖŞ“ÖŽqC“Ą‘ş‹ż’ji”çj: ‘ć90‰ń“ú–{”畆‰ČŠw‰ď‘‰ď i93.04.10j, Šň•Œ.

2455. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ˆŤŤŒŒŠÇ“ŕ”ç×–EŽî‚Ě rIL°2 ‹ÇŠ—Ă–@‚Ć‘ĺ—Ę“dŽqü—Ă–@‚Ě“]ˆÚ—\Œă‚Ě”äŠrŒŸ“˘. “Ą“c—T‰îC“Ą‰Ş˛C‘‘ňŠ˛’ji”çj: ‘ć9‰ń“ú–{”畆ˆŤŤŽîᇊw‰ď‘‰ďŠwp‘ĺ‰ď i93.06.06j, źŽR, ƒvƒƒOƒ‰ƒ€Ľ´˜^W, p.88, 1993.

2456. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŤŒŒŠÇ‰č×–EŽîi’†ěj‚Ě1—á. ‘‘ňŠ˛’jC“V–ě—˛•śC—é–Ř—T‰îi”çj: ‘ć17‰ń“ú–{ŹŽ™”畆‰ČŠwp‘ĺ‰ď i93.06.12j, “Œ‹ž.

2457. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘Űᝌ^‘gD”˝‰ž‚đ’ć‚ľ‚˝TENŒ^–ň]3—á‚Ě—Ő°, –Ɖu‘gDŠw“IŒŸ“˘. “”I‹BC‰q“ĄŒőCźŽR–Εvi”çj: ‘ć23‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď i93.07.03j, ‹ž“s.

2458. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Žčp—pŽč‘Ü‚É‚ć‚éƒAƒiƒtƒBƒ‰ƒLƒV[ƒVƒ‡ƒbƒN. óˆäŽőŽqi”çjCŠâ“c‹žŽqi—ŐŒŸjC‘ĺěŽiC•ÄŒłN‘ i”çj: ‘ć23‰ń“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ď i93.07.04j, ‹ž“s.

2459. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j śçG”^ávÇ‚ɑ΂ˇ‚鏬ŽÄŒÓ“’‚Ɲh[Îp‚Ě•š—pŽĄ—Ă. “Œˆę‹Ii”çj: ‘ć8‰ń“ú–{ŠŁáŠw‰ď i93.09.03j, ‰Ą•l.

2460. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j SCIDƒ}ƒEƒXˆÚAŠŁá”畆‚̖Ɖu‘gD‰ťŠw“I‚¨‚ć‚ŃƒTƒCƒgƒJƒCƒ“ˆâ“`Žq”­Œť‚ĚŒŸ“˘. ‘ĺěŽiC“Ą‘ş‹ż’ji”çjC•l“c—SŽqiś‰ťŒnjC‰q“ĄŒőC‘‘ňŠ˛’ji”çjC•“cŽüěCŽ›“c‰hŽii‰qśŠw•”j: ‘ć8‰ń“ú–{ŠŁáŠw‰ď i93.09.03j, ‰Ą•l.

2461. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j qíŤŠŁá‚É‚¨‚Ż‚éÔŒŒ‹…–ŒŽ‰Žż‘ăŽÓ‚ĚŒŸ“˘. “Ą‰Ş˛C‘ĺěŽii”çjC•l“c—SŽqiś‰ťŒnjC‚{”Ži”çjC–źŽ™–ë’‰‹MC’Ë–{şŽŸ˜Yi“ú‘ĺj: ‘ć8‰ń“ú–{ŠŁáŠw‰ď i93.09.03j, ‰Ą•l.

2462. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠÖßÇó‚đ—L‚ˇ‚驣ᝩłŽŇ‚Ě—Ő°“IŒŸ“˘. X“c”ü‰ŔŽqCŽíˆä—Ç“ńC‘ĺěŽiC“”I‹BC‰q“ĄŒői”çjC‚ŠÝŒ›“ńiŽŠOj: ‘ć8‰ń“ú–{ŠŁáŠw‰ď i93.09.03j, ‰Ą•l.

2463. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ú–{ŠŁáŠw‰ď“o˜^Ç—á‚̏WŒv|1993”N|. ‘ĺéŒË@’jCŹ‘ň–žCŒ´“cş‘ž˜YiŠŁáŠw‰ďjC‰q“ĄŒői”çj: ‘ć8‰ń“ú–{ŠŁáŠw‰ď i93.09.03j, ‰Ą•l, ‹L˜^W, p.53`65, 1993.

2464. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹŽ™‚̐qíŤŠŁá‚ĚŽĄ—Ă. Žíˆä—Ç“ńC‰Ş–{Œ‰CX“c”ü‰ŔŽqC‘ĺěŽiC“”I‹BC‰q“ĄŒői”çj: ‘ć8‰ń“ú–{ŠŁáŠw‰ď i93.09.03j, ‰Ą•l, ‹L˜^W, p.68`69, 1993.

2465. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’ˇŠúetretinate“Š—^’†‚̐qíŤŠŁá‚É‚¨‚Ż‚éUrsodeoxycholic acid•š—p—Ă–@‚ĚŒř‰Ę. “”I‹BC‰q“ĄŒőCźŽR–Εvi”çj: ‘ć8‰ń“ú–{ŠŁáŠw‰ď i93.09.04j, ‰Ą•l.

2466. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j qíŤŠŁá‚É‚¨‚Ż‚é1,25-Dihydroxyvitamin D3 reeceptor‚ĚRT-PCR‚đ—p‚˘‚˝‰đÍ. “”I‹BC‰q“ĄŒőC“Ą‘ş‹ż’jCźŽR–Εvi”çj: ‘ć8‰ń“ú–{ŠŁáŠw‰ď i93.09.04j, ‰Ą•l.

2467. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –{‘ԐŤŒŒŹ”ÂŒŒÇ‚É”ş‚Á‚˝’O“Ĺ—lŽî’Ż. “Ą“c—T‰îC“Ą‘ş‹ż’jC‘‘ňŠ˛’ji”çjCˆÉ“Ą“āCÂŽR’C•viˆßŠ}j: ‘ć57‰ń“ú–{”畆‰ČŠw‰ď“Œ•”Žx•”Šwp‘ĺ‰ď‘‰ď i93.09.26j, O‘O.

2468. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j SCIDƒ}ƒEƒX‚đ—p‚˘‚˝ˆÚAŠŁá”畆‚É‚¨‚Ż‚éŠŁáŒ^‘gD”˝‰ž‚ĚÄŒť. ‘ĺěŽiC“Ą‘ş‹ż’jC‰q“ĄŒőC‘‘ňŠ˛’jCźŽR–Εvi”çjCŽ›“c‰pŽii‰qśŠw•”j: ‘ć23‰ń“ú–{–ƉuŠw‰ď i93.11.18j, ĺ‘ä.

2469. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ž‰–bD‰Š‚Ĺ”­Ç‚ľ‚˝”畆‹Ř‰Š. ‹{“c‘ŽqCŠÖŞ“ÖŽqC‹´–{–ž•FC‰q“ĄŒőC’|čLˆę˜Yi”çj: ‘ć45‰ń“ú–{”畆‰ČŠw‰ďź•”Žx•”‘‰ď i93.11.20j, ‘ĺ•Ş.

2470. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ––˝_ŒoáŠQ‚đ‡•š‚ľ‚˝livedo racenosa. Aź“TŽqC‹g‘ňł_C‹TŽRFˆę˜Yi”çjCLŁ—˛ˆęC’ˇ’Jě‚ЂƂ݁i“ŕjC–{‹§i•a—j: ‘ć45‰ń“ú–{”畆‰ČŠw‰ďź•”Žx•”‘‰ď i93.11.20j, ‘ĺ•Ş.

2471. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j G•˝‘ŰᝊłŽŇ‚̖ƉuŠw“IˆŮí. Žíˆä—Ç“ńC‹ŕŽq‘i”çjC“n•Ó´ŽĄi•a—j: ‘ć44‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ďŠwp‘ĺ‰ď i93.11.27j, Žl“úŽs.

2472. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”畆’×ᇂ𔺂¤ƒTƒ‹ƒRƒCƒh[ƒVƒX. ŒË“c~CŠÖŞ“ÖŽqC‹´–{–ž•Fi”çj: ‘ć44‰ń“ú–{”畆‰ČŠw‰ď’†•”Žx•”‘‰ďŠwp‘ĺ‰ď i93.11.28j, Žl“úŽs.

2473. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒGƒbƒNƒŠƒ“ŠžŠíŠŻŠŕ‚Ě×–EŠ”Ž÷—§‚Ć‚ť‚Ě“ÁŤ. •ÄŒłN‘ C‰H‹ŕdŠěC–îŒűŒúCóˆäŽőŽqC‰q“ĄŒőCźŽR–Εvi”çj: ‘ć11‰ń“ú–{ƒqƒg×–EŠw‰ď i93.08.27j, ĺ‘ä.

2474. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒƒ‹ƒPƒ‹×–EŠŕ—R—ˆ”|—{×–EŠ”‚ĚŽ÷—§‚Ć‚ť‚̐Ťó. ‰q“ĄŒőC•ÄŒłN‘ C“Ą‘ş‹ż’ji”çjC•l“c—SŽqiś‰ťŒnjCźŽR–Εvi”çjCät“n’‰’ji“Œ–k‘ĺj: ‘ć11‰ń“ú–{ƒqƒg×–EŠw‰ď i93.08.27j, ĺ‘ä, Human Cell, 6(3): 96, 1993.

2475. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –Ř‘şŽ•aŠłŽŇ‚É‚¨‚Ż‚é––˝ŒŒƒŠƒ“ƒp‹…•a•Ď•”‘gD‚É‚¨‚Ż‚éƒTƒCƒgƒJƒCƒ“‚Ě”­Œť. ’ŘˆäL”üCŸ‰ŞŒ›śC‰Ş–{Œ‰C“Ą‘ş‹ż’ji”çj: ‘ć691‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.03.13j, “Œ‹ž.

2476. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒAƒiƒtƒBƒ‰ƒNƒgƒCƒhŽ‡”Á•a‚ĚŒZ–…—á. ‹´–{–ž•FC‚{”Ži”çjCă“cN‹viŽ™j: ‘ć692‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.05.15j, “Ą‘ň.

2477. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ’áCaŒŒÇ‚đ’ć‚ľ‚˝qíŤŠŁá. Žíˆä—Ç“ńCŽđˆä’qŒbC“Ą“c—T‰îC‚‹´¸Žii”çj: ‘ć692‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.05.15j, “Ą‘ň.

2478. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “dŽqüĆŽË‚Ş—LŒř‚Ĺ‚ ‚Á‚˝Šî’ę×–Eă”çŽî‚ĚÄ”­—á. ‹ŔęLěCŠÖŞ“ÖŽqC‹TŽRFˆę˜Yi”çjC‘ş“cWˆę˜Yi–k—˘ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[jC‰q“ĄŒői”çj: ‘ć692‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.05.16j, “Ą‘ň.

2479. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘яóáv]‚Ě“dŽqŒ°”÷‹žŠw“IŒŸ“˘. –Ţ—§•˝i’†“ú—FŒđ•a‰@jC‘‘ňŠ˛’ji”çjCŞ–{“TŽqC‹{‘ňŽľ˜Yi“dŒ°ƒZƒ“jCźŽR–Εvi”çj: ‘ć693‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.06.19j, ‰Ą•l.

2480. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j IFN°ƒÁ‚Ş—LŒř‚Ĺ‚ ‚Á‚˝‚­‚ˇ‚Ô‚čŒ^ŹlT×–E”’ŒŒ•a(ATL). ‹{“c‘ŽqCŠÖŞ“ÖŽqC‹´–{–ž•Fi”çjC‹ŕŠŰ“NŽRi‘—§‰Ą{‰ęj: ‘ć693‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.06.19j, ‰Ą•l.

2481. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j OKT4 epitopeŒ‡‘šÇŠłŽŇ‚É‚Ý‚ç‚ę‚˝•s’č‚ȍg”Á. ‘ĺěŽiC“Ą‘ş‹ż’jC‰q“ĄŒői”çj: ‘ć693‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.06.19j, ‰Ą•l.

2482. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Žw• •”‚É”­Ç‚ľ‚˝GlomusŽîá‡. Ä“Ą“T[CŠÖŞ“ÖŽqi”çjCŞ–{EiŠOj: ‘ć695‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.09.18j, ‰Ą•l.

2483. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰E˜•”‚ɐś‚ś‚˝ŽčŒ‘ĺ‚̐üˆŰ“÷Žî. Aź“TŽqC“yˆäŠó•śC‹TŽRFˆę˜Yi”çjC–{‹§i•a—j: ‘ć695‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.09.18j, “Œ‹ž.

2484. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Œ‹ŠjŤdermopanniculitis‚Ě1—á. Œü–ě“NCŠÖŞ“ÖŽqC‹´–{–ž•Fi”çj: ‘ć695‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.09.18j, “Œ‹ž.

2485. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Šç–ĘĽ“Ş•”ˆČŠO‚ɐś‚ś—Տ°f’f‚ލ˘“ď‚Ĺ‚ ‚Á‚˝Šî’ę×–Eă”çŽî|“–‰Č‚É‚¨‚Ż‚éWŒv|. ƒRƒ”ƒ@[ƒ`ĽƒAƒjƒR[CźŽR–Εvi”çj: ‘ć695‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.09.18j, ‰Ą•l.

2486. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –łč÷—ą‹…Ç, ŠĚ‹@”\áŠQ‚𔺂Á‚˝phenytoin–ň]. ŽRŒű‹ž”üCŠÖŞ“ÖŽqi”çj: ‘ć695‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.09.18j, “Œ‹ž.

2487. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “Ş•”–ŹŠÇ“÷Žî‚ĚLAK one-shot“Ž’—Ă–@. Œü–ě“NC‹{“c‘ŽqC‘‘ňŠ˛’ji”çjC‹ŔęLěC’|čLˆę˜Yi•‘ –ěÔ\Žšj: ‘ć105‰ń“ú–{”畆‰ČŠw‰ďŽ­Ž™“‡’n•ű‰ď i93.10.02`03j, Ž­Ž™“‡.

2488. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒPƒtƒ‰[ƒ‹R‚É‚ć‚é”畆”S–ŒŠáÇŒóŒQ. ŽRŒű‹ž”üCŠÖŞ“ÖŽqC‹´–{–ž•Fi”çj: ‘ć696‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.10.16j, “Ą‘ň.

2489. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘ą”­ŤƒŠƒ“ƒp•‚Žî‚ɑ΂ˇ‚鎊‰ĆƒŠƒ“ƒp‹…“Ž’—Ă–@‚ĚŽŽ‚Ý. ‹{“c‘ŽqCŽíˆä—Ç“ńCrěLŽqC‘‘ňŠ˛’ji”çj: ‘ć696‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.10.16j, _“ސě.

2490. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˆŤŤŒŒŠÇ“ŕ”ç×–EŽî(MHE)‚Ě1—á. “Ą“c—T‰îCAź“TŽqC‘‘ňŠ˛’ji”çj: ‘ć696‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.10.16j, ‰Ą•l.

2491. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Microangiopathy‚É‚ć‚éˆęŽí‚̩óg”Á|Buerger•a‚ĆŠÖŒW‚ ‚é‚Š|. Žíˆä—Ç“ńC‹´–{–ž•FC‰q“ĄŒőCźŽR–Εvi”çjC“‡’ÐˇˆęiŠOj: ‘ć697‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.11.20j, “Ą‘ň.

2492. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Ź”͈͊O‰Č“IŘœ‚ĆLAK‹Ç’–@‚Ş‘tŒř‚ľ‚˝“Ş•”ŒŒŠÇ“÷Žî. Ä“Ą“T[C‹´–{–ž•FC‘‘ňŠ˛’ji”çj: ‘ć697‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.11.20j, “Ą‘ň.

2493. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “–‰ČMCTD‚Ě—Ő°“I“Á’Ľ. —´–썲’mŽqC•˝źł_C’ËŒ´“NĆCŠÖŞ“ÖŽqC‰q“ĄŒőCVˆätŽ}CźŽR–Εvi”çj: ‘ć698‰ń“ú–{”畆‰ČŠw‰ď“Œ‹žŒ¤‹†’n•ű‰ď i93.12.18j, “Œ‹ž.

2494. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒqƒgˆŤŤŒŒŠÇ“ŕ”ç×–E‚Ě”|—{Š”Ž÷—§. ‘‘ňŠ˛’jC“Ą“c—T‰îi”çjC•l“c—SŽqiś‰ťŒnjC“Ą‘ş‹ż’jCźŽR–Εvi”çjC÷ˆä”ü“TCŽ›“c‰pŽii‰qśŠw•”j: ‘ć698‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.12.18j, “Œ‹ž.

2495. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒAƒiƒtƒBƒ‰ƒNƒgƒCƒhŽ‡”Á‚É‚¨‚Ż‚é—n˜A‹ŰRŒ´‚ĚŒŸo. ‹´–{–ž•FC“Ą‘ş‹ż’jCźŽR–Εvi”çj: ‘ć698‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.12.18j, “Œ‹ž.

2496. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j …“—‚Ć‘Ńóáv]‚É‚¨‚Ż‚éhŽĺ–Ɖu”˝‰ž‚Ě‘Šˆá. •“cŽüěCÎˆä‹MWi‰qśŠw•”jC“Ą“c—T‰îC“Ą‘ş‹ż’jC‘‘ňŠ˛’ji”çj: ‘ć698‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.12.18j, “Œ‹ž.

2497. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Focal dermal hypoplasia (Goltz). •ÄŒłN‘ C‹ß“ĄŽ •vi”çj: ‘ć699‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i94.01.22j, ‰Ą•l.

2498. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “–‰Č10”NŠÔ‚É‚¨‚Ż‚éBowen•a‚̏WŒv. ƒRƒ”ƒ@[ƒ`ĽƒAƒjƒR[C•ÄŒłN‘ CźŽR–ΕvCŸ‰ŞŒ›śi”çj: ‘ć699‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i94.01.22j, ‰Ą•l.

2499. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j •˛áŽ‚Ě•Ç‚ć‚č”­ś‚ľ‚˝—Lž™×–EŠŕ. ŽRŒű‹ž”üC•˝źł_C‰q“ĄŒői”çj: ‘ć699‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i94.01.22j, ‰Ą•l.

2500. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Bullous lichen planus. ’ž‘—YCě–ź˝Žii”çj: ‘ć699‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i94.01.22j, “Œ‹ž.

2501. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ’˜–ž‚Ȋ֐߉Š‚𔺂Á‚˝”畆ƒAƒŒƒ‹ƒM[ŤŒŒŠÇ‰Š. Aź“TŽqC‹g‘ňł_C“yˆäŠó•śC‹TŽRFˆę˜Yi”çj: ‘ć699‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i94.01.22j, “Œ‹ž.

2502. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒŠƒ“ƒpŠÇ“÷Žî‚Ş‹^‚í‚ę‚é“Ş•”–ŹŠÇ“÷Žî‚Ě1Ç—á. Œü–ě“NCŽRŒű‹ž”üC’ËŒ´“NĆC‘‘ňŠ˛’ji”çj: ‘ć699‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i94.01.22j, “Œ‹ž.

2503. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j —؏ó–ѕŠp‰ťÇi“y”ěj. ‹g‘ňł_C•ÄŒłN‘ CźŽR–Εvi”çj: ‘ć288‰ń“ú–{”畆‰ČŠw‰ď•Ÿ‰Ş’n•ű‰ď i94.02.19j, •Ÿ‰Ş.

2504. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Á‰ťŠÇúE‚É‚ÄŽ€–S‚ľ‚˝Wissler-FanconiÇŒóŒQ. Ä“Ą“T[C’ËŒ´“NĆC‹´–{–ž•FC‰q“ĄŒőCźŽR–Εvi”çjCÎěŽçCrěä•vi“ŕj: ‘ć57‰ń“ú–{”畆‰ČŠw‰ď“Œ‹žŽx•”Šwp‘ĺ‰ď i94.02.27j, “Œ‹ž.

2505. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Žîᇃ}[ƒJ[‚Ć‚ľ‚Ä‚Ě‘Á‰t‘BLFA-1—lRŒ´‚Ě—L—pŤ. ‹´–{–ž•FC“Ą‘ş‹ż’jC‘‘ňŠ˛’jCźŽR–Εvi”çjCŽR“c—şi‹v—Ż•Ä‘ĺj: ‘ć700‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i94.03.19j, “Œ‹ž.

2506. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˆÝŠŕ‚É”ş‚Á‚˝acanthosis nigricans. —´–썲’mŽqC’ËŒ´“NĆC•ÄŒłN‘ i”çj: ‘ć187‰ń“ú–{”畆‰ČŠw‰ď“ŒŠC’n•ű‰ď i94.03.20j, Šň•Œ.

2507. mŒ¤‹†‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘яóáv]‚Ě“dŽqŒ°”÷‹ž“IŒ¤‹†. –Ţ—§•˝i’†“ú—FŒđ•a‰@jC‘‘ňŠ˛’ji”çjCŞ–{“TŽqC‹{‘ňŽľ˜Yi“dŒ°ƒZƒ“jCźŽR–Εvi”çj: ‘ć2‰ń‘ŰˆăŠwĽś•¨Šw“dŽqŒ°”÷‹žƒVƒ“ƒ|ƒWƒEƒ€ i93.09.16j, –k‹ž.

2508. mŒ¤‹†‰ďi‘S‘jn i“Á•Ęu‰‰j “–Ž{Ý‚ĚŽĄ—Ă•űj-SLE-. ‰q“ĄŒői”çj: ‘ć8‰ńäPŒ´•aŒ¤‹†‰ď i94.01.28j, ‹{č.

2509. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j –{‘ԐŤŹ‡Œ^ƒNƒŠƒIƒOƒƒuƒŠƒ“ŒŒÇ. ‹g‘ňł_C—´–썲’mŽqC‹´–{–ž•Fi”çj: ‘ć17‰ń”畆–ŹŠÇ§˜b‰ď i94.01.27j, ‹{č.

2510. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰ČMCTD‚̏WŒv. —´–썲’mŽqC•˝źł_C’ËŒ´“NĆCŠÖŞ“ÖŽqC‰q“ĄŒőCVˆätŽ}CźŽR–Εvi”çj: ‘ć8‰ńäPŒ´•aŒ¤‹†‰ď i94.01.28j, ‹{č.

2511. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒAƒiƒtƒBƒ‰ƒNƒgƒCƒhŽ‡”Á‚Ě3—áiŹŽ™—á, ˜Vl—á, ŠĚŽžŠł‚É”ş‚¤—áj. “V–ě—˛•śC‹´–{–ž•FC‘‘ňŠ˛’jCźŽR–Εvi”çj: ‘ć2‰ń‰ß•qŤŒŒŠÇ‰ŠŹˆĎˆő‰ď i94.02.25j, “Œ‹ž.

2512. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j D’†‹…‚É‚ć‚é”畆”÷ŹŒŒŠÇ“ŕ”ç×–E”—ŁŠQ. ‘‘ňŠ˛’jC“V–ě—˛•śC“Ą‘ş‹ż’jCźŽR–Εvi”çj: ŒúśČ“Á’莞Šł“ŤŒŒŠÇ‰Š’˛¸Œ¤‹†”Ç•˝Ź5”N“x‘ć‚Q‰ń‘‰ď i94.02.25`26j, “Œ‹ž.

2513. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒAƒiƒtƒBƒ‰ƒNƒgƒCƒhŽ‡”Á‚É‚¨‚Ż‚é—n˜A‹ŰRŒ´‚ĚŒŸo. ‹´–{–ž•FC“Ą‘ş‹ż’jC‘‘ňŠ˛’jCźŽR–Εvi”çj: ŒúśČ“Á’莞Šł“ŤŒŒŠÇ‰Š’˛¸Œ¤‹†”Ç•˝Ź5”N“x‘ć‚Q‰ń‘‰ď i94.02.25`26j, “Œ‹ž.

2514. mŒ¤‹†‰ďi’n•űjn i‹L”Ou‰‰j ”畆ŽžŠł‚É‚¨‚Ż‚éƒXƒeƒƒCƒhŠO—pÜ‚ɂ‚˘‚Ä. •ÄŒłN‘ i”çj: OTCƒ}ƒ‹ƒ`ƒZƒ~ƒi[ i93.04.07j, Œú–Ř.

2515. mŒ¤‹†‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰ŠÇ×–E‚É‚ć‚é”畆”÷ŹŒŒŠÇ“ŕ”ç×–EáŠQ. ‘‘ňŠ˛’ji”çj: ‘ć8‰ń”畆ś•¨Ľś‰ťĽś—‘ĺăƒJƒ“ƒtƒ@ƒŒƒ“ƒX i93.07.31`08.01j, ŽOd.

2516. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j —ź‰şŽˆŘ’f‚ÉŽŠ‚Á‚˝Buerger•a‚Ě1—á. ˛“Ą’źĆCŠÖŞ“ÖŽqC‹´–{–ž•FC‘‘ňŠ˛’ji”çjCŞ–{EiŠOj: ‘ć696‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď i93.10.16j, “Œ‹ž.


<<22 ”ĺ”AŠí‰ČŠw>>

2517. mŒ´’˜n Optinal number of dialysate exchanges in automated peritoneal dialysis. ŒF–ě˜a—Yi”ĺjCŽR‰ş–ž‘ׁi‹ăBH‹Ć‘ĺjCŽđˆä‹Ši”ĺj: Adv. Perit. Dial., 9: 110`113, 1993.

2518. mŒ´’˜n The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. ‘ĺ–x—i”ĺjCScardino, P.T.CLapin, S.L.CSeale-Hawkins, C.CLink. J.CWheeler, T.M.iƒxƒCƒ‰[ˆă‰Č‘ĺj: Am. J. surg. Pathol., 17(12): 1252`1261, 1993.

2519. mŒ´’˜n Infrequent involement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer. “ŕ“c–Lşi”ĺjC˜a“c’m‰vi—Ő•a—jCÝŠy•q–çC‰oěWCŹŽÄŒ’i”ĺ: Br. J. Cancer., 68: 751`755, 1993.

2520. mŒ´’˜n Ultrasonic detection of non-palpable seminal vesicle invasion; A clinicopathologic study. ‘ĺ–x—CŽÂŒ´Žli”ĺjCWheller, T.M.CWessels, E.C.iƒxƒCƒ‰[ˆă‰Č‘ĺjC‘ŠŒ´łOi”ĺj: Br. J. Urol., 72: 799`808, 1993.

2521. mŒ´’˜n Delayed presentation of ureteric injury following arthrodesis of the hip joint. ‰oěWC‰–ě‰pŽjC“ŕ“c–LşC^‰şß•vCŹŽÄŒ’i”ĺj: Br. J. Urol., 73: 212`213, 1994.

2522. mŒ´’˜n Detection of microscopic extracapsular extension prior to radical prostatectomy for clinically localized prostate cancer. ‘ĺ–x—C‰oěWCŽÂŒ´Žli”ĺjCWheeler, T.M.CScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: J. Urol.

2523. mŒ´’˜n Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma. “ŕ“c–Lşi”ĺjC˜a“c’m‰vi—Ő•a—jCÝŠy•q–çC‰oěWC^‰şß•vCŹŽÄŒ’i”ĺj: J. Urol., 150: 1298`1301, 1993.

2524. mŒ´’˜n Malignant fibrous histiocytoma of the bladder with focal rhabdoid tumor differentiation. ‰oěWC“ŕ“c–LşCŹŽÄŒ’i”ĺjC‰Á‰ę“c–LCŠâŸşŒ[ˆęi•a—j: J. Urol., 151: 154`156, 1994.

2525. mŒ´’˜n Do cytokine-inducing substances penetrate through dialysis membranes and stimulate monocytes?. ŒF–ě˜a—YC‰Ą“c^“ńi”ĺjC“ě•”łlitƒZƒ“jCŽđˆä‹Ši”ĺj: Kidney Int., 43(Suppl.41): 205`208, 1993.

2526. mŒ´’˜n Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate. Thompson, T.C.CTimme, T.L.CKadmon, D.CPark, S.H.C‰oěWC‹g“cˆęŹi”ĺj: Mol. Carc., 7: 165`179, 1993.

2527. mŒ´’˜n Urea kinetics and clinical features long-term CAPD patients. ŒF–ě˜a—YC‚–Ř—TC‰Ą“c^“ńCŽu‘ş“NCŽđˆä‹Ši”ĺj: Perit. Dial. Int., 13(2): 180`182, 1993.

2528. mŒ´’˜n Minimizing the drainage period for continuous ambulatory peritoneal dialysis. ŒF–ě˜a—YC‰Ą“c^“ńCŽđˆä‹Ši”ĺj: Perit. Dial. Int., 14: 52`55, 1994.

2529. mŒ´’˜n The pathologic features and DNA ploidy value of prostate cancer detectable by sonography and by palpation. ‘ĺ–x—i”ĺjCWheeler, T.M.CGreene, D.R.CScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: Prostate, 23(4): 271`281, 1993.

2530. mŒ´’˜n Nodules resembling nodular hyperplasia in the peripheral zone of the prostare gland. ‘ĺ–x—C‰oěWi”ĺjCWheeler,T.M.: Urologic Pathology.

2531. mŒ´’˜n ‰ˇ‘jŒŒt‚Ě’Pƒ—â‹p•Ű‘ś‚É‚¨‚Ż‚é—L‹@ƒQƒ‹ƒ}ƒjƒEƒ€(Ge132)‚ĚŒř‰Ę. ^č‹`•FiŽŔ“ŽŒnjCŒF–ě˜a—YC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: ˆÚA, 28(3): 278`286, 1993.

2532. mŒ´’˜n V‚ľ‚˘t•Ű‘ś‰t‚Ě‘gŹ‚ÉŠÖ‚ˇ‚éŠî‘b“IŒ¤‹†. ^č‹`•FiŽŔ“ŽŒnjCŒF–ě˜a—YC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: Ą“ú‚ĚˆÚA, 7(2): 171, 1994.

2533. mŒ´’˜n Extracorporeal pulsatile peritoneal dialysis (EPPD)‚ĚŽŔŒą“IŒ¤‹†. ŒF–ě˜a—Yi”ĺjCŽR‰ş–ž‘ׁi‹ăBH‘ĺjCŽđˆä‹Ši”ĺj: lH‘ŸŠí, 23(2): 367`370, 1994.

2534. mŒ´’˜n ŽGŽíŒ˘‚Ě“ŕ‘Ÿ•\–Ę‚É‚¨‚Ż‚é• –Œ•¨ŽżˆÚ“Ž‘Ź“x‚Ě‘Ş’č. ŽR‰ş–ž‘ׁi‹ăBH‘ĺjCŒF–ě˜a—YCŽđˆä‹Ši”ĺjC’†źŒőiňHˆă‰Č‘ĺjCJ.W. MoncriefCR.P. PopovichiAcorn Research Laboratoryj: lH‘ŸŠí, 23(2): 371`374, 1994.

2535. mŒ´’˜n Œo’ź’°“I‘O—§‘B’´‰š”g–@‚É‚ć‚é Stage A ‘O—§‘BŠŕ‚Ĺ‚ĚŽc‘śŠŕŒŸo”\‚ĚŒŸ“˘. ‰oěWi”ĺjCËß°Ŕ° T. ˝śŮĂި°É (Í޲װˆă‰Č‘ĺ)C“ŕ“c–LşC^‰şß•vi”ĺj: “ú–{‰ć‘œˆăŠwŽGŽ, 12: 97`101, 1993.

2536. mŒ´’˜n Continuous ambulatory peritoneal dialysisŠłŽŇ‚É‚¨‚Ż‚é‰h—{Šw“IŒŸ“˘. ŒF–ě˜a—YC‚–Ř—TC‰Ą“c^“ńCŽđˆä‹ŠC÷ˆäŒ’ŽĄi”ĺj: “ú–{“§Í—Ă–@Šw‰ďŽGŽ, 26(4): 497`502, 1993.

2537. mŒ´’˜n CAPD‚É‚¨‚Ż‚鎝‘ąŤ‚Ü‚˝‚͍Ĕ­Ť• –Œ‰Š‚ɑ΂ˇ‚éˆęŠú“IƒJƒe[ƒeƒ‹ŒđŠˇ. ŒF–ě˜a—YCŽu‘ş“NC‰Ą“c^“ńCŽđˆä‹Ši”ĺjC–kžŠ‚Ý‚Ç‚čC”э‚Šě‹v—YiŽ™j: “ú–{“§Í—Ă–@Šw‰ďŽGŽ, 26(5): 657`661, 1993.

2538. mŒ´’˜n ŒŒ‰t“§Í‚¨‚ć‚ŃCAPDŠłŽŇ‚É‚¨‚Ż‚é—°Ž_ƒCƒZƒpƒ}ƒCƒVƒ“‚Ě–ň•¨“Ž‘Ԃɂ‚˘‚Ä. ŒŕŠ˛ƒCŒF–ě˜a—YCŽđˆä‹Ši”ĺjC•ě­ˆęC–Ř‘ş—˜”üC’Š’ˇ•ś–íi–ňÜj: “ú–{“§Í—Ă–@Šw‰ďŽGŽ, 26(7): 1299`1303, 1993.

2539. mŒ´’˜n CAPDŠłŽŇ‚Ě• –ŒŒŔŠOŕh‰ß“Ž‘ԁ|Œo–Ń×ŒŒŠÇŒŔŠOŕh‰ß”\‚¨‚ć‚ŃƒŠƒ“ƒp‹zŽű”\‚ɂ‚˘‚ā|. ŒF–ě˜a—YCŽu‘ş“NC‚–Ř—TC‰Ą“c^“ńCŽđˆä‹Ši”ĺj: “ú–{“§Í—Ă–@Šw‰ďŽGŽ, 26(8): 1387`1392, 1993.

2540. mŒ´’˜n Endotoxin fragments‚ ‚邢‚Ícytokine-inducing substances‚Ěhigh flux–Œƒ_ƒCƒAƒ‰ƒCƒU[’ʉ߂Ɋւˇ‚éŠî‘b“IŒ¤‹†. ‰Ą“c^“ńCŒF–ě˜a—YCŽđˆä‹Ši”ĺjC“ě•”łlitƒZƒ“j: “ú–{“§Í—Ă–@Šw‰ďŽGŽ, 26(9): 1475`1482, 1993.

2541. mŒ´’˜n RƒÁ-Senimoproteinƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ě‚É‚ć‚é‘O—§‘B‘gD‚̖Ɖu‘gD‰ťŠw“IŒŸ“˘; ‘O—§‘B”ě‘ĺÇ, ‘O—§‘BŠŕ“]ˆÚ‘ƒ, ‚¨‚ć‚Ń‘BŠŕˆČŠO‚Ě‘O—§‘BŽîᇂɂ‚˘‚Ä‚ĚŒŸ“˘. “Ą–ě’WlCŽu‘ş“NC‘şŽR‰ëˆęCÂ‹PşC‰ĄŽR‰p“ńC^‰şß•vCÎ‹´WCŹŽÄŒ’i”ĺjCŒK”ö’čmi•a—j: “ú–{”ĺ”AŠí‰ČŠw‰ďŽGŽ, 84(3): 527`534, 1993.

2542. mŒ´’˜n RƒÁ-Senimoproteinƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ě‚É‚ć‚é‘O—§‘B‘gD‚̖Ɖu‘gD‰ťŠw“IŒŸ“˘; ‘O—§‘BŠŕ‘gD‚É‚¨‚Ż‚é•Ş‰ť“x–ƉuőF‘Ô“x‚Ć‚Ě‘ŠŠÖŤ‚ɂ‚˘‚Ä. “Ą–ě’WlCÎ“c—T‘ĽC‘ĺ–x—C‘vŹ_Cź‘ş´ŽuC‰““Ą’‰—YCŹŽÄŒ’i”ĺjCŒK”ö’čmi•a—j: “ú–{”ĺ”AŠí‰ČŠw‰ďŽGŽ, 84(4): 720`728, 1993.

2543. mŒ´’˜n Œo”A“š“I‘O—§‘BŘœp(TURP)2,266—á‚Ě—Ő°“IŒŸ“˘. “ŕ“c–LşC‘Ť—§Œ÷ˆęCÂ‹PşC“Ą–ě’WlC‰ĄŽR‰p“ńCŹ–““ń–çC‹g‘ňˆę•FC•ěƒC–ĺ˜e˜abCŻŽi´ŽuC^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: “ú–{”ĺ”AŠí‰ČŠw‰ďŽGŽ, 84(5): 890`896, 1993.

2544. mŒ´’˜n Œo”A“š“I‘O—§‘BŘœpiTURP)2,266—á‚É‚¨‚Ż‚ép‘OĽp’†ĽpŒă‡•šÇ‚Ć‚ť‚Ě‘Îô. “ŕ“c–LşC‘Ť—§Œ÷ˆęCÂ‹PşC“Ą–ě’WlCŹ–““ń–çC‹g‘ňˆę•FC•ěƒC–ĺ˜e˜abCŻŽi´ŽuC‰ĄŽR‰p“ńC^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: “ú–{”ĺ”AŠí‰ČŠw‰ďŽGŽ, 84(5): 897`905, 1993.

2545. mŒ´’˜n Œo”A“š“I‘O—§‘BŘœp(TUR-P)Œă‚É”­ŒŠ‚ł‚ę‚˝‘O—§‘B‹ô”­Šŕ‚Ě—\Œă. “ŕ“c–LşCŒŕŠ˛ƒCŒüˆäLĆC‰oěWCÂ‹Pşi”ĺjCŒK”ö’čmi•a—jC‰ĄŽR‰p“ńC^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: “ú–{”ĺ”AŠí‰ČŠw‰ďŽGŽ, 84(7): 1293`1300, 1993.

2546. mŒ´’˜n Continent Appendix Stone‚ĚŽčpŒoŒą. Â‹PşC“ŕ“c–LşC‰ĄŽR‰p“ńCŒüˆäLĆC‘vŹ_Cź‘ş´ŽuC“Ą–ě’WlCŹŽÄŒ’i”ĺj: “ú–{”ĺ”AŠí‰ČŠw‰ďŽGŽ, 84(8): 1404`1410, 1993.

2547. mŒ´’˜n ‘O—§‘BŠŕ•aŠúf’f‚É‚¨‚Ż‚éŠeŽí‰ć‘œf’f–@‚Ě—L—pŤ‚ĆŒŔŠE. ‰oěWCěă’B‰›i”ĺjCźŠŞ”ŽCŒK”ö’čmi•a—jC“ŕ“c–LşC‰ĄŽR‰p“ńC^‰şß•vCŹŽÄŒ’i”ĺj: “ú–{”ĺ”AŠí‰ČŠw‰ďŽGŽ.

2548. mŒ´’˜n •\ÝŤäNă÷Šŕ‚ɑ΂ˇ‚éTUR-BtŒă‚ĚÄ”­–hŽ~‚ÉŠÖ‚ˇ‚錟“˘. Â‹PşC“ŕ“c–LşC‰ĄŽR‰p“ńCěă’B‰›C‘Ť—§Œ÷ˆęC^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: ”ĺ”A‹I—v, 39: 987`991, 1993.

2549. mŒ´’˜n ƒk[ƒhƒ}ƒEƒX‰ÂˆÚAŤLNCaPŽîᇂɑ΂ˇ‚鍂ƒGƒlƒ‹ƒM[“dŽqüĆŽË‚ɂ‚˘‚Ä‚ĚŠî‘b“IŒŸ“˘. “Ą–ě’WlC{ŽRˆę•äC‰F“s‹{‘ńŽĄC‰oěWC‰ĄŽR‰p“ńC^‰şß•vCÎ‹´Wi”ĺjC‘ž“cŒ°ŹC‚Œ´ÄCź—Ń—˛i•újCŒK”ö’čmi•a—j: –k—˘ˆăŠw, 23(2): 113`120, 1993.

2550. mŒ´’˜n ƒqƒg‘O—§‘B‚É“ÁˆŮ“I‚Č“œ’`”’‚đŽYś‚ˇ‚éƒk[ƒhƒ}ƒEƒX‰ÂˆÚAŤ‘O—§‘BŽîᇂ̌Ÿ“˘; LNCaPŽîᇂ𒆐S‚É. “Ą–ě’WlCŒĂ”¨˝”VCŠŰ“T•vCŒ´–ě—TŽiCÂ‹PşC“ŕ“c–LşCŹŽÄŒ’i”ĺjCŒĂŠÚęˆęiŽŔ“ŽjCŒK”ö’čmi•a—j: –k—˘ˆăŠw, 23(3): 194`200, 1993.

2551. mŒ´’˜n Immunohistochemical study with a monoclonal antibody againt ƒÁ seminoprotein for identification of bone metastasis from adenocarcinoma of the prostate. “Ą–ě’WlCŒĂ”¨˝”VC’|ěŸŽĄi”ĺjCŒK”ö’čmi•a—jC‰Ą“c^“ńC—›Šż‰hCÎ‹´Wi”ĺj: –k—˘ˆăŠw, 23(6): 417`423, 1993.

2552. mŒ´’˜n • o‹ž‰ş¸őĂ–ŹáŽŽčp‚ĚŒoŒą. Â‹PşC‘ş–{ŤrC‹y”\‹v—˛CˆÉ“ĄŒ[ˆęC{ŽRˆę•äCÝŠy•q–çC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: –k—˘ˆăŠw, 23: 330`333, 1993.

2553. mŒ´’˜n • o‹ž‰şt“Eœp‚ĚŒoŒą. Â‹PşC{ŽRˆę•äCŒĂ”¨˝”VC{ŽRo•äC“ŕ“c–LşC‰ĄŽR‰p“ńC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: –k—˘ˆăŠw, 23: 334`338, 1993.

2554. mŒ´’˜n • o‹ž‰şt“Eœp‚Ě‚S—á. Â‹PşC‰““Ą’‰—YC{ŽRo•äCŒ´–ě—TŽiC‰F“s‹{‘ńŽĄC“ŕ“c–LşC‰ĄŽR‰p“ńCŹŽÄŒ’i”ĺj: —Տ°”ĺ”AŠí‰Č, 47(11): 833`836, 1993.

2555. mŒ´’˜n ‹zˆřŠÇ‚đ—˜—p‚ľ‚˝ˆŔ‘S‚ĹŒř‰Ę“I‚ČƒŠƒ“ƒpŠf´p. ‰oěWC“ŕ“c–Lşi”ĺj: —Տ°”ĺ”AŠí‰Č, 47: 347`, 1993.

2556. m€Œ´’˜n ƒŠƒAƒ‹ƒ^ƒCƒ€‹¤Ĺ“_Œ^ƒŒ[ƒU[Œ°”÷‹ž‚É‚ć‚錌”A‚ĚŠÓ•Ę. •ş“Ą“§i”ĺj: ‘ć13‰ń“ú–{ƒŒ[ƒU[ˆăŠw‰ď‘ĺ‰ď‘ĺ‰ď˜_•śW, p.93`96, 1992.

2557. m’Z•ńn ’Sƒqƒg‘O—§‘B‘BŽîƒk[ƒhƒ}ƒEƒX‚É‚¨‚Ż‚é125‚h•WŽŻRƒKƒ“ƒ}[ƒvƒƒeƒCƒ“ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ě‚Ě‘Ě“ŕ“Ž‘Ô. “Ą–ě’Wli”ĺj: ŠjˆăŠw, 30(7): 795`798, 1993.

2558. mŒ¤‹†•ńn DIP‚É‚¨‚Ż‚é”ńƒCƒIƒ“Ť’áZ“§ˆłŤƒˆ[ƒh‘˘‰eÜIomeprol(E7337)‚Ě—Ő°“I—L—pŤ. ’Ź“c–L•˝C‘ĺÎK•FCó–ěWŽiCŽO–ؐ˝C“Č–{^liŽœŒbˆă‘ĺjŹŽÄŒ’C^‰şß•vCŒŕŠ˛ƒi”ĺj: Prog. Med., 13(Suppl.1): 307`317, 1993.

2559. mŒ¤‹†•ńiŒúśČjn ’ˇŠú—\Œă’ÇŐ‚ĚŒťó‚Ć–â‘č“_‚ĚŒŸ“˘. Žđˆä‹Ši”ĺjC‘qŽR‰pşi‘—§—Ă—{Šç—t“Œ•a‰@jC‚‹´š—˘iĂ‰ŞŒ§—§‚ą‚Ç‚ŕ•a‰@jC•x‘ňCˆęi‘—§—Ă—{ŠVŠƒ•a‰@jC•OŒ´—Di‘—§˛‘q•a‰@jCŹo‰ŔŽO i’é‹ž‘ĺj: •˝Ź‚S”N“xŒúś‰ČŠwŒ¤‹†t•s‘Sˆă—ĂŒ¤‹†Ž–‹ĆŒ¤‹†•ń‘, p.253`256, 1993.

2560. mŒ¤‹†•ńiŒúśČjn _“ŢěŒ§‚ĚŠwZŒŸ”A‚ĆŽ–ŒăŠÇ—ƒVƒXƒeƒ€”ť’čˆĎˆő‰ď•űŽŽ‚Ě—L—pŤ‚ɂ‚˘‚Ä. Žđˆä‹Ši”ĺj: •˝Ź‚S”N“xŒúś‰ČŠwŒ¤‹†t•s‘Sˆă—ĂŒ¤‹†Ž–‹ĆŒ¤‹†•ń‘, p.257`261, 1993.

2561. mŒ¤‹†•ńiŒúśČjn tˆÚA‚Ě“K‰ž.“K‡‚ĆŽŔŽ{‘̐§‚ÉŠÖ‚ˇ‚錤‹†. •ě´i“Œ‘ĺjCÎ‹´“š’jiă‘ĺjC‘ĺ’؏CiŒŐƒm–ĺ•a‰@jC”Œ´‰p•Fi‘—§˛‘q•a‰@jCŽđˆä‹Ši”ĺjCâˆä—Ú”üiZ‹gě•a‰@jCŽÂ“cëi‹ŕ‘ňˆă‘ĺjC‚–Ř Oi–ź‘ĺjC“cŒűŠě—Yi“Œ–k‘ĺjCŽ›‰ŞŒdi“Œ—ˆă‘ĺjC’ˇ‘ňr•FiˆÇ—Ń‘ĺjC•ĘŠD•śi“Œ‘ĺjC—źŠpš ’ji–ź‘ĺj: •˝Ź‚S”N“xŒúś‰ČŠwŒ¤‹†”ď‘ŸŠí‹ZpŒ¤‹†ŠJ”­Ž–‹ĆŒ¤‹†•ń‘, p.92`101, 1993.


<<22 2 ”ĺ”AŠí‰ČŠw>>

2562. mÇ—á•ńn Emphysematous pyelonephritis,ureteritis,and cystitis in a diabetic patient. ‰oěWC‰F“s‹{‘ńŽĄC“ŕ“c–LşC^‰şß•vCŹŽÄŒ’i”ĺj: Urologia Int.

2563. mÇ—á•ńn Œ´”­Ťtᱏă”ç“ŕŠŕ‚Ě‚P—á. “ŕ“c–LşCÎ“c—T‘ĽC{ŽRˆę•äCěă’B‰›Cź‘ş´ŽuC‰oěWC^‰şß•vCŹŽÄŒ’i”ĺj: ź“ú”ĺ”AŠí‰Č, 55: 1651`1653, 1993.

2564. mÇ—á•ńn ‘O—§‘B”ě‘ĺÇpŒă”AŽ¸‹Ö‚ĚŽĄŒą—á. Î‹´Wi”ĺj: ‘˝ŠíŠŻáŠQ‚ĚŠż•űŽĄ—Ă, p.94`95, 1993.

2565. mÇ—á•ńn –Ťt•s‘SŠłŽŇ‚É”­ś‚ľ‚˝äNă÷Žîᇂ̂Q—á. “ŕ“c–LşC’|ěŸŽĄCŹ–““ń–çCŒüˆäLĆC‰oěWC^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: ”ĺ”A‹I—v, 39: 1167`1170, 1993.

2566. mÇ—á•ńn ’Pt‚É”­ś‚ľ‚˝tᱎîᇂɑ΂ľ‚Đt•Ű‘śŽčpŒăBCGtáą“ŕ’“ü—Ă–@‚đs‚Á‚˝‚P—á. Â‹PşC‰““Ą’‰—YC‰–ě‰pŽjCŽu‘ş“NC‘Ť—§Œ÷ˆęCŹŽÄŒ’i”ĺj: ”ĺ”A‹I—v, 39: 463`465, 1993.

2567. mÇ—á•ńn t Oncocytoma ‚Ě‚P—á. ‘ş–{ŤrC“ŕ“c–LşC‹y”\‹v—˛CÎ“c—T‘ĽC‰F“s‹{‘ńŽĄC‰oěWC^‰şß•vCŹŽÄŒ’i”ĺj: ”ĺ”A‹I—v, 40: 47`50, 1994.

2568. mÇ—á•ńn MEP—Ă–@iMethotrexate, Etoposide, Cisplatinj‚É‚ÄˆęŽž“IŠ°‰đ‚Ě‚Ś‚ç‚ę‚˝, ‘O—§‘B•˝ŠŠ‹Ř“÷Žî‚Ě‚P—á. ‘vŹ_C“ŕ“c–LşCŒüˆäLĆC˜ZŠpŽüCŹŽÄŒ’i”ĺj: ”ĺ”A‹I—v, 40: 83`85, 1994.

2569. mÇ—á•ńn ”A×–Ef‚É‚ć‚č”­ŒŠ‚ľ“ž‚˝”A˜Hă”çŠŕ‚Ě2—á. Î“c—T‘ĽC“ŕ“c–LşCŒüˆäLĆCź‘ş´ŽuC^‰şß•vCŹŽÄŒ’i”ĺjCŒK”ö’čmi•a—jC‘ĺ–ě‰pŽĄi•a‰@•a—j: –k—˘ˆăŠw, 23: 201`204, 1993.

2570. mÇ—á•ńn ‰ş‘ĺĂ–ŹŽîᇌŒđ‚Ě‹U—zŤ‰ć‘œ‚đŽŚ‚ľ‚˝‚QÇ—á. Žu‘ş“NC‰oěWCŠŰ“T•vC“ŕ“c–LşCŹŽÄŒ’i”ĺj: —Տ°”ĺ”AŠí‰ČC47(9): 697`699, 1993.

2571. m—Տ°ŽĄŒąn ŹŽ™•Ű‘śŠú–Ťt•s‘SŠłŽ™‚̐tŤ•nŒŒ‚ɑ΂ˇ‚éKRN5702‚̔牺“Š—^‚Ě—Ő°ŒŸ“˘. ˆÉ“ĄŽŒČi“Œ—ˆă‘ĺjC–kěĆ’ji“ú‘ĺjCŽđˆä‹Ši”ĺjC–îč—Y•Fi“Ą“c•ŰŒ’‰qś‘ĺjCˆÉ“ĄdŒőiŽĐ‰ď•ŰŒŻ’†‹ž•a‰@jC‰Ş“c•q•vi•xŽRˆăŽ•‘ĺjC–q~i‹ß ‘ĺjC˜a“c”Ž‹`i•şŒÉˆă‘ĺjC”э‚Šě‹v—YiŽ™jC”’”ŻGŽiiç—tŒ§‚ą‚Ç‚ŕ•a‰@jCŹźNGi“Œ—ˆă‘ĺj: ŹŽ™‰Č—Տ°, 46(7): 1613`1628, 1993.

2572. m—Տ°ŽĄŒąn 90‹•ÎŒőƒŒ[ƒU[ƒtƒ@ƒCƒo[(Urolase R)‚É‚ć‚éŒo”A“š“I‘O—§‘BŘœp(VLAP)‚ĚŽĄ—ÐŹŃ. “ŕ“c–LşCŒ´–ě—TŽiC{ŽRˆę•äCź‘ş´ŽuCÂ‹PşC“Ą–ě’WlC‰ĄŽR‰p“ńC^‰şß•vC‰““Ą’‰—Y(”ĺ)Ca’J@‘Ľi‘—§‰Ą•ljCŹŽÄŒ’i”ĺj: ”ĺ”AŠíŠO‰Č, 6(8): 771`781, 1993.

2573. m—Տ°ŽĄŒąn ‚Z“§ˆłCAPD• –Œ“§Í‰t(CAPD-460)‚Ě—Ő°•]‰ż‚ÉŠÖ‚ˇ‚錟“˘|‘˝Ž{Ý—Տ°ŽŽŒąŹŃ|. ”g‘˝–ě“šMC‚‹´iC“Ţ‘q—EŽ˘C‰Ş“cˆę‹`i“ú‘ĺjC•˝‘ň—R•˝CŽđˆäMŽĄiVŠƒŽsŽĐ‰ďŽ–‹Ć‹Ś‰ďMŠy‰€•a‰@jCˆé“c˜a—YCŒäŽčô“N–çié‹Ęˆă‘ĺjC‘ž“c˜a•vC ’ˇŔMŽĄi“Œ—ˆă‘ĺjCź“cŽĄi•‘ –ěÔ\Žš•a‰@jCŽđˆä‹ŠCŒF–ě˜a—Yi”ĺjC‹gŽR’źŽ÷C÷ˆärˆę˜NiŽĐ‰ď•ŰŒŻŽO“‡•a‰@jC‰ş‘şˆŽiŒ§ź•”•lźˆă—ĂƒZƒ“ ƒ^[jC“V–ěňiŽĐ‰ď•ŰŒŻ’†‹ž•a‰@jCŽRěáÁCă‘q–Ż_im^‰ď”’ë•a‰@jCŽR–ŘŒË“š˜YC—Š‰Ş“żÝiL‘ĺjCěźGŽ÷i‚ ‚Š‚ˉď“y’J‘‡•a‰@jC—Ń“cd şC“ߐ{—_liŽĐ‰ď•ŰŒŻ“żŽR’†‰›•a‰@jCŔ“c–ži‚źÔ\Žš•a‰@jC‡‰Ž’‰MC’†–{‰ë•FiĎś‰ď”Ş”Ś‘‡•a‰@jCź‘şŠwi–ƒś”Ń’Ë•a‰@jC˛“Ą—˛iŒĂ‰ę•a ‰@jCŒ´“cFŽiCŒ´k•˝CÖ“Ą‘ׁCź‰Ž•Ÿ‘ i’ˇč‘ĺj: –ň—‚ĆŽĄ—Ă, 22(2): 311`328, 1994.

2574. m‘ŕn lH”A“šŠ‡–ń‹Ř‚É‚ć‚é”AŽ¸‹Ö‚ĚŽĄ—Ă. “Ą–ě’WlC“ŕ“c–LşCŹŽÄŒ’i”ĺj: Clinical Engineering, 4(11): 825`831, 1993.

2575. m‘ŕn ‘O—§‘B”ě‘ĺÇ‚Ć‘O—§‘BŠŕ, äNă÷Œz•”d‰ťÇ‚̊ӕʐf’f. “Ą–ě’WlCŹŽÄŒ’i”ĺj: Dysuria, 1(1): 12`16, 1993.

2576. m‘ŕn ƒRƒ‰[ƒQƒ“’“ü—Ă–@. ‰ĄŽR‰p“ńC“ŕ“c–Lşi”ĺj: Gerontology, 6: 178`183, 1994.

2577. m‘ŕn Œ’N‘Š’kŽş|–ŒŤtÇ‚Ɛf’f‚ł‚ę‚˝|. Žđˆä‹Ši”ĺj: ‚ˇ‚ą‚â‚Šƒtƒ@ƒ~ƒŠ[, (301): 25, 1994.

2578. m‘ŕn ƒUĽć’[ˆă—Á|lH”A“šŠ‡–ń‹Ř‚đ—p‚˘‚˝”AŽ¸‹Ö‚ĚŽĄ—Ă. “Ą–ě’Wli”ĺj: ƒGƒLƒXƒp[ƒgƒi[ƒX, 9: 182`185, 1993.

2579. m‘ŕn t•s‘S•Ű‘śŠú‚Ě–ň•¨—Ă–@|is‚đ’x‚ç‚š‚é‚˝‚߂Ɂ|. ‰ş“c‰vOCŽđˆä‹Ši”ĺj: ˆăŠw‚Ě‚ ‚ä‚Ý, 167(1): 11`14, 1993.

2580. m‘ŕn CAPDŠłŽŇ‚̍‡•šÇ|ŒŒ‰t“§Í‚Ć‚Ěˆá‚˘|. ŒF–ě˜a—Yi”ĺj: ˆăŠw‚Ě‚ ‚ä‚Ý, 167(1): 74`77, 1993.

2581. m‘ŕn ”AŽ¸‹Ö‚ĚŒŸ¸‚Ɛf’f. ‰ĄŽR‰p“ńi”ĺj: ŠĹŒě‹Zp, 40: 17`21, 1994.

2582. m‘ŕn ŹŽ™‚ŒŒˆł‚Ě‘Îô‚ĆŽĄ—Ă. ‰ş“c‰vOCŽđˆä‹Ši”ĺj: Œť‘ăˆă—ĂŠw, 8(4): 86`90, 1993.

2583. m‘ŕn |“`“ˆăŠw‚Ě—§ę‚Š‚ç|”ĺ”AŠí‰Č—Ěˆć‚ĚŠż•űŽĄ—ĂŠT˜_. Î‹´Wi”ĺj: Œť‘ă“Œ—mˆăŠw, 15(1): 55`59, 1994.

2584. m‘ŕn –Ťt•s‘SŹŽ™ŠłŽŇ‚ĆQOL. Žđˆä‹Ši”ĺj: ŽĄ—Ă, 75(10): 91`95, 1993.

2585. m‘ŕn tˆÚA—á‚Ĺ‚Ěœ•a•Ď. ŒF–ě˜a—YC•ş“Ą“§C‰““Ą’‰—YCŽđˆä‹Ši”ĺj: t‚ƍœ‘ăŽÓ, 7(1): 63`68, 1994.

2586. m‘ŕn ‚—îŽŇ‚Ě”r”AáŠQ. ‰ĄŽR‰p“ńi”ĺj: t‘Ÿ, 16(1): 25`38, 1993.

2587. m‘ŕn tŽžŠł‚ĚŽŔ‘H“I•ŰŒ’Žw“ą‚Í‚ą‚¤‚ˇ‚é. Žđˆä‹Ši”ĺj: śŠˆ‹łˆç, 37(7): 17`27, 1993.

2588. m‘ŕn tŽžŠł‚Ě•ŰŒ’Žw“ąĽŽŔ‘HQ&A. Žđˆä‹Ši”ĺj: śŠˆ‹łˆç, 37(7): 28`33, 1993.

2589. m‘ŕn CAPD‚̐ł‚ľ‚˘’mŽŻ‚ƐśŠˆŽw“ą. Žđˆä‹Ši”ĺj: śŠˆ‹łˆç, 38(2): 62`70, 1994.

2590. m‘ŕn –Ł—Í‚ ‚éCAPD. Žđˆä‹Ši”ĺj: ÎěŒ§t—F‰ďŽ, (47): 30`35, 1993.

2591. m‘ŕn ‹Ů‹}ŒŒ‰tň‰ť‘•’u. ‰ş“c‰vOCŽđˆä‹Ši”ĺj: ‘‡—Տ°, 42(‘): 155`159, 1993.

2592. m‘ŕn ‘O—§‘B”ě‘ĺÇŽĄ—Ă–ň. ‰ĄŽR‰p“ńCŹŽÄŒ’i”ĺj: ‘‡—Տ°, 42: 3171`3174, 1993.

2593. m‘ŕn ”r”AáŠQ‚Ě•a‘Ô. ‰ĄŽR‰p“ńi”ĺj: “Œ‹ž“sˆăŽt‰ďŽGŽ, 46(6): 1120`1125, 1993.

2594. m‘ŕn ”n’űt‚É”­ś‚ľ‚˝t×–EŠŕ. “Ą–ě’WlCŹŽÄŒ’i”ĺj: ”ĺ”AŠíŠO‰Č, 5(—Ő‘): 1992.

2595. m‘ŕn śtĂ–Ź‚̉đ–UŠw“IˆĘ’uˆŮí. “Ą–ě’WlCŹŽÄŒ’i”ĺj: ”ĺ”AŠíŠO‰Č, 5(—Ő‘): 1992.

2596. m‘ŕn ”A–ŒŠÇŠŕi”S‰t‘BŠŕj. “Ą–ě’WlCŹŽÄŒ’i”ĺj: ”ĺ”AŠíŠO‰Č, 5(—Ő‘): 1992.

2597. m‘ŕn ‚w‚w male ÇŒóŒQ. “Ą–ě’WlCŹŽÄŒ’i”ĺj: ”ĺ”AŠíŠO‰Č, 5(—Ő‘): 1992.

2598. m‘ŕn ŒŁtˆÚA|Ĺ‹ß‚̐i•ŕ|ŒŁtˆÚA‚É‚¨‚Ż‚é–Ɖu—}§—Ă–@. ‰““Ą’‰—YCŒF–ě˜a—Yi”ĺj: ”ĺ”AŠíŠO‰Č, 7(2): 117`124, 1994.

2599. m‘ŕn tŽžŠłŽĄ—Ă‚É‚¨‚Ż‚éƒVƒNƒƒXƒ|ƒŠƒ“‚̉ʂ˝‚ˇ–đŠ„|ŹŽ™Šú“Á”­Ťƒlƒtƒ[ƒ[ÇŒóŒQ|. ‰ş“c‰vOCŽđˆä‹Ši”ĺj: –k—˘ˆăŠw, 23(6): 391`395, 1993.

2600. m‘ŕn ”A˜HŒ‹Î‚Ě”ńŠĎŒŒ“IŽĄ—Á|‘ĚŠOŐŒ‚”gŒ‹Î”jÓp(ESWL)‚ɂ‚˘‚ā|. ^‰şß•vi”ĺj: –k—˘ˆăŠw, 23: 184`193, 1993.

2601. m‘ŕn ‚“xćiˆă—Ă‚ĚŽŔŰ; lH”A“šŠ‡–ń‹Ř‚đ—p‚˘‚˝”AŽ¸‹Ö‚ĚŽĄ—Ă. “Ą–ě’WlC“ŕ“c–LşCÎ‹´Wi”ĺj: –ňŽ–V•ń, 1766: 995`1001, 1993.

2602. m‘ŕn t‘Ÿ‚ɏáŠQ‚đŽ‚ÂŽ™“śś“k‚ւ̑Ήž|ŹŽ™CAPDŠłŽŇ‚ĚŠwZ•œ‹A‚đ‚ß‚Ž‚Á‚ā|. Žđˆä‹Ši”ĺjC–x‰z—R‹IŽqi‘‡‘Š’k•”j: —Ăˆç‚Ě‘‹, (86): 20`22, 1993.

2603. m‘ŕn tŽžŠłŽ™‚̐śŠˆŽw“ą. Žđˆä‹Ši”ĺjCŒĂŁş•viŒF–{’†‰›•a‰@jC’ˇâ—T”Ži‰Ą•lŽs—§ŹŽ™ƒAƒŒƒ‹ƒM[ƒZƒ“ƒ^[j: —Տ°ƒXƒ|[ƒcˆăŠw, 10(6): 639`642, 1993.

2604. m‘ŕn HCVŠ´ő—\–h(3)—Տ°HŠw‹ZŽt‚Ě—§ę‚Š‚ç. ´…”ÍŽqC‘Š CˆęitƒZƒ“j: —Տ°“§Í, 9(11): 65`71, 1993.

2605. m‘ŕn —Տ°HŠw‹ZŽt‚Ö–]‚Ţ‚ą‚Ɓ|“ú–{—Տ°HŠw‹ZŽt‰ď‚Š‚ç|. ‘Š CˆęitƒZƒ“j: —Տ°“§Í, 9(5): 41`45, 1993.

2606. m‘ŕn ‡•šÇ‚Ć‹ô”­Ç|ŒŒŠÇ’É. ŒF–ě˜a—Yi”ĺj: —Տ°“§Í, 9(7): 304`305, 1993.

2607. m‘ŕn –Ɖu—}§Ü‚̐V“WŠJ; ”ĺ”AŠí‰ČŽĄ—Ă–ňƒ}ƒjƒ…ƒAƒ‹|i•ŕ‚ƐV‚ľ‚˘“WŠJ|. ^‰şß•vCŹŽÄŒ’i”ĺj: —Տ°”ĺ”AŠí‰Č, 47(4): 64`68, 1993.

2608. muŔn —Ť‚É‘˝‚˘”AŽ¸‹Ö‚ĚŽčp. ^‰şß•vi”ĺj: ‚ˇ‚ą‚â‚Šƒtƒ@ƒ~ƒŠ[, 93.08.01.

2609. muŔn ”ĺ”AŠí‰Č‚ĚŠż•űŽĄ—Ă‚đ‚ß‚Ž‚Á‚Ä. Î‹´Wi”ĺj: Œť‘ă“Œ—mˆăŠw, 15(1): 72`89, 1994.

2610. muŔn ‹†‹É‚ĚƒAƒƒjƒeƒB. Î‹´Wi”ĺj: “ú–{ˆăŽ–V•ń, 3614: 28, 1993.

2611. muŔn “V‹çŠw‚Ń‚Í‚ś‚ß. ‰Ş’ź—Fi”ĺj: “ú–{ˆăŽ–V•ń, 3614: 43, 1993.

2612. muŔn ˜V”NŠú¸_Çó‚ɑ΂ˇ‚銿•ű—Ă˜V–@|”ĺ”AŠí‰Č—Ěˆć‚̐¸_Çó|. Î‹´Wi”ĺj: “ú–{“Œ—mˆăŠw‰ďę–ĺˆă’ʐM, 4(4): 26`34, 1994.

2613. muŔn ‘O—§‘BśŒŸj‚ĚˆęH•v|‚ć‚萸“x‚̍‚‚˘’´‰š”gƒKƒCƒh‰şśŒŸ‚Ě‚˝‚߂Ɂ|. ‰oěWCěă’B‰›i”ĺj: —Տ°”ĺ”AŠí‰Č, 47(11): 886, 1993.

2614. mŠwp‘n i•Ş’SŽˇ•Mj ‚Š‚ç‚ž‚̉Ȋw; Œ’Nf’fŽž‚ĚŒŸ”A, (‘): 374`378, ‰ş“c‰vOCŽđˆä‹Ši”ĺj. •ŇW ‰zěşŽOiş˜a‘ĺjC “ú–{•]˜_ŽĐ, “Œ‹ž, 93.11.25”­s.

2615. mŠwp‘n i•Ş’SŽˇ•Mj Annual Review t‘Ÿ1994; ”­’Btś—Šw‚̐i•ŕ, p.29`34, ‰ş“c‰vOCŽđˆä‹Ši”ĺj. •ŇW ‰zěşŽOiş˜a‘ĺjC’ˇ‘ňr•FiˆÇ—Ń‘ĺjCŹˆéŒŞ‹gi’}”g‘ĺjCˆÉ“Ą‘ńi‘—§ŹŽ™•a‰@jC ’†ŠOˆăŠwŽĐ, “Œ‹ž, 94.01.15”­s.

2616. mŠwp‘n i•Ş’SŽˇ•Mj CAPD‚Ě—Ő°; CAPD‚Ě•Ď–@, p.231`242, ŒF–ě˜a—Yi”ĺj. •ŇW ‘ž“c˜a•vi“Œ—ˆă‘ĺjC’†ěŹ”V•ăi“Œ‹ž“s‘˝–€˜Vlˆă—ĂƒZƒ“ƒ^[jCěŒű—ǐliŽœŒbˆă‘ĺjC “ě]“°, “Œ‹ž, 94.00.00”­s.


<<22 3 ”ĺ”AŠí‰ČŠw>>

2617. m‹ł‰Č‘n i•Ş’SŽˇ•Mj “§Í‡]‡]; ŒŒ‰t“§Í’†‚ĚŽ–ŒĚ‚Ć‘Îô, p.262`268, Žđˆä‹Ši”ĺj. •ŇW “ú–{“§Í—Ă–@Šw‰ď‘–ąˆĎˆő‰ďC “ú–{“§Í—Ă–@Šw‰ď, 93.06.26”­s.

2618. m‹ł‰Č‘n i•Ş’SŽˇ•Mj ŒŒ‰tň‰ť—Ă–@ƒnƒ“ƒhƒuƒbƒN; CAPD, p.269`278, ŒF–ě˜a—Yi”ĺj. •ŇW “§Í—Ă–@‡“Żę–ĺˆăˆő‰ďC ‹Ś“Żˆă‘o”ĹŽĐ, 93.12.15”­s.

2619. m‹ł‰Č‘n i•Ş’SŽˇ•Mj ŒŒ‰tň‰ť—Ă–@ƒnƒ“ƒhƒuƒbƒN; ŹŽ™t•s‘SŠłŽŇ‚Ě“§Í, p.381`391, Žđˆä‹Ši”ĺj. •ŇW “§Í—Ă–@‡“Żę–ĺˆĎˆő‰ďC ‹Ś“Żˆă‘o”ĹŽĐ, 93.12.15”­s.

2620. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj _Œo“ď•a•KŒgII|—Ă—{śŠˆ‚̉‡•; äNă÷’ź’°áŠQ, p.24`29, “Ą–ě’Wli”ĺj. •ŇW –k—˘‘ĺŠw“Œ•a‰@“ď•aŽĄ—ĂŒ¤‹†ƒZƒ“ƒ^[, _Œo“ď•aŒ¤C‰ď, 93.09.00”­s.

2621. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj Œ’N‚̍Lę; ‘O—§‘B”ě‘ĺÇ, 1193: 4, “Ą–ě’Wli”ĺj. –@Œ¤, “Œ‹ž, 93.10.21”­s.

2622. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj ĹV“ŕ‰ČŠw‘ĺŒn‚T; äNă÷—Ż’uƒJƒe[ƒeƒ‹‚Ě‘}“ü, ^‰şß•vCŹŽÄŒ’i”ĺj. ’†ŽR‘“X, 93.06.25”­s.


<<22 5 ”ĺ”AŠí‰ČŠw>>

2623. mŠw‰ďi‘Űjn i“Á•Ęu‰‰j TURP:Past, Present and Future. ŹŽÄŒ’i”ĺj: 1st China Congress on Endourology and ESWL (93.09.16), –k‹ž.

2624. mŠw‰ďi‘Űjn i“Á•Ęu‰‰j TURP: Past, present and future. ŹŽÄŒ’i”ĺj: First China Congress on Endourology and ESWL (93.09.16), –k‹ž, —\eW, p.21, 1993.

2625. mŠw‰ďi‘Űjn i“Á•Ęu‰‰j Technique of TURP,ELAP and HIFU. ŹŽÄŒ’i”ĺj: Renji Hospital Urological Society (93.09.20), ăŠC.

2626. mŠw‰ďi‘Űjn i“Á•Ęu‰‰j Technique of TURP, ELAP and HIFU. ŹŽÄŒ’i”ĺj: Renji Hospital Urological Society (93.09.20), ăŠC.

2627. mŠw‰ďi‘Űjn i“Á•Ęu‰‰j Current status of japanese dialysis treatment. Žđˆä‹Ši”ĺj: ‘ć1‰ń’†‰Ř–Ż‘ŒŒ‰tň‰ťˆăŠw‰ď‰ďˆő‘ĺ‰ď i93.05.16j, ‘ä–k.

2628. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€j Surgical and laser treatment of BPH. ŹŽÄŒ’i”ĺj: 2nd International Consultation of Benign Prostatic Hyperplasia (93.06.29), ƒpƒŠ.

2629. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Cyclosporin trial on nephrotic syndrome. Žđˆä‹Ši”ĺj: 8th Asian Congress of Pediatrics i94.02.06j, New Delhi.

2630. mŠw‰ďi‘Űjn iƒ[ƒNƒVƒ‡ƒbƒvj Once-a-week self-adminisered subcutaneou erythropoietin EPO: The optimal route of EPO administration for CAPD patients. Žđˆä‹ŠC‰Ą“c^“ńC‘ˆä‘ĽşC“ü]Œ[CŒF–ě˜a—Yi”ĺj: 4th Asian Congress of Pediatric Nephrology i93.04.09`11j, Taiwan.

2631. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j TURP Versus Open Prostatectomy: 20-Year Outocome. ŹŽÄŒ’CŻŽi´ŽuC‰oěWC“ŕ“c–LşC‰ĄŽR‰p“ńC^‰şß•vi”ĺj: American Assoc of Genitourinary Surgeons, 107th Meeting (93.04.16), ƒtƒFƒjƒbƒNƒX.

2632. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j TURP versus open prostatectomy: 20 years outcome. ŹŽÄŒ’CŻŽi´ŽuC‰oěWC“ŕ“c–LşC^‰şß•vi”ĺj: American Assoc. of Genifourinary Surgeons, 107th Meeting (93.04.16), ƒAƒƒŠƒJ, ƒtƒFƒjƒbƒNƒX, —\eW, p.9, 1993.

2633. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Clinical applications of monoclonal antibody against garmma seminoprotein. “Ą–ě’Wli”ĺj: Baylor Urology, update, 1993 (93.05.13), Houston.

2634. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Changing nature of prostate cancer. Scott BerkmaniƒxƒCƒ‰[ˆă‰Č‘ĺjC‘ĺ–x—i”ĺjCJeremy R. GoadCPeter T. ScardinoiƒxƒCƒ‰[ˆă‰Č‘ĺj: South Central Section of the American Urological Association, Incorporated (93.10.05), Acapulco.

2635. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The relationships of DNA ploidy value to the grade, cancer volume and extra capsular extension of prostate cancer. ‘ŠŒ´łOi”ĺjCEverard C. WesselsiƒxƒCƒ‰[ˆă‰Č‘ĺjC‘ĺ–x—i”ĺjCThomas W. WheelerCPeter T. ScardinoiƒxƒCƒ‰[ˆă‰Č‘ĺj: South Central Section of the American Urological Association, Incorporated (93.10.05), Acapulco.

2636. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Whole-Body Autoradiography of I-125 Labeled Monoclonal Antibody Against Gamma Seminoprotein for LNCaP Xenografts in Nude Mice. “Ą–ě’Wli”ĺj: South Central Section of the American Urological Association, Incorporated (93.10.05), Acapulco.

2637. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j IsgPSA Densityhmore useful than PSA levels in the diagnosis of prostate cancer?. ‘ĺ–x—i”ĺjCWessels, E.C.iƒxƒCƒ‰[ˆă‰Č‘ĺjC‘ŠŒ´łOi”ĺjCGillespie, R.I.CScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: The Almuni Meeting at Baylor College of Medicine; Prostate Cancer i93.00.00j.

2638. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Nodules resembling noular hyperplasia in the peripheral zone of the prostate. ‘ĺ–x—C‰oěWi”ĺjCWheeler, T.M.iƒxƒCƒ‰[ˆă‰Č‘ĺj: The United States-Canadian Division of the International Academy of Pathology i93.03.00j.

2639. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Pathologic features of prostate cancers detectable with current diagnostic tests. ‘ĺ–x—i”ĺjCWheeler, T.M.iƒxƒCƒ‰[ˆă‰Č‘ĺjC‘ŠŒ´łOi”ĺjCScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: Texas Urological Society i93.04.00j, Houston.

2640. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Measurement of GFR using constant subcutaneous infushion of non radiolabelled iothalamate. ‰ş“c‰vOCŽđˆä‹Ši”ĺj: 4th Asian Congress of Pediatric Nephrology i93.04.09`11j, Taiwan.

2641. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The use of serum marker PSA to distinguish clinically important form unimoportant prostate cancers detected by TURP. ‘ĺ–x—i”ĺjCWheele, T.M.CSriyuce, O.CScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: 2nd Annual Oncology Research Seminar i93.04.13j.

2642. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j DNA ploidy value of incidental prostate cancer found at cystoprostatectomy for bladder cancer. ‘ŠŒ´łOi”ĺjCWessels, E.C.iƒxƒCƒ‰[ˆă‰Č‘ĺjC‘ĺ–x—i”ĺjCWheele, T.M.CScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: 2nd Annual Oncology Research Seminar i93.04.13j.

2643. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j PSA and Gleason grade; An immunohistochemical study of prostate cancer. ‘ŠŒ´łOi”ĺjCLevobitCKinner, B.M.CWheeler, T.M.iƒxƒCƒ‰[ˆă‰Č‘ĺjC‘ĺ–x—i”ĺjCScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: American Urological Association i93.05.00j.

2644. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j DNA ploidy value of incidental prostate cancer found at cystoprostatectomy for bladder cancer. ‘ŠŒ´łOi”ĺjCWessels, E.C.CWheeler, T.M.iƒxƒCƒ‰[ˆă‰Č‘ĺjC‘ĺ–x—i”ĺjCP,T. ScardinoiƒxƒCƒ‰[ˆă‰Č‘ĺj: American Urological Association i93.05.00j.

2645. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The prognostic significance and mechanism of seminal vesicle invasio by prostate cancer. ‘ĺ–x—i”ĺjCWheeler, T.M.CLapin, S.L.CSearl-Hawkins, C.CLink, J.CScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: American Urological Association i93.05.00j.

2646. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The prognostic significance and mechanism of seminal vesicle invasion by prostate cancer. ‘ĺ–x—i”ĺjCWheeler, T.M.CLapin, S.L.CSearl-Hawkins, C.CLink, J.CScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: Houston Urological Society i93.06.12j.

2647. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The new TNM classification of prostate cancer; Pathologic features of cancers detected by PSA alone (Tlc). ‘ĺ–x—i”ĺjCWheeler, T,M.CScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: Eurosurgery i93.09.15`18j, London, Br. J. Surgery, (Suppl.80): 106.

2648. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Pathologic features of prostate cancer detectable with current diagnostic tests. ‘ĺ–x—i”ĺjCWheeler, T.M.CDunn, J.K.CScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: Souch Central Section of AUA i93.10.03`07j, Acapuluco.

2649. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The improvement of incontinece after radical prostatectomy. Goad, J.R.CRogers, E.iƒxƒCƒ‰[ˆă‰Č‘ĺjC‘ĺ–x—i”ĺjCKassabian, V.CScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: Souch Central Section of AUA i93.10.03`07j, Acapuluco.

2650. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Nature of Prostate Cancer detected with Current tests; Can we Distinguish Latent from Clinical Cancers. ‘ĺ–x—i”ĺjCScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: International School of Urology and Nephrology, 8th Course i93.11.18j, Italy.

2651. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Morphological distribution and pathologic features of prostate cancer. ‘ĺ–x—i”ĺjCScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: International School of Urology and Nephrology, 8th Course i93.11.20j, Italy.

2652. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Stagig Prostate Cancer: The 1992 system. ‘ĺ–x—i”ĺjCScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: International School of Urology and Nephrology, 8th Course i93.11.22j, Italy.

2653. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Results after Radical Prostatectomy Using PSA as a Measure of Outcome. ‘ĺ–x—i”ĺjCScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: International School of Urology and Nephrology, 8th Course i93.11.22j, Italy.

2654. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Video Tape Modified Radical Retropubic Prostatectomy. ‘ĺ–x—i”ĺjCScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: International School of Urology and Nephrology, 8th Course i93.11.22j, Italy.

2655. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Complications of Radical Retropubic Prostatectomy. ‘ĺ–x—i”ĺjCScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: International School of Urology and Nephrology, 8th Course i93.11.23j, Italy.

2656. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Rationale for the Treatment of Localized Prostate Cancer. ‘ĺ–x—i”ĺjCScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj: International School of Urology and Nephrology, 8th Course i93.11.24j, Italy.

2657. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j New solution for cold kidney preservation studied on isolated perfused kidney. ^č‹`•FiŽŔ“ŽjCŒF–ě˜a—YCWang, W.C‰““Ą’‰—YCŹŽÄŒ’i”ĺj: 3rd Congress of Asian Society of Transplantation i93.12.04`06j, Bangkok.

2658. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Hypertonic glucose increases total protein syncthesis and fibronectin gene expression on cultured rat mesothelial cells. ŒF–ě˜a—Yi”ĺjCSchiller, B.iRush Presbyterian Medical CenterjCMoran, J.E.iBaxter HealthcarejCHjille, J.T.iUniv. Illinoisj: 14th Annual Conference of Peritoneal Dialysis i94.01.24j, Orlando.

2659. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Evaluation of various simple methods for calculation of KT/V. “ě•”łlitƒZƒ“jCŒF–ě˜a—Yi”ĺjCŹŽR˝itƒZƒ“jCTouyama, A.i‚ ‚Ż‚Ú‚Ě•a‰@jC‘Š CˆęitƒZƒ“jCŹ–ě“ÖŽjCŹ—Ń’ź”VC‹g“cŕˆi‚ł‚Ş‚ÝzŠÂŠíƒNƒŠƒjƒbƒNj: 9th World Congress of International Society for Artificial Organs i93.07.04`08j, Amsterdam, I. J. Artif. Organs, 16(6): 391, 1993.

2660. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Optimal regimen for tidal peritoneal dialysis. ŒF–ě˜a—Yi”ĺjCŽR‰ş–ž‘ׁi‹ăBH‘ĺjCŽđˆä‹Ši”ĺj: 26th American Society of Nephrology i93.11.14`17j, Boston.

2661. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Effects of higy glucose levels on cell proliferation and TGF-ƒŔ expression in cultured rat mesothelial cells. ŒF–ě˜a—Yi”ĺjCSchiller-Moran, B.iRush Presbyterian Medical CenterjCHjelle, J.T.iUniv. of IllinoisjCMoran, J.E.iBaxter Healthcarej: 26th American Society of Nephrology i93.11.14`17j, Boston.

2662. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Modulation of monocyte chemoattractant protein (MCP-1) expression in the remnant kidnwy model by a low protein diet. Schiller-Moran, B.iRush Presbyterian Medical CenterjCDeleo, M.CWarren, E.iBaxter HealthcarejCŒF–ě˜a—Yi”ĺjCMoran, J.E.iBaxter Healthcarej: 26th American Society of Nephrology i93.11.14`17j, Boston.

2663. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Plasma endothelin level after kidney transplantation. ŒF–ě˜a—YC‘ˆä‘ĽşC‘vŹ_C^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: 3rd Congress of Asian Society of Transplantation i93.12.04`06j, Bangkok.

2664. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Effects of various impermeants of cold kidney preservation. ŒF–ě˜a—YCWang, W.i”ĺjC^č‹`•FiŽŔ“ŽjC‰““Ą’‰—Yi”ĺj: 3rd Congress of Asian Society of Transplantation i93.12.04`06j, Bangkok.

2665. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Serum erythropoietin level after renal transplantation. ‘vŹ_CŒF–ě˜a—YC‰F“s‹{‘ńŽĄC^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: 3rd Congress of Asian Society of Transplantation i93.12.04`06j, Bangkok.

2666. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Clinical experience with visual laser ablation of prostate for benign prostatic hyperplasia. “ŕ“c–LşCÂ‹PşC‰oěWC‰ĄŽR‰p“ńC“Ą–ě’WlC^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: 1st Chinese Endourology Meeting (93.09.16), Beijing.

2667. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ESWL experience in Kitasato University Hospital. ^‰şß•vC“ŕ“c–LşCŹŽÄŒ’CrěFC‹v•ŰŻˆęi”ĺj: 1st Chinese Endourology Meeting (93.09.17), Beijing.

2668. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j tƒTƒ“ƒSóŒ‹Î‚ĚŽĄ—ÁiESWL‚𒆐S‚Ć‚ľ‚āj. ^‰şß•vCrěFC‹v•ŰŻˆęi”ĺj: ‘ć7‰ń“ú–{EndourologyĽESWLŠw‰ď‘‰ď (93.11.20), ç—t.

2669. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •úŽËüĆŽËŒă‚Ě‘O—§‘BŠŕŒo‰ßŠĎŽ@‚É‚¨‚Ż‚éŒo’ź’°“I’´‰š”g‚Ě—L—pŤ. ‰oěWC—ŤŻŻi”ĺjCƒs[ƒ^[‚s. ƒXƒJƒ‹ƒfƒB[ƒmiƒxƒCƒ‰[ˆă‰Č‘ĺjCÎ‹´Wi”ĺj: ‘ć12‰ń“ú–{‰ć‘œˆăŠw‰ď (93.02.04`06), “Œ‹ž.

2670. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”A˜HˆŤŤŽîᇂɂ¨‚Ż‚éŠeŽíˆâ“`ŽqCŠŕ—}§ˆâ“`Žq‚̉đÍ. “ŕ“c–LşC˜ZŠpŽüCÎ“c—T‘Ľi”ĺjC˜a“c’m‰vi—Տ°•a—jCÝŠy•q–çC‰oěWCŹŽÄŒ’i”ĺj: ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (93.04.10), ‹ž“s.

2671. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘SŽŠ“Žy‘f–Ɖu‘Ş’čƒVƒXƒeƒ€‚É‚ć‚錌´PAP‚ĆPSA‘Ş’č‚Ě—Ő°“IˆÓ‹`i‘ć1•ńjŠî‘b“IŒŸ“˘. {ŽRo•äC“Ą–ě’WlCˆÉ“ĄŒ[ˆęC‘ĺě–ƒŽqC‰F“s‹{‘ńŽĄC‰oěWC‰ĄŽR‰p“ńCÎ‹´Wi”ĺjC‚‹´‰Á‘ăŽqi—ŐŒŸjCŽsěŒbŽqi‘‡—Տ°Œnj: ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (93.04.10), ‹ž“s.

2672. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘SŽŠ“Žy‘f–Ɖu‘Ş’čƒVƒXƒeƒ€‚É‚ć‚錌´PAP‚ĆPSA‘Ş’č‚Ě—Ő°“IˆÓ‹`i‘ć2•ńj—Տ°“IŒŸ“˘. ˆÉ“ĄŒ[ˆęC“Ą–ě’WlCŽÄ“c—Y“ńCŠ‹źŒMCÂ‹PşC“ŕ“c–LşC^‰şß•vCŹŽÄŒ’i”ĺjC‘ĺę—TŽqC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (93.04.10), ‹ž“s.

2673. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j • –Œ‹ž‰ş‚ɐt“Eop‚đŽ{s‚ľ‚˝ś‹‘吅tÇ‚Ě‚P—áiƒrƒfƒIj. Â‹PşC“ŕ“c–LşCÎ“c—T‘ĽC{ŽRo•äCŒ´–ě—TŽiC‰ĄŽR‰p“ńC^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (93.04.10), ‹ž“s.

2674. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒŒ[ƒU[(Urolase)‚É‚ć‚é‘O—§‘B”ě‘ĺÇŽĄ—Ă(Visual laser ablation of the prostate: VLAP)‚Ě—Ő°“IŒŸ“˘. “ߐ{•Ű—FCŒö•ś—TŒČC‘ĺXO”VC“ŕ“c–LşC‰ĄŽR‰p“ńCŹŽÄŒ’i”ĺjCŠŃˆä•ś•FC‰Ş–{dâX: ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (93.04.10), ‹ž“s.

2675. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ú–{l‘O—§‘BŠŕ‚ĚŽŠ‘RŽ€Žj|–k—˘‘ĺ20”NŠÔ‚ĚŒoŒą. ‰oěWC‰F“s‹{‘ńŽĄCŒ´–ě—TŽiC{ŽRˆę•äC{ŽRo•äCŒŕŠ˛ƒi”ĺjCŒK”ö’čmi•a—jC‰ĄŽR‰p“ńC“ŕ“c–LşC^‰şß•vCŹŽÄŒ’i”ĺj: ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (93.04.11), ‹ž“s.

2676. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j tƒTƒ“ƒSóŒ‹Î‚ɑ΂ˇ‚錋Î”jÓŽĄ—ĂŒă‚Ě’ˇŠúFollow up|Œ‹Î‚ĚÄ”­Ľ‘‘弐t‹@”\‚𒆐S‚Ɂ|. rěFC{ŽRˆę•äC‹v•ŰŻˆęCŹŽÄŒ’C^‰şß•vi”ĺj: ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (93.04.11), ‹ž“s.

2677. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j —Ť‚Ě• ˆłŤ”AŽ¸‹Ö‚ɑ΂ˇ‚éCollagen‚Ě”A“šŽüˆÍ’“ü—Ă–@. ‰ĄŽR‰p“ńCěă’B‰›C“ŕ“c–LşC‘vŹ_CŠŰ“T•vCŒĂ”¨˝”VCŽOžŠN“TC‹y”\‹v—˛CŹŽÄŒ’i”ĺj: ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (93.04.11), ‹ž“s.

2678. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j t•Ű‘ś‚É‚¨‚Ż‚é‘gD•‚Žî—}§•¨Žż‚ĚŒŸő|’P—ŁŠÁ—Źt‚É‚ć‚錟“˘|. ŒF–ě˜a—YC‰F“s‹{‘ńŽĄC‘ş–{ŤrCŽu‘ş“NCŹ‘q—TKC‰““Ą’‰—YCŹŽÄŒ’i”ĺjC^č‹`•FiŽŔ“Žj: ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (93.04.11), ‹ž“s.

2679. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘O—§‘B”ě‘ĺÇ‚ɑ΂ˇ‚éŒo”A“š“IƒŒ[ƒU[—Ă–@iƒrƒfƒIj. “ŕ“c–LşCŒ´–ě—TŽiC‰F“s‹{‘ńŽĄC‰oěWCÂ‹PşC“Ą–ě’WlC‰ĄŽR‰p“ńC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (93.04.11), ‹ž“s.

2680. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œo”A“š“I‘O—§‘BŘœpŒă‚ÉMRSA‚É‚ć‚éToxic Syndrome‚đ—ˆ‚ľ‚˝‚P—á. “Ą–{‹ąŽmC‰Ş–{dâXC‰i“cŠ˛’jCŠŃˆä•ś•FC‰–ě‰pŽji”ĺjC‹{ěŽOŽ÷•vCŒ´“c°”üiš˜H‰ÁjCŒÜ\—’‰p•vi“Œ‹ž“s—§‰qśŒ¤‹†Šj: ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (93.04.11), ‹ž“s.

2681. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œo”A“š“I‘O—§‘BŘœp(TUR-P)Œă‚ĚŒŒ’†‚¨‚ć‚Ń”A’†ƒTƒCƒgƒJƒCƒ“”Z“x‚Ě•Ď“Ž. “ü]Œ[C—›Šż‰hC–ĺ˜e˜abi”ĺjCŒË“c‹žŽqiƒoƒCƒIƒƒfƒBƒJƒ‹Ľƒ‰ƒ{jCŽR“cD‘Ľ: ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (93.04.12), ‹ž“s.

2682. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘O—§‘BŠŕ‚ɑ΂ˇ‚éŠeŽíŠŕˆâ“`Žq, Šŕ—}§ˆâ“`Žq‚̉đÍ. Î“c—T‘ĽC“ŕ“c–LşCŒüˆäLĆCÝŠy•q–çC‰oěWC˜a“c’m‰vi•a—jCź‘ş´ŽuCŹŽÄŒ’i”ĺj: ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (93.04.12), ‹ž“s.

2683. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –Ťt•s‘SŠłŽŇ‚É”­ś‚ľ‚˝äNă÷ŽîᇂĚ2—á. Ź–““ń–çC“ŕ“c–LşC‰““Ą’‰—Yi”ĺj: ‘ć38‰ń“ú–{“§Í—Ă–@Šw‰ď (93.07.17), –‹’Ł.

2684. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”A˜HˆŤŤŽîᇂ̂¨‚Ż‚é neurofibromatosis type 1, H-, K-, N-ras ˆâ“`Žq‚Ě PCR-SSCP ‰đÍ. “ŕ“c–LşCÝŠy•q–çC‰oěWCŹ–““ń–çCŹŽÄŒ’i”ĺjC˜a“c’m‰vi—Ő•a—j: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď (93.10.05`06), ĺ‘ä.

2685. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œo”A“š“I‘O—§‘BŘœp(TURP)Œă‚É”­ŒŠ‚ł‚ę‚˝‘O—§‘B‹ô”­Šŕ‚Ě—\Œă. “ŕ“c–LşCŒüˆäLĆCÎ“c—T‘ĽCěă’B‰›C‰oěWC‰ĄŽR‰p“ńCÎ‹´WCŹŽÄŒ’i”ĺj: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď (93.10.05`06), ĺ‘ä.

2686. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘O—§‘BŠŕ•aŠúf’f‚É‚¨‚Ż‚éŠeŽíŒŒ´Žîᇃ}[ƒJ[‚Ě—L—pŤ. ‰oěWC“ŕ“c–LşCŹŽÄŒ’i”ĺj: ‘ć31‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď‘‰ď (93.10.27), ‘ĺă.

2687. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’S‘O—§‘B”ě‘ĺÇ‘gDƒk[ƒhƒ}ƒEƒX‚É‚¨‚Ż‚é125I•WŽŻRƒKƒ“ƒ}[ƒZƒ~ƒmƒvƒƒeƒCƒ“ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ě‚Ě‘Ě“ŕ“Ž‘Ô. “Ą–ě’Wli”ĺj: ‘ć33‰ń“ú–{ŠjˆăŠw‰ď‘‰ď (93.10.28`30), ‹{č.

2688. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’SLNCaPŽîᇃk[ƒhƒ}ƒEƒX‚É‚¨‚Ż‚é125I•WŽŻRƒKƒ“ƒ}[ƒZƒ~ƒmƒvƒƒeƒCƒ“ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ě‚Ě‘Ě“ŕ“Ž‘Ô. “Ą–ě’WlCÎ‹´Wi”ĺj: ‘ć33‰ń“ú–{ŠjˆăŠw‰ď‘‰ď (93.10.28`30), ‹{č, ŠjˆăŠw, 30(8): 985, 1993.

2689. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œo”A“š“I‘O—§‘BŘœp(TURP)Œă‚É”­ŒŠ‚ł‚ę‚˝‘O—§‘B‹ô”­Šŕ‚Ě—\Œă. “ŕ“c–LşCŒüˆäLĆCÎ“c—T‘ĽCěă’B‰›C‰oěWC‰ĄŽR‰p“ńCÎ‹´WCŹŽÄŒ’i”ĺj: ‘ć31‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď‘‰ď (93.10.29), ‘ĺă.

2690. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Therasonic”jÎ‘•’u‚É‚ć‚é”A˜HŒ‹Î‚ĚŽĄ—ĂŒoŒą. Žu‘ş“NC‰Á“Ą–ŤC•ěƒC^‰şß•vCŹŽÄŒ’i”ĺj: ‘ć7‰ń“ú–{EndourologyĽESWLŠw‰ď‘‰ď (93.11.19), ç—t.

2691. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘O—§‘B”ě‘ĺÇ‚ɑ΂ˇ‚éHigh Intensity Focused Ultrasound (HIFU)—Ă–@iƒrƒfƒIj. “ŕ“c–LşC‰oěWCÂ‹PşC“Ą–ě’WlC‰ĄŽR‰p“ńC^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: ‘ć7‰ń“ú–{EndourologyĽESWLŠw‰ď‘‰ď (93.11.19), ç—t.

2692. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘O—§‘B”ě‘ĺÇ‚ɑ΂ˇ‚éUrolase‚đ—p‚˘‚˝VLAP(Visual Laser Ablation Prostatectomy)—Ă–@. “ŕ“c–LşC‰oěWCÂ‹PşC“Ą–ě’WlC‰ĄŽR‰p“ńC^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: ‘ć7‰ń“ú–{EndourologyĽESWLŠw‰ď‘‰ď (93.11.20), ç—t.

2693. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Prognosis of incidental (stage A) prostatic cancer. “ŕ“c–LşCŒüˆäLĆCÎ“c—T‘ĽCěă’B‰›C‰oěWC‰ĄŽR‰p“ńCÎ‹´WCŹŽÄŒ’i”ĺj: H (94.02.20), “ú–{ŠŕŽĄ—ĂŠw‰ďŽ, XXIX(2): 482, 1994.

2694. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹlŠú‚܂ŒǐՂľ“ž‚˝IgAtÇ‚ĚŒŸ“˘. ‰ş“c‰vOi”ĺjC”э‚Šě‹v—YiŽ™jCŒK”ö’čmi•a—jC‰Íź‹IşiŽ™jCŒF–ě˜a—YCŽđˆä‹Ši”ĺj: ‘ć28‰ń“ú–{ŹŽ™t‘Ÿ•aŠw‰ď i93.05.19`21j, •Ÿ“‡.

2695. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒsƒ…[ƒƒ}ƒCƒVƒ“(PAN)tÇ‚É‚¨‚Ż‚éŒoŒű‹z’…ÜAST-120‚ĚŒř‰Ę. Žđˆä‹ŠC‰ş“c‰vOCŒF–ě˜a—Yi”ĺjCŒK”ö’čmi•a—jCˆÉ¨“šmiŒŕ‰H‰ťŠwj: ‘ć28‰ń“ú–{ŹŽ™t‘Ÿ•aŠw‰ď i93.05.19`21j, •Ÿ“‡.

2696. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j y‘f–@‚É‚ć‚錌´ƒNƒŒƒAƒ`ƒjƒ“łí’l‚ĚŒŸ“˘|“Á‚ɏŹŽ™‚̐łí’l‚𒆐S‚ÉJaffe–@‚Ć‚Ě”äŠr|. ŒÜ\—’‚ˇ‚ÝŽqCÂ–Ř–F˜aC‘q“c–ži_“ŢěŒ§—\–hˆăŠw‹Ś‰ďjCŽđˆä‹Ši”ĺj: ‘ć28‰ń“ú–{ŹŽ™t‘Ÿ•aŠw‰ď i93.05.19`21j, •Ÿ“‡.

2697. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŕƒVƒƒƒ“ƒgěť˘“ď—á‚É‚¨‚Ż‚éă˜rŽÚ‘¤”çĂ–Ź‚¨‚ć‚ѐlHŒŒŠÇ‚đ—p‚˘‚˝blood access‚Ě”äŠr. ‰F“s‹{‘ńŽĄCŒF–ě˜a—YCŽđˆä‹Ši”ĺjC‚–Ř—TCç—t“N—YC“ú‘ä‰p—Yi‘Pm‰ď‘ćˆę•a‰@j: ‘ć38‰ń“ú–{“§Í—Ă–@Šw‰ď‘‰ď i93.07.17`18j, ç—t.

2698. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‰ƒbƒg• –Œ“§Í‚ɑ΂ˇ‚éŠeŽí~ˆłÜ‚Ě• –Œ‹@”\‹y‚ŃƒŠƒ“ƒp‹zŽű‚ɑ΂ˇ‚é‰e‹ż. ŒŕŠ˛ƒCŒF–ě˜a—YCŽđˆä‹Ši”ĺj: ‘ć38‰ń“ú–{“§Í—Ă–@Šw‰ď‘‰ď i93.07.17`18j, ç—t.

2699. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒVƒNƒƒXƒ|ƒŠƒ“Žg—p’†‚ĚˆÚAt‚É‚¨‚Ż‚éƒAƒ‹ƒhƒXƒeƒƒ“”˝‰žŤ‚ĚŒŸ“˘. ‰ş“c‰vOCŒF–ě˜a—YC•ş“Ą“§C^‰şß•vC‰““Ą’‰—YCŽđˆä‹ŠCŹŽÄŒ’i”ĺj: ‘ć29‰ń“ú–{ˆÚAŠw‰ď‘‰ď i93.09.16`18j, ‹ŕ‘ň.

2700. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j łít‹@”\‚̐tˆÚA—á‚É‚¨‚Ż‚鍜‘ăŽÓƒpƒ‰ƒ[ƒ^‚ĚŒŸ“˘. •ş“Ą“§CŒF–ě˜a—YC‰ş“c‰vOC^‰şß•vC‰““Ą’‰—YCŽđˆä‹ŠCŹŽÄŒ’i”ĺj: ‘ć29‰ń“ú–{ˆÚAŠw‰ď‘‰ď i93.09.16`18j, ‹ŕ‘ň.

2701. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Extracerporeal pulsatile peritoneal dialysis (EPPD). ŒF–ě˜a—Yi”ĺjCŽR‰ş–ž‘ׁi‹ăBH‘ĺjCŽđˆä‹Ši”ĺj: ‘ć31‰ń“ú–{lH‘ŸŠíŠw‰ď i93.10.14j, Žl“úŽs.

2702. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŕ‘Ÿ•\–Ę‚É‚¨‚Ż‚é• –Œ•¨ŽżˆÚ“Ž‘Ź“x‚Ě‘Ş’č`ŽGŽíŒ˘‚É‚¨‚Ż‚錟“˘. ŽR‰ş–ž‘ׁi‹ăBH‘ĺjCŒF–ě˜a—YCŽđˆä‹Ši”ĺjCPopovich, R.P.iUniv. of TexasjCMoncrief, J.W.iAustin Diagnostic Clinicj: ‘ć31‰ń“ú–{lH‘ŸŠíŠw‰ď i93.10.14j, Žl“úŽs.

2703. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Non-radiolabelled iothalamate (Io) Ž‘ąĂ’–@‚É‚ć‚éGFR‘Ş’č. ‰ş“c‰vOC{ŽRˆę•äCŽu‘ş“NC‰F“s‹{‘ńŽĄCŒF–ě˜a—YCŽđˆä‹Ši”ĺjCˆÉ¨“šmiŒŕ‰H‰ťŠwś•¨ˆăŠwŒ¤‹†Šj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.02`04j, ‰Ą•l.

2704. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j • –Œ“§‰ß”\(PP)˜´i‚ÉŠÖ‚ˇ‚é“Ž•¨ƒ‚ƒfƒ‹‚̍쐻. ŒF–ě˜a—YC{ŽRˆę•äC’‰ƑśCŽđˆä‹Ši”ĺjC^č‹`•FiŽŔ“Žj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.02`04j, ‰Ą•l.

2705. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒlƒtƒ[ƒ[‚đ’ć‚ľ‚˝‘ƒóŽ…‹…‘̍d‰ťÇ(FGS)‚É‚¨‚Ż‚éƒAƒ‹ƒuƒ~ƒ“‰×“d‚ĚŒŸ“˘. ŽO”ömCŽđˆä‹Ši”ĺjC‰Íź‹IşCÎŠŮ••vC–kžŠ‚Ý‚Ç‚čCV‘ş•ś—YiŽ™jC“ĄŒ´–FlC’ˇâ—T”ŽC‹g“c‹`KC—^‹VŽŔ”VC‰F“ěŽR‹M’jC“cŒűG˜aCÖ“Ą˜a‘ăCŹ ”‹´–őCś‹î‰ëşCŽÄŽáŒp—YCŽRŒű‹`ĆC“yˆäŒ[Žii_“ސ쏬Ž™FGSŒ¤‹†‰ďj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.02`04j, ‰Ą•l, —\eW, p.232.

2706. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Cytokine-Inducing Substance(CIS)‚ĚPAN–Œƒ_ƒCƒAƒ‰ƒCƒU[. ‰Ą“c^“ńCŒF–ě˜a—Yi”ĺjC“ě•”łlitƒZƒ“ƒ^[jCŽđˆä‹Ši”ĺj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.02`04j, ‰Ą•l.

2707. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j • –Œ“§Í‰tƒuƒhƒE“œ”Z“x‚ރ‰ƒbƒg”|—{’†”ç×–E(RMC)‚É—^‚Ś‚é‰e‹ż|‘B”\‚¨‚ć‚ŃTGF°ƒŔ gene expression|. ŒF–ě˜a—YCŽđˆä‹Ši”ĺj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.02`04j, ‰Ą•l.

2708. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’P—ŁŠÁ—Źƒ‰ƒbƒgt‚đ—p‚˘‚Ä‚ĚFK506‚̐t“ŐŤ‚ĚŒŸ“˘. ’‰ƑśCŒF–ě˜a—YC‰ş“c‰vOC‰““Ą’‰—YCŽđˆä‹ŠCŹŽÄŒ’i”ĺjC^č‹`•FiŽŔ“Žj: ‘ć36‰ń“ú–{t‘ŸŠw‰ď‘‰ď i93.12.02`04j, ‰Ą•l.

2709. mŠw‰ďi’n•űjn i“Á•Ęu‰‰j hŒo”A“š“I‘O—§‘BŘœphV‚ç‚ľ‚˘ŽĄ—Ă–@‚Í‚ť‚ę‚É‘ă‚肤‚é‚Š. ŹŽÄŒ’i”ĺj: ‘ć47‰ń–k—¤ˆăŠw‰ď‘‰ď, ‘ć361‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď–k—¤’n•ű‰ď (93.09.05), ‹ŕ‘ň.

2710. mŠw‰ďi’n•űjn i“Á•Ęu‰‰j gŒo”A“š“I‘O—§‘BŘœhV‚ľ‚˘ŽĄ—Ă–@‚Í‚ť‚ę‚É‘ă‚í‚肤‚é‚Š. ŹŽÄŒ’i”ĺj: ‘ć47‰ń–k—¤ˆăŠw‰ď‘‰ďĽ‘ć361‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď–k—¤’n•ű‰ď (93.09.05), ‹ŕ‘ň.

2711. mŠw‰ďi’n•űjn i“Á•Ęu‰‰j ŹŽ™ŠútŽžŠł|’ˇŠú—\Œă‚ĚŒťó‚Ć–â‘č“_|. Žđˆä‹Ši”ĺj: ‘ć10‰ń’†‘Žl‘ŹŽ™t‘Ÿ•aŠw‰ď i93.12.11`12j, L“‡.

2712. mŠw‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ˜V”NŠú¸_Çó‚ɑ΂ˇ‚銿•ű—Ă–@|”ĺ”AŠí‰Č—Ěˆć|. Î‹´Wi”ĺj: ‘ć50‰ńŠÖ“ŒbM‰zŽx•”‰ď (93.10.23).

2713. mŠw‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŹŽ™–ŤtŽžŠł‚̐ŹlŠúˆÚs‚ւ̑Ήž. Žđˆä‹Ši”ĺj: ‘ć35‰ń_“ސěˆăŠw‰ďŹŽ™‰Č•Ş‰Č‰ď‘ć205‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ŢěŒ§’n•ű‰ď i93.11.20j, ‰Ą•l.

2714. mŠw‰ďi’n•űjn iƒ[ƒNƒVƒ‡ƒbƒvj t”ĺ”AŠí‰ČŠłŽŇ‚Ö‚ĚLaparoscopic Surgery. Â‹PşC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: ‘ć23‰ń“ú–{t‘ŸŠw‰ď“Œ•”•”‰ď (93.05.14), ‰Ą•l.

2715. mŠw‰ďi’n•űjn iƒ[ƒNƒVƒ‡ƒbƒvj Laparoscopic Surgery|t”ĺ”AŠíŽžŠł‚Ö‚Ě“K—p‚ƏŤ—ˆ‚Ě“W–]. “c“‡“Ձi“Œ‘ĺjC‰““Ą’‰—Yi”ĺj: ‘ć23‰ń“ú–{t‘ŸŠw‰ď“Œ•”•”‰ď (93.05.14), ‰Ą•l.

2716. mŠw‰ďi’n•űjn iƒ[ƒNƒVƒ‡ƒbƒvj t”ĺ”AŠíŽžŠł‚Ö‚ĚLaparoscopic Surgery. Â‹PşC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: ‘ć23‰ń“ú–{t‘ŸŠw‰ď“Œ•”•”‰ď (93.05.14`15), ‰Ą•l.

2717. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –ŤlH“§ÍŠłŽŇ‚É‚¨‚Ż‚ét×–EŠŕ‚Ě‚P—á. ’|ěŸŽĄC‰F“s‹{‘ńŽĄCŒF–ě˜a—YC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: ‘ć492‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ‹ž’n•ű‰ď (93.07.08), “Œ‹ž.

2718. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j 125‚h•WŽŻRƒKƒ“ƒ}[ƒZƒ~ƒmƒvƒƒeƒCƒ“ƒ‚ƒmƒNƒƒi[ƒ‹R‘Ě‚Ě•úŽËü‚¨‚ć‚іƉuŠw“IˆŔ’萍‚ɂ‚˘‚Ä. “Ą–ě’WlCÎ‹´Wi”ĺjCź“c—BŽjCˆË“cˆędC’†‘ňŒ\ŽĄCÎˆäŸŒČi•új: ‘ć39‰ń“ú–{ŠjˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (93.07.10), “Œ‹ž.

2719. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒRƒlƒNƒ^[•”‹T—ô‚É‚ć‚čŽg—p•s”\‚Ć‚Č‚Á‚˝ƒCƒ“ƒtƒŒƒ^ƒuƒŒ‰AŒsƒvƒƒXƒe[ƒVƒXAM700‚Ě1—á. Ź—ѐš“ńC‘ş–{ŤrC“Ą–ě’WlC“ŕ“c–LşC^‰şß•vCÎ‹´WCŹŽÄŒ’i”ĺj: “ú–{”ĺ”AŠí‰ČŠw‰ď_“ސě’n•ű‰ď (93.09.09), ‰Ą•l.

2720. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ’P—ŁŠÁ—Źt‚đ—p‚˘‚˝nicaraven(AVS)t•Ű‘śŒř‰Ę‚ĚŒ¤‹†. ^č‹`•FiŽŔ“ŽjCŒF–ě˜a—YC’‰ƑśC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: ‘ć29‰ń“ú–{ˆÚAŠw‰ď‘‰ď (93.09.16), ‹ŕ‘ň.

2721. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “Á”­Ť•Đ‘¤—Ť‰ť“ű–[‚Ě‚PÇ—á. ‘ş–{ŤrC“Ą–ě’WlCŽÄ“c—Y“ńC‘ĺě–ƒŽqCŽu‘ş“NC’|ěŸŽĄCŠ‹źŒMCÂ‹PşCŹŽÄŒ’i”ĺjC‘O“c“OiŽY•wj: ‘ć58‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”Žx•”‘‰ď (93.10.14), ŽD–y.

2722. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘O—§‘B”ě‘ĺÇ, ‘O—§‘BŠŕ‚ɑ΂ˇ‚郌[ƒU[(VLAP)—Ă–@. “ŕ“c–LşC‹y”\‹v—˛C‘ˆä‘ĽşC‚–Ř—TCź‘ş´ŽuC–{“c’źNCÂ‹PşCŹŽÄŒ’i”ĺj: ‘ć58‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”Žx•”‘‰ď (93.10.14), ŽD–y.

2723. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘O—§‘B”ě‘ĺÇ‚ɑ΂ˇ‚郌[ƒU[(VLAP)—Ă–@‚É‚¨‚Ż‚éĆŽË•ű–@‚ĚŒŸ“˘iƒrƒfƒIj. “ŕ“c–LşCŒ´–ě—TŽiC{ŽRˆę•äCÝŠy•q–çCÂ‹PşC“Ą–ě’WlC‰ĄŽR‰p“ńC^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺj: ‘ć58‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”Žx•”‘‰ď (93.10.14), ŽD–y.

2724. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Œœ‚‚É‚ć‚éŒĄˆř—Í‚Ě’˛Ž‚ƐݒčiäNă÷Œz•”’Ţ‚čă‚°p‚ɉ—‚āj. “c’†‹•˝CŹěG–íiŠÖ“Œ’üM•a‰@jC‰ĄŽR‰p“ńC^‰şß•vCŹŽÄŒ’i”ĺj: ‘ć58‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”Žx•”‘‰ď (93.10.15), ŽD–y.

2725. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ¸őĂ–ŹáŽ‚ɑ΂ˇ‚épŽŽ‚ĚŒŸ“˘|ŠJ•úŽčp‚Ć• –Œ‹ž‰şŽčp‚Ć‚Ě”äŠr|. Â‹PşC‰““Ą’‰—YC‹y”\‹v—˛CˆÉ“ĄŒ[ˆęC{ŽRˆę•äC“Ą–ě’WlC‰ĄŽR‰p“ńCŹŽÄŒ’i”ĺj: ‘ć58‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”Žx•”‘‰ď (93.10.15), ŽD–y.

2726. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Urolase‚É‚ć‚é‘O—§‘BƒŒ[ƒU[ĆŽË‚ĚŽŔŒą“IŒ¤‹†. ź‘ş´ŽuC“ŕ“c–LşC‘şŽR‰ëˆęC‰oěWC‰ĄŽR‰p“ńCŹŽÄŒ’i”ĺjCŒK”ö’čmC‹T’J“Oi•a—j: ‘ć58‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”Žx•”‘‰ď (93.10.15), ŽD–y.

2727. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j TURP‚Ě•]‰ż‚ÉŠÖ‚ˇ‚é2Ž{Ý‚Ě”äŠrŒŸ“˘|pŒă‚ĚŽŠŠoÇó‚̉ü‘P, QOL‚̕ωť, ‚¨‚ć‚Ńˆă—Ă”ď‚ɂ‚˘‚ā|. ŒĂ”¨˝”VC‰ĄŽR‰p“ńC‘vŹ_CŽOžŠN“TCX—˛ŽiCŠŰ“T•vC‰Ą“c^“ńC•ěƒCŹŽÄŒ’i”ĺjC”ZŔM•vi“Œ–k‘ĺj: ‘ć58‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”Žx•”‘‰ď (93.10.15), ŽD–y.

2728. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒhƒ‹ƒjƒGŽĐťHM-3‚É‚¨‚Ż‚é”jÓ—Í‚Ć”jÓŠÂ‹Ť•Ď‰ť‚ĚŠÖŒW‚ɂ‚˘‚Ä. {ŽRˆę•äCŒ´–ě—TŽiC‹v•ŰŻˆęCrěFC{ŽRo•äC’†žŠO—˛C˜ZŠpŽüCŒüˆäLĆC^‰şß•vCŹŽÄŒ’i”ĺjC’–Ł’źli•‘ H‘ĺj: ‘ć58‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”Žx•”‘‰ď (93.10.15), ŽD–y.

2729. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j tˆÚAŒăƒŒƒmƒOƒ‰ƒtƒB‚É‚ć‚éƒTƒCƒNƒƒXƒ|ƒŠƒ“táŠQ‚̐f’f‚ĚŽŽ‚Ý. “Ą–ě’WlC‘ş–{ŤrC“ŕ“c–LşCăđ‹PsC‚‹´—Tˆę˜YC‹g‘ňˆę•FC’r“cŽ CŒF–ě˜a—YCÎ‹´Wi”ĺj: ‘ć58‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”Žx•”‘‰ď (93.10.15), ŽD–y.

2730. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Ž€‘̐tˆÚA‚̐t‹@”\‚ɉe‹ż‚ˇ‚éˆöŽq: “§Í‰ń”‚đŽw•W‚É‚ľ‚Ä‚ĚŒŸ“˘. ‰““Ą’‰—YCŒF–ě˜a—Yi”ĺjC‹{Œ´‰p•viś—jC•ş“Ą“§C‰ş“c‰vOC^‰şß•vCŹŽÄŒ’i”ĺjCŒY•”P•vC˛“ĄŒőŽjiŠOj: ‘ć58‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”Žx•”‘‰ď (93.10.15), ŽD–y.

2731. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘O—§‘BŠŕ•aŠúf’f‚É‚¨‚Ż‚éŠeŽí‰ć‘œf’f–@‚Ě—L—pŤ‚ĆŒŔŠE. ‰oěWCěă’B‰›Cň”ŽˆęCŒŕŠ˛ƒC‰F“s‹{‘ńŽĄi”ĺjCŒK”ö’čmC‹T’J“Oi•a—jCÎ‹´WCŹŽÄŒ’i”ĺj: ‘ć58‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”Žx•”‘‰ď (93.10.15), ŽD–y.

2732. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j 3Ží—Ţ‚ĚPSA‘Ş’čƒLƒbƒg(Tandem R, DELFIA, EIKEN)‚Ě‘ŠŒÝŠÖŒW‚ɂ‚˘‚Ä. ěă’B‰›CŒŕŠ˛ƒC‰F“s‹{‘ńŽĄC‰–ě‰pŽjCň”ŽˆęC‰oěWCÎ‹´WCŹŽÄŒ’i”ĺj: ‘ć58‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”Žx•”‘‰ď (93.10.15), ŽD–y.

2733. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j TURP‚Ě•]‰ż‚ÉŠÖ‚ˇ‚é2Ž{ÝŠÔ‚Ě”äŠrŒŸ“˘|pŒă‚ĚŽŠŠoÇó‚̉ü‘P, QOL‚̕ωť, ‚¨‚ć‚Ńˆă—Ă”ď‚ɂ‚˘‚ā|. ŒĂ”¨˝”Vi”ĺj: ‘ć58‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”Žx•”‘‰ď (93.10.15), ŽD–y.

2734. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Œă• –Œo‚É”­ś‚ľ‚˝•˝ŠŠ‹Ř“÷Žî‚Ě1—á. ‹y”\‹v—˛C’|ěŸŽĄC“Ą–ě’WlC‰–ě‰pŽjCŒĂ”¨˝”VCŽOžŠN“TCÝŠy•q–çC˛X–Ř–M–žCŹ—ѐš“ńC•ş“Ą“§CŹŽÄŒ’i”ĺj: ‘ć9‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď_“ސě’n•ű‰ď (94.02.10), ‰Ą•l.

2735. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘˝”X–E‰ťˆŢkt‚ɍ‡•š‚ľ‚˝”X–E“ŕoŒŒ‚Ě1Ç—á. ŠŰ“T•vC‰Ą“c^“ńC“Ą–ě’Wli”ĺjCźŠŞ”Ži•új: ‘ć9‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď_“ސě’n•ű‰ď (94.02.10), ‰Ą•l.

2736. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j 10‚ŠŒŽ’jŽ™‚̐tŒ‹Î‚ɑ΂ˇ‚éESWL‚É‚ć‚鎥—ĂŒoŒą. Œ´–ě—TŽiCrěFC‹v•ŰŻˆęC^‰şß•vCŹŽÄŒ’i”ĺj: ‘ć9‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď_“ސě’n•ű‰ď (94.02.10), ‰Ą•l.

2737. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j 17”NŠÔ‚É4‰ń‚Ěbiopsy‚É‚Äfollow‚ľ“ž‚˝ŹŽ™Šú”­ÇIgAtÇ‚Ě‚P—á. ‰ş“c‰vOi”ĺjC”э‚Šě‹v—YiŽ™jCŒF–ě˜a—Yi”ĺjCŒK”ö’čmi•a—jCŽđˆä‹Ši”ĺj: ‘ć23‰ń“ú–{t‘ŸŠw‰ď“Œ•”•”‰ď i93.05.14`15j, ‰Ą•l.

2738. mŒ¤‹†‰ďi‘Űjn i“Á•Ęu‰‰j “§Í‚Š‚ç‚Ý‚˝ŠwZŒŸ”A‚Ě•]‰ż. Žđˆä‹Ši”ĺj: “ú’†tŽžŠłŠÇ—Œ¤‹†‰ď i94.02.18j, “Œ‹ž.

2739. mŒ¤‹†‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Dialysis prescription. ŒF–ě˜a—Yi”ĺj: 5th PD Forum i93.10.03j, ‘ĺˆé.

2740. mŒ¤‹†‰ďi‘S‘jn i‰ď’ˇu‰‰j 1992”N“xtˆÚA—Տ°WŒv•ń. ŹŽÄŒ’i”ĺj: ‘ć27‰ń“ú–{tˆÚA—Տ°Œ¤‹†‰ď (94.01.28), ˛˘•Ű.

2741. mŒ¤‹†‰ďi‘S‘jn i“Á•Ęu‰‰j 1992”N“xtˆÚA—Տ°WŒv•ń. ŹŽÄŒ’i”ĺj: ‘ć27‰ń“ú–{tˆÚA—Տ°Œ¤‹†‰ď (94.01.28), ’ˇč.

2742. mŒ¤‹†‰ďi‘S‘jn i“Á•Ęu‰‰j ŽĐ‰ď“IŽ‹–ě‚Š‚ç‚Ý‚˝CAPD—Ă–@. Žđˆä‹Ši”ĺj: CAPDƒi[ƒXƒJƒŒƒbƒWă‹‰ƒR[ƒX i93.11.01j, “Œ‹ž.

2743. mŒ¤‹†‰ďi‘S‘jn i‹łˆçu‰‰j ŒŒ‰t“§Í’†‚ĚŽ–ŒĚ‚Ć‘Îô. Žđˆä‹Ši”ĺj: ŒúśČ“§Íˆă—Ï]Ž–ŽŇŒ¤C‰ď i93.07.23j, “Œ‹ž.

2744. mŒ¤‹†‰ďi‘S‘jn i‹łˆçu‰‰j • –Œ“§Í‚ĚŠî‘b, ś—Šw; …Ľ—nŽż‚Ě—A‘—“Ž‘Ô. ŒF–ě˜a—Yi”ĺj: ‘ć1‰ńMDƒJƒŒƒbƒW i93.09.04j, “Œ‹ž.

2745. mŒ¤‹†‰ďi‘S‘jn i‹łˆçu‰‰j ŽŠ“K“§Í‚ĆAPD—Ă–@. ŒF–ě˜a—Yi”ĺj: ‘ć3‰ńCAPDƒi[ƒXƒJƒŒƒbƒW i94.01.21j, “Œ‹ž.

2746. mŒ¤‹†‰ďi‘S‘jn i‹łˆçu‰‰j tŽžŠłŽ™‚Ě•a—‚Ć•ŰŒ’. Žđˆä‹Ši”ĺj: ‘S‘—{ŒěŠwZ‹łˆőŒ¤C‰ď i94.02.02j, ‹v—˘•l.

2747. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ˆÚAŒă‚É”­Ç‚ľ‚˝ƒ€ƒR[ƒ‹‹ŰÇ‚Ě1—á. ÝŠy•q–çCX—˛ŽiCŒF–ě˜a—YC^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺjC”Ń’Ë‚_C”¨—˛Žui“ŕjCěă’B‰›i”ĺj: ‘ć27‰ń“ú–{tˆÚA—Տ°Œ¤‹†‰ď (94.01.29), ’ˇč.

2748. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒRƒ“ƒvƒ‰ƒCƒAƒ“ƒX‚ĚˆŰŽ‚ޏd—v‚ĆŽv‚í‚ę‚˝IgAtÇƒLƒƒƒŠ[ƒI[ƒo[‚Ě‚P—á. ‰ş“c‰vOi”ĺjC”э‚Šě‹v—YC‰Íź‹IşiŽ™jCŒK”ö’čmi•a—jCŽđˆä‹Ši”ĺj: ‘ć15‰ńŹŽ™t•s‘SŒ¤‹†‰ď i93.09.09j, ‘q•~.

2749. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŠwZŒŸ”A‚É‚ć‚é’ˇŠú—\Œă’ÇŐ‚ĚŒťó‚Ć–â‘č“_‚ÉŠÖ‚ˇ‚錤‹†. Žđˆä‹Ši”ĺjC‘qŽR‰pşi‘—§—Ă—{Šç—t“Œ•a‰@jC˛Œ´—Di“ú‘ĺjC•x‘ňCˆęi‘—§—Ă—{ŠVŠƒ•a‰@jC‚‹´š—˘iĂ‰ŞŒ§—§‚ą‚Ç‚ŕ•a‰@j: Œúś‰ČŠwŒ¤‹†ut•s‘Sˆă—ĂŒ¤‹†Ž–‹Ćv•˝Ź‚T”N“xŒ¤‹†‹ĆŃ•ń‰ď i94.02.25j, “Œ‹ž.

2750. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j TURP‚ĚŽč‹Z‚đ‚ß‚Ž‚Á‚Ä. ŹŽÄŒ’i”ĺj: ‘ć3‰ń_ŒË”ĺ”AŠí‰ČŽčp‹Z–@ŒŸ“˘‰ď (93.07.22), _ŒË.

2751. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j TURP‚ĚŽč‹Z‚đ‚ß‚Ž‚Á‚Ä. ŹŽÄŒ’i”ĺj: ‘ć3‰ń_ŒË”ĺ”AŠí‰ČŽčpŽč‹ZŒŸ“˘‰ď (93.07.22), _ŒË.

2752. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j TURP‚ĚŽč‹Z‚ƐV‚ľ‚˘ŽĄ—Ă–@. ŹŽÄŒ’i”ĺj: ”ĺ”AŠíƒZƒ~ƒi[ (94.03.17), •ÄŽq.

2753. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j CAPD‚ĚŒťó‚ƍĄŒă‚̉ۑč. Žđˆä‹Ši”ĺj: ƒeƒ‹ƒ‚Š”ŽŽ‰ďŽĐŠwpu‰‰‰ď i93.05.13j, `–ě.

2754. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j CAPD‚ĚŒťó‚ƍĄŒă‚̉ۑč. Žđˆä‹Ši”ĺj: ÎěŒ§t—F‰ďŠwpu‰‰‰ď i93.06.27j, ‹ŕ‘ň.

2755. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ŹŽ™t•s‘S‚ĚŒ´ŽžŠł. Žđˆä‹Ši”ĺj: ‘ć10‰ńç—tŒ§tƒZƒ~ƒi[ i93.07.10j, ç—t.

2756. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ˆă—Ă‚Ě•Ď‘J. Žđˆä‹Ši”ĺj: •˝Ź‚T”N“x’nˆć•ŰŒ’•ŸŽƒƒT[ƒrƒX’˛Ž‹@\ƒR[ƒfƒBƒl[ƒ^[Œ¤C‰ď i93.07.29j, ‰Ą•l.

2757. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j –Ťt•s‘S‚ĚŠÇ—‚ĆŽĄ—Á|Ĺ‹ß‚̐i•ŕ|. Žđˆä‹Ši”ĺj: âoŽsˆăŽt‰ďŠwpu‰‰‰ď i93.09.21j, âo.

2758. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j –Ťt•s‘SŠłŽ™‚ɑ΂ˇ‚鐏’ˇƒzƒ‹ƒ‚ƒ“—Ă–@’†‚̍œ–§“x‚̕ωť. Žđˆä‹Ši”ĺj: ‘ć18‰ńé‹ĘŒ§t•s‘S§’k‰ďŒ¤‹†”­•\‰ď i93.11.22j, ‘ĺ‹{.

2759. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j “§ÍŽĄ—Ă‚É‚¨‚Ż‚éĹ‹ß‚Ě“ŽŒü. Žđˆä‹Ši”ĺj: ‘ć2‰ń‰ş“cŽst—F‰ďu‰‰‰ď i93.12.05j, ‰ş“c.

2760. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ŽĐ‰ď“IŽ‹–ě‚Š‚ç‚Ý‚˝CAPD. Žđˆä‹Ši”ĺj: ‘ć7‰ń–k—¤CAPD—Տ°§˜b‰ď i93.12.12j, ‹ŕ‘ň.

2761. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j t‘Ÿ‚Ě•a‘ԂƉh—{Žw“ą. Žđˆä‹Ši”ĺj: AĽMĽG‰h—{Œ¤‹†‰ď i94.03.05j, ‘ĺ‹{.

2762. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ŹŽ™–Ťt•s‘S‚Ě—Ő°. Žđˆä‹Ši”ĺj: ‘ć3‰ńˆ¤’mŹŽ™”A˜HŽžŠłŒ¤‹†‰ď i94.03.19j, –źŒĂ‰Ž.

2763. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ŠwZŒŸ”AƒVƒXƒeƒ€‚ƍĄŒă‚̉ۑč. Žđˆä‹Ši”ĺj: Ă‰ŞŽsˆăŽt‰ďŽĺĂŠwZt‘ŸŒŸfu‰‰‰ď i94.03.26j, Ă‰Ş.

2764. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j Current status of endstage renal disease treatment in Japan. ŒF–ě˜a—Yi”ĺj: Monthly Renal Meeting in Baxter Healthcare Corporation i93.06.23j, McGau Park.

2765. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j tŽžŠł‚ĚŽŔ‘H“I•ŰŒ’Žw“ą‚Í‚ą‚¤‚ˇ‚é. Žđˆä‹Ši”ĺj: tŽžŠłĽ“œ”A•a—\–h‚Ě‚˝‚ß‚ĚŒ¤C‰ď i94.02.05j, ’ˇ–ě.

2766. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ŹŽ™Šút•s‘S‚ĚŠÇ—‚ĆŽĄ—Á|Ĺ‹ß‚Ě’mŒŠ‚Š‚ç|. Žđˆä‹Ši”ĺj: ‹ß‹EŹŽ™t‘Ÿ•aŒ¤‹†‰ď i94.02.19j, ‘ĺă.

2767. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j tŽžŠł‚ĚŽŔ‘H“I•ŰŒ’Žw“ą‚Í‚ą‚¤‚ˇ‚é. Žđˆä‹Ši”ĺj: tŽžŠłĽ“œ”A•a—\–h‚Ě‚˝‚ß‚ĚŒ¤C‰ď i94.02.19j, L“‡.

2768. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j tŽžŠł‚ĚŽŔ‘H“I•ŰŒ’Žw“ą‚Í‚ą‚¤‚ˇ‚é. Žđˆä‹Ši”ĺj: tŽžŠłĽ“œ”A•a—\–h‚Ě‚˝‚ß‚ĚŒ¤C‰ď i94.02.26j, ç—t.

2769. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j tŽžŠł‚ĚŽŔ‘H“I•ŰŒ’Žw“ą‚Í‚ą‚¤‚ˇ‚é. Žđˆä‹Ši”ĺj: tŽžŠłĽ“œ”A•a—\–h‚Ě‚˝‚ß‚ĚŒ¤C‰ď i94.03.12j, H“c.

2770. mŒ¤‹†‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“, 21˘‹I‚Ě–k—˘‘ĺŠw•a‰@‚đ–͍ő‚ˇ‚é|–k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éŠŕf—Á|. “ŕ“c–Lşi”ĺj: –k—˘‘ĺŠwƒpƒlƒ‹ƒVƒ“ƒ|ƒWƒEƒ€ (93.12.15), ‘Š–ÍŒ´.

2771. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘O—§‘B”ě‘ĺÇ, ‘O—§‘BŠŕ‚ɑ΂ˇ‚郌[ƒU[(VLAP)—Ă–@. “ŕ“c–Lşi”ĺj: ‘O—§‘BƒŒ[ƒU[ŽĄ—ĂŒ¤‹†‰ď, ’†•”’n‹ć‘ĺ‰ď (93.04.26), –źŒĂ‰Ž.

2772. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘O—§‘B”ě‘ĺÇ, ‘O—§‘BŠŕ‚ɑ΂ˇ‚郌[ƒU[(VLAP)—Ă–@. “ŕ“c–Lşi”ĺj: ‘O—§‘BƒŒ[ƒU[ŽĄ—ĂŒ¤‹†‰ď, ź“ú–{’n‹ć‘ĺ‰ď (93.04.27), ‘ĺă.

2773. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘O—§‘B”ě‘ĺÇ, ‘O—§‘BŠŕ‚ɑ΂ˇ‚郌[ƒU[(VLAP)—Ă–@. “ŕ“c–Lşi”ĺj: ‘O—§‘BƒŒ[ƒU[ŽĄ—ĂŒ¤‹†‰ď, “Œ“ú–{’n‹ć‘ĺ‰ď (93.04.28), “Œ‹ž.

2774. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘O—§‘B”ě‘ĺÇ, ‘O—§‘BŠŕ‚ɑ΂ˇ‚郌[ƒU[(VLAP)—Ă–@. “ŕ“c–Lşi”ĺj: ‘O—§‘BƒŒ[ƒU[ŽĄ—ĂŒ¤‹†‰ď, ‹ăB’n‹ć‘ĺ‰ď (93.04.29), •Ÿ‰Ş.

2775. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Ž€‘̐tˆÚAp’źŒă‚̐t‹@”\: “§Í—Ă–@‚đŽw•W‚É‚ľ‚Ä‚ĚŒŸ“˘. ‰““Ą’‰—YCŒF–ě˜a—YC•ş“Ą“§C‰ş“c‰vOCŹŽÄŒ’CŽđˆä‹Ši”ĺj: ‘ć45‰ń_“ސětŒ¤‹†‰ď (93.06.18), ‰Ą•l.

2776. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ACE‘jŠQÜ‚É‚ć‚č‹}Ťt•s‘S‚đ‹N‚ą‚ľ‚˝Žr‘̐tˆÚA‚Ě2—á. •ş“Ą“§C‰ş“c‰vOCŒF–ě˜a—YC^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺjCź‘ňŽ“TC˛“ĄŒőŽjCŠ`“cÍiŠOjC”–Ř“oi–Ɖuj: ‘ć5‰ń_“ސěˆÚAŒ¤‹†‰ď (93.06.19), ‰Ą•l.

2777. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ”A˜HƒXƒg[ƒ}‘˘Ý‚đ—v‚ˇ‚鎞Šł, pŽŽ, ‡•šÇ‚ɂ‚˘‚Ä. “ŕ“c–Lşi”ĺj: ‘ć9‰ń_“ŢěŒ§ƒXƒg[ƒ}ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“uK‰ď (93.06.19), ‘Š–ÍŒ´.

2778. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j “–‰Č‚É‚¨‚Ż‚é‘ć‚P—á–Ú‚Ě• o‹ž‰şt“Eœp|”AŠÇˆŮŠŠJŒű‚É‚ć‚鏗Ž™”AŽ¸‹Ö—á|. ‰ĄŽR‰p“ńCÂ‹PşC‘ĺě–ƒŽqC{ŽRˆę•äCŒ´–ě—TŽiCŹŽÄŒ’i”ĺj: ‘ć44‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (93.06.26), ěč.

2779. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‹ô”­“I‚É’ń‹Ÿ‚ł‚ę‚˝t‚É‚ć‚é”ńŒŒ‰ś‘̐tˆÚA‚Ě‚P—á. ‰““Ą’‰—YCŒF–ě˜a—YC‰F“s‹{‘ńŽĄC^‰şß•vCŹŽÄŒ’i”ĺj: ‘ć44‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (93.06.26), ěč.

2780. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j MEP—Ă–@‚É‚ÄˆęŽž“IŠ°‰đ‚Ě“ž‚ç‚ę‚˝, ‘O—§‘B•˝ŠŠ‹Ř“÷Žî‚Ě1—á. ‘vŹ_C‰oěWC“ŕ“c–LşCŹŽÄŒ’i”ĺj: ‘ć10‰ń_“ŢěŒ§‘O—§‘BŽîᇌ¤‹†‰ď (93.07.03), ‰Ą•l.

2781. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘O—§‘BŒ´”­Ductal Adenocarcinoma‚Ě‚P—á. ěă’B‰›C‰oěWCŒă“ĄNŽ÷CŒĂ”¨˝”VC{ŽRˆę•äCŹŽÄŒ’i”ĺj: ‘ć10‰ń_“ŢěŒ§‘O—§‘BŽîᇌ¤‹†‰ď (93.07.03), ‰Ą•l.

2782. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘O—§‘B”ě‘ĺÇ‚̐f’f‚ĆŽĄ—Ă. “ŕ“c–Lşi”ĺj: ‰Ą•lŽs’†‹ćˆăŽt‰ďu‰‰‰ď (93.11.16), ‰Ą•l.

2783. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j •\ÝŤäNă÷Šŕ‚ɑ΂ˇ‚éTUR-BtŒă‚ĚÄ”­–hŽ~‚ÉŠÖ‚ˇ‚錟“˘. ‘vŹ_CÂ‹PşC“ŕ“c–LşCŹŽÄŒ’i”ĺj: ‘ć45‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (93.11.20), ěč.

2784. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j tˆÚAŒă‚ÉŠĚ×–EŠŕ‚É‚ć‚莀–S‚ľ‚˝HBƒLƒƒƒŠƒA[‚Ě1—á. X—˛ŽiCÝŠy•q–çCŒF–ě˜a—YC^‰şß•vC‰““Ą’‰—YCŹŽÄŒ’i”ĺjC‘ĺ‹v•Ű[li“ŕjC“ŒŠC—Ń—˛’ji‰Ą{‰ę‹¤Ď•a‰@j: ‘ć27‰ń“ú–{tˆÚA—Տ°Œ¤‹†‰ď (94.01.28), ’ˇč.

2785. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‘O—§‘B“ÁˆŮRŒ´‚ĆŠŕ“]ˆÚ‚Ć‚ĚŠÖŒW. ěă’B‰›C‘vŹ_C{ŽRˆę•äCŽOžŠN“TCŒĂ”¨˝”VC‰oěWCÎ‹´WCŹŽÄŒ’i”ĺj: ‘ć8‰ń_“ŢěŒ§”A˜HŤŠíŠŕˆÚ“]Œ¤‹†‰ď (94.02.24), ’Ź“c.

2786. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j “§ÍŠłŽŇ‚Ě‚bŒ^ŠĚ‰Š‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ÷ˆäŒ’ŽĄi‹´–{ƒNƒŠƒjƒbƒNjC‰ş“c‰vOC•ş“Ą“§CŒF–ě˜a—YCŽđˆä‹Ši”ĺj: ‘ć9‰ń_“ŢěŒ§“§ÍŽ{Ý˜A—‹Ś‹c‰ď i93.11.28j, ‰Ą•l.

2787. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j “Ť• –Œ‰ŠŠłŽŇ‚É‚¨‚Ż‚éCAPDƒJƒe[ƒeƒ‹ƒoƒCƒIƒtƒBƒ‹ƒ€‚Ě‘–¸“dŒ°“IŠĎŽ@. •ş“Ą“§CŒF–ě˜a—YCX—˛ŽiC‰ş“c‰vOC‰Ą“c^“ńCŽđˆä‹Ši”ĺj: ‘ć8‰ń_“ŢěŒ§CAPDŒ¤‹†‰ď i94.03.26j, ‰Ą•l.


<<22 7 ”ĺ”AŠí‰ČŠw>>

2788. mŠwpÜi‘“ŕÜjn Texas Urological Society (93.14.01), a prize of essay contest. Rogers, E.CGoldstoneiƒxƒCƒ‰[ˆă‰Č‘ĺjC‘ĺ–x—i”ĺjCWheeler, T.W.CScardino, P.T.iƒxƒCƒ‰[ˆă‰Č‘ĺj.

2789. mŠw‰ďŽĺĂi‘“ŕŠw‰ďjn ‘ć27‰ń“ú–{tˆÚA—Տ°Œ¤‹†‰ď, t‘ŸˆÚA‚ĚŽĺ‚Ć‚ľ‚Ä—Ő°‚ÉŠÖ‚ˇ‚錤‹†‰ď(94.01.28), ’ˇč, ŹŽÄŒ’i”ĺj.


<<23 Šá‰ČŠw>>

2790. mŒ´’˜n Histopathological study of hereditary cataractous lenses in SCR strain rat. ‰Ş–ě’q•śiL‘ĺjC‰F‰ę–ÎŽOCÎě“NiŠájCƒXƒ~ƒ„ƒZƒCƒS: Exp. Eye Res., 57: 567`576, 1993.

2791. mŒ´’˜n Aggravation of experimental allergic conjunctivities by environmental chemical and physical factors. ‹{“cŠ˛•vC“ď”g—´lC–x“ŕ_ŽjCÂ–ؔɁCÎě“NiŠáj: Folia Med. Cracov., 34: 129`138, 1993.

2792. mŒ´’˜n Chronic intoxication on organophosphorus pesticide and its treatment. Îě“NC‹{“cŠ˛•vCÂ–ؔɁiŠájCHanai, Y.i‰Ą•l‘‘ĺj: Folia Med. Cracov., 34: 139`151, 1993.

2793. mŒ´’˜n Functional innervation of bovine ophthalmic artery. ‹g•xŒ’ŽuiŠájCIto, Y.i‹ă‘ĺj: Graefes Arch. Clin. Exp. Ophthalmol., 232: 122`126, 1993.

2794. mŒ´’˜n Morphological study on cataractous lens of senescence accerelated mouse (SAM). ź–{_”VC‰F‰ę–ÎŽOCÎě“NCŽR‰ş‘‰qiŠáj: Graefes Arch. Ophthalmol., 231: 722`728, 1993.

2795. mŒ´’˜n Critial flicker frequency in acute and recovered optic neuritis. Lin-Chung WongCŽá‘q‰ë“oCÎě“NiŠáj: Jpn. J. Ophthalmol., 37(2): 122`129, 1993.

2796. mŒ´’˜n Histopathological study of congenitally diabetic yellow KK mouse lens. Cuoqiang, L.U.C‰F‰ę–ÎŽOC‹{“cŠ˛•vCÎě“NiŠáj: Jpn. J. Ophthalmol., 37: 369`378, 1993.

2797. mŒ´’˜n Cerebello-oculo-hapato-renal syndrome with possible mitochondrial dysfunction. Žá‘q‰ë“oC”ľ–ě’ˇ•śiŠájCTakeno, S.i–ňŠwj: Jpn. J. Ophthalmol., 37: 62`69, 1993.

2798. mŒ´’˜n Short-cycle periodic alternating (ping-pong) gaze. Îě‹ĎCÎě“NCŒü–ě˜a—YiŠáj: Neurology, 43(6): 1067`1070, 1993.

2799. mŒ´’˜n Accommodative adaptation and age of onset of myopia. Lin-Chung WoungC‰LŽ”ˆę•FC“y‰Ž–M•FCÎě“NiŠáj: Ophthalmic Physiol. Opt., 13: 366`370, 1993.

2800. mŒ´’˜n Healing response of the epithelium after lateral needle injury of mouse lens. Wei XiaoC‰F‰ę–ÎŽOCÎě“NiŠáj: Ophthalmic Res., 25(1): 235`244, 1993.

2801. mŒ´’˜n Intrathymic injection of donor antigen-presenting cells prolongs heart graft survival. Krokos, N.V.CBrons, I.G.M.CSriwatanawongsa, V.CMakisalo, H.C•ĐŒŠ–r•vCHff, S.CDavies, R., Calne, Y.iŠáj: Transplant. Proc., 25(1): 303`304, 1993.

2802. mŒ´’˜n ”_ě‹Ć‚ĆŠÖŒW‚ľ‚Ä”­ě‚đŒJ‚č•Ô‚ˇ. ěč‚˘‚Â݁iŠáj: H

2803. mŒ´’˜n ’E‰P…ť‘Ě‚É“_óŹ‘÷‚Ş‘˝””F‚ß‚ç‚ę‚˝‚P—á. ”–؍LĆiŠájC‹g–ě‹v”üŽqiŒ§—§ƒKƒ“ƒZƒ“ƒ^[jC’šŠC‚ľ‚̂Ӂi’šŠCŠá‰ČjC‰F‰ę–ÎŽOCÎě“NiŠáj: H

2804. mŒ´’˜n ’áŠáˆł—Γŕá‚ĚŠáˆł“ú“ŕ•Ď“Ž‚ɑ΂ˇ‚éƒ`ƒ‚ƒ[ƒ‹‚ĚŒř‰Ę. ‹g•xŒ’ŽuCt–ěŒ÷iŠáj: ‚ ‚˝‚ç‚ľ‚˘Šá‰Č, 10(6): 1993.

2805. mŒ´’˜n Ž‹_ŒoŽžŠł‚ĚŽĄ—Ă. Žá‘q‰ë“oiŠáj: ‚ ‚˝‚ç‚ľ‚˘Šá‰Č, 10(7): 1073`1081, 1993.

2806. mŒ´’˜n ‘˝Ę‚Č”]_ŒoÇó‚đ’ć‚ľ‚˝ˆŤŤƒŠƒ“ƒpŽî‚Ě‚P—á. –]ŒŽˆęC‹g“cŠ°iŠájC—Ń“c“N˜NC{“c“ě”üi“s—§_Œo•a‰@j: Šá‰Č—Տ°ˆă•ń, 87(10): 51`55, 1993.

2807. mŒ´’˜n ŽăŽ‹ŽĄ—Ă—pŠá‹ž”“‚ĚŽ‹ŠoŽŐŽUŒř‰Ę. ”g˜C‰hŽqiORTjC‰LŽ”ˆę•FiŠájCŹ’Ź—SŽqiORTjCÎě“NiŠáj: Šá‰Č—Տ°ˆă•ń, 87(6): 1330`1334, 1993.

2808. mŒ´’˜n ƒS[ƒOƒ‹Œ^ƒrƒfƒIƒrƒ…[ƒ[‚đ—p‚˘‚˝–é–ӏNJłŽŇ‚Ě‚˝‚ß‚ĚŽ‹Šo•â•‹ď‚ĚŽŽě. ‰LŽ”ˆę•FCÂ–ؔɁCÎě“NiŠájC“ú‰ş•”łGiƒ\ƒj[j: Ž‹Šo‚̉Ȋw, 14(4): 194`199, 1993.

2809. mŒ´’˜n _ŒoƒTƒ‹ƒRƒCƒh[ƒVƒX‚É”ş‚¤‹…ŒăŽ‹_ŒoÇ‚Ěˆę—á ‹g“cŠ°i“s—§_Œo•a‰@jC–]ŒŽˆęiŠájC’߉ވę‰pC‰œ‘şGi“s—§•{’†•a‰@j: _ŒoŠá‰Č, 10(4): 340`344, 1993.

2810. mŒ´’˜n ŠÂ‹Ť‰ťŠw•¨Žż‚ĚŽŔŒą“IƒAƒŒƒ‹ƒM[ŤŒ‹–Œ‰Š‚ւ̉e‹ż. “ď”g—´lC–{ŠÔŒ[‘ C–x“ŕ_ŽjC’Ň‘ň‰F•FC‹{“cŠ˛•vCÎě“NiŠáj: “ú–{Šá‰ČŠw‰ďŽGŽ, 97(3): 297`303, 1993.

2811. mŒ´’˜n ŠÂ‹Ť‰ťŠw•¨Žż‚ĆŠáƒAƒŒƒ‹ƒM[ŽžŠł; ‚Ć‚­‚ɉԕ˛Ç‚ɂ‚˘‚Ä. ‹{“cŠ˛•vC“ď”g—´liŠáj: •a‘Ԑś—, 12: 650`652, 1993.

2812. mŒ´’˜n ƒAƒXƒRƒ‹ƒrƒ“Ž_‚ĚŽŔŒą“IƒAƒŒƒ‹ƒM[ŤŒ‹–Œ‰Š‚ɑ΂ˇ‚éŒř‰Ę. Žs•Ó‹`ÍiŠáj: –k—˘ˆăŠw, 23(6): 424`430, 1993.

2813. mŒ´’˜n ƒuƒ‰ƒEƒ“ŠÇ(CRT) ‹}Ť–\˜I‚É‚ć‚郉ƒbƒg”]“ŕƒ‚ƒmƒAƒ~ƒ“”Z“x, s“Ž‚ւ̉e‹ż. Ą“c–LiŠáj: –k—˘ˆăŠw, 23: 354`361, 1993.

2814. mŒ´’˜n Œđ‘㐍ăŽÎˆĘ‚Ö‚ĚFadenŽčp‚ĚŒŸ“˘. oŒű—R‹G‘ăiORT)CŹ—яƒŽqi‘Š–ÍŒ´‹Ś“Ż•a‰@jCÂ–ؔɁCÎě“NiŠáj: —Տ°Šá‰Č, 47: 1473`1476, 1993.

2815. mŒ´’˜n IOL ‘}“ü˜VlŠá‚Ě–Ń—l‘Ě‹ŘŽűk”\. ‹g•xŒ’ŽuCÎě‹ĎC”ľ–ě’ˇ•śCź–{_”VCÎě“NiŠáj: —Տ°Šá‰Č, 47: 983`986, 1993.

2816. m€Œ´’˜n Šá‹…‰^“Ž‚Š‚ç‚Ý‚˝VDTě‹ĆŽž‚Ě”ć˜JŒťŰ. ˛“Ą”üŘŽqCÄ“Ą—˛iŠájCź–ěĘŽqiORTjCÂ–ؔɁCÎě“NiŠáj: “ú–{‚ĚŠá‰Č, 64: 240`243, 1993.

2817. m’Z•ńn The 1991 Japanese Neuro-Ophthalmology Society Meeting. Žá‘q‰ë“oiŠáj: J. Clin. Neuroophthalmol., 13(2): 144`146, 1993.

2818. mŒ¤‹†•ńn Ž‹ŠÂ‹Ť“ü—̓f˛ƒXƒvƒŒƒC‚Ć‚ľ‚Ä‚ĚHMD. ‰LŽ”ˆę•FiŠáj: (ŽĐ)Ć–žŠw‰ď, ˆŔ‘SŤ‚ĆČƒGƒlƒ‹ƒM[‚đl—ś‚ľ‚˝“š˜HĆ–žŠÂ‹Ť‚ÉŠÖ‚ˇ‚é“Á•ĘŒ¤‹†ˆĎˆő‰ď•ń‘, 48: 53, 1993.

2819. mŒ¤‹†•ńn Ž‹_Œo‰Š‚Ě”­ś•p“x‚ĆŽĄ—Ă‚ÉŠÖ‚ˇ‚錤‹†. Žá‘q‰ë“oiŠáj: ‘ĺ˜aŘŒ”ƒwƒ‹ƒXŕ’c‚̏•Ź‚Ě‚ć‚錤‹†‹ĆŃW, 18: 108`113, 1993.

2820. mŒ¤‹†•ńiŒúśČjn Œ’NƒŠƒrƒ“ƒOŽŔ‘H•ń; Ć–ž•Ň. Îě“NC‰LŽ”ˆę•FiŠájCŠŁł—Yi“ŒH‘ĺjCŹ’čN•˝i’†‹ž‘ĺjCÎě˜a•vi“ŒHŒ|‘ĺjCŸş“c—˛‹`i“ŒŽĹjC–ž“šŹiŽO•H“d‹@jC’†‘ş–FŽ÷i“ŒH‘ĺj: ŒúśČˆĎ‘ő•˝Ź‚S”N“xŒ’NƒŠƒrƒ“ƒOŽŔ‘HƒKƒCƒhƒ‰ƒCƒ“ěŹ•ń.


<<23 2 Šá‰ČŠw>>

2821. mÇ—á•ńn Duane retraction syndrome associated with Chiari I malformation Hideo YamanouchiCYuji IwasakiCKenji SugaiCŒü–ě˜a—YiŠáj: Ped. Neurol., 9(4): 327`329, 1993.

2822. mÇ—á•ńn ƒAƒCƒ}[ƒNƒŒƒR[ƒ_[‚đ—p‚˘‚˝ƒAƒ‹ƒcƒnƒCƒ}[Œ^’s•đ‚Ě‹L‰ŻáŠQ‚ĚŒŸ“˘. Žs•Ó‹`ÍCÄ“Ą—˛iŠájCˆä‘ňŽu–ź–ěCÎě“NiŠáj: Šá‰Č—Տ°ˆă•ń, 87(10): 2141`2146, 1993.

2823. mÇ—á•ńn ƒx[ƒ`ƒFƒbƒg•a‚Ě‚P—á. •Ÿ“‡ˆęĆiŠáj: Šá‰Č—Տ°ˆă•ń, 87(7): 1499`1504, 1993.

2824. mÇ—á•ńn ”]Š˛•”oŒŒ‚É‚ć‚é’P“ĆŠŠŽÔ_Œo–ƒáƒ‚Ě‚P—á. Ą“c–LC“ŠŽRG•vCŒü–ě˜a—YCÎě“NiŠáj: _ŒoŠá‰Č, 10(1): 35`39, 1993.

2825. mÇ—á•ńn ƒAƒ‹ƒR[ƒ‹’†“Ĺ‚É‚ć‚é‚ƍl‚Ś‚ç‚ę‚鎋_ŒoáŠQ‚Ěƒrƒ^ƒ~ƒ“‚b—Ă–@. Îě“NC”ľ–ě’ˇ•śiŠáj: —Տ°ŠÂ‹ŤˆăŠw, 2(1): 3`5, 1993.

2826. mÇ—á•ńn ƒeƒNƒmƒXƒgƒŒƒXŠáÇ. Â–ؔɁCÎě“NiŠáj: —Տ°Šá‰Č, 47(3j:559`560, 1993.

2827. mÇ—á•ńn ŽîᇓEoŒăŽŇ–ž‚ČŽ‹—͉ń•œ‚Ě”F‚ß‚ç‚ę‚˝Šáâ|ŠC–ČóŒŒŠÇŽî‚Ě‚P—á. ‰œ˜eŒŤˆęC“Ą“c“NCŹ“ˆ—ǍGCŒü–ě˜a—YiŠáj: —Տ°Šá‰Č, 87: 266`269, 1993.

2828. m‘ŕn Retina and optic nerve disorders. Žá‘q‰ë“oiŠáj: Cur. Opin. Ophthalmol., 4(6): 16`21, 1993.

2829. m‘ŕn ’˛ß‚ĚƒƒJƒjƒYƒ€: Ĺ‹ß‚ĚŒ¤‹†“ŽŒü. ‰LŽ”ˆę•FiŠáj: NANO Ophthalmol., 5: 13`15, 1993.

2830. m‘ŕn ƒNƒŠƒjƒJƒ‹ƒGƒRƒƒW[‚Ć‚Í. “ď”g—´liŠáj: Practitoners, 2: 1703`1706, 1993.

2831. m‘ŕn Œ`‘ÔŠoiŽ‹—́jáŠQGŽ‹_Œo. Žá‘q‰ë“oiŠáj: Šá‰Č, 34(10 —Ő‘n): 1045`1051, 1993.

2832. m‘ŕn Ž‹Œđł•”‹ß–T•a•Ď‚ĆŠá‰^“ŽŒn. Â–ؔɁCŒü–ě˜a—YCˆ˘•”[ŽuiŠáj: Šá‰Č, 35(2): 129`135, 1993.

2833. m‘ŕn Šáˆł‚Ě“ú“ŕ•Ď“ŽŽŠ—Ľ_Œo‚Ě–đŠ„|‘Ě“ŕŽžŒv’†•‚É‚ć‚éŠáˆł‚̐§Œä‹@\|. ‹g•xŒ’ŽuiŠájC–Ř“ŕ—Ç–žCDouglas, S.GregoryiƒCƒG[ƒ‹‘ĺjCX’źŠ˛iŽY‹Ćˆă‘ĺjCŽR“c‰p’qi•Ÿ‰Ş‘ĺj: Šá‰Č, 35(3): 239`247, 1993.

2834. m‘ŕn Šá“ŕ•˝ŠŠ‹ŘƒCƒIƒ“ƒ`ƒƒƒlƒ‹‚ĆŽó—e‘Ě‚Ě“ÁŤ‚ɂ‚˘‚Ä. ‹g•xŒ’ŽuiŠájC–ź”¨”Ž”Vi’†ŠOť–ňjCˆÉ“Ą—S”Vi‹ă‘ĺjCŒIŽR‚Đ‚ë‚ľi’†ŠOť–ňj: Šá–ň—, 7(1): 5`15, 1993.

2835. m‘ŕn ƒRƒ“ƒsƒ…[ƒ^[‚đ—˜—p‚ľ‚˝•ŰŒ’‘Ěˆç‚ĚŽö‹Ć|‘ć‚P•ń; ‘Ěˆç‚É‚¨‚Ż‚éƒRƒ“ƒsƒ…[ƒ^[—˜—p‚̉”\Ť‚ĆŽŽ‚Ý. Ź‘ňŽĄ•vC[–ě–žC“ü]—FśC‰ŞčŸ”ŽC‡“c_“ńi’}”g‘ĺjCź”ö˛•śi“Œ‘ĺj: Œ¤‹†•ń, 33: 121`136, 1993.

2836. m‘ŕn ƒRƒ“ƒsƒ…[ƒ^[‚đ—˜—p‚ľ‚˝•ŰŒ’‘Ěˆç‚ĚŽö‹Ć|‘ć‚Q•ń; •ŰŒ’‚É‚¨‚Ż‚éƒRƒ“ƒsƒ…[ƒ^[—˜—p‚̉”\Ť‚ĆŽŽ‚Ý. ‰ŞčŸ”ŽC[–ě–žCŹ‘ňŽĄ•vC“ü]—FśC‡“c_“ńi’}”g‘ĺjCź”ö˛•śi“Œ‘ĺj: Œ¤‹†•ń, 33: 137`147, 1993.

2837. m‘ŕn –{Zś“k‚̐śŠˆ‚ĆŒ’NŽŔ‘Ô‚ÉŠÖ‚ˇ‚é’˛¸. Ź‘ňŽĄ•vC’ҍOC‘]Ş–rŽqCŠŰ•lşC“ü]—FśC‰ŞčŸ”ŽCŠÖŒű—˛ˆęC’†—˘—Fˆęi’}”g‘ĺjCÎě“NiŠáj: Œ¤‹†•ń, 33: 205`234, 1933.

2838. m‘ŕn ”­ˆçŠú‚̐ś“k‚É‚¨‚Ż‚éŒ`‘Ô‚¨‚ć‚Ń‘Ě—Í‚ĚŒÂlˇ‚ɂ‚˘‚Ä‚ĚŠî‘b“IŒ¤‹†|’†Šw‚P”Nś’jŽqś“k‚̍œ”N—‰–bŒúĽ‹ŘŒúĽĹ‘ĺŽ_‘fŰŽć—Ęƒpƒ[‚ɂ‚˘‚Ä. Ź‘ňŽĄ•vC‰ŞčŸ”Ži’}”g‘ĺjC•Ÿ‰i“N•vi“Œ‘ĺjC‰Á‰ę’J~ŽqCŞ–{—Ei“ú—‘Ě‘ĺjC‘ş“cŒő”́i“Œ—ˆă‘ĺjCˆÉ“ĄĂ•vi“ú‘Ě‹Śj: Œ¤‹†•ń, 33: 251`275, 1993.

2839. m‘ŕn ‚ŕ‚Á‚ĆŠá‹…ŒőŠw‚đ, ‚ť‚ľ‚Ä‚ŕ‚Á‚ĆŠáŒőŠw‚đ. ‰LŽ”ˆę•FiŠáj: Ž‹Šo‚̉Ȋw, 14(2): 67, 1993.

2840. m‘ŕn ŠÂ‹Ť–â‘č‚Ć“ľE. “ď”g—´liŠáj: _ŒoŠá‰Č, 10(2): 137`145, 1993.

2841. m‘ŕn ŠÂ‹Ť–â‘č‚Ć“ľE. “ď”g—´liŠáj: _ŒoŠá‰Č, 10: 137`145, 1993.

2842. m‘ŕn ƒ}ƒ‹ƒ`ƒ`ƒƒƒ“ƒlƒ‹. ‰LŽ”ˆę•FiŠáj: _ŒoŠá‰Č, 11: 86`88, 1994.

2843. m‘ŕn “ľEˆŮí‚ĆŽŠ—Ľ_Œo. Œü–ě˜a—YCÎě“NiŠáj: “Œ‹ž—Žqˆă‰Č‘ĺŠwŽGŽ, 63(1): 88`99, 1993.

2844. m‘ŕn ŽY‹ĆŒŸf, VDT ŒŸf‚ĆŽ–ŒăŠÇ—. Îě“NiŠáj: “ú–{‚ĚŠá‰Č, 64(2): (3)`(7), 1993.

2845. m‘ŕn “ľE; _ŒoŽx”z‚Ɛś‘Ě“ŕŠˆŤ•¨Žż. ‹g•xŒ’ŽuiŠáj: “ú–{‚ĚŠá‰Č, 64(5): 3`7, 1993.

2846. m‘ŕn ‹}Œƒ‚ČŽ‹—͒ቺ‚đ‘i‚Ś‚˝‚Ć‚Ť. Žá‘q‰ë“oCÎě“NiŠáj: “ú–{ˆăŽt‰ďŽGŽ, 110(8): 1003`1006, 1993.

2847. m‘ŕn ŽY‹Ć‚É‚¨‚Ż‚éŠá‚ĚŒ’Ni“ÁW: Šá‚Ě•ŰŒ’). Â–ؔɁCÎě“NiŠáj: •ŰŒ’‚̉Ȋw, 35: 302`306, 1993.

2848. m‘ŕn ƒhƒCƒcĽƒGƒ€ƒXƒ^[ƒ‹—Տ°ŠÂ‹ŤˆăŠwŒ¤‹†Š‚ĚĐ‰î. “ď”g—´liŠáj: —Տ°ŠÂ‹ŤˆăŠw, 2: 31`40, 1993.

2849. m‘ŕn ’čŠúŒ’Nf’f‚ĚĹ‹ß‚ĚŒXŒü|Ž‹—ÍŒŸ¸, Šá’ęŒŸ¸, ŠáˆłŒŸ¸, ”’“ŕáŒŸ¸|. Â–ؔɁCÎě“NiŠáj: —Տ°Źl•a, 23: 1418`1421, 1993.

2850. muŔn Ž‹Šo‚ÉŠÖ‚ˇ‚éŽčŒy‚ČŽŤ‘‚ĚĐ‰î. ‰LŽ”ˆę•FiŠáj: Vision, 5(2): 91`92, 1993.

2851. muŔn Šá‹…‰^“Ž‚ĚŽí—Ţ‚Ć‘Ş’č–@. ‰LŽ”ˆę•FiŠáj: ŒőŠw, 23(1): 2`8, 1994.

2852. muŔn V‚ľ‚˘ŽŠ—Ľ_ŒoŒŸ¸–@“dŽq“ľEŒv(ƒCƒŠƒXƒR[ƒ_[jƒ[ƒNƒVƒ‡ƒbƒv. Îě“NiŠáj: _ŒoŠá‰Č, 10(2): 105, 1993.

2853. muŔn •‹yŒ^“dŽq“ľEŒv; ƒCƒŠƒXƒR[ƒ_(C-2514j‚ɂ‚˘‚Ä. Îě“NC“ď”g—´liŠájCŹ’Ź—SŽqiORTjCÎě‹ĎC“Ą“c“NiŠájCź–ěĘŽqiORTj: _ŒoŠá‰Č, 10(2): 106`110, 1993.

2854. muŔn “ľE‚ÉŠÖ‚ˇ‚éĹ‹ß‚Ě–ň—Šw“Ii•ŕ. ‹g•xŒ’ŽuiŠá‰Čj: _ŒoŠá‰Č, 10(2): 116`119, 1993.

2855. mŠwp‘n i’P’˜j ‰ťŠw•¨Žż‰ß•qÇ‚Á‚Ä‚Ç‚ń‚Č•a‹C, Îě“NiŠáj. ‡“Żo”Ĺ, “Œ‹ž, 93.00.00”­s.

2856. mŠwp‘n i•Ş’SŽˇ•Mj V—Տ°Šá‰Č‘S‘ ‘ć2ŠŞB; —źŠáŽ‹, Žá‘q‰ë“oCÎě“NiŠáj. •ŇW ŽsěGC‘źC ‹ŕŒ´o”Ĺ, “Œ‹ž, 93.08.20”­s.

2857. mŠwp‘n i•Ş’SŽˇ•Mj V—Տ°Šá‰Č‘S‘, 6ŠŞ‚`, ŠOŠá•”‘OŠá•”ŽžŠł(1); Šáâ|ŽžŠłEŠá‹…ˆĘ’uˆŮí: (5)‘Sg•a‚Ć‚ĚŠÖ˜A; (6)•ĎŤ‚ĆˆŢk; (7)Žîá‡; (8)Šá‹…‚ĚˆĘ’uˆŮí, Žá‘q‰ë“oiŠáj. •ŇW ŽsěGC‘źC ‹ŕŒ´o”Ĺ, “Œ‹ž, 93.90.20”­s.

2858. mŠwp‘n i•Ş’SŽˇ•Mj Šá•a•Ď‚đ“ǂށ|‘SgŽžŠł‚ĆŠá|; ‘ć2Í (3)Ž‹–ěŒ‡‘š, p.43`44, Žá‘q‰ë“oCÎě“NiŠáj. f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 93.00.00”­s.

2859. mŠwp‘n i•Ş’SŽˇ•Mj ŽŠ—Ľ_Œo‚ĚŠî‘b‚Ć—Ő°(‘S–ʉü’ů”Ĺ); “ľE, p.86`95, ”’ěTŽ˘CÎě“NiŠáj. •ŇW Œă“Ą—R•vCź”ö—TC˛“ĄĆ•vC ˆă–ňƒWƒƒ[ƒiƒ‹ŽĐ, “Œ‹ž, 93.00.00”­s.

2860. mŠwp‘n i•Ş’SŽˇ•Mj Ą“ú‚ĚŽĄ—ĂŽwj; Šá¸”ć˜J, Â–ؔɁiŠájC‘ź. ˆăŠw‘‰@, “Œ‹ž, 93.00.00”­s.

2861. mŠwp‘n i•Ş’SŽˇ•Mj Šá‹…‰^“Ž‚ĚŽŔŒąS—Šw; (‘ć4Í)’˛ß‚Ćçtçs‚É‚¨‚Ż‚鏇‰ž, p.79`99, ‰LŽ”ˆę•FiŠáj. •ŇW ‰Fâ—ÇŽOCŒĂ‰ęˆę’jC’†aK•vC –źŒĂ‰Ž‘ĺŠwo”ʼnď, –źŒĂ‰Ž, 93.05.00”­s.

2862. mŠwp‘n i•Ş’SŽˇ•Mj (V•Ň) Š´ŠoĽ’mŠoS—Šwƒnƒ“ƒhƒuƒbƒN; 17(1). Ĺ“_’˛ß‚Ě‹@\‚Ɛ§Œä, p.886`888, 906`907, ‰LŽ”ˆę•FiŠáj. •ŇW ‘ĺŽRCĄˆäC˜a‹CC ˝M‘–[, “Œ‹ž, 94.01.00”­s.


<<23 3 Šá‰ČŠw>>

2863. m‚ť‚Ě‘ź‚Ě’˜‘n u“ľE‹Ů’ŁÇ‚Ş‹^‚í‚ę, ‚ť‚ĚŒă“ŽŠá_Œo–ƒáƒ‚ސis‚ľ‚˝‚PÇ—áv‚ɑ΂ˇ‚éEditorial Comment. Œü–ě˜a—YiŠáj: _ŒoŠá‰Č, 10(1): 000`000, 1993.

2864. m‚ť‚Ě‘ź‚Ě’˜‘n HT+V-I ‚ĆŠá (Editorial Comment). Žá‘q‰ë“oiŠáj: _ŒoŠá‰Č, 10(2): 156, 1993.

2865. m‚ť‚Ě‘ź‚Ě’˜‘n ƒŒ[ƒxƒ‹•a‚ɑ΂ˇ‚é–ň•¨—Ă–@. Žá‘q‰ë“oiŠáj: _ŒoŠá‰Č, 10(2): 168, 1993.

2866. m‚ť‚Ě‘ź‚Ě’˜‘n i‹¤’˜j ‚ ‚Č‚˝‚ŕ‰ťŠw•¨Žż‰ß•qÇH Îě“NC‹{“cŠ˛•viŠáj. ”_•ś‹Ś, 93.00.00”­s.

2867. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj Šá‰Č: Year Book; _ŒoŠá‰Č, ŽÎŽ‹ŽăŽ‹, ŹŽ™Šá‰Č, 1: 149`163, “ď”g—´liŠáj. •ŇW ’Ř“cˆę’jCA“c“N•vC“c–ě•Ű—YC f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 93.00.00”­s.


<<23 5 Šá‰ČŠw>>

2868. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Morphological study on cataractous lens of senescence accerelated mouse (SAM). ź–{_”VC‰F‰ę–ÎŽOCÎě“NCŽR‰şiŠáj: 1st Thailand-Japan Meeting on Ophthalmology i93.00.00j, Bangkok.

2869. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The evaluation at the autonmic nervous system in elemial sensitivi-ties –{ŠÔŒ[‘ CRea.WJCÎě“NC“ď”g—´lCJohnson.AR, Piamote A,iŠáj: 11th Annual International Symposium on Man and His Enviroment in Health and Disease i93.00.00j, Dallas,TX

2870. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Pupillary response in chemically sensitive patients Îě“NCĄ“c–LC“ď”g—´liŠáj: 11th Annual International Symposium on Man and His Enviroment in Health and Disease i93.00.00j, Dallas,TX

2871. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Measurement of segmental pupillary response with video segmental P-upillography system. “Ą“c“NC‹g•xŒ’ŽuCŠÖ’JŽĄ‹vC”’ěTŽ˘CÎě“NiŠáj: Association for Research in Vision and Ophthalmology i93.05.04j, Florida.

2872. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j High prevalence of the MT11778 mutation in mitochondrial DNA in Japanese leber' shereditary optic neuropathy with clinical heterogenneity. ŽÂ“cŒ[C^“‡s•FC”ę“c–FŽ÷CŹŒű–F‹viŒc‘ĺjCŽá‘q‰ë“oCěč‚˘‚Â݁iŠáj: Association for Research in Vision and Ophthalmology i93.05.04j, Fiorida.

2873. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Pre- and post-synaptic effects of endothelins on the rabbit IRIS sphincter and dilator muscles. Îě‹ĎC‹g•xŒ’ŽuiŠájCŒ´“c–FĆCŽ­ŽćMi–ň—jCÎě“NiŠáj: Association for Research in Vision and Ophthalmology i93.05.04j, Fiorida, USA.

2874. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Eye movement related topographical organization of the monkey nucleus reticularis tegmenti pontis. ŽR“c“OliŠájCSuzuki, D.A.CBetelak, K.F.CYee, R.D.: Association for Research in Vision and Ophthalmology i93.05.04j, Florida.

2875. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Pre- and post-synaptic effects of endothelins on the rabbit iris sphincter and dilator muscles. Îě‹ĎC‹g•xŒ’ŽuCŒ´“c–FĆCŽ­ŽćMi–ň—jCÎě“NiŠáj: Association for Research in Vision and Ophthalmology i93.05.04j, Florida.

2876. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Rapid increase of intracellular calciumion concentration after kainate administration in cultured Muller cells. Žá‘q‰ë“oCŽá—Ń‹BriŠájCŽR–{¸iŠĹŒěŠw•”j: Association for Research in Vision and Ophthalmology i93.05.06j, Florida.

2877. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Analysis of HLA antigens in Behcet's disease; Change in HLA against time. ‰œ˜eŒŤˆęCĄ“c–LCÎě“NiŠáj: International Congress of Clinical Ecology i93.09.04`05j, ˆŽě.

2878. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Analysis of HLA antigens in Behcetfs disease[Change in HLA against time. ‰œ˜eŒŤˆęCĄ“c–LC˛“Ą”üŘŽqCÎě“NiŠáj: International Congress of Clinical Ecology i93.09.05j, ˆŽě.

2879. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Cytosolic calcium transients through AMPA/KAINATE receptor incultured Muller cells. Žá‘q‰ë“oCŽá—Ń‹BriŠájCŽR–{¸iŠĹŒěŠw•”j: AER Meeting (34the Annula AER Meeting Scientific Programme) i93.09.18j, Granada.

2880. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Cytosolic calcium transients through AMPA/KAINATE receptor in cultured Muller cells. Žá‘q‰ë“oCŽá—Ń‹BriŠájCŽR–{¸i‰đj: 34th Annual Meeting of the Association for Eye Research i93.09.18j, Granada, Spain.

2881. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Participation of foodcolorings in experimental allergic conjunctivities. Nakayama.TC“ď”g—´lC‹{“cŠ˛•vCÎě“NiŠáj: International Congress of Clinical Ecology i93.00.00j, ˆŽě.

2882. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Perticipation of food colorings in experimental allergic conjunctivitis. ’†ŽR’q•FC“ď”g—´lC‹{“cŠ˛•vCÎě“NiŠáj: ‘ć‚P‰ń‘Ű—Տ°ŠÂ‹ŤˆăŠw‰ď i93.09.04j, ˆŽě.

2883. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Leber •a‚Ě“ľE‚ɂ‚˘‚Ä. ‰Ą]~ŽqCŽá‘q‰ë“oiŠáj: 34th Annual AER Meeting i93.09.18j, Granada.

2884. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Subtle Afferent Pupillary Deffect in Leber's Hereditary@Optic Neuropathy. Yokoe, J.CŽá‘q‰ë“oCÎě“NiŠáj: 34th Annual Meeting of the Association for Eye Research i93.09.18j, Granada, Spain.

2885. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€j –Ô–Œ_Œoß×–EG˜˜_. Žá‘q‰ë“oiŠáj: ‘ć47‰ń“ú–{—Տ°Šá‰ČŠw‰ď i93.10.15j, ‰Ą•l.

2886. mŠw‰ďi‘S‘jn i“Á•Ęu‰‰j Ž‹_ŒoÇ‚ĚŽĄ—Ă. Îě“NiŠáj: ‘ć31‰ń“ú–{_ŒoŠá‰ČŠw‰ď i93.11.11j, ‰Ą•l.

2887. mŠw‰ďi‘S‘jn i“Á•Ęu‰‰j Ž‹_ŒoÇ‚ĚŽĄ—Ă. Îě“NiŠáj: ‘ć31‰ń“ú–{_ŒoŠá‰ČŠw‰ď i93.11.11`12j, ‰Ą•l.

2888. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€j ‹´”íŠW–Ô—l‘̂ƒǐՊዅ‰^“ŽuŽ‹ŤŠá‹…‰^“Žv‚ÉŠÖ‚ˇ‚éĹ‹ß‚̐i•ŕ ŽR“c“OliŠájC ‘ć52‰ń“ú–{•˝t_Œo‰ČŠw‰ďƒvƒŒƒVƒ“ƒ|ƒWƒEƒ€ i93.11.25`26j, ‰Ą•l

2889. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒEƒTƒM“ľEŠ‡–ń‹Ř‚¨‚ć‚ŃŽU‘ĺ‹Ř‚É‚¨‚Ż‚éƒGƒ“ƒhƒZƒŠƒ“ƒŒƒZƒvƒ^[‚Ě“Á’Ľ Îě‹ĎC‹g•xŒ’ŽuiŠájCŒ´“c–FĆi–ň—jCÎě“NiŠájCŽ­ŽćMi–ň—j: ‘ć67‰ń“ú–{–ň—Šw‰ď i93.03.22j, ‹ž“s.

2890. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ľEŽU•ś‹Ř‚ĚƒtƒB[ƒ‹ƒhŽhŒƒ‚É‚ć‚éŽűk”˝‰ž‚ɑ΂ˇ‚éƒGƒ“ƒhƒZƒŠƒ“[‚PA[‚R‚Ě—}§ě—p. Îě‹ĎC‹g•xŒ’ŽuiŠájCŒ´“c–FĆi–ň—jCÎě“NiŠájCŽ­ŽćMi–ň—j: ‘ć66‰ń“ú–{–ň—Šw‰ď i93.03.27j, ‰Ą•l.

2891. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒx[ƒ`ƒFƒbƒg•a‚É‚¨‚Ż‚éhŽĺ‘¤ˆöŽq‚Ɗ‹ŤˆöŽq‚ɂ‚˘‚Ä. ‰œ˜eŒŤˆęCĄ“c–LC“Ą“c“NC“ď”g—´lC‹{“cŠ˛•vCÎě“NiŠáj: ‘ć‚Q‰ń“ú–{—Տ°ŠÂ‹ŤˆăŠw‰ď‘‰ď i93.04.17j, “Œ‹ž.

2892. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”_ě‹Ć‚É‚ć‚č”­ś‚đŒJ‚č•Ô‚ˇƒx[ƒ`ƒFƒbƒg•a‚Ě‚P—á. ěč‚˘‚Â݁CÎě“NC•Ÿ“‡ˆęĆiŠáj: ‘ć‚Q‰ń“ú–{—Տ°ŠÂ‹ŤˆăŠw‰ď‘‰ď i93.04.17j, “Œ‹ž.

2893. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œ´“cŽ•a‚ɑ΂ˇ‚éƒAƒXƒRƒ‹ƒrƒ“Ž_‘ĺ—Ę“Š—^‚ĚŽŽ‚Ý. •y‰Ş•q–çCŽs•Ó‹`ÍC“ď”g—´lC‹{“cŠ˛•vCÎě“NiŠáj: ‘ć‚Q‰ń“ú–{—Տ°ŠÂ‹ŤˆăŠw‰ď‘‰ď i93.04.17j, “Œ‹ž.

2894. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “řĘ–䗝ŽB‰e‚É‚ć‚éˆŮí‰ńůŠá‹…‰^“Ž‚ĚŠĎŽ@. “y‰Ž–M•FCÂ–ؔɁC‰LŽ”ˆę•FiŠájC’ˇ’JěˆęŽqi“ŕjCÎě‘Ľ•vi“ú–{Œő“dj: ‘ć‚W‰ńŠá‰ČMEŠw‰ď i93.04.17j, “Œ‹ž.

2895. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒx[ƒ`ƒFƒbƒg•a‚É‚¨‚Ż‚éhŽĺ‘¤ˆöŽq‚ɂ‚˘‚Ä. ‰œ˜eŒŤˆęCĄ“c–LC“Ą“c“NC“ď”g—´lC‹{“cŠ˛•vCÎě“NiŠáj: ‘ć‚Q‰ń“ú–{—Տ°ŠÂ‹ŤˆăŠw‰ď‘‰ď i93.04.17`18j, “Œ‹ž.

2896. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’E‰P…ť‘̔玿“ŕ‚Éč÷—ąó•¨Žż‚Ş‘˝””F‚ß‚ç‚ę‚˝”’“ŕá‚Ě‚P—á. ”–؍LĆCŒĂ–ě‹v”üŽqiŠájC’šŠC‚ľ‚̂ԁi’šŠCŠá‰Čˆă‰@jC‰F‰ę–ÎŽOCÎě“NiŠáj: ‘ć32‰ń”’“ŕáŠw‰ď i93.05.15j, ”ŸŠŮ.

2897. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ~ƒ…[ƒ‰[×–E‚É‚¨‚Ż‚éƒOƒ‹ƒ^ƒ~ƒ“Ž_Žó—e‘Ě‘śÝ‚̉”\Ť. Žá‘q‰ë“oCŽá—Ń‹BrCěč‚˘‚Â݁iŠáj: ‘ć97‰ń“ú–{Šá‰ČŠw‰ď i93.06.07j, ŽD–y.

2898. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j …ť‘̂̉Á—î‚ÉŠÖ‚ˇ‚錤‹†@‡T. Œ`‘ÔŠw“I•Ď‰ť. ‰F‰ę–ÎŽOiŠájCŹŒ´Šě—˛i“Ć‹Ś‘ĺjC’|•@áÁi‹¤—§–ň‘ĺjCźŒSG•vi’é‹žjCĄ“cŒőŽjCpśŠ°”ViŽQ“Vj: ‘ć97‰ń“ú–{Šá‰ČŠw‰ď i93.06.07j, ŽD–y.

2899. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j …ť‘̂̉Á—î‚ÉŠÖ‚ˇ‚錤‹† ‡U.“§–žŤ‚Ɛś‰ťŠw“Iƒpƒ‰ƒ[ƒ^[‚̕ωť. pśŠ°”VCĄ“cŒőŽjiŽQ“VjC‰F‰ę–ÎŽOiŠájC’|•@áÁi‹¤—§–ň‘ĺjCźŒSG•vi’é‹ž‘ĺjCŹŒ´Šě—˛i“Ć‹Śˆă‘ĺj: ‘ć97‰ń“ú–{Šá‰ČŠw‰ď i93.06.07j, ŽD–y.

2900. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j …ť‘̂̉Á—î‚ÉŠÖ‚ˇ‚錤‹† ‡V.Ž_‰ť“Iƒpƒ‰ƒ[ƒ^[‚̕ωť. ŹŒ´Šě—˛i“Ć‹Śˆă‘ĺjCĄ“cŒőŽjCpśŠ°”ViŽQ“VjC‰F‰ę–ÎŽOiŠájC’|•@áÁi‹¤—§–ň‘ĺjCźŒSG•vi’é‹ž‘ĺj: ‘ć97‰ń“ú–{Šá‰ČŠw‰ď i93.06.07j, ŽD–y.

2901. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j …ť‘̂̉Á—î‚ÉŠÖ‚ˇ‚錤‹† (‡W) ‹@”\Ťƒ^ƒ“ƒpƒNŽż‚̕ωť. ’|•@áÁi‹¤—§–ň‘ĺjCźŒSG•vi’é‹ž‘ĺjC‰F‰ę–ÎŽOiŠájCŹŒ´Šě—˛i“Ć‹Śˆă‘ĺjCĄ“cŒőŽjCpśŠ°”ViŽQ“Vj: ‘ć97‰ń“ú–{Šá‰ČŠw‰ď i93.06.07j, ŽD–y.

2902. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒEƒTƒM“ľE•˝ŠŠ‹Ř‚ɑ΂ˇ‚éƒGƒ“ƒhƒZƒŠƒ“‚̍ě—p‚¨‚ć‚ŃƒvƒƒXƒ^ƒOƒ‰ƒ“ƒf˛ƒ“‚ĚŠÖ—^. Îě‹ĎC‹g•xŒ’ŽuCÎě“NiŠáj: ‘ć97‰ń“ú–{Šá‰ČŠw‰ď i93.06.07j, ŽD–y.

2903. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒqƒg‚¨‚ć‚ŃƒEƒTƒM“Eo“ľE•˝ŠŠ‹Ř‚ɑ΂ˇ‚é Substance P ‚¨‚ć‚Ń Histamine ‚̍ě—p. ‹g•xŒ’ŽuCÎě‹ĎCÎě“NiŠáj: ‘ć97‰ń“ú–{Šá‰ČŠw‰ď i93.06.07j, ŽD–y.

2904. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j —L‹@—Ӎܒ†“Ĺ‚Ě“ľEˆŮí‚ÉŠÖ‚ˇ‚éŽŔŒą“IŒ¤‹†|ƒ‰ƒbƒg“řĘ–Ń—l‘Ě‚ĚƒJƒeƒR[ƒ‹ƒAƒ~ƒ“ŠÜ—Ę•ŞÍ|. Ą“c–LC‹{“cŠ˛•vCÎě“NiŠáj: ‘ć97‰ń“ú–{Šá‰ČŠw‰ď i93.06.07j, ŽD–y.

2905. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘ÎŒő”˝‰ž‚̍\ŹŹ•Ş‚ɂ‚˘‚Ä‚ĚŒŸ“˘. •ŸŒ´‰ë”VC“y‰Ž–M•FiŠájCŹ’Ź—SŽqiORTjC“ď”g—´lC‰LŽ”ˆę•FCÂ–ؔɁCÎě“NiŠáj: ‘ć97‰ń“ú–{Šá‰ČŠw‰ď i93.06.07j, ŽD–y.

2906. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j BellŒťŰ—U”­ŒăŠJáَž‚ĚŠáˆĘ‚Ć‚ť‚ĚˆĘ’u•âł‚ɂ‚˘‚Ä. Ş–{“OC‹g“cŠ°C–]ŒŽˆęiŠájCŠâˆäžÄˆęiŒÜ“úŽs•ŰŒ’Šj: ‘ć97‰ń“ú–{Šá‰ČŠw‰ď i93.06.07j, ŽD–y.

2907. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŒđŠ´_ŒoŒně“Ž–ň‚Ě‹üÜA’˛ß‚ւ̉e‹ż. ‘ĺ’Ë‹I‰ŔiŠájCoŒű—R‹G‘ăC‘ĺ–ؐç‰ŔiORTjC“y‰Ž–M•FC‰LŽ”ˆę•FCÎě“NiŠáj: ‘ć97‰ń“ú–{Šá‰ČŠw‰ď i93.06.07j, ŽD–y.

2908. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j …•˝ŽÎŽ‹‚É‚¨‚Ż‚é—Z‘œŒP—ű‚ĚŒř‰Ę. AźiŽqCŹ’Ź—SŽqiORTjC“ď”g—´lCÂ–ؔɁC‰LŽ”ˆę•FCÎě“NiŠáj: ‘ć49‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď i93.07.09j, ‘ĺ’Ă.

2909. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j …•˝ŽÎŽ‹‚É‚¨‚Ż‚é‹üÜ“x‚̕ωť. AźiŽqCŹ’Ź—SŽqiORTjC“y‰Ž–M•FC“ď”g—´lCÂ–ؔɁCÎě“NiŠáj: ‘ć49‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď i93.07.09j, ‘ĺ’Ă.

2910. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŽÎŽ‹Žčp‚Ě“ľE‚ɑ΂ˇ‚é‰e‹ż. źˆäFŽqCŹ’Ź—SŽqiORTjC‹g•xŒ’ŽuC”’ěTŽ˘CÎě“NiŠáj: ‘ć49‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď i93.07.09j, ‘ĺ’Ă.

2911. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŽÎŽ‹Žčp‚Ě“ľE‚ɑ΂ˇ‚é‰e‹ż. źˆäFŽqCŹ’Ź—SŽqiORTjC‹g•xŒ’ŽuC”’ěTŽ˘CÎě“NiŠáj: ‘ć49‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď i93.07.10j, ‘ĺ’Ă.

2912. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒlƒRŠO‘¤ƒVƒ‹ƒrƒEƒXă”玿ˆć(LS)‚̔玿üđ‘Ě‚¨‚ć‚є玿Ž‹ŠWƒjƒ…[ƒƒ“‚̉ž“š“ÁŤ‚ɂ‚˘‚Ä. John McHaffieiƒo[ƒWƒjƒAB—§‘ĺjCVˆä“cF—TiŠájCŽÔ“cł’jiVŠƒ‘ĺj: ‘ć98‰ń“ú–{‰đ–UŠw‰ď‘‰ď i93.07.22`24j, ŽD–y.

2913. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ľE‘ÎŒő”˝‰ž”gŒ`‚̍\ŹŹ•Ş•Ş—Ł. ‰LŽ”ˆę•FC•ŸŒ´‰ë”ViŠájCŹ’Ź—SŽq(ORT)C“y‰Ž–M•FiŠáj: ŒőŠw˜A‡ƒVƒ“ƒ|ƒWƒEƒ€ˆŽě'93 i93.09.00j, ˆŽě.

2914. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒEƒTƒM“ľEŠ‡–ń‹Ř‚É‚¨‚Ż‚éƒGƒ“ƒhƒZƒŠƒ“Žűkě—p‚ĆBQ-123‚É‚ć‚éhR. Îě‹ĎiŠájCŒ´“c–FĆi–ň—jC‹g•xŒ’ŽuiŠájCŽ­ŽćMi–ň—jCÎě“NiŠáj: ‘ć13‰ń“ú–{Šá–ň—Šw‰ď i93.09.04j, Šň•Œ.

2915. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •ĐŠáŤ‚ĚŽ‹—͒ቺ‚đ‚Ť‚˝‚ľSgÇ‚Ş‹^‚í‚ę‚˝‚Q—á. ź–ěĘŽqCźˆäFŽqCŠCă‹v”üŽqiORTjC‰Ą“cO”üCÂ–ؔɁCÎě“NiŠáj: ‘ć34‰ń“ú–{Ž‹”\‹¸łŠw‰ď i93.09.10j, ‘q•~.

2916. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠOŽÎŽ‹‚đŽĺ‘i‚Ć‚ľ‚˝Žá”N—Γŕá‚Ě‚P—á. ”ľ–ě’ˇ•śC‹g•xŒ’ŽuCÎě“NiŠáj: ‘ć‚S‰ń“ú–{—ΓŕáŠw‰ď i93.09.17j, “Œ‹ž.

2917. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Šá‹…‰^“Ž‚Š‚ç‚Ý‚˝VDT˜A‘ąě‹Ć‚É‚¨‚Ż‚é”ć˜J‚Ě’~Ď‚Ć‹xŒeŽžŠÔ‚ĚŒŸ“˘. ˛“Ą”üŘŽqiŠáj: ‘ć47‰ń“ú–{—Տ°Šá‰ČŠw‰ďƒeƒNƒmƒXƒgƒŒƒXŠáÇƒOƒ‹[ƒvƒf˛ƒXƒJƒbƒVƒ‡ƒ“ i93.10.15j, ‰Ą•l.

2918. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŕ•Ş”名Ž‹_ŒoÇ‚ɑ΂ˇ‚éƒXƒeƒƒCƒhĽƒpƒ‹ƒX—Ă–@‚¨‚ć‚Ń•úŽËü•š—p—Ă–@. Œü–ě˜a—YC•y‰Ş•q–çC–]ŒŽˆęC”ľ–ě’ˇ•śiŠáj: ‘ć47‰ń“ú–{—Տ°Šá‰ČŠw‰ď@Šáâ| i93.10.15j, ‰Ą•l.

2919. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”~“ŐŤŽ‹_ŒoÇ‚Ş‹^‚í‚ę‚˝‚RÇ—á‚É‚¨‚Ż‚é”äŠrŒŸ“˘. ”ľ–ě’ˇ•śCt–ěŒ÷CŽá‘q‰ë“oCÎě“NiŠáj: ‘ć47‰ń“ú–{—Տ°Šá‰ČŠw‰ď i93.10.15j, ‰Ą•l.

2920. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ăó‰čŽî‚̐f’f‚É‚˘‚˝‚é‚܂ŋȐ܂̂ ‚Á‚˝‚“x‚Ě—źŠáŽ‹—͏áŠQ. ‰Ą]~ŽqCŽá‘q‰ë“oCÎě“NiŠájCˆ˘•”Œ\“NiŽR—œˆă‘ĺjC–ě‘ş–FŽqiŁě_ŒoƒNƒŠƒjƒbƒNj: ‘ć47‰ń—Տ°Šá‰ČŠw‰ďƒOƒ‹[ƒvƒf˛ƒXƒJƒbƒVƒ‡ƒ“ i93.10.15j, ‰Ą•l.

2921. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Oculokinetic Perimetry (OKP) ‚ĚŠá‰ČŒŸf‚ւ̉ž—p. Žá‘q‰ë“oiŠájCŒiŽRäݗ˘Žqi“Œ‹žŒxŽ@jC•l’†‹P•Fi“úÔˆă—ĂƒZƒ“ƒ^[jC´…Œhˆę˜YiŠájCé‰ş‚Đ‚ëŽqC´…“§C”nęƒnƒ‹ƒ~C–ŘŽM”ü’ĂŽ}iOKPƒXƒN ƒŠ[ƒjƒ“ƒOj: ‘ć47‰ń“ú–{—Տ°Šá‰ČŠw‰ď i93.10.16j, ‰Ą•l.

2922. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “dŽq“ľEŒv‚É‚ć‚éV‚ľ‚˘ŽŠ—Ľ_Œoƒpƒ^[ƒ“•ŞÍ. “ď”g—´lCÎě“NiŠájCŹ’Ź—SŽqCAźiŽqiORTjCŒŃ“c’źrCŹ—эK—Yi•lƒzƒgj: ‘ć47‰ń“ú–{—Տ°Šá‰ČŠw‰ď i93.10.16j, ‰Ą•l.

2923. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •ĐŠáŤ‚ĚŽ‹—͒ቺ‚đ‚Ť‚˝‚ľSgÇ‚Ş‹^‚í‚ę‚˝‚Q—á. ź–ěĘŽqCŠCă‹v”üŽqCźˆäFŽqiORTjCÂ–ؔɁCÎě“NiŠáj: ‘ć34‰ń“ú–{Ž‹”\‹¸łŠw‰ď i93.11.06`07j, ‘q•~.

2924. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘ĺŠw‹łˆçuŽ‹Šo‹@”\—Ă–@ŠwvęUŠJÝ‚Ě–ÚŽw‚ˇ‚Ć‚ą‚ë. Œü–ě˜a—YCÂ–ؔɁiŠájC“ĄŽR—R‹IŽqiORTjCVˆä“cF—TC‰F‰ę–ÎŽOiŠáj: ‘ć34‰ń“ú–{Ž‹”\‹¸łŠw‰ď i93.11.06`07j, ‘q•~.

2925. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒCƒk–Ń—l‘̋؂̐ś—–ň—Šw“IŤŽż. ‹g•xŒ’ŽuCt–ěŒ÷iŠáj: ‘ć46‰ń“ú–{ŽŠ—Ľ_ŒoŠw‰ď‘‰ď i93.11.06j, “Œ‹ž.

2926. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”]ŒŒŠÇˆŮí‚Ş”­ŒŠ‚ł‚ꂸŒŒ‰t‚ĚHyperviscosity Syndrome ‚ŞŒ´ˆö‚Ć‚ľ‚čl‚Ś‚ç‚ę‚˝ˆę‰ßŤ•ĐŠáŤŽ‹—͏áŠQ‚Ě•p”­—á. ’†—˘éKCVˆä“cF—TC”Ń“c’”VCŽá‘q‰ë“oCÎě“NiŠáj: ‘ć31‰ń“ú–{_ŒoŠá‰ČŠw‰ď i93.11.11j, ‰Ą•l.

2927. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Leber•a‚Ĺ‚Í‘ÎŒő”˝‰ž‚ޏáŠQ‚ł‚ę‚É‚­‚˘. Žá‘q‰ë“oC‰Ą]~ŽqiŠájC^“‡s•FC”ę“c–FŽ÷iŒc‘ĺj: ‘ć31‰ń“ú–{_ŒoŠá‰ČŠw‰ď i93.11.11j, ‰Ą•l.

2928. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰@”]_ŒoŠO‰Č‚É‚¨‚Ż‚é“ŽŠá_Œo–ƒáƒÇ—á‚Ě•ŞÍ. “c’†ç•FC‘q“c˛C‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOjCŒü–ě˜a—YiŠáj: ‘ć31‰ń“ú–{_ŒoŠá‰ČŠw‰ď i93.11.11`12j, ‰Ą•l.

2929. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰@”]_ŒoŠO‰Č‚É‚¨‚Ż‚é“ŽŠá_Œo–ƒáƒÇ—á‚Ě•ŞÍ. “c’†ç•FC‘q“c˛C‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOjCŒü–ě˜a—YiŠáj: ‘ć31‰ń“ú–{_ŒoŠá‰ČŠw‰ď i93.11.12j, ‰Ą•l.

2930. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •úŽËüŽĄ—Ă‚É‚ć‚čŒy‰ő‚ľ‚˝Šáâ|ë’[•”ÇŒóŒQ‚Ě‚P—á. ‰Ô—ÖŽç•FC‘ĺ’Ë‹I‰ŔCŒü–ě˜a—YiŠáj: ‘ć31‰ń“ú–{_ŒoŠá‰ČŠw‰ď i93.11.12j, ‰Ą•l.

2931. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Œ´’źliŠájC‘ĺ–ؐç‰ŔiORTjC“y‰Ž–M•FCÂ–ؔɁC‰LŽ”ˆę•FCÎě“NiŠájC‚–Ř•ô•vCˆ˘•”tŽ÷C”“Œ••FiVŠƒ‘ĺjCŹŽR“c_C“ú‰ş•”łGiƒ\ƒj[j: ‘ć29‰ń“ú–{ŠáŒőŠwŠw‰ď i93.11.22j, _ŒË.

2932. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j The response properties of corticostriatal and corticotectal neurons in the feline lateral suprasylvian cortex. Vˆä“cF—TiŠájCJohn McHaffie: ‘ć17‰ń“ú–{_Œo‰ČŠw‘ĺ‰ď i93.12.09j, –źŒĂ‰Ž.

2933. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žs•Ó‹`ÍC“ď”g—´lC‹{“cŠ˛•vCÎě“NiŠáj: ‘ć97‰ń“ú–{Šá‰ČŠw‰ď‘‰ď i93.00.00j, ŽD–y.

2934. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŽĺŹ•Ş•ŞÍ‚ƐŹ•Ş„’č–@‚É‚ć‚é“ľE‘ÎŒő”˝‰ž‚̉đÍ. ‰LŽ”ˆę•FC•ŸŒ´‰ë”ViŠájCŹ’Ź—SŽqiORTjC“y‰Ž–M•FiŠáj: “ú–{Ž‹ŠoŠw‰ď1993”N‰ÄŠúŒ¤‹†‰ď i93.07.00j, ” Ş.

2935. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ž_‰ť–hŽ~Ü‚É‚ć‚éŽŔŒą“I™‰Ô•˛ƒAƒŒƒ‹ƒM[ŤŒ‹–Œ‰Š. ’†ŽR’q•FC“ď”g—´lC”’ěTŽ˘C‹{“cŠ˛•vCÎě“NiŠáj: ‘ć47‰ń“ú–{—Տ°Šá‰ČŠw‰ď i93.10.16j, ‰Ą•l.

2936. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j “ľE‹Ů’ŁÇ‚É‚¨‚Ż‚é“ľE‚Ě•”ˆĘ•Ę‰đÍ. “Ą“c“NC“ď”g—´lCŽs•Ó‹`ÍC‹{“cŠ˛•vCŠÖ’JŽĄ‹vCŒü–ě˜a—YCÎě“NiŠáj: ‘ć47‰ń“ú–{—Տ°Šá‰ČŠw‰ď i93.10.16j, ‰Ą•l.

2937. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‹­–Œ‰Š‚ɐŻ‚Ú‚¤ó”’”Á‚𔺂¤Ž‹_Œo–Ô–Œ‰Š‚đ‡•š‚ľ‚˝•aŒ^. ŻŽiŽĄ‘ăCŽá‘q‰ë“oCÎě“NiŠáj: ‘ć47‰ń“ú–{—Տ°Šá‰ČŠw‰ď i93.10.16j, ‰Ą•l.

2938. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ~ƒgƒRƒ“ƒhƒŠƒAˆâ“`Žq‚Ě11778”Ô‰–Šî‘ÎˆŮí‚đ‚ŕ‚ƒŒ[ƒxƒ‹•a‚Ě’˛¸i‚ť‚Ě‚Q)|‰đÍ•ű–@‚Ćˆâ“`“I”wŒi|. –x“cŠě—TC“Ą–ŘŒcŽqC‘ě‚ނ‚ąC‹ŕˆä~i‡“V‘ĺjC^“‡s•FC”ę“c–FŽ÷CŽÂ“cŒ[CŽR“cŒbŽqCŹŒű–F‹viŒc‘ĺjCÎ“c‚Ý‚łŽqi‘—§ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“jC Žá‘q‰ë“oCÎě“NiŠájC’†‘ş˝Câˆä÷CŽR–{ßi_‘ĺjC—ŃŒöŽqCŽO’JˆęŽOC‹{č–ΗYC‰ş‰œmCˆäŠX÷i•şˆă‘ĺjCˆÉ˛•~–őC‘ĺ’ë‹I—YiŽ­‘ĺjC‘‹g’ź ”üC’ˇ‘ëd’qi—Ž‘ĺj: ‘ć‚V‰ń“ú–{—Տ°Šá‰ČŠw‰ď i93.11.12j, ‰Ą•l.

2939. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŽŔŒą“I“ŻŠŤŠp–ŒˆÚA‚É‚¨‚Ż‚ésite-specific immunosuppression ‚ĚŒř‰Ę. •ĐŒŠ–r•viŠájCD.J.G.White, P.G.Watson iƒPƒ“ƒuƒŠƒbƒWj: ‘ć10‰ń“ú–{Šp–ŒˆÚAŠw‰ď i94.02.18j, “Œ‹ž.

2940. mŠw‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€j _ŒoŠá‰Č“I—§ę‚ć‚袊ááىş‚ UPDATEŁ. Œü–ě˜a—YiŠáj: ‘ć31‰ń–k“ú–{Šá‰ČŠw‰ď i93.07.03j, •Ÿ“‡.

2941. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j RHTLV-1R‘Ě—zŤ‚Ě‚Ô‚Ç‚¤–Œ‰Š‚Ě‚P—á. t–ěŒ÷C•ŸŒ´‰ë”VCŽá‘q‰ë“oCÎě“NiŠáj: ‘ć10‰ńŠÖ“ŒŠá‰ČŠw‰ď i93.06.12j, “Œ‹ž.

2942. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Šp–ŒŹ‘÷‚đŽc‚ľ‚˝”í‹s‘ŇŽ™ÇŒóŒQ. ŻŽiŽĄ‘ăCŽá‘q‰ë“oCÎě“NiŠáj: ‘ć10‰ńŠÖ“ŒŠá‰ČŠw‰ď i93.06.13j, “Œ‹ž.

2943. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j p’†“ž‚ç‚ę‚˝“řĘŘ•Đ‚ć‚č•a—f’f‚ł‚ę‚˝ƒŠƒ“ƒpŽî. •y‰Ş•q–çCˆ˘•”[ŽuCŽá‘q‰ë“oCÎě“NiŠáj: ‘ć31‰ń–k“ú–{Šá‰ČŠw‰ď i93.07.02j, •Ÿ“‡.

2944. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŽÎŽ‹Žčp‚Ě“ľE‚É‹y‚Ú‚ˇ‰e‹ż. ěč‚˘‚Â݁C“Ą“c“NiŠájCźˆäFŽqiORTjCĄ“c–LC“y‰Ž–M•FC”’ěTŽ˘CÎě“NiŠáj: ‘ć59‰ń“ú–{’†‰›•”Šá‰ČŠw‰ď, ‘ć90‰ń’†‘Žl‘Šá‰ČŠw‰ď‡“ŻŠá‰ČŠw‰ď i93.09.17j, “‡Ş.

2945. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŠOŽÎŽ‹‚Ɉڍs‚ˇ‚é•”•Ş’˛ßŤ“ŕŽÎŽ‹‚Ě‹üÜ‚Ć’˛ß. oŒű—R‹G‘ă(ORT)C“ď”g—´lCÂ–ؔɁCŒü–ě˜a—YCÎě“NiŠáj: ‘ć59‰ń“ú–{’†•”Šá‰ČŠw‰ďC‘ć90‰ń’†‘Žl‘Šá‰ČŠw‰ďC‘ć12‰ń‹üÜ’˛ßŒ¤‹†‰ď i93.09.17j, ź].

2946. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‹­”çÇŠłŽŇ‚É‚Ý‚ç‚ę‚˝‘ĺ‚Ť‚Č–Ô–ŒF‘fă”ç—ôE‚đ’ć‚ľ‚˝Œă•”‹­–Œ‰Š‚Ě‚P—á ˛“Ą”üŘŽqCĄ“c–LC‰œ˜eŒŤˆęC‹{“cŠ˛•viŠáj: ‘ć59‰ń“ú–{’†•”Šá‰ČŠw‰ďC‘ć‚X‰ń’†‘Žl‘Šá‰ČŠw‰ď i93.09.19j, “‡Ş.

2947. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Crow-Fukase ÇŒóŒQ‚ĚŠá‰Č“IŒŸ“˘. •ŸŒ´‰ë”ViŠájCŠCă‹v”üŽqC‘ĺ–ؐç‰ŔiORTjC“y‰Ž–M•FCÂ–ؔɁiŠáj: ‘ć19‰ń_“ŢěŒ§Šá‰Čˆă‰ď–k—˘‘ĺŠw‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.00.00j, _“ސě.

2948. mŒ¤‹†‰ďi‘S‘jn i‹łˆçu‰‰j ’˛ßŒ¤‹†Ĺ‹ß‚Ě“ŽŒü. ‰LŽ”ˆę•FiŠáj: “ú–{Šá‰ČŠw‰ďę–ĺˆă§“x‘ć19‰ńuK‰ď i93.06.07j, ŽD–y.

2949. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ˜V”NŽŇ‚̐_Œo‹@”\‚ÉŠÖ‚ˇ‚錤‹†. Žs•Ó‹`ÍCÄ“Ą—˛CÎě“NiŠáj: ŒúśČ’ˇŽő‰ČŠw‘‡Œ¤‹†”ďŒ¤‹†”­•\‰ď i93.02.00j, –źŒĂ‰Ž.

2950. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ”|—{‰Ć“eƒ~ƒ…[ƒ‰[×–E‚É‚¨‚Ż‚é Excitotoxic amino acid ‚ĚŒř‰Ę. ěč‚˘‚Â݁CŽá‘q‰ë“oiŠáj: •˝Ź‚T”Nś—Œ¤Ž‹ŠoŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€–Ô–Œ_Œo‰ń˜H‚Ě‹@”\•Ş‰ť‚ĆŽ‹_ŒoÄś‚̐ś—Šw“I•ŞŽqś•¨Šw“IŒ¤‹† i93.08.19j, ˆ¤’m.

2951. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰G•˝ă”çŽî‚̏ŠŒŠ‚đ’ć‚ľ‚˝G•˝ă”çŠŕ‚Ě‚P—á. ”–؍LĆC’†‘ňł”ŽCŽá‘q‰ë“oiŠájCŒĂ–ě‹v”üŽqiŒ§—§‚Ş‚ńƒZƒ“ƒ^[j: ‘ć28‰ńŠá‰Č—Տ°•a—‘gDŒ¤‹†‰ď i93.09.17j, “‡Ş.

2952. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Ž‡ŠOüĆŽË‚É‚ć‚éŽŔŒą“IŠp–ŒˆÚA‚Ě‹‘â”˝‰ž‚Ě—}§. •ĐŒŠ–r•viŠájCD.J.G.White, P.G.WatsoniƒPƒ“ƒuƒŠƒbƒWj: ‘ć22‰ńˆă—p‰ž—pŽ‡ŠOüŒ¤‹†‰ď i93.11.26j, “Œ‹ž.

2953. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ”|—{–Ô–ŒF‘fă”ç×–E‚É‚¨‚Ż‚éƒXƒgƒŒƒX‰ž“š‚ɂ‚˘‚Ä. Žá‘q‰ë“oiŠáj: ŒúśČ“Á’莞Šł–Ô–Œ–Ź—–ŒˆŢkÇ’˛¸Œ¤‹†”Ç i94.01.13`14j, ‹ž“s.

2954. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j –Ô–Œ‚Ěƒjƒ…[ƒƒ“‚ĆƒOƒŠƒA‚Ě‘ŠŒÝŠÖŒW‚ɂ‚˘‚Ä‚Ě‚PlŽ@. Žá‘q‰ë“oCěč‚˘‚Â݁Cˆ˘‘]ŽqiŠáj: ‘ć‚Q‰ń”ljď‹c‚¨‚ć‚ŃŒ¤‹†”­•\‰ďƒvƒƒOƒ‰ƒ€ i94.02.04j, ‘ĺă.

2955. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j Ž‹_ŒoŽžŠł‚ĚŽĄ—Á|Œťó‚ƏŤ—ˆ|. Žá‘q‰ë“oiŠáj: –kŠC“š‘ĺŠwŠá‰ČŠw‹łŽşƒZƒ~ƒi[ i93.11.22j, –kŠC“š.

2956. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j Šá‰Č‚Š‚ç‚Ý‚˝“Ş’É. Žá‘q‰ë“oiŠáj: “Ą‘ňŽsŠá‰Čˆă‰ď i93.11.25j, “Ą‘ň.

2957. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j Ž‹_ŒoŽžŠł|f’f‚ĆŽĄ—Ă‚É‚¨‚Ż‚é–â‘č“_|. Žá‘q‰ë“oiŠáj: ‘ć10‰ńL“‡Œ§Šá‰Čˆă‰ďuK‰ď i94.02.05j, L“‡.

2958. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j –Ô–Œ×–E‚É‚¨‚Ż‚éƒOƒ‹ƒ^ƒ~ƒ“Ž_Žó—e‘Ě‚Ć‚ť‚Ě–đŠ„. Žá‘q‰ë“oiŠáj: ‘ć26‰ń‹ž“s•{—§ˆă‘ĺŠá‰ČƒZƒ~ƒi[ i94.03.09j, ‹ž“s.

2959. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j Šáˆł“ú“ŕ•Ď“Ž‚ĚŠî‘b‚Ć—Ő° ‹g•xŒ’ŽuiŠáj: “Ą‘ňŽsŠá‰Čˆă‰ď i94.03.17j, “Ą‘ň.

2960. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j Šá’ęŽĘ^ŒŸ¸‚ĚŠî‘b. –x“ŕ_ŽjiŠájC •˝Ź‚T”N“x_“ŢěŒ§f—Ă•úŽË‹ZŽtuK‰ď i93.00.00j, ‰Ą•l.

2961. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j Źl•a‚ĆŠá. •Ÿ“‡ˆęĆiŠáj: ‘ć26‰ńJA•wl•””Ç’ˇ‡“ŻŒ¤C‰ď i93.00.00j, ‹S“{ě.

2962. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j •Ä‘‚É‚¨‚Ż‚éÉŽq‘ĚŽčp‚Ě‹ß‹ľ‚ƏpŒăŠÇ—‚ɂ‚˘‚Ä. ”’ěTŽ˘iŠáj: ‘ć58‰ń_“ŢěŒ§Šá‰ČW’k‰ď i93.10.07j, ‰Ą•l.

2963. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ƒXƒNƒŠ[ƒjƒ“ƒOŽ‹–ěŒv‚ʼn˝‚Ş‚í‚Š‚é‚Š. Žá‘q‰ë“oiŠáj: ‘ć10‰ńM‘ĺŠá‰Č—Տ°Œ¤‹†‰ďu’ˇ–ěŒ§—ΓŕáƒZƒ~ƒi[v i93.11.14j, ź–{.

2964. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j Leber's idopathic stellate neuroretinitis ‚ĆŽv‚í‚ę‚˝‚P—á. Ą“c–LC‰œ˜eŒŤˆęC˛“Ą”üŘŽqC“Ą“c“NiŠáj: ‘ć20‰ń_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i93.12.02j, ‘Š–ÍŒ´

2965. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j VśŒŒŠÇ—Γŕá‚Əɮq‘̍Ź‘÷‚đ‚Ť‚˝‚ľ‚˝–Ź—–ŒŒŒŠÇŽî‚Ě‚P—á. –{ŠÔŒ[‘ C”’ěTŽ˘CŽs•Ó‹`ÍiŠáj: ‘ć20‰ń_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i93.12.02j, ‘Š–ÍŒ´.

2966. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ÉŽq‘ĚŽčp’źŒă‚É”­Ç‚ľ‚˝‹•ŒŒŤŽ‹_ŒoÇ—á. ’†—˘éKC”’ěTŽ˘CÎě“NiŠáj: ‘ć21‚P‰ń_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.03.10j, ‘Š–ÍŒ´.

2967. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j —ź‘¤Ž‹—͒ቺ‚Ɛ…•˝Šá‹…‰^“ŽˆŮí‚đ”F‚ß‚˝‹ť–Ą‚ ‚éÇ—á Îě‹ĎCŹě‘דTC“y‰Ž–M•FCÎě“NiŠájCŹŁ‚˘‚­Žqi‚Ť‚č‚Ş‹uŠá‰Čj: ‘ć21‰ń_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.03.10j, ‘Š–ÍŒ´.

2968. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ŽŠ—Ľ_ŒoŒn‚ĆŠáˆł“ú“ŕ•Ď“Ž. ‹g•xŒ’ŽuiŠáj: ‘ć21‰ń_“ŢěŒ§Šá‰Čˆă‰ď–k—˘‘ĺŠw‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.03.10j, ‘Š–ÍŒ´.

2969. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j çtçs•s‘SŒ^ŠÔŒ‡ŤŠOŽÎŽ‹‚É‚¨‚Ż‚é—Z‘œŒP—ű‚ĚŒř‰Ę. ’ˇ]Ž”üC‘ĺ–ؐç‰ŔiORTjCÂ–ؔɁCÎě“NiŠáj: ‘ć58‰ń_“ŢěŒ§Šá‰ČW’k‰ď i93.00.00j, ‰Ą•l.

2970. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‰Ć‘°Ť‘ĺ’°ƒ|ƒŠƒ|[ƒWƒX‚É”F‚ß‚ç‚ę‚˝–Ô–ŒF‘fă”ç”ě‘ĺ‚Ě‚P—á. ‰Ą“cO”üiŠájCŻŽi—ĎŽqCAźiŽq(ORT)CÂ–ؔɁiŠáj: ‘ć20‰ń_“ŢěŒ§Šá‰Čˆă‰ď–k—˘‘ĺŠw‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i93.00.00j, ‘Š–ÍŒ´.

2971. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ƒeƒNƒmƒXƒgƒŒƒXÇŒóŒQ‚ɂ‚˘‚Ä; “Á‚É‹üÜ’˛ßŒn‚ւ̉e‹ż. ‰Ą“cO”üC–x“ŕ_ŽjiŠáj: ‘ć‚R‰ń´…Žs—§•a‰@‰@“ŕŒ¤‹†‰ď i93.00.00j, ´….

2972. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Ge-132‚É‚ć‚é”|—{…ť‘Ě‚ĚŹ‘÷‘jŽ~ě—p‘ą•ń’á”Z“x‚Ĺ‚Ěě—p‚ɂ‚˘‚Ä. •Ÿ“‡ˆęĆiŠáj: ƒQƒ‹ƒ}ƒjƒEƒ€Œ¤‹†‰ď i93.00.00j, “Œ‹ž.

2973. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ƒ~ƒRƒiƒ][ƒ‹Aƒtƒ‹ƒRƒiƒ][ƒ‹•š—p‚Ş’…Œř‚ľ‚˝ƒAƒJƒ“ƒgƒAƒ[ƒoŠp–Œ‰Š‚Ě‚P—á. Źě‘דTC”ľ–ě’ˇ•śCÎě‹ĎC“ď”g—´lC‹{“cŠ˛•viŠáj: ‘ć20‰ń–k—˘‘ĺŠw_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i93.00.00j, ‘Š–ÍŒ´.

2974. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ŠÂ‹Ť‰˜ő•¨Žż‚ĆƒAƒŒƒ‹ƒM[. “ď”g—´liŠáj: ‘ć‚P‰ńŠÂ‹ŤƒAƒŒƒ‹ƒM[ƒtƒH[ƒ‰ƒ€ i93.00.00j, “Œ‹ž.

2975. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ”_–ň“ŐŤ‚ĆƒAƒŒƒ‹ƒM[. “ď”g—´liŠáj: ‘ć‚Q‰ńŠÂ‹ŤƒAƒŒƒ‹ƒM[ƒtƒH[ƒ‰ƒ€ i93.00.00j, “Œ‹ž.

2976. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ƒŒnƒ‰ƒbƒg‚É‚ć‚éŽŔŒą“I“ŻŠŤŠp–ŒˆÚA •ĐŒŠ–r•viŠáj: ƒŠƒTƒJƒ“ i93.04.08j, “Œ‹ž

2977. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j “–‰G•˝ă”çŽî‚ƍl‚Ś‚ç‚ę‚˝G•˝ă”çŠŕ‚Ě‚P—á. ”–؍LĆiŠájCŒĂ–ě‹v”üŽqCŠâŸşŒ[ˆęiŒ§—§ƒKƒ“ƒZƒ“ƒ^[CŠájCŽá‘q‰ë“oCÎě“NiŠáj: ‘ć59‰ń’†•”Šá‰ČŠw‰ďŠá•a—‘gDŒ¤‹†‰ď i93.09.19j, “‡Ş.

2978. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ƒ~ƒgƒRƒiƒ][ƒ‹Aƒtƒ‹ƒRƒiƒ][ƒ‹•š—p‚Ş’˜Œř‚ľ‚˝ƒAƒJƒ“ƒgƒAƒ[ƒoŠp–Œ‰Š‚Ě‚P—á. Źě‘דTC”ľ–ě’ˇ•śCÎě‹ĎC“ď”g—´lC‹{“cŠ˛•viŠáj: ‘ć20‰ń_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i93.12.02j, ‘Š–ÍŒ´.

2979. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j VDTě‹ĆŽŇ‚É‚¨‚Ż‚é‹ßŒŠŽhŒƒŽž‚Ě“ľE”˝‰ž. “y‰Ž–M•FCÂ–ؔɁC•ŸŒ´‰ë”VC‰LŽ”ˆę•FCÎě“NiŠáj: ‘ć‚U‰ńƒeƒNƒmƒXƒgƒŒƒXŠáÇŒ¤‹†‰ď i94.00.00j, “Œ‹ž.


<<24 Ž¨•@ˆôA‰ČŠw>>

2980. mŒ´’˜n Hearing loss in old age-change in hearing with age (presbyacusis). ‰Ş–{–qlCÝŠy“N–çiŽ¨•@j: Asian Med. J., 36: 472`477, 1993.

2981. mŒ´’˜n “ÁˆŮ‚ČŒo‰ß‚đ‚˝‚Ç‚Á‚˝ƒ€ƒ“ƒvƒX“ď’Ž€ŠmŽŔ—á. źŽRkˆę˜YCÝŠy“N–çC‰Ş–{–qlCŒĂ‘ňTˆęCŹ–ě—YˆęC˛–씣C•˝ŽR•űriŽ¨•@j: Audiol. Jpn., 36: 238`242, 1993.

2982. mŒ´’˜n Malignant tumors of the head and neck in young patients. ’ˇŔ‰p–žC‚‹´LbC‰Ş–{–qlC”Ş”ö˜a—YiŽ¨•@jCŠâŸşŒ[ˆęi•a—j: Auris Nasus Larynx, 20: 145`154, 1993.

2983. mŒ´’˜n ƒƒjƒG[ƒ‹•a‚Ě•Ű‘ś“IŽĄ—Ă‚ĚŒř‰Ę”ť’č‚ɂ‚˘‚Ä. “ż‘Œú“ńC“Ą–ě–žlC‹g”ö’miŽ¨•@j: Equilibrium Res., (suppl.9): 121`125, 1993.

2984. mŒ´’˜n ‚ß‚Ü‚˘Ľ•˝táŠQ‚ĚŽĄ—ĂŒř‰Ę”ť’čŠî€ˆÄěŹ‚Ě’†ŠÔ•ń|“ú–{•˝t_Œo‰ČŠw‰ďˆĎˆő‰ďƒAƒ“ƒP[ƒg’˛¸‚𒆐S‚Ɂ|. …‰z“S—C“n•Ós—Yi•xŽRˆă‘ĺjCź‰i‹Şi“Ţ—Çˆă‘ĺjC“ż‘Œú“ńiŽ¨•@j: Equilibrium Res., (suppl.9): 133`138, 1993.

2985. mŒ´’˜n ć“VŤŠáU‚ĚŠá‹…‰^“ŽŒŸ¸ŠŒŠ‚ĚŒŸ“˘. ‹g”ö’mC“ż‘Œú“ńC“Ą–ě–žlC’ˇŔ‰p–žCV“cŒ’‘ž˜YC–ěŒű_’jCŻ–ěŒ÷CVˆäŠî—miŽ¨•@j: Equilibrium Res., 52(2): 192`199, 1993.

2986. mŒ´’˜n •űŒüŒđ‘㐍ăŒüŤ“ŞˆĘŠáU‚đ”F‚ß‚˝––˝‘O’됍‚ß‚Ü‚˘. ˆäŒű–F–žC“ż‘Œú“ńC“Ą–ě–žlC‹g”ö’mC’ˇŔ‰p–žiŽ¨•@j: Equilibrium Res., 52(3): 374`380, 1993.

2987. mŒ´’˜n Wallenberg ÇŒóŒQ‚ĚŠáU‚ɂ‚˘‚Ä. VˆäŠî—mC“ż‘Œú“ńC“Ą–ě–žlC‹g”ö’mC’ˇŔ‰p–žCŻ–ěŒ÷iŽ¨•@j: Equilibrium Res., 52(4): 544`551, 1993.

2988. mŒ´’˜n ‚—îŽŇ‚É‚¨‚Ż‚é BPPV ‚Ě•˝tŒP—űŒř‰Ę‚Ć–ň•¨—Ă–@‚Ě”äŠr. “Ą–ě–žlC“ż‘Œú“ńC‹g”ö’mC’ˇŔ‰p–žiŽ¨•@jC•Ä“c•qiś•¨•¨—ŒnjCV“cŒ’‘ž˜YC–ěŒű_’jCŻ–ěŒ÷iŽ¨•@j: Equilibrium Res., 52(4): 559`564, 1993.

2989. mŒ´’˜n ƒƒjƒG[ƒ‹•a‚Ě‚ß‚Ü‚˘”­ě’ź‘O‚Č‚ç‚Ń‚É”­ě’†‚Ě•˝t‹@”\. “ż‘Œú“ńC‹g”ö’mC“Ą–ě–žliŽ¨•@jCˆÉ•Ű´ŽqCó–ě˜a]i—ŐŒŸjC•Ä“c•qiś•¨•¨—Œnj: Equilibrium Res., 52(4): 590`601, 1993.

2990. mŒ´’˜n ƒXƒ|[ƒcŠO‚É‚¨‚Ż‚鎨•@ˆôA‰Č—Ěˆć‚̏áŠQ. ‰Ş–{–qliŽ¨•@j: M.D. Orthop., 7: 77`85, 1994.

2991. mŒ´’˜n “ŻŽíˆÚAŒŰ–ŒŒ`Źp‚É‚¨‚Ż‚éƒtƒBƒuƒƒlƒNƒ`ƒ“‚ĚŽg—p. ’ˇŔ‰p–žCÝŠy“N–çC‰Ş–{–qlC“ż‘Œú“ńiŽ¨•@j: Prog. Med., 13(11): 214`215, 1993.

2992. mŒ´’˜n ŒűŠW—ôŽ™‚̍\‰š”­’B-Žq‰š‚̏K“ž‚ĆˆŮí\‰š‚ĚŒo‰ß. —é–ŘŒbŽqC‰Ş–{˜NŽqCŒ´—R‹ICV”üŹ“ńiŽ¨•@jC’šŽ”ŸsiŒ`ŠOj: ‰šşŒžŒęˆăŠw, 4(2): 189`197, 1993.

2993. mŒ´’˜n ˆô“ŞŒ‹Šj‚Ě‚P—á. ź‰Ş–ž—TC‚‹´LbCŒĂě_ŽOCŽR–{ˆę”ŽiŽ¨•@j: ŒűoĽˆô“މČ, 5(2): 133`136, 1993.

2994. mŒ´’˜n ‰şb‰î‰ťŠwÜŽčp. ”Ş”ö˜a—YCÝŠy“N–çiŽ¨•@j: Ž¨•@‚Ć—Ő°, 39(2): 735`736, 1993.

2995. mŒ´’˜n •˝t‹@”\‚É‚¨‚Ż‚é‰Á—î•Ď‰ťC––˝‘O’ëáŠQŠłŽŇ‚ĚŒŸ¸’l‚Ɛłí•W€’l‚ɂ‚˘‚ā|. “ż‘Œú“ńiŽ¨•@jCó–ě˜a]i—ŐŒŸjC“Ą–ě–žlC‹g”ö’miŽ¨•@j: Ž¨•@‚Ć—Ő°, 39(•â2): 775`787, 1993.

2996. mŒ´’˜n “–‰Č‚É‚¨‚Ż‚éneoadjuvant chemotherapy‚ĚŒoŒą|. ˆî–؏Ÿ‰pC‚‹´LbC‰Ş–{–qlC”Ş”ö˜a—YiŽ¨•@j: Ž¨•@‚Ć—Ő°, 39(•â2): 775`787, 1993.

2997. mŒ´’˜n A“ŞŠŕ×–EŤ–Ɖu”\‚É‚¨‚ć‚Ú‚ˇ•úŽËüĆŽË—ʂ̉e‹ż. ”Ş”ö˜a—YC‚‹´LbC‰Ş–{–qlCˆî–؏Ÿ‰piŽ¨•@j: Ž¨•@ˆôA‰ČĽ“ŞŒz•”ŠO‰Č, 65(10): 813`818, 1993.

2998. mŒ´’˜n •ÂÇŤ‡–°Žž–łŒÄ‹zÇŒóŒQ‚É‚¨‚Ż‚éƒZƒtƒ@ƒƒƒgƒŠ[‚ĚŒŸ“˘. –]ŒŽ‚sC‰Ş–{–qlC“Ą“cŽj˜YC˛–씣iŽ¨•@j: Ž¨•@ˆôA‰ČĽ“ŞŒz•”ŠO‰Č, 65(9): 717`723, 1993.

2999. mŒ´’˜n ŹŽ™‹}Ť•›•@o‰Š‚Ě—Ő°“IŒŸ“˘. ź‰Ş–ž—TCÝŠy“N–çC”Ş”ö˜a—YC”óŒű˛GiŽ¨•@j: Ž¨•@—Տ°, 86(10): 1452`1459, 1993.

3000. mŒ´’˜n —ź‘¤ş‘ѐł’†ŒĹ’č‚ɑ΂ˇ‚é‘O•űŠJ‘ĺp. ŒĂě_ŽOCÝŠy“N–çCV”üŹ“ńiŽ¨•@j: “ŞŒz•”ŠO‰Č, 3(2): 113`118, 1993.

3001. mŒ´’˜n ŹŽ™^ŽěŽîÇ‚Ě’j—ˇ. ź‰Ş–ž—TCÝŠy“N–çC‰Ş–{–qlCŒĂě_ŽOC˛–씣iŽ¨•@j: “ú–{Ž¨•@ˆôA‰ČŠw‰ď‰ď•ń, 96(9): 1430`1437, 1993.

3002. mŒ´’˜n ăˆô“ŞŠŕ51Ç—á‚ĚŽĄ—Ă. ”Ş”ö˜a—YC‚‹´LbC‰Ş–{–qlCŒĂě_ŽOCˆî–؏Ÿ‰piŽ¨•@j: “ú–{Ž¨•@ˆôA‰ČŠw‰ď‰ď•ń, 96(9): 1438`1446, 1993.

3003. mŒ´’˜n “ŤŒűoĽˆô“Ş’×ᇂ̗Տ°“IŒŸ“˘. ˆî–؏Ÿ‰pC‚‹´LbiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ČŠw‰ď‰ď•ń, 96(9): 1457`1464, 1993.

3004. mŒ´’˜n “Á”­Ť—ź‘¤ŤŠ´‰š“ď’Ž‚ĚŒŸ“˘|‹}‘Źis—á‚ɂ‚˘‚ā|. •˝ŽR•űrCÝŠy“N–çC‰Ş–{–qlC˛–씣CŒĂ‘ňTˆęiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ČŠw‰ď‰ď•ń, 96: 903`913, 1993.

3005. m€Œ´’˜i‰p•śjn Cholesteatoma in children -Sex difference-. ź‰Ş–ž—TCÝŠy“N–çC‰Ş–{–qlC˛–씣iŽ¨•@j: Cholesteatoma and Mastoid Surgery Proceedings of the Form International Conference Niigata Japan, p.259`262, 1992.

3006. mŒ¤‹†•ńn ‚”N—î˜J“­ŽŇ‚Ě•˝t‹@”\‚É‚¨‚Ż‚é‰Á—î•Ď‰ť‚ĚŒŸ“˘. “ż‘Œú“ńC“Ą–ě–žlC‹g”ö’mC•˝ŽR•űriŽ¨•@jCˆÉ•Ű´ŽqCó–ě˜a]C—é–؏~ŽqC‰Í–ěŒOC‘şŽR^‹|i—ŐŒŸjC•Ä“c•qiś•¨•¨—Œnj: ‚”N—î˜J“­ŽŇ‚Ě•˝t‹@”\‚Ɛg‚Ě‚ą‚Č‚ľ”\—Í‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†•ń‘i’†ŠÔ•ńj‚”N—îŽŇŒŮ—pŠJ”­‹Ś‰ď, pp.1`4, 1993.

3007. mŒ¤‹†•ńi•ś•”Čjn ’ź—§Žp¨‚Ć—§ˆĘ‰^“ŽŽž‚̏dS“Ž—h‰đÍ‚É‚ć‚é‘Ě•˝t•]‰ż‚ÉŠÖ‚ˇ‚錤‹†. “ż‘Œú“ńiŽ¨•@j: •ś•”Č•˝Ź‚S”N“x‰ČŠwŒ¤‹†”ď•â•‹ŕiˆę”ĘŒ¤‹†‚b–G‰č“IŒ¤‹†jŒ¤‹†•ń‘i‰Ű‘č”ԍ† 02807159j, pp.1`35, 1993.

3008. mŒ¤‹†•ńi•ś•”Čjn •˝t‹@”\‚É‚¨‚Ż‚é‰Á—î•Ď‰ťC––˝Ť‘O’ëáŠQŠłŽŇ‚ĚŒŸ¸’l‚Ɛłí•W€’l‚ɂ‚˘‚Ä. “ż‘Œú“ńiŽ¨•@jCó–ě˜a]i—ŐŒŸjC“Ą–ě–žlC‹g”ö’miŽ¨•@j: •˝t‹@”\‚Ě”­’B‚ƉÁ—î•Ď‰ť‚ÉŠÖ‚ˇ‚錤‹†CŒ¤‹†‘ă•\ŽŇĽ–ě––“š•FC•ś•”Č•˝Ź3Ľ4”N“x‰ČŠwŒ¤‹†”ď•â•‹ŕ‘‡‚`Œ¤‹†Ź‰Ę•ń‘, pp.775`787, 1993.

3009. mŒ¤‹†•ńiŒúśČjn “ÁˆŮ‚ČŒo‰ß‚đ‚˝‚Ç‚Á‚˝ƒ€ƒ“ƒvƒX“ď’Ž. ÝŠy“N–çCźŽRkˆę˜YC‰Ş–{–qlC˛–씣C•˝ŽR•űrCŹ–ě—YˆęiŽ¨•@j: ŒúśČ“Á’莞Šł‹}Ť‚“x“ď’Ž’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†‹ĆŃ•ń‘, p.99`102, 1993.

3010. mŒ¤‹†•ńiŒúśČjn “Á”­Ť“ď’Ž‚ĚŒŸ“˘|‰Ć‘°Ť“ď’Ž‚ĆŽá”NŒ^“Á“ď‚Ć‚Ě”äŠr|. ÝŠy“N–çC•˝ŽR•űrC‰Ş–{–qlC˛–씣CŻ–ěŒ÷C’†ŽR–žmiŽ¨•@j: ŒúśČ“Á’莞Šł‹}Ť‚“x“ď’Ž’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†‹ĆŃ•ń‘, p.179`182, 1993.

3011. mŒ¤‹†•ńiŒúśČjn “Ë”­Ť“ď’Ž‚ĚŽü”g”•Ę’Ž—͉ń•œŤ‚ĚŒŸ“˘. ÝŠy“N–çC˛–씣C‰Ş–{–qlC•˝ŽR•űriŽ¨•@j: ŒúśČ“Á’莞Šł‹}Ť‚“x“ď’Ž’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†‹ĆŃ•ń‘, p.55`56, 1993.

3012. mŒ¤‹†•ńiŒúśČjn “Ë”­Ť“ď’Ž‚ĚŒŒ‰tŒŸ¸i‘ć4•ńjƒ€ƒ“ƒvƒXIgMR‘̉ż. ÝŠy“N–çC‰Ş–{–qlCźŽRkˆę˜YC’†ŽR–žmCŹ–ě—YˆęC˛–씣iŽ¨•@jC‚‹{t’ji—ŐŒŸjC‘ĺ’J‰pŽ÷i—Ő•a—jCŸ–””ü”gCŽR•Ó°”üi—ŐŒŸj: ŒúśČ“Á’莞Šł‹}Ť‚“x“ď’Ž’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†‹ĆŃ•ń‘, p.47`49, 1993.

3013. mŒ¤‹†•ńiŒúśČjn “Ë”­Ť“ď’Ž‚ÉŠÖ‚ˇ‚郏[ƒNƒVƒ‡ƒbƒv‚Ě‚Ü‚Ć‚ß. ÝŠy“N–çC‰Ş–{–qlC˛–씣C•˝ŽR•űrC’†ŽR–žmiŽ¨•@j: ŒúśČ“Á’莞Šł‹}Ť‚“x“ď’Ž’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†‹ĆŃ•ń‘, p.89`91, 1993.

3014. mŒ¤‹†•ńiŒúśČjn ‚ß‚Ü‚˘Ľ•˝táŠQ‚ĚŽĄ—ĂŒř‰Ę”ť’čŠî€ˆÄěŹ‚Ě’†ŠÔ•ń. “n•Ós—YC…‰z“S—i•xŽRˆă‘ĺjCź‰i‹Şi“Ţ—Çˆă‘ĺjC“ż‘Œú“ńiŽ¨•@j: ŒúśČ“Á’莞Šł‘O’ë‹@”\ˆŮí’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†•ń‘, pp.148`149, 1993.

3015. mŒ¤‹†•ńiŒúśČjn ƒƒjƒG[ƒ‹•a‚Ě•Ű‘ś“IŽĄ—Ă‚ĚŽĄ—ĂŒř‰Ę‚Ě”ť’č‚ɂ‚˘‚Ä. “ż‘Œú“ńC“Ą–ě–žlC‹g”ö’miŽ¨•@j: ŒúśČ“Á’莞Šł‘O’ë‹@”\ˆŮí’˛¸Œ¤‹†”Ç•˝Ź‚S”N“xŒ¤‹†•ń‘, pp.132`133, 1993.


<<24 2 Ž¨•@ˆôA‰ČŠw>>

3016. mÇ—á•ńn A case of cavernous hemangioma in the internal auditory canal. “Ą–ě–žlC“ż‘Œú“ńC‹g”ö’mC–ŕŽRˆŔOC’†ŽR–žmiŽ¨•@j: Auris Nasus Larynx, 20: 303`308, 1993.

3017. mÇ—á•ńn ‰şˆô“ŞŽîᇂދ^‚í‚ę‚˝bó‘B‹@”\’ቺÇ‚Ě‚P—á. VˆäŠî—mCŒĂě_ŽOC–ŕŽRˆŔOCŠ™“c—˜•FiŽ¨•@j: Ž¨•@ˆôA‰ČĽ“ŞŒz•”ŠO‰Č, 65(8): 665`668, 1993.

3018. mÇ—á•ńn ‘¤“ލœ“ŕŒ´”­‚ƍl‚Ś‚ç‚ę‚˝ˆŤŤƒŠƒ“ƒpŽî‚Ě‚P—á. –ěŒű_’jC–]ŒŽ‚sCŠ™“c—˜•FCŹěŽ“ńiŽ¨•@j: Ž¨•@ˆôA‰ČĽ“ŞŒz•”ŠO‰Č, 65(9): 757`760, 1993.

3019. mÇ—á•ńn A“ރJƒ‹ƒ`ƒmƒCƒh‚Ě‚P—á. źŽRkˆę˜YCŒĂě_ŽOC‚‹´LbC‰Ş–{–qlC”Ş”ö˜a—YC–ŕŽRˆŔOCŠ™“c—˜•FCˆî–؏Ÿ‰piŽ¨•@j: Ž¨•@ˆôA‰ČĽ“ŞŒz•”ŠO‰Č, 65(9): 761`764, 1993.

3020. m‘ŕn ‹Ç’, “h•z, “\•t. ‚‹´LbiŽ¨•@j: JOHNS, 9(4): 603`606, 1993.

3021. m‘ŕn ‰šşŠO‰Č‚ĚŒťó‚Ć“W–]. LŁ”ŁiŽ¨•@j: JOHNS, 9(5): 695`699, 1993.

3022. m‘ŕn ‚ß‚Ü‚˘Ľ•˝táŠQ‚ĚƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. “ż‘Œú“ńiŽ¨•@j: JOHNS, 9(7): 1127`1132, 1993.

3023. m‘ŕn H“š”­şŽ–Žn. LŁ”ŁiŽ¨•@j: JOHNS, 9(8): 106`108, 1993.

3024. m‘ŕn ˜V”NŽŇ‚Ě–ĄĽ‚É‚¨‚˘. ź‰Ş–ž—TCÝŠy“N–çiŽ¨•@j: JOHNS, 9(8): 1993.

3025. m‘ŕn ŒŒˆłˆŮí‚Ć“ŕŽ¨áŠQ. ‰Ş–{–qliŽ¨•@j: JOHNS, 9: 969`973, 1993.

3026. m‘ŕn •@b‰îƒgƒŠƒNƒ[ƒ‹|Ž_“h•z—Ă–@. ”Ş”ö˜a—YCÝŠy“N–çiŽ¨•@j: ƒAƒŒƒ‹ƒM[‚Ě—Ő°, 13: 28`31, 1993.

3027. m‘ŕn ‡–°Žž–łŒÄ‹zÇŒóŒQ‚̐f’f‚ĆŽĄ—Ă. ‰Ş–{–qliŽ¨•@j: ˆăŽ–V•ń, (3633): 25`29, 1993.

3028. m‘ŕn “ď’Ž. ‰Ş–{–qliŽ¨•@j: Œť‘ăˆă—Ă, 25: 2597`2601, 1993.

3029. m‘ŕn ’†Ž¨‰ŠŽčp‚Ě‹łˆçŽGŠ´. ÝŠy“N–çiŽ¨•@j: Ž¨•@ˆôA‰Č“W–], 37: 107`109, 1993.

3030. m‘ŕn Ž¨•@ˆôA‰Č‚Ě‹@”\ŒŸ¸ƒ}ƒjƒ…ƒAƒ‹|’ŽŠoŒŸ¸(3)Œę‰š•Ů•ĘŒŸ¸. ‰Ş–{–qliŽ¨•@j: Ž¨•@ˆôA‰ČĽ“ŞŒz•”ŠO‰Č, 65(11‘): 23`30, 1993.

3031. m‘ŕn ƒRƒŒƒXƒeƒŠƒ““÷‰čŽîŽčp. ź‰Ş–ž—TCÝŠy“N–çiŽ¨•@j: Ž¨•@ˆôA‰ČĽ“ŞŒz•”ŠO‰ČMook, 24: 116`120, 1993.

3032. muŔn “úíf—Ă‚É‘˝‚˘˜V”NŽŇ‚Ě‘i‚Ś|‚P‚ß‚Ü‚˘. “ż‘Œú“ńiŽ¨•@j: Geriatric Medicine, 31(11): 1425`1426, 1993.

3033. muŔn –ڂł݂鎨•@ˆôA‰Č|“ŤŒűoĽˆô“Ş’×á‡. ˆî–؏Ÿ‰piŽ¨•@j: Ž¨•@ˆôA‰ČĽ“ŞŒz•”ŠO‰Č, 65(5): 342`343, 1993.

3034. muŔn –ڂł݂鎨•@ˆôA‰Č|—ź‘¤”˝‰ń_Œo–ƒáƒi—ź‘¤ş‘ѐł’†ˆĘŒĹ’čj‚ɑ΂ˇ‚é‘O•űŠJ‘ĺp|. ŒĂě_ŽOiŽ¨•@j: Ž¨•@ˆôA‰ČĽ“ŞŒz•”ŠO‰Č, 65(6): 416`417, 1993.

3035. muŔn –ڂł݂鎨•@ˆôA‰Č|“Á‚ÉŽĄ—Ă‚đ—v‚ľ‚Č‚˘Œűo•a•Ď. ‚‹´LbiŽ¨•@j: Ž¨•@ˆôA‰ČĽ“ŞŒz•”ŠO‰Č, 65(7): 512`513, 1993.

3036. mŠwp‘i‰p•śjn i•Ş’SŽˇ•Mj Sleep Apnea and Rhonchopathy; Role of dynamic cephalometry in upper airway evaluation of obstructive sleep apnea syndrome, p.100`106, ‰Ş–{–qliŽ¨•@jC“Ą“cŽj˜Y. 93.00.00”­s.


<<24 3 Ž¨•@ˆôA‰ČŠw>>

3037. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ƒi[ƒX‚Ě‚˝‚ß‚Ě–ňŽŤ“T; Ž¨•@‰Č—p–ňÜ, p.215`216, ź‰Ş–ž—TiŽ¨•@jC ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 93.00.00”­s.


<<24 5 Ž¨•@ˆôA‰ČŠw>>

3038. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€j Quality of life in head and neck cancer patients strategy of treatment for head and neck cancer patients in considering quality of live (QOL). ‰Ş–{–qlC‚‹´LbC”Ş”ö˜a—YCˆî–؏Ÿ‰piŽ¨•@j: 2nd Sino-Japanese Otolaryngology-Head and Neck Surgery Academic Conference. i93.12.02j.

3039. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Immunological aspects of inflammatory middle ear diseases|sex differences. ź‰Ş–ž—TCÝŠy“N–çC‰Ş–{–qlC˛–씣iŽ¨•@j: ‘Ű’†Ž¨‰ŠŠw‰ď i93.04.01j, ‘ĺ•Ş.

3040. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Treatment for carcinoma of the maxillary sinus in consideration of preservation of the feature. ”Ş”ö˜a—YC‚‹´LbC‰Ş–{–qlCˆî–؏Ÿ‰piŽ¨•@j: 15th World Congress of Otorhinolaryngology Head and Neck Surgery i93.06.20`25j, Istanbul, Turkey, Abstracts, p.270, 1993.

3041. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Mumps and sudden deafness. źŽRkˆę˜YC‰Ş–{–qlCÝŠy“N–çiŽ¨•@j: 15th World Congress of Otorhinolaryngology Head and Neck Surgery i93.06.20`25j, Istanbul, Turkey, Abstracts, p.271, 1993.

3042. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Predictability of surgical outcome for obstructive sleep apnea syndrome by dynamic cephalometry (area measurement of pharyngeal air space and tongue base with IBAS-1). ‰Ş–{–qlC“Ą“cŽj˜YC–]ŒŽ‚siŽ¨•@j: 15th World Congress of Otorhinolaryngology Head and Neck Surgery i93.06.20`25j, Istanbul, Turkey, Abstracts, p.4298, 1993.

3043. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Myringophasty in outpatient clinic. ’ˇŔ‰p–žCÝŠy“N–çC“ż‘Œú“ńC‰Ş–{–qliŽ¨•@j: 15th World Congress of Otorhinolaryngology Head and Neck Surgery i93.06.22j, Istanbul, Turkey, Abstracts, p.231, 1993.

3044. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Chemosurgery with trichloroacetic acid in allergic rhinitis. ”Ş”ö˜a—YiŽ¨•@j: International Symposium on Infection and Allergy of the Nose i93.10.10j, Seoul, Program, p.41.

3045. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Proteins in pituita from patients with allergic rhinitis. ˆäŒű–F–žCÝŠy“N–çC”Ş”ö˜a—YCźŽRkˆę˜YiŽ¨•@jCŽ­ŽćMi–ň—j: International Symposium on Infection and Allergy of the Nose i93.10.11j, Seoul, Program, p.43.

3046. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The role of the carbon dioxide LASER in treatment of carcinoma of the tongue and the floor of mouth. ˆî–؏Ÿ‰pC‚‹´LbC‰Ş–{–qlC”Ş”ö˜a—YiŽ¨•@j: 10th Congress International Society for LASER Surgery and Medicine i93.11.12j, Bangkok, Abstract, p.259, 1993.

3047. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Prognosis of meniere's disease by conservative treatment: Retrospective study on the time course of the disease. “ż‘Œú“ńC“Ą–ě–žlC‹g”ö’miŽ¨•@j: International Symposium on Vestivular Disorders i94.01.21j, L“‡.

3048. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Analysis of false vocal cord and ventricle. Â–ö‘CÝŠy“N–çC‚‹´LbC”Ş”ö˜a—YCˆî–؏Ÿ‰pC‹ŕŽqŒ÷iŽ¨•@j: 2nd World Congress on Laryngeal Cancer i94.02.20`24j, Sydney, Abstract, p.182, 1994.

3049. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The efficacy of simultaneous chemoradiotherapy for cancer of the larynx. ˆî–؏Ÿ‰pC‚‹´LbC‰Ş–{–qlC”Ş”ö˜a—YiŽ¨•@jCź—Ń—˛i•új: 2nd World Congress on Laryngeal Cancer i94.02.20`24j, Sydney, Abstract, p.183, 1994.

3050. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Sterilization of temporal fascia homograft in myringoplasty. ’ˇŔ‰p–žCÝŠy“N–çC“ż‘Œú“ńC‰Ş–{–qliŽ¨•@jC‘ĺ’J‰pŽ÷i—Ő•a—jC‚‹{t’ji—ŐŒŸj: 2nd Extraordinary International Symposium on Recent Advances in Otitis Media i93.04.01j, ‘ĺ•Ş, Abstracts, p.193, 1993.

3051. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Study on vomiting of vestibulo-autonnomic reflex. Ż–ěŒ÷C“ż‘Œú“ńC‹g”ö’mCVˆäŠî—miŽ¨•@jC•Ä“c•qiś•¨•¨—Œnj: International symposium on Vestivular Disorders i94.01.21`22j, L“‡.

3052. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j “Ë”­Ť“ď’Ž‚đ‚ß‚Ž‚鏔–â‘č|“Á‚É•aˆö,•a‘Ԃɂ‚˘‚ā| —Տ°“I—§ę‚Š‚ç‚Ě•aˆö,•a‘Ô‚Ö‚ĚƒAƒvƒ[ƒ`. ÝŠy“N–çiŽ¨•@j: ‘ć3‰ń“ú–{Ž¨‰ČŠw‰ď i93.11.04j, –źŒĂ‰Ž, Otol. Jpn., 3(4): 383, 1993.

3053. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j “Ë”­Ť“ď’Ž‚đ‚ß‚Ž‚鏔–â‘č|“Á‚É•aˆö,•a‘Ԃɂ‚˘‚ā| —Տ°“I—§ę‚Š‚ç‚Ě•aˆö,•a‘Ô‚Ö‚ĚƒAƒvƒ[ƒ`. ‰Ş–{–qliŽ¨•@j: ‘ć3‰ń“ú–{Ž¨‰ČŠw‰ď i93.11.04j, –źŒĂ‰Ž, Otol. Jpn., 3(4): 384, 1993.

3054. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰şb‰î‰ťŠwÜŽčp. ”Ş”ö˜a—YCÝŠy“N–çiŽ¨•@j: H i93.00.00j.

3055. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰Á—î•Ď‰ť‚É‚ć‚é’ź—§‚̉e‹ż. “ż‘Œú“ńiŽ¨•@jCˆÉ•Ű´ŽqC‰Í–ěŒOi—ŐŒŸjC‹g”ö’miŽ¨•@j: H i93.01.31j, Ž¨•@ˆôA‰Č“W–].

3056. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Šá‹…‰^“ŽˆŮí‚Ć’ź—§ŽždS“Ž—h‚Ć‚ĚŠÖŒW. “ż‘Œú“ńC“Ą–ě–žlC‹g”ö’miŽ¨•@j: H i93.01.31j, Ž¨•@ˆôA‰Č“W–].

3057. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j LennertƒŠƒ“ƒpŽî‚Ě‚PÇ—á. VˆäŠî—mC‚‹´LbC‰Ş–{–qlC”Ş”ö˜a—YCˆî–؏Ÿ‰piŽ¨•@jCŠ}ˆäŒ‰i•a—j: ‘ć17‰ń“ú–{“ŞŒz•”Žîᇊw‰ď i93.07.02j, “Œ‹ž, —\eW, p.102, 1993.

3058. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j A“ŞŠŕi“W—á‚Ě•Ű‘ś—Ă–@‚̐ŹŃ. ‚‹´LbC‰Ş–{–qlC”Ş”ö˜a—YCˆî–؏Ÿ‰piŽ¨•@jCź—Ń—˛i•új: ‘ć17‰ń“ú–{“ŞŒz•”Žîᇊw‰ď i93.07.02j, “Œ‹ž, —\eW, p.126, 1993.

3059. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ăŠŕ‚É‚¨‚Ż‚é‹@”\‰ˇ‘śŽčp—á‚ĚŒŸ“˘. ˆî–؏Ÿ‰pC‚‹´LbC‰Ş–{–qlC”Ş”ö˜a—YiŽ¨•@j: ‘ć17‰ń“ú–{“ŞŒz•”Žîᇊw‰ď i93.07.02j, “Œ‹ž, —\eW, p.87, 1993.

3060. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ă‚Ě‚˘‚í‚ä‚éFibrous Lesion‚Ě•a—Šw“IŒ¤‹†. Ź–ě—YˆęC‚‹´LbC‰Ş–{–qlC”Ş–Ř˜a—YCˆî–؏Ÿ‰piŽ¨•@j: ‘ć6‰ń“ú–{Œűoˆô“Ş‰ČŠw‰ď i93.09.00j, ŽD–y, ŒűoĽˆô“މČ, 6(1): 103, 1993.

3061. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •ÂÇŤ‡–°Žž–łŒÄ‹zÇŒóŒQ‚É‚¨‚Ż‚éƒZƒtƒ@ƒƒƒgƒŠ[‚ĚŒŸ“˘. –]ŒŽ‚sC‰Ş–{–qlC˛–씣C’ˇŔ‰p–žC“Ą“cŽj˜YiŽ¨•@j: ‘ć6‰ń“ú–{Œűoˆô“Ş‰ČŠw‰ď i93.09.00j, ŽD–y, ŒűoĽˆô“މČ, 6(1): 162, 1993.

3062. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘˝Œ`ŤüŽî‚Ě—Ő°“IŒŸ“˘. ŽR–{ˆę”ŽC‚‹´LbC‰Ş–{–qlC”Ş”ö˜a—YCˆî–؏Ÿ‰piŽ¨•@j: ‘ć6‰ń“ú–{Œűoˆô“Ş‰ČŠw‰ď i93.09.00j, ŽD–y, ŒűoĽˆô“މČ, 6(1): 39, 1993.

3063. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ž¨‰ş‘BŠŕ‚ĚŽĄ—Ă‚É‚¨‚Ż‚é•úŽËü•š—p‚ĚˆÓ‹`. ‚‹´LbC‰Ş–{–qlC”Ş”ö˜a—YCˆî–؏Ÿ‰piŽ¨•@j: ‘ć6‰ń“ú–{Œűoˆô“Ş‰ČŠw‰ď i93.09.00j, ŽD–y, ŒűoĽˆô“މČ, 6(1): 47, 1993.

3064. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “ŤŒűoĽˆô“Ş’×ᇂ̕a—‘gDŠw“IŒŸ“˘(‘ć2•ń). ˆî–؏Ÿ‰pC‚‹´LbiŽ¨•@j: ‘ć6‰ń“ú–{Œűoˆô“Ş‰ČŠw‰ď i93.09.00j, ŽD–y, ŒűoĽˆô“މČ, 6(1): 66, 1993.

3065. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒqƒgŒűŠWG“‚¨‚ć‚ѐăG“‚É‚¨‚Ż‚é‘gDŠw“IŒ¤‹†. ’†‘ş—vCŠ™“c—˜•FCˆî–؏Ÿ‰pC”Ş–Ř˜a—YC‚‹´LbCÝŠy“N–çiŽ¨•@j: ‘ć6‰ń“ú–{Œűoˆô“Ş‰ČŠw‰ď i93.09.00j, ŽD–y, ŒűoĽˆô“މČ, 6(1): 74, 1993.

3066. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒgƒŠƒNƒ[ƒ‹|Ž_‰şb‰î‰ťŠwÜŽčp‚ĚŽĄ—ĂŒř‰Ę‚Ě–ň—Šw“I”ť’č. źŽRkˆę˜YCÝŠy“N–çC”Ş”ö˜a—YCˆäŒű–F–žiŽ¨•@jCŽ­ŽćMi–ň—jCŽR–{ˆę”ŽiŽ¨•@j: ‘ć32‰ń“ú–{•@‰ČŠw‰ď i93.10.00j, ‘ĺ•Ş, “ú–{•@‰ČŠw‰ď‰ďŽ, 32(1): 125, 1993.

3067. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰Č‚ĹŒoŒą‚ľ‚˝•@•›•@oŒŒŠÇüˆŰŽî‚ĚŒŸ“˘. —é–Ř—§rC‚‹´LbC‰Ş–{–qlC”Ş”ö˜a—YCˆî–؏Ÿ‰piŽ¨•@j: ‘ć32‰ń“ú–{•@‰ČŠw‰ď i93.10.00j, ‘ĺ•Ş, “ú–{•@‰ČŠw‰ď‰ďŽ, 32(1): 139, 1993.

3068. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒqƒg•@’†Šu‚Ě‘gDŠw“IŒ¤‹†(‘ć7•ń). ˆî–؏Ÿ‰pCÝŠy“N–çC‚‹´LbC”Ş”ö˜a—YiŽ¨•@j: ‘ć32‰ń“ú–{•@‰ČŠw‰ď i93.10.00j, ‘ĺ•Ş, “ú–{•@‰ČŠw‰ď‰ďŽ, 32(1): 184, 1993.

3069. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ˜VlŤ“ď’Ž‚ĆŽ¨–Â. ”Ş–ŘšlCě’[ŒÜ\—éC˛“ĄPłC’šŽR–ŤCŽR‰şLˆęC–q“‡˜aŒŠCŒ´“c—E•FC‰Ş–{–qliŽ¨•@j: ‘ć38‰ń“ú–{’ŽŠoˆăŠw‰ď i93.10.16j, –źŒĂ‰Ž.

3070. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’ቚáŠQŒ^Š´‰š“ď’Ž“—á‚ĚŒŸ“˘. •˝ŽR•űrC˛–씣Cź‰Ş–ž—TC‰Ş–{–qlCÝŠy“N–çiŽ¨•@j: ‘ć38‰ń“ú–{’ŽŠoˆăŠw‰ď i93.10.16j, –źŒĂ‰Ž, Audiol. Jpn., 36(5): 543`544, 1993.

3071. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’ቚáŠQŒ^Š´‰š“ď’Ž‚Ě•aˆö‚Š‚ç‚Ý‚˝•Ş—Ţ‚ĚŽŽ‚Ý. ˛–씣C•˝ŽR•űrCź‰Ş–ž—TC‰Ş–{–qlCÝŠy“N–çiŽ¨•@j: ‘ć38‰ń“ú–{’ŽŠoˆăŠw‰ď i93.10.16j, –źŒĂ‰Ž, Audiol. Jpn., 36(5): 557`558, 1993.

3072. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’ቚáŠQŒ^Š´‰š“ď’Ž‚Ě•aˆö‚Š‚ç‚Ý‚˝•Ş—Ţ‚ĚŽŽ‚Ý. ‰iˆä_–¤C˛–씣C•˝ŽR•űrCź‰Ş–ž—TC‰Ş–{–qlCÝŠy“N–çiŽ¨•@j: ‘ć38‰ń“ú–{’ŽŠoˆăŠw‰ď i93.10.16j, –źŒĂ‰Ž, Audiol. Jpn., 36(5): 605`606, 1993.

3073. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹qŠĎ“IƒŠƒNƒ‹[ƒgƒƒ“ƒgŒŸ¸‚Ć‚ľ‚Ä‚ĚŽ¨Źœ‹Ř”˝ŽË臒lŒŸ¸. ó–ě˜a]CˆÉ•Ű´ŽqC‘şŽR^‹|C‰Í–ěŒOi—ŐŒŸjCź‰Ş–ž—TC‰Ş–{–qlC’|“ŕ‹`•viŽ¨•@j: ‘ć38‰ń“ú–{’ŽŠoˆăŠw‰ď i93.10.16j, –źŒĂ‰Ž, Audiol. Jpn., 36(5): 719`720, 1993.

3074. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j œ“ąŽó˜bŠíƒwƒbƒhƒoƒ“ƒh‚É‚ć‚é”ńŒŸŽ¨‚Ö‚ĚƒNƒƒXƒqƒ„ƒŠƒ“ƒO. ‘şŽR^‹|Có–ě˜a]C‰Í–ěŒOi—ŐŒŸjCź‰Ş–ž—TC’|“ŕ‹`•viŽ¨•@j: ‘ć38‰ń“ú–{’ŽŠoˆăŠw‰ď i93.10.16j, –źŒĂ‰Ž, Audiol. Jpn., 36(5): 723`724, 1993.

3075. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Žs”ĚƒI[ƒWƒIƒ[ƒ^‚ĆPC-98‚đ—˜—p‚ľ‚˝ABCŽŠ“Žƒ}ƒXƒLƒ“ƒO–@’Ž—ÍŒŸ¸ƒVƒXƒeƒ€‚ĚŠJ”­. ’|“ŕ‹`•viŽ¨•@j: ‘ć38‰ń“ú–{’ŽŠoˆăŠw‰ď i93.10.16j, –źŒĂ‰Ž, Audiol. Jpn., 36(5): 733`734, 1993.

3076. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ABCƒ}ƒXƒLƒ“ƒO–@‚̍œ“ą0dB‚Ě‹K€ƒtƒH[ƒXƒŒƒxƒ‹. ‰Í–ěŒOC‘şŽR^‹|Có–ě˜a]i—ŐŒŸjC’|“ŕ‹`•vCź‰Ş–ž—TiŽ¨•@j: ‘ć38‰ń“ú–{’ŽŠoˆăŠw‰ď i93.10.16j, –źŒĂ‰Ž, Audiol. Jpn., 36(5): 735`736, 1993.

3077. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j RŒ´—U”­‚É‚ć‚é•@`’†ƒJƒŠƒNƒŒƒCƒ“‚¨‚ć‚ŃƒLƒjƒ“‚Ě‘‘ĺ‚Ć—}§. źŽRkˆę˜YCÎˆä–L‘žCÝŠy“N–çC”Ş”ö˜a—YCˆäŒű–F–žiŽ¨•@jCŽ­ŽćMi–ň—j: ‘ć94‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď‘‰ď i93.10.20j, ‹ž“s, “ú–{Ž¨•@ˆôA‰ČŠw‰ď‰ď•ń, 96(10): 1720, 1993.

3078. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”˝•œŤ’†Ž¨‰Š‚Ě—Ő°“I‚¨‚ć‚іƉuŠw“IŒŸ“˘|’j—ˇ‚ɂ‚˘‚ā|. ź‰Ş–ž—TCÝŠy“N–çC‰Ş–{–qlC˛–씣iŽ¨•@j: ‘ć94‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď‘‰ď i93.10.20j, ‹ž“s, “ú–{Ž¨•@ˆôA‰ČŠw‰ď‰ď•ń, 96(10): 1767, 1993.

3079. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “Ë”­Ť“ď’Ž‚ĚŽóf•a“ú•Ę’Ž—Í‘œ‚ĚŒŸ“˘. ˛–씣Cź‰Ş–ž—TC•˝ŽR•űrC‰Ş–{–qlCÝŠy“N–çiŽ¨•@j: ‘ć3‰ń“ú–{Ž¨‰ČŠw‰ď i93.11.04j, –źŒĂ‰Ž, Otol. Jpn., 3(4): 392, 1993.

3080. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒRƒŒƒXƒeƒŠƒ““÷‰čŽî’P“ĆÇ‚ĚŽĄ—Ă–@‚ĚŒŸ“˘. ź‰Ş–ž—TC˛–씣C•˝ŽR•űrC‰Ş–{–qlCÝŠy“N–çiŽ¨•@j: ‘ć3‰ń“ú–{Ž¨‰ČŠw‰ď i93.11.04j, –źŒĂ‰Ž, Otol. Jpn., 3(4): 503, 1993.

3081. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j g‚Ě‚ą‚Č‚ľ”\—͂̉Á—î•Ď‰ť. “Ą“cMĆCŠŁ—mŽjC–]ŒŽ‘ĽşCź‰i‹Şi“Ţ—Çˆă‘ĺjC“ż‘Œú“ńiŽ¨•@jC–ě––“š•Fi•lźˆă‘ĺjC“ĄŒ´Ÿ•vi‹ŕ‘ň‘ĺj: ‘ć52‰ń“ú–{•˝t_Œo‰ČŠw‰ď‘‰ďŠwpu‰‰‰ď i93.11.25j, ‰Ą•l, —\eW, p.94, 1993.

3082. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚—îŽŇ‚̐g‘ĚŠˆ“ŽƒŒƒxƒ‹‚Ć‘Ě•˝t‹@”\. “ŕŽR–ői–kŒ¤jC“ż‘Œú“ńiŽ¨•@j: ‘ć52‰ń“ú–{•˝t_Œo‰ČŠw‰ď‘‰ďŠwpu‰‰‰ď i93.11.25j, ‰Ą•l, —\eW, p.95, 1993.

3083. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚ß‚Ü‚˘‚ɑ΂ˇ‚鎥—ĂŒř‰Ę”ť’čŠî€ˆÄ. …‰z“S—C“n•Ós—YCŤĎ“úo•vi•xŽRˆă‘ĺjCź‰i‹Şi“Ţ—Çˆă‘ĺjC“ż‘Œú“ńiŽ¨•@j: ‘ć52‰ń“ú–{•˝t_Œo‰ČŠw‰ď‘‰ďŠwpu‰‰‰ď i93.11.26j, ‰Ą•l, —\eW, p.153, 1993.

3084. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘ĺ“Ž–Ź‰ŠÇŒóŒQ‚̐_ŒoŽ¨‰Č“IŒŸ“˘. Ż–ěŒ÷C“ż‘Œú“ńC“Ą–ě–žlC‹g”ö’mC’ˇŔ‰p–žCˆî–؏Ÿ‰pCVˆäŠî—miŽ¨•@j: ‘ć52‰ń“ú–{•˝t_Œo‰ČŠw‰ď‘‰ďŠwpu‰‰‰ď i93.11.26j, ‰Ą•l, —\eW, p.158, 1993.

3085. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ž‹‰^“ŽŤŒăŠáU‚Ě—Ő°—á‚ĚŒŸ“˘. VˆäŠî—mC“ż‘Œú“ńC“Ą–ě–žlC‹g”ö’mC’ˇŔ‰p–žCŻ–ěŒ÷iŽ¨•@j: ‘ć52‰ń“ú–{•˝t_Œo‰ČŠw‰ď‘‰ďŠwpu‰‰‰ď i93.11.26j, ‰Ą•l, —\eW, p.177, 1993.

3086. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Transitory alternatinating saccade ‚đ’ć‚ľ‚˝Ç—á‚ɂ‚˘‚Ä. ŽR–{ˆę”ŽC‹g”ö’mC’ˇŔ‰p–žC“Ą–ě–žlC“ż‘Œú“ńiŽ¨•@j: ‘ć52‰ń“ú–{•˝t_Œo‰ČŠw‰ď‘‰ďŠwpu‰‰‰ď i93.11.26j, ‰Ą•l, —\eW, p.195, 1993.

3087. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •ÂÇŤ‡–°Žž–łŒÄ‹zÇŒóŒQ‚É‚¨‚Ż‚é’†ˆô“ŞŒv‘Ş‚ĚŒŸ“˘. –]ŒŽ‚sC‰Ş–{–qlC˛–씣C’ˇŔ‰p–žCÝŠy“N–çiŽ¨•@j: ‘ć4‰ń“ú–{“ŞŒz•”ŠO‰ČŠw‰ď i94.01.29j, ‹ž“s, —\eW, p.111, 1994

3088. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Galvanic body sway test|’Ž_ŒoŽîᇏǗá‚ɂ‚˘‚ā|. –ěŒű_’jC‹g”ö’mC“Ą–ě–žlC“ż‘Œú“ńiŽ¨•@j: ‘ć94‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď‘‰ď i93.10.20j, ‹ž“s, “ú–{Ž¨•@ˆôA‰ČŠw‰ď‰ď•ń, 96(10): 1753, 1993.

3089. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰Ě•‘Šęƒ[ƒLƒƒƒbƒvÇŒóŒQ‚Ě‚P—á. ”n‰z’q_CŽR’†‚C–ŕŽRˆŔOiŽ¨•@j: ‘ć84‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i93.06.12j, “Ą‘ň.

3090. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‚—îŽŇ‚Ě“úíśŠˆ“Žě‚ĆŠÖ˜AŽ–€‚ĚƒAƒ“ƒP[ƒg’˛¸. Ä“Ą‘ĺC“ż‘Œú“ńC“Ą–ě–žlC‹g”ö’mC•˝ŽR•űriŽ¨•@j: ‘ć84‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i93.06.12j, “Ą‘ň.

3091. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j bó“‚Ě•ÎˆĘ‚ŞŠÖ—^‚ľ‚˝‚ĆŽv‚í‚ę‚˝ˆôA“ŞˆŮíŠ´Ç‚Ě‚P—á. ’†‘ş—vC“Ą–ě–žlCÄ“Ą‘ĺiŽ¨•@j: ‘ć84‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i93.06.12j, “Ą‘ň.

3092. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –j•”Žî’Ż‚É‚ć‚č”­ŒŠ‚ł‚ę‚˝Šç–ĘˆŮ•¨‚ĚÇ—á. Š™“c—˜•FC–]ŒŽ‚sCˆäŒű–F–žCŹěŽ“ńiŽ¨•@j: ‘ć84‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i93.06.12j, “Ą‘ň.

3093. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰Ą{‰ęŽs’†‰›•ŰŒ’Š‚É‚¨‚Ż‚é‚RÎŽžŒŸf‚ĚŽŽs‚ɂ‚˘‚Ä. –]ŒŽ‚sCŠ™“c—˜•FCˆäŒű–F–žCŹěŽ“ńiŽ¨•@j: ‘ć84‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i93.06.12j, “Ą‘ň.

3094. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ă_ŒoâŽî. VˆäŠî—mC‚‹´LbC”Ş”ö˜a—YCˆî–؏Ÿ‰piŽ¨•@j: ‘ć84‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i93.06.12j, “Ą‘ň.

3095. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘˝”­“Ž–Ź‰Š‚É‚ć‚é‚ß‚Ü‚˘, “ď’Ž, Šç–ʐ_Œo–ƒáƒ‚Ě‚P—á. ŽR’†‚C“ż‘Œú“ńC“Ą–ě–žlC’ˇŔ‰p–žC˛–씣C–ěŒű_’jCŻ–ěŒ÷CVˆäŠî—miŽ¨•@j: ‘ć85‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i93.09.11j, ‘Š–ÍŒ´.

3096. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰ć•e‚É‚ć‚é‹C“šˆŮ•¨‚Ě‚Q—á. V“cŒő–MC•˝ŽR•űrCŹ–ě—YˆęCÄ“Ą‘ĺCŽR’†‚iŽ¨•@j: ‘ć85‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i93.09.11j, ‘Š–ÍŒ´.

3097. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “ŽŠá_Œo–ƒáƒ‚ŏ‰”­‚ľ‚˝•@o‰Ą–ä‹Ř“÷Žî‚Ě‚P—á. ‹v–ěŒ’ŽuCŒĂ‘ňTˆęCÎˆä–L‘žiŽ¨•@j: ‘ć85‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i93.09.11j, ‘Š–ÍŒ´.

3098. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˆŤŤ‰ť‚ľ‚˝•@•›•@o“ű“ŞŽî‚Ě‚P—á. ˆäŒű–F–žC–]ŒŽ‚sCŠ™“c—˜•FCŹěŽ“ńiŽ¨•@j: ‘ć85‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i93.09.11j, ‘Š–ÍŒ´.

3099. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Behcet•aŠłŽŇ‚É‚Ý‚ç‚ę‚˝‹}Ť‚“x“ď’Ž‚Ě‚P—á. L“‡‰ŽFCÝŠy“N–çC‰Ş–{–qlC•˝ŽR•űrC˛–씣CVˆäŠî—miŽ¨•@j: ‘ć85‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i93.09.11j, ‘Š–ÍŒ´.

3100. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ˆô“ŞˆŮíŠ´‚É‚ć‚č”­ŒŠ‚ł‚ę‚˝G“”XŽî‚Ě‚P—á. –]ŒŽ‚sCˆäŒű–F–žCŠ™“c—˜•FCŹěŽ“ńiŽ¨•@j: ‘ć86‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i93.11.27j, ‰Ą•l.

3101. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‰Ą{‰ęŽs’†‰›•ŰŒ’Š‚É‚¨‚Ż‚é‚RÎŽžŒŸf‚ĚŽŽs‚ɂ‚˘‚āi‘ć2•ńj. –]ŒŽ‚sCŠ™“c—˜•FCˆäŒű–F–žCŹěŽ“ńiŽ¨•@j: ‘ć86‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i93.11.27j, ‰Ą•l.

3102. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j •›ˆô“ŞŠÔŒ„‚𒆐S‚É‘śÝ‚ľ‚˝‘B—l”X–EŠŕ‚Ě‚P—á. ˆÉ“Ą”\ŹC”Ş”ö˜a—YCˆî–؏Ÿ‰pCVˆäŠî—miŽ¨•@j: ‘ć86‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i93.11.27j, ‘Š–ÍŒ´.

3103. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “–‰Č‚É‚¨‚Ż‚é•â’ŽŠíŠO—ˆ‚ĚŒť‹ľ. ˛–씣C‰Ş–{–qlC•˝ŽR•űrC—é–ŘŒbŽqC–Ř‘ş—R‹IC‰Ş–{˜NŽqiŽ¨•@j: ‘ć87‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i94.03.05j, ‰Ą•l.

3104. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “நŠďŒ`‚É‚ć‚Á‚Đ‘–Œ‰Š‚đ”˝•œ‚ľ‚˝‚PÇ—á. ’†‘ş—vC“ż‘Œú“ńC‰Ş–{–qlCŻ–ěŒ÷iŽ¨•@j: ‘ć87‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i94.03.05j, ‰Ą•l.

3105. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Šç–ʐ_Œo–ƒáƒ,‚ß‚Ü‚˘,“ď’Ž‚đŽĺ‘i‚É—ˆ‰@‚ľ‚˝Ź”]”]Š˛[Ç‚Ě‚P—á. ‰iˆä_–¤C‰Ş–{–qlC˛–씣C•˝ŽR•űrC“ż‘Œú“ńCŻ–ěŒ÷CˆÉ“Ą”\ŹiŽ¨•@j: ‘ć87‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i94.03.05j, ‰Ą•l.

3106. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j A“ŞŒŒŠÇŽî‚Ě‚P—á. —é–Ř—§rC”n‰z’q_C–ŕŽRˆŔOC”Ş”ö˜a—YiŽ¨•@j: ‘ć87‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď i94.03.05j, ‰Ą•l.

3107. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j “Ë”­Ť“ď’Ž‚ĚŽóf•a“ú•Ę’Ž—Í‘œ‚ĚŒŸ“˘. ˛–씣CÝŠy“N–çC‰Ş–{–qlC•˝ŽR•űriŽ¨•@j: ŒúśČ‹}Ť‚“x“ď’Ž’˛¸Œ¤‹†”Ç•˝Ź5”N“x‘ć1‰ń‘‰ď i93.08.21j, “Œ‹ž.

3108. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j “Á”­Ť—ź‘¤ŤŠ´‰š“ď’Ž‚ĚŒŸ“˘|Žá”NŒ^‚ƐŹlŒ^‚Ě”äŠr|. •˝ŽR•űrCÝŠy“N–çC‰Ş–{–qlC˛–씣iŽ¨•@j: ŒúśČ‹}Ť‚“x“ď’Ž’˛¸Œ¤‹†”Ç•˝Ź5”N“x‘ć1‰ń‘‰ď i93.08.21j, “Œ‹ž.

3109. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒƒjƒG[ƒ‹•a‚Ě—\Œă‚ɂ‚˘‚Ä. “ż‘Œú“ńiŽ¨•@j: ŒúśČ‘O’ë‹@”\ˆŮí’˛¸Œ¤‹†”Ç•˝Ź‚T”N“x‘‰ď i94.01.22`23j, L“‡.

3110. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j “Á”­Ť—ź‘¤ŤŠ´‰š“ď’Ž‚ĚŒŸ“˘. •˝ŽR•űrCÝŠy“N–çC‰Ş–{–qlC˛–씣iŽ¨•@j: ŒúśČ‹}Ť‚“x“ď’Ž’˛¸Œ¤‹†”Ç•˝Ź5”N“x‘ć2‰ń‘‰ď i94.02.18j, “Œ‹ž.

3111. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j “Ë”­Ť“ď’Ž‘ŠúŽófŽŇ‚Ě’Ž—͉ń•œ‚ĚŒŸ“˘. ˛–씣CÝŠy“N–çC‰Ş–{–qlC•˝ŽR•űriŽ¨•@j: ŒúśČ‹}Ť‚“x“ď’Ž’˛¸Œ¤‹†”Ç•˝Ź5”N“x‘ć2‰ń‘‰ď i94.02.18j, “Œ‹ž.

3112. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j “Ë”­Ť“ď’Ž•a“ú‹ć•Ş‚ĚŒŸ“˘. ‰Ş–{–qlC’†ŽR–žmCŹ–ě—YˆęiŽ¨•@j: ŒúśČ‹}Ť‚“x“ď’Ž’˛¸Œ¤‹†”Ç•˝Ź5”N“x‘ć2‰ń‘‰ď i94.02.18j, “Œ‹ž.

3113. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j “ŻŽí‹Ř–Œ‚đ—p‚˘‚˝ŒŰ–ŒŒ`Źp. ’ˇŔ‰p–žC‰Ş–{–qlCÝŠy“N–çiŽ¨•@j: ŽčpŽč‹ZŒ¤‹†‰ď i93.07.16j, ‰Ą•l.

3114. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j •˝Ź‚S”N‚ĚŽčpÇ—á‚ĚŒŸ“˘. Îˆä–L‘žCŒĂ‘ňTˆęiŽ¨•@jC‹v–ěŒ’Žui‘—§‘Š–ÍŒ´•a‰@j: ‘ć41‰ń‘Š•Ž¨•@ˆôA‰ČŒ¤‹†‰ď i93.07.10j, ‘Š–ÍŒ´.

3115. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Š{‰ş‘B‘ÁÎÇ‚É‚¨‚Ż‚é ESWLi‘ĚŠOŐŒ‚”gj—˜—p‚ĚŽŽ‚Ý. –ŕŽRˆŔOC”n‰z’q_C—é–Ř—§riŽ¨•@j: ‘ć41‰ń‘Š•Ž¨•@ˆôA‰ČŒ¤‹†‰ď i93.07.10j, ‘Š–ÍŒ´.

3116. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j A“Ş“ű“ŞŽî‚Ě‚PÇ—á. Š™“c—˜•FC–]ŒŽ‚sCˆäŒű–F–žiŽ¨•@jCŹěŽ“ńi‰Ą{‰ęŽs–Ż•a‰@j: ‘ć41‰ń‘Š•Ž¨•@ˆôA‰ČŒ¤‹†‰ď i93.07.10j, ‘Š–ÍŒ´.

3117. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Ž¨•@ˆôA‰Č—Ěˆć‚ĚŒ‹Šj. ‹ŕŽqŒ÷CÂ–ö‘iŽ¨•@j: ‘ć41‰ń‘Š•Ž¨•@ˆôA‰ČŒ¤‹†‰ď i93.07.10j, ‘Š–ÍŒ´.


<<25 ¸_‰ČŠw>>

3118. mŒ´’˜n Effects of tandospirone, a 5-HT1A receptor-related anxiolytic, on deytime sliipiness and phychomotor functions: a comparative double-blind study with diazepam. —é–Ř–q•FC“ŕŠCŒő’ŠC‘şčŒő–Mi¸j: Jpn. J. Psychopharmacol., 13(4): 213`224, 1993.

3119. mŒ´’˜n S‚Ě•a‚ĆŽŠŒČƒ‚ƒjƒ^[; •s–°Ç‚Ć•sˆŔ•a‚Ěę‡. Ží“c^ť—Yi¸j: Œť‘ă‚ĚƒGƒXƒvƒŠ, (314): 126`138, 1993.

3120. mŒ´’˜n ƒpƒjƒbƒNƒfƒBƒXƒI[ƒ_[‚ĚŽŠ—ĽŒP—ű–@. ’†“‡ß•vi¸j: Sgˆă—Ă, 5(11): 1510`1514, 1993.

3121. mŒ´’˜n BenzodiazepineŽó—e‘Ěě“ŽŤV‹K‡–°–ňzolipidem‚Ěƒqƒg‹L‰Ż‹@”\‚É‹y‚Ú‚ˇ‰e‹ż|triazolam, nitrazepam‚đ‘ÎĆ‚Ć‚ľ‚˝“ńd–ÓŒŸ”äŠrŽŽŒą|. —é–Ř–q•FC“ŕŠCŒő’ŠC‘şčŒő–Mi¸j: _Œo¸_–ň—, 15(6): 375`389, 1993.

3122. mŒ´’˜n Œ’íŹlƒ{ƒ‰ƒ“ƒeƒBƒA‚É‚¨‚Ż‚ébuspirone‚¨‚ć‚Ńbromazepam‚Ě’ˆÓ‚¨‚ć‚Ń’ZŠú‹L‰Ż‚É‹y‚Ú‚ˇ‰e‹ż. —é–Ř–q•FC“ŕŠCŒő’ŠC‘şčŒő–Mi¸j: _Œo¸_–ň—, 15(7): 453`463, 1993.

3123. mŒ´’˜n Buspirone‚Ćbromazepam‚Ědaytime sleepiness‚É‹y‚Ú‚ˇ‰e‹ż|Multiple sleep latensy test, Stanford sleepiness score‚¨‚ć‚ъ֐źŠw‰@‘ĺŠwŽŠŠo“I–°‹C“x’˛¸—pŽ†‚É‚ć‚錟“˘|. “ŕŠCŒő’ŠC—é–Ř–q•FCÎ‹˝‰Şƒi¸jCŠŽi–r•śi—ŐŒŸjC’|“ŕŽŽqC“‡“cŽœ•Fi–ňÜjC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: _Œo¸_–ň—, 15: 441`452, 1993.

3124. mŒ´’˜n ŽŠ“ŽŽÔ‰^“]‚É‹y‚Ú‚ˇR•sˆŔ–ňbuspirone‚̉e‹ż. –ƒś‹ÎC’†“‡˜aŽqC“ŕŠCŒő’ŠC“n•””CC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: _Œo¸_–ň—, 15: 465`473, 1993.

3125. mŒ´’˜n ImidazopyridineŒnV‹K‡–°–ňzolpidem‚ĆbenzodiazepineŒn‡–°–ňtriazolam‚¨‚ć‚Ńnitrazepam‚Ě daytime sleepiness‚É‹y‚Ú‚ˇ‰e‹ż|placebo‚đ‘ÎĆ‚Ć‚ľ‚˝“ńd–ÓŒŸ”äŠrŽŽŒą|. “ŕŠCŒő’ŠC™ŽRŒ’ŽuC—é–Ř–q•FC‘şčŒő–Mi¸j: _Œo¸_–ň—, 16: 45`56, 1994.

3126. mŒ´’˜n ¸_‰Č‹~‹}ˆă—Ă‚ĚŽŔ‘ԁ|Žń“sŒ—7Ž{Ý‹¤“ŻˆęÄ’˛¸‚ĚŒ‹‰Ę‚Š‚ç|. ”ň’šˆä–]CźŽR‘FCŽO‘î—RŽqi“Œ‹ž“s¸_ˆăŠw‘‡Œ¤‹†ŠjCŒvŒŠˆę—YC•˝“c–L–žiç—tŒ§¸_ˆă—ĂƒZƒ“ƒ^[jC’†“‡ß•vi¸jCŽđˆäł—Yi‹Ú•a‰@jC—Ń’ź Ž÷iź‘ň•a‰@jC•Ä‘ň—m‰îi–n“Œ•a‰@jC“yˆä‰iŽji•{’†•a‰@jCŒjěCˆęi“Œ–M‘ĺj: ¸__ŒoŠwŽGŽ, 96(2): 122`137, 1994.

3127. mŒ´’˜n ‡–°–ň‚ɂ‚˘‚Ä‚Ě”FŽŻ: Œťó‚Ć–â‘č“_|665–ź‚ĚƒAƒ“ƒP[ƒg’˛¸‚Š‚ç|. ‘şčŒő–Mi¸j: “ú–{ˆăŽ–V•ń, 3626: 32`48, 1993.

3128. mŒ´’˜n •˝Ź4”N“x•Ş’SŒ¤‹†|¸_‰Č‹~‹}ˆă—Ă‚Ě‚“x‰ť‚ÉŠÖ‚ˇ‚錤‹†i‘ć2•ńj. ŽRč•q—YiŽRč•a‰@jC‹TˆäŒ[•ăi‹î–Ř–ě•a‰@jC•–ؐé•vi“Œ–M‘ĺjC•‘ňŽi“úˆă‘ĺjCŒvŒŠˆę—Yiç—tŒ§¸_‰Čˆă—ĂƒZƒ“ƒ^[jCŽ÷_Šwi‚ą‚ž‚܃zƒXƒsƒ^ ƒ‹jC{“Ą_ˆę˜Yi“y˛•a‰@jC’Ă‹v]ˆę˜YiŁ–ěě•a‰@jC’†“‡ß•vi¸jCź“c“šOiŽŠŽĄČÁ–h’ĄjCźŽR‘Fi“s—§¸_ˆăŠwŒ¤‹†ŠjC•˝“c–L–žiç—tŒ§ ¸_‰Čˆă—ĂƒZƒ“ƒ^[jCŽç‰Ž—T•śi“s—§L”ö•a‰@jC˜a‹C—˛ŽOiVś‰ď•a‰@j: “ú–{¸_•a‰@‹Ś‰ďŽGŽ, 12(7): 55`75, 1993.

3129. mŒ´’˜n ‚‘Ź‰t‘ĚƒNƒƒ}ƒgƒOƒ‰ƒtƒB[‚É‚ć‚éƒEƒTƒMŽl‚ľ‚傤’†ƒˆ[ƒhƒzƒ‹ƒ€‚Ě’č—Ę. ‰i“c‰xŽqi“Œ•a‰@Œ¤‹†ŒnjCŠ}Œ´—FKi–ňŠw•”jCˆŔ“cCˆęi“Œ•a‰@Œ¤‹†ŒnjC‹v•Ű”Žşi–ňŠw•”jCŽO‰Y’ĺ‘Ľi¸j: •ŞÍ‰ťŠw, 42: 215`218, 1993.

3130. mŒ´’˜n ¸_•Ş—ô•a‚É‚¨‚Ż‚éP300 microstate. ŒĂ’m‹MŒbŽqCLehmann D.CŒĂ‰ę—Ç•FC—Ž‡ˆę‹vC“L–؍GC‘şčŒő–Mi¸j: —Տ°ˆăŠw, 36: 23`29, 1994.

3131. mŒ´’˜n ‚¤‚•a‚̏î•ńˆ—|ˆÓŽŻ“Iˆ—‚Ć–łˆÓŽŻ“Iˆ—. Ží“c^ť—Yi¸j: —Տ°¸_ˆăŠw, 22(9): 1241`1248, 1993.

3132. m€Œ´’˜n •s–°‚É‚ć‚ég‘Ě“IĽ¸_“I‰e‹ż. ’†“‡ß•vi¸j: —Տ°ŠĹŒě, 19(9): 1343`1348, 1993.

3133. mŒ¤‹†•ńiŒúśČjn ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ň•¨‚̏í—p—ĘˆË‘ś‚ɂ‚˘‚ā|‚ť‚Ě‚R: ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ň•¨’ˇŠú•ž—pŽŇ‚̐¸_‰^“Ž‹@”\‚ĚŒ¤‹†. ‘şčŒő–MC™ŽRŒ’ŽuC‰i‘ň‹IŽqC“ŕŠCŒő’ŠC—é–Ř–q•FCÎ‹˝‰Şƒi¸j: ŒúśČu¸_Ľ_ŒoŽžŠłˆĎ‘őŒ¤‹†”ďv–ň•¨ˆË‘ś‚Ě”­ś‹@˜‚Ć—Ő°‹y‚ŃŽĄ—Ă‚ÉŠÖ‚ˇ‚錤‹†•˝Ź‚S”N“xŒ¤‹†Ź‰Ę•ń‘, p.155`162, 1993.

3134. mŒ¤‹†•ńiŒúśČjn ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ň•¨í—p—ĘˆË‘ś‚ɂ‚˘‚ā|‚ť‚Ě3: ƒ[ƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ň•¨’ˇŠú•ž—pŽŇ‚̐¸_‰^“Ž‹@”\‚ĚŒ¤‹†. ‘şčŒő–MC™ŽRŒ’ŽuC‰i‘ň‹IŽqC“ŕŠCŒő’ŠC—é–Ř–q•FCÎ‹˝‰Şƒi¸j: ŒúśČu¸_Ľ_ŒoŽžŠłŒ¤‹†ˆĎ‘ő”ďv–ň•¨ˆË‘ś‚Ě”­ś‹@˜‚Ć—Ő°‹y‚ŃŽĄ—Ă‚ÉŠÖ‚ˇ‚錤‹†|•˝Ź4”N“xŒ¤‹†•ń‘, p.155`162, 1993.


<<25 2 ¸_‰ČŠw>>

3135. mÇ—á•ńn ’×ᇐŤ‘ĺ’°‰ŠpŒă‚Ě•p‰ń”r•Ö—á. ’†“‡ß•vi¸j: Sgˆă—Ă, 5(5): 686`687, 1993.

3136. mÇ—á•ńn ’s•đó‘Ô‚đ’ć‚ľ‚˝‚—ÍŠłŽŇ‚Ě‚P—á. ‹g“c–FŽqC˛“ĄŠěˆę˜Yi¸j: —Տ°“§Í, 9(10): 1507`1511, 1993.

3137. mÇ—á•ńn CAPD‚ĚŒp‘ą‚Ş•‰’S‚É‚Č‚č•ęeŽŠ‚ç‚Şƒhƒi[‚É‚Č‚Á‚˝tˆÚA‚Ě‚P—á. ˛“ĄŠěˆę˜Yi¸j: —Տ°“§Í, 9(12): 1729`1732, 1993.

3138. m—Տ°ŽĄŒąn ‰–Ž_sultoprideiƒoƒ‹ƒlƒ`[ƒ‹j‚̐¸_•Ş—ô•a‚ɑ΂ˇ‚é—Տ°•]‰ż|ŠO—ˆÇ—á‚𒆐S‚Ć‚ľ‚Ä. Z‹gHŽŸC‘şčŒő–MCˆîŒŠˆňşC’†“‡ß•vC‘ĺ’J‹`•vCÎ‹˝‰ŞƒC‚‹´–ž”äŒĂCŽá“c•””Ž•śCŽRéˆę˜YCÎˆä‘P‹Pi¸j: ‚ą‚ą‚ë‚Ě—Ő°ƒAĽƒ‰ĽƒJƒ‹ƒg, 12: 81`92, 1993.

3139. m—Տ°ŽĄŒąn ¸_•Ş—ô•a‚ɑ΂ˇ‚éƒlƒ‚ƒiƒvƒŠƒhŽU2%‚Ě—Ő°Œř‰Ę. ‘şčŒő–MCŒj“‡—ǏBC—é–Ř“§CZ‹gHŽŸCŠp“c’厥C“ď”g—ŽuCŽRéˆę˜YCŽRŠpxC‹g“c–FŽqC“n•Ó”Ci¸j: ˆăŠw‚Ć–ňŠw, 29: 1049`1060, 1993.

3140. m—Տ°ŽĄŒąn ¸__Œo‰Č—Ěˆć‚É‚¨‚Ż‚鐇–°áŠQ‚ɑ΂ˇ‚ézolpidem‚Ě—Ő°Œř‰Ę. •—ŐŒłC‹ŕ–쎠CŽR‰şŠiC‘şčŒő–Mi¸jC‘ź: —Տ°ˆă–ň, 9(Suppl.2): 23`39, 1993.

3141. m—Տ°ŽĄŒąn ¸_•Ş—ô•a, ‘‡‚¤‚•a‚É”ş‚¤•s–°‚ɑ΂ˇ‚ézolpidem‚Ě—Ő°•]‰ż|nitrazepam‚đ‘ÎĆ–ň‚Ć‚ľ‚˝“ńd–ÓŒŸ”äŠrŽŽŒą|. •—ŐŒłCŽR‰şŠiC˛“ĄŒőŒšC‘şčŒő–Mi¸jC‘ź: —Տ°ˆă–ň, 9: 107`136, 1993.

3142. m—Տ°ŽĄŒąn ¸_•Ş—ô•a‚ɑ΂ˇ‚éV‚ľ‚˘BenzisoxazolŒnR¸_•a–ňƒŠƒXƒyƒŠƒhƒ“‚Ě’ˇŠú“Š—^‚É‚¨‚Ż‚é—LŒřŤ‚¨‚ć‚ŃˆŔ‘SŤ‚ĚŒŸ“˘. Î‹˝‰ŞƒCŽO‰Y’ĺ‘Ľi¸jCŽR‰şŠiC‘ĺŒF‹P—YC‰Á“ĄLŸC”Ş–Ř„•˝C‹ŕ–쎠C‘şčŒő–Mi¸jCH“Ą‹`—YC‘ĺŒŽŽO˜YCˆî‰i˜a–LC“‡“cŽœ•FC’|“ŕŽŽqi“Œ•a‰@ –ňÜj: —Տ°¸_ˆăŠw, 23: 507`522, 1994.

3143. m‘ŕn •s–°. ‘şčŒő–Mi¸j: Clin. Neurosci., 11: 106, 1993.

3144. m‘ŕn V‚ľ‚˘Œü¸_–ň‚Ě“ŽŒü. ‘şčŒő–Mi¸j: Excerpta Medica News letter, 4: 2`4, 1994.

3145. m‘ŕn –Ťt•s‘S‚đ‚ß‚Ž‚鐸_ˆăŠw“I”–â‘č. ˛“ĄŠěˆę˜Yi¸j: Renal Failure, Dialysis and Transplantation, 46: 2`4, 1993.

3146. m‘ŕn t‹@”\áŠQ‚Ɛ¸_áŠQ. ˛“ĄŠěˆę˜Yi¸j: ˆăŠw‚Ć–ňŠw, 29(4): 899`908, 1993.

3147. m‘ŕn “§ÍŠłŽŇ‚Ö‚ĚŒü¸_–ňŽĄ—Ă. ˛“ĄŠěˆę˜Yi¸j: t‚Ć“§Í, 34(1): 531`537, 1993.

3148. m‘ŕn •s–°Ç. ‘şčŒő–Mi¸j: śŠˆ‹łˆç, 4: 66`70, 1993.

3149. m‘ŕn ‚Ä‚ń‚Š‚ń‚̏dĎó‘Ô‚ĚŽĄ—Ă. ‚‹´–ž”äŒĂC‘şčŒő–Mi¸j: ¸_‰ČŽĄ—ĂŠw, 8(7): 771`782, 1993.

3150. m‘ŕn •s–°. ‘şčŒő–Mi¸j: ‘Š–ÍŒ´ŽsˆăŽt‰ď•ń, 348: 1`4, 1993.

3151. m‘ŕn ŽŠ—ĽŒP—ű–@. ’†“‡ß•vi¸j: ‘Ěˆç‚̉Ȋw, 43(10): 806`811, 1993.

3152. m‘ŕn ‡–°áŠQ‚É‚¨‚Ż‚é–ň•¨—Ă–@. ‘şčŒő–Mi¸j: “Ą‘ňŽs“ŕ‰ČˆăŠw‰ď, 13: 76`87, 1993.

3153. m‘ŕn ‚—ÍŠłŽŇ‚Ě’s•đ‚ɂ‚˘‚Ä. ˛“ĄŠěˆę˜Yi¸j: “§Íƒtƒƒ“ƒeƒBƒA, 3(2): 11`15, 1993.

3154. m‘ŕn –ňÜ—U”­Ť‰^“ŽˆŮíÇ. ‚‹´–ž”äŒĂC‘şčŒő–Mi¸j: “ú–{—Տ°, 51(11): 2929`2934, 1993.

3155. m‘ŕn •s–°Ç‚̐f’f‚ĆŽĄ—Ă. ‘şčŒő–Mi¸j: –k—˘ˆăŠw, 24: 1`14, 1994.

3156. m‘ŕn ‰tó’ÁŠPÜ‚Ě——p|‚ť‚Ě—Ő°“I“Á’Ľ|. Î‹˝‰Şƒi¸j: –ň‚Ě’mŽŻ, 44(5): 130`132, 1993.

3157. m‘ŕn —Տ°ˆă‚Ě‚˝‚ß‚Ěˆă—Ă—p–ň•i“Y•t•ś‘‚ĚŠˆ—p–@|¸_‰Č‚Ě—˜—p—á. ‚‹´–ž”äŒĂC‘şčŒő–Mi¸j: —Տ°‚Ć–ň•¨ŽĄ—Ă, 12(7): 65`70, 1993.

3158. m‘ŕn ‡–°ĽŠoÁŠÖ˜AÇŒóŒQ, 18. Restless-legsÇŒóŒQ. “ŕŠCŒő’Ši¸j: —Տ°¸_ˆăŠw, ‘Š§†, ¸__Œo‰Č‚ĚÇŒóŒQ, 1994.

3159. m‘ŕn CAPD‚̐¸_ˆăŠw“I–â‘č‚Ć“K‰žŠî€. ˛“ĄŠěˆę˜Yi¸j: —Տ°“§Í, 10(1): 143`147, 1994.

3160. m‘ŕn “§ÍŠłŽŇ‚ĚQOL|QOL‚ĚŠT”O‚ĆŽw•W‚𒆐S‚Ɂ|. ˛“ĄŠěˆę˜Yi¸j: —Տ°“§Í, 9(6): 729`733, 1993.

3161. m‘ŕn ¸_“IáŠQ|‘˜_i‘ć‡]‡ZÍ. ¸_“IáŠQj. ˛“ĄŠěˆę˜Yi¸j: —Տ°“§Í, 9(7): 995`996, 1993.

3162. m‘ŕn ƒAƒNƒZƒXĽƒtƒF[ƒŠƒA[‚ɊׂÁ‚˝ŠłŽŇ‚̐¸_“IƒtƒHƒ[. ˛“ĄŠěˆę˜Yi¸j: —Տ°“§Í, 9(8): 1223`1227, 1993.

3163. m‘ŕn (1)˜AŒg‚Ě‚ŕ‚ż•ű|“œ”A•aŤtÇ‚ĚŠłŽŇ‚𒆐S‚Ɂ|‡U. ƒŠƒGƒ]ƒ“i˜AŒgj¸_ˆăŠw. ˛“ĄŠěˆę˜Yi¸j: —Տ°“§Í, 9(9): 1301`1305, 1993.

3164. m‘ŕn –ň•¨‚É‚ć‚é‹L‰ŻáŠQ. Î‹˝‰ŞƒCŽO‰Y’ĺ‘Ľi¸j: ˜V”NŠú’s•đ, 7(4): 443`450, 1993.

3165. m‘ŕn ‘ćŽO˘‘ă‚̍R‚¤‚–ň‚Ö‚ĚŠú‘Ň. ‘şčŒő–Mi¸j: ˜V”N¸_ˆăŠwŽGŽ, 8: 893`904, 1993.

3166. muŔn ‡–°Œ¤‹†‚ĚŠCŠOŽ–î|–k•Ä‚𒆐S‚Ɂ|. ’†“‡ß•vi¸j: ‡–°ŠwŒ¤‹†, 37(1): 18`20, 1993.

3167. muŔn ‡–°—Ă–@‚Ć‚ť‚̉ž—p. ’†“‡ß•vi¸j: “ú–{ˆăŽ–V•ń, (3601): 139`140, 1993.

3168. muŔn ƒ‘•]„Ž€‚Ě•a‚đ‹¤‚Éś‚Ť‚éi•Ÿź—E•v–ó, E.ƒzƒbƒcƒ}ƒCƒXƒ^[•Ňj|t“§ÍĽtˆÚAŠłŽŇ‚Š‚玥—ĂŽŇ‚Ö‚ĚƒƒbƒZ[ƒW|. ˛“ĄŠěˆę˜Yi¸j: —Տ°¸_ˆăŠw, 22(8): 102, 1993.

3169. mŠwp‘n i•Ş’SŽˇ•Mj _ŒoS—Šw, ¸_‰ČMook; ‚¤‚•a‚̐_ŒoS—Šw, 29: 324`332, Ží“c^ť—Yi¸j. •ŇW ’š‹•űôi‹ŕ‘ňˆă‘ĺjC ‹ŕŒ´o”Ĺ, “Œ‹ž, 93.08.20”­s.

3170. mŠwp‘n i•Ş’SŽˇ•Mj •s–°Ç‚ĚŽĄ—Ă; ‡–°–ň‚Ě‹L‰Ż‹@”\‚É‹y‚Ú‚ˇ‰e‹ż, p.52`54, Î‹˝‰Şƒi¸j. •ŇW X‰ˇ—iźŒŠ•a‰@jC “ú–{ƒVƒF[ƒŠƒ“ƒO, ‘ĺă, 93.00.00”­s.

3171. mŠwp‘n i•Ş’SŽˇ•Mj ‡–°Šwƒnƒ“ƒhƒuƒbƒN; ‡–°–ň‚É‚ć‚é‹L‰ŻáŠQ‚ĚŒŸ¸–@, p.550`556, Î‹˝‰ŞƒC—é–Ř–q•Fi¸j. •ŇW “ú–{‡–°Šw‰ďC ’Š‘q‘“X, “Œ‹ž, 94.01.25”­s.

3172. mŠwp‘n i•Ş’SŽˇ•Mj R¸_•a–ň; •›ě—p|‚ť‚Ě”­Ç‹@˜‚Ć‘Îô, p.87`104, Î‹˝‰Şƒi¸j. •ŇW “ú–{ś•¨Šw“I¸_ˆăŠw‰ďC Šw‰ďo”ĹƒZƒ“ƒ^[, “Œ‹ž, 94.00.00”­s.


<<25 3 ¸_‰ČŠw>>

3173. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ƒ‚ƒ_ƒ“ĽƒNƒŠƒjƒJƒ‹Ľƒ|ƒCƒ“ƒg¸_‰Č; ‹­”—Ť‚đ“Ç‚Ţ, p.70`71, Ží“c^ť—Yi¸j. •ŇW “‡‰’ˆŔ—Yi‘—§_ŒoĽ¸_ƒZƒ“ƒ^[jC•ŰčG•viŒc‘ĺjC ‹ŕŒ´o”Ĺ, “Œ‹ž, 93.06.20”­s.

3174. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj Ą“ú‚ĚŽĄ—ĂŽwj1993; •s–°|‡–°–ň‚ĚŽg‚˘•ű|, p.249`250, ‘şčŒő–Mi¸j. ˆăŠw‘‰@, “Œ‹ž, 93.00.00”­s.

3175. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ƒŒƒXƒŠƒ“ů”­”„1Žü”N‹L”OŠwpu‰‰‰ď‹L˜^W; ‰–Ž_ƒgƒ‰ƒ]ƒhƒ“iƒŒƒXƒŠƒ“ůj‚ĚŽg—pó‹ľ|–k—˘‘ĺŠw“Œ•a‰@‚É‚¨‚Ż‚éŽg—pŽŔŃ‚ć‚č|, p.25`33, ‘şčŒő–Mi¸j. ˆă‰ČŠwo”Ĺ, “Œ‹ž, 93.00.00”­s.

3176. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj –ň•¨ˆË‘ś; ’ÁŠP–ňˆË‘ś; —Տ°‚Ě—§ę‚Š‚ç, p.279`284, ‘şčŒő–Mi¸j. •ŇW ˛“ĄŒőŒšC•ŸˆäiC ˘ŠE•ŰŒ’’ʐMŽĐ, “Œ‹ž, 93.00.00”­s.

3177. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ƒ‚ƒ_ƒ“ƒNƒŠƒjƒJƒ‹ƒ|ƒCƒ“ƒg; ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œ’–Y‚Ě“Á’Ľ‚Ć‘Îô, p.192`193, ‘şčŒő–Mi¸j. •ŇW “‡‰’ˆŔ—YC•ŰčG’jC ‹ŕŒ´o”Ĺ, “Œ‹ž, 93.00.00”­s.

3178. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ‡–°Šwƒnƒ“ƒhƒuƒbƒN; ƒXƒgƒŒƒX‚Ɛ‡–°, p.91`97, ‘şčŒő–Mi¸j. •ŇW “ú–{‡–°Šw‰ďC ’Š‘q‘“X, “Œ‹ž, 94.01.25”­s.

3179. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ‡–°Šwƒnƒ“ƒhƒuƒbƒN; –{‘ԐŤ•s–°Ç, p.175`180, ‘şčŒő–Mi¸j. •ŇW “ú–{‡–°Šw‰ďC ’Š‘q‘“X, “Œ‹ž, 94.01.25”­s.

3180. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ‡–°Šwƒnƒ“ƒhƒuƒbƒN; ƒ[ƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn‡–°–ň‚Ě•›ě—p, p.379`398, ‘şčŒő–Mi¸j. •ŇW “ú–{‡–°Šw‰ďC ’Š‘q‘“X, “Œ‹ž, 94.01.25”­s.

3181. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn i•Ş’SŽˇ•Mj ƒ‚ƒ_ƒ“ĽƒNƒŠƒjƒJƒ‹Ľƒ|ƒCƒ“ƒg¸_‰Č; ŹŽ™ĽÂ”NŠúŠłŽŇ‚̐f—Ă‚Ěƒ|ƒCƒ“ƒg, p.44`45, ˛“ĄŠěˆę˜Yi¸j. •ŇW “‡‰’ˆŔ—Yi‘—§_ŒoĽ¸_ƒZƒ“ƒ^[jC•ŰčG•viŒc‘ĺjC ‹ŕŒ´o”Ĺ, “Œ‹ž, 93.06.20”­s.

3182. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn i•Ş’SŽˇ•Mj ¸_‰Čˆă—ĂƒKƒCƒh•˝Ź5”N“x”Ĺ; ‘Ţ‹p‚ˇ‚éŽáŽŇ‚˝‚ż|_ŒoÇĽ‚¤‚•a‚Š‚çlŽ@‚ˇ‚é‚Đ‚Ť‚ą‚ŕ‚čó‘Ô, p.44`61, ˛“ĄŠěˆę˜Yi¸j. NOVAo”Ĺ, “Œ‹ž, 93.06.28”­s.

3183. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn i•Ş’SŽˇ•Mj _Œo“ď•a•KŒg‡U|—Ă—{śŠˆ‚̉‡•|; ¸_Çó, 2: 75`80, ’†“‡ß•vi¸j. •ŇW –k—˘‘ĺŠw“Œ•a‰@“ď•aŽĄ—ĂƒZƒ“ƒ^[_Œo“ď•aŒ¤C‰ďŽŔsˆĎˆő‰ďC –k—˘‘ĺŠw“Œ•a‰@, _“ސě, 93.09.01”­s.

3184. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn i•Ş’SŽˇ•Mj ‚Ž‚Á‚ˇ‚č–°‚ę‚é–{; ‘şčŒő–Mi¸j. Žĺ•w‚ƐśŠˆ, “Œ‹ž, 93.00.00”­s.


<<25 5 ¸_‰ČŠw>>

3185. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Vigabatrin in healthy Japanese subjects: Single and multiple administration study. ‚‹´–ž”äŒĂCˆîŒŠˆňşC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: 20th International Epilepsy Congress i93.07.07j, Norway, Epilepsia, 34(Suppl.2): 117, 1993.

3186. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Žs”̉tó’ÁŠPÜ——pŽŇ‚Ě—Ő°“I“Á’Ľ. Î‹˝‰ŞƒC‹g“c–FŽqC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: ˘ŠE¸_•ŰŒ’˜A–ż1993”N˘ŠE‰ď‹c i93.08.24j, ç—t.

3187. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j The present situation and problems in treatment for psychiatric disorders complicated with physical illness in Japan. Šp“c^ŽĄC’†“‡ß•vCŽO‰Y’ĺ‘Ľi¸j: 1993 World Congress, World Federation for Mental Health i93.08.24j, ç—t.

3188. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Study of a new stress evaluation method. ‹e’r’ˇ“żi“Œ—ˆă‘ĺjCŒá‹˝W_i‘—§¸__ŒoƒZƒ“ƒ^[jC’†“‡ß•vi¸jC–ě‘ş”Ei“Œ‘ĺjC™]Şiă‰z‹łˆç‘ĺj: 1993 World Congress, World Federation for Mental Health i93.08.24j, ç—t.

3189. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Day care program at university hospital in Japan. ’†“‡ß•vC’ËŒ´•qłCŠ}Œ´—FKCŽO‰Y’ĺ‘Ľi¸j: 1993 World Congress, World Federation for Mental Health i93.08.25j, ç—t.

3190. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Development of a new questionnaire (Life Helth Questionnaire; LHQ) for the stress Mesurement of employee and psychosocial intervention at the workplace. –ě‘ş”Ei“Œ‘ĺjC‹e’r’ˇ“żi“Œ—ˆă‘ĺjC™]Şiă‰z‹łˆç‘ĺjC’†“‡ß•vi¸jCŒá‹˝W_i‘—§¸__ŒoƒZƒ“ƒ^[j: 12th World Congress of Psychosomatic medicine i93.08.30j, Bern, Switzerland.

3191. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Efficancy of a new anxiolytic tandospirone (SM-3997) on neuroses-a comparative double-blind study with diazepam. ‘şčŒő–Mi¸jCMori A.: 1st International Congress on Hormones Brain and Neuropsychopharmacology i93.09.13`17j, Rhodes, Greece, Neuropsychopharmacology, 9(Suppl.): 125, 1993.

3192. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Recent trends in the development of psychotropic drugs in Japan. ‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: 1st International Congress on Hormones, Brain and Neuropsychopharmacology i93.09.13`17j, Rhodes, Greece, Neuropsychopharmacology, 9(Suppl.): 50, 1993.

3193. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Phase ‡T single dose study of sabeluzole-Comarative study in healthy young vs elderly volunteers. ‘ĺ’J‹`•vC“‡“c‰hŽqC‘şčŒő–MCŹŒű“OCŽO‰Y’ĺ‘Ľi¸j: 1st International Congress on Hormones, Brain and Neuropsychopharmacology i93.09.14j, ƒ[ƒhƒX, ƒMƒŠƒVƒƒ, Abstract, p.56`57, 1993.

3194. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Phase ‡Tstudy of CL 284, 846, a non-benzodiazepine sedativehyphotic: (1) Double blind comparative studies with placebo. “ŕŠCŒő’ŠC—é–Ř–q•FC™ŽRŒ’ŽuC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: American College of Neuropsychopharmacology 32nd Annual Meeting i93.12.16j, Honolulu, Abstracts, p.191.

3195. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j New trends in the development of antidementia drugs in Japan. ‘şčŒő–Mi¸j: 32nd Annual Meeting of ACNP i93.12.17j, Honolulu.

3196. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Phase ‡T study of CL-284, 846, a non-benzediazepine selective-hyphotic: (2) The influences upon memory functions. —é–Ř–q•FC“ŕŠCŒő’ŠC™ŽRŒ’ŽuC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: American College of Neurophychopharmacology, 32nd Annual Meeting i93.12.14j, ƒnƒƒC, Abstracts, p.186, 1993.

3197. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Baytime sleepiness and cognitive test performance in patients with long-term benzodiazepine administration. ™ŽRŒ’ŽuC‰i‘ň‹IŽqC“ŕŠCŒő’ŠC—é–Ř–q•FCÎ‹˝‰ŞƒC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: American College of Neurophychopharmacology, 32nd Annual Meeting i93.12.14j, ƒnƒƒC, Abstracts, p.187, 1993.

3198. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Effects of unilateral lesion in the midbrain reticular formation and corpus callosum bisection onamygdaloid kindling in rats. ‘ĺ–씎ŽiC‚‹´–ž”äŒĂi¸jC“n•ÓŽ i“Œ•a‰@Œ¤‹†ŒnjC—é–Ř–q•FC‘şčŒő–Mi¸j: 20th International Epilepsy Congress i93.07.05j, Norway, Epilepsia, 34(Suppl.2): 60, 1993.

3199. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Disturbance of pattern cognition in schizophrenia. ŒĂ’m‹MŒbŽqC—Ž‡ˆę‹vC“L–؍GCˆîŒŠˆňşC‘şčŒő–Mi¸jCŒĂ‰ę—Ç•FiˆÇ—Ń‘ĺj: 12th International Congress of Electroencephalogaphy and Clinical Neurophysiology i93.09.04j, Vancouver, Canada, Electroencephlogr. Clin. Neurophysiol., 87(2): 129, 1993.

3200. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Effect of SC49088 (cycloserine) to hippocampal acetylcholine levels (Investigations with in vivo microdialysis method). ěŒű‹BC‘ĺ’J‹`•vi¸jC‰i“c‰xŽqi“Œ•a‰@Œ¤‹†ŒnjCVˆä‘ěCŽO‰Y’ĺ‘Ľi¸j: ‘ć6‰ń‘Ű˜V”N¸_ˆăŠw‰ď‹c i93.09.08j, ƒxƒ‹ƒŠƒ“.

3201. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Phase ‡T study of sdzena713 in Japan. ‘ĺ’J‹`•vC“L–؍GC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: 6th Congress of the International Psychogeriatric Association i93.09.08j, ƒxƒ‹ƒŠƒ“, Abstract Book, p.146, 1993.

3202. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Phase ‡T study of UM796-Single and multiple dose studies-. “‡“c‰hŽqC‘ĺ’J‹`•vC‘şčŒő–MC—é–Ř–q•Fi¸jCŹ—Ń”ü•ci—Տ°–ň—ŽŽŒą•”j: 6th Congress of the International Psychogeriatric Association i93.09.08j, ƒxƒ‹ƒŠƒ“, Abstract Book, p.148, 1993.

3203. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Growth hormone response to acetylcholinesterase inhibitor in Altzheimer-type dementia. ‹g“c–FŽqC‘ĺ’J‹`•vCěŒű‹BCŹ—ŃˆęLC—é–Ř—˛°CŽO‰Y’ĺ‘Ľi¸j: 1st International Congress on Hormones, Brain and Neuropsychopharmacology i93.09.14j, ƒ[ƒhƒX, ƒMƒŠƒVƒƒ.

3204. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒAƒ‹ƒR[ƒ‹‚Ć‚Ä‚ń‚Š‚ń. ‚‹´–ž”äŒĂi¸j: ‘ć5‰ń“ú–{ƒAƒ‹ƒR[ƒ‹¸_ˆăŠw‰ď i93.07.23j, ě‰z.

3205. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€j ‡–°‰ş‚ĚˆÓŽŻ‘ĚŒą. ’†“‡ß•vi¸j: ‘ć39‰ń“ú–{‡–°ˆăŠwS—Šw‰ď i93.10.24j, •Ÿ‰Ş.

3206. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€j ŽŠ—ĽŒP—ű–@‚Ě‘tŒř‹@˜|S—Šw“I‚Č‚ç‚тɐś—Šw“IŽw•W‚đ—p‚˘‚ā|u“ŞŠŚ‘Ť”M‚Š‚ç‚Ý‚˝ŽŠ—ĽŒP—ű–@‚Ě‘tŒř‹@˜v. ’†“‡ß•vi¸j: ‘ć16‰ń“ú–{ŽŠ—ĽŒP—űŠw‰ď i93.10.31j, “Œ‹ž.

3207. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€j ¸_‰Č‹~‹}ˆă—Ă‚ÉŠÖ‚ˇ‚éÁ–hĽŒxŽ@‚Ö‚ĚƒAƒ“ƒP[ƒg’˛¸‚Š‚ç. źŽR^i“Œ•a‰@‘‡‘Š’k•”jC’†“‡ß•vi¸jCŒvŒŠˆę—YC•˝“c–L–žiç—tŒ§¸_‰Čˆă—ĂƒZƒ“ƒ^[j: ‘ć6‰ń“ú–{‘‡•a‰@¸_ˆăŠw‰ď‘‰ď i93.12.02j, •lź.

3208. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j R‚¤‚–ň‚ĚŠJ”­ó‹ľ. ‘şčŒő–Mi¸j: ‘ć22‰ń¸__Œo–ň—ƒVƒ“ƒ|ƒWƒEƒ€ i94.02.06j, ‘ĺă.

3209. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŽvtŠú‚ĚMajor depression‚Ě‘‰Á‚ɂ‚˘‚ā|10`16Î”­Ç—á‚𒆐S‚Ɂ|. ˛“ĄŠěˆę˜YCX“cś‹LŽqCˆÉ“ĄˆčŽqCVˆä‘ěC—é–ؑבăCÔŻŒbŽqi¸j: ‘ć89‰ń“ú–{¸__ŒoŠw‰ď‘‰ď i93.05.22j, “Œ‹ž.

3210. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “§Í—Ă–@Ľś‘̐tˆÚAŠłŽŇ‚ĚƒCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg‚ĚŽŔ‘Ô. ˛“ĄŠěˆę˜Yi¸j: ‘ć34‰ń“ú–{SgˆăŠw‰ď‘‰ď i93.06.04j, ‰Ą•l.

3211. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ImidazopyridineŒnV‹K‡–°–ňzolpidem‚Ědaytime sleepiness‚É‹y‚Ú‚ˇ‰e‹ż|nitrazepam, triazolam, placebo‚đ‘ÎĆ‚Ć‚ľ‚˝”äŠrŒŸ“˘|. “ŕŠCŒő’ŠC—é–Ř–q•FCÎ‹˝‰Şƒi¸jCŠŽi–r•śi—ŐŒŸjC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: ‘ć18‰ń“ú–{‡–°Šw‰ďŠwp‘ĺ‰ď i93.06.18j, ‰F“s‹{.

3212. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ImidazophridineŒnV‹K‡–°–ňzolpedem‚Ěƒqƒg‹L‰Ż‹@”\‚É‹y‚Ú‚ˇ‰e‹ż. —é–Ř–q•FC“ŕŠCŒő’ŠC™ŽRŒ’ŽuCÎ‹˝‰ŞƒC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: ‘ć18‰ń“ú–{‡–°Šw‰ď i93.06.19j, ‰F“s‹{, —\eW, p.163, 1993.

3213. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒAƒ‹ƒcƒnƒCƒ}[Œ^’s•đ‹y‚ŃŒ’í‚—îŽŇ‚É‚¨‚Ż‚éƒRƒŠƒ“ƒGƒXƒeƒV[ƒ[‘jŠQ–ň‚ɑ΂ˇ‚鐏’ˇƒzƒ‹ƒ‚ƒ“•Ş”ĺ”˝‰ž‚ɂ‚˘‚Ä. ‹g“c–FŽqC‘ĺ’J‹`•vCěŒű‹BCŹ—ŃˆęLC—é–Ř—˛°C’Ź–쏲•FC—é–Ř–q•FCŽO‰Y’ĺ‘Ľi¸j: ‘ć8‰ń˜V”N¸_ˆăŠw‰ď i93.06.25j, ŽRŒ`, ˜V”N¸_ˆăŠwŽGŽ, 4(6): 663, 1993.

3214. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘ĺŠw•a‰@‚Ĺ‚ĚƒAƒ‹ƒR[ƒ‹ˆă—Ă‚Ö‚ĚŽć‚č‘g‚݂ɂ‚˘‚ā|“–‰@‚É‚¨‚Ż‚éŒo‰ß‚ĆŒťó. ‹g“c–FŽqi¸jC‘ĺ‹v•Ű—˘C—é–ؐ´Žqi‘‡‘Š’k•”jC”’ě‹łlCÎˆäé•FC‘ş‰Ş‰p—YC’†“‡ß•vi¸j: ‘ć5‰ńƒAƒ‹ƒR[ƒ‹¸_ˆăŠw‰ď i93.07.22j, ě‰z.

3215. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Duloxenine•ž—pŽŇ‚É‚¨‚Ż‚錌Ź”ƒZƒƒgƒjƒ“Žć‚荾‚Ý‘jŠQŒř‰Ę. Î‹˝‰ŞƒC‰i“c‰xŽqC‚‹´–ž”äŒĂC“ŕŠCŒő’ŠC’ËŒ´•qłC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: ‘ć23‰ń“ú–{_Œo¸_–ň—Šw‰ď”N‰ď i93.09.29j, “Œ‹ž.

3216. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j BenzodiazepineŒn‡–°–ň‚ĆƒGƒ^ƒm[ƒ‹‚Ě‘ŠŒÝě—p‚ɂ‚˘‚ā|¸_‰^“Ž‹@”\‹y‚Ń‹L‰Ż‹@”\‚É‹y‚Ú‚ˇ‰e‹ż|. —é–Ř–q•FC‘ş‰Ş‰p—YC‘şčŒő–Mi¸j: ‘ć28‰ń“ú–{ƒAƒ‹ƒR[ƒ‹ˆăŠw‰ď i93.10.04j, ‰Ą•l, ƒAƒ‹ƒR[ƒ‹Œ¤‹†‚Ć–ň•¨ˆË‘ś, 28(4): 218`219, 1993.

3217. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹŽ™‰Č“ÁŽęŠO—ˆi¸_‰Čj‚ĚŒoŒą‚Š‚çi‘ć2•ńj. ˆÉ“ĄˆčŽqC“L–؍GC˛“ĄŠěˆę˜Yi¸j: ‘ć11‰ń“ú–{ŹŽ™SgˆăŠw‰ď i93.10.09`11j, “Œ‹ž.

3218. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ś‘̐tˆÚA‚ĚŒő‚Ɖe. ˛“ĄŠěˆę˜Yi¸j: ‘ć11‰ń“ú–{ŹŽ™SgˆăŠw‰ď i93.10.10j, “Œ‹ž.

3219. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –k—˘‘ĺŠw•a‰@—cŽ™‚¨‚ć‚ŃŠw“ś•a“‚É‚¨‚Ż‚鐸_‰ČƒŠƒGƒ]ƒ“ŠłŽŇ‚Ě‚Ü‚Ć‚ß. Vˆä‘ěC“L–؍GCˆÉ“ĄˆčŽqC˛“ĄŠěˆę˜YCX“cś‹IŽqi¸j: ‘ć34‰ń“ú–{Ž™“śÂ”N¸_Šw‰ď‘‰ď i93.10.21`23j, VŠƒ.

3220. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚鏬Ž™¸_‰ČƒŠƒGƒ]ƒ“Šˆ“Ž‚Ě‚Ü‚Ć‚ß. Vˆä‘ěC“L–؍GCX“cś‹IŽqCˆÉ“ĄˆčŽqC˛“ĄŠěˆę˜Yi¸j: ‘ć34‰ń“ú–{Ž™“śÂ”N¸_Šw‰ď‘‰ď i93.10.23j, VŠƒ.

3221. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j NMDAŽó—e‘Ě‚ĆŠC”nƒAƒZƒ`ƒ‹ƒRƒŠƒ“•Ş”ĺ. ěŒű‹BC‘ĺ’J‹`•vCVˆä‘ěC—é–Ř–q•FC‘şčŒő–Mi¸j: ‘ć20‰ń”]Œ¤‹†‰ď i93.10.23j, Ž­Ž™“‡.

3222. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –k—˘‘ĺŠw•a‰@ŹŽ™•a“‚É‚¨‚Ż‚鐸_‰ČƒŠƒGƒ]ƒ“Šˆ“Ž. Vˆä‘ěC‰Ş“cGrC÷ˆäO”TC™ŽRŒ’ŽuC˛“ĄŠěˆę˜YCŽí“c^ť—Yi¸j: ‘ć6‰ń‘‡•a‰@¸_ˆăŠw‰ď‘‰ď i93.12.02j, •lź.

3223. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒfƒCƒPƒA’ˇŠú’ʏŠŽŇ‚Ě—Ő°“I“Á’Ľ‚Ć‚ť‚Ě“]‹A. Š}Œ´—FKC’†“‡ß•vCŽO‰Y’ĺ‘Ľi¸jC’ËŒ´•qłC‚–ě‰Ŕ–çC—é–Ř“§C‹TˆäŒ[•ăi‹î–Ř–ě•a‰@jC‰Á“ĄŒłˆę˜Yi“ŒŽ•‘ĺj: ‘ć14‰ń“ú–{ŽĐ‰ď¸_ˆăŠw‰ď i94.03.19j, ŽRŒ`.

3224. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒfƒCƒPƒA’ʏŠŽŇ‚̐¸_Çó‚̉ü‘P‚ɂ‚˘‚Ä. ‚–ě‰Ŕ–çi‹î–Ř–ě•a‰@jC’ËŒ´•qłi¸jC—é–Ř“§C‹TˆäŒ[•ăC’Ź“c—˛ŽĄC‹´–{—R‹NŽqC”‹Œ´“šŽqCě“c˛’mŽqi‹î–Ř–ě•a‰@jCŠ}Œ´—FKi¸jC‰Á“ĄŒłˆę˜Y i“ŒŽ•‘ĺj: ‘ć14‰ń“ú–{ŽĐ‰ď¸_ˆăŠw‰ď i94.03.19j, ŽRŒ`, ´˜^W, p.82, 1994.

3225. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒfƒCƒPƒA‚Ě—LŒřŤ‚ÉŠÖ‚ˇ‚錟“˘|Ä“ü‰@“ú”‚đŽw•W‚Ć‚ľ‚ā|. ’ËŒ´•qłi¸jC‚–ě‰Ŕ–çCŒIŒ´–Ť”VC—é–Ř“§C‹TˆäŒ[•ăi‹î–Ř–ě•a‰@jC‰Á“ĄŒłˆę˜Yi“ŒŽ•‘ĺjCŠ}Œ´—FKi¸j: ‘ć14‰ń“ú–{ŽĐ‰ď¸_ˆăŠw‰ď i94.03.19j, ŽRŒ`, ´˜^W, p.83, 1994.

3226. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒfƒCƒPƒA’ˇŠú’ʏŠŽŇ‚Ě—Ő°“I“Á’Ľ‚Ć‚ť‚Ě“]‹A. Š}Œ´—FKC’†“‡ß•vCŽO‰Y’ĺ‘Ľi¸jC’ËŒ´•qłC‚–ě‰Ŕ–çC—é–Ř“§C‹TˆäŒ[•ăi‹î–Ř–ě•a‰@jC‰Á“ĄŒłˆę˜Yi“ŒŽ•‘ĺj: ‘ć14‰ń“ú–{ŽĐ‰ď¸_ˆăŠw‰ď i94.03.19j, ŽRŒ`, ´˜^W, p.87, 1994.

3227. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j BenzodiazepineŒn–ň•¨’ˇŠú•ž—pŠłŽŇ‚̐¸_‰^“Ž‹@”\‚ĚŒ¤‹†. ™ŽRŒ’ŽuC‰i‘ň‹IŽqC“ŕŠCŒő’ŠC—é–Ř–q•FCÎ‹˝‰ŞƒC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: ‘ć23‰ń“ú–{_Œo¸_–ň—Šw‰ď”N‰ď i93.09.28j, “Œ‹ž, –ň•¨Ľ¸_Ľs“Ž, 13(6): 452, 1993.

3228. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Vigabatrin‚Ě‘ćˆę‘ŠŽŽŒą|¸_ě‹ĆŒŸ¸‚É—^‚Ś‚é‰e‹ż|. ‚‹´–ž”äŒĂCŽá“c•””Ž•śCÎ‹˝‰ŞƒCˆîŒŠˆňşC—é–Ř–q•FC‘şčŒő–Mi¸j: ‘ć27‰ń“ú–{‚Ä‚ń‚Š‚ńŠw‰ď i93.10.01j, O‘O, —\eW, p.145, 1993.

3229. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‹[ƒ`ƒ“”]”gŒŸ¸’†‚É”F‚ß‚ç‚ę‚˝—Տ°”­ě‚Ć”­ěŽž”]”g‚ɂ‚˘‚āi‘ć2•ńj. ‹g‘ş‹vmŽqC“y‰Ž‰ŔŽqCŠŽi–r•śC‚‹´–ž”äŒĂCÎ‹˝‰ŞƒCˆîŒŠˆňşC‘şčŒő–Mi¸j: ‘ć23‰ń“ú–{”]”gĽ‹Ř“d}Šw‰ďŠwp‘ĺ‰ď i93.11.18j, Ž­Ž™“‡, —\eW, p.255, 1993.

3230. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒoƒŠ“‡‚̐¸_ˆă—Ă‚ÉŠÖ‚ˇ‚é—\”ő’˛¸. ŒIŒ´–Ť”VC’ËŒ´•qłC“n•””CC‹g–ě‘Š‰pCÂŽRr”VC‹TˆäŒ[•ăi‹î–Ř–ě•a‰@jC‰Á“ĄŒłˆę˜Yi“ŒŽ•‘ĺjC”Ş–Ř„•˝iŒc‘ĺj: ‘ć14‰ń“ú–{ŽĐ‰ď¸_ˆăŠw‰ď i94.03.19j, ŽRŒ`, ´˜^W, p.112, 1994.

3231. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j —cŽáƒ‰ƒbƒgiśŒă3`4Tjüđ‘Ě‚É‚¨‚Ż‚éDopamine‚ĚMethamphetamine‚ɑ΂ˇ‚é”˝‰ž|”]“ŕ“§Í–@‚É‚ć‚錟“˘|. Vˆä‘ěCěŒű‹BC‰i“c‰xŽqC‘ĺ’J‹`•vCŽO‰Y’ĺ‘Ľi¸j: ‘ć16‰ń“ú–{ś•¨Šw“I¸_ˆăŠw‰ď i94.03.25j, _ŒË.

3232. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j Diazepam‚Ćlorazepam‚Ě–°‹C‚¨‚ć‚ѐ¸_‰^“Ž‹@”\‚ɑ΂ˇ‚é‰e‹ż. ™ŽRŒ’ŽuC‰i‘ň‹IŽqC“ŕŠCŒő’ŠC‰i“c‰xŽqC—é–Ř–q•FCÎ‹˝‰ŞƒC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: ‘ć16‰ń“ú–{ś•¨Šw“I¸_ˆăŠw‰ď i94.03.25j, _ŒË, ´˜^W, p.264, 1994.

3233. mŠw‰ďi‘S‘jn iŒöŠJuŔj ŽvtŠú‚̉ۑč‚Ć‚ť‚̑Ήž|ŽvtŠú‚̐S‚Ě”Y‚݁|. ˛“ĄŠěˆę˜Yi¸j: •˝Ź5”N“x•ś•”ČŽY‹Ć‹łˆçŽw“ąŽŇ—{ŹuŔiŠĹŒěj i93.07.29j, “Œ‹ž.

3234. mŠw‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j V‚ľ‚˘R‚¤‚–ň‚Ě—Ő°. ‘şčŒő–Mi¸j: ‘ć2‰ń” Ş¸_–ň—ƒVƒ“ƒ|ƒWƒEƒ€ i93.09.04j, ” Ş.

3235. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘˝Ę‚Ȑ¸_Çó‚É‚Ä‚ń‚Š‚ńŤˆŮí”g‚𔺂Á‚˝‚P—á. ‹g–{ÂCŠ}Œ´—FKC‚‹´–ž”äŒĂi¸jC‚‹´KŽ}i`–ě•a‰@j: ‘ć112‰ń_“ސ쐸_ˆăŠw‰ď i93.11.06j, ‰Ą•l, _“ŢěŒ§¸_ˆăŠw‰ďŽ, (43): 119.

3236. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‘ĺ—ĘƒJƒ‹ƒoƒ}ƒ[ƒsƒ“’†“Ĺ‚Ě1Ç—á. ÷ˆäO”TC’ç–M•Fi¸jCăžŠ‹glCŽá—Ń–ő‹vCó—˜–őC‹ß“Ą—Ż”üŽqC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć36‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ď i94.02.05j, “Œ‹ž.

3237. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Diazepam‚Ćlorazepam‚Ě–°‹C‚¨‚ć‚ѐ¸_‰^“Ž‹@”\‚ɑ΂ˇ‚é‰e‹ż. ™ŽRŒ’ŽuC‰i‘ň‹IŽqC“ŕŠCŒő’ŠC—é–Ř–q•FCÎ‹˝‰ŞƒC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: ‘ć2‰ń_“ސ쐸_–ň—Šw‰ď i94.02.17j, ‰Ą•l.

3238. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒƒ`ƒ‹ƒGƒtƒFƒhƒŠƒ“‚đŠÜ—L‚ľ‚Č‚˘Žs”̉tó’ÁŠPÜ——p‚Ě‚P—á. ‹g‘ş•śC‹g“c–FŽqC“c’†•üŽqC‰iŽR’ź“šC’†–ě’qmC‹g‰ŞłĆCÎ‹˝‰ŞƒC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: _“ސ쐸_ˆăŠw‰ď i94.03.12j, ‰Ą•l.

3239. mŒ¤‹†‰ďi‘S‘jn i‹łˆçu‰‰j ŽŠ•ÂÇŽ™‚ĚƒpƒjƒbƒNó‘Ô. ˛“ĄŠěˆę˜Yi¸j: •˝Ź5”N“xáŠQŽ™‹łˆçˆăŠwŠÖŒWę–ĺŒ¤C‰ďi‹łˆç’ĄŽĺĂj i93.06.30j, ˆďé.

3240. mŒ¤‹†‰ďi‘S‘jn i‹łˆçu‰‰j ’s•đ‚Ć–ňÜŤŒ’–Y|’s•đ‚Ƃ̊ӕʁ|. Î‹˝‰Şƒi¸j: Remote Site Teleconference i93.09.17j, “Œ‹ž.

3241. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€j ¸_‰Č‹~‹}ŠłŽŇƒP[ƒX‚Ě”Ŕ‘—ŽŔ‘ԁ|Á–hĽŒxŽ@’˛¸‚Š‚ç|. ’†“‡ß•vi¸jCźŽR^i“Œ•a‰@‘‡‘Š’k•”jC•˝“c–L–žCŒvŒŠˆę—Yiç—tŒ§¸_‰Čˆă—ĂƒZƒ“ƒ^[j: ‘ć1‰ń¸_‰Č‹~‹}ˆă—ĂŒ¤‹†‰ď i93.07.10j, ç—t.

3242. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ň•¨‚Ě—Ő°—p—ĘˆË‘ś‚ɂ‚˘‚Ä. ™ŽRŒ’Žui¸j: ‘ć3‰ńŒúśČ¸_Ľ_ŒoŽžŠłˆĎ‘ő”_ŽžŠłŠÖ˜A”Ǎ‡“ŻƒVƒ“ƒ|ƒWƒEƒ€ i93.11.12j, “Œ‹ž.

3243. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ˜V”NŠú’s•đ‚Ě–ň•¨—Ă–@. ‘ĺ’J‹`•vi¸j: ‘ć3‰ń—Տ°¸_–ň—Œ¤‹†‰ď i93.11.18j, “Œ‹ž.

3244. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‡–°–ň‚ĚŽg—p–@‚Ć–â‘č“_iƒVƒ“ƒ|ƒWƒEƒ€uŒť‘㐜Šˆ‚Ɛ‡–°|‡–°‚ĆQOL, Part‡Uvj. Î‹˝‰Şƒi¸j: ‘ć9‰ń•s–°Œ¤‹†‰ď i93.11.20j, “Œ‹ž.

3245. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j SC-49088iƒTƒCƒNƒƒZƒŠƒ“j‚ÉŒ’í‚—îŽŇ‚Ě”F’m‹@”\‚É‹y‚Ú‚ˇ‰e‹ż‚ɂ‚˘‚ā|Cognifive drug research (CDR) test‚É‚ć‚錟“˘|. ‘ĺ’J‹`•vC—é–Ř–q•FCěŒű‹BC“ŕŠCŒő’ŠCŒĂ’m‹MŒbŽqC‘şčŒő–Mi¸j: ‘ć20‰ń”]Œ¤‹†‰ď i93.10.28j, Ž­Ž™“‡, —\eW, p.23, 1993.

3246. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Diazepam‚Ćlorazepam‚Ě–°‹C‚¨‚ć‚ѐ¸_‰^“Ž‹@”\‚ɑ΂ˇ‚é‰e‹ż. Î‹˝‰ŞƒC™ŽRŒ’ŽuC‰i‘ň‹IŽqC“ŕŠCŒő’ŠC—é–Ř–q•FC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: ŒúśČ¸_Ľ_ŒoŽžŠłŒ¤‹†ˆĎ‘ő”–°áŠQ‚̐f’fĽŽĄ—Ă‹y‚щuŠw‚ÉŠÖ‚ˇ‚錤‹†•˝Ź5”N“xŒ¤‹†•ń‰ď i94.01.21j, “Œ‹ž.

3247. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŽvtŠúŠłŽŇ‚Ě“ü‰@ŽĄ—Á|ƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“˜_‚Ě—§ę‚Š‚ç|. ˛“ĄŠěˆę˜Yi¸j: ‘ć7‰ń“ú–{ŹŽ™¸_ˆăŠwŒ¤‹†‰ď i94.02.01j, ŽD–y.

3248. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ŽvtŠú‚̐S—‚ɂ‚˘‚ā|ŽvtŠú‚ĚŽ–—á‚ւ̉‡•‚ĚŽd•ű|. ˛“ĄŠěˆę˜Yi¸j: •˝Ź5”N“xŒ§‰›Œ§–kŠw‹ć‚Zś“kŽw“ą‘‰ď i94.03.09j, ‘Š–ÍŒ´.

3249. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j Ĺ‹ß‚Ě’†ŠwśĽ‚Zś‚̐S‚Ě”Y‚݁|ŽvtŠúŠO—ˆ‚ĚŒoŒą‚𒆐S‚Ɂ|. ˛“ĄŠěˆę˜Yi¸j: •˝Ź4”N“xŒ§‰›Œ§–kŠw‹ć‚Zś“kŽw“ą‘‰ď i93.03.04j, ŠC˜V–ź.

3250. mŒ¤‹†‰ďi’n•űjn iŒöŠJuŔj ‹łŽt‚ƐSgÇ. ’†“‡ß•vi¸j: _“ŢěŒ§ˆăŽt‰ďŠwZ•ŰŒ’•”‰ďŒ’NŽw“ąˆăuŔ i93.08.28j, ‰Ą•l.

3251. mŒ¤‹†‰ďi’n•űjn iŒöŠJuŔj ‚¤‚•a. ’†“‡ß•vi¸j: –k—˘‘ĺŠwˆăŠw•”ŒöŠJuŔ i93.10.16j, ‘Š–ÍŒ´.

3252. mŒ¤‹†‰ďi’n•űjn iŒöŠJuŔj ŽŠ—ĽŒP—ű–@. ’†“‡ß•vi¸j: ŽY‹Ć¸_•ŰŒ’Œ¤C‰ď i94.01.21j, ‰Ą•l.


<<26 •úŽËü‰ČŠw>>

3253. mŒ´’˜n Rat model of bone metastasis obtained by mammary cancer transplantation. ‘ž“cŒ°ŹCź—Ń—˛i•újC‚Œ´ÄCă‘O•ôŽqi•úŽËü•”jC’†ŽR–ΐMiŽŔ“ŽŒnj: Annals of Cancer Research and Therapy, 2(2): 193`198, 1993.

3254. mŒ´’˜n 99mTc-MAG3‚Ě‘ć‡U‘Š—Տ°ŽŽŒą|5Ž{Ý‚É‚ć‚鋤“ŻŒ¤‹†|. ÎˆäŸŒČi•újCÎ‹´Wi”ĺjC’Ë–{]—˜ŽqCˆÉ“Ą˜a•vi–k‘ĺjCŽR–{˜a‚CÎˆä–ői•Ÿˆäˆă‘ĺjCŹ—Ń–ÎŽ÷C’|“cŠ°C’†ě‹BC“ú’u‘ôˆęCě‘şŽőˆęiŽOd ‘ĺjCÎ‘ş‡ŽĄC•Ÿ’n–Ťi•şŒÉˆă‘ĺjC’š’ËŠÎŽ˘i•Ÿˆäˆă‘ĺj: ŠjˆăŠw, 30(4): 411`422, 1993.

3255. mŒ´’˜n 99mTc-MAG3‚Ě—Ő°“I—L—pŤ‚ĚŒŸ“˘|24Ž{Ý‚É‚ć‚é‘ć‡V‘Š—Տ°ŽŽŒą|. ÎˆäŸŒČi•újCÎ‹´Wi”ĺjC’š’ËŠÎŽ˘i•Ÿˆäˆă‘ĺj: ŠjˆăŠw, 30(5): 517`528, 1993.

3256. mŒ´’˜n QCT‚É‚ć‚é•GŠÖßÇ‚Ě•]‰ż; ˜’ĹĽ‘ĺ‘ڍœŠOč÷•”‚̍œ‰–—Ę‚Ć’Pƒ‚wüŽĘ^ŠŒŠ‚Ć‚Ě”äŠr. ÷ˆä´Žqi•újC—L•xŠ°iŽŠOjCX“c^Žjiś‘̍HjCŽR“ż‹`˜YiŽŠOj: ‘ć14‰ń_“ސěCaĽœ‘ăŽÓŒ¤‹†‰ď•ńW1994, p.15`20, 1994.

3257. mŒ´’˜n ŠOŤS‹ŘÁ‚É‚¨‚Ż‚éS”ŽüŠúRISƒv[ƒ‹ƒf[ƒ^‚ĚˆĘ‘Š‰đÍ‚Ě—L—pŤ. źŠŞ”Ži•újCŹ—Ń–ž–Fi“ŕj: “ú–{ˆăŠw•úŽËüŠw‰ďŽGŽ, 54(1): 55`66, 1994.

3258. mŒ´’˜n QCT‚É‚ć‚é‘ĺ‘ڍœ”玿ƒpƒ‰ƒ[ƒ^‚ÉŠÖ‚ˇ‚étŤœˆŮ‰h—{Ç‚ĚŽĄ—Ă–@•ĘŒŸ“˘. ÷ˆä´ŽqCź—Ń—˛C’r“crşi•újCŽç‰Ž—˜‰ŔC’Ë–{—Y‰îi“ŕj: “ú–{œŒ`‘ÔŒv‘ŞŠw‰ďŽGŽ, 3(1): 101`106, 1993.

3259. mŒ´’˜n ‘˝Ž{ÝĽ‘˝‹@Ží‚É‚¨‚Ż‚éƒnƒCƒhƒƒLƒVƒAƒpƒ^ƒCƒgĽƒtƒ@ƒ“ƒgƒ€‚ĚŒŸ“˘. ŹŽR˜asi“Œ‘ĺjCˆÉ“ŒšŽqi’ˇč‘ĺjCŹ’|‰p‹`i‘•ŰŽá–ö•a‰@jC÷ˆä´Žqi•újC—é–Ř‘i“‡“cŽs—§•a‰@jC’†‘ş—˜FiŽY‹Ćˆă‘ĺjC•Ÿ‰im•viěčˆă ‘ĺjC—kƒśi•şŒÉˆă‘ĺj: “ú–{œŒ`‘ÔŒv‘ŞŠw‰ďŽGŽ, 3(1): 21`27, 1993.

3260. mŒ´’˜n QCT‚É‚ć‚鍜‰–‚ƍœ‘“ŕŽ‰–b‚Ě’č—ʉť‚ÉŠÖ‚ˇ‚éŠî‘b“IŒ¤‹†. ’r“crşC÷ˆä´ŽqCź—Ń—˛i•újC‘Š‘ň^C—§•˝eli•úŽËü•”j: “ú–{œŒ`‘ÔŒv‘ŞŠw‰ďŽGŽ, 3(1): 29`35, 1993.

3261. m€Œ´’˜n ‚Ş‚ńŽĄ—Ă‚ÉŠń—^‚ˇ‚鎼‹C‹¤–Â‰ć‘œ. ’Š‘q‰p’ji‘—§‘Š–ÍŒ´•a‰@jC›Mˆęi•új: Innervision, 9(2): 70`73, 1994.

3262. m€Œ´’˜n Ň‘Žîá‡. ›Mˆęi•új: “ú“Ćˆă•ń, 38(2): 63`77, 1993.

3263. m€Œ´’˜n R”xŹ×–EŠŕƒ}ƒEƒXƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ě6H7‚ĚŽîˆÚƒk[ƒhƒ}ƒEƒX‚É‚¨‚Ż‚é‘Ě“ŕ•Ş•z‚ĚŒŸ“˘. “cŠŽŒČCÎˆäŸŒČCźŠŞ”ŽCźŽRłŒáCŠâ”g–΁i•újCˆË“cˆędi•úŽËü•”jCź—Ń—˛i•újC‹T’J“OCŠ}ˆäŒ‰Cě‹v•ŰˆŔ˜Ni•a—j: –ƉuŠjˆăŠw, 18(1): 19`23, 1993.

3264. m’Z•ńĽ‘Ź•ńn ’[‘‹ŽŽ GM ƒT[ƒxƒCƒ[ƒ^[‚É‚ć‚éŠČˆŐ‚Č˜IoŽžŠÔ‚̐„’č. ź–Šr”VCÂ–؏ŸŒČi‚q‚hŒnjC•lčG–žiś•¨jC‹Ęˆä—mˆęiś‰ťj: Isotope News, 10ŒŽ(402): 33, 1993.


<<26 2 •úŽËü‰ČŠw>>

3265. mÇ—á•ńn • o“ŕoŒŒ‚đ‚Ť‚˝‚ľ‚˝’_‚Ě‚¤Šŕ‚Ě1—á. ‰““Ą‚CźŠŞ”ŽCˆé•”‹`Œ›Cź—Ń—˛i•újCň‰Ć‹v’źC‹g“c@‹ICźŽR•Ű”äŒĂiŠOjC’†‰p’ji•a—j: “ú–{• •”‹~‹}ˆăŠw‰ďŽGŽ, 13: 733`736, 1993.

3266. m—Տ°ŽĄŒąn MRI—p‘˘‰eÜDV-7572(Gd°DTPA°BMA: Gadodiamide)‚ĚŒăŠú‘ć‡U‘Š—Տ°ŽŽŒą|”][Ç‚Ě‘˘‰eMRI‚ĚŒŸ“˘|. Ź—Ń’ź‹Ii“Œ‹ž—ˆă‘ĺjCŽu‰ęˆí•viŒc‘ĺjC’Ë–{_išƒ}ƒŠ‘ĺjC›Mˆęi•újC’†–ědsi‘ĺ•Şˆă‘ĺj: –ň—‚ĆŽĄ—Ă, 21(10): 3821`3837, 1993.

3267. m—Տ°ŽĄŒąn ”]ŒŒŠÇŽB‰e‚É‚¨‚Ż‚é”ńƒCƒIƒ“Ť‘˘‰eÜIoxilan (IOX)‚Ě—Ő°•]‰ż|Iohexol‚Ć‚Ě‘ć‡V‘Š‘˝Ž{Ý”äŠrŽŽŒą|. ‚‹´–rłC‹ťž‘Ş“TiŒF–{‘ĺjC“ü]ŒÜ˜NC‹{â˜a’jC‹e’r—zˆęCˆ˘•”Œĺi–k‘ĺjC‹Ęě–FtC’†—˘—´•FiŠâŽčˆă‘ĺjC‰Á“Ą•q˜YCV“Ą‰ëÍiH“c‘ĺjCŽRŒűV ˆęC×–î‹M—şiŽRŒ`‘ĺjC˛X–؍NlC’Ź“c“OC˛X–ؑ׎uC”’…ˆę˜Yi“Œ‘ĺjC‹v—Ż—TCZ]Š°ri‡“V‘ĺjC•˝ź‹žˆęCŽu‰ęˆí•vC•S“‡—S‹MiŒc‰ž‘ĺjCŹ —Ń’ź‹IC–L“cšŽqC—Ń’źlCŽ›“cˆęŽui“Œ‹ž—ˆă‘ĺjC‘OŒ´’‰sCŹ‘ňK•FiŠÖ“Œ’üM•a‰@jCź—Ń—˛C›Mˆęi•újCźŽRł–çC–ö’Ź“żti“ŒŠC‘ĺjCŽđˆä–M •viVŠƒ‘ĺjCˆÉ“Ąšć‰îC‰Ş–{_ˆę˜YC“c’†—˛ˆęC’|“ŕ–ΘaCěŒűłiVŠƒ‘ĺjCŒĂ‰ę—C•FC’|‰şŒłi“Ą“c•ŰŒ’‰qś‘ĺjC“ŕ‘Ĺ“úo•vCŠâčšC’†ě—T”Vi“Ţ—Ç ˆă‘ĺjCŹ–ěŽR–őlCˆäă—CˆęC–]ŒŽ“ž˜YCŞ–{—Ti‘ĺăŽs—§‘ĺjCŹ’Ë—˛OC•˝“x•vi‘ĺă‘ĺjCŒä‹Ÿ­‹Ii‘—§‘ĺă•a‰@jCŠÝě‚C•Šâr˜Yi˛‰ęˆă ‘ĺjC“n•ÓŽŽiCŹ‹Ę—˛’ji‹{čˆă‘ĺjC“n•”P–çié‹Ęˆă‘ĺjCŹě’¨–çiˆ¤•Q‘ĺj: —Տ°ˆă–ň, 9(8): 1807`1827, 1993.

3268. m‘ŕn ’P”­Ť“ŞŠW“ŕÎŠD‰ť‘œ. ’r“crşC›Mˆęi•új: Medicina, 30(10): 35`38, 1993.

3269. m‘ŕn ‹Ů‹}‰ć‘œf’f|“lje‚Ěƒ|ƒCƒ“ƒg. ă–ěŒbŽqC•Ÿ“cWi“Œ‹ž—ˆă‘ĺjCˆé•”‹`Œ›i•új: ‹~‹}ˆăŠw, 17(5): 600`603, 1993.

3270. m‘ŕn ‹Ů‹}‰ć‘œf’f|“lje‚Ěƒ|ƒCƒ“ƒg. ă–ěŒbŽqi“Œ‹ž—ˆă‘ĺjCˆé•”‹`Œ›i•új: ‹~‹}ˆăŠw, 17(6): 724`728, 1993.

3271. m‘ŕn “Ş•”ŠO‚Ě‰ć‘œf’fŠw. ›Mˆęi•új: ‹~‹}ˆăŠw, 17(9): 1013`1016, 1993.

3272. m‘ŕn pŒă• o“ŕoŒŒ‚ɑ΂ˇ‚éintervention. ˆé•”‹`Œ›C‰““Ą‚CźŠŞ”ŽCź‰iŒ[“ńi•újCŹź‰i“ńCă–ěŒbŽqi“Œ‹ž—ˆă‘ĺj: ‹~‹}ˆăŠw, 18(1): 59`62, 1994.

3273. muŔn ’†ŤŽq•úŽË‰ť•ŞÍ: ˆăŠwĽŽ•Šw. ‘ž“cŒ°Źi•új: Radioisotopes, 43(2): 105`107, 1994.

3274. muŔn ŹŽ™‰Č—Ěˆć‚ĚŠjˆăŠw. ÎˆäŸŒČi•új: f’f‚ĆŽĄ—Ă, 82(1): 111`121, 1994.

3275. muŔn ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ě. ÎˆäŸŒČi•új: ŽŒ`ŠO‰Č, 45(2): 204, 1994.

3276. muŔn ‚“xćiˆă—Ă‚ĚŽŔŰ; 111In°•WŽŻ”’ŒŒ‹…‚É‚ć‚鉊ÇƒVƒ“ƒ`ƒOƒ‰ƒtƒB. ÎˆäŸŒČi•új: –ňŽ–V•ń, (1788): 279`284, 1994.

3277. mŠwp‘n i‹¤’˜j œ‘e頏Ç; QCT‚É‚ć‚éf’f‚Š‚玥—Â܂Łi—Տ°•Ňj, ˆÉ“ŒšŽqi’ˇč‘ĺjCŹŽR˜asi“Œ‘ĺjCŹ’|‰p‹`iŽá–ö’Ź‘–ŻŒ’N•ŰŒŻ•a‰@jC÷ˆä´Žqi•újC—é–Ř‘i“‡“cŽs–Ż•a‰@jC’†‘ş—˜FiŽY‹Ćˆă‘ĺjC•Ÿ‰im•v iěčˆă‘ĺjC—kƒśi•şŒÉˆă‘ĺj. •ŇW ŹŽR˜asi“Œ‘ĺjC “ú–{ˆăŽ–V•ńŽĐ, “Œ‹ž, 94.03.15”­s.


<<26 3 •úŽËü‰ČŠw>>

3278. m‹ł‰Č‘n i•Ş’SŽˇ•Mj Á‰ťŠíf—Ăƒvƒ‰ƒNƒeƒBƒX; •ÂÇŤ‰Šát‚ւ̑Ήž‚Ě‚ľ‚Š‚˝, p.198`207, ˆé•”‹`Œ›i•új. •ŇW _’Ă’‰•Fi“Œ‹ž—ˆă‘ĺjC •śŒő“°, “Œ‹ž, 93.12.19”­s.

3279. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn i‹¤’˜j œ‘e頏Ç; QCT‚É‚ć‚éf’f‚Š‚玥—Â܂Łi‹Zp•Ňj, ˆÉ“ŒšŽqi’ˇč‘ĺjCŹŽR˜asi“Œ‘ĺjCŹ’|‰p‹`iŽá–ö’Ź‘–ŻŒ’N•ŰŒŻ•a‰@jC÷ˆä´Žqi•újC´…O”Višƒ}ƒŠˆă‘ĺjC’†‘ş—˜FiŽY‹Ćˆă‘ĺjC•Ÿ‰im•v iěčˆă‘ĺjC—kƒśi•şŒÉˆă‘ĺj. •ŇW ŹŽR˜asi“Œ‘ĺjC “ú–{ˆăŽ–V•ńŽĐ, “Œ‹ž, 93.10.20”­s.


<<26 5 •úŽËü‰ČŠw>>

3280. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Image features of atypical chronic pancreatitis differed from classic morphology. ˆé•”‹`Œ›i•újCă–ěŒbŽqC‹g“cňC“yŠň•ś•i“Œ‹ž—ˆă‘ĺjC‰““Ą‚CźŠŞ”Ži•új: ‘ć8‰ń‰˘B•úŽËüŠw‰ď‹c i93.09.16j, ƒEƒC[ƒ“, —\eW, 1993.

3281. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j QCT of cortical bone for assessing bone loss in patients with ROD. ÷ˆä´ŽqCź—Ń—˛i•újC’Ë–{—Y‰îi“ŕj: 9th International Bone Densitometory Workshop i93.09.27j, Traverse City, Calcif. Tissue Int., 52: 161, 1993.

3282. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Inhibitory effect of low-dose whole body irradiation on the growth of transplantable mammary cancer in rats. ‘ž“cŒ°ŹCź—Ń—˛i•újC‚Œ´ÄCă‘O•ôŽqi•úŽËü•”jC’†ŽR–ΐMiŽŔ“ŽŒnjC—ŤĂŽ÷i”’‹‰śˆă‘ĺj: ‘Ű•úŽËüŽîᇊw‰ď i93.06.22j, ‹ž“s, ´˜^W, p.485, 1993.

3283. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j V‚ľ‚˘•úŽËŤˆă–ň•i‚ĆŠjˆăŠwf—Á|ŹŽ™ŠjˆăŠw‚ƐV‚ľ‚˘•úŽËŤˆă–ň•i|. ÎˆäŸŒČi•új: ‘ć29‰ń“ú–{ˆăŠw•úŽËüŠw‰ďH‹G—Տ°‘ĺ‰ď i93.11.17j, ŽRŒű.

3284. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j f—Ă•úŽËü‹ZŽt‹łˆç‚É‚¨‚Ż‚郊ƒXƒNĽƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‹łˆç. Šâ”g–΁i•új: ‘ć6‰ń“ú–{ƒŠƒXƒNŒ¤‹†Šw‰ďŒ¤‹†”­•\‰ď i93.11.25j, “Œ‹ž, ˜_•śW, p.34`38, 1993.

3285. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‰ć‘œŒŸ¸‚Ş‹š• •”‚Ě‹~‹}f—Âɉʂ˝‚ˇ–đŠ„: CTŒŸ¸. –x’rdŽĄi‹~–˝j: ‘ć29‰ń“ú–{ŹŽ™•úŽËüŠw‰ď i93.05.22j, ‹ŕ‘ň.

3286. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j QCT‚É‚ć‚鍜‰–’č—Ę–@‚É‚¨‚Ż‚鍜‘“ŕŽ‰–b‚̉e‹ż‚ÉŠÖ‚ˇ‚éŠî‘b“IŒ¤‹†. ’r“crşC÷ˆä´ŽqCź—Ń—˛i•újC‘Š‘ň^C—§•˝eli•úŽËü•”j: ‘ć52‰ń“ú–{ˆăŠw•úŽËüŠw‰ď‘‰ď i93.04.01j, ‰Ą•l.

3287. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒAƒ‹ƒR[ƒ‹’E…‘fy‘f‚ɑ΂ˇ‚é‚wü, ƒvƒƒgƒ“‚¨‚ć‚ŃŽ‡ŠOü‚Ě’áü—ĘĆŽËŒř‰Ę. ‘ž“cŒ°ŹCź—Ń—˛i•újC‘]Ş—R”üŽqC‚ŽR‹v”üŽqiś•¨‰ťŠwŒnj: ‘ć35‰ń“ú–{ˆăŠw•úŽËüŠw‰ďś•¨•”‰ď i93.04.01j, ‰Ą•l, “ú–{ˆăŠw•úŽËüŠw‰ďŽGŽ, 52(12): 1471, 1993.

3288. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j QCT‚É‚ć‚鍜‰–’č—Ę–@‚É‚¨‚Ż‚鍜‘“ŕŽ‰–b‚̉e‹ż; łíƒ{ƒ‰ƒ“ƒeƒBƒA‚É‚ć‚錟“˘. ’r“crşC÷ˆä´ŽqCź—Ń—˛i•új: ‘ć52‰ń“ú–{ˆăŠw•úŽËüŠw‰ď‘‰ď i93.04.03j, ‰Ą•l.

3289. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ga-67ƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚É‚¨‚Ż‚é—ź‘¤‘S”x‚Ě‚Ń‚Ü‚ńŤRIWĎ‚ɂ‚˘‚Ä. źŠŞ”ŽCÎˆäŸŒČC’†‘ňŒ\ŽĄC–k–ě‰ëŽjC•Đ‹Ë‰ČŽqC‰““Ą‚C“cŠŽŒČCˆé•”‹`Œ›Cź—Ń—˛i•új: ‘ć52‰ń“ú–{ˆăŠw•úŽËüŠw‰ď i93.04.05j, ‰Ą•l, “ú–{ˆăŠw•úŽËüŠw‰ďŽGŽ, 53: 383, 1993.

3290. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’_“šƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚É‚ć‚éć“VŤ’_“šŠg’ŁÇ‚̏pŒă‰“ŠuŹŃ‚ĚŒŸ“˘. L•”˝ˆęCÎ“cŽĄ—YC—ŃšôC‘źi“s—§´ŁŹŽ™•a‰@jCÎˆäŸŒČi•új: ‘ć30‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ď‘‰ď i93.05.28j, ‘ĺă, “ú–{ŹŽ™ŠO‰ČŠw‰ďŽGŽ, 29(3): 708, 1993.

3291. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “–‰@‚É‚¨‚Ż‚éä`’°ŠÇˆâŽcÇ‚ĚŒoŒą|f’fă‚Ě–â‘č‚𒆐S‚Ɂ|. Š™Œ`łˆę˜YCÎ“cŽĄ—YC—ŃšôC‘źi“s—§´ŁŹŽ™•a‰@jCÎˆäŸŒČi•új: ‘ć30‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ď‘‰ď i93.05.28j, ‘ĺă, “ú–{ŹŽ™ŠO‰ČŠw‰ďŽGŽ, 29(3): 758, 1993.

3292. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j V‹ŒB-MAS‚É‚ć‚é”팟ŽŇ‚Ě‘Ş’č’l‚ĚŠˇŽZ‚ĚŒŸ“˘. ÷ˆä´Žqi•újCŹŽR˜asi“Œ‘ĺj: ‘ć13‰ń“ú–{œŒ`‘ÔŒv‘ŞŠw‰ď i93.07.01j, “Œ‹ž, —\eW, p.3, 1993.

3293. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j V‹ŒB-MAS‚É‚ć‚é‘Ş’č’l‚ĚŠˇŽZ‚ĚŒŸ“˘. ˆÉ“ŒšŽqi’ˇč‘ĺjCŹ’|‰p‹`i‹{éŒ§Žá–ö’Ź‘–ŻŒ’N•ŰŒŻ•a‰@jC÷ˆä´Žqi•újCŹŽR˜asi“Œ‘ĺj: ‘ć13‰ń“ú–{œŒ`‘ÔŒv‘ŞŠw‰ď i93.07.01j, “Œ‹ž, —\eW, p.4, 1993.

3294. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠjˆăŠw“IŽč–@‚É‚ć‚é‹ÇŠ”xŒŒ‰t—Ę‹y‚Ńƒż’l‚Ě‘Ş’č. ’†‘ňŒ\ŽĄCÎˆäŸŒČCź—Ń—˛i•új: ‘ć12‰ń“ú–{ˆă—p‰ć‘œHŠw‰ď i93.07.09j, “Œ‹ž, Medical Imaging Technology, 11(3): 437`438, 1993.

3295. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •úŽËü–hŒě‚É‚¨‚Ż‚éüŽżŒW”Ľ•úŽËü‰×dŒW”‚Ćƒ}ƒCƒNƒƒhƒWƒƒgƒŠ[. Šâ”g–΁i•új: ‘ć10‰ń“ú–{ˆăŠw•¨—Šw‰ďŒ¤‹†”­•\‰ď i93.07.23j, “Œ‹ž, ´˜^W, p.117, 1993.

3296. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j QCTƒf[ƒ^‚Ě•W€‰ť‚ĆŒ’í’l‚ĚŒŸ“˘. ŹŽR˜asi“Œ‘ĺjCˆÉ“ŒšŽqi’ˇč‘ĺjCŹ’|‰p‹`iŽá–ö’Ź‘–ŻŒ’N•ŰŒŻ•a‰@jC÷ˆä´Žqi•újC´…O”Višƒ}ƒŠˆă‘ĺjC—é–Ř‘i“‡“cŽs–Ż•a‰@jC’†‘ş—˜ FiŽY‹Ćˆă‘ĺjC•Ÿ‰im•viěčˆă‘ĺjC—kƒśi•şŒÉˆă‘ĺj: ‘ć11‰ń“ú–{œ‘ăŽÓŠw‰ď i93.07.31j, ‰Ą•l, “ú–{œ‘ăŽÓŠw‰ďŽGŽ, 11(3): 122, 1993.

3297. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”ńˆă—ĂŽ{Ý‚Ĺ‚Ěƒqƒg‚Ě•úŽËü”픘‚đ‚Ć‚ŕ‚Č‚¤ˆăŠwŒ¤‹†‚ĚđŒ|‚ť‚Ě‚P.ŠeŽíŠŠ|. Šâ”g–΁i•új: ‘ć66‰ń“ú–{ˆăŠw•úŽËü•¨—Šw‰ď‘ĺ‰ď i93.09.17j, ŽD–y, “ú–{ˆăŠw•úŽËüŠw‰ďŽ, 54: 93, 1993.

3298. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰p•śƒAƒuƒXƒgƒ‰ƒNƒgˆĎˆő‰ď(1990`1993”N)‚Ě‘Š‡. ăŒ´ŽüŽOi‹ă‘ĺjC‹S’ˏš•Fi‹v—Ż•Ä‘ĺjCŠâ”g–΁i•új: ‘ć66‰ń“ú–{ˆăŠw•úŽËü•¨—Šw‰ď‘ĺ‰ď i93.09.17j, ŽD–y, “ú–{ˆăŠw•úŽËüŠw‰ďŽ, 54: 93`94, 1993.

3299. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •¨—ˆĎˆő‰ďĽ•¨—•”‰ď40”NŠÔ‚ĚŒű“Ş”­•\˜_•śƒf[ƒ^ƒx[ƒX‚̍\’z. Šâ”g–΁i•újCăŒ´ŽüŽOi‹ă‘ĺjC‹S’ˏš•Fi‹v—Ż•Ä‘ĺj: ‘ć66‰ń“ú–{ˆăŠw•úŽËü•¨—Šw‰ď‘ĺ‰ď i93.09.17j, ŽD–y, “ú–{ˆăŠw•úŽËüŠw‰ďŽ, 54: 94, 1994.

3300. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠjˆăŠw“IŽč–@‚É‚ć‚é‹ÇŠ”]ŒŒ‰t—Ę‚¨‚ć‚Ń‹ÇŠƒż’l‚Ě‘Ş’č. ’†‘ňŒ\ŽĄCÎˆäŸŒČi•újCâˆä•ś•Fi“ŕj: ‘ć30‰ń“ú–{—Տ°ś—Šw‰ď i93.10.15j, “Œ‹ž, “ú–{—Տ°ś—Šw‰ďŽGŽ, 23(Suppl.): 110`111, 1993.

3301. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j 201Tl-SPECT‘œ‚É‚ć‚é”]ŽžŠłf’f‚̐¸“x‚ÉŠÖ‚ˇ‚錤‹†|•ű–@˜_‚ĚŒŸ“˘|. ź–{“OC”яŔ•i•úˆăŒ¤jC’Ź“cŠě‹v—YC–{“cŒ›‹ĆCˆäă—D‰îié‹Ęˆă‘ĺjC‘ş“cŒ[CŠŰ–ěL‘ĺiŒŐƒm–ĺ•a‰@jCÎˆäŸŒČCźŠŞ”Ži•új: ‘ć33‰ń“ú–{ŠjˆăŠw‰ď‘‰ď i93.10.28j, ‹{č, ŠjˆăŠw, 30(8): 891, 1993.

3302. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹŽ™‚É‚¨‚Ż‚é99mTc-GSA‚̩̏WĎ‹Čü‚̉đÍ‚É‚ć‚éŠĚ×–E‹@”\‚Ě•]‰ż. ŽR“cCCÎ“cŽĄ—Yi“s—§´ŁŹŽ™•a‰@jCÎˆäŸŒČi•új: ‘ć33‰ń“ú–{ŠjˆăŠw‰ď‘‰ď i93.10.28j, ‹{č, ŠjˆăŠw, 30(8): 901, 1993.

3303. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’_“š•Â˝ÇpŒă‚ĚŠĚ×–E‹@”\‚Ě•]‰ż‚É‚¨‚Ż‚é99mTc-GSA‚Ě—L—pŤ‚ɂ‚˘‚Ä. Î“cŽĄ—YC—ŃšôCŠ™Œ`łˆę˜Yi“s—§´ŁŹŽ™•a‰@jCÎˆäŸŒČC–x’rdŽĄi•új: ‘ć33‰ń“ú–{ŠjˆăŠw‰ď‘‰ď i93.10.28j, ‹{č, ŠjˆăŠw, 30(8): 902, 1993.

3304. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”xWĎ‚ŞI-123-IMP‚É‚ć‚é‹ÇŠ”]ŒŒ—Ź’č—Ę‘Ş’čŽž‚É‹y‚Ú‚ˇ‰e‹ż‚ĚŒŸ“˘. ‰““Ą‚CÎˆäŸŒČC‹g“c’¨ŒłCźŽRłŒáC’r“crşCźŠŞ”ŽC’†‘ňŒ\ŽĄC‹e’rŒhCˆË“cˆędCˆé•”‹`Œ›i•új: ‘ć33‰ń“ú–{ŠjˆăŠw‰ď‘‰ď i93.10.28`30j, ‹{č, ŠjˆăŠw, 30(8): 927, 1993.

3305. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ga-67ƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚Ě”xWĎ‚Ć‹š•”’Pƒ‚wü‘œ‚Ć‚ÉŠŒŠ‚Ě˜¨—Ł‚đŽŚ‚ľ‚˝Ç—á‚ĚŒŸ“˘. źŠŞ”ŽCÎˆäŸŒČC’†‘ňŒ\ŽĄC–k–ě‰ëŽjC•Đ‹Ë‰ČŽqC‰““Ą‚i•újCăˆä˜aŽqCˆË“cˆędi•úŽËü•”jCź—Ń—˛i•új: ‘ć33‰ń“ú–{ŠjˆăŠw‰ď‘‰ď i93.10.28`30j, ‹{č, ŠjˆăŠw, 30(8): 944, 1993.

3306. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j SPECT‚É‚ć‚é‹ÇŠäBŒŒ‰t—Ę‚¨‚ć‚Ń‹ÇŠƒż’l‚Ě‘Ş’č. ’†‘ňŒ\ŽĄCÎˆäŸŒČCźŠŞ”ŽC’r“crşCźŽRłŒái•újCÎˆä‰sŽC‹e’rŒhCˆË“cˆędi•úŽËü•”jCź—Ń—˛i•új: ‘ć33‰ń“ú–{ŠjˆăŠw‰ď‘‰ď i93.10.29j, ‹{č, ŠjˆăŠw, 30(8): 942, 1993.

3307. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ěč•a‚ɑ΂ˇ‚éI-123-MIBGS‹ŘSPECT‚ĚŒŸ“˘. ÎˆäŸŒČC’†‘ňŒ\ŽĄCźŠŞ”ŽC‰““Ą‚C’r“crşCźŽRłŒáC•Đ‹Ë‰ČŽqi•újCˆË“cˆędCÎˆä‰sŽi•úŽËü•”jCź—Ń—˛i•újC•˝Î‘iŽ™j: ‘ć33‰ń“ú–{ŠjˆăŠw‰ď‘‰ď i93.10.29j, ‹{č, ŠjˆăŠw, 30(8): 963, 1993.

3308. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Monte Carlo–@‚É‚ć‚éŒőŽqƒiƒ[ƒr[ƒ€‚̐ü—ĘŒvŽZ. Šâ”g–΁i•újCăŒ´ŽüŽOi‹v—Ż•Ä‘ĺjC‹S’ˏš•Fi‹ă‘ĺj: ‘ć6‰ń“ú–{•úŽËüŽîᇊw‰ď i93.11.06j, •Ÿ‰Ş, “ú–{•úŽËüŽîᇊw‰ďŽ, (Suppl.1): 209, 1993.

3309. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘O—§‘BŠŕ‹ÇŠZ“xf’f‚É‚¨‚Ż‚éMRI‚Ě—L—pŤ‚ĚÄŒŸ“˘|‘O—§‘B‘S“Eœ•W–{‚Ć‚Ě”äŠr|. źŠŞ”ŽC‹g“c’¨ŒłC–k–ě‰ëŽjCź‰iŒh“ńC•Đ‹Ë‰ČŽqC‰““Ą‚Cˆé•”‹`Œ›C›Mˆęi•újC‰oěWi”ĺjCŒK”ö’čmi•a—j: ‘ć13‰ń“ú–{‰ć‘œˆăŠw‰ď i94.02.03`05j, “Œ‹ž, “ú–{‰ć‘œˆăŠwŽGŽ, 12(5): 478, 1993.

3310. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j 99mTc-GSAŠĚSPECT‚É‚ć‚é‹ÇŠŠĚ—\”ő”\•]‰ż‚ĚŽŽ‚Ý. źŠŞ”ŽCÎˆäŸŒČC‹g“c’¨ŒłC–k–ě‰ëŽjCź‰iŒh“ńC•Đ‹Ë‰ČŽqC‰““Ą‚Cˆé•”‹`Œ›C’†‘ňŒ\ŽĄi•újCŽÄ“c‹v—Yi“ŕj: ‘ć13‰ń“ú–{‰ć‘œˆăŠw‰ď i94.02.03`05j, “Œ‹ž, “ú–{‰ć‘œˆăŠwŽGŽ, 12(5): 500, 1993.

3311. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĚĂ–Ź•ÂÇÇ‹y‚щş‘ĺĂ–Ź•ÂÇÇ‚ɑ΂ˇ‚éƒXƒeƒ“ƒg—Ż’u‚Ě‚P—á. ‹g“c’¨ŒłCźŠŞ”ŽC‰““Ą‚Cź‰iŒh“ńCˆé•”‹`Œ›i•új: ‘ć13‰ń“ú–{‰ć‘œˆăŠw‰ď i94.02.04j, “Œ‹ž, “ú–{‰ć‘œˆăŠwŽGŽ, 12(5): 497, 1993.

3312. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j HCC”j—ôÇ—á‚É‚¨‚Ż‚éTAE‚Ć•Ű‘ś—Ă–@‚Ě”äŠrŒŸ“˘. ź‰iŒh“ńCˆé•”‹`Œ›CźŠŞ”ŽC‰““Ą‚C‹g“c’¨ŒłCź—Ń—˛i•új: “ú–{• •”‹~‹}ˆăŠw‰ď i94.03.11j, ‘ĺă, “ú–{• •”‹~‹}ˆăŠw‰ďŽGŽ, 14(1): 211, 1994.

3313. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”]––˝ŒŒŠÇ‚É‚¨‚Ż‚錌—Ź“Ž‘Ô‚Ě•]‰ż. ’†‘ňŒ\ŽĄCÎˆäŸŒČC’r“crşC“cŠŽŒČCźŠŞ”ŽCźŽRłŒáC•Đ‹Ë‰ČŽqCź—Ń—˛i•új: ‘ć52‰ń“ú–{ˆăŠw•úŽËüŠw‰ď i93.04.05j, ‰Ą•l, “ú–{ˆăŠw•úŽËüŠw‰ďŽGŽ, 53(‘): 381, 1993.

3314. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j I-123-IMP SPECT‚đ—p‚˘‚˝ˆę“_ĚŒŒ‚É‚ć‚é‹ÇŠ”]ŒŒ—Ź’č—Ę–@‚ĚŒŸ“˘|“Ž, Ă–ŹĚŒŒ–@‚Ě”äŠr|. ‰““Ą‚CÎˆäŸŒČCźŠŞ”ŽC‹g“c’¨ŒłCźŽRłŒáC’r“crşCˆé•”‹`Œ›Cź—Ń—˛i•új: ‘ć52‰ń“ú–{ˆăŠw•úŽËüŠw‰ďŠwp”­•\‰ď i93.04.05j, ‰Ą•l, “ú–{ˆăŠw•úŽËüŠw‰ďŽGŽ, 53: 378, 1993.

3315. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠĚŒŔ‹ÇŤŒ‹ßŤ‰ßŒ`Ź‚Ě‰ć‘œf’f‚ĚŒŸ“˘. ‰““Ą‚CźŠŞ”ŽCˆé•”‹`Œ›i•újC^‹ĘŽő”üśC‘•Ş–ΔŽi“ŕjC‹g“c@‹IiŠOjC’†‰p’ji•a—j: ‘ć35‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď i93.09.21j, _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ, 90: 1989, 1993.

3316. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j œ‹×–EŽî‚ɐ”ş‚ľ‚˝“Ž–ŹáŽ—lœ”XŽî. ’r“crşCź—Ń—˛i•új: ‘ć29‰ń“ú–{ˆăŠw•úŽËüŠw‰ďH‹G—Տ°‘ĺ‰ď i93.11.15j, ŽRŒű, ´˜^W, 1993.

3317. mŠw‰ďi’n•űjn i‹łˆçu‰‰j ‹š’É‚Ć˜’É‚Ě‰ć‘œf’fi‚ť‚Ě‚Pœ“î•”j. ’r“crşi•új: _“ŢěŒ§•úŽËüˆăŠw‰ď i93.07.10j, ‰Ą•l.

3318. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j œƒVƒ“ƒ`ƒOƒ‰ƒ€‚ɂăŠƒ“ƒOóWĎ‚đŽŚ‚ľ‚˝—ǐŤˆÝ’×ᇂĚ1—á. ‘ş“cWˆę˜YC“cŠŽŒČC‹´–{ČŽOi•új: ‘ć39‰ń“ú–{ŠjˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i93.07.10j, “Œ‹ž, ŠjˆăŠw, 30(9): 1168, 1993.

3319. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j V‚ľ‚˘Žîᇃ}[ƒJ[(Cytokeratin-19)‚ĚŠî‘b“I‹y‚Ń—Ő°“IŒŸ“˘. •Đ‹Ë‰ČŽqCźŠŞ”ŽCÎˆäŸŒČCź‰iŒh“ńCźŽRłŒáC‰““Ą‚i•újCăˆä˜aŽqCˆË“cˆędi•úŽËü•”jCˆé•”‹`Œ›Cź—Ń—˛i•új: ‘ć40‰ń“ú–{ŠjˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i94.02.05j, “Œ‹ž.

3320. mŒ¤‹†‰ďi‘S‘jn i‹łˆçu‰‰j ”]ƒhƒbƒN‚ɂ‚˘‚Ä. ›Mˆęi•új: ‘ć7‰ńMRIuK‰ď i93.09.25j, ‰Ą•l.

3321. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Œ¤‹†Œťę‚Š‚ç‚ĚŠú‘Ň‚Ć–â‘č’ń‹N|“ú–{‚É‚¨‚Ż‚éˆăŠw—p‚ĚŒ´Žq•ŞŽq‹y‚ŃŒ´ŽqŠjƒf[ƒ^‚Ěƒj[ƒY. Šâ”g–΁i•új: 1993 Symposium on Nuclear Data, Japanese Nuclear Data Committee i93.11.19j, “ŒŠC‘ş.

3322. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ˆăŠw—p‚ĚŒ´ŽqĽ•ŞŽq‚¨‚ć‚ŃŒ´ŽqŠjƒf[ƒ^. Šâ”g–΁i•új: 1993 Symposium on Nuclear Data, Japanese Nuclear Data Committee i93.11.19j, “ŒŠC‘ş.

3323. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j œ”ՍœÜ‚É‚¨‚Ż‚éTAE‚ĚŒŸ“˘. źŠŞ”ŽC–x’rdŽĄC‰““Ą‚i•újC‰ĄŽRˆę•FC™–{Ÿ•FCV“Ął‹PC‘ĺ˜a“c—˛i‹~–˝jC‘Oě˜a•Fi“Œ‘ĺj: ‘ć7‰ń“ú–{ŠOŒ¤‹†‰ď i93.05.20`21j, ‰Ť“ę, “ú–{ŠOŒ¤‹†‰ďŽ, 7(2): 186, 1993.

3324. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Žčp•s”\ŠĚ–ĺ•”’_ŠÇŠŕ‚ÉZ-stent—Ż’uŒă‘Šú‚É• o“ŕoŒŒ‚đ‚Ť‚˝‚ľŽ€–S‚ľ‚˝1–UŒŸ—á. ‰““Ą‚CźŠŞ”ŽCź‰iŒh“ńCˆé•”‹`Œ›i•új: ‘ć7‰ńMetallic stentŒ¤‹†‰ď i93.06.19j, “Œ‹ž, —\eW, p.18, 1993.

3325. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Œ¨ŠÖß‚̉Á—î“I‘ލsŤ•Ď‰ť‚ĚMRI‚É‚¨‚Ż‚錟“˘. ’r“crşCź—Ń—˛i•újC‚ŠÝŒ›“ńiŽj: ‘ć22‰ń’f‘w‰f‘œŒ¤‹†‰ď i93.09.28j, “Œ‹ž, ´˜^W, 1993.

3326. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j äBinflammatory pseudotumor‚Ě‚P—á. •Đ‹Ë‰ČŽqC–k–ě‰ëŽjC‹g“c’¨ŒłCźŽRłŒáC‰““Ą‚CźŠŞ”ŽC’r“crşCˆé•”‹`Œ›C›MˆęCź—Ń—˛i•újCŒY•”“ŒŽĄiŠOjCŠâŸşŒ[ˆęi•a—j: ‘ć7‰ń• •”•úŽËüŒ¤‹†‰ď i93.11.07j, ŽRŒű.

3327. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‘˝”­ŤŠĚŒŔ‹ÇŤŒ‹ßŤ‰ßŒ`Ź‚Ě‚P—á. ‰““Ą‚CźŠŞ”ŽCˆé•”‹`Œ›i•új: ‘ć7‰ń• •”•úŽËüŒ¤‹†‰ď i93.11.07j, ŽRŒű, —\eW, p.31, 1993.

3328. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‘˘‰eMRI‚É‚ć‚éă‰ş_ŒoE‚ĚŠĎŽ@. •Đ‹Ë‰ČŽqC›MˆęC’r“crşCź—Ń—˛i•új: ‘ć23‰ń“ú–{_Œo•úŽËüŒ¤‹†‰ď i94.02.11j, _ŒË.

3329. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŠOœÇ‚Š‚ç“]‰ť‚ľ‚˝‚ƍl‚Ś‚ç‚ę‚éäCœ’á•Ş‰ťŒ^““÷Žî‚Ě‚P—á. ‰““Ą˜aŽqC–k–ě‰ëŽjC‹g“c’¨ŒłC•Đ‹Ë‰ČŽqCźŽRłŒáCźŠŞ”ŽC’r“crşC›MˆęCź—Ń—˛i•újC‘ĺ–ěŽiiŽŠOjCŠâŸşŒ[ˆęi•a—j: ‘ć5‰ńœ“î•”•úŽËüŒ¤‹†‰ď i94.02.18j, ‘ĺă.

3330. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j œ“]ˆÚĆŽËŒă‚̏C•œ‰ß’ö‚Ě‚wü‘œ. ź—Ń—˛i•új: ‘ć5‰ń“ú–{ˆăŠw•úŽËüŠw‰ďœ“î•”•úŽËüŒ¤‹†‰ď i94.02.18j, ‘ĺă, ´˜^W, p.24, 1994.

3331. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒqƒg”xŹ×–EŠŕ‚É”˝‰ž‚ˇ‚郂ƒmƒNƒ[ƒiƒ‹R‘Ě6H7‚đ—p‚˘‚˝Žîá‡imaging‚ĚŠî‘b“IŒŸ“˘. “cŠŽŒČi•új: ‘ć4‰ńé‹ĘŠjˆăŠw“ŻD‰ď i94.02.19j, Š‘ň.

3332. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j äF”Â’f—ôpŒă‚ĚMRI. –k–ě‰ëŽjC’r“crşC‰““Ą˜aŽqC‹g“c’¨ŒłC•Đ‹Ë‰ČŽqCźŽRłŒáCź—Ń—˛i•újC‚ŠÝŒ›“ńiŽŠOj: ‘ć5‰ńœ“î•”•úŽËüŒ¤‹†‰ď i94.02.19j, ‘ĺă, ´˜^W, p.43, 1994.

3333. mŒ¤‹†‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ}ƒCƒNƒƒRƒCƒ‹‚É‚ć‚éTAE‚É‚ÄŽ~ŒŒ‚ľ“ž‚˝’_ŠÇŠŕpŒă‹“ă‹ó’°oŒŒ‚Ě1—á. ‰““Ą‚CźŠŞ”ŽCˆé•”‹`Œ›i•új: ‘ć22‰ń“ú–{ŒŒŠÇ‘˘‰eĽIVRŒ¤‹†‰ď i93.05.15j, ‹ŕ‘ň, “ú–{ŒŒŠÇ‘˘‰eĽInterventional RadiologyŒ¤‹†‰ďŽGŽ, 8(1): 71, 1993.

3334. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j Œz’Ĺ‚Ć’ĹŠÔ”Â. ›Mˆęi•új: ‘ć10‰ń‘˝–€MRIŒ¤‹†‰ď i93.07.03j, “Œ‹ž.

3335. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ŽŒ`ŠO‰Č—Ěˆć‚ĚMRIiŒ¨ŠÖß‚ĚŽžŠłj. ’r“crşi•új: ‘ć6‰ńŠÖźMRIu‰‰‰ď i93.07.04j, ‘ĺă, ´˜^W, p.11, 1993.

3336. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j Ň’ŐҐ‘ŽžŠł‚ĚMRI. ›Mˆęi•új: ŽRŒűŒ§MRIƒ[ƒNƒVƒ‡ƒbƒv i93.09.04j, ŽRŒű.

3337. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j MRIŒŸ¸’†‚ĚˆŔ‘SŠÇ—‚ɂ‚˘‚Ä. ”Ń–ěiCŠâčCˆęCă–ě•×CŠâ“c‰ëŒČC–ö“c’qCŹ—э„C“cŒűł‹|C–î‹v•Űƒ•˝i–k—˘Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@jC“cŠŽŒČC‘ş“cWˆę˜Yi•új: ‘ć9‰ńé‹ĘMRŒ¤‹†‰ď i93.05.29j, ‘ĺ‹{.

3338. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j SPECT‚É‚ć‚é‹ÇŠ”xŒŒ‰t—Ę‚Ě‘Ş’č. ’†‘ňŒ\ŽĄCÎˆäŸŒČi•új: ‘ć653‰ń•úŽËüf—ĂŒ¤‹†‰ď i93.06.14j, “Œ‹ž.

3339. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ŒÇ—§ŤˆÝĂ–ŹáŽ‚ɑ΂ˇ‚éB-RTO‚ĚŒoŒą. ‰““Ą‚CźŠŞ”ŽCź‰iŒh“ńCˆé•”‹`Œ›i•újC^‹ĘŽő”üśC‘•Ş–ΔŽC‘şă‹§lCź“c–€–çi“ŕj: ‘ć5‰ńŠÖ“ŒIVRŒ¤‹†‰ď i93.07.10j, “Œ‹ž, IVR, 9(1): 103, 1994.

3340. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‰ß•qŤ”x‘Ÿ‰Š‚ĚGa-67ƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚ĚŒŸ“˘. źŠŞ”ŽCÎˆäŸŒČC•Đ‹Ë‰ČŽqC‰““Ą‚Cˆé•”‹`Œ›C’†‘ňŒ\ŽĄCź—Ń—˛i•új: ‘ć9‰ńŠÖ“Œ’n‹ćŒÄ‹zŠíŠjˆăŠwŒ¤‹†‰ď i93.09.11j, “Œ‹ž.

3341. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j CT‚É‚ć‚鍜‰–’č—Ę‚Ě”–â‘č. ÷ˆä´Žqi•új: ‘ć190‰ń“Œ‹ž’n‹ćˆăŠw•¨—ŠwŒ¤‹†‰ďƒZƒ~ƒi[ i93.09.13j, “Œ‹ž.

3342. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j MR‚ސf’f‚É—LŒř‚Ĺ‚ ‚Á‚˝Schizencephaly fused lips type‚Ě‚P—á. ‘ş“cWˆę˜YC“cŠŽŒČC‹´–{ČŽOi•újC˛“Ą‰ë•FCÎŠŮ••viŽ™j: ‘ć10‰ńé‹ĘMRŒ¤‹†‰ď i93.10.30j, ‘ĺ‹{.

3343. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j •úŽËü‰qśŠw‚̉ۑč. Šâ”g–΁i•új: ‘ć196‰ń“Œ‹žˆăŠw•¨—Œ¤‹†‰ď i94.03.14j, “Œ‹ž.


<<26 7 •úŽËü‰ČŠw>>

3344. mŠw‰ďŽĺĂi’n•ű‰ďjn ‘ć39‰ń“ú–{ŠjˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď, ÎˆäŸŒČi•új.

3345. mŠw‰ďŽĺĂi‚ť‚Ě‘źjn ‘ć14‰ń–ƉuŠjˆăŠwŒ¤‹†‰ď, ÎˆäŸŒČi•új.


<<27 –ƒŒ‰ČŠw>>

3346. mŒ´’˜n Time course in thoracic epidural pressure measurement. ‰œ•xr”VC“n•Ó•qCŒă“Ą•ś•vi–ƒj: Can. J. Anesth., 40(11): 1044`1048, 1993.

3347. mŒ´’˜n Effects of ƒż-human natriuretic peptide on renal hemodynamics and diuresis in dogs and perfused rat kidneys. “n•ÓŠŢi‘—§‚č•a‰@jCŒă“Ą•ś•vi–ƒj: Jpn. Circ. J., 58(2): 136`142, 1994.

3348. mŒ´’˜n Thiopental…—n‰t‚Š‚ç‚ĚƒqƒhƒƒLƒVƒ‹ƒ‰ƒWƒJƒ‹‚Ě”­ś. ‰œ•xr”Vi–ƒjC–ěŒł‚Ż‚˘Žqiś‰ťŒnjC’†‘ş‘‰qi•ŞśjCŒă“Ą•ś•vi–ƒj: ŽĽ‹C‹¤–Â‚ĆˆăŠw, 4: 42`45, 1993.

3349. mŒ´’˜n ‹š•”d–ŒŠO–ƒŒ‚ĚŽŠ—Ľ_ŒoŒn‚Ö‹y‚Ú‚ˇ‰e‹ż. rě^”VC‰iˆäˆęŹC‰Á“Ą´ŽiCŒă“Ą•ś•vi–ƒj: “ú–{—Տ°–ƒŒŠw‰ďŽ, 14(2): 122`129, 1994.

3350. mŒ´’˜n d–ŒŠO–ƒŒ‚Ć‘Sg–ƒŒ•š—p‚ޏzŠÂ“Ž‘Ô‚É‹y‚Ú‚ˇ‰e‹ż|Œz•”Žčp‚Ĺ‚ĚŒŸ“˘|. rě^”VC‰J‹{”͍KC‰iˆäˆęŹC‰Á“Ą´ŽiCŒă“Ą•ś•vi–ƒj: –ƒŒ, 42(10): 1464`1469, 1993.

3351. mŒ´’˜n ŠĚŒŒ—Ź‚ĚŽŐ’f‚ƍĩÁ—Ź‚É”ş‚¤ŒŒs“Ž‘Ô•Ŕ‚Ń‚É‘ăŽÓŒn‚É‹y‚Ú‚ˇ–ƒŒ–@‚̉e‹ż. ÷–{çŒbŽqC”’ˆäłrC‰Á“Ą´ŽiCŒă“Ą•ś•vi–ƒj: –ƒŒ, 42(8): 1142`1147, 1993.

3352. mŒ´’˜n ă• •”ŠJ• pŽž‚Ě“ŕ•Ş”弑ăŽÓ”˝‰ž‚ɑ΂ˇ‚éƒjƒ…[ƒƒŒƒvƒg–ƒŒ‚̉e‹ż. ‘şă‰ëŽqC–ěŒŠŽREC“n•Ó•qi–ƒj: –ƒŒ, 43(2): 171`176, 1994.

3353. mŒ´’˜n Ă–Ź–ƒŒ–ňƒvƒƒ|ƒtƒH[ƒ‹‚đ—p‚˘‚˝‘Sg–ƒŒi“ą“ü‹y‚ŃˆŰŽj—Տ°ŽŽŒą|—p—ĘŠm”FŽŽŒą|. ˇś—Ď•vi’†‘˜JĐ•a‰@jCŔ“cŽ—YiŽŠŽĄˆă‘ĺjC’r“c˜a”Vi•lźˆă‘ĺjCXŒ’ŽŸ˜Yi‹ž‘ĺjC‹g–liă‘ĺjC‹|í–Đ•śiL‘ĺjC™›•¨Ci–k‘ĺjC‹´–{ •Ű•Fi“Œ–k‘ĺjC“Ą“c’BŽmiŒQ”n‘ĺjC´…âXšćiŽŠŽĄˆă‘ĺjC…ŒűŒöMiç—t‘ĺjCŽR–{‹œi“ú‘ĺjC—é–Ř‘žix‰Í‘ä“ú‘ĺ•a‰@jCŹě—´C‰ĄŽR˜aŽqi“úˆă ‘ĺjC“B‹{–Léi“Œ‘ĺjC•Ÿ“‡˜aşiŒc‘ĺjC“Ą“cš—Yi“Œ‹ž—ˆă‘ĺjCŒă“Ą•ś•vi–ƒjC´–쐽ˆęiMB‘ĺjC‘şă˝ˆęi‹ŕ‘ň‘ĺjC“‡“cNOi–ź‘ĺjC“ŕ“c ˇ•viŠÖźˆă‘ĺjC“ĄXvi‘ĺăŽs‘ĺjCÖ“Ą—˛—Yi“ż“‡‘ĺjC‹g•ˆęi‹ă‘ĺjCX‰Ş‹œiŒF–{‘ĺjC‹g‘ş–]iŽ­Ž™“‡‘ĺj: –ƒŒ‚Ć‘hś, 29(1): 45`56, 1993.

3354. m’Z•ńn œ×“ŽŠíƒ`ƒFƒbƒJ. ‰ZśLˆęC”’ˆä“ÖŽjiMEƒZƒ“ƒ^[j: ƒNƒŠƒjƒJƒ‹ƒGƒ“ƒWƒjƒAƒŠƒ“ƒO, 4(10): 722`725, 1993.

3355. m’Z•ńn ˆă—Ă‚đŽx‚Ś‚éCE•”–ĺ. “n•Ó•qi–ƒj: ƒNƒŠƒjƒJƒ‹ƒGƒ“ƒWƒjƒAƒŠƒ“ƒO, 4(4): 236`238, 1993.

3356. m’Z•ńn —Տ°HŠw‹ZŽm—{Ź‚Ć•a‰@ŽŔK. “n•Ó•qi–ƒj: ƒNƒŠƒjƒJƒ‹ƒGƒ“ƒWƒjƒAƒŠƒ“ƒO, 4(7): 461`465, 1993.

3357. m’Z•ńn uˆă—Ă‚Ě—p‚É‹Ÿ‚ˇ‚éƒKƒXÝ”ő‚Ě•ŰˆŔŠÇ—‚ɂ‚˘‚āv‚̉üłiŒ’­”­‘ć650†j. “n•Ó•qi–ƒj: ƒNƒŠƒjƒJƒ‹ƒGƒ“ƒWƒjƒAƒŠƒ“ƒO, 5(3): 214`217, 1994.

3358. m’Z•ńn –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éˆă—Ă‹@Ší‚ĚŽő–˝‚ÉŠÖ‚ˇ‚é’˛¸. LŁ–ŤiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj: ˆă‰Č‹@ŠBŠw, 63(1): 21`27, 1994.

3359. m’Z•ńn –k—˘‘ĺŠw•a‰@MEƒZƒ“ƒ^[•”‚É‚¨‚Ż‚éˆă—Ă‹@Ší‚ĚŠÇ—. “n•Ó•qi–ƒj: ˆă‰Č‹@ŠBŠw, 63(11): 516`519, 1993.


<<27 2 –ƒŒ‰ČŠw>>

3360. mÇ—á•ńn Development of a subdural motor blockade. ˆŔ—˘•ś—Yi–ƒjC’‡’JŒ›C–”‹g—SŽqC‰ĂŽčěNlC’m”O´i‰Ť“ęŒ§—§’†•”•a‰@j: Anaesthesia, 48: 46`49, 1993.

3361. mÇ—á•ńn Oxygen flow reduction due to dust particle blockade of the oxygen filter. ‰œ•xr”VC“n•Ó•qCŒă“Ą•ś•vi–ƒj: Anesth. Analg., (76): 915`917, 1993.

3362. mÇ—á•ńn cŠu“ŕ‚Ö‚Ětraumatic intubation‚Ě‚P—á. –ÎŽč–Ř—R—˘C”’ˆäłrCrě^”VCŒă“Ą•ś•vi–ƒj: ICU‚ĆCCU, 17(10): 1037`1039, 1993.

3363. mÇ—á•ńn W’cH’†“Ĺ”­śŽž‚Ě–ƒŒ‰Č“I‘Ώˆ. ÷–{çŒbŽqCŒă“Ą•ś•vi–ƒj: “ú–{—Տ°–ƒŒŠw‰ďŽ, 13(6): 103`106, 1993.

3364. mÇ—á•ńn ƒwƒpƒŠƒ“‚̍R‹ĂŒĹě—p‚É’ďRŤ‚đŽŚ‚ľ‚˝S‘ŸŽčpÇ—á. ˆŔ—˘•ś—YCVˆäłNCŒă“Ą•ś•vi–ƒjCźě‰ˇiMEƒZƒ“ƒ^[j: –ƒŒ, 42(5): 753`755, 1993.

3365. mÇ—á•ńn Ň’Ĺ–ƒŒj‚É‚ć‚鍇•šÇ”­ś—Ś‚ÉŠÖ‚ˇ‚錟“˘|Sprottej‚É‚ć‚é“Ş’É‚Ě–hŽ~|. “ĄŒ´ŒjŽqC÷–{çŒbŽqC‰œ•xr”VC‰Á“Ą´ŽiC“n•Ó•qCŒă“Ą•ś•vi–ƒj: –ƒŒ, 42(7): 1086`1090, 1993.

3366. m—Տ°ŽĄŒąn ƒRƒ“ƒsƒ…[ƒ^‚É‚ć‚é–ƒŒ–ňÁ”ď—ĘŒvŽZ. ‰|–{Ž”üC’r“c“Œ”ü–ži‘—§‘Š–ÍŒ´•a‰@jC‰iˆäˆęŹi–ƒj: —Տ°–ƒŒ, 17(8): 1090`1092, 1993.

3367. m‘ŕn —Տ°HŠw•”–ĺ‚Şl‚Ś‚éŽčpŽşƒi[ƒX‚Ě‹łˆç‚ĆƒgƒŒ[ƒjƒ“ƒOƒƒjƒ…[. “n•Ó•qi–ƒj: ƒIƒyƒi[ƒVƒ“ƒO, 9(2): 28`33, 1994.

3368. m‘ŕn •a‰@‚É‚¨‚Ż‚éƒNƒŠƒjƒJƒ‹ƒGƒ“ƒWƒjƒAƒŠƒ“ƒO•”–ĺ‚ĚŒoĎŤ. “n•Ó•qi–ƒj: “ú–{MEŠw‰ďŽGŽ, 7(11): 27`33, 1993.

3369. m‘ŕn MEƒZƒ“ƒ^[‚ĚŒťó‚Ć‚ť‚Ě–đŠ„. ˆî–Ń”ŽiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj: —Տ°ƒ‚ƒjƒ^[, 4(1): 27`35, 1993.

3370. m‘ŕn tzŠÂ‚Ć–ƒŒ. Œă“Ą•ś•vi–ƒj: —Տ°–ƒŒ, 17(8): 1042`1046, 1993.

3371. muŔn Sƒ}ƒbƒT[ƒW‚Ě•ű–@. ’|’†’qşC“n•Ó•qi–ƒj: Clinical Engineering, 4(8): 594`595, 1993.

3372. muŔn ŒŒ‰t‰Á‰ˇŠí‚Ě•ŰŽçŠÇ—. ˛“ĄłŒ›iMEƒZƒ“ƒ^[j: ƒNƒŠƒjƒJƒ‹ƒGƒ“ƒWƒjƒAƒŠƒ“ƒO, 4(4): 293`295, 1993.

3373. muŔn ˆă—Ă‹@Ší‚ĚŒťó‚Ć‰Ű‘čĽˆŔ‘S‘΍ôĽ•ŰŽçŠÇ—. “n•Ó•qi–ƒj: —Տ°ŠĹŒě, 19(13): 1873`1876, 1993.

3374. muŔn ŠĎŒŒŽŽŒŒˆłƒ‚ƒjƒ^[. ˆî–Ń”ŽiMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 1896`1900, 1993.

3375. muŔn ”ńŠĎŒŒŽŽŒŒˆłƒ‚ƒjƒ^[. ŒĂ•˝‘iMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 1901`1903, 1993.

3376. muŔn “dŽq‘̉ˇŒv. “ŒđŒ\ˆęiMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 1925`1927, 1993.

3377. muŔn S”o—ĘŒv. Žç‰ŽŒłiMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 1928`1933, 1993.

3378. muŔn lHŒÄ‹zŠí. ‰ZśLˆęiMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 1964`1967, 1993.

3379. muŔn œ×“ŽŠí. ˛“ĄłŒ›iMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 1973`1977, 1993.

3380. muŔn —A‰tƒ|ƒ“ƒv. ŒĂŠ_’B–çiMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 1982`1985, 1993.

3381. muŔn ‹z“ü—Ă–@‹@Ší. ’r“cŒőŠěiMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 1986`1990, 1993.

3382. muŔn IABP. –ě‘ş’q”ViMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 1991`1994, 1993.

3383. muŔn •ŰˆçŠí. źě‰ˇiMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 1998`2001, 1993.

3384. muŔn ‚ˆłŽ_‘f—Ă–@‘•’u. –{‘˝—˛iMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 2002`2004, 1993.

3385. muŔn ‹zˆřŠí. H“Ą„ŽŔiMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 2011`2013, 1993.

3386. muŔn –ƒŒŠí. Ź—ŃŠ]iMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 2014`2017, 1993.

3387. muŔn ŒŒ‰t‰Á‰ˇŠí. H“Ą„ŽŔiMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 2024`2026, 1993.

3388. muŔn ‰Á‰ˇĽ—â‹pƒ}ƒbƒg. ŒĂŠ_’B–çiMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 2027`2029, 1993.

3389. muŔn “dŒšÝ”ői”ńí“dŒšj. ”Ń“‡Œő—YiMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 2107`2109, 1993.

3390. muŔn ˆă—ĂƒKƒXÝ”ő. LŁ–ŤiMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 2110`2114, 1993.

3391. muŔn ˆă—ĂƒKƒXƒ{ƒ“ƒx‚ĚŽć‚čˆľ‚˘. ”’ˆä“ÖŽjiMEƒZƒ“ƒ^[j: —Տ°ŠĹŒě, 19(13): 2115`2118, 1993.

3392. muŔn ˆă—Ă‹@Ší‚ĚˆŔ‘S‚ÉŠÖ‚ˇ‚é—pŒęˆę——. “n•Ó•qi–ƒj: —Տ°ŠĹŒě, 19(13): 2119`2124, 1993.


<<27 3 –ƒŒ‰ČŠw>>

3393. m‹ł‰Č‘n i’P’˜j ˆăŠwś‚ĆŒ¤Cˆă‚Ě‚˝‚ß‚Ě–ƒŒ‰ČƒKƒCƒhƒuƒbƒN; Œă“Ą•ś•vi–ƒj. ^‹ťŒđˆŐiŠ”jˆă‘o”Ĺ•”, “Œ‹ž, 93.11.20”­s.

3394. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ŠO—ˆ‘S‰Č’É‚ÝŽĄ—Ăƒ}ƒjƒ…ƒAƒ‹; –ƒ–ň‚Ć‚ť‚Ě—ŢŽ—–ň, p.50`64, \Žž’‰GCŕƒP]Žő”üŽqC•ŸˆäŽŸ–îi˛‰ęˆă‘ĺjC“IęŒłOi–ƒjC‘ź. •ŇW •ŸˆäŽŸ–îi˛‰ęˆă‘ĺjC‚–ؐ˝i“sĎś‰ď•a‰@jC ŽO—֏‘“X, “Œ‹ž, 93.11.30”­s.

3395. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ŠO—ˆ‘S‰Č’É‚ÝŽĄ—Ăƒ}ƒjƒ…ƒAƒ‹; ŠŕŠłŽŇ‚Ě’É‚Ý‚Ö‚ĚƒAƒvƒ[ƒ`, p.68`74, \Žž’‰GCŕƒP]Žő”üŽqC•ŸˆäŽŸ–îi˛‰ęˆă‘ĺjC“IęŒłOi–ƒjC‘ź. •ŇW •ŸˆäŽŸ–îi˛‰ęˆă‘ĺjC‚–ؐ˝i“sĎś‰ď•a‰@jC ŽO—֏‘“X, “Œ‹ž, 93.11.30”­s.

3396. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ME‚ĚŠî‘b’mŽŻ‚ĆˆŔ‘SŠÇ—i‰ü’ů‘ć2”Łj; ŒÄ‹z—Ă–@‹@Ší‚ĚŽć‚čˆľ‚˘‚Ć•ŰŽç, p.272`287, “n•Ó•qi–ƒj. •ŇW ME‹ZpuK‰ďƒeƒLƒXƒg•ŇWˆĎˆő‰ďC “ě]“°, “Œ‹ž, 93.05.20”­s.

3397. m‚ť‚Ě‘ź‚Ě’˜‘i“ü–ĺ‘jn i•Ş’SŽˇ•Mj “ü–ĺŒÄ‹z—Ă–@; ŒÄ‹z—Ă–@, –ňÜ—Ă–@, p.86`98, “n•Ó•qi–ƒj. Ž˝“°, “Œ‹ž, 93.10.25”­s.

3398. m‚ť‚Ě‘ź‚Ě’˜‘i“ü–ĺ‘jn i•Ş’SŽˇ•Mj “ü–ĺŒÄ‹z—Ă–@; ŒÄ‹z—Ă–@, ‹‹Žź, p.99`104, ‰ZśLˆęiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj. Ž˝“°, “Œ‹ž, 93.10.25”­s.

3399. m‚ť‚Ě‘ź‚Ě’˜‘i“ü–ĺ‘jn i•Ş’SŽˇ•Mj “ü–ĺŒÄ‹z—Ă–@; ŒÄ‹z—Ă–@, Ž_‘f—Ă–@, p.105`118, LŁ–ŤiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj. Ž˝“°, “Œ‹ž, 93.10.25”­s.

3400. m‚ť‚Ě‘ź‚Ě’˜‘i“ü–ĺ‘jn i•Ş’SŽˇ•Mj “ü–ĺŒÄ‹z—Ă–@; ŒÄ‹z—Ă–@, ‹@ŠíŠÇ—‚Ćƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒO, p.132`140, ‰ZśLˆęiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj. Ž˝“°, “Œ‹ž, 93.10.25”­s.

3401. m‚ť‚Ě‘ź‚Ě’˜‘i“ü–ĺ‘jn i•Ş’SŽˇ•Mj “ü–ĺŒÄ‹z—Ă–@; ŒÄ‹z—Ă–@, Š´ő‚Ě–hŽ~, p.191`198, LŁ–ŤiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj. Ž˝“°, “Œ‹ž, 93.10.25”­s.


<<27 5 –ƒŒ‰ČŠw>>

3402. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Circulation control with endogenous vasodilating substances, prostaglandin E1 (PGE1) and natriuretic peptide. Œă“Ą•ś•vi–ƒjC—Ť—Ź•Ÿi”’‹‰śjC—kg–…iăŠCˆă‰Č‘ĺjC’|ˆäË˜Yi“Œ‘ĺj: ‘ć4‰ń“ú’†—Տ°–ƒŒ“˘˜_‰ď i93.11.01`02j, ”Ž‘˝.

3403. mŠw‰ďi‘S‘jn i“Á•Ęu‰‰j •a‰@‚É‚¨‚Ż‚éƒNƒŠƒjƒJƒ‹ƒGƒ“ƒWƒjƒAƒŠƒ“ƒO•”–ĺ‚Ě–đŠ„. “n•Ó•qi–ƒj: ‘ć5‰ńƒoƒCƒIƒGƒ“ƒWƒjƒAƒŠƒ“ƒOŠwpu‰‰‰ď i93.07.24j, ž–ě.

3404. mŠw‰ďi‘S‘jn i‹łˆçu‰‰j •a‰@“ŕˆă—ĂŠí‚ĆƒmƒCƒY. “n•Ó•qi–ƒj: ‘ć32‰ń“ú–{ƒGƒ€ĽƒC[Šw‰ď‘ĺ‰ď i93.05.19j, b•{, ˆă—p“dŽq‚Ɛś‘̍HŠw, 31(Suppl.), 1993.

3405. mŠw‰ďi‘S‘jn i‹łˆçu‰‰j lHŒÄ‹zŠí‚ĚŽ–ŒĚ–hŽ~‘΍ô. “n•Ó•qi–ƒj: ‘ć7‰ń“ú–{ƒGƒ€ĽƒC[Šw‰ďH‹G‘ĺ‰ďCEˆŔ‘SŒ¤‹†‰ď i93.10.08j, “Œ‹ž.

3406. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ˆă—Ă‹@ŠíĽˆă—ĂŢ—ż‚Ě’ń‹Ÿ‚ĆŠÇ—ƒVƒXƒeƒ€. “n•Ó•qi–ƒj: ‘ć3‰ń“ú–{ŒÄ‹zŠÇ—Šw‰ď i93.07.31j, “Œ‹ž, “ú–{ŒÄ‹zŠÇ—Šw‰ďŽ, 3(1): 18, 1993.

3407. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‹@ŠBŠí‹ď‚ĚŠÇ—. “n•Ó•qi–ƒj: ‘ć13‰ń“ú–{—Տ°–ƒŒŠw‰ď‘‰ďƒVƒ“ƒ|ƒWƒEƒ€ i93.11.11j, •FŞ, “ú–{—Տ°–ƒŒŠw‰ďŽ, 14, 1994.

3408. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j VśŽ™Šú‚Ě’ˇŠú‹CŠÇ“ŕ‘}ŠÇ‚ŞŒ´ˆö‚ĆŽv‚í‚ę‚éˆô“ލA“Ş‹ˇó‚Ě‚P—á. –î“c_C‰iˆäˆęŹCˆŔ—˘•ś—YCŒă“Ą•ś•vi–ƒj: ‘ć40‰ń“ú–{–ƒŒŠw‰ď‘‰ď i93.04.22j, ˇ‰Ş, –ƒŒ, 42(Suppl.10): 118, 1993.

3409. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ˜’Ĺ–ƒŒúŽhj‚É‚ć‚éd–Œ—ôE‚ĆCSF—Źo—Ę‚ÉŠÖ‚ˇ‚éŽŔŒą“IŒ¤‹†. “ĄŒ´ŒjŽqC‰œ•xr”VC‰Á“Ą´ŽiCŒă“Ą•ś•vi–ƒj: ‘ć40‰ń“ú–{–ƒŒŠw‰ď‘‰ď i93.04.22`24j, ˇ‰Ş, –ƒŒ, 42(Suppl.10): 454, 1993.

3410. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’YŽ_ƒKƒX‹C• Žž‚Ě‘Ě“ŕ‰ßč’YŽ_ƒKƒX’™—Ż—Ę‚ĆŒÄo”źŒ¸ŽžŠÔ‚ĚŒŸ“˘: –ƒŒ–@‚É‚ć‚鍷‚ɂ‚˘‚Ä. ‰iˆäˆęŹC“IęŒłOC’|’†’qşC‰Á“Ą´ŽiCŒă“Ą•ś•vi–ƒj: ‘ć40‰ń“ú–{–ƒŒŠw‰ď‘‰ď i93.04.23j, ˇ‰Ş.

3411. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ`ƒIƒyƒ“ƒ^[ƒ‹…—n‰t‚Š‚ç”­ś‚ˇ‚éƒqƒhƒƒLƒVƒ‹ƒ‰ƒWƒJƒ‹‚Ɛś‘̂ɑ΂ˇ‚é‰e‹ż. ‰œ•xr”Vi–ƒjC–ěŒł‚Ż‚˘Žqiś‰ťŒnjC’†‘ş‘‰qi•ŞśjCŒă“Ą•ś•vi–ƒj: ‘ć15‰ńŽĽ‹C‹¤–ˆăŠw‰ď‘‰ď i93.05.11j, ‹ž“s.

3412. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –k—˘‘ĺŠw•a‰@MEƒZƒ“ƒ^[•”‚É‚¨‚Ż‚éˆă—Ă‹@Ší‚ĚŠÇ—. “n•Ó•qi–ƒj: ‘ć68‰ń“ú–{ˆă‰ČŠíŠBŠw‰ď‘ĺ‰ď i93.05.20j, “Œ‹ž, ˆă‰ČŠíŠBŠw, 63(4): 174`175, 1993.

3413. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –ƒŒŠíƒz[ƒX˜AŒ‹•”‚É‚¨‚Ż‚éƒtƒBƒ‹ƒ^‚ĚˆŔ‘SŤ‚ɂ‚˘‚Ä. ”’ˆä“ÖŽjCŹ—ŃŠ]C‰ZśLˆęiMEƒZƒ“ƒ^[jC–kŒ´Œ[iŠÖ“Œ’üM•a‰@jC“n•Ó•qi–ƒj: ‘ć68‰ń“ú–{ˆă‰ČŠíŠBŠw‰ď‘ĺ‰ď i93.05.20j, “Œ‹ž, ˆă‰ČŠíŠBŠw, 63(Suppl.1): 11`12, 1993.

3414. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •a‰@“ŕ‚ĹŽg—p‚ˇ‚éƒe[ƒuƒ‹ƒ^ƒbƒv‚Ě–â‘č“_. LŁ–ŤCŒĂ•˝‘C“ŒđŒ\ˆęCŽç‰ŽŒłC”Ń“‡Œő—YiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj: ‘ć68‰ń“ú–{ˆă‰ČŠíŠBŠw‰ď‘ĺ‰ď i93.05.20j, “Œ‹ž, ˆă‰ČŠíŠBŠw, 63(Suppl.1): 13`14, 1993.

3415. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j lHS”x‘•’u‘€ě—űK—p‹^Ž—”gŒ`”­ś‘•’u‚ĚŽŽě. ˆî–Ń”ŽC˛“ĄłŒ›C”Ń“‡Œő—YCŒĂŠ_’B–çC“ŒđŒ\ˆęCŒĂ•˝‘CŽç‰ŽŒłCźě‰ˇiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒjC’ˇ’Jě‹œi“ú–{Œő“dj: ‘ć68‰ń“ú–{ˆă‰ČŠíŠBŠw‰ď‘ĺ‰ď i93.05.22j, “Œ‹ž, ˆă‰ČŠíŠBŠw, 63(Suppl.1): 67`38, 1993.

3416. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒRƒ“ƒsƒ…[ƒ^‚É‚ć‚éˆă—Ă‹@Ší‚ĚŠÇ—. ŒĂŠ_’B–çCH“Ą„ŽŔC˛“ĄłŒ›C–ě‘ş’q”VCˆî–Ń”ŽCźě‰ˇiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj: ‘ć68‰ń“ú–{ˆă‰ČŠíŠBŠw‰ď‘ĺ‰ď i93.05.22j, “Œ‹ž, ˆă‰ČŠíŠBŠw, 63(Suppl.1): 71`72, 1993.

3417. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŒÄ‹C•ŮŠČˆŐŒŸ¸•ű–@‚ĚˆęlˆÄ. ‰ZśLˆęCŹ—ŃŠ]C”’ˆä“ÖŽjiMEƒZƒ“ƒ^[jC–kŒ´Œ[iŠÖ“Œ’üM•a‰@jC“n•Ó•qi–ƒj: ‘ć68‰ń“ú–{ˆă‰ČŠíŠBŠw‰ď‘ĺ‰ď i93.05.22j, “Œ‹ž, ˆă‰ČŠíŠBŠw, 63(Suppl.1): 77`78, 1993.

3418. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘O“Š–ň‚ĚƒNƒƒjƒWƒ“‚̓Cƒ\ƒtƒ‹ƒŒƒ“‚đ—p‚˘‚˝’ጌˆł–ƒŒ‚É—L—p‚Č•â•–ň‚Ć‚Č‚é‚Š. ‰J‹{”͍KCrě^”VCŒă“Ą•ś•vi–ƒj: ‘ć14‰ń“ú–{zŠÂ§ŒäˆăŠw‰ď‘‰ď i93.05.28j, b•{, ´˜^W, 14: 60, 1994.

3419. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j S”•Ď“Ž‚ĆŽűkŠúŒŒˆł•Ď“Ž‚Š‚ç‚Ý‚˝‚ˆĘ‹š•”d–ŒŠO–ƒŒ‚ĚŽŠ—Ľ_ŒoŠˆ“Ž‚É‹y‚Ú‚ˇ‰e‹ż. rě^”VC‰J‹{”͍KC‰iˆäˆęŹC‰Á“Ą´ŽiCŒă“Ą•ś•vi–ƒj: ‘ć14‰ń“ú–{zŠÂ§ŒäˆăŠw‰ď‘‰ď i93.05.28j, b•{, ´˜^W, p.53, 1993.

3420. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ventricular natriuretic peptide(VNP)‚̐ś•¨ŠˆŤ: hANP‚Ć‚Ě”äŠr. —Ť—Ź•Ÿi”’‹‰śjC’|ˆäË˜Yi“Œ‘ĺjCŒă“Ą•ś•vi–ƒj: ‘ć15‰ń“ú–{–ƒŒĽ–ň—Šw‰ď‘‰ď i93.07.02`03j, “Œ‹ž.

3421. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’ˇŠúlHŒÄ‹zŠÇ—ŠłŽŇ‚ĚˆÓŽŻ’˛¸‚ɂ‚˘‚Ä. ‰ZśLˆęCLŁ–ŤiMEƒZƒ“ƒ^[jC’ç–M•Fi‹~–˝jC“n•Ó•qi–ƒj: ‘ć15‰ń“ú–{lHŒÄ‹zŠw‰ď i93.07.09j, –źŒĂ‰Ž, lHŒÄ‹z, 10(2): 190, 1993.

3422. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j RƒŠƒ“Ž‰ŽżR‘ĚÇŒóŒQ‚Ě–ƒŒŒoŒą. ˆŔ—˘•ś—YC‰J‹{”͍KC‰œ•xr”VCŒă“Ą•ś•vC÷–{çŒbŽqi–ƒj: ‘ć13‰ń“ú–{—Տ°–ƒŒŠw‰ď‘‰ď i93.11.11j, •FŞ.

3423. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹zˆřƒVƒXƒeƒ€‚ÉŽg—p‚ˇ‚éŠeŽíƒtƒBƒ‹ƒ^‚Ě”äŠr. LŁ–ŤC“ŒđŒ\ˆęCŒĂ•˝‘C˛“ĄłŒ›iMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒjC––č‘ńLC‰œ“cwŽĄi–k—˘ŠÂ‹Ť‰ČŠwƒZƒ“ƒ^[jC˜a“cŽLiƒCƒ“ƒ^[ƒƒhĽƒWƒƒƒp ƒ“j: ‘ć22‰ń“ú–{•a‰@Ý”őŠw‰ď i93.11.11j, “Œ‹ž, •a‰@Ý”ő, 36(2): 77`79, 1994.

3424. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ž‘ąĺœ–ƒŒ‚Ě‚P‡•šÇ|—ƒ•tj‚Ě‘Ě“ŕŽc—Ż|. Ż–ě^—˘ŽqCVˆäłNCˆŔ—˘•ś—YCŒă“Ą•ś•vi–ƒj: ‘ć13‰ń“ú–{—Տ°–ƒŒŠw‰ď i93.11.12j, •FŞ.

3425. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠĽ“Ž–ŹƒoƒCƒpƒXp‚É‚¨‚Ż‚é‰ES‹ěo—Ś‘Ş’č‚Ě—L—pŤ. –ÎŽč–Ř—R—˘C‰iˆäˆęŹC”’ˆäłrCŒă“Ą•ś•vi–ƒj: ‘ć13‰ń“ú–{—Տ°–ƒŒŠw‰ď‘‰ď i93.11.13j, •FŞ.

3426. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j _ŒoáŠQ‚É”ş‚¤ŠŕŤáu’ɂɑ΂ˇ‚éR‚¤‚–ň‚ƍRázš–ň‚ĚŒř‰Ę. “IęŒłOC–î“c_CŒă“Ą•ś•vi–ƒj: ‘ć15‰ń“ú–{áu’ÉŠw‰ď i93.12.04j, ‹ž“s.

3427. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‹CŠÇŽxšk‚É‚¨‚Ż‚éƒJƒvƒgƒvƒŠƒ‹‚Ćƒuƒ‰ƒWƒLƒjƒ“|ƒTƒuƒXƒ^ƒ“ƒX‚o‚Ć‚ĚŠÖ˜A|. rě^”VC‰iˆäˆęŹCŒă“Ą•ś•vi–ƒjC”n“ˆł—˛CŽ­ŽćMi–ň—j: ‘ć40‰ń“ú–{–ƒŒŠw‰ď‘‰ď i93.04.22j, ˇ‰Ş, ‘ć40‰ń“ú–{–ƒŒŠw‰ď‘‰ď´˜^†, p.525, 1993.

3428. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒg‚̏oŒŒŤƒVƒ‡ƒbƒNƒ‚ƒfƒ‹‚Ö‚Ěƒż2Žó—e‘ĚŽhŒƒ–ň‚̉e‹ż. ‰Á“Ą´ŽiCŒă“Ą•ś•vi–ƒj: ‘ć40‰ń“ú–{–ƒŒŠw‰ď‘‰ď i93.04.22j, ˇ‰Ş, –ƒŒ, 42(Suppl.10): 385, 1993.

3429. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒpƒ‰ƒR[ƒg’†“Ĺ‚É‚ć‚éŽĺ—v‘ŸŠí‚̍RŽ_‰ťy‘f‚Ɖߎ_‰ťŽ‰Žż”Z“x‚Ě•Ď“Ž. ’|’†’qşC“n•Ó•qCŒă“Ą•ś•vi–ƒj: ‘ć40‰ń“ú–{–ƒŒŠw‰ď‘‰ď i93.04.24j, ˇ‰Ş.

3430. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j •Đ‘¤d–ŒŠO–ƒŒ‚̍d–ŒŠOƒJƒe[ƒeƒ‹‘˘‰eŠŒŠ. ˆŔ—˘•ś—YC–ÎŽč–Ř—R—˘Crě^”VC’|’†’qşC‰Á“Ą´ŽiCŒă“Ą•ś•vi–ƒj: ‘ć27‰ń“ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ď‘‰ď i93.07.23j, ˛‰ę, ´˜^W, p.70, 1993.

3431. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‚ƒ‹ƒqƒl™•úů‚É‚ć‚é—e—Ę‰Â•ĎŒ^żÜ. “IęŒłOC–î“c_C’|’†’qşC‰œ•xr”VC“n•Ó•qCŒă“Ą•ś•vi–ƒj: ‘ć27‰ń“ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ď i93.07.24j, ˛‰ę.

3432. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘яóáv]•”‚Ɉę’v‚ľ‚˝˜]–ŒŒ´”­Žîá‡. –î“c_CVˆäłNCŒă“Ą•ś•vi–ƒj: ‘ć27‰ń“ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ď‘‰ď i93.07.24j, ˛‰ę, —\eW, p.219, 1993.

3433. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j –Ťt•s‘SŠłŽŇ‚ĚƒxƒNƒƒjƒEƒ€‹Ř’oŠÉě—p‘J‰„‚ɂ‚˘‚Ä. ‰J‹{”͍KCrě^”VC‰Á“Ą´ŽiCŒă“Ą•ś•vi–ƒj: ‘ć13‰ń“ú–{—Տ°–ƒŒŠw‰ď i93.11.11j, •FŞ, ´˜^W, p.490, 1993.

3434. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j •Ş•Ř‚É‚ć‚éNO‘ăŽÓ•¨‚Ě•Ď“Ž. ‰œ•xr”Vi–ƒjC–ěŒł‚Ż‚˘Žqiś‰ťŒnjC’†‘ş‘‰qi•ŞśjCŒă“Ą•ś•vi–ƒj: ‘ć13‰ń“ú–{—Տ°–ƒŒŠw‰ď‘‰ď i93.11.12j, •FŞ, “ú–{—Տ°–ƒŒŠw‰ďŽ, 13: 412, 1993.

3435. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠŕŤáu’ɂɑ΂ˇ‚éƒJƒ‹ƒoƒ}ƒ[ƒsƒ“‚ĚŒř‰Ę. “IęŒłOC–î“c_C“n•Ó•qCŒă“Ą•ś•vi–ƒj: ‘ć13‰ń“ú–{—Տ°–ƒŒŠw‰ď‘‰ď i93.11.13j, •FŞ.

3436. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j S”•Ď“Ž‚ĆŽűkŠúŒŒˆł•Ď“Ž‚Š‚ç‚Ý‚˝˜•”d–ŒŠO–ƒŒ‚ĚŽŠ—Ľ_ŒoŠˆ“Ž‚É‹y‚Ú‚ˇ‰e‹ż. rě^”VCŻ‘ń’jC—^“ß”eÖC’†‘ş“N—YCŒă“Ą•ś•vi–ƒj: ‘ć13‰ń“ú–{—Տ°–ƒŒŠw‰ď‘‰ď i93.11.14j, •FŞ, ´˜^W, p.313, 1993.

3437. mŠw‰ďi’n•űjn i‹łˆçu‰‰j ˆă—ĂƒKƒX‚ĚˆŔ‘S. “n•Ó•qi–ƒj: “ú–{ƒGƒ€ĽƒC[Šw‰ď‘ć15‰ńME‹ZpuK‰ď i93.06.06j, “Œ‹ž.

3438. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ŠĚ‰E—tŘœp’†‚É”­ś‚ľ‚˝ŠĽ“Ž–ŹƒXƒpƒYƒ€‚Ě‚P—á. ŠŰŽRGC–î“c_C’|’†’qşC“n•Ó•qCŒă“Ą•ś•vi–ƒj: ‘ć33‰ń i93.09.18j, “Œ‹ž.

3439. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j lHŒÄ‹zŠí“_ŒŸ‚Ö‚Ěƒpƒ\ƒRƒ““ą“ü‚ĚŒŸ“˘. “ŒđŒ\ˆęCLŁ–ŤiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒjC”’ˆä“ÖŽjiMEƒZƒ“ƒ^[j: ‘ć2‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—Տ°HŠw‹ZŽt•”–ĺ i93.12.11j, ‘ĺ‹{.

3440. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Ý‘îlHŒÄ‹z—Ă–@‚É‚¨‚Ż‚é—Տ°HŠw‹ZŽt‚Ě–đŠ„|Ý‘îlHŒÄ‹z—Ă–@6”N‚ĚŒoŒą‚Š‚ç|. ‰ZśLˆęCŹ—ŃŠ]C”’ˆä“ÖŽjC“c‘şçHiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj: “ú–{ˆă‰ČŠíŠBŠw‰ď—Տ°HŠwŒ¤‹†‰ď—Տ°HŠw‹ZŽtŒ¤‹†”­•\‰ď i93.06.26j, ‘ĺ‹{.

3441. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ˆă—pƒeƒŒƒ[ƒ^‚ÉŠÖ‚ˇ‚é‰üł“d”g–@‚ɑ΂ˇ‚é‘Ήž. ŒĂ•˝‘C˛“ĄłŒ›C–ě‘ş’q”VCLŁ–ŤiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj: “ú–{ˆă‰ČŠíŠBŠw‰ď—Տ°HŠwŒ¤‹†‰ď—Տ°HŠw‹ZŽtŒ¤‹†”­•\‰ď i93.06.26j, ‘ĺ‹{.

3442. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒpƒ\ƒRƒ“‚đ—p‚˘‚˝ŠeŽíƒf[ƒ^ŽűW‹y‚Ńƒf[ƒ^ƒx[ƒX‰ť. ”’ˆä“ÖŽjC‰ZśLˆęCŹ—ŃŠ]C“c‘şçHiMEƒZƒ“ƒ^[jC–kŒ´Œ[iŠÖ“Œ’üM•a‰@jCLŁ–ŤiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj: “ú–{ˆă‰ČŠíŠBŠw‰ď—Տ°HŠwŒ¤‹†‰ď—Տ°HŠw‹ZŽtŒ¤‹†”­•\‰ď i93.06.26j, ‘ĺ‹{.

3443. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ƒ‚ƒ‹ƒqƒl‚ĚŽ‘ą‘ĺ—Ę“Š—^‚đ•K—v‚Ć‚ˇ‚éŠŕŤáu’ÉŠłŽŇ‚ĚÝ‘îŠÇ—. “IęŒłOC–î“c_i–ƒjC‰Á‰ę’J”ŁCźŒ´”Łi–ňÜjCâEŠ_˝iŠOjCŽR–{ŒPŽqi‘‡‘Š’k•”jC“n•Ó•qCŒă“Ą•ś•vi–ƒj: ‘ć1‰ń“ú–{ƒzƒXƒsƒXÝ‘îƒPƒAŒ¤‹†‰ď i93.07.04j, _ŒË.

3444. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j –ƒŒŠí“_ŒŸ‚ւ̉AˆłƒŠ[ƒNƒeƒXƒg‚Ě“ą“ü. Ź—ŃŠ]C”’ˆä“ÖŽjC“c‘şçHC‰ZśLˆęiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj: ‘ć6‰ńˆăHŠwŽĄ—ĂŒ¤‹†‰ďŠwp‘ĺ‰ď i94.02.27j, “Œ‹ž.

3445. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j ƒ^[ƒ~ƒiƒ‹ƒPƒA‚đŠÜ‚ŢƒyƒCƒ“ƒNƒŠƒjƒbƒN‚Ɛ_ŒoƒuƒƒbƒN‚Ě“K‰ž. Œă“Ą•ś•vi–ƒj: Š‹ü‹ć—Տ°ŽŒ`ŠO‰Čˆă‰ď i93.07.20j, Š‹ü.

3446. mŒ¤‹†‰ďi’n•űjn i“Á•Ęu‰‰j “ŕˆöŤ~ˆł—˜”Aƒzƒ‹ƒ‚ƒ“‚ƏzŠÂ. Œă“Ą•ś•vi–ƒj: ‘ć59‰ń‹ž“s–ƒŒ§˜b‰ď i93.07.26j, ‹ž“s.

3447. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j –ƒŒ‚Ć“ŕˆöŤ‚ĚŒŒŠÇě“Ž•¨Žż. Œă“Ą•ś•vi–ƒj: ‘ć128‰ńMB‘ĺŠwˆăŠwƒZƒ~ƒi[ i93.11.15j, ’ˇ–ě.

3448. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‡–°Žž–łŒÄ‹zÇŒóŒQ‚Ě‹C“šŠÇ—. Ż–ě^—˘ŽqC—^“ß”eÖC‰Á“Ą´ŽiCŒă“Ą•ś•vi–ƒj: _“Ţě–ƒŒę–ĺˆă‰ď i94.02.05j, ‰Ą•l.


<<28 —Տ°•a—Šw>>

3449. mŒ´’˜n Molecular weight analysis of cow's milk antigens in neonate sera. â“Œ—R‹ICŒÜ\—’@—YC“‡ŠŃˆčiŽ™jC‘ĺ’J‰pŽ÷i—Ő•a—j: Acta Pediatr. Jpn., 36: 65`70, 1994.

3450. mŒ´’˜n —Տ°•Ş—ŁŠ”‚ɑ΂ˇ‚éofloxacin‚Č‚Ç‚Ě”NŽŸ•ĘR‹ŰŠˆŤ‚ÉŠÖ‚ˇ‚錟“˘. Î“c—TŽqi‘ćˆęť–ňjC‘ź9–źC‘ĺ’J‰pŽ÷i—Ő•a—j: Chemotheraphy Jpn., 41(7): 740`749, 1993.

3451. mŒ´’˜n Interconversion of cyclosporin molecular from inducing peak broadening, tailing and splitting during reversed-phase liquid chromatography. źě—˛i—Ő•a—jC˜@ŒŠ‰p˘iś•¨•¨—‰ťjC—é–Ř‘”üiś‰ťŒnjC‹v•Ű”Žşi–ňŠw•”jC‘ĺ’J‰pŽ÷i—Ő•a—j: Chromatographia, 38(5/6): 359`364, 1994.

3452. mŒ´’˜n kinetic analysis of molecular interconversion of immunosuppressant FK506 by higy-performance liquid chromatography. źě—˛i—Ő•a—jC˜@ŒŠ‰p˘iś•¨•¨—jC—é–Ř‘”üiś‰ťŒnjC‹v•Ű”Žşi–ňŠw•”jC‘ĺ’J‰pŽ÷i—Ő•a—j: Pharm. Res., 10(12): 1785`1789, 1993.

3453. mŒ´’˜n PCRƒ_ƒCƒŒƒNƒgƒV[ƒNƒGƒ“ƒX–@‚đ—p‚˘‚˝ƒŔ°ƒOƒƒrƒ“ˆâ“`Žq•ĎˆŮ‚̉đÍ: ˆâ“`Žqf’f‚މ”\‚Ĺ‚ ‚Á‚˝Š™óÔŒŒ‹…Ť•nŒŒÇ‚¨‚ć‚Ń•sˆŔ’čƒwƒ‚ƒOƒƒrƒ“Burke. ‘ĺŠŃ—TŽqiś•¨‰ťŠwŒnjC˜a“c’m‰vi—Ő•a—jC–L‰Ş—TŽqi—ŐŒŸjCŠ™“cvŽőC‘ĺ‹v•Ű[li“ŕjC—é–؏t’jiś•¨•¨—‰ťjC‘ĺ’J‰pŽ÷i—Ő•a—j: –k—˘ˆăŠw, 24(1): 15`20, 1994.

3454. mŒ´’˜n ‚bŒ^–ŤŠĚ‰Š‚ĚƒCƒ“ƒ^[ƒtƒFƒƒ“—Ă–@‚É”ş‚¤C100-3R‘Ě‚¨‚ć‚ŃN14Œ^R‘̂̐„ˆÚ‚ɂ‚˘‚Ä. ÷ˆäŒc‘˘C”Ş–Řˆę•vi“Œ•a‰@—ŐŒŸjCa’J–ž—˛i“ŕjC“ŕŽRKMC‘ĺ’J‰pŽ÷i—Ő•a—j: —Տ°•a—, 42(2): 171`175, 1994.

3455. mŒ´’˜n ƒuƒƒƒŠƒ“ˆę’i–@‚É‚¨‚Ż‚é‹U‰AŤ”˝‰žˆöŽq‚ĚŒŸ“˘. ‰““Ą—mCŹ“‡ŒcŽqC•P“c‹v”üi“Œ•a‰@—ŐŒŸjCŽOd–슰ŠěiŠOjC“ŕŽRKMi—Ő•a—j: —Տ°•a—, 42(2): 171`175, 1994.

3456. mŒ´’˜n CŒ^–ŤŠĚ‰Š‚ĚƒCƒ“ƒ^[ƒtƒFƒƒ“—Ă–@‚É”ş‚¤C100-3R‘Ě‚¨‚ć‚ŃN14R‘̂̐„ˆÚ‚ɂ‚˘‚Ä. ÷ˆäŒc‘˘i—ŐŒŸjC“ŕŽRKMi—Ő•a—jCa’J–ž—˛i“ŕj: —Տ°•a—, 42(2): 171`175, 1994.

3457. m€Œ´’˜n Detection of urinary benzodiazepines by radioreceptor assay. źě—˛i—Ő•a—jC—é–Ř‘”üiś‰ťŒnjC‘ĺ’J‰pŽ÷i—Ő•a—jC‰i‘ň‹IŽqi¸jC‹ß“Ą—Ż”üŽqi–ňÜj: Recent Development in Therapeutic Drug Monitoring and Clinical Toxicology, p.337`340, 1992.

3458. mŒ¤‹†•ńn 5.ŒŒ´Šw“IŒŸ¸i”~“Łj, 6.ŒŒ´Šw“IŒŸ¸iCRPj. ź“c—zi—Ő•a—j: •˝Ź4”N“x¸“xŠÇ—’˛¸Œ¤C‰ďi_“ŢěŒ§‰qś•”j, p.54`72, 1992.

3459. mŒ¤‹†•ńn 5.ŒŒ´Šw“IŒŸ¸. ‹g“cŸ•Fiş˜a‘ĺjCź“c—zi—Ő•a—j: •˝Ź5”N“x¸“xŠÇ—’˛¸Œ¤C‰ďŽ‘—żi_“ŢěŒ§‰qś•”j, p.86`101, 1993.


<<28 2 —Տ°•a—Šw>>

3460. m—Տ°ŽĄŒąn –ň•¨”Z“x‘Ş’č‚É‚¨‚Ż‚éƒGƒ~ƒbƒg2000‰tóŽŽ–ň‚ÉŠÖ‚ˇ‚éŠî‘b“IŒŸ“˘. ‹ŕŽwˆč‘ăCŽRŒű“oŠóŽqCźč‹v”üC›Œ´Œ’ˆęi—ŐŒŸjC‘ĺ’J‰pŽ÷i—Ő•a—j: ˆăŠw‚Ć–ňŠw, 31(1): 209`214, 1994.

3461. m‘ŕn ŒŒ‰t‚Ćƒrƒ^ƒ~ƒ“. “ŕŽRKMi—Ő•a—j: ‚Š‚ç‚ž‚̉Ȋw, (171): 29`32, 1993.

3462. m‘ŕn ‹Ů‹}ŒŸ¸‚ւ̑Ήži’`”’j. Žë–ě—LěC‘ĺ’J‰pŽ÷i—Ő•a—j: ŒŸ¸‚Ć‹Zp, 21(5): 24`25, 1993.

3463. m‘ŕn “úŒoƒƒfƒBƒNƒCƒY‡F|—Տ°ŒŸ¸. ‘ĺ’JTˆęC‘ĺ’J‰pŽ÷i—Ő•a—j: “úŒoƒƒfƒBƒJƒ‹, (10ŒŽ10“ú†): 35`36, 1993.

3464. m‘ŕn Polymerase chain reaction(PCR)–@‚đ—p‚˘‚˝ˆâ“`Žq‰đÍ‚Ě—Ő°‰ž—p. ˜a“c’m‰vC‘ĺ’J‰pŽ÷i—Ő•a—j: –k—˘ˆăŠw, 23(6): 396`404, 1993.

3465. m‘ŕn ŒŸ¸’l‚Ě‚Ý‚Š‚˝: ŒŒ’†–ň•¨”Z“x|ƒeƒIƒtƒBƒŠƒ“. źě—˛C‘şźGŽ÷i—Ő•a—j: —Տ°ˆă, 19(‘): 1066`1067, 1993.

3466. m‘ŕn ƒrƒ^ƒ~ƒ“AĽE. “ŕŽRKMi—Ő•a—j: —Տ°ˆă, 19(‘): 659`661, 1993.

3467. m‘ŕn ƒrƒ^ƒ~ƒ“B1ĽB2ĽB6ĽB12ĽC1—tŽ_, ƒjƒRƒ`ƒ“Ž_. “ŕŽRKMi—Ő•a—j: —Տ°ˆă, 19(‘): 662`667, 1993.

3468. m‘ŕn ŒŒ‰tƒKƒX•ŞÍ‘•’u. ”’ˆäD•śi—ŐŒŸjC“ŕŽRKMi—Ő•a—j: —Տ°ŠĹŒě, 19(13): 1943`1946, 1993.

3469. m‘ŕn ’´‰š”gf’f‘•’u. “Ą“c’‰˜aCŒFâLi—ŐŒŸjC“ŕŽRKMi—Ő•a—j: —Տ°ŠĹŒě, 19(13): 1947`1950, 1993.

3470. m‘ŕn ‰ŠÇŽžŠł‚É‚¨‚Ż‚é”’ŒŒ‹…, CRP, ƒVƒAƒ‹Ž_‚Ě•Ď“Ž. Žë–ě—LěC‘ĺ’J‰pŽ÷i—Ő•a—j: —Տ°ŒŸ¸, 37(3): 1056`1058, 1993.

3471. muŔn ‚l’`”’‚Ě“Ż‘î. ‘ĺ’J‰pŽ÷i—Ő•a—j: ŒŸ¸‚Ć‹Zp, 21(6): 470`471, 1993.

3472. muŔn ƒż1Ž_Ť“œ’`”’. ‘ĺ’J‰pŽ÷i—Ő•a—j: —Տ°ˆă, 19(‘): 585`586, 1993.

3473. mŠwp‘n i•Ş’SŽˇ•Mj Diagnostics in the year 2000: Antibody, biosensor and nuclei aud Chapter 9; Nephelometric immunoassay for therapeutic drug monitoring, p.135`144, źě—˛i—Ő•a—j. •ŇW P.SinghiPresident of Chemtrak Inc.jCB.P.SharmaiSyva Co.jCP.TyleiSandoz Co.jC Van Nostrand Reinhold, New York, 93.00.00”­s.

3474. mŠwp‘n i•Ş’SŽˇ•Mj —Տ°ŒŸ¸Œ¤Cƒnƒ“ƒhƒuƒbƒNiV’ů3”Łj; Šî€”͈́iłí’lj, p.51`63, “ŕŽRKMi—Ő•a—j. •ŇW ‘ĺ’J‰pŽ÷i—Ő•a—jCXŽOŽ÷—Yi“Ć‹Śˆă‘ĺjC–k‘ş´‹gi“ú–{—Տ°ŒŸ¸ŽŠ“Ž‰ťŠw‰ďjC –ňŽ–“ú•ńŽĐ, “Œ‹ž, 94.03.15”­s.

3475. mŠwp‘n i•Ş’SŽˇ•Mj —Տ°‰ťŠwiŽO’ůj; –ň•¨‚¨‚ć‚Ń“Ĺ•¨, p.229`237, źě—˛i—Ő•a—j. •ŇW ˆÉ“ĄŒ[i‰qśŠw•”jCÄ“ĄłsC’O‰HłŽĄC u’kŽĐƒTƒCƒGƒ“ƒeƒBƒtƒBƒbƒN, “Œ‹ž, 92.12.00”­s.


<<28 3 —Տ°•a—Šw>>

3476. m‹ł‰Č‘n i•Ş’SŽˇ•Mj •a‹C‚̐Ź—§‚ż‚Ć—Ő°ŒŸ¸; śBŠíŽžŠł‚Ć—Ő°ŒŸ¸, p.194`211, ź“c—zi—Ő•a—jC–ě“c–FliŽY•wj. •ŇW ŒK“‡ŽŔiěŒ§—§•a‰@jC ˆăŽ•–ňo”Ĺ, “Œ‹ž, 93.04.20”­s.

3477. m‹ł‰Č‘n i•Ş’SŽˇ•Mj ŹŽ™—Տ°ŒŸ¸ƒ}ƒjƒ…ƒAƒ‹; ‹}Ť‘Š”˝‰ž’`”’iAPRƒXƒRƒA‚đŠÜ‚ށj, p.177`185, ź“c—zi—Ő•a—j. •ŇW ‘ĺ‘^•FC‰Í–ě‹Ď–çi“ú‘ĺjC •śŒő“°, “Œ‹ž, 93.10.23”­s.

3478. m‹ł‰Č‘n i•Ş’SŽˇ•Mj ŠĹŒě‚Ě‚˝‚ß‚Ě–ňŽ–“T; f’f—pŒŸ¸–ňi‰đŕj, p.454, ź“c—zi—Ő•a—j. •ŇW Î‹´Wi”ĺjCŽ›č–ž”üC“Ą“cŒbŽqiŠĹŒě•”jC•ŽR­ˆęi–ňÜjC ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 93.12.05”­s.

3479. m‹ł‰Č‘n i•Ş’SŽˇ•Mj —Տ°ŒŸ¸Œ¤Cƒnƒ“ƒhƒuƒbƒN; —Տ°ŒŸ¸ŠT˜_, —Տ°ŒŸ¸–@‚Ć—Ő°“IˆÓ‹`, p.1`50, ‘ĺ’J‰pŽ÷i—Ő•a—j. –ňŽ–“ú•ńŽĐ, “Œ‹ž, 94.03.15”­s.

3480. m‹ł‰Č‘n i•ŇWj —Տ°ŒŸ¸Œ¤Cƒnƒ“ƒhƒuƒbƒN; •ŇW ‘ĺ’J‰pŽ÷i—Ő•a—jCXŽOŽ÷—Yi“Ć‹Śˆă‘ĺjC–k‘ş´‹gi“ú–{—Տ°ŒŸ¸ŽŠ“Ž‰ťŠw‰ďj –ňŽ–“ú•ńŽĐ, “Œ‹ž, 94.03.15”­s.

3481. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj —Տ°•a—Šwi‘ć5ŠŞj, —Տ°‰ťŠw; ’`”’ŒŸ¸, 5: 5`19, ‘ĺ’J‰pŽ÷i—Ő•a—j. •ŇW ‘ĺęNŠ°i‹ß‘ĺjC ˆăŽ•–ňo”Ĺ, “Œ‹ž, 93.10.10”­s.

3482. m‚ť‚Ě‘ź‚Ě’˜‘iŽŤ“Tjn i•Ş’SŽˇ•Mj ŒŸ¸€ŽŤ‰‘'93; C-”˝‰žŤ’`”’i’萍jĽi’č—ʁj, APRƒXƒRƒA, p.658`660, ź“c—zi—Ő•a—j. •ŇW ÷—Ńˆč”V‰îiŽŠŽĄˆă‘ĺjCŒFâˆęŹi“ú‘ĺjC ‘ĺ’ːť–ň, “ż“‡, 93.05.00”­s.


<<28 5 —Տ°•a—Šw>>

3483. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Clinical significance of serum CRP quantitation by latex immunoassay with high sensitivity. Y’J’źli—Ő•a—jC”Ť‘ş˜a’ji—ŐŒŸjC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć17‰ń‘Ű—Տ°•a—Šw‰ď i93.10.08j, ƒƒLƒVƒR, ‘Ű—Տ°•a—Šw‰ď´˜^W, 1993.

3484. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Seven cases of advanced prostate cancer with ƒż2-macroglobulin deficiency. ‘ĺ’J‰pŽ÷i—Ő•a—j: 17th World Congress of Anatomic and Clinical Pathology i93.10.06j, ƒƒLƒVƒR.

3485. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Fluctuation of cerebrospinal fluid proteins in various meningitis. Žë–ě—LěC“ŕŽRKMC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć17‰ń‘Ű—Տ°•a—Šw‰ď i93.10.08j, ƒƒLƒVƒR,

3486. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj –ň•¨—Ă–@‚̐i•ŕ‚đŽx‚Ś‚˝—Ěˆć: ‚ť‚Ě‚P.‘Ě“ŕ–ň•¨”÷—Ę‘Ş’č–@‚̐i•ŕ. źě—˛i—Ő•a—j: ‘ć14‰ń“ú–{—Տ°–ň—Šw‰ď i93.09.21`22j, ‰Ą•l, —Տ°–ň—, 25(1): 369`371, 1994.

3487. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒŔ-tubulin‚É‚ć‚é“ŕ‘ŸƒJƒ“ƒWƒ_Ç‚Ěˆâ“`Žqf’f. ‘şźGŽ÷i—Ő•a—j: ‘ć37‰ń“ú–{ˆă^‹ŰŠw‰ď‘‰ď i93.10.10j, ‰Ą•l, “ú–{ˆă^‹ŰŠw‰ďŽGŽ, 34(‘1): 84, 1993.

3488. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŒÄ‹zŠíŒnŢ—ż‚ć‚čŒŸo‚ł‚ę‚˝ƒJƒ“ƒWƒ_‚đœ‚­^‹Ű‚Ě•aŒ´“IˆÓ‹`. ˆ˘•””ü’mŽqC“ŕ“cˆęOC‚–ؐç’߁i—ŐŒŸjC‘şźGŽ÷Cź“c—zC‘ĺ’J‰pŽ÷i—Ő•a—jC‹v•ÄŒői•a—jC: ‘ć67‰ń“ú–{Š´őÇŠw‰ď‘‰ď i93.04.15j, “Œ‹ž, Š´őÇŠwŽGŽ, 67(‘): 96, 1993.

3489. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j PCR–@‚É‚ć‚éCandida albicans‚ĚŒŸo‚ÉŠÖ‚ˇ‚錟“˘. ‘şźGŽ÷C˜a“c’m‰vi—Ő•a—jC‹v•ÄŒői•a—jC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć67‰ń“ú–{Š´őÇŠw‰ď‘‰ď i93.04.16j, “Œ‹ž, Š´őÇŠwŽGŽ, 67(‘): 184, 1993.

3490. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒuƒƒƒŠƒ“‘jŠQ’`”’‚ރuƒƒƒŠƒ“ˆę’i–@‚É‹y‚Ú‚ˇ‰e‹ż. ‰““Ą—mCŹ“‡ŒcŽqC•P“c‹v”üi—ŐŒŸjC“ŕŽRKMi—Ő•a—j: ‘ć42‰ń“ú–{—Տ°‰qśŒŸ¸Šw‰ď‘‰ď i93.05.21j, ŽD–y, ˆăŠwŒŸ¸, 42(3): 732, 1993.

3491. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“‚ĚƒŠƒZƒvƒ^[ƒAƒbƒZƒC‚Ě—Ő°‰ž—p: ŠłŽŇŒŒ‰t’†‚Ě’†“Ĺ–ň•¨‚¨‚ć‚Ń‚ť‚̝hR–ňiƒtƒ‹ƒ}ƒ[ƒjƒ‹j‚Ě”Z“x. źě—˛i—Ő•a—jC‹ß“Ą—Ż”üŽqi–ňÜjC’ç–M•FC‘Š”nˆęˆĺi‹~–˝jC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć15‰ń“ú–{’†“ĹŠw‰ď‘‰ď i93.07.09j, ‰F“s‹{.

3492. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŽžŠÔ•Ş‰đŒuŒő–@‚đ—p‚˘‚é|ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“ƒŒƒZƒvƒ^[ƒAƒbƒZƒC. ’|“ŕr•śi“Œ‘ĺjCźě—˛i—Ő•a—jCŒy•”Ş•vi“Œ‘ĺj: ‘ć66‰ń“ú–{‰ťŠw‰ďH‹G”N‰ď i93.09.00j.

3493. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Cobas argos 5 diff‚ĚŠî‘b“IŒŸ“˘. —]ŒÎ‹v”üŽqC‘O“c’‰LC•˝ˆä˝i—ŐŒŸjC‰vŽq‹MbC‘ĺ’JTˆęCŽë–ě—LěCY’J’źlC“c’†P”CC“ŕŽRKMC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć25‰ń“ú–{—Տ°ŒŸ¸ŽŠ“Ž‰ťŠw‰ď‘ĺ‰ď i93.09.17`18j, ç—t, “ú–{—Տ°ŒŸ¸ŽŠ“Ž‰ťŠw‰ďŽ, 18(4): 484, 1993.

3494. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒAƒNƒŠƒWƒjƒEƒ€ƒGƒXƒeƒ‹•WŽŻ‚đ‰ž—p‚ľ‚˝ŒŒ´ƒRƒoƒ‰ƒ~ƒ“•Ŕ‚Ń‚É—tŽ_‚Ě“ŻŽž‘SŽŠ“Ž‘Ş’č‚ÉŠÖ‚ˇ‚éŠî‘b“IŒŸ“˘. “ŕŽRKMC‰vŽq‹MbC‘ĺ’JTˆęCŽë–ě—LěCY’J’źlC“c’†P”CC‘ĺ’J‰pŽ÷i—Ő•a—jC‘O“c’‰Li—ŐŒŸj: ‘ć25‰ń“ú–{—Տ°ŒŸ¸ŽŠ“Ž‰ťŠw‰ď‘ĺ‰ď i93.09.17`18j, ç—t, “ú–{—Տ°ŒŸ¸ŽŠ“Ž‰ťŠw‰ďŽ, 18(4): 549, 1993.

3495. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ň•¨‚ĚƒŠƒZƒvƒ^[ƒAƒbƒZƒC‚Ě—Ő°‰ž—p: ’†“ĹŠłŽŇ‚É“Š—^‚ł‚ę‚˝hR–ňFlumazenil‚ĚŒŒ’†”Z“x‘Ş’č. źě—˛i—Ő•a—jC—é–Ř‘”üiś‰ťŒnjC‹ß“Ą—Ż”üŽqi–ňÜjCăžŠ‹glC’ç–M•Fi‹~–˝jC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć33‰ń“ú–{—Տ°‰ťŠw‰ď i93.10.01`03j, _ŒË.

3496. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒqƒgƒƒ‰ƒm[ƒ}×–EŠ”‚É‚¨‚Ż‚éc-myb‚Ěalternative splicing“]ŽĘŽY•¨‚Ě”­Œť. ˜a“c’m‰vi—Ő•a—jCóˆäŽőŽqC•ÄŒłN‘ C‰q“ĄŒői”çjC–F“cvi—ŐŒŸjC‘ĺŠŃ—TŽqiś•¨‰ťŠwŒnjC“ŕ“c–Lşi”ĺjC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć52‰ń“ú–{ŠŕŠw‰ď‘‰ď i93.10.05j, ĺ‘ä, “ú–{ŠŕŠw‰ď‘‰ď‹LŽ–, p.197, 1993.

3497. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j —nŒŒĽ‰“S‚É‚ć‚éV‚ľ‚˘ŒŒ‰t”|—{–@, ƒAƒCƒ\ƒŒ[ƒ^[‚Ě•]‰ż. ‚–ؐç’߁Cˆ˘•””ü’mŽqCŒĂ–Ř—Ęˆę˜Yi—ŐŒŸjC‘şźGŽ÷C‘ĺ’J‰pŽ÷i—Ő•a—jC‹v•ÄŒői•a—j: ‘ć37‰ń“ú–{ˆă^‹ŰŠw‰ď‘‰ď i93.10.11j, ‰Ą•l, “ú–{ˆă^‹ŰŠw‰ďŽGŽ, 34(‘1): 131, 1993.

3498. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXcommon primer‚đ—p‚˘‚˝PCR‚É‚ć‚éHSV-1, HSV-2, VZV, CMV gene‚Ě“ŻŽžŒŸo. –F“cvC‚‹{t’jCŽR•Ó°”üC–L‰Ş—TŽqCŸ–””ü”gi—ŐŒŸjC˜a“c’m‰vC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.20j, L“‡, —Տ°•a—, 41(•âű): 120, 1993.

3499. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j PCR–@‚É‚ć‚écandida albicans‚ĚŒŸoi‘ć‚Q•ńj. ‘şźGŽ÷C˜a“c’m‰vC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.20j, L“‡, —Տ°•a—, 41(•âű): 70 1993.

3500. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰ťŠw”­Œő•¨Žż‚đ—p‚˘‚˝ŒŒ´ƒRƒoƒ‰ƒ~ƒ“‹y‚Ń—tŽ_‚Ě‘SŽŠ“Ž“ŻŽž‘Ş’č‚ÉŠÖ‚ˇ‚錟“˘‚Ć‚ť‚Ě—Ő°“IˆÓ‹`. “ŕŽRKMC‰vŽq‹MbC‘ĺ’JTˆęCŽë–ě—LěCY’J’źlC“c’†P”CC‘ĺ’J‰pŽ÷i—Ő•a—jC‘O“c’‰Li—ŐŒŸj: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.20j, L“‡, —Տ°•a—, 41(•âű): 70, 1993.

3501. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒxƒNƒ^[ƒ‰ƒCƒQ[ƒVƒ‡ƒ“Nosted PCR‚É‚ć‚é–˘’m‚Ěˆâ“`Žqƒvƒƒ‚[ƒ^[—Ěˆć‚̉đÍ. ˜a“c’m‰vi—Ő•a—jC‘ĺŠŃ—TŽqiś•¨‰ťŠwŒnjC–F“cvi—ŐŒŸjCÔŻ“§i“ŕjC’Jş”ŽiŽY•wjC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.20j, L“‡, —Տ°•a—, 41(•âű): 95, 1993.

3502. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j PCR–@‚É‚ć‚éCandida albicans‚ĚŒŸoi‘ć2•ńj. ‘şźGŽ÷C˜a“c’m‰vi—Ő•a—jC‹v•ÄŒői•a—jC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.21j, L“‡, —Տ°•a—, 41(•â): 186, 1993.

3503. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Latex immunoassay‚É‚ć‚é”A’†free light chain‚Ě‘Ş’č–@‚ɂ‚˘‚Ä. ‘ĺ’JTˆęC‰vŽq‹MbCźě—˛C“ŕŽRKMC‘ĺ’J‰pŽ÷i—Ő•a—jC–L‰Ş—TŽqCŽu‘ş‰Ă•FCŽsěŒbŽqi—ŐŒŸj: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.21j, L“‡, —Տ°•a—, 41(•âű): 166, 1993.

3504. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘SŽŠ“ŽŒŒ‹…•Ş—Ţ‘•’uCOBAS ARGOS 5DIFF‚Ě—Ő°“I•]‰ż|‘ć‚Q•ń|. •˝ˆä˝C—]ŒÎ‹v”üŽqC‘O“c’‰Li—ŐŒŸjC‰vŽq‹MśC“c’†P”CC‘ĺ’JTˆęCY’J’źlCŽë–ě—LěC“ŕŽRKMC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.21j, L“‡, —Տ°•a—, 41(•âű): 214, 1993.

3505. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘SŽŠ“ŽŒŒ‹…•Ş—Ţ‘•’uCOBAS ARGOS 5DIFF‚ĚŠî‘b“IŒŸ“˘|‘ć‚P•ń|. —]ŒÎ‹v”üŽqC‘O“c’‰LC•˝ˆä˝i—ŐŒŸjC‰vŽq‹MśC‘ĺ’JTˆęCŽë–ě—LěCY’J’źlC“c’†P”CC“ŕŽRKMC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.21j, L“‡, —Տ°•a—, 41(•âű): 214, 1993.

3506. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘‰t’†‚ĚCRP, IgG‚¨‚ć‚ŃIL-6‚Ě’č—Ę‚Ć‚ť‚Ě—Ő°“IˆÓ‹`. ”Ş–Řˆę•vC÷ˆäŒc‘˘i—ŐŒŸjCŽë–ě—LěC“ŕŽRKMC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.21j, L“‡, —Տ°•a—, 41(•âű): 238, 1993.

3507. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j CRP‚̐ś—Šw“I•Ď“Ž•‚ÉŠÖ‚ˇ‚錟“˘. ”Ť‘ş˜a’ji—ŐŒŸjC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.21j, L“‡, —Տ°•a—, 41(•âű): 299, 1993.

3508. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –ŤŠÖßƒŠƒEƒ}ƒ`ŠłŽŇ‚É‚¨‚Ż‚鉊Çƒ}[ƒJ[‚ĆIL-2ƒŠƒZƒvƒ^[‚ɂ‚˘‚Ä. ÷ˆäŒc‘˘C”Ş–Řˆę•vi—ŐŒŸjC“ŕŽRKMC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.22), L“‡, —Տ°•a—, 41(•âű): 304, 1993.

3509. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠeŽí‘–Œ‰Š‚É‚¨‚Ż‚鐑‰t’`”’Ź•Ş‚¨‚ć‚ŃIL-6‚Ě•Ď“Ž. Žë–ě—LěC“ŕŽRKMC‘ĺ’J‰pŽ÷i—Ő•a—jCŽsěŒbŽqCŽu‘ş‰Ă•FC”Ť‘ş˜a’ji—ŐŒŸj: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.22j, L“‡, —Տ°•a—, 41(•âű): 298, 1993.

3510. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j CRP”÷—Ę’č—Ę‚Ě—Ő°“IˆÓ‹`|‘ć‚Q•ń|. Y’J’źli—Ő•a—jCŽsěŒbŽqC–L‰Ş—TŽqC”Ť‘ş˜a’ji—ŐŒŸjÎ“c—™iZ—F‹ŕ‘ŽjC“ŕŽRKMC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.22j, L“‡, —Տ°•a—, 41(•âű): 299, 1993.

3511. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j _Œo‰čŽîƒXƒNƒŠ[ƒjƒ“ƒO‚É‚¨‚Ż‚é’´‰š”gŒŸ¸‚ĚˆÓ‹`. “c’†P”CC“ŕŽRKMC‘ĺ’J‰pŽ÷i—Ő•a—jC’ß–ě˜a‘Ľi—ŐŒŸjC‘ĺ‹{“ŒśiŠOj: ‘ć40‰ń“ú–{—Տ°•a—Šw‰ď‘‰ď i93.10.22j, L“‡, —Տ°•a—, 41(•âű): 397, 1993.

3512. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“‚ĚƒŠƒZƒvƒ^[ƒAƒbƒZƒC‚Ě—Ő°‰ž—p: ’†“ĹŠłŽŇ‚ĚŒŒ´’†Flumazenili“ÁˆŮhR–ňj‚ĚŠˆŤ‘ăŽÓ•¨˜A‘ą“Š—^’~Ď‚ĚŒŸ“˘. źě—˛i—Ő•a—jC—é–Ř‘”üiś‰ťŒnjC‹ß“Ą—Ż”üŽqi–ňÜjCăžŠ‹gli‹~–˝jC‘ĺ’J‰pŽ÷i—Ő•a—j: “ú–{–ňŠw‰ď‘ć114”N‰ď i94.03.29j, “Œ‹ž.

3513. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŒŒŸ÷ˆŮíƒvƒƒgƒƒ“ƒrƒ“(PIVKA‡V)’l‚Ć‰ć‘œŠŒŠ‚Ć‚ĚŠÖŒW‚ɂ‚˘‚Ä. Ź“‡ŒcŽqC–؉ş•śŽqC—]ŒÎ‹v”üŽqC‘O“c’‰Li—ŐŒŸjC“ŕŽRKMi—Ő•a—j: ‘ć42‰ń“ú–{—Տ°‰qśŒŸ¸Šw‰ď‘‰ď i93.05.21j, ŽD–y, ˆăŠwŒŸ¸, 42(3): 691, 1993.

3514. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ŠeŽíŽžŠł‚É‚¨‚Ż‚鐑‰t’`”’Ź•Ş‚Ě•Ď“Ž. Žë–ě—LěC“c’†P”CCY’J’źlC‘ĺ’JTˆęC‰vŽq‹MbC“ŕŽRKMC‘ĺ’J‰pŽ÷i—Ő•a—j: ‘ć4‰ń_“ŢěŒ§—Տ°ŒŸ¸ˆăŠwŒ¤‹†‰ď i93.06.19j, ‰Ą•l.


<<29 ‹~–˝‹~‹}ˆăŠw>>

3515. mŒ´’˜n Endoscopic retrograde cholangiography in the nousurgical management of blust liver injury. ™–{Ÿ•FCó—˜–ői‹~–˝jCâŒű“NÍi“ŕjC‘ĺ˜a“c—˛i‹~–˝jC‘Oě˜a•Fi“Œ‘ĺj: J. Trauma, 35: 192`199, 1993.

3516. mŒ´’˜n ƒGƒfƒBƒgƒŠƒAƒ‹, ‹CŠÇŽxšb‘§‚Ě•a‘Ô‚ĆŽĄ—Ă‚Ě–â‘č“_. ‘Š”nˆęˆĺi‹~–˝j: ‹~‹}ˆăŠw, 17: 1749, 1993.

3517. mŒ´’˜n ‹~–˝‹~‹}ƒZƒ“ƒ^[‚É‚¨‚Ż‚édÇ“Ş•”ŠOŽĄ—Ă‚ĚŽŔŰ. –kŒ´F—YC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝jC‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOj: _ŒoŠO, 16: 149`153, 1993.

3518. mŒ´’˜n ’ōœ“Ž–Ź‡—Ź•”“Ž–ŹáŽ‚ɑ΂ˇ‚éRetrolabyrinthine presigmoid approach. –kŒ´F—Yi‹~–˝jC‹{â‰Ŕ’ji”]ŠOjC‘ĺ˜a“c—˛i‹~–˝jCí”Ő‰ĂˆęC“ü‘qŽŒČC‘q“c˛C–î“cŒŤŽOi”]ŠOj: _ŒoŠO, 21: 269`273, 1993.

3519. mŒ´’˜n äB‘š‚É‚¨‚Ż‚é”ńŽčp“IŽĄ—Ă‚Ćinterventional angiography. –x’rdŽĄC™–{Ÿ•Fi‹~–˝jC‘Oě˜a•Fi“Œ‘ĺj: “ú–{‹~‹}ˆăŠw‰ďŽGŽ, 4(2): 108`118, 1993.

3520. mŒ´’˜n ă•”Á‰ťŠÇ“ŕŽ‹‹žŒŸ¸‚É‚ć‚éƒpƒ‰ƒR[ƒg’†“Ĺ‚Ě—\Œă„’č|ƒƒWƒXƒeƒBƒbƒN‰ń‹A•ŞÍ‚É‚ć‚é—\Œă—\‘ރ‚ƒfƒ‹|. ó—˜–ői‹~–˝jC“c•Ó‘i“ŕjC’ß“c—z˜aiˆă—pî•ńjCLŁ—˛ˆęC‘•Ş–ΔŽi“ŕjC‘Š”nˆęˆĺi‹~–˝j: “ú–{‹~‹}ˆăŠw‰ďŽGŽ, 4(2): 119`126, 1993.

3521. mŒ´’˜n ‚­‚ŕ–Œ‰şoŒŒ‚É‚¨‚Ż‚é‹}Ž€‚ĚŒ´ˆö‚ĚŒŸ“˘. –kŒ´F—YC‘“c‘ěC‘Š”nˆęˆĺi‹~–˝j: ”]_ŒoŠO‰Č, 21: 781`786, 1993.

3522. mŒ´’˜n ”]Š˛ŽüˆÍ”]‘…‚ÉŒŔ‹Ç‚ľ‚˝oŒŒ‚đ’悡‚éoŒŒŒš•s–ž‚Ě‚­‚ŕ–Œ‰şoŒŒ‚Ě—Ő°“IŒŸ“˘. –kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝jCí”Ő‰ĂˆęC‘q“c˛C‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOjC›Mˆęi•új: ”]_ŒoŠO‰Č, 21: 903`908, 1993.

3523. m€Œ´’˜i‰p•śjn Diagnostic significance of serum neuron-specific enolase and myelin basic assay in patients with acute head injury. ŽRč‹`‹éC‘ĺ‚O–Ťi”]ŠOjC–kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝j: Recent Advances in Neurotraumatology, p.381`383, 1993.

3524. m€Œ´’˜n ‹~‹}ŽÔ“ŕS”x’âŽ~Ç—á‚É‚¨‚Ż‚éƒGƒsƒlƒtƒŠƒ“‘ĺ—Ę“Š—^–@‚ĚŒŸ“˘. ó—˜–őC‘Š”nˆęˆĺCV“Ął‹PC•˝“cŒő”ŽC™–{Ÿ•FC‘“c‘ěC•‘ň—˜˜YC‘ĺ˜a“c—˛i‹~–˝j: “ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ďŽGŽ, 14(1): 344`345, 1993.

3525. mŒ¤‹†•ńiŒúśČjn ƒhƒNƒ^[ƒJ[‹y‚Ń‹~‹}‹~–˝Žm‚Ě‹~–˝—Ś‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†. ‘ĺ˜a“c—˛i‹~–˝j: Œ¤‹†•ń‘, 1993.

3526. mŒ¤‹†•ńiŒúśČjn ŠÖ“Œ’nˆć‚É‚¨‚Ż‚é‹~–˝‹~‹}ˆă—Ă‚Ě—§ę‚Š‚ç‚Ý‚˝‘ŸŠí’ń‹ŸƒVƒXƒeƒ€‚ÉŠÖ‚ˇ‚錤‹†. ‘ĺ˜a“c—˛i‹~–˝j: Œ¤‹†•ń‘, 1993.

3527. mŒ¤‹†•ńiŒúśČjn ”]Ž€Ľ‘ŸŠíˆÚA‚ÉŠÖ‚ˇ‚錤‹†. ‘ĺ˜a“c—˛i‹~–˝j: Œ¤‹†•ń‘, 1993.

3528. mŒ¤‹†•ńiŒúśČjn ”]‹•ŒŒ‚É‚¨‚Ż‚éf—Ă‹Zp‚ÉŠÖ‚ˇ‚錤‹†. ‘ĺ˜a“c—˛i‹~–˝j: Œ¤‹†•ń‘, 1993.


<<29 2 ‹~–˝‹~‹}ˆăŠw>>

3529. mÇ—á•ńn H“šŒeŽş‚ĚŽŠ‘R”j—ô‚Ě1ŽĄŒą—á. ó—˜–őCâŒű“NÍC‘꓇í‰ëC™–{Ÿ•FC‹e–ě—˛–žCźŒűŽ•FC‘ĺ˜a“c—˛i‹~–˝j: “ú–{‹~‹}ˆăŠw‰ďŽGŽ, 4(4): 334`338, 1993.

3530. mÇ—á•ńn —L‹@ƒŠƒ“’†“Ĺ‚É‚ć‚étoxic myocarditis‚Ě1—á. ‘“c‘ěC‘ň“c—R”üŽqC’ç–M•FC“y‰Ž’ź—˛C‰Ą“ŕ‘ŽqC‘ĺ˜a“c—˛i‹~–˝jCŒK”ö’čmi•a—j: “ú–{‹~‹}ˆăŠw‰ďŽGŽ, 4(4): 359`363, 1993.

3531. m—Տ°ŽĄŒąn ‹~‹}—Ěˆć‚É‚¨‚Ż‚éNPƒXƒgƒŒƒX‚É‚ć‚éˆÝŽ_•Ş”ĺ˜´i‚ɑ΂ˇ‚éRamitidine’ŽË‰t‚Ě—p—ʐݒč‚Č‚ç‚Ń‚É—Ő°“I—L—pŤ‚ĚŒŸ“˘. ‘ĺ˜a“c—˛C‘źi‹~–˝j: —Տ°Źl•a, 23: 393`407, 1993.

3532. m‘ŕn A•¨ó‘ÔŠłŽŇ‚ĚŽĄ—Ă. ‘ĺ˜a“c—˛CˆÉ“Ą”ä˜CŽui‹~–˝j: Brain Nursing, 9: 747`751, 1993.

3533. m‘ŕn ŽlŽˆ“Ž–Ź‘š. V“Ął‹Pi‹~–˝j: ‹~‹}ˆăŠw, 17(7): 811`814, 1993.

3534. m‘ŕn ŠOŤ‹}Ť“ŞŠW“ŕŒŒŽî. –kŒ´F—Yi‹~–˝j: ‹~‹}ˆăŠw, 17: 1061`1063, 1993.

3535. m‘ŕn ‘˝”­ŠO; ‰Šúf—Ă‚Ě‚ ‚č•ű‚Ć‚ť‚ĚŽč‡Ľpitfall. V“Ął‹Pi‹~–˝j: œĽŠÖßĽx‘Ń, 6(4): 393`397, 1993.

3536. m‘ŕn ‹CŠÇŽx”A˜H‚wüŒŸ¸. –x’rdŽĄi‹~–˝j: ŽüŽYŠúˆăŠw, 23(‘): 433`437, 1993.

3537. m‘ŕn ‡•šÇ‚𔺂¤œ”ՍœÜ‚ĚŽĄ—Ă. V“Ął‹Pi‹~–˝j: ŽŒ`ĽĐŠQŠO‰Č, 36(11): 1409`1415, 1993.

3538. m‘ŕn ‚—îŽŇ‚Ě‚­‚ŕ–Œ‰şoŒŒ. –kŒ´F—Yi‹~–˝j: ‘‡—Տ°, 42: 3285`3289, 1993.

3539. muŔn ŒÄ‹zŠÇ—•KŒg; ƒxƒ“ƒ`ƒŒ[ƒ^‚đ—p‚˘‚˝ŒÄ‹zŠÇ—‚ĚŽŔŰ. ‘Š”nˆęˆĺi‹~–˝j: ‹~‹}ˆăŠw, 17: 238`245, 1993.

3540. muŔn ‰@“ੴő; ‚ť‚ĚŒťó‚Ć‘Îô|MRSA‚𒆐S‚Ɂ|‚Ż‚ń‚ł. ‘Š”nˆęˆĺi‹~–˝j: î•ń, 3: 3`5, 1993.

3541. muŔn ‹CŠÇĽ‹CŠÇŽx“ŕŽ‹‹žŒŸ¸. ‘Š”nˆęˆĺi‹~–˝j: ‘‡—Տ°, 42: 202`207, 1993.

3542. mŠwp‘n i•Ş’SŽˇ•Mj ĹV“ŕ‰ČŠw‘ĺŒn5|•W€‹~‹}ˆă—Ă; “Ş’É, ‘ĺ˜a“c—˛C–kˆä‘Ľ•vi‹~–˝j. •ŇW ˆä‘ş—T•vC”öŒ`‰x˜YC‚‹vŽj–›Cdˆä´ˆę˜YC ’†ŽR‘“X, “Œ‹ž, 93.06.25”­s.

3543. mŠwp‘n i•ŇWj Ň’ĹĽŇ‘ƒWƒƒ[ƒiƒ‹; ăˆĘŒz’ĹĽŒz‘‘š, 6: 631`626, •ŇW ‘ĺ˜a“c—˛i‹~–˝jC 93.06.00”­s.

3544. mŠwp‘n i•ŇWj ‹~‹}ˆăŠwĽ“Ş•”ŠO‚̐f’f‚ĆŽĄ—Ă; 17: 993`1095, •ŇW ‘ĺ˜a“c—˛i‹~–˝jC ‚ւ邡o”Ĺ, “Œ‹ž, 93.09.00”­s.


<<29 3 ‹~–˝‹~‹}ˆăŠw>>

3545. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj ‚ŒŒˆłŤ‹Ů‹}Ç; ‚­‚ŕ–Œ‰şoŒŒ, p.22`29, –kŒ´F—Yi‹~–˝j. ˆă‰ČŠwo”Ĺ, “Œ‹ž, 94.01.31”­s.

3546. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•ŇWj ŠĹŒě‚Ě‚˝‚ß‚Ě–ňŽ–“T; Rś•¨ŽżťÜ/‰ťŠw—Ă–@Ü, •ŇW Î‹´WCŽ›č–ž”üC“Ą“cŒbŽqC•ŽR­ˆęC‘Š”nˆęˆĺi‹~–˝jC ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 93.12.05”­s.

3547. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn iŠÄCj ‚ŒŒˆłŤ‹Ů‹}Ç; ŠÄC ‘ĺ˜a“c—˛i‹~–˝jC ˆă‰ČŠwo”Ĺ, “Œ‹ž, 94.01.31”­s.

3548. m‚ť‚Ě‘ź‚Ě’˜‘i“ü–ĺ‘jn i•Ş’SŽˇ•Mj “§ÍŠłŽŇ‚̍‡•šÇ‚Ć‚ť‚Ě‘Îô|’†•_Œo; ’ˇŠú“§Í—Ă–@‚É”ş‚¤–Ťd–Œ‰şŒŒŽî, p.47`54, ‘ĺ˜a“c—˛i‹~–˝j. •ŇW “ú–{“§Íˆă‰ďC “ú–{“§Íˆă‰ď, “Œ‹ž, 94.03.31”­s.


<<29 4 ‹~–˝‹~‹}ˆăŠw>>

3549. mŽ‹’ŽŠo‹łŢĽŽ‹’ŽŠoo”Ĺ•¨n i•ŇWj ŽŔ‘H‹~‹}‰—Ă(1)S”x‘hś–@; •ŇW ó—˜–ői‹~–˝jC ‚ë‚Á‚Ű‚¤VŽĐ, “Œ‹ž, 93.06.00”­s.

3550. mŽ‹’ŽŠo‹łŢĽŽ‹’ŽŠoo”Ĺ•¨n i•ŇWj ŽŔ‘H‹~‹}‰—Ă(2)“ŕ‰Č‹~‹}ŠłŽŇ‚̏‰—Ă; •ŇW ó—˜–ői‹~–˝jC ‚ë‚Á‚Ű‚¤VŽĐ, “Œ‹ž, 93.06.00”­s.

3551. mŽ‹’ŽŠo‹łŢĽŽ‹’ŽŠoo”Ĺ•¨n i•ŇWj ŽŔ‘H‹~‹}‰—Ă(3)ŠOŠłŽŇ‚̏‰—Ă; •ŇW ó—˜–ői‹~–˝jC ‚ë‚Á‚Ű‚¤VŽĐ, “Œ‹ž, 93.06.00”­s.

3552. mŽ‹’ŽŠo‹łŢĽŽ‹’ŽŠoo”Ĺ•¨n iŠÄCj ŽŔ‘H‹~‹}‰—Ă(1)S”x‘hś–@; ŠÄC ‘ĺ˜a“c—˛C‘Š”nˆęˆĺi‹~–˝jC ‚ë‚Á‚Ű‚¤VŽĐ, “Œ‹ž, 93.06.00”­s.

3553. mŽ‹’ŽŠo‹łŢĽŽ‹’ŽŠoo”Ĺ•¨n iŠÄCj ŽŔ‘H‹~‹}‰—Ă(2)“ŕ‰Č‹~‹}ŠłŽŇ‚̏‰—Ă; ŠÄC ‘ĺ˜a“c—˛C‘Š”nˆęˆĺi‹~–˝jC ‚ë‚Á‚Ű‚¤VŽĐ, “Œ‹ž, 93.06.00”­s.

3554. mŽ‹’ŽŠo‹łŢĽŽ‹’ŽŠoo”Ĺ•¨n iŠÄCj ŽŔ‘H‹~‹}‰—Ă(3)ŠOŠłŽŇ‚̏‰—Ă; ŠÄC ‘ĺ˜a“c—˛C‘Š”nˆęˆĺi‹~–˝jC ‚ë‚Á‚Ű‚¤VŽĐ, “Œ‹ž, 93.06.00”­s.


<<29 5 ‹~–˝‹~‹}ˆăŠw>>

3555. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Both ketone bodies and insulin cause decrease in total Pi and movement of Pi from mitochondria to cytosol in the working rat heart. ”’J‹`GC“y‰Ž’ź—˛C˛“Ą´‹MC‘“c‘ěi‹~–˝jCRichard L. VeechiNIAAA, NIH, USAj: Federation of American Societies for Experimental Biology '93 77th Annual Meeting i93.03.28`04.01j, New Orleans, FASEB Journal, 7(3): 313, 1993.

3556. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Activated charcoal interrupts enteroenteric circulation of phenobarbital but not midazolam. Žá—Ń–ő‹vi“ŕjCŠŰŽR–ΑPiŽŔ“ŽŒnjC”Ť‘ş˜a’ji—ŐŒŸjCźě—˛i—Ő•a—jC‘ĺ˜a“c—˛i‹~–˝j: 6th World Congress on Intensive & Critical Care Medicine i93.06.17j, Madrid.

3557. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Coronary angiographical evaluation of myocardial necrosis and left ventricular asynergy in subarachnoid hemorrhage. ‘“c‘ěC’r“c‘׎qC•‘ň—˜˜YC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: 6th World Congress on Intensive and Critical Care Medicine i93.06.14`18j, Madrid, Spain, Medicina Intensiva, 17(Suppl.1): 222, 1993.

3558. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Clinical evaluaiton of left ventricular asynergy accompanied by subarachnoid hemorrhage. ’r“c‘׎qi“ŕjC‘“c‘ěC•‘ň—˜˜YC–kŒ´F—YCHŽR‹vŽC’ç–M•FC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: 8th World Congress on Emergency and Disaster Medicine i93.06.20`23j, Stockholm, Sweden, Abstract, p.320, 1993.

3559. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Coronary angiographical evaluation of myocardial necrosis and left ventricular asynergy in subarachnoid hemorrhage. ‘“c‘ěC•‘ň—˜˜YC’r“c‘׎qC”’J‹`GC“y‰Ž’ź—˛C‘ĺ˜a“c—˛i‹~–˝j: 66th Scientific Sessions of American Heart Association i93.11.08`11j, Atlanta, Circulation, 88(4)(Part 2): 55, 1933.

3560. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ”]_ŒoŠO‰Čˆă‚Š‚ç‚Ý‚˝‘˝”­ŠO. ‘ĺ˜a“c—˛i‹~–˝j: ‘ć18‰ń“ú–{ŠO‰ČŒn˜A‡Šw‰ď i93.06.25j, ‘ĺ‹{.

3561. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘˝”­ŠO‚É”ş‚¤œÜ‚ĚŽĄ—Á|“Ş•”ŠO‚đ‡•š‚ľ‚˝ŽlŽˆœÜ‚ĚŽĄ—Ă‚Ć–â‘č“_. V“Ął‹PC–kŒ´F—YC™–{Ÿ•FC‘ĺ˜a“c—˛i‹~–˝jC‰ĄŽRˆę•FCŽ…–žˇŒ›iŽŠOj: ‘ć19‰ń“ú–{œÜŽĄ—ĂŠw‰ď i93.07.10j, “Œ‹ž, ´˜^W, p.98, 1993.

3562. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‹~‹}ˆă—Ă‚Ö‚ĚH•v. ‘ĺ˜a“c—˛i‹~–˝j: ‘ć52‰ń“ú–{”]_ŒoŠO‰ČŠw‰ď‘‰ď i93.09.20j, “Œ‹ž.

3563. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ”]_ŒoŠO‰Č‚Ć‹~‹}ˆă—Ă‚Ć‚ĚŠÖ‚í‚č|–k—˘‘ĺŠw‚ĚƒVƒXƒeƒ€‚Ě“Á’Ľ|. –kŒ´F—YC‘ĺ˜a“c—˛i‹~–˝jC‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOj: ‘ć52‰ń“ú–{”]_ŒoŠO‰ČŠw‰ď‘‰ď i93.09.20j, “Œ‹ž, ´˜^W, p.139, 1993.

3564. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j “Ý“IäB‘š‚É‚¨‚Ż‚éf’f‚ĆŽĄ—Â̐i•ŕ. ™–{Ÿ•FC‘꓇í‰ëC–x’rdŽĄC•˝“cŒő”ŽC‘ĺ˜a“c—˛i‹~–˝jC‘Oě˜a•Fi“Œ‘ĺj: ‘ć21‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ď i93.11.17`19j, L“‡.

3565. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒNƒ‚–Œ‰şoŒŒ(SAH)‹}ŤŠú‚É‚¨‚Ż‚éS”x‹@”\‚Ě•a‘Ԑś—. ‘“c‘ěC–kŒ´F—YC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć21‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ď i93.11.17`19j, L“‡, “ú–{‹~‹}ˆăŠw‰ďŽGŽ, 4(5): 429, 1933.

3566. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‚­‚ŕ–Œ‰şoŒŒ‚É‚¨‚Ż‚é‹}Ž€‚Ě•a‘Ô‚Ć‹@˜‚ÉŠÖ‚ˇ‚錟“˘. –kŒ´F—YC‘“c‘ěC‘Š”nˆęˆĺCí”Ő‰ĂˆęC‘ĺ˜a“c—˛i‹~–˝j: ‘ć21‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ď i93.11.17`19j, L“‡, “ú–{‹~‹}ˆăŠw‰ďŽGŽ, 4(5): 429, 1933.

3567. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j • •”ŠO‚É‚¨‚Ż‚é‰ć‘œf’f‚̐i•ŕ. –x’rdŽĄi‹~–˝j: ‘ć21‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ď i93.11.19j, L“‡, “ú–{‹~‹}ˆăŠw‰ďŽGŽ, 4(5): 422, 1993.

3568. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŒÄ‹z•s‘S—á‚Ě‰ć‘œf’f‚Ě—L—pŤ; ‹}Ť”xŽžŠł‚É‚¨‚Ż‚é‰ć‘œf’f‚ĚÄ”FŽŻ|‚ť‚Ě—L—pŤ‚ĆŒŔŠE. ‘Š”nˆęˆĺi‹~–˝j: ‘ć13‰ń“ú–{‰ć‘œˆăŠw‰ď i94.02.05j, “Œ‹ž.

3569. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚—îŽŇ‚­‚ŕ–Œ‰şoŒŒ—á‚ĚŒŸ“˘. –kŒ´F—YCˆÉ“Ą”ä˜CŽuC‹g“cF—FC‚–쐽C‘ˆäł„C‘ĺ˜a“c—˛i‹~–˝jCí”Ő‰ĂˆęC‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOj: ‘ć18‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i93.04.23j, –‹’Ł.

3570. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒNƒ‚–Œ‰şoŒŒ‹}ŤŠú‚É‚¨‚Ż‚鍶Žş•Ç‰^“ŽˆŮí‚̐Źˆö‚ĆŒoŽž“I•Ď‰ť‚ĚŒŸ“˘. ’r“c‘׎qi“ŕjC‘“c‘ěC–kŒ´F—YC•‘ň—˜˜YC‘ĺ“c„•äCâŒű“NÍCŽá—Ń–ő‹vC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć20‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď‘‰ď i93.06.08`11j, ŽD–y.

3571. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŹŽ™”xÁ15—á‚Ě‰ć‘œf’f. ŠÖŞ“OC’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽŔC–Ľ‰YŽ‘ĽC’ˇ“cŒúCŽl‘qł”ŽCŒ´^liŽ™jC–x’rdŽĄi•újC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć20‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď‘‰ď i93.06.09`11j, ŽD–y.

3572. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹ô”­Ť’á‘̉ˇ‚đ•š”­‚ľ‚˝¸_•Ş—ô•aŠłŽŇ‚É‚¨‚Ż‚éSzŠÂ“Ž‘Ô‚ĚŒŸ“˘. ăžŠ‹glC‘“c‘ěC’ç–M•FC•‘ň—˜˜YC•Đ‰Ş—SˆęC‘Š”nˆęˆĺCŹŒű“OC‘ĺ˜a“c—˛i‹~–˝j: ‘ć20‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď‘‰ď i93.06.09`11j, ŽD–y.

3573. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‚­‚ŕ–Œ‰şoŒŒ‚É‚¨‚Ż‚é‹}Ž€‚Ě•a‘Ô‚Ć‹@˜‚ÉŠÖ‚ˇ‚錟“˘. –kŒ´F—YC‘“c‘ěC‘Š”nˆęˆĺCó—˜–őC‘ĺ˜a“c—˛i‹~–˝j: ‘ć20‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď‘‰ď i93.06.09j, ŽD–y, ICU‚ĆCCU, (—Ő‘17): 164, 1993.

3574. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒŠƒsƒIƒh[ƒ‹ƒEƒ‹ƒgƒ‰ƒtƒ‹ƒCƒh‚É‚ć‚é’†“ĹÇ—á‚ĚŒŸ“˘. ó—˜–őCăžŠ‹glC•Đ‰Ş—SˆęC’ç–M•FCŽá—Ń–ő‹vC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝jC‹ß“Ą—Ż”üŽqi–ňÜj: ‘ć15‰ń“ú–{’†“ĹŠw‰ď i93.07.09j, ‰F“s‹{.

3575. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“’†“łɑ΂ˇ‚éƒtƒ‹ƒ}ƒ[ƒj[ƒ‹‘ĺ—ĘĽŠÔŒ‡“Š—^‚ĚŽĄ—ĂŒř‰Ę‚ĚŒŸ“˘. ăžŠ‹glC•Đ‰Ş—Sˆęi‹~–˝jC‹ß“Ą—Ż”üŽqi–ňÜjC’ç–M•FCŽá—Ń–ő‹vC‘“c‘ěC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć15‰ń“ú–{’†“ĹŠw‰ď i93.07.09`10j, ‰F“s‹{, ´˜^W, p.28, 1993.

3576. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŽlŽˆŒŒŠÇ‘š‚ɑ΂ˇ‚étemporary shunt tubeiƒAƒ“ƒXƒƒ“ƒ`ƒ…[ƒuj‚ĚŽg—pŒoŒą. V“Ął‹PC™–{Ÿ•FC‘ĺ˜a“c—˛i‹~–˝jC‰ĄŽRˆę•FCŽ…–žˇŒ›iŽŠOj: ‘ć19‰ń“ú–{œÜŽĄ—ĂŠw‰ď i93.07.10j, “Œ‹ž, ´˜^W, p.92, 1993.

3577. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”]ŒŒŠÇšk—\–h‚ɑ΂ˇ‚éUrokinaseŽ‘ą”]‘…ŠÁ—Ź—Ă–@‚ĚŒŸ“˘. –kŒ´F—Yi‹~–˝jCí”Ő‰Ăˆęi”]ŠOjC‘ĺ˜a“c—˛i‹~–˝jC‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOj: ‘ć52‰ń“ú–{”]_ŒoŠO‰ČŠw‰ď‘‰ď i93.09.20j, “Œ‹ž, ´˜^W, p.118, 1993.

3578. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ž{Ý“ŕƒR[ƒfƒBƒl[ƒ^[‚Ě—§ę‚Š‚ç|‚ť‚Ě—L—pŤ‚ĆÝ‚č•ű|. –ě‘ş’mŽqC‘ĺ˜a“c—˛i‹~–˝j: ‘ć35‰ń“ú–{•a‰@Šw‰ď i93.10.29j, “Œ‹ž.

3579. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹CŠÇŽxšb‘§”­ěŒ€ÇŒ^‚É‚ć‚éS”x’âŽ~—á‚Ě—Ő°“IŒŸ“˘. •Đ‰Ş—SˆęCăžŠ‹glCŽR–{aˆę˜YCó—˜–őC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć21‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ď i93.11.17`19j, L“‡.

3580. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“’†“łɑ΂ˇ‚éƒtƒ‹ƒ}ƒ[ƒj[ƒ‹‘ĺ—ĘĽŠÔŒ‡“Š—^‚ĚŽĄ—ĂŒř‰Ę‚ĚŒŸ“˘. ăžŠ‹glC’ç–M•FC•Đ‰Ş—SˆęCŽR–{aˆę˜YCŽá—Ń–ő‹vC‘“c‘ěC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝jCźě—˛i—Ő•a—jC‹ß“Ą—Ż”üŽqi–ňÜj: ‘ć21‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ď i93.11.17`19j, L“‡, “ú–{‹~‹}ˆăŠw‰ďŽGŽ, 4(5): 467, 1933.

3581. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “Ý“IŽlŽˆ“Ž–Ź‘š‚ĚŒŸ“˘. V“Ął‹PC™–{Ÿ•FC‘Š”nˆęˆĺC‰FˆäŒŞ“ńCŽá—Ń–ő‹vC‘ĺ˜a“c—˛i‹~–˝jC‰ĄŽRˆę•FCŽ…–žˇŒ›iŽŠOj: ‘ć21‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ď i93.11.19j, L“‡, “ú–{‹~‹}ˆăŠw‰ďŽGŽ, 4(5): 566, 1933.

3582. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j dÇŠłŽŇ‚Ě‹}ŤŠú‚É‚¨‚Ż‚éƒOƒ‹ƒ^ƒ~ƒ“ŒoŠÇ“Š—^‚Ě—L—pŤ‚ÉŠÖ‚ˇ‚錤‹†. •Đ‰Ş—SˆęCăžŠ‹glCó—˜–őC•‘ň—˜˜YC‘“c‘ěC™–{Ÿ•FC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć21‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď‘‰ď i94.02.24j, –źŒĂ‰Ž.

3583. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j —L‹@ƒŠƒ“’†“Ĺ‚É‚ć‚éS‹ŘáŠQ. “ĄŔ–M•Fi“ŕjC‘“c‘ěC’ç–M•FCăđ‹glCŽR–{aˆę˜YC•Đ‰Ş—SˆęCÂ–Ř‘Ľ–žCź‰ş–ΐlCĄˆäŠ°C•‘ň—˜˜YC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć21‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ď‘‰ď i94.02.24j, –źŒĂ‰Ž.

3584. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹}ŤŠú”]“Ž–ŹáŽÄ”j—ô‚ÉŠÖ‚ˇ‚錟“˘. –kŒ´F—YCí”Ő‰ĂˆęC‘ĺ“ä’mC‘ĺ˜a“c—˛i‹~–˝jC‹{â‰Ŕ’jC–î“cŒŤŽOi”]ŠOj: ‘ć19‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď i94.03.10j, ‹ž“s.

3585. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j S‹ŘƒGƒlƒ‹ƒM[‘ăŽÓ‚ƐS‹@”\‚ɑ΂ˇ‚éƒoƒiƒWƒEƒ€Œř‰Ę. ‘“c‘ěCŽR–{aˆę˜YC‚‹´ŠîC”’J‹`Gi‹~–˝jC˛“Ą´‹MC’r“c‘׎qC“y‰Ž’ź—˛i“ŕj: ‘ć58‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď i94.03.28`30j, “Œ‹ž, Jpn. Circ. J., 58(Suppl.1): 346, 1994.

3586. mŠw‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ”xŒŒđÇđÇ‚Ş‹^‚í‚ę‚˝–h…ƒXƒvƒŒ[’†“Ĺ‚Ě‚P—á. Â–Ř‘Ľ–žCĄˆäŠ°C•‘ň—˜˜YC’ç–M•FC‘“c‘ěC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć2‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i93.12.11j, ‘ĺ‹{.

3587. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Œo‰ß’†‚É‹}Ťt•s‘S‚đ•š”­‚ľ‚˝‚`Œ^‹}ŤŠĚ‰Š‚Ě‚Q—á. ’|“ŕN—YCâŒű“NÍCŽá—Ń–ő‹vC–kˆä‘Ľ•vi“ŕjC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć34‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ď i93.06.26j, “Œ‹ž, KJJAA, 14(1): 268`269, 1993.

3588. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j S”x‘hśŒă‚É”­Ç‚ľ‚˝ƒVƒ…ƒƒ‹ƒcƒ}ƒ“Œ^Œ€ÇŠĚ•s‘S‚Ě‚P—á. ŽR–{aˆę˜YC’ç–M•FC”’čŒh“ńC‹ß“Ąˆę‰pC•Đ‰Ş—SˆęCÂ–Ř‘Ľ–žCăžŠ‹glCĄˆäŠ°C‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć2‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď i93.12.11j, ‘ĺ‹{.

3589. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‹Ů‹}ŠJ‹šŽčp‚đ‚悤‚ľ‚˝‹|•”‰đ—ŁŤ‘ĺ“Ž–ŹáŽ”j—ô‚Ě‚P‹~–˝—á. ŽR–{aˆę˜YCźŒűŽ•FCĄˆäŠ°C•Đ‰Ş—SˆęCăžŠ‹glCÂ–Ř‘Ľ–žC‘꓇í‰ëC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć36‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ď i94.02.05j, “Œ‹ž.

3590. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j “M…‚ɑ΂ľPCPS‚đŽg—p‚ľ‚˝1‹~–˝—á. ăžŠ‹glCĄˆäŠ°C‘“c‘ěC•Đ‰Ş—SˆęC•‘ň—˜˜YC™–{Ÿ•FC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć36‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ď i94.02.05j, “Œ‹ž.

3591. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Ž‰–bÇđÇŒóŒQ‚ĚMRIŠŒŠ. HŽR‹vŽC–kˆä‘Ľ•vi“ŕjCV“Ął‹PC‰ĄŽRˆę•FCb”ăGŽŔC–x’rdŽĄCó—˜–őC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć36‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ď i94.02.05j, “Œ‹ž.

3592. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŠJ•úŤœ”ՍœÜ‚ĚŽĄ—Ïă‚Ě–â‘č“_. V“Ął‹PC™–{Ÿ•FC–x’rdŽĄC‘ĺ˜a“c—˛i‹~–˝jC‰ĄŽRˆę•FCŽ…–žˇŒ›iŽŠOj: ‘ć7‰ń“ú–{ŠOŒ¤‹†‰ď i93.05.21j, ‰Ť“ę, “ú–{ŠOŒ¤‹†‰ďŽ, 7(2): 128, 1993.

3593. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ”ńú’ʐŤ‹š•”ŠO‚É‚ć‚銼“Ž–Ź‘š‚ĚŽĄ–ü‰ß’ö‚đŠm”F‚ľ“ž‚˝1—á. HŽR‹vŽC‘“c‘ěC•‘ň—˜˜YC–kˆä‘Ľ•vCŽá—Ń–ő‹vCâŒű“NÍC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć7‰ń“ú–{ŠOŒ¤‹†‰ď i93.05.21j, ‰Ť“ę.

3594. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ŠOŤŹ’°‘š‚ĚCTŠŒŠ‚ĚŒŸ“˘. ó—˜–őC–x’rdŽĄC™–{Ÿ•FC‘꓇í‰ëC•˝“cŒő”ŽC‘Oě˜a•FC‘ĺ˜a“c—˛i‹~–˝j: ‘ć7‰ń“ú–{ŠOŒ¤‹†‰ď i93.05.21j, ‰Ť“ę, “ú–{ŠOŒ¤‹†‰ďŽ, 7(2): 175, 1993.

3595. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‚­‚ŕ–Œ‰şoŒŒ‚É‚¨‚Ż‚é‹}Ž€‚Ě•a‘Ô‚Ć‹@˜‚ÉŠÖ‚ˇ‚錟“˘. –kŒ´F—YC‘“c‘ěC‘Š”nˆęˆĺCí”Ő‰ĂˆęC‘ĺ˜a“c—˛i‹~–˝j: ‘ć6‰ń”]Ž€”]‘hśŒ¤‹†‰ď i93.06.12j, ‰F•”.

3596. mŒ¤‹†‰ďi’n•űjn i‹łˆçu‰‰j ‘ŸŠíˆÚA|‹~‹}ˆă—Ă‚Ě—§ę‚Š‚ç. ‘ĺ˜a“c—˛i‹~–˝j: ‘ć5‰ń_“ސěˆÚAŒ¤‹†‰ď i93.06.19j, ‰Ą•l.

3597. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‹ô”­Ť’á‘̉ˇÇ‚đ•š”­‚ľ‚˝¸__ŒoŽžŠł‚̐SzŠÂ“Ž‘Ô‚ĚŒŸ“˘. ăžŠ‹glC‘“c‘ěC’ç–M•FCŽR–{aˆę˜YC•Đ‰Ş—SˆęCÂ–Ř‘Ľ–žCź‰ş–ΐlC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć9‰ń_“ސě‹}ŤzŠÂ•s‘SŒ¤‹†‰ď i94.01.27j, ‰Ą•l.

3598. mŒ¤‹†‰ďi’n•űjn iˆę”ʍu‰‰j ‹~‹}ˆă—Ă‚ĆŒŒ‰tň‰ť. Žá—Ń–ő‹vi“ŕj: ‘ŠB“§Í‹ZŽt§˜b‰ď i94.03.20j, ‘Š–ÍŒ´.


<<29 7 ‹~–˝‹~‹}ˆăŠw>>

3599. mŠw‰ďŽĺĂi‘“ŕŠw‰ďjn ‘ć‚S‰ń“ú–{‹~‹}ˆăŠw‰ďŽw“ąˆăƒZƒ~ƒi[i93.08.25`27, ě“ށj, ‘ĺ˜a“c—˛i‹~–˝j.

3600. mŠw‰ďŽĺĂi‚ť‚Ě‘źjn ‘ć‚S‰ń_Œo‹~‹}Œ¤‹†‰ďi93.11.06, “Œ‹žj, ‘ĺ˜a“c—˛i‹~–˝j.

3601. mŠw‰ďŽĺĂi‚ť‚Ě‘źjn ‘ć‚R‰ń_Œo‹~‹}Œ¤‹†‰ď, ‘ĺ˜a“c—˛i‹~–˝j.


<<30 ś‘̍HŠw>>

3602. mŒ´’˜n A cultured skin substitute composed of fibroblasts and keratinocytes with a collagen matrix; Preliminary results of clinical trials. •–ö”\Œőiś‘̍HjCçݎ˝CÎŒ´GˆęC•“cŒ[C”’Îť•FC‘ĺ’|Ž”VC“ŕŔ‰hŽ÷C’šŽ”ŸsC‰–’JMKiŽŠOj: Ann. Plast. Surg., 31: 340`349, 1993.

3603. mŒ´’˜n The use of robotics technology to study human joint kinematics; A new methodology. “Ą]—T“šC”nŸş´Ž‘iś‘̍HjCWoo, S.L-YCLivesay, G.A.iƒsƒbƒcƒo[ƒO‘ĺjCrˆäLŽĄiŽO•H“d‹CjC’Ë–{s’jiŽŠOj: J. Biomech. Eng., 115: 211`217, 1993.

3604. mŒ´’˜n •Ď“Ž‚ˇ‚é‘Ź“xŒů”z‰ş‚É‚¨‚Ż‚錌đŒ`Ź. ‹´–{ŹLiś‘̍HjCů“c’źiç—tH‘ĺj: ś‘ĚŢ—ż, 11(6): 348`353, 1993.

3605. mŒ´’˜n ‚š‚ń’f—Ź’†‚É‚¨‚Ż‚éÔŒŒ‹…‚Ě•ĎŒ`i•˝s‰~”ÂŒ^ƒŒƒIƒXƒR[ƒv‚É‚ć‚é•ĎŒ`Žw”•]‰żj. ‹´–{ŹLiś‘̍HjC•D“cLŽĄi•xŽmƒtƒBƒ‹ƒ€jCů“c’źiç—tH‘ĺj: “ú–{‹@ŠBŠw‰ď˜_•śWA•Ň, 59(567): 2795`2799, 1993.

3606. mŒ´’˜n ˆę—l‚š‚ń’fę‚É‚¨‚Ż‚錌đŒ`Źi‰š“ʉ~Œ^ŽŽŒą‹@‚đ—p‚˘‚˝ŒŒđŒ`Ź“x•]‰żj. ‹´–{ŹLiś‘̍HjCů“c’źiç—tH‘ĺj: “ú–{‹@ŠBŠw‰ď˜_•śWB•Ň, 59(568): 3739`3742, 1993.

3607. mŒ´’˜n ‹C‘Ěˆł‹ě“Ž–ÍŒ^lHS”x‚ĚŠJ”­. ‹´–{ŹLiś‘̍HjC•y‰i˝ˆęi‹šŠOjC‹g“cŽŔC˛X–؍N‡iNOKj: “ú–{‹@ŠBŠw‰ď˜_•śWB•Ň, 60(570): 491`495, 1994.

3608. mŒ´’˜n ƒAƒeƒƒRƒ‰[ƒQƒ“ƒXƒ|ƒ“ƒW‚đ—p‚˘‚˝äNă÷ÄŒšp‚ĚŽŔŒą“IŒŸ“˘. “›ˆäŽőŠîC•“cł”ViVŠƒ‘ĺjC•–ö”\Œőiś‘̍HjC…‘ň—˛Ž÷C•ÄŽRŒ’ŽuC‚‹´“™C•ĐŽR–őŽmCŹŒ´Œ’ŽiCÄ“Ą˜a‰pC˛“Ąş‘ž˜YiVŠƒ‘ĺj: “ú–{”ĺ”AŠí‰ČŠw‰ďŽGŽ, 84: 1465`1469, 1993.

3609. mŒ´’˜n ‘O•űˆř‚Ťo‚ľ—Í•‰‰×Žž‚Ě•G“î‘gD“ŕ’Ł—́|‘ĺ‚Ť‚ł, •űŒü, ˆĘ’u‚Ě‘Ş’č|. “Ą]—T“šiś‘̍HjCLivesay, G.A.C”ŒűV“ńCWoo, S.L-Y.iƒsƒbƒcƒo[ƒO‘ĺj: “ú–{—Տ°ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ď, 14: 115`118, 1992.

3610. mŒ´’˜n ƒƒ{ƒeƒBƒNƒX‚É‚ć‚é•G‚UŽŠ—R“x‚ĚƒnƒCƒuƒŠƒbƒh§Œä|‚ć‚萜—“I‚ČđŒ‰ş‚Ĺ‚Ěin-vitro“Ž—hŤŽŽŒą‚đ‚ß‚´‚ľ‚ā|. “Ą]—T“šC”nŸş´Ž‘iś‘̍HjC’Ë–{s’jiŽŠOjCů“c’źiç—tH‘ĺj: “ú–{—Տ°ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ď, 14: 119`122, 1992.

3611. mŒ´’˜n ŠÖßŠŠ‚É‚¨‚Ż‚éƒqƒAƒ‹ƒƒ“Ž_‚Ě–đŠ„. ”nŸş´Ž‘C“Ą]—T“šCX“c^Žjiś‘̍HjC’Ë–{s’jiŽŠOjCŹŒ´Œ’’jCŽRŒű•q“ń˜YiŽ‘ś“°j: “ú–{—Տ°ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ď, 14: 233`236, 1992.


<<30 2 ś‘̍HŠw>>

3612. m‘ŕn •Ą‡”|—{”畆‚̍쐻‚ĆˆÚA. •–ö”\Œőiś‘̍Hj: Biomed. Perspect., 2: 67`71, 1993.

3613. m‘ŕn œ‘e頏ǂɔş‚¤‘ĺ‘ڍœŒz•”œÜ‚đ—\–h‚ˇ‚é‚˝‚߂̐f’fƒVƒXƒeƒ€‚ĚŠJ”­. X“c^Žjiś‘̍Hj: ƒCƒ“ƒi[ƒrƒWƒ‡ƒ“, 8Ľ7: 9`10, 1993.

3614. m‘ŕn ×–E”|—{‹Zp‚đ—˜—p‚ľ‚˝lH”畆. •–ö”\Œőiś‘̍Hj: ƒPƒ~ƒJƒ‹ƒGƒ“ƒWƒjƒAƒŠƒ“ƒO, 38: 38`43, 1993.

3615. m‘ŕn ŠÖß“•”ƒ‚ƒfƒ‹‰ť‚Ě‚˝‚߂̐ś‘̒萔. X“c^Žjiś‘̍Hj: ƒoƒCƒIƒƒJƒjƒYƒ€Šw‰ďŽ, 17(4): 209`215, 1993.

3616. m‘ŕn ˆă—Ă‚Ě–˘—ˆ‚đ‘ń‚­lH‘ŸŠí: lH”畆. •–ö”\Œőiś‘̍Hj: ŠĹŒě‹Zp, 40(6): 80`84, 1994.

3617. m‘ŕn ”|—{ƒqƒg”畆ƒ‚ƒfƒ‹. •–ö”\Œőiś‘̍Hj: ‘gD”|—{, 19: 211`214, 1993.

3618. m‘ŕn ”|—{×–E‚Ě‘ŸŠíƒ‚ƒfƒ‹. •–ö”\Œőiś‘̍Hj: ‘gD”|—{, 19: 471`472, 1993.

3619. m‘ŕn “Ž•¨ŠÖß‚ĚŽg–˝. ”nŸş´Ž‘iś‘̍Hj: “ú–{ŠíŠBŠw‰ďŽ, 97(902): 19`23, 1994.

3620. m‘ŕn ‘Ě‚Ě•\–Ę‚Ĺ–˝‚đŽç‚é”畆. •–ö”\Œőiś‘̍Hj: •\–Ę, 31: 661`671, 1993.

3621. muŔn œ‚ĆŠÖß‚Ě˜bi‚QjŠÖß‚Ě‚ľ‚­‚Ý. ”nŸş´Ž‘iś‘̍Hj: Clinical Engineering, 4(10): 759`764, 1993.

3622. muŔn œ‚ĆŠÖß‚Ě˜bi‚Rjg‘̂̉^“ŽŠw. ”nŸş´Ž‘iś‘̍Hj: Clinical Engineering, 4(11): 839`843, 1993.

3623. muŔn œ‚ĆŠÖß‚Ě˜bi‚Pjœ‚͍œ‘g. ”nŸş´Ž‘iś‘̍Hj: Clinical Engineering, 4(9): 674`679, 1993.

3624. muŔn ‹°—ł‚Ě—ÍŠw(‡U)‘ĺŒ^—¤ă“Ž•¨‚ĚŒŒ‰tzŠÂŒn‚ĚƒoƒCƒIƒƒJƒjƒNƒX. ‹´–{ŹLiś‘̍Hj: ƒƒJƒ‰ƒCƒt, (35): 10`11, 1994.

3625. muŔn ƒ`ƒ^ƒ“‡‹ŕ‚Ćƒ|ƒŠƒGƒ`ƒŒƒ“‚Ě–€–Ő. X“c^Žjiś‘̍Hj: ƒƒrƒI, 10(5): 5, 1993.

3626. muŔn ƒRƒoƒ‹ƒg‡‹ŕ‚Ě‘Ě“ŕ•…H‚ƓŐŤ. X“c^Žjiś‘̍Hj: ƒƒrƒI, 11(5): 3, 1994.

3627. muŔn –Œ‚͐ś‚Ť‚Ä‚˘‚é: ”畆‚̍Đś. •–ö”\Œőiś‘̍Hj: ˆę‰­l‚̉ťŠw, 17: 117`130, 1993.


<<30 3 ś‘̍HŠw>>

3628. m‚ť‚Ě‘ź‚Ě’˜‘iŠTŕ‘jn i•Ş’SŽˇ•Mj lH‘ŸŠí1993; ×–E‘gž‚ÝŒ^lH”畆, p.234`241, •–ö”\Œőiś‘̍Hj. •ŇW ˆ˘ŠÝ“SŽOi“Œ—ˆă‘ĺjC ’†ŽR‘“X, “Œ‹ž, 93.05.31”­s.

3629. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn i•Ş’SŽˇ•Mj ‚¨‚ŕ‚ľ‚낢‘@ˆŰ‚Ě‚Í‚Č‚ľ; ŠO‰ČŽčp‚Ć‘@ˆŰ, p.152`154, •–ö”\Œőiś‘̍Hj. •ŇW ‘@ˆŰŠw‰ďC “úŠ§H‹ĆV•ˇŽĐ, 93.07.05”­s.


<<30 5 ś‘̍HŠw>>

3630. mŠw‰ďi‘Űjn i‹łˆçu‰‰j The concept of incorporating drug delivery system into wound dressings. •–ö”\Œőiś‘̍Hj: International Symposium on Advances in Wound Healing and Wound Management i94.02.25j, Maui.

3631. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Cultured skin substitute composed of fibroblasts and keratinocytes within a collagen matrix. •–ö”\Œőiś‘̍Hj: ‹{čŠî‹ŕś‘Ě‘@ˆŰ‘ŰƒVƒ“ƒ|ƒWƒEƒ€ i93.06.00j, “Œ‹ž, —\eW, p.73`76, 1993.

3632. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€j Six-DOF forces and moments at the human knee joint; A mathematical description with respect to a non-orthogonal coordinate system. “Ą]—T“šiś‘̍HjCLivesay, Glen, A.iƒsƒbƒcƒo[ƒO‘ĺjC’Ë–{s’jiŽŠOjCWoo, Savio L-Y.CBromstrom Gailiƒsƒbƒcƒo[ƒO‘ĺjC”nŸş´Ž‘iś‘̍HjC“Ą“cłOiŽO•H“d‹CjCů“c’źiç—tH‘ĺj: 2nd International Symposium on Three-Dimensional Analysis of Human Movement i93.06.30`07.03j, ƒ|ƒAƒ`ƒGiƒtƒ‰ƒ“ƒXj, Proceedings, p.39`42, 1993.

3633. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Behavior of the human knee joint in 6DOF: Application of robotics system for the study of joint mechanics. “Ą]—T“šC”nŸş´Ž‘iś‘̍HjC’Ë–{s’jiŽŠOjCG.A. Livesayiƒsƒbƒcƒo[ƒO‘ĺjCů“c’źiç—tH‘ĺj: 2nd World Congress of Biomechanics i93.07.04`08j, ƒpƒŠ.

3634. mŠw‰ďi‘Űjn iˆę”ʍu‰‰j Cytotoxicity test on antibacterial drug using cultured skin substitute as wound surface model. •–ö”\Œőiś‘̍HjC”’Îť•FC‰–’JMKiŒ`ŠOj: Joint Meeting the Wound Healing Society and European Tissue Repair Society i93.08.00j, Amsterdam, —\eW, p.40, 1993.

3635. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Development of silver sulfadiazine-impregnated wound dressing domposed of polyurethane membrane and water absorbent fabric. •–ö”\Œőiś‘̍HjC’†‘şŒłMC‰–’JMKiŒ`ŠOj: Joint Meeting the Wound Healing Society and European Tissue Repair Society i93.08.00j, Amsterdam, —\eW, p.59, 1993.

3636. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Passivation film formation on the bearing surface in joint prosthesis. X“c^Žjiś‘̍HjC’†‘şL”VC’Ë–{s’jiŽŠOjCů“c’źiç—tH‘ĺj: 7th Int. Conf. Surface Modification Technology i93.10.31`11.04j, VŠƒ, —\eW, p.103, 1993.

3637. mŠw‰ďi‘S‘jn i“Á•Ęu‰‰j ×–E”|—{‹Zp‚đ—˜—p‚ľ‚˝lH”畆. •–ö”\Œőiś‘̍Hj: ‰ťŠwHŠw‰ďƒƒfƒBƒJƒ‹ƒeƒNƒmƒƒW[ę–ĺˆĎˆő‰ď“Á•Ęu‰‰‰ď i93.09.00j, “Œ‹ž, —\eW, p.1`45.

3638. mŠw‰ďi‘S‘jn i‹łˆçu‰‰j ŽŸ˘‘ă‚Ě‘n”핢Ţ: R‹ŰÜ™•ú‰ťƒVƒXƒeƒ€‚̔핢Ţ‚Ö‚Ě“ą“ü. •–ö”\Œőiś‘̍Hj: ‘ć18‰ń“ú–{ŠO‰ČŒn˜A‡Šw‰ď i93.06.25j, ‘ĺ‹{.

3639. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ”M‚É‚¨‚Ż‚鑍‡“IŠ´ő‘΍ô: ‘n”핢Ţ‚Ě–Ę‚Š‚ç. •–ö”\Œőiś‘̍Hj: ‘ć19‰ń“ú–{”MŠw‰ď i93.05.28j, ‘q•~, —\eW, p.40, 1993.

3640. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j —ÍŠo§Œäƒ}ƒjƒsƒ…ƒŒ[ƒ^[‚É‚ć‚éŠÖß•\–Ę‚Ě”FŽŻ‚Ć–€ŽC‘Ş’č. “Ą]—T“šC”nŸş´Ž‘iś‘̍HjC’Ë–{s’jCŽ…–žˇŒ›iŽŠOjCŽí‰Ş‰p–žC’ˇ’JěŒ’‰îi‰Ą•l‘ĺj: ‘ć5‰ńƒoƒCƒIƒGƒ“ƒWƒjƒAƒŠƒ“ƒOŠwpu‰‰‰ď i93.07.23`24j, ž–ě, ƒoƒCƒIƒGƒ“ƒWƒjƒAƒŠƒ“ƒOŠwpu‰‰˜_•śW, p.1`3, 1993.

3641. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •Ą‡”|—{”畆‚̍쐻‚ĆˆÚAŽŽŒą•]‰ż. •–ö”\Œőiś‘̍HjC”’Îť•FC”’čËWC•“cŒ[CŽR‰ş—ŠGC‰–’JMKiŒ`ŠOj: ‘ć42‰ń‚•ŞŽq“˘˜_‰ď i93.09.00j, “Œ‹ž.

3642. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ś‘ĚŢ—ż‚Ě–€–ՓŐŤ|ŽüˆÍ‰t’†—n‘śŽ_‘f‚̉e‹ż. ů“c’źiç—tH‘ĺjCX“c^Žjiś‘̍HjCź‘ň“N˜Yi“Œ”R‰ťŠwj: ‘ć37‰ńŢ—żŒ¤‹†˜A‡u‰‰‰ď i93.09.16`17j, ‹ž“s, —\eW, p.215`216, 1993.

3643. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •G‚UŽŠ—R“x‹@\ƒ‚ƒfƒ‹‚ɑ΂ˇ‚é—Í, ƒ‚[ƒƒ“ƒg‚̐”Šw“I‹Lq. “Ą]—T“šC”nŸş´Ž‘iś‘̍HjCů“c’źiç—tH‘ĺj: ‘ć71‰ń“ú–{ŠíŠBŠw‰ď‘S‘‘ĺ‰ď i93.10.02`04j, L“‡, u‰‰˜_•śW, No.930`963(Vol.A): 318`320, 1993.

3644. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒAƒm[ƒh•Ş‹É–@‚É‚ć‚éŠeŽí‘“ŕ“B‚̑ϐHŤ•]‰ż. X“c^Žjiś‘̍HjC’†‘şL”VCŽ…–žˇŒ›CŹ—Ń–žłiŽŠOjCů“c’źiç—tH‘ĺj: ‘ć8‰ń“ú–{ŽŒ`ŠO‰ČŠî‘bŠwpW‰ď i93.10.07j, ź–{, “ú–{ŽŒ`ŠO‰ČŠw‰ďŽ, 67(8): 1437, 1993.

3645. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘ź‰Ć•Ą‡”|—{”畆‚̍쐻‚Ć—Ő°•]‰ż. •–ö”\Œőiś‘̍HjC”’Îť•FC”’čËWC•“cŒ[CŽR‰ş—ŠGC‰–’JMKiŒ`ŠOj: ‘ć15‰ń“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ď i93.10.25j, _ŒË, —\eW, p.126, 1993.

3646. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j •GŠÖß‚Ě‚UŽŠ—R“x‚ɐś‚ś‚é—Í‚Ćƒ‚[ƒƒ“ƒg‚ĚŒv‘Ş. “Ą]—T“šC”nŸş´Ž‘iś‘̍HjC’Ë–{s’jiŽŠOjCLivesay, G. A.iƒsƒbƒcƒo[ƒO‘ĺjCWoo, S. L-Y.iƒsƒbƒcƒo[ƒO‘ĺj: ‘ć20‰ń“ú–{—Տ°ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ď i93.11.05`06j, ‹ž“s, ´˜^W, p.125, 1993.

3647. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŠC–ȍœ‚̍œ—Ŕ‘̐ϖ§“x‚ĚŒoŽž“I•Ď‰ť‚ɂ‚˘‚Ä. X“c^Žjiś‘̍HjC“ě‘ňˆç—YC傌´—L’jiŽŠOjCů“c’źiç—tH‘ĺj: ‘ć43‰ń‰ž—p—ÍŠw˜A‡u‰‰‰ď i94.01.25`27j, “Œ‹ž, —\eW, p.611, 1993.

3648. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘O\Žšx‘Ń‚¨‚ć‚ŃŒă\Žšx‘Ń‚Ě‚RŽŸŒłŒ`‘Ô”äŠr. ”ŒűV“ńi“ż“‡‘ĺjCLivesay, Glen, A.iƒsƒbƒcƒo[ƒO‘ĺjC“Ą]—T“šiś‘̍HjCChoi, Nam, Y.CHamer, C.D.CFU, F.H.CWoo, S.L-Y.iƒsƒbƒcƒo[ƒO‘ĺj: ‘ć19‰ń“ú–{ŽŒ`ŠO‰ČƒXƒ|[ƒcˆăŠw‰ďŠwpW‰ď i93.07.22`23j, ‹{č, “ú–{ŽŒ`ŠO‰ČƒXƒ|[ƒcˆăŠw‰ďŽGŽ, 13(2): 220, 1993.

3649. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠÖß‚̏ŠŠ‹@”\‚É‹y‚Ú‚ˇƒqƒAƒ‹ƒƒ“Ž_“Š—^‚ĚŒř‰Ę. ”nŸş´Ž‘C“Ą]—T“šiś‘̍HjCŽRŒű•q“ń˜YCŹŒ´Œ’’jiŽ‘ś“°j: ‘ć7‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď i93.10.07j, ź–{, “ú–{ŽŒ`ŠO‰ČŠw‰ďŽGŽ, 67(8): 1440, 1993.

3650. mŠw‰ďi‘S‘jn iŒöŠJuŔj ƒnƒCƒuƒŠƒbƒhlH‘ŸŠí: ”|—{”畆‚ĚŒťó‚ƏŤ—ˆŤ. •–ö”\Œőiś‘̍Hj: ‘ć39‰ńˆă—p‚•ŞŽqŒ¤‹†‰ď i93.12.00j, “Œ‹ž.

3651. mŒ¤‹†‰ďi‘S‘jn ih‘č•ńj —nŒŒĽŒŒđ‚Ć—Ź‚ę‚ĚŠÖŒW. ‹´–{ŹLiś‘̍Hj: ‘ć17‰ń“ú–{‹@ŠBŠw‰ďƒoƒCƒIƒGƒ“ƒWƒjƒAƒŠƒ“ƒO•”–吜‘Ě‚É‚¨‚Ż‚é—Ź‘Ě–â‘čŒ¤‹†‰ď i93.11.24j, ’}”g.

3652. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j Šm—Ś˜_“I FEM ƒ‚ƒfƒ‹‚É‚ć‚鍜‚Ě”j‰ó“`”d‹@\‚̉𖞂Ƒĺ‘ڍœŒz•”œÜ”­ś‹@˜‚ĚŒŸ“˘. X“c^Žjiś‘̍Hj: •ś•”Č‰ČŒ¤”ďd“_—ĚˆćƒoƒCƒIƒƒJƒjƒNƒX”ljď‹c i93.07.16j, ‘ĺă.

3653. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j lHŠÖß “Ž–Ę‚Š‚ç‚Ě‹ŕ‘Ž—no‚É‹y‚Ú‚ˇ•…HŠÂ‹Ť’†‚Ě pH ‚̉e‹ż. X“c^Žjiś‘̍HjC’†‘şL”VCŽR“c—F‹viŽŠOjCˆäă—tŽqi—\–hˆăŠwŒnjC”nŸş´Ž‘iś‘̍HjC’Ë–{s’jiŽŠOjCů“c’źiç—tH‘ĺj: ‘ć14‰ńƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ i94.03.12j, ‘ĺă, —\eW, p.14, 1993.

3654. mŒ¤‹†‰ďi‘S‘jn iŒöŠJuŔj R‹ŰÜŠÜ—L‘n”핢Ţ‚Ć”|—{”畆‚ĚŠJ”­í—Ş. •–ö”\Œőiś‘̍Hj: ‘ć38‰ńˆă—p‚•ŞŽqŒ¤‹†‰ď i93.10.00j, “Œ‹ž.


<<30 7 ś‘̍HŠw>>

3655. mŠwpÜi‘“ŕÜjn ŁŒűÜi“ú–{‹@‰ďŠw‰ďƒoƒCƒIƒƒJƒjƒNƒX•”–ĺ‚ć‚č, Šw–â“I‰ż’l‚̍‚‚˘Œ¤‹†‚đs‚Č‚Á‚˝Œ¤‹†ŽŇ‚ɑ΂ˇ‚鏧—ăÜj, “Ą]—T“šiś‘̍Hj.

3656. m“Á‹–ĽˆÓ “o˜^n ‘n”핢Ţi“ÁŒö•˝6-6153, 94.01.26j, •–ö”\Œőiś‘̍HjC‰–’JMKiŒ`ŠOj.

3657. mŠw‰ďŽĺĂi‘“ŕŠw‰ďjn “ú–{‹@ŠBŠw‰ď‘ć5‰ńƒoƒCƒIƒGƒ“ƒWƒjƒAƒŠƒ“ƒOŠwpu‰‰‰ď, ”nŸş´Ž‘iś‘̍Hj.


<<31 —Տ°–ň—ŠwE–ňÜŠw>>

3658. mŒ´’˜n Pahrmacokinetics of amoxapine and its active metabolites in healthy subjects. ’|“ŕŽŽqC‰Ą“cTˆęC“‡“cŽœ•Fi“Œ–ňÜjC‘ĺ’J‹`•vCŽO‰Y’ĺ‘Ľi¸jC‹v•Ű”Žşi–ňŠw•”j: Cur. Ther. Res., 53(4): 427`434, 1993.

3659. mŒ´’˜n Surface activities, biodegradability and antimicrobial properties of N-alkyl glycosylamines. ‰Í“c˜a—Yi‰qśŠw•”jC–îŒă˜a•vi–ňÜjC‘Vş”V•i–ňŠw•”jC“ŕ–x‹BiŽR–ě”ü—eŒ|p’Z‘ĺjCShuichi MatsumuraiŒc‘ĺj: J. Antibact. Antifung. Agents, 22(2): 69`75, 1994.

3660. mŒ´’˜n –Ťt•s‘SŠłŽŇ‚É‚¨‚Ż‚éŒoŒű—pƒZƒtƒFƒ€ŒnRśÜ‚ĚŒŒŸ÷’`”’Œ‹‡‚ÉŠÖ‚ˇ‚錤‹†. •ŽR­ˆęi–ňÜjCŒF–ě˜a—Yi”ĺjC–{‹´–΁C‘şŁ¨’ĂŽqC’Š’ˇ•ś–íi–ňÜj: Jpn. J. Antibiot., 46(4): 323`330, 1993.

3661. mŒ´’˜n Elevated serum transaminase values in volunteers after administration of placebo in a phase ‡T study. Ź—Ń”ü•ci—Տ°–ň—jCŽR“cL•viŹ“cŒ´Žs—§•a‰@jCŽÄ“c‹v—Yi“ŕjCźě—˛i—Ő•a—j: Jpn. J. Clin. Pharmacol. Ther., 24(3): 493`496, 1993.

3662. mŒ´’˜n Poxatidine‚Ě‘Ě“ŕ“Ž‘Ô‚É‹y‚Ú‚ˇ§Ž_Ü‚¨‚ć‚Ńsucralfate‚̉e‹ż. •ŽR­ˆęC’Ź“c[C‘şŁ¨’ĂŽqC’Š’ˇ•ś–íi–ňÜjC‹gŽR—F“ńi–ňŠw•”jCźŒłŽ›Ž—çi“ŕj: TDMŒ¤‹†, 11(1): 61`67, 1994.

3663. mŒ´’˜n Flecainide‚ĚƒqƒgŒŒ´‹y‚Ń‘Á‰t’†”Z“x‚Ě”äŠrŒ¤‹†. ˛ěŒŤˆęC•ŽR­ˆęC’Š’ˇ•ś–íi–ňÜjC–ؐě“c—˛ˆęi“ŕjC–Ń—˜Œö‘Ľi–žŽĄ–ň‰Č‘ĺj: TDMŒ¤‹†, 11(2): 87`93, 1994.

3664. mŒ´’˜n ˜V”NŽŇ‚É‚¨‚Ż‚écephalotine, cefpiramide, ceftizoxime, latamoxef‚Ě’`”’Œ‹‡‚ÉŠÖ‚ˇ‚錤‹†. •ŽR­ˆęC–{‹´–΁C‘şŁ¨’ĂŽqC’Š’ˇ•ś–íi–ňÜj: V–ň‚Ć—Ő°, 42(8): 1604`1608, 1993.

3665. mŒ´’˜n –Ťt•s‘SŠłŽŇ‚É‚¨‚Ż‚écalcitriol‚ĚŒŒŸ÷’`”’Œ‹‡‚ÉŠÖ‚ˇ‚錤‹†. •ŽR­ˆęC’Š’ˇ•ś–íi–ňÜjCŒF–ě˜a—YCŽđˆä‹Ši”ĺjC’†ŽRKŽqC[‘ň‰p—Y: “ú–{“§Í—Ă–@Šw‰ďŽGŽ, 26(12): 1771`1775, 1993.

3666. mŒ´’˜n HemodialysisŽ{sŽž‚É‚¨‚Ż‚éƒZƒtƒFƒ€ŒnRśÜ‚Ě’`”’Œ‹‡—Ś‚ÉŠÖ‚ˇ‚錤‹†|“Á‚ɍRŒŒ‰t‹ĂŒĹÜ‚̉e‹ż|. •ŽR­ˆęi–ňÜjCŒF–ě˜a—Yi”ĺjC‘şŁ¨’ĂŽqC’Š’ˇ•ś–íi–ňÜjCŽđˆä‹Ši”ĺj: “ú–{“§Í—Ă–@Šw‰ďŽGŽ, 26(4): 525`532, 1993.

3667. mŒ´’˜n “œ”A•a‚ɑ΂ˇ‚éƒ`[ƒ€ˆă—Ă‚ĚŽŔ‘Ô’˛¸: –ňÜŽt‚É‚ć‚銳ŽŇ‹łˆç‚ĚŒŸ“˘. Œ´“cKˆę˜YC’Ź“c[CŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜj: •a‰@–ňŠw, 19(3): 222`229, 1993.

3668. mŒ´’˜n ƒƒ`ƒ‹3-0-ƒAƒ‹ƒLƒ‹ƒOƒ‹ƒRƒsƒ‰ƒmƒVƒh‚̍‡Ź‚ƍR‹ŰŤ. –îŒă˜a•vi–ňÜjC‰Í“c˜a—Yi‰qśŠw•”jC“ŕ–x‹BiŽR–ě”ü—eŒ|p’Z‘ĺjC‘Vş”V•i–ňŠw•”jC’Š’ˇ•ś–íi–ňÜj: –ňŠwŽGŽ, 113(10): 733`736, 1993.

3669. m€Œ´’˜n ƒ}ƒNƒƒ‰ƒCƒhŒnRśÜƒNƒ‰ƒŠƒXƒƒ}ƒCƒVƒ“iƒNƒ‰ƒŠƒXč÷—ąRj‚Ě”z‡•Ď‰ťŽŽŒą. ‚‹´ŒŤŹC•ŽR­ˆęC‘şŁ¨’ĂŽqCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜj: “ú–{•a‰@–ňÜŽt‰ďŽGŽ, 30(1): 87`93, 1994.

3670. mŒ¤‹†•ńn ‚ƒJƒƒŠ[—A‰t—pƒ_ƒuƒ‹ƒoƒbƒOťÜTAB‚Ě‘€ěŤ‚¨‚ć‚Ń–ł‹ŰŤ‚ÉŠÖ‚ˇ‚鎎Œą. •˝ŽR•ŽiC“‡“cŽœ•Fi“Œ–ňÜj: JJPEN, 16(1): 47`52, 1994.

3671. mŒ¤‹†•ńn —A‰tƒZƒbƒg‚É‘g‚ݍž‚Ü‚ę‚˝’č—Ę“›‚Ě”÷ś•¨‰˜ő. ÎŽËł‰pi–ňŠw•”jCŹ—ѐç—mŽqi“Œ–ňÜjC‘ž“c‹v”üŽqi–k—˘Œ¤‹†ŠjC•˝ŽR•ŽiC“‡“cŽœ•Fi“Œ–ňÜj: •a‰@–ňŠw, 20(1): 85`88, 1994.

3672. mŒ¤‹†•ńiŒúśČjn –ňÜŽt‚ĚÝ‘îˆă—Ă‚Ö‚ĚŽQ‰Á‚Ě‚˝‚ß‚É. ”Ń“‡N“Tiă“c–ňÜŽt‰ďjCŽ˝”¨–ŤiĂ‰ŞŒ§–ňÜŽt‰ďjC‰Á“Ą”ŽNiˆę‹{–ňÜŽt‰ďjCě‘ş˛˜aŽqi“Œ‹žˆăŽ•‘ĺjC‹ß“Ą‹IŽqi“s—§_Œo•a‰@jC“‡“cŽœ•Fi“Œ–ň ÜjC’Ëčƒi“ú–{ˆăŽt‰ďjC’†ź•q•vi“ú–{–ňÜŽt‰ďjCźŽO˜Yiˆ¤’m‚Ý‚¸‚Ů‘ĺjCź”ö–Li˛˘•ŰŽs–ňÜŽt‰ďjCŽR–{M•vi“Œ‹ž“s–ňÜŽt‰ďj: Ý‘îˆă—Ă–ňÜ‹Ÿ‹‹„iŒŸ“˘ˆĎˆő‰ď•ń‘, 1994.

3673. mŒ¤‹†•ńiŒúśČjn Ý‘îˆă—Ă‚É•K—v‚Č–ňÜ“™‚Ě‹Ÿ‹‹‹y‚ŃˆŔ‘SŠm•Ű‚ÉŠÖ‚ˇ‚錤‹†. źŽO˜Yiˆ¤’m‚Ý‚¸‚Ů‘ĺjC’Ëčƒi“ú–{ˆăŽt‰ďjC–؉şˆŔŽqi”’”~Šw‰€jC‹ß“Ą‹IŽqi“s—§_Œo•a‰@jC‰ĄŽR•üłi“ú–{•a‰@–ňÜŽt‰ďjC“‡“cŽœ•Fi“Œ–ňÜjC ’†ź•q•vi“ú–{–ňÜŽt‰ďjC—é–Ř”Ei“Œ‹ž“s–ňÜŽt‰ďjC‰|–{„i‰Ť‰i–ň‹Çj: •˝Ź4”N“xŒúś‰ČŠwŒ¤‹†ˆă–ň•iˆŔ‘S‘΍ô“™Œ¤‹†•ń‘, 1993.

3674. mŒ¤‹†•ńiŒúśČjn –ňÜŽt‚Ě•a“‹Ć–ą‚É‚ć‚éˆă—Ă‚ĚŽż‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†. ‘ĺ‘^•Fi“ú‘ĺjCó–ěƒŒƒcŽqi“ú”ä’J•a‰@jCˆéč’ĺ•vi“Œ‹ž’üM•a‰@jCŠŁŒŤˆęi“Œ‹žˆăŽ•‘ĺjCÄ“Ą˜Đ–çi“ú‘ĺjC“‡“cŽœ•Fi“Œ–ňÜjC‰şěłŒŠi‘—§ ˆă‰Č‘ĺjC•˝–ěŒöîi“ú–{ˆă‰Č‘ĺjC“Ąă‰ëŽqi”ŒË•a‰@jC‹g–쐴‚i‡‘ĺj: •˝Ź5”N“xŒúśs­‰ČŠwŒ¤‹†’†ŠÔ•ń‘.


<<31 2 —Տ°–ň—ŠwE–ňÜŠw>>

3675. mÇ—á•ńn ƒZƒtƒFƒ€ŒnRśÜ‚Ě’`”’Œ‹‡‚ÉŠÖ‚ˇ‚錤‹†|˜V”NŽŇ‚¨‚ć‚ѐtáŠQŠłŽŇ‚É‚¨‚Ż‚é”äŠr|. •ŽR­ˆęC–{‹´–΁i–ňÜjCŒF–ě˜a—Yi”ĺjC‹´–{˛ŽqC‘şŁ¨’ĂŽqCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜj: TDMŒ¤‹†, 10(3): 277`278, 1993.

3676. mÇ—á•ńn •a‰@–ň‹Ç‚É‚¨‚Ż‚éę–ĺŠO—ˆoŒü‚É‚ć‚é•ž–ňŽw“ą‚̏[ŽŔ. ÔŁ•üGC˛ěŒŤˆęCaŒű‘OCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjC”¨—˛Žui“ŕj: ŒŽŠ§–ňŽ–, 35(7): 1431`1439, 1993.

3677. m‘ŕn ŒŒ’†ƒEƒCƒ‹ƒX‚̏Á“Ĺ. “‡“cŽœ•Fi“Œ–ňÜj: Infection Control, 2(1): 44`49, 1993.

3678. m‘ŕn ŠłŽŇŠÂ‹Ť‚Ć‚ľ‚Ă̐ś‘Ě‚ĚÁ“Ł|‰˜őŒš‚Ć‚ľ‚Ă̐ś‘Ě‚Ć‚ť‚̏Á“Ĺ•ű–@|. “‡“cŽœ•Fi“Œ–ňÜj: Infection Control, 2(3): 301`306, 1993.

3679. m‘ŕn }‰đŽŽ: ƒ‚ƒ‹ƒqƒlĽ‚ť‚Ě‘ź‚̍ě—pƒƒJƒjƒYƒ€. ‰Á‰ę’J”Łi–ňÜj: ƒ^[ƒ~ƒiƒ‹ƒPƒA, 3(1): 18`25, 1993.

3680. m‘ŕn “ü‰@’˛Ü‹ZpŠî–{—ż(400“_)‹Ć–ą‚ĚŽŔŰ(‡V)ŽŔ‘H•Ň; ¸__Œo‰Č. ’|“ŕŽŽqC“‡“cŽœ•Fi“Œ–ňÜj: ŒŽŠ§–ňŽ–, 35(11): 2594`2597, 1993.

3681. m‘ŕn •a“‚É‚¨‚Ż‚éˆă–ň•iŠÇ—. ’†ŽR–LC“‡“cŽœ•Fi“Œ–ňÜj: ŒŽŠ§–ňŽ–, 35(12): 2793`2880, 1993.

3682. m‘ŕn •Ä‘Ĺ‘ĺ‚Ě’†“ŏî•ńŽűWěŹ‰ďŽĐ‚Ć•§‘‚É‚¨‚Ż‚é’†“ĹŠÖ˜AŽ{Ý. ‹ß“Ą—Ż”üŽqC•ŽR­ˆęC’Š’ˇ•ś–íi–ňÜjC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ŒŽŠ§–ňŽ–, 35(5): 1011`1019, 1993.

3683. m‘ŕn “ü‰@’˛Ü‹ZpŠî–{—ż‹Ć–ą‚ĚŽŔŰ|’ŽË–ňƒZƒbƒgi’˛Üj|. ”ö’šŸ–çi–ňÜj: ŒŽŠ§–ňŽ–i10ŒŽ—ŐŽž‘Š§†j, 35(11): 2261`2272, 1993.

3684. m‘ŕn “ü‰@’˛Ü‹ZpŠî–{—ż‹Ć–ą‚ĚŽŔŰ|RŠŕÜ‚̍Ź‡|. ‰Á‰ę’J”Łi–ňÜj: ŒŽŠ§–ňŽ–i10ŒŽ—ŐŽž‘Š§†j, 35(11): 2276`2279, 1993.

3685. m‘ŕn “ü‰@’˛Ü‹ZpŠî–{—ż‹Ć–ą‚ĚŽŔŰ|–ň—đ|. ŽO‰Y•qGi–ňÜj: ŒŽŠ§–ňŽ–i10ŒŽ—ŐŽž‘Š§†j, 35(11): 2281`2292, 1993.

3686. m‘ŕn “ü‰@’˛Ü‹ZpŠî–{—ż‹Ć–ą‚ĚŽŔŰ. ‰Şč”ü‘ăŽqi–ňÜj: ŒŽŠ§–ňŽ–i10ŒŽ—ŐŽž‘Š§†j, 35(11): 2295`2300, 1993.

3687. m‘ŕn •a“‚É‚¨‚Ż‚éˆă–ň•iî•ńŠˆ“Ž‚ĚŽŔŰ. –]ŒŽ^‹|i–ňÜj: ŒŽŠ§–ňŽ–i10ŒŽ—ŐŽž‘Š§†j, 35(11): 2303`2310, 1993.

3688. m‘ŕn “ü‰@’˛Ü‹ZpŠî–{—ż‹Ć–ą‚ĚŽŔŰ|TPN’˛Ž‹Ć–ą. źŒ´”Łi–ňÜj: ŒŽŠ§–ňŽ–i10ŒŽ—ŐŽž‘Š§†j, 35(11): 2319`2325, 1993.

3689. m‘ŕn •a“Šˆ“Ž‚Ö‚ĚŽx‰‡uƒRƒ“ƒsƒ…[ƒ^—˜—p‚Ć–ňÜ‹Ć–ąv. ‚‹´ŒŤŹi–ňÜj: ŒŽŠ§–ňŽ–i10ŒŽ—ŐŽž‘Š§†j, 35(11): 2329`2337, 1993.

3690. m‘ŕn “ü‰@’˛Ü‹ZpŠî–{—ż‹Ć–ą‚ĚŽŔŰ‡U. Šî‘b•Ň, •a“Šˆ“Ž‚Ě‚˝‚ß‚ĚŠî‘b’mŽŻ|‰h—{ŠÇ—|. ˛ěŒŤˆęi–ňÜj: ŒŽŠ§–ňŽ–i10ŒŽ—ŐŽž‘Š§†j, 35(11): 2339`2344, 1993.

3691. m‘ŕn ŠłŽŇS—‚ĆŠłŽŇ‰Ć‘°‚̐ڂľ•ű. ˛“Ą’qŽqi–ňÜj: ŒŽŠ§–ňŽ–i10ŒŽ—ŐŽž‘Š§†j, 35(11): 2344`2348, 1993.

3692. m‘ŕn “ü‰@’˛Ü‹ZpŠî–{—ż‹Ć–ą‚ĚŽŔŰ‡V. ŽŔ‘H•Ň, ŒŒ‰t“ŕ‰Č. M‰Ş”üťŽqi–ňÜj: ŒŽŠ§–ňŽ–i10ŒŽ—ŐŽž‘Š§†j, 35(11): 2571`2576, 1993.

3693. m‘ŕn f—Éȕʕa“‹Ć–ą‚ĚŽŔŰuŠO‰Čv ‰Á‰ę’J”Łi–ňÜj: ŒŽŠ§–ňŽ–i10ŒŽ—ŐŽž‘Š§†j, 35(11): 2583`2588, 1993.

3694. m‘ŕn “ü‰@’˛Ü‹ZpŠî–{—ż‹Ć–ą‚ĚŽŔŰ|Ž¨•@ˆôA‰Č. ’Ź“c[i–ňÜj: ŒŽŠ§–ňŽ–i10ŒŽ—ŐŽž‘Š§†j, 35(11): 2638`2641, 1993.

3695. m‘ŕn Á“Ĺ–ň. “‡“cŽœ•Fi“Œ–ňÜj: “ú–{ˆăŽt‰ďŽGŽ, 110(11—Ő‘): 282`283, 1993.

3696. m‘ŕn ^‹ŰÇ‚Ě‘Šú”­ŒŠ‚ĚŽŽ‚Ý. –]ŒŽ^‹|i–ňÜjC‹v•ÄŒői•a—jC’ß“c—z˜aiˆă—pî•ńjC’Š’ˇ•ś–íi–ňÜjC‰œ•˝‰ë•Fi•a—j: “ú–{ˆă^‹ŰŠw‰ďŽGŽ, 34(3): 265`273, 1993.

3697. m‘ŕn “Y•t•ś‘30”N‚Ě•Ď‘J. –]ŒŽ^‹|i–ňÜj: —Տ°‚Ć–ň•¨ŽĄ—Ă, 12(7): 868`874, 1993.

3698. m‘ŕn —Տ°ˆă‚Ě‚˝‚ß‚Ěˆă—Ă—pˆă–ň•i“Y•t•ś‘‚ĚŠˆ—p–@|“Y•t•ś‘‚Ě‹tˆř‚ŤŠˆ—p–@|. •ŽR­ˆęi–ňÜj: —Տ°‚Ć–ň•¨ŽĄ—Ă, 12(7): 915`918, 1993.

3699. m‘ŕn Œü¸_–ň, “Á‚ɐ‡–°–ň“Š—^ŠłŽŇ‚Ö‚Ě•ž–ňŽw“ą. ’|“ŕŽŽqC“‡“cŽœ•Fi“Œ–ňÜj: ˜V‰ť‚ĆŽžŠł, 6(6): 875`878, 1993.

3700. muŔn —A‰tÜ‚ĚŽč‹ZŠÇ—; €”ő, Ź‡’˛Ž‚Š‚çŽg—p‚Ü‚Ĺ. ‰Á‰ę’J”ŁC’Š’ˇ•ś–íi–ňÜj: ƒn[ƒgƒi[ƒVƒ“ƒO, 6(12): 15`19, 1993.

3701. muŔn zŠÂŠíŒn–ň‚̉đŕ(1)~ˆłÜ. ˛ěŒŤˆęC’Š’ˇ•ś–íi–ňÜj: ƒn[ƒgƒi[ƒVƒ“ƒO, 6(6): 468`476, 1993.

3702. muŔn zŠÂŠíŒn–ň‚̉đŕ(2)‹•ŒŒŤSŽžŠłŽĄ—Ă–ň. ˛ěŒŤˆęC’Š’ˇ•ś–íi–ňÜj: ƒn[ƒgƒi[ƒVƒ“ƒO, 6(7): 574`581, 1993.

3703. muŔn zŠÂŠíŒn–ň‚̉đŕ(3)R•sŽ–ŹÜ‡@. ˛ěŒŤˆęC’Š’ˇ•ś–íi–ňÜj: ƒn[ƒgƒi[ƒVƒ“ƒO, 6(9): 742`747, 1993.

3704. muŔn ‚—îŽŇ‚Ö‚Ě•ž–ňŽw“ą|zŠÂŠí—p–ň‚𒆐S‚Ɂ|. ˛ěŒŤˆęCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜj: ƒn[ƒgƒi[ƒVƒ“ƒO, 7(3): 14`20, 1994.

3705. muŔn —A‰tÜ, lH“§Í—pÜ. •˝ŽR•ŽiC“‡“cŽœ•Fi“Œ–ňÜj: ˆă–ňƒWƒƒ[ƒiƒ‹, 30(1): 245`250, 1994.

3706. muŔn •a‹C‚Ć‚­‚ˇ‚č: Vˆă–ň•i; •sŽ–ŹŽĄ—Ă–ň|Naƒ`ƒƒƒlƒ‹—}§–ň|. ˛ěŒŤˆęi–ňÜjC’|“ŕKˆęi–žŽĄ–ň‰Č‘ĺj: ‰ťŠw‚Ć–ňŠw‚Ě‹łŽş, (112): 64`68, 1993.

3707. muŔn Šż•űƒGƒLƒXÜ‚Ě•ž–ňŽw“ą|Šż•ű–ň‚Ě–ňŒřĽ–ň—ě—p. ÔŁ•üGC•ŽR­ˆęC–îŒă˜a•vCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜj: ŒŽŠ§–ňŽ–, 36(3): 615`624, 1994.

3708. muŔn ƒg[ƒ^ƒ‹ƒVƒXƒeƒ€‚É‚¨‚Ż‚éůÜŽŠ“Ž•Ş•ď‹@‚ĚƒIƒ“ƒ‰ƒCƒ“‰ť. ™‘ş–qŽqi“Œ–ňÜj: _“ŢěŒ§•a‰@–ňÜŽt‰ď‰ďŽ, 75: 21`25, 1994.

3709. muŔn ’ŽËÜŹ‡‹Ć–ą‚ĚŽŔŰ(‡T). ÎŽËł‰pi–ňŠw•”jC•˝ŽR•Žii“Œ–ňÜjC‘ž“c‹v”üŽqi–k—˘Œ¤‹†ŠjC“‡“cŽœ•Fi“Œ–ňÜj: “ú–{•a‰@–ňÜŽt‰ďŽGŽ, 29(11): 1241`1245, 1993.

3710. muŔn ’ŽËÜŹ‡‹Ć–ą‚ĚŽŔŰ(‡U). ÎŽËł‰pi–ňŠw•”jC•˝ŽR•ŽiC‰Ą“cTˆęi“Œ–ňÜjC‘ž“c‹v”üŽqi–k—˘Œ¤‹†ŠjC“‡“cŽœ•Fi“Œ–ňÜj: “ú–{•a‰@–ňÜŽt‰ďŽGŽ, 29(12): 1385`1391, 1993.

3711. muŔn ˆă–ň•iî•ńƒZƒ“ƒ^[‚ĚŠJÝ‚Ć‚ť‚ĚŠˆ“Ž‚ĚŒťó. •ŽR­ˆęC–]ŒŽ^‹|C’r“c—R”üŽqC–Ř‘ş—˜”üC‘şŁ¨’ĂŽqCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜj: “ú–{•a‰@–ňÜŽt‰ďŽGŽ, 29(5): 597`601, 1993.

3712. muŔn ’ŽËÜŹ‡‹Ć–ą‚ĚŽŔŰ(‡V). ÎŽËł‰pi–ňŠw•”jC•˝ŽR•ŽiC‘Š‘ň­–ži“Œ–ňÜjC‘ž“c‹v”üŽqi–k—˘Œ¤‹†ŠjC“‡“cŽœ•Fi“Œ–ňÜj: “ú–{•a‰@–ňÜŽt‰ďŽGŽ, 30(1): 59`65, 1994.

3713. muŔn ‘ć14‰ń“ú•a–ňŽŔ–ąŒ¤C‰ď‚đŠJĂ‚ľ‚Ä. •ŽR­ˆęi–ňÜj: “ú–{•a‰@–ňÜŽt‰ďŽGŽ, 30(2): 159`160, 1994.

3714. muŔn ’ŽËÜ‚̍Ź‡. “‡“cŽœ•FC•˝ŽR•Žii“Œ–ňÜj: –ňŽ–V•ń, (1742): 449`452, 1993.


<<31 3 —Տ°–ň—ŠwE–ňÜŠw>>

3715. m‹ł‰Č‘n i•Ş’SŽˇ•Mj ŠĹŒě‚Ě‚˝‚ß‚Ě–ňŽ–“T; ‘˜_, ¸__ŒoŒně—p–ň‰đŕ, Ž•‰ČŒűo—pÜ‰đŕ, ŒŒ‰t—pÜ‰đŕ, ‘ăŽÓŤˆă–ň•i‰đŕ, ƒrƒ^ƒ~ƒ“Ü‰đŕ, Rś•¨Žż/‰ťŠw—Ă–@Ü‰đŕ. Á“ĹÜ‰đŕ, •ŽR­ˆęi–ňÜj. ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 93.12.05”­s.

3716. m‹ł‰Č‘n i•Ş’SŽˇ•Mj ŠĹŒě‚Ě‚˝‚ß‚Ě–ňŽ–“T; ¸__ŒoŒně—p–ň‰đŕ, —A‰tĽ•âł—pťÜ/‰h—{Ü‰đŕi•\‚đŠÜ‚ށj, ś•¨Šw“IťÜ‰đŕ, ”ö’šŸ–çi–ňÜj. ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 93.12.05”­s.

3717. m‹ł‰Č‘n i•ŇWj ŠĹŒě‚Ě‚˝‚ß‚Ě–ňŽ–“T; •ŇW Î‹´Wi”ĺjCŽ›č–ž”üiŽœŒbˆă‘ĺjCŽŞ“cŒbŽqiŠĹŒě•”jC•ŽR­ˆęi–ňÜjC ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 93.12.05”­s.

3718. m‹ł‰Č‘n i•ŇWj ŠĹŒě‚Ě‚˝‚ß‚Ě–ňŽ–“T; ”ö’šŸ–çi–ňÜj. •ŇW Î‹´Wi”ĺjCŽŞ“cŒbŽqiŠĹŒě•”jCŽ›č–ž”üiŽœŒbˆă‘ĺjC•ŽR­ˆęC”ö’šŸ–çi–ňÜjC‘źC •ŇW Î‹´W ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 93.12.05”­s.

3719. m‚ť‚Ě‘ź‚Ě’˜‘n i•Ş’SŽˇ•Mj Š´ő–hŽ~‘΍ô‚ƏÁ“ĹÜƒnƒ“ƒhƒuƒbƒN; Á“ĹÜ‚ĚŒř‰Ę”ť’č, p.44`53, “‡“cŽœ•FC•˝ŽR•Žii“Œ–ňÜj. •ŇW ě–ź—ŃŽĄiŠâŽčˆă‰Č‘ĺjC ˆă–ňƒWƒƒ[ƒiƒ‹ŽĐ, ‘ĺă, 93.10.01”­s.

3720. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn i•Ş’SŽˇ•Mj ƒtƒ@[ƒ}ƒVƒXƒg‚Ě‚˝‚߂̉p‰ď˜bƒvƒ‰ƒNƒeƒBƒX; ‡T.ƒVƒ`ƒ…ƒG[ƒVƒ‡ƒ“•Ę‰pŒę•\Œť 1.“Š–ňŒű‚Ĺ, p.3`15, ˛ěŒŤˆęi–ňÜj. iŠ”jƒ‰ƒCƒtĽƒTƒCƒGƒ“ƒX, “Œ‹ž, 93.12.15”­s.

3721. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn i•Ş’SŽˇ•Mj ƒtƒ@[ƒ}ƒVƒXƒg‚Ě‚˝‚߂̉p‰ď˜bƒvƒ‰ƒNƒeƒBƒX; ‡T.ƒVƒ`ƒ…ƒG[ƒVƒ‡ƒ“•Ę‰pŒę•\Œť 2.•ž–ňŽw“ą|“Š–ňŒű‚Ł|, p.17`30, ˛ěŒŤˆęi–ňÜj. iŠ”jƒ‰ƒCƒtĽƒTƒCƒGƒ“ƒX, “Œ‹ž, 93.12.15”­s.

3722. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn iŠÄCj ƒtƒ@[ƒ}ƒVƒXƒg‚Ě‚˝‚߂̉p‰ď˜bƒvƒ‰ƒNƒeƒBƒX; ŠÄC ’Š’ˇ•ś–íi–ňÜjCRichard PaulsonC iŠ”jƒ‰ƒCƒtĽƒTƒCƒGƒ“ƒX, “Œ‹ž, 93.12.15”­s.

3723. m‚ť‚Ě‘ź‚Ě’˜‘i“ü–ĺ‘jn i•Ş’SŽˇ•Mj ŽĄ—Ă–ňƒKƒCƒh'94; Á“Ĺ–ň, p.886`893, “‡“cŽœ•Fi“Œ–ňÜj. •ŇW ˜a“cUC‘ĺ‹v•Űşsi“Œ‘ĺjC‰i“c’źˆęi–h‰qˆă‘ĺjC–îč‹`—Yi“Œ‘ĺjC •śŒő“°, “Œ‹ž, 94.02.20”­s.

3724. m‚ť‚Ě‘ź‚Ě’˜‘i“ü–ĺ‘jn i•Ş’SŽˇ•Mj ƒNƒŠƒjƒJƒ‹Ľƒtƒ@[ƒ}ƒV[ŽŔ–ą; ‡U.ƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[Šˆ“Ž‚ĚŽŔŰ‚P.“ŕ‰ČŒn•a“‡F¸__Œo‰Č, p.152`159, ’|“ŕŽŽqi“Œ–ňÜj. •ŇW ‰œ‘şŸ•Fi_ŒË‘ĺjCÄ“Ąˆę•śŽšiŠÖźˆă‰Č‘ĺjCÄ“Ą˜Đ–çi“ú‘ĺjC“c’†”ü—Yišƒ}ƒŠ‘ĺjC•˝–ěŒöîi“ú‘ĺjC–{‰Ž•q˜YiŽ­Ž™“‡‘ĺjC ˆă–ňƒWƒƒ[ƒiƒ‹ŽĐ, ‘ĺă, 94.03.01”­s.

3725. m‚ť‚Ě‘ź‚Ě’˜‘i“ü–ĺ‘jn i•Ş’SŽˇ•Mj ƒNƒŠƒjƒJƒ‹Ľƒtƒ@[ƒ}ƒV[ŽŔ–ą; ƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[‚Ć’ŽËÜ‹Ÿ‹‹‹Ć–ą, p.53`59, •˝ŽR•ŽiC“‡“cŽœ•Fi“Œ–ňÜj. ˆă–ňƒWƒƒ[ƒiƒ‹ŽĐ, ‘ĺă, 94.03.01”­s.

3726. m‚ť‚Ě‘ź‚Ě’˜‘i“ü–ĺ‘jn i•Ş’SŽˇ•Mj Ă–Ź‰h—{‚ĚŽčˆř; Ă–Ź‰h—{Ü‚Ě’˛Ž, p.59`76, “‡“cŽœ•Fi“Œ–ňÜj. •ŇW ‰Ş“cłi‘ĺă‘ĺjC ˆă–ňƒWƒƒ[ƒiƒ‹ŽĐ, ‘ĺă, 94.03.01”­s.

3727. m‚ť‚Ě‘ź‚Ě’˜‘iŽŤ“Tjn i•Ş’SŽˇ•Mj Œ’NśŠˆˆăŠwŽ–“T; 5.ƒNƒXƒŠ‚đl‚Ś‚é, p.187`200, ’Š’ˇ•ś–íi–ňÜj. •ŇW X‰Ş‹ą•FiŠÖ“Œ˜JĐ•a‰@jC‘ĺ’Ë‹ą’ji–k—˘Œ¤‹†ŠjCX–{Œ“”Xiă‘ĺjC ƒ`ƒNƒ}G”ĹŽĐ, 94.03.04”­s.

3728. m‚ť‚Ě‘ź‚Ě’˜‘iŽŤ“Tjn i•Ş’SŽˇ•Mj Œ’NśŠˆˆăŠwŽ–“T; ƒNƒXƒŠ‚ĚŽg‚˘•ű, p.422`431, ’Š’ˇ•ś–íi–ňÜj. •ŇW X‰Ş‹ą•FiŠÖ“Œ˜JĐ•a‰@jC‘ĺ’Ë‹ą’ji–k—˘Œ¤‹†ŠjCX–{Œ“”Xiă‘ĺjC ƒ`ƒNƒ}G”ĹŽĐ, 94.03.04”­s.

3729. m‚ť‚Ě‘ź‚Ě’˜‘iŽŤ“Tjn i•Ş’SŽˇ•Mj Œ’NśŠˆˆăŠwŽ–“T; –ň‹Ç‚Ě—˜—p, p.432`442, ’Š’ˇ•ś–íi–ňÜj. •ŇW X‰Ş‹ą•FiŠÖ“Œ˜JĐ•a‰@jC‘ĺ’Ë‹ą’ji–k—˘Œ¤‹†ŠjCX–{Œ“”Xiă‘ĺjC ƒ`ƒNƒ}G”ĹŽĐ, 94.03.04”­s.

3730. m‚ť‚Ě‘ź‚Ě’˜‘iŽŤ“Tjn i•ŇWj ˆă–ň•iŽŻ•ĘƒR[ƒhˆę——'93; •ŇW “c’†”ü—YCÜˆäF’jC‰Í–ěŒ’ŽĄi“ú–{•a‰@–ňÜŽt‰ďˆă–ň•iŽŻ•ĘƒR[ƒhˆĎˆő‰ďjC•ŽR­ˆęi–ňÜjCŽÂ’Ë—TŽqC”’Žm“š—YC{‰ę”ŁC´“c˜a•FCŽRčŒ°C –ňŽ–”’•ńŽĐ, “Œ‹ž, 93.08.25”­s.


<<31 5 —Տ°–ň—ŠwE–ňÜŠw>>

3731. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Drug information and other services from pharmacist in emergency and critieal care medicine. M. Muratai“ú‘ĺjC‹ß“Ą—Ż”üŽqi–ňÜjCM. KaburagiCK. NishizawaCT. Unemotoi“ú‘ĺj: World Congress of Pharmacy and Pharmacentieal Sciennees i93.09.10j, “Œ‹ž.

3732. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Survey of team medicine for diabetic patients: A study on patient education by pahrmacists. Œú“cKˆę˜YC’Ź“c[CŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜj: World Congress of Pharmacy and Pharmacentical Sciences i93.09.09j, “Œ‹ž, —\eW, p.26, 1993.

3733. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Discriminant fanctions conducted for early prediction of visceral mycosis. –]ŒŽ^‹|i–ňÜjC‹v•ÄŒői•a—jCŽR‰ş‚Ś‚čŽqi“ŕjCM‰Ş”üťŽqC‘şŁ¨’ĂŽqC’Š’ˇ•ś–íi–ňÜj: 12th Congress of the International Society for Human and Animal Mycology i94.03.13`18j, Adolaide, Australia, Program and Abstracts, p.59, 1994.

3734. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Studies on pharmacokinetics of amphotericin B in rats(2). ‘şŁ¨’ĂŽqC–]ŒŽ^‹|C’Š’ˇ•ś–íi–ňÜjC™“cCiƒTƒ“ƒgƒŠ[jC‹v•ÄŒői•a—j: 12th Congress of the International Society for Human and Animal Mycology i94.03.13`18j, Adelaide, Australia, Program and Abstracts, p.88, 1994.

3735. mŠw‰ďi‘S‘jn ih‘č•ńj –ňÜ‹Ć–ą•]‰żƒ}ƒjƒ…ƒAƒ‹ěŹ‚Ě‚˝‚ß‚Ě’˛¸Œ¤‹†. ’Š’ˇ•ś–íi–ňÜjC–k‘ň••śC“Ąˆä’‰’jC‘ş“cłOC”Ş–ŘŤ–çC‰@ŁŒŠ‹`OCŁ’[–ő“ńC“ĄˆärŽuC—é–Ř“úoŽqCÎŽËł‰pi–ňÜjC–žÎÓ—YCŹ—Ń‹P–ži–ň Üj: ‘ć114”N‰ď“ú–{–ňŠw‰ď i94.03.29j, “Œ‹ž, •a‰@–ňŠw, 20(2): 79`83, 1994.

3736. mŠw‰ďi‘S‘jn ih‘č•ńj –ňÜ‰uŠw‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†. Ź‘C‘ž“cLC–k‘ň••śC•ŽR­ˆęi–ňÜjC‘Š—ljx˜YC‰ş“°‰’Œ —mC­“cŠ˛•v: ‘ć114”N‰ď“ú–{–ňŠw‰ď i94.03.29`31j, “Œ‹ž, —vŽ|W4, p.332, 1994.

3737. mŠw‰ďi‘S‘jn i‹łˆçu‰‰j •a“–ňÜŽt‚Ě—Ő°Šˆ“Ž. ‰Á‰ę’J”Łi–ňÜj: ‘ć15‰ń“ú–{–ƒŒĽ–ň—Šw‰ď‘‰ď i93.07.03j, “Œ‹ž.

3738. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j •a“Šˆ“Ž‚É‚¨‚Ż‚é–ň•iî•ń‚Ě‚ ‚č•ű|ˆăŽtĽŠĹŒě•w‚ɑ΂ľ‚ā|. –]ŒŽ^‹|C’Š’ˇ•ś–íi–ňÜj: ‘ć114”N‰ď“ú–{–ňŠw‰ď i94.03.30j, “Œ‹ž, —vŽ|W, p.200`201, 1994.

3739. mŠw‰ďi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj —Տ°ˆă—Ă‚Ö‚Ě–ňÜ‰uŠw“IƒAƒvƒ[ƒ`|–ň—đ“™‚đŠÜ‚ß‚Ä–ňÜ‰uŠw‚Ě‚˝‚ß‚Ěî•ńŒš. –]ŒŽ^‹|C’Š’ˇ•ś–íi–ňÜj: ‘ć13‰ńˆă—Ïî•ńŠw˜A‡‘ĺ‰ď i93.11.13j, “Œ‹ž, —\eW, p.57, 1993.

3740. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‹ÇŠ‘Ř—ŻŤƒ‚ƒ‹ƒqƒlżÜ“Š—^‚É‚¨‚Ż‚郂ƒ‹ƒqƒl‘ăŽÓ•¨‚Ě‘Ě“ŕ“Ž‘Ô. ŽR–{‰xŽqC‹gŽR—F“ńC“‡“c‰p‘ăi–ňŠw•”jC‰Á‰ę’J”ŁC‘şŁ¨’ĂŽqCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjC–kŽR—ćŽqC“Ą”ö‚Ü‚ä‚݁iŠĹŒě•”jC’|’†°KC‘D–{TěC‘ĺ ‹{“ŒśCŠ`“cÍiŠOjCŽO‰YŽő’jiŽ™jCŹŒIˆę‘ži‹ă‘ĺj: ‘ć10‰ń“ú–{TDMŠw‰ď (93.06.05), “Œ‹ž, —vŽ|W, p.76, 1993.

3741. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j V‹KÁ“ōÜTDi‰źĚj‚Ě•]‰ż. –]ŒŽ^‹|C‘şŁ¨’ĂŽqC˛“Ą“§C“ď”gş—YC•ŽR­ˆęCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjCŽRč•q˜aC‹v•ÄŒői•a—j: ‘ć67‰ńŠ´őÇŠw‰ď i93.04.15j, “Œ‹ž, Š´őÇŠwŽGŽ, 67(—Ő‘): 96, 1993.

3742. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j R^‹ŰÜ‚Ě•š—pŒř‰Ę‚ÉŠÖ‚ˇ‚éŠî‘b“IŒ¤‹†i‘ć3•ńj. M‰Ş”üťŽqC–]ŒŽ^‹|C‘şŁ¨’ĂŽqCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjCŽRč•q˜aC‹v•ÄŒői•a—j: ‘ć67‰ńŠ´őÇŠw‰ď i93.04.16j, “Œ‹ž, Š´őÇŠwŽGŽ, 67(—Ő‘): 97, 1993.

3743. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Šŕáu’ÉŠłŽŇ‚Ě—°Ž_ƒ‚ƒ‹ƒqƒl™•úů‚Ě‘Ě“ŕ“Ž‘Ô‚Ć’Á’ÉŒř‰Ę. ‰Á‰ę’J”ŁC‘şŁ¨’ĂŽqCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjC‘ĺ‹{“ŒśCŠ`“cÍiŠOjC“Ą”ö‚Ü‚ä‚݁C–kŽR—ćŽqiŠĹŒě•”jC“IęŒłOi–ƒjC•űG‘ׁi–žŽĄ–ň‰Č ‘ĺj: ‘ć10‰ń“ú–{TDMŠw‰ď i93.06.04`05j, “Œ‹ž, “ú–{TDMŒ¤‹†, 10(3): 258`260, 1993.

3744. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Flecainide‚ĚŒŒ‰t‹y‚Ń‘Á‰t’†”Z“x‚Ě”äŠrŒŸ“˘. ˛ěŒŤˆęC˛“Ą“§C•ŽR­ˆęC‘şŁ¨’ĂŽqC’Š’ˇ•ś–íi–ňÜjC‘şź€C–ؐě“c—˛ˆęi“ŕjC–Ń—˜Œö‘ĽCă™Fi–žŽĄ–ň‰Č‘ĺj: ‘ć10‰ń“ú–{TDMŠw‰ď i93.06.05j, “Œ‹ž, —vŽ|W, p.71, 1993.

3745. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –ňÜ•”–ĺ‚É‚¨‚Ż‚éƒ`[ƒ€ˆă—Ă‚Ö‚ĚŽQ‰ć|ŠłŽŇ‹łˆç‚ÉŠÖ‚ˇ‚éƒAƒ“ƒP[ƒg’˛¸‚ć‚č. Œú“cKˆę˜YC’Ź“c[CŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜj: ‘ć43‰ń“ú–{•a‰@Šw‰ď i93.06.17j, ˇ‰Ş, u‰‰W, p.140`141, 1993.

3746. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰@“ŕƒIƒ“ƒ‰ƒCƒ“ƒVƒXƒeƒ€‚É‚ć‚éˆă–ň•iî•ń‚Ě’ń‹Ÿ|“Y•t•ś‘î•ń‚Č‚ç‚Ń‚É–ňÜŽŻ•Ęî•ń. –]ŒŽ^‹|C•ŽR­ˆęC–Ř‘ş—˜”üC’r“c—R”üŽqC‘şŁ¨’ĂŽqCaŒű‘OCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjCŽćˆę—ECHŽRŒš•xCŠÖŒűŸ”üi•a‰@’ˇŽşj: ‘ć43‰ń“ú–{•a‰@Šw‰ď i93.06.17j, ˇ‰Ş, u‰‰W, p.510`511, 1993.

3747. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒAƒ€ƒzƒeƒŠƒVƒ“‚a‚Ě‘Ě“ŕ“Ž‘Ô‚ÉŠÖ‚ˇ‚錤‹†. ‘şŁ¨’ĂŽqC–]ŒŽ^‹|C•ŽR­ˆęC’Š’ˇ•ś–íi–ňÜjC™“cCiƒTƒ“ƒgƒŠ[ˆă–ňƒZƒ“ƒ^[j: ‘ć41‰ń“ú–{‰ťŠw—Ă–@Šw‰ď‘‰ď i93.06.17`18j, “Œ‹ž, ´˜^W, p.115, 1993.

3748. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’†“ĹÇ—áƒf[ƒ^ƒx[ƒX‚̍\’z. •Ÿ–{^—Žqi–ňŠw•”jC‹ß“Ą—Ż”üŽqi–ňÜjC‘Š”nˆęˆĺi‹~–˝jC’ß“c—z˜aiˆă—pî•ńjCó—˜–őC‘ĺ˜a“c—˛i‹~–˝jC–‘ĺ‰îC“‡“c‰p˘i–ňŠw•”jCŹ—Ń‹P –žC’Š’ˇ•ś–íi–ňÜj: ‘ć15‰ń“ú–{’†“ĹŠw‰ď‘‰ď i93.07.09j, ‰F“s‹{.

3749. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j “Ĺ•¨•ŞÍ‹@ŠíREMED‚Ö‚Ě—Ő°‚Ĺ‚ĚŽg—pŤ‚ĚŒŸ“˘. ‹ß“Ą—Ż”üŽqi–ňÜjCźč‹v”üi—ŐŒŸjC•Ÿ–{^—Žqi–ňŠw•”jCŒú“cKˆę˜YC‘şŁ¨’ĂŽqCŹ—Ń‹P–ži–ňÜjCźě—˛i—Ő•a—jC’Š’ˇ•ś–íi–ňÜjCó—˜ –őC‘Š”nˆęˆĺC‘ĺ˜a“c—˛i‹~–˝j: ‘ć15‰ń“ú–{’†“ĹŠw‰ď‘‰ď i93.07.10j, ‰F“s‹{.

3750. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –ňŠwś‚ĚŠO—ˆf—ĂŒŠŠwŽŔK‚ÉŠÖ‚ˇ‚錟“˘. źŽR—R”üŽqC™‘ş–qŽqC•ŽRC’|“ŕŽŽqC“‡“cŽœ•Fi“Œ–ňÜjCŽÄ“c‹v—Yi“ŕjC‰Á“ĄNsiŠOjCÄ“Ą–L˜ai“ŕjC‘ĺ’J‹`•vi¸jCŹ—Ń‹P–žC’Š’ˇ•ś–í i–ňÜjC‹gŽR—F“ńCźě˛Ž}i–ňŠw•”j: ‘ć3‰ń“ú–{•a‰@–ňŠw‰ď i93.07.17j, “Œ‹ž.

3751. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰@“ŕƒIƒ“ƒ‰ƒCƒ“ƒVƒXƒeƒ€‚É‚ć‚é–ňÜŽŻ•ĘƒvƒƒOƒ‰ƒ€‚Ě’ń‹Ÿ‚Ć‚ť‚Ě—L—pŤ. –]ŒŽ^‹|C•ŽR­ˆęC–Ř‘ş—˜”üC’r“c—R”üŽqC‘şŁ¨’ĂŽqC‰Á‰ę’J”ŁCaŒű‘OCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjCŽćˆę—ECHŽRŒš•xCŠÖŒűŸ”üi•a‰@’ˇŽşj: ‘ć3‰ń“ú–{•a‰@–ňŠw‰ď i93.07.17j, “Œ‹ž, —\eW, p.116`117, 1993.

3752. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒAƒ€ƒzƒeƒŠƒVƒ“‚a‚Ě‘Ě“ŕ“Ž‘Ô‚ÉŠÖ‚ˇ‚錤‹†i‘ć4•ńj. ‘şŁ¨’ĂŽqC–]ŒŽ^‹|C•ŽR­ˆęC’Š’ˇ•ś–íi–ňÜjC™“cCiƒTƒ“ƒgƒŠ[ˆă—ĂƒZƒ“ƒ^[jC‹v•ÄŒői•a—j: ‘ć37‰ń“ú–{ˆă^‹ŰŠw‰ď i93.10.10j, ‰Ą•l.

3753. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j R^‹ŰÜƒtƒ‹ƒRƒiƒ][ƒ‹‚Ě‘Ě“ŕ“Ž‘Ô. –]ŒŽ^‹|C‘şŁ¨’ĂŽqCŠ‹ź—R—˘ŽqCM‰Ş”üťŽqCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjCŽR‰ş‚Ś‚čŽqi“ŕj: ‘ć37‰ń“ú–{ˆă^‹ŰŠw‰ď i93.10.10j, ‰Ą•l, “ú–{ˆă^‹ŰŠw‰ďŽGŽ, 34(Suppl.1): 142, 1993.

3754. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ’†“ĹƒZƒ“ƒ^[Ý—§‚ÉŠÖ‚ˇ‚錟“˘. ‹ß“Ą—Ż”üŽqi–ňÜjC‘Š”nˆęˆĺCó—˜–ői‹~–˝jC•ŽR­ˆęi–ňÜjC’ç–M•FC‘ž“c„•äCŽá—Ń–ő‹vi‹~–˝jC’Š’ˇ•ś–íi–ňÜjC‘ĺ˜a“c—˛i‹~–˝j: ‘ć21‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ď i93.11.17j, L“‡.

3755. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŽčŽw‰˜ő‚ɑ΂ˇ‚éŽčŽwÁ“ʼnt‚ĚŒř‰Ę. ŹěK—YC“‡“cŽœ•Fi“Œ–ňÜjCŽO‰YNŽĄi—ŐŒŸjC’†‘şG‘ăiŠĹŒě•”j: ‘ć114”N‰ď“ú–{–ňŠw‰ď i94.03.29j, “Œ‹ž, u‰‰—vŽ|W4, p.235, 1994.

3756. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‰@“ŕťÜ‚̐ť‘˘Žwj‚ÉŠÖ‚ˇ‚錤‹†. ™Œ´ł‘ׁi“Œ—ˆă‘ĺjCÂŽR•qMi‹ă‘ĺjC“Ąˆä’‰’ji“ŒŠC‘ĺjC“‡“cŽœ•Fi“Œ–ňÜjCÎŒ´ˆč•FiŒc‘ĺjC÷ˆäł‘ž˜Yi”Žs—§”•a‰@j: ‘ć114”N‰ď“ú–{–ňŠw‰ď i94.03.29j, “Œ‹ž, u‰‰—vŽ|W4, p.331, 1994.

3757. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –ňŠwś‚ĚŠO—ˆf—ĂŒŠŠwŽŔK‚ÉŠÖ‚ˇ‚錟“˘i‚ť‚Ě‚Qj. ™‘ş–qŽqCźŽR—R”üŽqC•ŽRC’|“ŕŽŽqC“‡“cŽœ•Fi“Œ–ňÜj: ‘ć114”N‰ď“ú–{–ňŠw‰ď i94.03.30j, “Œ‹ž, u‰‰—vŽ|W4, p.261, 1994.

3758. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j V‚ľ‚˘ƒLƒbƒgťÜi—n‰đ‰t•t‚ŤŒĹŒ`’ŽËÜj‚Ě—L—pŤ‚ĚŒŸ“˘. •˝ŽR•ŽiCˆÉ“Ą“šŽqC–ě’†”ü˜aCŹ›—L”üCŠ—ś˛’mŽqC‰ĄˆäMŽqC“‡“cŽœ•Fi“Œ–ňÜj: ‘ć114”N‰ď“ú–{–ňŠw‰ď i94.03.30j, “Œ‹ž, u‰‰—vŽ|W4, p.262, 1994.

3759. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‘ŸŠí•Ű‘ś‰t(EC‰t‹y‚ŃUW‰t)‚ĚŠĚ•Ű‘śŤ‚Ě•]‰ż–@‚ĚŒŸ“˘. ‰Á‰ę’J”ŁCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjC•˝ˆä­•FC‰Ô“c˜a•FC•űG‘ׁi–žŽĄ–ň‰Č‘ĺj: ‘ć114”N‰ď“ú–{–ňŠw‰ď i94.03.31j, “Œ‹ž, —vŽ|W, p.273, 1994.

3760. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ‡–°–ňŽg—p“ŽŒü‚ɂ‚˘‚Ä‚ĚˆęlŽ@. –ě’†”ü˜aC’|“ŕŽŽqCŠ—ś˛’mŽqC“‡“cŽœ•Fi“Œ–ňÜjC‘şčŒő–MCŽO‰Y’ĺ‘Ľi¸j: ‘ć3‰ń“ú–{•a‰@–ňŠw‰ď i94.07.17j, “Œ‹ž, —\eW, p.100`101, 1993.

3761. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j R^‹ŰÜƒtƒ‹ƒRƒiƒ][ƒ‹‚Ě‘Ě“ŕ“Ž‘Ô. ‘şŁ¨’ĂŽqC–]ŒŽ^‹|CŠ‹ź—R—˘ŽqCM‰Ş”üťŽqCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjCŽR‰ş‚Ś‚čŽqi“ŕjC‹v•ÄŒői•a—j: ‘ć10‰ń“ú–{TDMŠw‰ď i93.06.04j, “Œ‹ž, “ú–{TDMŒ¤‹†, 10(3): 281`282, 1993.

3762. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒZƒtƒFƒ€ŒnRťÜ‚Ě’`”’Œ‹‡‚ÉŠÖ‚ˇ‚錤‹†|˜V”NŽŇ‚¨‚ć‚ѐtáŠQŠłŽŇ‚É‚¨‚Ż‚é”äŠr. •ŽR­ˆęC–{‹´–΁C‹´–{˛ŽqC‘şŁ¨’ĂŽqCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjCŒF–ě˜a—Yi”ĺj: ‘ć10‰ń“ú–{TDMŠw‰ď i93.06.04`05j, “Œ‹ž, —vŽ|W, p.85, 1993.

3763. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j G-CSFťÜ‚Ě“_“HĂ’Žž‚É‚¨‚Ż‚é—A‰tƒ‹[ƒg‚Ö‚Ě‹z’…. –îŒă˜a•vC”ö’šŸ–çC’Š’ˇ•ś–íi–ňÜjCˆž–ě•ś„i—ŐŒŸjC˛“ĄGi“ŕj: ‘ć35‰ń“ú–{—Տ°ŒŒ‰tŠw‰ď‘‰ď i93.11.10j, L“‡, —Տ°ŒŒ‰t, 34(10): 1309, 1993.

3764. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒAƒ‹ƒR[ƒ‹Ť‹}ŤˆÝ”S–Œ•a•Ď‚ɑ΂ˇ‚éƒmƒ‹ƒAƒhƒŒƒiƒŠƒ“`ŒđŠ´_ŒoŒn‚ĚˆÓ‹`. Œú“cKˆę˜YC’Š’ˇ•ś–íi–ňÜjCÎˆäŒö“šCŽÄ“c‹v—Yi“ŕj: “ú–{–ň—Šw‰ď‘‰ď i94.03.23j, ‹ž“s.

3765. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠO—ˆŠłŽŇ‚Ö‚Ě•ž–ňŽw“ą‚ĚŒťó‚ĆŠłŽŇ‚Š‚ç‚Ě•]‰ż. â‘q’qŽqC“ŕ“ĄŽj]C•ŽR­ˆęCˆÉ“Ą—msC–{‹´–΁CŹ’r”üŒbŽqCŁŒËvC˛“Ą“§CaŒű‘OC–îŒă˜a•vCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜj: ‘ć114”N‰ď“ú–{–ňŠw‰ď i94.03.29j, “Œ‹ž.

3766. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘SŽŠ“Ž–ň‘܍쐬‹@‚Ě“ą“ü‚É‚ć‚éŒř‰Ę. –{‹´–΁CaŒű‘OC˛“Ą“§C•ŽR­ˆęC˛ěŒŤˆęC–îŒă˜a•vCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjCŠÖŒűŸ”üCHŽRŒš•xCŽćˆę—Ei•a‰@Šé‰ćŽşj: ‘ć114”N‰ď“ú–{–ňŠw‰ď i94.03.29j, “Œ‹ž, u‰‰—vŽ|W4, p.246, 1994.

3767. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆ•űƒI[ƒ_[ƒVƒXƒeƒ€‚đŠˆ—p‚ľ‚˝’˛Ü‰ßŒë–hŽ~‘΍ô|ˆ•űⳏo—͏ă‚̍H•v‚ɂ‚˘‚ā|. ˆÉ“Ą—msC•ŽR­ˆęC“ŕ“ĄŽj]Cç—t”üçCV‘q—TŽqC˜Ič_ŽqC“n•ÓŰŽqC’†“ˆNŽqCŁŒËvCaŒű‘OC–îŒă˜a•vCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜj: ‘ć114”N‰ď“ú–{–ňŠw‰ď i94.03.29j, “Œ‹ž, u‰‰—vŽ|W4, p.247, 1994.

3768. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éƒGƒŠƒXƒƒ|ƒGƒ`ƒ“ťÜ‚Ě–ňÜŽg—p•]‰ż(DUE). “y‰Ž_ŽuC“‡“c‰p˘i–ňŠw•”jC–]ŒŽ^‹|C‰Á‰ę’J”ŁCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjCŠ™“cvŽőCŹ—Ń–Li“ŕjCŽđˆä‹Ši”ĺj: ‘ć114”N‰ď“ú–{–ňŠw‰ď i94.03.29j, “Œ‹ž, —vŽ|W, p.250, 1994.

3769. mŠw‰ďi’n•űjn i“Á•Ęu‰‰j —Տ°–ňÜ‹Ć–ą‚Ě‹ď‘Ě“IŽŔ‘H‚ƍĄŒă‚̉ۑč. ‰Á‰ę’J”Łi–ňÜj: ‘ć43‰ńÎěŒ§•a‰@–ňÜŽt‰ď’čŠú‘‰ď i93.04.24j, ‹ŕ‘ň, Îě•a–ňƒjƒ…[ƒX, (69): 15`23, 1993.

3770. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j Šŕáu’ÉŠÇ—‚É‚¨‚Ż‚é–ňÜŽt‚Ě–đŠ„. ‰Şč”ü‘ăŽqC‰Á‰ę’J”ŁCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜjCŽÄ“cŒbŽqC‹v•ŰŒbiŠĹŒě•”jC“IęŒłOCŒă“Ą•ś•vi–ƒj: ŠÖ“ŒƒuƒƒbƒNŠwp‘ĺ‰ď i93.08.29j, VŠƒ.

3771. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ƒEƒC[ƒNƒŠ[ƒV[ƒg‚Ě—L—pŤ‚ÉŠÖ‚ˇ‚錟“˘. “ď”gş—YC“ŒŽRˆŸ‹IŽqC–x‰złlC•ŽR­ˆęC˛“Ą“§C–{‹´–΁CaŒű‘OC–îŒă˜a•vCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜj: ‘ć1‰ń_“ŢěŒ§•a‰@–ňÜŽt‰ďŠwp‘ĺ‰ď i93.10.24j, ‰Ą•l, —\eW, p.44`45, 1993.

3772. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‚P‰ń—Ę’˛Ü‚É‚¨‚Ż‚éůÜĽƒJƒvƒZƒ‹Ü‚ĚˆŔ’萍‚ÉŠÖ‚ˇ‚錟“˘. ˜[KŽs˜NC–{‹´–΁C•ŽR­ˆęCŠ‹ź—R—˘ŽqC‹g“cçŒbC‘şŁ¨’ĂŽqCaŒű‘OC–îŒă˜a•vCŹ—Ń‹P–žC’Š’ˇ•ś–íi–ňÜj: ‘ć1‰ń_“ŢěŒ§•a‰@–ňÜŽt‰ďŠwp‘ĺ‰ď i93.10.24j, ‰Ą•l, —\eW, p.50`51, 1993.

3773. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j ‰h—{–@‚Ě‘I‘đ|Œo’°‰h—{‚ŠŒoĂ–Ź‰h—{‚Š|–ňÜŽt‚Ě—§ę‚Š‚ç. “‡“cŽœ•Fi“Œ–ňÜj: “ú–{Ă–ŹĽŒo’°‰h—{Œ¤‹†‰ď i94.02.09j, •Ÿ‰Ş, “ú–{Ă–ŹĽŒo’°‰h—{Œ¤‹†‰ďŽ, 9: 256`257, 1994.

3774. mŒ¤‹†‰ďi’n•űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j •ž–ňŽw“ą; ƒtƒ@[ƒ}ƒVƒ…[ƒeƒBƒJƒ‹ƒPƒA‚Ć‚ľ‚Ä‚Ě•ž–ňŽw“ą‚đ‚ß‚´‚ľ‚Ä. ‰Á‰ę’J”Łi–ňÜj: é“ě’n‹ć•a‰@–ňÜŽtƒZƒ~ƒi[ i94.01.29j, “Œ‹ž, —vŽ|W, p.11`17, 1994.


<<32 ˆă—ÎЉďŠwiˆăŠwŒ´˜_j>>

3775. mŒ´’˜n ˆăŽ––@ŠwŽŇ‚͈ă—Ă‚Ě‚˝‚߂ɉ˝‚Ş‚Ĺ‚Ť‚é‚Š|ˆăŽ––@Šw‚Š‚çˆăŠwŒ´˜_‚đ|. ‰SFˆęiˆăŠwŒ´˜_j: ƒWƒ…ƒŠƒXƒg, (1033): 58`67, 1993.

3776. mŒ¤‹†•ńiŒúśČjn ˜Vl‚̍ŕŽY‚ÉŠÖ‚ˇ‚é–@—Ľsˆ×‚ĚŒ¤‹†. ‰SFˆęiˆăŠwŒ´˜_j: ’ˇŽő‰ČŠw‘‡Œ¤‹†•˝Ź4”N“xŒ¤‹†•ń, 6: 46`49, 1993.


<<32 2 ˆă—ÎЉďŠwiˆăŠwŒ´˜_j>>

3777. m‘ŕn ƒCƒ“ƒtƒH[ƒ€ƒhĽƒRƒ“ƒZƒ“ƒg. ‰SFˆęiˆăŠwŒ´˜_j: Neurosurgeons, 12: 314`320, 1993.


<<32 3 ˆă—ÎЉďŠwiˆăŠwŒ´˜_j>>

3778. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn i•Ş’SŽˇ•Mj ƒtƒ@[ƒ}ƒVƒXƒg‚Ě‚˝‚߂̉p‰ď˜bƒvƒ‰ƒNƒeƒBƒX; ‡T.ƒVƒ`ƒ…ƒG[ƒVƒ‡ƒ“•Ę‰pŒę•\Œť 2.•ž–ňŽw“ą|“ü‰@ŠłŽŇ‚Ɂ|, p.31`39, ‰Á‰ę’J”Łi–ňÜj. iŠ”jƒ‰ƒCƒtĽƒTƒCƒGƒ“ƒX, “Œ‹ž, 93.12.15”­s.

3779. m‚ť‚Ě‘ź‚Ě’˜‘iŒ[–֏‘jn i•Ş’SŽˇ•Mj ƒtƒ@[ƒ}ƒVƒXƒg‚Ě‚˝‚߂̉p‰ď˜bƒvƒ‰ƒNƒeƒBƒX; Žĺ‚Č–ňÜ‚Ěŕ–ž‚ĚŽŔŰ, p.41`60, –]ŒŽ^‹|i–ňÜj. iŠ”jƒ‰ƒCƒtĽƒTƒCƒGƒ“ƒX, “Œ‹ž, 93.12.15”­s.


<<32 5 ˆă—ÎЉďŠwiˆăŠwŒ´˜_j>>

3780. mŠw‰ďi‘S‘jn i“Á•Ęu‰‰j ƒCƒ“ƒtƒH[ƒ€ƒhĽƒRƒ“ƒZƒ“ƒg‚ĆˆăŽ––@Šw. ‰SFˆęiˆăŠwŒ´˜_j: ‘ć1‰ń“ú–{ˆăŠw‰ď“Á•ĘƒVƒ“ƒ|ƒWƒEƒ€uˆă‚Ć–@v i93.08.28j, ĺ‘ä, ˆă‚Ć–@, p.18`29, 1994.

3781. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j –@—Ľ‰Ć‚Š‚ç‚Ý‚˝–â‘č“_|—Տ°‚̐搜•ű‚ɍl‚Ś‚Ä‚˘‚˝‚ž‚Ť‚˝‚˘‚ą‚Ɓ|. ‰SFˆęiˆăŠwŒ´˜_j: ƒVƒ“ƒ|ƒWƒEƒ€uśBˆă—Ă‹Zp‚̐i•ŕ‚Ɛś–˝—Ď—vi“ú–{Šwp‰ď‹cj i92.11.04j, “Œ‹ž, śBˆă—Ă‹Zp‚̐i•ŕ‚Ɛś–˝—Ď—, p.80`83, 1993.

3782. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒCƒ“ƒtƒH[ƒ€ƒhĽƒRƒ“ƒZƒ“ƒg. ‰SFˆęiˆăŠwŒ´˜_j: ‘ć40‰ń“ú–{–ƒŒŠw‰ď‘‰ď i93.04.23j, ˇ‰Ş, —\eW, p.99, 1993.

3783. mŒ¤‹†‰ďi‘Űjn iˆę”ʍu‰‰j áŠQVśŽ™ŽĄ—Ă‚Ě–@“I–â‘č. ‰Ć‰i“oiˆăŠwŒ´˜_j: ‘ć3‰ń‘Űś–˝—Ď—Ľ•ŸˆäƒZƒ~ƒi[ i93.11.19`21j, _Œo“ď•a, ƒqƒgĽƒQƒmƒ€Œ¤‹†‚ƎЉď, p.151`154, 1994.

3784. mŒ¤‹†‰ďi‘S‘jn iŒöŠJuŔj ś–˝ˆŰŽŽĄ—Ă‚Ě•úŠü‚đ‚ß‚Ž‚鎊ŒČŒˆ’č‚Ć‚ť‚Ě‘ăs. ‰SFˆęiˆăŠwŒ´˜_j: •ś•”Č‰ČŠwŒ¤‹†‘‡‚`Œ¤‹†”ǁuŠłŽŇ’†S‚Ěˆă—Ă‚đ‚ß‚Ž‚éŠwŰ“IŒ¤‹†v i94.01.23j, “Œ‹ž.


<<33 ˆă—pî•ńŠw>>

3785. mŒ´’˜n Mathematical model of cardiovascular mechanics for diagnostic analysis and treatment of heart failure: Part 2 analysis of vasodilator therapy and planning of optimal therapy. ’ß“c—z˜aiˆă—pî•ńjC˛“Ą“oŽu˜Yiś—jC’r“cŒ›şiˆă—pî•ńj: Med. Biol. Eng. Comput., 32(1): 12`18, 1994.

3786. mŒ´’˜n Mathematical model of cardiovascular mechanics for diagnostic analysis and treatment of heart failure: Part 1 model description and theoretical analysis. ’ß“c—z˜aiˆă—pî•ńjC˛“Ą“oŽu˜Yiś—jC”’‘鑝’jC’r“cŒ›şiˆă—pî•ńj: Med. Biol. Eng. Comput., 32(1): 3`11, 1994.

3787. m’Z•ńĽ‘Ź•ńn Mathematical analysis of bistable phenomenon in experimentally-induced ventricular tachycardia. ’r“cŒ›şC’|“ŕş”ŽC‹{Œ´‰p•viˆă—pî•ńj: J. Electrocardiol., 25(suppl.): 108, 1993.

3788. mŒ¤‹†•ńiŒúśČjn •sŽ–Ź–ň•¨ŽĄ—ĂƒKƒCƒhƒ‰ƒCƒ“. ™–{P–žC‹{Œ´‰p•viˆă—pî•ńjC”яŔG”VC’†‘şŒłbCtŒŠŒšˆęC‘ěOˆęCŠ}ŠŃGC‰ş‘şŽ˜NC…–ěN: “ú–{ˆăŽ–V•ń, 3629: 11`15, 1993.

3789. mŒ¤‹†•ńiŒúśČjn “Ž•¨ŽŔŒą‚É‚ć‚é–[ŽşŒ‹ß“`“ąŤ‰ń•œ‹Čü‚É‹y‚Ú‚ˇR•sŽ–ŹÜ‚ĚŒř‰Ę. ‹{Œ´‰p•viˆă—pî•ńj: •˝Ź4”N“xŒúśČzŠÂŠí•aŒ¤‹†ˆĎ‘ő”ď‚É‚ć‚錤‹†•ńW, ‘—§zŠÂŠí•aƒZƒ“ƒ^[, p.352`353, 1993.


<<33 2 ˆă—pî•ńŠw>>

3790. m‘ŕn ‘ĺ‹K–Í—Ő°ŽŽŒą‚Ě•K—vŤ‚Ć‚ť‚̉đÍ–@. ‹{Œ´‰p•viˆă—pî•ńj: ŒÄ‹z‚ƏzŠÂ, 41(11): 1025`1032, 1993.


<<33 3 ˆă—pî•ńŠw>>

3791. m‹ł‰Č‘n i‹¤’˜j ˆă—ĂŒnŠwś‚Ě‚˝‚ß‚ĚƒRƒ“ƒsƒ…[ƒ^“ü–ĺ; ’r“cŒ›şC’ß“c—z˜aC’|“ŕş”ŽC”’‘鑝’jCź–{˝ŽŸiˆă—pî•ńj. ’Š‘q‘“X, “Œ‹ž, 94.03.10”­s.

3792. m‹ł‰Č‘n i•ŇWj ˆă—ĂŒnŠwś‚Ě‚˝‚ß‚ĚƒRƒ“ƒsƒ…[ƒ^“ü–ĺ; •ŇW ’r“cŒ›şiˆă—pî•ńjC ’Š‘q‘“X, “Œ‹ž, 94.03.10”­s.


<<33 5 ˆă—pî•ńŠw>>

3793. mŠw‰ďi‘S‘jn ih‘č•ńj ŠłŽŇ‚Ö‚Ěˆă–ň•iî•ń‚Ě‚ ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†(2)•ž–ňŽw“ą[ŽŔ‚Ě‚˝‚ß‚Ě’˛¸Œ¤‹†. Ź—Ń‹P–žC’Š’ˇ•ś–íC‰Á‰ę’J”ŁC˛ěŒŤˆęC•ŽR­ˆęCaŒű‘Oi–ňÜj: ‘ć114”N‰ď“ú–{–ňŠw‰ď i94.03.29j, “Œ‹ž, •a‰@–ňŠw, 20(2): 119`121, 1994.

3794. mŠw‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘̉t§Œä‹@\‚ĚŒvŽZ‹@ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“. ’|“ŕş”ŽC’r“cŒ›şiˆă—pî•ńjC˛“Ą“oŽu˜Yiś—j: ‘ć71‰ń“ú–{ś—Šw‰ď‘ĺ‰ď i94.03.25j, ‚ź, —\eW, p.140, 1994.

3795. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ”ńüŒ`—\‘Ş‚đ—p‚˘‚˝S”ŽžŒn—ń‚Ě•s‹K‘Ľ•Ď“Ž‚ÉŠÖ‚ˇ‚錟“˘. ’r“cŒ›şC’|“ŕş”ŽC”’‘鑝’jC’ß“c—z˜aC‹{Œ´‰p•viˆă—pî•ńjC“yˆä˜a”üiś•¨•¨—Œnj: ‘ć32‰ń“ú–{ƒGƒ€ĽƒC[Šw‰ď‘ĺ‰ď i93.05.21j, b•{, ˆă—p“dŽq‚Ɛś‘̍HŠw, 31(Suppl.): 354, 1993.

3796. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j –[ŽşƒuƒƒbƒN‚̐”Šwƒ‚ƒfƒ‹‚É‚¨‚Ż‚éƒJƒIƒX. ’r“cŒ›şC’|“ŕş”Žiˆă—pî•ńjC—ŠZF“ńi“ŕjC“ޗljŔ—miś•¨•¨—ŒnjC”ŻN—YiŽŔ“ŽjC‹{Œ´‰p•viˆă—pî•ńj: “ú–{S“dŠw‰ď i93.09.25j, –źŒĂ‰Ž, S“d}, 13(4): 531, 1993.

3797. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ŒŁ—§ěŹ–â‘č‚̉đ–@‚ĆŒvŽZŽžŠÔ‚Ě•]‰ż. ’ß“c—z˜aC’r“cŒ›şiˆă—pî•ńjC˛“Ą“oŽu˜Yiś—j: ‘ć13‰ńˆă—Ïî•ńŠw˜A‡‘ĺ‰ď i93.11.26j, “Œ‹ž, ˜_•śW, p.563`564, 1993.

3798. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j MS-Windows”Ĺ“dŽq‹ł‰Č‘ƒVƒXƒeƒ€iś—Šwj‚̍쐬. ’|“ŕş”Žiˆă—pî•ńjC“ޗljŔ—miś•¨•¨—ŒnjC’r“cŒ›şC”’‘鑝’jC‹{Œ´‰p•viˆă—pî•ńjC˛“Ą“oŽu˜Yiś—j: ‘ć13‰ńˆă—Ïî•ńŠw˜A‡‘ĺ‰ď i93.11.26j, “Œ‹ž, ˜_•śW, p.673`676, 1993.

3799. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‹@”\‚đ‚ŕ‚“dŽq‹ł‰Č‘ƒVƒXƒeƒ€‚̍쐬. ’|“ŕş”ŽC”’‘鑝’jiˆă—pî•ńjC˛“Ą“oŽu˜Yiś—j: ‘ć71‰ń“ú–{ś—Šw‰ď‘ĺ‰ď i94.03.24j, ‚ź, —\eW, p.108, 1994.

3800. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆăŠw“ŒvŠw“dŽq‰ť‚ĚŽŽ‚Ý. ”’‘鑝’jC‹{Œ´‰p•vC’|“ŕş”ŽC’ß“c—z˜aC’r“cŒ›şiˆă—pî•ńjC˛“Ą“oŽu˜Yiś—j: ‘ć32‰ń“ú–{ƒGƒ€ĽƒC[Šw‰ď‘ĺ‰ď i93.05.20j, b•{, ˆă—p“dŽq‚Ɛś‘̍HŠw, 31(“Á•Ę): 407, 1993.

3801. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j –[ŽşƒuƒƒbƒN‚̐”Šwƒ‚ƒfƒ‹‚É‚¨‚Ż‚éƒJƒIƒX. ’r“cŒ›şC’|“ŕş”Žiˆă—pî•ńjC—ŠZF“ńi“ŕjC“ޗljŔ—miś•¨•¨—ŒnjC‹{Œ´‰p•viˆă—pî•ńj: ‘ć11‰ńS“d}M†î•ńˆ—ƒ[ƒNƒVƒ‡ƒbƒv i93.11.05j, ”MŠC, —\eW, p.10, 1993.


<<35 •¨—Šw>>

3802. mŒ´’˜n Rotational effects in the dissociative recombination of H2+ + e. ‚–؏Gˆęi•¨—j: J. Phys. B; At. Mol.Opt. Phys., 26: 4815`4832, 1993.

3803. mŒ´’˜n Origin of low-energy component and isotope effect on dissociative recombination of HeH+ and HeD+. T. TanabeCI. KatayamaCN. InoueCK. ChidaCY. ArakakiCT. WatanabeCM. Yoshizawai“Œ‘ĺjCM. SaitoCY. Haruyamai‹ž“s•{—§‘ĺjCK. Hosonoiă‘ĺjCT. Honmai“Œ–k‘ĺjCK. Nodai•úˆăŒ¤jCS. Ohtanii“d’Ę‘ĺjC‚–؏Gˆęi•¨—j: Phys. Rev. A, 49: 1531`1534, 1994.


<<35 2 •¨—Šw>>

3804. mŠwp‘i‰p•śjn i•Ş’SŽˇ•Mj AIP Conference Proceedings 295: The Physics of Electronic and Atomic Collisions; Basic problems in dissociative recombination of diatomic molecules, p.442`451, ‚–؏Gˆęi•¨—j. •ŇW T. AndersenCB. FastrupCF. FolkmannCH. KnudseniAArhus‘ĺjCN. AnderseniCopenhagen‘ĺjC American Institute of Physics, New York, 93.00.00”­s.

3805. mŠwp‘i‰p•śjn i•Ş’SŽˇ•Mj Dissociative Recombination, Theory, Experiment, and Applications; Theoretical problems in the dissociative recombination of H2+ + e, p.75`85, ‚–؏Gˆęi•¨—j. •ŇW B.R. RoweiRennes‘ĺjCJ.B.A. MitchelliWestern Ontario‘ĺjCA. CanosaiRennes‘ĺjC Plenum, New York, 93.00.00”­s.


<<35 5 •¨—Šw>>

3806. mŠw‰ďi‘Űjn i“Á•Ęu‰‰j Basic problems in dissociative recombination of diatomic molecules. ‚–؏Gˆęi•¨—j: International Conference on the Physics of Electronic and Atomic Collisions i93.07.00j, ƒfƒ“ƒ}[ƒN.

3807. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Off-the-energy shell effects in dissosiative recombination of H2+ + e ‡U. ‚–؏Gˆęi•¨—jCŒ´r‰îi’}”g‹Zp’Z‘ĺjC˛“Ą_Žji‚¨’ƒ‘ĺj: International Conference on the Physics of Electronic and Atomic Collisions i93.07.00j, ƒfƒ“ƒ}[ƒN, —\eW, 1•Şű: 339, 1993.

3808. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j HD+ - eŐ“Ë‚É‚¨‚Ż‚é‰đ—Ł‰ß’ö. ‚–؏Gˆęi•¨—j: “ú–{•¨—Šw‰ď i94.03.00j, •Ÿ‰Ş, —\eW, 4•Şű: 41, 1994.

3809. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j HeH+ ‹y‚Ń HeD+ ‚̉𗣐ŤÄŒ‹‡. “c•Ó“O”üC•ĐŽRˆę˜YCˆäăC’jCç“cŸ‹vCrŠ_—ÇŽŸC“n•ÓŠÂC‹g‘ňˇ’ji“Œ‘ĺjCÄ“ĄŠwCtŽR—mˆęi‹ž“s•{—§‘ĺjC×–ě˜a•Fiă‘ĺjC–{ŠÔŽőLi“Œ–k ‘ĺjC–ě“ckŽii•úˆăŒ¤jC‘ĺ’Jr‰îi“d’Ę‘ĺjC‚–؏Gˆęi•¨—j: “ú–{•¨—Šw‰ď i94.03.00j, •Ÿ‰Ş, —\eW, 4•Şű: 41, 1994.

3810. mŠw‰ďi’n•űjn iˆę”ʍu‰‰j ‚‰ˇˆć(0.1`20 eV)‰đ—ŁŤÄŒ‹‡‚Ě—˜_“IŒ¤‹†. ‚–؏Gˆęi•¨—j: “ú–{•¨—Šw‰ď i93.10.00j, ‰ŞŽR.

3811. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j •ŞŽqƒCƒIƒ“Ľ“dŽqŐ“Ë‚É‚ć‚é‰đ—Ł‰ß’ö. ‚–؏Gˆęi•¨—j: ƒVƒ“ƒ|ƒWƒEƒ€uŒ´Žq•ŞŽq‰ß’ö—˜_|‘˝‰żƒCƒIƒ“Œ´Žq•ŞŽq‚Ć‚ť‚ĚŽü•Óv i93.12.00j.

3812. mŒ¤‹†‰ďi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j •ŞŽqƒCƒIƒ“Ľ“dŽqŐ“Ë‚É‚ć‚é‰đ—Ł‰ß’ö. ‚–؏Gˆęi•¨—j: uƒCƒIƒ“ƒgƒ‰ƒbƒv‚Ćƒr[ƒ€’~ĎƒŠƒ“ƒO‚Ě‹Zp‚Ć•¨—vŒ¤‹†‰ď i94.01.00j, “Œ‹ž.


<<36 ‰ťŠw>>

3813. mŒ´’˜n Preparation of monolayer particle coated powder by the dry impact blending process utilizing mechanochemical treatment. –{“cG—˛C–Ř‘şłOC–{“c“ń—ti“Œ—‘ĺjCź–ěVŽmi‰ťjCŹÎ^ƒi“Œ—‘ĺj: Colloids Surfaces A: Physicochemical and Engineering Aspects, 82: 117`128, 1994.

3814. m€Œ´’˜i‰p•śjn Evaluation of homogeneity for sintered hydroxyapatite by CT-values. ź–ěVŽmi‰ťjC÷ˆä´Žqi•újCŹÎ^ƒi“Œ—‘ĺj: Proceedings of 3rd European Ceramic Society Conference, 3: 37`42, 1993.

3815. m€Œ´’˜i‰p•śjn Micro fabrication technology in granulation process. –{“cG—˛C–{“c“ń—ti“Œ—‘ĺjCź–ěVŽmi‰ťjCŹÎ^ƒi“Œ—‘ĺj: Proceedings of 6th International Symposium on Agglomeration, p.703`708, 1993.


<<36 5 ‰ťŠw>>

3816. mŠw‰ďi‘Űjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Micro fabrication technology in granulation process. –{“cG—˛C–{“c“ń—ti“Œ—‘ĺjCź–ěVŽmi‰ťjCŹÎ^ƒi“Œ—‘ĺj: 6th International Symposium on Agglomeration i93.11.15j, –źŒĂ‰Ž, Abstracts, p.68, 1993.

3817. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Evaluation of homogeneity for sintered hydroxyapatite by CT-values. ź–ěVŽmi‰ťjC÷ˆä´Žqi•újCŹÎ^ƒi“Œ—‘ĺj: 3rd European Ceramic Society Conference i93.09.13j, Madrid, Abstracts, p.113, 1993.

3818. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒŠƒ“Ž_‚Ć—n‰đ‘Ź“x‚ĚˆŮ‚Č‚é…Ž_‰ťƒJƒ‹ƒVƒEƒ€‚Š‚獇Ź‚ł‚ę‚˝ƒqƒhƒƒLƒVƒAƒpƒ^ƒCƒg”÷—ąŽq‚Ě“ÁŤ. ź–ěVŽmi‰ťjCŹÎ^ƒi“Œ—‘ĺj: ‘ć46‰ńƒRƒƒCƒh‚¨‚ć‚ŃŠE–ʉťŠw“˘˜_‰ď i93.10.10j, “Œ‹ž, —vŽ|W, p.328`329, 1993.

3819. mŠw‰ďi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒƒJƒmƒPƒ~ƒJƒ‹ŒťŰ‚đ—˜—p‚ľ‚˝”÷—ąŽq‚¨‚ć‚Ń’´”÷—ąŽq‚Ě•\–ʉüŽż‚Ć‚ť‚̉ߒö. –{“cG—˛CŹÎ^ƒC–{“c“ń—ti“Œ—‘ĺjCź–ěVŽmi‰ťj: ‘ć46‰ńƒRƒƒCƒh‚¨‚ć‚ŃŠE–ʉťŠw“˘˜_‰ď i93.10.10j, “Œ‹ž, —vŽ|W, p.494`495, 1993.

3820. mŒ¤‹†‰ďi‘S‘jn i‹łˆçu‰‰j ƒoƒCƒIƒZƒ‰ƒ~ƒbƒNƒX‚Ě•\–ʉüŽż. ź–ěVŽmi‰ťj: ‘ć17‰ń•\–ʉüŽżŒ¤‹†‰ď i93.11.19j, “Œ‹ž, —vŽ|W, p.12`15, 1993.


<<37 3 ƒhƒCƒcŒę>>

3821. m‹ł‰Č‘n i‹¤’˜j ƒhƒCƒcŒę‚Ě‘‹|‰ŠwŽŇ‚ĚŽ‹“_‚Š‚ç|; Î’ˏGŽ÷i“Œ–kŠw‰@‘ĺjC™–{Č–Mi“Ɓj. “Œ—mo”Ĺ, “Œ‹ž, 94.04.01”­s.


<<38 ś•¨Šw>>

3822. mŒ´’˜n Systematic evolution of 40 populations of Rana rugosa distributed in Japan elucidated by electrophoresis. Nishioka, M.CKodama, Y.CSumida, M.iL“‡‘ĺjC—´čłŽmiś•¨j: Sci. Rep. Lab. Amphibian Biol., Hiroshima Univ., 12: 83`131, 1993.


<<38 5 ś•¨Šw>>

3823. mŠw‰ďi‘Űjn iƒ|ƒXƒ^[u‰‰j Cortical photons in early development of frog eggs: Comparative study of photon emission between nuclear division and cytoplasmic fission. —´čłŽmiś•¨jC‘ĺŠŃMiś—j: International Society of Developmental Biologists 12th International Congress (ISDB) i93.08.08`13j, Vienna, Austria, Abstract Book (ISDB), p.44, 1993.

3824. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Lipid composition in vegetal, animal, ventral and dorsal half embryos during early development of Rana japonica. —´čłŽmiś•¨jC‘ę‘ň’ź’čiś—jC’†–{’źi‰đj: Zoological Science of Japan i93.11.21j, ‰Ť“ę, Zool. Sci., 10(Suppl.): 38, 1993.


<<39 ×–EŠw>>

3825. m€Œ´’˜n ×–E‹ÉŤ. ŽR‰Čł•˝i‰đj: ś‘̂̉Ȋw, 44(5): 430`431, 1993.

3826. m€Œ´’˜n ƒRƒ“ƒsƒ…[ƒ^[ƒOƒ‰ƒtƒBƒbƒNƒX‚đ—p‚˘‚˝‘gD×–E‚Ě—§‘̍č\’z–@‚ɂ‚˘‚ā| Cosmozone 2SA ‚ĚŽg—p—á|. Ÿ–”CiŒ`‘ÔŒnjC‹Ę–؉p–ži‰đjCÂŽR’ź‘Pi“ŕjCŽR‰Čł•˝i‰đj: ś—Šw‹ZpŒ¤‹†‰ď•ń, 15: 69`72, 1993.

3827. mŒ¤‹†•ńi•ś•”Čjn •˝Ź‚T”N“x‰ČŠwŒ¤‹†”ď•â•‹ŕŽŔŽ{•ń‘iŒ¤‹†ŽŔŃ•ń‘j§—ăŒ¤‹†i‚`jƒSƒ‹ƒW‘•’u‚ĚŒ`‘Ô‚Ć‹@”\‚Ě“Ž“I•Ď‰ť‚ÉŠÖ‚ˇ‚錤‹†. ‹Ę–؉p–ži‰đj.


<<39 2 ×–EŠw>>

3828. mŠwp‘n i•Ş’SŽˇ•Mj ‘T‚Ɛś–˝‰ČŠw; ‚ľ‚Č‚â‚Š‚ł‚Ć‚ľ‚˝‚˝‚Š‚ł|×–E‚Ě‚ˇ‚Ş‚˝, p.143`163, ŽR‰Čł•˝i‰đj. •ŇW ˇ‰i@‹ťi‰Ô‰€‘ĺjC ‹Iƒm‘‰Ž‘“X, “Œ‹ž, 94.02.10”­s.

3829. mŠwp‘n i•Ş’SŽˇ•Mj ƒ}ƒCƒNƒƒEƒF[ƒuĆŽË‚É‚ć‚鐜•¨ŽŽ—ż‚ĚŒĹ’čĽőF–@‚ĚŠî–{‚Ć‚ť‚̉ž—p; –Ɖu‘gD‰ťŠw‚ւ̉ž—pi‚Pj, p.107`113, ŽR‰Čł•˝i‰đj. •ŇW …•˝•q’mi“Œ‹žˆăŽ•‘ĺjC ŠwŰŠé‰ć, “Œ‹ž, 93.08.18”­s.


<<39 5 ×–EŠw>>

3830. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j ƒSƒ‹ƒW‘•’u‚ĚŒ`‘ÔŒ`Ź‰ß’ö‚É‚¨‚Ż‚éƒSƒ‹ƒW’`”’‚Ě“Ž‘Ô. ‹Ę–؉p–ži‰đj: ‘ć3‰ń’`”’Žż—A‘—ŽáŽčƒZƒ~ƒi[ i93.07.28j, Šň•Œ.

3831. mŠw‰ďi‘S‘jn iˆę”ʍu‰‰j Ž¨‰ş‘B‰îÝ•”“ąŠÇ‚Ěč÷—ą×–E‚̖Ɖu‘gD‰ťŠw“I“ÁŤ. Ÿ–”CiŒ`‘ÔŒnjC‹Ę–؉p–žCŽR‰Čł•˝i‰đj: ‘ć34‰ń“ú–{‘gD×–E‰ťŠw‰ď‘‰ď i93.10.29j, _ŒË, Acta Histochem. Cytochem., 26(5): 483, 1994, —\eW, p.66, 1993.

3832. mŒ¤‹†‰ďi‘S‘jn iˆę”ʍu‰‰j LR ƒzƒƒCƒgŽ÷Ž‰‚ĆŠŇŒłƒIƒXƒ~ƒEƒ€‚đ—p‚˘‚˝“dŒ°×–E‰ťŠw‚ĚŒŸ“˘|ŽŠ“Ž•ď–„‘•’u‚ւ̉ž—p|. Ÿ–”CiŒ`‘ÔŒnjC‹Ę–؉p–žCŽR‰Čł•˝i‰đj: ‘ć49‰ń•a—‹ZpŒ¤‹†‰ď i94.02.06j, “Œ‹ž, ´˜^W, p.5, 1994.